PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dhalla, KA; Guirguis, M				Dhalla, Kazim A.; Guirguis, Micheal			Barriers and incentives for conducting research amongst the ophthalmologists in Sub-Sahara Africa	PLOS ONE			English	Article							OPHTHALMIC RESEARCH; NIGERIAN OPHTHALMOLOGISTS; ATTITUDES; RESOURCES	Background Research is a critical component amongst the strategies to improve health outcomes of any country. The role of research assumes greater importance in Africa as it carries a larger share of the global burden of diseases, blindness, and low vision. "Vision 2020- the Right to Sight" is a WHO-IAPB collaborated initiative aiming to eliminate preventable blindness by the year 2020. High quality research in eye care is imperative for the initiative to succeed, however, there is a dearth of research in eye care in sub-Saharan Africa in general and specifically in the Eastern, Central, and Southern African (ECSA) region. Identifying the barriers that hamper research in this region is an important step towards the elimination of preventable blindness. Methods A structured questionnaire using the SurveyMonkey program was sent to ophthalmologists in the ECSA region and South Africa through their respective regional professional bodies. Results Lack of funding, inadequate time and poor research knowledge were the main research barriers while the ability to improve eye health care through research was the main incentive for conducting research. The response rate for South Africa was low, restricting comparisons with other ECSA countries. Conclusion The barriers mainly center on financial, human and administrative infrastructure and resources. In spite of the barriers, ophthalmologists in the study region are enthusiastic in research aiming to increase evidence-based knowledge to improve eye health care in line with the goals of "Vision 2020- the Right to Sight" initiative.	[Dhalla, Kazim A.] Dr Agarwals Eye Hosp, Dar Es Salaam, Tanzania; [Dhalla, Kazim A.] CCBRT Hosp, Dar Es Salaam, Tanzania; [Guirguis, Micheal] Univ Liverpool, Online Program, Edmonton, AB, Canada		Dhalla, KA (corresponding author), Dr Agarwals Eye Hosp, Dar Es Salaam, Tanzania.; Dhalla, KA (corresponding author), CCBRT Hosp, Dar Es Salaam, Tanzania.	kazimdhalla@hotmail.com	Dhalla, Kazim/AAW-1985-2020	Dhalla, Kazim/0000-0003-3838-1614				Anyaoku EN, 2014, HEALTH INFO LIBR J, V31, P148, DOI 10.1111/hir.12056; Aronson Barbara, 2002, Health Info Libr J, V19, P164, DOI 10.1046/j.1471-1842.2002.t01-1-00391.x; Bank SC, 2015, SEEING IS BEL; Brocato JJ, 2005, ACAD MED, V80, P244, DOI 10.1097/00001888-200503000-00008; Budenz DL, 2012, OPHTHALMOLOGY, V119, P1744, DOI 10.1016/j.ophtha.2012.04.017; Courtright P, 2013, ANN TROPICAL MED PAR; Courtright P, 2006, CAN J OPHTHALMOL, V41, P424, DOI 10.1016/S0008-4182(06)80003-7; Elliott IS, 2015, CLIN ORTHOP RELAT R, V473, P2120, DOI 10.1007/s11999-015-4254-5; Krosnick JA, 1999, ANNU REV PSYCHOL, V50, P537, DOI 10.1146/annurev.psych.50.1.537; Lloyd T, 2004, MED EDUC, V38, P848, DOI 10.1111/j.1365-2929.2004.01895.x; Mahmoud AO, 2012, MIDDLE EAST AFR J OP, V19, P123, DOI 10.4103/0974-9233.92128; Mahmoud AO, 2011, MIDDLE EAST AFR J OP, V18, P164, DOI 10.4103/0974-9233.80707; Mahmoud AO, 2011, ANN AFR MED, V10, P144, DOI 10.4103/1596-3519.82078; Palmer JJ, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-44; Sabzwari S, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-68; Sawyerr A., 2004, J HIGHER ED AFRICA, V2, P211; Smith H, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-72	17	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0197945	10.1371/journal.pone.0197945	http://dx.doi.org/10.1371/journal.pone.0197945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352057	gold, Green Submitted, Green Published			2022-12-26	WOS:000448076200001
J	Ferreira, BG; Oliveira, DC; Moreira, ASFP; Faria, AP; Guedes, LM; Franca, MGC; Alvarez, R; Isaias, RMS				Ferreira, Bruno G.; Oliveira, Denis C.; Moreira, Ana S. F. P.; Faria, Ana P.; Guedes, Lubia M.; Franca, Marcel G. C.; Alvarez, Rafael; Isaias, Rosy M. S.			Antioxidant metabolism in galls due to the extended phenotypes of the associated organisms	PLOS ONE			English	Article							LANGSDORFFII DESF. FABACEAE; CHLOROPHYLL FLUORESCENCE; OXIDATIVE STRESS; PLANT GALLS; PHOTOSYNTHESIS; PHENOLICS; TISSUES; LEAF; MANIPULATION; HERBIVORES	Animal-induced galls are considered extended phenotypes of their inducers, and therefore plant morphogenesis and metabolism may vary according to the species of gall inducers. The alterations in vacuolar and apoplastic polyphenols, carotenoids, chlorophyll fluorescence rates, PSII quantum yield, and phospholipid peroxidation were studied in galls induced by Ditylenchus gallaeformans (Nematoda) on Miconia albicans and M. ibaguensis (Melastomataceae), and by an unidentified Eriophyidae (Acarina) on M. ibaguensis. The focus currently addressed is gall metabolism as the extended phenotype of the gall inducers, and the neglected determination of gall functionalities over host plant peculiarities. Galls induced by D. gallaeformans on M. albicans and by the Eriophyidae on M. ibaguensis have increased accumulation of apoplastic and vacuolar phenolics, which is related to the control of phospholipid peroxidation and photoprotection. The galls induced by D. gallaeformans on M. ibaguensis have higher carotenoid and vacuolar polyphenol contents, which are related to excessive sunlight energy dissipation as heat, and photoprotection. Accordingly, antioxidant strategies varied according to the gall-inducing species and to the host plant species. The distinctive investments in carotenoid and/or in polyphenol concentrations in the studied galls seemed to be peculiar mechanisms to maintain oxidative homeostasis. These mechanisms were determined both by the stimuli of the gall-inducing organism and by the intrinsic physiological features of the host plant species. Therefore, the roles of both associated organisms in host plant-galling organisms systems over gall metabolism is attested.	[Ferreira, Bruno G.; Franca, Marcel G. C.; Isaias, Rosy M. S.] Univ Fed Minas Gerais, Dept Bot, Belo Horizonte, MG, Brazil; [Oliveira, Denis C.; Moreira, Ana S. F. P.; Faria, Ana P.] Univ Fed Uberlandia, Inst Biol, Uberlandia, MG, Brazil; [Guedes, Lubia M.] Univ Concepcion, Postgrad Ciencias Biol, Area Bot, Concepcion, Chile; [Alvarez, Rafael] Univ Leon, Dept Biol Mol, Area Biol Celular, Leon, Spain; [Ferreira, Bruno G.] Univ Fed Rio de Janeiro, Inst Biol, Dept Bot, Rio De Janeiro, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Uberlandia; Universidad de Concepcion; Universidad de Leon; Universidade Federal do Rio de Janeiro	Isaias, RMS (corresponding author), Univ Fed Minas Gerais, Dept Bot, Belo Horizonte, MG, Brazil.	rosy@icb.ufmg.br	Isaias, Rosy MS/C-3736-2013; Ferreira, Bruno G./F-9428-2013; de Faria, Ana P/C-3327-2016; Moreira, Ana Silvia FP/A-8149-2013; Nogal, Rafael Álvarez/B-2694-2019; de Oliveira, Denis Coelho/AAU-8139-2020	Isaias, Rosy MS/0000-0001-8500-3320; Ferreira, Bruno G./0000-0003-2156-2988; Nogal, Rafael Álvarez/0000-0002-1814-0293; de Oliveira, Denis Coelho/0000-0002-6386-918X	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [FAPEMIG APQ-02617-15]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES 99999.003956/2015-06]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 307011/20151, 140226/2017-6, 171182/2017-0]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (http://www.fapemig.br) (FAPEMIG APQ-02617-15 to RMSI), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br) (CAPES 99999.003956/2015-06 to BGF), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br) (CNPq 307011/20151 to RMSI; 140226/2017-6 to BGF; 171182/2017-0 to BGF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON WG, 1991, BIOCHEM SYST ECOL, V19, P615, DOI 10.1016/0305-1978(91)90077-D; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arduim, 1997, MANUAL BASICO METODO; Bagatto G, 1996, ENTOMOL EXP APPL, V79, P111, DOI 10.1007/BF00333828; BARNES JD, 1992, ENVIRON EXP BOT, V32, P85, DOI 10.1016/0098-8472(92)90034-Y; Bedetti CS, 2017, AUST J BOT, V65, P411, DOI 10.1071/BT16257; Bedetti CS, 2014, BIOCHEM SYST ECOL, V55, P53, DOI 10.1016/j.bse.2014.02.016; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Carneiro RGS, 2014, S AFR J BOT, V92, P97, DOI 10.1016/j.sajb.2014.02.011; Carneiro RGS, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01622; Castro AC, 2012, S AFR J BOT, V83, P121, DOI 10.1016/j.sajb.2012.08.007; Close DC, 2002, OIKOS, V99, P166, DOI 10.1034/j.1600-0706.2002.990117.x; Molinari HBC, 2007, PHYSIOL PLANTARUM, V130, P218, DOI 10.1111/j.1399-3054.2007.00909.x; Franca MGC, 2012, J PLANT RES, V125, P85, DOI 10.1007/s10265-011-0416-z; Carneiro RGD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129331; Isaias RMD, 2018, AUSTRAL ENTOMOL, V57, P238, DOI 10.1111/aen.12336; de Oliveira DC, 2011, PLANT SCI, V180, P489, DOI 10.1016/j.plantsci.2010.11.005; del Carmen Pinto M, 2007, J AGR FOOD CHEM, V55, P5956, DOI 10.1021/jf070537x; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Di Ferdinando M, 2014, ENVIRON EXP BOT, V103, P107, DOI 10.1016/j.envexpbot.2013.09.012; Dias MC, 2018, SCI HORTIC-AMSTERDAM, V231, P31, DOI 10.1016/j.scienta.2017.12.007; Ferreira BG, 2017, BOTANY, V95, P173, DOI 10.1139/cjb-2016-0189; Ferreira BG, 2017, FLORA, V227, P36, DOI 10.1016/j.flora.2016.12.008; Guedes LM, 2016, BIOCHEM SYST ECOL, V69, P266, DOI 10.1016/j.bse.2016.10.012; Gurr S, 1992, MOL PLANT PATHOLOGY, P51; Hartley SE, 1998, OECOLOGIA, V113, P492, DOI 10.1007/s004420050401; Hori K., 1992, P157; Huang MY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0446-0; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Khederi SJ, 2018, EXP APPL ACAROL, V75, P1, DOI 10.1007/s10493-018-0252-0; Kmiec K, 2018, PHOTOSYNTHETICA, V56, P989, DOI 10.1007/s11099-018-0813-9; Kmiec K, 2018, ENVIRON ENTOMOL, V47, P840, DOI 10.1093/ee/nvy055; Kot I, 2018, ENVIRON ENTOMOL, V47, P669, DOI 10.1093/ee/nvy047; Lichtenthaler HK, 1997, TRENDS PLANT SCI, V2, P316, DOI 10.1016/S1360-1385(97)89954-2; Constantino PDL, 2009, REV BRAS ENTOMOL, V53, P391, DOI 10.1590/S0085-56262009000300013; Mani M.S., 1964, ECOLOGY PLANT GALLS, DOI 10.1007/978-94-017-6230-4; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Motta LB, 2005, BIOCHEM SYST ECOL, V33, P971, DOI 10.1016/j.bse.2005.02.004; Nasareen P.N.M., 2014, Acta Biologica Indica, V3, P703; Nyman T, 2000, P NATL ACAD SCI USA, V97, P13184, DOI 10.1073/pnas.230294097; Oliveira DC, 2016, J INSECT PHYSIOL, V84, P103, DOI 10.1016/j.jinsphys.2015.11.012; Oliveira DC, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01249; Oxborough K, 2004, J EXP BOT, V55, P1195, DOI 10.1093/jxb/erh145; Pincebourde S, 2016, J INSECT PHYSIOL, V84, P137, DOI 10.1016/j.jinsphys.2015.07.006; Rossetti S, 2001, PLANT PHYSIOL BIOCH, V39, P433, DOI 10.1016/S0981-9428(01)01250-5; Samsone Ineta, 2012, Environmental and Experimental Biology, V10, P15; Isaias RMS, 2015, BBA-GEN SUBJECTS, V1850, P1509, DOI 10.1016/j.bbagen.2015.03.007; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2	52	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205364	10.1371/journal.pone.0205364	http://dx.doi.org/10.1371/journal.pone.0205364			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346955	Green Published, Green Submitted, gold			2022-12-26	WOS:000447938400008
J	Bourdon, M; Santulli, P; Maignien, C; Pocate-Cheriet, K; Alwohaibi, A; Marcellin, L; Blais, S; Chapron, C				Bourdon, Mathilde; Santulli, Pietro; Maignien, Chloe; Pocate-Cheriet, Khaled; Alwohaibi, Asim; Marcellin, Louis; Blais, Sarah; Chapron, Charles			The interval between oocyte retrieval and frozen-thawed blastocyst transfer does not affect the live birth rate and obstetrical outcomes	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; FREEZE-ALL PROTOCOL; EMBRYO-TRANSFER; OVARIAN STIMULATION; ENDOMETRIAL RECEPTIVITY; IMPACT; FRESH; TERMINOLOGY; STRATEGY; WEIGHT	Background The 'Freeze all' strategy, which consists of cryopreservation of all embryos after the ovarian stimulation has undergone extensive development in the past decade. The time required for the endometrium to revert to a prestimulation state after ovarian stimulation and thus the optimal time to perform a deferred embryo transfer after the stimulation has not been determined yet. Objective To investigate the impact of the time from oocyte retrieval to frozen-thawed blastocyst transfer (FBT) on live birth rate (LBR), obstetrical and neonatal outcomes, in 'Freeze-all' cycle. Materials and methods We conducted a large observational cohort study in a tertiary care university hospital including four hundred and seventy-four first autologous FBT performed after ovarian stimulation in 'freeze all' cycles. Reproductive outcomes were compared between FBT performed within the first menstrual cycle after the oocyte retrieval ('cycle 1' group) or delayed FBT ('cycle >= 2' group). The main Outcome Measure was the Live birth rate. Result(s) A total of 188 FBT were included in the analysis in the 'cycle 1' group and 286 in the 'cycle >= 2' group. No significant differences were found between FBT performed within the first menstrual cycle after oocyte retrieval (the 'cycle 1' group) and delayed FBT (the 'cycle >= 2' group) in terms of the live birth rate [59/188 (31.38%) vs. 85/286 (29.72%); p = 0.696] and the miscarriage rate [20/82 (24.39%) vs. 37/125 (29.60%), respectively; p = 0.413]. The obstetrical and neonatal outcomes were also not significantly different between the two groups. Conclusion Our study did not detect statistically significant differences in the LBR for FBT performed within the first menstrual cycle after oocyte retrieval versus FBT following subsequent cycles. Embryo-endometrium interaction after a FBT does not appear to be impaired by potential adverse effects of COS whatever the number of cycle between oocyte retrieval and embryo transfer.	[Bourdon, Mathilde; Santulli, Pietro; Maignien, Chloe; Alwohaibi, Asim; Marcellin, Louis; Blais, Sarah; Chapron, Charles] Univ Paris 05, Sorbonne Paris Cite, Hop Univ Paris Ctr, Ctr Hosp Univ CHU Cochin,AP HP,Fac Med,Dept Gynae, Paris, France; [Bourdon, Mathilde; Santulli, Pietro; Marcellin, Louis] Univ Paris 05, Sorbonne Paris Cite, Inst Cochin, Lab Immunol, Paris, France; [Pocate-Cheriet, Khaled] Univ Paris 05, Sorbonne Paris Cite, Hop Univ Paris Ctr, Ctr Hosp Univ CHU Cochin,AP HP,Fac Med,Serv Histo, Paris, France; [Marcellin, Louis; Chapron, Charles] Univ Paris 05, Sorbonne Paris Cite, Inst Cochin, Dept Genet Dev & Canc, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Santulli, P (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Hop Univ Paris Ctr, Ctr Hosp Univ CHU Cochin,AP HP,Fac Med,Dept Gynae, Paris, France.; Santulli, P (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Inst Cochin, Lab Immunol, Paris, France.	pietro.santulli@cch.aphp.fr	louis, marcellin/V-4728-2019; Santulli, Pietro/T-5201-2019	louis, marcellin/0000-0003-4482-9710; Santulli, Pietro/0000-0002-4985-7326	Finox Forward Research Grant	Finox Forward Research Grant	This study was partially supported by a Finox Forward Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Barfield WD, 2011, PEDIATRICS, V128, P177, DOI 10.1542/peds.2011-1037; Blockeel C, 2016, HUM REPROD, V31, P491, DOI 10.1093/humrep/dev339; Bourdon M, 2017, J ENDOMETR PELVIC PA, V9, P87, DOI 10.5301/jeppd.5000281; Brandes M, 2010, HUM REPROD, V25, P118, DOI 10.1093/humrep/dep341; Carbillon L, 2017, EUR J OBSTET GYN R B, V217, P137, DOI 10.1016/j.ejogrb.2017.08.032; Declercq E, 2015, FERTIL STERIL, V103, P888, DOI 10.1016/j.fertnstert.2014.12.119; Evans J, 2014, HUM REPROD UPDATE, V20, P808, DOI 10.1093/humupd/dmu027; Gameiro S, 2013, FERTIL STERIL, V100, P302, DOI 10.1016/j.fertnstert.2013.06.015; Gardner DK, 2002, J REPROD IMMUNOL, V55, P85, DOI 10.1016/S0165-0378(01)00136-X; Haouzi D, 2010, BIOL REPROD, V82, P679, DOI 10.1095/biolreprod.109.081299; Horcajadas JA, 2008, J CLIN ENDOCR METAB, V93, P4500, DOI 10.1210/jc.2008-0588; Ishihara O, 2014, FERTIL STERIL, V101, P128, DOI 10.1016/j.fertnstert.2013.09.025; Kalra SK, 2011, OBSTET GYNECOL, V118, P863, DOI 10.1097/AOG.0b013e31822be65f; Kamath MS, 2018, REPROD BIOMED ONLINE, V36, P94, DOI 10.1016/j.rbmo.2017.09.009; Kolte AM, 2015, HUM REPROD, V30, P495, DOI 10.1093/humrep/deu299; Labarta E, 2011, HUM REPROD, V26, P1813, DOI 10.1093/humrep/der126; Lattes K, 2017, HUM REPROD, V32, P368, DOI 10.1093/humrep/dew306; Liu SY, 2017, REPROD BIOMED ONLINE, V35, P189, DOI 10.1016/j.rbmo.2017.04.010; Maheshwari A, 2017, HUM REPROD UPDATE, P1, DOI [10.1093/humupd/dmx034, DOI 10.1093/HUMUPD/DMX034]; Ozgur K, 2018, J ASSIST REPROD GEN, V35, P135, DOI 10.1007/s10815-017-1048-6; Pelkonen S, 2010, HUM REPROD, V25, P914, DOI 10.1093/humrep/dep477; Pereira N, 2017, HUM REPROD, V32, P1410, DOI 10.1093/humrep/dex095; Salamonsen LA, 2009, REPROD FERT DEVELOP, V21, P923, DOI 10.1071/RD09145; Salomon LJ, 2005, ULTRASOUND OBST GYN, V25, P559, DOI 10.1002/uog.1901; Santos-Ribeiro S, 2016, HUM REPROD, V31, P2541, DOI 10.1093/humrep/dew194; Santulli P, 2011, FERTIL STERIL, V95, P507, DOI 10.1016/j.fertnstert.2010.09.018; Van Vaerenbergh I, 2011, REPROD BIOMED ONLINE, V22, P263, DOI 10.1016/j.rbmo.2010.11.002; Weinerman R, 2014, FERTIL STERIL, V102, P10, DOI 10.1016/j.fertnstert.2014.05.019; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009	29	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0206067	10.1371/journal.pone.0206067	http://dx.doi.org/10.1371/journal.pone.0206067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339700	Green Submitted, Green Published, gold			2022-12-26	WOS:000447761400037
J	Budtz-Jorgensen, E; Grandjean, P				Budtz-Jorgensen, Esben; Grandjean, Philippe			Application of benchmark analysis for mixed contaminant exposures: Mutual adjustment of perfluoroalkylate substances associated with immunotoxicity	PLOS ONE			English	Article							VACCINE ANTIBODY CONCENTRATIONS; PERFLUORINATED COMPOUNDS; POLYFLUOROALKYL COMPOUNDS; PRENATAL EXPOSURE; CHILDREN; HEALTH; RISK	Background Developmental exposure to perfluorinated alkylate substances (PFASs) is associated with deficient IgG antibody responses to childhood vaccines. As this immunotoxicity outcome may represent a critical effect, calculation of benchmark dose (BMD) results would be useful for defining protective limits of exposure. However, exposures to the major PFASs that are associated with this adverse effect are interrelated, and mutually adjusted BMD results would be desirable. Methods We carried out BMD calculations on prospective data from two prospective birth cohort studies from the Faroe Islands with a total of 1,146 children. Exposure data included serum concentrations of five major PFASs at birth and at age 5 years and, as outcome parameters, the serum concentrations of specific IgG antibodies against tetanus and diphtheria at ages 5 and 7. We calculated the BMDs and their lower confidence bounds (BMDLs) and included mutual adjustment for five major PFASs. BMD and BMDL were expressed in terms of the serum concentration of the PFASs. Results The BMDLs for the immunotoxicants were of similar magnitude before and after adjustment. As compared to linear dose-response models, the PFASs showed lower results for a piecewise linear model, which also provided a slightly better fit. Weaker associations with the antibody outcomes were observed after adjustments due to the correlation between the PFASs. However, while the adjustments resulted in elevated BMD results and p values, the BMDL values were not materially changed. Conclusions Adjustment for co-exposure to a related immunotoxicant increased both the BMD values and their standard errors, though affected the BMDL values only to a negligible extent. Thus, when correlated toxicants appear to affect the same outcome and none of them is known a priori to be solely responsible, all exposures may be considered responsible in BMD calculations. Our BMDL results, both before and after adjustment are generally below current exposure levels and therefore suggest that all five perfluorinated substances should attract regulatory attention, at least until additional evidence shows otherwise.	[Budtz-Jorgensen, Esben] Univ Copenhagen, Inst Publ Hlth, Dept Biostat, Copenhagen, Denmark; [Grandjean, Philippe] Univ Southern Denmark, Dept Environm Med, Odense, Denmark; [Grandjean, Philippe] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	University of Copenhagen; University of Southern Denmark; Harvard University; Harvard T.H. Chan School of Public Health	Grandjean, P (corresponding author), Univ Southern Denmark, Dept Environm Med, Odense, Denmark.; Grandjean, P (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	pgrand@hsph.harvard.edu	Grandjean, Philippe/I-2962-2014	Grandjean, Philippe/0000-0003-4046-9658; Budtz-Jorgensen, Esben/0000-0002-5551-0724	National Institute of Environmental Health Sciences, NIH [R01ES012199, R01ES026596, P42ES027706]; Danish Environmental Protection Agency as part of the environmental support program DANCEA (Danish Cooperation for Environment in the Arctic); Dynamical Systems Interdisciplinary Network, University of Copenhagen; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026596, P42ES027706, R01ES012199] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Danish Environmental Protection Agency as part of the environmental support program DANCEA (Danish Cooperation for Environment in the Arctic); Dynamical Systems Interdisciplinary Network, University of Copenhagen; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Institute of Environmental Health Sciences, NIH (R01ES012199, R01ES026596, and P42ES027706) (PG); the Danish Environmental Protection Agency as part of the environmental support program DANCEA (Danish Cooperation for Environment in the Arctic), and the Dynamical Systems Interdisciplinary Network, University of Copenhagen. All funding sources are public, and no private funding was involved. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry, 2018, DRAFT TOXICOLOGICAL; Alexander J, 2008, EFSA J, V6; Budtz-Jorgensen E, 2001, BIOMETRICS, V57, P698, DOI 10.1111/j.0006-341X.2001.00698.x; Butenhoff JL, 2004, REGUL TOXICOL PHARM, V39, P363, DOI 10.1016/j.yrtph.2004.03.003; CDC, 2015, FOURTH NATIONAL REPO; Corsini E, 2012, TOXICOL APPL PHARM, V258, P248, DOI 10.1016/j.taap.2011.11.004; CRUMP KS, 1995, RISK ANAL, V15, P79, DOI 10.1111/j.1539-6924.1995.tb00095.x; Dalsager L, 2016, ENVIRON INT, V96, P58, DOI 10.1016/j.envint.2016.08.026; DeWitt JC, 2012, TOXICOL PATHOL, V40, P300, DOI 10.1177/0192623311428473; Goldenthal EI, 1978, 137085 INT RES DEV C; Grandjean P., 2013, LATE LESSONS EARLY W, P517; Grandjean P, 2017, J IMMUNOTOXICOL, V14, P188, DOI 10.1080/1547691X.2017.1360968; Grandjean P, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-35; Grandjean P, 2012, JAMA-J AM MED ASSOC, V307, P391, DOI 10.1001/jama.2011.2034; Grandjean P, 2010, PURE APPL CHEM, V82, P383, DOI 10.1351/PAC-CON-09-05-04; Granum B, 2013, J IMMUNOTOXICOL, V10, P373, DOI 10.3109/1547691X.2012.755580; Guruge KS, 2009, J TOXICOL SCI, V34, P687, DOI 10.2131/jts.34.687; Gwinn MR, 2017, AM J PUBLIC HEALTH, V107, P1032, DOI 10.2105/AJPH.2017.303771; Kato K, 2009, ENVIRON SCI TECHNOL, V43, P2641, DOI 10.1021/es803156p; Kielsen K, 2016, J IMMUNOTOXICOL, V13, P270, DOI 10.3109/1547691X.2015.1067259; Knutsen HK, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5194; Lindstrom AB, 2011, ENVIRON SCI TECHNOL, V45, P7954, DOI 10.1021/es2011622; Liu JY, 2011, ENVIRON INT, V37, P1206, DOI 10.1016/j.envint.2011.05.001; Looker C, 2014, TOXICOL SCI, V138, P76, DOI 10.1093/toxsci/kft269; Mogensen UB, 2015, ENVIRON SCI TECHNOL, V49, P10466, DOI 10.1021/acs.est.5b02237; Mogensen UB, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0032-9; Mondal D, 2014, ENVIRON HEALTH PERSP, V122, P187, DOI 10.1289/ehp.1306613; National Toxicology Program, 2016, CONTRACT NO; Needham LL, 2011, ENVIRON SCI TECHNOL, V45, P1121, DOI 10.1021/es1019614; Peden-Adams MM, 2008, TOXICOL SCI, V104, P144, DOI 10.1093/toxsci/kfn059; Post GB, 2012, ENVIRON RES, V116, P93, DOI 10.1016/j.envres.2012.03.007; Seacat AM, 2002, TOXICOL SCI, V68, P249, DOI 10.1093/toxsci/68.1.249; Timmermann CAG, 2017, REPROD TOXICOL, V68, P164, DOI 10.1016/j.reprotox.2016.07.010; U.S. Environmental Protection Agency, 2014, HLTH EFF DOC PERFL S; United States Environmental Protection Agency (US EPA), 2012, EPA100R 12001; US Environmental Protection Agency, 2014, HLTH EFFECTS DOCUMEN; Van Loveren H., 1999, Biomarkers, V4, P135, DOI 10.1080/135475099230949; Weihe P, 2008, ENVIRON SCI TECHNOL, V42, P6291, DOI 10.1021/es800695m; White SS, 2011, J STEROID BIOCHEM, V127, P16, DOI 10.1016/j.jsbmb.2011.03.011; Zhang YF, 2013, ENVIRON SCI TECHNOL, V47, P10619, DOI 10.1021/es401905e; 2009, THE EFSA JOURNAL, V7, DOI DOI 10.2903/J.EFSA.2009.229R	41	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205388	10.1371/journal.pone.0205388	http://dx.doi.org/10.1371/journal.pone.0205388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339706	Green Published, gold, Green Submitted			2022-12-26	WOS:000447761400012
J	Fonseca, PAD; Id-Lahoucine, S; Reverter, A; Medrano, JF; Fortes, MS; Casellas, J; Miglior, F; Brito, L; Carvalho, MRS; Schenkel, FS; Nguyen, LT; Porto-Neto, LR; Thomas, MG; Canovas, A				Fonseca, Pablo Augusto de Souza; Id-Lahoucine, Samir; Reverter, Antonio; Medrano, Juan F.; Fortes, Marina S.; Casellas, Joaquim; Miglior, Filippo; Brito, Luiz; Carvalho, Maria Raquel S.; Schenkel, Flavio S.; Nguyen, Loan T.; Porto-Neto, Laercio R.; Thomas, Milton G.; Canovas, Angela			Combining multi-OMICs information to identify key-regulator genes for pleiotropic effect on fertility and production traits in beef cattle	PLOS ONE			English	Article							SERUM METABOLIC HORMONES; MEAT QUALITY TRAITS; CONTROL MUSCLE MASS; TESTOSTERONE CONCENTRATIONS; LINKAGE DISEQUILIBRIUM; PERIPUBERTAL PERIOD; THYROID-HORMONES; SERIAL ANALYSIS; CANDIDATE GENE; GROWTH-HORMONE	The identification of biological processes related to the regulation of complex traits is a difficult task. Commonly, complex traits are regulated through a multitude of genes contributing each to a small part of the total genetic variance. Additionally, some loci can simultaneously regulate several complex traits, a phenomenon defined as pleiotropy. The lack of understanding on the biological processes responsible for the regulation of these traits results in the decrease of selection efficiency and the selection of undesirable hitchhiking effects. The identification of pleiotropic key-regulator genes can assist in developing important tools for investigating biological processes underlying complex traits. A multi-breed and multi-OMICs approach was applied to study the pleiotropic effects of key-regulator genes using three independent beef cattle populations evaluated for fertility traits. A pleiotropic map for 32 traits related to growth, feed efficiency, carcass and meat quality, and reproduction was used to identify genes shared among the different populations and breeds in pleiotropic regions. Furthermore, data-mining analyses were performed using the Cattle QTL database (CattleQTLdb) to identify the QTL category annotated in the regions around the genes shared among breeds. This approach allowed the identification of a main gene network (composed of 38 genes) shared among breeds. This gene network was significantly associated with thyroid activity, among other biological processes, and displayed a high regulatory potential. In addition, it was possible to identify genes with pleiotropic effects related to crucial biological processes that regulate economically relevant traits associated with fertility, production and health, such as MYC, PPARG, GSK3B, TG and IYD genes. These genes will be further investigated to better understand the biological processes involved in the expression of complex traits and assist in the identification of functional variants associated with undesirable phenotypes, such as decreased fertility, poor feed efficiency and negative energetic balance.	[Fonseca, Pablo Augusto de Souza; Id-Lahoucine, Samir; Miglior, Filippo; Brito, Luiz; Schenkel, Flavio S.; Canovas, Angela] Univ Guelph, Dept Anim Biosci, Ctr Genet Improvement Livestock, Guelph, ON, Canada; [Fonseca, Pablo Augusto de Souza; Carvalho, Maria Raquel S.] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Reverter, Antonio; Porto-Neto, Laercio R.] CSIRO Agr & Food, Queensland Biosci Precinct, Brisbane, Qld, Australia; [Medrano, Juan F.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Fortes, Marina S.; Nguyen, Loan T.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Casellas, Joaquim] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Barcelona, Spain; [Miglior, Filippo] Canadian Dairy Network, Guelph, ON, Canada; [Thomas, Milton G.] Colorado State Univ, Dept Anim Sci, Ft Colins, CO USA	University of Guelph; Universidade Federal de Minas Gerais; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California Davis; University of Queensland; Autonomous University of Barcelona; Colorado State University	Canovas, A (corresponding author), Univ Guelph, Dept Anim Biosci, Ctr Genet Improvement Livestock, Guelph, ON, Canada.	acanovas@uoguelph.ca	Fonseca, Pablo/AAZ-2254-2021; Miglior, Filippo/AAV-4762-2020; Nguyen, Loan/Y-6093-2019; Nguyen, Loan/AAB-9170-2022; Fortes, Marina/AAN-6815-2020; Schenkel, Flavio/ABG-1842-2021; Carvalho, Maria Raquel Santos/HHN-1690-2022; Fortes, Marina R S/G-2302-2012; Porto-Neto, Laercio R/D-2594-2012; Cánovas, Angela/AAG-6282-2020; Reverter, Antonio/C-9699-2013; Id-Lahoucine, Samir/N-8510-2017	Nguyen, Loan/0000-0002-7783-5466; Fortes, Marina/0000-0002-7254-1960; Carvalho, Maria Raquel Santos/0000-0002-1744-448X; Fortes, Marina R S/0000-0002-7254-1960; Porto-Neto, Laercio R/0000-0002-3536-8265; Reverter, Antonio/0000-0002-4681-9404; Fonseca, Pablo Augusto de Souza/0000-0002-6917-7475; Schenkel, Flavio/0000-0001-8700-0633; Miglior, Filippo/0000-0003-2345-8842; Id-Lahoucine, Samir/0000-0001-5289-4788	Beef Farmers of Ontario; OMAFRA (Ontario Ministry of Agriculture, Food and Rural Affairs); Beef Cattle Research Council (BCRC); NSERC (Natural Sciences and Engineering Research Council); Ontario Centres of Excellence (OCE); Brazilian National Research Council (CNPq) [312068/2015-8]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ APQ-01377-17, APQ-01377-17]; Brazilian National Research Council	Beef Farmers of Ontario; OMAFRA (Ontario Ministry of Agriculture, Food and Rural Affairs); Beef Cattle Research Council (BCRC); NSERC (Natural Sciences and Engineering Research Council)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Centres of Excellence (OCE); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Beef Farmers of Ontario, OMAFRA (Ontario Ministry of Agriculture, Food and Rural Affairs), Beef Cattle Research Council (BCRC), NSERC (Natural Sciences and Engineering Research Council) and Ontario Centres of Excellence (OCE). MRSC is supported by a fellowship from the Brazilian National Research Council (CNPq 312068/2015-8) and grants from the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, APQ APQ-01377-17 and APQ-01377-17). PASF is supported by a fellowship from the Brazilian National Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonarakis SE, 2010, NAT REV GENET, V11, P380, DOI 10.1038/nrg2793; Ashkar FA, 2016, ZYGOTE, V24, P266, DOI 10.1017/S0967199415000167; Awda BJ, 2013, CAN J ANIM SCI, V93, P185, DOI 10.4141/CJAS2012-092; Bhattacharjee R, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124495; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Bolormaa S, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0337-y; Bolormaa S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004198; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Brito LFC, 2007, DOMEST ANIM ENDOCRIN, V33, P460, DOI 10.1016/j.domaniend.2006.09.004; Brito LFC, 2007, DOMEST ANIM ENDOCRIN, V33, P1, DOI 10.1016/j.domaniend.2006.04.001; Canovas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102551; Capuco AV, 2001, J DAIRY SCI, V84, P2430, DOI 10.3168/jds.S0022-0302(01)74693-0; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dittrich R, 2011, J REPROD IMMUNOL, V90, P58, DOI 10.1016/j.jri.2011.02.009; Dorn LD, 2011, J RES ADOLESCENCE, V21, P180, DOI 10.1111/j.1532-7795.2010.00722.x; Esmailizadeh AK, 2011, ANIM GENET, V42, P592, DOI 10.1111/j.1365-2052.2011.02197.x; Estanislao Goszczynski Daniel, 2016, Journal of Animal Science and Technology, V58, P14, DOI 10.1186/s40781-016-0095-3; Fernandez ME, 2017, REPROD DOMEST ANIM, V52, P911, DOI 10.1111/rda.12989; de Camargo GMF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1595-0; Fontanesi L, 2014, ANIM GENET, V45, P576, DOI 10.1111/age.12164; Fortes MRS, 2013, ANDROLOGY-US, V1, P644, DOI 10.1111/j.2047-2927.2013.00101.x; Fortes MRS, 2013, ANIM GENET, V44, P91, DOI 10.1111/j.1365-2052.2012.02367.x; Fortes MRS, 2010, P NATL ACAD SCI USA, V107, P13642, DOI 10.1073/pnas.1002044107; Grossi DD, 2015, MOL BIOL REP, V42, P245, DOI 10.1007/s11033-014-3767-4; Guo B, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-35; Gutierrez-Gil B, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00167; Hawken RJ, 2012, J ANIM SCI, V90, P1398, DOI 10.2527/jas.2011-4410; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2014, 10 WORLD C GEN APPL; Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015; Kadri NK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004049; Kim ST, 2012, REPROD SCI, V19, P31, DOI 10.1177/1933719111424449; Kuhn C, 2004, GENETICS, V167, P1873, DOI 10.1534/genetics.103.022749; LEE CY, 1991, DOMEST ANIM ENDOCRIN, V8, P481, DOI 10.1016/0739-7240(91)90017-E; Luque RM, 2018, J ENDOCRINOL, V237, P217, DOI 10.1530/JOE-18-0135; Ma ZF, 2014, THYROID, V24, P1195, DOI 10.1089/thy.2014.0052; MacLeod IM, 2014, GENETICS, V198, P1671, DOI 10.1534/genetics.114.168344; Mani AM, 2010, REPRODUCTION, V139, P139, DOI 10.1530/REP-09-0050; Meuwissen THE, 2001, GENET SEL EVOL, V33, P605, DOI 10.1051/gse:2001134; Meyerholz MM, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0231-6; Miretti S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-194; Moisa SJ, 2014, GENE REGULATION SYST, V8; Moreno JC, 2003, HORM RES, V60, P96, DOI 10.1159/000074509; Moreno JC, 2001, GENOMICS, V75, P70, DOI 10.1006/geno.2001.6586; Moreno JC, 2010, MOL CELL ENDOCRINOL, V322, P91, DOI 10.1016/j.mce.2010.03.010; Moser G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004969; Mu Y, 2016, CAN J ANIM SCI, V96, P448, DOI 10.1139/cjas-2015-0175; Mullen Michael Paul, 2011, Frontiers in Genetics, V2, P3, DOI 10.3389/fgene.2011.00003; Nguyen LT, 2017, J ANIM SCI, V95, P599, DOI 10.2527/jas.2016.0921; Nogueira G, 2008, BIOL REPROD, P146; O'Brien AMP, 2014, LIVEST SCI, V166, P121, DOI 10.1016/j.livsci.2014.05.007; Oh JD, 2015, ASIAN AUSTRAL J ANIM, V28, P1545, DOI 10.5713/ajas.15.0425; Petri T, 2015, BIOINFORMATICS, V31, P2836, DOI 10.1093/bioinformatics/btv215; Pezzi C, 2003, J DAIRY SCI, V86, P152, DOI 10.3168/jds.S0022-0302(03)73595-4; Rai U, 2015, PHARMACOL THERAPEUT, V152, P98, DOI 10.1016/j.pharmthera.2015.05.007; Rana K, 2014, ASIAN J ANDROL, V16, P675, DOI 10.4103/1008-682X.122861; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; Rorsman P, 2018, NATURE REV ENDOCRINO, V1, DOI [10.1038/nrendo.2017.165, DOI 10.1038/NRENDO.2017.165]; Saatchi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-442; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schering L, 2017, INT J BIOL SCI, V13, P532, DOI 10.7150/ijbs.18775; Scutari M, 2014, GENETICS, V198, P129, DOI 10.1534/genetics.114.165704; Siadkowska Eulalia, 2006, Animal Science Papers and Reports, V24, P225; Song L, 2014, CLIN CHIM ACTA, V431, P185, DOI 10.1016/j.cca.2014.01.019; Spicer LJ, 2007, BIOL REPROD, V77, P18, DOI 10.1095/biolreprod.106.058230; Stelzer G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2722-2; Stueve TR, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-78; Suravajhala P, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0217-x; Szklarczyk D., 2016, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKW937; Tait RG, 2016, J ANIM SCI, V94, P920, DOI 10.2527/jas.2015-9860; Thaller G, 2003, ANIM GENET, V34, P354, DOI 10.1046/j.1365-2052.2003.01011.x; Trapnell C, 2015, GENOME RES, V25, P1491, DOI 10.1101/gr.190595.115; Tsuruta S, 2017, J DAIRY SCI, V100, P7295, DOI 10.3168/jds.2017-12665; Twig G, 2012, J AUTOIMMUN, V38, pJ275, DOI 10.1016/j.jaut.2011.11.014; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Underwood KR, 2007, J AGR FOOD CHEM, V55, P9698, DOI 10.1021/jf071573z; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; Vitti M, 2016, PPAR RES, V2016, DOI 10.1155/2016/4612306; Walsh SW, 2011, ANIM REPROD SCI, V123, P127, DOI 10.1016/j.anireprosci.2010.12.001; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Weber KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152274; Welle SL, 2009, AM J PHYSIOL-CELL PH, V296, pC1245, DOI 10.1152/ajpcell.00154.2009; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Wu TH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S12; Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443; Xu R, 2003, J ANDROL, V24, P192; Yang H, 2011, REPROD SCI, V18, P1118, DOI 10.1177/1933719111407212; Zhang K, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130278; Zhang X, 2014, MOLECULES, V19, P9435, DOI 10.3390/molecules19079435; Zhang XM, 2017, IEEE T IND INFORM, V13, P4, DOI 10.1109/TII.2016.2607150; Zhu XY, 2004, CYTOKINE, V26, P262, DOI 10.1016/j.cyto.2004.03.007	95	24	24	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205295	10.1371/journal.pone.0205295	http://dx.doi.org/10.1371/journal.pone.0205295			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335783	Green Published, gold, Green Submitted			2022-12-26	WOS:000447701300025
J	Dong, DF; Zhou, HS; Na, SY; Niedra, R; Peng, YB; Wang, HJ; Seed, B; Zhou, GL				Dong, Danfeng; Zhou, Haisheng; Na, Soon-Young; Niedra, Rasma; Peng, Yibing; Wang, Huajun; Seed, Brian; Zhou, Guo Ling			GPR108, an NF-kappa B activator suppressed by TIRAP, negatively regulates TLR-triggered immune responses	PLOS ONE			English	Article							SIGNALING PATHWAYS; STRUCTURAL BASIS; TOLL; CELLS; SPECIFICITY; RECEPTORS; MYD88; MICE; RNA	Higher vertebrates have evolved innate and adaptive immune systems to defend against foreign substances and pathogens. Sophisticated regulatory circuits are needed to avoid inappropriate immune responses and inflammation. GPR108 is a seven-transmembrane family protein that activates NF-kappa B strongly when overexpressed. Surprisingly, its action in a physiological context is that of an antagonist of Toll-like receptor (TLR)-mediated signaling. Cells from Gpr108-null mice exhibit enhanced cytokine secretion and NF-kappa B and IRF3 signaling, whereas Gpr108-null macrophages reconstituted with GPR108 exhibit blunted signaling. Co-expression of TLRs and GPR108 reduces NF-kappa B and IFN beta promoter activation compared to expression of either TLRs or GPR108 alone. Upon TLR stimulation GPR108 abundance increases and the protein engages TLRs and their partners to reduce MyD88 expression and interfere with its binding to TLR4 through blocking MyD88 ubiquitination. In turn GPR108 is antagonized by TIRAP, an adaptor protein for TLR and MyD88. The interrelationships between GPR108 and innate immune signaling components are multifactorial and point to a membrane-associated signaling structure of significant complexity.	[Dong, Danfeng; Zhou, Haisheng; Na, Soon-Young; Niedra, Rasma; Wang, Huajun; Seed, Brian; Zhou, Guo Ling] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Dong, Danfeng; Zhou, Haisheng; Na, Soon-Young; Seed, Brian; Zhou, Guo Ling] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Dong, Danfeng; Peng, Yibing] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Lab Med, Shanghai, Peoples R China; [Zhou, Haisheng] Anhui Med Univ, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China; [Na, Soon-Young] Chonnam Natl Univ, Sch Biol Sci & Technol, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Gwangju, South Korea; [Na, Soon-Young] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Gwangju, South Korea	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Shanghai Jiao Tong University; Anhui Medical University; Chonnam National University; Chonnam National University	Zhou, GL (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Zhou, GL (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	gzhou@ccib.mgh.harvard.edu			National Natural Science Foundation of China [81772909]; Research Project of Science and Technology Commission of Shanghai [15YF140 7300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Project of Science and Technology Commission of Shanghai	This work was supported by National Natural Science Foundation of China(81772909), HZ, designed and executed experiments, interpreted data, and helped to prepare the article. And Research Project of Science and Technology Commission of Shanghai (15YF140 7300), DD, designed and executed experiments, interpreted data, and prepared the article.	ADERKA D, 1989, J IMMUNOL, V143, P3517; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anwar MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.28; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bloom J, 2005, METHOD ENZYMOL, V399, P249, DOI 10.1016/S0076-6879(05)99017-4; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Edgar AJ, 2007, DNA SEQUENCE, V18, P235, DOI 10.1080/10425170701207182; Eldering E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng153; Halsey TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r104; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; Langerak P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni187; Lee BC, 2016, P NATL ACAD SCI USA, V113, pE165, DOI 10.1073/pnas.1518615113; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Rajaraman P, 2009, CANCER EPIDEM BIOMAR, V18, P1651, DOI 10.1158/1055-9965.EPI-08-1041; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Yang Y, 2003, NAT BIOTECHNOL, V21, P447, DOI 10.1038/nbt803; Zhou GL, 2014, J CELL SCI, V127, P3916, DOI 10.1242/jcs.135269; Zhou GL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003950	28	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205303	10.1371/journal.pone.0205303	http://dx.doi.org/10.1371/journal.pone.0205303			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332431	Green Published, Green Submitted, gold			2022-12-26	WOS:000447638200049
J	Peacock, SD; Massey, TE; Vanner, SJ; King, WD				Peacock, Sarah D.; Massey, Thomas E.; Vanner, Stephen J.; King, Will D.			Telomere length in the colon is related to colorectal adenoma prevalence	PLOS ONE			English	Article							CANCER-RISK; LUNG-CANCER; CIGARETTE-SMOKING; BLOOD-LYMPHOCYTES; QUANTITATIVE PCR; ASSOCIATION; CARCINOMA; DYSFUNCTION; AGE; INSTABILITY	Telomere length has been associated with risk of several cancers. However, studies of the relationship between telomere length and colorectal cancer risk have been inconsistent. This study examined the relationship between telomere length in normal colon tissue and the prevalence of colorectal adenoma, a precursor to colorectal cancer. This nested case control study consisted of 85 patients aged 40 to 65 undergoing a screening colonoscopy: 40 cases with adenoma(s) detected at colonoscopy and 45 controls with normal colonoscopy. During the colonoscopy, two pinch biopsies of healthy, normal appearing mucosa were obtained from the descending colon. Relative telomere length (rTL) was quantified in DNA extracted from colon mucosa using quantitative real-time PCR. Logistic regression was used to assess the relationship between telomere length and adenoma prevalence and estimate odds ratios and 95% confidence intervals. rTL was significantly longer in colon tissue of individuals with adenomas compared to healthy individuals (p = 0.008). When rTL was categorized into quartiles according to the distribution of rTL among controls, individuals with the longest telomeres had increased odds of adenoma when compared to individuals with shortest telomeres (OR = 4.58, 95% CI: 1.19, 17.7). This study suggests that long telomeres in normal colon tissue are associated with increased colorectal cancer risk.	[Peacock, Sarah D.; King, Will D.] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Massey, Thomas E.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Vanner, Stephen J.] Queens Univ, Gastrointestinal Dis Res Unit, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Peacock, SD (corresponding author), Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.	sdpeacock@gmail.com			Canadian Cancer Society [19450]; Cancer Care Ontario; Terry Fox Foundation Transdisciplinary Training Program in Cancer Research; Canadian Institutes for Health Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); Cancer Care Ontario; Terry Fox Foundation Transdisciplinary Training Program in Cancer Research; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Cancer Society www.cancer.ca/research (19450) and Cancer Care Ontario www.cancercareontario.ca. SDP was supported by the Terry Fox Foundation Transdisciplinary Training Program in Cancer Research in partnership with the Canadian Institutes for Health Research. The funders had no role in the study design, data	Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Aviv A, 2001, Curr Hypertens Rep, V3, P145, DOI 10.1007/s11906-001-0029-3; Aviv A, 2017, TRENDS CANCER, V3, P253, DOI 10.1016/j.trecan.2017.02.005; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Boardman LA, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.3; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cui Y, 2012, CANCER EPIDEM BIOMAR, V21, P1807, DOI 10.1158/1055-9965.EPI-12-0657; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Engelhardt M, 1997, CLIN CANCER RES, V3, P1931; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fernandez-Rozadilla C, 2018, BRIT J CANCER, V118, P727, DOI 10.1038/bjc.2017.486; Friis-Ottessen M, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-8; Hackett JA, 2002, ONCOGENE, V21, P619, DOI 10.1038/sj.onc.1205061; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hellemans J, 2011, PCR TROUBLESHOOTING AND OPTIMIZATION: THE ESSENTIAL GUIDE, P139; Hou LF, 2012, CANCER LETT, V319, P130, DOI 10.1016/j.canlet.2012.01.028; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; JASS JR, 1989, WORLD J SURG, V13, P45, DOI 10.1007/BF01671153; King WD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-488; Lan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059230; Lan Q, 2009, CLIN CANCER RES, V15, P7429, DOI 10.1158/1078-0432.CCR-09-0845; Latifovic L, 2016, CANCER EPIDEM BIOMAR, V25, P374, DOI 10.1158/1055-9965.EPI-14-1364; Lee IM, 2010, CLIN CHEM LAB MED, V48, P259, DOI 10.1515/CCLM.2010.049; Liu J, 2011, CANCER-AM CANCER SOC, V117, P4247, DOI 10.1002/cncr.26015; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Machiela MJ, 2016, HUM MOL GENET, V25, P1663, DOI 10.1093/hmg/ddw027; Machiela MJ, 2015, INT J CANCER, V137, P311, DOI 10.1002/ijc.29393; Maxwell F, 2011, CLIN CANCER RES, V17, P5573, DOI 10.1158/1078-0432.CCR-10-3271; Mitro SD, 2016, ENVIRON HEALTH PERSP, V124, P651, DOI 10.1289/ehp.1510187; Murnane JP, 2006, DNA REPAIR, V5, P1082, DOI 10.1016/j.dnarep.2006.05.030; Murnane JP, 2012, MUTAT RES-FUND MOL M, V730, P28, DOI 10.1016/j.mrfmmm.2011.04.008; Naing C, 2017, BMC CANCER, P17; O'Sullivan J, 2006, CANCER EPIDEM BIOMAR, V15, P573, DOI 10.1158/1055-9965.EPI-05-0542; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Patel C. J., 2016, INT J EPIDEMIOL; Pavanello S, 2010, CARCINOGENESIS, V31, P216, DOI 10.1093/carcin/bgp278; PEIPINS LA, 1994, EPIDEMIOL REV, V16, P273, DOI 10.1093/oxfordjournals.epirev.a036154; Pericas JM, 2016, NEW ENGL J MED, V375, P387, DOI [10.1056/NEJMra1513581, 10.1056/NEJMc1604867]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piol-Felis C, 2015, J SURG ONCOL, V111, P899, DOI [10.1002/jso.23894, DOI 10.1002/JSO.23894]; Plentz RR, 2003, GUT, V52, P1304, DOI 10.1136/gut.52.9.1304; Pooley KA, 2010, CANCER RES, V70, P3170, DOI 10.1158/0008-5472.CAN-09-4595; Prescott J, 2012, MUTAT RES-FUND MOL M, V730, P75, DOI 10.1016/j.mrfmmm.2011.06.009; Qin Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088135; Risques RA, 2011, CANCER RES, V71, P1669, DOI 10.1158/0008-5472.CAN-10-1966; Roger L, 2013, JNCI-J NATL CANCER I, V105, P1202, DOI 10.1093/jnci/djt191; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sabatier L, 2005, MOL CANCER RES, V3, P139, DOI 10.1158/1541-7786.MCR-04-0194; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; SCHATZKIN A, 1994, JNCI-J NATL CANCER I, V86, P1053, DOI 10.1093/jnci/86.14.1053; Schatzkin A, 2002, NAT REV CANCER, V2, P19, DOI 10.1038/nrc702; Schatzkin A, 1999, ADV EXP MED BIOL, V470, P85; Seow WJ, 2014, CANCER RES, V74, P4090, DOI 10.1158/0008-5472.CAN-14-0459; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Sun B, 2015, LUNG CANCER, V88, P297, DOI 10.1016/j.lungcan.2015.03.011; Suraweera N, 2016, ONCOTARGET, V7, P36474, DOI 10.18632/oncotarget.9015; Tahara T, 2015, CLIN EXP MED, V15, P327, DOI 10.1007/s10238-014-0295-4; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wang HK, 2015, CARCINOGENESIS, V36, P1284, DOI 10.1093/carcin/bgv121; Weischer M, 2013, JNCI-J NATL CANCER I, V105, P459, DOI 10.1093/jnci/djt016; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Xie H, 2013, CANCER-AM CANCER SOC, V119, P1885, DOI 10.1002/cncr.27984; Zee RYL, 2009, CANCER EPIDEM BIOMAR, V18, P2280, DOI 10.1158/1055-9965.EPI-09-0360	73	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205697	10.1371/journal.pone.0205697	http://dx.doi.org/10.1371/journal.pone.0205697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332457	gold, Green Published, Green Submitted			2022-12-26	WOS:000447638200063
J	van den Berg, N; Mahomed, W; Olivier, NA; Swart, V; Crampton, BG				van den Berg, Noelani; Mahomed, Waheed; Olivier, Nicholas A.; Swart, Velushka; Crampton, Bridget G.			Transcriptome analysis of an incompatible Persea americana-Phytophthora cinnamomi interaction reveals the involvement of SA- and JA-pathways in a successful defense response	PLOS ONE			English	Article							REAL-TIME PCR; SALICYLIC-ACID; NONHOST RESISTANCE; PLANT DEFENSE; ARABINOGALACTAN PROTEINS; ARABIDOPSIS-THALIANA; CHALCONE SYNTHASE; GENE-EXPRESSION; JASMONIC ACID; DOWNY MILDEW	Phytophthora cinnamomi Rands (Pc) is a hemibiotrophic oomycete and the causal agent of Phytophthora root rot (PRR) of the commercially important fruit crop avocado (Persea americana Mill.). Plant defense against pathogens is modulated by phytohormone signaling pathways such as salicylic acid (SA), jasmonic acid (JA), ethylene (ET), auxin and abscisic acid. The role of specific signaling pathways induced and regulated during hemibiotroph-plant interactions has been widely debated. Some studies report SA mediated defense while others hypothesize that JA responses restrict the spread of pathogens. This study aimed to identify the role of SA- and JA- associated genes in the defense strategy of a resistant avocado rootstock, Dusa in response to Pc infection. Transcripts associated with SA-mediated defense pathways and lignin biosynthesis were upregulated at 6 hours post-inoculation (hpi). Results suggest that auxin, reactive oxygen species (ROS) and Ca2+ signaling was also important during this early time point, while JA signaling was absent. Both SA and JA defense responses were shown to play a role during defense at 18 hpi. Induction of genes associated with ROS detoxification and cell wall digestion (beta-1-3-glucanase) was also observed. Most genes induced at 24 hpi were linked to JA responses. Other processes at play in avocado at 24 hpi include cell wall strengthening, the formation of phenolics and induction of arabinogalactan, a gene linked to Pc zoospore immobility. This study represents the first transcriptome wide analysis of a resistant avocado rootstock treated with SA and JA compared to Pc infection. The results provide evidence of a biphasic defense response against the hemibiotroph, which initially involves SA-mediated gene expression followed by the enrichment of JA-mediated defense from 18 to 24 hpi. Genes and molecular pathways linked to Pc resistance are highlighted and may serve as future targets for manipulation in the development of PRR resistant avocado rootstocks.	[van den Berg, Noelani; Mahomed, Waheed; Swart, Velushka] Univ Pretoria, Dept Biochem Genet & Microbiol, Pretoria, Gauteng, South Africa; [van den Berg, Noelani; Mahomed, Waheed; Olivier, Nicholas A.; Swart, Velushka; Crampton, Bridget G.] Univ Pretoria, FABI, Pretoria, Gauteng, South Africa; [Olivier, Nicholas A.; Crampton, Bridget G.] Univ Pretoria, Dept Plant & Soil Sci, Pretoria, Gauteng, South Africa; [Olivier, Nicholas A.] Univ Pretoria, African Ctr Gene Technol Microarray Facil, Pretoria, Gauteng, South Africa	University of Pretoria; University of Pretoria; University of Pretoria; University of Pretoria	van den Berg, N (corresponding author), Univ Pretoria, Dept Biochem Genet & Microbiol, Pretoria, Gauteng, South Africa.; van den Berg, N (corresponding author), Univ Pretoria, FABI, Pretoria, Gauteng, South Africa.	noelani.vdberg@fabi.up.ac.za		Olivier, Nicholas/0000-0002-1719-7319; Swart, Velushka/0000-0001-9687-5650	Hans Merensky foundation; THRIP programme of the National Research Foundation of South Africa [TP14080787841]	Hans Merensky foundation; THRIP programme of the National Research Foundation of South Africa	The authors would like to thank the Hans Merensky foundation and the THRIP programme (TP14080787841) of the National Research Foundation of South Africa for funding. Trees were provided by Westfalia Technological Services.	Abuqamar S, 2013, MOL PLANT PATHOL, V14, P813, DOI 10.1111/mpp.12049; Acosta-Muniz CH, 2012, PHYSIOL PLANTARUM, V144, P59, DOI 10.1111/j.1399-3054.2011.01522.x; ALEXANDER D, 1993, P NATL ACAD SCI USA, V90, P7327, DOI 10.1073/pnas.90.15.7327; Allardyce JA, 2013, FUNCT INTEGR GENOMIC, V13, P217, DOI 10.1007/s10142-013-0314-7; Attard A, 2010, NEW PHYTOL, V187, P449, DOI 10.1111/j.1469-8137.2010.03272.x; Backer R, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00300; Balasubramanian V, 2012, BIOTECHNOL LETT, V34, P1983, DOI 10.1007/s10529-012-1012-6; Bartwal A, 2013, J PLANT GROWTH REGUL, V32, P216, DOI 10.1007/s00344-012-9272-x; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Bhavani P, 2013, GSTF INT J BIOFORMAT, V2, P1; Birkenbihl RP, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00076; Bittner-Eddy P, 1999, MOL PLANT MICROBE IN, V12, P792, DOI 10.1094/MPMI.1999.12.9.792; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campos ML, 2014, J CHEM ECOL, V40, P657, DOI 10.1007/s10886-014-0468-3; Campos ML, 2014, J CHEM ECOL, P1; Cannesan MA, 2012, PLANT PHYSIOL, V159, P1658, DOI 10.1104/pp.112.198507; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chen TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080816; Cohn J, 2001, CURR OPIN IMMUNOL, V13, P55, DOI 10.1016/S0952-7915(00)00182-5; Cook DE, 2015, ANNU REV PHYTOPATHOL, V53, P541, DOI 10.1146/annurev-phyto-080614-120114; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Csiszar J, 2014, PLANT PHYSIOL BIOCH, V78, P15, DOI 10.1016/j.plaphy.2014.02.010; Cui J, 2017, PLANT J, V89, P577, DOI 10.1111/tpj.13408; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; De Vleesschauwer D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00611; deBruxelles GL, 1996, PLANT PHYSIOL, V111, P381, DOI 10.1104/pp.111.2.381; del Rio LA, 2015, J EXP BOT, V66, P2827, DOI 10.1093/jxb/erv099; DEMPSEY DA, 1995, B I PASTEUR, V93, P167, DOI 10.1016/0020-2452(96)81488-6; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Encino-Lopez J, 2011, J PLANT PATHOLOGY MI, V2, P113; Engelbrecht J, 2013, PLANT DIS, V97, P1012, DOI 10.1094/PDIS-11-12-1007-RE; Engelbrecht J, 2013, S AFR J SCI, V109, DOI 10.1590/sajs.2013/20120058; Galli V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083727; Garcia-Pineda E, 2010, PLANT SOIL, V331, P45, DOI 10.1007/s11104-009-0225-5; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Guo YJ, 2009, BIOINFORMATICS, V25, P1195, DOI 10.1093/bioinformatics/btp129; Hardham AR, 2007, CELL MICROBIOL, V9, P31, DOI 10.1111/j.1462-5822.2006.00833.x; Hardham AR, 2005, MOL PLANT PATHOL, V6, P589, DOI 10.1111/J.1364-3703.2005.00308.X; Harvey JJW, 2008, MOL GENET GENOMICS, V279, P509, DOI 10.1007/s00438-008-0329-2; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Herrera-Vasquez A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00171; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; LAMB CJ, 1989, CELL, V56, P215, DOI 10.1016/0092-8674(89)90894-5; Leszczyszyn OI, 2013, METALLOMICS, V5, P1146, DOI 10.1039/c3mt00072a; Li HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023145; Li ST, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-295; Li XL, 2015, PLANT PHYSIOL BIOCH, V95, P1, DOI 10.1016/j.plaphy.2015.06.016; Liu QQ, 2017, MOL PLANT, V10, P483, DOI 10.1016/j.molp.2017.02.002; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Mahomed W, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-167; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; Metraux JP, 2002, TRENDS PLANT SCI, V7, P332, DOI 10.1016/S1360-1385(02)02313-0; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Moy P, 2004, MOL PLANT MICROBE IN, V17, P1051, DOI 10.1094/MPMI.2004.17.10.1051; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Nersissian AM, 1998, PROTEIN SCI, V7, P1915, DOI 10.1002/pro.5560070907; Nguema-Ona E, 2013, TRENDS PLANT SCI, V18, P445, DOI 10.1016/j.tplants.2013.03.006; NIDERMAN T, 1995, PLANT PHYSIOL, V108, P17, DOI 10.1104/pp.108.1.17; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; Oliver RP, 2004, MOL PLANT PATHOL, V5, P347, DOI 10.1111/j.1364-3703.2004.00228.x; Osswald W, 2014, FOREST PATHOL, V44, P169, DOI 10.1111/efp.12096; OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Reeksting BJ, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0893-2; Reeksting BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086399; Restrepo S, 2005, MOL PLANT MICROBE IN, V18, P913, DOI 10.1094/MPMI-18-0913; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Richard S, 2000, PLANT CELL PHYSIOL, V41, P982, DOI 10.1093/pcp/pcd017; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Robinson LH, 2003, AUSTRALAS PLANT PATH, V32, P53, DOI 10.1071/AP02064; Rookes JE, 2008, PHYSIOL MOL PLANT P, V72, P151, DOI 10.1016/j.pmpp.2008.08.005; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salzman RA, 2005, PLANT PHYSIOL, V138, P352, DOI 10.1104/pp.104.058206; Sanchez-Perez JDL, 2009, EUR J PLANT PATHOL, V124, P595, DOI 10.1007/s10658-009-9446-y; Santino A, 2013, PLANT CELL REP, V32, P1085, DOI 10.1007/s00299-013-1441-2; Schaller F, 2000, PLANTA, V210, P979, DOI 10.1007/s004250050706; Schrot J, 2015, TOXINS, V7, P1556, DOI 10.3390/toxins7051556; Sengupta D, 2015, J PLANT PHYSIOL, V179, P40, DOI 10.1016/j.jplph.2015.03.004; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Thatcher LF, 2005, FUNCT PLANT BIOL, V32, P1, DOI 10.1071/FP04135; Tobias P., 2012, MACQUARIE MATRIX, V2, P134; Tran LT, 2011, PLANTA, V234, P799, DOI 10.1007/s00425-011-1441-9; van den Berg N, 2018, PLANT PATHOL, V67, P1150, DOI 10.1111/ppa.12819; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vleeshouwers VGAA, 2000, PLANTA, V210, P853, DOI 10.1007/s004250050690; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; WANG MC, 1966, BIOCHEM BIOPH RES CO, V24, P832, DOI 10.1016/0006-291X(66)90323-8; Wang Y, 2013, PLANT CELL ENVIRON, V36, P1192, DOI 10.1111/pce.12052; Whitworth GB, 2010, METHOD ENZYMOL, V470, P19, DOI 10.1016/S0076-6879(10)70002-1; Zhang YG, 2011, J PLANT BIOL, V54, P303, DOI 10.1007/s12374-011-9167-6; Zhong RQ, 2000, PLANT PHYSIOL, V124, P563, DOI 10.1104/pp.124.2.563; Zhou C, 2010, J PROTEOME RES, V9, P5025, DOI 10.1021/pr100249c; Zhou ML, 2013, FUNCT INTEGR GENOMIC, V13, P241, DOI 10.1007/s10142-013-0316-5	103	18	18	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205705	10.1371/journal.pone.0205705	http://dx.doi.org/10.1371/journal.pone.0205705			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332458	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200064
J	Kressner, M; Arlt, F; Riepl, W; Meixensberger, J				Kressner, Maika; Arlt, Felix; Riepl, Wolf; Meixensberger, Juergen			Prognostic factors of microsurgical treatment of intracranial meningiomas - A multivariate analysis	PLOS ONE			English	Article							LIFE FOLLOWING SURGERY; MORBIDITY; RESECTION; SURVIVAL; POPULATION; SERIES; BASE	Objective Peri- and postoperative time course of meningioma patients who had undergone surgical treatment was evaluated to determine prognostic factors of neurological outcome by focusing on preoperative parameters. Material and methods A retrospective monocenter analysis was performed including patients who were operated in the Department of Neurosurgery, University Hospital Leipzig, from 2009 to 2015. Data from all patients with histologically confirmed diagnosis of intracranial meningioma treated microsurgically were included in the study. The individual characteristics of the patients, meningiomas and Karnofsky Performance scores (KPS) were analyzed by multivariate tests. Results Two hundred ninety-four patients with a median age of 61 years (range: 17-89) were included. Preoperative KPS (p < 0.001), skull base as tumor origin and tumor size (p < 0.05) proved to be significantly strong prognostic factors of KPS deterioration one year postoperative by multivariate analysis. According to uni- and bivariate analysis, the following prognostic factors could also be found: preoperative mass displacement, preexisting recurrence and presence of preoperative symptoms. In this study, age had no significant influence on deterioration in patient health state, measured by KPS, one year postoperative. Conclusion Patients generally obtained an improvement in KPS score after microsurgical treatment. The knowledge of prognostic factors can be very helpful in the decision-making process for meningioma treatment of the elderly, particularly to estimate the postoperative outcome and quality of life.	[Kressner, Maika; Arlt, Felix; Meixensberger, Juergen] Univ Hosp Leipzig, Dept Neurosurg, Leipzig, Germany; [Riepl, Wolf] Social Sci Res, Dresden, Germany	Leipzig University	Meixensberger, J (corresponding author), Univ Hosp Leipzig, Dept Neurosurg, Leipzig, Germany.	Juergen.Meixensberger@medizin.Uni-Leipzig.de						ADEGBITE AB, 1983, J NEUROSURG, V58, P51, DOI 10.3171/jns.1983.58.1.0051; Aizer AA, 2015, CANCER-AM CANCER SOC, V121, P4376, DOI 10.1002/cncr.29639; Anvari Kazem, 2016, Adv Biomed Res, V5, P83, DOI 10.4103/2277-9175.182214; AWAD IA, 1989, NEUROSURGERY, V24, P557, DOI 10.1227/00006123-198904000-00011; CHAN RC, 1984, J NEUROSURG, V60, P52, DOI 10.3171/jns.1984.60.1.0052; Cohen-Inbar O, 2010, ACTA NEUROCHIR, V152, P87, DOI 10.1007/s00701-009-0552-6; Dobran M, 2018, CLIN NEUROL NEUROSUR, V167, P173, DOI 10.1016/j.clineuro.2018.02.024; dos Santos CB, 2011, J NEUROSCI BEHAV HLT, V3, P8; Duntze J, 2012, NEUROCHIRURGIE, V58, P275, DOI 10.1016/j.neuchi.2012.01.006; Fernandez Christian, 2016, Adv Radiat Oncol, V1, P89, DOI 10.1016/j.adro.2016.03.001; GIJTENBEEK JMM, 1993, CLIN NEUROL NEUROSUR, V95, P291, DOI 10.1016/0303-8467(93)90104-O; Han MS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004705; Hasseleid BF, 2012, J NEUROSURG, V117, P999, DOI 10.3171/2012.9.JNS12294; Kalkanis SN, 2000, J NEURO-ONCOL, V48, P233, DOI 10.1023/A:1006476604338; Konglund A, 2013, ACTA NEUROCHIR, V155, P2263, DOI 10.1007/s00701-013-1872-0; Kotecha RS, 2013, CANCER-AM CANCER SOC, V119, P4350, DOI 10.1002/cncr.28366; Lin QT, 2016, EXP THER MED, V11, P2537, DOI 10.3892/etm.2016.3223; LONGSTRETH WT, 1993, CANCER, V72, P639, DOI 10.1002/1097-0142(19930801)72:3<639::AID-CNCR2820720304>3.0.CO;2-P; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2000, PATHOLOGY GENETICS T, P176; Thenier-Villa J, 2017, NEUROL MED-CHIR, V57, P35, DOI 10.2176/nmc.oa.2016-0169; Margalit N, 2013, J NEUROL SURG PART B, V74, P247, DOI 10.1055/s-0033-1342920; Markovic M, 2013, J BUON, V18, P430; McCarthy BJ, 1998, J NEUROSURG, V88, P831, DOI 10.3171/jns.1998.88.5.0831; Meister T., 1995, EVALUIERUNG PROGNOST; Miao YF, 2010, J CLIN NEUROSCI, V17, P446, DOI 10.1016/j.jocn.2009.07.111; Pechlivanis I, 2011, J NEUROSURG SCI, V55, P319; Rogers L, 2015, J NEUROSURG, V122, P4, DOI 10.3171/2014.7.JNS131644; SANKILA R, 1992, CANCER-AM CANCER SOC, V70, P1568, DOI 10.1002/1097-0142(19920915)70:6<1568::AID-CNCR2820700621>3.0.CO;2-Y; Saraf S, 2011, ONCOLOGIST, V16, P1604, DOI 10.1634/theoncologist.2011-0193; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; UMANSKY F, 1992, J NEUROL NEUROSUR PS, V55, P481, DOI 10.1136/jnnp.55.6.481; Wang YC, 2015, CLIN NEUROL NEUROSUR, V128, P112, DOI 10.1016/j.clineuro.2014.11.009; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Wu Hong-jie, 2011, Zhonghua Yi Xue Za Zhi, V91, P1051; Yamaguchi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097108; YATES JW, 1980, CANCER, V45, P2220, DOI 10.1002/1097-0142(19800415)45:8<2220::AID-CNCR2820450835>3.0.CO;2-Q; Zaher A, 2013, WORLD NEUROSURG, V80, P549, DOI 10.1016/j.wneu.2013.07.001	38	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0202520	10.1371/journal.pone.0202520	http://dx.doi.org/10.1371/journal.pone.0202520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325925	Green Submitted, Green Published, gold			2022-12-26	WOS:000447430800004
J	Peng, YC; Jiang, YM; Lu, J; Zou, YJ				Peng, Yichuan; Jiang, Yuming; Lu, Jian; Zou, Yajie			Examining the effect of adverse weather on road transportation using weather and traffic sensors	PLOS ONE			English	Article							VISIBILITY RELATED CRASHES; REDUCED VISIBILITY; IMPACT; PREDICTION; EXPERIENCE; BEHAVIORS; SIMULATOR; NETWORK; SAFETY	Adverse weather related to reduced visibility caused by fog and rain can seriously affect the mobility and safety of drivers. It is meaningful to develop effective intelligent transportation system (ITS) strategies to mitigate the negative effects of these different types of adverse weather related to reduced visibility by investigating the effect of rain and fog on traffic parameters. A number of previous researches focused on analyzing the effect of adverse weather related to reduced visibility by using simulated traffic and weather data. There are few researchers that addressed the impact of adverse weather instances using real-time data. Moreover, this paper conducts comprehensive investigation to clearly compare the changes of driving behavior and traffic parameters in adverse weather including fog and rain using real-time traffic and weather data collected by advanced vehicle-based traffic sensors and weather sensors. After some preliminary analysis, the analysis of variance method (ANOVA) was applied to further compare the significance of effects of these two kinds of adverse weather on traffic parameters. The conditional regression models were employed finally to explore the relationship between these two types of adverse weather and traffic parameters. The results would be beneficial to develop effective intelligent traffic control countermeasures under these different types of adverse weather conditions related to reduced visibility.	[Peng, Yichuan; Jiang, Yuming; Lu, Jian; Zou, Yajie] Tongji Univ, Minist Educ, Key Lab Rd & Traff Engn, Shanghai, Peoples R China	Tongji University	Lu, J (corresponding author), Tongji Univ, Minist Educ, Key Lab Rd & Traff Engn, Shanghai, Peoples R China.	jianjohnlu@tongji.edu.cn		peng, yichuan/0000-0002-6234-8083	Florida Department of Transportation, National Center for Transportation Systems Productivity and Management; Chinese National Science Foundation [71601143]; Shanghai Pujiang Program [16PJC088]; Florida Department of Transportation (FDOT); National Center for Transportation Systems Productivity and Management (NCTSPM)	Florida Department of Transportation, National Center for Transportation Systems Productivity and Management; Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Florida Department of Transportation (FDOT); National Center for Transportation Systems Productivity and Management (NCTSPM)	This work received support from the Florida Department of Transportation, National Center for Transportation Systems Productivity and Management, Chinese National Science Foundation (71601143), and Shanghai Pujiang Program (16PJC088).; The authors wish to thank the Florida Department of Transportation (FDOT) for providing the data that were used in this study, and for funding this research. The authors also thank Dr. Aty and Dr Amr Oloufa of UCF for their contributions to this study. The authors wish to thank the National Center for Transportation Systems Productivity and Management (NCTSPM) for partly funding this research. This study was also sponsored by the Chinese National Science Foundation (71601143) and Shanghai Pujiang Program (16PJC088).	Abdel-Aty M, 2004, PREDICTING FREEWAY C; Abdel-Aty MA, 2012, TRANSPORT RES C-EMER, V24, P288, DOI 10.1016/j.trc.2012.04.001; Ahmed M, 2014, J TRANSP SAF SECUR, V6, P183, DOI 10.1080/19439962.2013.824055; Bocker L, 2013, TRANSPORT REV, V33, P71, DOI 10.1080/01441647.2012.747114; Broughton KLM, 2007, ACCIDENT ANAL PREV, V39, P106, DOI 10.1016/j.aap.2006.06.009; Chen P, 2018, EXPERT SYSTEMS APPL; Cools M, 2010, WEATHER CLIM SOC, V2, P60, DOI 10.1175/2009WCAS1014.1; Datla S, 2008, J TRANSP GEOGR, V16, P358, DOI 10.1016/j.jtrangeo.2007.12.003; Edwards J. B., 1999, TRANSPORT RES F-TRAF, V2, P1, DOI [10.1016/S1369-8478(99)00003-0, DOI 10.1016/S1369-8478(99)00003-0]; Ghasemzadeh A, 2018, TRANSPORT RES C-EMER, V90, P379, DOI 10.1016/j.trc.2018.03.018; Hassan HM, 2013, J SAFETY RES, V45, P29, DOI 10.1016/j.jsr.2012.12.004; Jomaa D., 2013, J TRANSPORTATION TEC, V3, P123, DOI [10.4236/jtts.2013.32012, DOI 10.4236/JTTS.2013.32012]; Kilpelainen M, 2007, TRANSPORT RES F-TRAF, V10, P288, DOI 10.1016/j.trf.2006.11.002; Konstantopoulos P, 2010, ACCIDENT ANAL PREV, V42, P827, DOI 10.1016/j.aap.2009.09.022; Leviakangas P, 2010, P 17 WORLD C ITS BUS, P25; Ma XL, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040818; Ma XL, 2015, TRANSPORT RES C-EMER, V54, P187, DOI 10.1016/j.trc.2015.03.014; Mueller AS, 2012, ACCIDENT ANAL PREV, V48, P472, DOI 10.1016/j.aap.2012.03.003; Peng YC, 2017, TRANSPORT RES C-EMER, V74, P295, DOI 10.1016/j.trc.2016.11.022; Shahabi M, 2012, WVU201001; Tang JJ, 2018, PHYSICA A, V493, P430, DOI 10.1016/j.physa.2017.11.114; Tang JJ, 2018, EXPERT SYST APPL, V91, P452, DOI 10.1016/j.eswa.2017.09.025; Wang Y, 2017, J CLEAN PROD, V144, P203, DOI 10.1016/j.jclepro.2017.01.001; Yan XD, 2014, SAFETY SCI, V68, P275, DOI 10.1016/j.ssci.2014.04.013; Yan Y, 2017, PHYSICA A, V477, P149, DOI 10.1016/j.physa.2017.02.040; Ye X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197338; Zou YJ, 2018, J APPL STAT, V45, P1652, DOI 10.1080/02664763.2017.1389863	27	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205409	10.1371/journal.pone.0205409	http://dx.doi.org/10.1371/journal.pone.0205409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0VS	30325948	Green Published, Green Submitted, gold			2022-12-26	WOS:000447430800021
J	Altamirano-Torres, C; Salinas-Hernandez, JE; Cardenas-Chavez, DL; Rodriguez-Padilla, C; Resendez-Perez, D				Altamirano-Torres, Claudia; Salinas-Hernandez, Jannet E.; Cardenas-Chavez, Diana L.; Rodriguez-Padilla, Cristina; Resendez-Perez, Diana			Transcription factor TFIIE beta interacts with two exposed positions in helix 2 of the Antennapedia homeodomain to control homeotic function in Drosophila	PLOS ONE			English	Article							ECTOPIC EXPRESSION; YPWM MOTIF; HOX; PROTEINS; RECOGNITION; SPECIFICITY; DOMAIN; GENES; ROLES; BODY	Homeoproteins contain the conserved homeodomain (HD) and have an important role determining embryo body plan during development. HDs increase their DNA-binding specificity by interacting with additional cofactors outlining a Hox interactome with a multiplicity of protein-protein interactions. In Drosophila, the first link of functional contact with a general transcription factor (GTF) was found between Antennapedia (Antp) and BIP2 (TFIID complex). Hox proteins also interact with other components of Pol II machinery such as the subunit Med19 from Mediator (MED) complex, TFIIE beta and transcription-pausing factor M1BP. All these interactions clearly demonstrate Hox-driven transcriptional regulation, but the precise molecular mechanism remains unclear. In this paper, we focused on the Antp-TFIIE beta protein-protein interface to establish the specific contacts as well as its functional role. Using Bimolecular Fluorescence Complementation (BiFC) in cell culture and in vivo we found that TFIIE beta interacts with Antp through the HD independently of the YPWM motif and the direct physical interaction is at helix 2, specifically aminoacidic positions I32 and H36 of Antp. We also found, through ectopic assays, that these two positions in helix 2 are crucial for Antp homeotic function in head involution, and thoracic and antenna-to tarsus transformations. Interestingly, overexpression of Antp and TFIIE beta in the antennal disc showed that this interaction is required for the antenna-to-tarsus transformation. In conclusion, interaction of Antp with TFIIE beta is important for the functional specificity of Antennapedia, and amino acids 32 and 36 in Antp HD helix 2 are key for this interaction. Our results open the possibility to more broadly analyze Antp-TFIIE beta interaction on the transcriptional control for the activation and/or repression of target genes in the Hox interactome during Drosophila development.	[Altamirano-Torres, Claudia; Salinas-Hernandez, Jannet E.; Cardenas-Chavez, Diana L.; Rodriguez-Padilla, Cristina; Resendez-Perez, Diana] Univ Autonoma Nuevo Leon, Dept Virol & Immunol, Coll Biol Sci, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Altamirano-Torres, Claudia; Resendez-Perez, Diana] Univ Autonoma Nuevo Leon, Dept Cell Biol & Genet, Coll Biol Sci, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Salinas-Hernandez, Jannet E.] Univ Autonoma Nuevo Leon, Res Dept, Ctr Res & Dev Bilingual Educ, Monterrey, Nuevo Leon, Mexico; [Cardenas-Chavez, Diana L.] Tecnol Monterrey, Sch Sci & Engn, Puebla, Puebla, Mexico	Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; Tecnologico de Monterrey	Resendez-Perez, D (corresponding author), Univ Autonoma Nuevo Leon, Dept Virol & Immunol, Coll Biol Sci, San Nicolas De Los Garza, Nuevo Leon, Mexico.; Resendez-Perez, D (corresponding author), Univ Autonoma Nuevo Leon, Dept Cell Biol & Genet, Coll Biol Sci, San Nicolas De Los Garza, Nuevo Leon, Mexico.	diana.resendezpr@uanl.edu.mx	Resendez-Perez, Diana/AAE-3352-2019	Resendez-Perez, Diana/0000-0002-4709-7677; Altamirano-Torres, Claudia/0000-0001-5919-0660	Consejo Nacional de Ciencia y Tecnologia [181075, INFRA-2014-228193, 418086/260582]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants No. 181075 and INFRA-2014-228193 from Consejo Nacional de Ciencia y Tecnologia (www.conacyt.gob.mx). CAT was supported by graduate fellowship No. 418086/260582 from Consejo Nacional de Ciencia y Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeza M, 2015, ELIFE, V4, DOI 10.7554/eLife.06034; Bobola N, 2017, CURR OPIN GENET DEV, V43, P1, DOI 10.1016/j.gde.2016.09.008; Bondos SE, 2006, MOL CELL PROTEOMICS, V5, P824, DOI 10.1074/mcp.M500256-MCP200; Boube M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004303; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Cerda-Esteban N, 2014, DEV DYNAM, V243, P76, DOI 10.1002/dvdy.24075; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Emerald BS, 2003, DEVELOPMENT, V130, P1171, DOI 10.1242/dev.00323; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GIBSON G, 1988, DEVELOPMENT, V102, P657; Hudry B, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-5; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; LAI JS, 1992, GENE DEV, V6, P2058, DOI 10.1101/gad.6.11.2058; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; Papadopoulos DK, 2012, DEV BIOL, V367, P78, DOI 10.1016/j.ydbio.2012.04.021; Papadopoulos DK, 2011, P NATL ACAD SCI USA, V108, P11959, DOI 10.1073/pnas.1108686108; Plaza S, 2008, P NATL ACAD SCI USA, V105, P13439, DOI 10.1073/pnas.0806106105; POMERANTZ JL, 1992, GENE DEV, V6, P2047, DOI 10.1101/gad.6.11.2047; Prince F, 2008, DEVELOPMENT, V135, P1669, DOI 10.1242/dev.018028; SAUER F, 1995, NATURE, V375, P162, DOI 10.1038/375162a0; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; SUMIMOTO H, 1991, NATURE, V354, P401, DOI 10.1038/354401a0; Taniguchi Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/591374; Zouaz A, 2017, EMBO J	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205905	10.1371/journal.pone.0205905	http://dx.doi.org/10.1371/journal.pone.0205905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321227	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000447417900064
J	Carco, G; Gallo, L; Dalla Bona, M; Latorre, MA; Fondevila, M; Schiavon, S				Carco, Giuseppe; Gallo, Luigi; Dalla Bona, Mirco; Angeles Latorre, Maria; Fondevila, Manuel; Schiavon, Stefano			The influence of feeding behaviour on growth performance, carcass and meat characteristics of growing pigs	PLOS ONE			English	Article							HOUSED LARGE WHITE; FINISHING PIGS; FOOD-INTAKE; INTAKE PATTERN; PARAMETERS; EFFICIENCY; ANIMALS; PREDICT; TRAITS; TIME	This study investigated the effect of the feeding behaviour on growth performance, and carcass and meat characteristics of 96 barrows fed ad libitum or restrictively with high or low amino acids (AA) diets according to a 2 x 2 factorial design. The feeding behaviour traits were measured with automated feeders. From 86 kg BW, half of the pigs were given feeds with high indispensable (AA) contents, while the other half received feeds with indispensable AA contents reduced by 9% in early finishing (86-118 kg BW) and by 18% in late finishing (118-145 kg BW). Body lipid and protein retentions were estimated from BW and backfat depth measures recorded at the beginning and end of each period. Pigs were slaughtered at 145 kg BW and carcass and meat quality data were recorded. Phenotypic correlations among feeding behaviours, growth performances, and carcass and meat traits were computed from all the data after adjustment for the effects of feeding treatments. As feeding rate was the behavioural trait most highly correlated with performance and carcass traits, the records of each pig were classified into feeding rate tertiles. Then, the data were statistically analysed using a mixed model, which included feed restriction (FR), AA reduction (AAR), the FR x AAR interaction and the feeding rate tertile as fixed factors, and pen as a random factor. Pigs eating faster (52.1 to 118.9 g/min) had significantly greater final body weights (16%), average daily weight gains (27%), estimated protein gains (22%), estimated lipid retention (46%), carcass weights (16%), weights of lean cuts (14%), weights of fat cuts (21%), proportions of fat in the carcass (14%), and 4% lower proportions of carcass lean cuts than pigs eating slowly (12.6 to 38.2 g/min). Manipulating the eating rate, through management or genetic strategies, could affect feed intake and subsequent growth performance, hence carcass quality, but have little influence on feed efficiency.	[Carco, Giuseppe; Gallo, Luigi; Dalla Bona, Mirco; Schiavon, Stefano] Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Padua, Italy; [Angeles Latorre, Maria; Fondevila, Manuel] Univ Zaragoza, Dept Anim Prod & Food Sci, CITA IA2, Zaragoza, Spain	University of Padua; University of Zaragoza	Carco, G (corresponding author), Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Padua, Italy.	giuseppe.carco@phd.unipd.it	Schiavon, Stefano/C-6253-2011	Schiavon, Stefano/0000-0002-5539-8947	University of Padua [CPDR143385/ 2014, DOR1655405/2016, DOR1770032/17]; Regione Veneto under grant P.O.R. - F.S. E. [2105-41- 2121-2015]; Veronesi SPA (Quinto di Valpantena, Verona, Italy); Aldo Gini Foundation (Via Portello 15, Padua, Italy)	University of Padua; Regione Veneto under grant P.O.R. - F.S. E.; Veronesi SPA (Quinto di Valpantena, Verona, Italy); Aldo Gini Foundation (Via Portello 15, Padua, Italy)	This research was funded by the University of Padua under grants CPDR143385/ 2014, DOR1655405/2016, DOR1770032/17 (to SS), and Regione Veneto under grant P.O.R. - F.S. E. n. 2105-41- 2121-2015 (to MD). The authors would like to thank Veronesi SPA (Quinto di Valpantena, Verona, Italy) (http://www.veronesi.it/) (to SS) for financial and technical support and the Aldo Gini Foundation (Via Portello 15, Padua, Italy) for supporting the research activities of PhD student Giuseppe Carco, during his study period at the University of Zaragoza (http://www.unipd.it/fondazione-gini) (GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretta I, 2016, J ANIM SCI, V94, P3042, DOI 10.2527/jas.2016-0392; (AOAC) International A of OAC, 2012, OFF METH AN ASS OFF; Bornett HLI, 2000, ANIM SCI, V70, P457, DOI 10.1017/S135772980005181X; Carco G, 2018, APPL ANIM BEHAV SCI, V198, P27, DOI 10.1016/j.applanim.2017.09.020; Colpoys JD, 2016, PHYSIOL BEHAV, V159, P27, DOI 10.1016/j.physbeh.2016.03.003; DEHAER LCM, 1993, LIVEST PROD SCI, V33, P277, DOI 10.1016/0301-6226(93)90008-6; DEHAER LCM, 1993, LIVEST PROD SCI, V36, P233, DOI 10.1016/0301-6226(93)90056-N; DEHAER LCM, 1992, ANIM PROD, V54, P95, DOI 10.1017/S0003356100020614; Emmans G, 2001, P NUTR SOC, V60, P115, DOI 10.1079/PNS200059; Emmans GC, 1997, J THEOR BIOL, V186, P189, DOI 10.1006/jtbi.1996.0357; Ferguson NS, 2000, ANIM SCI, V70, P287, DOI 10.1017/S1357729800054746; Hyun Y, 1997, J ANIM SCI, V75, P1443; Kloareg M, 2006, ANIM SCI, V82, P241, DOI 10.1079/ASC200529; Labroue F, 1997, GENET SEL EVOL, V29, P451, DOI 10.1051/gse:19970403; LABROUE F, 1994, LIVEST PROD SCI, V40, P303, DOI 10.1016/0301-6226(94)90097-3; Le Naou T, 2014, J ANIM SCI, V92, P2008, DOI 10.2527/jas.2013-7505; Maselyne J, 2015, PHYSIOL BEHAV, V138, P37, DOI 10.1016/j.physbeh.2014.09.012; Meunier-Salaun MC, 2014, ANIMAL, V8, P1898, DOI 10.1017/S1751731114001839; Mordenti A, 2003, ITAL J ANIM SCI, V2, P73, DOI 10.4081/ijas.2003.73; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Newman RE, 2014, ANIM PROD SCI, V54, P319, DOI 10.1071/AN13120; Nielsen BL, 1999, APPL ANIM BEHAV SCI, V63, P79, DOI 10.1016/S0168-1591(99)00003-9; NIELSEN BL, 1995, LIVEST PROD SCI, V44, P73, DOI 10.1016/0301-6226(95)00060-X; Nyachoti CM, 2004, CAN J ANIM SCI, V84, P549, DOI 10.4141/A04-001; Rauw WM, 2006, J ANIM SCI, V84, P3404, DOI 10.2527/jas.2006-209; Ravarotto V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204618; SAS. SAS Institute, 2009, SAS STAT 9 4; Schiavon S, 2000, BRIT J NUTR, V84, P873; Schneider JD, 2011, J ANIM SCI, V89, P3326, DOI 10.2527/jas.2010-3154; Schulze V, 2003, LIVEST PROD SCI, V82, P105, DOI 10.1016/S0301-6226(03)00034-4; Topigs, 2012, FEED MAN TAL; VonFelde A, 1996, LIVEST PROD SCI, V47, P11, DOI 10.1016/S0301-6226(96)01006-8; YOUNG RJ, 1994, ANIM PROD, V58, P145, DOI 10.1017/S0003356100007182	33	16	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205572	10.1371/journal.pone.0205572	http://dx.doi.org/10.1371/journal.pone.0205572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321211	Green Published, gold			2022-12-26	WOS:000447417900037
J	Moon, CY; Nam, OH; Kim, M; Lee, HS; Kaushik, SN; Walma, DAC; Jun, HW; Cheon, K; Choi, SC				Moon, Chan-Yang; Nam, Ok Hyung; Kim, Misun; Lee, Hyo-Seol; Kaushik, Sagar N.; Walma, David A. Cruz; Jun, Ho-Wook; Cheon, Kyounga; Choi, Sung Chul			Effects of the nitric oxide releasing biomimetic nanomatrix gel on pulp-dentin regeneration: Pilot study	PLOS ONE			English	Article							MINERAL TRIOXIDE AGGREGATE; IMMATURE PERMANENT TEETH; PLATELET-RICH PLASMA; NEWLY FORMED TISSUES; STEM-CELLS; CALCIUM HYDROXIDE; IN-VITRO; ENDODONTIC REGENERATION; ANTIBACTERIAL EFFICACY; APICAL PERIODONTITIS	Successful disinfection alongside complete endodontic tissue regeneration and revascularization are the most desired clinical outcomes of regenerative endodontics. Despite reported clinical successes, significant limitations to the current regenerative endodontic procedure (REP) have been elucidated. To improve the current REP, an antibiotics and nitric oxide (NO) releasing biomimetic nanomatrix gel was developed. The study evaluates antibacterial effects of an antibiotics and NO releasing biomimetic nanomatrix gel on multispecies endodontic bacteria. Antibiotics, ciprofloxacin (CF) and metronidazole (MN) were mixed and encapsulated within the NO releasing biomimetic nanomatrix gel. The gel was synthesized and self-assembled from peptide amphiphiles containing various functional groups. Antibacterial effects of the antibiotics and NO releasing biomimetic nanomatrix gel were evaluated using bacterial viability assays involving endodontic microorganisms including clinical samples. Pulp-dentin regeneration was evaluated via animal-model experiments. The antibiotics and NO releasing biomimetic nanomatrix gel demonstrated a concentration dependent antibacterial effect. In addition, NO alone demonstrated a concentration dependent antibacterial effect on endodontic microorganism. An in vivo analysis demonstrated the antibiotics and NO releasing biomimetic nanomatrix gel promoted tooth revascularization with maturation of root canals. An optimal concentration of and NO releasing nanomatrix gel is suggested for its potential as a root treatment material for REP and an appropriate protocol for human trials. Further investigation is required to obtain a larger sample size and decide upon ideal growth factor incorporation.	[Moon, Chan-Yang; Nam, Ok Hyung; Kim, Misun; Lee, Hyo-Seol; Choi, Sung Chul] Kyung Hee Univ, Dept Pediat Dent, Seoul, South Korea; [Kaushik, Sagar N.; Jun, Ho-Wook] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Walma, David A. Cruz; Cheon, Kyounga] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA	Kyung Hee University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Choi, SC (corresponding author), Kyung Hee Univ, Dept Pediat Dent, Seoul, South Korea.; Cheon, K (corresponding author), Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA.	kcheon@uab.edu; pedochoi@khu.ac.kr	CHOI, SUNG CHUL/B-4574-2019; Nam, Ok Hyung/Q-9862-2019; NAM, OK HYUNG/A-9769-2019	CHOI, SUNG CHUL/0000-0001-7221-2000; Nam, Ok Hyung/0000-0002-6386-803X; NAM, OK HYUNG/0000-0002-6386-803X; Kaushik, Sagar/0000-0002-5891-5049; Kim, Mi Sun/0000-0001-8338-1838	National Institute of Dental and Craniofacial Research [KDE027401A];  [NRF-2016R1D1A1B03931063];  [2017M3A9E4048170]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE027401] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by KDE027401A (National Institute of Dental and Craniofacial Research); NRF-2016R1D1A1B03931063 and 2017M3A9E4048170. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAE, 2017, TREATM PROC AM ASS 2; AAE, 2013, REG END END COLL EXC, P1; Albuquerque MTP, 2014, J DENT RES, V93, P1222, DOI 10.1177/0022034514549809; Altaii M, 2017, DENT TRAUMATOL, V33, P235, DOI 10.1111/edt.12338; Anderson JM, 2009, ACS NANO, V3, P3447, DOI 10.1021/nn900884n; Andreasen JO, 2002, DENT TRAUMATOL, V18, P134, DOI 10.1034/j.1600-9657.2002.00097.x; Andukuri A, 2011, ACTA BIOMATER, V7, P225, DOI 10.1016/j.actbio.2010.08.013; Backlund CJ, 2014, J DENT RES, V93, P1089, DOI 10.1177/0022034514529974; Bakland LK, 2012, DENT TRAUMATOL, V28, P25, DOI 10.1111/j.1600-9657.2011.01049.x; Ban K, 2014, ACS NANO, V8, P10815, DOI 10.1021/nn504617g; Banchs F, 2004, J ENDODONT, V30, P196, DOI 10.1097/00004770-200404000-00003; Bose R, 2009, J ENDODONT, V35, P1343, DOI 10.1016/j.joen.2009.06.021; BUTLER WT, 1992, MATRIX, V12, P343, DOI 10.1016/S0934-8832(11)80030-2; Carpenter AW, 2012, CHEM SOC REV, V41, P3742, DOI 10.1039/c2cs15273h; Carrotte P, 2004, BRIT DENT J, V197, P735, DOI 10.1038/sj.bdj.4811897; Chen MYH, 2012, INT ENDOD J, V45, P294, DOI 10.1111/j.1365-2591.2011.01978.x; Chuensombat S, 2013, J ENDODONT, V39, P813, DOI 10.1016/j.joen.2012.11.041; CVEK M, 1992, ENDOD DENT TRAUMATOL, V8, P45; Dabbagh B, 2012, PEDIATR DENT, V34, P414; de Avila ED, 2015, BIOMATERIALS, V67, P84, DOI 10.1016/j.biomaterials.2015.07.030; Dimmeler S, 1999, CELL DEATH DIFFER, V6, P964, DOI 10.1038/sj.cdd.4400581; DSOUZA RN, 1995, J DENT RES, V74, P702, DOI 10.1177/00220345950740021301; Egusa H, 2012, J PROSTHODONT RES, V56, P151, DOI 10.1016/j.jpor.2012.06.001; Farges JC, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00185; Felippe WT, 2006, INT ENDOD J, V39, P2, DOI 10.1111/j.1365-2591.2005.01037.x; Galler K M, 2011, Adv Dent Res, V23, P333, DOI 10.1177/0022034511405326; Galler KM, 2008, TISSUE ENG PT A, V14, P2051, DOI 10.1089/ten.tea.2007.0413; Galler KM, 2012, TISSUE ENG PT A, V18, P176, DOI [10.1089/ten.tea.2011.0222, 10.1089/ten.TEA.2011.0222]; Galler KM, 2011, J ENDODONT, V37, P1536, DOI 10.1016/j.joen.2011.08.027; GRUETTER CA, 1979, J CYCLIC NUCL PROT, V5, P211; Hargreaves KM, 2013, J ENDODONT, V39, pS30, DOI 10.1016/j.joen.2012.11.025; Harichane Y, 2011, Adv Dent Res, V23, P307, DOI 10.1177/0022034511405322; Hetrick EM, 2008, ACS NANO, V2, P235, DOI 10.1021/nn700191f; Hoshino E, 1996, INT ENDOD J, V29, P125, DOI 10.1111/j.1365-2591.1996.tb01173.x; Hotwani Kavita, 2014, Restor Dent Endod, V39, P1, DOI 10.5395/rde.2014.39.1.1; Huang GTJ, 2009, REGEN MED, V4, P697, DOI 10.2217/RME.09.45; Huang George T-J, 2011, Front Biosci (Elite Ed), V3, P788, DOI 10.2741/e286; Iwaya S, 2001, DENT TRAUMATOL, V17, P185, DOI 10.1034/j.1600-9657.2001.017004185.x; Kaushik Sagar N, 2016, Biomater Res, V20, P14, DOI 10.1186/s40824-016-0061-7; Kaushik Sagar N, 2015, Biomater Res, V19, P9, DOI 10.1186/s40824-015-0032-4; Kim JO, 2015, INT J BIOL MACROMOL, V79, P217, DOI 10.1016/j.ijbiomac.2015.04.073; Kim ST, 2000, INT ENDOD J, V33, P233, DOI 10.1046/j.1365-2591.2000.00277.x; Kimura H, 2003, ACTA BIOCHIM POL, V50, P49; KUO PC, 1995, ANN SURG, V221, P220, DOI 10.1097/00000658-199503000-00003; Kushwaha M, 2010, BIOMATERIALS, V31, P1502, DOI 10.1016/j.biomaterials.2009.10.051; Labban N, 2014, DENT TRAUMATOL, V30, P429, DOI 10.1111/edt.12108; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Marconyak LJ, 2016, J ENDODONT, V42, P470, DOI 10.1016/j.joen.2015.10.013; McFarland J, 1907, J AMER MED ASSOC, V49, P1176; Mei YF, 2007, CELL TISSUE RES, V328, P117, DOI 10.1007/s00441-005-0003-5; Mitsiadis TA, 2012, NANOMEDICINE-UK, V7, P1743, DOI [10.2217/NNM.12.146, 10.2217/nnm.12.146]; Mujoo K, 2008, P NATL ACAD SCI USA, V105, P18924, DOI 10.1073/pnas.0810230105; Murray PE, 2007, J ENDODONT, V33, P377, DOI 10.1016/j.joen.2006.09.013; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Nosrat A, 2012, J ENDODONT, V38, P1428, DOI 10.1016/j.joen.2012.06.025; OSTBY B N, 1961, Acta Odontol Scand, V19, P324; Privett BJ, 2010, MOL PHARMACEUT, V7, P2289, DOI 10.1021/mp100248e; Rafter M, 2005, DENT TRAUMATOL, V21, P1, DOI 10.1111/j.1600-9657.2004.00284.x; Reynolds K, 2009, INT ENDOD J, V42, P84, DOI 10.1111/j.1365-2591.2008.01467.x; Rombouts C, 2017, J DENT RES, V96, P137, DOI 10.1177/0022034516671688; Rosenberg B, 2007, DENT TRAUMATOL, V23, P26, DOI 10.1111/j.1600-9657.2006.00453.x; Ruparel NB, 2012, J ENDODONT, V38, P1372, DOI 10.1016/j.joen.2012.06.018; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharin VG, 2011, STEM CELLS DEV, V20, P1287, DOI 10.1089/scd.2010.0411; Sharma Bandana, 2013, Patholog Res Int, V2013, P243168, DOI 10.1155/2013/243168; Shi S, 2005, Orthod Craniofac Res, V8, P191, DOI 10.1111/j.1601-6343.2005.00331.x; Shimizu E, 2012, J ENDODONT, V38, P1293, DOI 10.1016/j.joen.2012.06.017; Simon S, 2007, INT ENDOD J, V40, P186, DOI 10.1111/j.1365-2591.2007.01214.x; Siqueira JF, 1999, INT ENDOD J, V32, P361, DOI 10.1046/j.1365-2591.1999.00275.x; SMITH AJ, 1995, INT J DEV BIOL, V39, P273; Sun B, 2012, BIOMACROMOLECULES, V13, P3343, DOI 10.1021/bm301109c; Thomson A, 2010, AUST DENT J, V55, P446, DOI 10.1111/j.1834-7819.2010.01268.x; Torabinejad M, 2011, J ENDODONT, V37, P265, DOI 10.1016/j.joen.2010.11.004; Trevino EG, 2011, J ENDODONT, V37, P1109, DOI 10.1016/j.joen.2011.05.013; Trope M, 2008, PEDIATR DENT, V30, P206; Wang XJ, 2010, J ENDODONT, V36, P56, DOI 10.1016/j.joen.2009.09.039; Wigler R, 2013, J ENDODONT, V39, P319, DOI 10.1016/j.joen.2012.11.014; Witherspoon DE, 2008, J ENDODONT, V34, P1171, DOI 10.1016/j.joen.2008.07.005; Wu R, 2011, J BIOL CHEM, V286, P34923, DOI 10.1074/jbc.M111.239350; Yamauchi N, 2011, J ENDODONT, V37, P1636, DOI 10.1016/j.joen.2011.08.025; Yassen GH, 2013, J ENDODONT, V39, P269, DOI 10.1016/j.joen.2012.09.020; YATES JA, 1988, INT ENDOD J, V21, P313, DOI 10.1111/j.1365-2591.1988.tb01141.x; Zhu XF, 2014, J ENDODONT, V40, P1573, DOI 10.1016/j.joen.2014.05.010	84	16	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205534	10.1371/journal.pone.0205534	http://dx.doi.org/10.1371/journal.pone.0205534			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308037	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500100
J	Gentil, BJ; Lai, GT; Menade, M; Lariviere, R; Minotti, S; Gehring, K; Chapple, JP; Brais, B; Durham, HD				Gentil, Benoit J.; Gia-Thanh Lai; Menade, Marie; Lariviere, Roxanne; Minotti, Sandra; Gehring, Kalle; Chapple, J. -Paul; Brais, Bernard; Durham, Heather D.			Sacsin, mutated in the ataxia ARSACS, regulates intermediate filament assembly and dynamics	FASEB JOURNAL			English	Article						chaperone proteins; rare neurological diseases; cytoskeleton	RECESSIVE SPASTIC ATAXIA; HEAT-SHOCK PROTEINS; MARIE-TOOTH-DISEASE; MOTOR-NEURONS; NEUROFILAMENT PROTEIN; FRIEDREICHS-ATAXIA; STRESS-RESPONSE; ACIDIC PROTEIN; RADIAL GROWTH; MUTANT	Loss of sacsin, a large 520 kDa multidomain protein, causes autosomal recessive spastic ataxia of the Charlevoix-Saguenay, one of the most common childhood-onset recessive ataxias. A prominent feature is abnormal bundling of neurofilaments in many neuronal populations. This study shows the direct involvement of sacsin domains in regulating intermediate filament assembly and dynamics and identifies important domains for alleviating neurofilament bundles in neurons lacking sacsin. Peptides encoding sacsin internal repeat (SIRPT) 1, J-domains, and ubiquitin-like domain modified neurofilament assembly in vivo. The domains with chaperone homology, the SIRPT and the J-domain, had opposite effects, promoting and preventing filament assembly, respectively. In cultured Sacs(-/-) motor neurons, both the SIRPT1 and J-domain resolved preexisting neurofilament bundles. Increasing expression of heat shock proteins also resolved neurofilament bundles, indicating that this endogenous chaperone system can compensate to some extent for sacsin deficiency.Gentil, B. J., Lai, G.-T., Menade, M., Lariviere, R., Minotti, S., Gehring, K., Chapple, J.-P., Brais, B., Durham, H. D. Sacsin, mutated in the ataxia ARSACS, regulates intermediate filament assembly and dynamics.	[Gentil, Benoit J.; Gia-Thanh Lai; Minotti, Sandra; Durham, Heather D.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Gentil, Benoit J.; Gia-Thanh Lai] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Menade, Marie; Gehring, Kalle] McGill Univ, Grp Rech Axe Struct Prot, Dept Biochem, Montreal, PQ, Canada; [Lariviere, Roxanne; Brais, Bernard] McGill Univ, Montreal Neurol Inst, Lab Neurogenet Mot, Montreal, PQ, Canada; [Chapple, J. -Paul] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England	McGill University; McGill University; McGill University; McGill University; University of London; Queen Mary University London	Gentil, BJ (corresponding author), Currie Gym Off A210,475 Pine Ave West, Montreal, PQ H2W 1S4, Canada.	benoit.gentil@mcgill.ca	Gehring, Kalle/I-4403-2013; Brais, Bernard/Y-3910-2019	Gehring, Kalle/0000-0001-6500-1184; GENTIL, Benoit/0000-0003-2022-1890	Ataxia of Charlevoix-Saguenay Foundation; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/R003335/1]; BBSRC [BB/R003335/1] Funding Source: UKRI	Ataxia of Charlevoix-Saguenay Foundation; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Nicolas Sgarioto (Montreal Neurological Institute, McGill University) for the management of the Sacs<SUP>-/-</SUP> colonies. The authors thank Jeannie Mui and Dr. Vali (Facility for Electron Microscopy Research, McGill University) for help in microscope operation and data collection. This study was supported by grants from the Ataxia of Charlevoix-Saguenay Foundation (to H.D.D., B.B., K.G., and J.-P.C.) and Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/R003335/1 (to J.-P.C.). The authors declare no conflicts of interest.	Ackerley S, 2003, J CELL BIOL, V161, P489, DOI 10.1083/jcb.200303138; Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Anderson JF, 2010, J MOL BIOL, V400, P665, DOI 10.1016/j.jmb.2010.05.023; Baets J, 2010, NEUROLOGY, V75, P1181, DOI 10.1212/WNL.0b013e3181f4d86c; Batulan Z, 2003, J NEUROSCI, V23, P5789; Beaulieu JM, 1999, J CELL BIOL, V147, P531, DOI 10.1083/jcb.147.3.531; Benndorf R., 2014, MUTAT RES-REV MUTAT; BOUCHARD JP, 1979, CAN J NEUROL SCI, V6, P185, DOI 10.1017/S0317167100119614; BOUCHARD RW, 1979, CAN J NEUROL SCI, V6, P191, DOI 10.1017/S0317167100119626; Boumil EF, 2018, BIOL OPEN, V7, DOI 10.1242/bio.028795; COHLBERG JA, 1995, J BIOL CHEM, V270, P9334, DOI 10.1074/jbc.270.16.9334; COHLBERG JA, 1987, J BIOL CHEM, V262, P17009; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Deane CAS, 2016, CELL STRESS CHAPERON, V21, P837, DOI 10.1007/s12192-016-0708-2; Dekker SL, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00035; Duncan EJ, 2017, HUM MOL GENET, V26, P3130, DOI 10.1093/hmg/ddx197; El Euch-Fayache G, 2003, ARCH NEUROL-CHICAGO, V60, P982, DOI 10.1001/archneur.60.7.982; Ellis RJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0398; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Gentil BJ, 2013, INT J BIOCHEM CELL B, V45, P1499, DOI 10.1016/j.biocel.2013.04.009; Gentil BJ, 2012, FASEB J, V26, P1194, DOI 10.1096/fj.11-196345; Girard M, 2012, P NATL ACAD SCI USA, V109, P1661, DOI 10.1073/pnas.1113166109; Godsel LM, 2008, TRENDS CELL BIOL, V18, P28, DOI 10.1016/j.tcb.2007.11.004; He QX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142573; HEDBERG KK, 1986, EXP CELL RES, V163, P509, DOI 10.1016/0014-4827(86)90081-9; HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Izawa I, 2000, J BIOL CHEM, V275, P34521, DOI 10.1074/jbc.M003492200; Julien JP, 1998, PROG NUCLEIC ACID RE, V61, P1, DOI 10.1016/S0079-6603(08)60823-5; Kozlov G, 2011, J BIOL CHEM, V286, P20407, DOI 10.1074/jbc.M111.232884; Lariviere R, 2015, HUM MOL GENET, V24, P727, DOI 10.1093/hmg/ddu491; Laser-Azogui A, 2015, CURR OPIN CELL BIOL, V32, P92, DOI 10.1016/j.ceb.2015.01.003; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Lee S, 2014, J CELL SCI, V127, P4064, DOI 10.1242/jcs.153346; Leung C. L., 2006, CURR PROTOC CELL BIO; Li XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137298; Manzerra P, 1996, EXP CELL RES, V229, P35, DOI 10.1006/excr.1996.0341; MORRIS JR, 1982, J CELL BIOL, V92, P192, DOI 10.1083/jcb.92.1.192; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Ouyang Y, 2008, J NEUROL SCI, V264, P73, DOI 10.1016/j.jns.2007.07.022; Ouyang Y, 2006, NEUROLOGY, V66, P1103, DOI 10.1212/01.wnl.0000204300.94261.ea; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; Perng MD, 1999, J CELL SCI, V112, P2099; Perng MD, 2006, AM J HUM GENET, V79, P197, DOI 10.1086/504411; Robert A, 2016, BIOESSAYS, V38, P232, DOI 10.1002/bies.201500142; Romano A, 2013, HUM MUTAT, V34, P525, DOI 10.1002/humu.22269; Roy J, 1998, J NEUROSCI, V18, P9673; Sanchez I, 2000, J CELL BIOL, V151, P1013, DOI 10.1083/jcb.151.5.1013; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Tradewell ML, 2009, J NEUROPATH EXP NEUR, V68, P642, DOI 10.1097/NEN.0b013e3181a5deeb; Wiche Gerhard, 2011, Bioarchitecture, V1, P14; Wong NKY, 2000, J NEUROPATH EXP NEUR, V59, P972, DOI 10.1093/jnen/59.11.972; WONG PC, 1995, J CELL BIOL, V130, P1413, DOI 10.1083/jcb.130.6.1413; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Yuan AD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018309	61	16	16	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2982	2994		10.1096/fj.201801556R	http://dx.doi.org/10.1096/fj.201801556R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30332300	Bronze			2022-12-26	WOS:000457296600115
J	Paumier, JM; Py, NA; Garcia-Gonzalez, L; Bernard, A; Stephan, D; Louis, L; Checler, F; Khrestchatisky, M; Baranger, K; Rivera, S				Paumier, Jean-Michel; Py, Nathalie A.; Garcia-Gonzalez, Laura; Bernard, Anne; Stephan, Delphine; Louis, Laurence; Checler, Frederic; Khrestchatisky, Michel; Baranger, Kevin; Rivera, Santiago			Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking	FASEB JOURNAL			English	Article						amyloid peptide; amyloid precursor protein; Alzheimer disease; secretase; endosome	AMYLOID PRECURSOR PROTEIN; A-BETA; CELL-SURFACE; IN-VITRO; ALZHEIMERS-DISEASE; TISSUE INHIBITOR; SECRETASE; ACTIVATION; PEPTIDE; MT1-MMP	We previously demonstrated that membrane type 1 (MT1) matrix metalloproteinase (MMP) was up-regulated in the hippocampus of the model of transgenic mice bearing 5 familial mutations on human amyloid precursor protein (APP) and presenilin 1 of Alzheimer disease (AD), and that the proteinase increased the levels of amyloid peptide (A) and its APP C-terminal fragment of 99 aa in a heterologous cell system. Here we provide further evidence that MT1-MMP interacts with APP and promotes amyloidogenesis in a proteolytic-dependent manner in Swedish APP-expressing human embryonic kidney 293 (HEKswe) cells. MT1-MMP-mediated processing of APP releases a soluble APP fragment, sAPP95. This process partly requires the activation of endogenous MMP-2 but is independent of -site APP cleaving enzyme 1 (BACE-1) or -secretase activities. In contrast, MT1-MMP-mediated increase of A levels involved BACE-1 activity and was inhibited by tissue inhibitor of MMP-2, a natural inhibitor of both MT1-MMP and MMP-2. Interestingly, near abolishment of basal A production upon BACE-1 inhibition was rescued by MT1-MMP, indicating that the latter could mimic -secretase-like activity. Moreover, MT1-MMP promoted APP/A localization in endosomes, where A production mainly occurs. These data unveil new mechanistic insights to support the proamyloidogenic role of MT1-MMP based on APP processing and trafficking, and reinforce the idea that this proteinase may become a new potential therapeutic target in AD.Paumier, J.-M., Py, N. A., Gonzalez, L. G., Bernard, A., Stephan, D., Louis, L., Checler, F., Khrestchatisky, M., Baranger, K., Rivera, S. Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking.	[Paumier, Jean-Michel; Py, Nathalie A.; Garcia-Gonzalez, Laura; Bernard, Anne; Stephan, Delphine; Louis, Laurence; Khrestchatisky, Michel; Baranger, Kevin; Rivera, Santiago] Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France; [Checler, Frederic] UNS, Excellence Lab Labex Dev Innova Strategies Transd, IPMC, CNRS,UMR 7275, Valbonne, France; [Py, Nathalie A.] Neuron Experts, Fac Med Nord, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Aix-Marseille Universite	Baranger, K; Rivera, S (corresponding author), Aix Marseille Univ, CNRS, UMR 7051, Inst Neuropathophysiol INP,Fac Med Secteur Nord, CS80011,51 Bd Pierre Dramard, F-13344 Marseille 15, France.	kevin.baranger@univ-amu.fr; santiago.rivera@univ-amu.fr	Checler, Frederic/C-1241-2009	Checler, Frederic/0000-0003-2098-1750	Centre National de la Recherche Scientifique (CNRS); Aix-Marseille Universite; French National Research Agency (ANR), MAD5; Centre d'Excellence pour les Maladies Neurodegeneratives et le Vieillissement (DHUNE); Center of Excellence in Neurodegeneration (CoEN); Vaincre l'Alzheimer grants; Fonds Europeen de Developpement Regional (FEDER) in Provence-Alpes Cote d'Azur Region (PACA); Fondation pour la Recherche Medicale; Conseil General des Alpes Maritimes through the Excellence Laboratory (LabEx) Program Investment for the Future Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer Disease (DISTALZ); Excellence Initiative of Aix-Marseille Universite (A*MIDEX); French Investissements d'Avenir Programme; Fondation Plan Alzheimer; French Ministry of Research; Vaincre l'Alzheimer; ANR; France Alzheimer; French National Research Agency (ANR), PREVENTAD	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; French National Research Agency (ANR), MAD5(French National Research Agency (ANR)); Centre d'Excellence pour les Maladies Neurodegeneratives et le Vieillissement (DHUNE); Center of Excellence in Neurodegeneration (CoEN); Vaincre l'Alzheimer grants; Fonds Europeen de Developpement Regional (FEDER) in Provence-Alpes Cote d'Azur Region (PACA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil General des Alpes Maritimes through the Excellence Laboratory (LabEx) Program Investment for the Future Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer Disease (DISTALZ); Excellence Initiative of Aix-Marseille Universite (A*MIDEX)(French National Research Agency (ANR)); French Investissements d'Avenir Programme(French National Research Agency (ANR)); Fondation Plan Alzheimer; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Vaincre l'Alzheimer; ANR(French National Research Agency (ANR)); France Alzheimer; French National Research Agency (ANR), PREVENTAD(French National Research Agency (ANR))	This work was supported by funding from the Centre National de la Recherche Scientifique (CNRS) and Aix-Marseille Universite, and by public grants overseen by the French National Research Agency (ANR), MAD5 to S.R. and F.C., and PREVENTAD to M.K., as part of the second Investissements d'Avernir Program. The work was also supported by Centre d'Excellence pour les Maladies Neurodegeneratives et le Vieillissement (DHUNE), and a Center of Excellence in Neurodegeneration (CoEN) grant to S.R., by the Fondation Plan Alzheimer and France Alzheimer to S.R., by Vaincre l'Alzheimer grants to S.R., F.C., and M.K., by a grant to S.R. and M.K. from Fonds Europeen de Developpement Regional (FEDER) in Provence-Alpes Cote d'Azur Region (PACA), by grants to F.C. from Fondation pour la Recherche Medicale, and by the Conseil General des Alpes Maritimes through the Excellence Laboratory (LabEx) Program Investment for the Future Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer Disease (DISTALZ). K.B. was granted a research associate fellowship (Management of Talents) by Excellence Initiative of Aix-Marseille Universite (A*MIDEX), a French Investissements d'Avenir Programme and the Fondation Plan Alzheimer. N.P. was recipient of a doctoral fellowship from the French Ministry of Research. J.-M.P. was recipient of a doctoral fellowship from Vaincre l'Alzheimer. L.G.G. was granted by the ANR. RXP03 was kindly provided by V. Dive, and the TfR plasmid and antibodies were kindly provided by M. David. The authors declare no conflicts of interest.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Ahmad M, 2006, J BIOCHEM, V139, P517, DOI 10.1093/jb/mvj054; Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Baranger K, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00163; Baranger K, 2016, CELL MOL LIFE SCI, V73, P217, DOI 10.1007/s00018-015-1992-1; Baranger K, 2014, PROG BRAIN RES, V214, P313, DOI 10.1016/B978-0-444-63486-3.00014-1; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bylander JE, 2007, BIOL CHEM, V388, P1163, DOI 10.1515/BC.2007.156; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Caster AH, 2013, J BIOL CHEM, V288, P28567, DOI 10.1074/jbc.M113.481101; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Dive V, 2005, INT J CANCER, V113, P775, DOI 10.1002/ijc.20459; Dunys J., J BIOL CHEM; Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hara T, 2011, BIOCHEM BIOPH RES CO, V413, P277, DOI 10.1016/j.bbrc.2011.08.085; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jobin PG, 2017, BBA-MOL CELL RES, V1864, P2043, DOI 10.1016/j.bbamcr.2017.05.013; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Liao MC, 2010, BIOCHEMISTRY-US, V49, P1127, DOI 10.1021/bi901994d; Muller UC, 2017, NAT REV NEUROSCI, V18, P281, DOI 10.1038/nrn.2017.29; Neve RL, 2000, BRAIN RES, V886, P54, DOI 10.1016/S0006-8993(00)02869-9; Ogier C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-68; Ould-Yahoui A, 2013, CELL TRANSPLANT, V22, P993, DOI 10.3727/096368912X657468; Ould-yahoui A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008289; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Py NA, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00247, 10.3389/fnagi.2014.00247]; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; Rose C, 2018, NEUROBIOL AGING, V61, P23, DOI 10.1016/j.neurobiolaging.2017.09.008; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Sato H, 1996, FEBS LETT, V385, P238, DOI 10.1016/0014-5793(96)00389-4; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Tu SC, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-48; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Xie YQ, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.36; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Zhang ZT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9762	61	16	16	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2910	2927		10.1096/fj.201801076R	http://dx.doi.org/10.1096/fj.201801076R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30332299				2022-12-26	WOS:000457296600110
J	Bravo-Arredondo, JM; Kegulian, NC; Schmidt, T; Pandey, NK; Situ, AJ; Ulmer, TS; Langen, R				Bravo-Arredondo, Jose M.; Kegulian, Natalie C.; Schmidt, Thomas; Pandey, Nitin K.; Situ, Alan J.; Ulmer, Tobias S.; Langen, Ralf			The folding equilibrium of huntingtin exon 1 monomer depends on its polyglutamine tract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Huntington disease; electron paramagnetic resonance (EPR); nuclear magnetic resonance (NMR); polyglutamine; neurodegeneration; protein misfolding; conformational equilibrium	STRUCTURAL FEATURES; FLANKING SEQUENCES; SOLUTION NMR; CAG REPEAT; N-TERMINUS; DISEASE; AGGREGATION; PROTEIN; EXPANSION; CONFORMATION	Expansion of the polyglutamine (polyQ) tract in exon 1 of the huntingtin protein (Httex1) leads to Huntington's disease resulting in fatal neurodegeneration. However, it remains poorly understood how polyQ expansions alter protein structure and cause toxicity. Using CD, EPR, and NMR spectroscopy, we found here that monomeric Httex1 consists of two co-existing structural states whose ratio is determined by polyQ tract length. We observed that short Q-lengths favor a largely random-coil state, whereas long Q-lengths increase the proportion of a predominantly -helical state. We also note that by following a mobility gradient, Httex1 -helical conformation is restricted to the N-terminal N17 region and to the N-terminal portion of the adjoining polyQ tract. Structuring in both regions was interdependent and likely stabilized by tertiary contacts. Although little helicity was present in N17 alone, each Gln residue in Httex1 enhanced helix stability by 0.03-0.05 kcal/mol, causing a pronounced preference for the -helical state at pathological Q-lengths. The Q-length-dependent structuring and rigidification could be mimicked in proteins with shorter Q-lengths by a decrease in temperature, indicating that lower temperatures similarly stabilize N17 and polyQ intramolecular contacts. The more rigid -helical state of Httex1 with an expanded polyQ tract is expected to alter interactions with cellular proteins and modulate the toxic Httex1 misfolding process. We propose that the polyQ-dependent shift in the structural equilibrium may enable future therapeutic strategies that specifically target Httex1 with toxic Q-lengths.	[Bravo-Arredondo, Jose M.; Pandey, Nitin K.; Situ, Alan J.; Ulmer, Tobias S.; Langen, Ralf] Univ Southern Calif, Dept Physiol & Neurosci, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA; [Kegulian, Natalie C.; Schmidt, Thomas; Ulmer, Tobias S.; Langen, Ralf] Univ Southern Calif, Dept Biochem & Mol Med, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA; [Bravo-Arredondo, Jose M.] Univ Autonoma Tlaxcala, Fac Ciencias Basicas Ingn & Tecnol, Calzada Apizaquito S-N, Apizaco 90300, Tlaxcala, Mexico; [Kegulian, Natalie C.] Univ Southern Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [Schmidt, Thomas] NIDDK, Lab Chem Phys, NIH, Bethesda, MD 20892 USA	University of Southern California; University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Langen, R (corresponding author), Univ Southern Calif, Dept Physiol & Neurosci, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA.; Langen, R (corresponding author), Univ Southern Calif, Dept Biochem & Mol Med, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA.	langen@usc.edu	Kegulian, Natalie/AFF-8981-2022; Pandey, Nitin K./AAP-1523-2021; Kegulian, Natalie/AAF-1086-2022	Pandey, Nitin K./0000-0001-6124-4090; Kegulian, Natalie/0000-0002-8574-1099; Bravo-Arredondo, Jose M./0000-0001-7052-7076	Cure Huntington's Disease Initiative (CHDI) Award [A-12640]; National Institutes of Health [NS084345]; University of Southern California-Consejo Nacional de Ciencia y Tecnologia (USC-CONACyT) postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084345] Funding Source: NIH RePORTER	Cure Huntington's Disease Initiative (CHDI) Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California-Consejo Nacional de Ciencia y Tecnologia (USC-CONACyT) postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by Cure Huntington's Disease Initiative (CHDI) Award A-12640 and National Institutes of Health Grant NS084345. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by University of Southern California-Consejo Nacional de Ciencia y Tecnologia (USC-CONACyT) postdoctoral fellowship.	Baias M, 2017, J AM CHEM SOC, V139, P1168, DOI 10.1021/jacs.6b10893; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Caron NS, 2013, P NATL ACAD SCI USA, V110, P14610, DOI 10.1073/pnas.1301342110; Ceccon A, 2018, J AM CHEM SOC, V140, P6199, DOI 10.1021/jacs.8b02619; Chiki A, 2017, ANGEW CHEM INT EDIT, V56, P5202, DOI 10.1002/anie.201611750; Clabough Erin B. D., 2013, Yale Journal of Biology and Medicine, V86, P217; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; CRAMPIN J, 1978, NATURE, V272, P558, DOI 10.1038/272558a0; Crick SL, 2013, P NATL ACAD SCI USA, V110, P20075, DOI 10.1073/pnas.1320626110; Cui XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep05601; De Genst E, 2015, J MOL BIOL, V427, P2166, DOI 10.1016/j.jmb.2015.03.021; DeGuire SM, 2018, J BIOL CHEM, V293, P18540, DOI 10.1074/jbc.RA118.004621; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fodale V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112262; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hoffner G, 2005, J NEUROCHEM, V95, P125, DOI 10.1111/j.1471-4159.2005.03348.x; Hoffner G, 2015, MOL NEUROBIOL, V52, P1297, DOI 10.1007/s12035-014-8932-1; Hoffner G, 2014, BRAIN SCI, V4, P91, DOI 10.3390/brainsci4010091; Isas JM, 2015, BIOCHEMISTRY-US, V54, P3942, DOI 10.1021/acs.biochem.5b00281; Jayaraman M, 2012, BIOCHEMISTRY-US, V51, P2706, DOI 10.1021/bi3000929; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Kaliszewski M, 2015, CELL DEATH DIFFER, V22, P1413, DOI 10.1038/cdd.2015.80; Kang H, 2017, J AM CHEM SOC, V139, P8820, DOI 10.1021/jacs.7b00838; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kim M, 2013, PRION, V7, P221, DOI 10.4161/pri.23807; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Margulis BA, 2013, FEBS LETT, V587, P1997, DOI 10.1016/j.febslet.2013.05.022; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Modregger J, 2002, HUM MOL GENET, V11, P2547, DOI 10.1093/hmg/11.21.2547; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Newcombe EA, 2018, J MOL BIOL, V430, P1442, DOI 10.1016/j.jmb.2018.03.031; Owens GE, 2015, J MOL BIOL, V427, P2507, DOI 10.1016/j.jmb.2015.05.023; Pandey NK, 2018, J BIOL CHEM, V293, P2597, DOI 10.1074/jbc.M117.813667; Peters-Libeu C, 2012, J MOL BIOL, V421, P587, DOI 10.1016/j.jmb.2012.01.034; Posey AE, 2018, J BIOL CHEM, V293, P3734, DOI 10.1074/jbc.RA117.000357; Rosenblatt A, 2012, MOVEMENT DISORD, V27, P272, DOI 10.1002/mds.24024; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Sittler A, 1998, MOL CELL, V2, P427, DOI 10.1016/S1097-2765(00)80142-2; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Truant R, 2008, FEBS J, V275, P4252, DOI 10.1111/j.1742-4658.2008.06561.x; Urbanek A, 2018, ANGEW CHEM INT EDIT, V57, P3598, DOI 10.1002/anie.201711530; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Warner JB, 2017, J AM CHEM SOC, V139, P14456, DOI 10.1021/jacs.7b06659; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Zhang QC, 2011, J BIOL CHEM, V286, P8188, DOI 10.1074/jbc.M110.192013	53	22	22	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19613	19623		10.1074/jbc.RA118.004808	http://dx.doi.org/10.1074/jbc.RA118.004808			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30315108	hybrid, Green Published			2022-12-26	WOS:000454294900010
J	Potapenko, E; Cordeiro, CD; Huang, GZ; Storey, M; Wittwer, C; Dutta, AK; Jessen, HJ; Starai, VJ; Docampo, R				Potapenko, Evgeniy; Cordeiro, Ciro D.; Huang, Guozhong; Storey, Melissa; Wittwer, Christopher; Dutta, Amit K.; Jessen, Henning J.; Starai, Vincent J.; Docampo, Roberto			5-Diphosphoinositol pentakisphosphate (5-IP7) regulates phosphate release from acidocalcisomes and yeast vacuoles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI; POLYPHOSPHATE METABOLISM; GROWTH; CELL; PYROPHOSPHATASE; SPECIFICITY; HOMEOSTASIS; TRANSPORT; MEMBRANE	Acidocalcisomes of Trypanosoma brucei and the acidocalcisome-like vacuoles of Saccharomyces cerevisiae are acidic calcium compartments that store polyphosphate (polyP). Both organelles possess a phosphate-sodium symporter (TbPho91 and Pho91p in T. brucei and yeast, respectively), but the roles of these transporters in growth and orthophosphate (P-i) transport are unclear. We found here that Tbpho91(-/-) trypanosomes have a lower growth rate under phosphate starvation and contain larger acidocalcisomes that have increased P-i content. Heterologous expression of TbPHO91 in Xenopus oocytes followed by two-electrode voltage clamp recordings disclosed that myo-inositol polyphosphates stimulate both sodium-dependent depolarization of the oocyte membrane potential and P-i conductance. Deletion of the SPX domain in TbPho91 abolished this stimulation. Inositol pyrophosphates such as 5-diphosphoinositol pentakisphosphate generated outward currents in Na+/P-i-loaded giant vacuoles prepared from WT or from TbPHO91-expressing pho91 Delta strains but not from the pho91 Delta yeast strains or from the pho91 Delta strains expressing PHO91 or TbPHO91 with mutated SPX domains. Our results indicate that TbPho91 and Pho91p are responsible for vacuolar P-i and Na+ efflux and that myo-inositol polyphosphates stimulate the Na+/P-i symporter activities through their SPX domains.	[Potapenko, Evgeniy; Cordeiro, Ciro D.; Huang, Guozhong; Storey, Melissa; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Potapenko, Evgeniy; Cordeiro, Ciro D.; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Starai, Vincent J.] Univ Georgia, Dept Microbiol & Infect Dis, Athens, GA 30602 USA; [Wittwer, Christopher; Dutta, Amit K.; Jessen, Henning J.] Univ Freiburg, Dept Chem & Pharm, D-79098 Freiburg, Germany	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Freiburg	Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.; Docampo, R (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	rdocampo@uga.edu	Docampo, Roberto/X-9424-2019; Jessen, Henning/O-1157-2019	Docampo, Roberto/0000-0003-4229-8784; Jessen, Henning/0000-0002-1025-9484	NIAID, National Institutes of Health [AI077538]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060546, R01AI077538] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIAID, National Institutes of Health Grant AI077538 (to R. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akoda K, 2009, J MED ENTOMOL, V46, P1446, DOI 10.1603/033.046.0629; Albert C, 1997, BIOCHEM J, V327, P553, DOI 10.1042/bj3270553; Andreeva N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119594; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bru S, 2016, MOL MICROBIOL, V101, P367, DOI 10.1111/mmi.13396; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Desfougeres Y, 2016, J BIOL CHEM, V291, P22262, DOI 10.1074/jbc.M116.746784; Diaz P, 2008, PLACENTA, V29, P883, DOI 10.1016/j.placenta.2008.07.002; FERREIRA GC, 1993, J BIOENERG BIOMEMBR, V25, P483, DOI 10.1007/BF01108405; Gerasimaite R, 2017, J CELL SCI, V130, P1625, DOI 10.1242/jcs.201061; Gerasimaite R, 2017, ACS CHEM BIOL, V12, P648, DOI 10.1021/acschembio.7b00026; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hartman ML, 2013, CONTRIB NEPHROL, V180, P138, DOI 10.1159/000346793; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Huang GZ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004555; Hurlimann BC, 2007, MOL BIOL CELL, V18, P4438, DOI 10.1091/mbc.E07-05-0457; Jimenez V, 2015, MOL MICROBIOL, V97, P911, DOI 10.1111/mmi.13075; Lander N, 2013, J BIOL CHEM, V288, P34205, DOI 10.1074/jbc.M113.518993; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lemercier G, 2004, J BIOL CHEM, V279, P3420, DOI 10.1074/jbc.M309974200; Michaillat L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054160; Neef DW, 2003, MOL CELL BIOL, V23, P3788, DOI 10.1128/MCB.23.11.3788-3797.2003; Niyogi S, 2015, J CELL SCI, V128, P2363, DOI 10.1242/jcs.169466; Ramakrishnan S, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020033; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Rodrigues CO, 1999, MOL CELL BIOL, V19, P7712; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Saliba KJ, 2006, NATURE, V443, P582, DOI 10.1038/nature05149; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; SZCZEPANSKAKONKEL M, 1987, J BIOL CHEM, V262, P8000; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; Ulrich PN, 2014, J EUKARYOT MICROBIOL, V61, P155, DOI 10.1111/jeu.12093; Villa-Bellosta R, 2009, PFLUG ARCH EUR J PHY, V458, P1151, DOI 10.1007/s00424-009-0688-5; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Wild R, 2016, SCIENCE, V352, P986, DOI 10.1126/science.aad9858; Yabe I, 1999, J BIOL CHEM, V274, P34903, DOI 10.1074/jbc.274.49.34903; Yang YY, 2016, ACS CHEM BIOL, V11, P1362, DOI 10.1021/acschembio.5b00724	38	19	20	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19101	19112		10.1074/jbc.RA118.005884	http://dx.doi.org/10.1074/jbc.RA118.005884			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30315104	Green Published, hybrid			2022-12-26	WOS:000458467400030
J	Fujimoto, T; Nakamura, O; Saito, M; Tsuru, A; Matsumoto, M; Kohno, K; Inaba, K; Kadokura, H				Fujimoto, Takushi; Nakamura, Orie; Saito, Michiko; Tsuru, Akio; Matsumoto, Masaki; Kohno, Kenji; Inaba, Kenji; Kadokura, Hiroshi			Identification of the physiological substrates of PDIp, a pancreas-specific protein-disulfide isomerase family member	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; REDUCTASE; EXPRESSION; PEPTIDES; NETWORK; PATHWAY; OXIDASE; BINDING; ERDJ5; ERAD	About 20 members of the protein-disulfide isomerase (PDI) family are present in the endoplasmic reticulum of mammalian cells. They are thought to catalyze thiol-disulfide exchange reactions within secretory or membrane proteins to assist in their folding or to regulate their functions. PDIp is a PDI family member highly expressed in the pancreas and known to bind estrogen in vivo and in vitro. However, the physiological functions of PDIp remained unclear. In this study, we set out to identify its physiological substrates. By combining acid quenching and thiol alkylation, we stabilized and purified the complexes formed between endogenous PDIp and its target proteins from the mouse pancreas. MS analysis of these complexes helped identify the disulfide-linked PDIp targets in vivo, revealing that PDIp interacts directly with a number of pancreatic digestive enzymes. Interestingly, when pancreatic elastase, one of the identified proteins, was expressed alone in cultured cells, its proenzyme formed disulfide-linked aggregates within cells. However, when pancreatic elastase was co-expressed with PDIp, the latter prevented the formation of these aggregates and enhanced the production and secretion of proelastase in a form that could be converted to an active enzyme upon trypsin treatment. These findings indicate that the main targets of PDIp are digestive enzymes and that PDIp plays an important role in the biosynthesis of a digestive enzyme by assisting with the proper folding of the proenzyme within cells.	[Fujimoto, Takushi; Nakamura, Orie; Inaba, Kenji; Kadokura, Hiroshi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Saito, Michiko; Tsuru, Akio; Kohno, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Saito, Michiko] Kyoto Pharmaceut Univ, Biosci Res Ctr, Yamashina Ku, Kyoto 6078412, Japan; [Matsumoto, Masaki] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka, Fukuoka 8128582, Japan; [Kohno, Kenji] Nara Inst Sci & Technol, Inst Res Initiat, Nara 6300192, Japan; [Inaba, Kenji] Japan Sci & Technol Agcy JST, CREST, Saitama 3320012, Japan	Tohoku University; Nara Institute of Science & Technology; Kyoto Pharmaceutical University; Kyushu University; Nara Institute of Science & Technology; Japan Science & Technology Agency (JST)	Kadokura, H (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan.	hiroshi.kadokura.b3@tohoku.ac.jp	Kadokura, Hiroshi/AAE-1645-2019; Kohno, Kenji/AAZ-6573-2020	Kohno, Kenji/0000-0002-3503-6551; Kadokura, Hiroshi/0000-0001-7308-7141; Inaba, Kenji/0000-0001-8229-0467	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP15K07381, JP15H04335, JP24228002]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [JP26116005]; CREST [JPMJCR13M6]; Noda Institute for Scientific Research	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST(Core Research for Evolutional Science and Technology (CREST)); Noda Institute for Scientific Research(Noda Institute for Scientific Research)	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants JP15K07381 (to H. K.), JP15H04335 (to K. I.), and JP24228002 (to K. K.); Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant JP26116005 (to H. K. and K. I.); and CREST Grant JPMJCR13M6 (to K. I.). This work was also supported, in part, by a grant from the Noda Institute for Scientific Research (to H. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Bowley SR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14151; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Desilva MG, 1996, DNA CELL BIOL, V15, P9, DOI 10.1089/dna.1996.15.9; DeSilva MG, 1997, DNA CELL BIOL, V16, P269, DOI 10.1089/dna.1997.16.269; Eletto D, 2014, MOL CELL, V53, P562, DOI 10.1016/j.molcel.2014.01.004; Fu XM, 2010, BIOCHEM J, V429, P157, DOI 10.1042/BJ20091954; Fu XM, 2009, J MOL HISTOL, V40, P189, DOI 10.1007/s10735-009-9230-5; Fu XM, 2012, BIOCHEM J, V447, P115, DOI 10.1042/BJ20120868; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Higa A, 2014, MOL CELL BIOL, V34, P1839, DOI 10.1128/MCB.01484-13; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2013, BIOCHEM BIOPH RES CO, V440, P245, DOI 10.1016/j.bbrc.2013.09.063; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kim K, 2013, BLOOD, V122, P1052, DOI 10.1182/blood-2013-03-492504; Klappa P, 1998, EUR J BIOCHEM, V254, P63, DOI 10.1046/j.1432-1327.1998.2540063.x; KNAPPIK A, 1994, BIOTECHNIQUES, V17, P754; Lang T, 2009, ANESTH ANALG, V108, P751, DOI 10.1213/ane.0b013e3181966675; LOGSDON CD, 1985, J CELL BIOL, V100, P1200, DOI 10.1083/jcb.100.4.1200; Maegawa K, 2017, STRUCTURE, V25, P846, DOI 10.1016/j.str.2017.04.001; Oka OBV, 2015, BIOCHEM J, V469, P279, DOI 10.1042/BJ20141423; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; Okumura M, 2015, FREE RADICAL BIO MED, V83, P314, DOI 10.1016/j.freeradbiomed.2015.02.010; OSHIMA G, 1984, ARCH BIOCHEM BIOPHYS, V233, P212, DOI 10.1016/0003-9861(84)90619-2; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pandol S. J, 2010, EXOCRINE PANCREAS, P29; Poet GJ, 2017, EMBO J, V36, P693, DOI 10.15252/embj.201695336; RAJASEKARAN AK, 1993, J CELL SCI, V105, P333; Rajpal G, 2012, J BIOL CHEM, V287, P43, DOI 10.1074/jbc.C111.279927; Rawlings ND, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1; Ruddock LW, 2000, PROTEIN SCI, V9, P758; RUDLING MJ, 1990, P NATL ACAD SCI USA, V87, P3469, DOI 10.1073/pnas.87.9.3469; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Sato Y, 2012, FEBS J, V279, P2262, DOI 10.1111/j.1742-4658.2012.08593.x; Schulman S, 2016, ANTIOXID REDOX SIGN, V24, P1, DOI 10.1089/ars.2015.6530; SHIRASU Y, 1987, J BIOCHEM-TOKYO, V102, P1555, DOI 10.1093/oxfordjournals.jbchem.a122204; Sopha P, 2012, CELL STRUCT FUNCT, V37, P177, DOI 10.1247/csf.12017; Stopa JD, 2017, J BIOL CHEM, V292, P9063, DOI 10.1074/jbc.M116.771832; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tsuchiya Y, 2018, J CELL BIOL, V217, P1287, DOI 10.1083/jcb.201707143; Ushioda R, 2016, P NATL ACAD SCI USA, V113, pE6055, DOI 10.1073/pnas.1605818113; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	46	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18421	18433		10.1074/jbc.RA118.003694	http://dx.doi.org/10.1074/jbc.RA118.003694			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30315102	Green Published, hybrid			2022-12-26	WOS:000458467300001
J	Choi, IS; Kim, JH; Lee, JH; Suh, KJ; Lee, JY; Kim, JW; Kim, SH; Kim, JW; Lee, JO; Kim, YJ; Bang, SM; Lee, JS; Lee, KW				Choi, In Sil; Kim, Jee Hyun; Lee, Ju Hyun; Suh, Koung Jin; Lee, Ji Yun; Kim, Ji-Won; Kim, Se-Hyun; Kim, Jin Won; Lee, Jeong-Ok; Kim, Yu Jung; Bang, Soo-Mee; Lee, Jong Seok; Lee, Keun-Wook			A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study	PLOS ONE			English	Article							RANDOMIZED PHASE-III; SUPPORTIVE CARE; GASTROESOPHAGEAL ADENOCARCINOMA; PLUS; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; CISPLATIN; TRIAL; 5-FLUOROURACIL	Purpose The survival benefit of second-line chemotherapy in patients with metastatic gastric cancer (MGC) has recently been established. We conducted a nationwide population-based outcomes study of patients with MGC receiving second-line chemotherapy to better understand real-world treatment patterns and outcomes. Materials and methods Data were collected from the Health Insurance Review and Assessment Service database. We identified 509 newly diagnosed patients with MGC in 2010 who received second-line chemotherapy. These patients were divided into three groups for analyses: Group A comprised all patients who received second-line chemotherapy (N = 509); Group B comprised those who received fluoropyrimidine (Fp) plus platinum as first-line treatment, followed by irinotecan-based or taxane-based regimens as second-line chemotherapy (N = 284); and Group C comprised those who received Fp plus cisplatin as first-line treatment, followed by 5-fluorouracil (5-FU)/oxaliplatin, irinotecan-based, or taxane-based regimens as secondline chemotherapy (N = 184). Results Among patients who received first-line chemotherapy, 47.2% (509/1,078) continued to receive second-line chemotherapy. The most commonly used second-line chemotherapy regimens were 5-FU/irinotecan, 5-FU/oxaliplatin, and docetaxel. The median overall survival (OS) of all 509 patients was 5.2 months. The time from the start date of first-line chemotherapy to the start date of second-line chemotherapy > 6.1 months was an independent prognostic factor for improved OS. The type of chemotherapy regimen was not a significant factor affecting OS. Conclusion The findings provide a better understanding of second-line treatment patterns and outcomes in patients with MGC and will help guide treatment decisions in real-world clinical practice.	[Choi, In Sil] Seoul Natl Univ, Dept Internal Med, Coll Med, Boramae Med Ctr,Seoul Metropolitan Govt, Seoul, South Korea; [Kim, Jee Hyun; Lee, Ju Hyun; Suh, Koung Jin; Lee, Ji Yun; Kim, Ji-Won; Kim, Se-Hyun; Kim, Jin Won; Lee, Jeong-Ok; Kim, Yu Jung; Bang, Soo-Mee; Lee, Jong Seok; Lee, Keun-Wook] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Lee, KW (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Seongnam, South Korea.	hmodoctor@snubh.org		Kim, Jin Won/0000-0002-1357-7015				Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Choi IS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198544; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ford HER, 2014, LANCET ONCOL, V15, P78, DOI 10.1016/S1470-2045(13)70549-7; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Glimelius B, 1997, ANN ONCOL, V8, P163, DOI 10.1023/A:1008243606668; Ji SY, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-2; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Kang YK, 2009, ANN ONCOL, V20, P666, DOI 10.1093/annonc/mdn717; Kim DY, 2003, ANN ONCOL, V14, P383, DOI 10.1093/annonc/mdg106; Kim YS, 2010, CANCER RES TREAT, V42, P24, DOI 10.4143/crt.2010.42.1.24; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Lee KW, 2016, J CANCER RES CLIN, V142, P687, DOI 10.1007/s00432-015-2075-2; PYRHONEN S, 1995, BRIT J CANCER, V71, P587, DOI 10.1038/bjc.1995.114; Thuss-Patience PC, 2011, EUR J CANCER, V47, P2306, DOI 10.1016/j.ejca.2011.06.002; Tsuji K, 2012, JPN J CLIN ONCOL, V42, P686, DOI 10.1093/jjco/hys084; Wagner AD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub4; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6	20	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205853	10.1371/journal.pone.0205853	http://dx.doi.org/10.1371/journal.pone.0205853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346970	Green Published, gold, Green Submitted			2022-12-26	WOS:000447938400019
J	Farouk, S; Sabet, S; Abu Zahra, FA; El-Ghor, AA				Farouk, Shimaa; Sabet, Salwa; Abu Zahra, Fatma A.; El-Ghor, Akmal A.			Bone marrow derived-mesenchymal stem cells downregulate IL17A dependent IL6/STAT3 signaling pathway in CCl4-induced rat liver fibrosis	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; TGF-BETA; HEPATOCELLULAR-CARCINOMA; MOUSE MODEL; EXPRESSION; GROWTH; DIFFERENTIATION; IL-6; HEPATOCYTES; ACTIVATION	Therapeutic potential of bone marrow-derived mesenchymal stem cells (BM-MSCs) has been reported in several animal models of liver fibrosis. Interleukin (IL) 17A, IL6 and Stat3 have been described to play crucial roles in chronic liver injury. However, the modulatory effect of MSCs on these markers was controversial in different diseases. BM-MSCs might activate the IL6/STAT3 signaling pathway and promote cell invasion in hepatocellular carcinoma, but the immunomodulatory role of BM-MSCs on IL17A/IL6/STAT3 was not fully elucidated in liver fibrosis. In the present study, we evaluated the capacity of the BM-MSCs in the modulation of cytokines milieu and signal transducers, based on unique inflammatory genes Il17a and Il17f and their receptors Il17rc and their effect on the IL6/STAT3 pathway in CCl4-induced liver fibrosis in rats. A single dose of BM-MSCs was administered to the group with induced liver fibrosis, and the genes and proteins of interest were evaluated along six weeks after treatment. Our results showed a significant downregulation of Il17a, Il17ra,il17f and Il17rc genes. In accordance, BM-MSCs administration declined IL17, IL2 and IL6 serum proteins and downregulated IL17A and IL17RA proteins in liver tissue. Interestingly, BM-MSCs downregulated both Stat3 mRNA expression and p-STAT3, while Stat5a gene was downregulated and p-STAT5 protein was elevated. Also P-SMAD3 and TGF beta R2 proteins were downregulated in response to BM-MSCs treatment. Collectively, we suggest that BM-MSCs might play an immunomodulatory role in the treatment of liver fibrosis through downregulation of IL17A affecting IL6/STAT3 signaling pathway.	[Farouk, Shimaa] AL Neelain Univ, Fac Sci & Technol, Dept Biol & Biotechnol, Khartoum, Sudan; [Sabet, Salwa; El-Ghor, Akmal A.] Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt; [Abu Zahra, Fatma A.] Ain Shams Univ, Fac Med, Med Res Ctr, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Ain Shams University	Sabet, S (corresponding author), Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt.	salwa@sci.cu.edu.eg		Sabet, Salwa/0000-0002-4097-7866				Ahmed Soheir Kamal, 2014, International Journal of Stem Cells, V7, P87, DOI 10.15283/ijsc.2014.7.2.87; Al Ghrbawy NM, 2016, INDIAN J HEMATOL BLO, V32, P276, DOI 10.1007/s12288-015-0581-7; Ali G, 2012, SAUDI J GASTROENTERO, V18, P263, DOI 10.4103/1319-3767.98433; Baik M, 2011, ANN NY ACAD SCI, V1229, P29, DOI 10.1111/j.1749-6632.2011.06100.x; Blaas L, 2010, HEPATOLOGY, V51, P1319, DOI 10.1002/hep.23469; Cho KA, 2012, CELL BIOL INT, V36, P1267, DOI 10.1042/CBI20110634; Deng YR, 2013, J AUTOIMMUN, V46, P25, DOI 10.1016/j.jaut.2013.07.008; Dooley S, 2012, TGF PROGRESSION LIVE, P245; Downie T., 1990, THEORY PRACTICE HIST, V17, P386, DOI [10.1111/j.1365-2559.1990.tb00755.x, DOI 10.1111/J.1365-2559.1990.TB00755.X]; Fabregat I, 2016, FEBS J, V283, P2219, DOI 10.1111/febs.13665; Fallatah HI, 2014, ADV HEPATOLOGY, V2014, P15, DOI [10.1155/2014/357287, DOI 10.1155/2014/357287]; Fang BJ, 2004, TRANSPLANTATION, V78, P83, DOI 10.1097/01.TP.0000128326.95294.14; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Hammad LN, 2013, J IMMUNOTOXICOL, V10, P380, DOI 10.3109/1547691X.2012.758198; Hosui A, 2009, J EXP MED, V206, P819, DOI 10.1084/jem.20080003; Jang YO, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0198-6; Jang YO, 2014, LIVER INT, V34, P33, DOI 10.1111/liv.12218; Jiang JX, 2009, J HEPATOL, V51, P139, DOI 10.1016/j.jhep.2009.03.024; Kagan P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176173; Kia R, 2013, BRIT J CLIN PHARMACO, V75, P885, DOI 10.1111/j.1365-2125.2012.04360.x; Kiss Judit, 2008, Orvosi Hetilap, V149, P339, DOI 10.1556/OH.2008.28291; Kong XN, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00069; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Li DL, 2015, INT J CLIN EXP PATHO, V8, P11; Liu WH, 2015, J CELL MOL MED, V19, P511, DOI 10.1111/jcmm.12482; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Meng D, 2012, GASTROENTEROLOGY, V142, pS13; Merion RM, 2010, SEMIN LIVER DIS, V30, P411, DOI 10.1055/s-0030-1267541; Mi F, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170181; Milosavljevic N, 2018, TRANSPL INT, V31, P102, DOI 10.1111/tri.13023; Niu LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156090; O'Reilly S, 2014, J BIOL CHEM, V289, P9952, DOI 10.1074/jbc.M113.545822; Ogata H, 2006, ONCOGENE, V25, P2520, DOI 10.1038/sj.onc.1209281; OZAKI I, 1991, GASTROENTEROL JPN, V26, P472; Parekkadan B, 2007, BIOCHEM BIOPH RES CO, V363, P247, DOI 10.1016/j.bbrc.2007.05.150; Pinheiro D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187970; Puglisi MA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/860578; Seyhan H, 2006, J CELL MOL MED, V10, P922, DOI 10.1111/j.1582-4934.2006.tb00535.x; Sharma RR, 2014, TRANSFUSION, V54, P1418, DOI 10.1111/trf.12421; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Takahara Y, 2006, WORLD J GASTROENTERO, V12, P6473, DOI 10.3748/wjg.v12.i40.6473; Tan ZM, 2013, J IMMUNOL, V191, P1835, DOI 10.4049/jimmunol.1203013; Tang LY, 2017, J BIOL CHEM, V292, P4302, DOI 10.1074/jbc.M116.773085; Truong NH, 2016, COMP TREATMENT EFFIC, V2016, DOI [10.1155/2016/5720413, DOI 10.1155/2016/5720413]; Wang G, 2016, MOLECULES, V21, DOI 10.3390/molecules21060698; Wang H, 2011, SIGNAL TRANSDUCER AC, P536; Wang MR, 2016, IN VIVO, V30, P187; Xu MY, 2014, BBA-MOL BASIS DIS, V1842, P2237, DOI 10.1016/j.bbadis.2014.07.025; Yasumi Y, 2007, HEPATOL RES, V37, P248, DOI 10.1111/j.1872-034X.2007.00040.x; Yu J, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/1798260; Zepeda-Morales ASM, 2016, ANN HEPATOL, V15, P418, DOI 10.5604/16652681.1198820; Zepeda-Morales S, 2015, J HEPATOL, V62, pS335, DOI 10.1016/S0168-8278(15)30313-5; Zhang GZ, 2017, WORLD J GASTROENTERO, V23, P8152, DOI 10.3748/wjg.v23.i46.8152; Zhang H, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/436450; Zhang W, 2013, INT J BIOCHEM CELL B, V45, P736, DOI 10.1016/j.biocel.2012.12.019; Zhang XW, 2017, ONCOTARGET, V8, P9922, DOI 10.18632/oncotarget.14266; Zhao L, 2012, HEPATO-GASTROENTEROL, V59, P2389, DOI 10.5754/hge12288; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zong C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0366-7	65	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0206130	10.1371/journal.pone.0206130	http://dx.doi.org/10.1371/journal.pone.0206130			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346985	Green Published, gold, Green Submitted			2022-12-26	WOS:000447938400038
J	Sykes, DJ; Suriyampola, PS; Martins, EP				Sykes, Delawrence J.; Suriyampola, Piyumika S.; Martins, Emilia P.			Recent experience impacts social behavior in a novel context by adult zebrafish (Danio rerio)	PLOS ONE			English	Article							COMPLEXITY REDUCES AGGRESSION; ENVIRONMENTAL ENRICHMENT; ASSOCIATION PREFERENCES; SHOALING BEHAVIOR; PLASTICITY; NEUROGENESIS; DENSITY; RESPONSES; LIFE; MONOPOLIZATION	Many animals exhibit behavioral plasticity as they move between habitats seasonally, reside in fluctuating environments, or respond to human-induced environmental change. We know that physical environment during early development can have a lasting impact on behavior, and on the neural mechanisms that shape behavior. In adults, social context can have similar persistent effects on behavior and the brain. Here, we asked whether physical context impacts adult social behavior in a novel environment. We placed groups of adult zebrafish ( Danio rerio) in two different physical contexts. After two weeks, we measured group behavior in a novel context, and found that zebrafish with recent experience in a more-complex physical environment charged each other more often and tended to form tighter shoals than did fish that had been housed in less-complex environments. These differences were present regardless of the novel context in which we assayed behavior, and were not easily explained by differences in activity level. Our results demonstrate the impact of recent experiences on adult behavior, and highlight the importance of physical as well as social history in predicting animal behavior in novel situations.	[Sykes, Delawrence J.; Suriyampola, Piyumika S.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Sykes, Delawrence J.] Univ Michigan, Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Suriyampola, Piyumika S.; Martins, Emilia P.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Indiana University System; Indiana University Bloomington; University of Michigan System; University of Michigan; Arizona State University; Arizona State University-Tempe	Sykes, DJ (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.; Sykes, DJ (corresponding author), Univ Michigan, Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	sykesd@med.umich.edu		Martins, Emilia/0000-0002-8952-3240	National Science Foundation [IOS-1257562]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation IOS-1257562.	Barreto RE, 2011, ZOOLOGY, V114, P53, DOI 10.1016/j.zool.2010.09.001; Basquill SP, 1998, CAN J ZOOL, V76, P770, DOI 10.1139/cjz-76-4-770; Batzina A, 2012, AQUACULTURE, V370, P54, DOI 10.1016/j.aquaculture.2012.10.005; Bester-Meredith JK, 2007, ETHOLOGY, V113, P889, DOI 10.1111/j.1439-0310.2007.01393.x; Bhat A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125097; Bivand R., 2014, RGEOS INTERFACE GEOM; Boogert NJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0561; Borner KK, 2015, BEHAV ECOL SOCIOBIOL, V69, P645, DOI 10.1007/s00265-015-1875-3; Brockmark S, 2010, P ROY SOC B-BIOL SCI, V277, P3035, DOI 10.1098/rspb.2010.0561; Burns JG, 2009, ETHOLOGY, V115, P122, DOI 10.1111/j.1439-0310.2008.01585.x; Carfagnini AG, 2009, ENVIRON BIOL FISH, V86, P403, DOI 10.1007/s10641-009-9539-7; Cenni F, 2010, APPL ANIM BEHAV SCI, V122, P63, DOI 10.1016/j.applanim.2009.11.007; Corkum LD, 2004, J ETHOL, V22, P23, DOI 10.1007/s10164-003-0095-x; Cvikel N, 2015, CURR BIOL, V25, P206, DOI 10.1016/j.cub.2014.11.010; Danley PD, 2011, ENVIRON BIOL FISH, V92, P275, DOI 10.1007/s10641-011-9838-7; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; De Gasperin O, 2014, BEHAV ECOL SOCIOBIOL, V68, P639, DOI 10.1007/s00265-013-1678-3; Ebbesson LOE, 2012, J FISH BIOL, V81, P2151, DOI 10.1111/j.1095-8649.2012.03486.x; Fernald RD, 2015, ANIM BEHAV, V103, P259, DOI 10.1016/j.anbehav.2015.01.019; Filby AL, 2010, PHYSIOL BEHAV, V101, P576, DOI 10.1016/j.physbeh.2010.09.004; Fowler CD, 2002, J NEUROBIOL, V51, P115, DOI 10.1002/neu.10042; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Fulcher N, 2017, ZEBRAFISH, V14, P23, DOI 10.1089/zeb.2016.1295; Georgieff MK, 2015, DEV PSYCHOPATHOL, V27, P411, DOI 10.1017/S0954579415000061; Gerlai R, 2017, BEHAV GENET, V47, P125, DOI 10.1007/s10519-016-9818-y; Hamilton IM, 2002, CAN J ZOOL, V80, P2164, DOI 10.1139/Z02-199; Hastings NB, 2001, CLIN NEUROSCI RES, V1, P175, DOI 10.1016/S1566-2772(01)00003-2; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Kaspersson R, 2010, ANIM BEHAV, V79, P709, DOI 10.1016/j.anbehav.2009.12.025; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kotrschal A, 2012, BEHAV ECOL SOCIOBIOL, V66, P1485, DOI 10.1007/s00265-012-1403-7; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; Lipkind D, 2002, BEHAV BRAIN RES, V133, P31, DOI 10.1016/S0166-4328(01)00416-8; Lovden M, 2013, NEUROSCI BIOBEHAV R, V37, P2296, DOI 10.1016/j.neubiorev.2013.02.014; Maruska KP, 2013, INTEGR COMP BIOL, V53, P938, DOI 10.1093/icb/ict017; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mason G, 2013, ANIM BEHAV, V85, P1113, DOI 10.1016/j.anbehav.2013.02.002; Matrone G, 2017, CELL MOL LIFE SCI, V74, P1367, DOI 10.1007/s00018-016-2404-x; Moretz JA, 2007, ENVIRON BIOL FISH, V80, P91, DOI 10.1007/s10641-006-9122-4; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Noldus Information Technology, 2013, ETH XT VERS 10 0; Orpwood JE, 2008, ANIM BEHAV, V76, P143, DOI 10.1016/j.anbehav.2008.01.016; Ott SR, 2010, P ROY SOC B-BIOL SCI, V277, P3087, DOI 10.1098/rspb.2010.0694; Parichy DM, 2015, ELIFE, V4, DOI 10.7554/eLife.05635; Poot H, 2012, PHYSIOL BEHAV, V105, P821, DOI 10.1016/j.physbeh.2011.10.013; R Development Core Team, 2014, R LANG ENV STAT COMP; Rambo CL, 2017, PHYSIOL BEHAV, V171, P50, DOI 10.1016/j.physbeh.2016.12.032; Rezucha R, 2014, ANIM BEHAV, V88, P195, DOI 10.1016/j.anbehav.2013.12.010; Salvanes AGV, 2013, P R SOC LOND, V280; Salvanes AGV, 2007, ANIM BEHAV, V74, P805, DOI 10.1016/j.anbehav.2007.02.007; Seguin D, 2017, ANIM COGN, V20, P813, DOI 10.1007/s10071-017-1102-x; Shelton DS, 2015, J COMP PSYCHOL, V129, P72, DOI 10.1037/a0038382; Shelton DS, 2016, APA HDB COMP PSYCHOL; Sih A, 2013, ANIM BEHAV, V85, P1077, DOI 10.1016/j.anbehav.2013.02.017; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Slabbekoorn H, 2013, ANIM BEHAV, V85, P1089, DOI 10.1016/j.anbehav.2013.01.021; Snell-Rood EC, 2013, ANIM BEHAV, V85, P1004, DOI 10.1016/j.anbehav.2012.12.031; Sol D, 2013, ANIM BEHAV, V85, P1101, DOI 10.1016/j.anbehav.2013.01.023; Song ZB, 2011, ETHOLOGY, V117, P1009, DOI 10.1111/j.1439-0310.2011.01952.x; Stamps JA, 2016, BIOL REV, V91, P534, DOI 10.1111/brv.12186; Stewart A, 2011, NEUROMETHODS, V51, P157, DOI 10.1007/978-1-60761-953-6_13; Suriyampola PS, 2017, BEHAV ECOL, V28, P94, DOI 10.1093/beheco/arw138; Suriyampola PS, 2016, ZEBRAFISH, V13, P1, DOI 10.1089/zeb.2015.1159; Suriyampola PS, 2015, ETHOLOGY, V121, P785, DOI 10.1111/eth.12393; Suriyampola PS, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0009; Sykes DJ, 2017, THESIS; Taborsky B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2605; Teles MC, 2013, BEHAV BRAIN RES, V253, P17, DOI 10.1016/j.bbr.2013.07.012; Umeda K, 2017, DEV GROWTH DIFFER, V59, P107, DOI 10.1111/dgd.12345; Vital C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055503; Vital C, 2011, J COMP PSYCHOL, V125, P278, DOI 10.1037/a0023906; Ward AJW, 2004, BEHAV ECOL, V15, P925, DOI 10.1093/beheco/arh097; Way GP, 2015, ZEBRAFISH, V12, P144, DOI 10.1089/zeb.2014.1025; Webster MM, 2007, BEHAV ECOL SOCIOBIOL, V62, P273, DOI 10.1007/s00265-007-0462-7; Webster MM, 2006, BEHAV ECOL SOCIOBIOL, V60, P77, DOI 10.1007/s00265-005-0143-3; Zupanc GKH, 2006, J COMP PHYSIOL A, V192, P649, DOI 10.1007/s00359-006-0104-y	76	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0204994	10.1371/journal.pone.0204994	http://dx.doi.org/10.1371/journal.pone.0204994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4KR	30335773	Green Submitted, gold, Green Published			2022-12-26	WOS:000447701300019
J	Zlamal, F; Lenart, P; Kuruczova, D; Kalina, T; de la Torre, G; Ramallo, MA; Bienertova-Vasku, J				Zlamal, Filip; Lenart, Peter; Kuruczova, Daniela; Kalina, Tomas; de la Torre, Gabriel; Ramallo, Miguel A.; Bienertova-Vasku, Julie			Stress entropic load: New stress measurement method?	PLOS ONE			English	Article							COGNITIVE ASSESSMENT-TOOL; WINSCAT	While stress is a widely utilized concept, no direct methods facilitating its measurement are currently available. In our previous work we proposed stress entropic load (SEL) as a potential new marker of stress response in the human body. However, at that time no method for SEL measurement existed. In this pilot study we devised and then tested methodology for SEL measurement. Healthy male participants were monitored by indirect calorimetry and thermography while resting and subsequently while under prolonged mental effort. The acquired data was then used to calculate the temporal development of SEL for each participant. Our results show that SEL production increased significantly in participants subjected to prolonged mental effort. Furthermore, we observed that the calculated development of SEL over time may be used to accurately determine the time point at which participants started performing stressful tasks.	[Zlamal, Filip; Lenart, Peter; Bienertova-Vasku, Julie] Masaryk Univ, Fac Sci, Res Ctr Tox Cpds Environm RECETOX, Brno, Czech Republic; [Zlamal, Filip; Lenart, Peter; Kuruczova, Daniela; Bienertova-Vasku, Julie] Masaryk Univ, Fac Med, Dept Pathol Physiol, Brno, Czech Republic; [Kalina, Tomas] Masaryk Univ, Fac Sports Studies, Dept Athlet Swimming & Outdoor Sports, Brno, Czech Republic; [de la Torre, Gabriel; Ramallo, Miguel A.] Univ Cadiz, Dept Psychol, Campus Rio San Pedro, Cadiz, Spain	Masaryk University Brno; Masaryk University Brno; Masaryk University Brno; Universidad de Cadiz	Bienertova-Vasku, J (corresponding author), Masaryk Univ, Fac Sci, Res Ctr Tox Cpds Environm RECETOX, Brno, Czech Republic.; Bienertova-Vasku, J (corresponding author), Masaryk Univ, Fac Med, Dept Pathol Physiol, Brno, Czech Republic.	jbienert@med.muni.cz	Lenart, Peter/O-8720-2016; De la Torre, Gabriel G./A-5598-2015; Ramallo-Luna, Miguel Angel/AAG-8580-2020; Kuruczová, Daniela/ADP-1511-2022; Ramallo-Luna, Miguel Angel/GSN-7101-2022	Lenart, Peter/0000-0002-6811-0762; De la Torre, Gabriel G./0000-0001-8636-5956; Ramallo-Luna, Miguel Angel/0000-0002-2371-1396; Kuruczová, Daniela/0000-0002-6783-5251; Ramallo-Luna, Miguel Angel/0000-0002-2371-1396; Kalina, Tomas/0000-0003-0414-2922	CETOCOEN PLUS project of the Ministry of Education, Youth and Sports of the Czech Republic [CZ.02.1.01/0.0/0.0/15_003/ 0000469]; RECETOX [LM2015051, CZ.02.1.01/0.0/0.0/16_013/0001761]; Brno Ph.D. Talent program	CETOCOEN PLUS project of the Ministry of Education, Youth and Sports of the Czech Republic; RECETOX; Brno Ph.D. Talent program	The project was supported by the CETOCOEN PLUS (CZ.02.1.01/0.0/0.0/15_003/ 0000469) project of the Ministry of Education, Youth and Sports of the Czech Republic. The project was also supported by the RECETOX Research Infrastructure (LM2015051 and CZ.02.1.01/0.0/0.0/16_013/0001761). Furthermore, Peter Lenart received support from the Brno Ph.D. Talent program.	Bienertova-Vasku J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146667; Boon MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098822; Davis PJ, 2007, MATH METHODS NUMERIC; De la Torre GG, 2014, AEROSP SCI TECHNOL, V35, P87, DOI 10.1016/j.ast.2014.02.006; Ghosh S., 2018, KERNEL SMOOTHING PRI; Kane RL, 2005, AVIAT SPACE ENVIR MD, V76, pB183; Manzey D, 2008, SPACE PSYCHOL PSYCHI; Masaoka Y, 1997, INT J PSYCHOPHYSIOL, V27, P153, DOI 10.1016/S0167-8760(97)00052-4; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Rahman MA, 2007, THERM SCI, V11, P75, DOI 10.2298/TSCI0701075R; Seaton KA, 2009, AVIAT SPACE ENVIR MD, V80, pA62, DOI 10.3357/ASEM.BR09.2009; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; SELYE H, 1946, J CLIN ENDOCR METAB, V6, P117, DOI 10.1210/jcem-6-2-117	13	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205812	10.1371/journal.pone.0205812	http://dx.doi.org/10.1371/journal.pone.0205812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335807	Green Published, gold, Green Submitted			2022-12-26	WOS:000447701300059
J	Chang, NN; Lin, LH; Tu, TH; Jeng, MS; Chikaraishi, Y; Wang, PL				Chang, Ni-Na; Lin, Li-Hung; Tu, Tzu-Hsuan; Jeng, Ming-Shiou; Chikaraishi, Yoshito; Wang, Pei-Ling			Trophic structure and energy flow in a shallow-water hydrothermal vent: Insights from a stable isotope approach	PLOS ONE			English	Article							DEEP-SEA; KUEISHAN ISLAND; FOOD WEBS; CARBON; FRACTIONATION; COMMUNITIES; DELTA-N-15; SEDIMENTS; TAIWAN; RIDGE	Shallow-water hydrothermal vent ecosystems are distinct from the deep-sea counterparts, because they are in receipt of sustenance from both chemosynthetic and photosynthetic production and have a lack of symbiosis. The trophic linkage and energy flow in these ecosystems, however remain elusive, which allows us poor understanding of the whole spectrum of biological components distributed across such environmental gradients. In this study, a thorough isotopic survey was conducted on various biological specimens and suspended particulates collected along four transects across the venting features of a shallow water hydrothermal field off Kueishan Island, Taiwan. The isotope data combined with a Bayesian-based mixing model indicate that the vent-associated particulate organic matter (vent POM), as primary contribution of chemoautotrophic populations, has a high delta C-13 value (-18.2 +/- 1.1 parts per thousand) and a low delta N-15 value (-1.7 +/- 0.4 parts per thousand). Zooplankton and epibenthic crustaceans, as the fundamental consumers, exhibit delta C-13 and delta N-15 values ranging from -21.3 to -19.8 parts per thousand and +5.1 to +7.5 parts per thousand, respectively, and can utilize the vent POM for 38-53% of their diets. The vent-obligate crab Xenograpsus testudinatus shows a large variation in delta C-13 (from -18.8 to -13.9 parts per thousand) and delta N-15 values (from 1.1 to 9.8 parts per thousand), although an omnivorous trophic level (2.5) is identified for it using delta N-15 values of amino acids, and it can utilize the vent POM for 6-87% of its diet. The consistently low (< 10.0 parts per thousand) and overlapping delta N-15 values for most of the analyzed macroinvertebrates suggest extensive ingestion of chemosynthetic production complementing the photosynthetic production, a weak prey-predator relationship and low trophic complexity possibly imposed by the extreme environmental contexts of shallow water hydrothermal ecosystems.	[Chang, Ni-Na; Lin, Li-Hung; Tu, Tzu-Hsuan] Natl Taiwan Univ, Dept Geosci, Taipei, Taiwan; [Tu, Tzu-Hsuan; Wang, Pei-Ling] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan; [Jeng, Ming-Shiou] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Chikaraishi, Yoshito] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Chikaraishi, Yoshito] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa, Japan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Hokkaido University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Wang, PL (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan.	plwang@ntu.edu.tw	Chikaraishi, Yoshito/O-5250-2019	Chikaraishi, Yoshito/0000-0002-7506-1524; WANG, PEI-LING/0000-0002-4392-3935	Ministry of Science and Technology, Taiwan; Ministry of Education, Taiwan [MOST 105-2116-M-002-018, MOST 106-2116-M-002-025, MOST 106-2119-M-002-029, NTU-107L901002]; Taiwanese Ministry of Education (Higher Education Sprout Project) [NTU-107L901002]; Ministry of Science and Technology [MOST106-2119-M-002-029, MOST105-2116-M-002-018, MOST106-2116-M-002-025]; Ministry of Science and Technology	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); Taiwanese Ministry of Education (Higher Education Sprout Project); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	All sources of funding came from Ministry of Science and Technology, Taiwan (https://www.most.gov.tw) and Ministry of Education, Taiwan (https://www.edu.tw). The support came from Taiwanese Ministry of Education (Higher Education Sprout Project NTU-107L901002) and Ministry of Science and Technology (MOST106-2119-M-002-029) to LHL and Ministry of Science and Technology (MOST105-2116-M-002-018 and MOST106-2116-M-002-025) to PLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Ministry of Science and Technology and the Ministry of Education, Taiwan (MOST 105-2116-M-002-018; MOST 106-2116-M-002-025; MOST 106-2119-M-002-029; NTU-107L901002). We are grateful to Dr. Yu-Shih Lin (Department of Oceanography, National Sun Yat-sen University), Mr. Yu-Hsing Liu and Mr. Hsin-Yu Lin (Biodiversity Research Center, Academia Sinica) for their collaborative effort in the field sampling and to the technical staff of Geochemistry & Geomicrobiology Lab. (National Taiwan University) for their help in the laboratory. We would also like to thank the editors for their effort and support during the review process and the reviewers for their constructive comments.	Bennett SA, DEEP SEA RESL; Bergquist DC, 2007, MAR ECOL PROG SER, V330, P49, DOI 10.3354/meps330049; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Campbell BJ, 2004, APPL ENVIRON MICROB, V70, P6282, DOI 10.1128/AEM.70.10.6282-6289.2004; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chan BKK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148675; Chang NN, 2014, CONT SHELF RES, V84, P23, DOI 10.1016/j.csr.2014.04.021; Chen CTA, 2005, ACTA OCEANOL SIN, V24, P125; Chen XG, 2016, GEOCHEM J, V50, P341, DOI 10.2343/geochemj.2.0425; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Choy CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050133; Colaco A, 2002, DEEP-SEA RES PT I, V49, P395, DOI 10.1016/S0967-0637(01)00060-7; Comeault A, 2010, CAH BIOL MAR, V51, P351; CONWAY N, 1991, MAR BIOL, V108, P277, DOI 10.1007/BF01344343; Dando P.R., 1995, Geological Society Special Publication, V87, P303, DOI 10.1144/GSL.SP.1995.087.01.23; de Carvalho MC, 2009, J PHYCOL, V45, P761, DOI 10.1111/j.1529-8817.2009.00685.x; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DODDS WK, 1992, J PHYCOL, V28, P415, DOI 10.1111/j.0022-3646.1992.00415.x; Fisher CR, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.75; FISHER CR, 1994, MAR ECOL PROG SER, V103, P45, DOI 10.3354/meps103045; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Fry B., 2006, STABLE ISOTOPE ECOLO; Govenar B, 2005, MAR ECOL PROG SER, V305, P67, DOI 10.3354/meps305067; Govenar B, 2012, OCEANOGRAPHY, V25, P246, DOI 10.5670/oceanog.2012.23; Griffiths JR, 2017, GLOBAL CHANGE BIOL, V23, P2179, DOI 10.1111/gcb.13642; Ho TW, 2015, MAR BIOL, V162, P1787, DOI 10.1007/s00227-015-2711-z; HOCH MP, 1992, LIMNOL OCEANOGR, V37, P1447, DOI 10.4319/lo.1992.37.7.1447; House CH, 2003, ORG GEOCHEM, V34, P345, DOI 10.1016/S0146-6380(02)00237-1; Hu MYA, 2012, AQUAT BIOL, V15, P11, DOI 10.3354/ab00396; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Jeng MS, 2004, NATURE, V432, P969, DOI 10.1038/432969a; Kao SJ, 2003, DEEP-SEA RES PT II, V50, P1203, DOI 10.1016/S0967-0645(03)00018-3; KARL DM, 1980, SCIENCE, V207, P1345, DOI 10.1126/science.207.4437.1345; Kaunzinger CMK, 1998, NATURE, V395, P495, DOI 10.1038/26741; Levesque C, 2006, DEEP-SEA RES PT I, V53, P726, DOI 10.1016/j.dsr.2006.01.007; Levine MR, 2012, MAR ECOL PROG SER, V453, P79, DOI 10.3354/meps09602; Metges CC, 1996, J MASS SPECTROM, V31, P367, DOI 10.1002/(SICI)1096-9888(199604)31:4<367::AID-JMS310>3.0.CO;2-V; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Minagawa M, 1994, P 1994 SAPP IGBP S 1, P199; Morton B, 2006, J MAR BIOL ASSOC UK, V86, P141, DOI 10.1017/S0025315406012951; Ng N.K., 2000, National Taiwan Museum Special Publication Series, V10, P191; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PERSSON L, 1992, AM NAT, V140, P59, DOI 10.1086/285403; Phillips BT, 2017, DEEP-SEA RES PT II, V137, P480, DOI 10.1016/j.dsr2.2016.10.005; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; Portail M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162263; PREUSS A, 1989, Z NATURFORSCH C, V44, P397; RAVEN JA, 1994, NEW PHYTOL, V127, P271, DOI 10.1111/j.1469-8137.1994.tb04278.x; Raven JA, 2002, FUNCT PLANT BIOL, V29, P355, DOI 10.1071/PP01201; Sarrazin J, 1999, MAR ECOL PROG SER, V190, P89, DOI 10.3354/meps190089; Sarrazin J, 1999, MAR ECOL PROG SER, V185, P1, DOI 10.3354/meps185001; Sigman DM, 2009, ENCY OCEAN SCI; Sweetman AK, 2013, MAR ECOL PROG SER, V473, P115, DOI 10.3354/meps10050; Takeda M, 1993, NAT ENV SCI RES KAWA, P59; Tarasov VG, 1999, CONT SHELF RES, V19, P79, DOI 10.1016/S0278-4343(98)00073-9; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Thiermann F, 1997, MAR BIOL, V128, P149, DOI 10.1007/s002270050078; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2002, MAR BIOL, V141, P761, DOI 10.1007/s00227-002-0865-y; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; VANDOVER CL, 1989, MAR BIOL, V102, P257, DOI 10.1007/BF00428287; VANDOVER CL, 1994, LIMNOL OCEANOGR, V39, P51, DOI 10.4319/lo.1994.39.1.0051; Vereshchaka AL, 2000, MAR BIOL, V136, P11, DOI 10.1007/s002270050002; Wang L, 2017, MICROB ECOL, V73, P571, DOI 10.1007/s00248-016-0898-2; Wang L, 2015, J BASIC MICROB, V55, P1308, DOI 10.1002/jobm.201400811; Wang TW, 2014, MAR BIOL, V161, P2447, DOI 10.1007/s00227-014-2479-6; Wiafe G, 1996, J PLANKTON RES, V18, P1485, DOI 10.1093/plankt/18.8.1485; WINN CD, 1986, NATURE, V320, P744, DOI 10.1038/320744a0; Yang SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150597; Yang TF, 2005, GEOCHEM J, V39, P469, DOI 10.2343/geochemj.39.469	73	14	14	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204753	10.1371/journal.pone.0204753	http://dx.doi.org/10.1371/journal.pone.0204753			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332427	gold, Green Submitted, Green Published			2022-12-26	WOS:000447638200029
J	Harper, J; Adams, KJ; Bossi, G; Wright, DE; Stacey, AR; Bedke, N; Martinez-Hague, R; Blat, D; Humbert, L; Buchanan, H; Le Provost, GS; Donnellan, Z; Carreira, RJ; Paston, SJ; Weigand, LU; Canestraro, M; Sanderson, JP; Gordon-Smith, SB; Lowe, KL; Rygiel, KA; Powlesland, AS; Vuidepot, A; Hassan, NJ; Cameron, BJ; Jakobsen, BK; Dukes, J				Harper, Jane; Adams, Katherine J.; Bossi, Giovanna; Wright, Debbie E.; Stacey, Andrea R.; Bedke, Nicole; Martinez-Hague, Ruth; Blat, Dan; Humbert, Laure; Buchanan, Hazel; Le Provost, Gabrielle S.; Donnellan, Zoe; Carreira, Ricardo J.; Paston, Samantha J.; Weigand, Luise U.; Canestraro, Martina; Sanderson, Joseph P.; Gordon-Smith, Sophie Botta; Lowe, Kate L.; Rygiel, Karolina A.; Powlesland, Alex S.; Vuidepot, Annelise; Hassan, Namir J.; Cameron, Brian J.; Jakobsen, Bent K.; Dukes, Joseph			An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY TGN1412; CANCER-IMMUNOTHERAPY; CARDIOVASCULAR TOXICITY; CD28 SUPERAGONISTS; CYTOKINE STORM; THERAPY; CHALLENGES; MELANOMA; FUTURE; TRIAL	Robust preclinical testing is essential to predict clinical safety and efficacy and provide data to determine safe dose for first-in-man studies. There are a growing number of examples where the preclinical development of drugs failed to adequately predict clinical adverse events in part due to their assessment with inappropriate preclinical models. Preclinical investigations of T cell receptor (TCR)-based immunotherapies prove particularly challenging as these biologics are human-specific and thus the conventional testing in animal models is inadequate. As these molecules harness the full force of the immune system, and demonstrate tremendous potency, we set out to design a preclinical package that would ensure adequate evaluation of these therapeutics. Immune Mobilising Monoclonal TCR Against Cancer (ImmTAC) molecules are bi-specific biologics formed of an affinity-enhanced TCR fused to an anti-CD3 effector function. ImmTAC molecules are designed to activate human T lymphocytes and target peptides within the context of a human leukocyte antigen (HLA), thus require an intact human immune system and peptidome for suitable preclinical screening. Here we draw upon the preclinical testing of four ImmTAC molecules, including IMCgp100, the first ImmTAC molecule to reach the clinic, to present our comprehensive, informative and robust approach to in vitro preclinical efficacy and safety screening. This package comprises a broad range of cellular and molecular assays using human tissues and cultured cells to test efficacy, safety and specificity, and hence predict human responses in clinical trials. We propose that this entirely in vitro package offers a potential model to be applied to screening other TCR-based biologics.	[Harper, Jane; Bossi, Giovanna; Wright, Debbie E.; Stacey, Andrea R.; Bedke, Nicole; Martinez-Hague, Ruth; Blat, Dan; Humbert, Laure; Buchanan, Hazel; Le Provost, Gabrielle S.; Donnellan, Zoe; Carreira, Ricardo J.; Paston, Samantha J.; Weigand, Luise U.; Canestraro, Martina; Gordon-Smith, Sophie Botta; Lowe, Kate L.; Rygiel, Karolina A.; Powlesland, Alex S.; Vuidepot, Annelise; Hassan, Namir J.; Cameron, Brian J.; Jakobsen, Bent K.; Dukes, Joseph] Immunocore Ltd, Oxford, England; [Adams, Katherine J.; Sanderson, Joseph P.] Adaptimmune, Oxford, England		Dukes, J (corresponding author), Immunocore Ltd, Oxford, England.	Joseph.dukes@immunocore.com	Sanderson, Joseph/N-8308-2019; Dukes, Joseph/AAE-2931-2019	Sanderson, Joseph/0000-0002-1206-8833; 	Immunocore Ltd.	Immunocore Ltd.	The study was entirely funded by Immunocore Ltd. All authors were funded by Immunocore Ltd at the time of contribution to the manuscript. The funder was involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Bossi G, 2014, CANCER IMMUNOL IMMUN, V63, P437, DOI 10.1007/s00262-014-1525-z; Bossi G, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26840; Brehm MA, 2013, J INFECT DIS, V208, pS125, DOI 10.1093/infdis/jit319; Brennan FR, 2010, MABS-AUSTIN, V2, P233, DOI 10.4161/mabs.2.3.11782; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Covassin L, 2011, CLIN EXP IMMUNOL, V166, P269, DOI 10.1111/j.1365-2249.2011.04462.x; Farkona S, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0623-5; Fox BA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-214; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hunig T, 2005, IMMUNOL LETT, V100, P21, DOI 10.1016/j.imlet.2005.06.012; Kingsley E, 2017, 13 ANN PEGS SUMM BOS; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Lowe KL, 2018, GENE THER, V25, P176, DOI 10.1038/s41434-018-0019-6; McCormack E, 2013, CANCER IMMUNOL IMMUN, V62, P773, DOI 10.1007/s00262-012-1384-4; McKim JM, 2010, COMB CHEM HIGH T SCR, V13, P188, DOI 10.2174/138620710790596736; Merlino G, 2013, PIGM CELL MELANOMA R, V26, pE8, DOI 10.1111/pcmr.12099; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Mould DR, 2016, BIODRUGS, V30, P275, DOI 10.1007/s40259-016-0181-6; Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148; Oates J, 2015, MOL IMMUNOL, V67, P67, DOI 10.1016/j.molimm.2015.01.024; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pavlovic D, 2015, THER ADV NEUROL DISO, V8, P255, DOI 10.1177/1756285615602832; Purbhoo MA, 2006, J IMMUNOL, V176, P7308, DOI 10.4049/jimmunol.176.12.7308; Raman MCC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18851; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Ryan PC, 2012, ALTEX P, V1, P85; Sewell F, 2017, MABS-AUSTIN, V9, P742, DOI 10.1080/19420862.2017.1324376; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Thingnes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040377; Topp MS, 2015, LANCET ONCOL, V16, P57, DOI 10.1016/S1470-2045(14)71170-2; van den Berg CW, 2015, DEVELOPMENT, V142, P3231, DOI 10.1242/dev.123810; van Lent AU, 2009, J IMMUNOL, V183, P7645, DOI 10.4049/jimmunol.0902019; van Meer PJK, 2013, MABS-AUSTIN, V5, P810, DOI 10.4161/mabs.25234; Walker MR, 2011, INT IMMUNOPHARMACOL, V11, P1697, DOI 10.1016/j.intimp.2011.06.001	41	42	42	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205491	10.1371/journal.pone.0205491	http://dx.doi.org/10.1371/journal.pone.0205491			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321203	gold, Green Published, Green Submitted			2022-12-26	WOS:000447417900033
J	Leighton, X; Bera, A; Eidelman, O; Bubendorf, L; Zellweger, T; Banerjee, J; Gelmann, EP; Pollard, HB; Srivastava, M				Leighton, Ximena; Bera, Alakesh; Eidelman, Ofer; Bubendorf, Lukas; Zellweger, Tobias; Banerjee, Jaideep; Gelmann, Edward P.; Pollard, Harvey B.; Srivastava, Meera			Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; KI67 LABELING INDEX; SYNDECAN-1 EXPRESSION; RADICAL PROSTATECTOMY; REDUCED EXPRESSION; COLORECTAL-CANCER; SURVIVAL; PREDICTOR; MARKERS	Background Annexin A7 (ANXA7) is a member of the multifunctional calcium or phospholipid-binding annexin gene family. While low levels of ANXA7 are associated with aggressive types of cancer, the clinical impact of ANXA7 in prostate cancer remains unclear. Tissue microarrays (TMA) have revealed several new molecular markers in human tumors. Herein, we have identified the prognostic impact of ANXA7 in a prostate cancer using a tissue microarray containing 637 different specimens. Methods The patients were diagnosed with prostate cancer and long-term follow-up information on progression (median 5.3 years), tumor-specific and overall survival data (median 5.9 years) were available. Expression of Ki67, Bcl-2, p53, CD-10 (neutral endopeptidase), syndecan-1 (CD-138) and ANXA7 were analyzed by immunohistochemistry. Results A bimodal distribution of ANXA7 was observed. Tumors expressing either high or no ANXA7 were found to be associated with poor prognosis. However, ANXA7 at an optimal level, in between high and no ANXA7 expression, had a better prognosis. This correlated with low Ki67, Bcl-2, p53 and high syndecan-1 which are known predictors of early recurrence. At Gleason grade 3, ANXA7 is an independent predictor of poor overall survival with a p-value of 0.003. Neoadjuvant hormonal therapy, which is known to be associated with overexpression of Bcl-2 and inhibition of Ki67 LI and CD-10, was found to be associated with under-expression of ANXA7. Conclusions The results of this TMA study identified ANXA7 as a new prognostic factor and indicates a bimodal correlation to tumor progression.	[Leighton, Ximena; Bera, Alakesh; Eidelman, Ofer; Pollard, Harvey B.; Srivastava, Meera] USUHS, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Leighton, Ximena; Bera, Alakesh; Eidelman, Ofer; Pollard, Harvey B.; Srivastava, Meera] USUHS, Inst Mol Med, Bethesda, MD 20814 USA; [Bubendorf, Lukas] Univ Hosp Basel, Inst Pathol, Basel, Switzerland; [Zellweger, Tobias] St Clara Hosp, Div Urol, Basel, Switzerland; [Banerjee, Jaideep] George Washington Univ, Washington, DC USA; [Gelmann, Edward P.] Colombia Univ, Med Ctr, Dept Med, New York, NY USA	University of Basel; George Washington University	Srivastava, M (corresponding author), USUHS, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.; Srivastava, M (corresponding author), USUHS, Inst Mol Med, Bethesda, MD 20814 USA.	meera.srivastava@usuns.edu	Bera, Alakesh/J-5429-2019; Bubendorf, Lukas/G-5299-2015	Bera, Alakesh/0000-0002-2690-8178; Bubendorf, Lukas/0000-0001-5970-1803; Banerjee, Jaideep/0000-0002-8688-7137	Collaborative Health Initiative Research Program (CHIRP) [IAA-A-HL-14-007]	Collaborative Health Initiative Research Program (CHIRP)	The work was supported by the Collaborative Health Initiative Research Program (CHIRP) funding (Dr. Harvey Pollard; CHIRP ID# IAA-A-HL-14-007).	Ahn J, 2016, VITAM HORM, V100, P321, DOI 10.1016/bs.vh.2015.10.012; [Anonymous], 1997, CLASS MAL TUM; Bauer JJ, 1996, J UROLOGY, V156, P1511, DOI 10.1016/S0022-5347(01)65641-6; Bettencourt MC, 1996, J UROLOGY, V156, P1064, DOI 10.1016/S0022-5347(01)65703-3; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Bostwick DG, 2000, ARCH PATHOL LAB MED, V124, P995; Bubendorf L, 1998, HUM PATHOL, V29, P949, DOI 10.1016/S0046-8177(98)90199-X; Bubendorf L, 1996, J PATHOL, V178, P437, DOI 10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4; Bubendorf L, 1996, AM J PATHOL, V148, P1557; Denmeade SR, 2004, PROSTATE, V58, P211, DOI 10.1002/pros.10360; Denmeade SR, 2002, NAT REV CANCER, V2, P389, DOI 10.1038/nrc801; Dong Jin-Tang, 1997, Current Opinion in Oncology, V9, P101; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Fujiya M, 2001, JPN J CANCER RES, V92, P1074, DOI 10.1111/j.1349-7006.2001.tb01062.x; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Hilska M, 2005, DIS COLON RECTUM, V48, P2197, DOI 10.1007/s10350-005-0202-x; INKI P, 1994, BRIT J CANCER, V70, P319, DOI 10.1038/bjc.1994.300; Isaacs JT, 1997, AM J PATHOL, V150, P1511; Keshgegian AA, 1998, AM J CLIN PATHOL, V110, P443; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Leighton X, 2018, ANTICANCER RES, V38, P3831, DOI 10.21873/anticanres.12667; Leighton X, 2017, METHODS MOL BIOL, V1513, P23, DOI 10.1007/978-1-4939-6539-7_3; Matsumoto A, 1997, INT J CANCER, V74, P482, DOI 10.1002/(SICI)1097-0215(19971021)74:5<482::AID-IJC2>3.0.CO;2-#; McGrath S, 2016, PROSTATE INT, V4, P130, DOI 10.1016/j.prnil.2016.07.002; Moch H, 1999, AM J PATHOL, V154, P981, DOI 10.1016/S0002-9440(10)65349-7; Nocito A, 2001, J PATHOL, V194, P349, DOI 10.1002/1096-9896(200107)194:3<349::AID-PATH887>3.0.CO;2-D; Pulkkinen JO, 1997, ACTA OTO-LARYNGOL, V117, P312, DOI 10.3109/00016489709117794; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shimada K, 2013, J PATHOL, V231, P495, DOI 10.1002/path.4271; Shimada K, 2009, CANCER SCI, V100, P1248, DOI 10.1111/j.1349-7006.2009.01174.x; SHIPP MA, 1989, P NATL ACAD SCI USA, V86, P297, DOI 10.1073/pnas.86.1.297; Srivastava M, 2003, P NATL ACAD SCI USA, V100, P14287, DOI 10.1073/pnas.2235927100; Srivastava M, 2001, P NATL ACAD SCI USA, V98, P4575, DOI 10.1073/pnas.071055798; Srivastava M, 2007, INT J CANCER, V121, P2628, DOI 10.1002/ijc.23008; Srivastava M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/193635; Szarvas T, 2016, PROSTATE, V76, P977, DOI 10.1002/pros.23186; Torhorst J, 2001, AM J PATHOL, V159, P2249, DOI 10.1016/S0002-9440(10)63075-1; Torosyan Y, 2009, INT J CANCER, V125, P2528, DOI 10.1002/ijc.24592; VISAKORPI T, 1992, J NATL CANCER I, V84, P883, DOI 10.1093/jnci/84.11.883; VOELLER HJ, 1994, J UROLOGY, V151, P492; Wagoner J, 2007, AM J DERMATOPATH, V29, P555, DOI 10.1097/DAD.0b013e3181596978; Wang HZ, 2016, MOL NEUROBIOL, V53, P4883, DOI 10.1007/s12035-015-9411-z; Wiksten JP, 2001, INT J CANCER, V95, P1, DOI 10.1002/1097-0215(20010120)95:1<1::AID-IJC1000>3.0.CO;2-5; Wu XC, 2001, CANCER RES, V61, P5295; Zellweger T, 2003, PROSTATE, V55, P20, DOI 10.1002/pros.10209	45	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205837	10.1371/journal.pone.0205837	http://dx.doi.org/10.1371/journal.pone.0205837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321230	Green Submitted, Green Published, gold			2022-12-26	WOS:000447417900058
J	Ito, R; Higa, M; Goto, A; Aoshima, M; Ikuta, A; Ohashi, K; Yokoyama, S; Ohno, Y; Egawa, T; Miyata, H; Goto, K				Ito, Rika; Higa, Masaki; Goto, Ayumi; Aoshima, Megumi; Ikuta, Akihiro; Ohashi, Kazuya; Yokoyama, Shingo; Ohno, Yoshitaka; Egawa, Tatsuro; Miyata, Hirofumi; Goto, Katsumasa			Activation of adiponectin receptors has negative impact on muscle mass in C2C12 myotubes and fast-type mouse skeletal muscle	PLOS ONE			English	Article							HEALTH-CARE COSTS; IN-VIVO; AMPK; ATROPHY; CELLS; EXPRESSION; AUTOCRINE; PARADOX; DISEASE; BINDING	This study investigated the effects of AdipoRon, which is an agonist for adiponectin receptor 1 (AdipoR1) and AdipoR2, on the protein content, myotube diameter, and number of nuclei per myotube of C2C12 cells and skeletal muscle mass in C57BL/6J mice. AdipoRon suppressed the protein content, myotube diameter, and number of nuclei per myotube of C2C12 cells of C2C12 myotubes in a dose-dependent manner. Adiponectin-associated decline of protein content, diameter, and number of nuclei per myotube in C2C12 myotubes was partially rescued by knockdown of AdipoR1 and/or AdipoR2. Phosphorylation level of AMPK showed a trend to be increased by AdipoRon. A significant increase in phosphorylation level of AMPK was observed at 20 mu M AdipoRon. Knockdown of AdipoR1 and/or AdipoR2 rescued AdipoRon-associated decrease in protein content of C2C12 myotubes. AdipoRon-associated increase in phosphorylation level of AMPK in C2C12 myotubes was suppressed by knockdown of AdipoR1 and/or AdipoR2. Successive intravenous injections of AdipoRon into mice caused a decrease in the wet weight of plantaris muscle (PLA), but not in soleus muscle (SOL). Mean fiber cross-sectional area of PLA, but not of SOL, was significantly decreased by AdipoRon administration. On the one hand, the expression level of phosphorylated AMPK and ubiquitinated protein in SOL and PLA muscles was upregulated by AdipoRon administration. On the other hand, AdipoRon administration induced no changes in the expression level of puromycin-labeled proteins in both SOL and PLA muscles. Expression level of adiponectin in extensor digitorum longus (EDL) muscle was increased by aging, but not in SOL muscle. Aging had no effect on the expression level of AdipoR1 and AdipoR2 in both muscles. Phosphorylation level of AMPK in EDL was increased by aging, but not SOL muscle. Results from this study suggest that high level of circulating adiponectin may induce skeletal muscle atrophy, especially fast-type muscle.	[Ito, Rika; Miyata, Hirofumi] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Biol Sci, Yamaguchi, Yamaguchi, Japan; [Ito, Rika; Higa, Masaki; Aoshima, Megumi; Ikuta, Akihiro; Ohashi, Kazuya; Egawa, Tatsuro; Goto, Katsumasa] Toyohashi SOZO Univ, Dept Physiol, Grad Sch Hlth Sci, Toyohashi, Aichi, Japan; [Goto, Ayumi] Juntendo Univ, Sportol Ctr, Grad Sch Med, Tokyo, Japan; [Yokoyama, Shingo; Ohno, Yoshitaka] Toyohashi SOZO Univ, Lab Physiol, Sch Hlth Sci, Aichi, Japan; [Egawa, Tatsuro] Kyoto Univ, Lab Sports & Exercise Med, Grad Sch Human & Environm Studies, Kyoto, Kyoto, Japan	Yamaguchi University; Juntendo University; Kyoto University	Miyata, H (corresponding author), Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Biol Sci, Yamaguchi, Yamaguchi, Japan.; Goto, K (corresponding author), Toyohashi SOZO Univ, Dept Physiol, Grad Sch Hlth Sci, Toyohashi, Aichi, Japan.	hiro@yamaguchi-u.ac.jp; gotok@sepia.ocn.ne.jp	Goto, Katsumasa/T-6789-2019	Goto, Katsumasa/0000-0001-5380-4561	Japan Society for the Promotion of Science [17K01762, 18H03160]; Uehara Memorial Foundation; Naito Foundation; Descente Sports Foundation; All Japan Coffee Association; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan; Graduate School of Health Sciences, Toyohashi SOZO University;  [16K13022]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Descente Sports Foundation; All Japan Coffee Association(All Japan Coffee Association); Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Graduate School of Health Sciences, Toyohashi SOZO University; 	This study was supported, in part, by Grants-in-Aid for challenging Exploratory Research (16K13022, K.G.) and Grants-in-Aid for Scientific Research (17K01762, K.G.; 18H03160, K.G.) from the Japan Society for the Promotion of Science, the Uehara Memorial Foundation (K.G.), the Naito Foundation (K.G.), the Descente Sports Foundation (K.G.), the All Japan Coffee Association (K.G.), the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan (K.G.), and Graduate School of Health Sciences, Toyohashi SOZO University (K.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock JO, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1360-3; Delaigle AM, 2004, ENDOCRINOLOGY, V145, P5589, DOI 10.1210/en.2004-0503; Egawa T, 2015, AM J PHYSIOL-ENDOC M, V309, pE651, DOI 10.1152/ajpendo.00165.2015; Egawa T, 2014, AM J PHYSIOL-ENDOC M, V306, pE344, DOI 10.1152/ajpendo.00495.2013; Fiaschi T, 2009, CELL RES, V19, P584, DOI 10.1038/cr.2009.39; Goldspink G, 1999, J ANAT, V194, P323, DOI 10.1046/j.1469-7580.1999.19430323.x; Gonzalez AA, 2004, AM J PHYSIOL-REG I, V287, pR1270, DOI 10.1152/ajpregu.00409.2004; Goto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081929; Goto K, 2003, J APPL PHYSIOL, V94, P897, DOI 10.1152/japplphysiol.00408.2002; Gotoda T, 2016, J ATHEROSCLER THROMB, V23, P292, DOI 10.5551/jat.ED031; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hoeg LD, 2013, J APPL PHYSIOL, V114, P592, DOI 10.1152/japplphysiol.01046.2012; Huang C, 2015, NUTR METAB CARDIOVAS, V25, P594, DOI 10.1016/j.numecd.2015.03.010; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kojima A, 2007, J ORTHOP SCI, V12, P74, DOI 10.1007/s00776-006-1083-0; Koya T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077788; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Loncar G, 2013, EUR J INTERN MED, V24, P818, DOI 10.1016/j.ejim.2013.09.011; Menzaghi C, 2018, DIABETES, V67, P12, DOI 10.2337/dbi17-0016; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; PERRONE CE, 1995, J BIOL CHEM, V270, P2099, DOI 10.1074/jbc.270.5.2099; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Woodward L, 2017, BRIT J PHARMACOL, V174, P4007, DOI 10.1111/bph.13619; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557	30	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205645	10.1371/journal.pone.0205645	http://dx.doi.org/10.1371/journal.pone.0205645			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308063	Green Submitted, Green Published, gold			2022-12-26	WOS:000447173500112
J	Jiang, XP; Xia, S; He, XM; Ma, H; Feng, YZ; Liu, ZG; Wang, WT; Tian, M; Chen, HS; Peng, FG; Wang, L; Zhao, P; Ge, JW; Liu, D				Jiang, Xinpeng; Xia, Shuang; He, Xinmiao; Ma, Hong; Feng, Yanzhong; Liu, Ziguang; Wang, Wentao; Tian, Ming; Chen, Heshu; Peng, Fugang; Wang, Liang; Zhao, Peng; Ge, Junwei; Liu, Di			Targeting peptide-enhanced antibody and CD11c(+) dendritic cells to inclusion bodies expressing protective antigen against ETEC in mice	FASEB JOURNAL			English	Article						enterotoxigenic Escherichia coli; mucosal immune response; dendritic cells	ENTEROTOXIGENIC ESCHERICHIA-COLI; FIMBRIAL ADHESIN FAEG; YERSINIA-ENTEROCOLITICA; IMMUNE-RESPONSE; ORAL IMMUNIZATION; HEAT-LABILE; SERUM RESISTANCE; IN-VITRO; FACTOR-H; VACCINE	Enterotoxigenic Escherichia coli (ETEC) remains a massive burden in developing countries with increasing morbidity and mortality rates; it is also an important pathogen in the farming industry and is a leading cause of bacterial diarrhea. Our previous study showed that nanometer-sized inclusion bodies (IBs) of the fimbrial adhesin subunit protein (FaeG), mutation heat-stable enterotoxin a (mSTa), heat-labile enterotoxin b (LTb), and STb (nontargeting) fusion protein as an oral vaccine induced both systemic and mucosal immune responses. In this study, to enhance the protective efficacy to ETEC, we used Yersinia enterocolitica adhesive and M-cell-targeting peptides to analyze high-efficiency antigen-specific immune presentation in the gut. Here, we showed that immunization with the IBs of ETECFaeG-mSTa-LTb-STbinduced a specific systemic and mucosal immune response in the gut, whereas the combination of both targeting peptides resulted in the highest titer, protective immune response against ETEC. A lymphocyte proliferation assay has shown that the IBs induced immunologic memory. The specific antibody of the targeting groups could effectively neutralize toxins, thereby protecting the cells of the small intestine and reducing the level of cAMP and cGMP, and the groups with double targeting showed the best effect. The most important finding was that the targeting peptides stimulate the T helper (T-h) cells through T(h)17 and T(h)1 and that T(h)1 cells dominated the cellular immune response. We found that the targeting peptide could also activate CD11c(+) on lymphoid dendritic cells, which processed and presented antigens to T cells through T(h)1-mediated IFN- and IL-12, thereby enhancing the antibody titers. The double-targeting peptide had a better effect on stimulating the immune cells to enhance the antibody titers.Jiang, X., Xia, S., He, X., Ma, H., Feng, Y., Liu, Z., Wang, W., Tian, M., Chen, H., Peng, F., Wang, L., Zhao, P., Ge, J., Liu, D. Targeting peptide-enhanced antibody and CD11c(+) dendritic cells to inclusion bodies expressing protective antigen against ETEC in mice.	[Jiang, Xinpeng; He, Xinmiao; Ma, Hong; Feng, Yanzhong; Liu, Ziguang; Wang, Wentao; Tian, Ming; Chen, Heshu; Peng, Fugang; Wang, Liang; Liu, Di] Heilongjiang Acad Agr Sci, Minist Agr, Anim Husb Res Inst, Key Lab Combining Farming & Anim Husb, 368 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China; [Jiang, Xinpeng; Tian, Ming] Heilongjiang Acad Agr Sci, Postdoctoral Workstn, Harbin, Heilongjiang, Peoples R China; [Jiang, Xinpeng; Xia, Shuang; Zhao, Peng; Ge, Junwei] Northeast Agr Univ, Coll Vet Med, Dept Prevent Vet Med, Mucai St 69, Harbin 150030, Heilongjiang, Peoples R China	Heilongjiang Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Heilongjiang Academy of Agricultural Sciences; Northeast Agricultural University - China	Liu, D (corresponding author), Heilongjiang Acad Agr Sci, Minist Agr, Anim Husb Res Inst, Key Lab Combining Farming & Anim Husb, 368 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China.; Ge, JW (corresponding author), Northeast Agr Univ, Coll Vet Med, Dept Prevent Vet Med, Mucai St 69, Harbin 150030, Heilongjiang, Peoples R China.	gejunwei@neau.edu.cn; liudi1963@163.com	Jiang, Xinpeng/AAL-6237-2020; Ge, Junwei/GZM-8882-2022	Ge, Junwei/0000-0002-2460-1666	Scientific Research Institution Innovation Ability Raise Special in Heilongjiang Province [YC2016D001]; National Natural Science Foundation of China [31101845, 31671289]; Postdoctoral Foundation of Heilongjiang Province Grant [LBH-Z17202]	Scientific Research Institution Innovation Ability Raise Special in Heilongjiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Foundation of Heilongjiang Province Grant	This work was supported by Scientific Research Institution Innovation Ability Raise Special in Heilongjiang Province Grant YC2016D001, National Natural Science Foundation of China Grants 31101845 and 31671289, and Postdoctoral Foundation of Heilongjiang Province Grant LBH-Z17202. The authors declare no conflicts of interest.	Attia Z, 2018, EUR J IMMUNOL, V48, P1295, DOI 10.1002/eji.201747264; Becker Y, 2004, VIRUS GENES, V28, P5, DOI 10.1023/B:VIRU.0000012260.32578.72; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Biedzka-Sarek M, 2005, INFECT IMMUN, V73, P2232, DOI 10.1128/IAI.73.4.2232-2244.2005; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P5016, DOI 10.1128/IAI.00314-08; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P4100, DOI 10.1128/IAI.00313-08; Bijvelds MJC, 2015, J INFECT DIS, V212, P1806, DOI 10.1093/infdis/jiv300; CHINA B, 1993, INFECT IMMUN, V61, P3129, DOI 10.1128/IAI.61.8.3129-3136.1993; Clark MA, 2003, INT J MED MICROBIOL, V293, P17, DOI 10.1078/1438-4221-00242; Coddens A, 2017, VET MICROBIOL, V202, P64, DOI 10.1016/j.vetmic.2017.01.019; Demiri M, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12458; Duan Qiangde, 2017, J Vaccines Vaccin, V8, DOI 10.4172/2157-7560.1000367; Dubreuil JD, 2017, MICROB PATHOGENESIS, V113, P129, DOI 10.1016/j.micpath.2017.10.037; Garcia-Fruitos E, 2012, TRENDS BIOTECHNOL, V30, P65, DOI 10.1016/j.tibtech.2011.09.003; Goh YS, 2015, INFECT IMMUN, V83, P3722, DOI 10.1128/IAI.00547-15; Gualdoni GA, 2016, FASEB J, V30, P3800, DOI 10.1096/fj.201600522R; Haughney SL, 2014, NANOSCALE, V6, P13770, DOI 10.1039/c4nr03724c; Hays MP, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00132; Hogg KG, 2003, INFECT IMMUN, V71, P3563, DOI 10.1128/IAI.71.6.3563-3571.2003; HOLMGREN J, 1990, SCAND J INFECT DIS, P47; Hu CX, 2009, BIOTECHNOL LETT, V31, P991, DOI 10.1007/s10529-009-9966-8; Jepson MA, 2001, MICROBES INFECT, V3, P1183, DOI 10.1016/S1286-4579(01)01478-2; Jiang XP, 2014, APPL MICROBIOL BIOT, V98, P8301, DOI 10.1007/s00253-014-5893-2; Joensuu JJ, 2006, VACCINE, V24, P2387, DOI 10.1016/j.vaccine.2005.11.056; Kesik M, 2004, IMMUNOL LETT, V91, P197, DOI 10.1016/j.imlet.2003.12.001; Kim Sae-Hae, 2012, Immune Netw, V12, P165, DOI 10.4110/in.2012.12.5.165; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Lee MR, 2011, BIOCHEM BIOPH RES CO, V410, P602, DOI 10.1016/j.bbrc.2011.06.035; Liu HJ, 2017, FASEB J, V31, P1756, DOI 10.1096/fj.201601147R; LIU LM, 1993, J EXP MED, V177, P1299, DOI 10.1084/jem.177.5.1299; Liu WX, 2015, APPL MICROBIOL BIOT, V99, P3981, DOI 10.1007/s00253-014-6302-6; Liu WX, 2015, APPL MICROBIOL BIOT, V99, P855, DOI 10.1007/s00253-014-6099-3; Ma ST, 2018, MICROB CELL FACT, V17, DOI 10.1186/s12934-018-0861-7; Maassen CBM, 2003, VACCINE, V21, P2751, DOI 10.1016/S0264-410X(03)00220-2; Marquardt RR, 1999, FEMS IMMUNOL MED MIC, V23, P283, DOI 10.1016/S0928-8244(98)00147-3; Martinez V, 2005, J INFECT DIS, V191, P2053, DOI 10.1086/430320; Mayorga O, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00154; Neutra MR, 1999, J INFECT DIS, V179, pS441, DOI 10.1086/314800; NIELSEN E, 1980, ACTA PATH MICRO IM C, V88, P121; Osorio F, 2008, EUR J IMMUNOL, V38, P3274, DOI 10.1002/eji.200838950; Oth T, 2015, J INTERF CYTOK RES, V35, P748, DOI 10.1089/jir.2015.0022; Park SH, 2015, ONCOTARGET, V6, P21795, DOI 10.18632/oncotarget.5489; Peng HS, 2015, NANOSCALE, V7, P4354, DOI 10.1039/c4nr06377e; PILZ D, 1992, INFECT IMMUN, V60, P189, DOI 10.1128/IAI.60.1.189-195.1992; Rausch D, 2017, VET MICROBIOL, V202, P79, DOI 10.1016/j.vetmic.2016.02.002; Read LT, 2014, INFECT IMMUN, V82, P5308, DOI 10.1128/IAI.02496-14; Rivera F, 2016, EXP PARASITOL, V160, P31, DOI 10.1016/j.exppara.2015.11.002; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Siebers A, 1996, TRENDS MICROBIOL, V4, P22, DOI 10.1016/0966-842X(96)81501-0; Sioud M, 2013, FASEB J, V27, P3272, DOI 10.1096/fj.12-224758; Sperr WR, 2000, INT ARCH ALLERGY IMM, V122, P279, DOI 10.1159/000024410; Suzuki H, 2007, KIDNEY INT, V72, P319, DOI 10.1038/sj.ki.5002300; Trentini MM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00898; VANSNICK JL, 1979, J EXP MED, V149, P1519, DOI 10.1084/jem.149.6.1519; Verdonck F, 2005, VET IMMUNOL IMMUNOP, V103, P21, DOI 10.1016/j.vetimm.2004.08.012; Wang FJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-204; Wang XN, 2018, J APPL MICROBIOL, V124, P368, DOI 10.1111/jam.13652; Wedrychowicz H, 2007, VET PARASITOL, V147, P77, DOI 10.1016/j.vetpar.2007.03.023; Wijemanne P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113230; Xu WJ, 2013, NANOSCALE, V5, P9924, DOI 10.1039/c3nr03102k; Ye LP, 2017, MICROB PATHOGENESIS, V110, P325, DOI 10.1016/j.micpath.2017.07.015; Yu M, 2017, J APPL MICROBIOL, V122, P506, DOI 10.1111/jam.13352; Zhang W, 1999, FASEB J, V13, P913, DOI 10.1096/fasebj.13.8.913; Zhang WP, 2010, INFECT IMMUN, V78, P316, DOI 10.1128/IAI.00497-09; Zhang WP, 2009, INFECT IMMUN, V77, P699, DOI 10.1128/IAI.01165-08; Zhao Peng, 2015, Zhongguo Yufang Shouyi Xuebao / Chinese Journal of Preventive Veterinary Medicine, V37, P790	66	3	5	5	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2836	2847		10.1096/fj.201800289RRR	http://dx.doi.org/10.1096/fj.201800289RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30321067	Bronze			2022-12-26	WOS:000457296600104
J	Shetty, SP; Sturts, R; Vetick, M; Copeland, PR				Shetty, Sumangala P.; Sturts, Ryan; Vetick, Michael; Copeland, Paul R.			Processive incorporation of multiple selenocysteine residues is driven by a novel feature of the selenocysteine insertion sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						selenocysteine; selenoprotein; selenium; mRNA; ribonucleoprotein (RNP); RNA structure; 21st amino acid; stem loop structure	RNA-BINDING PROTEIN; SELENOPROTEIN MESSENGER-RNAS; MAMMALIAN SELENOCYSTEINE; SECIS RNA; UGA; EFFICIENCY; ELEMENT; CODON; MOTIF; SUBSET	RNA stem loop structures have been frequently shown to regulate essential cellular processes. The selenocysteine insertion sequence (SECIS) element, found in the 3 UTRs of all selenoprotein mRNAs, is an example of such a structure, as it is required for the incorporation of the 21st amino acid, selenocysteine (Sec). Selenoprotein synthesis poses a mechanistic challenge because Sec is incorporated during translation in response to a stop codon (UGA). Although it is known that a SECIS-binding protein (SBP2) is required for Sec insertion, the mechanism of action remains elusive. Additional complexity is present in the synthesis of selenoprotein P (SELENOP), which is the only selenoprotein that contains multiple UGA codons and possesses two SECIS elements in its 3 UTR. Thus, full-length SELENOP synthesis requires processive Sec incorporation. Using zebrafish Selenop, in vitro translation assays, and Se-75 labeling in HEK293 cells, we found here that processive Sec incorporation is an intrinsic property of the SECIS elements. Specifically, we identified critical features of SECIS elements that are required for processive Sec incorporation. A screen of the human SECIS elements revealed that most of these elements support processive Sec incorporation in vitro; however, we also found that the processivity of Sec incorporation into Selenop in cells is tightly regulated. We propose a model for processive Sec incorporation that involves differential recruitment of SECIS-binding proteins.	[Shetty, Sumangala P.; Sturts, Ryan; Vetick, Michael; Copeland, Paul R.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Copeland, PR (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 675 Hoes Ln, Piscataway, NJ 08854 USA.	paul.copeland@rutgers.edu		Vetick, Michael/0000-0003-2457-0481; Copeland, Paul/0000-0003-3343-0587	National Institutes of Health [GM077073, R21HD83616]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD083616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM077073 and R21HD83616 (to P. R. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Bifano AL, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-12; Bubenik JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062102; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Chapple CE, 2009, BIOINFORMATICS, V25, P674, DOI 10.1093/bioinformatics/btp020; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Fagegaltier D, 2000, NUCLEIC ACIDS RES, V28, P2679, DOI 10.1093/nar/28.14.2679; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Fixsen SM, 2010, J MOL BIOL, V399, P385, DOI 10.1016/j.jmb.2010.04.033; Fletcher JE, 2001, RNA, V7, P1442; Goody TA, 2004, RNA, V10, P254, DOI 10.1261/rna.5176604; Grundner-Culemann E, 1999, RNA, V5, P625, DOI 10.1017/S1355838299981542; Gupta M, 2007, J BIOL CHEM, V282, P36797, DOI 10.1074/jbc.M707061200; Gupta N, 2013, J MOL BIOL, V425, P2415, DOI 10.1016/j.jmb.2013.04.016; HILL KE, 1992, BIOCHEM BIOPH RES CO, V185, P260, DOI 10.1016/S0006-291X(05)80984-2; Howard MT, 2005, EMBO J, V24, P1596, DOI 10.1038/sj.emboj.7600642; Huang L, 2016, J MOL BIOL, V428, P790, DOI 10.1016/j.jmb.2015.09.026; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Kryukov GV, 2000, GENES CELLS, V5, P1049, DOI 10.1046/j.1365-2443.2000.00392.x; LEE BJ, 1989, J BIOL CHEM, V264, P9724; Lesoon A, 1997, MOL CELL BIOL, V17, P1977, DOI 10.1128/MCB.17.4.1977; Maiti B, 2009, HUM MUTAT, V30, P411, DOI 10.1002/humu.20879; Mariotti M, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx982; Mariotti M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt550; Martin GW, 1996, RNA, V2, P171; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Miniard AC, 2010, NUCLEIC ACIDS RES, V38, P4807, DOI 10.1093/nar/gkq247; Nasim MT, 2000, J BIOL CHEM, V275, P14846, DOI 10.1074/jbc.275.20.14846; Shetty SP, 2014, J BIOL CHEM, V289, P25317, DOI 10.1074/jbc.M114.590430; Stoytcheva Z, 2006, MOL CELL BIOL, V26, P9177, DOI 10.1128/MCB.00856-06; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Suppmann S, 1999, EMBO J, V18, P2284, DOI 10.1093/emboj/18.8.2284; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Tujebajeva RM, 2000, GENES CELLS, V5, P897, DOI 10.1046/j.1365-2443.2000.00375.x; Walczak R, 1996, RNA, V2, P367; Walczak R, 1998, RNA, V4, P74; Wen W, 1998, J BIOL CHEM, V273, P28533, DOI 10.1074/jbc.273.43.28533; Wu S, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160241	40	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19377	19386		10.1074/jbc.RA118.005211	http://dx.doi.org/10.1074/jbc.RA118.005211			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30323062	Green Published, hybrid			2022-12-26	WOS:000453537300019
J	Volkel, S; Stielow, B; Finkernagel, F; Berger, D; Stiewe, T; Nist, A; Suske, G				Voelkel, Sara; Stielow, Bastian; Finkernagel, Florian; Berger, Dana; Stiewe, Thorsten; Nist, Andrea; Suske, Guntram			Transcription factor Sp2 potentiates binding of the TALE homeoproteins Pbx1:Prep1 and the histone-fold domain protein Nf-y to composite genomic sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin immunoprecipitation (ChiP); gene regulation; transcription factor; transcription target gene; specificity protein 1 (Sp1); nuclear factor y (Nf-y); Pbx1; Prep1; TALE homeoproteins; transcription factor Sp2	DNA-BINDING; EXPRESSION; FAMILY; PREP1; PBX1; LOCALIZATION; INSIGHTS; MEIS1	Different transcription factors operate together at promoters and enhancers to regulate gene expression. Transcription factors either bind directly to their target DNA or are tethered to it by other proteins. The transcription factor Sp2 serves as a paradigm for indirect genomic binding. It does not require its DNA-binding domain for genomic DNA binding and occupies target promoters independently of whether they contain a cognate DNA-binding motif. Hence, Sp2 is strikingly different from its closely related paralogs Sp1 and Sp3, but how Sp2 recognizes its targets is unknown. Here, we sought to gain more detailed insights into the genomic targeting mechanism of Sp2. ChIP-exo sequencing in mouse embryonic fibroblasts revealed genomic binding of Sp2 to a composite motif where a recognition sequence for TALE homeoproteins and a recognition sequence for the trimeric histone-fold domain protein nuclear transcription factor Y (Nf-y) are separated by 11 bp. We identified a complex consisting of the TALE homeobox protein Prep1, its partner PBX homeobox 1 (Pbx1), and Nf-y as the major partners in Sp2-promoter interactions. We found that the Pbx1:Prep1 complex together with Nf-y recruits Sp2 to co-occupied regulatory elements. In turn, Sp2 potentiates binding of Pbx1:Prep1 and Nf-y. We also found that the Sp-box, a short sequence motif close to the Sp2 N terminus, is crucial for Sp2's cofactor function. Our findings reveal a mechanism by which the DNA binding-independent activity of Sp2 potentiates genomic loading of Pbx1:Prep1 and Nf-y to composite motifs present in many promoters of highly expressed genes.	[Voelkel, Sara; Stielow, Bastian; Finkernagel, Florian; Berger, Dana; Suske, Guntram] Philipps Univ Marburg, Ctr Tumor Biol & Immunol ZTI, Inst Mol Biol & Tumor Res IMT, D-35043 Marburg, Germany; [Stiewe, Thorsten; Nist, Andrea] Philipps Univ Marburg, Ctr Tumor Biol & Immunol ZTI, Genom Core Facil, D-35043 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Suske, G (corresponding author), Philipps Univ Marburg, Ctr Tumor Biol & Immunol ZTI, Inst Mol Biol & Tumor Res IMT, D-35043 Marburg, Germany.	Suske@imt.uni-marburg.de		Stiewe, Thorsten/0000-0003-0134-7826	Deutsche Forschungsgemeinschaft [SU102/8-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SU102/8-2 (to G. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baur F, 2010, PLOS ONE, V5, pA202, DOI 10.1371/journal.pone.0009587; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; Blasi F, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600245; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Dardaei L, 2014, P NATL ACAD SCI USA, V111, pE896, DOI 10.1073/pnas.1321200111; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Foley JW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-720; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Ladam F, 2018, ELIFE, V7, DOI 10.7554/eLife.36144; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Longobardi E, 2014, DEV DYNAM, V243, P59, DOI 10.1002/dvdy.24016; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Mathiasen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125789; Moorefield KS, 2004, J BIOL CHEM, V279, P13911, DOI 10.1074/jbc.M313589200; Nakamura M, 2004, J CELL BIOCHEM, V93, P887, DOI 10.1002/jcb.20255; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Penkov D, 2013, CELL REP, V3, P1321, DOI 10.1016/j.celrep.2013.03.029; Pereira F, 2016, SCI REP-UK, V6, DOI 10.1038/srep38383; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Schaeper ND, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-88; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Suske G, 2017, BBA-GENE REGUL MECH, V1860, P590, DOI 10.1016/j.bbagrm.2016.08.011; Terrados G, 2012, NUCLEIC ACIDS RES, V40, P7844, DOI 10.1093/nar/gks544; Volkel S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005102; Wang LG, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku846; Wernet MF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004210; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043; Xie JZ, 2010, J BIOL CHEM, V285, P4153, DOI 10.1074/jbc.M109.078881; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	44	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19250	19262		10.1074/jbc.RA118.005341	http://dx.doi.org/10.1074/jbc.RA118.005341			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30337366	Green Published, hybrid			2022-12-26	WOS:000453537300009
J	Reich, NO; Dang, E; Kurnik, M; Pathuri, S; Woodcock, CB				Reich, Norbert O.; Dang, Eric; Kurnik, Martin; Pathuri, Sarath; Woodcock, Clayton B.			The highly specific, cell cycle-regulated methyltransferase from Caulobacter crescentus relies on a novel DNA recognition mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUR-ALPHA; BASE; METHYLATION; BINDING; STABILIZATION; CATALYSIS; REVEALS; CCRM	Two DNA methyltransferases, Dam and beta-class cell cycle-regulated DNA methyltransferase (CcrM), are key mediators of bacterial epigenetics. CcrM from the bacterium Caulobacter crescentus (CcrM C. crescentus, methylates adenine at 5'-GANTC-3') displays 10(5)-10(7)-fold sequence discrimination against noncognate sequences. However, the underlying recognition mechanism is unclear. Here, CcrM C. crescentus activity was either improved or mildly attenuated with substrates having one to three mismatched bp within or adjacent to the recognition site, but only if the strand undergoing methylation is left unchanged. By comparison, single-mismatched substrates resulted in up to 10(6)-fold losses of activity with alpha (Dam) and gamma-class (M. HhaI) DNAmethyltransferases. Wefound that CcrM C. crescentus has a greatly expanded DNA-interaction surface, covering six nucleotides on the 5' side and eight nucleotides on the 3' side of its recognition site. Such a large interface may contribute to the enzyme's high sequence fidelity. CcrM C. crescentus displayed the same sequence discrimination with single-stranded substrates, and a surprisingly large (>10(7)-fold) discrimination against ssRNA was largely due to the presence of two or more riboses within the cognate (DNA) site but not outside the site. Results from C-terminal truncations and point mutants supported our hypothesis that the recently identified C-terminal, 80-residue segment is essential for dsDNA recognition but is not required for single-stranded substrates. CcrM orthologs from Agrobacterium tumefaciens and Brucella abortus share some of these newly discovered features of the C. crescentus enzyme, suggesting that the recognition mechanism is conserved. In summary, CcrM C. crescentus uses a previously unknown DNA recognition mechanism.	[Reich, Norbert O.; Dang, Eric; Kurnik, Martin; Pathuri, Sarath; Woodcock, Clayton B.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu	Kurnik, Martin/AFZ-2568-2022					Adhikari S, 2016, FEMS MICROBIOL REV, V40, P575, DOI 10.1093/femsre/fuw023; BASSING CH, 1992, GENE, V113, P83, DOI 10.1016/0378-1119(92)90672-C; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Cheng XD, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018747; Darbinian N, 2001, J CELL BIOCHEM, V80, P589, DOI 10.1002/1097-4644(20010315)80:4<589::AID-JCB1013>3.0.CO;2-0; Estabrook RA, 2009, J BIOL CHEM, V284, P22690, DOI 10.1074/jbc.M109.015966; Gonzalez D, 2014, NUCLEIC ACIDS RES, V42, P3720, DOI 10.1093/nar/gkt1352; Graebsch A, 2009, P NATL ACAD SCI USA, V106, P18521, DOI 10.1073/pnas.0907990106; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kozdon JB, 2013, P NATL ACAD SCI USA, V110, pE4658, DOI 10.1073/pnas.1319315110; Lu D, 2003, NATURE, V426, P96, DOI 10.1038/nature02088; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Robertson GT, 2000, J BACTERIOL, V182, P3482, DOI 10.1128/JB.182.12.3482-3489.2000; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Shamoo Y., 2002, ENCY LIFE SCI, P1; Shieh FK, 2006, J MOL BIOL, V362, P516, DOI 10.1016/j.jmb.2006.07.030; Weber J, 2016, ELIFE, V5, DOI 10.7554/eLife.11297; Woodcock CB, 2017, BIOCHEMISTRY-US, V56, P3913, DOI 10.1021/acs.biochem.7b00378; Wortman MJ, 2005, BBA-MOL CELL RES, V1743, P64, DOI 10.1016/j.bbamcr.2004.08.010; Wright R, 1997, J BACTERIOL, V179, P5869, DOI 10.1128/jb.179.18.5869-5877.1997; Youngblood B, 2008, NUCLEIC ACIDS RES, V36, P2917, DOI 10.1093/nar/gkn131; Youngblood B, 2006, BIOCHEMISTRY-US, V45, P15563, DOI 10.1021/bi061414t; Zhou B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004831	23	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19038	19046		10.1074/jbc.RA118.005212	http://dx.doi.org/10.1074/jbc.RA118.005212			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30323065	Green Published, hybrid			2022-12-26	WOS:000458467400018
J	Farrar, CS; Hocking, DC				Farrar, Christopher S.; Hocking, Denise C.			Assembly of fibronectin fibrils selectively attenuates platelet-derived growth factor-induced intracellular calcium release in fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; PHOSPHOLIPASE-C; FACTOR PDGF; CELLS; SHP-1; ACTIVATION; EXPRESSION; RECEPTOR	Cellular responses to platelet-derived growth factor (PDGF) are altered in a variety of pathological conditions, including cancers, fibroses, and vascular diseases, making PDGF-induced signaling pathways important therapeutic targets. The limited success of therapies designed to impact PDGF pathways may be overcome with a clearer understanding of how cells integrate signals from PDGF and the extracellular matrix (ECM). Here, we assessed the effects of fibronectin matrix assembly on the responsiveness of mesenchymal cells to PDGF. Our results indicate that fibroblast-mediated assembly of fibronectin fibrils attenuates intracellular calcium release in response to PDGF. The dose-dependent inhibition of PDGF-induced intracellular calcium release was specific to the ECM form of fibronectin. Further, a recombinant protein engineered to mimic ECM fibronectin similarly attenuated intracellular calcium release in response to PDGF. Of note, fibronectin attenuated the PDGF-calcium signaling axis at the level of phosphoinositide 3-kinase (PI3K) activation. Interestingly, ECM fibronectin did not alter other intracellular signals activated by PDGF, including activation of PDGF receptor beta, AKT Ser/Thr kinase, phospholipase C gamma 1, and extracellular signal-regulated kinase 1/2 (ERK1/2). Rather, fibronectin inhibited activation of the p55 regulatory subunit of PI3K in response to a variety of stimuli, indicating that ECM fibronectin selectively attenuates the intracellular calcium release cascade while leaving intact other PDGF signaling pathways. Selective regulation of calcium signaling by ECM fibronectin via the p55 regulatory subunit of PI3K represents a mechanism by which cells tune their response to PDGF and may therefore serve as a target to selectively regulate one branch of PDGF signaling.	[Farrar, Christopher S.; Hocking, Denise C.] Univ Rochester, Sch Med & Dent, Dept Biomed Engn, Rochester, NY 14642 USA; [Hocking, Denise C.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Farrar, Christopher S.] Vertex Pharmaceut, 50 Northern Ave, Boston, MA 02210 USA	University of Rochester; University of Rochester; Vertex Pharmaceuticals	Hocking, DC (corresponding author), Univ Rochester, Box 711,601 Elmwood Ave, Rochester, NY 14642 USA.	denise_hocking@urmc.rochester.edu			National Institutes of Health [R01 EB018210, R01 GM081513]; National Institutes of Health (NIH) [T32 HL066988]; NIH NRSA Predoctoral Fellowship [F31 HL132559]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066988, F31HL132559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 EB018210 and R01 GM081513 (to D. C. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the National Institutes of Health (NIH) predoctoral training grant, "Multidisciplinary Training in Pulmonary Research" (Grant T32 HL066988) and by NIH NRSA Predoctoral Fellowship F31 HL132559. Present address: Vertex Pharmaceuticals, 50 Northern Ave., Boston, MA 02210.	Akiyama SK, 2013, CURR PROT CELL BIOL, V60, DOI DOI 10.15.11-10.15.13; ANTONIADES HN, 1992, P NATL ACAD SCI USA, V89, P3942, DOI 10.1073/pnas.89.9.3942; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BERK BC, 1986, SCIENCE, V232, P87, DOI 10.1126/science.3485309; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cuddon P, 2008, BIOL RES, V41, P183, DOI 10.4067/S0716-97602008000200008; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Eriksson A, 1992, GROWTH FACTORS, V6, DOI 10.3109/08977199209008867; Evren S, 2013, GENOMICS, V102, P491, DOI 10.1016/j.ygeno.2013.10.001; Faes S, 2015, INT J MOL SCI, V16, P21138, DOI 10.3390/ijms160921138; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Gildner CD, 2014, MATRIX BIOL, V34, P33, DOI 10.1016/j.matbio.2014.01.017; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; Hocking DC, 2002, J CELL BIOL, V158, P175, DOI 10.1083/jcb.200112031; Hollenbeck ST, 2004, J VASC SURG, V40, P351, DOI 10.1016/j.jvs.2004.03.047; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Jiang MH, 2016, CELL REP, V16, P769, DOI 10.1016/j.celrep.2016.06.035; Johenning FW, 2002, J NEUROSCI, V22, P5344; KLINGHOFFER RA, 1995, J BIOL CHEM, V270, P22208, DOI 10.1074/jbc.270.38.22208; Lin FB, 2014, J INVEST DERMATOL, V134, P1119, DOI 10.1038/jid.2013.420; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; Matsuoka T, 2014, CANCERS, V6, P1441, DOI 10.3390/cancers6031441; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MCNEIL PL, 1985, J CELL BIOL, V101, P372, DOI 10.1083/jcb.101.2.372; Mukherjee S, 2013, INT J BIOCHEM CELL B, V45, P1516, DOI 10.1016/j.biocel.2013.04.018; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Park CS, 2003, J BIOL CHEM, V278, P37064, DOI 10.1074/jbc.M304968200; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; ROBSON MC, 1992, LANCET, V339, P23, DOI 10.1016/0140-6736(92)90143-Q; SALTER MW, 1995, J NEUROSCI, V15, P2961; Sarelius IH, 2016, J PHYSIOL-LONDON, V594, P687, DOI 10.1113/JP271478; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Shi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094988; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Sottile J, 1998, J CELL SCI, V111, P2933; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; TIAN WN, 1994, J BIOL CHEM, V269, P14798; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Valdes JA, 2013, J CELL PHYSIOL, V228, P1452, DOI 10.1002/jcp.24298; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935; Windsor L. J, 2002, MATRIX METALLOPROTEI, DOI DOI 10.8.6-10.8.7; Wojciechowski K, 2004, PROTEIN EXPRES PURIF, V36, P131, DOI 10.1016/j.pep.2004.04.004; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687; Zhang JN, 2015, INT J CANCER, V136, P1769, DOI 10.1002/ijc.29234	55	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18655	18666		10.1074/jbc.RA118.004020	http://dx.doi.org/10.1074/jbc.RA118.004020			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30323067	Green Published, hybrid			2022-12-26	WOS:000458467300020
J	Alecsandru, D; Barrio, A; Andia, V; Cruz, E; Aparicio, P; Serna, J; Cruz, M; Pellicer, A; Garcia-Velasco, JA				Alecsandru, Diana; Barrio, Ana; Andia, Victor; Cruz, Edgar; Aparicio, Pilar; Serna, Jose; Cruz, Maria; Pellicer, Antonio; Antonio Garcia-Velasco, Juan			Pancreatic autoimmunity: An unknown etiology on patients with assisted reproductive techniques (ART)-recurrent reproductive failure	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; TYPE-2 DIABETES-MELLITUS; THYROID-DYSFUNCTION; POSITION STATEMENT; T-LYMPHOCYTES; ADULTS; ONSET; AUTOANTIBODIES; PREVALENCE; PHENOTYPE	Pancreatic Autoimmunity is defined as the presence of autoantibodies and more frequent need for insulin treatment. Affected women presenting recurrent implantation failure (RIF) or recurrent miscarriage (RM) are often misdiagnosed. The objective of thestudy was to describe clinical and metabolic profiles suggestive of Pancreatic Autoimmunity and therapeutic strategy in patients with RIF/RM. We analyzed retrospectively 735 patients, and have identified a subset (N = 20) with similar metabolic characteristics. At the same time, we included a control group (n = 39), with similar demographic characteristics and negative for pancreatic, thyroid or celiac disease autoimmunity. The patients identified with autoimmune metabolic problem (N = 20) had relatives with diabetes mellitus. At 120 minutes after Oral Glucose Tolerance Test (OGTT) low level of insulin secretion (<2 IU/ml) was found in 70% of patients. Glutamic acid decarboxylase 65 (GAD 65) antibodies, with or without other autoantibodies, were positive in 80% of patients and anti-IA2 alone were positive I the rest. Since pregestational period, insulin administration was recommended for 10 patients, metformin for 4 patients and exclusively diet control in 5 of them. Significantly increased live bith rates (LBR) per cycle were observed after metabolic control (52%) compared with live birth rate (LBR) after cycles without control (7.5%) (p<0.0001). We noticed 2 cases of pre-eclampsia and 6 low-birth weights. Insulin administration was needed during the pregnancy in 68% of patients and after childbirth in 31.57% of them. In our control group, all of patients (n = 39) underwent ART (53.8% SET and 46.1% DET) with a 50% (SET) and 61.9% (DET) live birth rate (LBR) per cycle. Patients with RIF/RM, normal BMI, low insulin levels after OGTT could benefit from additional metabolic immune testing. A correct diagnosis and treatment could have a positive impact on their reproductive results and live birth rate.	[Alecsandru, Diana; Barrio, Ana; Aparicio, Pilar; Antonio Garcia-Velasco, Juan] IVI RMA Madrid, Valentian Infertil Inst IVI, Dept Immunol, Madrid, Spain; [Alecsandru, Diana; Barrio, Ana; Aparicio, Pilar; Antonio Garcia-Velasco, Juan] IVI RMA Madrid, Valentian Infertil Inst IVI, Dept Reprod Endocrinol & Infertil, Madrid, Spain; [Andia, Victor] Gregorio Maranon Univ Hosp, Dept Endocrinol & Diabet, Madrid, Spain; [Cruz, Edgar; Cruz, Maria] IVI RMA Madrid, Valencian Infertil Inst IVI, Madrid, Spain; [Serna, Jose] IVI RMA Zaragoza, Valencian Infertil Inst IVI, Zaragoza, Spain; [Pellicer, Antonio] IVI RMA Valencia, Valencian Infertil Inst IVI, Valencia, Spain; [Antonio Garcia-Velasco, Juan] Rey Juan Carlos Univ, Madrid, Spain	General University Gregorio Maranon Hospital; Universidad Rey Juan Carlos	Alecsandru, D (corresponding author), IVI RMA Madrid, Valentian Infertil Inst IVI, Dept Immunol, Madrid, Spain.; Alecsandru, D (corresponding author), IVI RMA Madrid, Valentian Infertil Inst IVI, Dept Reprod Endocrinol & Infertil, Madrid, Spain.	Diana.Alecsandru@ivirma.com	Pellicer, Antonio/AAA-6005-2020	Pellicer, Antonio/0000-0002-8254-863X; Garcia-Velasco, Juan/0000-0003-1005-8727				Akesson C, 2010, CLIN EXP IMMUNOL, V161, P48, DOI 10.1111/j.1365-2249.2010.04114.x; Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; Barova H, 2004, PHYSIOL RES, V53, P279; Bartha JL, 2001, AM J OBSTET GYNECOL, V184, P965, DOI 10.1067/mob.2001.112394; Buzzetti R, 2007, DIABETES CARE, V30, P932, DOI 10.2337/dc06-1696; Conway G, 2014, EUR J ENDOCRINOL, V171, pP1, DOI 10.1530/EJE-14-0253; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; De Leiva A, 2007, DIABETES CARE, V30, pS127, DOI 10.2337/dc07-s204; Giubilato S, 2011, EUR HEART J, V32, P1214, DOI 10.1093/eurheartj/ehq499; Kordonouri O, 2011, PEDIATR DIABETES, V12, P31, DOI 10.1111/j.1399-5448.2010.00666.x; Kousta E, 2001, BRIT J OBSTET GYNAEC, V108, P716; Laugesen E, 2015, DIABETIC MED, V32, P843, DOI 10.1111/dme.12700; Li YJ, 2011, DIABETES RES CLIN PR, V94, P242, DOI 10.1016/j.diabres.2011.07.027; Liuzzo G, 2007, J AM COLL CARDIOL, V50, P1450, DOI 10.1016/j.jacc.2007.06.040; Maioli M, 2010, EUR J ENDOCRINOL, V163, P541, DOI 10.1530/EJE-10-0427; Medenica S, 2015, EUR REV MED PHARMACO, V19, P977; Miskiewicz P, 2015, ENDOCR PRACT, V21, P993, DOI 10.4158/EP15700.OR; Mjosberg J, 2010, BIOL REPROD, V82, P698, DOI 10.1095/biolreprod.109.081208; Omori Y, 2005, DIABETES CARE, V28, P2592, DOI 10.2337/diacare.28.10.2592; Pedicino D, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/184258; Pipi E, 2014, WORLD J DIABETES, V5, P505, DOI 10.4239/wjd.v5.i4.505; Salley KES, 2007, J CLIN ENDOCR METAB, V92, P4546, DOI 10.1210/jc.2007-1549; Sorgjerd EP, 2013, AUTOIMMUNITY, V46, P74, DOI 10.3109/08916934.2012.732132; Tomer Y, 2015, J AUTOIMMUN, V60, P32, DOI 10.1016/j.jaut.2015.03.006; TUOMI T, 1993, DIABETES, V42, P359, DOI 10.2337/diabetes.42.2.359; Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724; Yang ZF, 2007, DIABETES RES CLIN PR, V76, P126, DOI 10.1016/j.diabres.2006.08.013; Zhou ZG, 2013, DIABETES, V62, P543, DOI 10.2337/db12-0207	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0203446	10.1371/journal.pone.0203446	http://dx.doi.org/10.1371/journal.pone.0203446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346951	Green Submitted, Green Published, gold			2022-12-26	WOS:000447938400004
J	Brcic, J; Herrmann, B; Sala, A				Brcic, Jure; Herrmann, Bent; Sala, Antonello			Predictive models for codend size selectivity for four commercially important species in the Mediterranean bottom trawl fishery in spring and summer: Effects of codend type and catch size	PLOS ONE			English	Article							NEPHROPS-NORVEGICUS L.; SQUARE-MESH CODENDS; DIAMOND-MESH; GADUS-MORHUA; LARGER MESH; CIRCUMFERENCE; HADDOCK; ENDS; THICKNESS; NUMBER	Models to predict codend size selectivity for four major commercial species-European hake (Merluccius merluccius), Norway lobster (Nephrops norvegicus), deep-water rose shrimp (Parapenaeus longirostris), and Atlantic horse mackerel (Trachurus trachurus)-in Mediterranean bottom trawl fisheries were established based on data collected during fishing trials using the two legal codends: a 40 mm square-mesh codend and a 50 mm diamond-mesh codend. The models were applied to predict the extent to which size selection depend on codend type, also accounting for the potential effect of codend catch size and fishing season. The size selectivity of the two codends was evaluated and compared in identical simulated controlled conditions. Mesh type significantly affected the size selection of Norway lobster alone, with a slightly better performance of the 40 mm square-mesh codend. A high risk of retention of undersized individuals was predicted for both codends for all species except Norway lobster.	[Brcic, Jure] Univ Split, Dept Marine Studies, Split, Croatia; [Herrmann, Bent] North Sea Sci Pk, Fishing Gear Technol, SINTEF Fisheries & Aquaculture, Hirtshals, Denmark; [Herrmann, Bent] Univ Tromso, Tromso, Norway; [Sala, Antonello] Inst Biol Resources & Marine Biotechnol IRBIM, Italian Natl Res Council CNR, Ancona, Italy	University of Split; SINTEF; UiT The Arctic University of Tromso; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Istituto per le Risorse Biologiche Biotecnologie Marine (IRBIM-CNR)	Sala, A (corresponding author), Inst Biol Resources & Marine Biotechnol IRBIM, Italian Natl Res Council CNR, Ancona, Italy.	antonello.sala@cnr.it	Brčić, Jure/D-4337-2017; Sala, Antonello/B-8517-2016	Sala, Antonello/0000-0001-7066-1152; Herrmann, Bent/0000-0003-1325-6198; Brcic, Jure/0000-0003-3181-1749	Interreg research project MARTE+ [CUP D79E1000085007]; EU-FP7 project "BENTHIS" [312088]	Interreg research project MARTE+; EU-FP7 project "BENTHIS"	This work was funded by the Interreg research project MARTE+ (grant agreement CUP D79E1000085007 to AS) and the EU-FP7 project "BENTHIS" (grant agreement no. 312088 to AS). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin C, 2010, J APPL ICHTHYOL, V26, P71, DOI 10.1111/j.1439-0426.2009.01376.x; Aydin C, 2011, AFR J BIOTECHNOL, V10, P5037; Brcic J, 2015, FISH RES, V172, P352, DOI 10.1016/j.fishres.2015.07.035; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Cacaud P., 2005, STUDIES REV GEN FISH; Council of the European Communities, 2009, GREEN PAP REF COMM F; Damalas D, 2015, ICES J MAR SCI, V72, P2600, DOI 10.1093/icesjms/fsv141; Deval MC, 2009, J APPL ICHTHYOL, V25, P372, DOI 10.1111/j.1439-0426.2009.01239.x; Eigaard OR, 2011, FISH RES, V110, P39, DOI 10.1016/j.fishres.2011.03.010; FRYER RJ, 1991, ICES J MAR SCI, V48, P281, DOI 10.1093/icesjms/48.3.281; Grimaldo E, 2009, FISH RES, V95, P198, DOI 10.1016/j.fishres.2008.08.019; Guijarro B, 2006, ICES J MAR SCI, V63, P52, DOI 10.1016/j.icesjms.2005.08.011; Herrmann B, 2005, FISH RES, V71, P15, DOI 10.1016/j.fishres.2004.08.021; Herrmann B, 2005, FISH RES, V71, P1, DOI 10.1016/j.fishres.2004.08.024; Herrmann B, 2007, FISH RES, V84, P222, DOI 10.1016/j.fishres.2006.10.020; Herrmann Bent, 2012, Journal of Northwest Atlantic Fishery Science, V44, P1, DOI 10.2960/J.v44.m680; Herrmann B, 2015, ICES J MAR SCI, V72, P686, DOI 10.1093/icesjms/fsu124; Herrmann B, 2013, FISH RES, V145, P22, DOI 10.1016/j.fishres.2013.03.002; Ingolfsson OA, 2007, ICES J MAR SCI, V64, P1836, DOI 10.1093/icesjms/fsm150; Katsanevakis S, 2006, FISH RES, V81, P229, DOI 10.1016/j.fishres.2006.07.002; Kaykac H, 2009, SCI MAR, V73, P597, DOI 10.3989/scimar.2009.73n3597; Madsen N, 2002, FISH RES, V57, P223, DOI 10.1016/S0165-7836(01)00355-1; Mytilineou C, 1998, SCI MAR, V62, P107; O'Neill FG, 2016, FISH RES, V176, P94, DOI 10.1016/j.fishres.2015.12.012; O'Neill FG, 2003, FISH RES, V60, P107, DOI 10.1016/S0165-7836(02)00056-5; ONeill FG, 1996, FISH RES, V28, P291, DOI 10.1016/0165-7836(96)00501-2; Ordines F, 2006, AQUAT LIVING RESOUR, V19, P329, DOI 10.1051/alr:2007003; Ozbilgin H, 2002, FISH RES, V58, P323, DOI 10.1016/S0165-7836(01)00394-0; Pol MV, 2016, FISH RES, V184, P54, DOI 10.1016/j.fishres.2016.06.013; R Core Team, 2021, R LANGUAGE ENV STAT; Sala A, 2008, FISH RES, V93, P8, DOI 10.1016/j.fishres.2008.02.003; Sala A, 2006, AQUAT LIVING RESOUR, V19, P317, DOI 10.1051/alr:2007002; Sala A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160354; Sala A, 2015, FISH RES, V161, P182, DOI 10.1016/j.fishres.2014.07.011; Sala A, 2011, FISH RES, V110, P252, DOI 10.1016/j.fishres.2011.04.012; Sala A, 2010, FISH RES, V103, P63, DOI 10.1016/j.fishres.2010.02.003; Sarda F, 1993, SCI MAR, V57, P167; Stergiou KI, 1997, FISH RES, V29, P203, DOI 10.1016/S0165-7836(96)00542-5; Stewart PAM, 1985, 32 SCOT FISH; Tosunoglu Z, 2008, J APPL ICHTHYOL, V24, P311, DOI 10.1111/j.1439-0426.2008.01067.x; Tsagarakis K, 2014, ICES J MAR SCI, V71, P1219, DOI 10.1093/icesjms/fst074; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wienbeck H, 2014, FISH RES, V150, P28, DOI 10.1016/j.fishres.2013.10.007; Wienbeck H, 2011, FISH RES, V109, P80, DOI 10.1016/j.fishres.2011.01.019; Wileman D.A., 1996, 1126 ICES COOP	45	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0206044	10.1371/journal.pone.0206044	http://dx.doi.org/10.1371/journal.pone.0206044			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346961	Green Published, gold			2022-12-26	WOS:000447938400034
J	Costa-Martins, AG; Lima, L; Alves, JMP; Serrano, MG; Buck, GA; Camargo, EP; Teixeira, MMG				Costa-Martins, Andre G.; Lima, Luciana; Alves, Joao Marcelo P.; Serrano, Myrna G.; Buck, Gregory A.; Camargo, Erney P.; Teixeira, Marta M. G.			Genome-wide identification of evolutionarily conserved Small Heat-Shock and eight other proteins bearing alpha-crystallin domain-like in kinetoplastid protists	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; SEQUENCE ALIGNMENT; TRYPANOSOMA-CRUZI; SWISS-MODEL; IN-VITRO; P23; HSP90; PARASITISM; SELECTION; NUDC	Small Heat-Shock Proteins (sHSPs) and other proteins bearing alpha-crystallin domains (ACD) participate in defense against heat and oxidative stress and play important roles in cell cycle, cytoskeleton dynamics, and immunological and pathological mechanisms in eukaryotes. However, little is known about these proteins in early-diverging lineages of protists such as the kinetoplastids. Here, ACD-like proteins (ACDp) were investigated in genomes of 61 species of 12 kinetoplastid genera, including Trypanosoma spp. (23 species of mammals, reptiles and frogs), Leishmania spp. (mammals and lizards), trypanosomatids of insects, Phytomonas spp. of plants, and bodonids. Comparison of ACDps based on domain architecture, predicted tertiary structure, phylogeny and genome organization reveals a kinetoplastid evolutionarily conserved repertoire, which diversified prior to trypanosomatid adaptation to parasitic life. We identified 9 ACDp orthologs classified in 8 families of TryACD: four previously recognized (HSP20, Tryp23A, Tryp23B and ATOM69), and four characterized for the first time in kinetoplastids (TryACDP, TrySGT1, TryDYX1C1 and TryNudC). A single copy of each ortholog was identified in each genome alongside TtyNudC1/ TrypNudC2 homologs and, overall, ACDPs were under strong selection pressures at main phylogenetic lineages. Transcripts of all ACDPs were identified across the life stages of T. cruzi, T. brucei and Leishmania spp., but proteomic profiles suggested that most ACDPs may be species- and stage-regulated. Our findings establish the basis for functional studies, and provided evolutionary and structural support for an underestimated repertoire of ACDps in the kinetoplastids.	[Costa-Martins, Andre G.; Lima, Luciana; Alves, Joao Marcelo P.; Camargo, Erney P.; Teixeira, Marta M. G.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, SP, Brazil; [Lima, Luciana; Camargo, Erney P.; Teixeira, Marta M. G.] INCT EpiAmO Inst Nacl Epidemiol Amazonia Ocidenta, Porto Velho, RO, Brazil; [Serrano, Myrna G.; Buck, Gregory A.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA	Universidade de Sao Paulo; Virginia Commonwealth University	Costa-Martins, AG; Teixeira, MMG (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, SP, Brazil.; Teixeira, MMG (corresponding author), INCT EpiAmO Inst Nacl Epidemiol Amazonia Ocidenta, Porto Velho, RO, Brazil.	andreguilherme@usp.br; mmgteix@icb.usp.br	Alves, Joao M.P./G-8927-2011; Guilherme da Costa Martins, André/AAP-7653-2021; Teixeira, Marta M G/B-1115-2009; Camargo, Erney/A-6765-2009	Alves, Joao M.P./0000-0001-5914-2087; Guilherme da Costa Martins, André/0000-0003-2719-8224; Camargo, Erney/0000-0003-0011-5871	Brazilian agency CNPq; Brazilian agency FAPESP [2016/07487-0]; Brazilian agency CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [001]; National Science Foundation, Assembling the Tree of Life program [NSF DEB-0830056]; CAPES (PROTAX); CAPES (IINCT-EpiAmO)	Brazilian agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian agency CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Science Foundation, Assembling the Tree of Life program(National Science Foundation (NSF)); CAPES (PROTAX)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES (IINCT-EpiAmO)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from the Brazilian agencies CNPq (Universal program), FAPESP (EPC, project number 2016/07487-0), and CAPES (this study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Finance Code 001). The National Science Foundation, Assembling the Tree of Life program, supported genome sequencing of several kinetoplastids (PI Gregory A. Buck, NSF DEB-0830056 Assembling the Tree of Life: Phylum Euglenozoa) in the Nucleic Acids Research Facilities at Virginia Commonwealth University. AGCM and LL are beneficiaries of postdoctoral fellowships from CAPES (PROTAX and IINCT-EpiAmO, respectively)	Alcolea PJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2672-8; Alves JMP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-190; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Batista FAH, 2015, FEBS J, V282, P388, DOI 10.1111/febs.13141; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Carra S, 2017, CELL STRESS CHAPERON, V22, P601, DOI 10.1007/s12192-017-0787-8; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chandrasekar G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063123; Chuang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073841; Drini S, 2016, GENOME BIOL EVOL, V8, P1980, DOI 10.1093/gbe/evw140; Droll D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003286; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Espinosa OA, 2018, PARASITOLOGY, V145, P430, DOI [10.1017/S0031182016002092, 10.1017/s0031182016002092]; Espinosa-Alvarez O, 2018, INT J PARASITOL, V48, P569, DOI 10.1016/j.ijpara.2017.12.008; Faircloth LM, 2009, CELL STRESS CHAPERON, V14, P95, DOI 10.1007/s12192-008-0061-1; Felts SJ, 2003, CELL STRESS CHAPERON, V8, P108, DOI 10.1379/1466-1268(2003)008<0108:PASPWC>2.0.CO;2; Fermino BR, 2015, INT J PARASITOL-PAR, V4, P368, DOI 10.1016/j.ijppaw.2015.10.005; Fermino BR, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-313; Ferreira RC, 2008, J EUKARYOT MICROBIOL, V55, P427, DOI 10.1111/j.1550-7408.2008.00342.x; Flegontov P, 2013, CURR BIOL, V23, P1787, DOI 10.1016/j.cub.2013.07.045; Folgueira C, 2007, FEMS MICROBIOL REV, V31, P359, DOI 10.1111/j.1574-6976.2007.00069.x; Fu QQ, 2016, SCI CHINA LIFE SCI, V59, P455, DOI 10.1007/s11427-016-5029-2; Fukasawa Y, 2017, MOL BIOL EVOL, V34, P1574, DOI 10.1093/molbev/msx096; Bondino HG, 2012, PLANTA, V235, P1299, DOI 10.1007/s00425-011-1575-9; Garcia HA, 2011, INT J PARASITOL, V41, P1385, DOI 10.1016/j.ijpara.2011.09.001; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamilton PB, 2007, MOL PHYLOGENET EVOL, V44, P15, DOI 10.1016/j.ympev.2007.03.023; Hamilton PB, 2012, TRENDS PARASITOL, V28, P136, DOI 10.1016/j.pt.2012.01.006; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; de la Cruz OH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19611; Hombach A, 2015, CELL STRESS CHAPERON, V20, P673, DOI 10.1007/s12192-015-0595-y; Jackson AP, 2016, CURR BIOL, V26, P161, DOI 10.1016/j.cub.2015.11.055; Jackson AP, 2012, P NATL ACAD SCI USA, V109, P3416, DOI 10.1073/pnas.1117313109; Janouskovec J, 2016, CURR BIOL, V26, pR174, DOI 10.1016/j.cub.2015.12.057; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; Lima L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038385; Lima L, 2012, PROTIST, V163, P856, DOI 10.1016/j.protis.2011.12.003; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LoTurco JJ, 2013, BIOL PSYCHIAT, V73, P497, DOI 10.1016/j.biopsych.2013.01.025; Reis-Cunha JL, 2018, CURR GENOMICS, V19, P87, DOI 10.2174/1389202918666170911161311; Lukes J, 2018, TRENDS PARASITOL, V34, P466, DOI 10.1016/j.pt.2018.03.002; Lukes J, 2014, MOL BIOCHEM PARASIT, V195, P115, DOI 10.1016/j.molbiopara.2014.05.007; Mani J, 2016, MOL BIOL EVOL, V33, P337, DOI 10.1093/molbev/msv219; Mani J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7646; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McCallister C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09363; Meldau S, 2011, PLANT SIGNAL BEHAV, V6, P1479, DOI 10.4161/psb.6.10.17708; Montalvo-Alvarez AM, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/695432; Ogi H, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.12; Opperdoes FR, 2016, J EUKARYOT MICROBIOL, V63, P657, DOI 10.1111/jeu.12315; Paul A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00426; Pele J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-133; Perez-Morales D, 2015, CELL STRESS CHAPERON, V20, P767, DOI 10.1007/s12192-015-0607-y; Perez-Morales D, 2009, EXP PARASITOL, V123, P182, DOI 10.1016/j.exppara.2009.06.019; Poulain P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009990; Rahman K, 2017, J BIOL CHEM, V292, P18644, DOI 10.1074/jbc.M117.809301; Requena JM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/301326; Riera J, 2007, FEBS LETT, V581, P3057, DOI 10.1016/j.febslet.2007.05.065; Rodrigues CMF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2241-2; Silva NSM, 2018, INT J BIOL MACROMOL, V108, P193, DOI 10.1016/j.ijbiomac.2017.11.161; Singh MK, 2017, J THERM BIOL, V69, P149, DOI 10.1016/j.jtherbio.2017.06.004; Smith MD, 2015, MOL BIOL EVOL, V32, P1342, DOI 10.1093/molbev/msv022; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tammimies K, 2013, BIOL PSYCHIAT, V73, P583, DOI 10.1016/j.biopsych.2012.08.012; Urmenyi Turan P, 2014, Subcell Biochem, V74, P119, DOI 10.1007/978-94-007-7305-9_5; Yusof NA, 2016, CELL STRESS CHAPERON, V21, P707, DOI 10.1007/s12192-016-0696-2; Zanetti A, 2016, EUR J PROTISTOL, V56, P232, DOI 10.1016/j.ejop.2016.09.004; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; Zhang C, 2016, CELL RES, V26, P239, DOI 10.1038/cr.2015.152; Zhao XY, 2013, CELL MICROBIOL, V15, P571, DOI 10.1111/cmi.12056	75	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0206012	10.1371/journal.pone.0206012	http://dx.doi.org/10.1371/journal.pone.0206012			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346990	Green Submitted, Green Published, gold			2022-12-26	WOS:000447938400031
J	Takemoto, R; Anami, A; Koga, H				Takemoto, Ryuichi; Anami, Ai; Koga, Hiroshi			Relationship between birth weight to placental weight ratio and major congenital anomalies in Japan	PLOS ONE			English	Article							GESTATIONAL-AGE; FETAL-GROWTH; SINGLETON DELIVERIES; HEART-DEFECTS; COHORT; MALFORMATIONS; PARITY; RETARDATION; ASSOCIATION; PREGNANCIES	Recent studies have indicated that birth weight to placental weight (BW/PW) ratio is related to perinatal outcomes, but the effect of congenital abnormalities on BW/PW ratio remains unclear. We performed this study to elucidate correlations between BW/PW ratio and congenital abnormalities. Subjects were 735 singleton infants born at 34-41 weeks of gestation admitted to our center between 2010 and 2016. Of these, 109 infants (15%) showed major congenital anomalies. Major congenital anomalies and subgroups were diagnosed according to European Surveillance of Congenital Anomalies criteria. The primary outcome was the association between BW/PW ratio and major congenital anomaly, and secondary outcomes were the distribution pattern of BW/PW ratio with major anomalies and by major anomaly subgroups in each categorization (<10th percentile, 10-90th percentile, or >90th percentile) of BW/PW ratio. BW/PW ratio was not associated (P = 0.20) with presence (adjusted mean BWPW ratio = 5.02, 95% confidence interval [CI] 4.87-5.18) or absence (adjusted mean BW/PW ratio = 4.91, 95%CI 4.85-4.97) of major anomalies, after adjusting for gestational age and sex. Proportions of infants with major anomalies according to BW/ PW ratio categories were as follows: 12% in <10th percentile, 15% in 10-90th percentile, and 25% in >90th percentile of BW/PW ratio. Among major anomalies of the nervous system, congenital heart defects, and orofacial clefts, BW/PW ratio showed equally distributed trend across the three BW/PW ratio categories, but showed unequally distributed trend for anomalies of the digestive system, other anomalies/syndromes, or chromosomal abnormalities. BW/PW ratio was not associated with major congenital anomaly, and was distributed diffusely according to major anomaly subgroups. Major anomalies may tend to aggregate in the 90th percentile of the BW/PW ratio.	[Takemoto, Ryuichi; Koga, Hiroshi] Natl Hosp Org, Beppu Med Ctr, Dept Pediat, Beppu, Oita, Japan; [Anami, Ai] Natl Hosp Org, Beppu Med Ctr, Dept Obstet & Gynecol, Beppu, Oita, Japan		Koga, H (corresponding author), Natl Hosp Org, Beppu Med Ctr, Dept Pediat, Beppu, Oita, Japan.	sakuraliberty@me.com	Koga, Hiroshi/AAR-3755-2020	Koga, Hiroshi/0000-0001-9583-9842				Albalawi A, 2017, J ULTRAS MED, V36, P965, DOI 10.7863/ultra.16.04023; Arendt LH, 2016, AM J EPIDEMIOL, V183, P1122, DOI 10.1093/aje/kwv336; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Bolisetty S, 2002, ARCH DIS CHILD-FETAL, V86, P140; Hutcheon JA, 2012, OBSTET GYNECOL, V119, P1251, DOI 10.1097/AOG.0b013e318253d3df; KHOURY MJ, 1988, PEDIATRICS, V82, P83; Lubinsky M, 2017, AM J MED GENET A, V173, P151, DOI 10.1002/ajmg.a.37985; Malik S, 2007, PEDIATRICS, V119, pE976, DOI 10.1542/peds.2006-2742; Matthiesen NB, 2016, CIRCULATION, V134, P1546, DOI 10.1161/CIRCULATIONAHA.116.021793; NAEYE RL, 1987, HUM PATHOL, V18, P387, DOI 10.1016/S0046-8177(87)80170-3; Ocak S, 2011, ANIM REPROD SCI, V128, P45, DOI 10.1016/j.anireprosci.2011.08.011; Ogawa M, 2016, EUR J OBSTET GYN R B, V206, P225, DOI 10.1016/j.ejogrb.2016.09.004; Ohtaki T, 2012, ANIM SCI J, V83, P644, DOI 10.1111/j.1740-0929.2012.01012.x; Pri-Paz S, 2012, ULTRASOUND OBST GYN, V39, P648, DOI 10.1002/uog.10093; Risnes KR, 2009, AM J EPIDEMIOL, V170, P622, DOI 10.1093/aje/kwp182; Shehata F, 2011, BJOG-INT J OBSTET GY, V118, P741, DOI 10.1111/j.1471-0528.2011.02892.x; de Paula CFS, 2008, J ULTRAS MED, V27, P1583, DOI 10.7863/jum.2008.27.11.1583; SNIJDERS RJM, 1993, AM J OBSTET GYNECOL, V168, P547, DOI 10.1016/0002-9378(93)90491-Z; STOLL C, 1991, J MED GENET, V28, P325, DOI 10.1136/jmg.28.5.325; Strand K, 2016, BJOG-INT J OBSTET GY, V123, P2131, DOI 10.1111/1471-0528.13827; Thompson JMD, 2007, BJOG-INT J OBSTET GY, V114, P715, DOI 10.1111/j.1471-0528.2007.01327.x; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Wallace JM, 2013, PLACENTA, V34, P269, DOI 10.1016/j.placenta.2012.12.007	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0206002	10.1371/journal.pone.0206002	http://dx.doi.org/10.1371/journal.pone.0206002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346975	Green Submitted, Green Published, gold			2022-12-26	WOS:000447938400030
J	Beck, WS; Hall, EK				Beck, Whitney S.; Hall, Ed K.			Confounding factors in algal phosphorus limitation experiments	PLOS ONE			English	Article							NUTRIENT LIMITATION; PERIPHYTON GROWTH; TROPICAL STREAM; ATLANTIC FOREST; TOXICITY; LIGHT; RESPONSES; PATTERNS; NITROGEN; RELEASE	Assessing algal nutrient limitation is critical for understanding the interaction of primary production and nutrient cycling in streams, and nutrient diffusing substrate (NDS) experiments are often used to determine limiting nutrients such as nitrogen (N) and phosphorus (P). Unexpectedly, many experiments have also shown decreased algal biomass on NDS P treatments compared to controls. To address whether inhibition of algal growth results from direct P toxicity, NDS preparation artifacts, or environmental covariates, we first quantified the frequency of nutrient inhibition in published experiments. We also conducted a meta-analysis to determine whether heterotrophic microbial competition or selective grazing could explain decreases in algal biomass with P additions. We then deployed field experiments to determine whether P-inhibition of algal growth could be explained by P toxicity, differences in phosphate cation (K vs. Na), differences in phosphate form (monobasic vs. dibasic), or production of H2O2 during NDS preparation. We found significant inhibition of algal growth in 12.9% of published NDS P experiments as compared to 4.7% and 3.6% of N and NP experiments. The meta-analysis linear models did not show enhanced heterotrophy on NDS P treatments or selective grazing of P-rich algae. Our field experiments did not show inhibition of autotrophic growth with P additions, but we found significantly lower gross primary productivity (GPP) and biomass-specific GPP of benthic algae on monobasic phosphate salts as compared to dibasic phosphate salts, likely because of reduced pH levels. Additionally, we note that past field experiments and meta-analyses support the plausibility of direct P toxicity or phosphate form (monobasic vs. dibasic) leading to inhibition of algal growth, particularly when other resources such as N or light are limiting. Given that multiple mechanisms may be acting simultaneously, we recommend practical, cost-effective steps to minimize the potential for P-inhibition of algal growth as an artifact of NDS experimental design.	[Beck, Whitney S.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Beck, Whitney S.; Hall, Ed K.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Hall, Ed K.] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA; [Hall, Ed K.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University	Beck, WS (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.; Beck, WS (corresponding author), Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA.	whitney.beck@colostate.edu		Beck, Whitney/0000-0002-0306-6086	NSF IGERT Grant [DGE-0966346]; NSF [IOS-1456959, DEB-1046408, DEB-1045960, DEB-1045991]; Colorado Mountain Club	NSF IGERT Grant; NSF(National Science Foundation (NSF)); Colorado Mountain Club	WSB was supported by NSF IGERT Grant No. DGE-0966346 'I-WATER: Integrated Water, Atmosphere, Ecosystems Education and Research Program' to Colorado State University and this work represents a product of NSF IOS-1456959 to EKH. Project support also came from NSF Grant Nos. DEB-1046408, DEB-1045960, DEB-1045991, and the Colorado Mountain Club.	Ambrose HE, 2004, J N AM BENTHOL SOC, V23, P701, DOI 10.1899/0887-3593(2004)023<0701:PRTILA>2.0.CO;2; Ambrose HE, 2003, THESIS; Bechtold HA, 2012, LIMNOL OCEANOGR, V57, P1544, DOI 10.4319/lo.2012.57.5.1544; Beck WS, 2017, FRESHWATER BIOL, V62, P1667, DOI 10.1111/fwb.12989; Bernhardt ES, 2004, FRESHWATER BIOL, V49, P14, DOI 10.1046/j.1365-2426.2003.01161.x; Borchardt Mark A., 1996, P183, DOI 10.1016/B978-012668450-6/50036-9; BROWN EJ, 1981, MICROBIAL ECOL, V7, P199, DOI 10.1007/BF02010303; Capps KA, 2011, J N AM BENTHOL SOC, V30, P522, DOI 10.1899/10-146.1; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; CHRISTIE EK, 1975, AUST J AGR RES, V26, P423, DOI 10.1071/AR9750423; Chu SP, 1943, J ECOL, V31, P109, DOI 10.2307/2256545; Corkum LD, 1996, HYDROBIOLOGIA, V333, P37, DOI 10.1007/BF00020962; Costello DM, 2016, FRESHWATER BIOL, V61, P2129, DOI 10.1111/fwb.12641; Eckert RA, 2014, HYDROBIOLOGIA, V722, P183, DOI 10.1007/s10750-013-1699-y; Elsaholi M, 2011, INLAND WATERS, V1, P74, DOI 10.5268/IW-1.2.341; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; FAIRCHILD GW, 1985, ECOLOGY, V66, P465, DOI 10.2307/1940395; Flecker AS, 2002, ECOLOGY, V83, P1831, DOI 10.2307/3071768; Francoeur SN, 2001, J N AM BENTHOL SOC, V20, P358, DOI 10.2307/1468034; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; GRANT BR, 1969, COMP BIOCHEM PHYSIOL, V29, P995, DOI 10.1016/0010-406X(69)91001-9; GRIMM N B, 1986, Journal of the North American Benthological Society, V5, P2, DOI 10.2307/1467743; GROVES RH, 1976, AUST J BOT, V24, P681, DOI 10.1071/BT9760681; GRUNDON NJ, 1972, J ECOL, V60, P171, DOI 10.2307/2258049; Gustina GW, 2000, ARCT ANTARCT ALP RES, V32, P127, DOI 10.2307/1552444; HEDDLE EM, 1975, AUST J BOT, V23, P151, DOI 10.1071/BT9750151; HOAGLAND KD, 1993, J PHYCOL, V29, P537, DOI 10.1111/j.0022-3646.1993.00537.x; Hood JM, 2014, FRESHW SCI, V33, P1093, DOI 10.1086/678693; Jensen TE, 1976, ASPECTS PHOSPHATE UT; Jones JB, 1998, COMMUN SOIL SCI PLAN, V29, P1779, DOI 10.1080/00103629809370068; Keck F, 2012, FRESHWATER BIOL, V57, P1410, DOI 10.1111/j.1365-2427.2012.02802.x; Koricheva J., 2013, HDB METAANALYSIS ECO, P195, DOI DOI 10.23943/PRINCETON/9780691137285.001.0001; Lamberti Gary A., 1996, P533, DOI 10.1016/B978-012668450-6/50046-1; Lang DA, 2012, FRESHW SCI, V31, P1096, DOI 10.1899/12-031.1; LEHMAN JT, 1976, LIMNOL OCEANOGR, V21, P646, DOI 10.4319/lo.1976.21.5.0646; Lewis WM, 2010, FRESHWATER BIOL, V55, P1973, DOI 10.1111/j.1365-2427.2010.02431.x; LONERAGAN JF, 1982, SOIL SCI SOC AM J, V46, P345, DOI 10.2136/sssaj1982.03615995004600020027x; Lourenco-Amorim C, 2014, FRESHWATER BIOL, V59, P2365, DOI 10.1111/fwb.12441; McNeely C, 2007, ECOLOGY, V88, P391, DOI 10.1890/0012-9658(2007)88[391:GTCACS]2.0.CO;2; Mooney RJ, 2016, FRESHW SCI, V35, P873, DOI 10.1086/686699; Mosisch TD, 1999, AQUAT BOT, V64, P167, DOI 10.1016/S0304-3770(99)00014-5; Moulton TP, 2004, J N AM BENTHOL SOC, V23, P868, DOI 10.1899/0887-3593(2004)023<0868:EOEASO>2.0.CO;2; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; MUSICK HB, 1978, BOT GAZ, V139, P108, DOI 10.1086/336976; Neeson TM, 2013, OIKOS, V122, P265, DOI 10.1111/j.1600-0706.2012.20256.x; Parker DL, 1997, APPL ENVIRON MICROB, V63, P2324, DOI 10.1128/AEM.63.6.2324-2329.1997; Pepe-Ranney C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00703; Planas D., 1996, ALGAL ECOLOGY FRESHW, P497; PRINGLE CM, 1987, CAN J FISH AQUAT SCI, V44, P619, DOI 10.1139/f87-075; PRINGLE CM, 1994, CAN J FISH AQUAT SCI, V51, P1443, DOI 10.1139/f94-144; Reisinger AJ, 2016, FRESHW SCI, V35, P474, DOI 10.1086/685829; Ribot M, 2015, AQUAT SCI, V77, P695, DOI 10.1007/s00027-015-0412-9; Rier ST, 2014, FRESHWATER BIOL, V59, P1039, DOI 10.1111/fwb.12327; Rohatgi A., 2015, WEBPLOTDIGITIZER VER; ROSSITER RC, 1952, AUST J AGR RES, V3, P227, DOI 10.1071/AR9520227; Rugenski AT, 2008, J N AM BENTHOL SOC, V27, P52, DOI 10.1899/07-046R1.1; Sanderson BL, 2009, J N AM BENTHOL SOC, V28, P832, DOI 10.1899/09-072.1; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Scott JT, 2008, J N AM BENTHOL SOC, V27, P332, DOI 10.1899/07-108.1; Snyder EB, 2002, CAN J FISH AQUAT SCI, V59, P564, DOI 10.1139/F02-021; STEVENSON RJ, 1982, T AM MICROSC SOC, V101, P151, DOI 10.2307/3225768; Suplee MW, 2009, J AM WATER RESOUR AS, V45, P123, DOI 10.1111/j.1752-1688.2008.00265.x; Tanaka T, 2014, APPL ENVIRON MICROB, V80, P7659, DOI 10.1128/AEM.02741-14; Tank JL, 2017, METHODS IN STREAM ECOLOGY, VOL 2: ECOSYSTEM FUNCTION, 3RD EDITION, P147, DOI 10.1016/B978-0-12-813047-6.00009-7; U. S. EPA, 1997, 4450 US EPA; U. S. EPA, 1993, 3532 US EPA; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; Van Moorleghem C, 2013, HYDROBIOLOGIA, V709, P41, DOI 10.1007/s10750-013-1442-8; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER; WINTERBOURN M J, 1989, New Zealand Natural Sciences, V16, P57	72	14	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205684	10.1371/journal.pone.0205684	http://dx.doi.org/10.1371/journal.pone.0205684			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335857	gold, Green Submitted, Green Published			2022-12-26	WOS:000447701300044
J	Brenes, CLM; Jones, KW; Schlesinger, P; Robalino, J; Vierling, L				Brenes, Carlos L. Munoz; Jones, Kelly W.; Schlesinger, Peter; Robalino, Juan; Vierling, Lee			The impact of protected area governance and management capacity on ecosystem function in Central America	PLOS ONE			English	Article							PROPENSITY SCORE; MATCHING ESTIMATORS; FOREST MANAGEMENT; DECENTRALIZATION; CONSERVATION; CLASSIFICATION; PERFORMANCE; INDICATORS; LOCATION; LANDSAT	Protected areas (PAs) are a prominent approach to maintaining and enhancing biodiversity and ecosystem services. A critical question for safeguarding these resources is how PA governance processes and management structures influence their effectiveness. We conduct an impact evaluation of 12 PAs in three Central American countries to assess how processes in management restrictions, management capacity, and decentralization affect the annual change in the satellite-derived Normalized Difference Vegetation Index (NDVI). NDVI varies with greenness that relates to plant production, biomass, and important ecosystem functions related to biodiversity and ecosystem services such as water quality and carbon storage. Any loss of vegetation cover in the form of deforestation or degradation would show up as a decrease in NDVI values over time and gains in vegetation cover and regeneration as an increase in NDVI values. Management restriction categories are based on international classifications of strict versus multiple-use PAs, and capacity and decentralization categories are based on key informant interviews of PA managers. We use matching to create a counterfactual of non-protected observations and a matching estimator and regression to estimate treatment effects of each sub-sample. On average, strict and multiple-use PAs have a significant and positive effect on NDVI compared to non-protected land uses. Both high and low decentralized PAs also positively affect NDVI. High capacity PAs have a positive and significant effect on NDVI, while low capacity PAs have a negative effect on NDVI. Our findings advance knowledge on how governance and management influence PA effectiveness and suggest that capacity may be more important than governance type or management restrictions in maintaining and enhancing NDVI. This paper also provides a guide for future studies to incorporate measures of PA governance and management into impact evaluations.	[Brenes, Carlos L. Munoz; Schlesinger, Peter; Vierling, Lee] Univ Idaho, Dept Nat Resources & Soc, Moscow, ID 83843 USA; [Brenes, Carlos L. Munoz; Robalino, Juan] Trop Agr Res & Higher Educ Ctr CATIE, Econ & Environm Dev Res Program EfD Cent Amer, Turrialba, Costa Rica; [Jones, Kelly W.] Colorado State Univ, Human Dimens Nat Resources, Ft Collins, CO 80523 USA; [Schlesinger, Peter] Trop Agr Res & Higher Educ Ctr CATIE, Postgrad Sch, Turrialba, Costa Rica; [Robalino, Juan] Univ Costa Rica, Sch Econ, San Jose, Costa Rica	Idaho; University of Idaho; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; Colorado State University; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; Universidad Costa Rica	Brenes, CLM (corresponding author), Univ Idaho, Dept Nat Resources & Soc, Moscow, ID 83843 USA.; Brenes, CLM (corresponding author), Trop Agr Res & Higher Educ Ctr CATIE, Econ & Environm Dev Res Program EfD Cent Amer, Turrialba, Costa Rica.	carlosglobal@gmail.com	Brenes, Carlos L. Muñoz/X-7661-2018	Brenes, Carlos L. Muñoz/0000-0001-6760-3592; Jones, Kelly/0000-0001-9664-7615	National Aeronautics and Space Administration (NASA) Land-Cover and Land-Use Change (LCLUC) Program [NNX13AC70G]; Ministerio de Ciencia, Tecnologia y Telecomunicaciones (MICITT); Consejo Nacional para Investigaciones Cientificas y Tecnologicas (CONICIT) in Costa Rica (CLMB)	National Aeronautics and Space Administration (NASA) Land-Cover and Land-Use Change (LCLUC) Program; Ministerio de Ciencia, Tecnologia y Telecomunicaciones (MICITT); Consejo Nacional para Investigaciones Cientificas y Tecnologicas (CONICIT) in Costa Rica (CLMB)	Funding for this research was provided through the National Aeronautics and Space Administration (NASA) Land-Cover and Land-Use Change (LCLUC) Program (http://lcluc.umd.edu) grant NNX13AC70G (KJ) and the Ministerio de Ciencia, Tecnologia y Telecomunicaciones (MICITT, https://www.micit.go.cr) and Consejo Nacional para Investigaciones Cientificas y Tecnologicas (CONICIT, http://www.conicit.go.cr) in Costa Rica (CLMB). The funding institutions had no participation in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A., 2002, SIMPLE BIAS CORRECTE; Abadie A, 2011, J BUS ECON STAT, V29, P1, DOI 10.1198/jbes.2009.07333; Agrawal A, 2005, WORLD DEV, V33, P1101, DOI 10.1016/j.worlddev.2005.04.009; Agrawal A, 1999, J DEV AREAS, V33, P473; Agrawal A, 2008, SCIENCE, V320, P1460, DOI 10.1126/science.1155369; Alix-Garcia JM, 2012, LAND ECON, V88, P613, DOI 10.3368/le.88.4.613; Alix-Garcia JM, 2010, WORKING PAPER; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; [Anonymous], 2010, UNEPCBDCOPDECX2; [Anonymous], 2016, WORLD DAT PROT AR WD; Artiga R., 2003, TECHNICAL DOCUMENTS; Artiga R., 2002, CASO PLAN TRIFINIO A; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bai ZG, 2008, SOIL USE MANAGE, V24, P223, DOI 10.1111/j.1475-2743.2008.00169.x; Becker SO, 2007, STATA J, V7, P71, DOI 10.1177/1536867X0700700104; Blackman A, 2015, GLOBAL ENVIRON CHANG, V31, P50, DOI 10.1016/j.gloenvcha.2014.12.004; Blackman A, 2015, ECOL ECON, V112, P14, DOI 10.1016/j.ecolecon.2015.01.009; Borrini-Feyerabend G., 2003, POLICY MATTERS, V12, P92; Brenes CL, 2016, J LAND USE SCI, P1; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cabello J, 2012, BIODIVERS CONSERV, V21, P3287, DOI 10.1007/s10531-012-0370-7; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Carranza T, 2014, CONSERV LETT, V7, P216, DOI 10.1111/conl.12049; Carranza T, 2014, BIOL CONSERV, V173, P10, DOI 10.1016/j.biocon.2014.03.004; Coad L, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0281; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; Cordero-Sancho S, 2007, INT J REMOTE SENS, V28, P1577, DOI 10.1080/01431160600887680; Dearden P, 2005, ENVIRON MANAGE, V36, P89, DOI 10.1007/s00267-004-0131-9; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Dudley N., 2013, BEST PRACT PROTECT A; Dudley N, 2008, GUIDELINES APPL PROT, DOI DOI 10.2305/IUCN.CH.2008.PAPS.2.EN; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Faguet JP, 2013, WORLD DEV, V53, P2, DOI 10.1016/j.worlddev.2013.01.002; Ferraro P., 2009, ENV PROGRAM POLICY E, P75, DOI [10.1002/ev.297, DOI 10.1002/EV.297]; Ferraro PJ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025011; Fuhr H., 2011, INT J ADM SCI ORG, V18; Garbulsky MF, 2004, J VEG SCI, V15, P711, DOI 10.1111/j.1654-1103.2004.tb02313.x; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; German Society for International Cooperation (GIZ), 2011, EST REG TRIF 2010 DA; Getzner M., 2014, International Journal of Sustainable Society, V6, P82; Gibson C.C., 2000, PEOPLE FORESTS COMMU, P1; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Jones KW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141380; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Khandker S.R., 2010, HDB IMPACT EVALUATIO; Larson AM, 2007, INT FOREST REV, V9, P734, DOI 10.1505/ifor.9.3.734; Larson AM, 2003, PUBLIC ADMIN DEVELOP, V23, P211, DOI 10.1002/pad.271; Larson AM, 2008, ANNU REV ENV RESOUR, V33, P213, DOI 10.1146/annurev.environ.33.020607.095522; Lautze J, 2011, NAT RESOUR FORUM, V35, P1, DOI 10.1111/j.1477-8947.2010.01339.x; Macura B, 2013, ENV EVIDENCE, V2, P1, DOI [10.1186/2047, DOI 10.1186/2047]; Macura B, 2015, ENVIRON EVID, V4, DOI 10.1186/s13750-015-0051-6; Miteva DA, 2012, OXFORD REV ECON POL, V28, P69, DOI 10.1093/oxrep/grs009; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Nolte C, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015039; Nolte C, 2013, P NATL ACAD SCI USA, V110, P4956, DOI 10.1073/pnas.1214786110; Nolte C, 2013, CONSERV BIOL, V27, P155, DOI 10.1111/j.1523-1739.2012.01930.x; Nygren A, 2005, WORLD DEV, V33, P639, DOI 10.1016/j.worlddev.2004.11.002; Pan W., 2015, PROPENSITY SCORE ANA, P3, DOI [10.1002/sim.3697PMC3472075, DOI 10.1002/SIM.3697PMC3472075]; Pfaff A., 2013, ENCY ENERGY NATURAL, P144, DOI DOI 10.1111/J.1523-1739.2012.01930.X; Pfaff A, 2014, WORLD DEV, V55, P7, DOI 10.1016/j.worlddev.2013.01.011; Pfaff A, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.1990; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Rencher A., 2013, METHODS MULTIVARIATE; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Schmitt-Harsh M, 2013, PHOTOGRAMM ENG REM S, V79, P457, DOI 10.14358/PERS.79.5.457; Schmitt-Harsh M, 2013, APPL GEOGR, V40, P40, DOI 10.1016/j.apgeog.2013.01.007; Shafer CL, 2015, GLOB ECOL CONSERV, V3, P331, DOI 10.1016/j.gecco.2014.12.007; Simonetti E., 2014, TECHNICAL REPORTPHEN; Sims KRE, 2010, J ENVIRON ECON MANAG, V60, P94, DOI 10.1016/j.jeem.2010.05.003; Tacconi L, 2007, GLOBAL ENVIRON CHANG, V17, P338, DOI 10.1016/j.gloenvcha.2007.01.002; Tang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019116; UNEP-WCMC IUNC, 2016, PROTECTED PLANET REP; UNESCO, 2011, 18 NEW BIOSPH RES AD; Vergara-Asenjo G, 2014, GLOBAL ENVIRON CHANG, V28, P205, DOI 10.1016/j.gloenvcha.2014.07.002; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Wendland KJ, 2015, LAND ECON, V91, P149, DOI 10.3368/le.91.1.149	85	14	14	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205964	10.1371/journal.pone.0205964	http://dx.doi.org/10.1371/journal.pone.0205964			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4KR	30335845	gold, Green Published, Green Submitted			2022-12-26	WOS:000447701300079
J	Fuentes-Santos, I; Labarta, U; Fernandez-Reiriz, MJ				Fuentes-Santos, Isabel; Labarta, Uxio; Jose Fernandez-Reiriz, Maria			Characterizing individual variability in mussel (Mytilus galloprovincialis) growth and testing its physiological drivers using Functional Data Analysis	PLOS ONE			English	Article							SELF-THINNING MODEL; CLEARANCE RATE; SPAT; POPULATIONS; RESPONSES; DENSITY; RATES	Determining the magnitude and causes of intrinsic variability is a main issue in the analysis of bivalve growth. Inter-individual variability in bivalve growth has been attributed to differences in the physiological performance. This hypothesis has been commonly tested comparing the physiological rates of fast and slow growers after size differentiation has occurred. This experimental design may detect a link between growth and physiological performance, but we cannot interpret the posterior physiological performance as a driver for the prior growth variability. Considering these limitations, this work introduces a new methodological framework for the analysis of bivalve growth variability. We have conducted sequential measurements of size and physiological performance (feeding, digestion and metabolic rates) in even-sized mussels growing under homogeneous environmental conditions. This experimental design allows us to distinguish between changes over time within individuals, i.e. growth and trends in the physiological rates, from differences between individuals with respect to a baseline level. In addition, Functional Data Analysis provides powerful tools to summarize all the information obtained in the exhaustive sampling scheme and to test whether differences in the physiological performance enhance growth dispersion. Our results report an increasing dispersion in both size and physiological performance over time. Although mussels grew during the experiment, it is difficult to detect any increasing or decreasing temporal pattern in their feeding, digestion and metabolic rates due to the large inter-individual variability. Comparison between the growth and physiological patterns of mussels with final size above (fast growers) and below (slow growers) the median found that fast growers had larger feeding and digestion rates and lower metabolic expenditures during the experimental culture than mussels with slow growth, which agrees with the hypothesis of a physiological basis for bivalve growth variability.	[Fuentes-Santos, Isabel; Labarta, Uxio; Jose Fernandez-Reiriz, Maria] CSIC, IIM, C Eduardo Cabello 6, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Fuentes-Santos, I (corresponding author), CSIC, IIM, C Eduardo Cabello 6, Vigo, Spain.	isafusa@iim.csic.es	Fuentes-Santos, Isabel/AAT-5447-2021	Fuentes-Santos, Isabel/0000-0002-3298-9648	FIGEBIV [AGL2013-49144-C3-2-R]; EU H2020 project ClimeFish [EU 677039]; CSIC-PIE project [CSIC 201540E107]	FIGEBIV; EU H2020 project ClimeFish; CSIC-PIE project	This study has been funded by project FIGEBIV (AGL2013-49144-C3-2-R), EU H2020 project ClimeFish (EU 677039) and CSIC-PIE project (CSIC 201540E107).	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arranz K, 2016, HYDROBIOLOGIA, V772, P261, DOI 10.1007/s10750-016-2672-3; Bayne BL, 2000, J EXP MAR BIOL ECOL, V251, P185, DOI 10.1016/S0022-0981(00)00211-2; Bayne BL, 1999, PHYSIOL BIOCHEM ZOOL, V72, P705, DOI 10.1086/316714; Camacho AP, 1995, AQUACULTURE, V138, P349, DOI 10.1016/0044-8486(95)01139-0; CONOVER RJ, 1966, LIMNOL OCEANOGR, V11, P338, DOI 10.4319/lo.1966.11.3.0338; Cubillo AM, 2015, J SEA RES, V95, P84, DOI 10.1016/j.seares.2014.09.009; Cubillo AM, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00180.1; Cuevas A, 2004, COMPUT STAT DATA AN, V47, P111, DOI 10.1016/j.csda.2003.10.021; Escati-Penaloza G, 2010, FISH RES, V105, P91, DOI 10.1016/j.fishres.2010.03.007; Febrero M, 2008, ENVIRONMETRICS, V19, P331, DOI 10.1002/env.878; Febrero-Bande M, 2012, J STAT SOFTW, V51, P1; Fernandez-Reiriz MJ, 2017, DUBROVNIK; Ferraty F., 2006, SPR S STAT; Filgueira R, 2006, LIMNOL OCEANOGR-METH, V4, P284, DOI 10.4319/lom.2006.4.284; Filgueira R, 2008, REV BIOL MAR OCEANOG, V43, P391; Fuentes-Santos I, 2014, REV AQUACULT, V6, P115, DOI 10.1111/raq.12032; Gosling E, 2008, BIVALVE MOLLUSCS BIO; Guinez R, 1999, AM NAT, V154, P341, DOI 10.1086/303234; IVLEV VS, 1966, J FISH RES BOARD CAN, V23, P1727, DOI 10.1139/f66-160; Fernandez-Reiriz MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148245; Fernandez-Reiriz MJ, 2015, AQUACULTURE, V446, P42, DOI 10.1016/j.aquaculture.2015.04.025; Labarta U., 2004, BATEEIROS MAR MEJILL; Larson JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112252; Pernet F, 2008, J EXP BIOL, V211, P969, DOI 10.1242/jeb.014639; Peteiro LG, 2010, AQUACULT ENG, V42, P25, DOI 10.1016/j.aquaeng.2009.09.003; Ramsay J. O, 2006, FUNCTIONAL DATA ANAL; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Silverman B.W., 1986, DENSITY ESTIMATION S; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Tamayo D, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2905-z; Tamayo D, 2015, J EXP MAR BIOL ECOL, V471, P92, DOI 10.1016/j.jembe.2015.05.017; Tamayo D, 2014, MAR BIOL, V161, P1627, DOI 10.1007/s00227-014-2447-1; Tamayo D, 2013, J COMP PHYSIOL B, V183, P893, DOI 10.1007/s00360-013-0764-1; Tamayo D, 2011, AQUACULTURE, V321, P113, DOI 10.1016/j.aquaculture.2011.08.024; Vincenzi S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003828; Widdows J., 1985, P161; Winberg G., 1956, FISH RES BD CAN T SE, V194, P185	39	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205981	10.1371/journal.pone.0205981	http://dx.doi.org/10.1371/journal.pone.0205981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335841	Green Published, gold, Green Submitted			2022-12-26	WOS:000447701300084
J	Meyer, AN; Gallo, LH; Ko, J; Cardenas, G; Nelson, KN; Siari, A; Campos, AR; Whisenant, TC; Donoghue, DJ				Meyer, April N.; Gallo, Leandro H.; Ko, Juyeon; Cardenas, Guillermo; Nelson, Katelyn N.; Siari, Asma; Campos, Alexandre R.; Whisenant, Thomas C.; Donoghue, Daniel J.			Oncogenic mutations in IKK beta function through global changes induced by K63-linked ubiquitination and result in autocrine stimulation	PLOS ONE			English	Article							NF-KAPPA-B; SET ENRICHMENT ANALYSIS; MULTIPLE-MYELOMA; KINASE INHIBITOR; CELL LYMPHOMA; CANCER; GENE; ACTIVATION; WEBGESTALT; PLATFORM	Mutations at position K171 in the kinase activation loop of Inhibitor of kappa B kinase beta (IKK beta) occur in multiple myeloma, spleen marginal zone lymphoma and mantle cell lymphoma. Previously, we demonstrated that these result in constitutive kinase activation and stimulate Signal Transducer and Activator of Transcription 3 (STAT3). This work also identified K147 as a site of K63-linked regulatory ubiquitination required for activation of signaling pathways. We now present a more detailed analysis of ubiquitination sites together with a comprehensive examination of the signaling pathways activated by IKK beta K171E mutants. Downstream activation of STAT3 is dependent upon the activity of: UBE2N, the E2 ubiquitin ligase involved in K63-linked ubiquitination; TAK1 (MAP3K7), or TGF beta Activated Kinase, which forms a complex required for NF kappa B activation; JAK kinases, involved proximally in the phosphorylation of STAT transcription factors in response to inflammatory cytokines; and gp130, or IL-6 Receptor Subunit Beta which, upon binding IL-6 or other specific cytokines, undergoes homodimerization leading to activation of associated JAKs, resulting in STAT activation. We further demonstrate, using an IL-6-responsive cell line, that IKK beta K171E mutants stimulate the release of IL-6 activity into conditioned media. These results show that IKK beta K171E mutants trigger an autocrine loop in which IL-6 is secreted and binds to the IL-6 receptor complex gp130, resulting in JAK activation. Lastly, by examining the differential abundance of proteins associated with K63-only-ubiquitinated IKK beta K171E, proteomic analysis demonstrates the global activation of proliferative responses. As cancers harboring K171-mutated IKK beta are likely to also exhibit activated STAT3 and p44/42 MAPK (Erk1/2), this suggests the possibility of using MAPK (Erk1/2) and JAK inhibitors, or specific ubiquitination inhibitors. K63-linked ubiquitination occurs in other kinases at sites homologous to K147 in IKK beta, including K578 in BRAF V600E, which serves as an oncogenic driver in melanoma and other cancers.	[Meyer, April N.; Gallo, Leandro H.; Ko, Juyeon; Cardenas, Guillermo; Nelson, Katelyn N.; Donoghue, Daniel J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Siari, Asma] Univ Joseph Fourier Grenoble, Grenoble, France; [Campos, Alexandre R.] Sanford Burnham Prebys Med Discovery Inst, Prote Facil, La Jolla, CA USA; [Whisenant, Thomas C.] Univ Calif San Diego, Ctr Computat Biol & Bioinformat, La Jolla, CA 92093 USA; [Donoghue, Daniel J.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Donoghue, DJ (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.; Donoghue, DJ (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	ddonoghue@ucsd.edu			UC San Diego Foundation; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER	UC San Diego Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge generous support from the UC San Diego Foundation.	Agarwal NK, 2016, BLOOD, V127, P605, DOI 10.1182/blood-2015-07-658781; An L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02344; Bea S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/pnas.1314608110; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen JQ, 2013, CURR OPIN IMMUNOL, V25, P4, DOI 10.1016/j.coi.2012.12.005; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Deng JX, 2008, CHEMMEDCHEM, V3, P1677, DOI 10.1002/cmdc.200800217; Fan YH, 2011, CELL SIGNAL, V23, P660, DOI 10.1016/j.cellsig.2010.11.017; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Gallo LH, 2014, CELL CYCLE, V13, P3964, DOI 10.4161/15384101.2014.988026; Gilmore TD, 2007, CANCER CELL, V12, P95, DOI 10.1016/j.ccr.2007.07.010; Grande F, 2007, BIOORGAN MED CHEM, V15, P288, DOI 10.1016/j.bmc.2006.09.073; Hodge CD, 2016, ONCOTARGET, V7, P64471, DOI 10.18632/oncotarget.10948; Hodge CD, 2015, ACS CHEM BIOL, V10, P1718, DOI 10.1021/acschembio.5b00222; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Iwai K, 2014, NAT REV MOL CELL BIO, V15, P503, DOI 10.1038/nrm3836; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Liang L, 2013, CELL SIGNAL, V25, P247, DOI 10.1016/j.cellsig.2012.09.003; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Meyer AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084497; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murray MY, 2015, CELL CYCLE, V14, P2367, DOI 10.1080/15384101.2014.998067; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Pulvino M, 2012, BLOOD, V120, P1668, DOI 10.1182/blood-2012-02-406074; Rawlins P, 1999, INT J IMMUNOPHARMACO, V21, P799, DOI 10.1016/S0192-0561(99)00047-8; Rossi D, 2011, BLOOD, V118, P4930, DOI 10.1182/blood-2011-06-359166; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Tyanova S, 2018, METHODS MOL BIOL, V1711, P133, DOI 10.1007/978-1-4939-7493-1_7; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vatsveen TK, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0306-x; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Wu JQ, 2013, ACS CHEM BIOL, V8, P643, DOI 10.1021/cb3005897; Wu XF, 2015, IMMUNOL REV, V266, P161, DOI 10.1111/imr.12310; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444; Zhang YT, 2016, MOL CANCER THER, V15, P1504, DOI 10.1158/1535-7163.MCT-15-0999	45	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206014	10.1371/journal.pone.0206014	http://dx.doi.org/10.1371/journal.pone.0206014			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335863	Green Submitted, gold, Green Published			2022-12-26	WOS:000447701300089
J	Smith, JA; Bar-Peled, M				Smith, James Amor; Bar-Peled, Maor			Identification of an apiosyltransferase in the plant pathogen Xanthomonas pisi	PLOS ONE			English	Article							EXTRACELLULAR POLYSACCHARIDE; UDP-APIOSE; GLYCOSYLTRANSFERASE; BIOSYNTHESIS; CLASSIFICATION; CAMPESTRIS; BACILLUS; GENE; WEB; BETA-1,2-XYLOSYLTRANSFERASE	The rare branched-chain sugar apiose, once thought to only be present in the plant kingdom, was found in two bacterial species: Geminicoccus roseus and Xanthomonas pisi. Glycans with apiose residues were detected in aqueous methanol-soluble fractions as well as in the insoluble pellet fraction of X. pisi. Genes encoding bacterial uridine diphosphate apiose (UDP-apiose) synthases (bUASs) were characterized in these bacterial species, but the enzyme(s) involved in the incorporation of the apiose into glycans remained unknown. In the X. pisi genome two genes flanking the XpUAS were annotated as hypothetical glycosyltransferase (GT) proteins. The first GT (here on named XpApiT) belongs to GT family 90 and has a Leloir type B fold and a putative lipopolysaccharide-modifying (LPS) domain. The second GT (here on XpXylT) belongs to GT family 2 and has a type A fold. The XpXylT and XpApiT genes were cloned and heterologously expressed in E. coli. Analysis of nucleotide sugar extracts from E. coli expressing XpXylT or XpApiT with UAS showed that recombinant XpApiT utilized UDP-apiose and XpXylT utilized UDP-xylose as substrate. Indirect activity assay (UDP-Glo) revealed that XpApiT is an apiosyltransferase (ApiT) able to specifically use UDP-apiose. Further support for the apiosyltransferase activity was demonstrated by in microbe co-expression of UAS and XpApiT in E. coli showing the utilization of UDP-apiose to generate an apioside detectable in the pellet fraction. This work provides evidence that X. pisi developed the ability to synthesize an apioside of indeterminate function; however, the evolution of the bacterial ApiT remains to be determined. From genetic and evolutionary perspectives, the apiose operon may provide a unique opportunity to examine how genomic changes reflect ecological adaptation during the divergence of a bacterial group.	[Smith, James Amor; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Smith, James Amor; Bar-Peled, Maor] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.; Bar-Peled, M (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.; Bar-Peled, M (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	peled@ccrc.uga.edu			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-12ER16324]; U.S. Department of Energy [DE-FG02-93ER20097]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	The Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy is acknowledged through Grant DE-FG02-12ER16324 (M.B-P.) for funding studies of Apiose synthesis. The authors also acknowledge the U.S. Department of Energy-funded Center for Plant and Microbial Complex Carbohydrates through Grant DE-FG02-93ER20097 for funding analytical equipment support.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bansal K, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.02993-16, 10.1128/aem.02993-16]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun SG, 2005, MOL PLANT MICROBE IN, V18, P674, DOI 10.1094/MPMI-18-0674; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Broach B, 2012, FEBS J, V279, P100, DOI 10.1111/j.1742-4658.2011.08402.x; Brockhausen I, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00492; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Castle SA, 2008, EUKARYOT CELL, V7, P1611, DOI 10.1128/EC.00458-07; Chang YC, 1999, J BACTERIOL, V181, P5636, DOI 10.1128/JB.181.18.5636-5643.1999; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; DOW JM, 1995, MOL PLANT MICROBE IN, V8, P768, DOI 10.1094/MPMI-8-0768; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Gardiner DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084995; Gloster TM, 2014, CURR OPIN STRUC BIOL, V28, P131, DOI 10.1016/j.sbi.2014.08.012; GOTO M, 1958, NATURE, V182, P1516, DOI 10.1038/1821516a0; Guyett P, 2009, CARBOHYD RES, V344, P1072, DOI 10.1016/j.carres.2009.03.026; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; HART DA, 1970, BIOCHEM J, V116, P569, DOI 10.1042/bj1160569; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Hwang S, 2014, J BIOL CHEM, V289, P35620, DOI 10.1074/jbc.M114.614917; JANSSON PE, 1975, CARBOHYD RES, V45, P275, DOI 10.1016/S0008-6215(00)85885-1; Jarrell KF, 2014, MICROBIOL MOL BIOL R, V78, P304, DOI 10.1128/MMBR.00052-13; Kahler CM, 1996, J BACTERIOL, V178, P6677, DOI 10.1128/jb.178.23.6677-6684.1996; Kanipes MI, 2008, J BACTERIOL, V190, P1568, DOI 10.1128/JB.01696-07; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; Kay E, 2010, BIOCHEM SOC T, V38, P1290, DOI 10.1042/BST0381290; Klutts JS, 2008, J BIOL CHEM, V283, P14327, DOI 10.1074/jbc.M708927200; Klutts JS, 2007, J BIOL CHEM, V282, P17890, DOI 10.1074/jbc.M701941200; Leemhuis H, 2003, J BIOTECHNOL, V103, P203, DOI 10.1016/S0168-1656(03)00126-3; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Li Z, 2016, J BIOL CHEM, V291, P19051, DOI 10.1074/jbc.M116.724708; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marrec-Fairley M, 2000, MOL MICROBIOL, V37, P1019, DOI 10.1046/j.1365-2958.2000.02054.x; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MELTON LD, 1976, CARBOHYD RES, V46, P245, DOI 10.1016/S0008-6215(00)84296-2; Messner P, 2004, J BACTERIOL, V186, P2517, DOI 10.1128/JB.186.9.2517-2519.2004; ORTMANN R, 1972, BIOCHIM BIOPHYS ACTA, V289, P293, DOI 10.1016/0005-2744(72)90080-0; Raetz C. R., 1996, ESCHERICHIA COLI SAL; RAETZ CRH, 1993, J BACTERIOL, V175, P5745, DOI 10.1128/JB.175.18.5745-5753.1993; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Ramkumar N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005551; Rezanka T, 2013, PHYTOCHEMISTRY, V88, P34, DOI 10.1016/j.phytochem.2013.01.003; Sheikh MO, 2017, GLYCOBIOLOGY, V27, P206, DOI 10.1093/glycob/cww114; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Sindhuwinata N, 2010, GLYCOBIOLOGY, V20, P718, DOI 10.1093/glycob/cwq019; Smith J, 2016, J BIOL CHEM, V291, P21434, DOI 10.1074/jbc.M116.749069; Smith JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184953; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; Teng Y, 2006, GENE, V371, P7, DOI 10.1016/j.gene.2005.08.027; van Heijenoort J, 2001, GLYCOBIOLOGY, V11, p25R; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Wyckoff TJO, 1998, TRENDS MICROBIOL, V6, P154, DOI 10.1016/S0966-842X(98)01230-X; Yang T, 2012, ANAL BIOCHEM, V421, P691, DOI 10.1016/j.ab.2011.12.028; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761	63	1	1	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206187	10.1371/journal.pone.0206187	http://dx.doi.org/10.1371/journal.pone.0206187			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335828	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300100
J	Derda, AA; Pfanne, A; Bar, C; Schimmel, K; Kennel, PJ; Xiao, K; Schulze, PC; Bauersachs, J; Thum, T				Derda, Anselm A.; Pfanne, Angelika; Baer, Christian; Schimmel, Katharina; Kennel, Peter J.; Xiao, Ke; Schulze, P. Christian; Bauersachs, Johann; Thum, Thomas			Blood-based microRNA profiling in patients with cardiac amyloidosis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; HEART-FAILURE; HYPERTROPHY; MIR-339-3P	Introduction Amyloidosis is caused by dysregulation of protein folding resulting in systemic or organ specific amyloid aggregation. When affecting the heart, amyloidosis can cause severe heart failure, which is associated with a high morbidity and mortality. Different subtypes of cardiac amyloidosis exist e.g. transthyretin cardiac amyloidosis and senile cardiac amyloidosis. Today, diagnostics is primarily based on cardiac biopsies and no clinically used circulating blood-based biomarkers existing. Therefore, our aim was to identify circulating microRNAs in patients with different forms of amyloidosis. Methods Blood was collected from healthy subjects (n = 10), patients with reduced ejection fraction (EF < 35%; n = 10), patients affected by transthyretin cardiac amyloidosis (n = 13) as well as senile cardiac amyloidosis (n = 11). After performing TaqMan array profiling, promising candidates, in particular miR-99a-5p, miR-122-5p, miR-27a-3p, miR-221-3p, miR-1180-3p, miR-155-5p, miR-339-3p, miR-574-3p, miR-342-3p and miR-329-3p were validated via quantitative real time PCR. Results The validation experiments revealed a significant upregulation of miR-339-3p in patients affected with senile cardiac amyloidosis compared to controls. This corresponded to the array profiling results. In contrast, there was no deregulation in the other patient groups. Conclusion miR-339-3p was increased in blood of patients with senile cardiac amyloidosis. Therefore, miR-339-3p is a potential candidate as biomarker for senile cardiac amyloidosis in future studies. Larger patient cohorts should be investigated.	[Derda, Anselm A.; Pfanne, Angelika; Baer, Christian; Schimmel, Katharina; Xiao, Ke; Thum, Thomas] Hannover Med Sch, IMTTS, IFB Tx, Hannover, Germany; [Derda, Anselm A.; Bauersachs, Johann; Thum, Thomas] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Kennel, Peter J.; Schulze, P. Christian] Columbia Univ, Med Ctr, Div Cardiol, New York, NY USA; [Kennel, Peter J.] Weill Cornell Med, Dept Med, New York, NY USA; [Schulze, P. Christian] Friedrich Schiller Univ Jena, Univ Hosp Jena, Div Cardiol Pneumol Angiol & Intens Med Care, Dept Internal Med 1, Jena, Germany; [Bauersachs, Johann; Thum, Thomas] Hannover Med Sch, Excellence Cluster REBIRTH, Hannover, Germany; [Thum, Thomas] Imperial Coll London, NHLI London, London, England	Hannover Medical School; Hannover Medical School; Columbia University; Cornell University; Friedrich Schiller University of Jena; Hannover Medical School; Imperial College London	Thum, T (corresponding author), Hannover Med Sch, IMTTS, IFB Tx, Hannover, Germany.; Thum, T (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany.; Thum, T (corresponding author), Hannover Med Sch, Excellence Cluster REBIRTH, Hannover, Germany.; Thum, T (corresponding author), Imperial Coll London, NHLI London, London, England.	thum.thomas@mh-hannover.de	Schimmel, Katharina/GLV-7054-2022; Kennel, Peter J/K-8127-2019; Bär, Christian/AAC-5914-2019; Schulze, Christian/AGJ-7744-2022; Derda, Anselm A./AAI-7953-2021	Kennel, Peter J/0000-0002-7347-1298; Schulze, Christian/0000-0001-9442-7141; Thum, Thomas/0000-0003-4360-1511; Bar, Christian/0000-0001-9276-9383; Schimmel, Katharina/0000-0001-7002-5113	REBIRTH Excellence Cluster;  [KFO311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114813] Funding Source: NIH RePORTER	REBIRTH Excellence Cluster; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research was funded by the REBIRTH Excellence Cluster (http://www.rebirthhannover.de/de/home.html) (to TT and JB) and the KFO311 (http://www.kfo311.de) (to TT and JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauersachs J, 2011, CIRC RES, V109, P334, DOI 10.1161/CIRCRESAHA.110.228676; Derda AA, 2015, INT J CARDIOL, V196, P115, DOI 10.1016/j.ijcard.2015.05.185; Ellis KL, 2013, EUR J HEART FAIL, V15, P1138, DOI 10.1093/eurjhf/hft078; Falk RH, 2005, CIRCULATION, V112, P2047, DOI 10.1161/CIRCULATIONAHA.104.489187; Feliciano A, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.544; Heymans S, 2013, CIRCULATION, V128, P1420, DOI 10.1161/CIRCULATIONAHA.112.001357; Hoyer C, 2008, MED KLIN, V103, P153, DOI 10.1007/s00063-008-1022-2; Jaguszewski M, 2014, EUR HEART J, V35, P999, DOI 10.1093/eurheartj/eht392; Jentzsch C, 2012, J MOL CELL CARDIOL, V52, P13, DOI 10.1016/j.yjmcc.2011.07.010; Palladini G, 2004, BLOOD, V103, P2936, DOI 10.1182/blood-2003-08-2788; Patel KS, 2015, J INTERN MED, V278, P126, DOI 10.1111/joim.12383; Stammet P, 2012, CRIT CARE MED, V40, P3209, DOI 10.1097/CCM.0b013e31825fdd5e; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vegter EL, 2016, EUR J HEART FAIL, V18, P457, DOI 10.1002/ejhf.495; Wang CX, 2012, J CELL BIOCHEM, V113, P2040, DOI 10.1002/jcb.24075; Weber CEM, 2016, CANCER RES, V76, P3562, DOI 10.1158/0008-5472.CAN-15-2932; Zhou C, 2015, ONCOL LETT, V10, P2842, DOI 10.3892/ol.2015.3661	17	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204235	10.1371/journal.pone.0204235	http://dx.doi.org/10.1371/journal.pone.0204235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332417	Green Submitted, Green Published, gold			2022-12-26	WOS:000447638200011
J	Rodriguez-Poncelas, A; Barcelo, MA; Saez, M; Coll-de-Tuero, G				Rodriguez-Poncelas, Antonio; Barcelo, Maria A.; Saez, Marc; Coll-de-Tuero, Gabriel			Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort	PLOS ONE			English	Article							ACUTE INTERSTITIAL NEPHRITIS; ACUTE-RENAL-FAILURE; INCREASED RISK; INJURY; OVERUTILIZATION; PREVALENCE; EQUATION; OVERUSE	Background Proton Pump Inhibitors (PPIs) have been associated with chronic kidney disease (CKD). Our objective was to quantify the association between PPI use and incident CKD in a population-based cohort. Methods and findings We used a population-based retrospective cohort, including people aged 15 years or over, between January 1, 2005 and December 31, 2012. PPI use was measured in a follow-up session by recording prescriptions. Incident CKD was defined as an estimated glomerular filtration rate < 60 ml/min/1.73 m(2) and/or urinary albumin level to creatinine level >= 30 mg/g, in two or more determinations over a period of at least 3 months of the follow-up. Proton Pump Inhibitor use was associated with incident CKD in analysis adjusted for different clinical variables (Hazard Ratio (HR) 1.18; 95% CI 1.04-1.51) in individuals who used PPI in the basal visit (HR 1.37; 95% CI 1.25-1.50) and in those who started to use PPI during the follow-up. High doses of PPI increased the risk of incident CKD (HR 1.92; 95%CI 1.00-6.19) for any type of exposure to PPIs (HR 2.40; 95%CI 1.65-3.46) and for individuals who used high doses throughout the follow-up. This risk of incident CKD increased after three months' exposure to PPIs, (HR1.78; 95% CI 1.39-2.25) between the third and sixth months and (HR 1.30; 95%CI 1.07-1.72) after the sixth month. Conclusions PPI use is associated with a higher risk of incident CKD. This association is greater for high doses and becomes apparent after three months' exposure.	[Rodriguez-Poncelas, Antonio; Coll-de-Tuero, Gabriel] Univ Inst Res Primary Care JordiGol IdIAPGol, Res Support Unit, Girona, Spain; [Barcelo, Maria A.; Saez, Marc] Univ Girona, Res Grp Stat Econometr & Hlth GRECS, Girona, Spain; [Barcelo, Maria A.; Saez, Marc; Coll-de-Tuero, Gabriel] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Coll-de-Tuero, Gabriel] Univ Girona, Dept Med Sci, Girona, Spain	Universitat de Girona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat de Girona	Saez, M (corresponding author), Univ Girona, Res Grp Stat Econometr & Hlth GRECS, Girona, Spain.; Saez, M (corresponding author), CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.	marc.saez@udg.edu	Barceló, Maria A/AAT-6212-2020	Barceló, Maria A/0000-0001-9720-690X	FIS, 'Instituto de Salud Carlos III', ISCIII, Spanish Ministry of Economy and Competitiveness [PI15/00140]; project 'Grant to improve the scientific productivity of the research groups of the University of Girona 2016-2018' (MPCUdG2016)	FIS, 'Instituto de Salud Carlos III', ISCIII, Spanish Ministry of Economy and Competitiveness; project 'Grant to improve the scientific productivity of the research groups of the University of Girona 2016-2018' (MPCUdG2016)	This work was partly funded by the research project PI15/00140 from FIS, 'Instituto de Salud Carlos III', ISCIII, Spanish Ministry of Economy and Competitiveness and by the project 'Grant to improve the scientific productivity of the research groups of the University of Girona 2016-2018' (MPCUdG2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P. K., 2012, STAT MODELS BASED CO; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], UAULV115012014; Antoniou Tony, 2015, CMAJ Open, V3, pE166, DOI 10.9778/cmajo.20140074; Arora P, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0325-4; Barcelo MA, 2002, GAC SANIT S, V16, P59; Barcelo MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148594; Basile DP, 2004, CURR OPIN NEPHROL HY, V13, P1, DOI 10.1097/00041552-200401000-00001; Betensky RA, 2015, ANN NEUROL, V78, P839, DOI 10.1002/ana.24538; Blank ML, 2014, KIDNEY INT, V86, P837, DOI 10.1038/ki.2014.74; Cahir C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-408; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Durand C, 2012, CLIN MED INSIGHTS-GA, V5, P65, DOI 10.4137/CGast.S9588; Fahrmeir L, MULTIVARIATE STAT MO; Forgacs I, 2008, BMJ-BRIT MED J, V336, P2, DOI 10.1136/bmj.39406.449456.BE; Geevasinga N, 2006, CLIN GASTROENTEROL H, V4, P597, DOI 10.1016/j.cgh.2005.11.004; GRUNDY S. M., 2005, CRITICAL PATHWAYS CA, V4, P198, DOI DOI 10.1097/00132577-200512000-00018; Harmark L, 2007, BRIT J CLIN PHARMACO, V64, P819, DOI 10.1111/j.1365-2125.2007.02927.x; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Heidelbaugh JJ, 2012, THER ADV GASTROENTER, V5, P219, DOI 10.1177/1756283X12437358; Heidelbaugh JJ, 2010, AM J MANAG CARE, V16, pE228; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Kablfleisch JD, 1980, STAT ANAL FAILURE TI; Klepser DG, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-150; Lazarus B, 2016, JAMA INTERN MED, V176, P238, DOI 10.1001/jamainternmed.2015.7193; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; Ministerio de Sanidad SS, 2011, INF TER SIST NAC SAL, V35, P124; Muriithi AK, 2014, AM J KIDNEY DIS, V64, P558, DOI 10.1053/j.ajkd.2014.04.027; Otero A, 2010, NEFROLOGIA, V30, P78, DOI 10.3265/Nefrologia.pre2009.Dic.5732; Pottegard A, 2016, THER ADV GASTROENTER, V9, P671, DOI 10.1177/1756283X16650156; Praga M, 2010, KIDNEY INT, V77, P956, DOI 10.1038/ki.2010.89; Ramirez E, 2010, CURR CLIN PHARMACOL, V5, P288, DOI 10.2174/157488410793352067; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sierra F, 2007, ALIMENT PHARM THER, V26, P545, DOI 10.1111/j.1365-2036.2007.03407.x; Simpson DP, 2017, STAT SCI, V32, P46, DOI DOI 10.1214/16-STS576; Singh A, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/1973086; Spurgeon-Pechman KR, 2007, AM J PHYSIOL-RENAL, V293, pF269, DOI 10.1152/ajprenal.00279.2006; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Xie Y, 2016, J AM SOC NEPHROL, V27, P3153, DOI 10.1681/ASN.2015121377; Yang Y, 2017, DRUG DES DEV THER, V11, P1291, DOI 10.2147/DDDT.S130568	48	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204231	10.1371/journal.pone.0204231	http://dx.doi.org/10.1371/journal.pone.0204231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332411	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200010
J	Widman, DG; Gornisiewicz, S; Shacham, S; Tamir, S				Widman, Douglas G.; Gornisiewicz, Savanna; Shacham, Sharon; Tamir, Sharon			In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NUCLEAR EXPORT; HUMAN CYTOMEGALOVIRUS; INSITU HYBRIDIZATION; HUMAN POLYOMAVIRUS; DNA HYBRIDIZATION; RAPID DETECTION; PROTEIN; AGNOPROTEIN; REPLICATION	Infection of immunocompromised individuals with normally benign opportunistic viruses is a major health burden globally. Infections with viruses such as Epstein-Barr virus (EBV), human cytomegalovirus (HCMV), Kaposi's sarcoma virus (KSHV), adenoviruses (AdV), BK virus (BKPyV), John Cunningham virus (JCPyV), and human papillomavirus (HPV) are significant concerns for the immunocompromised, including when these viruses exist as a co-infection with human immunodeficiency virus (HIV). These viral infections are more complicated in patients with a weakened immune system, and often manifest as malignancies resulting in significant morbidity and mortality. Vaccination is not an attractive option for these immune compromised individuals due to defects in their adaptive immune response. Verdinexor is part of a novel class of small molecules known as SINE (Selective Inhibitor of Nuclear Export) compounds. These small molecules demonstrate specificity for the nuclear export protein XPO1, to which they bind and block function, resulting in sequestration of XPO1-dependent proteins in the nucleus of the cell. In antiviral screening, verdinexor demonstrated varying levels of efficacy against all of the aforementioned viruses including previously with HIV. Studies by other labs have discussed likely mechanisms of action for verdinexor (ie. XPO1-dependence) against each virus. GLP toxicology studies suggest that anti-viral activity can be achieved at a tolerable dose range, based on the safety profile of a previous phase 1 clinical trial of verdinexor in healthy human volunteers. Taken together, these results indicate verdinexor has the potential to be a broad spectrum antiviral for immunocompromised subjects for which vaccination is a poor option.	[Widman, Douglas G.; Gornisiewicz, Savanna; Shacham, Sharon; Tamir, Sharon] Karyopharm Therapeut, Dept Neurofegenerat & Infect Dis, Newton, MA 02459 USA		Widman, DG (corresponding author), Karyopharm Therapeut, Dept Neurofegenerat & Infect Dis, Newton, MA 02459 USA.	dwidman@karypopharm.com		Widman, Douglas/0000-0002-3585-6373	Karyopharm; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201100006I, HHSN27200005, HHSN272201100013I, HHSN27200006]	Karyopharm; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services	All authors of this manuscript are employed by, and hold stake in, Karyopharm Therapeutics, developer and marketer of SINE compounds. The funder (Karyopharm) provided support in the form of salaries for authors [DGW, SG, SS, and ST] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This project has been funded with federal funds from the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract no. HHSN272201100006I task order number HHSN27200005 and contract no. HHSN272201100013I task order number HHSN27200006 (ST).	Akan I, 2006, VIROLOGY, V349, P66, DOI 10.1016/j.virol.2006.01.025; Blachon S, 2005, J BIOL CHEM, V280, P36088, DOI 10.1074/jbc.M505138200; Boons E, 2015, EBIOMEDICINE, V2, P1102, DOI 10.1016/j.ebiom.2015.07.041; Boyle SM, 1999, J VIROL, V73, P6872, DOI 10.1128/JVI.73.8.6872-6881.1999; CHOU S, 1983, NEW ENGL J MED, V308, P921, DOI 10.1056/NEJM198304213081603; CHOWDHURY SI, 1986, J VIROL METHODS, V14, P285, DOI 10.1016/0166-0934(86)90030-3; Darbinyan A, 2004, J VIROL, V78, P8593, DOI 10.1128/JVI.78.16.8593-8600.2004; Darbinyan A, 2002, ONCOGENE, V21, P5574, DOI 10.1038/sj.onc.1205744; Davis R W, 1980, Methods Enzymol, V65, P404; Deng WT, 2003, J VIROL, V77, P10213, DOI 10.1128/JVI.77.19.10213-10226.2003; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FORGHANI B, 1985, J CLIN MICROBIOL, V22, P656, DOI 10.1128/JCM.22.4.656-658.1985; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; GOMES SA, 1985, J VIROL METHODS, V12, P105, DOI 10.1016/0166-0934(85)90012-6; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Leung AYH, 2001, BLOOD, V98, P1971, DOI 10.1182/blood.V98.6.1971; Li XJ, 2009, J VIROL, V83, P2531, DOI 10.1128/JVI.02209-08; Lundberg L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005122; Manos-Turvey A, 2016, BIOORG MED CHEM LETT, V26, P5087, DOI 10.1016/j.bmcl.2016.08.080; Mathew C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01171; Matoba T, 2008, NEUROPATHOLOGY, V28, P286, DOI 10.1111/j.1440-1789.2007.00878.x; Merabova N, 2008, J VIROL, V82, P1558, DOI 10.1128/JVI.01680-07; NOBREGA FG, 1983, ANAL BIOCHEM, V131, P141, DOI 10.1016/0003-2697(83)90145-8; Perwitasari O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167221; Perwitasari O, 2014, J VIROL, V88, P10228, DOI 10.1128/JVI.01774-14; Prichard MN, 2007, J VIROL METHODS, V144, P86, DOI 10.1016/j.jviromet.2007.04.001; Sanchez V, 2007, J VIROL, V81, P11730, DOI 10.1128/JVI.02760-06; Saribas AS, 2016, J CELL PHYSIOL, V231, P2115, DOI 10.1002/jcp.25329; Sariyer IK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-255; Schmid M, 2012, J VIROL, V86, P2282, DOI 10.1128/JVI.06275-11; Services USDoHaH, 2006, GUID IND ANT PROD DE; Shishido-Hara Y, 2015, NEUROPATHOLOGY, V35, P487, DOI 10.1111/neup.12203; Siddiqui N, 2012, WIRES RNA, V3, P13, DOI 10.1002/wrna.101; Suzuki T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000801; Tamir S, 2016, VERDINEXOR CLIN STAG; van Aalderen MC, 2012, NETH J MED, V70, P172; Wang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36226; WIRTH JJ, 1982, J RETICULOENDOTH SOC, V31, P325; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	40	24	24	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0200043	10.1371/journal.pone.0200043	http://dx.doi.org/10.1371/journal.pone.0200043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332435	Green Published, Green Submitted, gold			2022-12-26	WOS:000447638200002
J	Espindola, AS; Schneider, W; Cardwell, KF; Carrillo, Y; Hoyt, PR; Marek, SM; Melouk, HA; Garzon, CD				Espindola, Andres S.; Schneider, William; Cardwell, Kitty F.; Carrillo, Yisel; Hoyt, Peter R.; Marek, Stephen M.; Melouk, Hassan A.; Garzon, Carla D.			Inferring the presence of aflatoxin-producing Aspergillus flavus strains using RNA sequencing and electronic probes as a transcriptomic screening tool	PLOS ONE			English	Article							BIOSYNTHESIS GENE-CLUSTER; NUCLEIC-ACID ANALYSIS; FLANKING REGIONS; METAGENOMIC DATA; MAIZE KERNELS; UNITED-STATES; PARASITICUS; AFLR; CONTAMINATION; NIDULANS	E-probe Diagnostic for Nucleic acid Analysis (EDNA) is a bioinformatic tool originally developed to detect plant pathogens in metagenomic databases. However, enhancements made to EDNA increased its capacity to conduct hypothesis directed detection of specific gene targets present in transcriptomic databases. To target specific pathogenicity factors used by the pathogen to infect its host or other targets of interest, e-probes need to be developed for transcripts related to that function. In this study, EDNA transcriptomics (EDNAtran) was developed to detect the expression of genes related to aflatoxin production at the transcriptomic level. E-probes were designed from genes up-regulated during A. flavus aflatoxin production. EDNAtran detected gene transcripts related to aflatoxin production in a transcriptomic database from corn, where aflatoxin was produced. The results were significantly different from e-probes being used in the transcriptomic database where aflatoxin was not produced (atoxigenic AF36 strain and toxigenic AF70 in Potato Dextrose Broth).	[Espindola, Andres S.; Schneider, William; Cardwell, Kitty F.; Carrillo, Yisel; Marek, Stephen M.; Melouk, Hassan A.; Garzon, Carla D.] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA; [Espindola, Andres S.; Cardwell, Kitty F.] Oklahoma State Univ, NIMFFAB, Stillwater, OK 74078 USA; [Hoyt, Peter R.] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Espindola, AS (corresponding author), Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA.; Espindola, AS (corresponding author), Oklahoma State Univ, NIMFFAB, Stillwater, OK 74078 USA.	andres.espindola@okstate.edu	Marek, Stephen/Q-6911-2019; Garzon, Carla/AAM-5686-2020; Espindola, Andres/A-5056-2016	Marek, Stephen/0000-0002-0146-8049; Garzon, Carla/0000-0002-2095-6638; Espindola, Andres/0000-0002-9658-0673; Hoyt, Peter/0000-0002-2767-0923	Oklahoma Agricultural Research Station [OKL 02859]; Department of Entomology and Plant Pathology, Oklahoma State University; U.S. Department of Agriculture, Agricultural Research Service [8044-22000-040-00D]	Oklahoma Agricultural Research Station; Department of Entomology and Plant Pathology, Oklahoma State University; U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was funded by the Oklahoma Agricultural Research Station (project number OKL 02859), the Department of Entomology and Plant Pathology, Oklahoma State University, and the U.S. Department of Agriculture, Agricultural Research Service (Appropriated Project #8044-22000-040-00D).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blagden T, 2016, J FOOD PROTECT, V79, P574, DOI 10.4315/0362-028X.JFP-15-440; BROWN RL, 1993, J FOOD PROTECT, V56, P967, DOI 10.4315/0362-028X-56.11.967; Callicott KA, 2015, LETT APPL MICROBIOL, V60, P60, DOI 10.1111/lam.12337; Cangelosi GA, 2014, APPL ENVIRON MICROB, V80, P5884, DOI 10.1128/AEM.01763-14; CHANG PK, 1993, APPL ENVIRON MICROB, V59, P3273, DOI 10.1128/AEM.59.10.3273-3279.1993; Chang PK, 2005, FUNGAL GENET BIOL, V42, P914, DOI 10.1016/j.fgb.2005.07.004; Chang PK, 2004, J BIOTECHNOL, V107, P245, DOI 10.1016/j.jbiotec.2003.10.012; Cotty PJ, 1997, MYCOL RES, V101, P698, DOI 10.1017/S0953756296003139; DAVIS ND, 1966, APPL MICROBIOL, V14, P378, DOI 10.1128/AEM.14.3.378-380.1966; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ehrlich KC, 2005, J APPL MICROBIOL, V99, P518, DOI 10.1111/j.1365-2672.2005.02637.x; Ehrlich KC, 2004, APPL MICROBIOL BIOT, V65, P473, DOI 10.1007/s00253-004-1670-y; Espindola A, 2015, INT J DATA MIN BIOIN, V12, P115, DOI 10.1504/IJDMB.2015.069422; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; HILL RA, 1983, APPL ENVIRON MICROB, V45, P628, DOI 10.1128/AEM.45.2.628-633.1983; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; KLICH MA, 1988, T BRIT MYCOL SOC, V91, P99, DOI 10.1016/S0007-1536(88)80010-X; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; KURTZMAN CP, 1987, A VAN LEEUW J MICROB, V53, P147, DOI 10.1007/BF00393843; LLEWELLYN GC, 1992, INT BIODETER BIODEGR, V29, P111, DOI 10.1016/0964-8305(92)90011-C; MARSH SF, 1984, PHYTOPATHOLOGY, V74, P1284, DOI 10.1094/Phyto-74-1284; MATELES RI, 1965, APPL MICROBIOL, V13, P208, DOI 10.1128/AEM.13.2.208-211.1965; Minto RE, 1997, CHEM REV, V97, P2537, DOI 10.1021/cr960032y; Nierman WC, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00168-15; Probst C, 2007, APPL ENVIRON MICROB, V73, P2762, DOI 10.1128/AEM.02370-06; REDDY TV, 1971, APPL MICROBIOL, V22, P393, DOI 10.1128/AEM.22.3.393-396.1971; Robens J, 2003, J TOXICOL-TOXIN REV, V22, P139, DOI 10.1081/TXR-120024089; SQUIRE RA, 1981, SCIENCE, V214, P877, DOI 10.1126/science.7302565; Stobbe AH, 2014, PHYTOPATHOLOGY, V104, P1125, DOI 10.1094/PHYTO-11-13-0310-R; Stobbe AH, 2013, J MICROBIOL METH, V94, P356, DOI 10.1016/j.mimet.2013.07.002; TRAIL F, 1995, APPL ENVIRON MICROB, V61, P2665, DOI 10.1128/AEM.61.7.2665-2673.1995; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; van Egmond HP, 2007, ANAL BIOANAL CHEM, V389, P147, DOI 10.1007/s00216-007-1317-9; Visser M, 2016, VIROLOGY, V495, P122, DOI 10.1016/j.virol.2016.05.008; Wetterstrand KA, 2018, DNA SEQUENCING COSTS; Woloshuk CP, 1997, PHYTOPATHOLOGY, V87, P164, DOI 10.1094/PHYTO.1997.87.2.164; WOLOSHUK CP, 1994, APPL ENVIRON MICROB, V60, P2408, DOI 10.1128/AEM.60.7.2408-2414.1994; Wu F, 2008, COST EFFECTIVENESS A, V9543, P203; Yu JH, 1996, CURR GENET, V29, P549, DOI 10.1007/s002940050084; YU JJ, 1995, APPL ENVIRON MICROB, V61, P2365, DOI 10.1128/AEM.61.6.2365-2371.1995	41	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0198575	10.1371/journal.pone.0198575	http://dx.doi.org/10.1371/journal.pone.0198575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325975	Green Submitted, Green Published, gold			2022-12-26	WOS:000447430800001
J	Lin, W; Xie, YC; Cheng, PY; Dong, LY; Hung, GU; Chiu, PY				Lin, Wei; Xie, Yuan-Chang; Cheng, Po-Ya; Dong, Ling-Ying; Hung, Guang-Uei; Chiu, Pai-Yi			Association of visual hallucinations with very mild degenerative dementia due to dementia with Lewy bodies	PLOS ONE			English	Article							NEUROPSYCHIATRIC SYMPTOMS; ALZHEIMERS-DISEASE; PREVALENCE; DIAGNOSIS; MANAGEMENT	Background and purpose Complex, well-formed, and detailed visual hallucinations (VHs) are among the core clinical features of dementia with Lewy bodies (DLB). We investigated the diagnostic value of VHs in different types of very mild degenerative dementia. Methods Participants were required to complete a structured interview form recording their basic data, clinical history, neuropsychological tests, and neuropsychiatric symptoms. Basic demographic characteristics of the participants were summarized and compared. The frequency and association factors of VHs were compared among three major degenerative dementia groups, namely, Alzheimer's disease (AD), Parkinson's disease dementia (PDD), and DLB. Results A total of 197 patients with dementia and a clinical dementia rating of 0.5 were investigated, comprising 124 with AD, 35 with PDD, and 38 with DLB. A significantly higher frequency of VHs was found in the DLB group compared with the other groups (DLB, PDD, and AD = 31.6%, 11.4%, and 4.0%; p < 0.001). A multivariable logistic regression test for associations of positive VHs revealed that DLB was the only independently predictive factor (odds ratio: 13.62; p < 0.001). Conclusion Our findings revealed a high diagnostic value of VHs in very mild degenerative dementia. VHs in this stage of dementia were significantly associated with DLB, and more than 30% of patients with very mild dementia caused by DLB presented with VHs.	[Lin, Wei; Xie, Yuan-Chang] Chang Bin Show Chwan Mem Hosp, Dept Neurol, Changhua, Taiwan; [Cheng, Po-Ya; Dong, Ling-Ying; Chiu, Pai-Yi] Show Chwan Mem Hosp, Dept Neurol, Changhua, Taiwan; [Hung, Guang-Uei] Chang Bing Show Chwan Mem Hosp, Dept Nucl Med, Changhua, Taiwan	Show Chwan Memorial Hospital; Chang Bing Show Chwan Memorial Hospital	Chiu, PY (corresponding author), Show Chwan Mem Hosp, Dept Neurol, Changhua, Taiwan.; Hung, GU (corresponding author), Chang Bing Show Chwan Mem Hosp, Dept Nucl Med, Changhua, Taiwan.	106143@gmail.com; paiyibox@gmail.com		Chiu, Pai-Yi/0000-0003-2552-4516				Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Bostrom F, 2007, INT J GERIATR PSYCH, V22, P713, DOI 10.1002/gps.1738; Chiu PY, 2018, INT J GERIATR PSYCH, V33, P193, DOI 10.1002/gps.4706; Cummings J L, 1988, J Geriatr Psychiatry Neurol, V1, P24, DOI 10.1177/089198878800100106; Cummings JL, 1994, NEUROLOGY, V44; Del Ser T, 2000, INT J GERIATR PSYCH, V15, P1034, DOI 10.1002/1099-1166(200011)15:11<1034::AID-GPS231>3.0.CO;2-5; Donaghy PC, 2018, PSYCHOL MED, V48, P2384, DOI 10.1017/S0033291717003956; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Hashimoto M, 2015, DEMENT GER COGN D EX, V5, P244, DOI 10.1159/000381800; Johnson DK, 2011, ALZ DIS ASSOC DIS, V25, P326, DOI 10.1097/WAD.0b013e31820d89b6; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lopez-Pousa S, 2007, REV NEUROLOGIA, V45, P683, DOI 10.33588/rn.4511.2007535; McKeith I, 2004, LANCET NEUROL, V3, P19, DOI 10.1016/S1474-4422(03)00619-7; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Molano J, 2010, BRAIN, V133, P540, DOI 10.1093/brain/awp280; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Peavy GM, 2013, AM J GERIAT PSYCHIAT, V21, P509, DOI 10.1016/j.jagp.2012.10.022; Ricci Monica, 2009, Arch Gerontol Geriatr, V49, pe101, DOI 10.1016/j.archger.2008.10.001; Sadak TI, 2014, RES GERONTOL NURS, V7, P44, DOI 10.3928/19404921-20130918-01; Shin S, 2012, J NEUROL NEUROSUR PS, V83, P1155, DOI 10.1136/jnnp-2012-303391; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Whitfield T, 2017, ALZHEIMERS DEMENT, V13, pP1461, DOI [10.1016/j.jalz.2017.07.526, DOI 10.1016/J.JALZ.2017.07.526]	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205909	10.1371/journal.pone.0205909	http://dx.doi.org/10.1371/journal.pone.0205909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0RD	30321234	gold, Green Published, Green Submitted			2022-12-26	WOS:000447417900065
J	Michalak, I; Mironiuk, M; Marycz, K				Michalak, Izabela; Mironiuk, Malgorzata; Marycz, Krzysztof			A comprehensive analysis of biosorption of metal ions by macroalgae using ICP-OES, SEM-EDX and FTIR techniques	PLOS ONE			English	Article							EQUINE METABOLIC SYNDROME; FEED SUPPLEMENT; AQUEOUS-SOLUTION; BIOMASS; MICROELEMENTS; OPTIMIZATION; MANAGEMENT; BIOSORBENT; NUTRIENT; CATIONS	In the present study, a comprehensive approach to the biosorption process was proposed. Biosorption of Cr(III), Mn(II) and Mg(II) ions by a freshwater macroalga Cladophora glomerata was examined using several advanced techniques including FTIR (Fourier Transform Infrared Spectroscopy), ICP-OES (Inductively Coupled Plasma-Optical Emission Spectrometry) and SEM-EDX (Scanning Electron Microscopy with Energy Dispersive X-Ray Spectroscopy). The enriched biomass can become a valuable, bioactive feed additive for different breeds of animals. Additionally, the collected algal biomass was soaked in water in order to reduce the content of carbohydrate, what is especially important for animals with metabolic disorders. The content of starch was reduced by 22% but additionally some elements-mainly Si, K and P were removed from the biomass. It was shown that the natural macroalga had better biosorption properties than soaked. Cr(III) ions were sorbed by the biomass in the highest extent, then Mn(II) and finally Mg(II) ions. The content of chromium in the enriched algal biomass increased almost similar to 200 000 times, manganese similar to 75 times and magnesium similar to 4.5 times (both for Mg(II) ions used from magnesium sulphate, as well as from magnesium chloride) when compared to the natural Cladophora glomerata. In the case of the soaked biomass the increase of the content of elements in the enriched biomass was as follows similar to 17 165 times for Cr, similar to 25 times for Mn and for Mg similar to 3.5 times for chloride and 3.8 times for sulphate. The type of magnesium salt (chloride or sulphate) had no significant effect on the algal sorption capacity. The proposed mechanism of the biosorption is ion exchange in which mainly potassium participated. The applied FTIR analysis enabled the identification of the functional groups that participated in the biosorption process-mainly carboxyl and hydroxyl. The main changes in the appearance of the spectra were observed for the following wavenumbers-3300-3400; 2900; 1700; 1400-1500 and 1200-1300 cm(-1). The application of SEM-EDX proved that the metal ions were sorbed on the surface of both tested algae.	[Michalak, Izabela; Mironiuk, Malgorzata] Wroclaw Univ Sci & Technol, Dept Adv Mat Technol, Fac Chem, Wroclaw, Poland; [Marycz, Krzysztof] Wroclaw Univ Environm & Life Sci, Fac Biol & Anim Sci, Dept Expt Biol, Wroclaw, Poland; [Marycz, Krzysztof] Justus Liebig Univ, Equine Clin Equine Surg, Fac Vet Med, Giessen, Germany	Wroclaw University of Science & Technology; Wroclaw University of Environmental & Life Sciences; Justus Liebig University Giessen	Michalak, I (corresponding author), Wroclaw Univ Sci & Technol, Dept Adv Mat Technol, Fac Chem, Wroclaw, Poland.	izabela.michalak@pwr.edu.pl	Michalak, Izabela/P-3770-2015	Michalak, Izabela/0000-0001-8084-9642; Mironiuk, Malgorzata/0000-0002-0353-4644	National Science Centre in Poland [2015/18/E/ NZ9/00607]	National Science Centre in Poland(National Science Centre, Poland)	This work was supported by 2015/18/E/ NZ9/00607, National Science Centre in Poland, https://www.ncn.gov.pl/?language=en, to IM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argo CM, 2015, VET J, V206, P170, DOI 10.1016/j.tvjl.2015.07.027; Badescu IS, 2017, J APPL PHYCOL, V29, P1069, DOI 10.1007/s10811-016-0997-y; Bilal M, 2018, MAR DRUGS, V16, DOI 10.3390/md16020065; Blackman M, 1998, ANIM SCI, V66, P745, DOI 10.1017/S1357729800009334; BRADY JM, 1995, ENZYME MICROB TECH, V17, P791, DOI 10.1016/0141-0229(95)00142-R; Chameroy KA, 2011, EQUINE VET J, V43, P494, DOI 10.1111/j.2042-3306.2010.00302.x; Chen C, 2007, CHEMOSPHERE, V69, P1610, DOI 10.1016/j.chemosphere.2007.05.043; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; Deng LP, 2007, BIODEGRADATION, V18, P393, DOI 10.1007/s10532-006-9074-6; Deniz F, 2018, INT J PHYTOREMEDIAT, V20, P362, DOI 10.1080/15226514.2017.1393387; Dmytryk Agnieszka, 2014, ScientificWorldJournal, V2014, P356328, DOI 10.1155/2014/356328; Godlewska K, 2018, OPEN CHEM, V16, P689, DOI 10.1515/chem-2018-0075; Ibrahim WM, 2011, J HAZARD MATER, V192, P1827, DOI 10.1016/j.jhazmat.2011.07.019; Kalinski K, 2012, J ELECTRON MICROSC, V61, P47, DOI 10.1093/jmicro/dfr086; Khuantrairong T, 2011, INT J AGRIC BIOL, V13, P297; Kiran B, 2016, INT J PHYTOREMEDIAT, V18, P1067, DOI 10.1080/15226514.2016.1183577; Longland AC, 2011, VET REC, V168, DOI 10.1136/vr.d157; Makkar HPS, 2016, ANIM PROD SCI, V56, P519, DOI 10.1071/AN15557; Makkar HPS, 2016, BROAD HOR FAO ROME I, V27, P1; Marycz K, 2018, RES VET SCI, V118, P115, DOI 10.1016/j.rvsc.2018.01.015; Marycz K, 2017, MAR DRUGS, V15, DOI 10.3390/md15120385; Mazur LP, 2018, J ENVIRON MANAGE, V223, P215, DOI 10.1016/j.jenvman.2018.05.086; McGowan CM, 2013, VET J, V196, P153, DOI 10.1016/j.tvjl.2012.10.007; Messyasz B, 2015, OPEN CHEM, V13, P1108, DOI 10.1515/chem-2015-0124; Michalak I, 2011, J ANIM PHYSIOL AN N, V95, P374, DOI 10.1111/j.1439-0396.2010.01065.x; Michalak I, 2019, WASTE BIOMASS VALORI, V10, P3403, DOI 10.1007/s12649-018-0351-5; Michalak I, 2015, OPEN CHEM, V13, P1341, DOI 10.1515/chem-2015-0149; Michalak I, 2012, CHINESE SCI BULL, V57, P736, DOI 10.1007/s11434-011-4924-y; Michalak I, 2011, MICROCHIM ACTA, V172, P65, DOI 10.1007/s00604-010-0468-0; Michalak I, 2010, ENG LIFE SCI, V10, P209, DOI 10.1002/elsc.200900039; Michalak I, 2009, INT J ENVIRON AN CH, V89, P583, DOI 10.1080/03067310802627213; MOORE LF, 1976, PLANTA, V128, P179, DOI 10.1007/BF00390321; Pouya MR, 2017, SEP SCI TECHNOL, V52, P2062, DOI 10.1080/01496395.2017.1324492; Saeid A, 2013, J APPL PHYCOL, V25, P1607, DOI 10.1007/s10811-013-9984-8; Saeid A, 2013, J APPL PHYCOL, V25, P667, DOI 10.1007/s10811-012-9901-6; Saeid A, 2016, ALGAL RES, V19, P342, DOI 10.1016/j.algal.2016.02.008; Samuel MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118999; Santos S.C.R., 2018, HIGH TECH VALUE, P69, DOI [10.1016/B978-0-444-63774-1.00003-X, DOI 10.1016/B978-0-444-63774-1.00003-X]; Wang SY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091453; Witek-Krowiak A, 2013, CENT EUR J CHEM, V11, P1505, DOI 10.2478/s11532-013-0274-8	40	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205590	10.1371/journal.pone.0205590	http://dx.doi.org/10.1371/journal.pone.0205590			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321205	Green Published, gold, Green Submitted			2022-12-26	WOS:000447417900040
J	Vandoni, M; Correale, L; Puci, MV; Galvani, C; Codella, R; Togni, F; La Torre, A; Casolo, F; Passi, A; Orizio, C; Montomoli, C				Vandoni, Matteo; Correale, Luca; Puci, Mariangela Valentina; Galvani, Christel; Codella, Roberto; Togni, Fabio; La Torre, Antonio; Casolo, Francesco; Passi, Alberto; Orizio, Claudio; Montomoli, Cristina			Six minute walk distance and reference values in healthy Italian children: A cross-sectional study	PLOS ONE			English	Article							ADOLESCENTS; STATEMENT; DISEASE; AGE	The 6-minute walking test (6MWT) is a simple assessment tool to evaluate exercise capacity. The result of the test is the distance that a subject can walk at a constant and normal pace within 6 minutes (6MWD) and reflects the aerobic/fitness performance related to walking function. Use of 6MWT has been relevant to assess exercise tolerance either in healthy children or in patients with, heart, lung and metabolic diseases. Our aim was to find 6MWT reference values in healthy Italian children. The 6MWT was performed in 5614 children aged 6-11 years recruited from primary Italian schools. Age related reference percentiles of the covered distance were gender-modeled. A linear and quadratic regression model was used to predict 6MWT performance. Males walked longer distances than females, respectively 598.8 +/- 83.9 m vs 592.1 +/- 77.6 m (p = 0.0016). According to the regression analysis, 6MWD was positively related to age, gender and height, while it was negatively related to body weight [(6MWD = -160.16 + 93.35x age (years) -4.05x age(2) (years) + 7.34x gender (m) + 2.12x weight (kg) -2.50x height (cm)]. Reference values were established for the 6MWT in healthy children. The age related 6MWD percentiles provided a useful tool in the assessment of capacity in 6-11 year children, in fact they may be helpful to evaluate the effect of a given treatment or rehabilitation program and represent a feasible measure as to prevention within the primary school context. It was found a substantial difference from other countries for 6mwd values. In our study, factors such as age, weight and height were relevant for the prediction of 6MWD, similarly to other studies. Therefore, these variables should be taken into account in context of exercise performance.	[Vandoni, Matteo; Correale, Luca] Univ Pavia, Dept Publ Hlth Expt & Forens Med, LAMA, Pavia, Italy; [Puci, Mariangela Valentina; Montomoli, Cristina] Univ Pavia, Dept Publ Hlth Expt & Forens Med, Unit Biostat & Clin Epidemiol, Pavia, Italy; [Galvani, Christel] Univ Cattolica Sacro Cuore, Dept Psychol, Appl Exercise Physiol Lab, Milan, Italy; [Codella, Roberto; La Torre, Antonio] Univ Milan, Sch Exercise Sci, Dept Biomed Sci Hlth, Milan, Italy; [Codella, Roberto; Togni, Fabio; Orizio, Claudio] Univ Brescia, Dept Clin & Expt Sci, Brescia, Italy; [Codella, Roberto; Casolo, Francesco] Univ Cattolica Sacro Cuore, Dept Pedag, Exercise & Sport Sci Degree Course, Milan, Italy; [Codella, Roberto; Passi, Alberto] Univ Insubria, Dept Med & Surg, Varese, Italy; [Codella, Roberto] IRCCS Policlin San Donato, Metab Res Ctr, San Donato Milanese, Italy	University of Pavia; University of Pavia; Catholic University of the Sacred Heart; University of Milan; University of Brescia; Catholic University of the Sacred Heart; University of Insubria; IRCCS Policlinico San Donato	Vandoni, M (corresponding author), Univ Pavia, Dept Publ Hlth Expt & Forens Med, LAMA, Pavia, Italy.	matteo.vandoni@unipv.it	Montomoli, Cristina/AAO-8036-2020; vandoni, matteo/AAS-7299-2021	vandoni, matteo/0000-0002-3405-9364; Montomoli, Cristina/0000-0002-8526-5846; Codella, Roberto/0000-0003-1608-1899; Puci, Mariangela Valentina/0000-0001-5656-6845; CORREALE, LUCA/0000-0003-0452-4015	Bando Unico Regione Lombardia [24]	Bando Unico Regione Lombardia	This work was supported by Bando Unico Regione Lombardia n. 24 del 14/06/2017- serie ordinaria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels B, 2013, PHYS THER, V93, P529, DOI 10.2522/ptj.20120210; Ben Saad H, 2009, PEDIATR PULM, V44, P316, DOI 10.1002/ppul.20942; Buber J, 2014, HEART FAIL CLIN, V10, P23, DOI 10.1016/j.hfc.2013.09.012; Capodaglio P, 2013, DISABIL REHABIL, V35, P1199, DOI 10.3109/09638288.2012.726313; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; D'silva C, 2012, INDIAN J PEDIATR, V79, P597, DOI 10.1007/s12098-011-0559-x; de Andrade LB, 2014, J PEDIAT-BRAZIL, V90, P250, DOI 10.1016/j.jped.2013.08.006; FELLINGHAM GW, 1978, MED SCI SPORT EXER, V10, P132; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Goemans N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084120; Griese M, 2010, Open Respir Med J, V4, P1, DOI 10.2174/1874306401004010001; ISTAT, 2017, SPORT ET DETT; Klepper SE, 2011, PEDIATR PHYS THER, V23, P32, DOI 10.1097/PEP.0b013e3182095e44; Lammers AE, 2008, ARCH DIS CHILD, V93, P464, DOI 10.1136/adc.2007.123653; MENIER DR, 1968, J PHYSIOL-LONDON, V197, P717, DOI 10.1113/jphysiol.1968.sp008584; Mylius CF, 2016, EXPERT REV RESP MED, V10, P1335, DOI 10.1080/17476348.2016.1258305; Nixon PA, 1996, J PEDIATR-US, V129, P362, DOI 10.1016/S0022-3476(96)70067-7; Paridon SM, 2006, CIRCULATION, V113, P1905, DOI 10.1161/CIRCULATIONAHA.106.174375; Cacau LDP, 2018, RESP CARE, V63, P339, DOI 10.4187/respcare.05686; Cacau LDP, 2016, BRAZ J CARDIOVA SURG, V31, P381, DOI 10.5935/1678-9741.20160081; Priesnitz CV, 2009, PEDIATR PULM, V44, P1174, DOI 10.1002/ppul.21062; Ramanathan RP, 2014, LUNG INDIA, V31, P35, DOI 10.4103/0970-2113.125892; Rostagno C, 2003, EUR J HEART FAIL, V5, P247, DOI 10.1016/S1388-9842(02)00244-1; Takken T, 2009, PEDIATR NEPHROL, V24, P2217, DOI 10.1007/s00467-009-1259-x; Tonklang Nakharin, 2011, Journal of the Medical Association of Thailand, V94, P470; Ulrich S, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-49	26	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205792	10.1371/journal.pone.0205792	http://dx.doi.org/10.1371/journal.pone.0205792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321226	Green Submitted, Green Published, gold			2022-12-26	WOS:000447417900053
J	Enweronu-Laryea, CC; Andoh, HD; Frimpong-Barfi, A; Asenso-Boadi, FM				Enweronu-Laryea, Christabel C.; Andoh, Hilary D.; Frimpong-Barfi, Audrey; Asenso-Boadi, Francis M.			Parental costs for in-patient neonatal services for perinatal asphyxia and low birth weight in Ghana	PLOS ONE			English	Article							HEALTH-CARE	The major causes of newborn deaths in sub-Saharan Africa are well-known and countries are gradually implementing evidence-based interventions and strategies to reduce these deaths. Facility-based care provides the best outcome for sick and or small babies; however, little is known about the cost and burden of hospital-based neonatal services on parents in West Africa, the sub-region with the highest global neonatal death burden. To estimate the actual costs borne by parents of newborns hospitalised with birth-associated brain injury (perinatal asphyxia) and preterm/low birth weight, this study examined economic costs using micro-costing bottom-up approach in two referral hospitals operating under the nationwide social health insurance scheme in an urban setting in Ghana. We prospectively assessed the process of care and parental economic costs for 25 out of 159 cases of perinatal asphyxia and 33 out of 337 cases of preterm/low birth weight admitted to hospital on the day of birth over a 3 month period. Results showed that medical-related costs accounted for 66.1% (IQR 49% - 81%) of out-of-pocket payments irrespective of health insurance status. On average, families spent 8.1% and 9.1% of their annual income on acute care for preterm/LBW and perinatal asphyxia respectively. The mean out-of-pocket expenditure for preterm/LBW was $147.6 (median $101.8) and for perinatal asphyxia was $132.3 (median $124). The study revealed important gaps in the financing and organization of health service delivery that may impact the quality of care for hospitalised newborns. It also provides information for reviewing complementary health financing options for newborn services and further economic evaluations.	[Enweronu-Laryea, Christabel C.] Univ Ghana, Dept Child Hlth, Sch Med & Dent, Accra, Ghana; [Andoh, Hilary D.] Greater Accra Reg Hosp, Ghana Hlth Serv, Accra, Ghana; [Frimpong-Barfi, Audrey] Tema Gen Hosp, Ghana Hlth Serv, Tema, Greater Accra R, Ghana; [Asenso-Boadi, Francis M.] Univ Cape Coast, Dept Econ, Cape Coast, Ghana; [Asenso-Boadi, Francis M.] Natl Hlth Insurance Author, Head Off, Accra, Ghana	University of Ghana; Ghana Health Service; Ghana Health Service; University of Cape Coast	Enweronu-Laryea, CC (corresponding author), Univ Ghana, Dept Child Hlth, Sch Med & Dent, Accra, Ghana.	ccelaryea@ug.edu.gh		Enweronu-Laryea, Christabel/0000-0001-9346-5365	London School of Economics and Political Science	London School of Economics and Political Science	The authors received no specific funding for this work. The work is self-funded thesis (of the corresponding author) for Master of Science in Health Economics Policy and Management at London School of Economics and Political Science.	Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Ahearne Caroline E, 2016, World J Clin Pediatr, V5, P67, DOI 10.5409/wjcp.v5.i1.67; Allison PD, 2000, SAGE U PAPERS SERIES; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; Ansah EK, 2009, PLOS MED, V6, P48, DOI 10.1371/journal.pmed.1000007; Barnett PG, 2009, MED CARE, V47, pS82, DOI 10.1097/MLR.0b013e31819e1f3f; Behrman R, 2007, REPRESENTING COMMITT; Bhutta ZA, 2014, LANCET; Blencowe H, 2013, TROP MED INT HEALTH, V18, P303, DOI 10.1111/tmi.12048; Browne JL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008175; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Drummond M.F., 2005, EC EVALUATION HLTH C; Dzakpasu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049430; Ekwochi U, 2014, CLINICOECONOMIC OUTC, V6, P29, DOI 10.2147/CEOR.S54674; Flessa S, 2004, INT J HLTH PLANNING, V19, P6377; Ghana Statistical Service Ghana Health Service & ICF International, 2014, GHAN DEM HLTH SURV; Gold MR, 1996, COST EFFECTIVENESS H; Hodek JM, 2011, HEALTH ECON REV, V1, DOI 10.1186/2191-1991-1-6; Jacobs P, 1999, PHARMACOECONOMICS, V15, P551, DOI 10.2165/00019053-199915060-00003; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Kaplan RS, 2011, HARVARD BUS REV, V89, P47; Keel G, 2017, HEALTH POLICY, V121, P755, DOI 10.1016/j.healthpol.2017.04.013; Lambon-Quayefio M, 2017, HEALTH ECON REV, V7, DOI 10.1186/s13561-017-0169-z; Martin LA, 2009, IHI INNOVATION SERIE; Mensah J, 2010, HEALTH ECON, V19, P95, DOI 10.1002/hec.1633; Ministry of Health, GHAN NEWB HLTH STRAT; Mogyorosy Z, 2005, WORKING PAPERS U YOR; Moxon SG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S7; Odd DE, 2011, PEDIATRICS, V127, pE1498, DOI 10.1542/peds.2010-3604; Paradise J, 2014, IMPACT CHILDRENS HLT; Porter M.E., 2006, REDEFINING HLTH CARE; Renfrew MJ, 2014, LANCET; Spear SJ, 2005, HARVARD BUS REV, V83, P78; Thompson S, 0301 HERU; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; WHO and UN Partners, 2015, COUNTR STAT GLOB HLT	36	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0204410	10.1371/journal.pone.0204410	http://dx.doi.org/10.1371/journal.pone.0204410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0UN	30312312	Green Published, Green Submitted, gold			2022-12-26	WOS:000447427300009
J	Smirnov, A; Lena, AM; Cappello, A; Panatta, E; Anemona, L; Bischetti, S; Annicchiarico-Petruzzelli, M; Mauriello, A; Melino, G; Candi, E				Smirnov, Artem; Lena, Anna Maria; Cappello, Angela; Panatta, Emanuele; Anemona, Lucia; Bischetti, Simone; Annicchiarico-Petruzzelli, Margherita; Mauriello, Alessandro; Melino, Gerry; Candi, Eleonora			ZNF185 is a p63 target gene critical for epidermal differentiation and squamous cell carcinoma development	ONCOGENE			English	Article							E-CADHERIN; LIM DOMAIN; P53 HOMOLOG; ADHESION; EXPRESSION; REVEALS; TRANSCRIPTION; PROTEIN; SKIN; PROLIFERATION	Development and maintenance of healthy stratified epithelia require the coordination of complex transcriptional programmes. The transcription factor p63, a member of the p53 family, plays a crucial role in epithelial development and homeostasis. Analysis of the p63-dependent transcriptome indicated that one important aspect of p63 functions in epithelial development is the regulation of cell-cell and cell-matrix adhesion programmes. However, limited knowledge exists on the relevant cell-cell adhesion molecules involved in physiological epithelial formation. Similarly, limited data are available to understand if deregulation of the cell-cell adhesion programme is important in tumour formation. Here, using the epidermis as an experimental model with the RNA sequencing approach, we identify a novel p63-regulated gene induced during differentiation, ZNF185. ZNF185 is an actin-cytoskeleton-associated Lin-l 1, Isl-1 and Mec-3 (LIM) domain containing protein, whose function is poorly known. We found that p63 binds to a specific enhancer region, promoting its expression to sustain epithelial differentiation. ZNF185 silencing strongly impaired keratinocyte differentiation according to gene array analysis. ZNF185 is detected at the cell-cell periphery where it physically interacts with E-cadherin, indicating that it is important to maintain epithelial integrity beyond its pro-differentiation role. Interestingly, poorly differentiated, including head and neck, cervical and oesophageal, squamous cell carcinomas display loss of ZNF185 expression. Together, these studies reinforce that p63 is a crucial gene for maintaining epithelial tissue integrity and support the deregulation of the cell-cell adhesion programme,which plays a critical role in carcinoma development.	[Smirnov, Artem; Lena, Anna Maria; Cappello, Angela; Panatta, Emanuele; Anemona, Lucia; Bischetti, Simone; Mauriello, Alessandro; Melino, Gerry; Candi, Eleonora] Univ Roma Tor Vergata, Dept Expt Med & Surg, Via Montpellier 1, I-00133 Rome, Italy; [Annicchiarico-Petruzzelli, Margherita; Candi, Eleonora] Ist Dermopat Immacolata IRCCS, Via Monti Creta 104, I-00163 Rome, Italy; [Melino, Gerry] Univ Cambridge, MRC Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England	University of Rome Tor Vergata; IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Cambridge	Melino, G; Candi, E (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Surg, Via Montpellier 1, I-00133 Rome, Italy.; Candi, E (corresponding author), Ist Dermopat Immacolata IRCCS, Via Monti Creta 104, I-00163 Rome, Italy.; Melino, G (corresponding author), Univ Cambridge, MRC Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	gerry.melino@uniroma2.it; candi@uniroma2.it	Cappello, Angela/AAL-6109-2021; Smirnov, Artem/AAB-3496-2020; Lena, Anna Maria/AAI-5042-2020; Anemona, lucia/AAB-3491-2022; Annicchiarico-Petruzzelli, Margherita/AAG-7746-2020	Smirnov, Artem/0000-0002-1575-8725; Anemona, lucia/0000-0002-3711-2714; Annicchiarico-Petruzzelli, Margherita/0000-0002-4717-4740; Panatta, Emanuele/0000-0001-8723-9564	AIRC [IG-15653]; IDI-IRCCS;  [RF-2016-02362541]; MRC [MC_U132670600, MC_UU_00025/2] Funding Source: UKRI	AIRC(Fondazione AIRC per la ricerca sul cancro); IDI-IRCCS; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Dr. Ivano Amelio for his assistance with the gene microarray analysis, Dr. Alessandro Terrinoni for his assistance with RNA seq experiment, and Dr. Alessandra Gambacurta for reagents and scientific discussion. The authors also thank all laboratory members for their helpful discussion. This work has been partially supported by AIRC Grant IG-15653 to GM. This work has been mainly supported by IDI-IRCCS (RC to EC and GM) and RF-2016-02362541 (to EC).	Amelio I, 2012, J CELL BIOL, V199, P347, DOI 10.1083/jcb.201203134; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Bao XM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0840-9; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beaudry VG, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001168; Beck Tim N, 2016, Cancers Head Neck, V1, DOI 10.1186/s41199-016-0003-z; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Carroll DK, 2007, CELL CYCLE, V6, P255, DOI 10.4161/cc.6.3.3799; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Cassandri M, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.71; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cavazza A, 2016, STEM CELL REP, V6, P618, DOI 10.1016/j.stemcr.2016.03.003; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Ferone G, 2013, HUM MOL GENET, V22, P531, DOI 10.1093/hmg/dds464; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gallant-Behm CL, 2013, CELL CYCLE, V12, P409, DOI 10.4161/cc.23593; Gonzalez HE, 2003, ARCH OTOLARYNGOL, V129, P754, DOI 10.1001/archotol.129.7.754; Guo ZH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005473; Hatzfeld M, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a029157; Heiss NS, 1997, GENOMICS, V43, P329, DOI 10.1006/geno.1997.4810; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Koster MI, 2006, DEV BIOL, V289, P253, DOI 10.1016/j.ydbio.2005.10.041; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Kroigard AB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189887; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Luxenburg C, 2015, NAT CELL BIOL, V17, P592, DOI 10.1038/ncb3146; McDade SS, 2014, NUCLEIC ACIDS RES, V42, P6270, DOI 10.1093/nar/gku299; Medina PP, 2005, HUM MOL GENET, V14, P973, DOI 10.1093/hmg/ddi091; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Osada M, 2005, J INVEST DERMATOL, V125, P52, DOI 10.1111/j.0022-202X.2005.23801.x; Oti M, 2015, GENOM DATA, V5, P159, DOI 10.1016/j.gdata.2015.06.002; Perez-Moreno M, 2008, P NATL ACAD SCI USA, V105, P15399, DOI 10.1073/pnas.0807301105; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Saladi SV, 2017, CANCER CELL, V31, P35, DOI 10.1016/j.ccell.2016.12.001; Shalom-Feuerstein R, 2011, CELL DEATH DIFFER, V18, P887, DOI 10.1038/cdd.2010.159; Shimomura Y, 2008, DEVELOPMENT, V135, P743, DOI 10.1242/dev.006718; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Vanaja DK, 2003, CANCER RES, V63, P3877; Vasilaki E, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aag3232; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Warner SMB, 2013, AM J RESP CELL MOL, V49, P978, DOI 10.1165/rcmb.2012-0447OC; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wu N, 2012, J BIOL CHEM, V287, P5627, DOI 10.1074/jbc.M111.328120; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zarnegar BJ, 2012, AM J HUM GENET, V91, P435, DOI 10.1016/j.ajhg.2012.07.007; Zhang JS, 2007, ONCOGENE, V26, P111, DOI 10.1038/sj.onc.1209769	57	23	24	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2019	38	10					1625	1638		10.1038/s41388-018-0509-4	http://dx.doi.org/10.1038/s41388-018-0509-4			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN8DD	30337687	Green Published, hybrid			2022-12-26	WOS:000460423800004
J	Hewitt, SC; Li, R; Adams, N; Winuthayanon, W; Hamilton, KJ; Donoghue, LJ; Lierz, SL; Garcia, M; Lydon, JP; DeMayo, FJ; Adelman, K; Korach, KS				Hewitt, Sylvia C.; Li, Rong; Adams, Nyssa; Winuthayanon, Wipawee; Hamilton, Katherine J.; Donoghue, Lauren J.; Lierz, Sydney L.; Garcia, Marleny; Lydon, John P.; DeMayo, Francesco J.; Adelman, Karen; Korach, Kenneth S.			Negative elongation factor is essential for endometrial function	FASEB JOURNAL			English	Article						uterus; NELF; Pol II pausing; decidualization	TRANSCRIPTION; DECIDUALIZATION; EXPRESSION	Pausing of RNA polymerase II (Pol II) during early transcription, mediated by the negative elongation factor (NELF) complex, allows cells to coordinate and appropriately respond to signals by modulating the rate of transcriptional pause release. Promoter proximal enrichment of Pol II occurs at uterine genes relevant to reproductive biology; thus, we hypothesized that pausing might impact endometrial response by coordinating hormonal signals involved in establishing and maintaining pregnancy. We deleted the NELF-B subunit in the mouse uterus using PgrCre (NELF-B UtcKO). Resulting females were infertile. Uterine response to the initial decidual stimulus of NELF-B UtcKO was similar to that of control mice; however, subsequent full decidual response was not observed. Cultured NELF-B UtcKO stromal cells exhibited perturbances in extracellular matrix components and also expressed elevated levels of the decidual prolactin Prl8a2, as well as altered levels of transcripts encoding enzymes involved in prostaglandin synthesis and metabolism. Because endometrial stromal cell decidualization is also critical to human reproductive health and fertility, we used small interfering to suppress NELF-B or NELF-E subunits in cultured human endometrial stromal cells, which inhibited decidualization, as reflected by the impaired induction of decidual markers PRL and IGFBP1. Overall, our study indicates NELF-mediated pausing is essential to coordinate endometrial responses and that disruption impairs uterine decidual development during pregnancy.Hewitt, S. C., Li, R., Adams, N., Winuthayanon, W., Hamilton, K. J., Donoghue, L. J., Lierz, S. L., Garcia, M., Lydon, J. P., DeMayo, F. J., Adelman, K., Korach, K. S. Negative elongation factor is essential for endometrial function.	[Hewitt, Sylvia C.; Hamilton, Katherine J.; Donoghue, Lauren J.; Lierz, Sydney L.; Garcia, Marleny; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, POB 12233, Res Triangle Pk, NC 27709 USA; [Li, Rong; Adams, Nyssa; DeMayo, Francesco J.] NIEHS, Pregnancy & Female Reprod Grp, Reprod & Dev Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA; [Winuthayanon, Wipawee] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA; [Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Adelman, Karen] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Washington State University; Baylor College of Medicine; Harvard University; Harvard Medical School	Hewitt, SC (corresponding author), NIEHS, Receptor Biol Sect, Reprod & Dev Biol Lab, 111 Alexander Dr,MD E4-01, Res Triangle Pk, NC 27701 USA.	sylvia.hewitt@nih.gov	Hewitt, Sylvia/W-8752-2019; Winuthayanon, Wipawee/U-2153-2019	Hewitt, Sylvia/0000-0001-7713-0805; Winuthayanon, Wipawee/0000-0002-5196-8471; Adelman, Karen/0000-0001-5364-334X; Lierz, Sydney/0000-0002-9185-8576	NIH (NIEHS) [1Z1AE5070065]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES103311, ZIAES070065] Funding Source: NIH RePORTER	NIH (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Drs. Karina Rodriguez and Ru-Pin Alicia Chi [both from the U.S. National Institutes of Health/National Institute of Environmental Health Sciences (NIH/NIEHS)] for critically reading the manuscript. The authors thank the NIH, NIEHS Histology Core for processing of tissue samples, and the NIEHS Microarray Core for analysis of samples. The expert surgical and animal care of the NIEHS Comparative Medicine Branch is greatly appreciated. This research was supported, in part, by the Intramural Research Program of the NIH, (NIEHS Grant 1Z1AE5070065 to K.S.K). The authors declare no conflicts of interest.	Adams NR, 2017, BIOL REPROD, V97, P400, DOI 10.1093/biolre/iox108; Adams NR, 2015, ADV ANAT EMBRYOL CEL, V216, P27, DOI 10.1007/978-3-319-15856-3_3; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Amleh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005034; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Cha JM, 2015, ADV ANAT EMBRYOL CEL, V216, P69, DOI 10.1007/978-3-319-15856-3_5; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Gupte R, 2013, P NATL ACAD SCI USA, V110, P14616, DOI 10.1073/pnas.1309898110; Hewitt SC, 2018, ENDOCR REV, V39, P664, DOI 10.1210/er.2018-00087; Hewitt SC, 2015, ENVIRON HEALTH PERSP, V123, P344, DOI 10.1289/ehp.1307935; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Kommagani R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005937; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Liu XL, 2015, TRENDS BIOCHEM SCI, V40, P516, DOI 10.1016/j.tibs.2015.07.003; McEwan M, 2009, CYTOKINE GROWTH F R, V20, P241, DOI 10.1016/j.cytogfr.2009.05.004; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Patel B, 2015, HUM REPROD UPDATE, V21, P155, DOI 10.1093/humupd/dmu056; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Sun JL, 2011, J BIOL CHEM, V286, P36248, DOI 10.1074/jbc.M111.269167; Sun JL, 2010, J BIOL CHEM, V285, P6443, DOI 10.1074/jbc.M109.084285; Teng CT, 2002, BIOCHEM CELL BIOL, V80, P7, DOI 10.1139/o01-215; Watanabe H, 2006, J MOL ENDOCRINOL, V36, P81, DOI 10.1677/jme.1.01825; Williams LH, 2015, MOL CELL, V58, P311, DOI 10.1016/j.molcel.2015.02.003; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007	28	4	4	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					3010	3023		10.1096/fj.201801752	http://dx.doi.org/10.1096/fj.201801752			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30332301	Green Published, Bronze			2022-12-26	WOS:000457296600117
J	Xi, TY; Jin, F; Zhu, Y; Wang, JL; Tang, L; Wang, YZ; Liebeskind, DS; Scalzo, F; He, ZY				Xi, Tianyang; Jin, Feng; Zhu, Ying; Wang, Jialu; Tang, Ling; Wang, Yanzhe; Liebeskind, David S.; Scalzo, Fabien; He, Zhiyi			miR-27a-3p protects against blood-brain barrier disruption and brain injury after intracerebral hemorrhage by targeting endothelial aquaporin-11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						brain; endothelium; microRNA (miRNA); aquaporin; post-transcriptional regulation; blood-brain barrier; brain injury; intracerebral hemorrhage; miR-27a-3p; neurological deficit	EDEMA; ANGIOGENESIS; PERMEABILITY; MICRORNAS; MIR-23A; MODEL; WATER	Previous studies have reported that miR-27a-3p is down-regulated in the serum of patients with intracerebral hemorrhage (ICH), but the implication of miR-27a-3p down-regulation in post-ICH complications remains elusive. Here we verified miR-27a-3p levels in the serum of ICH patients by real-time PCR and observed that miR-27a-3p is also significantly reduced in the serum of these patients. We then further investigated the effect of miR-27a-3p on post-ICH complications by intraventricular administration of a miR-27a-3p mimic in rats with collagenase-induced ICH. We found that the hemorrhage markedly reduced miR-27a-3p levels in the hematoma, perihematomal tissue, and serum and that intracerebroventricular administration of the miR-27a-3p mimic alleviated behavioral deficits 24 h after ICH. Moreover, ICH-induced brain edema, vascular leakage, and leukocyte infiltration were also attenuated by this mimic. Of note, miR-27a-3p mimic treatment also inhibited neuronal apoptosis and microglia activation in the perihematomal zone. We further observed that the miR-27a-3p mimic suppressed the up-regulation of aquaporin-11 (AQP11) in the perihematomal area and in rat brain microvascular endothelial cells (BMECs). Moreover, miR-27a-3p down-regulation increased BMEC monolayer permeability and impaired BMEC proliferation and migration. In conclusion, miR-27a-3p down-regulation contributes to brain edema, blood-brain barrier disruption, neuron loss, and neurological deficits following ICH. We conclude that application of exogenous miR-27a-3p may protect against post-ICH complications by targeting AQP11 in the capillary endothelial cells of the brain.	[Xi, Tianyang; Jin, Feng; Zhu, Ying; Wang, Jialu; Tang, Ling; Wang, Yanzhe; He, Zhiyi] China Med Univ, Affiliated Hosp 1, Dept Neurol, 155 N Nanjing St, Shenyang 110001, Liaoning, Peoples R China; [Liebeskind, David S.; Scalzo, Fabien] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	China Medical University; University of California System; University of California Los Angeles	He, ZY (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Neurol, 155 N Nanjing St, Shenyang 110001, Liaoning, Peoples R China.	hezhiyi0301@sina.com	Scalzo, Fabien/AAM-6328-2020	Scalzo, Fabien/0000-0001-9755-8104	National Natural Science Foundation of China [81271291]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (81271291). The authors declare that they have no conflicts of interest with the contents of this article.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Appelboom G, 2013, J NEUROL NEUROSUR PS, V84, P488, DOI 10.1136/jnnp-2012-303160; Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Ban JJ, 2017, BIOCHEM BIOPH RES CO, V488, P316, DOI 10.1016/j.bbrc.2017.05.040; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Di Stefano V, 2011, VASC PHARMACOL, V55, P111, DOI 10.1016/j.vph.2011.08.001; do Amaral AE, 2018, PHARMACOL RES, V128, P274, DOI 10.1016/j.phrs.2017.10.002; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Gong Y, 2004, STROKE, V35, P2571, DOI 10.1161/01.STR.0000145485.67827.d0; He QW, 2013, MOL NEUROBIOL, V47, P976, DOI 10.1007/s12035-013-8396-8; Ikeda M, 2011, J BIOL CHEM, V286, P3342, DOI 10.1074/jbc.M110.180968; Koike S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060861; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Madeira A, 2014, OBESITY, V22, P2010, DOI 10.1002/oby.20792; Musto A, 2015, CELL DEATH DIFFER, V22, P1047, DOI 10.1038/cdd.2014.198; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Rump K, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0211-9; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Stylli SS, 2017, J NEUROSURG, V126, P1131, DOI 10.3171/2016.1.JNS151454; Sun LQ, 2017, BIOCHEM BIOPH RES CO, V482, P1141, DOI 10.1016/j.bbrc.2016.12.001; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Wang J, 2003, ANN NEUROL, V54, P655, DOI 10.1002/ana.10750; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2002, NEUROSURG CLIN N AM, V13, P371, DOI 10.1016/S1042-3680(02)00007-4; Xi TY, 2017, BIOCHEM BIOPH RES CO, V494, P144, DOI 10.1016/j.bbrc.2017.10.064; Yakata K, 2011, J STRUCT BIOL, V174, P315, DOI 10.1016/j.jsb.2011.01.003; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; Yang J, 2015, STROKE, V46, P1009, DOI 10.1161/STROKEAHA.114.007154; Young JA, 2013, BLOOD, V122, P2911, DOI 10.1182/blood-2012-12-473017; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167; Zhou SS, 2018, ACTA PHARMACOL SIN, V39, P1073, DOI 10.1038/aps.2018.30; Zhu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121608	41	62	65	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20041	20050		10.1074/jbc.RA118.001858	http://dx.doi.org/10.1074/jbc.RA118.001858			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30337368	Green Published, hybrid			2022-12-26	WOS:000454685900014
J	Zhou, JY; Yang, LY; Ozohanics, O; Zhang, X; Wang, JJ; Ambrus, A; Arjunan, P; Brukh, R; Nemeria, NS; Furey, W; Jordan, F				Zhou, Jieyu; Yang, Luying; Ozohanics, Oliver; Zhang, Xu; Wang, Junjie; Ambrus, Attila; Arjunan, Palaniappa; Brukh, Roman; Nemeria, Natalia S.; Furey, William; Jordan, Frank			A multipronged approach unravels unprecedented protein-protein interactions in the human 2-oxoglutarate dehydrogenase multienzyme complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tricarboxylic acid cycle (TCA cycle) (Krebs cycle); hydrogen exchange mass spectrometry; isothermal titration calorimetry (ITC); dehydrogenase; mass spectrometry (MS); chemical cross-linking MS; human 2-oxoglutarate dehydrogenase complex; neurodegeneration; oxidative stress; protein complex interaction loci; site-selected fluorescent labeling	ALPHA-KETOGLUTARATE DEHYDROGENASE; DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE COMPONENT; MAMMALIAN PYRUVATE-DEHYDROGENASE; EXCHANGE MASS-SPECTROMETRY; CLEAVABLE CROSS-LINKER; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; BINDING DOMAIN; E1 COMPONENT	The human 2-oxoglutaric acid dehydrogenase complex (hOGDHc) plays a pivotal role in the tricarboxylic acid (TCA) cycle, and its diminished activity is associated with neurodegenerative diseases. The hOGDHc comprises three components, hE1o, hE2o, and hE3, and we recently reported functionally active E1o and E2o components, enabling studies on their assembly. No atomic-resolution structure for the hE2o component is currently available, so here we first studied the interactions in the binary subcomplexes (hE1o-hE2o, hE1o-hE3, and hE2o-hE3) to gain insight into the strength of their interactions and to identify the interaction loci in them. We carried out multiple physico-chemical studies, including fluorescence, hydrogen-deuterium exchange MS (HDX-MS), and chemical cross-linking MS (CL-MS). Our fluorescence studies suggested a strong interaction for the hE1o-hE2o subcomplex, but a much weaker interaction in the hE1o-hE3 subcomplex, and failed to identify any interaction in the hE2o-hE3 subcomplex. The HDX-MS studies gave evidence for interactions in the hE1o-hE2o and hE1o-hE3 subcomplexes comprising full-length components, identifying: (i) the N-terminal region of hE1o, in particular the two peptides (YVEEM22)-Y-18 and (ENPKSVHKSWDIF39)-E-27 as constituting the binding region responsible for the assembly of the hE1o with both the hE2o and hE3 components into hOGDHc, an hE1 region absent in available X-ray structures; and (ii) a novel hE2o region comprising residues from both a linker region and from the catalytic domain as being a critical region interacting with hE1o. The CL-MS identified the loci in the hE1o and hE2o components interacting with each other.	[Zhou, Jieyu; Yang, Luying; Zhang, Xu; Wang, Junjie; Brukh, Roman; Nemeria, Natalia S.; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Ozohanics, Oliver; Ambrus, Attila] Semmelweis Univ, MTA SE Lab Neurobiochem, Dept Med Biochem, 27-29 Tuzolto Utca, H-1094 Budapest, Hungary; [Arjunan, Palaniappa; Furey, William] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Arjunan, Palaniappa; Furey, William] Vet Affairs Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Semmelweis University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Nemeria, NS; Jordan, F (corresponding author), Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA.	nemeria@newark.rutgers.edu; frjordan@newark.rutgers.edu	ZHANG, XU/AAL-6729-2020; Ozohanics, Oliver/AAH-4449-2019; Ambrus, Attila/O-4301-2017	Ozohanics, Oliver/0000-0002-2705-9921; Ambrus, Attila/0000-0001-6014-3175; Furey, William/0000-0002-7788-0689	Hungarian Academy of Sciences MTA Grant [02001]; Hungarian Scientific Research Fund OTKA Grant [112230]; Hungarian Brain Research Program Grants [KTIA_13_NAP-A-III/6, 2017-1.2.1-NKP-2017-00002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121469] Funding Source: NIH RePORTER	Hungarian Academy of Sciences MTA Grant; Hungarian Scientific Research Fund OTKA Grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Brain Research Program Grants; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research at Semmelweis Medical University was supported by the following grants, all awarded to Professor Veronika Adam-Vizi (Dept. of Medical Biochemistry, MTA-SE Laboratory for Neurobiochemistry, Semmelweis University, H-1094 Budapest, Hungary), Hungarian Academy of Sciences MTA Grant 02001, Hungarian Scientific Research Fund OTKA Grant 112230, and Hungarian Brain Research Program Grants KTIA_13_NAP-A-III/6 and 2017-1.2.1-NKP-2017-00002.	Al-Alaway A. I. A., 2013, THESIS; Ambrus A, 2016, BBA-MOL BASIS DIS, V1862, P2098, DOI 10.1016/j.bbadis.2016.08.013; Arjunan P, 2014, J BIOL CHEM, V289, P30161, DOI 10.1074/jbc.M114.592915; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BEHAL RH, 1994, J BIOL CHEM, V269, P31372; BRADFORD AP, 1987, FEBS LETT, V222, P211, DOI 10.1016/0014-5793(87)80221-1; Brautigam CA, 2011, J BIOL CHEM, V286, P23476, DOI 10.1074/jbc.M110.202960; Byron O, 2017, SUBCELL BIOCHEM, V83, P523, DOI 10.1007/978-3-319-46503-6_19; CAROTHERS DJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P409, DOI 10.1016/0003-9861(89)90309-3; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chandrasekhar K, 2013, J BIOL CHEM, V288, P15402, DOI 10.1074/jbc.M113.466789; Chen HL, 2016, J NEUROCHEM, V139, P823, DOI 10.1111/jnc.13836; Frank RAW, 2007, J MOL BIOL, V368, P639, DOI 10.1016/j.jmb.2007.01.080; Gibson GE, 2015, J NEUROCHEM, V134, P86, DOI 10.1111/jnc.13096; Gotze M, 2015, J AM SOC MASS SPECTR, V26, P83, DOI 10.1007/s13361-014-1001-1; Grimm M, 2015, NUCLEIC ACIDS RES, V43, pW362, DOI 10.1093/nar/gkv463; Guevara EL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42760; Hage C, 2017, ANGEW CHEM INT EDIT, V56, P14551, DOI 10.1002/anie.201708273; Hamuro Y, 2008, RAPID COMMUN MASS SP, V22, P1041, DOI 10.1002/rcm.3467; Han MK, 2002, BIOCHEMISTRY-US, V41, P3468, DOI 10.1021/bi015901e; Harris RA, 1997, ADV ENZYME REGUL, V37, P271, DOI 10.1016/S0065-2571(96)00009-X; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; HUNTER A, 1986, EUR J BIOCHEM, V155, P103, DOI 10.1111/j.1432-1033.1986.tb09464.x; Kan ZY, 2011, J AM SOC MASS SPECTR, V22, P1906, DOI 10.1007/s13361-011-0236-3; Kikuchi G, 2008, P JPN ACAD B-PHYS, V84, P246, DOI [10.2183/pjab.84.246, 10.2183/pjab/84.246]; Knapp JE, 1998, J MOL BIOL, V280, P655, DOI 10.1006/jmbi.1998.1924; Koike K, 2000, EUR J BIOCHEM, V267, P3005, DOI 10.1046/j.1432-1033.2000.01320.x; Li W., 2015, NUCLEIC ACIDS RES, V43, pW58, DOI DOI 10.1093/nar/gkv316; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; Marrott NL, 2014, BIOCHEM J, V463, P405, DOI 10.1042/BJ20140359; MATTEVI A, 1993, J MOL BIOL, V230, P1200, DOI 10.1006/jmbi.1993.1236; McCartney RG, 1998, J BIOL CHEM, V273, P24158, DOI 10.1074/jbc.273.37.24158; Muller MQ, 2010, ANAL CHEM, V82, P6958, DOI 10.1021/ac101241t; Murphy GE, 2005, STRUCTURE, V13, P1765, DOI 10.1016/j.str.2005.08.016; NAKANO K, 1994, EUR J BIOCHEM, V224, P179, DOI 10.1111/j.1432-1033.1994.tb20010.x; Nemeria NS, 2018, BBA-BIOENERGETICS, V1859, P932, DOI 10.1016/j.bbabio.2018.05.001; Nemeria NS, 2014, J BIOL CHEM, V289, P29859, DOI 10.1074/jbc.M114.591073; PACKMAN LC, 1987, BIOCHEM J, V242, P531, DOI 10.1042/bj2420531; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Perham RN, 2002, BIOCHEM SOC T, V30, P47, DOI 10.1042/bst0300047; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; REED LJ, 1975, P NATL ACAD SCI USA, V72, P3068, DOI 10.1073/pnas.72.8.3068; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Ricaud PM, 1996, J MOL BIOL, V264, P179, DOI 10.1006/jmbi.1996.0632; RICE JE, 1992, EMBO J, V11, P3229, DOI 10.1002/j.1460-2075.1992.tb05400.x; ROBIEN MA, 1992, BIOCHEMISTRY-US, V31, P3463, DOI 10.1021/bi00128a021; Sanderson SJ, 1996, BIOCHEM J, V319, P109, DOI 10.1042/bj3190109; SCHULDINER S, 1977, P NATL ACAD SCI USA, V74, P1851, DOI 10.1073/pnas.74.5.1851; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Smolle M, 2006, J BIOL CHEM, V281, P19772, DOI 10.1074/jbc.M601140200; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Vijayakrishnan S, 2010, J MOL BIOL, V399, P71, DOI 10.1016/j.jmb.2010.03.043; WAGENKNECHT T, 1992, J STRUCT BIOL, V109, P70, DOI 10.1016/1047-8477(92)90069-M; WAGENKNECHT T, 1990, J BIOL CHEM, V265, P22402; Wagner T, 2011, CHEM BIOL, V18, P1011, DOI 10.1016/j.chembiol.2011.06.004; Wang J., 2014, THESIS; Wang JJ, 2015, BIOCHEMISTRY-US, V54, P69, DOI 10.1021/bi5013113; Wang JJ, 2014, J BIOL CHEM, V289, P15215, DOI 10.1074/jbc.M113.544080; Wang YG, 2017, NATURE, V552, P273, DOI 10.1038/nature25003; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; YEAMAN SJ, 1986, TRENDS BIOCHEM SCI, V11, P293, DOI 10.1016/0968-0004(86)90033-2	66	13	13	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19213	19227		10.1074/jbc.RA118.005432	http://dx.doi.org/10.1074/jbc.RA118.005432			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30323066	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000453537300006
J	Sherp, AM; Lee, SG; Schraft, E; Jez, JM				Sherp, Ashley M.; Lee, Soon Goo; Schraft, Evelyn; Jez, Joseph M.			Modification of auxinic phenoxyalkanoic acid herbicides by the acyl acid amido synthetase GH3.15 from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; X-ray crystallography; enzyme kinetics; auxin; protein structure; 2; 4-D; acyl acid amido synthetase; Gretchen Hagen 3; herbicide tolerance; herbicides; Arabidopsis thaliana; structure-activity relationship	BOX PROTEIN TIR1; INDOLE-3-BUTYRIC ACID; PLANT HORMONES; ENZYME ACTION; FAMILY; RESISTANCE; BIOSYNTHESIS; MECHANISM; REVEALS; PATHWAY	Herbicide-resistance traits are the most widely used agriculture biotechnology products. Yet, to maintain their effectiveness and to mitigate selection of herbicide-resistant weeds, the discovery of new resistance traits that use different chemical modes of action is essential. In plants, the Gretchen Hagen 3 (GH3) acyl acid amido synthetases catalyze the conjugation of amino acids to jasmonate and auxin phytohormones. This reaction chemistry has not been explored as a possible approach for herbicide modification and inactivation. Here, we examined a set of Arabidopsis GH3 proteins that use the auxins indole-3-acetic acid (IAA) and indole-3-butyric acid (IBA) as substrates along with the corresponding auxinic phenoxyalkanoic acid herbicides 2,4-dichlorophenoxylacetic acid (2,4-D) and 4-(2,4-dichlorophenoxy)butyric acid (2,4-DB). The IBA-specific AtGH3.15 protein displayed high catalytic activity with 2,4-DB, which was comparable to its activity with IBA. Screening of phenoxyalkanoic and phenylalkyl acids indicated that side-chain length of alkanoic and alkyl acids is a key feature of AtGH3.15's substrate preference. The X-ray crystal structure of the AtGH3.152,4-DB complex revealed how the herbicide binds in the active site. In root elongation assays, Arabidopsis AtGH3.15-knockout and -overexpression lines grown in the presence of 2,4-DB exhibited hypersensitivity and tolerance, respectively, indicating that the AtGH3.15-catalyzed modification inactivates 2,4-DB. These findings suggest a potential use for AtGH3.15, and perhaps other GH3 proteins, as herbicide-modifying enzymes that employ a mode of action different from those of currently available herbicide-resistance traits.	[Sherp, Ashley M.; Lee, Soon Goo; Schraft, Evelyn; Jez, Joseph M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@wustl.edu		Lee, Soon Goo/0000-0002-1541-8587	National Science Foundation [DBI-1427621]; Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]	National Science Foundation(National Science Foundation (NSF)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE))	The MS measurement was performed at the Proteomics & Mass Spectrometry Facility at the Donald Danforth Plant Science Center based upon work supported by grants from the National Science Foundation (DBI-1427621) for acquisition of the QTRAP 6500 LC-MS/MS. Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research under Grant DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Behrens MR, 2007, SCIENCE, V316, P1185, DOI 10.1126/science.1141596; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; CHALEFF RS, 1984, SCIENCE, V224, P1443, DOI 10.1126/science.224.4656.1443; Charles JM, 2000, MUTAT RES-GEN TOX EN, V472, P75, DOI 10.1016/S1383-5718(00)00130-3; Chen QF, 2010, J BIOL CHEM, V285, P29780, DOI 10.1074/jbc.M110.146431; Detzel C, 2013, APPL MICROBIOL BIOT, V97, P4887, DOI 10.1007/s00253-012-4401-9; DHALLUIN K, 1992, METHOD ENZYMOL, V216, P415; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enders TA, 2015, AM J BOT, V102, P180, DOI 10.3732/ajb.1400285; Eyer L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159269; Grossmann K, 2010, PEST MANAG SCI, V66, P113, DOI 10.1002/ps.1860; Harrison DHT, 1997, BIOCHEMISTRY-US, V36, P16134, DOI 10.1021/bi9717136; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Korasick DA, 2015, CURR OPIN PLANT BIOL, V27, P22, DOI 10.1016/j.pbi.2015.05.007; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; McErlich A.F., 2014, AUTOMATION FUTURE WE, P11, DOI [10.1007/978-94-007-7512-1_2, DOI 10.1007/978-94-007-7512-1_2]; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Peterson MA, 2016, WEED TECHNOL, V30, P303, DOI 10.1614/WT-D-15-00131.1; Rao V. S., 1940, PRINCIPLES WEED SCI, P199; Rippert P, 2004, PLANT PHYSIOL, V134, P92, DOI 10.1104/pp.103.032441; Salehin M, 2015, PLANT CELL, V27, P9, DOI 10.1105/tpc.114.133744; Service RF, 2007, SCIENCE, V316, P1114, DOI 10.1126/science.316.5828.1114; Shaner DL, 2000, PEST MANAG SCI, V56, P320, DOI 10.1002/(SICI)1526-4998(200004)56:4<320::AID-PS125>3.3.CO;2-2; Sherp AM, 2018, J BIOL CHEM, V293, P4277, DOI 10.1074/jbc.RA118.002006; Song YL, 2014, J INTEGR PLANT BIOL, V56, P106, DOI 10.1111/jipb.12131; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Steiner HY, 2013, PLANT PHYSIOL, V161, P1587, DOI 10.1104/pp.112.209817; Sterling T, 1997, HERBICIDE ACTIVITY T, V1, P111; Strader Lucia C, 2010, Plant Physiol, V153, P1577, DOI 10.1104/pp.110.157461; Tan S, 2006, AMINO ACIDS, V30, P195, DOI 10.1007/s00726-005-0254-1; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; United States Environmental Protection Agency, 2005, EPA738F05002; United States Environmental Protection Agency, 2005, EPA738F05001; Westfall CS, 2016, P NATL ACAD SCI USA, V113, P13917, DOI 10.1073/pnas.1612635113; Westfall CS, 2013, J BIOL CHEM, V288, P19304, DOI 10.1074/jbc.R113.475160; Westfall CS, 2012, SCIENCE, V336, P1708, DOI 10.1126/science.1221863; Westfall CS, 2010, PLANT SIGNAL BEHAV, V5, P1607, DOI 10.4161/psb.5.12.13941; Wright TR, 2010, P NATL ACAD SCI USA, V107, P20240, DOI 10.1073/pnas.1013154107; Zolman BK, 2000, GENETICS, V156, P1323	43	6	8	4	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17731	17738		10.1074/jbc.RA118.004975	http://dx.doi.org/10.1074/jbc.RA118.004975			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30315112	Green Published, hybrid			2022-12-26	WOS:000450409500006
J	Harrus, D; Khoder-Agha, F; Peltoniemi, M; Hassinen, A; Ruddock, L; Kellokumpu, S; Glumoff, T				Harrus, Deborah; Khoder-Agha, Fawzi; Peltoniemi, Miika; Hassinen, Antti; Ruddock, Lloyd; Kellokumpu, Sakari; Glumoff, Tuomo			The dimeric structure of wild-type human glycosyltransferase B4GaIT1	PLOS ONE			English	Article							GOLGI N-GLYCOSYLTRANSFERASES; CRYSTAL-STRUCTURES; GLYCOPROTEIN GALACTOSYLTRANSFERASE; LACTOSE SYNTHETASE; ALPHA-LACTALBUMIN; CATALYTIC DOMAIN; BINDING-SITES; ENZYME; BETA-1,4-GALACTOSYLTRANSFERASE; PURIFICATION	Most glycosyltransferases, including B4GaIT1 (EC 2.4.1.38), are known to assemble into enzyme homomers and functionally relevant heteromers in vivo. However, it remains unclear why and how these enzymes interact at the molecular/atomic level. Here, we solved the crystal structure of the wild-type human B4GaIT1 homodimer. We also show that B4GaIT1 exists in a dynamic equilibrium between monomer and dimer, since a purified monomer reappears as a mixture of both and as we obtained crystal forms of the monomer and dimer assemblies in the same crystallization conditions. These two crystal forms revealed the unliganded B4GaIT1 in both the open and the closed conformation of the Trp loop and the lid regions, responsible for donor and acceptor substrate binding, respectively. The present structures also show the lid region in full in an open conformation, as well as a new conformation for the GlcNAc acceptor loop (residues 272-288). The physiological relevance of the homodimer in the crystal was validated by targeted mutagenesis studies coupled with FRET assays. These showed that changing key catalytic amino acids impaired homomer formation in vivo. The wild-type human B4GaIT1 structure also explains why the variant proteins used for crystallization in earlier studies failed to reveal the homodimers described in this study.	[Harrus, Deborah; Khoder-Agha, Fawzi; Peltoniemi, Miika; Hassinen, Antti; Ruddock, Lloyd; Kellokumpu, Sakari; Glumoff, Tuomo] Univ Oulu, Fac Biochem & Mol Med, Aapistie 7A, Oulu, Finland; [Hassinen, Antti] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland	University of Oulu; University of Helsinki	Glumoff, T (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Aapistie 7A, Oulu, Finland.	tuomo.glumoff@oulu.fi	Khoder-Agha, Fawzi/G-5735-2019; Khoder-Agha, Fawzi/M-2943-2019	Khoder-Agha, Fawzi/0000-0003-0784-4997; Khoder-Agha, Fawzi/0000-0003-0784-4997; Hassinen, Antti/0000-0001-9491-2868; Ruddock, Lloyd/0000-0002-6247-686X; Harrus, Deborah/0000-0002-7651-672X	Academy of Finland [285232]; University of Oulu; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); University of Oulu; Emil Aaltonen Foundation	This work has been funded by the Academy of Finland (no. 285232 to Dr. Sakari Kellokumpu), University of Oulu, and Emil Aaltonen Foundation (to Dr. Antti Hassinen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AOKI D, 1990, EMBO J, V9, P3171, DOI 10.1002/j.1460-2075.1990.tb07515.x; BELLA A, 1977, BIOCHEM J, V167, P621, DOI 10.1042/bj1670621; Bernauer J, 2008, BIOINFORMATICS, V24, P652, DOI 10.1093/bioinformatics/btn022; Boeggeman E, 2002, GLYCOBIOLOGY, V12, P395, DOI 10.1093/glycob/cwf045; BREW K, 1968, P NATL ACAD SCI USA, V59, P491, DOI 10.1073/pnas.59.2.491; BRODBECK U, 1967, J BIOL CHEM, V242, P1391; Brown JR, 2009, J BIOL CHEM, V284, P4952, DOI 10.1074/jbc.M805782200; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faure G, 2012, NUCLEIC ACIDS RES, V40, pD847, DOI 10.1093/nar/gkr845; Gaciarz A, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0721-x; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; GEREN CR, 1975, BIOCHEMISTRY-US, V14, P1461, DOI 10.1021/bi00678a017; Gunasekaran K, 2003, BIOCHEMISTRY-US, V42, P3674, DOI 10.1021/bi034046r; Hagemans D, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00056; Harrus D, 2018, CELL MOL LIFE SCI, V75, P833, DOI 10.1007/s00018-017-2659-x; Hassinen A, 2014, J BIOL CHEM, V289, P26937, DOI 10.1074/jbc.M114.595058; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KHATRA BS, 1974, EUR J BIOCHEM, V44, P537, DOI 10.1111/j.1432-1033.1974.tb03513.x; Kokkonen N, 2019, ANTIOXID REDOX SIGN, V30, P5, DOI 10.1089/ars.2017.7389; KREZDORN CH, 1993, EUR J BIOCHEM, V212, P113, DOI 10.1111/j.1432-1033.1993.tb17640.x; Krissinel E, 2015, NUCLEIC ACIDS RES, V43, pW314, DOI 10.1093/nar/gkv314; Malissard M, 1996, EUR J BIOCHEM, V239, P340, DOI 10.1111/j.1432-1033.1996.0340u.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOREMEN KW, 1991, J BIOL CHEM, V266, P16876; MORRISON JF, 1971, J BIOL CHEM, V246, P3977; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; NAKAZAWA K, 1993, J BIOCHEM-TOKYO, V113, P747; NAVARATNAM N, 1988, EUR J BIOCHEM, V171, P623, DOI 10.1111/j.1432-1033.1988.tb13833.x; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; POWELL JT, 1974, EUR J BIOCHEM, V48, P217, DOI 10.1111/j.1432-1033.1974.tb03759.x; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ramakrishnan B, 2005, BIOCHEMISTRY-US, V44, P3202, DOI 10.1021/bi0479454; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramakrishnan B, 2004, BIOCHEMISTRY-US, V43, P12513, DOI 10.1021/bi049007+; Ramakrishnan B, 2003, J BIOMOL STRUCT DYN, V21, P1; Ramakrishnan B, 2002, BIOCHEM BIOPH RES CO, V291, P1113, DOI 10.1006/bbrc.2002.6506; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Ramakrishnan B, 2007, J MOL BIOL, V365, P570, DOI 10.1016/j.jmb.2006.10.034; Ramakrishnan B, 2012, J BIOL CHEM, V287, P28666, DOI 10.1074/jbc.M112.373514; Ramakrishnan B, 2010, CURR OPIN STRUC BIOL, V20, P536, DOI 10.1016/j.sbi.2010.07.004; Ramasamy V, 2005, J MOL BIOL, V353, P53, DOI 10.1016/j.jmb.2005.07.050; Ramasamy V, 2003, J MOL BIOL, V331, P1065, DOI 10.1016/S0022-2836(03)00790-3; RAO GJS, 1978, BIOCHIM BIOPHYS ACTA, V541, P435, DOI 10.1016/0304-4165(78)90153-8; TANG BL, 1992, J BIOL CHEM, V267, P10122; TEASDALE RD, 1994, GLYCOBIOLOGY, V4, P917, DOI 10.1093/glycob/4.6.917; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1	54	9	9	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0205571	10.1371/journal.pone.0205571	http://dx.doi.org/10.1371/journal.pone.0205571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352055	gold, Green Submitted, Green Published			2022-12-26	WOS:000448076200010
J	Alotaibi, RM; Rezk, HR; Juliana, CI; Guure, C				Alotaibi, Refah Mohammed; Rezk, Hoda Ragab; Juliana, Consul Iworikumo; Guure, Chris			Breast cancer mortality in Saudi Arabia: Modelling observed and unobserved factors	PLOS ONE			English	Article							MARITAL-STATUS; SURVIVAL; BURDEN; TRENDS; RISK; INJURIES; DISEASES; FRAILTY; HEALTH	Background Breast cancer is one of the most dangerous and frequently occurring cancers among women, and it also affects men. We aimed to determine the prevalence and factors associated with mortality among patients with breast cancer in Saudi Arabia. Method Data for this analysis of breast cancer mortality among Saudi Arabians were obtained from the Saudi Arabian Cancer Registry at the King Faisal Hospital and Research Centre. Both descriptive and inferential statistical analyses were conducted using proportions, chisquared tests, and the Cox regression model. Frequentist and Bayesian inferential statistics were used to estimate the risk ratios. A frailty term was specified to control for suspected heterogeneity across regions. Bayesian and deviance information criteria were used to discriminate between the frequentist and Bayesian frailty models, respectively. Results Out of 5,411 patients, 708 (13.08%) deaths occurred that were attributable to breast cancer. Of those, 12 (1.69%) were men. Among patients who died of breast cancer, 353 (49.86%) had tumours that originated on the left side and 338 (47.74%) on the right side. In terms of the stage or extent of breast cancer, 318 (44.92%) deaths occurred among patients who had distant metastases, followed by 304 (42.94%) who had regional metastases and 86 (12.15%) with localized cancers. Men were 72% more likely than women to die from breast cancer. Divorcees were twice as likely to die, compared to their married counterparts. Patients whose tumours were classified as Grade IV had the highest mortality rate, which was 5.0 times higher than patients with Grade I tumours (credible interval (Crl); 1.577, 14.085) and 3.7 times higher than patients with Grade II tumours (Crl; 1.205, 9.434). Conclusion There is a high prevalence of breast cancer mortality among Saudi Arabian women, with the highest prevalence among divorced women. Though the prevalence of breast cancer mortality among men is lower than that of women, men had a higher risk of death. We therefore recommend an intensive health education programme for both men and women. These programmes should discuss the consequences of divorce, the prevalence of breast cancer among men, and early diagnoses and treatments for breast cancer.	[Alotaibi, Refah Mohammed; Rezk, Hoda Ragab] Princess Nourah Bint Abdulrahman Univ, Fac Sci, Dept Math Sci, Riyadh, Saudi Arabia; [Rezk, Hoda Ragab] Al Azhar Univ, Dept Stat, Cairo, Egypt; [Juliana, Consul Iworikumo] Niger Delta Univ, Dept Math, Comp Sci, Amassama, Bayelsa State, Nigeria; [Guure, Chris] Univ Ghana, Sch Publ Hlth, Dept Biostat, Legon, Ghana	Princess Nourah bint Abdulrahman University; Egyptian Knowledge Bank (EKB); Al Azhar University; University of Ghana	Guure, C (corresponding author), Univ Ghana, Sch Publ Hlth, Dept Biostat, Legon, Ghana.	cbguure@ug.edu.gh	Guure, Chris/H-8071-2019; Alotaibi, Refah/AAZ-1168-2021	Guure, Chris/0000-0001-6595-9587; Alotaibi, Refah/0000-0002-9449-7489; Rezk, hoda/0000-0002-7501-7232				Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Al-Qahtani MS, 2007, SAUDI MED J, V28, P1590; Ali M., 1993, DIVORCE IN ISLAM; Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; American Cancer Society, 2016, CANC FACTS FIGURES 2; Anders CK, 2009, SEMIN ONCOL, V36, P237, DOI 10.1053/j.seminoncol.2009.03.001; Anderson WF, 2010, J CLIN ONCOL, V28, P232, DOI 10.1200/JCO.2009.23.8162; Atlanta. Breast Cancer Mortality, 2006, SCI LETT, V157, P157; Balekouzou A, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0368-0; Ballantyne PJ, 2004, J CLIN NURS, V13, P11, DOI 10.1111/j.1365-2702.2004.00921.x; Bartonsville, 2018, REASONS RACIAL DIFFE; Chan SWW, 2017, ASIAN J SURG, V40, P444, DOI 10.1016/j.asjsur.2016.02.003; CLAYTON DG, 1991, BIOMETRICS, V47, P467, DOI 10.2307/2532139; Gazette S., SAUDIGAZETTE COM SA; Gomez SL, 2016, CANCER-AM CANCER SOC, V122, P1618, DOI 10.1002/cncr.29885; HARTVEIT F, 1983, CLIN ONCOL, V9, P135; Hill TD, 2005, ANN EPIDEMIOL, V15, P773, DOI 10.1016/j.annepidem.2005.01.001; Holleczek B, 2011, CANCER EPIDEMIOL, V35, P399, DOI 10.1016/j.canep.2011.01.008; Ibrahim EM, 2008, MED ONCOL, V25, P387, DOI 10.1007/s12032-008-9051-5; Ito Y, 2009, CANCER SCI, V100, P2390, DOI 10.1111/j.1349-7006.2009.01311.x; Kashfi F, 2002, J REPROD INFERTILITY, V3; Ly D, 2013, INT J CANCER, V132, P1918, DOI 10.1002/ijc.27841; Mar C, 2018, B C MED J, V60, P20; Martinez ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175515; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; Motamed N, 2004, SURVEY RISK FACTORS; Muir D, 2003, ARCH PATHOL LAB MED, V127, P36; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Perkins CI, 2004, CANCER CAUSE CONTROL, V15, P637, DOI 10.1023/B:CACO.0000036171.44162.5f; Registry N., 2002, CANC INCIDENCE REPOR; ROSS CE, 1990, J MARRIAGE FAM, V52, P1059, DOI 10.2307/353319; Sahu SK, 2000, LIFETIME DATA ANAL, V6, P207, DOI 10.1023/A:1009633524403; Sinha D, 1997, J AM STAT ASSOC, V92, P1195, DOI 10.2307/2965586; Sughrue T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103313; Titus-Ernstoff L, 2000, EPIDEMIOLOGY, V11, P181, DOI 10.1097/00001648-200003000-00017	35	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0206148	10.1371/journal.pone.0206148	http://dx.doi.org/10.1371/journal.pone.0206148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30347002	Green Published, Green Submitted, gold			2022-12-26	WOS:000447938400040
J	Rodriguez-Gomez, I; Manas, A; Losa-Reyna, J; Rodriguez-Manas, L; Chastin, SFM; Alegre, LM; Garcia-Garcia, FJ; Ara, I				Rodriguez-Gomez, Irene; Manas, Asier; Losa-Reyna, Jose; Rodriguez-Manas, Leocadio; Chastin, Sebastien F. M.; Alegre, Luis M.; Garcia-Garcia, Francisco J.; Ara, Ignacio			Associations between sedentary time, physical activity and bone health among older people using compositional data analysis	PLOS ONE			English	Article							HIGH-IMPACT EXERCISE; MINERAL DENSITY; POSTMENOPAUSAL WOMEN; RISK-FACTORS; POPULATION; BEHAVIOR; FRACTURE; ADULTS; OSTEOPOROSIS; FRAILTY	Introduction Aging is associated with a progressive decrease in bone mass (BM), and being physical active is one of the main strategies to combat this continuous loss. Nonetheless, because daily time is limited, time spent on each movement behavior is co-dependent. The aim of this study was to determine the relationship between BM and movement behaviors in elderly people using compositional data analysis. Methods We analyzed 871 older people [395 men (76.9 +/- 5.3y) and 476 women (76.7 +/- 4.7y)]. Time spent in sedentary behavior (SB), light physical activity (LPA) and moderate-to-vigorous physical activity (MVPA), was assessed using accelerometry. BM was determined by bone densitometry (DXA). The sample was divided according to sex and bone health indicators. Results The combined effect of all movement behaviors (PA and SB) was significantly associated with whole body, leg and femoral region BM in the whole sample (p<0.05), with leg and pelvic BM (p<0.05) in men and, with whole body, arm and leg BM (p<0.05) in women. In men, arm and pelvic BM were negatively associated with SB and whole body, pelvic and leg BM were positively associated with MVPA (p<0.05). In women, whole body and leg BM were positively associated with SB. Arm and whole body BM were positively associated and leg BM was negatively associated with LPA and arm BM was negatively associated with MVPA (p<0.05). Women without bone fractures spent less time in SB and more in LPA and MVPA than the subgroup with bone fractures. Conclusion We identified that the positive effect of MVPA relative to the other behaviors on bone mass is the strongest overall effect in men. Furthermore, women might decrease bone fracture risk through PA increase and SB reduction, despite the fact that no clear benefits of PA for bone mass were found.	[Rodriguez-Gomez, Irene; Manas, Asier; Losa-Reyna, Jose; Rodriguez-Manas, Leocadio; Alegre, Luis M.; Garcia-Garcia, Francisco J.; Ara, Ignacio] GIBER Frailty & Hlth Aging CIBERFES, Madrid, Spain; [Manas, Asier; Losa-Reyna, Jose; Alegre, Luis M.; Ara, Ignacio] Univ Castilla La Mancha, GENUD Toledo Res Grp, Toledo, Spain; [Losa-Reyna, Jose; Garcia-Garcia, Francisco J.] Virgen Valle Hosp, Geriatr Dept, Toledo, Spain; [Rodriguez-Manas, Leocadio] Univ Hosp Getafe, Geriatr Dept, Getafe, Spain; [Chastin, Sebastien F. M.] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Chastin, Sebastien F. M.] Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium	Universidad de Castilla-La Mancha; Hospital Universitario de Getafe; Glasgow Caledonian University; Ghent University	Ara, I (corresponding author), GIBER Frailty & Hlth Aging CIBERFES, Madrid, Spain.; Ara, I (corresponding author), Univ Castilla La Mancha, GENUD Toledo Res Grp, Toledo, Spain.	Ignacio.ara@uclm.es	Alegre, Luis M./K-5777-2012; Rodríguez-Gómez, Irene/AAC-7886-2019; Garcia-Garcia, Francisco Jose/R-9258-2017; Chastin, Sebastien/ABF-1455-2020; Losa-Reyna, Jose/L-8341-2014; Bote, Asier Mañas/S-8856-2017	Alegre, Luis M./0000-0002-4502-9275; Rodríguez-Gómez, Irene/0000-0002-1622-7109; Garcia-Garcia, Francisco Jose/0000-0003-3690-6069; Chastin, Sebastien/0000-0003-1421-9348; Losa-Reyna, Jose/0000-0001-9545-5654; Bote, Asier Mañas/0000-0002-1683-1365; Ara Royo, Ignacio/0000-0002-2854-6684	Biomedical Research Networking Center on Frailty and Healthy Aging (CIBERFES); FEDER funds from the European Union [CB16/10/00477, CB16/10/00456]; Government of Castilla-La Mancha (Institute of Health Sciences, Ministry of Health of Castilla-La Mancha) [PI2010/020, 03031-00]; Spanish Government (Spanish Ministry of Economy, "Ministerio de Economia y Competitividad," Instituto de Salud Carlos III) [PI10/01532, PI031558, PI11/01068]; European Grants (Seventh Framework Programme: FRAILOMIC); Universidad de Castilla-La Mancha [2014/10340, 2015/4062]	Biomedical Research Networking Center on Frailty and Healthy Aging (CIBERFES); FEDER funds from the European Union(European Commission); Government of Castilla-La Mancha (Institute of Health Sciences, Ministry of Health of Castilla-La Mancha); Spanish Government (Spanish Ministry of Economy, "Ministerio de Economia y Competitividad," Instituto de Salud Carlos III); European Grants (Seventh Framework Programme: FRAILOMIC); Universidad de Castilla-La Mancha	This work was supported by the Biomedical Research Networking Center on Frailty and Healthy Aging (CIBERFES) and FEDER funds from the European Union (CB16/10/00477) and (CB16/10/00456). It was further funded by grants from the Government of Castilla-La Mancha (PI2010/020; Institute of Health Sciences, Ministry of Health of Castilla-La Mancha, 03031-00), Spanish Government (Spanish Ministry of Economy, "Ministerio de Economia y Competitividad," Instituto de Salud Carlos III, PI10/01532, PI031558, PI11/01068), and by European Grants (Seventh Framework Programme: FRAILOMIC). Irene Rodriguez Gomez and Asier Manas Bote received a PhD grant from the Universidad de Castilla-La Mancha "Contratos predoctorales para la formacion de personal investigador en el marco del Plan Propio de I+D+i, cofinanciados por el Fondo Social Europeo" (2014/10340 and 2015/4062, respectively).	Aguilar-Farias N, 2014, J SCI MED SPORT, V17, P293, DOI 10.1016/j.jsams.2013.07.002; Ahlborg HG, 2010, BMC MUSCULOSKEL DIS, V11, P1; Allison SJ, 2013, BONE, V53, P321, DOI 10.1016/j.bone.2012.12.045; Martinez-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043134; Babatunde OO, 2012, OSTEOPOROSIS INT, V23, P109, DOI 10.1007/s00198-011-1801-0; Bartl R., 2009, OSTEOPOROSIS DIAGNOS, Vsecond; BASSEY EJ, 1995, BONE, V16, P469; Beck TJ, 2011, MED SCI SPORT EXER, V43, P80, DOI 10.1249/MSS.0b013e3181e57bab; Braun SI, 2017, J AGING PHYS ACTIV, V25, P173, DOI 10.1123/japa.2016-0046; Carcaillon L, 2012, J CLIN ENDOCR METAB, V97, P2898, DOI 10.1210/jc.2012-1271; Carson V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4852-0; Carson V, 2016, APPL PHYSIOL NUTR ME, V41, pS294, DOI 10.1139/apnm-2016-0026; Cauley JA, 2013, J GERONTOL A-BIOL, V68, P1243, DOI 10.1093/gerona/glt093; Chastin SFM, 2014, BONE, V64, P254, DOI 10.1016/j.bone.2014.04.009; Chastin SFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139984; Colley Rachel, 2010, Health Rep, V21, P63; de Deportes CS., ENCUESTA HABITOS DEP; Espallargues M, 2001, OSTEOPOROSIS INT, V12, P811, DOI 10.1007/s001980170031; Fuzeki E, 2017, SPORTS MED, P1; Gaba A, 2012, ARCH GERONTOL GERIAT, V54, pE315, DOI 10.1016/j.archger.2012.02.001; Garcia-Garcia FJ, 2011, J NUTR HEALTH AGING, V15, P852, DOI 10.1007/s12603-011-0075-8; Garry P., 1999, NUTR CLIN CARE, V2, P146, DOI DOI 10.1046/j.1523-5408.1999.00108.x; Gerdhem P, 2003, OSTEOPOROSIS INT, V14, P208, DOI 10.1007/s00198-002-1362-3; Giangregorio LM, 2014, OSTEOPOROSIS INT, V25, P821, DOI 10.1007/s00198-013-2523-2; Hannam K, 2017, OSTEOPOROSIS INT, V28, P2813, DOI 10.1007/s00198-016-3863-5; Hannam K, 2017, OSTEOPOROSIS INT, V28, P1001, DOI 10.1007/s00198-016-3810-5; Hartley A, 2017, J GERONTOLOGY A; Health UDo Services H., 2004, BON HLTH OST REP SUR, P87; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Johansson J, 2015, BONE, V81, P72, DOI 10.1016/j.bone.2015.07.001; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Kauppi M., 2015, DETERMINANTS BONE ST; Kemmler W, 2015, OSTEOPOROSIS INT, V26, P2491, DOI 10.1007/s00198-015-3165-3; Kemmler W, 2013, OSTEOPOROSIS INT, V24, P1937, DOI 10.1007/s00198-012-2248-7; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Korpelainen R, 2006, OSTEOPOROSIS INT, V17, P109, DOI 10.1007/s00198-005-1924-2; Langsetmo L, 2012, BONE, V50, P401, DOI 10.1016/j.bone.2011.11.009; Manas A, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.11.003; Manas A, 2017, EUR J SPORT SCI, V17, P940, DOI 10.1080/17461391.2017.1327983; Marks R, 2010, INT J GEN MED, V3, P1, DOI 10.2147/IJGM.S5906; Martyn-St James M, 2006, OSTEOPOROSIS INT, V17, P1225, DOI 10.1007/s00198-006-0083-4; Martyn-St James M, 2008, BRIT J SPORTS MED; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; McMillan LB, 2017, PRESCRIBING PHYS ACT; Morseth B, 2011, NORSK EPIDEMIOLOGI, V20; Multanen J, 2017, OSTEOPOROSIS INT, V28, P1323, DOI 10.1007/s00198-016-3875-1; Noel SE, 2017, J BONE MINERAL RES; Nokes NR, 2012, AM J HEALTH PROMOT, V26, P341, DOI 10.4278/ajhp.100622-QUAN-208; Pedisic Z, 2014, KINESIOLOGY, V46, P135; Ratzlaff CR, 2010, ARTHRIT CARE RES, V62, P1452, DOI 10.1002/acr.20243; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Rizzoli R, 2014, OSTEOPOROSIS INT, V25, P2507, DOI 10.1007/s00198-014-2755-9; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Zhao R, 2015, OSTEOPOROSIS INT, V26, P1605, DOI 10.1007/s00198-015-3034-0; Zhao RQ, 2014, SPORTS MED, V44, P1393, DOI 10.1007/s40279-014-0220-8	55	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0206013	10.1371/journal.pone.0206013	http://dx.doi.org/10.1371/journal.pone.0206013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX7HS	30346973	Green Published, Green Submitted, gold			2022-12-26	WOS:000447938400032
J	Erdem, G; Singh, AK; Brusnahan, AJ; Moore, AN; Barson, WJ; Leber, A; Vidal, JE; Atici, S; King, SJ				Erdem, Guliz; Singh, Anirudh K.; Brusnahan, Anthony J.; Moore, Amber N.; Barson, William J.; Leber, Amy; Vidal, Jorge E.; Atici, Serkan; King, Samantha J.			Pneumococcal colonization among tracheostomy tube dependent children	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; UNITED-STATES; SEROTYPE 35B; DISEASE; RISK	Streptococcus pneumoniae colonization is a precursor to pneumococcal disease. Although children with a tracheostomy have an increased risk of pneumococcal pneumonia, the pneumococci colonizing their lower airways remain largely uncharacterized. We sought to compare lower respiratory tract isolates colonizing tracheostomy patients and a convenience sample of isolates from individuals intubated for acute conditions. We collected pneumococcal isolates from the lower respiratory tract of 27 patients with a tracheostomy and 42 patients intubated for acute conditions. We compared the penicillin susceptibility, rates of co-colonization, genetic background, and serotype of isolates colonizing these patient populations. Isolates from both groups showed high genetic diversity. Forty multi-locus sequence types and 20 serotypes were identified. There was no significant difference in serotype distribution, co-colonization rates, vaccine coverage, or non-susceptibility to penicillin among pneumococcal isolates from the two groups. Colonization of the lower airways with non-vaccine serotypes 15B/C, 23B and 35B was noted for the first time in patients with tracheostomies and supports recently observed increases in nasopharyngeal colonization and disease due to these serotypes.	[Erdem, Guliz; Barson, William J.; King, Samantha J.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Erdem, Guliz; Barson, William J.; King, Samantha J.] Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Singh, Anirudh K.; Brusnahan, Anthony J.; Moore, Amber N.; King, Samantha J.] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Leber, Amy] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH USA; [Vidal, Jorge E.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Atici, Serkan] Marmara Univ, Dept Pediat, Sch Med, Istanbul, Turkey	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Emory University; Rollins School Public Health; Marmara University	Erdem, G; King, SJ (corresponding author), Ohio State Univ, Coll Med, Columbus, OH 43210 USA.; Erdem, G; King, SJ (corresponding author), Nationwide Childrens Hosp, Columbus, OH 43205 USA.; King, SJ (corresponding author), Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA.	guliz.erdem@nationwidechildrens.org; samantha.king@nationwidechildrens.org	Atici, Serkan/ABB-8427-2020; king, samantha/AAS-4813-2021	Atici, Serkan/0000-0002-3329-1866; Moore, Amber/0000-0003-4550-7043	Infectious Disease Consortium award from Nationwide Children's Hospital	Infectious Disease Consortium award from Nationwide Children's Hospital	This study was supported by an Infectious Disease Consortium award from Nationwide Children's Hospital to G.E. and S.J.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Nationwide Children's Hospital.	Adler A, 2012, J CLIN MICROBIOL, V50, P3368, DOI 10.1128/JCM.00763-12; BROOK I, 1979, CHEST, V76, P420, DOI 10.1378/chest.76.4.420; BURMAN LA, 1985, REV INFECT DIS, V7, P133; Chochua S, 2017, EMERG INFECT DIS, V23, P922, DOI 10.3201/eid2306.170071; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Hathaway LJ, 2004, J BACTERIOL, V186, P3721, DOI 10.1128/JB.186.12.3721-3729.2004; Institute CaLS, 2014, PERF STAND ANT SUSC; Kaur R, 2016, PEDIATR INFECT DIS J, V35, P901, DOI 10.1097/INF.0000000000001206; Lee GM, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0001; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Menezes APD, 2013, J CLIN MICROBIOL, V51, P2470, DOI 10.1128/JCM.00743-13; O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833; Olarte L, 2017, J CLIN MICROBIOL, V55, P724, DOI 10.1128/JCM.01778-16; Park IH, 2012, MBIO, V3, DOI 10.1128/mBio.00035-12; van Hoek AJ, 2012, J INFECTION, V65, P17, DOI 10.1016/j.jinf.2012.02.017; Weinberger R, 2018, VACCINE, V36, P572, DOI 10.1016/j.vaccine.2017.11.085; Whatmore AM, 1999, J BACTERIOL, V181, P3144, DOI 10.1128/JB.181.10.3144-3154.1999	18	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0206305	10.1371/journal.pone.0206305	http://dx.doi.org/10.1371/journal.pone.0206305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339709	Green Submitted, Green Published, gold			2022-12-26	WOS:000447761400044
J	Kato, K; Ishida, S; Tanaka, M; Mitsuyama, E; Xiao, JZ; Odamaki, T				Kato, Kumiko; Ishida, Sachiko; Tanaka, Masami; Mitsuyama, Eri; Xiao, Jin-zhong; Odamaki, Toshitaka			Association between functional lactase variants and a high abundance of Bifidobacterium in the gut of healthy Japanese people	PLOS ONE			English	Article							MICROBIOTA COMPOSITION; PROBIOTICS; DIET	Previous studies have shown that Japanese people exhibit a higher abundance of Bifidobacterium compared to people from other countries. Among the possible factors affecting the gut microbiota composition, an association of functional lactase gene variants with a higher abundance of Bifidobacterium in the gut has been proposed in some reports. However, no Japanese subjects were included in these studies. In this study, we investigated the possible contribution of functional lactase loci to the high abundance of Bifidobacterium in Japanese populations. Based on a data analysis assessing 1,068 healthy Japanese adults, a number of subjects is at least seven times greater than that reported in available online data. all subjects possessed CC genotype at rs4988235 and the GG at rs182549, which are associated with low lactase activity. We observed a positive correlation between dairy product intake and Bifidobacterium abundance in the gut. Considering previous reports, which revealed that four additional functional lactase loci, rs145946881, rs41380347, rs41525747 and rs869051967 (ss820486563), are also associated with low lactase activity in Japanese people, our findings imply the possible contribution of host genetic variation-associated low lactase activity to the high abundance of Bifidobacterium in the Japanese population.	[Kato, Kumiko; Mitsuyama, Eri; Xiao, Jin-zhong; Odamaki, Toshitaka] Morinaga Milk Ind Co LTD, Next Generat Sci Inst, Zama, Kanagawa, Japan; [Ishida, Sachiko] DeNA Life Sci Inc, Next Generat Sci Inst, Business Planning Grp, Tokyo, Japan; [Tanaka, Masami] DeNA Life Sci Inc, R&D Grp, Tokyo, Japan	Morinaga Milk Industry Company, Ltd	Kato, K (corresponding author), Morinaga Milk Ind Co LTD, Next Generat Sci Inst, Zama, Kanagawa, Japan.	ku-katou@morinagamilk.co.jp		Ishida, Sachiko/0000-0001-6463-3059	Morinaga Milk Industry Co., LTD.; DeNA Life Science, Inc.; ME-BYO industry in FY2016	Morinaga Milk Industry Co., LTD.; DeNA Life Science, Inc.; ME-BYO industry in FY2016	Our work was funded by Morinaga Milk Industry Co., LTD., DeNA Life Science, Inc., and the Kanagawa Prefecture's model project related to the creation of ME-BYO industry in FY2016. Employees of Morinaga Milk Industry Co., LTD., KK, EM, JX and TO, and those of DeNA Life Science, Inc., SI and MT, were received salary from each company. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; de Vrese M, 2001, AM J CLIN NUTR, V73, p421S, DOI 10.1093/ajcn/73.2.421s; Di Gioia D, 2014, APPL MICROBIOL BIOT, V98, P563, DOI 10.1007/s00253-013-5405-9; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Hisada T, 2015, ARCH MICROBIOL, V197, P919, DOI 10.1007/s00203-015-1125-0; Hosomi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04511-0; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Itan Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-36; Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Liebert A, 2017, HUM GENET, V136, P1445, DOI 10.1007/s00439-017-1847-y; Logan AC, 2005, MED HYPOTHESES, V64, P533, DOI 10.1016/j.mehy.2004.08.019; Mackenzie BW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00130; Mattar R, 2012, CLIN EXP GASTROENTER, V5, P113, DOI 10.2147/CEG.S32368; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Nishijima S, 2016, DNA RES, V23, P125, DOI 10.1093/dnares/dsw002; Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rideout JR, 2014, PEERJ, V2, DOI 10.7717/peerj.545; Rothschild D, 2017, BIORXIV, DOI [10.1101/150540, DOI 10.1101/150540]; Salamon D, 2018, POL ARCH INTERN MED, V128, P336, DOI 10.20452/pamw.4246; Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020; Tandon D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195643; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; World Economic Forum, 2018, GLOBAL COMPETITIVENE	33	27	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0206189	10.1371/journal.pone.0206189	http://dx.doi.org/10.1371/journal.pone.0206189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339693	Green Published, Green Submitted, gold			2022-12-26	WOS:000447761400043
J	Lanoue, J; Leonardos, ED; Khosla, S; Hao, XM; Grodzinski, B				Lanoue, Jason; Leonardos, Evangelos D.; Khosla, Shalin; Hao, Xiuming; Grodzinski, Bernard			Effect of elevated CO2 and spectral quality on whole plant gas exchange patterns in tomatoes	PLOS ONE			English	Article							LONG-TERM EXPOSURE; BLUE-LIGHT; CARBON-DIOXIDE; CHLOROPHYLL CONTENT; ATMOSPHERIC CO2; WATER-USE; PHOTOSYNTHESIS; GROWTH; ENRICHMENT; RESPIRATION	In controlled environment plant production facilities, elevating either light or CO2 levels generally has led to increased biomass and yield due to enhanced canopy photosynthesis. Today, advancements in light-emitting diodes (LEDs) have made this technology a viable option for both supplementary lighting in greenhouses and a sole lighting source in controlled environment chambers. Our study used tomato plants grown under both ambient CO2 (AC) and elevated CO2 (EC) conditions then exposed them to various CO2 and lighting treatments during both whole plant and leaf level measurements. Plants grown under EC reached the first flower developmental stage 8 days sooner and were approximately 15 cm taller than those grown under AC. However, under AC plants had more leaf area while their dry weights were similar. Of note, under EC chlorophyll a and b were lower, as were carotenoids per unit leaf area. Whole plant analyses, under all CO2 challenges, showed that plants exposed to high-pressure sodium (HPS), red-blue LED, and red-white LED had similar photosynthesis, respiration, and daily carbon gain. Under different light qualities, day-time transpiration rates were similar among CO2 conditions. Day-time water-use efficiency (WUE) was higher in plants grown and exposed to EC. Similarly, WUE of plants grown under AC but exposed to short-term elevated CO2 conditions was higher than those grown and tested under AC during all light treatments. Under all CO2 conditions, plants exposed to red-white and red-blue LEDs had lower WUE than those exposed to HPS lighting. Assessing alterations due to CO2 and light quality on a whole plant basis, not merely on an individual leaf basis, furthers our understanding of the interactions between these two parameters during controlled environment production. Principle component analyses of both whole plant and leaf data indicates that increasing CO2 supply has a more dramatic effect on photosynthesis and WUE than on transpiration.	[Lanoue, Jason; Leonardos, Evangelos D.; Grodzinski, Bernard] Univ Guelph, Dept Plant Agr, Guelph, ON, Canada; [Lanoue, Jason; Hao, Xiuming] Agr & Agri Food Canada, Harrow Res & Dev Ctr, Harrow, ON, Canada; [Khosla, Shalin] Ontario Minist Agr Food & Rural Affairs, Harrow, ON, Canada	University of Guelph; Agriculture & Agri Food Canada	Lanoue, J (corresponding author), Univ Guelph, Dept Plant Agr, Guelph, ON, Canada.; Lanoue, J (corresponding author), Agr & Agri Food Canada, Harrow Res & Dev Ctr, Harrow, ON, Canada.	jlanoue@uoguelph.ca	Lanoue, Jason/AAF-3363-2020	Lanoue, Jason/0000-0002-8935-5718	National Science and Engineering Research Council of Canada; Lighting Science Group Company; Ontario Greenhouse Vegetable Growers; University of Guelph; Agriculture and Agri-foods Canada; Ontario Government; United States Department of Agriculture (USDA-NIFA)	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Lighting Science Group Company; Ontario Greenhouse Vegetable Growers; University of Guelph; Agriculture and Agri-foods Canada(Agriculture & Agri Food Canada); Ontario Government; United States Department of Agriculture (USDA-NIFA)	Funding for the project was provided to Dr. Bernard Grodzinski in part by National Science and Engineering Research Council of Canada, Lighting Science Group Company, Ontario Greenhouse Vegetable Growers, and the University of Guelph. Scholarships were provided to Jason Lanoue by Agriculture and Agri-foods Canada (Research Affiliate Program), the University of Guelph (Vitamin Scholarship and Ontario Graduate Scholarship), the Ontario Government (Ontario Graduate Scholarship), and the United States Department of Agriculture (USDA-NIFA travel grant).	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Ainsworth EA, 2014, NEW PHYTOL, V165, P351; Alloway Brian J., 2008, P1, DOI 10.1007/978-1-4020-6860-7_1; ASSMANN SM, 1985, NATURE, V318, P285, DOI 10.1038/318285a0; AZCONBIETO J, 1983, PLANT PHYSIOL, V71, P574, DOI 10.1104/pp.71.3.574; BESFORD RT, 1993, VEGETATIO, V104, P441, DOI 10.1007/BF00048173; Booth BBB, 2017, J CLIMATE, V30, P3039, DOI [10.1175/jcli-d-16-0178.1, 10.1175/JCLI-D-16-0178.1]; BOWES G, 1991, PLANT CELL ENVIRON, V14, P795, DOI 10.1111/j.1365-3040.1991.tb01443.x; Bugbee B., 2017, LIGHT EMITTING DIODE; CAVE G, 1981, PHYSIOL PLANTARUM, V51, P171, DOI 10.1111/j.1399-3054.1981.tb02694.x; Daloso DM, 2016, NEW PHYTOL, V211, P809, DOI 10.1111/nph.13950; DAVIS SD, 1978, CROP SCI, V18, P280, DOI 10.2135/cropsci1978.0011183X001800020021x; De Vries FWTP., 1982, PHASES DEV MODELS; DELUCIA EH, 1985, PHOTOSYNTH RES, V7, P175, DOI 10.1007/BF00037008; Dodd AN, 2004, NEW PHYTOL, V162, P63, DOI 10.1111/j.1469-8137.2004.01005.x; DUTTON RG, 1988, PLANT PHYSIOL, V86, P355, DOI 10.1104/pp.86.2.355; EVANS G. C, 1961, NEW PHYTOL, V60, P150, DOI 10.1111/j.1469-8137.1961.tb06249.x; Evans JR, 2014, FUNCT PLANT BIOL, V41, P223, DOI 10.1071/FP10900; Goldschmidt EE, 1922, PLANT PHYSIOL, V99, P1443; Gomez C, 2015, HORTSCIENCE, V50, P112, DOI 10.21273/HORTSCI.50.1.112; GRODZINSKI B, 1992, BIOSCIENCE, V42, P517, DOI 10.2307/1311882; HICKLENTON PR, 1978, CAN J PLANT SCI, V58, P801, DOI 10.4141/cjps78-119; HO LC, 1977, ANN APPL BIOL, V87, P191, DOI 10.1111/j.1744-7348.1977.tb01875.x; HURD RG, 1968, ANN BOT-LONDON, V32, P531, DOI 10.1093/oxfordjournals.aob.a084227; Kim HaeRan, 2010, Advances in Bio Research, V1, P46; KIMBALL BA, 1979, J AM SOC HORTIC SCI, V104, P515; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; KRAMER PJ, 1981, BIOSCIENCE, V31, P29, DOI 10.2307/1308175; Kumar KGS, 2016, ACTA HORTIC, V1134, P111, DOI 10.17660/ActaHortic.2016.1134.15; LANGE OL, 1971, PLANTA, V100, P76, DOI 10.1007/BF00386887; Lanoue J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01076; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Leonardos ED, 2014, ENVIRON EXP BOT, V107, P84, DOI 10.1016/j.envexpbot.2014.05.007; Liu XiaoYing, 2012, African Journal of Biotechnology, V11, P6169; Madsen E., 1976, THESIS, P75; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Medrano H, 2015, CROP J, V3, P220, DOI 10.1016/j.cj.2015.04.002; MICALLEF BJ, 1995, PLANTA, V196, P327, DOI 10.1007/BF00201392; MORISON JIL, 1984, AUST J PLANT PHYSIOL, V11, P361, DOI 10.1071/PP9840361; MORTENSEN LM, 1987, SCI HORTIC-AMSTERDAM, V33, P1, DOI 10.1016/0304-4238(87)90028-8; Mulholland BJ, 1997, J EXP BOT, V48, P1853, DOI 10.1093/jexbot/48.315.1853; NAKAMURA S, 1994, APPL PHYS LETT, V64, P1687, DOI 10.1063/1.111832; NeSmith D. S., 1998, HortTechnology, V8, P495; Poorter H, 1997, PLANT CELL ENVIRON, V20, P472, DOI 10.1046/j.1365-3040.1997.d01-84.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pregitzer KS, 2008, NEW PHYTOL, V180, P153, DOI 10.1111/j.1469-8137.2008.02564.x; Reinert RA, 1997, NEW PHYTOL, V137, P411, DOI 10.1046/j.1469-8137.1997.00846.x; ROGERS HH, 1992, PLANT CELL ENVIRON, V15, P749, DOI 10.1111/j.1365-3040.1992.tb01018.x; Runkle ES, 2001, J AM SOC HORTIC SCI, V126, P275, DOI 10.21273/JASHS.126.3.275; SHARKEY TD, 1981, PLANT PHYSIOL, V68, P33, DOI 10.1104/pp.68.1.33; Singh D, 2015, RENEW SUST ENERG REV, V49, P139, DOI 10.1016/j.rser.2015.04.117; Springer CJ, 2007, NEW PHYTOL, V176, P243, DOI 10.1111/j.1469-8137.2007.02196.x; STITT M, 1991, PLANT CELL ENVIRON, V14, P741, DOI 10.1111/j.1365-3040.1991.tb01440.x; STITT M, 1986, PLANT PHYSIOL, V81, P1115, DOI 10.1104/pp.81.4.1115; Swann ALS, 2016, P NATL ACAD SCI USA, V113, P10019, DOI 10.1073/pnas.1604581113; Tazoe Y, 2009, J EXP BOT, V60, P2291, DOI 10.1093/jxb/erp035; Tepperman JM, 2004, PLANT J, V38, P725, DOI 10.1111/j.1365-313X.2004.02084.x; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467; Tremblay N, 1998, HORTTECHNOLOGY, V8; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Whitehead D, 2004, GLOBAL CHANGE BIOL, V10, P925, DOI 10.1111/j.1529-8817.2003.00739.x; Winder TL, 1998, PLANT CELL PHYSIOL, V39, P813, DOI 10.1093/oxfordjournals.pcp.a029439; Wittwer SH, 1966, ACTA HORTIC, V4, P129; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; WOODWARD FI, 1995, NEW PHYTOL, V131, P311, DOI 10.1111/j.1469-8137.1995.tb03067.x; Xu ZZ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00701; YELLE S, 1989, PLANT PHYSIOL, V90, P1465, DOI 10.1104/pp.90.4.1465; YELLE S, 1990, J AM SOC HORTIC SCI, V115, P52, DOI 10.21273/JASHS.115.1.52	69	20	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205861	10.1371/journal.pone.0205861	http://dx.doi.org/10.1371/journal.pone.0205861			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335803	Green Published, gold, Green Submitted			2022-12-26	WOS:000447701300065
J	Ohara, Y; Hara, T; Orias, AAE; Tani, S; Inoue, N; Mizuno, J				Ohara, Yukoh; Hara, Takeshi; Orias, Alejandro A. Espinoza; Tani, Satoshi; Inoue, Nozomu; Mizuno, Junichi			In vitro biomechanical evaluation of a monocoque plate-spacer construct for cervical open-door laminoplasty	PLOS ONE			English	Article							SPINOUS PROCESSES; TECHNICAL NOTE; NECK PAIN; PRESERVATION; MUSCULATURE; MYELOPATHY; HISTORY; CLOSURE; RATES; AREA	Purpose To evaluate biomechanical differences between two surgical procedures for cervical open-door laminoplasty using human cadaveric spines. Methods Twenty-four cervical vertebrae (C4-C6) from eight fresh-frozen human cervical spines were subjected to mechanical testing after being instrumented for open-door laminoplasty using a newly designed plate-spacer device with a monocoque structure (plate-spacer group; n = 12) or by conventional miniplate-alone fixation (miniplate group; n = 12). Cantilever bending testing was performed by applying a compressive load in the cranio-caudal direction to the base of the spinous process of the reconstructed laminar arch constructs until failure and strength and stiffness of the laminar arch were determined. The results are presented as mean +/- standard deviation. Results The plate-spacer group was approximately twice as strong as the miniplate group (27.6 +/- 16.5 N vs. 13.5 +/- 7.3 N, p < 0.05). Stiffness in the plate-spacer group exhibited the same trend (19.6 +/- 9.3 N/mm vs. miniplate group: 11.4 +/- 6.9 N/mm, p < 0.05). Conclusion The fixation with the monocoque plate-spacer construct for open-door laminoplasty provided higher structural properties when compared against the plate-alone fixation. The spacer in the plate-spacer construct appears to contribute by preventing large deformations of the laminar arch caused by bending in cranio-caudal direction. Future studies will be required to investigate stress/strain distribution in the laminar arch constructs.	[Ohara, Yukoh; Mizuno, Junichi] Shin Yurigaoka Gen Hosp, Ctr Minimally Invas Spinal Surg, Kawasaki, Kanagawa, Japan; [Ohara, Yukoh; Hara, Takeshi] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo, Japan; [Orias, Alejandro A. Espinoza; Inoue, Nozomu] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Tani, Satoshi] Jikei Univ, Sch Med, Dept Neurosurg, Tokyo, Japan	Juntendo University; Rush University; Jikei University	Ohara, Y (corresponding author), Shin Yurigaoka Gen Hosp, Ctr Minimally Invas Spinal Surg, Kawasaki, Kanagawa, Japan.; Ohara, Y (corresponding author), Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo, Japan.	yukoh@juntendo.ac.jp		Ohara, Yukoh/0000-0002-1816-0219	Ammtec Inc. (Tokyo, Japan); Orthopedic Biomechanics Fund at Rush University Medical Center	Ammtec Inc. (Tokyo, Japan); Orthopedic Biomechanics Fund at Rush University Medical Center	This study was supported by research funding from Ammtec Inc. (Tokyo, Japan) and Orthopedic Biomechanics Fund at Rush University Medical Center. Ammtec Inc. provided devices used for the study and costs for the cadaveric specimens, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Chen H, 2017, EUR SPINE J, V26, P1140, DOI 10.1007/s00586-016-4785-9; Deutsch H, 2004, J SPINAL DISORD TECH, V17, P317, DOI 10.1097/01.bsd.0000091070.73042.23; FRANK E, 1994, BRIT J NEUROSURG, V8, P197, DOI 10.3109/02688699409027967; Goto T, 2002, J NEUROSURG, V97, P323, DOI 10.3171/spi.2002.97.3.0323; Harrison DE, 2001, CLIN BIOMECH, V16, P276, DOI 10.1016/S0268-0033(01)00006-7; HIRABAYASHI K, 1983, SPINE, V8, P693, DOI 10.1097/00007632-198310000-00003; Hirano Y, 2018, NEUROSURG CLIN N AM, V29, P107, DOI 10.1016/j.nec.2017.09.019; Jiang JL, 2012, J CLIN NEUROSCI, V19, P804, DOI 10.1016/j.jocn.2011.09.021; Kanemura A, 2008, J NEUROSURG-SPINE, V8, P121, DOI 10.3171/SPI/2008/8/2/121; Kim P, 2007, J NEUROSURG-SPINE, V7, P293, DOI 10.3171/SPI-07/09/293; Kimura A, 2018, SPINE, V43, P10, DOI 10.1097/BRS.0000000000002267; Kurokawa R, 2015, NEUROL MED-CHIR, V55, P529, DOI 10.2176/nmc.ra.2014-0387; Lara-Almunia M, 2017, INT J SPINE SURG, V11, DOI 10.14444/4006; Liu G, 2015, ASIAN SPINE J, V9, P849, DOI 10.4184/asj.2015.9.6.849; Matsumoto M, 2008, J NEUROSURG-SPINE, V9, P530, DOI 10.3171/SPI.2008.4.08176; Matsuoka Hidenori, 2017, Surg Neurol Int, V8, P217, DOI 10.4103/sni.sni_204_17; Nagashima H, 2013, SPINAL SURG, V27, P139; Nasto LA, 2017, J ORTHOP TRAUMATOL, V18, P135, DOI 10.1007/s10195-016-0440-9; OBrien MF, 1996, SPINE, V21, P474, DOI 10.1097/00007632-199602150-00012; Okada M, 2009, SPINE, V34, P1119, DOI 10.1097/BRS.0b013e31819c3b61; Ono A, 2007, J NEUROSURG-SPINE, V7, P230, DOI 10.3171/SPI-07/08/230; Park JH, 2015, J CLIN NEUROSCI, V22, P308, DOI 10.1016/j.jocn.2014.07.018; Rhee JM, 2011, SPINE, V36, P9, DOI 10.1097/BRS.0b013e3181fea49c; Riew K Daniel, 2013, Evid Based Spine Care J, V4, P42, DOI 10.1055/s-0033-1341606; Sakaura H, 2010, SPINE, V35, pE782, DOI 10.1097/BRS.0b013e3181d34614; Shaffrey CI, 1999, J NEUROSURG, V90, P170, DOI 10.3171/spi.1999.90.2.0170; Suk KS, 2007, SPINE, V32, pE656, DOI 10.1097/BRS.0b013e318158c573; Tadepalli Srinivas C, 2011, Iowa Orthop J, V31, P207; Tani S, 2010, NEUROL MED-CHIR, V50, P1132, DOI 10.2176/nmc.50.1132; Tung KL, 2015, J ORTHOP SURG-HONG K, V23, P174, DOI 10.1177/230949901502300211; Yamane K, 2016, EUR SPINE J, V25, P1869, DOI 10.1007/s00586-016-4398-3; Yeh KT, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0049-8	32	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0204147	10.1371/journal.pone.0204147	http://dx.doi.org/10.1371/journal.pone.0204147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335764	gold, Green Published, Green Submitted			2022-12-26	WOS:000447701300007
J	Zwolak, JP; Kalantre, SS; Wu, XY; Ragole, S; Taylor, JM				Zwolak, Justyna P.; Kalantre, Sandesh S.; Wu, Xingyao; Ragole, Stephen; Taylor, Jacob M.			QFlow lite dataset: A machine-learning approach to the charge states in quantum dot experiments	PLOS ONE			English	Article								Background Over the past decade, machine learning techniques have revolutionized how research and science are done, from designing new materials and predicting their properties to data mining and analysis to assisting drug discovery to advancing cybersecurity. Recently, we added to this list by showing how a machine learning algorithm (a so-called learner) combined with an optimization routine can assist experimental efforts in the realm of tuning semiconductor quantum dot (QD) devices. Among other applications, semiconductor quantum dots are a candidate system for building quantum computers. In order to employ QDs, one needs to tune the devices into a desirable configuration suitable for quantum computing. While current experiments adjust the control parameters heuristically, such an approach does not scale with the increasing size of the quantum dot arrays required for even near-term quantum computing demonstrations. Establishing a reliable protocol for tuning QD devices that does not rely on the gross-scale heuristics developed by experimentalists is thus of great importance. Materials and methods To implement the machine learning-based approach, we constructed a dataset of simulated QD device characteristics, such as the conductance and the charge sensor response versus the applied electrostatic gate voltages. The gate voltages are the experimental 'knobs' for tuning the device into useful regimes. Here, we describe the methodology for generating the dataset, as well as its validation in training convolutional neural networks. Results and discussion From 200 training sets sampled randomly from the full dataset, we show that the learner's accuracy in recognizing the state of a device is 96.5% when using either current-based or charge-sensor-based training. The spread in accuracy over our 200 training sets is 0.5% and 1.8% for current- and charge-sensor-based data, respectively. In addition, we also introduce a tool that enables other researchers to use this approach for further research: QFlow lite a Python-based mini-software suite that uses the dataset to train neural networks to recognize the state of a device and differentiate between states in experimental data. This work gives the definitive reference for the new dataset that will help enable researchers to use it in their experiments or to develop new machine learning approaches and concepts.	[Zwolak, Justyna P.; Kalantre, Sandesh S.; Wu, Xingyao; Ragole, Stephen; Taylor, Jacob M.] Univ Maryland, Joint Ctr Quantum Informat & Comp Sci, College Pk, MD 20742 USA; [Zwolak, Justyna P.; Kalantre, Sandesh S.; Taylor, Jacob M.] NIST, Gaithersburg, MD 20899 USA; [Kalantre, Sandesh S.] Indian Inst Technol, Dept Phys, Bombay 400076, Maharashtra, India; [Wu, Xingyao; Ragole, Stephen; Taylor, Jacob M.] Univ Maryland, Joint Quantum Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University System of Maryland; University of Maryland College Park	Zwolak, JP (corresponding author), Univ Maryland, Joint Ctr Quantum Informat & Comp Sci, College Pk, MD 20742 USA.; Zwolak, JP (corresponding author), NIST, Gaithersburg, MD 20899 USA.	jpzwolak@gmail.com	Zwolak, Justyna P/E-8457-2011	Zwolak, Justyna P/0000-0002-2286-3208; Kalantre, Sandesh/0000-0002-3086-3769	S. N. Bose Fellowship; National Science Foundation Physics Frontier Center at the Joint Quantum Institute; Army Research Laboratory	S. N. Bose Fellowship; National Science Foundation Physics Frontier Center at the Joint Quantum Institute; Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL))	SSK acknowledges financial support from the S. N. Bose Fellowship. We acknowledge funding from the National Science Foundation Physics Frontier Center at the Joint Quantum Institute and the Army Research Laboratory funded Center for Distributed Quantum Information.	Ashoori RC, 1996, NATURE, V379, P413, DOI 10.1038/379413a0; Baart TA, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4952624; Bernien H, 2017, NATURE, V551, P579, DOI 10.1038/nature24622; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Botzem T, 2018, TUNING METHODS SEMIC; Brown KR, 2016, NPJ QUANTUM INFORM, V2, DOI 10.1038/npjqi.2016.34; Chinchor N., 1992, MUC4 92; Deep Blue, 2011, IBMS 100 IC PROGR, DOI [10.1038/529445a, DOI 10.1038/529445A]; Denker John S, 1989, ADV NEURAL INFORM PR, P323; Ekanadham C., 2018, NETFLIX TECHNOLOGY B; Gambetta JM, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-016-0004-0; Gibney E, 2016, NATURE, V529, P445, DOI 10.1038/529445a; Griffiths D. J., 1999, INTRO ELECTRODYNAMIC; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Jochem T., 1995, Proceedings of the Intelligent Vehicles '95. Symposium (Cat. No.95TH8132), P107, DOI 10.1109/IVS.1995.528266; Johnson A. S., 2005, THESIS; Jones E., 2001, SCIPY OPEN SOURCE SC; Kalantre SS, 2017, MACHINE LEARNING TEC; Karzig T, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.235305; Kingma D. P., 2015, P INT C LEARN REPR, P1; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Lekitsch B, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601540; Levy S., 2018, WIRED; Li RY, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar3960; Liu YY, 2015, SCIENCE, V347, P285, DOI 10.1126/science.aaa2501; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Lundqvist S., 1983, THEORY INHOMOGENEOUS; Manouchehri K, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/6/065304; Melnikov AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34226; Montgomery M., 2016, FORBES; Muller T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03251-7; Mukhopadhyay U, 2018, APPL PHYS LETT, V112, DOI 10.1063/1.5025928; National Institute of Standards and Technology, 2018, QUANT DOT DAT MACH L; Neill C, 2018, SCIENCE, V360, P195, DOI 10.1126/science.aao4309; Nielsen M. A., 2011, QUANTUM COMPUTATION, DOI DOI 10.1017/CBO9780511976667; OHare R., 2017, IMPERIAL COLL LONDON; Oliphant T.E., 2006, A GUIDE TO NUMPY, V1; Saffman M, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/20/202001; Sarkar T., 2018, DATA SCI; Sete EA, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON REBOOTING COMPUTING (ICRC); Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Sparkes Andrew, 2010, Autom Exp, V2, P1, DOI 10.1186/1759-4499-2-1; Unitt C, 2005, J OPT B-QUANTUM S O, V7, pS129, DOI 10.1088/1464-4266/7/7/001; van der Wiel WG, 2003, REV MOD PHYS, V75, P1, DOI 10.1103/RevModPhys.75.1; van Diepen CJ, 2018, APPL PHYS LETT, V113, DOI 10.1063/1.5031034; Williams K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1289; Zajac DM, 2016, PHYS REV APPL, V6, DOI 10.1103/PhysRevApplied.6.054013	50	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205844	10.1371/journal.pone.0205844	http://dx.doi.org/10.1371/journal.pone.0205844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332463	Green Published, Green Submitted, gold			2022-12-26	WOS:000447638200072
J	Christodoulou, MD; Battey, NH; Culham, A				Christodoulou, Maria D.; Battey, Nicholas Hugh; Culham, Alastair			Can you make morphometrics work when you know the right answer? Pick and mix approaches for apple identification	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRICS; INTEGRATIVE TAXONOMY; COMPLEX; CLASSIFICATION; REGIONS; BIOLOGY; SURFACE	Morphological classification of living things has challenged science for several centuries and has led to a wide range of objective morphometric approaches in data gathering and analysis. In this paper we explore those methods using apple cultivars, a model biological system in which discrete groups are pre-defined but in which there is a high level of overall morphological similarity. The effectiveness of morphometric techniques in discovering the groups is evaluated using statistical learning tools. No one technique proved optimal in classification on every occasion, linear morphometric techniques slightly out-performing geometric (72.6% accuracy on test set versus 66.7%). The combined use of these techniques with post-hoc knowledge of their individual successes with particular cultivars achieves a notably higher classification accuracy (77.8%). From this we conclude that even with pre-determined discrete categories, a range of approaches is needed where those categories are intrinsically similar to each other, and we raise the question of whether in studies where potentially continuous natural variation is being categorised the level of match between categories is routinely set too high.	[Christodoulou, Maria D.; Culham, Alastair] Univ Reading Whiteknights, Univ Reading Herbarium, Sch Biol Sci, Harborne Bldg, Reading, Berks, England; [Battey, Nicholas Hugh] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Christodoulou, Maria D.] Univ Oxford, Dept Stat, Oxford, England	University of Reading; University of Reading; University of Oxford	Culham, A (corresponding author), Univ Reading Whiteknights, Univ Reading Herbarium, Sch Biol Sci, Harborne Bldg, Reading, Berks, England.	a.culham@reading.ac.uk	Christodoulou, Maria/AAH-4213-2021; Culham, Alastair/AAP-8192-2021	Christodoulou, Maria/0000-0003-0968-2311; Culham, Alastair/0000-0002-7440-0133	 [BBSRC: 1132848]		This work was supported by BBSRC: 1132848 (NHB), https://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Angelova A, 2013, PROC CVPR IEEE, P811, DOI 10.1109/CVPR.2013.110; Bouveyron C, 2014, J CLASSIF, V31, P49, DOI 10.1007/s00357-014-9147-x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Buj I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099833; Christodoulou MD, 2016, QUANTIFICATION OF FR; Clark JY, 2017, P 4 INT S BIOL SHAP, P29, DOI [10.1142/9789813225701_0002, DOI 10.1142/9789813225701_0002]; Clark S, 1983, MANUAL KEY IDENTIFIC; Compton JA, 1997, BOT J LINN SOC, V123, P1, DOI 10.1006/bojl.1996.0070; Corinna C, 1995, MACH LEARN, V20, P1, DOI DOI 10.1007/BF00994018; Corney DPA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042112; Corney DPA, 2012, TAXON, V61, P231, DOI 10.1002/tax.611016; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; da Silva FL, 2015, COMPUT ELECTRON AGR, V114, P68, DOI 10.1016/j.compag.2015.03.012; DEFRA, 2018, WHOL FRUIT VEG PRIC, DOI [10.1093/sysbio/syu016, DOI 10.1093/SYSBIO/SYU016]; Guisande C, 2010, FISH RES, V102, P240, DOI 10.1016/j.fishres.2009.12.003; HASTIE T, 1995, ANN STAT, V23, P73, DOI 10.1214/aos/1176324456; Hey J, 2003, TRENDS ECOL EVOL, V18, P597, DOI 10.1016/j.tree.2003.08.014; Hey J, 2006, TRENDS ECOL EVOL, V21, P447, DOI 10.1016/j.tree.2006.05.011; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; John GHG, 1995, P 11 C UNC ART INT, P338, DOI [DOI 10.1109/TGRS.2004.834800, 10.1.1.8. 3257.]; Kampichler C, 2010, ECOL INFORM, V5, P441, DOI 10.1016/j.ecoinf.2010.06.003; Kim SJ, 2006, ELECTRON ENG, V1, P1; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kuhn M., 2014, CARET CLASSIFICATION; Laurito M, 2015, ZOOMORPHOLOGY, V134, P447, DOI 10.1007/s00435-015-0271-x; Lecocq T, 2015, ZOOL SCR, V44, P281, DOI 10.1111/zsc.12107; Linnaeus C., 1957, SPECIES PLANTARUM FA; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; Lycett SJ, 2013, J ARCHAEOL SCI, V40, P1508, DOI 10.1016/j.jas.2012.11.005; Magauer M, 2014, BOT J LINN SOC, V176, P486, DOI 10.1111/boj.12214; Mamos T, 2014, J ZOOL SYST EVOL RES, V52, P237, DOI 10.1111/jzs.12062; Marrama G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188806; McKay BD, 2014, SYST BIOL, V63, P505, DOI 10.1093/sysbio/syu016; Merces MP, 2015, MOL PHYLOGENET EVOL, V82, P426, DOI 10.1016/j.ympev.2014.09.020; Morgan J., 1993, THE BOOK OF APPLES; Nilsback ME, 2008, SIXTH INDIAN CONFERENCE ON COMPUTER VISION, GRAPHICS & IMAGE PROCESSING ICVGIP 2008, P722, DOI 10.1109/ICVGIP.2008.47; Noiton DAM, 1996, J AM SOC HORTIC SCI, V121, P773, DOI 10.21273/JASHS.121.5.773; Ozuysal M, 2010, IEEE T PATTERN ANAL, V32, P448, DOI 10.1109/TPAMI.2009.23; Palmeri TJ, 2004, NAT REV NEUROSCI, V5, P291, DOI 10.1038/nrn1364; Pante E, 2015, SYST BIOL, V64, P152, DOI 10.1093/sysbio/syu083; Poland J., 2009, VEGETATIVE KEY BRIT; Qian G-Z, 1933, TAXON, V59, P3; Quinlan JR, 2015, C5 0 VERSION 2 07; R Core Team, 2021, R LANGUAGE ENV STAT; Rohlf F. J., 2013, TPSDIG 2 17; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2003, SYST BIOL, V52, P66, DOI 10.1080/10635150390132759; Ronikier M, 2014, TAXON, V63, P116, DOI 10.12705/631.4; Sanders R., 2010, THE APPLE BOOK; Santana FS, 2014, ECOL INFORM, V24, P248, DOI 10.1016/j.ecoinf.2013.12.001; Schmidt-Roach S, 2014, ZOOL J LINN SOC-LOND, V170, P1, DOI 10.1111/zoj12092; Sinha P, 2002, NAT NEUROSCI, V5, P1093, DOI 10.1038/nn949; Skoracka A, 2014, BIOL J LINN SOC, V111, P421, DOI 10.1111/bij.12213; Stoyanova DK, 2017, J FORENSIC SCI, V62, P1434, DOI 10.1111/1556-4029.13439; Van Bocxlaer B, 2010, PALEOBIOLOGY, V36, P497, DOI 10.1666/08068.1; Veleminska J, 2013, AM J PHYS ANTHROPOL, V152, P558, DOI 10.1002/ajpa.22373; von Ahn L, 2003, LECT NOTES COMPUT SC, V2656, P294; Werbos P.J., 1974, THESIS HARVARD U CAM; Wilf P, 2016, P NATL ACAD SCI USA, V113, P3305, DOI 10.1073/pnas.1524473113; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342; Zheng L, 2007, PROGR PATTERN RECOGN	66	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205357	10.1371/journal.pone.0205357	http://dx.doi.org/10.1371/journal.pone.0205357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0RD	30321222	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000447417900027
J	Xargay-Torrent, S; Carreras-Badosa, G; Borrat-Padrosa, S; Prats-Puig, A; Soriano, P; Alvarez-Castano, E; Ferris, MJ; De Zegher, F; Ibanez, L; Lopez-Bermejo, A; Bassols, J				Xargay-Torrent, Silvia; Carreras-Badosa, Gemma; Borrat-Padrosa, Sara; Prats-Puig, Anna; Soriano, Pilar; Alvarez-Castano, Elena; Jose Ferris, Ma; De Zegher, Francis; Ibanez, Lourdes; Lopez-Bermejo, Abel; Bassols, Judit			Circulating sex hormone binding globulin: An integrating biomarker for an adverse cardio-metabolic profile in obese pregnant women	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MATERNAL OBESITY; FREE TESTOSTERONE; SERUM ANDROGENS; BIRTH-WEIGHT; YOUNG-ADULTS; RISK-FACTORS; INSULIN; MEN; ASSOCIATION	Sex hormone-binding globulin (SHBG) negatively associates with pre-gestational body mass index (BMI) and gestational weight gain. The link with other cardio-metabolic risk factors in pregnant women is poorly understood. Our aim was to study the association of SHBG levels with common cardio-metabolic risk parameters in pregnant woman. Serum SHBG was quantified in 291 Caucasian pregnant women (142 with normal weight, 42 with pregestational obesity, 50 with gestational obesity and 57 with pregestational plus gestational obesity) with uncomplicated pregnancies and parturition. Cardio-metabolic [C-reactive protein (CRP), blood pressure (BP), glycosylated hemoglobin (HbAc1), glucose, C-peptide, insulin, triglycerides and high molecular weight (HMW) adiponectin], and endocrine [testosterone and estradiol] parameters were also assessed. SHBG was negatively correlated with BMI, but also with CRP, BP, HbAc1, pre and postload glucose, C-peptide, HOMA-IR, triglycerides; and positively with HMW adiponectin (all p<0.01 to p<0.0001). These associations were more robust in women with pregestational plus gestational obesity, who had lower SHBG, in comparison to normal-weight women (p<0.0001). In multivariate analyses in women with pregestational plus gestational obesity SHBG showed independent associations with CRP (beta = -0.352, p = 0.03, R-2 = 8.0%), DBP (beta = -0.353, p = 0.03, R-2 = 7.0%) and SBP (beta = -0.333, p = 0.04, R-2 = 6.0%) independently of BMI and metabolic and endocrine parameters. SHBG is decreased in pregnant women with pregestational plus gestational obesity in association with common cardio-metabolic parameters. SHBG could represent an integrating biomarker for an adverse cardio-metabolic profile in pregnant women with pregestational plus gestational obesity.	[Xargay-Torrent, Silvia; Carreras-Badosa, Gemma; Lopez-Bermejo, Abel] Girona Biomed Res Inst IDIBGI, Obes & Cardiovasc Risk Pediat, Salt, Spain; [Borrat-Padrosa, Sara; Lopez-Bermejo, Abel] Dr Trueta Univ Hosp, Dept Pediat, Girona, Spain; [Prats-Puig, Anna] EUSES Univ Sch, Dept Phys Therapy, Salt, Spain; [Soriano, Pilar] Fundacio Salut Emporda, Clin Lab, Figueres, Spain; [Alvarez-Castano, Elena] Dr Trueta Univ Hosp, Dept Gynecol, Girona, Spain; [Jose Ferris, Ma] Dr Trueta Univ Hosp, Clin Lab, Girona, Spain; [De Zegher, Francis] Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Ibanez, Lourdes] Univ Barcelona, Hosp St Joan de Deu, Endocrinol, Barcelona, Spain; [Ibanez, Lourdes] ISCIII, Ctr Invest Biorned Red Diabet & Enfermedades Meta, Madrid, Spain; [Bassols, Judit] Girona Biomed Res Inst IDIBGI, Maternofetal Metab Reseach, Salt, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); KU Leuven; University of Barcelona; Instituto de Salud Carlos III; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI)	Lopez-Bermejo, A (corresponding author), Girona Biomed Res Inst IDIBGI, Obes & Cardiovasc Risk Pediat, Salt, Spain.; Lopez-Bermejo, A (corresponding author), Dr Trueta Univ Hosp, Dept Pediat, Girona, Spain.; Bassols, J (corresponding author), Girona Biomed Res Inst IDIBGI, Maternofetal Metab Reseach, Salt, Spain.	alopezbermejo@idibgi.org; jbassols@idibgi.org	Ibanez, Lourdes/F-8316-2014; Prats-Puig, Anna/ABE-6969-2020; Prats, Anna/V-4223-2019	Ibanez, Lourdes/0000-0003-4595-7191; Prats-Puig, Anna/0000-0002-5253-3808; FERRI, M JOSE/0000-0002-2885-7175; Bassols, Judit/0000-0001-8821-6655; Carreras-Badosa, Gemma/0000-0003-2100-0221	Ministerio de Ciencia e Innovacion, Institute de Salud Carlos III (littp /Mow es), Madrid, Spain [PI14/01625, PI16/01335]; FEDER (Fondo Europeo de Desarrollo Regional)	Ministerio de Ciencia e Innovacion, Institute de Salud Carlos III (littp /Mow es), Madrid, Spain; FEDER (Fondo Europeo de Desarrollo Regional)(European Commission)	This work was supported by Ministerio de Ciencia e Innovacion, Institute de Salud Carlos III (littp /Mow es), Madrid, Spain (grant numbers PI14/01625 to JB and PI16/01335 to ALB), projects co -funded by FEDER (Fondo Europeo de Desarrollo Regional). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirbasli M, 2009, METABOLISM, V58, P1256, DOI 10.1016/j.metabol.2009.03.024; Alevizaki M, 2008, MENOPAUSE, V15, P461, DOI 10.1097/gme.0b013e31814faf41; Aydin B, 2016, J CLIN RES PEDIATR E, V8, P1, DOI 10.4274/jcrpe.2764; Bartha JL, 2000, ACTA OBSTET GYN SCAN, V79, P839, DOI 10.1034/j.1600-0412.2000.079010839.x; BIRKELAND KI, 1993, J CLIN ENDOCR METAB, V76, P275, DOI 10.1210/jc.76.2.275; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Calderon-Margalit R, 2010, J CLIN ENDOCR METAB, V95, P4424, DOI 10.1210/jc.2009-2643; Canoy D, 2014, EUR J ENDOCRINOL, V170, P863, DOI 10.1530/EJE-13-1046; Carlsen SM, 2006, EUR J ENDOCRINOL, V155, P365, DOI 10.1530/eje.1.02200; Carrascosa A, 2008, Endocrinol Nutr, V55, P484, DOI 10.1016/S1575-0922(08)75845-5; Clegg D, 2017, ENDOCRINOLOGY, V158, P1095, DOI 10.1210/en.2016-1677; Cussons AJ, 2006, ATHEROSCLEROSIS, V185, P227, DOI 10.1016/j.atherosclerosis.2005.10.007; Dharashivkar S, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0158-0; Elmlinger MW, 2002, CLIN CHEM LAB MED, V40, P1151, DOI 10.1515/CCLM.2002.202; Falbo A, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-23; Firtser S, 2012, ATHEROSCLEROSIS, V222, P257, DOI 10.1016/j.atherosclerosis.2012.02.020; Gaillard R, 2015, EUR J EPIDEMIOL, V30, P1141, DOI 10.1007/s10654-015-0085-7; Galloway PJ, 2001, ARCH DIS CHILD, V85, P489, DOI 10.1136/adc.85.6.489; GLASS AR, 1977, J CLIN ENDOCR METAB, V45, P1211, DOI 10.1210/jcem-45-6-1211; GUZICK DS, 1994, FERTIL STERIL, V61, P598; Hammond GL, 2012, CURR OPIN ENDOCRINOL, V19, P183, DOI 10.1097/MED.0b013e328353732f; Hedderson MM, 2014, DIABETES CARE, V37, P1296, DOI 10.2337/dc13-1965; Hu S, 2007, HUM REPROD, V22, P1532, DOI 10.1093/humrep/dem028; Ibanez L, 2011, FERTIL STERIL, V96, P220, DOI 10.1016/j.fertnstert.2011.03.107; Jaspers L, 2016, J CLIN ENDOCR METAB, V101, P2844, DOI 10.1210/jc.2016-1435; Jin Z, 2009, GYNECOL ENDOCRINOL, V25, P647, DOI 10.1080/09513590903015437; Kahn SM, 2002, J ENDOCRINOL, V175, P113, DOI 10.1677/joe.0.1750113; Kopp HP, 2001, EXP CLIN ENDOCR DIAB, V109, P365, DOI 10.1055/s-2001-17408; Mongraw-Chaffin ML, 2015, J CLIN ENDOCR METAB, V100, pE596, DOI 10.1210/jc.2014-2934; Morisset AS, 2011, GYNECOL ENDOCRINOL, V27, P905, DOI 10.3109/09513590.2011.569602; Nicholas LM, 2013, FASEB J, V27, P3786, DOI 10.1096/fj.13-227918; Olson CM, 2008, ANNU REV NUTR, V28, P411, DOI 10.1146/annurev.nutr.28.061807.155322; Palomba S, 2015, HUM REPROD UPDATE, V21, P575, DOI 10.1093/humupd/dmv029; Rexrode KM, 2003, CIRCULATION, V108, P1688, DOI 10.1161/01.CIR.0000091114.36254.F3; Rodriguez-Cuenca S, 2006, MOL CELL ENDOCRINOL, V249, P58, DOI 10.1016/j.mce.2006.01.005; Sendemir A, 2008, GYNECOL ENDOCRINOL, V24, P105, DOI 10.1080/09513590701690274; SIMMONS D, 1995, J CLIN ENDOCR METAB, V80, P2217, DOI 10.1210/jc.80.7.2217; Sir-Petermann T, 2002, HUM REPROD, V17, P2573, DOI 10.1093/humrep/17.10.2573; Skilton MR, 2014, ARTERIOSCL THROM VAS, V34, P1064, DOI 10.1161/ATVBAHA.113.302934; Sun L, 2013, DIABETES RES CLIN PR, V99, P168, DOI 10.1016/j.diabres.2012.05.019; Thadhani R, 2003, AM J OBSTET GYNECOL, V189, P171, DOI 10.1067/mob.2003.343; Vanbillemont G, 2012, CLIN ENDOCRINOL, V76, P111, DOI 10.1111/j.1365-2265.2011.04155.x; Vejrazkova D, 2014, J STEROID BIOCHEM, V139, P122, DOI 10.1016/j.jsbmb.2012.11.007; Veltman-Verhulst SM, 2010, HUM REPROD, V25, P3123, DOI 10.1093/humrep/deq272; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wang Q, 2015, INT J EPIDEMIOL, V44, P623, DOI 10.1093/ije/dyv093; Wuu J, 2002, EUR J CANCER PREV, V11, P283, DOI 10.1097/00008469-200206000-00012	47	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205592	10.1371/journal.pone.0205592	http://dx.doi.org/10.1371/journal.pone.0205592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321217	Green Published, gold, Green Submitted			2022-12-26	WOS:000447417900041
J	Gunupuru, LR; Arunachalam, C; Malla, KB; Kahla, A; Perochon, A; Jia, JG; Thapa, G; Doohan, FM				Gunupuru, Lokanadha R.; Arunachalam, Chanemougasoundharam; Malla, Keshav B.; Kahla, Amal; Perochon, Alexandre; Jia, Jianguang; Thapa, Ganesh; Doohan, Fiona M.			A wheat cytochrome P450 enhances both resistance to deoxynivalenol and grain yield	PLOS ONE			English	Article							FUSARIUM HEAD BLIGHT; MYCOTOXIN DEOXYNIVALENOL; UDP-GLUCOSYLTRANSFERASE; ARABIDOPSIS-THALIANA; TRANSCRIPTOME ANALYSIS; SUSCEPTIBLE WHEAT; TRITICUM-AESTIVUM; GENE-EXPRESSION; GRAMINEARUM; CEREALS	The mycotoxin deoxynivalenol (DON) serves as a plant disease virulence factor for the fungi Fusarium graminearum and F. culmorum during the development of Fusarium head blight (FHB) disease on wheat. A wheat cytochrome P450 gene from the subfamily CYP72A, TaCYP72A, was cloned from wheat cultivar CM82036. TaCYP72A was located on chromosome 3A with homeologs present on 3B and 3D of the wheat genome. Using gene expression studies, we showed that TaCYP72A variants were activated in wheat spikelets as an early response to F. graminearum, and this activation was in response to the mycotoxic Fusarium virulence factor deoxynivalenol (DON). Virus induced gene silencing (VIGS) studies in wheat heads revealed that this gene family contributes to DON resistance. VIGS resulted in more DON-induced discoloration of spikelets, as compared to mock VIGS treatment. In addition to positively affecting DON resistance, TaCYP72A also had a positive effect on grain number. VIGS of TaCYP72A genes reduced grain number by more than 59%. Thus, we provide evidence that TaCYP72A contributes to host resistance to DON and conclude that this gene family warrants further assessment as positive contributors to both biotic stress resistance and grain development in wheat.	[Doohan, Fiona M.] Univ Coll Dublin, Sch Biol & Environm Sci, Sci Ctr East, Dublin 4, Ireland; Univ Coll Dublin, Earth Inst, Sci Ctr East, Dublin 4, Ireland	University College Dublin; University College Dublin	Doohan, FM (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Sci Ctr East, Dublin 4, Ireland.	fiona.doohan@ucd.ie	Thapa, Ganesh/H-6631-2019; Doohan, Fiona M/A-7462-2008	Thapa, Ganesh/0000-0002-4743-6253; Doohan, Fiona/0000-0002-1953-6070; Kahla, Amal/0000-0002-7444-8903	Science Foundation Ireland [10/IN.1/B3028, 14/1A/2508]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	We acknowledge Science Foundation Ireland for providing funding (project nos. 10/IN.1/B3028 and 14/1A/2508).; We acknowledge Science Foundation Ireland for providing funding (project nos. 10/IN.1/B3028 and 14/1A/2508). We thank: Hermann Buerstmayr (IFA-Tulln, Austria) for providing wheat seeds of cvs. CM82036 and Remus; Robert Proctor (USDA) for F. graminearum fungi; Steven R. Scofield (Purdue University, USA) for BSMV VIGS vectors. The authors thank the International Wheat Genome Sequencing Consortium for pre-publication access to IWGSC RefSeq v1.0. The authors declare they have no competing interests.	Ansari KI, 2007, THEOR APPL GENET, V114, P927, DOI 10.1007/s00122-006-0490-0; Bai GH, 1996, PLANT DIS, V80, P975, DOI 10.1094/PD-80-0975; Bak S, 2011, ARABIDOPSIBOOK AM, V9; Boddu J, 2007, MOL PLANT MICROBE IN, V20, P1364, DOI 10.1094/MPMI-20-11-1364; Bottalico A, 2002, EUR J PLANT PATHOL, V108, P611, DOI 10.1023/A:1020635214971; Brennan JM, 2005, PLANT PATHOL, V54, P156, DOI 10.1111/j.1365-3059.2005.01157.x; Buerstmayr H, 2003, THEOR APPL GENET, V107, P503, DOI 10.1007/s00122-003-1272-6; Chetouhi C, 2016, FUNCT INTEGR GENOMIC, V16, P183, DOI 10.1007/s10142-016-0476-1; Gardiner SA, 2010, MOL PLANT MICROBE IN, V23, P962, DOI 10.1094/MPMI-23-7-0962; GUNUPURU L, 2017, TROPICAL PLANT PATHO, P1; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Ito M, 2013, APPL ENVIRON MICROB, V79, P1619, DOI 10.1128/AEM.03227-12; Kluger B, 2013, ANAL BIOANAL CHEM, V405, P5031, DOI 10.1007/s00216-012-6483-8; Kugler KG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-728; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; Li X, 2010, PHYTOPATHOLOGY, V100, P183, DOI 10.1094/PHYTO-100-2-0183; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma LL, 2010, MOL BIOL REP, V37, P785, DOI 10.1007/s11033-009-9606-3; Ma M, 2016, J EXP BOT, V67, P1397, DOI 10.1093/jxb/erv542; Morant M, 2003, CURR OPIN BIOTECH, V14, P151, DOI 10.1016/S0958-1669(03)00024-7; Nicholson P, 2003, EUR J PLANT PATHOL, V109, P691, DOI 10.1023/A:1026026307430; Osborne LE, 2007, INT J FOOD MICROBIOL, V119, P103, DOI 10.1016/j.ijfoodmicro.2007.07.032; Paquette SM, 2000, DNA CELL BIOL, V19, P307, DOI 10.1089/10445490050021221; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Perochon A, 2015, PLANT PHYSIOL, V169, P2895, DOI 10.1104/pp.15.01056; Pestka JJ, 2010, WORLD MYCOTOXIN J, V3, P323, DOI 10.3920/WMJ2010.1247; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Prall W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163024; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Ryan TA., 1976, MINITAB STAT SOFTWAR; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Schuler Mary A., 2006, Phytochemistry Reviews, V5, P205, DOI 10.1007/s11101-006-9035-z; Schweiger W, 2010, MOL PLANT MICROBE IN, V23, P977, DOI 10.1094/MPMI-23-7-0977; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Sobrova Pavlina, 2010, Interdiscip Toxicol, V3, P94, DOI 10.2478/v10102-010-0019-x; Soltanloo H, 2010, PLANT OMICS, V3, P162; Tian YS, 2016, ELECTRON J BIOTECHN, V19, P15, DOI 10.1016/j.ejbt.2015.11.001; Walter S, 2015, J EXPT BOT; Walter S, 2008, FUNCT INTEGR GENOMIC, V8, P421, DOI 10.1007/s10142-008-0089-4; Walter Stephanie, 2011, Mycotoxin Res, V27, P221, DOI 10.1007/s12550-011-0099-2; WEI CM, 1974, MOL CELL BIOCHEM, V3, P215, DOI 10.1007/BF01686646; Xiang Y, 2011, J EXP BOT, V62, P5471, DOI 10.1093/jxb/err226; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	47	36	36	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0204992	10.1371/journal.pone.0204992	http://dx.doi.org/10.1371/journal.pone.0204992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312356	Green Submitted, Green Published, gold			2022-12-26	WOS:000447427300018
J	Kottapalli, J; David-Schwartz, R; Khamaisi, B; Brandsma, D; Lugassi, N; Egbaria, A; Kelly, G; Granot, D				Kottapalli, Jayaram; David-Schwartz, Rakefet; Khamaisi, Belal; Brandsma, Danja; Lugassi, Nitsan; Egbaria, Aiman; Kelly, Gilor; Granot, David			Sucrose-induced stomatal closure is conserved across evolution	PLOS ONE			English	Article							CRASSULACEAN ACID METABOLISM; GUARD-CELL APOPLAST; VICIA-FABA L; ABSCISIC-ACID; PHLOEM TRANSPORT; COMPANION CELLS; CUCURBITA-PEPO; APERTURE SIZE; LAND PLANTS; MESOPHYLL	As plants evolved to function on land, they developed stomata for effective gas exchange, for photosynthesis and for controlling water loss. We have recently shown that sugars, as the end product of photosynthesis, close the stomata of various angiosperm species, to coordinate sugar production with water loss. In the current study, we examined the sugar responses of the stomata of phylogenetically different plant species and species that employ different photosynthetic mechanisms (i.e., C-3, C-4 and CAM). To examine the effect of sucrose on stomata, we treated leaves with sucrose and then measured their stomatal apertures. Sucrose reduced stomatal aperture, as compared to an osmotic control, suggesting that regulation of stomata by sugars is a trait that evolved early in evolutionary history and has been conserved across different groups of plants.	[Kottapalli, Jayaram; David-Schwartz, Rakefet; Khamaisi, Belal; Brandsma, Danja; Lugassi, Nitsan; Egbaria, Aiman; Kelly, Gilor; Granot, David] Agr Res Org, Volcani Ctr, Inst Plant Sci, Rishon Leziyyon, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Granot, D (corresponding author), Agr Res Org, Volcani Ctr, Inst Plant Sci, Rishon Leziyyon, Israel.	granot@agri.gov.il	David-Schwartz, Rakefet/ABI-3825-2020; David-Schwartz, Rakefet/O-7263-2016	David-Schwartz, Rakefet/0000-0001-5923-8636; Granot, David/0000-0002-4047-0272				Aguyoh J, 2010, INT J SCI NAT, V1, P7; ALLAWAY WG, 1973, PLANTA, V110, P63, DOI 10.1007/BF00386923; [Anonymous], 2013, AM J BIOSCI, DOI [10.11648/j.ajbio.20130102.13, DOI 10.11648/J.AJBIO.20130102.13]; Atroosh K. B., 2013, Journal of Agricultural Science (Toronto), V5, P136; Ayre BG, 2003, PLANT PHYSIOL, V131, P1518, DOI 10.1104/pp.012054; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Bates GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049641; BIELESKI RL, 1966, PLANT PHYSIOL, V41, P447, DOI 10.1104/pp.41.3.447; Black CC, 2003, PHOTOSYNTH RES, V76, P329, DOI 10.1023/A:1024978220193; Chen ZH, 2017, TRENDS PLANT SCI, V22, P124, DOI 10.1016/j.tplants.2016.09.005; Cook ME, 1998, INT J PLANT SCI, V159, P881, DOI 10.1086/314082; Cooper D, 1980, POPULUS DELTOIDES BA, P530; Daloso DM, 2016, NEW PHYTOL, V211, P809, DOI 10.1111/nph.13950; Dekkers BJW, 2008, PLANT MOL BIOL, V67, P151, DOI 10.1007/s11103-008-9308-6; Delatte TL, 2011, PLANT PHYSIOL, V157, P160, DOI 10.1104/pp.111.180422; DITTRICH P, 1978, PLANTA, V139, P167, DOI 10.1007/BF00387143; Dogan E, 2008, IRRIGATION SCI, V26, P131, DOI 10.1007/s00271-007-0079-7; Doi M, 2015, PLANT PHYSIOL, V169, P1205, DOI 10.1104/pp.15.00134; Duckett JG, 2009, NEW PHYTOL, V183, P1053, DOI 10.1111/j.1469-8137.2009.02905.x; Ewert MS, 2000, PLANT CELL ENVIRON, V23, P195, DOI 10.1046/j.1365-3040.2000.00539.x; Fandika IR, 2011, AUST J CROP SCI, V5, P742; FISCHER RA, 1968, PLANT PHYSIOL, V43, P1947, DOI 10.1104/pp.43.12.1947; Franks PJ, 2007, PLANT PHYSIOL, V143, P78, DOI 10.1104/pp.106.089367; Gago J, 2016, PLANT PHYSIOL, V171, P265, DOI 10.1104/pp.15.01660; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; GHAMARNIA H, 2015, INT J PLANT SOIL SCI, V4, P535, DOI DOI 10.9734/IJPSS/2015/14098; Grassini P, 2009, AGR FOREST METEOROL, V149, P1254, DOI 10.1016/j.agrformet.2009.02.012; HEATH OVS, 1949, NEW PHYTOL, V48, P186, DOI 10.1111/j.1469-8137.1949.tb05119.x; Hei SM, 2018, FUNCT PLANT BIOL, V45, P509, DOI [10.1071/FP17180, 10.1071/fp17180]; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Kang Y, 2007, J EXP BOT, V58, P4061, DOI 10.1093/jxb/erm262; Kang Y, 2007, PLANT CELL ENVIRON, V30, P551, DOI 10.1111/j.1365-3040.2007.01635.x; Kelly G, 2013, PLANT J, V75, P977, DOI 10.1111/tpj.12258; Knop C, 2004, PLANT PHYSIOL, V134, P204, DOI 10.1104/pp.103.029264; KOCH KE, 1982, PLANT PHYSIOL, V69, P757, DOI 10.1104/pp.69.4.757; Laby RJ, 2000, PLANT J, V23, P587, DOI 10.1046/j.1365-313x.2000.00833.x; LANGE OL, 1971, PLANTA, V100, P76, DOI 10.1007/BF00386887; Lawson T, 2014, NEW PHYTOL, V203, P1064, DOI 10.1111/nph.12945; Lawson T, 2011, PROG BOT, V72, P265, DOI 10.1007/978-3-642-13145-5_11; LEE J, 1992, J EXP BOT, V43, P951, DOI 10.1093/jxb/43.7.951; LEE JS, 1995, AUST J PLANT PHYSIOL, V22, P357, DOI 10.1071/PP9950357; Li Y, 2016, PHYSIOL PLANTARUM, V156, P252, DOI 10.1111/ppl.12353; Ligrone R, 2012, ANN BOT-LONDON, V109, P851, DOI 10.1093/aob/mcs017; Lloyd FE, 1908, WASHINGTON YB, V82, P1; Lu P, 1997, PLANT PHYSIOL, V114, P109, DOI 10.1104/pp.114.1.109; LU P, 1995, FEBS LETT, V362, P180, DOI 10.1016/0014-5793(95)00239-6; Lugassi N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01114; Mahmood K.T., 2010, J PHARM SCI RES, V2, P775, DOI DOI 10.1371/JOURNAL.PONE.0095492; McCourt RM, 2004, TRENDS ECOL EVOL, V19, P661, DOI 10.1016/j.tree.2004.09.013; Medeiros DB, 2018, PLANT J, V94, P583, DOI 10.1111/tpj.13889; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Mott KA, 2014, PLANT CELL ENVIRON, V37, P1184, DOI 10.1111/pce.12226; Mott KA, 2009, PLANT CELL ENVIRON, V32, P1479, DOI 10.1111/j.1365-3040.2009.02022.x; Nyakudya IW, 2011, AGR WATER MANAGE, V98, P1649, DOI 10.1016/j.agwat.2011.06.002; Outlaw WH, 2001, PLANT PHYSIOL, V126, P1716, DOI 10.1104/pp.126.4.1716; PEARSON CJ, 1973, AUST J BIOL SCI, V26, P1035, DOI 10.1071/BI9731035; Pires ND, 2012, PHILOS T R SOC B, V367, P508, DOI 10.1098/rstb.2011.0252; RASCHKE K, 1978, PLANT PHYSIOL, V62, P84, DOI 10.1104/pp.62.1.84; Reidel EJ, 2009, PLANT PHYSIOL, V149, P1601, DOI 10.1104/pp.108.134791; Schittenhelm S, 2014, J AGRON CROP SCI, V200, P46, DOI 10.1111/jac.12039; Schluepmann H, 2004, PLANT PHYSIOL, V135, P879, DOI 10.1104/pp.104.039503; Stadler R, 2003, PLANT PHYSIOL, V133, P528, DOI 10.1104/pp.103.024240; Sussmilch FC, 2017, PLANT SIGNAL BEHAV, V12, DOI 10.1080/15592324.2017.1365210; Talbott LD, 1996, PLANT PHYSIOL, V111, P1051, DOI 10.1104/pp.111.4.1051; TURGEON R, 1975, PLANTA, V123, P53, DOI 10.1007/BF00388060; Turgeon R, 2009, ANNU REV PLANT BIOL, V60, P207, DOI 10.1146/annurev.arplant.043008.092045; VANKIRK CA, 1978, PLANT PHYSIOL, V61, P361, DOI 10.1104/pp.61.3.361; Wang L, 2011, NEW PHYTOL, V190, P9, DOI 10.1111/j.1469-8137.2011.03649.x; Weise A, 2008, PLANT MOL BIOL, V68, P251, DOI 10.1007/s11103-008-9366-9; Wilkinson S, 1998, PLANT PHYSIOL, V117, P703, DOI 10.1104/pp.117.2.703; Zhang CK, 2009, P NATL ACAD SCI USA, V106, P18849, DOI 10.1073/pnas.0904189106; Zhou XB, 2007, CAN J PLANT SCI, V87, P471, DOI 10.4141/P06-035	73	20	20	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205359	10.1371/journal.pone.0205359	http://dx.doi.org/10.1371/journal.pone.0205359			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312346	Green Published, Green Submitted, gold			2022-12-26	WOS:000447427300028
J	Skorina, EH; Luo, M; Oo, WY; Tao, WJ; Chen, FC; Youssefian, S; Rahbar, N; Onal, CD				Skorina, Erik H.; Luo, Ming; Oo, Wut Yee; Tao, Weijia; Chen, Fuchen; Youssefian, Sina; Rahbar, Nima; Onal, Cagdas D.			Reverse pneumatic artificial muscles (rPAMs): Modeling, integration, and control	PLOS ONE			English	Article							SOFT; RUBBER	Despite offering many advantages over traditional rigid actuators, soft pneumatic actuators suffer from a lack of comprehensive, computationally efficient models and precise embedded control schemes without bulky flow-control valves and extensive computer hardware. In this article, we consider an inexpensive and reliable soft linear actuator, called the reverse pneumatic artificial muscle (rPAM), which consists of silicone rubber that is radially constrained by symmetrical double-helix threading. We describe analytical and numerical static models of this actuator, and compare their performance against experimental results. To study the application of rPAMs to operate underlying kinematic linkage skeletons, we consider a single degree-of-freedom revolute joint that is driven antagonistically by two of these actuators. An analytical model is then derived, and its accuracy in predicting the static joint angle as a function of input pressures is presented. Using this analytical model, we perform dynamic characterization of this system. Finally, we propose a sliding-mode controller, and a sliding mode controller augmented by a feed-forward term to modulate miniature solenoid valves that control air flow to each actuator. Experiments show that both controllers function well, while the feed-forward term improves the performance of the controller following dynamic trajectories.	[Skorina, Erik H.; Luo, Ming; Tao, Weijia; Chen, Fuchen; Onal, Cagdas D.] Worcester Polytech Inst, Robot Engn Program, Worcester, MA 01609 USA; [Oo, Wut Yee] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Youssefian, Sina; Onal, Cagdas D.] Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA; [Rahbar, Nima] Worcester Polytech Inst, Dept Civil Engn, Worcester, MA 01609 USA	Worcester Polytechnic Institute; Stanford University; Worcester Polytechnic Institute; Worcester Polytechnic Institute	Onal, CD (corresponding author), Worcester Polytech Inst, Robot Engn Program, Worcester, MA 01609 USA.; Onal, CD (corresponding author), Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA.	cdonal@wpi.edu	Rahbar, Nima/D-3005-2012	Rahbar, Nima/0000-0003-0159-0025				[Anonymous], 2000, IEEE INT C ROB AUT, DOI DOI 10.1109/ROBOT.2000.845299; [Anonymous], 2012, D57591 ASTM; [Anonymous], 2006, D41206 STANDARD TEST; Bishop-Moser J., 2013, ASME 2013 INT DES EN; Bishop-Moser J, 2013, IEEE INT C INT ROBOT, P4460, DOI 10.1109/IROS.2013.6696997; Bishop-Moser J, 2013, IEEE INT C INT ROBOT, P5021, DOI 10.1109/IROS.2013.6697082; Brown D., 2015, TRACKER VIDEO ANAL M; Chou CP, 1996, IEEE T ROBOTIC AUTOM, V12, P90, DOI 10.1109/70.481753; Cianchetti M, 2013, IEEE INT C INT ROBOT, P3576, DOI 10.1109/IROS.2013.6696866; Crocker L., 2007, P ADHESION, V99; Gaylord RH., 1958, US Patent, Patent No. [2,844,126, 2844126]; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; Kim B, 2012, INT J PRECIS ENG MAN, V13, P759, DOI 10.1007/s12541-012-0099-y; Klute G. K., 1999, 1999 IEEE/ASME International Conference on Advanced Intelligent Mechatronics (Cat. No.99TH8399), P221, DOI 10.1109/AIM.1999.803170; Kothera CS, 2009, J MECH DESIGN, V131, DOI 10.1115/1.3158982; Krishnan G, 2014, IEEE INT C INT ROBOT, P587, DOI 10.1109/IROS.2014.6942619; Krishnan G, 2012, PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING TECHNICAL CONFERENCES AND COMPUTERS AND INFORMATION IN ENGINEERING CONFERENCE 2012, VOL 4, PTS A AND B, P1089; Liu W, 2003, J APPL MECH-T ASME, V70, P853, DOI 10.1115/1.1630812; Luo M, 2014, P IEEE INT C TECHN P; Luo M, 2015, IEEE INT CONF TECH; Luo M, 2014, SOFT ROBOT, V1, P136, DOI 10.1089/soro.2013.0011; Marchese A. D., 2014, P IEEE INT C ROB AUT; Martinez RV, 2014, ADV FUNCT MATER, V24, P3003, DOI 10.1002/adfm.201303676; Martins PALS, 2006, STRAIN, V42, P135, DOI 10.1111/j.1475-1305.2006.00257.x; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Onal C. D., 2011, INT S ROB RES ISRR, P4608, DOI DOI 10.1109/ICRA.2011.5980139; Onal CD, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/026003; Onal CD, 2012, P IEEE RAS-EMBS INT, P1038, DOI 10.1109/BioRob.2012.6290290; Onal CD, 2005, IEEE INT S IND EMG I; Schulte HFJ., 1961, APPL EXTERNAL POWER; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Skorina E., 2016, IEEE INT C ROB AUT I; Skorina EH, 2015, IEEE INT CONF ROBOT, P2544, DOI 10.1109/ICRA.2015.7139540; Tolley MT, 2014, SOFT ROBOT, V1, P213, DOI 10.1089/soro.2014.0008; Tondu B, 2012, J INTEL MAT SYST STR, V23, P225, DOI 10.1177/1045389X11435435; UTKIN VI, 1977, IEEE T AUTOMAT CONTR, V22, P212, DOI 10.1109/TAC.1977.1101446; Vergari C, 2011, J BIOMECH, V44, P719, DOI 10.1016/j.jbiomech.2010.10.038; Youssefian S, 2013, CONTACT BEHAV SOFT S	38	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0204637	10.1371/journal.pone.0204637	http://dx.doi.org/10.1371/journal.pone.0204637			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312314	Green Published, gold, Green Submitted			2022-12-26	WOS:000447427300011
J	Zugni, F; Ruju, F; Pricolo, P; Alessi, S; Iorfida, M; Colleoni, MA; Bellomi, M; Petralia, G				Zugni, Fabio; Ruju, Francesca; Pricolo, Paola; Alessi, Sarah; Iorfida, Monica; Colleoni, Marco Angelo; Bellomi, Massimo; Petralia, Giuseppe			The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PROSPECTIVE CLINICAL-TRIAL; BONE METASTASES; OVARIAN-CANCER; F-18-FLUCICLOVINE PET/CT; LUNG-CANCER; FDG-PET/CT; E-CADHERIN; DIFFUSION; MRI	This study investigates the impact of whole-body MRI (WB-MRI) in addition to CT of chest-abdomen-pelvis (CT-CAP) and 18F-FDG PET/CT (PET/CT) on systemic treatment decisions in standard clinical practice for patients with advanced breast cancer (ABC). WB-MRI examinations in ABC patients were extracted from our WB-MRI registry (2009-2017). Patients under systemic treatment who underwent WB-MRI and a control examination (CT-CAP or PET/CT) were included. Data regarding progressive disease (PD) reported either on WB-MRI or on the control examinations were collected. Data regarding eventual change in treatment after the imaging evaluation were collected. It was finally evaluated whether the detection of PD by any of the two modalities had induced a change in treatment. Among 910 WB-MRI examinations in ABC patients, 58 had a paired control examination (16 CT-CAP and 42 PET/CT) and were analysed. In 23/58 paired examinations, additional sites of disease were reported only on WB-MRI and not on the control examination. In 17/28 paired examinations, PD was reported only on WB-MRI and not on the control examination. In 14 out of the 28 pairs of examinations that were followed by a change in treatment, PD had been reported only on WBMRI (14/28; 50%), while stable disease had been reported on the control examination. In conclusion, WB-MRI disclosed PD earlier than the control examination (CT-CAP or PET/CT), and it was responsible alone for 50% of all changes in treatment.	[Zugni, Fabio] Univ Milan, Postgrad Sch Radiodiagnost, Milan, Italy; [Ruju, Francesca; Pricolo, Paola; Alessi, Sarah; Bellomi, Massimo; Petralia, Giuseppe] European Inst Oncol IEO, Dept Radiol Sci & Radiat Therapy, Milan, Italy; [Iorfida, Monica; Colleoni, Marco Angelo; Bellomi, Massimo; Petralia, Giuseppe] European Inst Oncol IEO, Div Med Senol, Milan, Italy; [Bellomi, Massimo; Petralia, Giuseppe] Univ Milan, Dept Oncol, Milan, Italy	University of Milan; IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); University of Milan	Zugni, F (corresponding author), Univ Milan, Postgrad Sch Radiodiagnost, Milan, Italy.	fabio.zugni@unimi.it	iorfida, monica/AAS-6612-2020; Bellomi, Massimo/AAM-4352-2020; alessi, sarah/AAO-3642-2020; ZUGNI, FABIO/AAB-1854-2021	ZUGNI, FABIO/0000-0001-9448-4760; pricolo, paola/0000-0001-5081-5628; PETRALIA, Giuseppe/0000-0003-3502-3643; PETRALIA, GIUSEPPE/0000-0001-8483-3816				Ahmad Sarji S, 2006, Biomed Imaging Interv J, V2, pe59, DOI 10.2349/biij.2.4.e59; Body J-J, 2017, CRIT REV ONCOL; Bos R, 2002, J CLIN ONCOL, V20, P379, DOI 10.1200/JCO.20.2.379; Cardoso F, 2016, BREAST; Catalano OA, 2017, INT J ONCOL, V51, P281, DOI 10.3892/ijo.2017.4012; Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008; Cho N, 2018, EUR J NUCL MED MOL I, V45, P328, DOI 10.1007/s00259-017-3849-3; Coakley FV, 2002, RADIOLOGY, V223, P495, DOI 10.1148/radiol.2232011081; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Dashevsky BZ, 2015, EUR J NUCL MED MOL I, V42, P1666, DOI 10.1007/s00259-015-3080-z; Dimopoulos MA, 2015, J CLIN ONCOL, V33, P657, DOI 10.1200/JCO.2014.57.9961; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Feuerlein S, 2009, AM J ROENTGENOL, V193, P1070, DOI 10.2214/AJR.08.2093; Fujii S, 2008, EUR RADIOL, V18, P18, DOI 10.1007/s00330-007-0732-9; Goldstein NS, 2002, AM J CLIN PATHOL, V118, P425, DOI 10.1309/JMRD-W08Y-6K8M-7AD8; Hamaoka T, 2010, BRIT J CANCER, V102, P651, DOI 10.1038/sj.bjc.6605546; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kim HY, 2008, RADIOLOGY, V246, P596, DOI 10.1148/radiol.2461061907; Kosmin M, 2017, EUR J CANCER, V77, P109, DOI 10.1016/j.ejca.2017.03.001; Kwast ABG, 2012, BREAST CANCER RES TR, V135, P271, DOI 10.1007/s10549-012-2160-z; Kwee TC, 2009, EUR J RADIOL, V70, P409, DOI 10.1016/j.ejrad.2009.03.054; Li CI, 2005, BRIT J CANCER, V93, P1046, DOI 10.1038/sj.bjc.6602787; Lin NU, 2013, BREAST, V22, P203, DOI 10.1016/j.breast.2013.03.006; Michielsen K, 2014, EUR RADIOL, V24, P889, DOI 10.1007/s00330-013-3083-8; Morone M, 2017, AM J ROENTGENOL, V209, pW336, DOI 10.2214/AJR.17.17984; Murakami M, 2006, INT J GYNECOL CANCER, V16, P99, DOI 10.1111/j.1525-1438.2006.00471.x; National Collaborating Centre for Cancer (UK), 2009, ADV BREAST CANC DIAG; Padhani A R, 2011, Cancer Imaging, V11 Spec No A, pS129, DOI 10.1102/1470-7330.2011.9034; Padhani AR, 2016, EUR UROL, V69, P1, DOI 10.1016/j.eururo.2015.07.036; Padhani AR, 2014, J MAGN RESON IMAGING, V39, P1049, DOI 10.1002/jmri.24548; Pockett RD, 2010, EUR J CANCER CARE, V19, P755, DOI 10.1111/j.1365-2354.2009.01135.x; Prabhakar HB, 2007, RADIOGRAPHICS, V27, P145, DOI 10.1148/rg.271065080; Schmidt GP, 2005, INVEST RADIOL, V40, P743, DOI 10.1097/01.rli.0000185878.61270.b0; Shie P, 2008, CLIN NUCL MED, V33, P97, DOI 10.1097/RLU.0b013e31815f23b7; Singhai R, 2011, N AM J MED SCI, V3, P227, DOI 10.4297/najms.2011.3227; Sundquist M, 2017, BREAST, V31, P46, DOI 10.1016/j.breast.2016.10.005; Takahara T, RAD MED, V22, P275; Ulaner GA, 2017, CLIN NUCL MED, V42, P912, DOI 10.1097/RLU.0000000000001820; Ulaner GA, 2017, J NUCL MED, V58, P1037, DOI 10.2967/jnumed.116.183335; Ulaner GA, 2016, J NUCL MED, V57, P1350, DOI 10.2967/jnumed.115.170456; Walker R, 2007, J CLIN ONCOL, V25, P1121, DOI 10.1200/JCO.2006.08.5803; White NS, 2014, CANCER RES, V74, P4638, DOI 10.1158/0008-5472.CAN-13-3534; Wibmer AG, 2018, EUR J HYBRID IMAG, V2, DOI 10.1186/s41824-017-0019-6; Yang HL, 2011, EUR RADIOL, V21, P2604, DOI 10.1007/s00330-011-2221-4; Yankeelov TE, 2011, SEMIN ONCOL, V38, P16, DOI 10.1053/j.seminoncol.2010.11.007	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205251	10.1371/journal.pone.0205251	http://dx.doi.org/10.1371/journal.pone.0205251			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312335	gold, Green Submitted, Green Published			2022-12-26	WOS:000447427300025
J	Jung, SH; Hwang, HJ; Kang, D; Park, HA; Lee, HC; Jeong, D; Lee, K; Park, HJ; Ko, YG; Lee, JS				Jung, Seung Hee; Hwang, Hyun Jung; Kang, Donghee; Park, Hyun A.; Lee, Hyung Chul; Jeong, Daecheol; Lee, Keunwook; Park, Heon Joo; Ko, Young-Gyu; Lee, Jae-Seon			mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53	ONCOGENE			English	Article							ONCOGENE-INDUCED SENESCENCE; BINDING PARTNER; AKT; GROWTH; CELLS; ACTIVATION; RICTOR; RAPTOR; TOR	Loss of PTEN, the major negative regulator of the PI3K/AKT pathway induces a cellular senescence as a failsafe mechanism to defend against tumorigenesis, which is called PTEN-loss-induced cellular senescence (PICS). Although many studies have indicated that the mTOR pathway plays a critical role in cellular senescence, the exact functions of mTORC1 and mTORC2 in PICS are not well understood. In this study, we show that mTOR acts as a critical relay molecule downstream of PI3K/AKT and upstream of p53 in PICS. We found that PTEN depletion induces cellular senescence via p53-p21 signaling without triggering DNA damage response. mTOR kinase, a major component of mTORC1 and mTORC2, directly binds p53 and phosphorylates it at serine 15. mTORC1 and mTORC2 compete with MDM2 and increase the stability of p53 to induce cellular senescence via accumulation of the cell cycle inhibitor, p21. In embryonic fibroblasts of PTEN-knockout mice, PTEN deficiency also induces mTORC1 and mTORC2 to bind to p53 instead of MDM2, leading to cellular senescence. These results collectively demonstrate for the first time that mTOR plays a critical role in switching cells from proliferation signaling to senescence signaling via a direct link between the growth-promoting activity of AKT and the growth-suppressing activity of p53.	[Jung, Seung Hee; Hwang, Hyun Jung; Kang, Donghee; Park, Hyun A.; Lee, Hyung Chul; Lee, Jae-Seon] Inha Univ, Dept Mol Med, Coll Med, Incheon 22212, South Korea; [Jung, Seung Hee; Hwang, Hyun Jung; Kang, Donghee; Park, Hyun A.; Lee, Hyung Chul; Park, Heon Joo; Lee, Jae-Seon] Inha Univ, Coll Med, Hypoxia Related Dis Res Ctr, Incheon 22212, South Korea; [Jeong, Daecheol; Lee, Keunwook] Hallym Univ, Dept Biomed Sci, Chunchon 24252, Gangwon Do, South Korea; [Park, Heon Joo] Inha Univ, Dept Microbiol, Coll Med, Incheon 22212, South Korea; [Ko, Young-Gyu] Korea Univ, Div Life Sci, Seoul 02841, South Korea	Inha University; Inha University; Hallym University; Inha University; Korea University	Lee, JS (corresponding author), Inha Univ, Dept Mol Med, Coll Med, Incheon 22212, South Korea.; Lee, JS (corresponding author), Inha Univ, Coll Med, Hypoxia Related Dis Res Ctr, Incheon 22212, South Korea.	jaeslee@inha.ac.kr			National Research Foundation (NRF) - Korean government (MSIT) [MRC 2014R1A5A2009392, 2017R1A2B2007542, 2017M2A2A7A01070591]	National Research Foundation (NRF) - Korean government (MSIT)	The pcDNA3-Flag mTOR WT and mTOR KD constructs were generously gifted by Jie Chen (University of Illinois, Illinois, USA). We acknowledge Korea Mouse Phenotyping Center (KMPC) for providing mouse embryonic fibroblasts. This work was supported by grants to JSL (MRC 2014R1A5A2009392, 2017R1A2B2007542, and 2017M2A2A7A01070591) through the National Research Foundation (NRF) funded by the Korean government (MSIT).	Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Astle MV, 2012, ONCOGENE, V31, P1949, DOI 10.1038/onc.2011.394; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Di Mitri D, 2016, TRENDS CELL BIOL, V26, P215, DOI 10.1016/j.tcb.2015.10.005; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jung SH, 2016, CELL DEATH DIFFER, V23, P417, DOI 10.1038/cdd.2015.107; Kolesnichenko M, 2012, CELL CYCLE, V11, P2391, DOI 10.4161/cc.20683; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee GH, 2016, J CELL BIOL, V215, P705, DOI 10.1083/jcb.201605121; Lee JJ, 2011, CELL DEATH DIFFER, V18, P666, DOI 10.1038/cdd.2010.139; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Moral M, 2009, CANCER RES, V69, P1099, DOI 10.1158/0008-5472.CAN-08-3240; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Xie JL, 2013, NAT CELL BIOL, V15, P1263, DOI 10.1038/ncb2877; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	37	55	56	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2019	38	10					1639	1650		10.1038/s41388-018-0521-8	http://dx.doi.org/10.1038/s41388-018-0521-8			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN8DD	30337688	Green Published, hybrid			2022-12-26	WOS:000460423800005
J	Mrak, P; Krastel, P; Lukancic, PP; Tao, JS; Pistorius, D; Moore, CM				Mrak, Peter; Krastel, Philipp; Lukancic, Petra Pivk; Tao, Jianshi; Pistorius, Dominik; Moore, Charles M.			Discovery of the actinoplanic acid pathway in Streptomyces rapamycinicus reveals a genetically conserved synergism with rapamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actinobacteria; natural product biosynthesis; polyketide; protein farnesylation; genomics; target of rapamycin (TOR); peptide biosynthesis; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); actinoplanic acid; pathway; rapamycin; synergy	BIOSYNTHETIC GENE-CLUSTER; POTENT INHIBITORS; ESCHERICHIA-COLI; NATURAL-PRODUCTS; RAS; EVOLUTION; METHYLTRANSFERASE; ELAIOPHYLIN; EXPRESSION; CHEMISTRY	Actinobacteria possess a great wealth of pathways for production of bioactive compounds. Following advances in genome mining, dozens of natural product (NP) gene clusters are routinely found in each actinobacterial genome; however, the modus operandi of this large arsenal is poorly understood. During investigations of the secondary metabolome of Streptomyces rapamycinicus, the producer of rapamycin, we observed accumulation of two compounds never before reported from this organism. Structural elucidation revealed actinoplanic acid A and its demethyl analogue. Actinoplanic acids (APLs) are potent inhibitors of Ras farnesyltransferase and therefore represent bioactive compounds of medicinal interest. Supported with the unique structure of these polyketides and using genome mining, we identified a gene cluster responsible for their biosynthesis in S. rapamycinicus. Based on experimental evidence and genetic organization of the cluster, we propose a stepwise biosynthesis of APL, the first bacterial example of a pathway incorporating the rare tricarballylic moiety into an NP. Although phylogenetically distant, the pathway shares some of the biosynthetic principles with the mycotoxins fumonisins. Namely, the core polyketide is acylated with the tricarballylate by an atypical nonribosomal peptide synthetase-catalyzed ester formation. Finally, motivated by the conserved colocalization of the rapamycin and APL pathway clusters in S. rapamycinicus and all other rapamycin-producing actinobacteria, we confirmed a strong synergism of these compounds in antifungal assays. Mining for such evolutionarily conserved coharboring of pathways would likely reveal further examples of NP sets, attacking multiple targets on the same foe. These could then serve as a guide for development of new combination therapies.	[Mrak, Peter; Lukancic, Petra Pivk] Novartis Tech Operat, Antiinfect, Kolodvorska 27, SI-1234 Menges, Slovenia; [Krastel, Philipp; Pistorius, Dominik; Moore, Charles M.] Novartis Inst BioMed Res, Novartis Campus, CH-4056 Basel, Switzerland; [Tao, Jianshi] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Mrak, Peter] Univ Ljubljana, Ljubljana 1000, Slovenia	Novartis; Novartis; University of Ljubljana	Mrak, P (corresponding author), Novartis Tech Operat, Antiinfect, Kolodvorska 27, SI-1234 Menges, Slovenia.; Moore, CM (corresponding author), Novartis Inst BioMed Res, Novartis Campus, CH-4056 Basel, Switzerland.	peter.mrak@novartis.com; charles-1.moore@novartis.com		Pistorius, Dominik/0000-0003-1949-9924				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arp J, 2018, P NATL ACAD SCI USA, V115, P3758, DOI 10.1073/pnas.1721790115; Baranasic D, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00581-13; BERGSTROM JD, 1995, ANNU REV MICROBIOL, V49, P607, DOI 10.1146/annurev.mi.49.100195.003135; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Blank L, 2002, MICROBIOL-SGM, V148, P133, DOI 10.1099/00221287-148-1-133; Blazic M, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0352-z; Bloudoff K, 2017, BBA-PROTEINS PROTEOM, V1865, P1587, DOI 10.1016/j.bbapap.2017.05.010; Butchko RAE, 2006, J AGR FOOD CHEM, V54, P9398, DOI 10.1021/jf0617869; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Chang CY, 2018, BIOCHEMISTRY-US, V57, P3278, DOI 10.1021/acs.biochem.8b00174; Cheong JW, 2007, BLOOD, V110, p539A; Condurso HL, 2012, NAT PROD REP, V29, P1099, DOI 10.1039/c2np20023f; Deepa N., 2017, J VET MED RES, V4, P1093; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang AQ, 2000, J ANTIBIOT, V53, P158, DOI 10.7164/antibiotics.53.158; Flanagan PR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00477-17; Gaubitz C, 2016, TRENDS BIOCHEM SCI, V41, P532, DOI 10.1016/j.tibs.2016.04.001; Gerber R, 2009, J AM CHEM SOC, V131, P3148, DOI 10.1021/ja8091054; Gonzalez S, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00061; Haydock SF, 2004, J BIOTECHNOL, V113, P55, DOI 10.1016/j.jbiotec.2004.03.022; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Horn F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00616-14; Huang H, 2015, CHIN J NAT MEDICINES, V13, P90, DOI 10.1016/S1875-5364(15)60012-7; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; JAKLITSCH WM, 1991, J GEN MICROBIOL, V137, P533, DOI 10.1099/00221287-137-3-533; Katz L, 2016, J IND MICROBIOL BIOT, V43, P155, DOI 10.1007/s10295-015-1723-5; Khanna A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25823; Kieser T, 2000, PRACTICAL STREPTOMYC, P249; Kong FM, 2011, J NAT PROD, V74, P547, DOI 10.1021/np1003388; Kosec G, 2012, METAB ENG, V14, P39, DOI 10.1016/j.ymben.2011.11.003; Kumar Y, 2008, INT J SYST EVOL MICR, V58, P1369, DOI 10.1099/ijs.0.65408-0; Kuscer E, 2007, J BACTERIOL, V189, P4756, DOI 10.1128/JB.00129-07; Ladner CC, 2016, J IND MICROBIOL BIOT, V43, P371, DOI 10.1007/s10295-015-1704-8; Lia Y, 2013, MYCOLOGY, V4, P179, DOI DOI 10.1080/21501203.2013.874540; Lin SJ, 2009, P NATL ACAD SCI USA, V106, P4183, DOI 10.1073/pnas.0808880106; Massengo-Tiasse RP, 2009, CELL MOL LIFE SCI, V66, P1507, DOI 10.1007/s00018-009-8704-7; Melchinger W., 2013, BLOOD, V122, P3076; Moorthy NSHN, 2013, CURR MED CHEM, V20, P4888, DOI 10.2174/09298673113206660262; Mott BT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13891; Niessner H, 2011, J INVEST DERMATOL, V131, P468, DOI 10.1038/jid.2010.297; Nikodinovic J, 2003, BIOTECHNIQUES, V35, P932, DOI 10.2144/03355bm05; Paradkar A, 2013, J ANTIBIOT, V66, P411, DOI 10.1038/ja.2013.26; Patridge E, 2016, DRUG DISCOV TODAY, V21, P204, DOI 10.1016/j.drudis.2015.01.009; Petronikolou N, 2015, CHEM BIOL, V22, P1480, DOI 10.1016/j.chembiol.2015.09.011; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Proctor RH, 1999, FUNGAL GENET BIOL, V27, P100, DOI 10.1006/fgbi.1999.1141; Pye CR, 2017, P NATL ACAD SCI USA, V114, P5601, DOI 10.1073/pnas.1614680114; Ramon-Garcia S, 2011, ANTIMICROB AGENTS CH, V55, P3861, DOI 10.1128/AAC.00474-11; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rudolph MM, 2013, MICROBIOL-SGM, V159, P1416, DOI 10.1099/mic.0.067322-0; Saxena N, 2008, CANCER INVEST, V26, P948, DOI 10.1080/07357900802087275; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Siegl T, 2013, METAB ENG, V19, P98, DOI 10.1016/j.ymben.2013.07.006; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SILVERMAN KC, 1995, APPL MICROBIOL BIOT, V43, P610; SINGH SB, 1994, J AM CHEM SOC, V116, P11606, DOI 10.1021/ja00104a066; SINGH SB, 1995, J ORG CHEM, V60, P7896, DOI 10.1021/jo00129a033; Struck AW, 2012, CHEMBIOCHEM, V13, P2642, DOI 10.1002/cbic.201200556; Sun YH, 2009, APPL MICROBIOL BIOT, V82, P303, DOI 10.1007/s00253-008-1793-7; Tatebe H, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7040077; Tsao CC, 2009, FUNGAL GENET BIOL, V46, P126, DOI 10.1016/j.fgb.2008.11.008; van Dam TJP, 2011, J MOL EVOL, V73, P209, DOI 10.1007/s00239-011-9469-9; Wambaugh MA, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001644; Wang JY, 2017, MEDCHEMCOMM, V8, P841, DOI 10.1039/c7md00030h; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; WHO, 2017, 20 WHO MOD LIST ESS; Yoo YJ, 2017, J IND MICROBIOL BIOT, V44, P537, DOI 10.1007/s10295-016-1834-7; Zaleta-Rivera K, 2006, BIOCHEMISTRY-US, V45, P2561, DOI 10.1021/bi052085s; Ziemert N, 2016, NAT PROD REP, V33, P988, DOI 10.1039/c6np00025h	76	11	12	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					19982	19995		10.1074/jbc.RA118.005314	http://dx.doi.org/10.1074/jbc.RA118.005314			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30327433	Green Published, hybrid			2022-12-26	WOS:000454685900004
J	Iniesta, C; Alvarez-del Arco, D; Garcia-Sousa, LM; Alejos, B; Diaz, A; Sanz, N; Garrido, J; Meulbroek, M; Pujol, F; Moreno, S; de Apocada, MJFR; Coll, P; Antela, A; del Romero, J; Ayerdi, O; Riera, M; Hernandez, J; del Amo, J				Iniesta, Carlos; Alvarez-del Arco, Debora; Miguel Garcia-Sousa, Luis; Alejos, Belen; Diaz, Asuncion; Sanz, Nieves; Garrido, Jorge; Meulbroek, Michael; Pujol, Ferran; Moreno, Santiago; Fuster-Ruiz de Apocada, Maria Jose; Coll, Pep; Antela, Antonio; del Romero, Jorge; Ayerdi, Oskar; Riera, Melchor; Hernandez, Juanse; del Amo, Julia			Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017	PLOS ONE			English	Article							HIGH-RISK; HIV; MEN; SEX; ACCEPTABILITY; MSM	Objective To assess the awareness, knowledge, use, and willingness to use and need of PrEP among men who have sex with men (MSM) and transgender women (TW) who attended World Gay Pride (WGP) 2017 in Madrid. Design and methods Online survey. Participants were recruited through gay-oriented dating apps and HIV Non-Governmental Organizations' social media. Inclusion criteria included being MSM or TW, age 18 years old or above, and having attended WGP in Madrid. Information regarding the participant's awareness and knowledge, use or willingness to use, and need for PrEP was collected, as well as sociodemographic characteristics. Participants were considered to be in need of PrEP if they met one of the following indication criteria: having practiced unprotected anal intercourse with more than 2 partners, having practiced chemsex, or having engaged in commercial sex-all in the preceding 6 months. Descriptive and multivariable analyses with logistic regression were conducted. Results 472 participants met the inclusion criteria and completed the questionnaire. The mean age was 38, 97.7% were MSM, 77% had a university education, and 85% were living in Spain, mostly in big cities. Overall, 64% of participants were aware of PrEP, but only 33% knew correctly what PrEP was. 67% of HIV-negative participants were willing to take PrEP, although only 5% were taking it during WGP, mostly due to lack of access. 43% of HIV-negative respondents met at least one PrEP indication criteria. For HIV-negative men living in Spain, university education and living in big cities was associated with PrEP awareness. Lower education level and meeting PrEP criteria was associated with willingness to use PrEP. Conclusions Our study shows that among MSM attending WGP 2017 in Madrid, there was limited PrEP awareness, low accuracy of PrEP knowledge, and a high need and willingness to use PrEP. Health authorities should strengthen existing preventive strategies and implement PrEP.	[Iniesta, Carlos; Miguel Garcia-Sousa, Luis; Alejos, Belen; Diaz, Asuncion; del Amo, Julia] Carlos III Hlth Inst, Natl Ctr Epidemiol, Madrid, Spain; [Alvarez-del Arco, Debora] Univ Complutense Madrid, Madrid, Spain; [Alvarez-del Arco, Debora] La Doctora Alvarez Commun Agcy, Madrid, Spain; [Sanz, Nieves] Asociac CoRIS, Madrid, Spain; [Garrido, Jorge] Apoyo Posit, Madrid, Spain; [Meulbroek, Michael; Pujol, Ferran] Projecte NOMS, Hispanosida, Barcelona, Spain; [Moreno, Santiago] Hosp Univ Ramon & Cajal, Madrid, Spain; [Moreno, Santiago] Univ Alcala Henares, Madrid, Spain; [Fuster-Ruiz de Apocada, Maria Jose] Seisida, Madrid, Spain; [Coll, Pep] AIDS Res Inst IrsiCaixa, Barcelona, Spain; [Antela, Antonio] Univ Santiago Compostela, Hosp Clin, Infect Dis Dept, Santiago De Compostela, Spain; [del Romero, Jorge; Ayerdi, Oskar] Unidad ITS VIH, Ctr Sanitario Sandoval IdISSC, Madrid, Spain; [Riera, Melchor] Hosp Son Espases, Palma de Mallorca, Spain; [Hernandez, Juanse] Grp Trabajo Tratamientos VIH gTt VIH, Barcelona, Spain	Complutense University of Madrid; Hospital Universitario Ramon y Cajal; Universidad de Alcala; Institut de Recerca de la Sida - IrsiCaixa; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Hospital Universitari Son Espases	Iniesta, C (corresponding author), Carlos III Hlth Inst, Natl Ctr Epidemiol, Madrid, Spain.	ciniesta@isciii.es	Riera, Melchor/AEU-0584-2022; Diaz, Asuncion/Q-6016-2017; Alvarez-del Arco, Debora/E-1744-2015	Diaz, Asuncion/0000-0002-8309-4270; Alvarez-del Arco, Debora/0000-0003-4079-9219; Iniesta, Carlos/0000-0002-0928-2679; Garcia Sousa, Luis Miguel/0000-0002-1816-9803	Spanish Network of Excellence on HIV (RIS) [RD16CIII/0002/]; CIBERESP	Spanish Network of Excellence on HIV (RIS); CIBERESP	This work has been supported by the Spanish Network of Excellence on HIV ((RIS) (RD16CIII/0002/) and CIBERESP.	AGENCIA ESPANOLA de Medicamentos y Productos Sanitarios. Ficha tecnica Truvada, 2017, FICH TECN TRUV; [Anonymous], 2017, PREVENTION SEXUAL TR; [Anonymous], 2017, INF COM BIOET FIN PU; [Anonymous], 2017, PROFILLAXIS PREEXPOS; Area  de Vigilancia de VIH y Comportamientos de Riesgo, 2016, AR VIG VIH COMP RIES; Ayerdi-Aguirrebengoa O, 2017, ENFERM INFEC MICR CL, V35, P299, DOI 10.1016/j.eimc.2016.06.006; Bil JP, 2015, AIDS, V29, P955, DOI 10.1097/QAD.0000000000000639; Calabrese SK, 2015, AM J PUBLIC HEALTH, V105, P1960, DOI 10.2105/AJPH.2015.302816; Cambiano V, 2018, LANCET INFECT DIS, V18, P85, DOI [10.1016/S1473-3099(17)30540-6, 10.1016/s1473-3099(17)30540-6]; European Centre for Disease Prevention and Control ECDC, 2013, EMIS NETW; European Medicines Agency, 2018, TRUV SUMM PROD CHAR; Fernandez-Balbuena S, 2013, HIV MED, V14, P252, DOI 10.1111/j.1468-1293.2012.01056.x; Ferrer L, 2016, AIDS BEHAV, V20, P1423, DOI 10.1007/s10461-016-1379-9; Folch C, 2011, EUR ADDICT RES, V17, P271, DOI 10.1159/000329931; Frankis JS, 2016, SEX TRANSM INFECT, V92, P279, DOI 10.1136/sextrans-2015-052101; Goedel WC, 2019, GLOB PUBLIC HEALTH, V14, P112, DOI 10.1080/17441692.2017.1391859; Gourlay A, 2017, CLIN INFECT DIS, V64, P1644, DOI 10.1093/cid/cix212; Grupo de Estudio de Sida de la SEIMC (GeSIDA), 2016, REC PROF PREEXP AD P; Lima VD, 2010, JAIDS-J ACQ IMM DEF, V55, P460, DOI 10.1097/QAI.0b013e3181f2ac87; Lodi S, 2014, AIDS, V28, P1, DOI [10.1097/01.aids.0000433241.78739.79, DOI 10.1097/01.AIDS.0000433241.78739.79]; Lorente N, 2012, AIDS CARE, V24, P468, DOI 10.1080/09540121.2011.626394; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Garcia LM, 2019, ENFERM INFEC MICR CL, V37, P656, DOI 10.1016/j.eimc.2018.05.012; Ministerio de Sanidad SS e I, 2013, PLAN ESTR PREV CONTR; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Pharris A., 2017, 2017 GESIDA C VIG; Rocha LM, 2014, J INT AIDS SOC, V17, P150, DOI 10.7448/IAS.17.4.19734; Spanish Statistical Office, 2013, SPAN SEX HLTH SURV	28	13	15	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0204738	10.1371/journal.pone.0204738	http://dx.doi.org/10.1371/journal.pone.0204738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX5DH	30339690	Green Published, gold			2022-12-26	WOS:000447761400005
J	Liu, Z; Abbaszadeh, S; Sullivan, CJ				Liu, Zheng; Abbaszadeh, Shiva; Sullivan, Clair Julia			Spatial-temporal modeling of background radiation using mobile sensor networks	PLOS ONE			English	Article							RADIOACTIVE SOURCES	Modeling of background radiation for the urban environment plays an important role in homeland security. However, background radiation is difficult to assess due to its spatial-temporal fluctuations caused by the variation in soil composition, building materials, and weather patterns etc. To address the challenge of background radiation modeling, we developed a mobile sensor network to continuously monitor the background radiation; we also proposed a maximum likelihood estimation algorithm to decouple and estimate the background's spatial distribution and temporal fluctuation. Experimental results demonstrated how this background radiation monitoring system accurately recognized high background regions in the experimental area, and successfully captured temporal fluctuation trends of background radiation during rains. Our system provides an efficient solution to model the temporal fluctuation and spatial distribution of background radiation.	[Liu, Zheng; Abbaszadeh, Shiva; Sullivan, Clair Julia] Univ Illinois, Dept Nucl Plasma & Radiol Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Liu, Z (corresponding author), Univ Illinois, Dept Nucl Plasma & Radiol Engn, Urbana, IL 61801 USA.	zliu86@illinois.edu		Abbaszadeh, Shiva/0000-0001-6345-2408	Defense Threat Reduction Agency [HDTRA 1-14-1-0011]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This study was supported by the grant HDTRA 1-14-1-0011 awarded by the Defense Threat Reduction Agency.	[Anonymous], 2007, FUSION 2007, DOI [10.1109/icif.2007.4408094, DOI 10.1109/ICIF.2007.4408094]; Bai EW, 2015, IEEE T NUCL SCI, V62, P3274, DOI 10.1109/TNS.2015.2497327; Brennan SM, 2005, IEEE T NUCL SCI, V52, P813, DOI 10.1109/TNS.2005.850487; Chandy M, 2008, NETW SENS SYST 2008; Deb B, 2013, IEEE T NUCL SCI, V60, P1315, DOI 10.1109/TNS.2013.2247060; Fujinami N, 1996, ENVIRON INT, V22, pS181; Gunatilaka Ajith, 2007, 2007 Information, Decision and Control, P236, DOI 10.1109/IDC.2007.374556; Heath M.T., 2002, SCI COMPUTING INTRO; Liu AS, 2011, PLAST RECONSTR SURG, V127, P1755, DOI 10.1097/PRS.0b013e31820cf233; Livesay RJ, 2014, J ENVIRON RADIOACTIV, V137, P137, DOI 10.1016/j.jenvrad.2014.07.010; Mercier JF, 2009, J ENVIRON RADIOACTIV, V100, P527, DOI 10.1016/j.jenvrad.2009.03.002; Morelande MR, 2009, IEEE T SIGNAL PROCES, V57, P4220, DOI 10.1109/TSP.2009.2026618; Nemzek RJ, 2004, IEEE T NUCL SCI, V51, P1693, DOI 10.1109/TNS.2004.832582; Philips GW, 2005, PRIMER DETECTION NUC; Salikhov N, 2011, INT COSM RAY C, V11, P367; Stephens DL, 2004, IEEE T NUCL SCI, V51, P2273, DOI 10.1109/TNS.2004.834713; Takeyasu M, 2006, J ENVIRON RADIOACTIV, V88, P74, DOI 10.1016/j.jenvrad.2006.01.001	17	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205092	10.1371/journal.pone.0205092	http://dx.doi.org/10.1371/journal.pone.0205092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339704	gold, Green Submitted, Green Published			2022-12-26	WOS:000447761400007
J	Li, QY; Wu, JL; Zhao, ZH				Li, Qianyu; Wu, Jinglu; Zhao, Zhonghua			Spatial and temporal distribution of Polycyclic Aromatic Hydrocarbons (PAHs) in sediments from Poyang Lake, China	PLOS ONE			English	Article							ORGANOCHLORINE PESTICIDES OCPS; ECOLOGICAL RISK-ASSESSMENT; FRASER-RIVER BASIN; FRESH-WATER LAKE; SOURCE APPORTIONMENT; SURFACE SEDIMENTS; YANGTZE-RIVER; LOWER REACHES; FLUXES; CONTAMINANTS	Concentrations of polycyclic aromatic hydrocarbons (PAHs) were measured in 22 surface sediment samples and an approximately 100-year scale sediment core collected from Poyang Lake. This valuable sediments enable analysis of spatial and temporal distribution patterns of PAH sources, and determine the anthropogenic impacts on Poyang Lake. Total PAH concentrations in the surface sediments ranged from 73.2 to 367.2 ng/g dw, and higher residues were encountered in regions with high-density populations and intensive human activities. Total PAH concentrations in the sediment core ranged from 42.0 to 334.0 ng/g dw and were grouped in two clusters (pre-1990s and post-1990s to the present). PAH concentrations in sediments changed both temporally and spatially, suggesting a difference in PAH sources. Before the 1990s, major PAH sources in the sediment core were from coal, wood and grass combustion. This finding naturally agrees with open lake conditions on a spatial scale, which were related to agricultural activities. Petroleum combustion from industrialization and urbanization has become the predominant PAH source in the sediment core from the 1990s to the present and corresponds to sources observed in the southwestern lake near the relatively developed Nanchang City. In the northern lake leading to the Yangtze River, certain petroleum-related contaminants from shipping have become the main PAH sources. The different PAH sources observed in sediments generally reflect the degree of socio-economic development in the Poyang Lake valley, which is consistent with the local written records, indirectly validating the connection of sediment PAH records to the history of human activities in and around Poyang Lake.	[Li, Qianyu; Wu, Jinglu; Zhao, Zhonghua] Chinese Acad Sci, State Key Lab Lake & Environm Sci, Nanjing Inst Geog & Limnol, Nanjing, Jiangsu, Peoples R China; [Li, Qianyu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, JL (corresponding author), Chinese Acad Sci, State Key Lab Lake & Environm Sci, Nanjing Inst Geog & Limnol, Nanjing, Jiangsu, Peoples R China.	w.jinglu@niglas.ac.cn	li, qianyu/GXV-6594-2022		National Natural Science Foundation of China [41373017, 41576171, 41671477]; National Basic Research Program of China [2015FY110900-03, 2012FY111800-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China grant numbers 41373017 and 41576171 to JW and grant no. 41671477 to ZZ (http://www.nsfc.gov.cn/). This study was also supported by the National Basic Research Program of China grant numbers 2015FY110900-03 and 2012FY111800-03 to ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Hernandez CM, 2014, CHEMOSPHERE, V94, P36, DOI 10.1016/j.chemosphere.2013.09.007; Bortey-Sam N, 2014, SCI TOTAL ENVIRON, V496, P471, DOI 10.1016/j.scitotenv.2014.07.071; Bucheli TD, 2004, CHEMOSPHERE, V56, P1061, DOI 10.1016/j.chemosphere.2004.06.002; Castro-Jimenez J, 2012, ENVIRON POLLUT, V166, P40, DOI 10.1016/j.envpol.2012.03.003; CHEN JS, 1989, HYDROBIOLOGIA, V176, P159, DOI 10.1007/BF00026551; Cortazar E, 2008, CHEMOSPHERE, V72, P1467, DOI 10.1016/j.chemosphere.2008.05.006; Dahle S, 2003, SCI TOTAL ENVIRON, V306, P57, DOI 10.1016/S0048-9697(02)00484-9; Dong Y.Y., 2012, CONTINGENT VALUATION, P5; Eggleton J, 2004, ENVIRON INT, V30, P973, DOI 10.1016/j.envint.2004.03.001; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrison RM, 1996, ENVIRON SCI TECHNOL, V30, P825, DOI 10.1021/es950252d; He X.W., 2015, ENTERP EC, V10, P148; He XR, 2014, MAR POLLUT BULL, V80, P52, DOI 10.1016/j.marpolbul.2014.01.051; Howsam M., 1998, PAHS RELATED COMPOUN, P137; Kannan K, 2005, ENVIRON SCI TECHNOL, V39, P4700, DOI 10.1021/es050064f; KHALILI NR, 1995, ATMOS ENVIRON, V29, P533, DOI 10.1016/1352-2310(94)00275-P; LAFLAMME RE, 1978, GEOCHIM COSMOCHIM AC, V42, P289, DOI 10.1016/0016-7037(78)90182-5; Larsen RK, 2003, ENVIRON SCI TECHNOL, V37, P1873, DOI 10.1021/es0206184; Lee RGM, 2005, ENVIRON SCI TECHNOL, V39, P1436, DOI 10.1021/es048745i; Li RF, 2011, WATER RESOURCES PROT, V9, P13; Li SY, 2016, ENVIRON SCI POLLUT R, V23, P4812, DOI 10.1007/s11356-015-5705-y; Liang Y, 2015, ACTA GEOCHIM, V34, P38, DOI 10.1007/s11631-014-0017-3; Lim LH, 1999, ENVIRON SCI TECHNOL, V33, P3538, DOI 10.1021/es990392d; Liu M, 2000, ENVIRON POLLUT, V110, P357, DOI 10.1016/S0269-7491(99)00292-4; [刘志刚 Liu Zhigang], 2015, [环境科学学报, Acta Scientiae Circumstantiae], V35, P1265; Lu M, 2012, SCI TOTAL ENVIRON, V433, P491, DOI 10.1016/j.scitotenv.2012.06.108; Mai BX, 2002, ENVIRON POLLUT, V117, P457, DOI 10.1016/S0269-7491(01)00193-2; Parlanti E., 1990, ETUDE GOLFE LION GOL; Qin N, 2013, ECOL INDIC, V24, P599, DOI 10.1016/j.ecolind.2012.08.019; Ravindra K, 2006, ATMOS ENVIRON, V40, P771, DOI 10.1016/j.atmosenv.2005.10.011; Reasoner M.A., 1993, J PALEOLIMNOL, V8, P273, DOI [10.1007/BF00177859, DOI 10.1007/BF00177859]; Roose P, 2005, TRAC-TREND ANAL CHEM, V24, P897, DOI 10.1016/j.trac.2005.10.007; Saha M, 2009, MAR POLLUT BULL, V58, P189, DOI 10.1016/j.marpolbul.2008.04.049; Semenov MY, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-4969-3; Shankman D, 2003, PROF GEOGR, V55, P434, DOI 10.1111/0033-0124.5504003; Shen BB, 2017, J LIMNOL, V76, P129, DOI 10.4081/jlimnol.2016.1529; Singh KP, 2008, ENVIRON MONIT ASSESS, V136, P183, DOI 10.1007/s10661-007-9674-6; Tsapakis M, 2006, ENVIRON SCI TECHNOL, V40, P4922, DOI 10.1021/es060487x; Wang Fu, 2016, Earth Science - Journal of China University of Geosciences, V41, P971, DOI 10.3799/dqkx.2016.081; Warren N, 2003, APPL GEOCHEM, V18, P159, DOI 10.1016/S0883-2927(02)00159-2; Wilcke W, 2007, GEODERMA, V141, P157, DOI 10.1016/j.geoderma.2007.07.007; Wu Guoxiang, 2008, THESIS; Wu JL, 2013, J PALEOLIMNOL, V50, P245, DOI 10.1007/s10933-013-9718-6; Xinhua News Agency, 2012, NUMB VEH NANCH CIT H; Xu D., 2001, YANGTZE RIVER, V32, P21; Yao J, 2009, ACTA AGR JIANGXI, V21, P125; Yuan GL, 2011, J HAZARD MATER, V185, P336, DOI 10.1016/j.jhazmat.2010.09.039; Yunker MB, 2002, ORG GEOCHEM, V33, P489, DOI 10.1016/S0146-6380(02)00002-5; Yunker MB, 2003, ORG GEOCHEM, V34, P1429, DOI 10.1016/S0146-6380(03)00136-0; Zhao ZH, 2016, LIMNOL OCEANOGR, V61, P47, DOI 10.1002/lno.10197; Zhao ZH, 2014, ECOTOX ENVIRON SAFE, V104, P323, DOI 10.1016/j.ecoenv.2014.01.037; Zhao ZH, 2009, CHEMOSPHERE, V77, P1191, DOI 10.1016/j.chemosphere.2009.09.022; Zhi H, 2015, CHEMOSPHERE, V119, P1134, DOI 10.1016/j.chemosphere.2014.09.054; Zhong WJ, 2014, SCI MOSAIC, V8, P231	54	13	13	11	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205484	10.1371/journal.pone.0205484	http://dx.doi.org/10.1371/journal.pone.0205484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335771	Green Published, gold, Green Submitted			2022-12-26	WOS:000447701300034
J	Mihailovic, N; Brand, C; Lahme, L; Schubert, F; Bormann, E; Eter, N; Alnawaiseh, M				Mihailovic, Natasa; Brand, Cristin; Lahme, Larissa; Schubert, Friederike; Bormann, Eike; Eter, Nicole; Alnawaiseh, Maged			Repeatability, reproducibility and agreement of foveal avascular zone measurements using three different optical coherence tomography angiography devices	PLOS ONE			English	Article							RETINAL VEIN OCCLUSION; HEALTHY-SUBJECTS; DIABETIC-RETINOPATHY; VISUAL-ACUITY; AREA; DENSITY; EYES	Purpose To evaluate the repeatability, the reproducibility and the agreement of foveal avascular zone (FAZ) measurements using three different optical coherence tomography angiography (OCT-A) devices. Procedures This prospective study included 24 eyes of 24 healthy volunteers. OCT-A imaging was performed using RTVue XR Avanti, Canon OCT-HS100 and Spectralis OCT-A. Repeated measurements were performed under the same conditions on two separate days, and the area of the FAZ was determined and analyzed using the above devices. Results All three devices showed a high ICC and there was no significant difference between the ICCs (pairwise comparison) of the three devices (Optovue-Canon (p = 0.66); Canon-Heidelberg (p = 0.21); Heidelberg-Optovue (p = 0.37). Agreement analysis of the three devices revealed a significant elevation of FAZ area values with the Heidelberg device and a slight underestimation of the FAZ area with the Canon device. Nevertheless, overall we found a high level of agreement between all of the three devices (ICC >= 0.958 (0.905-0.982)). Conclusions Good reproducibility and repeatability were observed for all three devices. However, the agreement analysis revealed slight, but significant differences, which might limit alternating use of these devices for clinical research and follow-up examinations.	[Mihailovic, Natasa; Lahme, Larissa; Schubert, Friederike; Eter, Nicole; Alnawaiseh, Maged] Univ Munster, Med Ctr, Dept Ophthalmol, Munster, Germany; [Brand, Cristin] Univ Munster, Inst Reprod & Regenerat Biol, Ctr Reprod Med & Androl, Munster, Germany; [Bormann, Eike] Univ Munster, Inst Biostat & Clin Res, Munster, Germany	University of Munster; University of Munster; University of Munster	Mihailovic, N (corresponding author), Univ Munster, Med Ctr, Dept Ophthalmol, Munster, Germany.	nat.mihailovic@gmail.com			University of Muenster	University of Muenster	We acknowledge support by Open Access Publication Fund of University of Muenster.	Alnawaiseh M., 2017, RETINA; Alnawaiseh M, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0293-2; Baba T, 2017, RETINA-J RET VIT DIS, V37, P444, DOI 10.1097/IAE.0000000000001205; Balaratnasingam C, 2016, OPHTHALMOLOGY, V123, P2352, DOI 10.1016/j.ophtha.2016.07.008; Brand C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13528-4; Brautaset R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149138; Carpineto P, 2016, BRIT J OPHTHALMOL, V100, P671, DOI 10.1136/bjophthalmol-2015-307330; Corvi F, 2018, AM J OPHTHALMOL, V186, P25, DOI 10.1016/j.ajo.2017.11.011; Coscas G, 2016, DEV OPHTHALMOL, V56, P1, DOI 10.1159/000442768; de Carlo Talisa E, 2015, Int J Retina Vitreous, V1, P5; Gozlan J, MEDICINE BALTIMORE, V96, pe6427; Guo JX, 2017, OPHTHALMOLOGICA, V237, P21, DOI 10.1159/000453112; Hussain Nazimul, 2016, Int J Retina Vitreous, V2, P27; Iafe NA, 2016, INVEST OPHTH VIS SCI, V57, P5780, DOI 10.1167/iovs.16-20045; Jia YL, 2015, P NATL ACAD SCI USA, V112, pE2395, DOI 10.1073/pnas.1500185112; Mastropasqua R, 2017, EUR J OPHTHALMOL, V27, P336, DOI 10.5301/ejo.5000858; Mastropasqua R, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/343515; Mendis KR, 2010, INVEST OPHTH VIS SCI, V51, P5864, DOI 10.1167/iovs.10-5333; Munk MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177059; Pilotto E, 2018, OPHTHALMIC RES, V59, P206, DOI 10.1159/000485463; Samara WA, 2015, RETINA-J RET VIT DIS, V35, P2188, DOI 10.1097/IAE.0000000000000847; Wakabayashi T, 2017, INVEST OPHTH VIS SCI, V58, P2087, DOI 10.1167/iovs.16-21208; Zhang M, 2016, INVEST OPHTH VIS SCI, V57, P5101, DOI 10.1167/iovs.16-19776	23	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206045	10.1371/journal.pone.0206045	http://dx.doi.org/10.1371/journal.pone.0206045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335839	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300091
J	Simbotwe, M; Fujikura, D; Ohnuma, M; Omori, R; Furuta, Y; Muuka, GM; Hang'ombe, BM; Higashi, H				Simbotwe, Manyando; Fujikura, Daisuke; Ohnuma, Miyuki; Omori, Ryosuke; Furuta, Yoshikazu; Muuka, Geoffrey Munkombwe; Hang'ombe, Bernard Mudenda; Higashi, Hideaki			Development and application of a Bacillus anthracis protective antigen domain-1 in-house ELISA for the detection of antiprotective antigen antibodies in cattle in Zambia	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; CHEETAH ACINONYX-JUBATUS; LUANGWA VALLEY; WESTERN ZAMBIA; NORTH-DAKOTA; OUTBREAK; WILDLIFE; VACCINE; HUMANS; IMMUNITY	In Zambia, anthrax outbreaks among cattle are reported on nearly an annual basis. Presently, there is a lack of serological assays and information to develop an anthrax management and control strategy. In this study, an indirect enzyme-linked immunosorbent assay (ELISA) based on recombinant protective antigen domain 1 (rPA-D1) of Bacillus anthracis was developed and used to detect anti-PA antibodies in cattle in Zambia. An antigen coating of 10 ng/well and a serum dilution of 1: 100 were determined to be the optimal rPA-D1 ELISA titration conditions. The intra-and inter-assay% coefficients of variation were less than 10% and 15%, respectively. The rPA-D1 ELISA could detect seroconversion in the cattle 1 month after anthrax vaccination. In a cross-sectional study conducted in the Western Province, Zambia, 187 serum samples from 8 herds of cattle were screened for anti-PA antibodies using the rPA-D1 ELISA. The seropositive rate of the serum samples was 8%, and the mean anti-PA antibody was 0.358 ELISA units. Additionally, we screened 131 cattle serum samples from Lusaka, which is a nonendemic area, and found no significant association between the antibody levels and sampling area (endemic versus nonendemic area). Conversely, significant differences were observed between the anti-PA antibody levels and herds, anti-PA antibody levels and vaccination status and anti-PA antibody levels and vaccination timing. Collectively, these findings suggest that the rPA-D1 ELISA is a useful tool for the detection of anti-PA antibodies in cattle in Zambia. The low proportion of seropositive sera indicates that there is inadequate cattle vaccination in the Western Province and, in addition to other epidemiological factors, this may precipitate the anthrax outbreak recurrence.	[Simbotwe, Manyando; Fujikura, Daisuke; Ohnuma, Miyuki; Furuta, Yoshikazu; Higashi, Hideaki] Hokkaido Univ, Res Ctr Zoonosis Control, Div Infect & Immun, Sapporo, Hokkaido, Japan; [Simbotwe, Manyando; Omori, Ryosuke; Furuta, Yoshikazu; Higashi, Hideaki] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Fujikura, Daisuke] Asahikawa Med Univ, Educ Res Promot Ctr, Asahikawa, Hokkaido, Japan; [Omori, Ryosuke] Hokkaido Univ, Res Ctr Zoonosis Control, Div Bioinformat, Sapporo, Hokkaido, Japan; [Muuka, Geoffrey Munkombwe] Minist Fisheries & Livestock, Cent Vet Res Inst, Bacteriol Sect, Lusaka, Zambia; [Hang'ombe, Bernard Mudenda] Univ Zambia, Sch Vet Med, Microbiol Unit, Lusaka, Zambia; [Higashi, Hideaki] Hokudai Ctr Zoonosis Control Zambia, Lusaka, Zambia	Hokkaido University; Hokkaido University; Asahikawa Medical College; Hokkaido University; University of Zambia	Higashi, H (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Infect & Immun, Sapporo, Hokkaido, Japan.; Higashi, H (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.; Higashi, H (corresponding author), Hokudai Ctr Zoonosis Control Zambia, Lusaka, Zambia.	hidea-hi@czc.hokudai.ac.jp	Furuta, Yoshikazu/AAB-2219-2020	Furuta, Yoshikazu/0000-0003-4710-1389; Higashi, Hideaki/0000-0002-5370-7865	Programme for Leading Graduate Schools, Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)	Programme for Leading Graduate Schools, Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Programme for Leading Graduate Schools, Ministry of Education, Culture, Sports, Science and Technology (MEXT) and partly by Japan Initiative for Global Research Network on Infectious Diseases (J-GRID). Funders had no role in study design, decision to publish or manuscript preparation.	Abboud N, 2008, CLIN VACCINE IMMUNOL, V15, P1115, DOI 10.1128/CVI.00015-08; Cizauskas CA, 2014, J ANIM ECOL, V83, P1078, DOI 10.1111/1365-2656.12207; Flick-Smith HC, 2002, INFECT IMMUN, V70, P1653, DOI 10.1128/IAI.70.3.1653-1656.2002; Good KM, 2008, J WILDLIFE DIS, V44, P721, DOI 10.7589/0090-3558-44.3.721; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Gupta PK, 2003, FEBS LETT, V554, P505, DOI 10.1016/S0014-5793(03)01226-2; Hang'ombe MB, 2012, TROP DOCT, V42, P136, DOI 10.1258/td.2012.110454; Hassan JRM, MICROBES HLTH; Hugh-Jones ME, 2002, REV SCI TECH OIE, V21, P359, DOI 10.20506/rst.21.2.1336; IACONOCONNORS LC, 1994, CLIN DIAGN LAB IMMUN, V1, P78, DOI 10.1128/CDLI.1.1.78-82.1994; Kasese-Chanda N., 2017, HLTH PRESS ZAMBIA B, V1, P50; KAUFMANN AF, 1973, J AM VET MED ASSOC, V163, P442; KEPPIE J, 1963, BRIT J EXP PATHOL, V44, P446; Kingston JJ, 2015, INDIAN J MICROBIOL, V55, P29, DOI 10.1007/s12088-014-0494-4; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; Lembo T, 2011, EMERG INFECT DIS, V17, P387, DOI 10.3201/eid1703.101290; Lewerin SS, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-7; MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989; Marcus H, 2004, INFECT IMMUN, V72, P3471, DOI 10.1128/IAI.72.6.3471-3477.2004; Mongoh MN, 2008, ZOONOSES PUBLIC HLTH, V55, P279, DOI 10.1111/j.1863-2378.2008.01135.x; Mongoh MN, 2008, PUBLIC HEALTH REP, V123, P352, DOI 10.1177/003335490812300315; Munang'andu HM, 2012, J VET SCI, V13, P293, DOI 10.4142/jvs.2012.13.3.293; Munang'andu HM, 2012, ACTA TROP, V124, P162, DOI 10.1016/j.actatropica.2012.07.008; Munangandu HM, 1996, JPN J VET RES, V44, P175; Mwambi PEM, 2017, CUTANEOUS ANTHRAX OU, V1, P38; Okinaka RT, 1999, J BACTERIOL, V181, P6509, DOI 10.1128/JB.181.20.6509-6515.1999; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Quinn CP, 2002, EMERG INFECT DIS, V8, P1103, DOI 10.3201/eid0810.020380; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Republic of Zambia Ministry of Agriculture and Livestock Department of Livestock Veterinary Development, 2010, ANN REPORT; Reuveny S, 2001, INFECT IMMUN, V69, P2888, DOI 10.1128/IAI.69.5.2888-2893.2001; Siamudaala VM, 2006, JPN J VET RES, V54, P15; Sitali DC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005580; TUCHILI LM, 1993, VET REC, V132, P487, DOI 10.1136/vr.132.19.487-a; Turnbull PCB, 2004, VACCINE, V22, P3340, DOI 10.1016/j.vaccine.2004.02.037; TURNBULL PCB, 1992, EPIDEMIOL INFECT, V108, P299, DOI 10.1017/S0950268800049773; Turnbull PCB, 1999, J APPL MICROBIOL, V87, P318, DOI 10.1046/j.1365-2672.1999.00903.x; TURNBULL PCB, 1991, VET REC, V128, P399, DOI 10.1136/vr.128.17.399; Turner AJ, 1999, J APPL MICROBIOL, V87, P294, DOI 10.1046/j.1365-2672.1999.00894.x; Turner WC, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00245.1; UCHIDA I, 1993, MOL MICROBIOL, V9, P487, DOI 10.1111/j.1365-2958.1993.tb01710.x; VANNESS GB, 1971, SCIENCE, V172, P1303, DOI 10.1126/science.172.3990.1303; Varshney A., 2016, J BIOTERROR BIODEF, V7, DOI [10.4172/2157-2526.1000147, DOI 10.4172/2157-2526.1000147]; Varshney A, 2016, DEFENCE SCI J, V66, P645, DOI 10.14429/dsj.66.10805; WHO, 2008, WORLD MAL REP 2008, P10	45	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205986	10.1371/journal.pone.0205986	http://dx.doi.org/10.1371/journal.pone.0205986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335853	Green Submitted, Green Published, gold			2022-12-26	WOS:000447701300085
J	Wang, FM; Wang, JD; Hung, YW				Wang, Fuhmei; Wang, Jung-Der; Hung, Yu-Wen			Universal health insurance, health inequality and oral cancer in Taiwan	PLOS ONE			English	Article							LIFE EXPECTANCY; CHILD HEALTH; SURVIVAL; CARE; EXTRAPOLATION; DISPARITY; LOST	Introduction The introduction of universal health insurance coverage aims to provide equal accessibility and affordability of health care, but whether such a policy eliminates health inequalities has not been conclusively determined. This research aims to examine the healthcare outcomes of oral cancer and determine whether the universal coverage system in Taiwan has reduced health inequality. Methods Linking the databases of the National Cancer Registry with the National Mortality Registry in Taiwan, we stratified patients with oral squamous cell carcinoma by gender and income to estimate the incidence rate, cumulative incidence rate aged from 20 to 79 (CIR20-79), life expectancy, and expected years of life lost (EYLL). The difficulties with asymmetries and short follow-up periods were resolved through applying survival analysis extrapolation methods. Results While all people showed a general improvement in life expectancy after the introduction of the NHI, the estimated change in EYLL's of the high-, middle-, and low-income female patients were found to have +0.3, -0.5 and -7 years of EYLL, respectively, indicating a reduction in health inequality. Improvements for the male patients were unremarkable. There was no drop in the CIR20-79 of oral cancer in disadvantaged groups as in those with higher incomes. Conclusions Universal coverage alone may not reduce health inequality across different income groups for oral cancer unless effective preventive measures are implemented for economically disadvantaged regions.	[Wang, Fuhmei] Natl Cheng Kung Univ, Dept Econ, Tainan, Taiwan; [Wang, Jung-Der; Hung, Yu-Wen] Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University	Wang, JD (corresponding author), Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med, Tainan, Taiwan.	jdwang121@gmail.com			National Science Council of Taiwan [NSC 102-2314-B-006-029-MY2, NSC 102-2811-B-006-018, NSC101-314-Y-006-001]; Ministry of Health and Welfare of Taiwan [DOH102-TD-C-111-003]; Ministry of Science and Technology of Taiwan [MOST 105-241-H006-091]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare of Taiwan; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan (Grant no. NSC 102-2314-B-006-029-MY2, NSC 102-2811-B-006-018 and NSC101-314-Y-006-001), Ministry of Health and Welfare of Taiwan (DOH102-TD-C-111-003), and the Ministry of Science and Technology of Taiwan (Grant no. MOST 105-241-H006-091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript with the registered number of 201006061R.	Akhtar S, 2013, CANCER CAUSE CONTROL, V24, P257, DOI 10.1007/s10552-012-0113-9; Andersson TML, 2013, STAT MED, V32, P5286, DOI 10.1002/sim.5943; [Anonymous], 2016, SURVEY FAMILY INCOME; Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321; Chang H., 2002, HARV HLTH POLICY REV, V3, P40; Chen YK, 1999, ORAL ONCOL, V35, P173, DOI 10.1016/S1368-8375(98)00101-8; Cheng SH, 1998, SOC SCI MED, V47, P613, DOI 10.1016/S0277-9536(98)00103-8; Chu PC, 2008, VALUE HEALTH, V11, P1102, DOI 10.1111/j.1524-4733.2008.00350.x; Currie J, 1995, SCAND J ECON, V97, P603, DOI 10.2307/3440545; Curtis LJ, 2001, HEALTH ECON, V10, P287, DOI 10.1002/hec.591; Davis W., 1978, CANC REGISTRATION IT; Decker Sandra L, 2004, Appl Health Econ Health Policy, V3, P205, DOI 10.2165/00148365-200403040-00004; Department of Health and Welfare, 2008, PERF PREV ALL CANC 5; Donnelly DW, 2011, CANCER EPIDEMIOL, V35, pE55, DOI 10.1016/j.canep.2011.06.002; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; Ghani WMN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-82; Hung MC, 2015, CANCER EPIDEMIOL, V39, P126, DOI 10.1016/j.canep.2014.12.004; Hwang JS, 1999, STAT MED, V18, P1627, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1627::AID-SIM159>3.3.CO;2-4; International Agency for Research on Cancer, 2003, IARC MONOGRAPHS EVAL, V85; Jackson C, 2017, MED DECIS MAKING, V37, P377, DOI 10.1177/0272989X16639900; Ko Y, 2006, J ORAL PATHOL MED, V24, P450; Morton A, 2014, J HEALTH ECON, V36, P164, DOI 10.1016/j.jhealeco.2014.04.005; Petersen PE, 2009, ORAL ONCOL, V45, P454, DOI 10.1016/j.oraloncology.2008.05.023; Rachet B, 2010, BRIT J CANCER, V103, P446, DOI 10.1038/sj.bjc.6605752; Smith KE, 2016, HLTH INEQUALITIES CR, P265; von dem Knesebeck O, 2003, SOC SCI MED, V57, P1643, DOI 10.1016/S0277-9536(03)00020-0; Wagstaff A, 2000, J HUM RESOUR, V35, P716, DOI 10.2307/146369; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wong YK, 2006, ORAL ONCOL, V42, P893, DOI 10.1016/j.oraloncology.2005.12.007; World Health Organization, 2013, INT CLASSIFICATION D; Yang SC, 2017, LUNG CANCER, V108, P183, DOI 10.1016/j.lungcan.2017.04.001	31	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205731	10.1371/journal.pone.0205731	http://dx.doi.org/10.1371/journal.pone.0205731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4KR	30335806	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300048
J	Marston, M; Zaba, B; Eaton, JW				Marston, Milly; Zaba, Basia; Eaton, Jeffrey W.			Relative patterns of sexual activity and fertility among HIV positive and negative women-Evidence from 46 DHS	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; IMPACT; PREGNANCY; MORTALITY	Objectives Projections of fertility of HIV positive women as ART scales up are needed to plan prevention of mother-to-child transmission (PMTCT) services. We describe differences in exposure to pregnancy between HIV positive and HIV negative women by age, region and national ART coverage to evaluate the extent to which behavioural differences explain lower fertility among HIV positive women and assess whether exposure to pregnancy has changed with antiretroviral treatment (ART) scale-up. Methods We analysed 46 nationally representative household surveys in sub-Saharan Africa conducted between 2003 and 2015 to estimate risk of exposure to recent sex and pregnancy of HIV positive and HIV negative women by age using a log binomial model. We tested for regional and urban/rural differences and associations with national ART coverage. We estimated an adjusted fertility rate ratio of HIV positive to HIV negative women adjusting for differences in exposure to pregnancy. Results Exposure to pregnancy differs significantly between HIV positive and negative women by age, modified by region. Younger HIV positive women have a higher exposure to pregnancy than HIV negative women and the opposite is true at older ages. The switch occurs at 2529 for rural women and 30-34 for urban women. There was no evidence that exposure to pregnancy of HIV positive women have changed as national ART coverage increased. The inferred rate of fecundity of HIV positive women when adjusted for differences in exposure to pregnancy were lower than unadjusted fertility rate ratios in women aged 20-29 and 20-24 in urban and rural areas respectively varying between 0.6 and 0.9 over regions. Discussion The direct effects of HIV on fertility are broadly similar across ages, while the dramatic age gradient that has frequently been observed is largely attributable to variation in relative sexual exposure by age.	[Marston, Milly; Zaba, Basia] London Sch Hyg & Trop Med, London, England; [Eaton, Jeffrey W.] Imperial Coll London, Dept Infect Dis Epidemiol, London, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Marston, M (corresponding author), London Sch Hyg & Trop Med, London, England.	milly.marston@lshtm.ac.uk		Eaton, Jeffrey/0000-0001-7728-728X	Wellcome Trust [085477/Z/08/Z]; UNAIDS; NIH [R03AI125001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI125001] Funding Source: NIH RePORTER; MRC [MR/R015600/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); UNAIDS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	M.M. was supported by the Wellcome Trust (085477/Z/08/Z). J.W.E was supported by UNAIDS and NIH (R03AI125001).	Chen WJ, 2010, SEX TRANSM INFECT, V86, pI22, DOI 10.1136/sti.2010.043620; Elul B, 2016, JAIDS-J ACQ IMM DEF, V72, P324, DOI 10.1097/QAI.0000000000000963; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Gray RH, 1998, LANCET, V351, P98, DOI 10.1016/S0140-6736(97)09381-1; Gregson S, 1999, AIDS, V13, pS249; Lewis JJC, 2004, AIDS, V18, pS35, DOI 10.1097/00002030-200406002-00005; Makumbi FE, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/519492; Marston M, 2017, TROP MED INT HEALTH, V22, P1542, DOI 10.1111/tmi.12983; Marston M, 2016, AIDS LONDON ENGLAND, DOI [10.1097/QAD.0000000000001305, DOI 10.1097/QAD.0000000000001305]; Marston M, 2012, TROP MED INT HEALTH, V17, pe58, DOI 10.1111/j.1365-3156.2011.02924.x; Mayaud P., 2001, WOMEN INFERTILITY SU, p71 ; Mayaud P., 2013, PRINCIPLES MED AFRIC, p279 ; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; Mumah JN, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25579; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Ross A, 1999, AIDS, V13, P2133, DOI 10.1097/00002030-199910220-00017; Ross A, 2004, AIDS, V18, P799, DOI 10.1097/00002030-200403260-00012; Souza E, 2015, AJAR-AFR J AIDS RES, V14, P315, DOI 10.2989/16085906.2015.1093512; Terceira N, 2003, POP STUD-J DEMOG, V57, P149, DOI 10.1080/0032472032000097074; Tsevat DG, 2017, AM J OBSTET GYNECOL, V216, P1, DOI 10.1016/j.ajog.2016.08.008; UNAIDS, **NON-TRADITIONAL**; Yeatman S, 2016, TROP MED INT HEALTH, V21, P1071, DOI 10.1111/tmi.12747; Zaba B, 1998, AIDS, V12, pS41	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204584	10.1371/journal.pone.0204584	http://dx.doi.org/10.1371/journal.pone.0204584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332414	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200017
J	Perrichon, P; Mager, EM; Pasparakis, C; Stieglitz, JD; Benetti, DD; Grosell, M; Burggren, WW				Perrichon, Prescilla; Mager, Edward M.; Pasparakis, Christina; Stieglitz, John D.; Benetti, Daniel D.; Grosell, Martin; Burggren, Warren W.			Combined effects of elevated temperature and Deepwater Horizon oil exposure on the cardiac performance of larval mahi-mahi, Coryphaena hippurus	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; WEATHERED CRUDE-OIL; SALMON ONCORHYNCHUS-GORBUSCHA; FISH EMBRYOS; DEVELOPMENTAL TOXICITY; EXXON-VALDEZ; ULTRAVIOLET-RADIATION; OXYGEN-CONSUMPTION; ZEBRAFISH; SALINITY	The 2010 Deepwater Horizon oil spill coincided with the spawning season of many pelagic fish species in the Gulf of Mexico. Yet, few studies have investigated physiological responses of larval fish to interactions between anthropogenic crude oil exposure and natural factors (e.g. temperature, oxygen levels). Consequently, mahi mahi (Coryphaena hippurus) embryos were exposed for 24 hours to combinations of two temperatures (26 and 30 degrees C) and six concentrations of oiled fractions of weathered oil (from 0 to 44.1 mu g Sigma 50PAHs.L-1). In 56 hours post-fertilization larvae, heart rate, stroke volume and cardiac output were measured as indicators of functional cardiac phenotypes. Fluid accumulation and incidence of edema and hematomas were quantified as indicators of morphological impairments. At both 26 and 30 degrees C, oil-exposed larvae suffered dose-dependent morphological impairments and functional heart failure. Elevation of temperature to 30 degrees C appeared to induce greater physiological responses (bradycardia) at PAH concentrations in the range of 3.0-14.9 mu g.L-1. Conversely, elevated temperature in oil-exposed larvae reduced edema severity and hematoma incidence. However, the apparent protective role of warmer temperature does not appear to protect against enhanced mortality. Collectively, our findings show that elevated temperature may slightly decrease larval resilience to concurrent oil exposure.	[Perrichon, Prescilla; Mager, Edward M.; Burggren, Warren W.] Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA; [Pasparakis, Christina; Stieglitz, John D.; Grosell, Martin] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Benetti, Daniel D.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Ecosyst & Soc, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Perrichon, Prescilla] Inst Marine Res, Austevoll Res Stn, Storebo, Norway	University of North Texas System; University of North Texas Denton; University of Miami; University of Miami; Institute of Marine Research - Norway	Perrichon, P (corresponding author), Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA.; Perrichon, P (corresponding author), Inst Marine Res, Austevoll Res Stn, Storebo, Norway.	prescilla.perrichon@gmail.com	Pasparakis, Christina/AAG-4583-2022; Burggren, Warren W/A-1561-2016; Pasparakis, Christina/AFK-6308-2022; PERRICHON, Prescilla/O-9715-2014	Burggren, Warren W/0000-0001-8023-420X; PERRICHON, Prescilla/0000-0002-1410-878X	Gulf of Mexico Research Initiative [SA-1520]	Gulf of Mexico Research Initiative	This research was made possible by a grant from the Gulf of Mexico Research Initiative. Data are publicly available through the Gulf of Mexico Research Initiative Information and Data Cooperative (GRIIDC) at https://data.gulfresearchinitiative.org (doi:<10.7266/N7PR7T17>; doi:<10.7266/N7T151PG>; doi: <10.7266/N7C53HX0). Grant N0; SA-1520; Name: Relationship of Effects of Cardiac Outcomes in fish for Validation of Ecological Risk (RECOVER) to MG, WWB and DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrajano TA, 2005, TREATISE ON GEOCHEMISTRY, VOL 9: ENVIRONMENTAL GEOCHEMISTRY, P475; Alloy M, 2016, ENVIRON SCI TECHNOL, V50, P2011, DOI 10.1021/acs.est.5b05356; Andersen O, 2015, AQUAT TOXICOL, V165, P9, DOI 10.1016/j.aquatox.2015.04.023; ANDERSON JW, 1974, MAR BIOL, V27, P75, DOI 10.1007/BF00394763; Billiard SM, 2006, TOXICOL SCI, V92, P526, DOI 10.1093/toxsci/kfl011; Booth AM, 2007, ENVIRON SCI TECHNOL, V41, P457, DOI 10.1021/es0615829; Brette F, 2014, SCIENCE, V343, P772, DOI 10.1126/science.1242747; Carls MG, 2009, HUM ECOL RISK ASSESS, V15, P1084, DOI 10.1080/10807030903304708; Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317; Di Giulio R.T., 2008, TOXICOLOGY FISHES, DOI [10.1016/0278-6915(91)90171-3, DOI 10.1016/0278-6915(91)90171-3]; Dubansky B, 2013, ENVIRON SCI TECHNOL, V47, P5074, DOI 10.1021/es400458p; Edmunds RC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17326; Esbaugh AJ, 2016, SCI TOTAL ENVIRON, V543, P644, DOI 10.1016/j.scitotenv.2015.11.068; Fielder DS, 2005, AQUACULTURE, V250, P201, DOI 10.1016/j.aquaculture.2005.04.045; Fingas MF, 2005, INT OIL SPILL C P, P2659, DOI [DOI 10.7901/2169-3358-1999-1-281, 10.7901/2169-3358-1999-1-281]; Forth HP, 2017, ENVIRON TOXICOL CHEM, V36, P1450, DOI 10.1002/etc.3672; FUKUHARA O, 1990, MAR BIOL, V106, P169, DOI 10.1007/BF01314797; GIBBS ROBERT H., 1959, BULL MARINE SCI GULF AND CARIBBEAN, V9, P117; Gracia-Lopez V, 2004, AQUACULTURE, V237, P485, DOI 10.1016/j.aquaculture.2004.04.018; Hart PR, 1995, AQUACULTURE, V136, P221, DOI 10.1016/0044-8486(95)01061-0; Heintz RA, 1999, ENVIRON TOXICOL CHEM, V18, P494, DOI 10.1002/etc.5620180318; Heintz RA, 2000, MAR ECOL PROG SER, V208, P205, DOI 10.3354/meps208205; Hicken CE, 2011, P NATL ACAD SCI USA, V108, P7086, DOI 10.1073/pnas.1019031108; Incardona JP, 2006, TOXICOL APPL PHARM, V217, P308, DOI 10.1016/j.taap.2006.09.018; Incardona JP, 2016, AQUAT TOXICOL, V177, P515, DOI 10.1016/j.aquatox.2016.06.016; Incardona JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep13499; Incardona JP, 2014, P NATL ACAD SCI USA, V111, pE1510, DOI 10.1073/pnas.1320950111; Incardona JP, 2013, AQUAT TOXICOL, V142, P303, DOI 10.1016/j.aquatox.2013.08.011; Incardona JP, 2012, P NATL ACAD SCI USA, V109, pE51, DOI 10.1073/pnas.1108884109; Incardona JP, 2011, J EXPO SCI ENV EPID, V21, P3, DOI 10.1038/jes.2010.51; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Jayasundara N, 2017, ENVIRON SCI TECHNOL, V51, P8763, DOI 10.1021/acs.est.7b01913; Jayasundara N, 2015, TOXICOL SCI, V143, P469, DOI 10.1093/toxsci/kfu245; Jonsson G, 2004, ENVIRON TOXICOL CHEM, V23, P1538, DOI 10.1897/03-173; Jung JH, 2013, CHEMOSPHERE, V91, P1146, DOI 10.1016/j.chemosphere.2013.01.019; Khursigara AJ, 2017, SCI TOTAL ENVIRON, V579, P797, DOI 10.1016/j.scitotenv.2016.11.026; Kim YS, 2015, FISHERIES SCI, V81, P891, DOI 10.1007/s12562-015-0901-8; Kitchens LL, 2014, FISH OCEANOGR, V23, P460, DOI 10.1111/fog.12081; Kopp R, 2005, J EXP BIOL, V208, P2123, DOI 10.1242/jeb.01620; Kopp R, 2010, PHYSIOL GENOMICS, V42A, P8, DOI 10.1152/physiolgenomics.00052.2010; Lema SC, 2007, AQUAT TOXICOL, V82, P296, DOI 10.1016/j.aquatox.2007.03.002; Liu ZF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035302; Lyons MC, 2011, ECOTOX ENVIRON SAFE, V74, P904, DOI 10.1016/j.ecoenv.2010.12.013; Mager EM, 2014, ENVIRON SCI TECHNOL, V48, P7053, DOI 10.1021/es501628k; Marty GD, 1997, CAN J FISH AQUAT SCI, V54, P1846, DOI 10.1139/cjfas-54-8-1846; Melbye AG, 2009, ENVIRON TOXICOL CHEM, V28, P1815, DOI 10.1897/08-545.1; Mirkovic T, 1998, PHYSIOL ZOOL, V71, P191, DOI 10.1086/515896; Miyanishi H, 2013, AM J PHYSIOL-REG I, V304, pR423, DOI 10.1152/ajpregu.00384.2012; Nelson D, 2016, AQUAT TOXICOL, V180, P274, DOI 10.1016/j.aquatox.2016.10.012; Pasparakis C, 2017, AQUAT TOXICOL, V191, P113, DOI 10.1016/j.aquatox.2017.07.021; Pasparakis C, 2016, AQUAT TOXICOL, V181, P113, DOI 10.1016/j.aquatox.2016.10.022; Pelster B, 1999, COMP BIOCHEM PHYS A, V124, P407, DOI 10.1016/S1095-6433(99)00132-4; Perrichon P, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00464; Perrichon P, 2017, BIOL OPEN, V6, P800, DOI 10.1242/bio.025692; Perrichon P, 2016, SCI TOTAL ENVIRON, V568, P952, DOI 10.1016/j.scitotenv.2016.04.186; Perrichon P, 2015, SCI TOTAL ENVIRON, V524, P52, DOI 10.1016/j.scitotenv.2015.04.018; Plata DL, 2008, ENVIRON SCI TECHNOL, V42, P2432, DOI 10.1021/es702384f; Rhodes S, 2005, ECOTOX ENVIRON SAFE, V60, P247, DOI 10.1016/j.ecoenv.2004.08.002; Rooker JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076080; Rooker JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034180; Ryerson TB, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046726; Ryerson TB, 2012, P NATL ACAD SCI USA, V109, P20246, DOI 10.1073/pnas.1110564109; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schonweger G, 2000, AM J PHYSIOL-REG I, V279, pR1634, DOI 10.1152/ajpregu.2000.279.5.R1634; Sorhus E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31058; Stieglitz JD, 2017, AQUACULTURE, V479, P1, DOI 10.1016/j.aquaculture.2017.05.006; Stieglitz JD, 2016, ENVIRON TOXICOL CHEM, V35, P2613, DOI 10.1002/etc.3436; Stieglitz JD, 2012, AQUAC RES, V43, P1557, DOI 10.1111/j.1365-2109.2011.02961.x; Sweet LE, 2017, ENVIRON TOXICOL CHEM, V36, P1592, DOI 10.1002/etc.3687; U.S. EPA, 2014, ENVIRON JUSTICE; Xu EG, 2016, ENVIRON SCI TECHNOL, V50, P7842, DOI 10.1021/acs.est.6b02205; Yufera M, 2007, AQUACULTURE, V268, P53, DOI 10.1016/j.aquaculture.2007.04.050; [No title captured]	75	30	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0203949	10.1371/journal.pone.0203949	http://dx.doi.org/10.1371/journal.pone.0203949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332409	gold, Green Published, Green Submitted			2022-12-26	WOS:000447638200008
J	Vowels, MJ; Mark, KP; Vowels, LM; Wood, ND				Vowels, Matthew J.; Mark, Kristen P.; Vowels, Laura M.; Wood, Nathan D.			Using spectral and cross-spectral analysis to identify patterns and synchrony in couples' sexual desire	PLOS ONE			English	Article							RELATIONSHIP SATISFACTION; MENSTRUAL-CYCLE; DISCREPANCY; ASSOCIATIONS; EXPERIENCE; FREQUENCY; IMPACT; DYSFUNCTION; STRATEGIES; BEHAVIOR	Sexual desire discrepancy is one of the most frequently reported sexual concerns for individuals and couples and has been shown to be negatively associated with sexual and relationship satisfaction. Sexual desire has increasingly been examined as a state-like construct that ebbs and flows, but little is known about whether there are patterns in the fluctuation of sexual desire. Utilizing spectral and cross-spectral analysis, we transformed 30 days of dyadic daily diary data for perceived levels of sexual desire for a non-clinical sample of 133 couples (266 individuals) into the frequency domain to identify shared periodic state fluctuations in sexual desire. Spectral analysis is a technique commonly used in physics and engineering that allows time series data to be analyzed for the presence of regular cycles of fluctuation. Cross-spectral analysis allows for dyadic data to be analyzed for shared rates of fluctuation between partners as well as the degree of (a)synchrony (or phase shift) between these fluctuations. Men and women were found to exhibit fluctuations in sexual desire at various frequencies including rates of once and twice per month, and to have sexual desire that was unlikely to fluctuate over periods of three days or less and therefore exhibited persistence. Similar patterns of fluctuation were exhibited within couples and these patterns were found to be largely synchronous. While instances of desire discrepancy may arise due to differences in rates of sexual desire fluctuation and random fluctuations, such instances may be normal for romantic relationships. The results have important implications for researchers, clinicians, and educators in that they corroborate the supposition that sexual desire ebbs and flows and suggest that it does so with predictable regularity.	[Vowels, Matthew J.] Univ Surrey, Dept Elect & Elect Engn, Guildford, Surrey, England; [Vowels, Matthew J.] Univ Surrey, Dept Mus & Media, Guildford, Surrey, England; [Mark, Kristen P.] Univ Kentucky, Dept Kinesiol & Hlth Promot, Lexington, KY 40506 USA; [Vowels, Laura M.] Univ Southampton, Dept Psychol, Southampton, Hants, England; [Wood, Nathan D.] Univ Kentucky, Dept Family Sci, Lexington, KY USA; [Mark, Kristen P.] Univ Kentucky, 122 Seaton Ctr, Lexington, KY 40506 USA	University of Surrey; University of Surrey; University of Kentucky; University of Southampton; University of Kentucky; University of Kentucky	Mark, KP (corresponding author), Univ Kentucky, Dept Kinesiol & Hlth Promot, Lexington, KY 40506 USA.; Mark, KP (corresponding author), Univ Kentucky, 122 Seaton Ctr, Lexington, KY 40506 USA.	kristen.mark@uky.edu	Vowels, Laura M/Z-4281-2019; Wood, Nathan/ABP-3330-2022; Mark, Kristen/ABD-9064-2020	Wood, Nathan/0000-0002-6755-1654; Vowels, Matthew/0000-0002-8811-1156; Mark, Kristen/0000-0002-0524-3357; Vowels, Laura/0000-0001-5594-2095	American Institute of Bisexuality; Patty Brisben Foundation for Women's Sexual Health	American Institute of Bisexuality; Patty Brisben Foundation for Women's Sexual Health	These foundations provided funding for data collection: American Institute of Bisexuality-http://www.americaninstituteofbisexuality.org/ and Patty Brisben Foundation for Women's Sexual Health. The funding was awarded to KPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich F, 2000, J ROY STAT SOC D-STA, V49, P1, DOI 10.1111/1467-9884.00216; [Anonymous], 1983, SIGNALS SYSTEMS; [Anonymous], 2017, MATLAB R2017B; Basson R, 2000, J SEX MARITAL THER, V26, P51, DOI 10.1080/009262300278641; Basson R, 2005, CAN MED ASSOC J, V172, P1327, DOI 10.1503/cmaj.1020174; Baumeister RF, 2001, PERS SOC PSYCHOL REV, V5, P242, DOI 10.1207/S15327957PSPR0503_5; BECK JG, 1991, J SEX RES, V28, P443, DOI 10.1080/00224499109551618; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bodenmann G, 2006, J NERV MENT DIS, V194, P494, DOI 10.1097/01.nmd.0000228504.15569.b6; Broersen PMT, 2006, DIGIT SIGNAL PROCESS, V16, P754, DOI 10.1016/j.dsp.2006.01.001; Brown KW, 1998, J PERS, V66, P105, DOI 10.1111/1467-6494.00005; Bullivant SB, 2004, J SEX RES, V41, P82, DOI 10.1080/00224490409552216; Cacioppo S, 2012, J SEX MED, V9, P1048, DOI 10.1111/j.1743-6109.2012.02651.x; Caruso S, 2014, J SEX MED, V11, P211, DOI 10.1111/jsm.12348; Carvalho J, 2011, J SEX RES, V48, P254, DOI 10.1080/00224491003605475; Carvalho J, 2010, J SEX MED, V7, P928, DOI 10.1111/j.1743-6109.2009.01568.x; Chatfield C., 2005, ANAL TIME SERIES INT; Christmas J, 2013, IEEE INT WORKS MACH, DOI 10.1109/MLSP.2013.6661980; Colonius T, 2017, ARXIV170804393; COOLEY JW, 1965, MATH COMPUT, V19, P297, DOI 10.2307/2003354; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Davies S, 1999, ARCH SEX BEHAV, V28, P553, DOI 10.1023/A:1018721417683; Dawson SJ., 2014, CURRENT SEXUAL HLTH, V6, P211, DOI [10.1007/s11930-014-0027-5, DOI 10.1007/S11930-014-0027-5]; DeLamater JD, 2005, J SEX RES, V42, P138, DOI 10.1080/00224490509552267; Efron B, 1998, INTRO BOOTSTRAP; Ellison CR, 2001, WOMEN THER, V24, P147; Enders CK, 2016, BEHAV RES THER, P1; Enders CK, 2011, STRUCT EQU MODELING, V18, P35, DOI 10.1080/10705511.2011.532695; Fleischmann Patrick, 2015, International Journal of Microwave Science and Technology, DOI 10.1155/2015/757591; Gentleman W. M, 1966, PROC NOVEMBER 7 10 1, P563, DOI DOI 10.1145/1464291.1464352; GOTTMAN JM, 1981, CHILD DEV, V52, P393, DOI 10.2307/1129157; GOTTMAN JM, 1979, PSYCHOL BULL, V86, P338, DOI 10.1037/0033-2909.86.2.338; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Haykin S., 2003, SIGNALS SYSTEMS, V2nd ed.; Heisenberg W., 1930, PHYS PRINCIPLES QUAN; Herbenick D, 2014, J SEX MED, V11, P2196, DOI 10.1111/jsm.12625; Hirschenhauser K, 2002, HORM BEHAV, V42, P172, DOI 10.1006/hbeh.2002.1815; Impett EA, 2008, DEV PSYCHOL, V44, P722, DOI 10.1037/0012-1649.44.3.722; IRCAM, 2018, WIND SIZ; Jenkins G., 1968, SPECTRAL ANAL ITS AP; KAPLAN HS, 1977, J SEX MARITAL THER, V3, P3; LARSEN RJ, 1987, J PERS SOC PSYCHOL, V52, P1195, DOI 10.1037/0022-3514.52.6.1195; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Laurenceau JP, 2005, J FAM PSYCHOL, V19, P86, DOI 10.1037/0893-3200.19.1.86; Levine SB, 2002, J SEX MARITAL THER, V28, P39, DOI 10.1080/009262302317251007; Mark KP, 2018, ARCH SEXUAL BEHAV; Mark KP, 2015, CURRENT SEXUAL HLTH, P7; Mark KP, 2018, J SEX RES, V55, P563, DOI 10.1080/00224499.2018.1437592; Mark KP, 2016, J SEX MED, V13, P1359, DOI 10.1016/j.jsxm.2016.06.011; Mark KP, 2014, CAN J HUM SEX, V23, P27, DOI 10.3138/cjhs.23.1.A2; Mark KP, 2012, SEX RELATSH THER, V27, P133, DOI 10.1080/14681994.2012.678825; Mark KP, 2012, J SEX MARITAL THER, V38, P198, DOI 10.1080/0092623X.2011.606877; Mass R, 2009, HORM BEHAV, V55, P267, DOI 10.1016/j.yhbeh.2008.06.007; MathWorks Inc, 2017, MATLAB USERS GUIDE; McNulty JK, 2016, ARCH SEX BEHAV, V45, P85, DOI 10.1007/s10508-014-0444-6; Murray SH, 2012, SEX RELATSH THER, V27, P3, DOI 10.1080/14681994.2011.649251; Nason GP, 2014, STAT, V3, P351, DOI 10.1002/sta4.69; Olsson A, 2005, SCAND J CARING SCI, V19, P381, DOI 10.1111/j.1471-6712.2005.00357.x; Paul S, 2016, ADV COMPUTATION MODE; Peplau LA, 2003, CURR DIR PSYCHOL SCI, V12, P37, DOI 10.1111/1467-8721.01221; Pillsworth EG, 2004, J SEX RES, V41, P55, DOI 10.1080/00224490409552213; Regan P., 2001, LUST WHAT WE KNOW HU; Regan PC, 2006, SOC BEHAV PERSONAL, V34, P95, DOI 10.2224/sbp.2006.34.1.95; Schaffir J, 2006, J SEX MARITAL THER, V32, P305, DOI 10.1080/00926230600666311; Sieber M, 2015, ARXIV150804642; SILBER M, 1994, ARCH SEX BEHAV, V23, P397, DOI 10.1007/BF01541405; Sprecher S, 2002, J SEX RES, V39, P190, DOI 10.1080/00224490209552141; STANISLAW H, 1988, ARCH SEX BEHAV, V17, P499, DOI 10.1007/BF01542338; Stowell D, 2014, METHODS ECOL EVOL, V5, P901, DOI 10.1111/2041-210X.12223; USECHE B, 1990, ADOLESCENCE, V25, P291; Vowels LM, 2020, SEX RELATSH THER, V35, P46, DOI 10.1080/14681994.2018.1441991; Watkinson J., 2001, ART DIGITAL AUDIO, V3rd; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wickramarachi P, 2003, EFFECTS WINDOWING SP, P10; Zoubir AM, 2010, SIGNAL PROCESS, V90, P1424, DOI 10.1016/j.sigpro.2009.11.030	76	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205330	10.1371/journal.pone.0205330	http://dx.doi.org/10.1371/journal.pone.0205330			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX3PM	30332440	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000447638200051
J	Nakamoto, S; Kumamoto, Y; Igarashi, K; Fujiyama, Y; Nishizawa, N; Ei, S; Tajima, H; Kaizu, T; Watanabe, M; Yamashita, K				Nakamoto, Shuji; Kumamoto, Yusuke; Igarashi, Kazuharu; Fujiyama, Yoshiki; Nishizawa, Nobuyuki; Ei, Shigenori; Tajima, Hiroshi; Kaizu, Takashi; Watanabe, Masahiko; Yamashita, Keishi			Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma	PLOS ONE			English	Article							CANCER; SURVIVAL; DIAGNOSIS; MIDDLE	Background Promoter DNA methylation of Cysteine dioxygenase type1 (CDO1) gene has been clarified as a molecular diagnostic and prognostic indicator in various human cancers. The aim of this study is to investigate the clinical relevance of CDO1 methylation in primary biliary tract cancer (BTC). Methods CDO1 DNA methylation was assessed by quantitative methylation-specific PCR in 108 BTC tumor tissues and 101 corresponding normal tissues. BTC was composed of extrahepatic cholangiocarcinoma (EHCC) (n = 81) and ampullary carcinoma (AC) (n = 27). Results The CDO1 methylation value in the tumor tissues was significantly higher than that in the corresponding normal tissues (p< 0.0001). The overall survival (OS) in EHCC patients with hypermethylation was poorer than those with hypomethylation (p = 0.0018), whereas there was no significant difference in AC patients. Multivariate analysis identified that CDO1 hypermethylation, preoperative serum CA19-9 and perineural invasion were independent prognostic factors in EHCC. The EHCC patients with CDO1 hypermethylation exhibited more dismal prognosis than those with hypomethylation even in low group of CA19-9 level (p = 0.0006). Conclusions Our study provided evidence that promoter DNA methylation of CDO1 gene could be an excellent molecular diagnostic and prognostic biomarker in primary EHCC. The combination of CDO1 methylation and preoperative serum CA19-9 effectively enriched EHCC patients who showed the most dismal prognosis. These markers would be beneficial for clinical clarification of the optimal strategies in EHCC.	[Nakamoto, Shuji; Kumamoto, Yusuke; Igarashi, Kazuharu; Fujiyama, Yoshiki; Nishizawa, Nobuyuki; Ei, Shigenori; Tajima, Hiroshi; Kaizu, Takashi; Watanabe, Masahiko; Yamashita, Keishi] Kitasato Univ Hosp, Dept Surg, Minami Ku, Sagamihara, Kanagawa, Japan; [Yamashita, Keishi] Kitasato Univ, Sch Med, Res & Dev Ctr New Med Frontiers, Div Adv Surg Oncol,Minami Ku, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University	Yamashita, K (corresponding author), Kitasato Univ Hosp, Dept Surg, Minami Ku, Sagamihara, Kanagawa, Japan.; Yamashita, K (corresponding author), Kitasato Univ, Sch Med, Res & Dev Ctr New Med Frontiers, Div Adv Surg Oncol,Minami Ku, Sagamihara, Kanagawa, Japan.	keishi23@med.kitasato-u.ac.jp		Yamashita, Keishi/0000-0002-8492-0300; Nakamoto, Shuji/0000-0002-6225-9355				Andresen K, 2015, HEPATOLOGY, V61, P1651, DOI 10.1002/hep.27707; Andresen K, 2012, EPIGENETICS-US, V7, P1249, DOI 10.4161/epi.22191; Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; Cai WK, 2014, INT J CLIN EXP PATHO, P7; Deckers IAG, 2015, CLIN CANCER RES, V21, P3492, DOI 10.1158/1078-0432.CCR-14-2049; Flemming JA, 2016, CANCER-AM CANCER SOC, V122, P2534, DOI 10.1002/cncr.30074; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Igarashi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188178; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kawamata H, 2013, ANTICANCER RES, P33; Kayahara M, 1999, ANN SURG, V229, P76, DOI 10.1097/00000658-199901000-00010; Kojima K, 2017, Dis Esophagus, V30, P1, DOI 10.1093/dote/dow001; Kojima K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194785; Kondo S, 2004, ANN SURG, V240, P95, DOI 10.1097/01.sla.0000129491.43855.6b; Meller S, 2016, EPIGENETICS-US, V11, P871, DOI 10.1080/15592294.2016.1241931; Minatani N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144862; Nagakawa Takukazu, 2002, J Hepatobiliary Pancreat Surg, V9, P569, DOI 10.1007/s005340200076; Nimura Y, 2000, J Hepatobiliary Pancreat Surg, V7, P155, DOI 10.1007/s005340050170; Sakamoto Y, 2005, SURGERY, V137, P396, DOI 10.1016/j.surg.2004.10.008; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tyson GL, 2014, DIGEST DIS SCI, V59, P3103, DOI 10.1007/s10620-014-3276-2; Ushiku H, 2017, GASTRIC CANCER, V20, P784, DOI 10.1007/s10120-017-0697-6; Ushiku Hideki, 2017, Dis Esophagus, V30, P1, DOI 10.1111/dote.12496; Valle JW, 2016, ANN ONCOL, V27, pv28, DOI 10.1093/annonc/mdw324; Vedeld HM, 2015, INT J CANCER, V136, P844, DOI 10.1002/ijc.29039; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yamashita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113546	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205864	10.1371/journal.pone.0205864	http://dx.doi.org/10.1371/journal.pone.0205864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325974	Green Published, gold, Green Submitted			2022-12-26	WOS:000447430800049
J	Chen, Y; Yuan, X; Xiao, ZP; Jin, HW; Zhang, LR; Liu, ZM				Chen, Ya; Yuan, Xia; Xiao, Zhangping; Jin, Hongwei; Zhang, Liangren; Liu, Zhenming			Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening	PLOS ONE			English	Article							ABC TRANSPORTER; MULTIDRUG-RESISTANCE-PROTEIN-4 MRP4/ABCC4; CONFERS RESISTANCE; CRYSTAL-STRUCTURE; DOCKING; SUBSTRATE; VALIDATION; TOPOTECAN; THERAPY; MODEL	Multidrug resistance protein 4 (MRP4/ABCC4) is an ATP-binding cassette (ABC) transporter. It is associated with multidrug resistance (MDR), which is becoming a growing challenge to the treatment of cancer and infections. In the context of several types of cancer in which MRP4 is overexpressed, MRP4 inhibition manifests striking effects against cancer progression and drug resistance. In this study, we combined ligand-based and structurebased drug design strategy, by searching the SPECS chemical library to find compounds that are most likely to bind to MRP4. Clustering analysis based on a two-dimensional fingerprint was performed to help with visual selection of potential compounds. Cell viability assays with potential inhibitors and the anticancer drug 6-MP were carried out to identify their bioactivity. As a result, 39 compounds were tested and seven of them reached inhibition above 55% with 6-MP. Then compound Cpd23 was discovered to improve HEK293/MRP4 cell sensibility to 6-MP dramatically, and low concentration Cpd23 (5 mu M) achieved the equivalent effect of 50 mu M MK571. The accumulation of 6-MP was determined by validated high-performance liquid chromatography methods, and pretreatment of the HEK293/MRP4 cells with 50 mu M MK571 or Cpd23 resulted in significantly increased accumulation of 6-MP by approximately 1.5 times. This compound was first reported with a novel scaffold compared with previously known MRP4 inhibitors, which is a hopeful molecular tool that can be used for overcoming multidrug resistance research.	[Chen, Ya; Yuan, Xia; Xiao, Zhangping; Jin, Hongwei; Zhang, Liangren; Liu, Zhenming] Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing, Peoples R China	Peking University	Zhang, LR; Liu, ZM (corresponding author), Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing, Peoples R China.	liangren@bjmu.edu.cn; zmliu@bjmu.edu.cn	Zhang, Liang/GWM-6088-2022; liu, zhenming/D-8766-2012	Chen, Ya/0000-0001-5273-1815	National Natural Science Foundation of China [21772005, 21572010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [grant numbers 21772005, 21572010], http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; [Chen Ya 陈亚], 2016, [Journal of Chinese Pharmaceutical Sciences, 中国药学], V25, P428; Cheng AL, 2003, J MED CHEM, V46, P3572, DOI 10.1021/jm020266b; Cheung LN, 2015, BIOCHEM PHARMACOL, V93, P380, DOI 10.1016/j.bcp.2014.11.006; Cheung L, 2014, BIOCHEM PHARMACOL, V91, P97, DOI 10.1016/j.bcp.2014.05.023; Dantzig AH, 2003, ADV DRUG DELIVER REV, V55, P133, DOI 10.1016/S0169-409X(02)00175-8; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; El-Sheikh AAK, 2008, MOL PHARMACOL, V74, P964, DOI 10.1124/mol.107.043661; Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nicholls A, 2004, J COMPUT AID MOL DES, V18, P451, DOI 10.1007/s10822-004-5202-8; Prehm P, 2013, FOOD CHEM TOXICOL, V62, P76, DOI 10.1016/j.fct.2013.08.028; Ravna AW, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-20; Ravna AW, 2008, BIOORG MED CHEM LETT, V18, P3481, DOI 10.1016/j.bmcl.2008.05.047; Rush TS, 2005, J MED CHEM, V48, P1489, DOI 10.1021/jm040163o; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sager G, 2012, J MED CHEM, V55, P3049, DOI 10.1021/jm2014666; Sirisha K, 2011, BIOORGAN MED CHEM, V19, P3249, DOI 10.1016/j.bmc.2011.03.051; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Tian Q, 2006, CURR DRUG METAB, V7, P105, DOI 10.2174/138920006774832550; Tian Q, 2005, PHARM RES-DORDR, V22, P1837, DOI 10.1007/s11095-005-7595-z; Tian Q, 2005, DRUG DEVELOP RES, V64, P1, DOI 10.1002/ddr.10427; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wen JG, 2015, J PHARMACOL EXP THER, V354, P358, DOI 10.1124/jpet.115.225656; Wittgen HGM, 2012, BIOCHEM PHARMACOL, V84, P366, DOI 10.1016/j.bcp.2012.04.012; Xie M, 2011, MOL PHARMACOL, V80, P281, DOI 10.1124/mol.111.071134; Zhang YK, 2015, AAPS J, V17, P802, DOI 10.1208/s12248-015-9757-1	37	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205175	10.1371/journal.pone.0205175	http://dx.doi.org/10.1371/journal.pone.0205175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321196	gold, Green Submitted, Green Published			2022-12-26	WOS:000447417900018
J	Hazarika, RR; Sostaric, N; Sun, YF; van Noort, V				Hazarika, Rashmi R.; Sostaric, Nikolina; Sun, Yifeng; van Noort, Vera			Large-scale docking predicts that sORF-encoded peptides may function through protein-peptide interactions in Arabidopsis thaliana	PLOS ONE			English	Article							LIGAND-BINDING POCKETS; FLEXIBLE DOCKING; RESOURCE; GROMACS; ENZYMES; PACKAGE; ENOD40; CELL; RNA	Several recent studies indicate that small Open Reading Frames (sORFs) embedded within multiple eukaryotic non-coding RNAs can be translated into bioactive peptides of up to 100 amino acids in size. However, the functional roles of the 607 Stress Induced Peptides (SIPs) previously identified from 189 Transcriptionally Active Regions (TARs) in Arabidopsis thaliana remain unclear. To provide a starting point for functional annotation of these plant-derived peptides, we performed a large-scale prediction of peptide binding sites on protein surfaces using coarse-grained peptide docking. The docked models were subjected to further atomistic refinement and binding energy calculations. A total of 530 peptide-protein pairs were successfully docked. In cases where a peptide encoded by a TAR is predicted to bind at a known ligand or cofactor-binding site within the protein, it can be assumed that the peptide modulates the ligand or cofactor-binding. Moreover, we predict that several peptides bind at protein-protein interfaces, which could therefore regulate the formation of the respective complexes. Protein-peptide binding analysis further revealed that peptides employ both their backbone and side chain atoms when binding to the protein, forming predominantly hydrophobic interactions and hydrogen bonds. In this study, we have generated novel predictions on the potential protein-peptide interactions in A. thaliana, which will help in further experimental validation.	[Hazarika, Rashmi R.; Sostaric, Nikolina; Sun, Yifeng; van Noort, Vera] Katholieke Univ Leuven, Dept Microbial & Mol Syst, Leuven, Belgium; [Sun, Yifeng] Katholieke Univ Leuven, Fac Engn Technol, Campus Grp T, Leuven, Belgium; [van Noort, Vera] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands	KU Leuven; KU Leuven; Leiden University; Leiden University - Excl LUMC	van Noort, V (corresponding author), Katholieke Univ Leuven, Dept Microbial & Mol Syst, Leuven, Belgium.; van Noort, V (corresponding author), Leiden Univ, Inst Biol Leiden, Leiden, Netherlands.	vera.vannoort@kuleuven.be	sun, yifeng/AAM-2834-2021; van Noort, Vera/GWZ-9038-2022; van Noort, Vera/E-1053-2011	van Noort, Vera/0000-0002-8436-6602; Hazarika, Rashmi Rekha/0000-0002-5843-0535; Sostaric, Nikolina/0000-0002-1470-7846	KU Leuven Research Fund; Research Foundation - Flanders (FWO) [1112318N]; Research Foundation - Flanders (FWO); Flemish Government - department EWI	KU Leuven Research Fund(KU Leuven); Research Foundation - Flanders (FWO)(FWO); Research Foundation - Flanders (FWO)(FWO); Flemish Government - department EWI	This work has been supported by the KU Leuven Research Fund. NS is a doctoral fellow (1112318N) of the Research Foundation - Flanders (FWO). The computational resources and services used in this work were provided by the VSC (Flemish Supercomputer Center), funded by the Research Foundation - Flanders (FWO) and the Flemish Government - department EWI.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Antes I, 2010, PROTEINS, V78, P1084, DOI 10.1002/prot.22629; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Beekman AM, 2016, CHEMMEDCHEM, V11, P802, DOI 10.1002/cmdc.201500497; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacherjee A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003277; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Butenko M.A., 2012, RECEPTOR LIKE KINASE, V13, P195, DOI DOI 10.1007/978-3-642-23044-8_11; Butenko MA, 2014, PLANT CELL, V26, P1838, DOI 10.1105/tpc.113.120071; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Cardinale D, 2011, P NATL ACAD SCI USA, V108, pE542, DOI 10.1073/pnas.1104829108; Case D.S., 2017, AMBER, V16; Crappe J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-648; CRESPI MD, 1994, EMBO J, V13, P5099, DOI 10.1002/j.1460-2075.1994.tb06839.x; De Coninck B, 2013, J EXP BOT, V64, P5297, DOI 10.1093/jxb/ert295; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding F, 2010, J CHEM INF MODEL, V50, P1623, DOI 10.1021/ci100218t; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P888, DOI 10.1016/j.jmgm.2011.01.004; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fletcher S, 2006, J R SOC INTERFACE, V3, P215, DOI 10.1098/rsif.2006.0115; Gao M, 2012, P NATL ACAD SCI USA, V109, P3784, DOI 10.1073/pnas.1117768109; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Glaser F, 2006, PROTEINS, V62, P479, DOI 10.1002/prot.20769; Gross A, 2016, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00211; Grunewald W, 2010, EMBO J, V29, P2700, DOI 10.1038/emboj.2010.181; Gutmanas A, 2014, NUCLEIC ACIDS RES, V42, pD285, DOI 10.1093/nar/gkt1180; Hashimoto Y, 2008, DEV GROWTH DIFFER, V50, pS269, DOI 10.1111/j.1440-169X.2008.00994.x; Hazarika RR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1458-y; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kilburg D, 2016, ADV PROTEIN CHEM STR, V105, P27, DOI 10.1016/bs.apcsb.2016.06.002; Ko J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-198; Kurcinski M, 2015, NUCLEIC ACIDS RES, V43, pW419, DOI 10.1093/nar/gkv456; Ladoukakis E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r118; Laskowski RA, 1996, PROTEIN SCI, V5, P2438; Lease KA, 2006, PLANT PHYSIOL, V142, P831, DOI 10.1104/pp.106.086041; Lee H, 2015, NUCLEIC ACIDS RES, V43, pW431, DOI 10.1093/nar/gkv495; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; London N, 2013, CURR OPIN CHEM BIOL, V17, P952, DOI 10.1016/j.cbpa.2013.10.011; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Marin-Gonzalez E, 2012, PLANT SCI, V196, P18, DOI 10.1016/j.plantsci.2012.07.009; Matsubayashi Y, 2011, PLANT CELL PHYSIOL, V52, P5, DOI 10.1093/pcp/pcq169; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Murphy E, 2012, PLANT CELL, V24, P3198, DOI 10.1105/tpc.112.099010; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollard KS, 2005, STAT BIOL HEALTH, P249; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Quan MY, 2015, INT J MOL SCI, V16, P5467, DOI 10.3390/ijms16035467; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Ruiz-Orera J, 2014, ELIFE, V3, DOI 10.7554/eLife.03523; Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315; Schindler CEM, 2015, STRUCTURE, V23, P1507, DOI 10.1016/j.str.2015.05.021; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shuichi Miyamoto, SETTLE AN ANALYTICAL, DOI [10.1002/jcc.540130805, DOI 10.1002/JCC.540130805]; STEIN A, 2008, PLOS ONE, V3; Tavormina P, 2015, PLANT CELL, V27, P2095, DOI 10.1105/tpc.15.00440; Tien MZ, 2013, PEERJ, V1, DOI 10.7717/peerj.80; Trabuco LG, 2012, NUCLEIC ACIDS RES, V40, pW423, DOI 10.1093/nar/gks398; Trellet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058769; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Velankar S, 2013, NUCLEIC ACIDS RES, V41, pD483, DOI 10.1093/nar/gks1258; Wabik J, 2015, MOLECULES, V20, P10763, DOI 10.3390/molecules200610763; Yamaguchi YL, 2016, J EXP BOT, V67, P4813, DOI 10.1093/jxb/erw208; Yu Xuhong, 2010, Arabidopsis Book, V8, pe0135, DOI 10.1199/tab.0135	81	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205179	10.1371/journal.pone.0205179	http://dx.doi.org/10.1371/journal.pone.0205179			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321192	Green Submitted, gold, Green Published			2022-12-26	WOS:000447417900019
J	Park, SJ; Yang, HK; Byun, SJ; Park, KH; Hwang, JM				Park, Sang Jun; Yang, Hee Kyung; Byun, Seong Jun; Park, Kyu Hyung; Hwang, Jeong-Min			Ocular motor cranial nerve palsy and increased risk of stroke in the general population	PLOS ONE			English	Article							RETINAL ARTERY-OCCLUSION; NATIONWIDE INCIDENCE; VEIN OCCLUSION; ISOLATED 3RD; KOREA; 4TH; OCULOMOTOR; INFARCTION; TROCHLEAR; COHORT	Purpose To determine whether ocular motor cranial nerve (CN) palsy raises the risk of subsequent stroke in the general population. Methods We investigated the association between ocular motor CN palsy and occurrence of stroke using the National Health Insurance Service-National Sample Cohort database from 2002 to 2013. We included individuals aged. 20 years on January 1 st, 2004, and excluded those having any paralytic strabismus, disorders in binocular movement, diplopia and any cerebrovascular diseases before entering the cohort. Incident ocular motor CN palsy was identified by diagnostic codes for third, fourth, and sixth nerve palsies. To determine the effect of incident ocular motor CN palsy on the occurrence of subsequent stroke, we used time-varying covariate Cox regression models. Model 1 included only incident third, fourth, and sixth nerve palsies as a time-varying covariate. Model 2 included Model 1 and defined demographic information. Model 3 included Model 2, comorbidity, co-medication, and the Charlson index score. Results Among 727,689 individuals in the cohort, 1,633 patients developed ocular motor CN palsy and 17,657 patients suffered stroke. Cox regression models showed that development of ocular motor CN palsy was associated with an increased risk of subsequent stroke (hazard ratio [HR] = 4.65; 95% confidence intervals [CIs], 3.74-5.80 in Model 1), and the results were consistent even after adjusting for demographic factors and confounders in Model 2 and 3. Men, older age, and individuals not living in Seoul/Incheon area were associated with an increased risk of stroke, while individuals with higher income were associated with decreased risk of stroke in both Model 2 and 3. Sensitivity analyses using propensity score-based matching produced similar results in all three Models (HR = 1.95; 95% CI, 1.55-2.46 in Model 1, HR = 1.91; 95% CI, 1.52-2.41 in Model 2, and HR = 1.63; 95% CI, 1.29-2.06 in Model 3). Conclusions The occurrence of ocular motor CN palsy is a significant risk factor of subsequent stroke even after adjusting for demographic factors and confounders in the general population. Physicians may need to educate patients with ocular motor CN palsy regarding the higher risk of future stroke.	[Park, Sang Jun; Yang, Hee Kyung; Byun, Seong Jun; Park, Kyu Hyung; Hwang, Jeong-Min] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea	Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea.	hjm@snu.ac.kr	Park, Sang Jun/C-3234-2015	Park, Sang Jun/0000-0003-0542-2758	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2017R1A2B4011450]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2017R1A2B4011450) to JMH. The funding organizations had no role in the design or conduct of this research.	Abbate R, 2003, NEUROL SCI, V24, pS11, DOI 10.1007/s100720300027; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Dosunmu EO, 2018, AM J OPHTHALMOL, V185, P110, DOI 10.1016/j.ajo.2017.10.019; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Gupta A, 2016, STROKE, V47, P719, DOI 10.1161/STROKEAHA.115.011889; Hoi CP, 2016, CEREBROVASC DIS, V41, P273, DOI 10.1159/000444128; KIM JS, 1993, STROKE, V24, P581, DOI 10.1161/01.STR.24.4.581; Kwon S, 2003, HEALTH POLICY PLANN, V18, P84, DOI 10.1093/heapol/18.1.84; Lee J, 2016, BOUND VALUE PROBL, DOI 10.1186/s13661-016-0603-x; Park B., 2003, REPORT EVALUATION VA, P19; Park SJ, 2017, RETINA-J RET VIT DIS, V37, P2326, DOI 10.1097/IAE.0000000000001485; Park SJ, 2015, NEUROLOGY, V85, P1578, DOI 10.1212/WNL.0000000000002085; Park SJ, 2015, OPHTHALMOLOGY, V122, P2336, DOI 10.1016/j.ophtha.2015.07.018; Park SJ, 2015, OPHTHALMOLOGY, V122, P2063, DOI 10.1016/j.ophtha.2015.06.018; Park SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120067; Park SJ, 2014, OPHTHALMOLOGY, V121, P1933, DOI 10.1016/j.ophtha.2014.04.029; Park SJ, 2014, OPHTHALMOLOGY, V121, P1274, DOI 10.1016/j.ophtha.2013.12.024; Park SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080174; Park UC, 2008, EYE, V22, P691, DOI 10.1038/sj.eye.6702720; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; RICHARDS BW, 1992, AM J OPHTHALMOL, V113, P489, DOI 10.1016/S0002-9394(14)74718-X; Rim TH, 2017, ACTA OPHTHALMOL, V95, pE656, DOI 10.1111/aos.13488; Shin JY, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3517; Tamhankar MA, 2013, OPHTHALMOLOGY, V120, P2264, DOI 10.1016/j.ophtha.2013.04.009; Tiffin PAC, 1996, EYE, V10, P377, DOI 10.1038/eye.1996.77	25	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205428	10.1371/journal.pone.0205428	http://dx.doi.org/10.1371/journal.pone.0205428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321220	Green Published, Green Submitted, gold			2022-12-26	WOS:000447417900031
J	Reddy, PS; Dhaware, MG; Reddy, DS; Reddy, BP; Divya, K; Sharma, KK; Bhatnagar-Mathur, P				Reddy, Palakolanu Sudhakar; Dhaware, Mahamaya G.; Reddy, Dumbala Srinivas; Reddy, Bommineni Pradeep; Divya, Kummari; Sharma, Kiran K.; Bhatnagar-Mathur, Pooja			Comprehensive evaluation of candidate reference genes for real-time quantitative PCR (RT-qPCR) data normalization in nutri-cereal finger millet [Eleusine Coracana (L.)]	PLOS ONE			English	Article							L. GAERTN.; ABIOTIC STRESS; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; VALIDATION; IDENTIFICATION; TOLERANCE; SELECTION; CALCIUM; GENOME	Finger millet (Eleusine coracana L.) is an annual herbaceous self-pollinating C-4 cereal crop of the arid and semi-arid regions of the world. Finger millet is a food security crop proven to have resilience to changing climate and scores very high in nutrition. In the current study, we have assessed sixteen candidate reference genes for their appropriateness for the normalization studies in finger millet subjected to experimental regimes and treatments. Ten candidate reference genes (GAPDH, beta-TUB, CYP, EIF4 alpha, TIP41, UBC, G6PD, S24, MACP and MDH) were cloned and six (ACT, ELF1 alpha, PP2A, PT, S21 and TFIID) were mined from the NCBI database as well as from the literature. Expression stability ranking of the finger millet reference genes was validated using four different statistical tools i.e., geNorm, Norm-Finder, BestKeeper, Delta Ct and RefFinder. From the study, we endorse MACP, CYP, EIF4 alpha to be most stable candidate reference genes in all 'tissues', whereas PT, TFIID, MACP ranked high across genotypes, beta-TUB, CYP, ELF1 alpha were found to be best under abiotic stresses and 'all samples set'. The study recommends using minimum of two reference genes for RT-qPCR data normalizations in finger millet. All in all, CYP, beta-TUB, and EF1 alpha, in combination were found to be best for robust normalizations under most experimental conditions. The best and the least stable genes were validated for confirmation by assessing their appropriateness for normalization studies using EcNAC1 gene. The report provides the first comprehensive list of suitable stable candidate reference genes for nutritional rich cereal finger millet that will be advantageous to gene expression studies in this crop.	[Reddy, Palakolanu Sudhakar; Dhaware, Mahamaya G.; Reddy, Dumbala Srinivas; Reddy, Bommineni Pradeep; Divya, Kummari; Sharma, Kiran K.; Bhatnagar-Mathur, Pooja] Int Crops Res Inst Semi Arid Trop, Hyderabad, Telangana, India	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Reddy, PS (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Telangana, India.	p.sudhakarreddy@cgiar.org	Sharma, Kiran/GZL-1834-2022; Sudhakar Reddy, Palakolanu/B-3807-2019		Department of Science and Technology, Govt. of India, New Delhi, through SERB Core Research Grant (CRG)	Department of Science and Technology, Govt. of India, New Delhi, through SERB Core Research Grant (CRG)	This work was partially supported by the Department of Science and Technology, Govt. of India, New Delhi, through SERB Core Research Grant (CRG). No other funding was received for this work. This work was undertaken as part of the CGIAR Research Program on Grain Legumes & Dryland Cereals (CRP-GLDC). ICRISAT is a member of the CGIAR Consortium. The CGIAR Consortium did not provide any additional funding.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Babitha KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137098; Babu BK, 2014, MOL BIOL REP, V41, P3081, DOI 10.1007/s11033-014-3168-8; Bhatt D, 2013, MOL BIOL REP, V40, P1155, DOI 10.1007/s11033-012-2157-z; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Ceasar SA, 2011, PLANT CELL REP, V30, P1759, DOI 10.1007/s00299-011-1084-0; Ceasar SA, 2009, BIOTECHNOL LETT, V31, P779, DOI 10.1007/s10529-009-9933-4; Chen JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep46494; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dida M. M., 2006, Cereals and millets, P333; Dida MM, 2007, THEOR APPL GENET, V114, P321, DOI 10.1007/s00122-006-0435-7; Duan MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01605; Fernandez P, 2011, PLANT CELL REP, V30, P63, DOI 10.1007/s00299-010-0944-3; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Getachew Gashaw, 2014, Journal of Applied Biosciences, V74, P6059; Goron TL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00157; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gupta N, 2012, MOL BIOL REP, V39, P2089, DOI 10.1007/s11033-011-0956-2; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Gutierrez N, 2011, MOL BREEDING, V28, P13, DOI 10.1007/s11032-010-9456-7; Hema R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099110; Hittalmani S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3850-z; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kanwal P, 2014, PLANT CELL REP, V33, P1403, DOI 10.1007/s00299-014-1625-4; Kong QS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130865; Krishnamurthy L, 2014, PLANT SCI, V227, P51, DOI 10.1016/j.plantsci.2014.07.001; Kumar A, 2014, APPL BIOCHEM BIOTECH, V172, P2955, DOI 10.1007/s12010-013-0714-0; Kumar K, 2013, PLANT CELL TISS ORG, V115, P13, DOI 10.1007/s11240-013-0335-x; Kundu A, 2013, PLANT CELL REP, V32, P1647, DOI 10.1007/s00299-013-1478-2; Latha AM, 2005, PLANT SCI, V169, P657, DOI 10.1016/j.plantsci.2005.05.009; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Liu Q., 2018, MOLECULES, V23; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Mariot RF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120854; Martins PK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28348; Mgonja MA, 2005, P 1 INT FING MILL ST; Mirza N, 2014, GENE, V550, P171, DOI 10.1016/j.gene.2014.08.005; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Pudake RN, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0609-9; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Rahman H, 2014, PLANT MOL BIOL, V85, P485, DOI 10.1007/s11103-014-0199-4; Ramegowda V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040397; Reddy PS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00529; Reddy PS., 2015, PLANT GENE, V1, P35, DOI [DOI 10.1016/J.PLGENE.2015.02.001, 10.1016/j.plgene.2015.02.001]; Sharma D, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02028; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Singh RK, 2015, APPL BIOCHEM BIOTECH, V177, P207, DOI 10.1007/s12010-015-1738-4; Singh UM, 2015, GENE, V566, P37, DOI 10.1016/j.gene.2015.04.021; Takan JP, 2012, MOL BIOTECHNOL, V50, P145, DOI 10.1007/s12033-011-9429-z; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189405; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405; Zmienko A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118226	61	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205668	10.1371/journal.pone.0205668	http://dx.doi.org/10.1371/journal.pone.0205668			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321245	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000447417900044
J	Konongoi, SL; Nyunja, A; Ofula, V; Owaka, S; Koka, H; Koskei, E; Eyase, F; Langat, D; Mancuso, J; Lutomiah, J; Sang, R				Konongoi, Samson Limbaso; Nyunja, Albert; Ofula, Victor; Owaka, Samuel; Koka, Hellen; Koskei, Edith; Eyase, Fredrick; Langat, Daniel; Mancuso, James; Lutomiah, Joel; Sang, Rosemary			Human and entomologic investigations of chikungunya outbreak in Mandera, Northeastern Kenya, 2016	PLOS ONE			English	Article							VIRUS-INFECTION; REUNION ISLAND; EPIDEMIC; FEVER; SEROPREVALENCE; COINFECTIONS; REEMERGENCE; MOSQUITOS; COMOROS; SOMALIA	Chikungunya is a reemerging vector borne pathogen associated with severe morbidity in affected populations. Lamu, along the Kenyan coast was affected by a major chikungunya outbreak in 2004. Twelve years later, we report on entomologic investigations and laboratory confirmed chikungunya cases in northeastern Kenya. Patient blood samples were received at the Kenya Medical Research Institute (KEMRI) viral hemorrhagic fever laboratory and the immunoglobulin M enzyme linked immunosorbent assay (IgM ELISA) was used to test for the presence of IgM antibodies against chikungunya and dengue. Reverse transcription polymerase chain reaction (RT-PCR) utilizing flavivirus, alphavirus and chikungunya specific primers were used to detect acute infections and representative PCR positive samples sequenced to confirm the circulating strain. Immature mosquitoes were collected from water-holding containers indoors and outdoors in the affected areas in northeastern Kenya. A total of 189 human samples were tested; 126 from Kenya and 63 from Somalia. 52.9% (100/189) tested positive for Chikungunya virus (CHIKV) by either IgM ELISA or RT-PCR. Sequence analysis of selected samples revealed that the virus was closely related to that from China (2010). 29% (55/189) of the samples, almost all from northeastern Kenya or with a history of travel to northern Kenya, tested positive for dengue IgM antibodies. Entomologic risk assessment revealed high house, container and Breteau indices of, 14.5, 41.9 and 17.1% respectively. Underground water storage tanks were the most abundant, 30.1%, of which 77.4% were infested with Aedes aegypti mosquitoes. These findings confirm the presence of active chikungunya infections in the northeastern parts of Kenya. The detection of dengue IgM antibodies concurrently with chikungunya virus circulation emphasizes on the need for improved surveillance systems and diagnostic algorithms with the capacity to capture multiple causes of arbovirus infections as these two viruses share common vectors and eco-systems. In addition sustained entomological surveillance and vector control programs targeting most productive containers are needed to monitor changes in vector densities, for early detection of the viruses and initiate vector control efforts to prevent possible outbreaks.	[Konongoi, Samson Limbaso; Lutomiah, Joel; Sang, Rosemary] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Konongoi, Samson Limbaso; Nyunja, Albert; Ofula, Victor; Owaka, Samuel; Koka, Hellen; Koskei, Edith; Eyase, Fredrick; Mancuso, James; Lutomiah, Joel; Sang, Rosemary] US Army Med Res Directorate, Nairobi, Kenya; [Eyase, Fredrick] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya; [Langat, Daniel] Kenya Minist Hlth, Div Dis Surveillance & Response, Nairobi, Kenya	Kenya Medical Research Institute; Jomo Kenyatta University of Agriculture & Technology	Konongoi, SL (corresponding author), Kenya Govt Med Res Ctr, Nairobi, Kenya.; Konongoi, SL (corresponding author), US Army Med Res Directorate, Nairobi, Kenya.	Limbaso.konongoi@usamru-k.org	Eyase, Fredrick/AHA-7545-2022; Mancuso, James/M-9339-2016	Mancuso, James/0000-0002-0717-8202	World Health Organization Kenya office; Global Emerging Infections Surveillance (GEIS) program of the United States Army Medical Research Directorate Kenya (USAMRD-K)	World Health Organization Kenya office; Global Emerging Infections Surveillance (GEIS) program of the United States Army Medical Research Directorate Kenya (USAMRD-K)	This work was funded by the World Health Organization Kenya office and the Global Emerging Infections Surveillance (GEIS) program of the United States Army Medical Research Directorate Kenya (USAMRD-K) for the field based entomological investigations. This manuscript is reporting on data generated from samples passively sent to the central laboratory in a public health response activity.	[Anonymous], 2015, INT J-TORONTO; Baba M, 2013, J INFECT DEV COUNTR, V7, P51, DOI 10.3855/jidc.2411; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Caglioti C, 2013, NEW MICROBIOL, V36, P211; CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243; Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530; Edwards FW, 1941, MOSQUITOES ETHIOPIAN; Edwards T, 2016, EMERG INFECT DIS, V22, P2003, DOI 10.3201/eid2211.161017; Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016; Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2; Hertz JT, 2012, AM J TROP MED HYG, V86, P171, DOI 10.4269/ajtmh.2012.11-0393; JUPP PG, 1990, J AM MOSQUITO CONTR, V6, P415; Konongoi L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0641-0; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; LaBeaud A, 2015, PLOS NEGL TROP DIS, V9; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Lu X, 2014, VIRUS GENES, V48, P15, DOI 10.1007/s11262-013-0991-2; Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371; MOUCHET J, 1971, B WORLD HEALTH ORGAN, V45, P383; Nei M., 2000, MOL EVOLUTION PHYLOG; Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645; Organizacion Mundial de la Salud (OMS), 1995, DENGUE DENGUE HEMORR, V548; Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906; Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Sang RC, 2008, AM J TROP MED HYG, V78, P77; Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189; Staikowsky F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007603; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Vorndam Vance, 1997, P313; Waggoner J, 2017, MALARIA CHIKUNGUNYA; Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921; Zammarchi L, 2016, EMERG INFECT DIS, V22, P2025, DOI 10.3201/eid2211.161225	44	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205058	10.1371/journal.pone.0205058	http://dx.doi.org/10.1371/journal.pone.0205058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308064	Green Submitted, Green Published, gold			2022-12-26	WOS:000447173500035
J	Servia, L; Serrano, JCE; Pamplona, R; Badia, M; Montserrat, N; Portero-Otin, M; Trujillano, J				Servia, Luis; Serrano, Jose C. E.; Pamplona, Reinald; Badia, Mariona; Montserrat, Neus; Portero-Otin, Manuel; Trujillano, Javier			Location-dependent effects of trauma on oxidative stress in humans	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; TOTAL ANTIOXIDANT CAPACITY; HEAD-INJURY; DAMAGE; ICU; BIOMARKERS; NUTRIENTS; GLUTAMINE; SEVERITY	Though circulating antioxidant capacity in plasma is homeostatically regulated, it is not known whether acute stressors (i.e. trauma) affecting different anatomical locations could have quantitatively different impacts. For this reason, we evaluated the relationship between the anatomical location of trauma and plasma total antioxidant capacity (TAC) in a prospective study, where the anatomical locations of trauma in polytraumatic patients (n = 66) were categorized as primary affecting the brain -traumatic brain injury (TBI)-, thorax, abdomen and pelvis or extremities. We measured the following: plasma TAC by 2 independent methods, the contribution of selected antioxidant molecules (uric acid, bilirubin and albumin) to these values and changes after 1 week of progression. Surprisingly, TBI lowered TAC (919 +/- 335 mu M Trolox equivalents (TE)) in comparison with other groups (thoracic trauma 1187 +/- 270 mu M TE; extremities 1025 +/- 276 mu M TE; p = 0.004). The latter 2 presented higher hypoxia (PaO2/FiO(2) 272 +/- 87 mmHg) and hemodynamic instability (inotrope use required in 54.5%) as well. Temporal changes in TAC are also dependent on anatomical location, as thoracic and extremity trauma patients' TAC values decreased (1187 +/- 270 to 1045 +/- 263 mu M TE; 1025 +/- 276 to 918 +/- 331 mu M TE) after 1 week (p < 0.01), while in TBI these values increased (919 +/- 335 to 961 +/- 465 mu M TE). Our results show that the response of plasma antioxidant capacity in trauma patients is strongly dependent on time after trauma and location, with TBI failing to induce such a response.	[Servia, Luis; Badia, Mariona; Montserrat, Neus; Trujillano, Javier] Univ Lleida IRBLleida, Univ Hosp Arnau Vilanova, Dept Crit Care Unit, Lleida, Spain; [Serrano, Jose C. E.; Pamplona, Reinald; Portero-Otin, Manuel] Univ Lleida IRBLleida, Fac Med, Dept Expt Med, Lleida, Spain	Universitat de Lleida; University Hospital Arnau de Vilanova; Universitat de Lleida	Trujillano, J (corresponding author), Univ Lleida IRBLleida, Univ Hosp Arnau Vilanova, Dept Crit Care Unit, Lleida, Spain.; Portero-Otin, M (corresponding author), Univ Lleida IRBLleida, Fac Med, Dept Expt Med, Lleida, Spain.	manuel.portero@mex.udl.cat; jtruji@cmb.udl.cat	Portero-Otin, Manuel/B-7122-2009; Badia, Mariona/AAB-5513-2020; Serrano, Jose C. E./C-6557-2011; Trujillano, Javier/A-4325-2010; Goixart, Lluis Servia/C-6561-2011; Pamplona, Reinald/A-7359-2010	Portero-Otin, Manuel/0000-0002-1823-0299; Badia, Mariona/0000-0002-0923-1417; Serrano, Jose C. E./0000-0001-6714-6061; Trujillano, Javier/0000-0001-8071-7711; Goixart, Lluis Servia/0000-0001-9513-1465; Pamplona, Reinald/0000-0003-4337-6107	IRBLleida biobank; RETICS BIOBANCOS [RD09/0076/00059]; Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III [PI 11-1532, PI 17-00134, 14-01115, 14-00328]; Generalitat of Catalonia [2014SGR168]; FEDER	IRBLleida biobank; RETICS BIOBANCOS; Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III; Generalitat of Catalonia; FEDER(European Commission)	This work has been partially supported by the IRBLleida biobank and RETICS BIOBANCOS RD09/0076/00059, the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (PI 11-1532; PI 17-00134; 14-01115 and 14-00328) and the Generalitat of Catalonia (2014SGR168). FEDER Funds are also acknowledged: "A way to make Europe". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen M, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/168652; Andrews PJD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1542; Association for the Advancement of Automotive Medicine, 2008, ABBREVIATED INJURY S; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Berger MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6981; Berger MM, 2005, CLIN NUTR, V24, P172, DOI 10.1016/j.clnu.2004.10.003; Butcher N, 2009, INJURY, V40, pS12, DOI 10.1016/j.injury.2009.10.032; Chand N, 2007, HEPATOLOGY, V45, P230, DOI 10.1002/hep.21480; Chuang CC, 2006, CRIT CARE, V10, DOI 10.1186/cc4826; Crimi E, 2006, FREE RADICAL BIO MED, V40, P398, DOI 10.1016/j.freeradbiomed.2005.10.054; Crook MA, 2009, NUTRITION, V25, P1004, DOI 10.1016/j.nut.2009.04.001; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Doise JM, 2008, FUND CLIN PHARMACOL, V22, P203, DOI 10.1111/j.1472-8206.2008.00573.x; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Goodyear-Bruch C, 2002, AM J CRIT CARE, V11, P543, DOI 10.4037/ajcc2002.11.6.543; GRUM CM, 1985, CHEST, V88, P763, DOI 10.1378/chest.88.5.763; Grune T, 2007, CURR OPIN CLIN NUTR, V10, P712, DOI 10.1097/MCO.0b013e3282f0c97c; Heyland D, 2013, NEW ENGL J MED, V369, P484, DOI 10.1056/NEJMc1306658; Heyland DK, 2005, INTENS CARE MED, V31, P327, DOI 10.1007/s00134-004-2522-z; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lemineur T, 2006, CURR OPIN CLIN NUTR, V9, P704, DOI 10.1097/01.mco.0000247467.41661.f3; Motoyama T, 2003, CRIT CARE MED, V31, P1048, DOI 10.1097/01.CCM.0000055371.27268.36; Oldham KM, 2002, JPEN-PARENTER ENTER, V26, P189, DOI 10.1177/0148607102026003189; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Pascual C, 1998, CRIT CARE MED, V26, P705, DOI 10.1097/00003246-199804000-00019; Perez-Barcena J, 2014, INTENS CARE MED, V40, P539, DOI 10.1007/s00134-014-3230-y; Rael LT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-57; RAMAKERS BP, 2011, CRIT CARE, V15; Rana SV, 2006, MOL CELL BIOCHEM, V291, P161, DOI 10.1007/s11010-006-9210-y; Roth E, 2004, CURR OPIN CLIN NUTR, V7, P161, DOI 10.1097/00075197-200403000-00010; Serrano JCE, 2013, MOL NUTR FOOD RES, V57, P459, DOI 10.1002/mnfr.201200513; Servia L, 2014, CRIT CARE, V18, DOI 10.1186/cc13917; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Tsai KV, 2000, FREE RADICAL BIO MED, V28, P926, DOI 10.1016/S0891-5849(00)00180-5; Tsuchiya M, 2008, ANESTH ANALG, V107, P1946, DOI 10.1213/ane.0b013e318187c96b; van Zanten ARH, 2014, JAMA-J AM MED ASSOC, V312, P514, DOI 10.1001/jama.2014.7698; Wischmeyer PE, 2014, CRIT CARE, V18, DOI 10.1186/cc13836	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205519	10.1371/journal.pone.0205519	http://dx.doi.org/10.1371/journal.pone.0205519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308018	gold, Green Submitted, Green Published			2022-12-26	WOS:000447173500094
J	Choo, MS; Piao, S; Oh, SJ				Choo, Min Soo; Piao, SongZhe; Oh, Seung-June			The preventive effect of a free radical scavenger on oxidative stress after the relief of partial bladder outlet obstruction in a rat model	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; CARDIOVASCULAR-DISEASES; EXPRESSION; PROSTATE; LASER; WOMEN	Aims To investigate the effect of a free radical scavenger (tempol) after relief of partial bladder outlet obstruction (pBOO) on bladder function in a rat model. Methods pBOO was induced in 50 eight-week-old female Sprague-Dawley rats and relieved 3 weeks later. The rats were divided randomly into 5 groups: sham-operated, tempol-treated for 1 week (Treat-1w) or 3 weeks (Treat-3w), and no treatment for 1 week (nonTreat-1w) or 3 weeks (nonTreat-3w). Awaken cystometrograms were obtained 1 or 3 weeks after relief according to the grouping. The bladders were isolated and weighed. H&E, Masson's trichrome and TUNEL staining were used to analyze histological changes. The oxidative stress assessed using malondialdehyde. The expression of beta-3 adrenoreceptor was examined by Western blotting. Results The tempol-treated groups exhibited a significant decrease in the number of non-voiding contractions per voiding cycle (nonTreat-1w vs. Treat-1w, 1.18 +/- 0.82 vs. 0.36 +/- 0.40, P = 0.010; nonTreat-3w vs. Treat-3w, 1.51 +/- 0.69 vs. 0.23 +/- 0.25, P = 0.002). The thickness and collagen fiber deposition of the detrusor muscle layer was significantly decreased in the treated groups. Apoptosis detected was mainly observed in the urothelial cell layer, although the rate of apoptosis was significantly decreased in the treated groups (48.9 +/- 3.36% vs. 32.7 +/- 11.10%, P = 0.024; 25.8 +/- 4.67% vs. 15.7 +/- 9.83%, P = 0.314). The tempol-treated groups showed significant decreases in the MDA concentrations at both 1 and 3 weeks after relief. The expression of the beta-3 adrenoreceptor was increased in the tempol-treated rats. Conclusions Ischemic reperfusion injury after relief of pBOO caused histological and functional changes in the bladder. Free radical scavenger treatment prevented this oxidative stress.	[Choo, Min Soo] Hallym Univ, Dongtan Sacred Heart Hosp, Dept Urol, Hwaseong, South Korea; [Piao, SongZhe] Taizhou Hosp Zhejiang Prov, Dept Urol, Taizhou, Peoples R China; [Oh, Seung-June] Seoul Natl Univ, Coll Med, Dept Urol, Seoul Natl Univ Hosp, Seoul, South Korea	Hallym University; Seoul National University (SNU); Seoul National University Hospital	Oh, SJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Urol, Seoul Natl Univ Hosp, Seoul, South Korea.	sjo@snu.ac.kr		Choo, Min Soo/0000-0002-7852-5822	Seoul National University Hospital research fund [04-2013-0490]	Seoul National University Hospital research fund	This study was supported by grant no. 04-2013-0490 from the Seoul National University Hospital research fund.	Antunes AA, 2015, J UROLOGY, V193, P2028, DOI 10.1016/j.juro.2014.12.095; Azadzoi KM, 2007, J UROLOGY, V178, P710, DOI 10.1016/j.juro.2007.03.096; Barros MAP, 2015, TRANSPL P, V47, P2478, DOI 10.1016/j.transproceed.2015.08.001; Bisogni S, 2012, INT BRAZ J UROL, V38, P552, DOI 10.1590/S1677-55382012000400016; Chai TC, 1999, J UROLOGY, V161, P1689, DOI 10.1016/S0022-5347(05)69006-4; Cho MC, 2011, NEUROUROL URODYNAM, V30, P1343, DOI 10.1002/nau.21050; Chuang YC, 2018, NEUROUROL URODYNAM, V37, P708, DOI 10.1002/nau.23381; Dybowski BA, 2014, UROLOGY, V84, P898, DOI 10.1016/j.urology.2014.06.027; Gotoh D, 2018, NEUROUROL URODYNAM, V37, P666, DOI 10.1002/nau.23372; Jain AK, 2015, CURR PHARM DESIGN, V21, P4441, DOI 10.2174/1381612821666150803151758; Kang YJ, 2011, KOREAN J UROL, V52, P835, DOI 10.4111/kju.2011.52.12.835; Keihani S, 2015, UROLOGY, V86, P151, DOI 10.1016/j.urology.2015.02.019; Kurizaki Y, 2013, NEUROUROL URODYNAM, V32, P88, DOI 10.1002/nau.22278; Levin RM, 1999, EXP PHYSIOL, V84, P171, DOI 10.1111/j.1469-445X.1999.tb00082.x; Li WJ, 2010, J KOREAN MED SCI, V25, P1652, DOI 10.3346/jkms.2010.25.11.1652; Lin ATL, 1998, EUR UROL, V34, P448, DOI 10.1159/000019780; Lin CD, 2016, LUTS, V8, P30, DOI 10.1111/luts.12094; Nomiya M, 2015, INT J UROL, V22, P40, DOI 10.1111/iju.12652; Park Min Gu, 2010, Int Neurourol J, V14, P157, DOI 10.5213/inj.2010.14.3.157; Rosenbaugh EG, 2013, AM J PHYSIOL-REG I, V304, pR917, DOI 10.1152/ajpregu.00395.2012; Solomon E, 2018, NEUROUROL URODYNAM, V37, P368, DOI 10.1002/nau.23307; Steers William D, 2002, Rev Urol, V4 Suppl 4, pS7; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Yamaguchi O, 2007, NEUROUROL URODYNAM, V26, P752, DOI 10.1002/nau.20420	24	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0199800	10.1371/journal.pone.0199800	http://dx.doi.org/10.1371/journal.pone.0199800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346942	Green Published, gold, Green Submitted			2022-12-26	WOS:000447938400001
J	Dubois, JD; Poitras, I; Voisin, JIA; Mercier, C				Dubois, Jean-Daniel; Poitras, Isabelle; Voisin, Julien I. A.; Mercier, Catherine			Effect of pain on deafferentation-induced modulation of somatosensory evoked potentials	PLOS ONE			English	Article							PHANTOM-LIMB PAIN; NERVOUS-SYSTEM REORGANIZATION; UPPER-EXTREMITY AMPUTEES; CORTICAL REORGANIZATION; PREAMPUTATION PAIN; TRANSIENT DEAFFERENTATION; RAPID MODULATION; SENSORY CORTEX; ARM AMPUTATION; MOTOR CORTEX	There is a large body of evidence showing substantial sensorimotor reorganizations after an amputation. These reorganizations are believed to contribute to the development of phantom limb pain, but alternatively, pain might influence the plasticity triggered by the deafferentation. The aim of this study was to test whether pain impacts on deafferentation-induced plasticity in the somatosensory pathways. Fifteen healthy subjects participated in 2 experimental sessions (Pain, No Pain) in which somatosensory evoked potentials (SSEPs) associated with electrical stimulation of the ulnar nerve were assessed before and after temporary ischemic deafferentation induced by inflation of a cuff around the wrist. In the Pain session capsaicin cream was applied on the dorsum of the hand 30 minutes prior to cuff inflation. Results show that pain decreased the amplitude of the N20 (main effect of condition, p = 0.033), with a similar trend for the P25. Temporary ischemic deafferentation had a significant effect on SSEPs (main effect of time), with an increase in the P25 (p = 0.013) and the P45 amplitude (p = 0.005), together with a reduction of the P90 amplitude (p = 0.002). Finally, a significant time x condition interaction, reflecting state-dependent plasticity, was found for the P90 only, the presence of pain decreasing the reduction of amplitude observed in response to deafferentation. In conclusion, these results show that nociceptive input can influence the plasticity induced by a deafferentation, which could be a contributing factor in the cortical somatosensory reorganization observed in chronic pain populations.	[Dubois, Jean-Daniel; Poitras, Isabelle; Voisin, Julien I. A.; Mercier, Catherine] Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Dubois, Jean-Daniel; Poitras, Isabelle; Voisin, Julien I. A.; Mercier, Catherine] Laval Univ, Dept Rehabil, Pavillon Ferdinand Vandry, Quebec City, PQ, Canada	Laval University; Laval University	Mercier, C (corresponding author), Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada.; Mercier, C (corresponding author), Laval Univ, Dept Rehabil, Pavillon Ferdinand Vandry, Quebec City, PQ, Canada.	catherine.mercier@rea.ulaval.ca		Mercier, Catherine/0000-0002-2037-6916	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 355896-2012]; Canadian Institutes of Health Research (CIHR); Institut de recherche Robert-Sauve en sante et securite au travail (IRSST); Fonds de recherche Quebec - Sante (FRQS)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Institut de recherche Robert-Sauve en sante et securite au travail (IRSST); Fonds de recherche Quebec - Sante (FRQS)	This study was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) [http://www.nserc-crsng.gc.ca; grant number RGPIN 355896-2012]. IP is supported by fellowships from Canadian Institutes of Health Research (CIHR, http://www.cihr-irsc.gc.ca) and by Institut de recherche Robert-Sauve en sante et securite au travail (IRSST, http://www.irsst.qc.ca). CM is supported by a salary award from Fonds de recherche Quebec - Sante (FRQS, http://www.frqs.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh J, 2017, NEUROSCIENCE; Bruurmijn MLCM, 2017, BRAIN, V140, P3166, DOI 10.1093/brain/awx274; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; COHEN LG, 1991, BRAIN, V114, P615, DOI 10.1093/brain/114.1.615; Dancey E, 2016, J NEUROPHYSIOL; Dancey E, 2016, PAIN, V157, P1682, DOI 10.1097/j.pain.0000000000000570; Desmond DM, 2010, INT J REHABIL RES, V33, P279, DOI 10.1097/MRR.0b013e328336388d; Flor H, 2002, LANCET NEUROL, V1, P182, DOI 10.1016/S1474-4422(02)00074-1; Flor H, 1998, EXP BRAIN RES, V119, P205, DOI 10.1007/s002210050334; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Flor Herta, 2008, Expert Rev Neurother, V8, P809, DOI 10.1586/14737175.8.5.809; Frot M, 2001, PAIN, V94, P65, DOI 10.1016/S0304-3959(01)00342-6; Gagne M, 2009, NEUROSCIENCE, V162, P78, DOI 10.1016/j.neuroscience.2009.04.061; Gagne M, 2011, HUM BRAIN MAPP, V32, P509, DOI 10.1002/hbm.21038; Giummarra MJ, 2011, CLIN J PAIN, V27, P691, DOI 10.1097/AJP.0b013e318216906f; Grove GL., 2006, HDB NONINVASIVE METH, V2; Hanley MA, 2007, J PAIN, V8, P102, DOI 10.1016/j.jpain.2006.06.004; Hari R, 1998, NEUROSCI LETT, V240, P131, DOI 10.1016/S0304-3940(97)00945-2; Henry DE, 2011, PM&R, V3, P1116, DOI 10.1016/j.pmrj.2011.05.018; Hoshiyama M, 1997, BRAIN TOPOGR, V10, P23, DOI 10.1023/A:1022206906360; Hoshiyama M, 2001, BRAIN RES, V908, P140, DOI 10.1016/S0006-8993(01)02623-3; JENSEN TS, 1985, PAIN, V21, P267, DOI 10.1016/0304-3959(85)90090-9; Jutzeler CR, 2015, NEUROIMAGE-CLIN, V9, P599, DOI 10.1016/j.nicl.2015.09.018; KAKIGI R, 1994, NEUROSCI RES, V20, P165, DOI 10.1016/0168-0102(94)90034-5; Karl A, 2004, PAIN, V110, P90, DOI 10.1016/j.pain.2004.03.013; KATZ J, 1990, PAIN, V43, P319, DOI 10.1016/0304-3959(90)90029-D; KATZ J, 1991, ANESTHESIOLOGY, V75, P876, DOI 10.1097/00000542-199111000-00020; Kikkert S, 2018, CORTEX, V106, P174, DOI 10.1016/j.cortex.2018.05.013; Kikkert S, 2016, ELIFE, V5, DOI 10.7554/eLife.15292; Kooijman CM, 2000, PAIN, V87, P33, DOI 10.1016/S0304-3959(00)00264-5; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Legatt AD, 2000, J CLIN NEUROPHYSIOL, V17, P321, DOI 10.1097/00004691-200005000-00009; Lotze M, 2001, BRAIN, V124, P2268, DOI 10.1093/brain/124.11.2268; Mackert BM, 2003, NEUROREPORT, V14, P409, DOI 10.1097/01.wnr.0000054967.99678.56; Maclver K, 2008, BRAIN, V131, P2181, DOI 10.1093/brain/awn124; Makin TR, 2015, BRAIN, V138, P2140, DOI 10.1093/brain/awv161; Makin TR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2571; Mavromatis N, 2016, NEUROSCIENCE, V330, P403, DOI 10.1016/j.neuroscience.2016.06.008; McNulty PA, 2002, J PHYSIOL-LONDON, V538, P279, DOI 10.1113/jphysiol.2001.013200; Mercier C, 2006, BRAIN, V129, P2202, DOI 10.1093/brain/awl180; Moseley GL, 2012, NEUROREHAB NEURAL RE, V26, P646, DOI 10.1177/1545968311433209; Murphy BA, 2003, CLIN NEUROPHYSIOL, V114, P1477, DOI 10.1016/S1388-2457(03)00131-7; Nikolajsen L, 1997, PAIN, V72, P393, DOI 10.1016/S0304-3959(97)00061-4; Raffin E, 2016, NEUROIMAGE; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Reilly KT, 2006, BRAIN, V129, P2211, DOI 10.1093/brain/awl154; Roll R, 2012, NEUROIMAGE, V62, P510, DOI 10.1016/j.neuroimage.2012.05.016; Rossi S, 2003, CLIN NEUROPHYSIOL, V114, P1351, DOI 10.1016/S1388-2457(03)00073-7; ROSSINI PM, 1994, BRAIN RES, V642, P169, DOI 10.1016/0006-8993(94)90919-9; SANES JN, 1988, P NATL ACAD SCI USA, V85, P2003, DOI 10.1073/pnas.85.6.2003; SELTZER Z, 1991, PAIN, V46, P327, DOI 10.1016/0304-3959(91)90115-E; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tinazzi M, 2003, EUR J NEUROSCI, V18, P3053, DOI 10.1111/j.1460-9568.2003.03043.x; Tinazzi M, 1997, NEUROSCI LETT, V223, P21, DOI 10.1016/S0304-3940(97)13382-1; Vaso A, 2014, PAIN, V155, P1384, DOI 10.1016/j.pain.2014.04.018; WALL R, 1985, SOUTHERN MED J, V78, P34, DOI 10.1097/00007611-198501000-00009; WIESENFELD Z, 1980, PAIN, V8, P285, DOI 10.1016/0304-3959(80)90074-3; Yin Y, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0359-6; Ziemann U, 1998, J NEUROSCIENCE OFFIC, V18, DOI [10.1038/375482a0, DOI 10.1038/375482A0]	59	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0206141	10.1371/journal.pone.0206141	http://dx.doi.org/10.1371/journal.pone.0206141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346981	gold, Green Published, Green Submitted			2022-12-26	WOS:000447938400039
J	Mays, JC; Kelly, MC; Coon, SL; Holtzclaw, L; Rath, MF; Kelley, MW; Klein, DC				Mays, Joseph C.; Kelly, Michael C.; Coon, Steven L.; Holtzclaw, Lynne; Rath, Martin F.; Kelley, Matthew W.; Klein, David C.			Single-cell RNA sequencing of the mammalian pineal gland identifies two pinealocyte subtypes and cell type-specific daily patterns of gene expression	PLOS ONE			English	Article							ENZYMATIC FORMATION; NICOTINIC RECEPTOR; HEPOXILIN A(3); ASTROCYTES; MICROGLIA; MELATONIN; ANTIGEN	The vertebrate pineal gland is dedicated to the production of the hormone melatonin, which increases at night to influence circadian and seasonal rhythms. This increase is associated with dramatic changes in the pineal transcriptome. Here, single-cell analysis of the rat pineal transcriptome was approached by sequencing mRNA from similar to 17,000 individual pineal cells, with the goals of profiling the cells that comprise the pineal gland and examining the proposal that there are two distinct populations of pinealocytes differentiated by the expression of Asmt, which encodes the enzyme that converts N-acetylserotonin to melatonin. In addition, this analysis provides evidence of cell-specific time-of-day dependent changes in gene expression. Nine transcriptomically distinct cell types were identified: similar to 90% were classified as melatonin-producing alpha- and beta-pinealocytes (1:19 ratio). Non-pinealocytes included three astrocyte subtypes, two microglia subtypes, vascular and leptomeningeal cells, and endothelial cells. alpha-Pinealocytes were distinguished from beta-pinealocytes by similar to 3-fold higher levels of Asmt transcripts. In addition, alpha-pinealocytes have transcriptomic differences that likely enhance melatonin formation by increasing the availability of the Asmt cofactor S-adenosyl-methionine, resulting from increased production of a precursor of S-adenosylmethionine, ATP. These transcriptomic differences include similar to 2-fold higher levels of the ATP-generating oxidative phosphorylation transcriptome and similar to 8-fold lower levels of the ribosome transcriptome, which is expected to reduce the consumption of ATP by protein synthesis. These findings suggest that alpha-pinealocytes have a specialized role in the pineal gland: efficiently O-methylating the N-acetylserotonin produced and released by beta-pinealocytes, thereby improving the overall efficiency of melatonin synthesis. We have also identified transcriptomic changes that occur between night and day in seven cell types, the majority of which occur in beta-pinealocytes and to a lesser degree in alpha-pinealocytes; many of these changes were mimicked by adrenergic stimulation with isoproterenol. The cellular heterogeneity of the pineal gland as revealed by this study provides a new framework for understanding pineal cell biology at single-cell resolution.	[Mays, Joseph C.; Kelly, Michael C.; Kelley, Matthew W.] Natl Inst Deafness & Other Commun Disorders, Sect Dev Neurosci, Lab Cochlear Dev, Div Intramural Res,NIH, Bethesda, MD USA; [Coon, Steven L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Genom Core Facil, Off Sci Director, Intramural Res Program,NIH, Bethesda, MD USA; [Holtzclaw, Lynne] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Microscopy & Imaging Core, Off Sci Director, Intramural Res Program,NIH, Bethesda, MD USA; [Rath, Martin F.] Univ Copenhagen, Panum Inst, Dept Neurosci, Copenhagen, Denmark; [Klein, David C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Off Sci Director, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Mays, Joseph C.] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY USA; [Kelly, Michael C.] NCI, Single Cell Anal Facil, Frederick Natl Lab Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Copenhagen; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Klein, DC (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Off Sci Director, Intramural Res Program, NIH, Bethesda, MD 20892 USA.	kleind@mail.nih.gov	Rath, Martin/AAL-9732-2021	Rath, Martin/0000-0002-4047-6324; Holtzclaw, Lynne/0000-0001-5102-8992; Mays, Joseph/0000-0003-4903-938X	Intramural Research Programs of the National Institute of National Institute on Deafness and Other Communication Disorders; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Novo Nordisk Foundation [NNF15OC0015988, NNF170C0026938]; Lundbeck Foundation [R108-A10301]; Carlsberg Foundation [CF15-0515, CF17-0070]; Independent Research Fund Denmark [8020-000378]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZICHD008958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000059] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute of National Institute on Deafness and Other Communication Disorders; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); Independent Research Fund Denmark; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Intramural Research Programs of the National Institute of National Institute on Deafness and Other Communication Disorders (to J.C.M., M.C.K, and M.W.K) (https://www.nidcd.nih.gov/ and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (to L.H., S.L.C., and D.C.K.) (http://www.nichd.nih.gov/), by Novo Nordisk Foundation (grants NNF15OC0015988 and NNF170C0026938, to M.F.R.) (http:// novonordiskfonden.dk/en), Lundbeck Foundation (grant R108-A10301, to M.F.R.) (https://www.lundbeckfonden.com/en/), Carlsberg Foundation (grants CF15-0515 and CF17-0070, to M.F.R.) (http://www.carlsbergfondet.dk/en), Independent Research Fund Denmark (grant 8020-000378, to M.F.R.) (https://dff.dk/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOYO VJ, 1991, NEUROENDOCRINOLOGY, V54, P594, DOI 10.1159/000125965; Arendt J, 1998, REV REPROD, V3, P13, DOI 10.1530/revreprod/3.1.13; Arendt J., 1995, MELATONIN MAMMALIAN; Bailey MJ, 2009, J BIOL CHEM, V284, P7606, DOI 10.1074/jbc.M808394200; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; CALVO J, 1984, J ANAT, V138, P405; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Carvalho-Sousa Claudia Emanuele, 2011, Front Endocrinol (Lausanne), V2, P10, DOI 10.3389/fendo.2011.00010; Cruz-Machado SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040142; Fourgeaud L, 2007, CELL, V131, P1034, DOI 10.1016/j.cell.2007.11.031; Hartley SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137548; Hernandez SC, 2004, MOL PHARMACOL, V66, P978, DOI 10.1124/mol.104.002345; Holtzclaw LA, 2002, GLIA, V39, P69, DOI 10.1002/glia.10085; Ivanov I, 2015, GENE, V573, P1, DOI 10.1016/j.gene.2015.07.073; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Kim JS, 2010, MOL CELL ENDOCRINOL, V314, P128, DOI 10.1016/j.mce.2009.05.013; Klein D C, 1983, Prog Clin Biol Res, V125, P169; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; KLEIN DC, 1985, CIBA F SYMP, V117, P38; Klein DC, 2004, J BIOL RHYTHM, V19, P264, DOI 10.1177/0748730404267340; KORF HW, 1985, CELL TISSUE RES, V239, P81, DOI 10.1007/BF00214906; LOPEZMUNOZ F, 1992, J PINEAL RES, V12, P145, DOI 10.1111/j.1600-079X.1992.tb00041.x; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; Moller M, 2006, CHRONOBIOL INT, V23, P393, DOI 10.1080/07420520500521855; Morin F, 2001, J NEUROCHEM, V78, P88, DOI 10.1046/j.1471-4159.2001.00407.x; OSTHOLM T, 1988, DEV BRAIN RES, V42, P1, DOI 10.1016/0165-3806(88)90197-6; Pace-Asciak CR, 2015, BBA-MOL CELL BIOL L, V1851, P383, DOI 10.1016/j.bbalip.2014.09.007; PACEASCIAK CR, 1993, BIOCHEM BIOPH RES CO, V197, P869, DOI 10.1006/bbrc.1993.2559; PEDERSEN EB, 1993, CELL TISSUE RES, V272, P257, DOI 10.1007/BF00302731; Perreau-Lenz S, 2004, EUR J NEUROSCI, V19, P318, DOI 10.1111/j.0953-816X.2003.03132.x; PEVET P, 1977, J NEURAL TRANSM, V40, P289, DOI 10.1007/BF01257021; Raj B, 2018, NAT BIOTECHNOL, V36, P442, DOI 10.1038/nbt.4103; Rath MF, 2016, ENDOCRINOLOGY, V157, P2028, DOI 10.1210/en.2015-1888; Rath MF, 2013, NEUROCHEM RES, V38, P1100, DOI 10.1007/s11064-012-0906-y; REYNAUD D, 1994, J BIOL CHEM, V269, P23976; REYNAUD D, 1994, J NEUROCHEM, V62, P126; REYNAUD D, 1995, ADV PROSTAG THROMB L, V23, P183; Rocha SF, 2014, CIRC RES, V115, P581, DOI 10.1161/CIRCRESAHA.115.304718; Rodriguez MPI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167063; Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999; ROSENSTEIN RE, 1990, BRAIN RES BULL, V25, P339, DOI 10.1016/0361-9230(90)90080-J; Rovsing L, 2011, J NEUROCHEM, V119, P262, DOI 10.1111/j.1471-4159.2011.07405.x; SAEZ JC, 1991, BRAIN RES, V568, P265, DOI 10.1016/0006-8993(91)91407-R; Sarrazin S, 2006, BBA-REV CANCER, V1765, P25, DOI 10.1016/j.bbcan.2005.08.004; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; SCHAAD NC, 1993, BRAIN RES, V614, P251, DOI 10.1016/0006-8993(93)91042-Q; Siangjong L, 2017, ACTA PHYSIOL, V219, P188, DOI 10.1111/apha.12642; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Suzuki T, 1995, Kaibogaku Zasshi, V70, P130; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Villela D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/618432; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wang X, 1997, J NEUROSCI METH, V73, P187, DOI 10.1016/S0165-0270(97)02237-1; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Yoon JY, 2014, AM J PHYSIOL-CELL PH, V306, pC726, DOI 10.1152/ajpcell.00354.2013; Yoshida S, 2008, NEUROSCIENCE, V152, P407, DOI 10.1016/j.neuroscience.2007.12.029; YOSHIMOTO T, 1984, PROSTAGLANDINS, V28, P279, DOI 10.1016/0090-6980(84)90063-7; Yu HJ, 2016, J PINEAL RES, V61, P69, DOI 10.1111/jpi.12328; ZANG X, 1985, J NEUROPATH EXP NEUR, V44, P486, DOI 10.1097/00005072-198509000-00004; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980	62	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205883	10.1371/journal.pone.0205883	http://dx.doi.org/10.1371/journal.pone.0205883			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30347410	gold, Green Published, Green Submitted			2022-12-26	WOS:000447938400021
J	Bergallo, P; Castagnari, V; Fernandez, A; Mejia, R				Bergallo, Paola; Castagnari, Valentina; Fernandez, Alicia; Mejia, Raul			Regulatory initiatives to reduce sugar-sweetened beverages (SSBs) in Latin America	PLOS ONE			English	Article							OBESITY PREVENTION; POLICY OPTIONS; FOOD; ENVIRONMENT; LESSONS; TAX	Background and objectives Latin American (LA) countries have begun to adopt a variety of regulations targeting sugar-sweetened beverages (SSBs) for public health reasons. Our objective was to characterize the regulatory strategies designed to reduce SSB consumption over the last decade, and assess the available evidence on their enforcement and impact. Methods We searched legal and public health databases for public and private SSBs regulations in 14 LA countries and then conducted a systematic review of the available literature. We tracked comparative variations in the type of body issuing the regulations, their scope, and binding status. We present data following a 5-category framework we named NUTRE that classifies SSBs regulations as: (1) restrictions to SSB availability in schools (N), (2) taxes and other economic incentives to discourage consumption (U), (3) restrictions on advertising and marketing (T), (4) regulations on government procurement and subsidies (R), and (5) product labeling rules (E). Results Since 2006, 14 LA countries have adopted at least 39 public and private SSB regulatory initiatives across the NUTRE framework. Comprehensive efforts have only been approved by Chile, Mexico and Ecuador, while the rest have comparatively few initiatives. 28 out of the 39 regulatory initiatives were passed by legislative and executive bodies; 11 initiatives represent self-regulatory undertakings by the beverage industries. An 86% (24/28) of public sector regulations are binding; 56% (22/39) contain explicit monitoring or evaluation methods; and 62% (24/39) provide for sanctions. Moreover, 23 regulations specify the body in charge of monitoring the new rules and standards. Conclusions LA countries are targeting SSB consumption through a variety of mechanisms, particularly via restrictions to availability in schools and through taxes. Interdisciplinary evidence comparing alternative regulatory strategies is scarce, and few studies offer data on impact and implementation challenges. More evidence and further comparative assessments are needed to support future decision-making.	[Bergallo, Paola; Castagnari, Valentina] Univ Torcuato Di Tella, Law Dept, Buenos Aires, DF, Argentina; [Fernandez, Alicia] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Mejia, Raul] Ctr Estudios Estado & Soc, Buenos Aires, DF, Argentina	Universidad Torcuato Di Tella; University of California System; University of California San Francisco	Bergallo, P (corresponding author), Univ Torcuato Di Tella, Law Dept, Buenos Aires, DF, Argentina.	pbergallo@utdt.edu		Mejia, Raul/0000-0002-7782-0934	International Development Research Centre [N885]	International Development Research Centre	This paper is part of a research on sugar sweetened beverages consumption in Argentina financed by the International Development Research Centre (https://www.idrc.ca) Grant N885. The funders had no role in study design data collection and analysis decision to publish or preparation of the manuscript.	Alvarado M, 2017, PREV MED, V105, pS23, DOI 10.1016/j.ypmed.2017.07.013; [Anonymous], 2017, ADV RIGHT HLTH VITAL; Colchero MA, 2017, SALUD PUBLICA MEXICO, V59, P137, DOI 10.21149/7994; Arrua A, 2017, PUBLIC HEALTH NUTR, V20, P2308, DOI 10.1017/S1368980017000866; Asociacion Nacional de Empresarios de Colombia (ANDI), IND BEB ALC AS COMPR; Bae Sang Geun, 2012, J Prev Med Public Health, V45, P47, DOI 10.3961/jpmph.2012.45.1.47; Barquera S, 2013, OBES REV, V14, P69, DOI 10.1111/obr.12096; Batis C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002057; Borges MC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002195; Borgmeier I, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-184; Charvel S, 2015, J PUBLIC HEALTH POL, V36, P426, DOI 10.1057/jphp.2015.28; Chiang PH, 2011, PUBLIC HEALTH NUTR, V14, P1601, DOI 10.1017/S1368980011001042; Chriqui JF, 2013, J PUBLIC HEALTH POL, V34, P403, DOI 10.1057/jphp.2013.17; Colchero MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163463; Colchero M. A., 2017, HLTH AFF, P10; Contreras Landgrave Georgina, 2014, Rev. Mex. de trastor. aliment, V5, P50; CORNELSEN L, 2015, FOOD RES COLLABORATI; Corvalan C, 2013, OBES REV, V14, P79, DOI 10.1111/obr.12099; Crovetto M, 2009, REV CHIL NUTR, V36, P32; El economista, 2017, EL EC           0119; Falbe J, 2016, AM J PUBLIC HEALTH, V106, P1865, DOI 10.2105/AJPH.2016.303362; Flores Huerta Samuel, 2011, Bol. Med. Hosp. Infant. Mex., V68, P69; Franck C, 2013, AM J PUBLIC HEALTH, V103, P1949, DOI 10.2105/AJPH.2013.301279; Franco Liliana, 2017, AMBITO FINANCIE 1213; Galicia L, 2016, REV PANAM SALUD PUBL, V40, P138; Gallegos Gallegos Rossana Patricia, 2016, Horiz. sanitario, V15, P155; Gaviria Alejandro, 2016, EL ESPECTADOR; Gomez EJ, 2015, J HEALTH POLIT POLIC, V40, P73, DOI 10.1215/03616878-2854588; Grunert KG, 2010, J PUBLIC HEALTH-HEID, V18, P261, DOI 10.1007/s10389-009-0307-0; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Hawkes C, 2010, AM J PREV MED, V38, P457, DOI 10.1016/j.amepre.2010.01.011; Hawley KL, 2013, PUBLIC HEALTH NUTR, V16, P430, DOI 10.1017/S1368980012000754; Barrera LH, 2016, AM J PREV MED, V51, P264, DOI 10.1016/j.amepre.2016.02.021; Instituto Nacional de Salud Publica, 2016, REV CURR LAB REG PRA; Kain J, 2014, CURR OBES REP, V3, P150, DOI 10.1007/s13679-014-0097-8; Khandpur N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060688; Latnovic L, 2013, Int J Obes Suppl, V3, pS12, DOI 10.1038/ijosup.2013.5; Lobelo F, 2013, J SCHOOL HEALTH, V83, P668, DOI 10.1111/josh.12080; Mair J.S., 2005, USE ZONING RESTRICT; Mandle J, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.25912; Moise N, 2011, J PUBLIC HEALTH POL, V32, P458, DOI 10.1057/jphp.2011.39; Monterrosa EC, 2015, HEALTH POLICY PLANN, V30, P28, DOI 10.1093/heapol/czt094; Pomeranz JL, 2012, J PUBLIC HEALTH POL, V33, P75, DOI 10.1057/jphp.2011.46; Popkin B, 2013, OBES REV, V14, P1, DOI 10.1111/obr.12108; Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2; Republic of Korea Ministry of Food and Drug Safety, PROM HLTH DIETS SAF; Silver LD, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002283; Studdert DM, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001848; Theodore FL, 2017, PEDIATR OBES, V12, P312, DOI 10.1111/ijpo.12144; Travino Ronzon E, 2014, REV INVESTIGACION ED; Zhang Q, 2014, CURR OBES REP, V3, P171, DOI 10.1007/s13679-014-0099-6	51	31	31	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205694	10.1371/journal.pone.0205694	http://dx.doi.org/10.1371/journal.pone.0205694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX5DH	30339667	gold, Green Published			2022-12-26	WOS:000447761400020
J	Yarnoff, BO; Hoerger, TJ; Shrestha, SS; Simpson, SK; Burrows, NR; Anderson, AH; Xie, DW; Chen, HY; Pavkov, ME				Yarnoff, Benjamin O.; Hoerger, Thomas J.; Shrestha, Sundar S.; Simpson, Siobhan K.; Burrows, Nilka R.; Anderson, Amanda H.; Xie, Dawei; Chen, Hsiang-Yu; Pavkov, Meda E.		CRIC Study Investigators	Modeling the impact of obesity on the lifetime risk of chronic kidney disease in the United States using updated estimates of GFR progression from the CRIC study	PLOS ONE			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; COST-EFFECTIVENESS; WEIGHT-GAIN; US ADULTS; OVERWEIGHT; METAANALYSIS; HYPERTENSION; CKD	Rationale & objective As the prevalence of obesity continues to rise in the United States, it is important to understand its impact on the lifetime risk of chronic kidney disease (CKD). Study design The CKD Health Policy Model was used to simulate the lifetime risk of CKD for those with and without obesity at baseline. Model structure was updated for glomerular filtration rate (GFR) decline to incorporate new longitudinal data from the Chronic Renal Insufficiency Cohort (CRIC) study. Setting and population The updated model was populated with a nationally representative cohort from National Health and Nutrition Examination Survey (NHANES). Outcomes Lifetime risk of CKD, highest stage and any stage. Model, perspective, & timeframe Simulation model following up individuals from current age through death or age 90 years. Results Lifetime risk of any CKD stage was 32.5% (95% CI 28.6%-36.3%) for persons with normal weight, 37.6% (95% CI 33.5%-41.7%) for persons who were overweight, and 41.0% (95% CI 36.7%-45.3%) for persons with obesity at baseline. The difference between persons with normal weight and persons with obesity at baseline was statistically significant (p<0.01). Lifetime risk of CKD stages 4 and 5 was higher for persons with obesity at baseline (Stage 4: 2.1%, 95% CI 0.9%-3.3%; stage 5: 0.6%, 95% CI 0.0%-1.1%), but the differences were not statistically significant (stage 4: p = 0.08; stage 5: p = 0.23). Limitations Due to limited data, our simulation model estimates are based on assumptions about the causal pathways from obesity to CKD, diabetes, and hypertension. Conclusions The results of this study indicate that obesity may have a large impact on the lifetime risk of CKD. This is important information for policymakers seeking to set priorities and targets for CKD prevention and treatment.	[Yarnoff, Benjamin O.; Hoerger, Thomas J.; Simpson, Siobhan K.] RTI Int, Res Triangle Pk, NC 27709 USA; [Shrestha, Sundar S.; Burrows, Nilka R.; Pavkov, Meda E.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Anderson, Amanda H.] Tulane Univ, New Orleans, LA 70118 USA; [Xie, Dawei; Chen, Hsiang-Yu] Univ Penn, Philadelphia, PA 19104 USA	Research Triangle Institute; Centers for Disease Control & Prevention - USA; Tulane University; University of Pennsylvania	Yarnoff, BO (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	byarnoff@rti.org		Hoerger, Thomas/0000-0003-4154-7806; Yarnoff, Benjamin/0000-0002-5147-1588	Centers for Disease Control and Prevention (CDC) [200-2008-27958]; National Institute of Diabetes and Digestive and Kidney Diseases [U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, U01DK060902]; Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science Award [NIH/NCATS UL1TR000003]; Johns Hopkins University [UL1 TR-000424]; University of Maryland [GCRC M01 RR-16500]; Clinical and Translational Science Collaborative of Cleveland; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [UL1TR000439]; NIH road map for Medical Research, Michigan Institute for Clinical and Health Research (MICHR) [UL1TR000433]; University of Illinois at Chicago CTSA [UL1RR029879]; Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases [P20 GM109036]; Kaiser Permanente NI H/NCRR UCSF-CTSI [UL1 RR-024131]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002548, UL1TR002003, UL1TR000439, UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060980, U01DK060990, U01DK060902, U01DK060963, U01DK061021, U24DK060990, U01DK060984, U01DK061028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109036] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science Award; Johns Hopkins University(Johns Hopkins University); University of Maryland; Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH road map for Medical Research, Michigan Institute for Clinical and Health Research (MICHR); University of Illinois at Chicago CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases; Kaiser Permanente NI H/NCRR UCSF-CTSI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by funding (Contract #200-2008-27958 to TJH) from the Centers for Disease Control and Prevention (CDC). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of CDC. Funding for the CRIC Study was obtained under a cooperative agreement from National Institute of Diabetes and Digestive and Kidney Diseases (U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, and U01DK060902). In addition, this work was supported in part by: the Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science Award NIH/NCATS UL1TR000003, Johns Hopkins University UL1 TR-000424, University of Maryland GCRC M01 RR-16500, Clinical and Translational Science Collaborative of Cleveland, UL1TR000439 from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH road map for Medical Research, Michigan Institute for Clinical and Health Research (MICHR) UL1TR000433, University of Illinois at Chicago CTSA UL1RR029879, Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases P20 GM109036, Kaiser Permanente NI H/NCRR UCSF-CTSI UL1 RR-024131.	Botoseneanu A, 2010, J AGING HEALTH; Boulware LE, 2003, JAMA-J AM MED ASSOC, V290, P3101, DOI 10.1001/jama.290.23.3101; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; DAgati V. D., 2016, NATURE REV NEPHROLOG; de Boer IH, 2009, AM J KIDNEY DIS, V54, P1043, DOI 10.1053/j.ajkd.2009.07.018; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Elsayed EF, 2008, AM J KIDNEY DIS, V52, P29, DOI 10.1053/j.ajkd.2008.02.363; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; GARRISON RJ, 1987, PREV MED, V16, P235, DOI 10.1016/0091-7435(87)90087-9; Hall ME, 2014, INT J NEPHROL RENOV, V7, P75, DOI 10.2147/IJNRD.S39739; Hoerger TJ, 2015, AM J KIDNEY DIS, V65, P403, DOI 10.1053/j.ajkd.2014.09.023; Hoerger TJ, 2012, J AM SOC NEPHROL, V23, P2035, DOI 10.1681/ASN.2012040347; Hoerger TJ, 2010, AM J KIDNEY DIS, V55, P452, DOI 10.1053/j.ajkd.2009.11.016; Hoerger TJ, 2010, AM J KIDNEY DIS, V55, P463, DOI 10.1053/j.ajkd.2009.11.017; Kopple JD, 2001, AM J KIDNEY DIS, V37, pS66, DOI 10.1053/ajkd.2001.20748; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; National Center for Health Statistics, 2016, 2015 SPEC RAC ETHN H; Ogden CL, 2015, PREVALENCE OBESITY A; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; Saran R, 2017, AM J KIDNEY DIS, V69, DOI 10.1053/j.ajkd.2016.12.004; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205530	10.1371/journal.pone.0205530	http://dx.doi.org/10.1371/journal.pone.0205530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339684	gold, Green Submitted, Green Published			2022-12-26	WOS:000447761400015
J	Shi, YR; Lim, Y; Suh, CS				Shi, Yongren; Lim, Yisook; Suh, Chan S.			Innovation or deviation? The relationship between boundary crossing and audience evaluation in the music field	PLOS ONE			English	Article							SECURITIES ANALYSTS; CATEGORY; TECHNOLOGY; CONSEQUENCES; TRADITION; CULTURE	Prior research in organizations has shown that the spanning of distinct social categories usually leads to an unfavorable reaction from the audience. In the music field, however, a recombination of categories has long been celebrated as a major source of innovation. In this research, we conduct a systematical research on the effect of spanning behavior by musicians with a particular focus on the structural heterogeneity of categorical boundaries. We first ask whether the blending of distinct music genres is penalized in the music field, and then investigate how the outcomes of spanning behavior are differentiated by the structural characteristics of each genres. After collecting a comprehensive dataset of musicians in the United States from diverse sources including AllMusic, iTunes, and MusicBrainz, we construct a two-mode network of musicians and subgenres. In calculating musicians' genre-spanning behavior, we suggest a new diversity metric by incorporating the affinity between genres. Our results suggest that genre-generalist musicians who combine distinct music genres are more likely to be devaluated by listeners compared to genre-specialists who adhere to a single genre. Moreover, we find that musicians tend to be more penalized when they blend genres that have nonporous boundaries rather than penetrable boundaries. This research expands our understanding of the conditions under which boundary crossing leads to negative audience evaluation.	[Shi, Yongren] Univ Iowa, Dept Sociol, Iowa City, IA 52242 USA; [Lim, Yisook] Yonsei Univ, Inst Social Dev Studies, Seoul, South Korea; [Suh, Chan S.] Chung Ang Univ, Dept Sociol, Seoul, South Korea	University of Iowa; Yonsei University; Chung Ang University	Suh, CS (corresponding author), Chung Ang Univ, Dept Sociol, Seoul, South Korea.	sociochan@cau.ac.kr			Chung-Ang University Research Grants in South Korea	Chung-Ang University Research Grants in South Korea	This research was supported by the Chung-Ang University Research Grants in South Korea (https://rsch.cau.ac.kr/). No grant number is available at this moment. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], 2004, PHYS REV E, DOI DOI 10.1103/PhysRevE.70.056131; Becker H. S., 1982, ART WORLDS; Bennett A, 2004, POETICS, V32, P223, DOI 10.1016/j.poetic.2004.05.004; Bourdieu P., 1984, DISTINCTION SOCIAL C; Bryson B, 1996, AM SOCIOL REV, V61, P884, DOI 10.2307/2096459; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; DIMAGGIO P, 1982, MEDIA CULT SOC, V4, P33, DOI 10.1177/016344378200400104; Dowd T, 2006, LEAS ORG MAN SERIES, P205; Foster JG, 2015, AM SOCIOL REV, V80, P875, DOI 10.1177/0003122415601618; Gelman A., 2007, DATA ANAL USING REGR; Goldberg A, 2016, AM SOCIOL REV, V81, P215, DOI 10.1177/0003122416632787; Hannan M.T., 2007, LOGICS ORG THEORY AU; Hsu G, 2006, ADMIN SCI QUART, V51, P420, DOI 10.2189/asqu.51.3.420; Hsu G, 2009, AM SOCIOL REV, V74, P150, DOI 10.1177/000312240907400108; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Jones BF, 2009, REV ECON STUD, V76, P283, DOI 10.1111/j.1467-937X.2008.00531.x; Katz, 2010, CAPTURING SOUND TECH; Keuschnigg M, 2017, SOC FORCES, V96, P449, DOI 10.1093/sf/sox043; Kovacs B, 2015, SOCIOL SCI, V2, P252, DOI 10.15195/v2.a13; Kovacs B, 2014, ADMIN SCI QUART, V59, P1, DOI 10.1177/0001839214523602; Kovacs B, 2010, RES SOCIOL ORGAN-RES, V31, P175, DOI 10.1108/S0733-558X(2010)0000031008; Lampel J, 2000, ORGAN SCI, V11, P263, DOI 10.1287/orsc.11.3.263.12503; Lena JC, 2008, AM SOCIOL REV, V73, P697, DOI 10.1177/000312240807300501; Leung MD, 2014, AM SOCIOL REV, V79, P136, DOI 10.1177/0003122413518638; Leyshon A, 2009, ENVIRON PLANN A, V41, P1309, DOI 10.1068/a40352; Mattsson JT, 2010, MANAGE DECIS, V48, P1355, DOI 10.1108/00251741011082107; MUTHEN BO, 1991, J EDUC MEAS, V28, P338, DOI 10.1111/j.1745-3984.1991.tb00363.x; MUTHEN BO, 1994, SOCIOL METHOD RES, V22, P376, DOI 10.1177/0049124194022003006; Negro G, 2013, ORGAN SCI, V24, P684, DOI 10.1287/orsc.1120.0764; Negro G, 2011, ORGAN SCI, V22, P1449, DOI 10.1287/orsc.1100.0619; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Park Minsu, 2015, 9 INT AAAI C WEB SOC; Perry, 2004, PROPHETS HOOD POLITI; Peterson R., 1997, CREATING COUNTRY MUS; Peugh JL, 2010, J SCHOOL PSYCHOL, V48, P85, DOI 10.1016/j.jsp.2009.09.002; Pinheiro J., 2021, CRAN, V3, P1; Pontikes EG, 2014, SOCIOL SCI, V1, P311, DOI 10.15195/v1.a20; Pontikes EG, 2012, ADMIN SCI QUART, V57, P81, DOI 10.1177/0001839212446689; Rao, 1982, SANKHY INDIAN J ST A, V44, P1, DOI DOI 10.1007/S13171-010-0002-9; Roy WG, 2010, ANNU REV SOCIOL, V36, P183, DOI 10.1146/annurev.soc.012809.102618; Roy WilliamG., 2002, QUAL SOCIOL, V25, P459; Schumpeter J.A., 1939, BUSINESS CYCLES THEO; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Shi YR, 2017, PROCEEDINGS OF THE 2017 ACM WEB SCIENCE CONFERENCE (WEBSCI '17), P213, DOI 10.1145/3091478.3091520; Shi YR, 2016, SOC SCI RES, V59, P97, DOI 10.1016/j.ssresearch.2016.04.021; Silver D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155471; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stirling A., 1998, SPRU ELECT WORKING P, V28, P1; Stirling A, 2007, J R SOC INTERFACE, V4, P707, DOI 10.1098/rsif.2007.0213; Uzzi B, 2005, AM J SOCIOL, V111, P447, DOI 10.1086/432782; Uzzi B, 2013, SCIENCE, V342, P468, DOI 10.1126/science.1240474; Zuckerman EW, 1999, AM J SOCIOL, V104, P1398, DOI 10.1086/210178; Zuckerman EW, 2000, ADMIN SCI QUART, V45, P591, DOI 10.2307/2667110	55	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0203065	10.1371/journal.pone.0203065	http://dx.doi.org/10.1371/journal.pone.0203065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4KR	30335744	Green Submitted, gold, Green Published			2022-12-26	WOS:000447701300003
J	Ciani, JFC; Guerrel, J; Baitchman, E; Diaz, R; Evans, M; Ibanez, R; Ross, H; Klaphake, E; Nissen, B; Pessier, AP; Power, ML; Arlotta, C; Snellgrove, D; Wilson, B; Gratwicke, B				Camperio Ciani, Julio Federico; Guerrel, Jorge; Baitchman, Eric; Diaz, Rigoberto; Evans, Matthew; Ibanez, Roberto; Ross, Heidi; Klaphake, Eric; Nissen, Bradley; Pessier, Allan P.; Power, Michael L.; Arlotta, Caitlin; Snellgrove, Donna; Wilson, Brad; Gratwicke, Brian			The relationship between spindly leg syndrome incidence and water composition, overfeeding, and diet in newly metamorphosed harlequin frogs (Atelopus spp.)	PLOS ONE			English	Article							CALCIUM-METABOLISM; RANA-CATESBEIANA; TADPOLES; PROTEIN; DISEASE; GROWTH; HEALTH	Spindly Leg Syndrome (SLS) is a persistent animal welfare issue associated with the rearing of amphibians in captivity. We conducted two experiments to investigate the effects of diet, water composition and overfeeding on prevalence of SLS in newly metamorphosed harlequin frogs (Atelopus spp.). In our first experiment, we offered 400 full-sibling tadpoles of Atelopus certus isocaloric diets in treatments of 31%, 37%, 42% and 48% crude protein respectively. Tadpoles fed higher protein diets metamorphosed faster, but the incidence of SLS exceeded 80% in all treatments leading to the conclusion that variation in dietary protein was not responsible for causing SLS. We used 720 full-sibling Atelopus glyphus tadpoles in a second experiment to examine the effects of diet type, water composition and diet ration on SLS. We found that an overall incidence of 58% spindly leg in tadpoles reared in tap water, but reduced to about 10% in water treated by reverse osmosis and then reconstituted. It is possible that the reverse osmosis treatment removed some factor that caused the SLS, or that the reconstitution may have added a mineral lacking in the original tap water. Within tap water treatments, overfeeding tadpoles in tanks increased the incidence of SLS. We recommend further experimental research into this condition to identify the causative factors in the water. Additional research into the nutritional composition of food available to wild tadpoles would be useful in formulating captive diets, that have to date been solely based on surrogate species.	[Camperio Ciani, Julio Federico; Guerrel, Jorge; Diaz, Rigoberto; Ibanez, Roberto; Ross, Heidi; Nissen, Bradley] Smithsonian Trop Res Inst, Panama Amphibian Rescue & Conservat Project, Panama City, Panama; [Baitchman, Eric; Gratwicke, Brian] Zoo New England, 1 Franklin Pk Rd, Boston, MA 02121 USA; [Evans, Matthew; Power, Michael L.; Arlotta, Caitlin] Smithsonians Natl Zoo & Conservat Biol Inst, Washington, DC USA; [Ibanez, Roberto] Secretaria Nacl Ciencia Tecnol & Innovac, Sistema Nacl Invest, Panama City, Panama; [Klaphake, Eric] Cheyenne Mt Zoo, Colorado Springs, CO USA; [Pessier, Allan P.] Washington State Univ, Coll Vet Med, Pullman, WA 99164 USA; [Snellgrove, Donna] Waltham Ctr Pet Nutr, Freeby Lane, Melton Mowbray, Leics, England; [Wilson, Brad] Atlanta Bot Gardens, Atlanta, GA USA	Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Secretaria Nacional de Ciencia, Tecnologia e Innovacin (SENACYT); Washington State University; Mars; WALTHAM Petcare Science Institute	Gratwicke, B (corresponding author), Zoo New England, 1 Franklin Pk Rd, Boston, MA 02121 USA.	gratwickeb@si.edu	Nissen, Bradley/W-6175-2019	Nissen, Bradley/0000-0001-6547-5734; Gratwicke, Brian/0000-0002-7332-4060	National Science Foundation [1227005]; First Quantum Minerals; Woodtiger Fund; Waltham Center for Pet Nutrition	National Science Foundation(National Science Foundation (NSF)); First Quantum Minerals; Woodtiger Fund; Waltham Center for Pet Nutrition	The experiments were conducted in a laboratory facility established by the National Science Foundation Field Stations and Marine Laboratories Improvement Grant # 1227005. The Panama Amphibian Rescue and Conservation Project is a collaborative project between the Cheyenne Mountain Zoo, the Houston Zoo, Zoo New England and the Smithsonian Institution and provides core operational support for this project. RI, HR and JG were supported in part by a grant from First Quantum Minerals, JFCC was supported by a grant from the Woodtiger Fund. BG is grateful to Susan and Frank Mars for their continued financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Donna Snellgrove is employed by Waltham Center for Pet Nutrition. Waltham Center for Pet Nutrition provided support in the form of salary for author DS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ALLEN ME, 1989, J ZOO WILDLIFE MED, V20, P26; Alvarez D, 2002, FUNCT ECOL, V16, P640, DOI 10.1046/j.1365-2435.2002.00658.x; Antwis RE, 2009, COMP BIOCHEM PHYS A, V154, P184, DOI 10.1016/j.cbpa.2009.06.008; BALDWIN GF, 1980, J EXP BIOL, V88, P357; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Briggs J.C., 1977, QUALITY RIVERS US 19; CarmonaOsalde C, 1996, AQUACULTURE, V141, P223, DOI 10.1016/0044-8486(95)01232-X; Claunch Natalie, 2015, Journal of Herpetological Medicine and Surgery, V25, P72, DOI 10.5818/1529-9651-25.3.72; Estrada A, 2013, GOLDEN FROGS PANAMA, P19; Ferrie GM, 2014, ZOO BIOL, V33, P485, DOI 10.1002/zoo.21180; Gratwicke B, 2016, ANIM CONSERV, V19, P324, DOI 10.1111/acv.12249; GUARDABASSI A, 1960, Z ZELLFORSCH MIK ANA, V51, P278; Hakvoort H., 1990, Lacerta, V48, P117; Hokvoort JH, 1995, P 5 INT S PATH REPT, P271; Klaphake Eric, 2010, Veterinary Clinics of North America Exotic Animal Practice, V13, P375, DOI 10.1016/j.cvex.2010.05.007; Kupferberg SJ, 1997, AM ZOOL, V37, P146; Marshall GA, 2009, P WORLD MARIC SOC BL, V11, P445, DOI [10.1111/J.1749-7345.1980.TB00139.X, DOI 10.1111/J.1749-7345.1980.TB00139.X]; Martins FMS, 2013, ZOO BIOL, V32, P457, DOI 10.1002/zoo.21067; McWilliams, 2008, NUTR RECOMMENDATIONS; Michaels CJ, 2015, J ANIM PHYSIOL AN N, V99, P391, DOI 10.1111/jpn.12203; Mitchell M.A., 2009, MANUAL EXOTIC PET PR; POLLACK ED, 1989, AM ZOOL, V29, pA163; Shaw SD, 2012, J ZOO WILDLIFE MED, V43, P549, DOI 10.1638/2011-0276R1.1; St Claire MB, 2005, CONTEMP TOP LAB ANIM, V44, P8; STIFFLER DF, 1993, J EXP BIOL, V184, P47; Tapley B, 2015, ZOO BIOL, V34, P46, DOI 10.1002/zoo.21170; UCLA, 2017, MIX EFF LOG REGR R D; Venesky MD, 2012, OECOLOGIA, V169, P23, DOI 10.1007/s00442-011-2171-1; Verschooren E., 2011, J PHYSL PATHOPHYSIOL, V2, P34; Wright KM., 2001, AMPHIBIAN MED CAPTIV	30	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0204314	10.1371/journal.pone.0204314	http://dx.doi.org/10.1371/journal.pone.0204314			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325919	Green Submitted, gold, Green Published			2022-12-26	WOS:000447430800007
J	Otero, I; Castellnou, M; Gonzalez, I; Arilla, E; Castell, L; Castellvi, J; Sanchez, F; Nielsen, JO				Otero, Iago; Castellnou, Marc; Gonzalez, Itziar; Arilla, Etel; Castell, Llorenc; Castellvi, Jordi; Sanchez, Francesc; Nielsen, Jonas O.			Democratizing wildfire strategies. Do you realize what it means? Insights from a participatory process in the Montseny region (Catalonia, Spain)	PLOS ONE			English	Article							FIRE MANAGEMENT; POLITICAL ECOLOGY; ENVIRONMENTAL-CHANGE; RISK-MANAGEMENT; KNOWLEDGE; FOREST; SCALE; CONSERVATION; ADAPTATION; GOVERNANCE	Participatory planning networks made of government agencies, stakeholders, citizens and scientists are receiving attention as a potential pathway to build resilient landscapes in the face of increased wildfire impacts due to suppression policies and land-use and climate changes. A key challenge for these networks lies in incorporating local knowledge and social values about landscape into operational wildfire management strategies. As large wildfires overcome the suppression capacity of the fire departments, such strategies entail difficult decisions about intervention priorities among different regions, values and socioeconomic interests. Therefore there is increasing interest in developing tools that facilitate decision-making during emergencies. In this paper we present a method to democratize wildfire strategies by incorporating social values about landscape in both suppression and prevention planning. We do so by reporting and critically reflecting on the experience from a pilot participatory process conducted in a region of Catalonia (Spain). There, we built a network of researchers, practitioners and citizens across spatial and governance scales. We combined knowledge on expected wildfires, landscape co-valuation by relevant actors, and citizen participation sessions to design a wildfire strategy that minimized the loss of social values. Drawing on insights from political ecology and transformation science, we discuss what the attempt to democratize wildfire strategies entails in terms of power relationships and potential for social-ecological transformation. Based on our experience, we suggest a trade-off between current wildfire risk levels and democratic management in the fire-prone regions of many western countries. In turn, the political negotiation about the landscape effects of wildfire expert knowledge is shown as a potential transformation pathway towards lower risk landscapes that can re-define agency over landscape and foster community re-learning on fire. We conclude that democratizing wildfire strategies ultimately entails co-shaping the landscapes and societies of the future.	[Otero, Iago; Nielsen, Jonas O.] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, Berlin, Germany; [Otero, Iago] Univ Autonoma Barcelona, Inst Environm Sci & Technol, Cerdanyola Del Valles, Spain; [Castellnou, Marc; Arilla, Etel; Castell, Llorenc; Castellvi, Jordi] Catalan Reg Govt, Dept Home Affairs, Fire Dept, GRAF, Cerdanyola Del Valles, Spain; [Gonzalez, Itziar; Sanchez, Francesc] Inst Cartog Revolta, Barcelona, Spain; [Nielsen, Jonas O.] Humboldt Univ, Geog Dept, Berlin, Germany	Humboldt University of Berlin; Autonomous University of Barcelona; Humboldt University of Berlin	Otero, I (corresponding author), Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, Berlin, Germany.; Otero, I (corresponding author), Univ Autonoma Barcelona, Inst Environm Sci & Technol, Cerdanyola Del Valles, Spain.	iago.otero.armengol@hu-berlin.de		Nielsen, Jonas/0000-0002-9518-7511; Castellnou Ribau, Marc/0000-0002-7893-6744	German Excellence Initiative through the Integrative Research Institute on Transformations of Human-Environment Systems (IRI THESys) of the Humboldt University of Berlin; Spanish government [CSO2014-54513-R]	German Excellence Initiative through the Integrative Research Institute on Transformations of Human-Environment Systems (IRI THESys) of the Humboldt University of Berlin; Spanish government(Spanish GovernmentEuropean Commission)	This research was funded by the German Excellence Initiative through the Integrative Research Institute on Transformations of Human-Environment Systems (IRI THESys) of the Humboldt University of Berlin. The public participation sessions were partly funded by the Spanish government's project CSO2014-54513-R (SINALECO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abrams JB, 2015, ECOL SOC, V20, DOI 10.5751/ES-07848-200334; Ager AA, 2015, RISK ANAL, V35, P1393, DOI 10.1111/risa.12373; Almstedt A, 2013, FOREST CHRON, V89, P664, DOI 10.5558/tfc2013-119; Anderson G.L., 2015, ACTION RES DISSERTAT, DOI 10.4135/9781452226644.n3; [Anonymous], CONFLICTING FIRE REG; Asara V., 2015, DEGROWTH VOCABULARY, P169; Asara V, 2015, SUSTAIN SCI, V10, P375, DOI 10.1007/s11625-015-0321-9; Bartolome J, BIOL CONSERV; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Brown K., 2013, WORLD SOCIAL SCI REP, P100, DOI DOI 10.1787/9789264203419-13-EN; Brummel RF, 2010, J ENVIRON PLANN MAN, V53, P681, DOI 10.1080/09640568.2010.488090; Buizer M, 2016, GEOFORUM, V68, P48, DOI 10.1016/j.geoforum.2015.11.011; Butler WH, 2010, ECOL SOC, V15; Calkin DE, 2015, FOR ECOSYST, V2, DOI 10.1186/s40663-015-0033-8; Campbell D., 1995, CAMPBELL PREDICTION; Carroll MS, 2006, RURAL SOCIOL, V71, P261, DOI 10.1526/003601106777789701; Carroll MS, 2005, SOC NATUR RESOUR, V18, P301, DOI 10.1080/08941920590915224; Cash DW, 2006, ECOL SOC, V11; Castellnou M., 2009, 5 C FOR ESP MONT SOC; Castellnou M, 2013, ESTRATEGIA TACTICAS; Castellnou M., 2017, INT C PRESCR FIR BAR; Chapin FS, 2008, BIOSCIENCE, V58, P531, DOI 10.1641/B580609; Costa P., 2011, HDB PREPARED PROJECT; Donovan GH, 2007, FRONT ECOL ENVIRON, V5, P73, DOI 10.1890/1540-9295(2007)5[73:BCWYWF]2.0.CO;2; Eriksen C, 2007, GEOGR J, V173, P242, DOI 10.1111/j.1475-4959.2007.00239.x; Eriksen C, 2011, INT J WILDLAND FIRE, V20, P612, DOI 10.1071/WF10018; Everett Y, 2002, COMMUNITIES FLAMES, P125; Everett Y, 2011, SOC NATUR RESOUR, V24, P319, DOI 10.1080/08941920903313835; Fischer AP, 2016, FRONT ECOL ENVIRON, V14, P277, DOI 10.1002/fee.1283; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Gazzard R, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0341; Gonzalez-Hidalgo M, 2014, ENVIRON PLANN A, V46, P1014, DOI 10.1068/a45600; Howitt R, 2014, GEOGR RES-AUST, V52, P61, DOI 10.1111/1745-5871.12036; Huffman MR, 2013, ECOL SOC, V18, DOI 10.5751/ES-05843-180403; Kull CA, 2002, POLIT GEOGR, V21, P927, DOI 10.1016/S0962-6298(02)00054-9; Martinez-Alier J., 2002, SCHWERWIEGENDER RECH; McLennan BJ, 2012, ENVIRON HAZARDS-UK, V11, P1, DOI 10.1080/17477891.2011.608835; Moore P, 2002, COMM FLAM P INT C CO; Morehouse BJ, 2008, PROF GEOGR, V60, P495, DOI 10.1080/00330120802211836; Morehouse BJ, 2010, INT J WILDLAND FIRE, V19, P123, DOI 10.1071/WF08064; Moritz MA, 2014, NATURE, V515, P58, DOI 10.1038/nature13946; Moser SC, 2016, CURR OPIN ENV SUST, V20, DOI 10.1016/j.cosust.2016.10.001; Mouffe C., 2005, DEMOCRATIC PARADOX; Nelson DR, 2007, ANNU REV ENV RESOUR, V32, P395, DOI 10.1146/annurev.energy.32.051807.090348; North MP, 2015, SCIENCE, V349, P1280, DOI 10.1126/science.aab2356; O'Brien K, 2013, PROG HUM GEOG, V37, P587, DOI 10.1177/0309132512469589; O'Neill SJ, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014018; OBrien K., 2012, PROG HUM GEOGR, V36; Olsson P, 2007, ECOL SOC, V12; Otero I, 2015, SITJA LLOP, V38, P22; Otero I, 2017, POSITION SCI TRANSFO, P2017; Otero I, 2017, GEOFORUM, V85, P234, DOI 10.1016/j.geoforum.2017.07.020; Otero I, 2015, ECOL SOC, V20, DOI 10.5751/ES-07378-200207; Otero I, 2011, ECOL ECON, V70, P1297, DOI 10.1016/j.ecolecon.2009.09.011; Plana E., 2015, SOCIAL FACTOR TERRIT; Rawluk A, 2017, J ENVIRON MANAGE, V185, P11, DOI 10.1016/j.jenvman.2016.10.052; Reason Peter, 2008, SAGE HDB ACTION RES, V2nd; Regos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094906; Robbins, 2020, BOOKDOWN TEMPLATE; Robinson J, 2008, FUTURES, V40, P70, DOI 10.1016/j.futures.2007.06.007; Sletto B, 2008, WORLD DEV, V36, P1938, DOI 10.1016/j.worlddev.2008.02.008; Swyngedouw E, 2003, ANTIPODE, V35, P898, DOI 10.1111/j.1467-8330.2003.00364.x; Tabara D, 2003, RISK ANAL, V23, P249, DOI 10.1111/1539-6924.00305; Tedim F, 2016, INT J DISAST RISK RE, V18, P138, DOI 10.1016/j.ijdrr.2016.06.005; Thompson M, 2015, SCIENCE, P350; Vicente O, 2012, INCENDI GUALBA SANTA; Xue J, 2014, ECOL ECON, V105, P130, DOI 10.1016/j.ecolecon.2014.06.003	67	15	15	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0204806	10.1371/journal.pone.0204806	http://dx.doi.org/10.1371/journal.pone.0204806			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0VS	30325926	Green Submitted, Green Published, gold			2022-12-26	WOS:000447430800011
J	Vonesh, E; Gooch, KL; Khangulov, V; Schermer, CR; Johnston, KM; Szabo, SM; Rumsfeld, JS				Vonesh, E.; Gooch, K. L.; Khangulov, V.; Schermer, C. R.; Johnston, K. M.; Szabo, S. M.; Rumsfeld, J. S.			Cardiovascular risk profile in individuals initiating treatment for overactive bladder - Challenges and learnings for comparative analysis using linked claims and electronic medical record databases	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; BETA(3)-ADRENOCEPTOR AGONIST; SELECTION BIAS; UNITED-STATES; HYPERTENSION; MIRABEGRON; CARE; PATTERNS; INCONTINENCE; PERSISTENCE	For managing overactive bladder (OAB), mirabegron, a beta 3 adrenergic receptor agonist, is typically used as second-line pharmacotherapy after antimuscarinics. Therefore, patients initiating treatment with mirabegron and antimuscarinics may differ, potentially impacting associated clinical outcomes. When using observational data to evaluate real-world safety and effectiveness of OAB treatments, residual bias due to unmeasured confounding and/or confounding by indication are important considerations. Falsification analysis, in which clinically irrelevant endpoints are tested as a reference, can be used to assess residual bias. The objective in this study was to compare baseline cardiovascular risk among OAB patients by treatment, and assess the presence of residual bias via falsification analysis of OAB patients treated with mirabegron or antimuscarinics, to determine whether clinically relevant comparisons across groups would be feasible. Linked electronic health record and claims data (Optum/Humedica) for OAB patients in the United States from 2011-2015 were available, with index defined as first date of OAB treatment during this period. Unadjusted characteristics were compared across groups at index and propensity-matching conducted. Falsification endpoints (hepatitis C, shingles, community-acquired pneumonia) were compared between groups using odds ratios (ORs) and 95% confidence intervals (CI). The study identified 10,311 antimuscarinic-and 408 mirabegron-treated patients. Mirabegron patients were predominantly older males, with more comorbidities. The analytic sample included 1,188 antimuscarinic patients propensity-matched to 396 mirabegron patients; after matching, no significant baseline differences remained. Estimates of falsification ORs were 0.7 (CI: 0.3-1.7) for shingles, 1.5 (CI: 0.3-8.2) for hepatitis C, 0.8 (CI: 0.4-1.8) and 0.9 (CI: 0.6-1.4) for pneumonia. While propensity matching successfully balanced observed covariates, wide CIs prevented definitive conclusions regarding residual bias. Accordingly, further observational comparisons by treatment group were not pursued. In real-world analysis, bias-detection methods could not confirm that differences in cardiovascular risk in patients receiving mirabegron versus antimuscarinics were fully adjusted for, precluding clinically relevant comparisons across treatment groups.	[Vonesh, E.] Northwestern Univ, Dept Biostat, Chicago, IL 60611 USA; [Gooch, K. L.; Schermer, C. R.] Astellas Pharma USA, Med Affairs, Northbrook, IL USA; [Khangulov, V.] Boston Strateg Partners, Boston, MA USA; [Johnston, K. M.; Szabo, S. M.] Broadstreet HEOR, Vancouver, BC, Canada; [Rumsfeld, J. S.] Univ Colorado, Fac Med, Denver, CO 80202 USA	Northwestern University; University of Colorado System; University of Colorado Denver	Johnston, KM (corresponding author), Broadstreet HEOR, Vancouver, BC, Canada.	kjohnston@broadstreetheor.com			Astellas Pharma US; Broadstreet Health Economics and Outcomes Research (HEOR); Boston Strategic Partners (BSP)	Astellas Pharma US(Astellas Pharmaceuticals); Broadstreet Health Economics and Outcomes Research (HEOR); Boston Strategic Partners (BSP)	KLG, EV, and CRS were employed by Astellas Pharma US, who provided funding for the study, at the time of project completion. SMS and KMJ are employed by and receive salary from Broadstreet Health Economics and Outcomes Research (HEOR). VK is employed by and receives salary from Boston Strategic Partners (BSP). Broadstreet HEOR and BSP received funding from Astellas Pharma US for research and analytic services. Astellas Pharma US provided support in the form of salaries for authors KLG and CRS. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arnold BF, 2016, EPIDEMIOLOGY, V27, P637, DOI 10.1097/EDE.0000000000000504; Astellas, 2012, MYRBETRICTM HIGHLIGH; Bhide AA, 2012, RES REP UROL, V4, P41, DOI 10.2147/RRU.S28930; Bisognano J, 2004, AM J HYPERTENS, V17, P676, DOI 10.1016/j.amjhyper.2004.04.007; Brookhart MA, 2010, MED CARE, V48, pS114, DOI 10.1097/MLR.0b013e3181dbebe3; Chancellor MB, 2013, CLIN THER, V35, P1744, DOI 10.1016/j.clinthera.2013.08.017; Chapple CR, 2013, EUR UROL, V63, P296, DOI 10.1016/j.eururo.2012.10.048; Crawford AG, 2010, POPUL HEALTH MANAG, V13, P151, DOI 10.1089/pop.2009.0039; Curtis Bradley, 2014, J Med Econ, V17, P21, DOI 10.3111/13696998.2013.862538; Feldstein AC, 2008, DIABETES CARE, V31, P1960, DOI 10.2337/dc08-0426; Fishman PA, 2011, J CLIN HYPERTENS, V13, P821, DOI 10.1111/j.1751-7176.2011.00528.x; Goldman HB, 2016, UROLOGY, V87, P64, DOI 10.1016/j.urology.2015.09.025; Gormley EA, 2015, J UROLOGY, V193, P1572, DOI 10.1016/j.juro.2015.01.087; Herschorn S, 2013, UROLOGY, V82, P1457, DOI 10.1016/j.urology.2013.08.001; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Khullar V, 2013, EUR UROL, V63, P283, DOI 10.1016/j.eururo.2012.10.016; Klompas M, 2011, MAYO CLIN PROC, V86, P1146, DOI 10.4065/mcp.2011.0305; LaMori J, 2016, J MED ECON, V19, P364, DOI 10.3111/13696998.2015.1127252; McAdam-Marx C, 2009, CLIN THER, V31, P1116, DOI 10.1016/j.clinthera.2009.05.007; Ng D, 2015, VALUE HEALTH, V18, pA189, DOI 10.1016/j.jval.2015.03.1093; Nitti VW, 2013, J UROLOGY, V189, P1388, DOI 10.1016/j.juro.2012.10.017; Parsons LS., 2004, P 29 ANN SAS US GROU; Pelletier Elise M, 2009, Am J Manag Care, V15, pS108; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Raghupathi W, 2014, HEALTH INF SCI SYST, V2, DOI 10.1186/2047-2501-2-3; ROCHON J, 1991, BIOMETRICS, V47, P1383, DOI 10.2307/2532393; Rothman KJ, 2012, MODERN EPIDEMIOLOGY; Rowan CG, 2015, PHARMACOEPIDEM DR S, V24, P1170, DOI 10.1002/pds.3849; Rozenbaum MH, 2015, VACCINE, V33, P3193, DOI 10.1016/j.vaccine.2015.05.001; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Sturmer T, 2010, AM J EPIDEMIOLOGY; Tsai ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121016; United States Food and Drug Administration, 2016, US EL HLTH REC DAT C; United States Food and Drug Administration, 2016, MIN PROSP SURV PLAN; Weycker D, 2014, J ONCOL PHARM PRACT, V20, P190, DOI 10.1177/1078155213492450; Wimmer NJ, 2013, J AM COLL CARDIOL, V62, P2147, DOI 10.1016/j.jacc.2013.07.036; Yeaw J, 2009, J MANAGE CARE PHARM, V15, P728, DOI 10.18553/jmcp.2009.15.9.728; Yu YF, 2005, VALUE HEALTH, V8, P495, DOI 10.1111/j.1524-4733.2005.00041.x	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205640	10.1371/journal.pone.0205640	http://dx.doi.org/10.1371/journal.pone.0205640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325968	gold, Green Published, Green Submitted			2022-12-26	WOS:000447430800029
J	Aqrawi, LA; Chen, XJ; Jensen, JL; Morthen, MK; Thiede, B; Utheim, OA; Palm, O; Tashbayev, B; Utheim, TP; Galtung, HK				Aqrawi, Lara A.; Chen, Xiangjun; Jensen, Janicke Liaaen; Morthen, Mathias Kaurstad; Thiede, Bernd; Utheim, Oygunn Aass; Palm, Oyvind; Tashbayev, Behzod; Utheim, Tor Paaske; Galtung, Hilde Kanli			Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjogren's syndrome	PLOS ONE			English	Article							CLASSIFICATION CRITERIA; SALIVA; OSMOLARITY; PREVALENCE; BIOMARKERS; CONSENSUS; PATTERNS; DEFINES	Ocular dryness is a characteristic feature of primary Sjogren's syndrome (pSS). This may result in dry eye disease (DED), leading to damage of the ocular surface. Additional, non-invasive diagnostic techniques are needed when evaluating pSS patients. Hence, screening for disease-specific biomarkers in biological fluid could be promising. We have previously examined the proteome of tear fluid from pSS patients through Liquid chromatography-mass spectrometry (LC-MS), and conducted a thorough ocular evaluation of patients with pSS. In this study we further explored the association between dry eye manifestations and protein expression in tear fluid of pSS patients. Medical history of 27 patients and 32 healthy controls was gathered. Subjective complaints were registered through questionnaires. Objective findings including tear osmolarity, tear film break up time (TFBUT), Schirmer's test, and ocular and corneal surface staining were also recorded. LC-MS was conducted formerly on tear fluid from all subjects in order to generate proteomic biomarker profiles. Scaffold was employed to analyse the LC-MS data for quantitative differences between patient and control groups, and the mean spectral counts were calculated for the five most upregulated proteins in relation to DED manifestations. Dysregulated cellular processes were identified in pSS patients using FunRichv3 enrichment analysis. The five most upregulated proteins previously identified in pSS patients were DNA (apurinic or apyrimidinic site) lyase (APEX1), thioredoxin-dependent peroxidase reductase (PRDX3), copine (CPNE1), aconitate hydratase (ACO2), and LIM domain only protein 7 (LMO7), in descending order. A significant increase in mean spectral counts for these proteins were observed in pSS patients with pathological DED manifestations compared to healthy controls (p<0.0001). Consequently, dysregulated cellular pathways involving innate and adaptive immunity were also detected. In conclusion, our observations suggest a relationship between presence of dry eye signs and upregulated proteins in tear fluid from patients with pSS. Further studies are needed in order to replicate the concepts explored and analyses performed in a greater cohort of pSS patients, where sensitivity and specificity of the methods conducted can also be verified further.	[Aqrawi, Lara A.; Chen, Xiangjun; Jensen, Janicke Liaaen; Tashbayev, Behzod] Univ Oslo, Dept Oral Surg & Oral Med, Fac Dent, Oslo, Norway; [Chen, Xiangjun; Morthen, Mathias Kaurstad; Utheim, Oygunn Aass; Tashbayev, Behzod] Norwegian Dry Eye Clin, Oslo, Norway; [Thiede, Bernd] Univ Oslo, Dept Biosci, Oslo, Norway; [Utheim, Oygunn Aass; Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Palm, Oyvind] Oslo Univ Hosp, Dept Rheumatol, Oslo, Norway; [Utheim, Tor Paaske] Oslo Univ Hosp, Dept Plast & Reconstruct Surg, Oslo, Norway; [Utheim, Tor Paaske; Galtung, Hilde Kanli] Univ Oslo, Dept Oral Biol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Galtung, HK (corresponding author), Univ Oslo, Dept Oral Biol, Oslo, Norway.	h.k.galtung@odont.uio.no	Tashbayev, Behzod/AAZ-6268-2020; Aqrawi, Lara A./AAG-8894-2019; Galtung, Hilde/ABD-9199-2020	Aqrawi, Lara A./0000-0002-3666-842X; Jensen, Janicke Liaaen/0000-0003-4276-9611; Tashbayev, Behzod/0000-0003-2566-8800; Palm, Oyvind/0000-0001-5395-0665	Faculty of Dentistry, University of Oslo	Faculty of Dentistry, University of Oslo	The study was funded by the Faculty of Dentistry, University of Oslo.	Antero DC, 2011, REV ASSOC MED BRAS, V57, P318; Aqrawi LA, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1228-x; Baer AN, 2010, J RHEUMATOL, V37, P1143, DOI 10.3899/jrheum.090804; Baldini C, 2008, AUTOIMMUN REV, V7, P185, DOI 10.1016/j.autrev.2007.11.002; Baldini C, 2014, RHEUMATOLOGY, V53, P839, DOI 10.1093/rheumatology/ket427; Bowman SJ, 2004, SCAND J RHEUMATOL, V33, P39, DOI 10.1080/03009740310004676; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Craig JP, 2017, OCUL SURF, V15, P276, DOI 10.1016/j.jtos.2017.05.008; Delaleu N, 2015, ARTHRITIS RHEUMATOL, V67, P1084, DOI 10.1002/art.39015; Fleissig Y, 2009, ORAL DIS, V15, P61, DOI 10.1111/j.1601-0825.2008.01465.x; Foulks GN, 2015, OCUL SURF, V13, P118, DOI 10.1016/j.jtos.2014.12.001; Gayton JL, 2009, CLIN OPHTHALMOL, V3, P405; Giovelli RA, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0482-9; Giusti L, 2007, PROTEOMICS, V7, P1634, DOI 10.1002/pmic.200600783; Goransson LG, 2011, SCAND J RHEUMATOL, V40, P221, DOI 10.3109/03009742.2010.536164; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; Hu S, 2011, PROTEOMICS, V11, P1499, DOI 10.1002/pmic.201000206; Jacobi C, 2011, CORNEA, V30, P1289, DOI 10.1097/ICO.0b013e31821de383; Jonsson R, 2007, ANN NY ACAD SCI, V1108, P433, DOI 10.1196/annals.1422.046; Jonsson R, 2013, JAMA-J AM MED ASSOC, V310, P1854, DOI 10.1001/jama.2013.278448; Jonsson R, 2011, IMMUNOL LETT, V141, P1, DOI 10.1016/j.imlet.2011.06.007; Lee J H, 1988, Korean J Ophthalmol, V2, P69; Li B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05772; Lim SA, 2015, CORNEA, V34, P1466, DOI 10.1097/ICO.0000000000000612; Lopez-Miguel A, 2016, AM J OPHTHALMOL, V161, P133, DOI 10.1016/j.ajo.2015.09.039; Maldini C, 2014, ARTHRIT CARE RES, V66, P454, DOI 10.1002/acr.22115; Peluso G, 2007, ARTHRITIS RHEUM, V56, P2216, DOI 10.1002/art.22738; Ramos-Casals M, 2012, NAT REV RHEUMATOL, V8, DOI 10.1038/nrrheum.2012.53-c2; Rose-Nussbaumer J, 2015, AM J OPHTHALMOL, V160, P1150, DOI 10.1016/j.ajo.2015.08.021; Ryu OH, 2006, RHEUMATOLOGY, V45, P1077, DOI 10.1093/rheumatology/kei212; Shiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI [10.1136/annrheumdis-2016-210571, 10.1002/art.39859]; Szalai E, 2012, CORNEA, V31, P867, DOI 10.1097/ICO.0b013e3182532047; Tashbayev B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10809-w; Tomosugi N, 2005, J PROTEOME RES, V4, P820, DOI 10.1021/pr0497576; Versura P, 2013, EXPERT REV MOL DIAGN, V13, P119, DOI [10.1586/erm.12.142, 10.1586/ERM.12.142]; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	36	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205762	10.1371/journal.pone.0205762	http://dx.doi.org/10.1371/journal.pone.0205762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312344	Green Published, gold, Green Submitted			2022-12-26	WOS:000447427300055
J	Dhayat, NA; Marti, N; Kollmann, Z; Troendle, A; Bally, L; Escher, G; Grossl, M; Ackermann, D; Ponte, B; Pruijm, M; Muller, M; Vogt, B; Birkhauser, MH; Bochud, M; Fluck, CE				Dhayat, Nasser A.; Marti, Nesa; Kollmann, Zahraa; Troendle, Amineh; Bally, Lia; Escher, Genevieve; Grossl, Michael; Ackermann, Daniel; Ponte, Belen; Pruijm, Menno; Muller, Michael; Vogt, Bruno; Birkhauser, Martin H.; Bochud, Murielle; Fluck, Christa E.		SKIPOGH Study Grp	Urinary steroid profiling in women hints at a diagnostic signature of the polycystic ovary syndrome: A pilot study considering neglected steroid metabolites	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; MALE SEXUAL-DIFFERENTIATION; BACKDOOR PATHWAY; ANDROGEN BIOSYNTHESIS; DIHYDROTESTOSTERONE SYNTHESIS; CORTISOL METABOLISM; PRODUCTION-RATES; TESTOSTERONE; HYPERANDROGENISM; ANDROSTENEDIONE	Background Although the polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women with vast metabolic consequences, its etiology remains unknown and its diagnosis is still made by exclusion. This study aimed at characterizing a large number of urinary steroid hormone metabolites and enzyme activities in women with and without PCOS in order to test their value for diagnosing PCOS. Methods Comparative steroid profiling of 24h urine collections using an established in-house gas-chromatography mass spectrometry method. Data were collected mostly prospectively. Patients were recruited in university hospitals in Switzerland. Participants were 41 women diagnosed with PCOS according to the current criteria of the Androgen Excess and PCOS Society Task Force and 66 healthy controls. Steroid profiles of women with PCOS were compared to healthy controls for absolute metabolite excretion and for substrate to product conversion ratios. The AUC for over 1.5 million combinations of metabolites was calculated in order to maximize the diagnostic accuracy in patients with PCOS. Sensitivity, specificity, PPV, and NPV were indicated for the best combinations containing 2, 3 or 4 steroid metabolites. Results The best single discriminating steroid was androstanediol. The best combination to diagnose PCOS contained four of the forty measured metabolites, namely androstanediol, estriol, cortisol and 20 beta DHcortisone with AUC 0.961 (95% CI 0.926 to 0.995), sensitivity 90.2% (95% CI 76.9 to 97.3), specificity 90.8% (95% CI 81.0 to 96.5), PPV 86.0% (95% CI 72.1 to 94.7), and NPV 93.7% (95% CI 84.5 to 98.2). Conclusion PCOS shows a specific 24h urinary steroid profile, if neglected metabolites are included in the analysis and non-conventional data analysis applied. PCOS does not share a profile with hyperandrogenic forms of congenital adrenal hyperplasias due to single steroid enzyme deficiencies. Thus PCOS diagnosis by exclusion may no longer be warranted. Whether these findings also apply to spot urine and serum, remains to be tested as a next step towards routine clinical applicability.	[Dhayat, Nasser A.; Escher, Genevieve; Grossl, Michael; Ackermann, Daniel; Vogt, Bruno] Univ Bern, Inselspital, Univ Hosp, Dept Nephrol & Hypertens, Bern, Switzerland; [Dhayat, Nasser A.; Escher, Genevieve; Grossl, Michael; Ackermann, Daniel; Vogt, Bruno] Univ Bern, Inselspital, Univ Hosp, Dept BioMed Res, Bern, Switzerland; [Marti, Nesa; Fluck, Christa E.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Pediat,Pediat Endocrinol & Diabetol, Bern, Switzerland; [Marti, Nesa; Fluck, Christa E.] Univ Bern, Bern Univ Hosp, Inselspital, Dept BioMed Res, Bern, Switzerland; [Kollmann, Zahraa; Muller, Michael; Birkhauser, Martin H.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Obstet & Gynecol, Bern, Switzerland; [Troendle, Amineh] Lindenhofspital, Bern, Switzerland; [Bally, Lia] Univ Bern, Bern Univ Hosp, Inselspital, Dept Diabet Endocrinol Clin Nutr & Metab, Bern, Switzerland; [Ponte, Belen] Univ Hosp Geneva, Dept Specialties Internal Med, Nephrol Serv, Geneva, Switzerland; [Pruijm, Menno] Univ Hosp Lausanne, Nephrol Serv, Lausanne, Switzerland; [Bochud, Murielle] Univ Hosp Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Fluck, CE (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Pediat,Pediat Endocrinol & Diabetol, Bern, Switzerland.; Fluck, CE (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept BioMed Res, Bern, Switzerland.	christa.flueck@dbmr.unibe.ch	Dhayat, Nasser A/J-1350-2016; Pruijm, Menno/AAA-4281-2020; Vogt, Bruno/AAS-2876-2020	Dhayat, Nasser A/0000-0001-8310-5921; Pruijm, Menno/0000-0003-1027-1851; Vogt, Bruno/0000-0002-1548-6387; Flueck, Christa/0000-0002-4568-5504; Groessl, Michael/0000-0002-6740-5980; Escher, Genevieve/0000-0002-5125-2262; Marti, Nesa/0000-0002-0482-4280	Swiss National Science Foundation [320030-146127, FN 33CM30-124087]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by two free project grants of the Swiss National Science Foundation (www.snf.ch), namely grant numbers 320030-146127 and FN 33CM30-124087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auchus RJ, 2004, TRENDS ENDOCRIN MET, V15, P432, DOI 10.1016/j.tem.2004.09.004; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; BARDIN CW, 1967, J CLIN INVEST, V46, P891, DOI 10.1172/JCI105588; Biason-Lauber A, 2013, MOL CELL ENDOCRINOL, V371, P124, DOI 10.1016/j.mce.2013.01.017; Blumenfeld Z, 2016, CLIN MED INSIGHTS-RE, V10, DOI 10.4137/CMRH.S35567; Dhayat NA, 2015, J STEROID BIOCH MOL; Dhayat NA, 2017, J STEROID BIOCHEM, V165, P312, DOI 10.1016/j.jsbmb.2016.07.009; Fassnacht M, 2003, J CLIN ENDOCR METAB, V88, P2760, DOI 10.1210/jc.2002-021875; Fluck CE, 2011, AM J HUM GENET, V89, P201, DOI 10.1016/j.ajhg.2011.06.009; Gambineri A, 2006, J CLIN ENDOCR METAB, V91, P2295, DOI 10.1210/jc.2005-2222; Gibson-Helm M, 2017, J CLIN ENDOCR METAB, V102, P604, DOI 10.1210/jc.2016-2963; Homma K, 2006, J CLIN ENDOCR METAB, V91, P2643, DOI 10.1210/jc.2005-2460; Kamrath C, 2012, J CLIN ENDOCR METAB, V97, pE367, DOI 10.1210/jc.2011-1997; Legro RS, 2013, J CLIN ENDOCR METAB, V98, P4565, DOI 10.1210/jc.2013-2350; Marti N, 2017, MOL CELL ENDOCRINOL, V441, P116, DOI 10.1016/j.mce.2016.07.029; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Munzker J, 2015, J CLIN ENDOCR METAB, V100, P653, DOI 10.1210/jc.2014-2523; Nelson VL, 2001, J CLIN ENDOCR METAB, V86, P5925, DOI 10.1210/jc.86.12.5925; O'Reilly MW, 2017, J CLIN ENDOCR METAB, V102, P840, DOI 10.1210/jc.2016-3285; O'Reilly MW, 2014, J CLIN ENDOCR METAB, V99, P1027, DOI 10.1210/jc.2013-3399; Peigne M, 2014, ANN ENDOCRINOL-PARIS, V75, P194, DOI 10.1016/j.ando.2014.07.111; Piltonen T, 2002, HUM REPROD, V17, P620, DOI 10.1093/humrep/17.3.620; Ponte B, 2014, HYPERTENSION, V63, P136, DOI 10.1161/HYPERTENSIONAHA.113.02321; Pruijm M, 2013, EUR RADIOL; RODIN A, 1994, NEW ENGL J MED, V330, P460, DOI 10.1056/NEJM199402173300703; Saito K, 2016, J STEROID BIOCHEM, V158, P31, DOI 10.1016/j.jsbmb.2016.02.010; Tsilchorozidou T, 2003, J CLIN ENDOCR METAB, V88, P5907, DOI 10.1210/jc.2003-030240; Turcu A, 2014, COMPR PHYSIOL, V4, P1369, DOI 10.1002/cphy.c140006; Walker BR, 2000, CLIN ENDOCRINOL, V52, P77, DOI 10.1046/j.1365-2265.2000.00893.x	30	21	23	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0203903	10.1371/journal.pone.0203903	http://dx.doi.org/10.1371/journal.pone.0203903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308019	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500010
J	McDonald, ND; DeMeester, KE; Lewis, AL; Grimes, CL; Boyd, EF				McDonald, Nathan D.; DeMeester, Kristen E.; Lewis, Amanda L.; Grimes, Catherine Leimkuhler; Boyd, E. Fidelma			Structural and functional characterization of a modified legionaminic acid involved in glycosylation of a bacterial lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; N-ACETYLNEURAMINIC ACID; SIALIC-ACID; VIBRIO-VULNIFICUS; ESCHERICHIA-COLI; FACTOR-H; 5,7-DIACETAMIDO-3,5,7,9-TETRADEOXY-D-GLYCERO-D-GALACTO-NON-2-ULOSONIC ACID; CAPSULAR POLYSACCHARIDE; NONULOSONIC ACIDS; BIOFILM FORMATION	Nonulosonic acids (NulOs) are a diverse family of alpha-keto acid carbohydrates present across all branches of life. Bacteria biosynthesize NulOs among which are several related prokaryotic-specific isomers and one of which, N-acetylneuraminic acid (sialic acid), is common among all vertebrates. Bacteria display various NulO carbohydrates on lipopolysaccharide (LPS), and the identities of these molecules tune host-pathogen recognition mechanisms. The opportunistic bacterial pathogen Vibrio vulnificus possesses the genes for NulO biosynthesis; however, the structures and functions of the V. vulnificus NulO glycan are unknown. Using genetic and chemical approaches, we show here that the major NulO produced by a clinical V. vulnificus strain CMCP6 is 5-N-acetyl-7-N-acetyl-D-alanyl-legionaminic acid (Leg5Ac7AcAla). The CMCP6 strain could catabolize modified legionaminic acid, whereas V. vulnificus strain YJ016 produced but did not catabolize a NulO without the N-acetyl-D-alanyl modification. In silico analysis suggested that Leg5Ac7 AcAla biosynthesis follows a noncanonical pathway but appears to be present in several bacterial species. Leg5Ac7AcAla contributed to bacterial outer-membrane integrity, as mutant strains unable to produce or incorporate Leg5Ac7AcAla into the LPS have increased membrane permeability, sensitivity to bile salts and antimicrobial peptides, and defects in biofilm formation. Using the crustacean model, Artemia franciscana, we demonstrate that Leg5Ac7AcAla-deficient bacteria have decreased virulence potential compared with WT. Our data indicate that different V. vulnificus strains produce multiple NulOs and that the modified legionaminic acid Leg5Ac7AcAla plays a critical role in the physiology, survivability, and pathogenicity of V. vulnificus CMCP6.	[McDonald, Nathan D.; Grimes, Catherine Leimkuhler; Boyd, E. Fidelma] Univ Delaware, Dept Biol Sci, 341 Wolf Hall, Newark, DE 19716 USA; [DeMeester, Kristen E.; Grimes, Catherine Leimkuhler] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Lewis, Amanda L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University of Delaware; University of Delaware; Washington University (WUSTL)	Boyd, EF (corresponding author), Univ Delaware, Dept Biol Sci, 341 Wolf Hall, Newark, DE 19716 USA.	fboyd@udel.edu		McDonald, Nathan/0000-0003-3650-9493; Lewis, Amanda/0000-0001-6195-3030	National Science Foundation Career Award [DEB-0844409]; University of Delaware graduate fellowship award; National Institutes of Health Chemistry-Biology Interface (CBI) Training Grant [5T32GM008550]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110758, P20GM104316, P20GM103446] Funding Source: NIH RePORTER	National Science Foundation Career Award(National Science Foundation (NSF)); University of Delaware graduate fellowship award; National Institutes of Health Chemistry-Biology Interface (CBI) Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Science Foundation Career Award DEB-0844409 (to E. F. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Funded by a University of Delaware graduate fellowship award.; Supported by National Institutes of Health Chemistry-Biology Interface (CBI) Training Grant 5T32GM008550.	Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; Anderson GG, 2010, INFECT IMMUN, V78, P963, DOI 10.1128/IAI.00925-09; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bax M, 2011, INFECT IMMUN, V79, P2681, DOI 10.1128/IAI.00009-11; Carda-Dieguez M, 2018, VIRULENCE, V9, P981, DOI 10.1080/21505594.2018.1455464; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chang YC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003846; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; Friedrich V, 2017, GLYCOBIOLOGY, V27, P342, DOI 10.1093/glycob/cww129; Greiner LL, 2004, INFECT IMMUN, V72, P4249, DOI 10.1128/IAI.72.7.4249-4260.2004; Ha C, 2014, MICROB PATHOGENESIS, V71-72, P8, DOI 10.1016/j.micpath.2014.04.001; Haines-Menges B, 2014, INFECT IMMUN, V82, P3667, DOI 10.1128/IAI.01854-14; Hashii N, 2003, CARBOHYD RES, V338, P2711, DOI 10.1016/j.carres.2003.06.003; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Inzana TJ, 2012, VET MICROBIOL, V161, P113, DOI 10.1016/j.vetmic.2012.07.008; Inzana TJ, 2002, INFECT IMMUN, V70, P4870, DOI 10.1128/IAI.70.9.4870-4879.2002; Jurcisek J, 2005, INFECT IMMUN, V73, P3210, DOI 10.1128/IAI.73.6.3210-3218.2005; Kenyon JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11166-4; Kenyon JJ, 2015, GLYCOBIOLOGY, V25, P644, DOI 10.1093/glycob/cwv007; Kim BS, 2018, MBIO, V9, DOI 10.1128/mBio.02262-17; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; KNIREL YA, 1994, EUR J BIOCHEM, V221, P239, DOI 10.1111/j.1432-1033.1994.tb18734.x; Knirel YA, 2003, ADV CARBOHYD CHEM BI, V58, P371, DOI 10.1016/S0065-2318(03)58007-6; KNIREL YA, 1984, CARBOHYD RES, V133, pC5, DOI 10.1016/0008-6215(84)85213-1; Kondadi PK, 2012, J BACTERIOL, V194, P2540, DOI 10.1128/JB.00126-12; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Kurniyati K, 2017, MOL MICROBIOL, V103, P67, DOI 10.1111/mmi.13544; Lee MN, 2014, J GEN APPL MICROBIOL, V60, P169, DOI 10.2323/jgam.60.169; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lewis AL, 2016, GLYCOBIOLOGY, V26, P1107, DOI 10.1093/glycob/cww068; Lewis AL, 2011, APPL ENVIRON MICROB, V77, P5782, DOI 10.1128/AEM.00712-11; Lewis AL, 2009, P NATL ACAD SCI USA, V106, P13552, DOI 10.1073/pnas.0902431106; Li XM, 2010, CARBOHYD RES, V345, P1581, DOI 10.1016/j.carres.2010.04.008; Lubin JB, 2015, INFECT IMMUN, V83, P3126, DOI 10.1128/IAI.00345-15; Lubin JB, 2012, APPL ENVIRON MICROB, V78, P3407, DOI 10.1128/AEM.07395-11; MacLean LL, 2011, CARBOHYD RES, V346, P2589, DOI 10.1016/j.carres.2011.09.003; Matthew Z, 2013, RSC ADV, V4, P3413; McDonald ND, 2016, MBIO, V7, DOI 10.1128/mBio.02237-15; McNally DJ, 2007, J BIOL CHEM, V282, P14463, DOI 10.1074/jbc.M611027200; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; PARSONS NJ, 1988, MICROB PATHOGENESIS, V5, P303, DOI 10.1016/0882-4010(88)90103-9; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; SILVER RP, 1988, REV INFECT DIS, V10, pS282; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Tsvetkov YE, 2001, CARBOHYD RES, V331, P233, DOI 10.1016/S0008-6215(01)00041-6; Twine SM, 2008, FEBS J, V275, P4428, DOI 10.1111/j.1742-4658.2008.06589.x; Velkov T, 2013, INNATE IMMUN-LONDON, V19, P265, DOI 10.1177/1753425912459092; VIMR E, 1995, J IND MICROBIOL, V15, P352, DOI 10.1007/BF01569991; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; VIMR ER, 1989, J BACTERIOL, V171, P1106, DOI 10.1128/jb.171.2.1106-1117.1989; Vinogradov E, 2017, CARBOHYD RES, V440-441, P10, DOI 10.1016/j.carres.2017.01.002; Vinogradov E, 2009, CARBOHYD RES, V344, P484, DOI 10.1016/j.carres.2008.12.017; WESSELS MR, 1987, J BIOL CHEM, V262, P8262; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Williams TC, 2014, PATHOGENS, V3, P822, DOI 10.3390/pathogens3040822; Yamamoto M, 2015, J VET MED SCI, V77, P823, DOI 10.1292/jvms.14-0655	66	3	3	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19113	19126		10.1074/jbc.RA118.004966	http://dx.doi.org/10.1074/jbc.RA118.004966			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30315110	Green Published, hybrid			2022-12-26	WOS:000458467400023
J	Madison, BJ; Clark, KA; Bhachech, N; Hollenhorst, PC; Graves, BJ; Currie, SL				Madison, Bethany J.; Clark, Kathleen A.; Bhachech, Niraja; Hollenhorst, Peter C.; Graves, Barbara J.; Currie, Simon L.			Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN-FOS at composite DNA sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONAL LANDSCAPE; CRYSTAL-STRUCTURE; PROTEIN; SPECIFICITY; FAMILY; ACTIVATION; EXPRESSION; REVEAL; DOMAIN; PHOSPHORYLATION	Many different transcription factors (TFs) regulate gene expression in a combinatorial fashion, often by binding in close proximity to each other on composite cis-regulatory DNA elements. Here, we investigated how ETS TFs bind with the AP1 TFs JUN-FOS at composite DNA-binding sites. DNA-binding ability with JUN-FOS correlated with the phenotype of ETS proteins in prostate cancer. We found that the oncogenic ETS-related gene (ERG) and ETS variant (ETV) 1/4/5 subfamilies co-occupy ETS-AP1 sites with JUN-FOS in vitro, whereas JUN-FOS robustly inhibited DNA binding by the tumor suppressors ETS homologous factor (EHF) and SAM pointed domain-containing ETS TF (SPDEF). EHF bound ETS-AP1 DNA with tighter affinity than ERG in the absence of JUN-FOS, possibly enabling EHF to compete with ERG and JUN-FOS for binding to ETS-AP1 sites. Genome-wide mapping of EHF- and ERG-binding sites in prostate epithelial cells revealed that EHF is preferentially excluded from closely spaced ETS-AP1 DNA sequences. Structural modeling and mutational analyses indicated that adjacent positively charged surfaces from EHF and JUN-FOS use electrostatic repulsion to disfavor simultaneous DNA binding. Conservation of positive residues on the JUN-FOS interface identified E74-like ETS TF 1 (ELF1) as an additional ETS TF exhibiting anticooperative DNA binding with JUN-FOS, and we found that ELF1 is frequently down-regulated in prostate cancer. In summary, divergent electrostatic features of ETSTFs at their JUN-FOS interface enable distinct binding events at ETS-AP1 DNA sites, which may drive specific targeting of ETS TFs to facilitate distinct transcriptional programs.	[Madison, Bethany J.; Clark, Kathleen A.; Bhachech, Niraja; Graves, Barbara J.; Currie, Simon L.] Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Madison, Bethany J.; Clark, Kathleen A.; Bhachech, Niraja; Graves, Barbara J.; Currie, Simon L.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Hollenhorst, Peter C.] Indiana Univ Sch Med, Med Sci Program, Bloomington, IN 47405 USA; [Graves, Barbara J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Currie, Simon L.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University Bloomington; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Graves, BJ (corresponding author), Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84112 USA.; Graves, BJ (corresponding author), Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.; Graves, BJ (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	barbara.graves@hci.utah.edu		Currie, Simon/0000-0001-5083-1484	National Institutes of Health [R01GM38663, R01CA204121]; NATIONAL CANCER INSTITUTE [P30CA042014, R01CA204121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01GM38663 (to B. J. G.) and R01CA204121 (to P. C. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Agarkar VB, 2010, J MOL BIOL, V397, P278, DOI 10.1016/j.jmb.2010.01.017; Albino D, 2012, CANCER RES, V72, P2889, DOI 10.1158/0008-5472.CAN-12-0212; Ando M, 2016, CANCER RES, V76, P1814, DOI 10.1158/0008-5472.CAN-14-3816; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Bose R, 2017, NATURE, V546, P671, DOI 10.1038/nature22820; Cangemi R, 2008, ONCOGENE, V27, P2877, DOI 10.1038/sj.onc.1210953; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng XH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004656; Currie SL, 2017, J MOL BIOL, V429, P2975, DOI 10.1016/j.jmb.2017.06.024; Currie SL, 2017, NUCLEIC ACIDS RES, V45, P2223, DOI 10.1093/nar/gkx068; Ferguson HA, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.20.e98; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kim S, 2006, MOL CELL BIOL, V26, P2467, DOI 10.1128/MCB.26.7.2467-2478.2006; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Plotnik JP, 2014, NUCLEIC ACIDS RES, V42, P11928, DOI 10.1093/nar/gku929; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Regan MC, 2013, P NATL ACAD SCI USA, V110, P13374, DOI 10.1073/pnas.1301726110; Robinson D, 2015, CELL, V162, P454, DOI 10.1016/j.cell.2015.06.053; Selvaraj N, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0089-7; SGOURAS DN, 1995, EMBO J, V14, P4781, DOI 10.1002/j.1460-2075.1995.tb00160.x; Shah NH, 2018, ELIFE, V7, DOI 10.7554/eLife.35190; Shah NH, 2016, ELIFE, V5, DOI 10.7554/eLife.20105; Shiina M, 2015, J MOL BIOL, V427, P1655, DOI 10.1016/j.jmb.2014.07.020; Shrivastava T, 2014, LEUKEMIA, V28, P2040, DOI 10.1038/leu.2014.111; Sizemore GM, 2017, NAT REV CANCER, V17, P337, DOI 10.1038/nrc.2017.20; Stephens DN, 2013, J BIOL CHEM, V288, P34304, DOI 10.1074/jbc.M113.504399; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tugores A, 2001, J BIOL CHEM, V276, P20397, DOI 10.1074/jbc.M010930200; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	59	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18624	18635		10.1074/jbc.RA118.003352	http://dx.doi.org/10.1074/jbc.RA118.003352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30315111	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000458467300017
J	Martinez-Rodriguez, MD; Uribe-Noguez, LA; Arroyo-Anduiza, CI; Mata-Marin, JA; Benitez-Arvizu, G; Portillo-Lopez, ML; Ocana-Mondragon, A				de la Luz Martinez-Rodriguez, Maria; Uribe-Noguez, Luis A.; Arroyo-Anduiza, Carla I.; Antonio Mata-Marin, Jose; Benitez-Arvizu, Gamaliel; Portillo-Lopez, Maria L.; Ocana-Mondragon, Alicia			Prevalence and risk factors of Occult Hepatitis C infections in blood donors from Mexico City	PLOS ONE			English	Article							VIRUS-INFECTION; HCV INFECTION; EPIDEMIOLOGY; MANAGEMENT; DIAGNOSIS	Background The circulatory system is the main mechanism for transmission of the Hepatitis C Virus (HCV). A new class of HCV infections, Occult HCV infection (OCI), is defined as the presence of HCV-RNA in hepatocytes with the absence of HCV in the serum/plasma utilizing current laboratory assays. Different groups have reported the prevalence of OCI; however, its associated risk factors have not been established. In Mexico, there are no reports about OCI, so the objective of our study was to determine the prevalence of OCI in total blood donors in Mexico City, as well as its associated risk factors. Methods Blood donors that were considered eligible for donation, according to NOM 253-SSA1-2012, were randomly selected. Demographic data was collected from 1,037 donors. Plasma and peripheral blood mononuclear cells were assessed for HCV-RNA. The presence of HCV-RNA was determined by nested PCR for the 5'-UTR region. Logistic regression was used to calculate the odds ratio (OR) and 95% confidence interval (95%CI) to determine the level of association. Results The prevalence of OCI was 3.4% among blood donors. Homosexual relationships (OR = 5.52, 95%CI: 1.53-19.92, p<0.05) and acupuncture (OR = 3.56, 95%CI: 1.41-8.98, p<0.05) were significantly associated with OCI. Conclusion There is a significant presence of OCI in the blood donor population in Mexico City. The main risk factors for OCI transmission are homosexual relationships and acupuncture. This study supports the increased use of sensitive and specific screening tests for blood bank testing.	[de la Luz Martinez-Rodriguez, Maria; Uribe-Noguez, Luis A.; Ocana-Mondragon, Alicia] Inst Mexicano Seguro Social, Ctr Med Nacl La Raza, Unidad Invest Med Inmunol & Infectol, Mexico City, DF, Mexico; [Arroyo-Anduiza, Carla I.] Inst Mexicano Seguro Social, Ctr Med Nacl La Raza, Banco Cent Sangre, Mexico City, DF, Mexico; [Antonio Mata-Marin, Jose] Inst Mexicano Seguro Social, Ctr Med Nacl La Raza, Hosp Infectol, Mexico City, DF, Mexico; [Benitez-Arvizu, Gamaliel; Portillo-Lopez, Maria L.] Inst Mexicano Seguro Social, Banco Cent Sangre, Ctr Med Nacl Siglo XXI, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social	Martinez-Rodriguez, MD (corresponding author), Inst Mexicano Seguro Social, Ctr Med Nacl La Raza, Unidad Invest Med Inmunol & Infectol, Mexico City, DF, Mexico.	lumaro61@yahoo.com.mx		Noguez, Uribe/0000-0003-2452-782X	Consejo Nacional de Ciencia y Tecnologia y Fondo Sectorial de Investigacion en Salud y Seguridad Social [2015-1-261113]; Fondos de Investigacion en Salud Instituto Mexicano del Seguro Social Proyectos [FIS/IMSS/PROT/G15]	Consejo Nacional de Ciencia y Tecnologia y Fondo Sectorial de Investigacion en Salud y Seguridad Social; Fondos de Investigacion en Salud Instituto Mexicano del Seguro Social Proyectos	This study was funded in part by Consejo Nacional de Ciencia y Tecnologia y Fondo Sectorial de Investigacion en Salud y Seguridad Social [no. 2015-1-261113] to MLMR, as well by Fondos de Investigacion en Salud Instituto Mexicano del Seguro Social Proyectos [no. FIS/IMSS/PROT/G15] to MLMR.	[Anonymous], NOM087ECOLSSA1; [Anonymous], NOM253SSA1; Attar BM, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/579147; Baptista-Gonzalez H, 2016, ANN HEPATOL, V15, P846, DOI 10.5604/16652681.1222100; Carreno V, 2008, J CLIN MICROBIOL, V46, P3550, DOI 10.1128/JCM.01148-08; Carreno V, 2012, WORLD J GASTROENTERO, V18, P2887, DOI 10.3748/wjg.v18.i23.2887; Castillo I, 2004, J INFECT DIS, V189, P7, DOI 10.1086/380202; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; De Marco L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008128; El Shazly Y, 2015, J MED VIROL, V87, P424, DOI 10.1002/jmv.24074; Eldaly O.M., 2016, EGYPT J MED MICROBIO, V25, P1, DOI [10.12816/0036803, DOI 10.12816/0036803]; Gorodezky C, 2004, MANUAL PROCEDIMIENTO, P23; Holland J, 1998, PATHOLOGY, V30, P192, DOI 10.1080/00313029800169226; Idrees M, 2011, INFECT GENET EVOL, V11, P442, DOI 10.1016/j.meegid.2010.12.004; Katayama K, 2004, INTERVIROLOGY, V47, P57, DOI 10.1159/000076643; Koutsoudakis G, 2017, GASTROENTEROLOGY, V152, P472, DOI 10.1053/j.gastro.2016.12.015; Lanini S, 2016, CLIN MICROBIOL INFEC, V22, P833, DOI 10.1016/j.cmi.2016.07.035; Lemos MA, 2014, INFECT CONT HOSP EP, V35, P1319, DOI 10.1086/678079; Lin H, 2016, INTERVIROLOGY, V59, P204, DOI 10.1159/000455854; Maticic M, 2001, J PERIODONTOL, V72, P11, DOI 10.1902/jop.2001.72.1.11; Mukherjee R, 2015, JALA-J LAB AUTOM, V20, P519, DOI 10.1177/2211068214563794; Naghdi R, 2017, ANN HEPATOL, V16, P510, DOI 10.5604/01.3001.0010.0277; Panduro A, 2011, SALUD PUBLICA MEXICO, V53, pS37; Pham TNQ, 2010, LIVER INT, V30, P502, DOI 10.1111/j.1478-3231.2009.02193.x; Quiroga JA, 2016, TRANSFUSION, V56, P1883, DOI 10.1111/trf.13645; Rezaee-Zayareh MS, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.34181; Rojo-Medina J, 2012, ISBT SCI SERIES, V7, P244, DOI [10.1111/j.1751-2824.2012.01604.x, DOI 10.1111/J.1751-2824.2012.01604.X]; Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672; Sohn HS, 2016, GUT LIVER, V10, P126, DOI 10.5009/gnl14403; Villatoro J, 2012, SALUD MENT, V35, P447; Wilkins T, 2015, AM FAM PHYSICIAN, V91, P835; World Health Organization, 2017, GLOBAL HEPATITIS REP	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205659	10.1371/journal.pone.0205659	http://dx.doi.org/10.1371/journal.pone.0205659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339689	gold, Green Published, Green Submitted			2022-12-26	WOS:000447761400019
J	Bonnett, SA; Dennison, D; Files, M; Bajpai, A; Parish, T				Bonnett, Shilah A.; Dennison, Devon; Files, Megan; Bajpai, Anumita; Parish, Tanya			A class of hydrazones are active against non-replicating Mycobacterium tuberculosis	PLOS ONE			English	Article							CATALASE-PEROXIDASE GENE; IN-VITRO; ANTIMYCOBACTERIAL ACTIVITY; PERSISTENCE; THIACETAZONE; DERIVATIVES; HYDRAZIDES; RESISTANCE; DORMANCY; SYSTEM	There is an urgent need for the development of shorter, simpler and more tolerable drugs to treat antibiotic tolerant populations of Mycobacterium tuberculosis. We previously identified a series of hydrazones active against M. tuberculosis. We selected five representative compounds for further analysis. All compounds were active against non-replicating M. tuberculosis, with two compounds demonstrating greater activity under hypoxic conditions than aerobic culture. Compounds had bactericidal activity with MBC/MIC of < 4 and demonstrated an inoculum-dependent effect against aerobically replicating bacteria. Bacterial kill kinetics demonstrated a faster rate of kill against non-replicating bacilli generated by nutrient starvation. Compounds had limited activity against other bacterial species. In conclusion, we have demonstrated that hydrazones have some attractive properties in terms of their anti-tubercular activity.	[Bonnett, Shilah A.; Dennison, Devon; Files, Megan; Bajpai, Anumita; Parish, Tanya] Infect Dis Res Inst, TB Discovery Res, Seattle, WA 98102 USA		Parish, T (corresponding author), Infect Dis Res Inst, TB Discovery Res, Seattle, WA 98102 USA.	tanya.parish@idri.org	; Parish, Tanya/A-8912-2014	Dennison, Devon/0000-0002-3229-0343; Parish, Tanya/0000-0001-7507-0423	NIAID of the National Institutes of Health [R01AI095652, R01AI132634]; Bill and Melinda Gates Foundation [OPP1024038]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095652, R01AI132634] Funding Source: NIH RePORTER	NIAID of the National Institutes of Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIAID of the National Institutes of Health under award numbers R01AI095652 and R01AI132634 and by the Bill and Melinda Gates Foundation under grant OPP1024038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Alahari A, 2009, MOL MICROBIOL, V71, P1263, DOI 10.1111/j.1365-2958.2009.06604.x; Andreani A, 2008, J MED CHEM, V51, P809, DOI 10.1021/jm701246g; Bedia KK, 2006, EUR J MED CHEM, V41, P1253, DOI 10.1016/j.ejmech.2006.06.009; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bonnett SA, 2016, ACS INFECT DIS, V2, P5, DOI 10.1021/acsinfecdis.6b00075; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; Cho Sanghyun, 2015, Methods Mol Biol, V1285, P281, DOI 10.1007/978-1-4939-2450-9_17; Early Julie, 2015, Methods Mol Biol, V1285, P269, DOI 10.1007/978-1-4939-2450-9_16; Fattorini L, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.072; Grzegorzewicz AE, 2015, ACS INFECT DIS, V1, P91, DOI 10.1021/id500032q; Hu WX, 2006, BIOORG MED CHEM LETT, V16, P2213, DOI 10.1016/j.bmcl.2006.01.048; Imramovsky A, 2007, BIOORGAN MED CHEM, V15, P2551, DOI 10.1016/j.bmc.2007.01.051; Institute CaLS, 1999, METH DET BACT ACT AN; John SF, 2016, TUBERCULOSIS, V101, pS73, DOI 10.1016/j.tube.2016.09.025; Khan SA, 2009, EUR J MED CHEM, V44, P2270, DOI 10.1016/j.ejmech.2008.06.008; Kucukguzel SG, 1999, EUR J MED CHEM, V34, P1093, DOI 10.1016/S0223-5234(99)00129-4; Loncle C, 2004, EUR J MED CHEM, V39, P1067, DOI 10.1016/j.ejmech.2004.07.005; Maccari R, 2005, BIOORG MED CHEM LETT, V15, P2509, DOI 10.1016/j.bmcl.2005.03.065; Mandewale MC, 2015, BIOINORG CHEM APPL, V2015, DOI 10.1155/2015/153015; MATHIOPOULOS C, 1991, MOL MICROBIOL, V5, P1903, DOI 10.1111/j.1365-2958.1991.tb00814.x; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; Musser JM, 1996, J INFECT DIS, V173, P196, DOI 10.1093/infdis/173.1.196; Ollinger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060531; Quemard A, 1996, J AM CHEM SOC, V118, P1561, DOI 10.1021/ja950998b; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Sriram D, 2005, BIOORG MED CHEM LETT, V15, P4502, DOI 10.1016/j.bmcl.2005.07.011; Todeschini AR, 1998, EUR J MED CHEM, V33, P189, DOI 10.1016/S0223-5234(98)80008-1; Tudo G, 2010, FUTURE MED CHEM, V2, P1371, DOI 10.4155/FMC.10.219; Vavrikova E, 2011, EUR J MED CHEM, V46, P5902, DOI 10.1016/j.ejmech.2011.09.054; Ventura C, 2008, J MED CHEM, V51, P612, DOI 10.1021/jm701048s; Vergara FMF, 2009, EUR J MED CHEM, V44, P4954, DOI 10.1016/j.ejmech.2009.08.009; Vicini P, 2002, EUR J MED CHEM, V37, P553, DOI 10.1016/S0223-5234(02)01378-8; Vicini P, 2006, EUR J MED CHEM, V41, P624, DOI 10.1016/j.ejmech.2006.01.010; WAYNE LG, 1994, ANTIMICROB AGENTS CH, V38, P2054, DOI 10.1128/AAC.38.9.2054; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; WHO, 2017, GLOB TUB REP 2017; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	43	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0198059	10.1371/journal.pone.0198059	http://dx.doi.org/10.1371/journal.pone.0198059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332412	gold, Green Published, Green Submitted			2022-12-26	WOS:000447638200001
J	Enisoglu-Atalay, V; Atasever-Arslan, B; Yaman, B; Cebecioglu, R; Kul, A; Ozilhan, S; Ozen, F; Catal, T				Enisoglu-Atalay, Vildan; Atasever-Arslan, Belkis; Yaman, Bugra; Cebecioglu, Rumeysa; Kul, Aykut; Ozilhan, Selma; Ozen, Fatih; Catal, Tunc			Chemical and molecular characterization of metabolites from Flavobacterium sp.	PLOS ONE			English	Article							FRESH-WATER; KAPPA-B; SP NOV.; QUERCETIN; DERIVATIVES; INJURY; CELLS; DFT	In this study, a Flavobacterium sp. is isolated from natural spring, and identified using molecular techniques. Extracellular and intracellular secondary metabolites are identified using solid phase microextraction gas chromatography-mass spectrometry and ultra performance liquid chromatography. Cytotoxic activity of the extracellular compounds produced by the Flavobacterium sp. and quercetin as the standard are measured using ECV304 human endothelial cells in vitro. Our results show that Flavobacterim sp. isolate has the highest percentage of similarity with Flavobacterium cheonhonense strain ARSA-15 (99%). Quercetin is detected as the major extracellular compound produced by the Flavobacterium sp. Methanol extract of Flavobacterium sp. resulted in a higher cell viability results when compared to DMSO extracts. Computational chemistry approach was used and it has been found that polar solvent (methanol) contributed to higher antioxidant activity. In conclusion, Flavobacterium sp. can be used to produce quercetin for industrial purposes.	[Enisoglu-Atalay, Vildan; Yaman, Bugra; Cebecioglu, Rumeysa; Catal, Tunc] Uskudar Univ, Istanbul Res Applicat & Inovat Ctr PROMER, Istanbul, Turkey; [Enisoglu-Atalay, Vildan; Ozen, Fatih] Uskudar Univ, Dept Bioengn, Istanbul, Turkey; [Atasever-Arslan, Belkis; Yaman, Bugra; Cebecioglu, Rumeysa; Catal, Tunc] Uskudar Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Kul, Aykut; Ozilhan, Selma] Uskudar Univ, Personalized Med Applicat & Res Ctr KIMER, Istanbul, Turkey	Uskudar University; Uskudar University; Uskudar University; Uskudar University	Catal, T (corresponding author), Uskudar Univ, Istanbul Res Applicat & Inovat Ctr PROMER, Istanbul, Turkey.; Catal, T (corresponding author), Uskudar Univ, Dept Mol Biol & Genet, Istanbul, Turkey.	tunc.catal@uskudar.edu.tr	Catal, Tunc/AAO-1200-2020; KUL, Aykut/AAD-9258-2020	KUL, Aykut/0000-0002-1195-0939; Atasever Arslan, Belkis/0000-0001-5827-8484	Istanbul Development Agency [TR10/16/YNY/0167]	Istanbul Development Agency(Turkiye Cumhuriyeti Kalkinma Bakanligi)	This study was supported by Istanbul Development Agency (Grant No. TR10/16/YNY/0167). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN DJ, 1975, BIOCHEM SOC T, V3, P741, DOI 10.1042/bst0030741; Carrasco-Torres G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4674918; Chaudhary DK, 2018, INT J SYST EVOL MICR, V68, P305, DOI 10.1099/ijsem.0.002504; Chen WM, 2017, INT J SYST EVOL MICR, V67, P875, DOI 10.1099/ijsem.0.001693; De Bruyn F, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0326-1; Dennington R., 2016, GAUSSVIEW VERSION 6; Ekwe AP, 2017, INT J SYST EVOL MICR, V67, P2166, DOI 10.1099/ijsem.0.001920; Frisch A., 2007, REFERENCE VERSION 4; Gao FJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00285; Griffiths Keith, 2016, Diseases, V4, DOI 10.3390/diseases4030028; Iturriaga M, 2017, VET MICROBIOL, V210, P101, DOI 10.1016/j.vetmic.2017.09.009; Jeevitha D, 2016, J MOL STRUCT, V1120, P15, DOI 10.1016/j.molstruc.2016.05.003; Jing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30812; Kato S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20041; Lee S, 2012, J MICROBIOL, V50, P562, DOI 10.1007/s12275-012-1229-z; Li SY, 2017, INT J BIOL MACROMOL, V102, P1059, DOI 10.1016/j.ijbiomac.2017.04.070; Liang NJ, 2014, MOLECULES, V19, P19180, DOI 10.3390/molecules191119180; Lin S, 2014, FOOD CHEM, V145, P220, DOI 10.1016/j.foodchem.2013.08.048; Liu Y, 2017, ONCOTARGETS THER, V10, P4023, DOI 10.2147/OTT.S136821; Nam HK, 2012, BIOTECHNOL LETT, V34, P483, DOI 10.1007/s10529-011-0786-2; Thuan NH, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2208-7; Nishimura K, 2017, ARCH BIOCHEM BIOPHYS, V636, P11, DOI 10.1016/j.abb.2017.10.013; Parr RG, 1999, J AM CHEM SOC, V121, P1922, DOI 10.1021/ja983494x; PARR RG, 1983, J AM CHEM SOC, V105, P7512, DOI 10.1021/ja00364a005; Pauling L., 1960, NATURE CHEM BOND; Pearson R. G., 1973, HARD SOFT ACIDS BASE; Peng ZX, 2017, INT IMMUNOPHARMACOL, V52, P281, DOI 10.1016/j.intimp.2017.09.022; Pirildar S, 2010, PHARM BIOL, V48, P32, DOI 10.3109/13880200903029373; Praveena R, 2014, J MOL STRUCT, V1061, P114, DOI 10.1016/j.molstruc.2014.01.002; Shenin Iu D, 1996, Antibiot Khimioter, V41, P6; Shi, 2012, ENV NAT RESOUR RES, V2, P106, DOI [10.5539/enrr.v2n1p106., DOI 10.5539/ENRR.V2N1P106]; SHOJI J, 1985, J ANTIBIOT, V38, P538, DOI 10.7164/antibiotics.38.538; SINGH PD, 1984, J ANTIBIOT, V37, P773, DOI 10.7164/antibiotics.37.773; Bustos PS, 2016, ENVIRON TOXICOL PHAR, V48, P253, DOI 10.1016/j.etap.2016.11.004; Srivastava S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24049; Takahashi K, 1996, ENZYME MICROB TECH, V19, P456, DOI 10.1016/S0141-0229(96)00026-9; Wang X, 2016, ONCOL LETT, V12, P4357, DOI 10.3892/ol.2016.5259; Waskiewicz A., 2014, ENCY FOOD MICROBIOLO, VSecond, P938, DOI [10.1016/B978-0-12-384730-0.00126-9, DOI 10.1016/B978-0-12-384730-0.00126-9]; Wu LD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05352-7; Zhang P, 2018, HUM EXP TOXICOL, V37, P618, DOI 10.1177/0960327117714037; Zhang W, 2017, ANTICANCER RES, V37, P4041, DOI 10.21873/anticanres.11789; Zheng YZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08024-8; Zhou Bin, 2014, Sheng Wu Gong Cheng Xue Bao, V30, P674	43	14	15	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205817	10.1371/journal.pone.0205817	http://dx.doi.org/10.1371/journal.pone.0205817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332474	gold, Green Submitted, Green Published			2022-12-26	WOS:000447638200069
J	Maghami, S; Zardooz, H; Khodagholi, F; Binayi, F; Saber, RR; Hedayati, M; Sahraei, H; Ansari, MA				Maghami, Soheila; Zardooz, Homeira; Khodagholi, Fariba; Binayi, Fatemeh; Saber, Roya Ranjbar; Hedayati, Mehdi; Sahraei, Hedayat; Ansari, Mohammad Ali			Maternal separation blunted spatial memory formation independent of peripheral and hippocampal insulin content in young adult male rats	PLOS ONE			English	Article							EARLY-LIFE STRESS; LONG-TERM-POTENTIATION; ANXIETY-LIKE BEHAVIOR; CORTICOSTERONE; EXPRESSION; ISLETS; BRAIN; RECEPTORS; EXPOSURE; UNDERNUTRITION	This study explores the effects of maternal separation as a chronic early life stress (ELS) on pancreatic islets insulin content and secretion, and their potential relationship with the hippo campus insulin content and spatial memory in young adulthood. Male rat offspring were divided into two groups: stress (STR) and non-stress (non-STR) groups. The animals of the STR group were separated from their mothers during postnatal days (PND) 1 to 21. During the weaning time, that is, PND-0 to PND-21, the body weight and length of the pups were measured. Blood samples were collected on PND-1, 21, 29 and 34 and during young adulthood (53 2 days) to determine plasma corticosterone and insulin levels. The young adult animals were also tested for spatial memory. One day after the memory test, the animals were decapitated and their pancreases were removed to measure the islets insulin content and secretion. Finally, the animals' hippocampi were isolated to determine their insulin content and insulin receptor protein amounts. During the period of weaning, the body weight and length of pups belonging to the STR group were significantly lower as compared to those in the non-STR group. Maternal separation did not change the plasma levels of insulin but increased plasma corticosterone levels from PND-21 to young adulthood and also reduced the islets insulin content but did not affect insulin secretion and the hippocampus insulin content and insulin receptor protein amount. Although, at the end of the memory tests, rats of the STR group reached the escape box at almost the same time and distance and with the same errors as rats of the non-STR group, the distance traveled to reach the escape box showed a steep reduction in the non-STR group as compared to the STR group after the first trial. Moreover, as compared to the STR group, the non-STR group showed an increasing trend for direct strategy to find the escape box. The islets insulin content and secretion, and the plasma insulin concentration were not significantly correlated with the hippocampus insulin content. From the results of the present study, it appears that the main behavioral effect of the maternal separation stress in the spatial memory task was to impair the strategy used by the animals to reach the escape box. This may indicate that maternal separation stress affects brain regions other than the hippocampus. Moreover, due to the reduction of the body weight and length of offspring belonging to the STR group, it should be further considered that both maternal separation and early life malnutrition are directly (and mechanistically) linked to cognitive alterations later in life in ways that are not dependent on peripheral and hippocampal insulin content.	[Maghami, Soheila; Khodagholi, Fariba] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Maghami, Soheila; Zardooz, Homeira; Binayi, Fatemeh; Saber, Roya Ranjbar] Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran; [Zardooz, Homeira] Shahid Beheshti Univ Med Sci, Neurophysiol Res Ctr, Tehran, Iran; [Khodagholi, Fariba] Shahid Beheshti Univ Med Sci, Neurobiol Res Ctr, Tehran, Iran; [Hedayati, Mehdi] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Cellular & Mol Res Ctr, Tehran, Iran; [Sahraei, Hedayat] Baqiyatallah Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Ansari, Mohammad Ali] Shahid Beheshti Univ, Laser & Plasma Res Inst, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Baqiyatallah University of Medical Sciences (BMSU); Shahid Beheshti University	Zardooz, H (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran.; Zardooz, H (corresponding author), Shahid Beheshti Univ Med Sci, Neurophysiol Res Ctr, Tehran, Iran.	hameira_zardooz@yahoo.com	Khodagholi, Fariba/AAZ-4436-2020; zardooz, homeira/V-5293-2019	zardooz, homeira/0000-0001-8307-1848	Research Deputy of School of Medicine, Shahid Beheshti University of Medical Sciences [13/740]; Neurophysiology Research Center, Shahid Beheshti University of Medical Sciences [35]	Research Deputy of School of Medicine, Shahid Beheshti University of Medical Sciences; Neurophysiology Research Center, Shahid Beheshti University of Medical Sciences	This work was supported by Research Deputy of School of Medicine, Shahid Beheshti University of Medical Sciences, http://msp.sbmu.ac.ir/index.jsp?siteid=73, [Grant Number: 13/740]; and Neurophysiology Research Center, Shahid Beheshti University of Medical Sciences, http://nphrc.sbmu.ac.ir/, [Grant Number: 35]. HZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aksic M, 2013, ACTA NEUROBIOL EXP, V73, P394; Alberry B, 2016, BEHAV BRAIN RES, V308, P94, DOI 10.1016/j.bbr.2016.04.031; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Beaudry JL, 2012, DIABETES-METAB RES, V28, P560, DOI 10.1002/dmrr.2310; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Bernardi JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062031; Blazquez E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00161; Cao XJ, 2014, DEV PSYCHOBIOL, V56, P1102, DOI 10.1002/dev.21130; Chocyk A, 2013, PHARMACOL REP, V65, P1462, DOI 10.1016/S1734-1140(13)71506-8; Foscolo DRC, 2008, METAB BRAIN DIS, V23, P375, DOI 10.1007/s11011-008-9102-9; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Croteau JD, 2017, BEHAV BRAIN RES, V316, P82, DOI 10.1016/j.bbr.2016.08.055; Crumeyrolle-Arias M, 2014, PSYCHONEUROENDOCRINO, V42, P207, DOI 10.1016/j.psyneuen.2014.01.014; Daniels WMU, 2004, METAB BRAIN DIS, V19, P3, DOI 10.1023/B:MEBR.0000027412.19664.b3; Daniels WMU, 2004, METAB BRAIN DIS, V19, P15, DOI 10.1023/B:MEBR.0000027413.42946.61; Darcet F, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00136; Duarte A. I., 2012, J AGING RES, V2012; Fadel JR, 2016, CURR OPIN BEHAV SCI, V9, P47, DOI 10.1016/j.cobeha.2015.12.004; Figueiredo IL, 2016, NUTRITION, V32, P1019, DOI 10.1016/j.nut.2016.02.016; Gareau MG, 2006, PEDIATR RES, V59, P83, DOI 10.1203/01.pdr.0000190577.62426.45; Gehrand AL, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12972; Gulinello M, EUR J NEUROSCI, DOI [10.1016/j.bbr.2016.04.031, DOI 10.1016/J.BBR.2016.04.031]; Ivy AS, 2010, J NEUROSCI, V30, P13005, DOI 10.1523/JNEUROSCI.1784-10.2010; JORDAN TC, 1982, RES EXP MED, V180, P201, DOI 10.1007/BF01852291; Judo C, 2010, NEUROSCIENCE, V169, P1705, DOI 10.1016/j.neuroscience.2010.06.035; Kapoor A, 2006, J PHYSIOL-LONDON, V572, P31, DOI 10.1113/jphysiol.2006.105254; Karbaschi R, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0177-3; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Koe AS, 2014, PSYCHONEUROENDOCRINO, V42, P124, DOI 10.1016/j.psyneuen.2014.01.009; Kosten TA, 2012, NEUROSCI BIOBEHAV R, V36, P1985, DOI 10.1016/j.neubiorev.2012.07.003; Kullmann S, 2016, PHYSIOL REV, V96, P1169, DOI 10.1152/physrev.00032.2015; Kyriaki G, 2003, CELL MOL NEUROBIOL, V23, P1, DOI 10.1023/A:1022598900246; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lai MC, 2011, PEDIATR NEONATOL, V52, P122, DOI 10.1016/j.pedneo.2011.03.008; Lesage J, 2002, J NEUROENDOCRINOL, V14, P135, DOI 10.1046/j.0007-1331.2001.00753.x; Magarinos AM, 2000, P NATL ACAD SCI USA, V97, P11056, DOI 10.1073/pnas.97.20.11056; Majcher-Maslanka I, 2018, NEUROSCIENCE, V379, P316, DOI 10.1016/j.neuroscience.2018.03.038; Marques AH, 2015, BRAIN RES, V1617, P28, DOI 10.1016/j.brainres.2014.10.051; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; McEwen BS, 2010, ANN NY ACAD SCI, V1204, pE38, DOI 10.1111/j.1749-6632.2010.05568.x; McLay RN, 1998, PHYSIOL BEHAV, V63, P933, DOI 10.1016/S0031-9384(97)00529-5; Moosavi M, 2007, BEHAV BRAIN RES, V176, P230, DOI 10.1016/j.bbr.2006.10.011; Nouhi F, 2011, NEUROCHEM RES, V36, P870, DOI 10.1007/s11064-011-0417-2; O'Leary TP, 2013, LEARN MEMORY, V20, P85, DOI 10.1101/lm.028076.112; Oreland S, 2010, INT J DEV NEUROSCI, V28, P139, DOI 10.1016/j.ijdevneu.2009.12.005; Osmanovic J, 2010, STRESS, V13, P123, DOI 10.3109/10253890903080379; Aguggia JP, 2013, BEHAV BRAIN RES, V248, P25, DOI 10.1016/j.bbr.2013.03.040; Paternain L, 2016, BEHAV BRAIN RES, V299, P51, DOI 10.1016/j.bbr.2015.11.031; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Ragozzino ME, 1999, BEHAV NEUROSCI, V113, P32, DOI 10.1037/0735-7044.113.1.32; Rezende LF, 2014, BRIT J NUTR, V112, P900, DOI 10.1017/S0007114514001238; Rich EL, 2009, J NEUROSCI, V29, P7208, DOI 10.1523/JNEUROSCI.6068-08.2009; Roohbakhsh A, 2007, CLIN EXP PHARMACOL P, V34, P223, DOI 10.1111/j.1440-1681.2007.04576.x; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sadeghimahalli F, 2015, ENDOCRINE, V48, P493, DOI 10.1007/s12020-014-0337-4; Salimi M, 2016, J PHYSIOL PHARMACOL, V67, P653; SANDI C, 2007, NEURAL PLAST, V2007; Schwabe L, 2012, NEUROSCI BIOBEHAV R, V36, P1740, DOI 10.1016/j.neubiorev.2011.07.002; Solas M, 2010, NEUROPSYCHOPHARMACOL, V35, P1664, DOI 10.1038/npp.2010.13; Sousa VC, 2014, NEUROBIOL AGING, V35, P1680, DOI 10.1016/j.neurobiolaging.2014.01.024; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Szyf M, 2005, FRONT NEUROENDOCRIN, V26, P139, DOI 10.1016/j.yfrne.2005.10.002; Tao Shan, 2015, J Otol, V10, P21, DOI 10.1016/j.joto.2015.07.001; Uys JDK, 2006, NEUROSCIENCE, V137, P619, DOI 10.1016/j.neuroscience.2005.08.089; Uys JDK, 2006, ANN NY ACAD SCI, V1071, P542, DOI 10.1196/annals.1364.060; Valladolid-Acebes I, 2013, NEUROBIOL LEARN MEM, V106, P18, DOI 10.1016/j.nlm.2013.06.012; VIAU V, 1991, ENDOCRINOLOGY, V129, P2503, DOI 10.1210/endo-129-5-2503; Wu HY, 2006, J UROLOGY, V175, P1148, DOI 10.1016/S0022-5347(05)00321-6; Yankelevitch-Yahav R., 2015, J VIS EXP, V97; Zardooz H, 2010, PHYSIOL RES, V59, P973, DOI 10.33549/physiolres.931896; Zardooz H, 2012, EXCLI J, V11, P163; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893; Zimmerberg B, 2003, DEV PSYCHOBIOL, V42, P52, DOI 10.1002/dev.10086	74	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204731	10.1371/journal.pone.0204731	http://dx.doi.org/10.1371/journal.pone.0204731			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332425	Green Submitted, Green Published, gold			2022-12-26	WOS:000447638200026
J	Osorio-Guarin, JA; Quackenbush, CR; Cornejo, OE				Osorio-Guarin, Jaime A.; Quackenbush, Corey R.; Cornejo, Omar E.			Ancestry informative alleles captured with reduced representation library sequencing in Theobroma cacao	PLOS ONE			English	Article							SELECTION; GENOME; L.	As the source of chocolate, cacao has become one of the most important crops in the world. The identification of molecular markers to understand the demographic history, genetic diversity and population structure plays a pivotal role in cacao breeding programs. Here, we report the use of a modified genotyping-by-sequencing (GBS) approach for large-scale single nucleotide polymorphism (SNP) discovery and allele ancestry mapping. We identified 12,357 bi-allelic SNPs after filtering, of which, 7,009 variants were ancestry informative. The GBS approach proved to be rapid, cost-effective, and highly informative for ancestry assignment in this species.	[Osorio-Guarin, Jaime A.] Corp Colombiana Invest Agr Agrosavia Mosquera, Ctr Invest Tibaitata, Cundinamarca, Colombia; [Quackenbush, Corey R.; Cornejo, Omar E.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Quackenbush, Corey R.] US Army, Div Mol & Translat Sci, Med Res Inst Infect Dis USAMRI ID, Ft Detrick, MD USA	Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Washington State University	Cornejo, OE (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	omar.cornejo@wsu.edu			Agrosavia (Colombia)	Agrosavia (Colombia)	Omar E. Cornejo received a modest grant from Agrosavia (Colombia) that covered the training of Jaime Osorio and the generation of sequencing libraries. The funder provided support in the form of salaries for author Jaime Osorio, and provided financial support to perform the experiments, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank Path Umaharan, Lambert Motilal, and Annelle Holder-John for providing the germplasm material and associated information used in this study. The authors thank Joanna Kelley for assistance in revising the final version of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Jaime Osorio was supported through funds assigned from Agrosavia-Colombia to the Cornejo Lab to work on the library preparation of the samples.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alipour H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01293; Andrews S., 2010, FASTQC QUALITY CONTR; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Bartley BGD, 2005, GENETIC DIVERSITY OF CACAO AND ITS UTILIZATION: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9780851996196.0000; Bastien M, 2018, GENOME, V61, P449, DOI 10.1139/gen-2017-0236; Bonner I. F., 2009, CURR PROTOC HUM GENE, V18, DOI [10.1002/0471142905.hg1802s62., DOI 10.1002/0471142905.HG1802S62]; Broad Institute, 2018, PIC TOOLK; Chung YS, 2017, HORTIC ENVIRON BIOTE, V58, P425, DOI 10.1007/s13580-017-0297-8; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cooke TF, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005631; Cornejo OE, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0168-6; Cosme S, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1045-4; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cuatrecasas J., 1964, CONTRIB US NAT MUS, V35, P379, DOI DOI 10.1016/0165-5728(95)00055-7; Dantas LG, 2010, GENET MOL BIOL, V33, P94, DOI 10.1590/S1415-47572009005000103; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Duchene S, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0312-6; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ganal MW, 2012, J BIOSCIENCES, V37, P821, DOI 10.1007/s12038-012-9225-3; Gautier M, 2013, MOL ECOL, V22, P3165, DOI 10.1111/mec.12089; Gurgul A, 2019, GENOMICS, V111, P186, DOI 10.1016/j.ygeno.2018.02.002; He JF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00484; Henderson JS, 2007, P NATL ACAD SCI USA, V104, P18937, DOI 10.1073/pnas.0708815104; HUNTER JR, 1990, ECON BOT, V44, P425, DOI 10.1007/BF02859775; Ji K, 2013, GENET RESOUR CROP EV, V60, P441, DOI 10.1007/s10722-012-9847-1; Johnson JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127013; Krueger F., 2018, TRIM GALORE; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Livingstone D, 2015, DNA RES, V22, P279, DOI 10.1093/dnares/dsv009; Livingstone D, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02008; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lu F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7914; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Motamayor JC, 2002, HEREDITY, V89, P380, DOI 10.1038/sj.hdy.6800156; Motamayor JC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r53; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; Ogata N, 2009, CHOCOLATE MESOAMERIC, P69, DOI [10.5744/florida/9780813029535.003.0003, DOI 10.5744/FLORIDA/9780813029535.003.0003]; Osorio-Guarin JA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01994; Osorio-Guarin JA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2568-7; Othman A, 2007, FOOD CHEM, V100, P1523, DOI 10.1016/j.foodchem.2005.12.021; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2018, R LANG ENV STAT COMP; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Torkamaneh D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161333; Wood G.A.R., 1985, COCOA, V4th; World Cocoa Foundation, 2014, COC MARK UPD; Zhang DP, 2012, GENET RESOUR CROP EV, V59, P239, DOI 10.1007/s10722-011-9680-y	52	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0203973	10.1371/journal.pone.0203973	http://dx.doi.org/10.1371/journal.pone.0203973			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332408	gold, Green Submitted, Green Published			2022-12-26	WOS:000447638200009
J	Martinez-Hesterkamp, S; Rebollo, S; Perez-Camacho, L; Garcia-Salgado, G; Fernandez-Pereira, JM				Martinez-Hesterkamp, Sara; Rebollo, Salvador; Perez-Camacho, Lorenzo; Garcia-Salgado, Gonzalo; Manuel Fernandez-Pereira, Jose			Assessing the ability of novel ecosystems to support animal wildlife through analysis of diurnal raptor territoriality	PLOS ONE			English	Article							BUZZARD BUTEO-BUTEO; PLANTATION FORESTS; NORTHERN GOSHAWK; REPRODUCTIVE SUCCESS; TREE PLANTATIONS; HOME-RANGE; CONSERVATION; DENSITY; BIODIVERSITY; POPULATION	Novel ecosystems have emerged through human intervention and are rapidly expanding around the world. Whether they can support animal wildlife has generated considerable controversy. Here we developed a new approach to evaluate the ability of a novel forest ecosystem, dominated by the exotic tree species Eucalyptus globulus, to support animal wildlife in the medium and long term. To evaluate this ability, we took advantage of the fact that species territory size decreases with increasing habitat quality, and we used territoriality of a raptor guild composed of Northern Goshawk (Accipiter gentilis), Eurasian Sparrowhawk (A. nisus) and Common Buzzard (Buteo buteo) as indicator. We compared the territoriality of these species in the novel ecosystem with that in other ecosystems found in the literature. Average distances between con-specifics in the novel ecosystem were similar, or even shorter, than those in other ecosystems. Average distances between Goshawk con-specifics were among the shortest described in the literature. All three species nested preferably in mixed stands abundant in large exotic trees, with high structural complexity and abundance of native species within the stand. Key factors supporting this diverse and dense raptor community were the special forest management system implemented in the study area and the agricultural matrix located close to forest plantations that complements the supply of prey. Our results suggest that forest management that promotes a complex and suitable forest structure can increase the ability of novel forest ecosystems to support wildlife biodiversity, particularly a diverse nesting community of forest-dwelling raptors and their preys. The results further suggest the suitability of territoriality for assessing this potential of novel ecosystems.	[Martinez-Hesterkamp, Sara; Rebollo, Salvador; Perez-Camacho, Lorenzo; Garcia-Salgado, Gonzalo; Manuel Fernandez-Pereira, Jose] Univ Alcala, Dept Life Sci, Ecol & Forest Restorat Grp, Univ Campus, Madrid, Spain	Universidad de Alcala	Perez-Camacho, L (corresponding author), Univ Alcala, Dept Life Sci, Ecol & Forest Restorat Grp, Univ Campus, Madrid, Spain.	lorenzo.perez@uah.es	Rebollo, Salvador/L-6451-2014; Pérez-Camacho, Lorenzo/L-6093-2014; GARCIA-SALGADO, GONZALO/F-7122-2019	Rebollo, Salvador/0000-0001-8797-1122; GARCIA-SALGADO, GONZALO/0000-0002-4729-5710; Perez-Camacho, Lorenzo/0000-0002-0723-055X	Spanish Ministerio de Ciencia y Tecnologia [CGL2007-60533/BOS, CGL2010-18312/BOS, CGL2014-53308-P]; REMEDINAL network [S-0505/AMB/0335, S2009 AMB-1783, S2013/MAE-2719]; University of Alcala [CCG2014/BIO-002]; FPI fellowship from the Ministerio de Educacion y Ciencia [BES-2008-006630]; FPU fellowship from the Ministerio de Educacion y Ciencia [AP2006-00891]	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); REMEDINAL network; University of Alcala; FPI fellowship from the Ministerio de Educacion y Ciencia(German Research Foundation (DFG)); FPU fellowship from the Ministerio de Educacion y Ciencia(German Research Foundation (DFG)National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding from the Spanish Ministerio de Ciencia y Tecnologia (CGL2007-60533/BOS, CGL2010-18312/BOS and CGL2014-53308-P); the REMEDINAL network (S-0505/AMB/0335, S2009 AMB-1783 and S2013/MAE-2719) and the University of Alcala (CCG2014/BIO-002). S.M.H. and G.G.S. were supported by FPI and FPU fellowships from the Ministerio de Educacion y Ciencia (BES-2008-006630 and AP2006-00891, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamczyk S, 2008, BIRD CONSERV INT, V18, P349, DOI 10.1017/S0959270908007570; [Anonymous], 1991, S BIOL TROFIA HABITA; [Anonymous], 2006, BIOLOGIA, V61, P597; Bates D, LME4 LINEAR MIXED EF; Bird DM., 2007, RAPTOR RES MANAGEMEN; Bridgewater P, 2011, FRONT ECOL ENVIRON, V9, P423, DOI 10.1890/1540-9295-9.8.423; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Brown D., 1975, WILDFOWL, V26, P102; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Crook J. H., 1965, Symposia of the Zoological Society of London, VNo. 14, P181; de la Hera I, 2013, ANIM BIODIV CONSERV, V36, P153; Demerdzhiev DA, 2011, ACTA ZOOL BULGAR, P87; ESRI, 2010, ARCGIS DESKT REL 10; FAO, 2020, GLOBAL FOREST RESOUR; Fasola Mauro, 1993, Avocetta, V17, P11; Ferguson-Lees J, 2001, RAPTORS WORLD; Garcia-Salgado G, 2018, FOREST ECOL MANAG, V409, P817, DOI 10.1016/j.foreco.2017.12.020; Garcia-Salgado G., 2017, TROPHIC ECOLOGY NEST; Garcia-Salgado G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127585; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Ippi S, 2018, EMU, V118, P293, DOI 10.1080/01584197.2018.1438848; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Kennedy Patricia L., 2013, P127; Kenward R.E., 2006, THE GOSHAWK; Kenward RE, 2001, ECOLOGY, V82, P1905, DOI 10.2307/2680056; Lindenmayer D, 2015, CAN J FOREST RES, V45, P1427, DOI 10.1139/cjfr-2015-0072; Lindenmayer DB, 2008, CONSERV LETT, V1, P129, DOI 10.1111/j.1755-263X.2008.00021.x; Lindenmayer DB, 2004, BIOL CONSERV, V119, P151, DOI 10.1016/j.biocon.2003.10.028; Lourenco R, 2011, POPUL ECOL, V53, P175, DOI 10.1007/s10144-010-0199-4; lvarez-Taboada MF, 2005, THESIS; Machange RW, 2005, J ARID ENVIRON, V63, P223, DOI 10.1016/j.jaridenv.2005.03.031; Manuel-Valdes CM, 2006, TERCER INVENTARIO FO; Marshall MR, 2004, ECOLOGY, V85, P432, DOI 10.1890/02-0548; Marti Carl D., 1993, Current Ornithology, V10, P47; Martinez-Hesterkamp S, 2015, TERRITORIALITY SPATI; Moser BW, 2003, J RAPTOR RES, V37, P286; NEWTON I, 1977, J ANIM ECOL, V46, P425, DOI 10.2307/3821; NEWTON I, 1986, J ANIM ECOL, V55, P361, DOI 10.2307/4714; Newton I., 1986, SPARROWHAWK; Newton I., 1979, POPULATION ECOLOGY R; Newton Ian, 2003, P5; NILSSON IN, 1982, BIOL J LINN SOC, V18, P1, DOI 10.1111/j.1095-8312.1982.tb02030.x; Ozaki K, 2006, CONSERV BIOL, V20, P1507, DOI 10.1111/j.1523-1739.2006.00444.x; PATTERSON IJ, 1980, ARDEA, V68, P53; Peery MZ, 2000, AUK, V117, P511, DOI 10.1642/0004-8038(2000)117[0511:FAIVIH]2.0.CO;2; Penteriani V, 1997, J RAPTOR RES, V31, P308; Perez-Camacho L, 2015, OECOLOGIA, V177, P379, DOI 10.1007/s00442-014-3146-9; Petty SJ, 2003, IBIS, V145, P472, DOI 10.1046/j.1474-919X.2003.00191.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; R Core Team, 2021, R LANGUAGE ENV STAT; Rebollo S, 2017, J AVIAN BIOL, V48, P1226, DOI 10.1111/jav.01337; Rebollo S, 2017, BIRD STUDY, V64, P464, DOI 10.1080/00063657.2017.1395807; Reich RM, 2004, ECOL MODEL, V176, P109, DOI 10.1016/j.ecolmodel.2003.09.039; Rivas-Martinez S., 1987, MEMORIA MAPA SERIES; Rogers AM, 2014, DIVERS DISTRIB, V20, P34, DOI 10.1111/ddi.12123; Rutz Christian, 2006, Studies in Avian Biology, P158; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Seaton R, 2010, EMU, V110, P316, DOI 10.1071/MU09050; Sergio F, 2005, NATURE, V436, P192, DOI 10.1038/436192a; Sim IMW, 2001, BIRD STUDY, V48, P317, DOI 10.1080/00063650109461231; StatSoft I, STAT DAT AN SOFTW SY; Stephens SS, 2007, J FOREST, V105, P307; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tubbs C.R., 1974, THE BUZZARD; Veiras X, 2011, ANALISIS PROPUESTAS; Zuberogoitia I, 2006, ARDEOLA, V53, P83	68	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205799	10.1371/journal.pone.0205799	http://dx.doi.org/10.1371/journal.pone.0205799			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325967	Green Submitted, gold, Green Published			2022-12-26	WOS:000447430800041
J	Harano, K; Wang, Y; Lim, B; Seitz, RS; Morris, SW; Bailey, DB; Hout, DR; Skelton, RL; Ring, BZ; Masuda, H; Rao, AUK; Van Laere, S; Bertucci, F; Woodward, WA; Reuben, JM; Krishnamurthy, S; Ueno, NT				Harano, Kenichi; Wang, Ying; Lim, Bora; Seitz, Robert S.; Morris, Stephan W.; Bailey, Daniel B.; Hout, David R.; Skelton, Rachel L.; Ring, Brian Z.; Masuda, Hiroko; Rao, Arvind U. K.; Van Laere, Steven; Bertucci, Francois; Woodward, Wendy A.; Reuben, James M.; Krishnamurthy, Savitri; Ueno, Naoto T.			Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; NEOADJUVANT CHEMOTHERAPY; LYMPHOCYTES; TRIAL	In patients with triple-negative breast cancer (TNBC), tumor-infiltrating lymphocytes (TILs) are associated with improved survival. Lehmann et al. identified 4 molecular subtypes of TNBC [basal-like (BL) 1, BL2, mesenchymal (M), and luminal androgen receptor (LAR)], and an immunomodulatory (IM) gene expression signature indicates the presence of TILs and modifies these subtypes. The association between TNBC subtype and TILs is not known. Also, the association between inflammatory breast cancer (IBC) and the presence of TILs is not known. Therefore, we studied the IM subtype distribution among different TNBC subtypes. We retrospectively analyzed patients with TNBC from the World IBC Consortium dataset. The molecular subtype and the IM signature [positive (IM+) or negative (IM-)] were analyzed. Fisher's exact test was used to analyze the distribution of positivity for the IM signature according to the TNBC molecular subtype and IBC status. There were 88 patients with TNBC in the dataset, and among them 39 patients (44%) had IBC and 49 (56%) had non-IBC. The frequency of IM+ cases differed by TNBC subtype (p = 0.001). The frequency of IM+ cases by subtype was as follows: BL1, 48% (14/29); BL2, 30% (3/10); LAR, 18% (3/17); and M, 0% (0/21) (in 11 patients, the subtype could not be determined). The frequency of IM+ cases did not differ between patients with IBC and non-IBC (23% and 33%, respectively; p = 0.35). In conclusion, the IM signature representing the underlying molecular correlate of TILs in the tumor may differ by TNBC subtype but not by IBC status.	[Harano, Kenichi; Lim, Bora; Woodward, Wendy A.; Reuben, James M.; Krishnamurthy, Savitri; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Harano, Kenichi; Lim, Bora; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Harano, Kenichi] Nippon Med Sch, Grad Sch Med, Dept Pulmonol Med & Oncol, Bunkyo Ku, Tokyo, Japan; [Wang, Ying; Rao, Arvind U. K.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Seitz, Robert S.; Morris, Stephan W.; Bailey, Daniel B.; Hout, David R.; Skelton, Rachel L.; Ring, Brian Z.] Insight Genet Inc, Nashville, TN USA; [Ring, Brian Z.] Huazhong Univ Sci & Technol, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Masuda, Hiroko] Showa Univ, Dept Breast Surg Oncol, Shinagawa Ku, Tokyo, Japan; [Rao, Arvind U. K.; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Van Laere, Steven] Univ Antwerp, Ctr Oncol Res, Fac Med & Hlth Sci, Antwerp, Belgium; [Bertucci, Francois] Inst Paoli Calmettes, Predict Oncol Team, CRCM, Marseille, France; [Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Krishnamurthy, Savitri] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Nippon Medical School; University of Texas System; UTMD Anderson Cancer Center; Huazhong University of Science & Technology; Showa University; University of Texas System; UTMD Anderson Cancer Center; University of Antwerp; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Krishnamurthy, S; Ueno, NT (corresponding author), Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA.; Ueno, NT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA.; Krishnamurthy, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	skrishna@mdanderson.org; nueno@mdanderson.org	, 0000-0002-4182-6058/F-9978-2014; Woodward, Wendy/AAX-6593-2020	, 0000-0002-4182-6058/0000-0002-4182-6058; Bertucci, Francois/0000-0002-0157-0959; Woodward, Wendy/0000-0002-7935-739X	Japan Cancer Society "My Oncology Dream award 2014"; Insight Genetics, Inc.	Japan Cancer Society "My Oncology Dream award 2014"; Insight Genetics, Inc.	KH received the Japan Cancer Society "My Oncology Dream award 2014". The funder, Insight Genetics, Inc., provided support in the form of stock and salaries for authors RSS, SWM, DBB, DRH, RLS, and BZR. Insight Genetics, Inc., performed the analysis of gene expression profile data and played a role in the decision to publish.	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Alessandro Poggi MG, 2016, VACCINES, V4, P41, DOI [10.1186/s12943-017-0621-z, DOI 10.1186/S12943-017-0621-Z]; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chen X, 2012, CANCER INFORM, V11, P147, DOI 10.4137/CIN.S9983; Dawood S, 2011, ANN ONCOL, V22, P515, DOI 10.1093/annonc/mdq345; Dawood S, 2011, CANCER-AM CANCER SOC, V117, P1819, DOI 10.1002/cncr.25682; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dongre A, 2017, CANCER RES, V77, P3982, DOI 10.1158/0008-5472.CAN-16-3292; Fouad TM, 2014, ADV EXP MED BIOL, V816, P53, DOI 10.1007/978-3-0348-0837-8_3; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Ibrahim SA, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0621-z; Issa-Nummer Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079775; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Masuda H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3579; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; Miyashita M, 2014, BREAST CANCER RES TR, V148, P525, DOI 10.1007/s10549-014-3197-y; Ring BZ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2198-0; Van Laere SJ, 2013, CLIN CANCER RES, V19, P4685, DOI 10.1158/1078-0432.CCR-12-2549	23	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0204513	10.1371/journal.pone.0204513	http://dx.doi.org/10.1371/journal.pone.0204513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312311	Green Published, gold, Green Submitted			2022-12-26	WOS:000447427300010
J	Martins, VD; Pinho, JD; Teixeira, AAL; Nogueira, LR; Silva, FF; Maulen, VE; Khayat, AS; Calixto, JDR; Costa, HA; Ramalho, LNZ; Silva, GEB				Martins, Vicenilma de Andrade; Pinho, Jaqueline Diniz; Lima Teixeira Junior, Antonio Augusto; Nogueira, Leudivan Ribeiro; Silva, Fabio Franca; Maulen, Victor Eduardo; Khayat, Andre Salim; Rodrigues Calixto, Jose de Ribamar; Costa, Herikson Araujo; Zambelli Ramalho, Leandra Naira; Barros Silva, Gyl Eanes			P16(INK4a) expression in patients with penile cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RISK HUMAN-PAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLINICAL PRESENTATION; DIAGNOSIS; MARKER; IDENTIFICATION; POPULATION; VALIDATION; PROGNOSIS	Background Infection with human papillomavirus (HPV) is reported to be present in 30-50% of penile cancer cases. The immunohistochemical test for p16(INK4a) is used as an indicator of the presence of HPV and as a prognostic marker for squamous cell carcinomas in various sites. However, the role of this marker in penile carcinoma has not yet been completely elucidated. The aim of this study was to analyze whether the expression of p16(INK4a) is associated with the presence of HPV, histological parameters, and survival in penile cancer. Methods A study was conducted from 2014 to 2016 that included 55 patients with penile carcinoma. HPV DNA was detected through PCR using fresh tumor tissue, and immunohistochemistry was performed for analysis of p16(INK4a) protein using paraffin-embedded tissue. Evaluation of histological parameters was performed following complete embedding of the tumor tissue in paraffin. Results HPV DNA (low-risk and high-risk genotypes) was found in 49 (89.1%) cases, and 46/49 (93.9%) showed high-oncogenic risk HPV (HR-HPV). Of the 22 cases positive for p16(INK4a), HR-HPV DNA was present in 21 (95.5%) (p = 0.032). Regarding histological parameters, p16(INK4a) and HR-HPV were significantly associated only with tumor subtype (p = 0.036 and p = 0.032, respectively); all carcinomas with basaloid characteristics were positive for p16(INK4a). Although HPV+ patients had a higher disease-free survival (p<0.001), p16(INK4a) expression was not associated with patient survival. Conclusions Our study, using fresh tissue samples, showed the highest incidence of HPV compared to that observed in the literature. Expression of the p16(INK4a) protein was significantly associated with the presence of HR-HPV and this expression may serve as a marker for the presence of the virus. The p16(INK4a) protein was not associated with the histological prognostic parameters, with the exception of tumor subtype, nor with patient survival. In the results, we showed that the objective of the present study was reached.	[Martins, Vicenilma de Andrade] Fed Univ Maranhao UFMA, Postgrad Program Adult & Child Hlth PPGSAC, Sao Luis, Brazil; [Pinho, Jaqueline Diniz; Khayat, Andre Salim] Fed Univ Para UFPA, Postgrad Program Genet & Mol Biol PPGBM, Belem, Para, Brazil; [Lima Teixeira Junior, Antonio Augusto] Fed Univ Maranhao UFMA, Postgrad Program Adult Hlth PPGSAD, Sao Luis, Brazil; [Nogueira, Leudivan Ribeiro] Maranhense Inst Oncol Aldenora Bello IMOAB, Sao Luis, Brazil; [Silva, Fabio Franca] State Univ Ceara UECE, Northeast Network Biotechnol Program RENORBIO, Ceara, Brazil; [Maulen, Victor Eduardo] Presidente Dutra Univ Hosp HUPD, Sao Luis, Brazil; [Rodrigues Calixto, Jose de Ribamar] Fed Univ Maranhao UFMA, Dept Med II, Sao Luis, Brazil; [Costa, Herikson Araujo] Fed Univ Maranhao UFMA, Dept Phys Educ, Pinheiro, Brazil; [Zambelli Ramalho, Leandra Naira; Barros Silva, Gyl Eanes] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol, Ribeirao Preto, Brazil	Universidade Federal do Maranhao; Universidade Federal do Para; Universidade Federal do Maranhao; Universidade Estadual do Ceara; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade de Sao Paulo	Silva, GEB (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol, Ribeirao Preto, Brazil.	gyleanes@fmrp.usp.br	Khayat, Andre/AAF-2415-2019; Silva, Gyl/ABE-3852-2021; Ramalho, Leandra Náira Zambelli/A-3983-2010; Ramalho, Leandra/AAA-6432-2021	Ramalho, Leandra Náira Zambelli/0000-0002-3486-5294; Augusto Lima Teixeira Junior, Antonio/0000-0002-0072-6202	Foundation for Scientific Research and Development of Maranhao (FAPEMA) [00696/14]	Foundation for Scientific Research and Development of Maranhao (FAPEMA)	The study was funded by the Foundation for Scientific Research and Development of Maranhao (FAPEMA) under grant number 00696/14 and coordination the author GEBS. FAPEMA website is: http://www.fapema.br. Lenders had no role in designing the study, collecting and analyzing data, deciding to publish or preparing the manuscript.	Alemany L, 2016, EUR UROL, V69, P953, DOI 10.1016/j.eururo.2015.12.007; Barocas DA, 2010, UROL CLIN N AM, V37, P343, DOI 10.1016/j.ucl.2010.04.002; Bethune G, 2012, UROLOGY, V79, P1092, DOI 10.1016/j.urology.2011.12.048; Branca M, 2004, INT J GYNECOL PATHOL, V23, P354, DOI 10.1097/01.pgp.0000139639.79105.40; BURGERS JK, 1992, UROL CLIN N AM, V19, P247; Carozzi F, 2013, LANCET ONCOL, V14, P168, DOI 10.1016/S1470-2045(12)70529-6; Christodoulidou M, 2015, CURR PROB CANCER, V39, P126, DOI 10.1016/j.currproblcancer.2015.03.010; Cubilla AL, 2001, INT J SURG PATHOL, V9, P111, DOI 10.1177/106689690100900204; Cubilla AL, 2011, AM J SURG PATHOL, V35, P253, DOI 10.1097/PAS.0b013e318203cdba; Cubilla AL, 2010, AM J SURG PATHOL, V34, P104, DOI 10.1097/PAS.0b013e3181c76a49; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Emerson RE, 2001, MODERN PATHOL, V14, P963, DOI 10.1038/modpathol.3880419; Faraj SF, 2017, VIRCHOWS ARCH, P1; Fernandez-Nestosa MJ, 2017, AM J SURG PATHOL, V41, P820, DOI 10.1097/PAS.0000000000000821; Ferrandiz-Pulido C, 2013, J AM ACAD DERMATOL, V68, P73, DOI 10.1016/j.jaad.2012.05.029; Ferraz LdC, 2012, J HLTH SCI I, DOI [10.1002/path.1394, DOI 10.1002/PATH.1394]; Ferreux E, 2003, J PATHOL, V201, P109, DOI 10.1002/path.1394; Flaherty A, 2014, UROL ONCOL-SEMIN ORI; Fonseca AGD, 2010, REV PAN-AMAZ SAUDE, V1, P85, DOI [10.5123/S2176-62232010000200010, DOI 10.5123/S2176-62232010000200010]; Gil AO, 2001, BRAZ J UROL, V27, P461; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Gunia S, 2012, J UROLOGY, V187, P899, DOI 10.1016/j.juro.2011.10.149; Hernandez BY, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00009; Iftner T, 2002, J NATI CANC I MONOGR, P80; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; Jordan RC, 2012, AM J SURG PATHOL, V36, P945, DOI 10.1097/PAS.0b013e318253a2d1; Klaes R, 2002, AM J SURG PATHOL, V26, P1389, DOI 10.1097/00000478-200211000-00001; Lopes A, 2002, J UROLOGY, V168, P81, DOI 10.1016/S0022-5347(05)64836-7; Micali G, 2006, J AM ACAD DERMATOL, V54, P369, DOI 10.1016/j.jaad.2005.05.007; Ornellas A, 2004, ONCOLOGIA MOL, P224; Poetsch M, 2011, VIRCHOWS ARCH, V458, P221, DOI 10.1007/s00428-010-1007-4; Rubin MA, 2001, AM J PATHOL, V159, P1211, DOI 10.1016/S0002-9440(10)62506-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sano T, 1998, AM J PATHOL, V153, P1741, DOI 10.1016/S0002-9440(10)65689-1; SARKAR FH, 1992, J UROLOGY, V147, P389, DOI 10.1016/S0022-5347(17)37245-2; Senba M, 2009, ACTA VIROL, V53, P43, DOI 10.4149/av_2009_01_43; Singh S, 2010, BBA-GENE REGUL MECH, V1799, P788, DOI 10.1016/j.bbagrm.2010.07.004; Steinestel J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1268-z; Tornesello ML, 2000, J GEN VIROL, V81, P2969, DOI 10.1099/0022-1317-81-12-2969; Velazquez EE, 2007, ANAL QUANT CYTOL, V29, P185; Vignat J, 2017, INT J CANC; VOUSDEN K, 1993, FASEB J, V7, P872, DOI 10.1096/fasebj.7.10.8393818; Wang SS, 2004, CANCER EPIDEM BIOMAR, V13, P1355	43	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205350	10.1371/journal.pone.0205350	http://dx.doi.org/10.1371/journal.pone.0205350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312320	gold, Green Published, Green Submitted			2022-12-26	WOS:000447427300027
J	Kang, S; Kim, BR; Kang, MH; Kim, DY; Lee, DH; Oh, SC; Min, BW; Um, JW				Kang, Sanghee; Kim, Bo Ram; Kang, Myoung-Hee; Kim, Dae-Young; Lee, Dae-Hee; Oh, Sang Cheul; Min, Byung Wook; Um, Jun Won			Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial-mesenchymal transition in human colon cancer cells	PLOS ONE			English	Article							COLORECTAL-CANCER; BREAST-CANCER; STAT3 ACTIVATION; GROWTH; PROGRESSION; METASTASIS; PATHOGENESIS; APOPTOSIS; RECEPTOR; SIGNALS	Metformin, a first-line drug used to treat type 2 diabetes, has also been shown to have anti-cancer effects against a variety of malignancies, including colorectal cancer. Although inhibition of the mTOR pathway is known to be the most important mechanism for the antitumor effects of metformin, other mechanisms remain unclear. The purpose of this study was to identify the antitumor mechanism of metformin in colorectal cancer using high-throughput data, and then test the mechanism experimentally. We identified the gene signature of metformin-treated colon cancer cells. This signature was processed for prediction using colon adenocarcinoma patient data from the Cancer Genome Atlas to classify the patients showing a gene expression pattern similar to that in metformin-treated cells. This patient group showed better overall and disease-free survival. Furthermore, pathway analysis revealed that the metformin-predicted group was characterized by decreased interleukin (IL)-6 pathway signaling, epithelial-mesenchymal transition, and colon cancer metastatic signaling. We induced epithelial-mesenchymal transition in colon cancer cell lines via IL-6 treatment, which increased cell motility and promoted invasion. However, these effects were blocked by metformin. These findings suggest that blockade of IL-6-induced epithelial-mesenchymal transition is an antitumor mechanism of metformin.	[Kang, Sanghee; Min, Byung Wook] Korea Univ, Coll Med, Dept Surg, Guro Hosp, Seoul, South Korea; [Kim, Bo Ram; Lee, Dae-Hee; Oh, Sang Cheul] Korea Univ, Dept Oncol, Guro Hosp, Seoul, South Korea; [Kang, Myoung-Hee] Univ Ulsan, Coll Med, Dept Convergence Med, ASAN Med Ctr, Seoul, South Korea; [Kim, Dae-Young; Lee, Dae-Hee] Korea Univ, Grad Sch Med, Coll Med, Seoul, South Korea; [Um, Jun Won] Korea Univ, Coll Med, Ansan Hosp, Dept Surg, Gyeonggi Do, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Um, JW (corresponding author), Korea Univ, Coll Med, Ansan Hosp, Dept Surg, Gyeonggi Do, South Korea.	junwonum@korea.ac.kr	Kang, Sanghee/W-1117-2019	Kang, Sanghee/0000-0002-6097-8831; Min, Byung Wook/0000-0002-3621-5113	Korea University [K0716521]; National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [NRF-2018R1C1B6007721]	Korea University; National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work is supported by Korea University Grant (K0716521) to JWU and National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. NRF-2018R1C1B6007721) to SHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Bae YK, 2015, J BREAST CANCER, V18, P256, DOI 10.4048/jbc.2015.18.3.256; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Deng XS, 2012, CELL CYCLE, V11, P367, DOI 10.4161/cc.11.2.18813; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Farina AR, 2014, CANCERS, V6, P240, DOI 10.3390/cancers6010240; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; He JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17423; Huang L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0301-7; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Isakovic A, 2007, CELL MOL LIFE SCI, V64, P1290, DOI 10.1007/s00018-007-7080-4; Jalving M, 2010, EUR J CANCER, V46, P2369, DOI 10.1016/j.ejca.2010.06.012; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Knupfer H, 2010, INT J COLORECTAL DIS, V25, P135, DOI 10.1007/s00384-009-0818-8; Lee JH, 2012, INT J CANCER, V131, P752, DOI 10.1002/ijc.26421; Li LH, 2012, J AM STAT ASSOC, V107, P120, DOI 10.1198/jasa.2011.ap10446; Li XY, 2014, TOHOKU J EXP MED, V233, P175, DOI 10.1620/tjem.233.175; Ma FX, 2015, CELL TRANSPLANT, V24, P2585, DOI 10.3727/096368915X687462; Nagasaki T, 2014, BRIT J CANCER, V110, P469, DOI 10.1038/bjc.2013.748; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Qaseem A, 2017, ANN INTERN MED, V166, P58, DOI 10.7326/M16-0570; Quante M, 2013, GASTROENTEROLOGY, V145, P63, DOI 10.1053/j.gastro.2013.03.052; Quinn BJ, 2013, TRENDS ENDOCRIN MET, V24, P469, DOI 10.1016/j.tem.2013.05.004; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vazquez-Martin A, 2010, CELL CYCLE, V9, P3807, DOI 10.4161/cc.9.18.13131; Wang XH, 2013, MOL CANCER THER, V12, P1026, DOI 10.1158/1535-7163.MCT-12-0895; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhao ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095884	38	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205449	10.1371/journal.pone.0205449	http://dx.doi.org/10.1371/journal.pone.0205449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308035	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500080
J	Wei, N; Li, J; Fang, C; Chang, J; Xirou, V; Syrigos, NK; Marks, BJ; Chu, E; Schmitz, JC				Wei, Ning; Li, Jun; Fang, Cheng; Chang, Jin; Xirou, Vasiliki; Syrigos, Nick K.; Marks, Benjamin J.; Chu, Edward; Schmitz, John C.			Targeting colon cancer with the novel STAT3 inhibitor bruceantinol	ONCOGENE			English	Article							PROTEIN-KINASE-D; COMBINATION; METASTASIS; EXPRESSION; BRUSATOL; TRIAL	STAT3, a transcriptional mediator of oncogenic signaling, is constitutively active in similar to 70% of human cancers. The development of STAT3 inhibitors remains an active area of research as no inhibitors have yet to be approved for the treatment of human cancer. Herein, we revealed that bruceantinol (BOL) is a novel STAT3 inhibitor demonstrating potent antitumor activity in in vitro and in vivo human colorectal cancer (CRC) models. BOL strongly inhibited STAT3 DNA-binding ability (IC50 = 2.4 pM), blocked the constitutive and IL-6-induced STAT3 activation in a dose- and time-dependent manner, and suppressed transcription of STAT3 target genes encoding anti-apoptosis factors (MCL-1, PTTG1, and survivin) and cell-cycle regulators (c-Myc). Structure-activity relationship studies demonstrated that the C15 side chain on BOL affected its ability to bind STAT3. Administration of 4 mg/kg BOL significantly inhibited CRC tumor xenografts [p < 0.001], but no effect was observed in a STAT3(-/-) tumor model. Additional studies showed that BOL effectively sensitized MEK inhibitors through repression of p-STAT3 and MCL-1 induction, known resistance mechanisms of MEK inhibition. Taken together, our findings suggest BOL is a novel therapeutic STAT3 inhibitor that can be used either alone or in combination with MEK inhibitors for the treatment of human CRC.	[Wei, Ning; Marks, Benjamin J.; Chu, Edward; Schmitz, John C.] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15213 USA; [Wei, Ning; Marks, Benjamin J.; Chu, Edward; Schmitz, John C.] Univ Pittsburgh, UPMC Hillman Canc Ctr, Canc Therapeut Program, Pittsburgh, PA 15260 USA; [Li, Jun] Liaoning Univ Tradit Chinese Med, Basic Med Sci Coll, Shenyang, Liaoning, Peoples R China; [Fang, Cheng] Univ Pittsburgh, Computat Modeling & Simulat Program, Pittsburgh, PA USA; [Chang, Jin] Taishan Med Univ, Dept Oncol, Tai An, Shandong, Peoples R China; [Xirou, Vasiliki; Syrigos, Nick K.] Univ Athens, Med Sch, Athens, Greece	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Liaoning University of Traditional Chinese Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Shandong First Medical University & Shandong Academy of Medical Sciences; National & Kapodistrian University of Athens	Wei, N; Schmitz, JC (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15213 USA.; Wei, N; Schmitz, JC (corresponding author), Univ Pittsburgh, UPMC Hillman Canc Ctr, Canc Therapeut Program, Pittsburgh, PA 15260 USA.	chinaweining@yahoo.com; schmitzjc@upmc.edu	FANG, CHENG/B-6718-2016; WEI, NING/AAF-8368-2020; SYRIGOS, NIKOLAOS/ABB-6880-2021; WEI, NING/P-8505-2019; Syrigos, Nick/ABC-6339-2021	FANG, CHENG/0000-0002-9767-2043; WEI, NING/0000-0003-2723-4061; WEI, NING/0000-0003-2723-4061; Syrigos, Nick/0000-0001-8082-594X	UPCI NCI Cancer Center Support Grant Developmental Funds [P30CA047904]; China National Natural Sciences Foundation [81202556]; Pennsylvania Department of Health	UPCI NCI Cancer Center Support Grant Developmental Funds; China National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Pennsylvania Department of Health	This project was supported, in part, by funds from the UPCI NCI Cancer Center Support Grant Developmental Funds (P30CA047904). This project used the UPCI Cytometry Facility and the UPCI Animal Facility, which are supported, in part, by P30CA047904. This project also was supported, in part, by Grants (No. 81202556) from the China National Natural Sciences Foundation. This project is funded, in part, under a grant with the Pennsylvania Department of Health.	Arseneau J C, 1983, Invest New Drugs, V1, P239; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Castelletti D, 2010, MOL CANCER THER, V9, P3145, DOI 10.1158/1535-7163.MCT-10-0539; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Cuendet M, 2004, CLIN CANCER RES, V10, P1170, DOI 10.1158/1078-0432.CCR-0362-3; Demain AL, 2011, MICROB BIOTECHNOL, V4, P687, DOI 10.1111/j.1751-7915.2010.00221.x; Gurel G, 2009, J MOL BIOL, V389, P146, DOI 10.1016/j.jmb.2009.04.005; Huang W, 2016, ONCOGENE, V35, P783, DOI 10.1038/onc.2015.215; Jung KH, 2017, CLIN CANCER RES, V23, P5537, DOI 10.1158/1078-0432.CCR-16-2253; Kohne CH, 2009, ONCOLOGIST, V14, P478, DOI 10.1634/theoncologist.2008-0202; Lam W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001270; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Li YZ, 2015, P NATL ACAD SCI USA, V112, P1839, DOI 10.1073/pnas.1424171112; LIAO LL, 1976, MOL PHARMACOL, V12, P167; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mata-Greenwood E, 2002, LEUKEMIA, V16, P2275, DOI 10.1038/sj.leu.2402696; Morikawa T, 2011, CLIN CANCER RES, V17, P1452, DOI 10.1158/1078-0432.CCR-10-2694; Oh SB, 2014, CANCER LETT, V353, P95, DOI 10.1016/j.canlet.2014.07.007; Sen M, 2012, CANCER DISCOV, V2, P694, DOI 10.1158/2159-8290.CD-12-0191; Vartanian S, 2016, MOL CELL PROTEOMICS, V15, P1220, DOI 10.1074/mcp.M115.055509; Vultur A, 2014, ONCOGENE, V33, P1850, DOI 10.1038/onc.2013.131; Wei N, 2015, ONCOTARGET, V6, P4745, DOI 10.18632/oncotarget.2938; Wei N, 2014, MOL CANCER THER, V13, P1130, DOI 10.1158/1535-7163.MCT-13-0880; WISEMAN CL, 1982, AM J CLIN ONCOL-CANC, V5, P389, DOI 10.1097/00000421-198208000-00007; Wu SY, 2015, ONCOTARGET, V6, P40866, DOI 10.18632/oncotarget.5885; Yan Z, 2017, CHIN J INTEGR MED, V23, P153, DOI 10.1007/s11655-016-2501-6; Yang JH, 2013, J ETHNOPHARMACOL, V147, P442, DOI 10.1016/j.jep.2013.03.034; Zhao CG, 2015, ONCOTARGET, V6, P14472, DOI 10.18632/oncotarget.3991; Zhao C, 2016, ONCOTARGET, V7, P12917, DOI 10.18632/oncotarget.7338; Zhao M, 2011, PHYTOTHER RES, V25, P1796, DOI 10.1002/ptr.3477; Zhou C, 2014, ONCOGENE, V33, P851, DOI 10.1038/onc.2013.16	33	42	42	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2019	38	10					1676	1687		10.1038/s41388-018-0547-y	http://dx.doi.org/10.1038/s41388-018-0547-y			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN8DD	30348989				2022-12-26	WOS:000460423800008
J	Hargrove, TY; Wawrzak, Z; Fisher, PM; Child, SA; Nes, WD; Guengerich, FP; Waterman, MR; Lepesheva, GI				Hargrove, Tatiana Y.; Wawrzak, Zdzislaw; Fisher, Paxtyn M.; Child, Stella A.; Nes, W. David; Guengerich, F. Peter; Waterman, Michael R.; Lepesheva, Galina I.			Binding of a physiological substrate causes large-scale conformational reorganization in cytochrome P450 51	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; conformational change; catalysis; X-ray crystallography; structure-function; drug target; druggability; sterol 14alpha-demethylase (CYP51); sterol biosynthesis; substrate binding	STEROL 14-ALPHA-DEMETHYLASE CYP51; STRUCTURAL-BASIS; CRYSTAL-STRUCTURES; TRYPANOSOMA-CRUZI; INHIBITION; P450; PREFERENCES; ACTIVATION; MECHANISMS; OXIDATION	Sterol 14-demethylases (CYP51s) are phylogenetically the most conserved cytochromes P450, and their three-step reaction is crucial for biosynthesis of sterols and serves as a leading target for clinical and agricultural antifungal agents. The structures of several (bacterial, protozoan, fungal, and human) CYP51 orthologs, in both the ligand-free and inhibitor-bound forms, have been determined and have revealed striking similarity at the secondary and tertiary structural levels, despite having low sequence identity. Moreover, in contrast to many of the substrate-promiscuous, drug-metabolizing P450s, CYP51 structures do not display substantial rearrangements in their backbones upon binding of various inhibitory ligands, essentially representing a snapshot of the ligand-free sterol 14-demethylase. Here, using the obtusifoliol-bound I105F variant of Trypanosoma cruzi CYP51, we report that formation of the catalytically competent complex with the physiological substrate triggers a large-scale conformational switch, dramatically reshaping the enzyme active site (3.5-6.0 movements in the FG arm, HI arm, and helix C) in the direction of catalysis. Notably, our X-ray structural analyses revealed that the substrate channel closes, the proton delivery route opens, and the topology and electrostatic potential of the proximal surface reorganize to favor interaction with the electron-donating flavoprotein partner, NADPH-cytochrome P450 reductase. Site-directed mutagenesis of the amino acid residues involved in these events revealed a key role of active-site salt bridges in contributing to the structural dynamics that accompanies CYP51 function. Comparative analysis of apo-CYP51 and its sterol-bound complex provided key conceptual insights into the molecular mechanisms of CYP51 catalysis, functional conservation, lineage-specific substrate complementarity, and druggability differences.	[Hargrove, Tatiana Y.; Child, Stella A.; Guengerich, F. Peter; Waterman, Michael R.; Lepesheva, Galina I.] Vanderbilt Univ, Sch Med, Dept Biochem, 622 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Life Sci Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL 60439 USA; [Fisher, Paxtyn M.; Nes, W. David] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Lepesheva, Galina I.] Vanderbilt Univ, Struct Biol Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Northwestern University; Texas Tech University System; Texas Tech University; Vanderbilt University	Lepesheva, GI (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 622 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	galina.i.lepesheva@vanderbilt.edu			National Institutes of Health [R33 AI119782, R01 GM067871]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI119782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM067871 (to G. I. L. and F. P. G.). Synthesis of obtusifoliol and eburicol was supported by National Institutes of Health Grant R33 AI119782 (to W. D. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Conner KP, 2014, BIOCHEMISTRY-US, V53, P1428, DOI 10.1021/bi401547j; Conner KP, 2011, ARCH BIOCHEM BIOPHYS, V507, P56, DOI 10.1016/j.abb.2010.10.006; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guengerich FP, 2007, J BIOCHEM MOL TOXIC, V21, P163, DOI 10.1002/jbt.20174; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hargrove TY, 2017, J BIOL CHEM, V292, P6728, DOI 10.1074/jbc.M117.778308; Hargrove TY, 2016, J LIPID RES, V57, P1552, DOI 10.1194/jlr.M069229; Hargrove TY, 2015, J BIOL CHEM, V290, P23916, DOI 10.1074/jbc.M115.677310; Hargrove TY, 2013, J BIOL CHEM, V288, P31602, DOI 10.1074/jbc.M113.497990; Hargrove TY, 2012, J LIPID RES, V53, P311, DOI 10.1194/jlr.M021865; Hargrove TY, 2011, J BIOL CHEM, V286, P26838, DOI 10.1074/jbc.M111.237099; Hiruma Y, 2013, J MOL BIOL, V425, P4353, DOI 10.1016/j.jmb.2013.07.006; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva GI, 2007, ARCH BIOCHEM BIOPHYS, V464, P221, DOI 10.1016/j.abb.2007.05.017; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva GI, 2018, PARASITOLOGY, V145, P1820, DOI 10.1017/S0031182018000562; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lockart MM, 2018, J INORG BIOCHEM, V183, P157, DOI 10.1016/j.jinorgbio.2018.02.021; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Mast N, 2011, J BIOL CHEM, V286, P5607, DOI 10.1074/jbc.M110.188433; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Sen K, 2009, J PHYS CHEM B, V113, P8170, DOI 10.1021/jp902932p; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Sevrioukova IF, 2017, P NATL ACAD SCI USA, V114, P486, DOI 10.1073/pnas.1616198114; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Vidakovic M, 1998, BIOCHEMISTRY-US, V37, P9211, DOI 10.1021/bi980189f; Yoshida Y, 2000, BIOCHEM BIOPH RES CO, V273, P799, DOI 10.1006/bbrc.2000.3030	37	13	13	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19344	19353		10.1074/jbc.RA118.005850	http://dx.doi.org/10.1074/jbc.RA118.005850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30327430	hybrid, Green Published			2022-12-26	WOS:000453537300016
J	Bulla, I; Spickanll, IH; Gromov, D; Romero-Severson, EO				Bulla, Ingo; Spickanll, Ian H.; Gromov, Dmitry; Romero-Severson, Ethan Obie			Sensitivity of joint contagiousness and susceptibility-based dynamic optimal control strategies for HIV prevention	PLOS ONE			English	Article							INFECTIOUS-DISEASES; COST-EFFECTIVENESS; CONTACT RATES; TRANSMISSION; MEN; SEX; COMBINATIONS; EPIDEMICS; MODELS; IMPACT	Predicting the population-level effects of an infectious disease intervention that incorporate multiple modes of intervention is complicated by the joint non-linear dynamics of both infection transmission and the intervention itself. In this paper, we consider the sensitivity of Dynamic Optimal Control Profiles (DOCPs) for the optimal joint investment in both a contagiousness and susceptibility-based control of HIV to bio-behavioral, economic, and programmatic assumptions. The DOCP is calculated using recently developed numerical algorithms that allow controls to be represented by a set of piecewise constant functions that maintain a constant yearly budget. Our transmission model assumes multiple stages of HIV infection corresponding to acute and chronic infection and both within- and between-individual behavioral heterogeneity. We parameterize a baseline scenario from a longitudinal study of sexual behavior in MSM and consider sensitivity of the DOCPs to deviations from that baseline scenario. In the baseline scenario, the primary determinant of the dominant control were programmatic factors, regardless of budget. In sensitivity analyses, the qualitative aspects of the optimal control policy were often robust to significant deviation in assumptions regarding transmission dynamics. In addition, we found several conditions in which long-term joint investment in both interventions was optimal. Our results suggest that modeling in the service of decision support for intervention design can improve population-level effects of a limited set of economic resources. We found that economic and programmatic factors were as important as the inherent transmission dynamics in determining population-level intervention effects. Given our finding that the DOCPs were robust to alternative biological and behavioral assumptions it may be possible to identify DOCPs even when the data are not sufficient to identify a transmission model.	[Bulla, Ingo] Ernst Moritz Arndt Univ Greifswald, Dept Math & Comp Sci, Greifswald, Germany; [Spickanll, Ian H.] Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA; [Gromov, Dmitry] St Petersburg State Univ, Fac Appl Math & Control Proc, St Petersburg, Russia; [Romero-Severson, Ethan Obie] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87544 USA	Ernst Moritz Arndt Universitat Greifswald; Centers for Disease Control & Prevention - USA; Saint Petersburg State University; United States Department of Energy (DOE); Los Alamos National Laboratory	Romero-Severson, EO (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87544 USA.	eoromero@lanl.gov	Gromov, Dmitry/M-3634-2015; Romero-Severson, Ethan Obie/ABB-1185-2021	Gromov, Dmitry/0000-0002-3009-0620; 	Centers for Disease Control and Prevention/OID/NCHHSTP/DSTDP, Department of Health and Human Services [17FED1710397];  [HIH R01AI087520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087520] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention/OID/NCHHSTP/DSTDP, Department of Health and Human Services; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in in part with Federal funds from the Centers for Disease Control and Prevention/OID/NCHHSTP/DSTDP, Department of Health and Human Services, under Interagency Agreement No. 17FED1710397. This project was also funded by HIH R01AI087520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, MATLAB OPT TOOLB REL; [Anonymous], 2014, PREEXP PROPH PREV HI; Aral SO, 2012, SEX TRANSM INFECT, V88, P157, DOI 10.1136/sextrans-2011-050389; Behncke H, 2000, OPTIM CONTR APPL MET, V21, P269, DOI 10.1002/oca.678; Bellan SE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001801; Biswas MHA, 2014, MATH BIOSCI ENG, V11, P761, DOI 10.3934/mbe.2014.11.761; Blanchard JF, 2011, SEX TRANSM INFECT, V87, P2, DOI 10.1136/sti.2010.047555; Blank S, 2005, SEX TRANSM DIS, V32, pS65, DOI 10.1097/01.olq.0000175401.37527.de; Brown VL, 2011, MATH BIOSCI, V231, P126, DOI 10.1016/j.mbs.2011.02.009; Castilho C., 2006, ELECTRON J DIFFERENT, V2006, P1; Centers for Disease Control and Prevention, 2008, MMWR-MORBID MORTAL W, V59, P1201; Clarke J, 2013, B MATH BIOL, V75, P1747, DOI 10.1007/s11538-013-9867-9; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Eaton JW, 2014, P NATL ACAD SCI USA, V111, P16202, DOI 10.1073/pnas.1323007111; Francis PJ, 2004, J ECON DYN CONTROL, V28, P2037, DOI 10.1016/j.jedc.2003.08.001; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Gromov D, 2018, MATH MED BIOL, V35, P469, DOI 10.1093/imammb/dqx015; Halloran ME, 2006, J BIOPHARM STAT, V16, P415, DOI 10.1080/10543400600719236; Hansen E, 2011, J MATH BIOL, V62, P423, DOI 10.1007/s00285-010-0341-0; Henry CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09467; Hutchinson AB, 2016, JAIDS-J ACQ IMM DEF, V71, P323, DOI 10.1097/QAI.0000000000000838; JACQUEZ JA, 1988, MATH BIOSCI, V92, P119, DOI 10.1016/0025-5564(88)90031-4; Janes HE, 2017, J INFECT DIS, V215, P1376, DOI 10.1093/infdis/jix086; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Laguzet L, 2015, MATH BIOSCI, V263, P180, DOI 10.1016/j.mbs.2015.03.002; Le Vu S, 2018, EPIDEMICS-NETH, V23, P1, DOI 10.1016/j.epidem.2017.10.001; Lenhart Neilan, 2010, DIMACS SER DISCRETE; Morton R., 1974, Advances in Applied Probability, V6, P622, DOI 10.2307/1426183; Pinkerton SD, 2008, AIDS BEHAV, V12, P677, DOI 10.1007/s10461-007-9329-1; Powers KA, 2014, P NATL ACAD SCI USA, V111, P15867, DOI 10.1073/pnas.1418496111; Romero-Severson EO, 2015, AM J EPIDEMIOL, V182, P255, DOI 10.1093/aje/kwv044; Romero-Severson EO, 2016, P NATL ACAD SCI USA, V113, P2690, DOI 10.1073/pnas.1522930113; Romero-Severson EO, 2013, EPIDEMIOLOGY, V24, P516, DOI 10.1097/EDE.0b013e318294802e; Rosenberg ES, 2014, LANCET HIV, V1, pE112, DOI 10.1016/S2352-3018(14)00011-3; Rowthorn RE, 2009, J R SOC INTERFACE, V6, P1135, DOI 10.1098/rsif.2008.0402; Selley F, 2015, SIAM J APPL DYN SYST, V14, P168, DOI 10.1137/130947039; Shattock AJ, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20627; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Zhang XD, 2012, DIE MOULD IND, V04, P44, DOI DOI 10.1515/1948-4690.1041; Zhou YG, 2013, MATH BIOSCI ENG, V10, P1691, DOI 10.3934/mbe.2013.10.1691	40	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0204741	10.1371/journal.pone.0204741	http://dx.doi.org/10.1371/journal.pone.0204741			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335855	Green Submitted, Green Published, gold			2022-12-26	WOS:000447701300012
J	Dickey, G; Preziosi, BM; Clark, CT; Bowden, TJ				Dickey, Grant; Preziosi, Brian M.; Clark, Charles T.; Bowden, Timothy J.			The impact of ocean acidification on the byssal threads of the blue mussel (Mytilus edulis)	PLOS ONE			English	Article							ATTACHMENT STRENGTH; MECHANICAL-PROPERTIES; FOOD AVAILABILITY; ADHESION; PLAQUE; MAINE	Blue mussel (Mytilus edulis) produce byssal threads to anchor themselves to the substrate. These threads are always exposed to the surrounding environmental conditions. Understanding how environmental pH affects these threads is crucial in understanding how climate change can affect mussels. This work examines three factors (load at failure, thread extensibility, and total thread counts) that indicate the performance of byssal threads as well as condition index to assess impacts on the physiological condition of mussels held in artificial seawater acidified by the addition of CO2. There was no significant variation between the control (similar to 786 mu atm CO2/similar to 7.98 pH/similar to 2805 mu mol kg(-1) total alkalinity) and acidified (similar to 2555 mu atm CO2/similar to 7.47 pH/similar to 2650 mu mol kg(-1) total alkalinity) treatment groups in any of these factors. The results of this study suggest that ocean acidification by CO2 addition has no significant effect on the quality and performance of threads produced by M. edulis.	[Dickey, Grant; Preziosi, Brian M.; Clark, Charles T.; Bowden, Timothy J.] Univ Maine, Sch Food & Agr, Aquaculture Res Inst, Hitchner Hall, Orono, ME 04469 USA	University of Maine System; University of Maine Orono	Preziosi, BM (corresponding author), Univ Maine, Sch Food & Agr, Aquaculture Res Inst, Hitchner Hall, Orono, ME 04469 USA.	brian.preziosi@maine.edu	Bowden, Tim/AAE-6582-2022	Bowden, Timothy/0000-0002-2295-1179	National Science Foundation EPSCoR award [1355457]; Maine Agricultural and Forest Experimental Station (MAFES); USDA National Institute of Food and Agriculture, Hatch through Maine Agricultural & Forest Experiment Station [ME0-21803]; USDA National Institute of Food and Agriculture, Hatch through Maine Agricultural and Forest Experiment Station [3625]	National Science Foundation EPSCoR award; Maine Agricultural and Forest Experimental Station (MAFES); USDA National Institute of Food and Agriculture, Hatch through Maine Agricultural & Forest Experiment Station; USDA National Institute of Food and Agriculture, Hatch through Maine Agricultural and Forest Experiment Station	This work was funded in part by the National Science Foundation EPSCoR award #1355457. Brian Preziosi was supported by the Maine Agricultural and Forest Experimental Station (MAFES). This project was supported by the USDA National Institute of Food and Agriculture, Hatch (or McIntire-Stennis, Animal Health, etc.) project number #ME0-21803 through the Maine Agricultural & Forest Experiment Station; Maine Agricultural and Forest Experiment Station Publication number 3625.	Babarro JMF, 2008, J MAR BIOL ASSOC UK, V88, P783, DOI 10.1017/S0025315408001367; Bayne B.L., 1976, MARINE MUSSELS THEIR; Bell EC, 1996, J EXP BIOL, V199, P1005; Bouhlel Z, 2017, J EXP BIOL, V220, P984, DOI 10.1242/jeb.141440; Brazee SL, 2006, BIOL BULL-US, V211, P263, DOI 10.2307/4134548; Bresnahan Philip J.  Jr., 2014, Methods in Oceanography, V9, P44, DOI 10.1016/j.mio.2014.08.003; Campbell AL, 2014, ENVIRON SCI TECHNOL, V48, P9745, DOI 10.1021/es502739m; DMR, 2017, MOST REC MAIN COMM L; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Edmond J. M., 1970, HIGH PRECISION DETER; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Filippidi E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0827; Gosling E., 2015, MARINE BIVALVE MOLLU, V2nd; Lachance AA, 2008, AQUAT BIOL, V2, P119, DOI 10.3354/ab00041; LEE CY, 1990, CAN J ZOOL, V68, P2005, DOI 10.1139/z90-282; Messerman NA, 2014, B EUR ASSOC FISH PAT, V34, P54; Moeser GM, 2006, J EXP BIOL, V209, P881, DOI 10.1242/jeb.02050; Moeser GM, 2006, J EXP BIOL, P209; Moreau V, 2005, J SHELLFISH RES, V24, P545; O'Donnell MJ, 2013, NAT CLIM CHANGE, V3, P587, DOI 10.1038/NCLIMATE1846; PRICE HA, 1981, J ZOOL, V194, P245, DOI 10.1111/j.1469-7998.1981.tb05771.x; Rawson PD, 1996, HEREDITY, V77, P599, DOI 10.1038/hdy.1996.187; Rawson PD, 2001, J SHELLFISH RES, V20, P31; Rodriguez NRM, 2015, BIOFOULING, V31, P221, DOI 10.1080/08927014.2015.1026337; Salisbury J., 2008, EOS T AM GEOPHYS UN, V89, P513, DOI [10.1029/2008EO500001, DOI 10.1029/2008EO500001]; TAMARIN A, 1976, J MORPHOL, V149, P199, DOI 10.1002/jmor.1051490205; THG GMRI, 2016, MAIN FARM SHELLF MAR; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Waite JH, 2017, J EXP BIOL, V220, P517, DOI 10.1242/jeb.134056; YOUNG GA, 1985, MAR ECOL PROG SER, V24, P261, DOI 10.3354/meps024261; Yu J, 2011, NAT CHEM BIOL, V7, P588, DOI [10.1038/NCHEMBIO.630, 10.1038/nchembio.630]; Zhao XG, 2017, MAR ECOL PROG SER, V565, P67, DOI 10.3354/meps11992	32	12	12	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205908	10.1371/journal.pone.0205908	http://dx.doi.org/10.1371/journal.pone.0205908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335823	gold, Green Published			2022-12-26	WOS:000447701300074
J	Hall, JA; Barrett, G; Copas, A; Phiri, T; Malata, A; Stephenson, J				Hall, Jennifer Anne; Barrett, Geraldine; Copas, Andrew; Phiri, Tambosi; Malata, Address; Stephenson, Judith			Reassessing pregnancy intention and its relation to maternal, perinatal and neonatal outcomes in a low-income setting: A cohort study	PLOS ONE			English	Article							UNINTENDED PREGNANCY; UNPLANNED PREGNANCY; MENTAL-DISORDERS; POSTNATAL DEPRESSION; UNITED-STATES; WOMEN; PREVALENCE; INTERVENTIONS; METAANALYSIS; POPULATION	Background It is unclear whether unintended pregnancies are associated with adverse outcomes. Data are predominantly from high-income countries and have methodological limitations, calling the findings into question. This research was designed to overcome these limitations and assess the relationships between pregnancy intention and miscarriage, stillbirth, low birthweight, neonatal death and postnatal depression in a low-income country. Methods The pregnancy intention of 4,244 pregnant women in Mchinji District, Malawi, was measured using the validated Chichewa version of the London Measure of Unplanned Pregnancy (LMUP). Women were re-interviewed postnatally to assess pregnancy outcome. Postnatal depression was assessed using the WHO's Self-Reporting Questionnaire. Multivariable regressions were conducted, with the choice of confounders informed by a preexisting conceptual epidemiological hierarchy. Results Planned pregnancies are associated with a reduced risk of any (adjusted RR 0.90 [95% CI 0.86, 0.95]) or high symptoms of depression (adjusted RR 0.76 [95% CI 0.63, 0.91]) compared to unplanned pregnancies in rural Malawi. There was no relationship between pregnancy intention and the composite measure of miscarriage, stillbirth, low birthweight and neonatal death. There was some evidence that greater pregnancy intention was associated with reduced adjusted risk of stillbirth (0.93 [95% CI 0.87, 1.00]). Conclusion Our study is the first to use a psychometrically valid measure of pregnancy intention, and to do so antenatally. As pregnancy intention increases, the risk of postnatal depression and, possibly, stillbirth decreases. This suggests a new, clinical use for the LMUP; identifying women antenatally who are at risk of these adverse pregnancy outcomes.	[Hall, Jennifer Anne; Barrett, Geraldine; Stephenson, Judith] UCL Inst Womens Hlth, Res Dept Reprod Hlth, London, England; [Copas, Andrew] UCL Inst Epidemiol & Hlth Care, Dept Infect & Populat Hlth, London, England; [Phiri, Tambosi] MaiMwana Project, Mchinji, Malawi; [Malata, Address] Malawi Univ Sci & Technol, Zomba, Malawi	University of London; University College London; University of London; University College London	Hall, JA (corresponding author), UCL Inst Womens Hlth, Res Dept Reprod Hlth, London, England.	jennifer.hall@ucl.ac.uk		Hall, Jennifer/0000-0002-2084-9568; Barrett, Geraldine/0000-0002-9738-1051; Copas, Andrew/0000-0001-8968-5963	Wellcome Trust [097268/Z/11/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by a three-year personal Research Training Fellowship from the Wellcome Trust (https://wellcome.ac.uk) to JAH, award number 097268/Z/11/Z. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dallal F. H., 2012, Eastern Mediterranean Health Journal, V18, P432; Assefa N, 2012, SEX REPROD HEALTHC, V3, P107, DOI 10.1016/j.srhc.2012.06.002; Bachrach CA, 1999, FAM PLANN PERSPECT, V31, P251, DOI 10.2307/2991577; Backhausen MG, 2014, EUR J CONTRACEP REPR, V19, P57, DOI 10.3109/13625187.2013.851183; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Barrett G, 2002, SOC SCI MED, V55, P545, DOI 10.1016/S0277-9536(01)00187-3; Bowie C., 2013, EPIDEMIOLOGY MATERNA; Cheney K, 2016, AUST NZ J OBSTET GYN, V56, P426, DOI 10.1111/ajo.12466; Chilale HK, UNPUB; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Flower A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-238; Fourn L, 1999, Sante, V9, P7; Hall J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-200; Hall JA, 2017, MATERN CHILD HLTH J, V21, P670, DOI 10.1007/s10995-016-2237-0; Hall JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165621; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Joyce T, 2002, DEMOGRAPHY, V39, P199, DOI 10.2307/3088371; Kokubu M, 2012, ARCH WOMEN MENT HLTH, V15, P211, DOI 10.1007/s00737-012-0279-x; Lakha F, 2006, LANCET, V368, P1782, DOI 10.1016/S0140-6736(06)69737-7; Lewycka S, 2010, REDUCING MATERNAL NE; Lindberg L, 2015, MATERN CHILD HLTH J, V19, P1087, DOI 10.1007/s10995-014-1609-6; Malawi DHS, 2004, MALAWI DEMOGRAPHIC H; Malawi DHS, 2010, MAL DEM HLTH SURV; Malawi NSO UNICEF, 2008, MAL MULT IND CLUST S; McCrory C, 2013, PAEDIATR PERINAT EP, V27, P208, DOI 10.1111/ppe.12027; Mercier RJ, 2013, BJOG-INT J OBSTET GY, V120, P1116, DOI 10.1111/1471-0528.12255; Mohllajee AP, 2007, OBSTET GYNECOL, V109, P678, DOI 10.1097/01.AOG.0000255666.78427.c5; Morof D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035381; Petersen R, 1997, WOMEN HEALTH ISS, V7, P234, DOI 10.1016/S1049-3867(97)00009-1; Polis CB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173639; Rabin RF, 2009, AM J PREV MED, V36, P439, DOI 10.1016/j.amepre.2009.01.024; Rahman A, 2013, B WORLD HEALTH ORGAN, V91, P593, DOI 10.2471/BLT.12.109819; Rassi A, 2013, AUST NZ J PUBL HEAL, V37, P568, DOI 10.1111/1753-6405.12098; Rocca CH, 2013, PERSPECT SEX REPRO H, V45, P122, DOI 10.1363/4512213; ROSENZWEIG MR, 1993, J HUM RESOUR, V28, P205, DOI 10.2307/146201; Roshanaei S, 2015, E MEDITERR HEALTH J, V21, P572, DOI 10.26719/2015.21.8.572; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1111/j.1931-2393.2003.tb00111.x; Santelli JS, 2009, STUD FAMILY PLANN, V40, P87, DOI 10.1111/j.1728-4465.2009.00192.x; Speizer IS, 2004, PERSPECT SEX REPRO H, V36, P198; Stanford J B, 2000, Matern Child Health J, V4, P183; Stewart RC, 2010, SOC PSYCH PSYCH EPID, V45, P551, DOI 10.1007/s00127-009-0094-5; Stewart RC, 2009, J AFFECT DISORDERS, V112, P126, DOI 10.1016/j.jad.2008.04.001; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; UNDP, 2017, HUMAN DEV REPORT; Borges ALV, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0087-7; Wado YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096304; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1	47	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205487	10.1371/journal.pone.0205487	http://dx.doi.org/10.1371/journal.pone.0205487			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4KR	30335769	Green Published, gold, Green Submitted			2022-12-26	WOS:000447701300035
J	Hummel, M; Talsma, EF; Van der Honing, A; Gama, AC; Van Vugt, D; Brouwer, ID; Spillane, C				Hummel, Marijke; Talsma, Elise F.; Van der Honing, Ati; Gama, Arthur Chibwana; Van Vugt, Daniel; Brouwer, Inge D.; Spillane, Charles			Sensory and cultural acceptability tradeoffs with nutritional content of biofortified orange-fleshed sweetpotato varieties among households with children in Malawi	PLOS ONE			English	Article							BETA-CAROTENE; CONSUMER ACCEPTABILITY; PLANNED BEHAVIOR; SCHOOL-CHILDREN; CONSUMPTION; ACCEPTANCE; ATTRIBUTES; INTENTION	Background Biofortified orange-fleshed sweetpotato (OFSP) varieties are being promoted to reduce vitamin A deficiencies due to their higher beta-carotene content. For OFSP varieties to have impact they need to be accepted and consumed at scale amongst populations suffering from vitamin A deficiencies. Objective We investigated the sensory and cultural acceptability of OFSP varieties amongst households with children aged between 2-5 years old in two areas in Central and Southern Malawi using an integrated model of the Theory of Planned Behavior (TPB) and the Health Belief Model (HBM). Methods Sensory acceptability was measured using a triangle, preference and acceptance test using three OFSP varieties and one control variety, among 270 adults and 60 children. Based on a food ethnographic study, a questionnaire on cultural acceptability was developed and administered to 302 caretakers. Data were analyzed by calculating Spearman's correlations between constructs and multiple linear regression modeling. Results The sensory evaluation indicates that all three OFSP varieties are accepted (scores > 3 on 5-point scale), but there is a preference for the control variety over the three OFSP varieties. Almost all caretakers are intending to frequently prepare OFSP for their child in future (97%). Based on regression analysis, the constructs 'subjective norms' (beta = 0.25, p = 0.00) reflecting social pressure, and 'attitudes toward behavior' (beta = 0.14 p = 0.01), reflecting the feelings towards serving their child OFSP, were the best predictors for caretakers' behavior to prepare OFSP for their child. Conclusions Our study shows that both sensory and cultural attributes can influence acceptability of varieties and consumption amongst households with children. Considering these attributes can improve the impact of biofortified crops in future programming, by reducing Vitamin A deficiencies through the intake of these nutrient-rich crops.	[Hummel, Marijke; Spillane, Charles] Natl Univ Ireland Galway, Ryan Inst, Plant & AgriBiosci Res Ctr PABC, Galway, Ireland; [Hummel, Marijke; Gama, Arthur Chibwana; Van Vugt, Daniel] Int Potato Ctr CIP, Lilongwe, Malawi; [Hummel, Marijke; Talsma, Elise F.; Brouwer, Inge D.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Talsma, Elise F.; Van der Honing, Ati] Int Ctr Trop Agr CIAT, Harvest Plus, Cali, Colombia; [Gama, Arthur Chibwana] Christian Aid Malawi, Lilongwe, Malawi	Ollscoil na Gaillimhe-University of Galway; CGIAR; International Potato Center (CIP); Wageningen University & Research; Alliance; International Center for Tropical Agriculture - CIAT	Spillane, C (corresponding author), Natl Univ Ireland Galway, Ryan Inst, Plant & AgriBiosci Res Ctr PABC, Galway, Ireland.	charles.spillane@nuigalway.ie	; Spillane, Charles/H-3786-2013	Hummel, Marijke/0000-0001-9853-6353; Chibwana, Arthur/0000-0002-2115-4151; Spillane, Charles/0000-0003-3318-323X	United States Agency for International Development under the Feed the Future Malawi Improved Seed Systems and Technologies project [AID-BFS-G-11-00002]; CropBioFort project - Irish Research Council's New Foundations programme; Science Foundation Ireland (SFI) [13/IA/1820]; Concern Worldwide; Ministry of Agriculture, Department of Agriculture Extension Services in Katuli and Mngwangwa	United States Agency for International Development under the Feed the Future Malawi Improved Seed Systems and Technologies project(United States Agency for International Development (USAID)); CropBioFort project - Irish Research Council's New Foundations programme; Science Foundation Ireland (SFI)(Science Foundation Ireland); Concern Worldwide; Ministry of Agriculture, Department of Agriculture Extension Services in Katuli and Mngwangwa	This work was supported by the United States Agency for International Development under the Feed the Future Malawi Improved Seed Systems and Technologies project [grant number AID-BFS-G-11-00002]. CS and MH acknowledge funding support from the CropBioFort project funded by the Irish Research Council's New Foundations programme. CS acknowledges support from Science Foundation Ireland (SFI) Grant No 13/IA/1820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all adults and children that were participating in this study. We would also like to thank the interviewers for their work in the field. Furthermore, we are very grateful for being hosted at the International Potato Center (CIP) in Malawi. We would also like to express our gratitude towards Concern Worldwide and the Ministry of Agriculture, Department of Agriculture Extension Services in Katuli and Mngwangwa for supporting us with conducting the research and mobilizing research participants.	Aberman N., 2015, MAPPING LINKAGES AGR; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2013, J APPL SOC PSYCHOL, V43, P155, DOI 10.1111/j.1559-1816.2012.00989.x; Anderson L, 2015, ROOT TUBER BANANA TE; [Anonymous], 2009, WHO GLOBAL DATABASE; [Anonymous], 1994, CROSS CULTURAL RES M; AOAC, 2005, OFFICIAL METHODS ANA; Berre D, 2017, FIELD CROP RES, V214, P113, DOI 10.1016/j.fcr.2017.08.026; Birol E, 2015, FOOD SECUR, V7, P555, DOI 10.1007/s12571-015-0464-7; Bouis HE, 2017, GLOB FOOD SECUR-AGR, V12, P49, DOI 10.1016/j.gfs.2017.01.009; Bouwkamp J.C., 1985, INTRODUCTION 1, P11; Bovell-Benjamin AC, 2007, ADV FOOD NUTR RES, V52, P1, DOI 10.1016/S1043-4526(06)52001-7; Burgos B., 2009, 15 TRIENN S INT SOC; CIP Sr, 2015, OR FLESH SWEETP VAR, P12; DenHartog AP, 2006, FOOD HABITS AND CONSUMPTION IN DEVELOPING COUNTRIES: MANUAL FOR FIELD STUDIES, P1, DOI 10.3920/978-90-8686-667-0; Department of Nutrition HaAitOoPaCD-O Ministry of Health (MOH), 2011, NAT MICR SURV 2009; Fanou-Fogny N, 2011, J NUTR EDUC BEHAV, V43, P219, DOI 10.1016/j.jneb.2010.03.008; Glanz K., 2008, HLTH BEHAV HLTH ED T; Guinard JX, 2000, TRENDS FOOD SCI TECH, V11, P273, DOI 10.1016/S0924-2244(01)00015-2; Hagenimana Vital, 2000, Food and Nutrition Bulletin, V21, P414; Hotz C, 2012, BRIT J NUTR, V108, P163, DOI 10.1017/S0007114511005174; ICF NSONMa, 2017, MAL DEM HLTH SURV 20; International Potato Center (CIP), 2015, OR FLESH SWEETP VAR; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Kempgen S, 2009, HANDB SPRACH KOMMUN, V1, P1; Lagerkvist CJ, 2016, FOOD QUAL PREFER, V52, P143, DOI 10.1016/j.foodqual.2016.04.009; Laurie SM, 2013, J SCI FOOD AGR, V93, P1610, DOI 10.1002/jsfa.5932; Lawless H. T., 2010, SENSORY EVALUATION F; Low JW, 2017, GLOBAL FOOD SECURITY, DOI [10. 1016/j. gfs. 2017. 01. 004, 10.1016/j.gfs.2017.01.004, DOI 10.1016/J.GFS.2017.01.004]; Macharia-Mutie CW, 2011, ECOL FOOD NUTR, V50, P375, DOI 10.1080/03670244.2011.604584; McGuire S, 2016, FOOD SECUR, V8, P179, DOI 10.1007/s12571-015-0528-8; Miller K, 2001, STUD FAMILY PLANN, V32, P161, DOI 10.1111/j.1728-4465.2001.00161.x; Mudege NN, 2017, FOOD SECUR, V9, P387, DOI 10.1007/s12571-017-0651-9; National Statistical Office (NSO) Community Health Services Unit (CHSU) [Malawi] Centers for Disease Control and Prevention (CDC) Emory University, 2017, MAL MICR SURV 2015 1; National Statistics Office, 2017, INT HOUS SURV 2016 2; Nejad LM, 2005, SENSORIA J MIND BRAI, V1, P63, DOI [DOI 10.7790/EJAP.V1I1.10, 10.7790/ejap.v1i1.10]; OLSON JA, 1989, J NUTR, V119, P105, DOI 10.1093/jn/119.1.105; Rah JH, 2004, J NUTR EDUC BEHAV, V36, P238, DOI 10.1016/S1499-4046(06)60386-2; RANDALL DM, 1994, BRIT J SOC PSYCHOL, V33, P405, DOI 10.1111/j.2044-8309.1994.tb01037.x; Services DoCCaM, 2018, CLIMATE MALAWI 2006; Skinner JD, 2002, J AM DIET ASSOC, V102, P1638, DOI 10.1016/S0002-8223(02)90349-4; Sulamoyo DS, 2012, CONT TREND ORGAN DEV, P1; Sun XY, 2006, J NUTR EDUC BEHAV, V38, P276, DOI [10.1016/j.jneb.2006.04.144, 10.1016/J.JNEB.2006.04.144]; TAKAHATA Y, 1993, JPN J BREED, V43, P421; Talsma EF, 2017, NUTR REV, V75, P798, DOI 10.1093/nutrit/nux037; Talsma EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073433; Tittonell P, 2013, FIELD CROP RES, V143, P76, DOI 10.1016/j.fcr.2012.10.007; Tomlins K, 2007, J SCI FOOD AGR, V87, P2436, DOI 10.1002/jsfa.2931; Tomlins K, 2012, FOOD CHEM, V131, P14, DOI 10.1016/j.foodchem.2011.07.072; van Jaarsveld PJ, 2005, AM J CLIN NUTR, V81, P1080; WHO, 2011, WHO GLOBAL DATABASE	51	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0204754	10.1371/journal.pone.0204754	http://dx.doi.org/10.1371/journal.pone.0204754			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335772	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300013
J	Lopez-Toledo, L; Perez-Decelis, A; Macedo-Santana, F; Cuevas, E; Endress, BA				Lopez-Toledo, Leonel; Perez-Decelis, Angeles; Macedo-Santana, Franceli; Cuevas, Eduardo; Endress, Bryan A.			Chronic leaf harvesting reduces reproductive success of a tropical dry forest palm in northern Mexico	PLOS ONE			English	Article							BRAHEA-ACULEATA; DEFOLIATION; GROWTH; MANAGEMENT; HERBIVORY; SONORA; SUSTAINABILITY; PERFORMANCE; ARECACEAE; RESPONSES	Palm leaves represent one of the most important non-timber forest products in tropical and subtropical regions. Brahea aculeata is an endemic palm of northwest Mexico, whose leaves are intensively exploited for roof thatch and handcrafts. As part of a long-term defoliation experiment, we evaluated the effects of different leaf harvest on foliar and reproductive traits of adults and attributes of their progeny. We conducted a six-year manipulative experiment and applied three harvesting treatments to adults: high harvest, low harvest and no harvest (control). We recorded leaf production and size, flower and fruit production, seed germination and seedling growth. We also explored trade-offs among foliar and reproductive traits. Harvested palms exhibited drastically reduced reproductive activity, producing fewer flowers and fruits (up to 80 and 90% fewer than unharvested palms). However, individuals in both harvest treatments had larger leaves and increased leaf production rates, compared to control palms. For harvested palms, we registered first a slight increase in leaf traits and a decline in reproductive attributes. These traits showed a gradual reduction and for six period attained very low proportional values compared to control palms (similar to 0.10), however individuals in the harvested treatments maintained the greatest leaf lengths and leaf production rates. Seed germination and seedling growth rates of progeny from harvested palms were significantly lower than control palms, with seeds from the high harvest treatment having the lowest seed production and germination rates. Relationships among leaf (size/production) and reproductive traits (flower/fruit production) were positive during the fourth year, but showed negative relationships for the fifth year suggesting a trade-off between reproduction and growth functions. Leaf harvesting in B. aculeata seems to alter patterns of resource allocation away from reproduction as reflected in a decrease in the probability of reproduction, seed number, germination, and vigor, causing a strong decrease in the reproductive success of this species. Results showed that the consequences of long-term leaf harvest not only affect harvested individuals, but also the fitness and vigor of progeny. This type of long-term studies is essential to understand the population dynamics of non-timber forest products and helps inform sustainable harvesting programs considering intensity, frequencies and periods for recovery from defoliation. Also results may help to explain how intensive and non-planned management schemes may negatively affect vital rates and long-term dynamics of populations from non-timber forest products and other components of the ecosystem.	[Lopez-Toledo, Leonel; Perez-Decelis, Angeles; Macedo-Santana, Franceli] Univ Michoacana, Inst Invest Recursos Nat, Morelia, Michoacan, Mexico; [Cuevas, Eduardo] Univ Michoacana, Fac Biol, Morelia, Michoacan, Mexico; [Endress, Bryan A.] Oregon State Univ, Eastern Oregon Agr & Nat Resource Program, La Grande, OR USA	Universidad Michoacana de San Nicolas de Hidalgo; Universidad Michoacana de San Nicolas de Hidalgo; Oregon State University	Lopez-Toledo, L (corresponding author), Univ Michoacana, Inst Invest Recursos Nat, Morelia, Michoacan, Mexico.	llopezt@umich.mx	Lopez-Toledo, Leonel/GZL-4224-2022; Lopez-Toledo, Leonel/AAS-5239-2021	Lopez-Toledo, Leonel/0000-0003-3424-5746	Research Program 2017 Coordinacion de la Investigacion Cientifica of Universidad Michoacana de San Nicolas de Hidalgo [CIC-3249981]; Lakeside Foundation; San Diego Zoo Global Posdoctoral Program; CONACYT at Programa de Maestria en Ecologia Integrativa [574137, 352452]	Research Program 2017 Coordinacion de la Investigacion Cientifica of Universidad Michoacana de San Nicolas de Hidalgo; Lakeside Foundation; San Diego Zoo Global Posdoctoral Program; CONACYT at Programa de Maestria en Ecologia Integrativa	This study was supported by the Research Program 2017 Coordinacion de la Investigacion Cientifica of Universidad Michoacana de San Nicolas de Hidalgo (CIC-3249981), the Lakeside Foundation and the San Diego Zoo Global Posdoctoral Program. APD and FMS thank the Master grant from CONACYT at Programa de Maestria en Ecologia Integrativa (Scholarship number 574137 and 352452, respectively).	Ackerly DD, 2000, BIOSCIENCE, V50, P979, DOI 10.1641/0006-3568(2000)050[0979:TEOPET]2.0.CO;2; Agrawal AA, 2001, AM NAT, V157, P555, DOI 10.1086/319932; Aikens ML, 2015, AM J BOT, V102, P1901, DOI 10.3732/ajb.1500198; ANDERSON AB, 1995, CONSERV BIOL, V9, P47, DOI 10.1046/j.1523-1739.1995.09010047.x; Anten NPR, 2003, ECOLOGY, V84, P2905, DOI 10.1890/02-0454; Anten NPR, 2001, FUNCT ECOL, V15, P804, DOI 10.1046/j.0269-8463.2001.00582.x; Anten NPR, 2001, FUNCT ECOL, V15, P252, DOI 10.1046/j.1365-2435.2001.00517.x; BALICK MJ, 1992, CONSERV BIOL, V6, P128, DOI 10.1046/j.1523-1739.1992.610128.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bazzaz FA, 2000, SEEDS ECOLOGY REGENE; Bazzaz Fakhri A., 1997, P1, DOI 10.1016/B978-012083490-7/50002-5; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; BOWERS MD, 1993, ECOLOGY, V74, P1778, DOI 10.2307/1939936; Coronel-Ortega M, 2010, SISTEMAS BIOCOGNITIV; Crawley M.J., 2007, R BOOK; Crawley MJ, 1983, HERBIVORY DYNAMICS P; Cunningham A. B., 2001, Applied ethnobotany: people, wild plant use and conservation; Cunningham E, 1997, TRENDS ECOL EVOL, V12, P337, DOI 10.1016/S0169-5347(97)01160-9; Endress BA, 2004, ECOL APPL, V14, P1139, DOI 10.1890/02-5365; Endress BA, 2006, FOREST ECOL MANAG, V234, P181, DOI 10.1016/j.foreco.2006.07.020; Felger RS, 1999, PALMS ARECACEAE SONO, V18, P1; Felger RS, 2001, TREES OF SONORA; Galecki A, 2013, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4614-3900-4; Gurevitch J., 2002, ECOLOGY PLANTS; Haro JME, 2010, DIVERSIDAD AMENAZAS; HENDERSON A, 1995, FIELD GUIDE PALMS AM; Hernandez-Barrios JC, 2015, J APPL ECOL, V52, P389, DOI 10.1111/1365-2664.12384; Joyal E, 1996, ECON BOT, V50, P429, DOI 10.1007/BF02866526; Kuznetsova A, 2016, PACKAGE LMERTEST TES; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; LEHTILA K, 1995, FUNCT ECOL, V9, P511, DOI 10.2307/2390017; Liu F, 2009, PLANT SYST EVOL, V277, P61, DOI 10.1007/s00606-008-0103-2; Lopez-Toledo L, 2011, FOREST ECOL MANAG, V261, P1901, DOI 10.1016/j.foreco.2011.02.013; Lopez-Toledo L, 2015, BOT SCI, V93, P461, DOI 10.17129/botsci.58; Lopez-Toledo L, 2013, PLANT ECOL, V214, P1115, DOI 10.1007/s11258-013-0235-5; Lopez-Toledo L, 2012, J ECOL, V100, P1245, DOI 10.1111/j.1365-2745.2012.01992.x; Macedo-Santana F., 2015, THESIS; Mandle L, 2012, J ECOL, V100, P997, DOI 10.1111/j.1365-2745.2012.01982.x; MARQUIS RJ, 1992, ECOLOGY, V73, P143, DOI 10.2307/1938727; Martinez-Balleste A, 2008, FOREST ECOL MANAG, V256, P1320, DOI 10.1016/j.foreco.2008.06.029; Martinez-Balleste A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120666; Martinez-Camilo R, 2011, AGROCIENCIA-MEXICO, V45, P507; Martinez-Ramos M, 2009, J ECOL, V97, P1050, DOI 10.1111/j.1365-2745.2009.01531.x; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; MENDOZA A, 1987, J ECOL, V75, P545, DOI 10.2307/2260433; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; OYAMA K, 1990, BIOTROPICA, V22, P119, DOI 10.2307/2388403; Pamponet TC, 2013, EXP AGR, V49, P435, DOI 10.1017/S0014479713000148; Pfab MF, 1999, PLANT ECOL, V145, P317, DOI 10.1023/A:1009869011237; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pulido MT, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-1; Quero H., 2000, INFORME FINAL PROYEC, DOI [10.15468/wd3toj, DOI 10.15468/WD3TOJ]; Quero HJ, 2014, IUCN RED LIST THREAT; QUESADA M, 1995, ECOLOGY, V76, P437, DOI 10.2307/1941202; R Core Team, 2021, R LANGUAGE ENV STAT; Ratsirarson J, 1996, CONSERV BIOL, V10, P40, DOI 10.1046/j.1523-1739.1996.10010040.x; Reekie E, 2015, REPROD ALLOCATION PL; SAGERS CL, 1995, ECOLOGY, V76, P1835, DOI 10.2307/1940715; Secretaria de Medio Ambiente Recursos Naturales (SEMARNAT). Norma Oficial Mexicana-059-ECOL-2010, 2010, NORM OF MEX 059 ECOL; Shackleton CM, 2015, ECOLOGICAL SUSTAINAB; Staffan Karlsson P, 2005, REPROD ALLOCATION PL; Ticktin T, 2004, J APPL ECOL, V41, P11, DOI 10.1111/j.1365-2664.2004.00859.x; van Lent J, 2014, J ECOL, V102, P709, DOI 10.1111/1365-2745.12216; Zuidema PA, 2007, ECOL APPL, V17, P118, DOI 10.1890/1051-0761(2007)017[0118:TSBPAR]2.0.CO;2	64	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205178	10.1371/journal.pone.0205178	http://dx.doi.org/10.1371/journal.pone.0205178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335793	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300023
J	Bilal, HM; Aziz, T; Maqsood, MA; Farooq, M; Yan, GJ				Bilal, Hafiz Muhammad; Aziz, Tariq; Maqsood, Muhammad Aamer; Farooq, Muhammad; Yan, Guijun			Categorization of wheat genotypes for phosphorus efficiency	PLOS ONE			English	Article							BRASSICA CULTIVARS; ACQUISITION; PLANTS; BREAD; TOLERANCE; NITROGEN; ROOTS; YIELD	Production of phosphorus efficient crop cultivars can increase food productivity and decrease environmental pollution. Categorization of existing germplasm is a prerequisite to develop P efficient crop cultivars. For first experiment, 30 wheat genotypes were grown in hydroponics with two P levels (i.e., deficit, 20 pm KH2PO4 and adequate, 200 pm KH2PO4). Genotypes differed significantly for various P efficiency parameters. Two genotypes (Dirk and Bhakkar-02) showed < 25% decrease in growth at P deficiency. Genotype Seher-06 proved to be inefficient. Twelve selected genotypes based on the first experiment were sown in soil with two P levels (0 and 30 mg P kg(-1)) till maturity. As expected, genotypes differed for grain yield at both P levels. The efficient cultivars selected on the basis of both absolute and relative dry matter production at both P levels such as Dirk. Genotypes were grouped into three, four and nine classes on the basis of various parameters for P efficiency as proposed by different researchers. Most genotypes behaved in a similar fashion by different categorization methods and also at different P supply. The method to categorize the genotypes into three classes and plotting them into 9 classes proposed by Gill and his coworkers, is the best to differentiate the minor differences in genotypes. At least three different parameters at both P regimes should be used. The parameters may vary as per objectives of the study and/or growth conditions.	[Bilal, Hafiz Muhammad; Aziz, Tariq; Maqsood, Muhammad Aamer] Univ Agr Faisalabad, Inst Soil & Environm Sci, Faisalabad, Pakistan; [Bilal, Hafiz Muhammad; Aziz, Tariq; Farooq, Muhammad; Yan, Guijun] Univ Western Australia, UWA Sch Agr & Environm, Perth, WA, Australia; [Farooq, Muhammad] Univ Agr Faisalabad, Dept Agron, Faisalabad, Pakistan; [Farooq, Muhammad] Sultan Qaboos Univ, Dept Crop Sci, Coll Agr & Marine Sci, Al Khoud, Oman	University of Agriculture Faisalabad; University of Western Australia; University of Agriculture Faisalabad; Sultan Qaboos University	Bilal, HM (corresponding author), Univ Agr Faisalabad, Inst Soil & Environm Sci, Faisalabad, Pakistan.; Bilal, HM (corresponding author), Univ Western Australia, UWA Sch Agr & Environm, Perth, WA, Australia.	hbilal11@gmail.com	Aziz, Tariq/AAN-8927-2020; Maqsood, Muhammad/AAT-9731-2020; Farooq, Muhammad/F-1617-2010; Yan, Guijun/A-9809-2011	Aziz, Tariq/0000-0002-4300-3813; Farooq, Muhammad/0000-0003-4368-9357; Yan, Guijun/0000-0001-9628-1211; Muhammad Bilal, Hafiz/0000-0002-3102-684X				Alam S.M., 2003, PAKISTAN J SOIL SCI, V22, P72; [Anonymous], 2016, EUR J AGRON, V76, P95, DOI [10.1016/J.EJA.2016.02.003, DOI 10.1016/J.EJA.2016.02.003]; [Anonymous], 2006, STAT METHODS APPL; Aziz T, 2015, PLANT CELL ENVIRON, V38, P790, DOI 10.1111/pce.12450; Aziz T, 2014, PLANT CELL ENVIRON, V37, P943, DOI 10.1111/pce.12210; Aziz T, 2011, J PLANT NUTR, V34, P2006, DOI 10.1080/01904167.2011.610487; Aziz T, 2011, J PLANT NUTR, V34, P522, DOI 10.1080/01904167.2011.538114; Bates TR, 2001, PLANT SOIL, V236, P243, DOI 10.1023/A:1012791706800; BATTEN GD, 1984, EUPHYTICA, V33, P81, DOI 10.1007/BF00022753; Biabanaki Farzaneh Sadate, 2009, Archives of Agronomy and Soil Science, V55, P91, DOI 10.1080/03650340802350618; Blackshaw RE, 2004, WEED SCI, V52, P406, DOI 10.1614/WS-03-122R; Buckley C, 2015, NUTR CYCL AGROECOSYS, V102, P319, DOI 10.1007/s10705-015-9702-9; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Delgado A, 2008, J PLANT NUTR SOIL SC, V171, P552, DOI 10.1002/jpln.200625052; Fageria NK, 1993, SCREENING CROP GENOT; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Ghaffar S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174349; Gill HS., 2004, ARCH AGRON SOIL SCI, V50, P563, DOI DOI 10.1080/03650340410001729708; GILL KS, 1991, GENOME, V34, P362, DOI 10.1139/g91-058; Gunes A, 2006, SOIL SCI PLANT NUTR, V52, P470, DOI 10.1111/j.1747-0765.2006.00068.x; Hinsinger P, 2011, PLANT SOIL, V348, P29, DOI 10.1007/s11104-011-0903-y; Jones J. B. Jr., 1990, Soil testing and plant analysis., P389; Kang MS, 1998, ADV AGRON, V62, P199; Kosar H. S., 2003, Pakistan Journal of Agricultural Sciences, V40, P28; Lambers H, 2006, ANN BOT-LONDON, V98, P693, DOI 10.1093/aob/mcl114; Lambers H, 2012, ANN BOT-LONDON, V110, P329, DOI 10.1093/aob/mcs130; Lynch JP, 2001, PLANT SOIL, V237, P225, DOI 10.1023/A:1013324727040; Ma JF, 2000, PLANT CELL PHYSIOL, V41, P383, DOI 10.1093/pcp/41.4.383; Ma QF, 2011, CROP PASTURE SCI, V62, P467, DOI 10.1071/CP10386; Manske GGB, 2000, PLANT SOIL, V221, P189, DOI 10.1023/A:1004727201568; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; Nelson D., 1983, PUBLICATION AM SOC A, P539, DOI 10.2134/agronmonogr9.2.2-d.c29; OHALLORAN IP, 1993, CAN J SOIL SCI, V73, P359, DOI 10.4141/cjss93-038; Ortiz-Monasterio JI, 2002, P 5 INT TRIT S JUN 3, P1; Osborne LD, 2002, AUST J AGR RES, V53, P295, DOI 10.1071/AR01080; Ozturk L, 2005, PLANT SOIL, V269, P69, DOI 10.1007/s11104-004-0469-z; Plaxton WC, 1999, PLANT RESPONSES ENV, P491; Rahim A, 2010, SOIL ENVRON, V29, P15; RAHMATULLAH, 1994, ARID SOIL RES REHAB, V8, P227, DOI 10.1080/15324989409381397; Rashid A., 2005, SOIL SCI; Sandana P, 2016, EUR J AGRON, V76, P95, DOI 10.1016/j.eja.2016.02.003; Shane MW, 2006, PLANT CELL ENVIRON, V29, P1989, DOI 10.1111/j.1365-3040.2006.01574.x; Tariq Aziz, 2005, Pakistan Journal of Agricultural Sciences, V42, P8; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Wang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135160; WATANABE F. S., 1965, SOIL SCI SOC AMER PROC, V29, P677	46	27	29	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205471	10.1371/journal.pone.0205471	http://dx.doi.org/10.1371/journal.pone.0205471			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332479	Green Published, Green Submitted, gold			2022-12-26	WOS:000447638200055
J	Dionne, A; Le, CK; Poupart, S; Autmizguine, J; Meloche-Dumas, L; Turgeon, J; Fournier, A; Dahdah, N				Dionne, Audrey; Le, Cathie-Kim; Poupart, Steffany; Autmizguine, Julie; Meloche-Dumas, Leamarie; Turgeon, Jean; Fournier, Anne; Dahdah, Nagib			Profile of resistance to IVIG treatment in patients with Kawasaki disease and concomitant infection	PLOS ONE			English	Article							CORONARY-ARTERY ABNORMALITIES; GAMMA-GLOBULIN TREATMENT; STEROID PULSE THERAPY; INTRAVENOUS IMMUNOGLOBULIN; VIRAL-INFECTIONS; INFLAMMASOME ACTIVATION; CHILDREN; MANAGEMENT; DIAGNOSIS	Introduction Kawasaki disease (KD) can be associated with concomitant viral or bacterial infections. Children with persistent or recurrent fever 36 hours after the end of intravenous immunoglobulin (IVIG) are considered to be resistant to treatment and are at increased risk for coronary complications. Although concomitant infection does not affect coronary outcome, it is unknown how it influences the response to IVIG treatment. Methodology Retrospective cohort study between 2008 and 2016 in a tertiary pediatric university hospital, including 154 children, of which 59 (38%) had concomitant infection. Results Children with concomitant infection were more likely to have fever 48 hours after initial IVIG treatment (36% vs 20%, p = 0.05) and to be treated with a second dose (33% vs 18%, p = 0.04). Children with infection had higher C-reactive protein at the time of diagnosis (148 vs 112 mg/L, p = 0.04), and 48 hours after IVIG administration (111 vs 59 mg/L, p = 0.003). Nevertheless, there was no statistically significant difference in the prevalence of coronary complications (Z-score > 2.5) between children with and without concomitant infection (36% vs 39%, p = 0.68). Conclusion Children with KD and concomitant infection are more likely to have persistent fever and elevated inflammatory markers after treatment. This association increases the likelihood of receiving a second dose of IVIG but not the risk of coronary complication. Accordingly,prospective studies to distinguish true IVIG resistance from infection induced persistent fever is warranted.	[Dionne, Audrey; Le, Cathie-Kim; Poupart, Steffany; Meloche-Dumas, Leamarie; Fournier, Anne; Dahdah, Nagib] CHU Ste Justine, Dept Cardiol, Montreal, PQ, Canada; [Dionne, Audrey] Harvard Med Sch, Boston Childrens Hosp, Dept Cardiol, Dept Pediat, Boston, MA USA; [Le, Cathie-Kim] CHU Laval, Dept Pediat, Quebec City, PQ, Canada; [Autmizguine, Julie] Univ Montreal, Dept Pharmacol, Montreal, PQ, Canada; [Autmizguine, Julie] CHU Ste Justine, Res Ctr, Montreal, PQ, Canada; [Autmizguine, Julie; Turgeon, Jean] CHU Ste Justine, Dept Pediat, Montreal, PQ, Canada	Universite de Montreal; Harvard University; Boston Children's Hospital; Harvard Medical School; Laval University; Universite de Montreal; Universite de Montreal; Universite de Montreal	Dahdah, N (corresponding author), CHU Ste Justine, Dept Cardiol, Montreal, PQ, Canada.	nagth.dahdah.hsj@ssss.gouv.qc.ca		Dahdah, Nagib/0000-0001-7715-3169				Alphonse MP, 2016, J IMMUNOL, V197, P3481, DOI 10.4049/jimmunol.1600388; Benseler SM, 2005, PEDIATRICS, V116, pE760, DOI 10.1542/peds.2005-0559; Burns JC, 2008, J PEDIATR-US, V153, P833, DOI 10.1016/j.jpeds.2008.06.011; Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009; Chang LY, 2014, J FORMOS MED ASSOC, V113, P148, DOI 10.1016/j.jfma.2013.12.008; Chen SJ, 2016, JAMA PEDIATR, V170, P1156, DOI 10.1001/jamapediatrics.2016.2055; Cohen P, 2014, J CELL SCI, V127, P2383, DOI 10.1242/jcs.149831; Dallaire F, 2011, J AM SOC ECHOCARDIOG, V24, P60, DOI 10.1016/j.echo.2010.10.004; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; Downie ML, 2016, J PEDIATR-US, V179, P124, DOI 10.1016/j.jpeds.2016.08.060; Furukawa T, 2008, ARCH DIS CHILD, V93, P142, DOI 10.1136/adc.2007.126144; Guillaume MP, 2018, CARDIOL YOUNG, V28, P739, DOI 10.1017/S1047951117002864; Huang XJ, 2015, REV SOC BRAS MED TRO, V48, P243, DOI 10.1590/0037-8682-0091-2015; Jordan-Villegas A, 2010, PEDIATR INFECT DIS J, V29, P770, DOI 10.1097/INF.0b013e3181dba70b; Kim GB, 2014, KOREAN CIRC J, V44, P250, DOI 10.4070/kcj.2014.44.4.250; Kim Ja Hye, 2012, Korean J Pediatr, V55, P470, DOI 10.3345/kjp.2012.55.12.470; Kim T, 2007, EUR J PEDIATR, V166, P421, DOI 10.1007/s00431-006-0251-8; Lee Y, 2015, ARTERIOSCL THROM VAS, V35, P2605, DOI 10.1161/ATVBAHA.115.306475; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Phuong L, 2018, PEDIATR DRUGS, V20, P59, DOI 10.1007/s40272-017-0269-6; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Son MB, 2011, J PEDIATR-US, V158, P644, DOI 10.1016/j.jpeds.2010.10.012; Suzuki H, 2011, PEDIATR INFECT DIS J, V30, P871, DOI 10.1097/INF.0b013e318220c3cf; Teraguchi M, 2013, PEDIATR CARDIOL, V34, P959, DOI 10.1007/s00246-012-0589-9; Tremoulet AH, 2016, CONTEMP CLIN TRIALS, V48, P70, DOI 10.1016/j.cct.2016.04.002; Turnier JL, 2015, PEDIATRICS, V136, pE609, DOI 10.1542/peds.2015-0950; Wallace CA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e78	28	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0206001	10.1371/journal.pone.0206001	http://dx.doi.org/10.1371/journal.pone.0206001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332473	Green Submitted, Green Published, gold			2022-12-26	WOS:000447638200081
J	Biswal, DK; Roychowdhury, T; Pandey, P; Tandon, V				Biswal, Devendra Kumar; Roychowdhury, Tanmoy; Pandey, Priyatama; Tandon, Veena			De novo genome and transcriptome analyses provide insights into the biology of the trematode human parasite Fasciolopsis buski	PLOS ONE			English	Article							PROTEIN-KINASES; INTESTINAL FLUKES; HEMOGLOBIN; ANNOTATION; MODEL; PRAZIQUANTEL; EXPLORATION; MYOGLOBINS; REGIONS; GENE	Many trematode parasites cause infection in humans and are thought to be a major public health problem. Their ecological diversity in different regions provides challenging questions on evolution of these organisms. In this report, we perform transcriptome analysis of the giant intestinal fluke, Fasciolopsis buski, using next generation sequencing technology. Short read sequences derived from polyA containing RNA of this organism were assembled into 30,677 unigenes that led to the annotation of 12,380 genes. Annotation of the assembled transcripts enabled insight into processes and pathways in the intestinal fluke, such as RNAi pathway and energy metabolism. The expressed kinome of the organism was characterized by identifying all protein kinases. A rough draft genome assembly for Fasciolopsis buski is also reported herewith with SRA accessions for crosschecking the findings in the analyzed transcriptome data. Transcriptome data also helped us to identify some of the expressed transposable elements. Though many Long Interspersed elements (LINEs) were identified, only two Short Interspersed Elements (SINEs) were visible. Overall transcriptome and draft genome analysis of F. buski helped us to characterize some of its important biological characteristics and provided enormous resources for development of a suitable diagnostic system and anti-parasitic therapeutic molecules.	[Biswal, Devendra Kumar] North Eastern Hill Univ, Bioinformat Ctr, Shillong, Meghalaya, India; [Roychowdhury, Tanmoy; Pandey, Priyatama] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi, India; [Tandon, Veena] North Eastern Hill Univ, Dept Zool, Shillong, Meghalaya, India; [Roychowdhury, Tanmoy] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Pandey, Priyatama] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Tandon, Veena] Biotech Pk, Lucknow, Uttar Pradesh, India	North Eastern Hill University; Jawaharlal Nehru University, New Delhi; North Eastern Hill University; Mayo Clinic; University of Southern California	Tandon, V (corresponding author), North Eastern Hill Univ, Dept Zool, Shillong, Meghalaya, India.; Tandon, V (corresponding author), Biotech Pk, Lucknow, Uttar Pradesh, India.	tandonveena@gmail.com	Roychowdhury, Tanmoy/AAZ-7889-2021	Biswal, Devendra/0000-0003-1093-7166; Tandon, Veena/0000-0003-4315-2082	Department of Biotechnology, Government of India [BT/48/NE/TBP/2010]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The work was supported by the Department of Biotechnology, Government of India under the DBT-NER Twinning program BT/48/NE/TBP/2010 dated March 14, 2011, sanctioned to VT, AB and DKB. (http://www.dbtindia.nic.in/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida GT, 2012, EXP PARASITOL, V132, P22, DOI 10.1016/j.exppara.2011.06.010; Andrade LF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-215; [Anonymous], 1995, B WORLD HEALTH ORGAN, V73, P397; Barrett J., 1981, BIOCH PARASITIC HELM; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bhatti H S, 2000, Indian J Pathol Microbiol, V43, P73; Bishnupada Roy, 2003, International handbook of foodborne pathogens, P563; Biswal DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157459; Biswal DK, 2013, PEERJ, V1, DOI 10.7717/peerj.207; Brindley PJ, 2003, TRENDS PARASITOL, V19, P79, DOI 10.1016/S1471-4922(02)00061-2; BUNNAG D, 1983, Southeast Asian Journal of Tropical Medicine and Public Health, V14, P216; Cantacessi C, 2012, MOL CELL PROTEOMICS, V11, P1340, DOI 10.1074/mcp.M112.019844; CDC, 2009, DPDX FASC; Chai JY, 2009, KOREAN J PARASITOL, V47, pS69, DOI 10.3347/kjp.2009.47.S.S69; Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Dalton JP, 2006, PARASITIC FLATWORMS: MOLECULAR BIOLOGY, BIOCHEMISTRY, IMMUNOLOGY AND PHYSIOLOGY, P348, DOI 10.1079/9780851990279.0348; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Datta S., 2004, Indian Journal of Animal Health, V43, P53; de Guzman JV, 2007, J PARASITOL, V93, P97, DOI 10.1645/GE-846R3.1; Eisenmann DM, 2005, WNT SIGNALING WORMBO; Elsworth B, 2011, INT J PARASITOL, V41, P881, DOI 10.1016/j.ijpara.2011.03.009; Finnegan DJ, 2012, CURR BIOL, V22, pR432, DOI 10.1016/j.cub.2012.04.025; FISHELSON Z, 1995, MEM I OSWALDO CRUZ, V90, P289, DOI 10.1590/S0074-02761995000200029; Garg G, 2013, J PROTEOMICS, V89, P202, DOI 10.1016/j.jprot.2013.06.017; Garg G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S8; GOLDBERG DE, 1995, BIOESSAYS, V17, P177, DOI 10.1002/bies.950170213; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gupta A, 1999, INDIAN J PATHOL MICR, V42, P59; HANDOYO I, 1986, Tropical Biomedicine, V3, P113; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HARINASUTA T, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1214; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Horn M, 2011, ACS CHEM BIOL, V6, P609, DOI 10.1021/cb100411v; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jilkova A, 2011, J BIOL CHEM, V286, P35770, DOI 10.1074/jbc.M111.271304; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le TH, 2004, T ROY SOC TROP MED H, V98, P193, DOI 10.1016/S0035-9203(03)00022-1; Lee H H, 1986, Gaoxiong Yi Xue Ke Xue Za Zhi, V2, P21; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; Matveev V, 2007, MOL BIOL EVOL, V24, P1656, DOI 10.1093/molbev/msm083; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Melamed P, 2004, NAT GENET, V36, P786, DOI 10.1038/ng0804-786; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Minning DM, 1999, NATURE, V401, P497, DOI 10.1038/46822; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Molehin AJ, 2012, PARASITOLOGY, V139, P681, DOI 10.1017/S0031182011002435; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Muralidhar S, 2000, Indian J Pathol Microbiol, V43, P69; Nakagawa K., 1992, J PARASITOL, V8, P161; NEWPORT GR, 1988, J BIOL CHEM, V263, P13179; Nie HM, 2013, PARASITOL RES, V112, P1833, DOI 10.1007/s00436-013-3328-0; Pandey V, NEXT GENERATION GENO; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Prasad PK, 2007, PARASITOL RES, V101, P1581, DOI 10.1007/s00436-007-0680-y; Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455; Rashid AK, 1999, EUR J BIOCHEM, V260, P717, DOI 10.1046/j.1432-1327.1999.00194.x; Rashid AK, 1997, J BIOL CHEM, V272, P2992, DOI 10.1074/jbc.272.5.3000; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Robertson AP, 2012, PARASITIC HELMINTHS, P233; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roy B., 1993, Acta Parasitologica, V38, P72; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smit A, 1996, REPEATMASKER OPEN 30; Tandon V, 2012, MOL DETECTION HUMAN, P353; TARASCHEWSKI H, 1986, ZBL BAKT-INT J MED M, V262, P542; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Waeschenbach A, 2012, MOL PHYLOGENET EVOL, V63, P834, DOI 10.1016/j.ympev.2012.02.020; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wheat CW, 2011, METHODS MOL BIOL, V772, P129, DOI 10.1007/978-1-61779-228-1_7; World Health Organization (WHO), 1995, WHO TECHN REP SER, V849, P1; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Young ND, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001004; Young ND, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000719; Young ND, 2010, BIOTECHNOL ADV, V28, P222, DOI 10.1016/j.biotechadv.2009.12.003; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	88	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205570	10.1371/journal.pone.0205570	http://dx.doi.org/10.1371/journal.pone.0205570			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325945	Green Published, gold, Green Submitted			2022-12-26	WOS:000447430800025
J	Li, YR; Zhao, LY; Yu, DM; Ding, GQ				Li, Yaru; Zhao, Liyun; Yu, Dongmei; Ding, Gangqiang			The prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly populations in China	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; LIPOPROTEINS; CHOLESTEROL; PREVENTION; MELLITUS; GLUCOSE; ALCOHOL; LIPIDS	Objectives This study aimed to examine the prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly Chinese populations. Methods The 2010-2012 China National Nutrition and Health Survey (CNNHS) is a nationally representative cross-sectional study. In the present study, a total of 69,974 participants aged. 45 years were included. Dyslipidemia was defined based on the Chinese adult dyslipidemia prevention guide. A multivariable logistic regression model was performed to examine the associations between risk factors and dyslipidemia. Results The prevalence of dyslipidemia was 39.9%, 46.8%, and 59.3% in participants with normal glucose, prediabetes, and type 2 diabetes mellitus (T2DM). Women had a lower dyslipidemia prevalence than men (38.7% vs. 43.3%). Dyslipidemia prevalence was positively associated with the education level and inversely correlated with the physical activity level, and negatively related to age only among prediabetes and T2DM groups (P for trend < 0.05). Obesity, abdominal obesity, and hypertension were associated with dyslipidemia. Conclusions The prevalence of dyslipidemia was relatively high among middle-aged and elderly T2DM person. There are different associations between multiple risk factors and dyslipidemia in different diabetic progression stages.	[Li, Yaru; Zhao, Liyun; Yu, Dongmei; Ding, Gangqiang] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Ding, GQ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China.	gangqiangding@163.com	ding, gangqiang/AHD-5012-2022		Special Fund for Health-scientific Research in the Public Interest [20120212]	Special Fund for Health-scientific Research in the Public Interest	This research was supported by the Special Fund for Health-scientific Research in the Public Interest (No. 20120212).	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Chen W, 2017, CHIN CIRCUL J, P521; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Gu DF, 2005, CIRCULATION, V112, P658, DOI 10.1161/CIRCULATIONAHA.104.515072; Haffner Steven M, 2004, Diabetes Care, V27 Suppl 1, pS68; Hannuksela ML, 2002, CRIT REV CL LAB SCI, V39, P225, DOI 10.1080/10408360290795529; Hirakawa Y, 2017, J EPIDEMIOL, V27, P123, DOI 10.1016/j.je.2016.04.001; Khavandi M, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0818-1; Li YR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199293; Martin SS, 2013, J AM COLL CARDIOL, V62, P732, DOI 10.1016/j.jacc.2013.01.079; Mooradian AD, 2003, ARCH INTERN MED, V163, P33, DOI 10.1001/archinte.163.1.33; Organization World Health, 2006, DEF DIAGN DIAB MELL; Pagidipati NJ, 2016, JAMA CARDIOL, V1, P145, DOI 10.1001/jamacardio.2016.0183; Pan L, 2016, ATHEROSCLEROSIS, V248, P2, DOI 10.1016/j.atherosclerosis.2016.02.006; Qi L, 2015, INT J ENV RES PUB HE, V12, P13455, DOI 10.3390/ijerph121013455; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Slagter SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096406; STEVENSON JC, 1993, ATHEROSCLEROSIS, V98, P83, DOI 10.1016/0021-9150(93)90225-J; Sun GZ, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-189; Taskinen MR, 2015, ATHEROSCLEROSIS, V239, P483, DOI 10.1016/j.atherosclerosis.2015.01.039; Trumbo P, 2002, J AM DIET ASSOC, V102, P1621, DOI 10.1016/S0002-8223(02)90346-9; Wakabayashi I, 2014, ALCOHOL CLIN EXP RES, V38, P1689, DOI 10.1111/acer.12425; Wang LM, 2017, JAMA-J AM MED ASSOC, V317, P2515, DOI 10.1001/jama.2017.7596; Wang SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017326; Yan L, 2016, J CLIN LIPIDOL, V10, P150, DOI 10.1016/j.jacl.2015.10.009; Yang Z, 2013, EXP CLIN ENDOCR DIAB, V121, P372, DOI 10.1055/s-0033-1341520; Zhao WH, 2007, BIOMED ENVIRON SCI, V20, P329	30	20	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205709	10.1371/journal.pone.0205709	http://dx.doi.org/10.1371/journal.pone.0205709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325950	gold, Green Published, Green Submitted			2022-12-26	WOS:000447430800034
J	Lincoln, NK; McCoy, MD; Ladefoged, TN				Lincoln, Noa Kekuewa; McCoy, Mark D.; Ladefoged, Thegn N.			Stable carbon and nitrogen isotopes in kukui (Aleurites moluccanus) endocarp along rainfall and elevation gradients: Archaeological implications	PLOS ONE			English	Article							DIET; DELTA-C-13; CLIMATE; RECONSTRUCTION; PATTERNS; HOLOCENE; C-13	Stable carbon and nitrogen isotopes are often used to make inferences of past environments and social patterns. We analyze delta C-13 and delta N-15 values in contemporary kukui (Aleurites moluccanus) endocarp to examine the effects of site environment. Results from across environmental transects on Hawai'i Island show strong patterns for both stable isotopes. For delta C-13 a robust linear relationship with elevation is exhibited, strengthened by the inclusion of rainfall. This relationship breaks down at a minimum threshold of annual rainfall, possible relating to physiological responses to drought. For delta N-15, the only significant relationship observed pertains to substrate age. The endocarp from kukui is one of the most readily identified plant remains in the Pacific archaeological records and is often targeted for radiocarbon dating. We discuss the potential implications of our results regarding ancient climate, inferred diets, and habitat composition.	[Lincoln, Noa Kekuewa] Univ Hawaii, Dept Trop Plants & Soil Sci, Honolulu, HI 96822 USA; [McCoy, Mark D.] Southern Methodist Univ, Dept Anthropol, Dallas, TX USA; [Ladefoged, Thegn N.] Univ Auckland, Anthropol, Auckland, New Zealand; [Ladefoged, Thegn N.] Te Punaha Matatini, New Zealand Ctr Res Excellence, Auckland, New Zealand	University of Hawaii System; Southern Methodist University; University of Auckland	Lincoln, NK (corresponding author), Univ Hawaii, Dept Trop Plants & Soil Sci, Honolulu, HI 96822 USA.	nlincoln@hawaii.edu		Lincoln, Noa/0000-0003-1070-4290	University of Auckland Faculty Research Development Fund; Southern Methodist University Research Council; Tropical Plant and Soil Sciences department of the University of Hawai'i	University of Auckland Faculty Research Development Fund; Southern Methodist University Research Council; Tropical Plant and Soil Sciences department of the University of Hawai'i	We would like to thank Mara Mulrooney for help in the field, Patrick Kirch for his thoughts and insights, Jillian Swift for her thorough and helpful reviews, and the other reviewers of the paper. We appreciate the editor, Sian Halcrow, who handled this paper in an efficient manner. This research was partially funded by a grant from the University of Auckland Faculty Research Development Fund, the Southern Methodist University Research Council grant, and the Tropical Plant and Soil Sciences department of the University of Hawai'i.	BARNOLA JM, 1987, NATURE, V329, P408, DOI 10.1038/329408a0; Beard BL, 2000, J FORENSIC SCI, V45, P1049; Bocherens H, 2004, CAN J ZOOL, V82, P576, DOI 10.1139/Z04-017; Bocherens H., 2003, INT J, DOI [10.1002/oa.662/full, DOI 10.1002/OA.662/FULL]; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Cernusak LA, 2013, NEW PHYTOL, V200, P950, DOI 10.1111/nph.12423; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1985, GEOCHIM COSMOCHIM AC, V49, P97, DOI 10.1016/0016-7037(85)90194-2; Drake BL, 2012, J ARCHAEOL SCI, V39, P2888, DOI 10.1016/j.jas.2012.04.027; Fox-Dobbs K, 2007, CAN J ZOOL, V85, P458, DOI 10.1139/Z07-018; Friend A. D., 1989, FUNCTIONAL ECOLOGY, P117; Giambelluca T. W., 2014, EVAPOTRANSPIRA UNPUB; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; GOODFRIEND GA, 1990, QUATERNARY RES, V34, P186, DOI 10.1016/0033-5894(90)90030-O; Handley LL, 1999, AUST J PLANT PHYSIOL, V26, P185, DOI 10.1071/PP98146; HAYES JM, 1990, ORG GEOCHEM, V16, P1115, DOI 10.1016/0146-6380(90)90147-R; Keeling CD, 1979, ENVIRON INT, V2, P229, DOI [10.1016/0160-4120(79)90005-9, DOI 10.1016/0160-4120(79)90005-9]; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Ladefoged TN, 2009, J ARCHAEOL SCI, V36, P2374, DOI 10.1016/j.jas.2009.06.030; Lincoln N., 2017, INDIGENOUS POLYNESIA, DOI [10.1093/acrefore/9780199389414.001.0001/acrefore-9780199389414-e-376, DOI 10.1093/ACREFORE/9780199389414.001.0001/ACREFORE-9780199389414-E-376]; Lincoln N, 2014, J ARCHAEOL SCI, V49, P192, DOI 10.1016/j.jas.2014.05.008; Lincoln N, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00328.1; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Nitsch E.K., 2015, SCI TECHNOL ARCHAEOL, V1, P1, DOI [10.1179/2054892315Y.0000000001, DOI 10.1179/2054892315Y.0000000001]; Riehl S, 2014, P NATL ACAD SCI USA, V111, P12348, DOI 10.1073/pnas.1409516111; Roberts P, 2013, J QUATERNARY SCI, V28, P360, DOI 10.1002/jqs.2624; Scheidegger Y, 2000, OECOLOGIA, V125, P350, DOI 10.1007/s004420000466; Schoeninger Margaret J., 1995, Evolutionary Anthropology, V4, P83, DOI 10.1002/evan.1360040305; Schubert O., 2014, AGU FALL M; Stewart BW, 1998, GEODERMA, V82, P173, DOI 10.1016/S0016-7061(97)00101-8; Swift J. A., 2018, P NATL ACAD SCI USA; Vitousek P., 2018, COMMUNICATION; Vitousek Peter M., 1995, Pacific Science, V49, P2; Vitousek PM, 2004, SCIENCE, V304, P1665, DOI 10.1126/science.1099619; VITOUSEK PM, 1989, OECOLOGIA, V78, P383, DOI 10.1007/BF00379113; VITOUSEK PM, 1990, OECOLOGIA, V84, P362, DOI 10.1007/BF00329760; von Sperber C, 2017, ECOLOGY, V98, P1117, DOI 10.1002/ecy.1751; WHITE CD, 1989, J ARCHAEOL SCI, V16, P451, DOI 10.1016/0305-4403(89)90068-X	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0204654	10.1371/journal.pone.0204654	http://dx.doi.org/10.1371/journal.pone.0204654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0VS	30325930	Green Published, Green Submitted, gold			2022-12-26	WOS:000447430800010
J	Sumabat, LG; Kemerait, RC; Kim, DK; Mehta, YR; Brewer, MT				Sumabat, Leilani G.; Kemerait, Robert C., Jr.; Kim, Dong Kyun; Mehta, Yeshwant R.; Brewer, Marin T.			Clonality and geographic structure of host-specialized populations of Corynespora cassiicola causing emerging target spot epidemics in the southeastern United States	PLOS ONE			English	Article							STEM BLIGHT FUNGI; PATHOGENIC FUNGUS; CHESTNUT BLIGHT; DIVERSITY; EVOLUTION; GENE; RECOMBINATION; SEQUENCES; BACTERIA; DISTANCE	Corynespora cassiicola is a destructive plant-pathogenic fungus causing widespread target spot epidemics, including outbreaks on cotton, soybean, and tomato in the southeastern United States. Previous studies revealed that populations from the three hosts are genetically distinct and host specialized. Although variation in aggressiveness to cotton and tomato were observed, no genetic diversity was detected within populations sampled from each of these hosts. We aimed to gain a better understanding of the emerging target spot epidemics by developing microsatellite markers for C. cassiicola to assess genetic variation, population structure, and to infer modes of reproduction and mechanisms of dispersal. Two hundred sixty-five isolates from cotton, soybean, tomato, and other host plants were genotyped with 13 microsatellite markers. Genotypic diversity revealed genetic variation within each of the populations collected from different hosts, with the population from cotton dominated by clonal genotypes and showing the least genetic diversity. In addition, C. cassiicola populations on different host species were genetically distinct and structured based on host species. No association between genetic and geographic distances was identified in the tomato populations, and the association in cotton populations was low. However, significant regional geographic structure was detected in the soybean populations of C. cassiicola. These results further support previous findings of introduced host specialized isolates or the evolution of more aggressive strains on each host. The lack of geographic structure suggests that the clones on cotton and tomato spread rapidly, or similar founder populations were established by human-mediated dispersal, and that dispersal is not limited. However, regional geographic structure of populations on soybean suggests limited dispersal among more established populations of C. cassiicola, or genetic differences in founder populations that colonized different geographic areas.	[Sumabat, Leilani G.; Kim, Dong Kyun; Brewer, Marin T.] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; [Kemerait, Robert C., Jr.] Univ Georgia, Dept Plant Pathol, Tifton, GA 31793 USA; [Mehta, Yeshwant R.] Inst Agron Parana IAPAR, Londrina, Brazil	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Instituto Agronomico de Campinas (IAC)	Brewer, MT (corresponding author), Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA.	mtbrewer@uga.edu			Cotton Incorporated [14-280]	Cotton Incorporated(Cotton R&D Corp)	This study was funded by Cotton Incorporated contract 14-280 to M.T.B. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAGNOSTAKIS SL, 1987, MYCOLOGIA, V79, P23, DOI 10.2307/3807741; Atallah ZK, 2010, FUNGAL GENET BIOL, V47, P416, DOI 10.1016/j.fgb.2010.02.003; Bennett D., 2016, WHATS KNOWN TARGET S; Brewer MT, 2015, PHYTOPATHOLOGY, V105, P815, DOI 10.1094/PHYTO-10-14-0282-R; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Butler S, 2016, PLANT DIS, V100, P535, DOI 10.1094/PDIS-07-15-0785-PDN; Campbell H. L., 2012, CORYNESPORA LEAF SPO, P18; Carbone I, 1999, EVOLUTION, V53, P11, DOI [10.1111/j.1558-5646.1999.tb05329.x, 10.2307/2640916]; Croll D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002608; Deon M, 2014, FUNGAL BIOL-UK, V118, P32, DOI 10.1016/j.funbio.2013.10.011; Dixon LJ, 2009, PHYTOPATHOLOGY, V99, P1015, DOI 10.1094/PHYTO-99-9-1015; Edmisten, 2012, TARGET LEAF SPOT FOU; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Faske T., 2016, TARGET SPOT WHAT DO; Fournier E, 2008, J EVOLUTION BIOL, V21, P122, DOI 10.1111/j.1420-9101.2007.01462.x; Frenkel O, 2012, PLANT PATHOL, V61, P106, DOI 10.1111/j.1365-3059.2011.02502.x; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Fry WE, 2013, PLANT DIS, V97, P296, DOI 10.1094/PDIS-08-12-0791-FE; Fulmer AM, 2012, PLANT DIS, V96, P1066, DOI 10.1094/PDIS-01-12-0035-PDN; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Galbieri R., 2014, American Journal of Plant Sciences, V5, P3805; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Goodwin SB, 1997, PHYTOPATHOLOGY, V87, P992, DOI 10.1094/PHYTO.1997.87.10.992; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; KINGSLAND GC, 1986, TROP PEST MANAGE, V32, P283; Koenning SR, 2006, PLANT DIS, V90, P974, DOI 10.1094/PD-90-0974C; Lee S.B., 1988, FUNGAL GENET REP, V35, P23, DOI [10.4148/1941-4765.1531, DOI 10.4148/1941-4765.1531]; Leroy T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-64; Li HX, 2016, PHYTOPATHOLOGY, V106, P900, DOI 10.1094/PHYTO-01-16-0006-R; LITT M, 1989, AM J HUM GENET, V44, P397; Lopez D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00276; MANTEL N, 1967, CANCER RES, V27, P209; Martin DP, 2011, MOL ECOL RESOUR, V11, P943, DOI 10.1111/j.1755-0998.2011.03026.x; Mayer C, 2006, PHOBOS 3 3 11; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; McDonald BA, 2016, PHYTOPATHOLOGY, V106, P948, DOI 10.1094/PHYTO-03-16-0131-RVW; Mehl H. L., 2013, APPL RES FIELD CROP; Milgroom MG, 2003, PLANT DIS, V87, P608, DOI 10.1094/PDIS.2003.87.6.608; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; Milgroom MG, 2008, MOL ECOL, V17, P4446, DOI 10.1111/j.1365-294X.2008.03927.x; Milgroom MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106740; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Price P.P., 2015, PLANT HLTH PROG, V16, P223, DOI [10.1094/PHP-BR-15-0036, DOI 10.1094/PHP-BR-15-0036]; Prospero S, 2009, PHYTOPATHOLOGY, V99, P739, DOI 10.1094/PHYTO-99-6-0739; Prussin AJ, 2014, PLANT DIS, V98, P504, DOI 10.1094/PDIS-06-13-0664-RE; Rafiei V, 2018, PLANT PATHOL, V67, P76, DOI 10.1111/ppa.12713; Robin C, 2017, MOL ECOL, V26, P1952, DOI 10.1111/mec.14039; Schlub RL, 2009, OVERVIEW TARGET SPOT, DOI [10.17660/ActaHortic.2009.808.1, DOI 10.17660/ACTAHORTIC.2009.808.1]; Schoch CL, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.64.01; Schoebel CN, 2013, J EVOLUTION BIOL, V26, P600, DOI 10.1111/jeb.12077; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Silva WPK, 2003, MYCOL RES, V107, P567, DOI 10.1017/S0953756203007755; Silva WPK, 1998, PLANT PATHOL, V47, P267, DOI 10.1046/j.1365-3059.1998.00245.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Sousa A, 2017, MOL BIOL EVOL, V34, P2879, DOI 10.1093/molbev/msx221; Stenberg P, 2003, MOL ECOL NOTES, V3, P329, DOI 10.1046/j.1471-8286.2003.00408.x; Sumabat LG, 2018, PHYTOPATHOLOGY, V108, P892, DOI 10.1094/PHYTO-12-17-0407-R; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wright S, 1943, GENETICS, V28, P114	65	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205849	10.1371/journal.pone.0205849	http://dx.doi.org/10.1371/journal.pone.0205849			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321244	Green Published, gold, Green Submitted			2022-12-26	WOS:000447417900059
J	Zajaczkowski, MA; Gajic, A; Kaczynska, A; Zajaczkowski, S; Kobiela, J; Kaminski, R; Kosinski, A				Zajaczkowski, Milosz Andrzej; Gajic, Andrej; Kaczynska, Agata; Zajaczkowski, Stanislaw; Kobiela, Jaroslaw; Kaminski, Rafal; Kosinski, Adam			Individual variability of vascularization of the anterior papillary muscle within the right ventricle of human heart	PLOS ONE			English	Article							RIGHT CORONARY-ARTERY; MYOCARDIAL-INFARCTION; COLLATERAL CIRCULATION; MODERATOR BAND; RUPTURE; PATTERN; PATHOPHYSIOLOGY; ANGIOGENESIS; SECONDARY; OCCLUSION	Background To date there is scarce published evidence reporting the dual blood supply reaching anterior papillary muscle (APM), which descends from both major coronary arteries. Such a vascular configuration can prevent the dysfunction of right ventricular entire valvular system in case of the occlusion of proximal part of either right coronary artery (RCA) or left coronary artery (LCA). The aim of our study was to determine the vascular pattern of APM blood supply which originates from two main coronary arteries, in the context of the APM and septomarginal trabecula (SMT) topography. Methods The study was carried out using tissue obtained from 36 human hearts. The material was divided into four morphological types of SMT/APM arrangement. Vascularization and blood supply pattern of papillary muscle was investigated following the analysis of multiple tissue cross sections. The origin of APM arterial supply was traced back to both main coronary arteries. Cross-sectional area of the arteries was estimated at the base of APM and compared within mixed male-female population, aged 18-76. Results We noted that as much as 78% of entire APM material had a blood supply vasculature originating from both LCA and RCA branches. In contrast, 22% of cases APM was supplied by a single coronary artery, while in each case it proved to be LCA. We have never found APM arterial supply provided exclusively by RCA. In case of double AMP blood supply an average of total cross-section area of the arteries branching from LCA, was noted to be in excess of two and a half times bigger in type III and more than two times bigger in type IV, as compared with the arteries originating from RCA. Conclusions Our research confirm the possibility of double blood supply which vascularizes APM, but the finding does not necessarily apply in all cases. However, APM seems to be predominantly vascularized by arteries deriving from LCA, regardless of their morphological type.	[Zajaczkowski, Milosz Andrzej; Kaczynska, Agata; Kaminski, Rafal; Kosinski, Adam] Med Univ Gdansk, Dept Clin Anat, Gdansk, Poland; [Gajic, Andrej] Univ Sarajevo, Dept Pathol, Fac Vet Med, Sarajevo, Bosnia & Herceg; [Zajaczkowski, Stanislaw] Med Univ Gdansk, Dept Physiol, Gdansk, Poland; [Kobiela, Jaroslaw] Med Univ Gdansk, Dept Gen Endocrine & Transplant Surg, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; University of Sarajevo; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Zajaczkowski, MA (corresponding author), Med Univ Gdansk, Dept Clin Anat, Gdansk, Poland.	milosz.zajaczkowski@gumed.edu.pl	Kosiński, Adam/N-6300-2018	Kosiński, Adam/0000-0001-7507-2285; Grzybiak, Marek/0000-0002-3119-160X; Gajic, Andrej/0000-0001-5138-9368; Zajaczkowski, Stanislaw/0000-0002-9872-7368	National Science Center [ST-02-0088/07/212]	National Science Center(National Science Centre, Poland)	The study was supported by National Science Center, ST-02-0088/07/212 (http://www.nauka.gov.pl/en/) to AK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDY GH, 1979, AM J CARDIOL, V44, P1401, DOI 10.1016/0002-9149(79)90460-0; Carroll R, 2003, ANGIOLOGY, V54, P119, DOI 10.1177/000331970305400116; CLEMENTS SD, 1985, CLIN CARDIOL, V8, P93, DOI 10.1002/clc.4960080206; Dabrowski Wojciech, 2011, Anestezjol Intens Ter, V43, P239; Dobyns BM, 1936, ANAT REC, V66, P397, DOI 10.1002/ar.1090660403; FARRERBROWN G, 1968, BRIT HEART J, V30, P527; FARRERBROWN G, 1968, BRIT HEART J, V30, P679; Fiore A, 2018, EUR J CARDIO-THORAC, V53, P874, DOI 10.1093/ejcts/ezx351; Fulton WFM, 1963, SCOTT MED J, V8; GEFT IL, 1984, AM J CARDIOL, V53, P991, DOI 10.1016/0002-9149(84)90623-4; Goldstein JA, 2002, J AM COLL CARDIOL, V40, P841, DOI 10.1016/S0735-1097(02)02048-X; Gouda P, 2017, ECHOCARDIOGR-J CARD, V34, P786, DOI 10.1111/echo.13498; Gross L, 1933, AM HEART J, V9, P165, DOI 10.1016/S0002-8703(33)90712-7; Gross L., 1921, BLOOD SUPPLY HEART I; HILTON T, 1990, AM HEART J, V119, P1410, DOI 10.1016/S0002-8703(05)80194-2; JAHNKE EJ, 1967, ARCH SURG-CHICAGO, V95, P880; KINCH JW, 1994, NEW ENGL J MED, V330, P1211, DOI 10.1056/NEJM199404283301707; Kosinski A, 2010, ARCH MED SCI, V6, P733, DOI 10.5114/aoms.2010.17089; LEVIN DC, 1974, CIRCULATION, V50, P831, DOI 10.1161/01.CIR.50.4.831; Meoli DF, 2004, J CLIN INVEST, V113, P1684, DOI 10.1172/JCI200420352; NISHIMURA RA, 1983, AM J CARDIOL, V51, P373, DOI 10.1016/S0002-9149(83)80067-8; Ondrus T, 2013, EXP CLIN CARDIOL, V18, P27; Paulin S., 1983, CORONARY ARTERIOGRAP, P257; Reig J, 2000, CLIN ANAT, V13, P244, DOI 10.1002/1098-2353(2000)13:4<244::AID-CA3>3.3.CO;2-8; Risau W, 1998, CIRC RES, V82, P926; SETARO J F, 1992, Cardiology Clinics, V10, P69; TOPAZ O, 1992, AM HEART J, V124, P810, DOI 10.1016/0002-8703(92)90304-E; Tracz W, ECHOKARDIOGRAFIA PRA; Van Der Bolt CLB, 1996, ISOLATED ACUTE OCCLU, P247; VOCI P, 1995, CIRCULATION, V91, P1714, DOI 10.1161/01.CIR.91.6.1714; Von Ludinghausen M, 2003, EUR J ANAT, V7, P101; Zajaczkowski M, 2018, ADV CLIN EXP MED, V27, P623, DOI 10.17219/acem/68692	32	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205786	10.1371/journal.pone.0205786	http://dx.doi.org/10.1371/journal.pone.0205786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321241	Green Published, Green Submitted, gold			2022-12-26	WOS:000447417900052
J	Kim, JS; Kim, DS; Lee, KC; Lee, JS; King, GM; Kang, S				Kim, Jong-Shik; Kim, Dae-Shin; Lee, Keun Chul; Lee, Jung-Sook; King, Gary M.; Kang, Sanghoon			Microbial community structure and functional potential of lava-formed Gotjawal soils in Jeju, Korea	PLOS ONE			English	Article							SP NOV.; ESCHERICHIA-COLI; GENE; POLYPHOSPHATE; SEQUENCE	The Gotjawal areas of Jeju Island, Korea, are comprised of unmanaged forests growing on volcanic soils. They support unique assemblages of vascular plants from both northern and southern hemispheres, but are threatened by human disturbance. The health and ecosystem function of these assemblages likely depends in part on the diversity and community structure of soil microbial communities, about which little is known. To assess the diversity of Gotjawal soil microbial communities, twenty samples were collected in November 2010 from 4 representatives of Gotjawal forests. While soil properties and microbial communities measured by 16S rRNA gene sequence data were marginally distinct among sites by PER-MANOVA (p = 0.017-0.191), GeoChip data showed significant differences among sites (p < 0.006). Gene composition overall, and the composition of 3 functional gene categories had similar structures themselves and similar associations with environmental factors. Among these communities, phosphorous cycling genes exhibited the most distinct patterns. 16S rRNA gene sequence data resulted in a mean 777 operational taxonomic units (OTUs), which included the following major phyla: Proteobacteria (27.9%), Actinobacteria (17.7%), Verrucomicrobia (14.3%), Acidobacteria (9.6%), Planctomycetes (9.8%), Bacteroidetes (8.9%), and Chloroflexi (2.2%). Indicator species analysis (ISA) was used to determine the taxa with high indicator value, which represented the following: uncultured Chlamydiaceae, Caulobacter, uncultured Sinobacteraceae, Paenibacillus, Arenimonas, Clostridium sensu. stricto, uncultured Burkholderiales incertae sedis, and Nocardioides in Aewol (AW), Aquicella, uncultured Planctomycetia, and Aciditerrimonas in Gujwa-Seongsan (GS), uncultured Acidobacteria Gp1, and Hamadaea in Hankyeong-Andeok (HA), and Bosea, Haliea, and Telmatocola in Jocheon-Hamdeok (JH) Gotjawal. Collectively, these results demonstrated the uniqueness of microbial communities within each Gotjawal region, likely reflecting different patterns of soil, plant assemblages and microclimates.	[Kim, Jong-Shik] Gyeongbuk Inst Marine Bioind, Uljin, South Korea; [Kim, Dae-Shin] World Heritage & Mt Hallasan Res Inst, Jeju, Jeju Special Se, South Korea; [Lee, Keun Chul; Lee, Jung-Sook] Korea Res Inst Biosci & Biotechnol, Korean Collect Type Cultures, Jeongup, South Korea; [King, Gary M.] Louisiana State Univ, Biol Sci, Baton Rouge, LA 70803 USA; [Kang, Sanghoon] Baylor Univ, Dept Biol, Waco, TX 76798 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Louisiana State University System; Louisiana State University; Baylor University	Kim, JS (corresponding author), Gyeongbuk Inst Marine Bioind, Uljin, South Korea.; Kang, S (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.	soilmicrobiome@gmail.com; sanghoon_kang@baylor.edu		Kim, Jong-Shik/0000-0002-8181-1707				Ahlgren IF, 1974, FIRE AND ECOSYSTEM; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; AKIYAMA M, 1992, J BIOL CHEM, V267, P22556; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Crews TE, 2001, BIOGEOCHEMISTRY, V52, P259, DOI 10.1023/A:1006441726650; CROOKE E, 1994, J BIOL CHEM, V269, P6290; de Brevern AG, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-114; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Jones DL, 2011, SOIL BIOL, V26, P169, DOI 10.1007/978-3-642-15271-9_7; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jung SaiHo, 2009, Journal of Korean Nature, V2, P175; KANTVILAS G, 1989, VEGETATIO, V84, P99, DOI 10.1007/BF00036510; Kim JS, 2015, MICROBIOLOGYOPEN, V4, P301, DOI 10.1002/mbo3.238; Kim KK, 2014, ANTON LEEUW INT J G, V105, P915, DOI 10.1007/s10482-014-0146-z; King CE, 2012, ISME J, V6, P1558, DOI 10.1038/ismej.2011.206; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lee KC, 2017, INT J SYST EVOL MICR, V67, P2975, DOI 10.1099/ijsem.0.002061; Lee KC, 2015, INT J SYST EVOL MICR, V65, P3320, DOI 10.1099/ijsem.0.000414; Lee KC, 2015, INT J SYST EVOL MICR, V65, P3125, DOI 10.1099/ijsem.0.000388; Lee KC, 2015, INT J SYST EVOL MICR, V65, P952, DOI 10.1099/ijs.0.000044; Legendre P, 2000, J STAT COMPUT SIM, V67, P37, DOI 10.1080/00949650008812035; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Louca S, 2016, SCIENCE, V353, P1272, DOI 10.1126/science.aaf4507; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MANTEL N, 1967, CANCER RES, V27, P209; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Mullaney EJ, 2003, BIOCHEM BIOPH RES CO, V312, P179, DOI 10.1016/j.bbrc.2003.09.176; Park JB, 2010, CHARACTERIZATION LAV; Rocca JD, 2015, ISME J, V9, P1693, DOI 10.1038/ismej.2014.252; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Turner BL, 2002, PHILOS T ROY SOC B, V357, P449, DOI 10.1098/rstb.2001.0837; Wodzinski RJ, 1996, ADV APPL MICROBIOL, V42, P263, DOI 10.1016/S0065-2164(08)70375-7	35	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0204761	10.1371/journal.pone.0204761	http://dx.doi.org/10.1371/journal.pone.0204761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312313	Green Published, gold, Green Submitted			2022-12-26	WOS:000447427300013
J	Engidaw, MT; Wassie, MM; Teferra, AS				Engidaw, Melaku Tadege; Wassie, Molla Mesele; Teferra, Alemayehu Shimeka			Anemia and associated factors among adolescent girls living in Aw-Barre refugee camp, Somali regional state, Southeast Ethiopia	PLOS ONE			English	Article							DEFICIENCY; IRON	Background Adolescent girls have a higher risk of anemia due to an increased requirement, low intake of hematopoietic nutrients and low intake of a nutrient that enhance absorption of these hematopoietic nutrients. Adolescent girls living in refugee camps are more vulnerable to anemia. The study aimed to determine the prevalence of anemia and associated factors among adolescent girls aged 10-19 years in Aw-Barre refugee camp, Somalia regional state, Southeast Ethiopia. Methods A cross-sectional study design was employed. Study participants were recruited using a simple random sampling technique. A structured questionnaire was used to collect the data. Hemoglobin level was tested using HemoCueHb 301 from 10 mu l finger prick blood samples. Adolescents with a hemoglobin level of <12.5gm/dl after altitude adjustment were classified as anemic. Data were entered using Epi Info version 7.0 and analyzed using SPSS version 20.0. Binary logistic regression was used to explore the association of independent variables with anemia. Variables having P-value <= 0.05 was considered to be statistically significant. Results Four hundred thirty-seven adolescent girls participated in the study with a response rate of 95.83%. The prevalence of anemia was 22% (95% CI (17.6, 26.1)). Late adolescents were 2 times more likely to have anemia as compared to early adolescents (AOR: 1.95, 95% CI (1.09, 3.47). Those who stayed >= 8 years in the camp were 3 times more likely to develop anemia (AOR: 2.92, 95% CI (1.14, 7.50)). Those who ate heme iron food sources less than one time per month were 11 times more likely to develop anemia compared to those who ate more than twice within a week (AOR: 11.42, 95% CI (3.42, 38.18)). Conclusions The prevalence of anemia among adolescent girls was a moderate public health problem. Education and awareness on adolescent nutrition with special attention of late adolescents and duration in the refugee camps is warranted. Moreover, promoting the intake of foods rich in heme iron is suggested.	[Engidaw, Melaku Tadege] Debre Tabor Univ, Coll Hlth Sci, Social & Populat Hlth Unit, Debre Tabor, Ethiopia; [Wassie, Molla Mesele] Univ Gondar, Inst Publ Hlth, Dept Human Nutr, Gondar, Ethiopia; [Teferra, Alemayehu Shimeka] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	University of Gondar; University of Gondar	Engidaw, MT (corresponding author), Debre Tabor Univ, Coll Hlth Sci, Social & Populat Hlth Unit, Debre Tabor, Ethiopia.	meltad24@gmail.com	Wassie, Molla/S-1946-2019; Engidaw, Melaku Tadege/S-4873-2019	Wassie, Molla/0000-0002-3565-2397; Engidaw, Melaku Tadege/0000-0002-1970-5102				[Anonymous], 2011, INT J BIOL MED RES; [Anonymous], 2008, WORLDWIDE PREVALENCE; Benson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057998; Bilukha OO, 2014, MMWR-MORBID MORTAL W, V63, P638; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Gupta R K C, 2013, Nepal Med Coll J, V15, P129; Haider J, 2011, ETHIOP J HLTH DEV, V25; Kaur S., 2006, Indian Journal of Community Medicine, V31, P255; Khatib I. M., 2010, Eastern Mediterranean Health Journal, V16, P187; Kishore J., 2006, NATL HLTH PROGRAMS I, P82; Mann J, 2002, ESSENTIALS HUMAN NUT, P536; Nutritional Assessment of Adolescent Refugees D Nepal, 1999, MMWR MORB MORTAL WKL, V49, P864; Organization W H, 2002, WORLD HLTH REP 2002; Organization W.H., 2001, IR DEF AN ASS PREV C; Paxton GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038194; Prinzo ZW, 2002, P NUTR SOC, V61, P251, DOI 10.1079/PNS2002151; Rage IA, 2012, BASED EXPERIENCE CON; Seal AJ, 2005, J NUTR, V135, P808, DOI 10.1093/jn/135.4.808; Sonden K, 2014, EURO SURVEILL, V19; Swindale A., 2006, FHI 360FANTA; WFP/UNHCR/ARRA, 2008, ETH 2008 JOINT ASS M, P6; WFP/UNHCR/ARRA, 2010, ETH 2010 JOINT ASS M, P23; Whitney E, 2008, UNDERSTANDING NUTR, P575; WHO, 2001, IR DEF AN ASS PREV C, P17; WHO, 2011, WHONMHNHDMNM111; WHO, 2006, WHO CHILD GROWTH STA; WHO Scientific Group on Nutritional Anaemias & World Health Organization, 1968, NUTR AN REP WHO SCI; Woodruff BA, 2006, PUBLIC HEALTH NUTR, V9, P26, DOI 10.1079/PHN2005825; 1995, WHO TECH REP SER, V854, P263	29	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205381	10.1371/journal.pone.0205381	http://dx.doi.org/10.1371/journal.pone.0205381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308060	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500065
J	Nagel, S; MacLeod, RAF; Meyer, C; Kaufmann, M; Drexler, HG				Nagel, Stefan; MacLeod, Roderick A. F.; Meyer, Corinna; Kaufmann, Maren; Drexler, Hans G.			NKL homeobox gene activities in B-cell development and lymphomas	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; T-ALL; TRANSCRIPTION FACTORS; HODGKIN-LYMPHOMA; EXPRESSION; DIFFERENTIATION; NETWORK; BINDING; CANCER; NKX3.1	Homeobox genes encode transcription factors which regulate basic processes in development and cell differentiation. Several members of the NKL subclass are deregulated in T-cell progenitors and support leukemogenesis. We have recently described particular expression patterns of nine NKL homeobox genes in early hematopoiesis and T-cell development. Here, we screened NKL homeobox gene activities in normal B-cell development and extended the NKL-code to include this lymphoid lineage. Analysis of public expression profiling datasets revealed that HHEX and NKX6-3 were the only members differentially active in naive B-cells, germinal center B-cells, plasma cells and memory B-cells. Subsequent examination of different types of B-cell malignancies showed both aberrant overexpression of NKL-code members and ectopic activation of subclass members physiologically silent in lymphopoiesis including BARX2, DLX1, EMX2, NKX2-1, NKX2-2 and NKX3-2. Based on these findings we performed detailed studies of the B-cell specific NKL homeobox gene NKX6-3 which showed enhanced activity in patient subsets of follicular lymphoma, mantle cell lymphoma and diffuse large B-cell lymphoma (DLBCL), and in three DLBCL cell lines to serve as in vitro models. While excluding genomic and chromosomal rearrangements at the locus of NKX6-3 (8p11) promoter studies demonstrated that B-cell factors MYB and PAX5 activated NKX6-3 transcription. Furthermore, aberrant BMP7/SMAD1-signalling and deregulated expression of chromatin complex components AUTS2 and PCGF5 promoted NKX6-3 activation. Finally, NKL homeobox genes HHEX, HLX, MSX1 and NKX6-3 were expressed in B-cell progenitors and generated a regulatory gene network in cell lines which we propose may provide physiological support for NKL-code formation in early B-cell development. Together, we identified an NKL-code in B-cell development whose violation may deregulate differentiation and promote malignant transformation.	[Nagel, Stefan; MacLeod, Roderick A. F.; Meyer, Corinna; Kaufmann, Maren; Drexler, Hans G.] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Nagel, S (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	sna@dsmz.de						Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Bauer M, 2016, CHROMOSOMA, V125, P471, DOI 10.1007/s00412-015-0539-4; Bernhart SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep37393; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bodor C, 2016, CANCER METAST REV, V35, P109, DOI 10.1007/s10555-016-9608-2; Boller S, 2014, IMMUNOL REV, V261, P102, DOI 10.1111/imr.12206; Brendolan A, 2005, DEVELOPMENT, V132, P3113, DOI 10.1242/dev.01884; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Casero D, 2015, NAT IMMUNOL, V16, P1282, DOI 10.1038/ni.3299; Dadi S, 2012, CANCER CELL, V21, P563, DOI 10.1016/j.ccr.2012.02.013; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; Dybkaer K, 2015, J CLIN ONCOL, V33, P1379, DOI 10.1200/JCO.2014.57.7080; Fernandez V, 2010, CANCER RES, V70, P1408, DOI 10.1158/0008-5472.CAN-09-3419; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Girardi T, 2017, BLOOD, V129, P1113, DOI 10.1182/blood-2016-10-706465; Hartmann EM, 2010, BLOOD, V116, P953, DOI 10.1182/blood-2010-01-263806; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Katagiri T, 2016, COLD SPRING HARB PER, V8; Kishi H, 2002, BLOOD, V99, P576, DOI 10.1182/blood.V99.2.576; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Kusy S, 2010, J EXP MED, V207, P2141, DOI 10.1084/jem.20100745; Longo NS, 2009, BLOOD, V113, P3706, DOI 10.1182/blood-2008-10-183632; Ma ESK, 2017, METHODS MOL BIOL, V1541, P279, DOI 10.1007/978-1-4939-6703-2_22; MacLeod RAF, 2011, METHODS MOL BIOL, V731, P57, DOI 10.1007/978-1-61779-080-5_6; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; Melchers F, 2015, J CLIN INVEST, V125, P2203, DOI 10.1172/JCI78083; Mendez A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004696; Montavon T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0367; Nagel Stefan, 2018, Oncotarget, V9, P14338, DOI 10.18632/oncotarget.24512; Nagel S, 2017, ONCOTARGET, V8, P66815, DOI 10.18632/oncotarget.18609; Nagel S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171164; Nagel S, 2016, ONCOTARGET, V7, P45398, DOI 10.18632/oncotarget.9982; Nagel S, 2015, LEUKEMIA LYMPHOMA, V56, P480, DOI 10.3109/10428194.2014.924119; Nagel S, 2014, LEUKEMIA LYMPHOMA, V55, P1893, DOI 10.3109/10428194.2013.864762; Nagel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061447; Owens BM, 2006, BRIT J HAEMATOL, V132, P216, DOI 10.1111/j.1365-2141.2005.05850.x; Robles EF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11889; Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024; Scott DW, 2014, BLOOD, V123, P1214, DOI 10.1182/blood-2013-11-536433; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Smith E, 2004, J LEUKOCYTE BIOL, V75, P973, DOI 10.1189/jlb.1103554; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; Villarese P, 2018, LEUKEMIA, V32, P61, DOI 10.1038/leu.2017.176	48	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205537	10.1371/journal.pone.0205537	http://dx.doi.org/10.1371/journal.pone.0205537			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308041	Green Submitted, Green Published, gold			2022-12-26	WOS:000447173500102
J	Britt, RD; Thompson, MA; Wicher, SA; Manlove, LJ; Roesler, A; Fang, YH; Roos, C; Smith, L; Miller, JD; Pabelick, CM; Prakash, YS				Britt, Rodney D., Jr.; Thompson, Michael A.; Wicher, Sarah A.; Manlove, Logan J.; Roesler, Anne; Fang, Yun-Hua; Roos, Carolyn; Smith, Leslie; Miller, Jordan D.; Pabelick, Christina M.; Prakash, Y. S.			Smooth muscle brain-derived neurotrophic factor contributes to airway hyperreactivity in a mouse model of allergic asthma	FASEB JOURNAL			English	Article						TrkB; neurotrophin; fibrosis; extracellular matrix	MATRIX METALLOPROTEINASES; MECHANISMS; EXPRESSION; HYPEROXIA; RELEASE; HEALTH; PATHOGENESIS; REACTIVITY; SECRETION; SEVERITY	Recent studies have demonstrated an effect of neurotrophins, particularly brain-derived neurotrophic factor (BDNF), on airway contractility [via increased airway smooth muscle (ASM) intracellular calcium [Ca2+](i)] and remodeling (ASM proliferation and extracellular matrix formation) in the context of airway disease. In the present study, we examined the role of BDNF in allergen-induced airway inflammation using 2 transgenic models: 1) tropomyosin-related kinase B (TrkB) conditional knockin (TrkBKI) mice allowing for inducible, reversible disruption of BDNF receptor kinase activity by administration of 1NMPP1, a PP1 derivative, and 2) smooth muscle-specific BDNF knockout (BDNFfl/fl/SMMHC11(Cre/0)) mice. Adult mice were intranasally challenged with PBS or mixed allergen (Alternaria alternata, Aspergillus fumigatus, house dust mite, and ovalbumin) for 4 wk. Our data show that administration of 1NMPP1 in TrkBKI mice during the 4-wk allergen challenge blunted airway hyperresponsiveness (AHR) and reduced fibronectin mRNA expression in ASM layers but did not reduce inflammation per se. Smooth muscle-specific deletion of BDNF reduced AHR and blunted airway fibrosis but did not significantly alter airway inflammation. Together, our novel data indicate that TrkB signaling is a key modulator of AHR and that smooth muscle-derived BDNF mediates these effects during allergic airway inflammation.Britt, R. D., Jr., Thompson, M. A., Wicher, S. A., Manlove, L. J., Roesler, A., Fang, Y.-H., Roos, C., Smith, L., Miller, J. D., Pabelick, C. M., Prakash, Y. S. Smooth muscle brain-derived neurotrophic factor contributes to airway hyperreactivity in a mouse model of allergic asthma.	[Britt, Rodney D., Jr.; Fang, Yun-Hua; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA; [Thompson, Michael A.; Wicher, Sarah A.; Manlove, Logan J.; Roesler, Anne; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA; [Roos, Carolyn; Smith, Leslie; Miller, Jordan D.] Mayo Clin, Dept Surg, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Prakash, YS (corresponding author), Mayo Clin, Dept Anesthesiol & Physiol, 4-184 W Jos SMH,200 First St SW, Rochester, MN 55905 USA.	prakash.ys@mayo.edu	Britt, Rodney/AAA-8253-2022	Britt, Rodney/0000-0002-0027-9545; Miller, Jordan/0000-0002-9868-4097; Wicher, Sarah/0000-0002-0079-7924; Prakash, Y S/0000-0002-2968-224X	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL088029, HL56470, K99 HL131682, T32 HL105355]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105355, K99HL131682, R01HL088029, R01HL056470, R00HL131682] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Jacob Teske (Mayo Clinic) for technical assistance in the smooth muscle and airway thickness analyses. This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL088029 and HL56470 (to Y.S.P.), K99 HL131682 (to R.D.B., Jr.), and T32 HL105355 (to S.A.W.). The authors declare no conflicts of interest.	Abcejo AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044343; Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Aravamudan B, 2016, AM J PHYSIOL-LUNG C, V311, pL270, DOI 10.1152/ajplung.00414.2015; Aravamudan B, 2012, AM J PHYSIOL-LUNG C, V303, pL669, DOI 10.1152/ajplung.00018.2012; Aravamudan B, 2012, J CELL MOL MED, V16, P812, DOI 10.1111/j.1582-4934.2011.01356.x; Aven L, 2014, FASEB J, V28, P897, DOI 10.1096/fj.13-238212; Braun A, 2004, BRIT J PHARMACOL, V141, P431, DOI 10.1038/sj.bjp.0705638; Braun A, 2000, CLIN EXP ALLERGY, V30, P178; Braun A, 1999, AM J RESP CELL MOL, V21, P537, DOI 10.1165/ajrcmb.21.4.3670; Burgess JK, 2009, PULM PHARMACOL THER, V22, P379, DOI 10.1016/j.pupt.2008.12.007; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chapman DG, 2014, J CELL BIOCHEM, V115, P2055, DOI 10.1002/jcb.24881; Chaudhuri R, 2005, CLIN EXP ALLERGY, V35, P949, DOI 10.1111/j.1365-2222.2005.02286.x; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611; Davies Donna E, 2009, Proc Am Thorac Soc, V6, P678, DOI 10.1513/pats.200907-067DP; Dekkers Bart G J, 2009, Proc Am Thorac Soc, V6, P683, DOI 10.1513/pats.200907-056DP; Elshaw SR, 2004, BRIT J PHARMACOL, V142, P1318, DOI 10.1038/sj.bjp.0705883; Faksh A, 2016, PEDIATR RES, V79, P391, DOI 10.1038/pr.2015.232; Freeman MR, 2017, AM J PHYSIOL-LUNG C, V313, pL360, DOI 10.1152/ajplung.00580.2016; Garcia-Suarez O, 2009, RESP PHYSIOL NEUROBI, V167, P281, DOI 10.1016/j.resp.2009.06.001; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Hempstead Barbara L, 2015, Trans Am Clin Climatol Assoc, V126, P9; Hirota N, 2013, CHEST, V144, P1026, DOI 10.1378/chest.12-3073; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Hoyle GW, 2003, CYTOKINE GROWTH F R, V14, P551, DOI 10.1016/S1359-6101(03)00061-3; Iijima K, 2014, J IMMUNOL, V193, P1549, DOI 10.4049/jimmunol.1302984; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Lagente V, 2010, J MOL CELL CARDIOL, V48, P440, DOI 10.1016/j.yjmcc.2009.09.017; Namura K, 2007, CLIN IMMUNOL, V122, P181, DOI 10.1016/j.clim.2006.10.011; Nassenstein C, 2004, PROG BRAIN RES, V146, P347; Piedimonte G, 2003, PEDIATR INFECT DIS J, V22, pS66, DOI 10.1097/00006454-200302001-00010; Prakash YS, 2006, AM J PHYSIOL-LUNG C, V291, pL447, DOI 10.1152/ajplung.00501.2005; Prakash YS, 2016, AM J PHYSIOL-LUNG C, V311, pL1113, DOI 10.1152/ajplung.00370.2016; Prakash YS, 2014, PHARMACOL THERAPEUT, V143, P74, DOI 10.1016/j.pharmthera.2014.02.006; Prakash YS, 2013, AM J PHYSIOL-LUNG C, V305, pL912, DOI 10.1152/ajplung.00259.2013; Prakash YS, 2009, AM J RESP CELL MOL, V41, P603, DOI 10.1165/rcmb.2008-0151OC; Prakash Ys, 2010, Expert Rev Respir Med, V4, P395, DOI 10.1586/ers.10.29; Raap U, 2005, J ALLERGY CLIN IMMUN, V115, P1268, DOI 10.1016/j.jaci.2005.02.007; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rochlitzer S, 2006, BIOCHEM SOC T, V34, P594, DOI 10.1042/BST0340594; Royce SG, 2012, MOL CELL ENDOCRINOL, V351, P167, DOI 10.1016/j.mce.2012.01.007; Rydell-Tormanen K, 2013, PULM PHARMACOL THER, V26, P13, DOI 10.1016/j.pupt.2012.04.003; Sathish V, 2013, AM J RESP CELL MOL, V48, P431, DOI 10.1165/rcmb.2012-0129OC; Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174; Song XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001707; Sopi RB, 2008, AM J PHYSIOL-LUNG C, V295, pL348, DOI 10.1152/ajplung.00067.2008; Thompson MA, 2015, BBA-MOL CELL RES, V1853, P2506, DOI 10.1016/j.bbamcr.2015.06.008; Virchow JC, 1998, AM J RESP CRIT CARE, V158, P2002, DOI 10.1164/ajrccm.158.6.9803023; Vohra PK, 2013, BBA-MOL CELL RES, V1833, P2953, DOI 10.1016/j.bbamcr.2013.07.019; Wang SY, 2016, J CELL PHYSIOL, V231, P1586, DOI 10.1002/jcp.25254; Watanabe T, 2015, AM J RESP CELL MOL, V53, P844, DOI 10.1165/rcmb.2015-0015OC; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yao Q, 2005, AM J PHYSIOL-LUNG C, V289, pL307, DOI 10.1152/ajplung.00030.2005; Yarova PL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0282; Zuccato C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022966	60	22	22	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					3024	3034		10.1096/fj.201801002R	http://dx.doi.org/10.1096/fj.201801002R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30351991	Green Published, Bronze			2022-12-26	WOS:000457296600118
J	Wiernicki, I; Parafiniuk, M; Kolasa-Wolosiuk, A; Gutowska, I; Kazimierczak, A; Clark, J; Baranowska-Bosiacka, I; Szumilowicz, P; Gutowski, P				Wiernicki, Ireneusz; Parafiniuk, Miroslaw; Kolasa-Wolosiuk, Agnieszka; Gutowska, Izabela; Kazimierczak, Arkadiusz; Clark, Jeremy; Baranowska-Bosiacka, Irena; Szumilowicz, Pawel; Gutowski, Piotr			Relationship between aortic wall oxidative stress/proteolytic enzyme expression and intraluminal thrombus thickness indicates a novel pathomechanism in the progression of human abdominal aortic aneurysm	FASEB JOURNAL			English	Article						vascular biology; arterial wall; parietal thrombus; antioxidant activity; matrix metalloproteinase-9	SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASES; ELASTIN DEGRADATION; COVERED WALL; STRESS; CATALASE; DEGENERATION; INFILTRATION; GELATINASE; ACTIVATION	The possibility that oxidative stress promotes degradation of the extracellular matrix and a relationship between intraluminal thrombus (ILT) thickness and proteolytic activity within the abdominal aortic aneurysm (AAA) wall has been suggested. In the present study, the hypothesis that thin ILT is correlated with an increase in oxidative stress-related enzymes and matrix metalloproteinase-9 (MMP-9) expression within the human AAA wall was investigated. We also studied the antioxidant activity of superoxide dismutases, catalase, glutathione peroxidase, glutathione reductase, and thioredoxin within the full-thickness AAA wall and through fluoroimmunohistochemical staining of catalase and MMP-9 expression within the inner and outer media, in relation to ILT thickness. Reactive oxygen species control the degradation and remodeling of the extracellular matrix by up-regulating proteolytic enzymes, such as MMPs. Results showed that oxidative stress and proteolytic enzyme expression were simultaneously, significantly higher within thin thrombus (10 mm)-covered aneurysm wall when compared with the wall covered by thick thrombus (25 mm). These findings provide the first demonstration, to our knowledge, of a causative link between oxidative stress instigating proteolytic enzyme expression at the tissue level and human AAA development. Presence of a thin circumferential thrombus should always be considered as a risk factor for the greatest increase in aneurysm growth rate and rupture, giving an indication for surgery timing.Wiernicki, I., Parafiniuk, M., Kolasa-Woosiuk, A., Gutowska, I., Kazimierczak, A., Clark, J., Baranowska-Bosiacka, I., Szumilowicz, P., Gutowski, P. Relationship between aortic wall oxidative stress/proteolytic enzyme expression and intraluminal thrombus thickness indicates a novel pathomechanism in the progression of human abdominal aortic aneurysm.	[Wiernicki, Ireneusz; Kazimierczak, Arkadiusz; Szumilowicz, Pawel; Gutowski, Piotr] Pomeranian Med Univ, Dept Vasc Surg & Angiol, Fac Lab Diagnost & Mol Med, Al Powstancow Wielkopolskich 72, PL-70111 Szczecin, Poland; [Parafiniuk, Miroslaw] Pomeranian Med Univ, Dept Forens Med, Fac Lab Diagnost & Mol Med, Szczecin, Poland; [Kolasa-Wolosiuk, Agnieszka] Pomeranian Med Univ, Dept Histol & Embryol, Fac Lab Diagnost & Mol Med, Szczecin, Poland; [Gutowska, Izabela] Pomeranian Med Univ, Dept Biochem & Human Nutr, Fac Lab Diagnost & Mol Med, Szczecin, Poland; [Clark, Jeremy] Pomeranian Med Univ, Dept Clin & Mol Biochem, Fac Lab Diagnost & Mol Med, Szczecin, Poland; [Baranowska-Bosiacka, Irena] Pomeranian Med Univ, Fac Lab Diagnost & Mol Med, Dept Biochem & Med Chem, Szczecin, Poland	Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University	Wiernicki, I (corresponding author), Pomeranian Med Univ, Dept Vasc Surg & Angiol, Fac Lab Diagnost & Mol Med, Al Powstancow Wielkopolskich 72, PL-70111 Szczecin, Poland.	irekwie@wp.pl	Clark, Jeremy S.C./E-1665-2016; Wiernicki, Ireneusz/O-1803-2019; Kolasa-Wołosiuk, Agnieszka/M-5963-2014	Clark, Jeremy S.C./0000-0003-3179-5638; Kolasa-Wołosiuk, Agnieszka/0000-0002-6933-7643; Parafiniuk, Miroslaw/0000-0002-3005-2202				Adolph R, 1997, J VASC SURG, V25, P916, DOI 10.1016/S0741-5214(97)70223-4; Behr-Andersen C, 2019, J CARDIOVASC SURG, V60, P221, DOI 10.23736/S0021-9509.17.09921-9; BUSUTTIL RW, 1982, J SURG RES, V32, P214, DOI 10.1016/0022-4804(82)90093-2; CAMPA JS, 1987, ATHEROSCLEROSIS, V65, P13, DOI 10.1016/0021-9150(87)90003-7; Delbosc S, 2013, CARDIOVASC RES, V100, P307, DOI 10.1093/cvr/cvt194; DOBRIN PB, 1984, ARCH SURG-CHICAGO, V119, P405; Eliason JL, 2005, CIRCULATION, V112, P232, DOI 10.1161/CIRCULATIONAHA.104.517391; Elmore JR, 1998, ANN VASC SURG, V12, P221, DOI 10.1007/s100169900144; Folkesson M, 2007, THROMB HAEMOSTASIS, V98, P427, DOI 10.1160/TH06-11-0638; Fontaine V, 2004, AM J PATHOL, V164, P2077, DOI 10.1016/S0002-9440(10)63766-2; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Golledge J, 2008, CIRCULATION, V118, P2382, DOI 10.1161/CIRCULATIONAHA.108.802074; Grigoryants V, 2005, J VASC SURG, V41, P108, DOI 10.1016/j.jvs.2004.09.033; Henderson EL, 1999, CIRCULATION, V99, P96, DOI 10.1161/01.CIR.99.1.96; HOLMES DR, 1995, J VASC SURG, V21, P761, DOI 10.1016/S0741-5214(05)80007-2; Houard X, 2009, FASEB J, V23, P1376, DOI 10.1096/fj.08-116202; Houard X, 2009, CARDIOVASC RES, V82, P532, DOI 10.1093/cvr/cvp048; ITOH Y, 1995, J BIOL CHEM, V270, P16518, DOI 10.1074/jbc.270.28.16518; Kazi M, 2005, ARTERIOSCL THROM VAS, V25, P1341, DOI 10.1161/01.ATV.0000166601.49954.21; KOCH AE, 1990, AM J PATHOL, V137, P1199; KUSHIHASHI T, 1991, Nippon Acta Radiologica, V51, P219; Li PF, 1997, FEBS LETT, V404, P249, DOI 10.1016/S0014-5793(97)00093-8; LopezCandales A, 1997, AM J PATHOL, V150, P993; Martin-Ventura JL, 2012, THROMB HAEMOSTASIS, V108, P435, DOI 10.1160/TH12-04-0248; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; Mayranpaa MI, 2009, J VASC SURG, V50, P388, DOI 10.1016/j.jvs.2009.03.055; Miller FJ, 2002, ARTERIOSCL THROM VAS, V22, P560, DOI 10.1161/01.ATV.0000013778.72404.30; Nchimi A, 2016, EUR RADIOL, V26, P2378, DOI 10.1007/s00330-015-4010-y; NEWMAN KM, 1994, ARTERIOSCLER THROMB, V14, P1315, DOI 10.1161/01.ATV.14.8.1315; Parastatidis I, 2013, ARTERIOSCL THROM VAS, V33, P2389, DOI 10.1161/ATVBAHA.113.302175; Pincemail J, 2012, REDOX REP, V17, P139, DOI 10.1179/1351000212Y.0000000012; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; Ramella M, 2017, AM J TRANSL RES, V9, P5485; Ramos-Mozo P, 2011, ARTERIOSCL THROM VAS, V31, P3011, DOI 10.1161/ATVBAHA.111.237537; Reeps C, 2009, PATHOBIOLOGY, V76, P243, DOI 10.1159/000228900; Sakalihasan N, 1996, J VASC SURG, V24, P127, DOI 10.1016/S0741-5214(96)70153-2; Sho E, 2004, EXP MOL PATHOL, V76, P108, DOI 10.1016/j.yexmp.2003.11.003; Sillesen H, 2015, BRIT J SURG, V102, P894, DOI 10.1002/bjs.9824; Sinha I, 2007, J SURG RES, V138, P156, DOI 10.1016/j.jss.2006.07.011; Tamarina NA, 1997, SURGERY, V122, P264, DOI 10.1016/S0039-6060(97)90017-9; Tanaka H, 2017, JOVE-J VIS EXP, DOI 10.3791/55763; THOMPSON RW, 1995, J CLIN INVEST, V96, P318, DOI 10.1172/JCI118037; Tsai SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28612; Tsuruda T, 2008, CIRC RES, V102, P1368, DOI 10.1161/CIRCRESAHA.108.173682; Umeda H, 2001, ARCH BIOCHEM BIOPHYS, V385, P209, DOI 10.1006/abbi.2000.2145; Urbonavicius S, 2008, EUR J VASC ENDOVASC, V36, P273, DOI 10.1016/j.ejvs.2008.05.009; Virag L, 2015, ANN BIOMED ENG, V43, P2852, DOI 10.1007/s10439-015-1354-z; Wiernicki I, 2008, EUR J CLIN INVEST, V38, P883, DOI 10.1111/j.1365-2362.2008.02040.x; Wiernicki I, 2011, DIS MARKERS, V31, P67, DOI [10.1155/2011/783721, 10.3233/DMA-2011-0799]; Wiernicki I, 2010, ATHEROSCLEROSIS, V212, P161, DOI 10.1016/j.atherosclerosis.2010.04.033; Wilson WRW, 2006, CIRCULATION, V113, P438, DOI 10.1161/CIRCULATIONAHA.105.551572; Xu CP, 2001, J VASC SURG, V33, P91, DOI 10.1067/mva.2001.109744; Yu ZH, 2016, J VASC SURG, V64, P737, DOI 10.1016/j.jvs.2015.03.045	54	15	16	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					885	895		10.1096/fj.201800633R	http://dx.doi.org/10.1096/fj.201800633R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30351992	Bronze			2022-12-26	WOS:000457401500069
J	Borchert, AJ; Downs, DM				Borchert, Andrew J.; Downs, Diana M.			Analyses of variants of the Ser/Thr dehydratase IlvA provide insight into 2-aminoacrylate metabolism in Salmonella enterica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pyridoxal phosphate; reactive nitrogen species (RNS); bacterial metabolism; Salmonella enterica; stress; 2-aminoacrylate; mathematical modeling; metabolic network; RidA; serine; threonine dehydratase	THREONINE DEAMINASE; ESCHERICHIA-COLI; REACTION SPECIFICITY; TYPHIMURIUM; FAMILY; YJGF; BIOSYNTHESIS; PURIFICATION; TRANSDUCTION; ISOLEUCINE	RidA is a conserved and broadly distributed protein that has enamine deaminase activity. In a variety of organisms tested thus far, lack of RidA results in the accumulation of the reactive metabolite 2-aminoacrylate (2AA), an obligate intermediate in the catalytic mechanism of several pyridoxal 5-phosphate (PLP)-dependent enzymes. This study reports the characterization of variants of the biosynthetic serine/threonine dehydratase (EC 4.3.1.19; IlvA), which is a significant generator of 2AA in the bacteria Salmonella enterica, Escherichia coli, and Pseudomonas aeruginosa and the yeast Saccharomyces cerevisiae. Two previously identified mutations, ilvA3210 and ilvA3211, suppressed the phenotypic growth consequences of 2AA accumulation in S. enterica. Characterization of the respective protein variants suggested that they affect 2AA metabolism in vivo by two different catalytic mechanisms, both leading to an overall reduction in serine dehydratase activity. To emphasize the physiological relevance of the in vitro enzyme characterization, we sought to explain in vivo phenotypes using these data. A simple mathematical model describing the impact these catalytic deficiencies had on 2AA production was generally supported by our data. However, caveats arose when kinetic parameters, determined in vitro, were used to predict formation of the isoleucine precursor 2-ketobutyrate and model in vivo (growth) behaviors. Altogether, our data support the need for a holistic approach, including in vivo and in vitro analyses, to generate data used in understanding and modeling metabolism.	[Borchert, Andrew J.; Downs, Diana M.] Univ Georgia, Dept Microbiol, 361 Biol Sci Bldg,120 Cedar St, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Downs, DM (corresponding author), Univ Georgia, Dept Microbiol, 361 Biol Sci Bldg,120 Cedar St, Athens, GA 30602 USA.	dmdowns@uga.edu	Borchert, Andrew John/AAH-5655-2021	Borchert, Andrew John/0000-0003-1435-3643	National Institutes of Health Competitive Grants Program Award [GM095837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095837] Funding Source: NIH RePORTER	National Institutes of Health Competitive Grants Program Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Competitive Grants Program Award GM095837 (to D. M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; BARAK Z, 1987, J BACTERIOL, V169, P3750, DOI 10.1128/jb.169.8.3750-3756.1987; Bazurto JV, 2016, MICROB CELL, V3, P260, DOI 10.15698/mic2016.06.509; Bazurto JV, 2016, MBIO, V7, DOI 10.1128/mBio.01840-15; Bazurto JV, 2011, GENETICS, V187, P623, DOI 10.1534/genetics.110.124362; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Borchert AJ, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00140-17; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNS RO, 1968, J BIOL CHEM, V243, P178; Burns RO., 1971, METHOD ENZYMOL, V17B, P555; Cardinale S, 2012, BIOTECHNOL J, V7, P856, DOI 10.1002/biot.201200085; CHAN RK, 1972, VIROLOGY, V50, P883, DOI 10.1016/0042-6822(72)90442-4; CHEN JW, 1991, J BACTERIOL, V173, P2328, DOI 10.1128/JB.173.7.2328-2340.1991; Christopherson MR, 2008, J BACTERIOL, V190, P3057, DOI 10.1128/JB.01700-07; Christopherson MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043082; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS L, 1965, ANAL BIOCHEM, V12, P36, DOI 10.1016/0003-2697(65)90139-9; Downs DM, 2018, AIMS MICROBIOL, V4, P289, DOI 10.3934/microbiol.2018.2.289; Downs DM, 2015, MOL MICROBIOL, V96, P211, DOI 10.1111/mmi.12945; DOWNS DM, 1994, J BACTERIOL, V176, P4858, DOI 10.1128/jb.176.16.4858-4864.1994; EISENSTEIN E, 1995, ARCH BIOCHEM BIOPHYS, V316, P311, DOI 10.1006/abbi.1995.1042; Enos-Berlage JL, 1998, J BACTERIOL, V180, P6519, DOI 10.1128/JB.180.24.6519-6528.1998; Ernst DC, 2018, MBIO, V9, DOI 10.1128/mBio.00084-18; Ernst DC, 2016, MOL MICROBIOL, V101, P210, DOI 10.1111/mmi.13384; Ernst DC, 2016, J BACTERIOL, V198, P536, DOI 10.1128/JB.00804-15; Flynn JM, 2013, MOL MICROBIOL, V89, P751, DOI 10.1111/mmi.12313; Flynn JM, 2013, J BACTERIOL, V195, P3603, DOI 10.1128/JB.00463-13; Gallagher DT, 2004, METHOD ENZYMOL, V380, P85; Galloway NR, 2013, CRYST GROWTH DES, V13, P2833, DOI 10.1021/cg400171z; Hodge-Hanson KM, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00751-17; Hodge-Hanson KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185544; HOFLER JG, 1978, J BIOL CHEM, V253, P1245; Kim JH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.88; Kittleson JT, 2012, CURR OPIN CHEM BIOL, V16, P329, DOI 10.1016/j.cbpa.2012.06.009; Koenigsknecht MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048207; Koenigsknecht MJ, 2010, TRENDS MICROBIOL, V18, P240, DOI 10.1016/j.tim.2010.03.003; Kuznetsova IM, 2014, INT J MOL SCI, V15, P23090, DOI 10.3390/ijms151223090; Lal PB, 2014, MOL MICROBIOL, V94, P843, DOI 10.1111/mmi.12801; Lambrecht JA, 2013, MBIO, V4, DOI 10.1128/mBio.00033-13; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Lambrecht JA, 2010, J BIOL CHEM, V285, P34401, DOI 10.1074/jbc.M110.160515; LAROSSA RA, 1987, BIOESSAYS, V7, P125, DOI 10.1002/bies.950070308; Mehta V, 2016, BIOORG MED CHEM LETT, V26, P1005, DOI 10.1016/j.bmcl.2015.12.044; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schmitz G, 2004, J BACTERIOL, V186, P803, DOI 10.1128/JB.186.3.803-810.2004; SEGEL IH, 1992, BIOCHEM EDUC, V20, P155, DOI 10.1016/0307-4412(92)90060-Y; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; Toney MD, 2011, BBA-PROTEINS PROTEOM, V1814, P1407, DOI 10.1016/j.bbapap.2011.05.019; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; ZARLENGO MH, 1968, J BIOL CHEM, V243, P186	53	4	4	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19240	19249		10.1074/jbc.RA118.005626	http://dx.doi.org/10.1074/jbc.RA118.005626			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30327426	Green Published, hybrid			2022-12-26	WOS:000453537300008
J	Cai, R; Qimuge, N; Ma, ML; Wang, YQ; Tang, GR; Zhang, Q; Sun, YM; Chen, XC; Yu, TY; Dong, WZ; Yang, GS; Pang, WJ				Cai, Rui; Qimuge, Naren; Ma, Meilin; Wang, Yingqian; Tang, Guorong; Zhang, Que; Sun, Yunmei; Chen, Xiaochang; Yu, Taiyong; Dong, Wuzi; Yang, Gongshe; Pang, Weijun			MicroRNA-664-5p promotes myoblast proliferation and inhibits myoblast differentiation by targeting serum response factor and Wnt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); muscle; myogenesis; Wnt pathway; cell proliferation; cell differentiation; post-transcriptional regulation	SKELETAL-MUSCLE; SIGNALING PATHWAY; GENE ONTOLOGY; CELL; EXPRESSION; SRF; TRANSCRIPTION; MYOCARDIN; MYOGENESIS; GROWTH	MicroRNAs (miRNAs) are noncoding RNAs that regulate gene expression at the post-transcriptional level and are involved in the regulation of the formation, maintenance, and function of skeletal muscle. Using miRNA sequencing and bioinformatics analysis, we previously found that the miRNA miR-664-5p is significantly differentially expressed in longissimus dorsi muscles of Rongchang pigs. However, the molecular mechanism by which miR-664-5p regulates myogenesis remains unclear. In this study, using flow cytometry, 5-ethynyl-2-deoxyuridine staining, and cell count and immunofluorescent assays, we found that cell-transfected miR-664-5p mimics greatly promoted proliferation of C2C12 mouse myoblasts by increasing the proportion of cells in the S- and G(2)-phases and up-regulating the expression of cell cycle genes. Moreover, miR-664-5p inhibited myoblast differentiation by down-regulating myogenic gene expression. In contrast, miR-664-5p inhibitor repressed myoblast proliferation and promoted myoblast differentiation. Mechanistically, using dual-luciferase reporter gene experiments, we demonstrated that miR-664-5p directly targets the 3-UTR of serum response factor (SRF) and Wnt1 mRNAs. We also observed that miR-664-5p inhibits both mRNA and protein levels of SRF and Wnt1 during myoblast proliferation and myogenic differentiation, respectively. Furthermore, the activating effect of miR-664-5p on myoblast proliferation was attenuated by SRF overexpression, and miR-664-5p repressed myogenic differentiation by diminishing the accumulation of nuclear -catenin. Of note, miR-664-5p's inhibitory effect on myogenic differentiation was abrogated by treatment with Wnt1 protein, the key activator of the Wnt/-catenin signaling pathway. Collectively, our findings suggest that miR-664-5p controls SRF and canonical Wnt/-catenin signaling pathways in myogenesis.	[Cai, Rui; Qimuge, Naren; Ma, Meilin; Wang, Yingqian; Tang, Guorong; Zhang, Que; Sun, Yunmei; Chen, Xiaochang; Yu, Taiyong; Dong, Wuzi; Yang, Gongshe; Pang, Weijun] Northwest A&F Univ, Coll Anim Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Pang, WJ (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling 712100, Shaanxi, Peoples R China.	pwj1226@nwsuaf.edu.cn	Tang, jay/GXF-3897-2022; Cai, Rui/GRO-1869-2022	Tang, Guping/0000-0003-3256-740X	National Natural Science Foundation [31572366, 31872979]; National Basic Research Programs of China [2015CB943102]; National Key Research and Development Program of China [2017YFD0502002]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Programs of China(National Basic Research Program of China); National Key Research and Development Program of China	This work was supported by National Natural Science Foundation Grants 31572366 and 31872979, National Basic Research Programs of China Grant 2015CB943102, and the National Key Research and Development Program of China Grant 2017YFD0502002. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham ST, 2016, IN VITRO CELL DEV-AN, V52, P935, DOI 10.1007/s11626-016-0058-5; Abu-Elmagd M, 2010, DEV BIOL, V337, P211, DOI 10.1016/j.ydbio.2009.10.023; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chen B, 2015, BIOMED PHARMACOTHER, V75, P1, DOI 10.1016/j.biopha.2015.08.012; Chen H, 2016, FISH SHELLFISH IMMUN, V55, P577, DOI 10.1016/j.fsi.2016.06.036; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; DALTON S, 1993, PHILOS T ROY SOC B, V340, P325, DOI 10.1098/rstb.1993.0074; Du JJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5276271; Du JJ, 2016, BIOSCI BIOTECH BIOCH, V80, P706, DOI 10.1080/09168451.2015.1123604; Feng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.462; Goljanek-Whysall K, 2012, CLIN SCI, V123, P611, DOI 10.1042/CS20110634; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Han XR, 2015, FASEB J, V29, P3054, DOI 10.1096/fj.14-259952; Hauschka SD, 2001, MOL CELL, V8, P1, DOI 10.1016/S1097-2765(01)00297-0; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; L'honore A, 2003, MOL BIOL CELL, V14, P2151, DOI 10.1091/mbc.e02-07-0451; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Ma ML, 2017, RNA BIOL, V14, P347, DOI 10.1080/15476286.2017.1279786; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Polioudakis D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126535; Price MA, 1996, PHILOS T ROY SOC B, V351, P551, DOI 10.1098/rstb.1996.0054; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shi L, 2015, CELL SIGNAL, V27, P1895, DOI 10.1016/j.cellsig.2015.05.001; Sokol NS, 2012, CURR TOP DEV BIOL, V99, P59, DOI 10.1016/B978-0-12-387038-4.00003-3; Song P, 2014, MOL MED REP, V10, P1030, DOI 10.3892/mmr.2014.2261; Sun ZR, 2014, INT J MOL MED, V33, P1097, DOI 10.3892/ijmm.2014.1672; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van Delft JHM, 2010, TOXICOL SCI, V117, P381, DOI 10.1093/toxsci/kfq214; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang HY, 2015, INT J ONCOL, V47, P641, DOI 10.3892/ijo.2015.3034; Wang R, 2015, GENET MOL RES, V14, P7315, DOI 10.4238/2015.July.3.7; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Wei W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.184; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yang Y, 2015, INT J CLIN EXP MED, V8, P18123; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zeng CX, 2015, ONCOTARGET, V6, P12224, DOI 10.18632/oncotarget.3652; Zhou HL, 2014, RNA, V20, P1431, DOI 10.1261/rna.045757.114	59	17	18	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19177	19190		10.1074/jbc.RA118.003198	http://dx.doi.org/10.1074/jbc.RA118.003198			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30323063	Green Published, hybrid			2022-12-26	WOS:000453537300002
J	Zhang, Q; Han, X; Chen, JF; Xie, XM; Xu, JF; Zhao, Y; Shen, J; Hu, L; Xu, PL; Song, H; Zhang, L; Zhao, B; Wang, YJ; Xia, ZP				Zhang, Qiong; Han, Xu; Chen, Jinfeng; Xie, Xiaomei; Xu, Jiafeng; Zhao, Yang; Shen, Jie; Hu, Lin; Xu, Pinglong; Song, Hai; Zhang, Long; Zhao, Bin; Wang, Ying-jie; Xia, Zongping			Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) mediate cell density-dependent proinflammatory responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hippo pathway; NF-B; histone deacetylase (HDAC); inflammation; cytokine; cell signaling; Yes-associated protein (YAP); COX-2; TAZ; TEADs	NF-KAPPA-B; HIPPO PATHWAY; CYCLOOXYGENASE-2 EXPRESSION; TUMOR-SUPPRESSOR; PROLIFERATION ARREST; TEAD/TEF FAMILY; UP-REGULATION; ORGAN SIZE; GROWTH; DROSOPHILA	A proper inflammatory response is critical to the restoration of tissue homeostasis after injury or infection, but how such a response is modulated by the physical properties of the cellular and tissue microenvironments is not fully understood. Here, using H358, HeLa, and HEK293T cells, we report that cell density can modulate inflammatory responses through the Hippo signaling pathway. We found that NF-B activation through the proinflammatory cytokines interleukin-1 (IL-1) and tumor necrosis factor (TNF) is not affected by cell density. However, we also noted that specific NF-B target genes, such as cyclooxygenase 2 (COX-2), are induced much less at low cell densities than at high cell densities. Mechanistically, we observed that the transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) are localized to the nucleus, bind to TEA domain transcription factors (TEADs), recruit histone deacetylase 7 (HDAC7) to the promoter region of COX-2, and repress its transcription at low cell density and that high cell density abrogates this YAP/TAZ-mediated transcriptional repression. Of note, IL-1 stimulation promoted cell migration and invasion mainly through COX-2 induction, but YAP inhibited this induction and thus cell migration and invasion. These results suggest that YAP/TAZ-TEAD interactions can repress COX-2 transcription and thereby mediate cell density-dependent modulation of proinflammatory responses. Our findings highlight that the cellular microenvironment significantly influences inflammatory responses via the Hippo pathway.	[Zhang, Qiong; Han, Xu; Xie, Xiaomei; Xu, Jiafeng; Zhao, Yang; Xu, Pinglong; Song, Hai; Zhang, Long; Zhao, Bin; Xia, Zongping] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Qiong; Han, Xu; Xie, Xiaomei; Xu, Jiafeng; Zhao, Yang; Xu, Pinglong; Song, Hai; Zhang, Long; Zhao, Bin; Xia, Zongping] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Qiong; Chen, Jinfeng; Xia, Zongping] Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou 450052, Henan, Peoples R China; [Zhang, Qiong; Wang, Ying-jie] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Shen, Jie] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Xie, Xiaomei] Zhejiang Gongshang Univ, Youth League Comm, Hangzhou 310018, Zhejiang, Peoples R China; [Hu, Lin] Soochow Univ, Inst Biol Sci, Suzhou 215000, Jiangsu, Peoples R China; [Hu, Lin] Soochow Univ, Inst Med Sci, Suzhou 215000, Jiangsu, Peoples R China	Zhejiang University; Zhejiang University; Zhengzhou University; Zhejiang University; Zhejiang University; Zhejiang Gongshang University; Soochow University - China; Soochow University - China	Xia, ZP (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Xia, ZP (corresponding author), Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China.; Xia, ZP (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou 450052, Henan, Peoples R China.	zxia2018@zzu.edu.cn	Zhang, Long/AAT-6571-2021; Xu, Pinglong/AAF-6838-2019; Xu, Pinglong/AAN-2506-2021	Zhang, Long/0000-0001-8139-0474; Xu, Pinglong/0000-0001-7726-5443; Hu, Lin/0000-0001-8986-3918	National Key Research and Development Program of China, Stem Cell and Translational Research Grant [2016YFA0100300]; Natural Science Foundation of China [31571445, 31371416, 31401200]	National Key Research and Development Program of China, Stem Cell and Translational Research Grant; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research and Development Program of China, Stem Cell and Translational Research Grant 2016YFA0100300 (to Z.X. and Y.W.) and Natural Science Foundation of China Grants 31571445 and 31371416 (to Z.X.) and 31401200 (to X.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abolhassani M, 2008, INFLAMM RES, V57, P419, DOI 10.1007/s00011-007-7213-0; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Basan M, 2009, HFSP J, V3, P265, DOI 10.2976/1.3086732; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cha YI, 2006, DEV BIOL, V289, P263, DOI 10.1016/j.ydbio.2005.10.013; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Cianchi F, 2001, GASTROENTEROLOGY, V121, P1339, DOI 10.1053/gast.2001.29691; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ehsanian R, 2010, ONCOGENE, V29, P6160, DOI 10.1038/onc.2010.339; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Guo XC, 2017, GENE DEV, V31, P247, DOI 10.1101/gad.294348.116; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Howe LR, 2001, J BIOL CHEM, V276, P20108, DOI 10.1074/jbc.M010692200; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Huang SP, 2005, J BIOMED SCI, V12, P229, DOI 10.1007/s11373-004-8177-5; Jang BC, 2000, J BIOL CHEM, V275, P39507, DOI 10.1074/jbc.M003224200; Jiang SW, 1996, J BIOL CHEM, V271, P9510, DOI 10.1074/jbc.271.16.9510; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Kim HS, 2003, LUNG CANCER-J IASLC, V42, P163, DOI 10.1016/S0169-5002(03)00290-3; Kim M, 2015, CELL REP, V11, P270, DOI 10.1016/j.celrep.2015.03.015; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kulinsky VI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P595, DOI 10.1134/S0006297907060028; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nowell CS, 2016, NAT CELL BIOL, V18, P168, DOI 10.1038/ncb3290; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Schwartz L, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-21; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Sharif GM, 2015, ONCOGENE, V34, P5879, DOI 10.1038/onc.2015.44; Sheehan KM, 1999, JAMA-J AM MED ASSOC, V282, P1254, DOI 10.1001/jama.282.13.1254; Shimomura T, 2014, BIOCHEM BIOPH RES CO, V443, P917, DOI 10.1016/j.bbrc.2013.12.100; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Tucker ON, 1999, CANCER RES, V59, P987; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang DZ, 2004, P NATL ACAD SCI USA, V101, P415, DOI 10.1073/pnas.0307640100; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Williams CS, 2000, J CLIN INVEST, V105, P1589, DOI 10.1172/JCI9621; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XU TA, 1995, DEVELOPMENT, V121, P1053; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yip-Schneider MT, 2000, CARCINOGENESIS, V21, P139, DOI 10.1093/carcin/21.2.139; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu SJ, 2013, CLIN CANCER RES, V19, P1389, DOI 10.1158/1078-0432.CCR-12-1959; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang Q, 2017, NAT CELL BIOL, V19, P362, DOI 10.1038/ncb3496; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	75	22	24	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18071	18085		10.1074/jbc.RA118.004251	http://dx.doi.org/10.1074/jbc.RA118.004251			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30315101	hybrid, Green Published			2022-12-26	WOS:000451375200005
J	Hand, K; Wilkinson, MC; Madine, J				Hand, Kieran; Wilkinson, Mark C.; Madine, Jillian			Isolation and purification of recombinant immunoglobulin light chain variable domains from the periplasmic space of Escherichia coli	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; CIRCULAR-DICHROISM; SELF-ASSOCIATION; PROTEIN; STABILITY; FIBRILLOGENICITY; TRAFFICKING; SEQUENCE; PEPTIDE	Immunoglobulin light chain amyloidosis is the most common form of systemic amyloidosis. However, very little is known about the underlying mechanisms that initiate and modulate the associated protein aggregation and deposition. Model systems have been established to investigate these disease-associated processes. One of these systems comprises two 114 amino acid light-chain variable domains of the kappa 4 IgG family, SMA and LEN. Despite high sequence identity (93%), SMA is amyloidogenic in vivo, but LEN adopts a stable dimer, displaying amyloidogenic properties only under destabilising conditions in vitro. We present here a refined and reproducible periplasmic expression and purification protocol for SMA and LEN that improves on existing methods and provides high yields of pure protein (10-50mg/L), particularly suitable for structural studies that demand highly concentrated and purified proteins. We confirm that recombinant SMA and LEN proteins have structure and dimerization capabilities consistent with the native proteins and employ fluorescence to probe internalization and cellular localization within cardiomyocytes. We propose periplasmic expression and simplified chromatographic steps outlined here as an optimized method for production of these and other variable light chain domains to investigate the underlying mechanisms of light chain amyloidosis. We show that SMA and LEN can be internalised within cardiomyocytes and were observed to localise to the perinuclear area, assessed by confocal microscopy as a possible mechanism for underlying cytotoxicity and pathogenesis associated with amyloidosis.	[Hand, Kieran; Wilkinson, Mark C.; Madine, Jillian] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England	University of Liverpool	Madine, J (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.	J.Madine@liv.ac.uk	Madine, Jillian/AAM-6232-2021	Madine, Jillian/0000-0001-9963-5871; Wilkinson, Mark/0000-0003-3109-6888	British Heart Foundation [FS/12/61/29877]; Biotechnology and Biological Sciences Research Council DTP Studentship	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council DTP Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the British Heart Foundation (to JM), FS/12/61/29877, www.bhf.org.uk, and the Biotechnology and Biological Sciences Research Council DTP Studentship (to KH), www.bbsrc.ukri.org/skills/investing-doctoraltraining/dtp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Blancas-Mejia LM, 2009, J MOL BIOL, V386, P1153, DOI 10.1016/j.jmb.2008.12.069; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Davis DP, 2000, IMMUNITY, V13, P433, DOI 10.1016/S1074-7613(00)00043-1; Yauner LD, 2008, PROTEINS, V72, P684, DOI 10.1002/prot.21934; Dispenzieri A, 2015, MAYO CLIN PROC, V90, P1054, DOI 10.1016/j.mayocp.2015.06.009; Dow BA, 2015, PROTEIN EXPRES PURIF, V108, P9, DOI 10.1016/j.pep.2014.12.017; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GLENNER GG, 1969, J HISTOCHEM CYTOCHEM, V17, P769, DOI 10.1177/17.12.769; Goemans C, 2014, BBA-MOL CELL RES, V1843, P1517, DOI 10.1016/j.bbamcr.2013.10.014; Huang F, 2013, EUR J NANOMED, V5, P51, DOI 10.1515/ejnm-2012-0009; Khurana R, 2003, AMYLOID, V10, P97, DOI 10.3109/13506120309041731; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Lavatelli F, 2008, MOL CELL PROTEOMICS, V7, P1570, DOI 10.1074/mcp.M700545-MCP200; Levinson RT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01278; Lux K, 2005, J VIROL, V79, P11776, DOI 10.1128/JVI.79.18.11776-11787.2005; Marin-Argany M, 2016, J BIOL CHEM, V291, P19813, DOI 10.1074/jbc.M116.736736; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; NEU HC, 1965, J BIOL CHEM, V240, P3685; Oberti L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16953-7; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V245, P713, DOI 10.1006/bbrc.1998.8515; Park SJ, 1998, BIOTECHNOL TECH, V12, P815, DOI 10.1023/A:1008844013548; Poshusta TL, 2013, INT J MOL SCI, V14, P22604, DOI 10.3390/ijms141122604; PRAS M, 1968, J CLIN INVEST, V47, P924; Qin ZJ, 2007, BIOCHEMISTRY-US, V46, P3521, DOI 10.1021/bi061716v; Raffen R, 1998, PROTEIN ENG, V11, P303, DOI 10.1093/protein/11.4.303; Raffen R, 1999, PROTEIN SCI, V8, P509; Ramirez-Alvarado M, 2012, CURR TOP MED CHEM, V12, P2523; RAMIREZALVARADO M, 2007, PROTEIN MISFOLDING B, P183; Redler RL, 2016, J MOL EVOL, V82, P11, DOI 10.1007/s00239-015-9717-5; Ribela MTCP, 2000, PROTEIN EXPRES PURIF, V18, P115, DOI 10.1006/prep.1999.1184; Rognoni P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076022; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Sipe JD, 2016, AMYLOID, V23, P209, DOI 10.1080/13506129.2016.1257986; SOLOMON A, 1985, METHOD ENZYMOL, V116, P101; Souillac PO, 2002, J BIOL CHEM, V277, P12657, DOI 10.1074/jbc.M109230200; Sreerama N, 1999, BIOCHEMISTRY-US, V38, P10814, DOI 10.1021/bi990516z; STEVENS FJ, 1981, BIOCHEM J, V195, P213, DOI 10.1042/bj1950213; STEVENS FJ, 1980, P NATL ACAD SCI-BIOL, V77, P1144, DOI 10.1073/pnas.77.2.1144; STEVENS PW, 1995, PROTEIN SCI, V4, P421; Teng JM, 2004, LAB INVEST, V84, P440, DOI 10.1038/labinvest.3700069; Trinkaus-Randall V, 2005, AM J PATHOL, V166, P197, DOI 10.1016/S0002-9440(10)62244-4; Vallejo LF, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-11; Vasquez-Laslop N, 2001, J BACTERIOL, V183, P2399, DOI 10.1128/JB.183.8.2399-2404.2001; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; WINZOR DJ, 1963, BIOCHEMISTRY-US, V2, P1263, DOI 10.1021/bi00906a016	50	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0206167	10.1371/journal.pone.0206167	http://dx.doi.org/10.1371/journal.pone.0206167			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30347409	Green Submitted, Green Published, gold			2022-12-26	WOS:000447938400042
J	Menon, JA; Kusanthan, T; Mwaba, SOC; Juanola, L; Kok, MC				Menon, J. A.; Kusanthan, T.; Mwaba, S. O. C.; Juanola, L.; Kok, M. C.			'Ring' your future, without changing diaper - Can preventing teenage pregnancy address child marriage in Zambia?	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; REPRODUCTIVE HEALTH	Teenage pregnancy and child marriage are prevalent in Zambia and are complexly interrelated issues with common causes and effects. The aim of this study was to explore factors in the social and cultural environment shaping young people's sexual behaviour, with specific attention to teenage pregnancy and child marriage in Eastern Zambia. The study was conducted in selected wards in Petauke, Chadiza and Katete districts, using an exploratory mixed-method design including a household survey, focus group discussions and in-depth interviews. The participants included 1,434 young females and males aged 15 to 24, female and male parents and caregivers; grandmothers; traditional leaders; teachers; health and social workers; representatives from youth associations, community-based and non-governmental organizations; and district level policy makers. Qualitative data were analysed using thematic content analysis and NVivo was used to manage the data, while survey data were analysed using Stata. The study revealed a high prevalence rate of teenage pregnancy (48%) and child marriage (13%) among young women. The mean age at first pregnancy or fatherhood was lower among female (17) than male respondents (20). A clear interlinkage between teenage pregnancy and child marriage was found, the two issues were mutually reinforcing. While teenage pregnancy appeared both as a cause and consequence of child marriage, marriage was mostly a common response to pregnancy. Early sexual debut, limited knowledge and use of contraception, poverty and limited future perspectives as well as sexual and gender norms were identified as the main causative factors of teenage pregnancy and therefore, child marriage. Based on the findings, a conceptual model to explain the interrelationships between young people's sexual behaviour, teenage pregnancy and child marriage is discussed. To address teenage pregnancy and child marriage in Eastern Zambia, there is a need to look into the realities and needs of young people regarding sex and relationships.	[Menon, J. A.; Mwaba, S. O. C.] Univ Zambia, Dept Psychol, Lusaka, Zambia; [Kusanthan, T.] Univ Zambia, Dept Gender Studies, Lusaka, Zambia; [Juanola, L.; Kok, M. C.] KIT Royal Trop Inst, KIT Hlth, Amsterdam, Netherlands	University of Zambia; University of Zambia	Menon, JA (corresponding author), Univ Zambia, Dept Psychol, Lusaka, Zambia.	anithamenon316@gmail.com		Menon, J. Anitha/0000-0002-7388-7509	Dutch Ministry of Foreign Affairs	Dutch Ministry of Foreign Affairs	Funding was received from The Dutch Ministry of Foreign Affairs.; The study was part of a baseline study for the Yes I Do programme (2016-2020), in Zambia implemented by an Alliance including Plan Zambia and Generation Alive. The programme focuses on forming a social movement, empowering and meaningfully engage young people, improving access to information and services, stimulating education and economic empowerment for especially girls and enhancing evidence-based lobby and advocacy for improved legal and policy frameworks, in the light of enhancing youth sexuality and prevention of teenage pregnancy and child marriage. The Yes I Do programme, which is implemented in Ethiopia, Kenya, Malawi, Mozambique, Zambia, Indonesia and Pakistan, is funded by the Dutch Ministry of Foreign Affairs. The programme is implemented by a consortium composed of the following Dutch partners: Plan Netherlands, Amref, Rutgers, Choice for Youth and Sexuality and the Royal Tropical Institute (KIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FH, 2005, HLTH CARE SEEKING UT; Alene GD, 2004, AIDS CARE, V16, P57, DOI 10.1080/09540120310001633976; Aliu B., 2012, INT J PSYCHOL COUNSE, V4, P6, DOI [10.5897/IJPC11.030, DOI 10.5897/IJPC11.030]; [Anonymous], 2012, MOTHERHOOD CHILDHOOD; [Anonymous], 2012, EV THREAT ANT RES; Bhanji S. M., 2014, J WOMENS HLTH CARE, V3, P161, DOI [10.4172/2167-0420.1000161, DOI 10.4172/2167-0420.1000161]; Biddlecom Ann E, 2007, Afr J Reprod Health, V11, P99, DOI 10.2307/25549734; Blackstone SR, 2017, INT Q COMMUNITY HEAL, V37, P79, DOI 10.1177/0272684X16685254; Creswell J.W., 2003, HDB MIXED METHODS SO, V209, P209, DOI DOI 10.4135/9781506335193; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Douglas K, 2005, IMPACT SEX HIV ED PR; Innocenti Research Centre, 2001, EARL MARR CHILD SPOU; Kamal SMM, 2015, J BIOSOC SCI, V47, P120, DOI 10.1017/S0021932013000746; Kapungwe A., 2003, AFR SOCIOL REV, V7, P35, DOI [https://doi.org/10.4314/asr.v7i1.23129, DOI 10.4314/ASR.V7I1.23129]; Kipp Walter, 2007, Int J Adolesc Med Health, V19, P383; Lambani M. N., 2015, Journal of Sociology and Social Anthropology, V6, P171; Lindberg C, 2006, COMPR CHILD ADOLES N, V29, P73, DOI 10.1080/01460860600677577; Loaiza E., 2013, ADOLESCENT PREGNANCY; Mbozi P., 2000, MEDIA HIV AIDS E SO; Meekers D, 2002, STUD FAMILY PLANN, V33, P335, DOI 10.1111/j.1728-4465.2002.00335.x; Nangoma A., 2013, FINAL ADVOCACY RES R; Ngomi KB, 2009, UTILISATION SEXUAL R; Odimegwu C, 2016, AFR J REPROD HEALTH, V20, P94, DOI 10.29063/ajrh2016/v20i3.14; Plan International, 2016, END CHILD MARR ZAMB; Restless Development, 2014, TEEN PREGN ZAMB DESK; Steward WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071778; Swidler A, 2007, STUD FAMILY PLANN, V38, P147, DOI 10.1111/j.1728-4465.2007.00127.x; UNFPA, 2013, GIRLH NOT MOTH PREV; UNICEF, 2015, QUAL STUD CHILD MARR; Walker Judith-Ann, 2012, Afr J Reprod Health, V16, P231; Warner Elizabeth, 2004, AM U J GENDER SOCIAL, V12, P233; Williamson N, 2013, MOTHERHOOD CHILDHOOD; Yarrow E, 2015, GETTING EVIDENCE ASI; Zambia Statistics Agency Ministry of Health Zambia ICF., 2019, ZAMB DEM HLTH SURV 2; Zulu EM, 2002, POP STUD-J DEMOG, V56, P311, DOI 10.1080/00324720215933	35	14	14	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205523	10.1371/journal.pone.0205523	http://dx.doi.org/10.1371/journal.pone.0205523			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX7HS	30346966	gold, Green Published, Green Submitted			2022-12-26	WOS:000447938400012
J	Birch, JM; Ullman, K; Struve, T; Agger, JF; Hammer, AS; Leijon, M; Jensen, HE				Birch, Julie Melsted; Ullman, Karin; Struve, Tina; Agger, Jens Frederik; Hammer, Anne Sofie; Leijon, Mikael; Jensen, Henrik Elvang			Investigation of the viral and bacterial microbiota in intestinal samples from mink (Neovison vison) with pre-weaning diarrhea syndrome using next generation sequencing	PLOS ONE			English	Article							ENTEROADHERENT ENTEROCOCCUS-HIRAE; STAPHYLOCOCCUS-DELPHINI; ESCHERICHIA-COLI; FARMED MINK; INFECTION; BIOLOGY; KITS; COLONIZATION; MUSTELIDAE; SCHREIBER	Pre-weaning diarrhea (PWD) in mink kits is a common multifactorial syndrome on commercial mink farms. Several potential pathogens such as astroviruses, caliciviruses, Escherichia coli and Staphylococcus delphini have been studied, but the etiology of the syndrome seems complex. In pooled samples from 38 diarrheic and 42 non-diarrheic litters, each comprising of intestinal contents from 2-3 mink kits from the same litter, the bacterial populations were studied using Illumina Next Generation Sequencing technology and targeted 16S amplicon sequencing. In addition, we used deep sequencing to determine and compare the viral intestinal content in 31 healthy non-diarrheic and 30 diarrheic pooled samples (2-3 mink kits from the same litter per pool). The results showed high variations in composition of the bacterial species between the pools. Enterococci, staphylococci and streptococci dominated in both diarrheic and non-diarrheic pools. However, enterococci accounted for 70% of the reads in the diarrheic group compared to 50% in the non-diarrheic group and this increase was at the expense of staphylococci and streptococci which together accounted for 45% and 17% of the reads in the non-diarrheic and diarrheic group, respectively. Moreover, in the diarrheic pools there were more reads assigned to Clostridia, Escherichia-Shigella and Enterobacter compared to the non-diarrheic pools. The taxonomically categorized sequences from the virome showed that the most prevalent viruses in all pools were caliciviruses and mamastroviruses (almost exclusively type 10). However, the numbers of reads assigned to caliciviruses were almost 3 times higher in the diarrheic pools compared the non-diarrheic pools and Sapporo-like caliciviruses were more abundant than the Norwalklike caliciviruses. The results from this study have contributed to the insight into the changes in the intestinal microbiota associated with the PWD syndrome of mink.	[Birch, Julie Melsted; Agger, Jens Frederik; Hammer, Anne Sofie; Jensen, Henrik Elvang] Univ Copenhagen, Dept Vet & Anim Sci, Fac Hlth & Med Sci, Frederiksberg C, Denmark; [Ullman, Karin; Leijon, Mikael] Natl Vet Inst, Dept Microbiol, Uppsala, Sweden; [Struve, Tina] Kopenhagen Fur, Kopenhagen Fur Diagnost, Glostrup, Denmark	University of Copenhagen; National Veterinary Institute SVA	Birch, JM (corresponding author), Univ Copenhagen, Dept Vet & Anim Sci, Fac Hlth & Med Sci, Frederiksberg C, Denmark.	jubi@sund.ku.dk	Ullman, Karin/HGB-8576-2022	Jensen, Henrik Elvang/0000-0001-7277-7829; Leijon, Mikael/0000-0001-8701-9887	Pelsdyrafgiftsfonden; Dansk Pelsdyravlerforenings Forskningsfond; Innovation Fund Denmark	Pelsdyrafgiftsfonden; Dansk Pelsdyravlerforenings Forskningsfond; Innovation Fund Denmark	This project was cofounded by Pelsdyrafgiftsfonden, Dansk Pelsdyravlerforenings Forskningsfond and the Innovation Fund Denmark. Tina Struve (TS) is employed by Kopenhagen Fur as a diagnostic veterinarian and coordinator for more PhD studies. The funder provided support in the form of salaries for authors [JMB, KU, TS, JFA, ASH, ML and HEJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahl MI, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.434; Belak S, 2013, REV SCI TECH OIE, V32, P893; Birch JM, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-017-0312-1; Bodewes R, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-89; Brown JR, 2015, CLIN INFECT DIS, V60, P881, DOI 10.1093/cid/ciu940; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Cattoli G., 2013, ASTROVIRUS RES ESSEN, P135; Chalmers G, 2015, CAN J VET RES, V79, P129; Chriel M., 1997, Dansk Pelsdyravl, V60, P196; Clausen T. N., 2004, Scientifur, V28, P87; Cortez V, 2017, ANNU REV VIROL, V4, P327, DOI 10.1146/annurev-virology-101416-041742; Danieu P. K., 2005, Proceedings of the Institute for Zoo and Wildlife Research, Berlin, P122; De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024; Dietz H. H., 2006, BRIEF COMPENDIUM MOS; Englund L, 2002, VET MICROBIOL, V85, P1, DOI 10.1016/S0378-1135(01)00472-2; ETHERIDGE ME, 1988, J CLIN MICROBIOL, V26, P1741, DOI 10.1128/JCM.26.9.1741-1744.1988; ETHERIDGE ME, 1992, LAB ANIM SCI, V42, P548; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Gary JM, 2014, J COMP PATHOL, V151, P314, DOI 10.1016/j.jcpa.2014.08.004; Guardabassi L, 2012, VET MICROBIOL, V159, P351, DOI 10.1016/j.vetmic.2012.04.004; Gugolek A, 2015, J EXP ZOOL PART A, V323, P637, DOI 10.1002/jez.1954; Guo M, 2001, ARCH VIROL, V146, P479, DOI 10.1007/s007050170157; Hansen S. J., 2014, THESIS; HAVE P, 1992, VET MICROBIOL, V31, P1, DOI 10.1016/0378-1135(92)90135-G; HENRIKSEN P, 1987, Dansk Veterinaertidsskrift, V70, P580; Henriksen P, 1988, P 4 INT C AN PROD IF, P208; Hermann-Bank ML, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0419-4; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; HYLDGAARD-JENSEN C, 1989, Dansk Veterinaertidsskrift, V72, P566; Jensen BB, ANN REPORT 1993 1994, P127; Johnson CJ, 2017, VIRUSES, V9, P1, DOI [10.1007/978-1-4614-4735-1_4, DOI 10.1007/978-1-4614-4735-1_4]; Jonach B, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-68; Jorgensen M, 1996, ACTA VET SCAND, V37, P163; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; Larsson J, 2014, J COMP PATHOL, V151, P137, DOI 10.1016/j.jcpa.2014.04.003; Larsson J., 2016, NEONATAL PORCINE DIA; Marker LM, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix092; Matamoros S, 2013, TRENDS MICROBIOL, V21, P167, DOI 10.1016/j.tim.2012.12.001; Moller S. H., 2000, Scientifur, V24, P37; Nicklas JL, 2010, J CLIN MICROBIOL, V48, P2814, DOI 10.1128/JCM.00916-09; PEDERSEN K, 1992, ACTA VET SCAND, V33, P95; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Sledge DG, 2010, VET PATHOL, V47, P751, DOI 10.1177/0300985810364514; Smits SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071595; Smura T, 2016, P 11 INT SCI C FUR A, P17; Svansson V, 1991, THESIS; Svennekjaer NC, 1954, DANSK PELSDYRAVL, V17, P384; Vulfson L, 2001, VET MICROBIOL, V79, P143, DOI 10.1016/S0378-1135(00)00343-6; Vulfson L, 2003, VET MICROBIOL, V93, P235, DOI 10.1016/S0378-1135(03)00037-3; Whittaker RH, 1972, EVOLUTION MEASUREMEN, P213; Williams C, 1998, ACTA VET SCAND, V39, P473; Zhao HP, 2017, CURR MICROBIOL, V74, P1169, DOI 10.1007/s00284-017-1301-3; Zhu HC, 2009, J GEN VIROL, V90, P883, DOI 10.1099/vir.0.007732-0	54	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205890	10.1371/journal.pone.0205890	http://dx.doi.org/10.1371/journal.pone.0205890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335814	Green Submitted, Green Published, gold			2022-12-26	WOS:000447701300069
J	Akagawa, M; Miyakoshi, N; Kasukawa, Y; Ono, Y; Yuasa, Y; Nagahata, I; Sato, C; Tsuchie, H; Nagasawa, H; Hongo, M; Shimada, Y				Akagawa, Manabu; Miyakoshi, Naohisa; Kasukawa, Yuji; Ono, Yuichi; Yuasa, Yusuke; Nagahata, Itsuki; Sato, Chiaki; Tsuchie, Hiroyuki; Nagasawa, Hiroyuki; Hongo, Michio; Shimada, Yoichi			Effects of activated vitamin D, alfacalcidol, and low-intensity aerobic exercise on osteopenia and muscle atrophy in type 2 diabetes mellitus model rats	PLOS ONE			English	Article							BONE-MINERAL DENSITY; SKELETAL-MUSCLE; INSULIN-RESISTANCE; D SUPPLEMENTATION; OSTEOPOROTIC FRACTURE; BODY-COMPOSITION; GLYCEMIC CONTROL; HIP FRACTURE; OLDER-ADULTS; RISK	Diabetes mellitus causes secondary osteoporosis and muscle atrophy. The ability of alfacalcidol (ALF) and exercise (Exe) to inhibit osteoporosis and muscle atrophy in type 2 diabetes mellitus (T2DM) model rats was examined. Twenty-week-old Otsuka Long-Evans Tokushima Fatty rats were randomized to ALF (orally 0.1 mu g/kg/day), Exe (treadmill exercise at 10 m/min, 60 min/day, 5 days/week), Comb (ALF and Exe), and Cont (T2DM control treated with vehicle and no exercise) groups (n = 8-10 per group). Sedentary Long-Evans Tokushima Otsuka rats were used as a non-hyperphagic control. After treatment for 2 or 6 weeks, blood glucose (BG) levels, cross-sectional area (CSA) of tibialis anterior muscle fibers, femoral bone mineral density (BMD), and relative quantities of muscle anabolic markers (Pax7, MyoD, and myogenin) and catabolic markers (Atrogin-1, MuRF1, and REDD1) of the soleus muscle assessed by real-time polymerase chain reaction assays were measured. Exe and Comb treatments for 6 weeks decreased BG levels compared with those of the Cont group. ALF, Exe, and Comb treatments for 2 and 6 weeks recovered the CSA compared with that of the Cont group. ALF and Comb treatments for 6 weeks increased femoral BMDs compared with those of the Cont group. After 2 weeks of treatment, Comb treatment increased MyoD expression and decreased MuRF1 expression. ALF or Exe monotherapy significantly decreased Atrogin-1 or MuRF1 expression after 2 weeks of treatment, respectively. After 6 weeks of treatment, ALF and Comb treatments decreased Atrogin-1 and REDD1. These results demonstrate that a combination of ALF and Exe improved CSA from the early phase of treatment by stimulating skeletal muscle differentiation and suppressing muscle catabolic genes. Improvements in BG, BMD, and CSA were observed as long-term effects of the combination therapy. Continued suppression of muscle catabolic genes was observed as a background to these effects.	[Akagawa, Manabu; Miyakoshi, Naohisa; Kasukawa, Yuji; Ono, Yuichi; Yuasa, Yusuke; Nagahata, Itsuki; Sato, Chiaki; Tsuchie, Hiroyuki; Nagasawa, Hiroyuki; Hongo, Michio; Shimada, Yoichi] Akita Univ, Grad Sch Med, Dept Orthoped Surg, Akita, Akita, Japan	Akita University	Miyakoshi, N (corresponding author), Akita Univ, Grad Sch Med, Dept Orthoped Surg, Akita, Akita, Japan.	miyakosh@doc.med.akita-u.ac.jp		Ono, Yuichi/0000-0001-9250-457X; Kasukawa, Yuji/0000-0001-7008-675X; Nagasawa, Hiroyuki/0000-0001-7641-8188; TSUCHIE, HIROYUKI/0000-0001-5011-7184	Japan Society for the Promotion of Science (JSPS) KAKENHI [17K10920]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant No. 17K10920), https://www.jsps.go.jp/index.html.	Allet L, 2010, DIABETOLOGIA, V53, P458, DOI 10.1007/s00125-009-1592-4; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Binder EF, 2004, JAMA-J AM MED ASSOC, V292, P837, DOI 10.1001/jama.292.7.837; Bischoff-Ferrari H A, 2009, BMJ, V339, pb3692, DOI 10.1136/bmj.b3692; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Garcia LA, 2011, ENDOCRINOLOGY, V152, P2976, DOI 10.1210/en.2011-0159; George PS, 2012, DIABETIC MED, V29, pE142, DOI 10.1111/j.1464-5491.2012.03672.x; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gregg EW, 2000, DIABETES CARE, V23, P1272, DOI 10.2337/diacare.23.9.1272; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hars M, 2016, J BONE MINER RES, V31, P2048, DOI 10.1002/jbmr.2878; He H, 2016, OSTEOPOROSIS INT, V27, P473, DOI 10.1007/s00198-015-3241-8; Hinton PS, 2015, METABOLISM, V64, P905, DOI 10.1016/j.metabol.2015.04.004; Howe TE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000333, 10.1002/14651858.CD000333.pub2]; IDF Diabet Atlas Grp, 2015, DIABETES RES CLIN PR, V109, P461, DOI 10.1016/j.diabres.2015.05.037; Iwamoto J, 2005, EXP ANIM TOKYO, V54, P1, DOI 10.1538/expanim.54.1; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kasukawa Y, 2010, BIOMED RES-TOKYO, V31, P273, DOI 10.2220/biomedres.31.273; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Kawao N, 2015, J CELL BIOCHEM, V116, P687, DOI 10.1002/jcb.25040; Kelley GA, 2007, PUBLIC HEALTH, V121, P643, DOI 10.1016/j.puhe.2007.02.014; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; Kinoshita H, 2016, J BONE MINER METAB, V34, P171, DOI 10.1007/s00774-015-0664-4; Leenders M, 2013, J AM MED DIR ASSOC, V14, P585, DOI 10.1016/j.jamda.2013.02.006; Mathey J, 2002, CALCIFIED TISSUE INT, V70, P305, DOI 10.1007/s00223-001-2077-8; Mavros Y, 2013, DIABETES CARE, V36, P2372, DOI 10.2337/dc12-2196; Minshull C, 2016, CALCIFIED TISSUE INT, V98, P426, DOI 10.1007/s00223-015-0099-x; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Miyakoshi N, 2013, J BONE MINER METAB, V31, P556, DOI 10.1007/s00774-013-0443-z; Miyakoshi N, 2010, BIOMED RES-TOKYO, V31, P329, DOI 10.2220/biomedres.31.329; Murata K, 2002, MED STAT EVIDENCE BA; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nader GA, 2001, J APPL PHYSIOL, V90, P1936, DOI 10.1152/jappl.2001.90.5.1936; NORMAN AW, 1980, SCIENCE, V209, P823, DOI 10.1126/science.6250216; Papaioannou A, 2003, OSTEOPOROSIS INT, V14, P677, DOI 10.1007/s00198-003-1423-2; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Poolsup N, 2016, DIABETIC MED, V33, P290, DOI 10.1111/dme.12893; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Sakamoto K, 2013, J ORTHOP SCI, V18, P110, DOI 10.1007/s00776-012-0328-3; Schwartz AV, 2011, JAMA-J AM MED ASSOC, V305, P2184, DOI 10.1001/jama.2011.715; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherrington C, 1997, ARCH PHYS MED REHAB, V78, P208, DOI 10.1016/S0003-9993(97)90265-3; Shiraki M, 1996, ENDOCR J, V43, P211, DOI 10.1507/endocrj.43.211; SMITH CK, 1994, J CELL PHYSIOL, V159, P379, DOI 10.1002/jcp.1041590222; Song YQ, 2013, DIABETES CARE, V36, P1422, DOI 10.2337/dc12-0962; Takagi S, 2017, CALCIFIED TISSUE INT, V101, P631, DOI 10.1007/s00223-017-0310-3; Tanaka K, 2014, BIOCHEM BIOPH RES CO, V450, P482, DOI 10.1016/j.bbrc.2014.05.145; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Wallace BA, 2000, CALCIFIED TISSUE INT, V67, P10, DOI 10.1007/s00223001089; Wallace C, 2002, DIABETES CARE, V25, P1983, DOI 10.2337/diacare.25.11.1983; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Wolff I, 1999, OSTEOPOROSIS INT, V9, P1, DOI 10.1007/s001980050109; Yamamoto M, 2009, J BONE MINER RES, V24, P702, DOI 10.1359/JBMR.081207	60	15	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204857	10.1371/journal.pone.0204857	http://dx.doi.org/10.1371/journal.pone.0204857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332436	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200037
J	Shepherd, LD; Bulgarella, M; de Lange, PJ				Shepherd, Lara D.; Bulgarella, Mariana; de Lange, Peter J.			Genetic structuring of the coastal herb Arthropodium cirratum (Asparagaceae) is shaped by low gene flow, hybridization and prehistoric translocation	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; NEW-ZEALAND; NULL ALLELES; SOFTWARE; DOMESTICATION; COLONIZATION; DIVERSITY; INFERENCE; PROGRAM	We examined the genetic structuring of rengarenga (Arthropodium cirratum; Asparagaceae), an endemic New Zealand coastal herb, using nuclear microsatellite markers. This species was brought into cultivation by Maori within the last 700-800 years for its edible roots and was transplanted beyond its natural distribution as part of its cultivation. We found very high levels of genetic structuring in the natural populations (F-ST = 0.84), indicating low levels of gene flow. Reduced genetic diversity was found in the translocated populations, suggesting a large loss of genetic diversity early in the domestication process. The data indicates that rengarenga was brought into cultivation independently at least three times, with the sources of these introductions located within a narrow area encompassing about 250km of coastline. Hybridization was inferred between A. cirratum and the closely related A. bifurcatum, despite A. birfucatum not occurring in the vicinity.	[Shepherd, Lara D.; Bulgarella, Mariana] Museum New Zealand Papa Tongarewa, Wellington, New Zealand; [de Lange, Peter J.] Unitec Inst Technol, Environm & Anim Sci, Auckland, New Zealand	Unitec NZ	Shepherd, LD (corresponding author), Museum New Zealand Papa Tongarewa, Wellington, New Zealand.	lara.shepherd@tepapa.govt.nz	de Lange, Peter/V-1338-2018; Bulgarella, Mariana/U-6951-2019; Bulgarella, Mariana/C-2760-2008	de Lange, Peter/0000-0001-6699-7083; Bulgarella, Mariana/0000-0002-7582-8529; Bulgarella, Mariana/0000-0002-7582-8529; Shepherd, Lara/0000-0002-7136-0017	Rutherford Discovery Fellowship from the Royal Society of New Zealand [RDF-MNZ1201]; Royal Society of New Zealand's Marsden Fund [MAU0709]	Rutherford Discovery Fellowship from the Royal Society of New Zealand(Royal Society of New Zealand); Royal Society of New Zealand's Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This study was funded by a Rutherford Discovery Fellowship from the Royal Society of New Zealand (contract number RDF-MNZ1201) to LDS and the Royal Society of New Zealand's Marsden Fund (contract number MAU0709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON A, 1991, ANTIQUITY, V65, P767, DOI 10.1017/S0003598X00080510; Bulgarella M, 2017, APPL PLANT SCI, V5, DOI 10.3732/apps.1700041; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Colenso W., 1880, T NZ I, V13, P3; Department of Conservation, 1996, CONS MAN STRAT BAY P, V1; Department of Conservation, 1996, AM J BOT, V2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ersts PJ, 2015, GEOGRAPHIC DISTANCE; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Gross BL, 2014, AM J BOT, V101, P1770, DOI 10.3732/ajb.1400297; Harris GF, 1996, J POLYNESIAN SOC, V105, P271; Heenan PB, 2004, NEW ZEAL J BOT, V42, P233, DOI 10.1080/0028825X.2004.9512900; HOLM S, 1979, SCAND J STAT, V6, P65; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Miller AJ, 2011, AM J BOT, V98, P1389, DOI 10.3732/ajb.1000522; Muir G, 2005, MOL ECOL, V14, P549, DOI 10.1111/j.1365-294X.2004.02418.x; Norton DA, 1997, BIODIVERS CONSERV, V6, P765, DOI 10.1023/B:BIOC.0000010401.93153.29; ORNDUFF R, 1965, ECOLOGY, V46, P864, DOI 10.2307/1934020; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pritchard JK, 2000, GENETICS, V155, P945; Reid I, 2009, INTRO PLANT LIFE NEW; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Shepherd LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152455; Shepherd LD, 2011, J PLANT RES, V124, P311, DOI 10.1007/s10265-010-0379-5; Thorsen MJ, 2009, PERSPECT PLANT ECOL, V11, P285, DOI 10.1016/j.ppees.2009.06.001; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Whistler W, 2009, PLANTS CANOE PEOPLE; Wilmshurst JM, 2011, P NATL ACAD SCI USA, V108, P1815, DOI 10.1073/pnas.1015876108; Yen D., 1990, NGA MAHI MAORI TE WA; Zhou Wei, 2012, Plant Diversity and Resources, V34, P187, DOI 10.3724/SP.J.1143.2012.11169	35	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204943	10.1371/journal.pone.0204943	http://dx.doi.org/10.1371/journal.pone.0204943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332433	Green Published, Green Submitted, gold			2022-12-26	WOS:000447638200044
J	Tichelbacker, T; Bergau, L; Puls, M; Friede, T; Mutze, T; Maier, LS; Frey, N; Hasenfuss, G; Zabel, M; Jacobshagen, C; Sossalla, S				Tichelbaecker, Tobias; Bergau, Leonard; Puls, Miriam; Friede, Tim; Muetze, Tobias; Maier, Lars Siegfried; Frey, Norbert; Hasenfuss, Gerd; Zabel, Markus; Jacobshagen, Claudius; Sossalla, Samuel			Insights into permanent pacemaker implantation following TAVR in a real-world cohort	PLOS ONE			English	Article							AORTIC-VALVE-REPLACEMENT; CONDUCTION ABNORMALITIES; TRANSCATHETER; PREDICTORS; REGURGITATION; COMPLICATIONS; DEVICE; STENOSIS; OUTCOMES; IMPACT	Background Permanent pacemaker implantation (PPI) following TAVR is a frequent post interventional complication and its management remains controversial. Objective We sought to elucidate the electrophysiological, procedural, and clinical baseline parameters that are associated with and perhaps predict the need for PPI after TAVR in a heterogeneous-valve-type real-world cohort. Methods Overall, 494 patients receiving TAVR at our center from April 2009 to August 2015 were screened. ECG analyses and clinical parameters were collected prospectively. Results Overall, 401 patients in this all-comers real-world TAVR cohort with a PPI rate of 16% were included. The mean age was 82 years, and the mean duration to PPI was 5.5 days. A large proportion of Edwards SAPIEN valves (81%), DirectFlow, Core Valve, and Portico were implanted. The main indications for PPI were atrioventricular (AV) block III, AV-block Mobitz type II, bradycardic atrial fibrillation and persistent sinus bradycardia. Between groups with and without PPI, significant differences were noted in the prevalence of post TAVR balloon dilatation, resting heart rate, QRS interval, PR interval with a cut-off of >178 ms, left anterior fascicular block and RBBB in univariate analyses. In the subsequent multiple regression analysis, post TAVR balloon dilatation and a PR interval with a cut-off of >178 ms were significant predictors of PPI. Conclusion This real-world cohort differs from others in its size and heterogeneous valve selection, and indicates for the first time that patients with post balloon dilatation or prolonged PR interval are at a higher risk for pacemaker dependency after TAVR.	[Tichelbaecker, Tobias; Bergau, Leonard; Puls, Miriam; Hasenfuss, Gerd; Zabel, Markus; Jacobshagen, Claudius; Sossalla, Samuel] Univ Med Ctr Goettingen, Clin Cardiol & Pneumol, Gottingen, Germany; [Tichelbaecker, Tobias; Bergau, Leonard; Puls, Miriam; Friede, Tim; Muetze, Tobias; Hasenfuss, Gerd; Zabel, Markus; Jacobshagen, Claudius; Sossalla, Samuel] DZHK German Ctr Cardiovasc Res, Partner Site Goettingen, Gottingen, Germany; [Tichelbaecker, Tobias] Univ Hosp Cologne, Heart Ctr Cologne, Cologne, Germany; [Friede, Tim; Muetze, Tobias] Univ Med Ctr Goettingen, Dept Med Stat, Gottingen, Germany; [Maier, Lars Siegfried; Sossalla, Samuel] Univ Hosp Regensburg, Dept Internal Med 2, Cardiol, Pneumol,Intens Care, Regensburg, Germany; [Frey, Norbert] Univ Hosp Kiel, Dept Internal Med 3, Kiel, Germany	University of Gottingen; German Centre for Cardiovascular Research; University of Cologne; University of Gottingen; University of Regensburg; University of Kiel; Schleswig Holstein University Hospital	Sossalla, S (corresponding author), Univ Med Ctr Goettingen, Clin Cardiol & Pneumol, Gottingen, Germany.; Sossalla, S (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Goettingen, Gottingen, Germany.; Sossalla, S (corresponding author), Univ Hosp Regensburg, Dept Internal Med 2, Cardiol, Pneumol,Intens Care, Regensburg, Germany.	Samuel.Sossalla@klinik.uni-regensburg.de	Sossalla, Samuel/AAF-3611-2020; Frey, Norbert/A-9695-2010; Friede, Tim/ABF-1132-2021; Tichelbäcker, Tobias/ADV-9980-2022; Frey, Norbert/M-7749-2019; Maier, Lars/AAQ-8313-2021	Friede, Tim/0000-0001-5347-7441; Tichelbäcker, Tobias/0000-0002-5321-1819; Frey, Norbert/0000-0001-7611-378X; Maier, Lars/0000-0001-9915-4429; Bergau, Leonard/0000-0001-7025-9315; Sossalla, Samuel/0000-0001-8034-2673				[Anonymous], GUID MAN VALV HEART, DOI [10.1016/S0140-6736(15)60308-7, DOI 10.1016/S0140-6736(15)60308-7]; Athappan G, 2013, J AM COLL CARDIOL, V61, P1585, DOI 10.1016/j.jacc.2013.01.047; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Fink N, 2017, INT J CARDIOL, V230, P537, DOI 10.1016/j.ijcard.2016.12.062; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gonska B, 2017, CLIN RES CARDIOL, V106, P590, DOI 10.1007/s00392-017-1093-2; Holzhey D, 2016, ANN THORAC SURG, V101, P658, DOI 10.1016/j.athoracsur.2015.07.090; Husser O, 2016, JACC-CARDIOVASC INTE, V9, P244, DOI 10.1016/j.jcin.2015.09.036; Jerez-Valero M, 2014, JACC-CARDIOVASC INTE, V7, P1022, DOI 10.1016/j.jcin.2014.04.012; Khawaja MZ, 2011, CIRCULATION, V123, P951, DOI 10.1161/CIRCULATIONAHA.109.927152; Kirkfeldt RE, 2014, EUR HEART J, V35, P1186, DOI 10.1093/eurheartj/eht511; Kirkfeldt RE, 2012, EUROPACE, V14, P1132, DOI 10.1093/europace/eus054; Kodali S, 2015, EUR HEART J, V36, P449, DOI 10.1093/eurheartj/ehu384; Larsen PD, 2017, HEART LUNG CIRC, V26, P235, DOI 10.1016/j.hlc.2016.06.1206; Lee DS, 2010, J AM COLL CARDIOL, V55, P774, DOI 10.1016/j.jacc.2009.11.029; Lee MY, 2015, ARRHYTH ELECTROPHYSI, V4, P81, DOI 10.15420/aer.2015.04.02.81; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Maisano F, 2015, EUR HEART J, V36, P413, DOI 10.1093/eurheartj/ehu410; Murray MI, 2015, J INTERV CARDIOL, V28, P109, DOI 10.1111/joic.12182; Nazif TM, 2015, JACC-CARDIOVASC INTE, V8, P60, DOI 10.1016/j.jcin.2014.07.022; R Core Team, 2021, R LANGUAGE ENV STAT; Rampat R, 2017, JACC-CARDIOVASC INTE, V10, P1247, DOI 10.1016/j.jcin.2017.03.044; Reardon MJ, 2017, NEW ENGL J MED, V376, P1321, DOI 10.1056/NEJMoa1700456; Siontis GCM, 2014, J AM COLL CARDIOL, V64, P129, DOI 10.1016/j.jacc.2014.04.033; van Buuren S, 2011, J STAT SOFTW, V45, P1; Walther T, 2015, J AM COLL CARDIOL, V65, P2173, DOI 10.1016/j.jacc.2015.03.034; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	29	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204503	10.1371/journal.pone.0204503	http://dx.doi.org/10.1371/journal.pone.0204503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332419	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200015
J	Jovani, V; Blasco-Blasco, M; Pascual, E; Ruiz-Cantero, MT				Jovani, Vega; Blasco-Blasco, Mar; Pascual, Eliseo; Teresa Ruiz-Cantero, M.			Challenges to conquer from the gender perspective in medicine: The case of spondyloarthritis	PLOS ONE			English	Article							SOCIETY CLASSIFICATION CRITERIA; ANKYLOSING-SPONDYLITIS; AXIAL SPONDYLOARTHRITIS; DIAGNOSIS; DELAY; WOMEN; W27	Background Diagnostic delay is well-known in spondyloarthritis and studies have demonstrated a longer deferral in women. The aim of this study was to explore whether diagnostic delay of spondyloarthritis depends on clinical manifestations expressed by patients according to sex or whether it is related to a doctor's misdiagnosis bias. Methods A cross-sectional study of 96 men and 54 women with spondyloarthritis was performed at Alicante University General Hospital in Spain using a semistructured interview and clinical records. Comparative sex analysis were done via Student's T and Mann-Whitney U tests for parametric and nonparametric continuous variables, chi-square and Fisher's exact tests for unpaired categorical variables, and McNemar's test for paired ones. Findings The median diagnostic delay in women 7.5 (11.5) years is higher than men 4 (11) years, with a difference close to statistical significance (p = 0.053). A total of 30.2% of men received a first correct diagnosis of spondyloarthritis versus 11.1% of women (p = 0.016), indicating that men have higher probability of not having a misdiagnosis of spondyloarthritis (odds ratio = 3.5; 1.3-9). Eleven different health services referred male patients to the rheumatology clinic but only six in the case of female. No sex differences were detected in patients' manifestations of back pain at onset. However, medical records registered differences (women 44.4%, men 82.1%; p < 0.001). There were differences between patients (women 57.7%, men 35.2%; p = 0.008) and medical records in peripheral signs/symptoms at onset (women 55.6%, men 17.9%; p < 0.001). Conclusion The few differences of self-reported manifestations between both sexes with spondyloarthritis as compared with their clinical records (more axial pain in men and more peripheral pain in women) suggests that the professionals' annotations reflect what they expect according to Literature, which could explain the higher misdiagnosis and diagnostic delay in women with spondyloarthritis.	[Jovani, Vega] Alicante Univ Gen Hosp, Rheumatol Dept, Alicante, Spain; [Blasco-Blasco, Mar; Teresa Ruiz-Cantero, M.] Univ Alicante, Publ Hlth Dept, Alicante, Spain; [Pascual, Eliseo] Miguel Hernandez Univ, Dept Med, Alicante, Spain; [Teresa Ruiz-Cantero, M.] CIBERESP, Madrid, Spain	General University Hospital of Alicante; Universitat d'Alacant; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Jovani, V (corresponding author), Alicante Univ Gen Hosp, Rheumatol Dept, Alicante, Spain.	vegajovani@gmail.com		Jovani, Vega/0000-0001-8529-4551; Blasco-Blasco, Mar/0000-0003-1386-7108; Pascual, Eliseo/0000-0002-3056-4478	FEDER-Instituto de Salud Carlos III. Ministerio de Ciencia e Innovacion. Espana [PI11/00865]	FEDER-Instituto de Salud Carlos III. Ministerio de Ciencia e Innovacion. Espana	This study was supported with funding FEDER-Instituto de Salud Carlos III. Ministerio de Ciencia e Innovacion. Espana (Grant PI11/00865). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2009, CLIN RHEUMATOL, V28, P327, DOI 10.1007/s10067-008-1049-z; Behar VM, 2017, JOINT BONE SPINE, V84, P467, DOI 10.1016/j.jbspin.2016.06.005; CALIN A, 1975, NEW ENGL J MED, V293, P835, DOI 10.1056/NEJM197510232931701; Carmona L, 2001, ANN RHEUM DIS, V60, P1040, DOI 10.1136/ard.60.11.1040; Deodhar A, 2016, CLIN RHEUMATOL, V35, P1769, DOI 10.1007/s10067-016-3231-z; Feldtkeller E, 2000, CURR OPIN RHEUMATOL, V12, P239, DOI 10.1097/00002281-200007000-00002; Fernandez-Carballido C, 2017, ARTHRIT CARE RES, V69, P150, DOI 10.1002/acr.22908; Gerdan V, 2012, J RHEUMATOL, V39, P1996, DOI 10.3899/jrheum.120106; HART FD, 1959, ANN RHEUM DIS, V18, P15, DOI 10.1136/ard.18.1.15; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; HILL HFH, 1976, ANN RHEUM DIS, V35, P267, DOI 10.1136/ard.35.3.267; Jovani V, 2017, J RHEUMATOL, V44, P174, DOI 10.3899/jrheum.160825; Krasselt M, 2019, CLIN REV ALLERG IMMU, V56, P346, DOI 10.1007/s12016-017-8631-6; Lenhart S, 1993, J Am Med Womens Assoc (1972), V48, P155; Malterud K, 2015, THEOR MED BIOETH, V36, P411, DOI 10.1007/s11017-015-9347-3; Moll JMH, 2007, REUMATISMO, V59, P13, DOI 10.4081/reumatismo.2007.1s.13; Munoz-Fernandez S, 2011, ANN RHEUM DIS, V70, P827, DOI 10.1136/ard.2010.141200; Postacchini F, 1999, LUMBAR DISC HERNIATION, P151; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Ruiz MT, 1997, J EPIDEMIOL COMMUN H, V51, P106, DOI 10.1136/jech.51.2.106; Rusman T, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0744-2; Schiotis R, 2011, RHEUMATOLOGY, V50, P132, DOI 10.1093/rheumatology/keq253; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Sieper J, 2013, ANN RHEUM DIS, V72, P1621, DOI 10.1136/annrheumdis-2012-201777; Sorensen J, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204867; Sykes MP, 2015, RHEUMATOLOGY, V54, P2283, DOI 10.1093/rheumatology/kev288; TYSON TL, 1953, ANN RHEUM DIS, V12, P40, DOI 10.1136/ard.12.1.40; WRIGHT V, 1991, BRIT J RHEUMATOL, V30, P1	29	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205751	10.1371/journal.pone.0205751	http://dx.doi.org/10.1371/journal.pone.0205751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312342	Green Submitted, Green Published, gold			2022-12-26	WOS:000447427300053
J	Kimuda, SG; Biraro, IA; Bagaya, BS; Raynes, JG; Cose, S				Kimuda, Simon G.; Biraro, Irene Andia; Bagaya, Bernard S.; Raynes, John G.; Cose, Stephen			Characterising antibody avidity in individuals of varied Mycobacterium tuberculosis infection status using surface plasmon resonance	PLOS ONE			English	Article							MEDIATED-IMMUNITY; IMMUNOGLOBULIN-G; VACCINATION; MATURATION; RESPONSES; IMPAIRS	There is increasing evidence supporting a role for antibodies in protection against tuberculosis (TB), with functional antibodies being described in the latent state of TB infection. Antibody avidity is an important determinant of antibody-mediated protection. This study characterised the avidity of antibodies against Ag85A, an immunodominant Mycobacterium tuberculosis (M.tb) antigen and constituent of several anti-TB vaccine candidates, in individuals of varied M.tb infection status. Avidity of Ag85A specific antibodies was measured in 30 uninfected controls, 34 individuals with latent TB infection (LTBI) and 75 active pulmonary TB (APTB) cases, employing the more commonly used chaotrope-based dissociation assays, and surface plasmon resonance (SPR). Chaotrope-based assays indicated that APTB was associated with a higher antibody avidity index compared to uninfected controls [adjusted geometric mean ratio (GMR): 1.641, 95% confidence interval (CI): 1.153, 2.337, p = 0.006, q = 0.018] and to individuals with LTBI [adjusted GMR: 1.604, 95% CI: 1.282, 2.006, p < 0.001, q < 0.001]. SPR assays showed that APTB was associated with slower dissociation rates, an indication of higher avidity, compared to uninfected controls (adjusted GMR: 0.796, 95% CI: 0.681, 0.932, p = 0.004, q = 0.012) and there was also weak evidence of more avid antibodies in the LTBI compared to the uninfected controls (adjusted GMR: 0.871, 95% CI: 0.763, 0.994, p = 0.041, q = 0.123). We found no statistically significant differences in anti-Ag85A antibody avidity between the APTB and LTBI groups. This study shows that antibodies of increased avidity are generated against a principle vaccine antigen in M.tb infected individuals. It would be important to determine whether TB vaccines are able to elicit a similar response. Additionally, more research is needed to determine whether antibody avidity is important in protection against infection and disease.	[Kimuda, Simon G.; Cose, Stephen] Makerere Univ, Sch Biomed Sci, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda; [Kimuda, Simon G.; Biraro, Irene Andia; Cose, Stephen] Uganda Virus Res Inst, Med Res Council, Immunomodulat & Vaccines Programme, Entebbe, Uganda; [Kimuda, Simon G.; Biraro, Irene Andia; Cose, Stephen] London Sch Hyg & Trop Med, Uganda Res Unit, Entebbe, Uganda; [Biraro, Irene Andia] Makerere Univ, Sch Med, Dept Internal Med, Coll Hlth Sci, Kampala, Uganda; [Bagaya, Bernard S.] Makerere Univ, Sch Biomed Sci, Dept Immunol & Mol Biol, Coll Hlth Sci, Kampala, Uganda; [Raynes, John G.; Cose, Stephen] London Sch Hyg & Trop Med, London, England	Makerere University; Uganda Virus Research Institute; Makerere University; Makerere University; University of London; London School of Hygiene & Tropical Medicine	Cose, S (corresponding author), Makerere Univ, Sch Biomed Sci, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda.; Cose, S (corresponding author), Uganda Virus Res Inst, Med Res Council, Immunomodulat & Vaccines Programme, Entebbe, Uganda.; Cose, S (corresponding author), London Sch Hyg & Trop Med, Uganda Res Unit, Entebbe, Uganda.; Cose, S (corresponding author), London Sch Hyg & Trop Med, London, England.	stephen.cose@lshtm.ac.uk	Raynes, John G/G-7932-2011	Raynes, John G/0000-0002-8536-1328; Cose, Stephen/0000-0002-5156-037X; Kimuda, Simon/0000-0001-6818-617X	Wellcome Trust Uganda; Wellcome Trust [084344, 107743]; Commonwealth Scholarship Commission Split Site PhD Fellowship; DELTAS Africa Initiative [107743]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); UK Government; Immunomodulation and Vaccine Programme laboratory team at the MRC/UVRI and LSHTM Uganda Research Unit; Department of Immunology and Infection of the London School of Hygiene & Tropical Medicine	Wellcome Trust Uganda; Wellcome Trust(Wellcome TrustEuropean Commission); Commonwealth Scholarship Commission Split Site PhD Fellowship; DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); UK Government; Immunomodulation and Vaccine Programme laboratory team at the MRC/UVRI and LSHTM Uganda Research Unit; Department of Immunology and Infection of the London School of Hygiene & Tropical Medicine	This study was supported by a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity held by IAB and SGK, funded by Wellcome Trust Strategic Award Grant no. 084344. SGK also received support from a Commonwealth Scholarship Commission Split Site PhD Fellowship and through the DELTAS Africa Initiative (Grant no. 107743). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS), Alliance for Accelerating Excellence in Science in Africa (AESA), and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (Grant no. 107743) and the UK Government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Moses Egesa and the Kampala Tuberculosis (KTB) study staff for collecting and storing the samples. The authors also thank the Immunomodulation and Vaccine Programme laboratory team at the MRC/UVRI and LSHTM Uganda Research Unit and the Department of Immunology and Infection of the London School of Hygiene & Tropical Medicine for their support.	Achkar JM, 2013, CELL HOST MICROBE, V13, P250, DOI 10.1016/j.chom.2013.02.009; Ahmad S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/814943; Alexander MR, 2015, J VIROL, V89, P5981, DOI 10.1128/JVI.00320-15; Arias-Bouda LMP, 2003, CLIN DIAGN LAB IMMUN, V10, P702, DOI 10.1128/CDLI.10.4.702-709.2003; Ashenafi S, 2013, THORAX, V68, P269, DOI 10.1136/thoraxjnl-2012-201817; Azzurri A, 2006, INT J IMMUNOPATH PH, V19, P199; Bhatt K, 2015, CLIN VACCINE IMMUNOL, V22, P258, DOI 10.1128/CVI.00721-14; Biraro IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111517; Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Bottermann M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37457; Brennan MJ, 2017, CLIN VACCINE IMMUNOL, V24, DOI [10.1128/CVI.00142-17, 10.1128/cvi.00142-17]; Cabrera G, 2005, BIOTECHNOL APPL BIOC, V41, P67; Davidow A, 2005, INFECT IMMUN, V73, P6846, DOI 10.1128/IAI.73.10.6846-6851.2005; de Valliere S, 2005, INFECT IMMUN, V73, P6711, DOI 10.1128/IAI.73.10.6711-6720.2005; Demkow U, 2007, J PHYSIOL PHARMACOL, V58, P117; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Esmail H, 2016, NAT MED, V22, P1090, DOI 10.1038/nm.4161; Fletcher HA, 2016, T ROY SOC TROP MED H, V110, P212, DOI 10.1093/trstmh/trw016; Fletcher HA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11290; Glatman-Freedman A, 1998, CLIN MICROBIOL REV, V11, P514, DOI 10.1128/CMR.11.3.514; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Jelicic K, 2013, NAT IMMUNOL, V14, P1256, DOI 10.1038/ni.2746; Johnson CM, 1997, TUBERCLE LUNG DIS, V78, P257, DOI 10.1016/S0962-8479(97)90006-X; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Khurana S, 2013, J INFECT DIS, V208, P413, DOI 10.1093/infdis/jit178; Kimuda SG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188396; Kimuda SG, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/1593143; Klasse PJ, 2016, EXPERT REV VACCINES, V15, P295, DOI 10.1586/14760584.2016.1128831; Kunnath-Velayudhan S, 2012, J INFECT DIS, V206, P697, DOI 10.1093/infdis/jis421; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Lule SA, 2015, VACCINE, V33, P796, DOI 10.1016/j.vaccine.2014.12.015; Manivannan S, 2012, INDIAN J EXP BIOL, V50, P542; Nair N, 2009, J INFECT DIS, V200, P1031, DOI 10.1086/605648; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Perley CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098938; Pissani F, 2014, TRENDS IMMUNOL, V35, P278, DOI 10.1016/j.it.2014.02.010; Reddy SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032242; Romero-Steiner S, 2005, CLIN DIAGN LAB IMMUN, V12, P1029, DOI 10.1128/CDLI.12.9.1029-1035.2005; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Sebina I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106796; Torrado E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061681; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; van de Bovenkamp FS, 2016, J IMMUNOL, V196, P1435, DOI 10.4049/jimmunol.1502136; Vordermeier HM, 1996, CLIN EXP IMMUNOL, V106, P312, DOI 10.1046/j.1365-2249.1996.d01-845.x; WHO, 2017, GLOB TUB REP; Zimmermann N, 2016, EMBO MOL MED, V8, P1325, DOI 10.15252/emmm.201606330; Zuniga J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/193923	50	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205102	10.1371/journal.pone.0205102	http://dx.doi.org/10.1371/journal.pone.0205102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312318	Green Published, gold, Green Submitted			2022-12-26	WOS:000447427300021
J	Shu, JJ; Teo, BM; Chan, WK				Shu, Jian-Jun; Teo, Bin Melvin; Chan, Weng Kong			Slip of fluid molecules on solid surfaces by surface diffusion	PLOS ONE			English	Article							BOUNDARY-CONDITION; LIQUID; MECHANISMS	The mechanism of fluid slip on a solid surface has been linked to surface diffusion, by which mobile adsorbed fluid molecules perform hops between adsorption sites. However, slip velocity arising from this surface hopping mechanism has been estimated to be significantly lower than that observed experimentally. In this paper, we propose a re-adsorption mechanism for fluid slip. Slip velocity predictions via this mechanism show the improved agreement with experimental measurements.	[Shu, Jian-Jun; Teo, Bin Melvin; Chan, Weng Kong] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Shu, JJ (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.	mjjshu@ntu.edu.sg	Chan, Weng Kong/A-3825-2011; Shu, Jian-Jun/A-3828-2011					Berezhkovskii AM, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4928741; BLAKE TD, 1990, COLLOID SURFACE, V47, P135, DOI 10.1016/0166-6622(90)80068-F; Bowles AP, 2011, J PHYS CHEM C, V115, P8613, DOI 10.1021/jp1106108; Butt H-J, 2013, PHYS CHEM INTERFACES, P177; BYCHUK OV, 1995, PHYS REV LETT, V74, P1795, DOI 10.1103/PhysRevLett.74.1795; Cao BY, 2009, INT J MOL SCI, V10, P4638, DOI 10.3390/ijms10114638; de Gennes PG, 2002, LANGMUIR, V18, P3413, DOI 10.1021/la0116342; Gross A, 2009, THEORETICAL SURFACE SCIENCE: A MICROSCOPIC PERSPECTIVE, SECOND EDITION, P1, DOI 10.1007/978-3-540-68969-0; Huang P, 2006, J FLUID MECH, V566, P447, DOI 10.1017/S0022112006002229; Kennard EH, 1954, KINETIC THEORY GASES; Lauga E., 2007, SPRINGER HDB EXPT FL, VC.YarinA.L.FossJ.F.Eds.SpringerBerlinHeidelberga, P1219; Lichter S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.086001; Lichter S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.226001; Mabry JN, 2015, J PHYS CHEM LETT, V6, P2065, DOI 10.1021/acs.jpclett.5b00799; Martini A, 2008, J FLUID MECH, V600, P257, DOI 10.1017/S0022112008000475; RUCKENSTEIN E, 1983, J COLLOID INTERF SCI, V96, P488, DOI 10.1016/0021-9797(83)90050-4; Shu JJ, 2017, APPL MECH REV, V69, DOI 10.1115/1.4036191; Shu JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165175; Shu JJ, 2016, SOFT MATTER, V12, P8388, DOI 10.1039/c6sm01178k; TOLSTOI D.M., 1952, DOKL AKAD NAUK SSSR, V85, P1089; Wang FC, 2011, SOFT MATTER, V7, P8628, DOI 10.1039/c1sm05543g; Yang FQ, 2010, CHEM ENG COMMUN, V197, P544, DOI 10.1080/00986440903245948	22	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205443	10.1371/journal.pone.0205443	http://dx.doi.org/10.1371/journal.pone.0205443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308059	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500078
J	Sahu, S; Li, R; Loers, G; Schachner, M				Sahu, Sudhanshu; Li, Rong; Loers, Gabriele; Schachner, Melitta			Knockdown of chondroitin-4-sulfotransferase-1, but not of dermatan-4-sulfotransferase-1, accelerates regeneration of zebrafish after spinal cord injury	FASEB JOURNAL			English	Article						axonal regrowth; glycosaminoglycans; chondroitin sulfate; dermatan sulfate	CHONDROITIN SULFATE PROTEOGLYCANS; PROMOTES FUNCTIONAL RECOVERY; CELL-ADHESION MOLECULE; DERMATAN SULFATE; HYBRID CHAINS; AXONAL REGENERATION; EXPRESSION CLONING; BINDING ACTIVITIES; GROWTH-FACTORS; SULFOTRANSFERASE	Glycosaminoglycans such as chondroitin sulfate (CS) and dermatan sulfate (DS) are long chains of repeating disaccharide units, covalently linked to core proteins to form proteoglycans. Proteoglycans can be cell membrane-bound or are part of the extracellular matrix. They are important in a wide range of biologic processes, including development, synaptic plasticity, and regeneration after injury, as well as modulation of growth factor signaling, cell migration, survival, and proliferation. Synthesis of CS and DS in the Golgi apparatus is mediated by sulfotransferases that modify sugar chains through transfer of sulfate groups to specific positions on the sugar moieties. To clarify the functions of CS and DS during nervous system regeneration, we studied the effect of chondroitin 4-O-sulfotransferase-1/carbohydrate sulfotransferase-11 (C4ST-1/Chst-11) and dermatan 4-O-sulfotransferase-1/Chst-14 (D4ST-1/Chst-14) down-regulation on spinal cord regeneration in larval and adult zebrafish. In our study, knockdown of C4ST1/Chst-11 accelerated regeneration after spinal cord injury in larval and adult zebrafish and knockdown of D4ST1/Chst-14 did not alter regenerative capacity. From these and previous observations, we drew the conclusion that different CS and DS expression patterns can be growth permitting, growth inhibiting, or neutral for regrowing or sprouting axons, depending on the tissue environment of a particular animal species.Sahu, S., Li, R., Loers, G., Schachner, M. Knockdown of chondroitin-4-sulfotransferase-1, but not of dermatan-4-sulfotransferase-1, accelerates regeneration of zebrafish after spinal cord injury.	[Sahu, Sudhanshu; Li, Rong; Schachner, Melitta] Shantou Univ, Med Coll, Ctr Neurosci, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China; [Loers, Gabriele] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Dept Cell Biol & Neurosci, Piscataway, NJ USA	Shantou University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick	Schachner, M (corresponding author), Shantou Univ, Med Coll, Ctr Neurosci, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China.	schachner@stu.edu.cn	Sahu, Sudhanshu Sekhar/M-2678-2019	RONG, LI/0000-0003-1828-5713	Li Kashing Foundation	Li Kashing Foundation	The authors thank and Prof. Junhui Bian and Dr. Frieda Law for encouragement during the work and Dr. Stanley Li Lin for editing the text (all from Shantou University Medical College). This work was funded by the Li Kashing Foundation. The authors declare no conflicts of interest.	Akyuaz N, 2013, EXP NEUROL, V247, P517, DOI 10.1016/j.expneurol.2013.01.025; Aquino RS, 2016, FRONT BIOSCI-LANDMRK, V21, P1260, DOI 10.2741/4455; Avram S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/642798; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bian S, 2011, J CELL SCI, V124, P4051, DOI 10.1242/jcs.088120; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Dyck SM, 2015, EXP NEUROL, V269, P169, DOI 10.1016/j.expneurol.2015.04.006; Evers MR, 2001, J BIOL CHEM, V276, P36344, DOI 10.1074/jbc.M105848200; Fukuda M, 2001, J BIOL CHEM, V276, P47747, DOI 10.1074/jbc.R100049200; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Habicher J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121957; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; Hiraoka N, 2001, GLYCOBIOLOGY, V11, P495, DOI 10.1093/glycob/11.6.495; James MO, 2013, DRUG METAB REV, V45, P401, DOI 10.3109/03602532.2013.835613; Kang HG, 2002, J BIOL CHEM, V277, P34766, DOI 10.1074/jbc.M204907200; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Kosho T, 2016, PEDIATR INT, V58, P88, DOI 10.1111/ped.12878; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Lee HJ, 2012, J NEUROTRAUM, V29, P1850, DOI 10.1089/neu.2011.2290; Li HP, 2013, J NEUROTRAUM, V30, P413, DOI 10.1089/neu.2012.2513; Li R, 2018, PHARMACOL BIOCHEM BE, V171, P30, DOI 10.1016/j.pbb.2018.05.013; Lieberoth Bettina C., 2003, Methods in Cell Science, V25, P65, DOI 10.1023/B:MICS.0000006848.57869.4c; Lin RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014557; Ma LP, 2017, MOL NEUROBIOL, V54, P3253, DOI 10.1007/s12035-016-9876-4; Ma LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095098; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; MARK M P, 1990, International Journal of Developmental Biology, V34, P191; Miller GM, 2015, EXP NEUROL, V274, P115, DOI 10.1016/j.expneurol.2015.08.015; Mitsunaga C, 2006, J BIOL CHEM, V281, P18942, DOI 10.1074/jbc.M510870200; Mizumoto S, 2009, BIOCHEM J, V419, P387, DOI 10.1042/BJ20081639; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Nandini CD, 2005, J BIOL CHEM, V280, P4058, DOI 10.1074/jbc.M412074200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Okuda T, 2000, J BIOL CHEM, V275, P40605, DOI 10.1074/jbc.M007983200; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; Pomin VH, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010027; Radek KA, 2009, WOUND REPAIR REGEN, V17, P118, DOI 10.1111/j.1524-475X.2008.00449.x; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Rost S, 2016, NEUROSCIENCE, V312, P74, DOI 10.1016/j.neuroscience.2015.11.013; Sahu S, 2018, MOL NEUROBIOL, V55, P859, DOI 10.1007/s12035-016-0254-z; Schwartz NB, 2018, FEBS LETT, V592, P3791, DOI 10.1002/1873-3468.13026; Senn C, 2002, MOL CELL NEUROSCI, V20, P712, DOI 10.1006/mcne.2002.1142; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yick LW, 2000, NEUROREPORT, V11, P1063, DOI 10.1097/00001756-200004070-00032; Yu Y, 2013, EUR J NEUROSCI, V38, P2280, DOI 10.1111/ejn.12222	51	11	11	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2252	2262		10.1096/fj.201800852RR	http://dx.doi.org/10.1096/fj.201800852RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30339470	Bronze			2022-12-26	WOS:000457296600058
J	Xu, L; Chirasani, VR; Carter, JS; Pasek, DA; Dokholyan, NV; Yamaguchi, N; Meissner, G				Xu, Le; Chirasani, Venkat R.; Carter, Jordan S.; Pasek, Daniel A.; Dokholyan, Nikolay V.; Yamaguchi, Naohiro; Meissner, Gerhard			Ca2+-mediated activation of the skeletal-muscle ryanodine receptor ion channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ryanodine receptor; skeletal muscle; mutagenesis; computation; sarcoplasmic reticulum (SR); Ca2+activation; Ca2+release channel; calcium homeostasis; ion gating; structure-function analysis	RELEASE CHANNEL; CALCIUM-RELEASE; SARCOPLASMIC-RETICULUM; STRUCTURAL BASIS; RYR1; CAFFEINE; HELIX; S6	Cryo-electron micrograph studies recently have identified a Ca2+-binding site in the 2,200-kDa ryanodine receptor ion channel (RyR1) in skeletal muscle. To clarify the role of this site in regulating RyR1 activity, here we applied mutational, electrophysiological, and computational methods. Three amino acid residues that interact directly with Ca2+ were replaced, and these RyR1 variants were expressed in HEK293 cells. Single-site RyR1-E3893Q, -E3893V, -E3967Q, -E3967V, and -T5001A variants and double-site RyR1-E3893Q/E3967Q and -E3893V/E3967V variants displayed cellular Ca2+ release in response to caffeine, which indicated that they retained functionality as caffeine-sensitive, Ca2+-conducting channels in the HEK293 cell system. Using [H-3]ryanodine binding and single-channel measurements of membrane isolates, we found that single- and double-site RyR1-E3893 and -E3967 variants are not activated by Ca2+. We also noted that RyR1-E3893Q/E3967Q and -E3893V/E3967V variants maintain caffeine- and ATP-induced activation and that RyR1-E3893Q/E3967Q is inhibited by Mg2+ and elevated Ca2+. RyR1-T5001A exhibited decreased Ca2+ sensitivity compared with WT-RyR1 in single-channel measurements. Computational methods suggested that electrostatic interactions between Ca2+ and negatively charged glutamate residues have a critical role in transducing the functional effects of Ca2+ on RyR1. We conclude that the removal of negative charges in the recently identified RyR1 Ca2+-binding site impairs RyR1 activation by physiological Ca2+ concentrations and results in loss of binding to Ca2+ or reduced Ca2+ affinity of the binding site.	[Xu, Le; Chirasani, Venkat R.; Pasek, Daniel A.; Dokholyan, Nikolay V.; Meissner, Gerhard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Chirasani, Venkat R.; Dokholyan, Nikolay V.] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Chirasani, Venkat R.; Dokholyan, Nikolay V.] Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Carter, Jordan S.; Yamaguchi, Naohiro] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Carter, Jordan S.; Yamaguchi, Naohiro] Clemson Univ, Cardiac Signaling Ctr, Charleston, SC 29425 USA	University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Medical University of South Carolina; Clemson University	Meissner, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	meissner@med.unc.edu	Chirasani, Venkata Reddy/AFN-6812-2022; Chirasani, Venkata Reddy/ABB-4967-2021; Xu, Le/HDN-9623-2022; Dokholyan, Nikolay/B-2238-2009	Chirasani, Venkata Reddy/0000-0003-1416-0438; Chirasani, Venkata Reddy/0000-0003-1416-0438; Dokholyan, Nikolay/0000-0002-8225-4025; Meissner, Gerhard/0000-0001-5185-4389	National Institutes of Health [AR018687, P20GM103499, UL1TR001450]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AR018687 (to G. M.) and P20GM103499 and UL1TR001450 (to N. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bai XC, 2016, CELL RES, V26, P995, DOI 10.1038/cr.2016.89; Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; Bhat MB, 1997, BIOPHYS J, V73, P1329, DOI 10.1016/S0006-3495(97)78166-9; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; DeLano WL, 2011, PYMOL MOL GRAPH SYST; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Fessenden JD, 2001, P NATL ACAD SCI USA, V98, P2865, DOI 10.1073/pnas.041608898; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; Gomez AC, 2014, BIOCHEMISTRY-US, V53, P1373, DOI 10.1021/bi401586h; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Mei YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054208; Meissner G, 2017, J GEN PHYSIOL, V149, P1065, DOI 10.1085/jgp.201711878; Murayama T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0103-x; Murayama T, 2011, J BIOL CHEM, V286, P35571, DOI 10.1074/jbc.M111.255240; O'Brien JJ, 2002, BIOPHYS J, V82, P2428, DOI 10.1016/S0006-3495(02)75586-0; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Ramachandran S, 2013, J BIOL CHEM, V288, P6154, DOI 10.1074/jbc.M112.433789; Rios E, 2018, J GEN PHYSIOL, V150, P521, DOI 10.1085/jgp.201711959; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; SMITH JS, 1985, NATURE, V316, P446, DOI 10.1038/316446a0; Sun B, 2016, J BIOL CHEM, V291, P26024, DOI 10.1074/jbc.M116.758821; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Wang Y, 2006, J BIOL CHEM, V281, P15572, DOI 10.1074/jbc.M600090200; Wei RS, 2016, CELL RES, V26, P977, DOI 10.1038/cr.2016.99; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Xu L, 2018, J BIOL CHEM, V293, P2015, DOI 10.1074/jbc.M117.803247; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950	37	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19501	19509		10.1074/jbc.RA118.004453	http://dx.doi.org/10.1074/jbc.RA118.004453			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30341173	Green Published, hybrid			2022-12-26	WOS:000453537300029
J	Patzelt, J; Ulrich, M; Becker, A; Muller, KAL; Jorbenadze, R; Droppa, M; Zhang, WZ; Mandel, S; Habel, L; Lausberg, H; Poss, J; Geisler, T; Borst, O; Rosenberger, P; Schlensak, C; Gawaz, M; Schreieck, J; Seizer, P; Langer, HF				Patzelt, Johannes; Ulrich, Miriam; Becker, Annika; Mueller, Karin A. L.; Jorbenadze, Rezo; Droppa, Michal; Zhang, Wenzhong; Mandel, Sarah; Habel, Lisa; Lausberg, Henning; Poess, Janine; Geisler, Tobias; Borst, Oliver; Rosenberger, Peter; Schlensak, Christian; Gawaz, Meinrad; Schreieck, Juergen; Seizer, Peter; Langer, Harald F.			Previous TAVR in patients undergoing percutaneous edge-to-edge mitral valve repair (PMVR) affects improvement of MR	PLOS ONE			English	Article							TRANSCATHETER; IMPLANTATION; REGURGITATION; REPLACEMENT; ECHOCARDIOGRAPHY; OUTCOMES; REGISTRY; SURGERY; SYSTEM; RISK	Background Patients after transcatheter aortic valve replacement (TAVR) and persistent severe mitral regurgitation (MR) are increasingly treated with percutaneous edge-to-edge mitral valve repair (PMVR). The impact of a former TAVR on PMVR procedures is not clear. Methods and results We retrospectively analyzed 332 patients undergoing PMVR using the MitraClip system with respect to procedural and clinical outcome. 21 of these 332 patients underwent TAVR before PMVR. Intra-procedural transthoracic (TTE) and transesophageal echocardiograms (TEE) immediately before and after clip implantation as well as invasive hemodynamic measurements were evaluated. At baseline, we found a significantly smaller mitral valve anterior-posterior diameter in the TAVR cohort (p < 0.001). A reduction of MR by at least three grades was achieved in a smaller fraction in the TAVR cohort as compared to the cohort with a native aortic valve (p = 0.02). Accordingly, we observed a smaller post-procedural cardiac output in the TAVR cohort (p = 0.02). Conclusion PMVR in patients who had a TAVR before, is associated with altered MR anatomy before and a reduced improvement of MR after the procedure. Future larger and prospective studies will have to determine, whether a previous TAVR influences long-term clinical outcome of patients undergoing PMVR.	[Patzelt, Johannes; Ulrich, Miriam; Becker, Annika; Mueller, Karin A. L.; Jorbenadze, Rezo; Droppa, Michal; Zhang, Wenzhong; Mandel, Sarah; Habel, Lisa; Geisler, Tobias; Borst, Oliver; Gawaz, Meinrad; Schreieck, Juergen; Seizer, Peter; Langer, Harald F.] Eberhard Karls Univ Tubingen, Dept Cardiol & Cardiovasc Med, Univ Hosp, Tubingen, Germany; [Zhang, Wenzhong] Affiliated Hosp Qingdao Univ, Dept Cardiol, Qingdao, Shandong, Peoples R China; [Lausberg, Henning; Schlensak, Christian] Eberhard Karls Univ Tubingen, Dept Cardiovasc Surg, Univ Hosp, Tubingen, Germany; [Poess, Janine] Univ Hosp Schleswig Holstein, Univ Herzzentrum Lubeck, Med Clin 2, Kiel, Germany; [Rosenberger, Peter] Eberhard Karls Univ Tubingen, Dept Anesthesiol, Univ Hosp, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Qingdao University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Kiel; Schleswig Holstein University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Patzelt, J (corresponding author), Eberhard Karls Univ Tubingen, Dept Cardiol & Cardiovasc Med, Univ Hosp, Tubingen, Germany.	johannes.patzelt@med.uni-tuebingen.de	Geisler, Tobias/AAO-4472-2020	Patzelt, Johannes/0000-0003-1492-1460; Borst, Oliver/0000-0003-4002-4085; Droppa, Michal/0000-0001-5807-7615	German research foundation [KFO 274]; Volkswagen foundation (Lichtenberg program); German Heart foundation; Deutsche Forschungsgemeinschaft; University of Tubingen	German research foundation(German Research Foundation (DFG)); Volkswagen foundation (Lichtenberg program); German Heart foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	This study was supported by grants from the German research foundation (KFO 274), the Volkswagen foundation (Lichtenberg program) and the German Heart foundation. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen.	Arora S, 2017, AM J CARDIOL, V120, P331, DOI 10.1016/j.amjcard.2017.04.029; Chakravarty T, 2015, AM J CARDIOL, V115, P942, DOI 10.1016/j.amjcard.2015.01.022; D'Ancona G, 2017, EUROINTERVENTION, V13, P475, DOI 10.4244/EIJ-D-17-00222; De Chiara B, 2011, CATHETER CARDIO INTE, V78, P638, DOI 10.1002/ccd.23045; Douglas PS, 2015, J AM SOC ECHOCARDIOG, V28, P210, DOI 10.1016/j.echo.2014.10.009; Erkapic D, 2012, J CARDIOVASC ELECTR, V23, P391, DOI 10.1111/j.1540-8167.2011.02211.x; Feldman T, 2015, J AM COLL CARDIOL, V66, P2844, DOI 10.1016/j.jacc.2015.10.018; Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355; Foster E, 2007, AM J CARDIOL, V100, P1577, DOI 10.1016/j.amjcard.2007.06.066; Franco E, 2012, J AM COLL CARDIOL, V60, pE35, DOI 10.1016/j.jacc.2012.05.061; Gaede L, 2018, CLIN RES CARDIOL, V107, P60, DOI 10.1007/s00392-017-1158-2; Gaemperli O, 2013, CIRCULATION, V127, P1018, DOI 10.1161/CIRCULATIONAHA.112.135061; Geis NA, 2018, EUR J HEART FAIL, V20, P598, DOI 10.1002/ejhf.910; Harries Iwan, 2015, Indian Heart J, V67, P60, DOI 10.1016/j.ihj.2015.02.005; Kappetein AP, 2012, EUR HEART J, V33, P2403, DOI 10.1093/eurheartj/ehs255; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Ledwoch J, 2014, CATHETER CARDIO INTE, V84, P599, DOI 10.1002/ccd.25460; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mohr FW, 2014, EUR J CARDIO-THORAC, V46, P808, DOI 10.1093/ejcts/ezu290; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Patzelt J, 2018, EUR HEART J-CARD IMG, V19, P785, DOI 10.1093/ehjci/jex173; Patzelt J, 2017, INT J CARDIOL, V236, P356, DOI 10.1016/j.ijcard.2016.12.190; Patzelt J, 2016, CIRCULATION, V133, P1517, DOI 10.1161/CIRCULATIONAHA.115.020923; Patzelt J, 2016, JACC-CARDIOVASC INTE, V9, P151, DOI 10.1016/j.jcin.2015.09.038; Ponikowski Piotr, 2016, Rev Esp Cardiol (Engl Ed), V69, P1167, DOI 10.1016/j.rec.2016.11.005; Reardon MJ, 2017, NEW ENGL J MED, V377, P197, DOI 10.1056/NEJMc1706234; Walther T, 2015, J AM COLL CARDIOL, V65, P2173, DOI 10.1016/j.jacc.2015.03.034	28	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205930	10.1371/journal.pone.0205930	http://dx.doi.org/10.1371/journal.pone.0205930			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339701	Green Published, Green Submitted, gold			2022-12-26	WOS:000447761400026
J	Haighton, C; Kidd, J; O'Donnell, A; Wilson, G; McCabe, K; Ling, J				Haighton, Catherine; Kidd, Jess; O'Donnell, Amy; Wilson, Graeme; McCabe, Karen; Ling, Jonathan			'I take my tablets with the whiskey': A qualitative study of alcohol and medication use in mid to later life	PLOS ONE			English	Article							DRUG-INTERACTIONS; CONCOMITANT USE; OLDER; DRINKING; PREVALENCE; HEALTH; INTERVENTION; NURSES; SAMPLE; RISK	Background Concurrent alcohol and medication use can result in significant problems especially in mid to later life. Alcohol is often used instead of medication for a number of health-related conditions. This novel qualitative study explored concurrent alcohol and medication use, as well as the use of alcohol for medicinal purposes, in a sample of individuals in mid to later life. Methods Twenty-four interviews (12 men/12 women, ages 51-90 years) and three focus groups (n = 27, 6 men/21 women, ages 50-95 years) from three branches of Age UK and two services for alcohol problems in North East England. Results Older people in this study often combined alcohol and medication, frequently without discussing this with their family doctor. However, being prescribed medication could act as a motivating factor to stop or reduce alcohol consumption. Participants also used alcohol to self-medicate, to numb pain, aid sleep or cope with stress and anxiety. Some participants used alcohol to deal with depression although alcohol was also reported as a cause of depression. Women in this study reported using alcohol to cope with mental health problems while men were more likely to describe reducing their alcohol consumption as a consequence of being prescribed medication. Conclusions As older people often combine alcohol and medication, health professionals such as family doctors, community nurses, and pharmacists should consider older patients' alcohol consumption prior to prescribing or dispensing medication and should monitor subsequent drinking. In particular, older people should be informed of the dangers of concurrent alcohol and medication use.	[Haighton, Catherine] Northumbria Univ, Dept Social Work Educ & Community Wellbeing, Newcastle Upon Tyne, Tyne & Wear, England; [Haighton, Catherine; Kidd, Jess; O'Donnell, Amy; Wilson, Graeme] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Wilson, Graeme] Univ Edinburgh, Reid Sch Mus, Edinburgh, Midlothian, Scotland; [McCabe, Karen; Ling, Jonathan] Univ Sunderland, Sch Nursing & Hlth Sci, Sunderland, Durham, England	Northumbria University; Newcastle University - UK; University of Edinburgh; University of Sunderland	Haighton, C (corresponding author), Northumbria Univ, Dept Social Work Educ & Community Wellbeing, Newcastle Upon Tyne, Tyne & Wear, England.; Haighton, C (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England.	Katie.haighton@northumbria.ac.uk	Wilson, Graeme/AAQ-2499-2020; Ling, Jonathan/AAY-4098-2020; Haighton, Catherine/H-1528-2015	Wilson, Graeme/0000-0003-2587-257X; Ling, Jonathan/0000-0003-2932-4474; Haighton, Catherine/0000-0002-8061-0428; O'Donnell, Amy/0000-0003-4071-9434	United Kingdom Charity Age UK South Tyneside; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research	United Kingdom Charity Age UK South Tyneside; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by a grant from the United Kingdom Charity Age UK South Tyneside (http://www.ageuk.org.uk/southtyneside/). The organisation assisted in the identification and recruitment of study participants as described above. Apart from this, the funders had no role in study design, analysis, decision to publish, or preparation of the manuscript. CH was and JL is a partially funded staff member of Fuse, the Centre for Translational Research in Public Health, a UKCRC Public Health Research Centre of Excellence. Funding for Fuse from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, is gratefully acknowledged.	ADAMS WL, 1995, J AM GERIATR SOC, V43, P1021, DOI 10.1111/j.1532-5415.1995.tb05567.x; Aira M, 2005, INT J GERIATR PSYCH, V20, P680, DOI 10.1002/gps.1340; Aira M, 2008, FAM PRACT, V25, P445, DOI 10.1093/fampra/cmn065; [Anonymous], 1995, IMPERATIVE HLTH PUBL; Atkinson RM, 2002, AM J GERIAT PSYCHIAT, V10, P649, DOI 10.1176/appi.ajgp.10.6.649; Barrett L. L., 2005, PRESCRIPTION DRUG US; Brennan PL, 2011, PAIN MED, V12, P1049, DOI 10.1111/j.1526-4637.2011.01156.x; Brennan PL, 2005, ADDICTION, V100, P777, DOI 10.1111/j.1360-0443.2005.01074.x; Breslow RA, 2015, ALCOHOL CLIN EXP RES, V39, P371, DOI 10.1111/acer.12633; Bryman A., 2008, SOCIAL RES METHODS, V3rd; Carney MA, 2000, J CONSULT CLIN PSYCH, V68, P788, DOI 10.1037/0022-006X.68.5.788; Clarke A. E., 2005, SITUATIONAL ANAL GRO; Cousins G, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-57; CRAWFORD R, 1980, INT J HEALTH SERV, V10, P365, DOI 10.2190/3H2H-3XJN-3KAY-G9NY; Dare J, 2014, HEALTH SOC CARE COMM, V22, P524, DOI 10.1111/hsc.12110; DAVIDSON KM, 1995, BRIT J PSYCHIAT, V166, P199, DOI 10.1192/bjp.166.2.199; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Haighton C., 2017, ALCOHOL AGING CLIN P; Haighton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148601; Hallgren MA, 2010, EUR J PUBLIC HEALTH, V20, P616, DOI 10.1093/eurpub/ckq111; Holley-Moore G, 2016, DRINK WISE AGE WELL; Hunter B, 2011, AUST NZ J PSYCHIAT, V45, P343, DOI 10.3109/00048674.2010.549997; Ilomaki J, 2013, DRUG ALCOHOL REV, V32, P218, DOI 10.1111/j.1465-3362.2012.00496.x; Ilomaki J, 2013, ANN PHARMACOTHER, V47, P257, DOI 10.1345/aph.1R449; Ilomaki J, 2011, ANN PHARMACOTHER, V45, P1240, DOI 10.1345/aph.1Q375; Ilomaki J, 2008, ALCOHOL, V42, P261, DOI 10.1016/j.alcohol.2008.02.002; Immonen S, 2013, SCAND J PRIM HEALTH, V31, P73, DOI 10.3109/02813432.2013.788272; Kaner EFS, 2001, BRIT J GEN PRACT, V51, P822; Kuhn T., 1962, STRUCTURE SCI RESOLU; Lock CA, 2004, FAM PRACT, V21, P270, DOI 10.1093/fampra/cmh310; Lock CA, 2002, J ADV NURS, V39, P333, DOI 10.1046/j.1365-2648.2002.02294.x; Moore Alison A, 2007, Am J Geriatr Pharmacother, V5, P64, DOI 10.1016/j.amjopharm.2007.03.006; Moos RH, 2010, AGING MENT HEALTH, V14, P33, DOI 10.1080/13607860902918264; Office for National Statistics, 2012, GEN LIF SURV 2010; Onder G, 2002, PHARMACOEPIDEM DR S, V11, P385, DOI 10.1002/pds.721; Pond R, 2010, J HEALTH PSYCHOL, V15, P734, DOI 10.1177/1359105310368068; Pringle KE, 2005, J AM GERIATR SOC, V53, P1930, DOI 10.1111/j.1532-5415.2005.00474.x; Pringle KE, 2006, J AGING HEALTH, V18, P837, DOI 10.1177/0898264306293583; QSR International, 2012, NVIVO QUAL DAT AN SO; Reid MC, 1998, J GEN INTERN MED, V13, P729, DOI 10.1046/j.1525-1497.1998.00223.x; Riley JL, 2009, J PAIN, V10, P944, DOI 10.1016/j.jpain.2009.03.005; Robinson OC, 2014, QUAL RES PSYCHOL, V11, P25, DOI 10.1080/14780887.2013.801543; Sacco P, 2015, AGING MENT HEALTH, V19, P279, DOI 10.1080/13607863.2014.933307; Sacco P, 2013, DRUG ALCOHOL DEPEN, V131, P157, DOI 10.1016/j.drugalcdep.2012.10.008; Sproule BA, 1999, INT J GERIATR PSYCH, V14, P851, DOI 10.1002/(SICI)1099-1166(199910)14:10<851::AID-GPS33>3.3.CO;2-C; Stahl ST, 2014, J BEHAV MED, V37, P736, DOI 10.1007/s10865-013-9524-7; Strauss A, 1997, GROUNDED THEORY PRAC; Veenstra M., 2012, Norsk Epidemiologi, V22, P135; Wilson GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071792	49	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205956	10.1371/journal.pone.0205956	http://dx.doi.org/10.1371/journal.pone.0205956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4KR	30335835	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000447701300077
J	Kaczmarek, L; Zawierucha, K; Buda, J; Stec, D; Gawlak, M; Michalczyk, L; Roszkowska, M				Kaczmarek, Lukasz; Zawierucha, Krzysztof; Buda, Jakub; Stec, Daniel; Gawlak, Magdalena; Michalczyk, Lukasz; Roszkowska, Milena			An integrative redescription of the nominal taxon for the Mesobiotus harmsworthi group (Tardigrada: Macrobiotidae) leads to descriptions of two new Mesobiotus species from Arctic	PLOS ONE			English	Article							HUFELANDI GROUP TARDIGRADA; ANNOTATED ZOOGEOGRAPHY; LIMNOTERRESTRIAL TARDIGRADE; MOLECULAR-DATA; SOUTH-AMERICA; EUTARDIGRADA; DIVERSITY; BIOGEOGRAPHY; SPITSBERGEN; PHYLOGENY	The Mesobiotus harmsworthi group has a global distribution, with localities in polar, temperate and tropical zones. Since the first species of the harmsworthi group was described in the beginning of the 20th century, tens of new species within the group were found and named. However, the diagnosis of the nominal Mesobiotus harmsworthi is insufficient and enigmatic, thus it can be is a serious obstacle in solving the taxonomy of this group. Here, we integratively redescribe the nominal species for the genus Mesobiotus, i.e., Mesobiotus harmsworthiand clarify taxonomic statuses of the two subspecies: M. harmsworthi harmsworthiand M. harmsworthi obscurus that have been recognised as distinct taxa for more than three decades. Traditionally, egg chorion in M. harmsworthi was considered almost smooth and without any traces of areolation, however here we report many misunderstandings that accumulated across decades and we show that, in fact, the chorion in this species exhibits a partially developed areolation. We present an integrative (morphological, morphometric and molecular) diagnosis of the nominal taxon and we confirm that it differs from other species of the harmsworthi group by morphological characters of both animals and eggs. Additionally, we describe two new species of the genus Mesobiotus: M. skorackii sp. nov. from the Kyrgyz Republic (using classical morphological description) and M. occultatus sp. nov. from Svalbard Archipelago (by means of integrative taxonomy). Finally, we also provide the first genetic phylogeny of the genus Mesobiotus based on COI sequences which, together with molecular species delimitation, independently confirms the validity of the analysed taxa.	[Kaczmarek, Lukasz; Zawierucha, Krzysztof; Buda, Jakub; Roszkowska, Milena] Adam Mickiewicz Univ, Dept Anim Taxon & Ecol, Fac Biol, Poznan, Poland; [Stec, Daniel; Michalczyk, Lukasz] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Entomol, Krakow, Poland; [Gawlak, Magdalena] Natl Res Inst, Inst Plant Protect, Poznan, Poland; [Roszkowska, Milena] Adam Mickiewicz Univ, Dept Bioenerget, Fac Biol, Poznan, Poland	Adam Mickiewicz University; Jagiellonian University; Adam Mickiewicz University	Kaczmarek, L (corresponding author), Adam Mickiewicz Univ, Dept Anim Taxon & Ecol, Fac Biol, Poznan, Poland.	kaczmar@amu.edu.pl	Stec, Daniel/AAL-3532-2020; Buda, Jakub/ABE-5873-2021; Kaczmarek, Lukasz/A-2000-2008; Michalczyk, Lukasz/D-1362-2009	Kaczmarek, Lukasz/0000-0002-5260-6253; Zawierucha, Krzysztof/0000-0002-0754-1411; Michalczyk, Lukasz/0000-0002-2912-4870; Stec, Daniel/0000-0001-6876-0717; Gawlak, Magdalena/0000-0001-7994-2882; Buda, Jakub/0000-0002-4584-5897	Polish Ministry of Science and Higher Education via the Diamond Grant programme [DIA 2011035241]; Polish Ministry of Science and Higher Education via the Iuventus Plus programme [IP2014 017973]	Polish Ministry of Science and Higher Education via the Diamond Grant programme; Polish Ministry of Science and Higher Education via the Iuventus Plus programme	Sampling in Svalbard in 2013 was supported by the Polish Ministry of Science and Higher Education via the Diamond Grant programme (grant no. DIA 2011035241 to KZ). The study was supported by the Polish Ministry of Science and Higher Education via the Iuventus Plus programme (grant no. IP2014 017973 to LK and LM).; We are grateful to Witek Morek and Julia Barczyk (Jagiellonian University, Poland) for samples with two unidentified Mesobiotus species used in the present study for molecular analyses. This research has been conducted in the framework of the activities of BARg (the Biodiversity and Astrobiology Research group). Paratypes of M. h. obscurus were kindly loaned to us by the Zoological Museum of Hamburg University and a specimen of M. harmsworthi from the Murray collection was kindly provided by the National Museum of Scotland in Edinburgh. Sampling in Svalbard in 2013 was supported by the Polish Ministry of Science and Higher Education via the Diamond Grant programme (grant no. DIA 2011035241 to KZ). The study was supported by the Polish Ministry of Science and Higher Education via the Iuventus Plus programme (grant no. IP2014 017973 to LK and LM).	[Anonymous], 1834, MACROBIOTUS HUFELAND; ARGUE CW, 1971, CAN J ZOOLOG, V49, P401, DOI 10.1139/z71-060; BERTOLANI R, 1993, ZOOL SCR, V22, P127, DOI 10.1111/j.1463-6409.1993.tb00347.x; Bertolani R, 2014, MOL PHYLOGENET EVOL, V76, P110, DOI 10.1016/j.ympev.2014.03.006; Bertolani Roberto, 2011, Zootaxa, V2997, P19; BISEROV V I, 1991, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V118, P193; Cesari M, 2016, INVERTEBR SYST, V30, P635, DOI 10.1071/IS15045; Cesari M, 2009, MOL ECOL RESOUR, V9, P699, DOI 10.1111/j.1755-0998.2009.02538.x; Czechowski P, 2012, INVERTEBR SYST, V26, P526, DOI 10.1071/IS12034; Dabert Jacek, 2008, Zootaxa, V1719, P41; Dabert M, 2010, MOL PHYLOGENET EVOL, V56, P222, DOI 10.1016/j.ympev.2009.12.020; Dastych H., 1988, Monografie Fauny Polski, V16, P1; DASTYNCH H, 1985, Acta Zoologica Cracoviensia, V28, P169; de Barros Rosa, 1942, REV BRASIL BIOL, V2, P373; Degma P, 2009, ACTUAL CHECKLIST TAR; Degma P, 2007, ZOOTAXA, P41, DOI 10.11646/zootaxa.1579.1.2; Doyere LMF, 1840, ANN SCI NATURELLES 2, V14, P269; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Guidetti R, 2005, ZOOTAXA, P1, DOI 10.11646/zootaxa.845.1.1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HORNING DS, 1978, NEW ZEAL J ZOOL, V5, P185, DOI 10.1080/03014223.1978.10428316; Jorgensen A, 2007, J LIMNOL, V66, P77, DOI 10.4081/jlimnol.2007.s1.77; Kaczmarek L, 2016, NEW ZEAL J ZOOL, V43, P234, DOI 10.1080/03014223.2016.1156553; Kaczmarek L, 2007, ANN ZOOL, V57, P363; Kaczmarek L, 2017, ZOOTAXA, V4363, P101, DOI 10.11646/zootaxa.4363.1.4; Kaczmarek L, 2016, ZOOTAXA, V4203, P1, DOI 10.11646/zootaxa.4203.1.1; Kaczmarek L, 2015, ZOOTAXA, V3923, P1, DOI 10.11646/zootaxa.3923.1.1; Kaczmarek L, 2011, ZOOTAXA, P29, DOI 10.11646/zootaxa.2781.1.2; Kaczmarek L, 2014, ZOOTAXA, V3790, P357, DOI 10.11646/zootaxa.3790.2.5; Kaczmarek L, 2014, ZOOTAXA, V3763, P1, DOI 10.11646/zootaxa.3763.1.1; Kaczmarek L, 2012, POLAR BIOL, V35, P1013, DOI 10.1007/s00300-011-1149-0; Kaczmarek Lukasz, 2009, Acta Zoologica Cracoviensia Ser B-Invertebrata, V52B, P87, DOI 10.3409/azc.52b_1-2.87-99; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; kenthal W, 1926, HDB ZOOLOGIE, V3, P58; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Mapalo MA, 2017, RAFFLES B ZOOL, V65, P440; Mapalo MA, 2016, ZOOTAXA, V4126, P411, DOI 10.11646/zootaxa.4126.3.6; Marcus E, 1936, TIERREICH, V66, P1; Marley NJ, 2011, ZOOTAXA, P51, DOI 10.11646/zootaxa.2819.1.2; Maucci W., 1991, B MUSEO CIVICO STORI, V15, P279; Mcinnes SJ, 2017, ZOOTAXA, V4284, P1, DOI 10.11646/zootaxa.4284.1.1; MCINNES SJ, 1994, J NAT HIST, V28, P257, DOI 10.1080/00222939400770131; MCINNES SJ, 1991, PEDOBIOLOGIA, V35, P11; Michalczyk L, 2003, ZOOTAXA, V331, P1, DOI DOI 10.11646/ZOOTAXA.331.1.1; Michalczyk L, 2012, ZOOTAXA, P1; Michalczyk L, 2013, J LIMNOL, V72, P175, DOI 10.4081/jlimnol.2013.s1.e22; Mironov Sergey V., 2012, Zootaxa, V3253, P54; Morek W, 2019, J ZOOL SYST EVOL RES, V57, P1, DOI 10.1111/jzs.12233; Morek W, 2016, CONTRIB ZOOL, V85, P173, DOI 10.1163/18759866-08502003; Murray J., 1907, T ROY SOC EDINBURGH, V45, P669, DOI DOI 10.1017/S0080456800011789; Nelson DR, 2015, ECOLOGY AND GENERAL BIOLOGY, VOL I: THORP AND COVICH'S FRESHWATER INVERTEBRATES, 4TH EDITION, P347, DOI 10.1016/B978-0-12-385026-3.00017-6; Nelson DR, 2010, AQUAT ECOL SER, P455, DOI 10.1016/B978-0-12-374855-3.00014-5; Niesporczaki Dastych H., 1980, MONOGR FAUNY POLSKI, V9, P1; Petersen B., 1951, MEDDELSER GRONLAND K, V150, P5; Pilato G, 1996, NEW ZEAL J ZOOL, V23, P375, DOI 10.1080/03014223.1996.9518097; Pilato G., 1989, Animalia (Catania), V15, P83; PILATO G, 1991, Tropical Zoology, V4, P167; Pilato G., 1981, Animalia (Catania), V8, P51; PILATO G, 1972, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V10, P65; Pilato G., 1975, Animalia, V2, P79; Pilato G, 2000, B SEDUTE ACCADEMIA G, V33, P103; Pilato G, 1998, B SEDUTE ACCADEMIA G, V353, P263; Pilato G, 2006, NEW ZEAL J ZOOL, V33, P39, DOI 10.1080/03014223.2006.9518429; Pilato G, 2010, ZOOTAXA, P1; Pilato G, 2014, ZOOTAXA, V 3754, P173, DOI 10.11646/zootaxa.3754.2.6; Ramazzotti G., 1983, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V41, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roszkowska M, 2018, ZOOTAXA, V4450, P550, DOI 10.11646/zootaxa.4450.5.2; Roszkowska M, 2016, ZOOTAXA, V4105, P243, DOI 10.11646/zootaxa.4105.3.2; Sands CJ, 2008, CLADISTICS, V24, P861, DOI 10.1111/j.1096-0031.2008.00219.x; SCHUSTER RO, 1980, T AM MICROSC SOC, V99, P284, DOI 10.2307/3226004; SCHUSTER ROBERT O., 1965, UNIV CALIF PUBL ZOOL, V76, P1; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Stec D, TURK ZOOL; Stec D, 2018, SYST BIODIVERS, V16, P357, DOI 10.1080/14772000.2018.1424267; Stec D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192210; Stec D, 2017, TURK J ZOOL, V41, P800, DOI 10.3906/zoo-1701-47; Stec D, 2017, ANN ZOOL, V67, P181, DOI 10.3161/00034541ANZ2017.67.2.001; Stec D, 2015, ZOOTAXA, V4052, P501, DOI 10.11646/zootaxa.4052.5.1; Thulin G, 1928, HEREDITAS, V11, P207, DOI 10.1111/j.1601-5223.1928.tb02488.x; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Vecchi M, 2016, INVERTEBR SYST, V30, P303, DOI 10.1071/IS15033; Vicente F, 2013, ZOOTAXA, V3626, P245, DOI 10.11646/zootaxa.3626.2.2; Welnicz W, 2011, J ZOOL SYST EVOL RES, V49, P34, DOI 10.1111/j.1439-0469.2010.00595.x; Zawierucha K, 2018, ANN ZOOL, V68, P179, DOI 10.3161/00034541ANZ2018.68.1.007; Zawierucha K, 2017, POLAR BIOL, V40, P1385, DOI 10.1007/s00300-016-2063-2; Zawierucha K, 2016, ZOOTAXA, V4196, P498, DOI 10.11646/zootaxa.4196.4.2; Zawierucha K, 2016, POLAR BIOL, V39, P713, DOI 10.1007/s00300-015-1827-4; Zawierucha K, 2015, POLAR RES, V34, DOI 10.3402/polar.v34.24168; Zeller C., 2010, THESIS; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	93	35	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204756	10.1371/journal.pone.0204756	http://dx.doi.org/10.1371/journal.pone.0204756			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332426	Green Submitted, gold, Green Published			2022-12-26	WOS:000447638200030
J	Basanovic, J; Notebaert, L; Clarke, PJF; MacLeod, C; Jawinski, P; Chen, NTM				Basanovic, Julian; Notebaert, Lies; Clarke, Patrick J. F.; MacLeod, Colin; Jawinski, Philippe; Chen, Nigel T. M.			Inhibitory attentional control in anxiety: Manipulating cognitive load in an antisaccade task	PLOS ONE			English	Article							WORKING-MEMORY LOAD; SELECTIVE ATTENTION; TRAIT ANXIETY; PROCESSING EFFICIENCY; BIAS; DISTRACTION; PERFORMANCE; MECHANISMS; FACES	Theorists have proposed that heightened anxiety vulnerability is characterised by reduced attentional control performance and have made the prediction in turn that elevating cognitive load will adversely impact attentional control performance for high anxious individuals to a greater degree than low anxious individuals. Critically however, existing attempts to test this prediction have been limited in their methodology and have presented inconsistent findings. Using a methodology capable of overcoming the limitations of previous research, the present study sought to investigate the effect of manipulating cognitive load on inhibitory attentional control performance of high anxious and low anxious individuals. High and low trait anxious participants completed an antisaccade task, requiring the execution of prosaccades towards, or antisaccades away from, emotionally toned stimuli while eye movements were recorded. Participants completed the antisaccade task under conditions that concurrently imposed a lesser cognitive load, or greater cognitive load. Analysis of participants' saccade latencies revealed high trait anxious participants demonstrated generally poorer inhibitory attentional control performance as compared to low trait anxious participants. Furthermore, conditions imposing greater cognitive load, as compared to lesser cognitive load, resulted in enhanced inhibitory attentional control performance across participants generally. Crucially however, analyses did not reveal an effect of cognitive load condition on anxiety-linked differences in inhibitory attentional control performance, indicating that elevating cognitive load did not adversely impact attentional control performance for high anxious individuals to a greater degree than low anxious individuals. Hence, the present findings are inconsistent with predictions made by some theorists and are in contrast to the findings of earlier investigations. These findings further highlight the need for research into the relationship between anxiety, attentional control, and cognitive load.	[Basanovic, Julian; Notebaert, Lies; MacLeod, Colin] Univ Western Australia, Sch Psychol Sci, Ctr Adv Res Emot, Crawley, Australia; [Clarke, Patrick J. F.] Curtin Univ, Sch Psychol, Bentley, WA, Australia; [Jawinski, Philippe] Humboldt Univ, Dept Psychol, Berlin, Germany; [Chen, Nigel T. M.] Curtin Univ, Sch Occupat Therapy Social Work & Speech Pathol, Bentley, WA, Australia	University of Western Australia; Curtin University; Humboldt University of Berlin; Curtin University	Basanovic, J (corresponding author), Univ Western Australia, Sch Psychol Sci, Ctr Adv Res Emot, Crawley, Australia.	julian.basanovic@uwa.edu.au	Basanovic, Julian/Y-5868-2019; Notebaert, Lies/H-5546-2014; Jawinski, Philippe/N-2417-2019	Basanovic, Julian/0000-0002-3686-8720; Notebaert, Lies/0000-0002-5849-4045; Jawinski, Philippe/0000-0002-2994-3075; MacLeod, Colin/0000-0003-2407-7339; Clarke, Patrick/0000-0003-0303-4479	Australian Research Council [FL170100167, DP170104533]	Australian Research Council(Australian Research Council)	This study was funded in part by Australian Research Council Laureate Fellowship: FL170100167 (C.M.) and Australian Research Council Discovery Project: DP170104533 (C.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari TL, 2008, COGN AFFECT BEHAV NE, V8, P229, DOI 10.3758/CABN.8.3.229; Ansari TL, 2011, NEUROPSYCHOLOGIA, V49, P1146, DOI 10.1016/j.neuropsychologia.2011.01.019; Ansari TL, 2010, COGNITION EMOTION, V24, P241, DOI 10.1080/02699930903381531; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Basanovic J, 2017, BEHAV RES THER, V99, P47, DOI 10.1016/j.brat.2017.09.002; Berggren N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00188; Berggren N, 2013, BIOL PSYCHOL, V92, P440, DOI 10.1016/j.biopsycho.2012.03.007; Berggren N, 2012, J COGN PSYCHOL, V24, P79, DOI 10.1080/20445911.2011.618450; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Chen NTM, 2015, BIOL PSYCHOL, V104, P139, DOI 10.1016/j.biopsycho.2014.12.002; Chen NTM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086474; Cisler J. M., 2011, CLIN PSYCHOL REV, V30, P1, DOI [10.1016/j.cpr.2009.11.003, DOI 10.1016/J.CPR.2009.11.003.MECHANISMS]; Derakshan N, 2010, BEHAV RES THER, V48, P1180, DOI 10.1016/j.brat.2010.08.009; Derakshan N, 2009, EUR PSYCHOL, V14, P168, DOI 10.1027/1016-9040.14.2.168; Derakshan N, 2009, EXP PSYCHOL, V56, P48, DOI 10.1027/1618-3169.56.1.48; Edwards MS, 2017, COGNITION EMOTION, V31, P671, DOI 10.1080/02699931.2016.1152232; Engle RW, 2010, CURR ANTHROPOL, V51, pS17, DOI 10.1086/650572; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Eysenck MW, 2011, PERS INDIV DIFFER, V50, P955, DOI 10.1016/j.paid.2010.08.019; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Garner M, 2009, EUR NEUROPSYCHOPHARM, V19, pS599, DOI 10.1016/S0924-977X(09)70960-5; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; King R, 2011, PSYCHOPHYSIOLOGY, V48, DOI 10.1111/j.1469-8986.2010.01062.x; Konstantinou N, 2014, ATTEN PERCEPT PSYCHO, V76, P1985, DOI 10.3758/s13414-014-0742-z; Konstantinou N, 2013, J EXP PSYCHOL HUMAN, V39, P919, DOI 10.1037/a0033037; Koster EHW, 2006, BEHAV RES THER, V44, P1757, DOI 10.1016/j.brat.2005.12.011; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lavie N, 2010, CURR DIR PSYCHOL SCI, V19, P143, DOI 10.1177/0963721410370295; Mitchell JP, 2002, J COGNITIVE NEUROSCI, V14, P95, DOI 10.1162/089892902317205357; Moser JS, 2012, EMOTION, V12, P213, DOI 10.1037/a0026156; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Najmi S, 2015, COGNITION EMOTION, V29, P1210, DOI 10.1080/02699931.2014.975188; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pessoa Luiz, 2010, Dialogues Clin Neurosci, V12, P433; Pacheco-Unguetti AP, 2010, PSYCHOL SCI, V21, P298, DOI 10.1177/0956797609359624; Reinholdt-Dunne ML, 2012, J COGN PSYCHOL, V24, P54, DOI 10.1080/20445911.2011.560111; ROBERTS RJ, 1994, J EXP PSYCHOL GEN, V123, P374, DOI 10.1037/0096-3445.123.4.374; Spielberger CD, 1994, USE PSYCHOL TESTING, P292, DOI DOI 10.1002/9780470479216.CORPSY0943; STAMPE DM, 1993, BEHAV RES METH INSTR, V25, P137, DOI 10.3758/BF03204486; Stuyven E, 2000, ACTA PSYCHOL, V104, P69, DOI 10.1016/S0001-6918(99)00054-2; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Unsworth N, 2011, ACTA PSYCHOL, V137, P90, DOI 10.1016/j.actpsy.2011.03.004; Van Dillen LF, 2009, NEUROIMAGE, V45, P1212, DOI 10.1016/j.neuroimage.2009.01.016; Wang ZG, 2010, VISION RES, V50, P220, DOI 10.1016/j.visres.2009.11.013; Wieser MJ, 2009, COGN AFFECT BEHAV NE, V9, P314, DOI 10.3758/CABN.9.3.314; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671	48	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205720	10.1371/journal.pone.0205720	http://dx.doi.org/10.1371/journal.pone.0205720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0VS	30325947	Green Published, Green Submitted, gold			2022-12-26	WOS:000447430800036
J	Yang, WW; Gao, X; Zhang, XH; Hu, YH; Guo, H; Wang, K; Yan, YZ; He, J; Zhang, JY; Ma, JL; Mao, L; Mu, LT; Liu, JM; Li, SG; Ding, YS; Zhang, M; Ma, RL; Guo, SX				Yang, Wenwen; Gao, Xiang; Zhang, Xianghui; Hu, Yunhua; Guo, Heng; Wang, Kui; Yan, Yizhong; He, Jia; Zhang, Jingyu; Ma, Jiaolong; Mao, Lei; Mu, Lati; Liu, Jiaming; Li, Shugang; Ding, Yusong; Zhang, Mei; Ma, Rulin; Guo, Shuxia			Impact of interactions among metabolic syndrome components on the development of cardiovascular disease among Kazakhs in Xinjiang	PLOS ONE			English	Article							DEFINITION; POPULATION; MORTALITY; HEART; PREDICTOR; DIAGNOSIS	Background Few prospective studies have explored the effect of interactions among metabolic syndrome (MS) components on the development of cardiovascular disease (CVD) in the Kazakh population in Xinjiang Province of China. Method As of December 2016, 2,644 participants who completed a baseline survey over a period of 5 years or more were included in the study. The multiplicative interactions among MS components were evaluated by incorporation of the product terms into a logistic regression model. The additive interactions among MS components were evaluated by calculating the additive interaction index. Logistic regression was used to construct a predictive model, and CVD risk level was divided according to the risk probability of the population that did not eventually have CVD. Results When we analyzed the independent risk of MS and its components on developing CVD, only blood pressure(BP) and waist circumference(WC) were associated with CVD. A linear association was found between the risk of CVD, BP/WC, and the number of other components (trend, P<0.001). The risk of developing CVD increased when BP and WC coexisted, or when combined BP/WC with MS (>= 3 components except for BP and WC) was present; however, there were no significant interactions among MS components. After the CVD hazards were divided into four levels, it was showed that over 19.92% of the incidence probability was in the population under mediate-risk while over 35.24% of them was in the high-risk group, respectively. Conclusions BP and WC were independent risk factors for CVD in the Kazakh population. The risk of CVD was greatly increased when BP and WC coexisted or when combined BP/WC with MS (>= 3 components except for BP and WC) was present, but no significant interactions were found among MS components.	[Yang, Wenwen; Gao, Xiang; Zhang, Xianghui; Hu, Yunhua; Guo, Heng; Wang, Kui; Yan, Yizhong; He, Jia; Zhang, Jingyu; Ma, Jiaolong; Mao, Lei; Mu, Lati; Liu, Jiaming; Li, Shugang; Ding, Yusong; Zhang, Mei; Ma, Rulin; Guo, Shuxia] Shihezi Univ Sch Med, Dept Publ Hlth, Shihezi, Shihezi, Xinjiang, Peoples R China; [Gao, Xiang] Penn State Univ, Dept Nutr Sci, 109 Chandlee Lab, University Pk, PA 16802 USA; [Guo, Shuxia] Shihezi Univ, Sch Med, Minist Educ, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Guo, Shuxia] Shihezi Univ, Sch Med, Minist Educ, Key Lab Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China	Shihezi University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Shihezi University; Shihezi University	Ma, RL; Guo, SX (corresponding author), Shihezi Univ Sch Med, Dept Publ Hlth, Shihezi, Shihezi, Xinjiang, Peoples R China.; Guo, SX (corresponding author), Shihezi Univ, Sch Med, Minist Educ, Dept Pathol, Shihezi, Xinjiang, Peoples R China.; Guo, SX (corresponding author), Shihezi Univ, Sch Med, Minist Educ, Key Lab Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China.	marulin@126.com; gsxshzu@sina.com		Zhang, XiangHui/0000-0002-1829-1681; zhong, yan/0000-0003-1957-5421	National Natural Science Foundation of China [81560551]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 81560551).; We sincerely thank those who participated in the study. We would also like to thank the clinical laboratory of First Affiliated Hospital of Shihezi University School of Medicine for their test work. This research was supported by National Natural Science Foundation of China (No. 81560551).	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Breslow N E, 1980, IARC Sci Publ, P5; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chen YC, 2014, J HUM HYPERTENS, V28, P689, DOI 10.1038/jhh.2013.152; Dada AS, 2016, MEDICINES, V3, P15, DOI DOI 10.3390/MEDICINES302001510; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guo H., 2010, J EPIDEMIOL, V31, p747 750; [郭恒 GUO Heng], 2011, [中华高血压杂志, Chinese Journal of Hypertension], V19, P538; He J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106723; He Jia, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P1164; Hoshino A, 2008, CIRC J, V72, P404, DOI 10.1253/circj.72.404; Hwang YC, 2009, INT J CARDIOL, V134, P313, DOI 10.1016/j.ijcard.2008.12.025; Ishikawa S, 2007, CIRC J, V71, P26, DOI 10.1253/circj.71.26; Kang GD, 2010, CIRC J, V74, P456, DOI 10.1253/circj.CJ-09-0422; Khang YH, 2010, ATHEROSCLEROSIS, V213, P579, DOI 10.1016/j.atherosclerosis.2010.09.009; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lawlor DA, 2006, DIABETOLOGIA, V49, P41, DOI 10.1007/s00125-005-0040-3; Liu C, 2016, CHINESE J CLIN HEALT; Martiniuk ALC, 2007, J HYPERTENS, V25, P73, DOI 10.1097/HJH.0b013e328010775f; Ninomiya T, 2007, STROKE, V38, P2063, DOI 10.1161/STROKEAHA.106.479642; Oda E, 2006, DIABETES CARE, V29, P2566, DOI 10.2337/dc06-1453; Suh S, 2014, ENDOCRINOL METAB, V29, P522, DOI 10.3803/EnM.2014.29.4.522; Sundstrom J, 2006, BMJ-BRIT MED J, V332, P878, DOI 10.1136/bmj.38766.624097.1F; Tanomsup S, 2007, DIABETES CARE, V30, P2138, DOI 10.2337/dc07-0388; Wei W, 2003, CHINESE J CARDIOLOGY, P31; 陈伟伟, 2017, [中国循环杂志, Chinese Circulation Journal], V32, P521	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205703	10.1371/journal.pone.0205703	http://dx.doi.org/10.1371/journal.pone.0205703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325976	Green Submitted, Green Published, gold			2022-12-26	WOS:000447430800033
J	Dekker, R; Hristova, YV; Hijmans, JM; Geertzen, JHB				Dekker, Rienk; Hristova, Yoanna V.; Hijmans, Juha M.; Geertzen, Jan H. B.			Pre-operative rehabilitation for dysvascular lower-limb amputee patients: A focus group study involving medical professionals	PLOS ONE			English	Article							TOTAL JOINT REPLACEMENT; QUALITY-OF-LIFE; PULMONARY REHABILITATION; POSTOPERATIVE OUTCOMES; PHYSICAL-THERAPY; AMPUTATION; EXERCISE; SURGERY; PREHABILITATION; PROGRAM	Background Major lower-limb amputation (LLA) predisposes patients post-operatively to a significant decline in daily-life functioning. The physical condition of amputee patients prior to surgery is significantly deteriorated due to chronic peripheral vascular disease (PVD) and diabetes, which accounts for the majority of LLAs in the adult population. A common strategy called pre-rehabilitation has been used in multiple patient populations to prepare the patient for undergoing a surgical event and to improve post-operative patient outcomes. Pre-rehabilitation might enhance the outcome of dysvascular LLA patients and reduce the high post-operative mortality rates. However, experience of experts with pre-rehabilitation and feasibility of a pre-rehabilitation program in this group remains unknown. Objective To investigate the experiences of medical professionals and researchers in the field of LLA with the use of pre-rehabilitation in general and in particular PVD patients. Additionally, the study examines their opinions regarding need for and feasibility of a pre-rehabilitation program for dysvascular patients at risk for an LLA. Methods Two explorative focus group discussions were organized with in total 16 experts in the field of treatment and research of LLA. Transcribed data were coded using the Atlas. ti software package. Thematic analysis with inductive approach was opted to arrange and interpret codes. Results The experiences of the experts with pre-rehabilitation in dysvascular patients were scarce. The experts described dysvascular patients at risk for an LLA as a difficult group for prerehabilitation due to short time window prior to surgery, older age, multiple co-morbidities and lack of motivation for behavioral change. The experts concluded that a pre-rehabilitation program should focus on patients who have sufficient time in advance before the amputation for pre-rehabilitation and who are motivated to participate. Conclusion Although in general the effects of pre-rehabilitation are promising, pre-operative rehabilitation in dysvascular patients at risk for an LLA seems not feasible. Future research could focus on a better monitoring of dysvascular patients and the development of pre-rehabilitation in subgroups of younger dysvascular LLA patients.	[Dekker, Rienk; Hijmans, Juha M.; Geertzen, Jan H. B.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil, Groningen, Netherlands; [Hristova, Yoanna V.] Univ Groningen, Fac Med, Groningen, Netherlands	University of Groningen; University of Groningen	Dekker, R (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil, Groningen, Netherlands.	r.dekker01@umcg.nl	Hijmans, Juha/X-5814-2019	Hijmans, Juha/0000-0003-3968-9602				Abou-Zamzam AM, 2003, ANN VASC SURG, V17, P86, DOI 10.1007/s10016-001-0340-0; Andrews Lucy, 2012, Nurs Child Young People, V24, P14; Arthur HM, 2000, ANN INTERN MED, V133, P253, DOI 10.7326/0003-4819-133-4-200008150-00007; Back M, 2008, EUR J CARDIOVASC NUR, V7, P307, DOI 10.1016/j.ejcnurse.2008.02.001; Baker CS, 2012, PM&R, V4, P756, DOI 10.1016/j.pmrj.2012.06.005; Barrows C. W., 2000, INT J CONT HOSPITALI, V12, P190, DOI [10.1108/09596110010320751, DOI 10.1108/09596110010320751]; Bobbio A, 2008, EUR J CARDIO-THORAC, V33, P95, DOI 10.1016/j.ejcts.2007.10.003; Bragaru M, 2011, SPORTS MED, V41, P721, DOI 10.2165/11590420-000000000-00000; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; Butler D J, 1992, J Am Board Fam Pract, V5, P69; Carli F, 2005, CURR OPIN CLIN NUTR, V8, P23, DOI 10.1097/00075197-200501000-00005; Chin T, 2002, AM J PHYS MED REHAB, V81, P321, DOI 10.1097/00002060-200205000-00001; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P334, DOI 10.1016/0003-9993(92)90006-I; Dillingham TR, 2002, SOUTH MED J, V95, P875; Ditmyer Marcia M, 2002, Orthop Nurs, V21, P43; Dronkers JJ, 2010, CLIN REHABIL, V24, P614, DOI 10.1177/0269215509358941; Esquenazi A, 1996, ARCH PHYS MED REHAB, V77, pS18, DOI 10.1016/S0003-9993(96)90239-7; Fitzpatrick MC, 1999, CLIN ORTHOP RELAT R, P98; Fortington LV, 2013, EUR J VASC ENDOVASC, V46, P124, DOI 10.1016/j.ejvs.2013.03.024; Fortington LV, 2013, PROSTHET ORTHOT INT, V37, P305, DOI 10.1177/0309364612469385; Geertzen JHB, 2008, AMPUTATIE PROTHESIOL; Gill TM, 2003, ARCH PHYS MED REHAB, V84, P394, DOI 10.1053/apmr.2003.50020; Hoets H., 2012, FOCUS GROUP MODERATO; Hulzebos E., 2012, COCHRANE DB SYST REV, V11; Kohler F., 2012, ACUTE MED REHABILIAT, V1, P107; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Lacey A., 2007, QUALITATIVE DATA ANA; Landry MD, 2007, INT J REHABIL RES, V30, P297, DOI 10.1097/MRR.0b013e3282f14422; Marcinkowski K, 2005, ORTHOP NURS, V24, P202; Mina DS, 2014, PHYSIOTHERAPY, V100, P196, DOI 10.1016/j.physio.2013.08.008; Morano MT, 2013, ARCH PHYS MED REHAB, V94, P53, DOI 10.1016/j.apmr.2012.08.206; PINZUR MS, 1992, CLIN ORTHOP RELAT R, P239; Powell RA, 1996, INT J SOC PSYCHIATR, V42, P193, DOI 10.1177/002076409604200303; Prouty A, 2006, ORTHOP NURS, V25, P257; RACE KEH, 1994, EVALUATION REV, V18, P730, DOI 10.1177/0193841X9401800605; Rochester CL, 2008, RESP CARE, V53, P1196; Rosenfeldt F, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-20; Siggeirsdottir K, 2005, ACTA ORTHOP, V76, P555, DOI 10.1080/17453670510041565; Taylor SM, 2005, J VASC SURG, V42, P227, DOI 10.1016/j.jvs.2005.04.015; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turner DA, 2011, CRIT CARE MED, V39, P2593, DOI 10.1097/CCM.0b013e3182282bbe; US Department of Veterans Affairs, VA DOD CLIN PRACT GU; Valkenet K, 2011, CLIN REHABIL, V25, P99, DOI 10.1177/0269215510380830; van Twillert S, 2014, J REHABIL MED, V46, P915, DOI 10.2340/16501977-1846; Weiner P, 1998, WORLD J SURG, V22, P427, DOI 10.1007/s002689900410; Wiesinger GF, 2001, J REHABIL MED, V33, P260; Yetzer E A, 1996, Orthop Nurs, V15, P45	48	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0204726	10.1371/journal.pone.0204726	http://dx.doi.org/10.1371/journal.pone.0204726			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0RD	30321178	Green Submitted, Green Published, gold			2022-12-26	WOS:000447417900011
J	Prays, N; Dominik, P; Sanger, A; Franko, U				Prays, Nadia; Dominik, Peter; Saenger, Anja; Franko, Uwe			Biogas residue parameterization for soil organic matter modeling	PLOS ONE			English	Article							ANAEROBIC-DIGESTION; NITROGEN DYNAMICS; CARBON; MINERALIZATION; DECOMPOSITION; EMISSIONS; TURNOVER; GROWTH; PLANTS; WASTE	A variety of biogas residues (BGRs) have been used as organic fertilizer in agriculture. The use of these residues affects the storage of soil organic matter (SOM). In most cases, SOM changes can only be determined in long-term observations. Therefore, predictive modeling can be an efficient alternative, provided that the parameters required by the model are known for the considered BGRs. This study was conducted as a first approach to estimating the organic matter (OM) turnover parameters of BGRs for process modeling. We used carbon mineralization data from six BGRs from an incubation experiment, representing a range of substrate inputs, to calculate a turnover coefficient k controlling the velocity of fresh organic matter (FOM) decay and a synthesis coefficient eta describing the SOM creation from FOM. An SOM turnover model was applied in inverse mode to identify both parameters. In a second step, we related the parameters k and eta to chemical properties of the corresponding BGRs using a linear regression model and applied them to a long-term scenario simulation. According to the results of the incubation experiment, the k values ranged between 0.28 and 0.58 d(-1) depending on the chemical composition of the FOM. The estimated. values ranged between 0.8 and 0.89. The best linear relationship of k was found to occur with pH (R-2 = 0.863). Parameter. is related to the C-t/N-org ratio (R-2 = 0.696). Long-term scenario simulations emphasized the necessity of specific k and eta values related to the chemical properties for each BGR. However, further research is needed to validate and improve these preliminary results.	[Prays, Nadia] UFZ Helmholtz Ctr Environm Res, Dept Bioenergy, Halle, Germany; [Prays, Nadia] UFZ Helmholtz Ctr Environm Res, Dept Soil Syst Sci, Halle, Germany; [Dominik, Peter] Tech Univ Berlin, Dept Ecol, Chair Soil Sci, Berlin, Germany; [Saenger, Anja] Leibniz Inst Agr Engn Potsdam Bornim, Dept Technol Assessment & Subst Cycles, Potsdam, Germany; [Franko, Uwe] UFZ Helmholtz Ctr Environm Res, Dept Soil Syst Sci, Halle, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Berlin; Leibniz Institut fur Agrartechnik und Biookonomie (ATB); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Prays, N (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Bioenergy, Halle, Germany.; Prays, N (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Syst Sci, Halle, Germany.	nadia.prays@ufz.de		Prays, Nadia/0000-0003-3134-7704	Helmholtz Association of German Research Centres within the Initiative and Networking Fund for the Department of Bioenergy	Helmholtz Association of German Research Centres within the Initiative and Networking Fund for the Department of Bioenergy	The present study was supported by the Helmholtz Association of German Research Centres within the Initiative and Networking Fund for the Department of Bioenergy (UFZ), https://www.helmholtz.de/transfer/technologietransfer/transferinstrumente/innovationsfonds_der_helmholtz_zentren/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the anonymous reviewers for their careful reading and very helpful and constructive comments. The present study was supported by the Helmholtz Association of German Research Centres within the Initiative and Networking Fund for the Department of Bioenergy (UFZ).	Agency for Renewable Resources, 2010, BIOG MESSPR; Carr AS, 2013, GEODERMA, V200, P189, DOI 10.1016/j.geoderma.2013.02.012; Chen RR, 2012, BIOMASS BIOENERG, V45, P221, DOI 10.1016/j.biombioe.2012.06.014; Chen RR, 2011, SOIL BIOL BIOCHEM, V43, P2194, DOI 10.1016/j.soilbio.2011.07.003; Coban H, 2015, SOIL BIOL BIOCHEM, V86, P108, DOI 10.1016/j.soilbio.2015.03.023; Daniel-Gromke J, 2017, CURRENT DEV PR UNPUB; de la Fuente C, 2013, BIOL FERT SOILS, V49, P313, DOI 10.1007/s00374-012-0719-9; DeGroot MH, 1986, PROBABILITY AND STAT; Ernst G, 2008, SOIL BIOL BIOCHEM, V40, P1413, DOI 10.1016/j.soilbio.2007.12.026; Federal Ministry of the Environment NCaNS, 2016, CLIM ACT PLAN 2050 G, P67; Fouda S, 2013, J PLANT NUTR SOIL SC, V176, P572, DOI 10.1002/jpln.201100233; Franko, 1989, THESIS; FRANKO U, 1995, ECOL MODEL, V81, P213, DOI 10.1016/0304-3800(94)00172-E; Franko U., 1995, ARCH AGRON SOIL SCI, V39, P155, DOI [10.1080/03650349509365898, DOI 10.1080/03650349509365898]; Franko U, 2011, GEODERMA, V166, P119, DOI 10.1016/j.geoderma.2011.07.019; Gonzalez-Perez JA, 2012, ORG GEOCHEM, V53, P119, DOI 10.1016/j.orggeochem.2012.08.001; Haraldsen TK, 2011, WASTE MANAGE RES, V29, P1271, DOI 10.1177/0734242X11411975; Henriksen TM, 1999, SOIL BIOL BIOCHEM, V31, P1121, DOI 10.1016/S0038-0717(99)00030-9; Hodge A, 2000, TRENDS PLANT SCI, V5, P304, DOI 10.1016/S1360-1385(00)01656-3; Koerschens Martin, 2010, Archives of Agronomy and Soil Science, V56, P375, DOI 10.1080/03650340903410246; Lettau T, 1999, J PLANT NUTR SOIL SC, V162, P171, DOI 10.1002/(SICI)1522-2624(199903)162:2<171::AID-JPLN171>3.0.CO;2-M; Li SM, 2016, SOIL TILL RES, V163, P290, DOI 10.1016/j.still.2016.07.001; De la Rosa JM, 2012, GEODERMA, V191, P24, DOI 10.1016/j.geoderma.2012.01.032; Moller K, 2008, NUTR CYCL AGROECOSYS, V82, P209, DOI 10.1007/s10705-008-9196-9; Moller K, 2015, AGRON SUSTAIN DEV, V35, P1021, DOI 10.1007/s13593-015-0284-3; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nielsen K, PFLANZENBAULICHE VER, V51; Nkoa R, 2014, AGRON SUSTAIN DEV, V34, P473, DOI 10.1007/s13593-013-0196-z; Odlare M, 2008, WASTE MANAGE, V28, P1246, DOI 10.1016/j.wasman.2007.06.005; Paul EA, 2017, GEODERMA, V292, P9, DOI [10.1016/j.geoderma.2017.01.008, DOI 10.1016/J.GEODERMA.2017.01.008]; Post J, 2008, ENVIRON MODELL SOFTW, V23, P125, DOI 10.1016/j.envsoft.2007.05.010; Prays N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154232; REINHOLD G, 1991, ARCH ACKER PFL BODEN, V35, P129; RIVARD CJ, 1995, APPL BIOCHEM BIOTECH, V51-2, P125, DOI 10.1007/BF02933417; Royer-Tardif S, 2010, SOIL BIOL BIOCHEM, V42, P813, DOI 10.1016/j.soilbio.2010.01.018; Sanger A, 2014, ARCH AGRON SOIL SCI, V60, P1779, DOI 10.1080/03650340.2014.907491; Sanger A, 2011, BIOL FERT SOILS, V47, P249, DOI 10.1007/s00374-010-0528-y; Sanger A, 2010, J PLANT NUTR SOIL SC, V173, P692, DOI 10.1002/jpln.200900254; Smith P, 1997, GEODERMA, V81, P153, DOI 10.1016/S0016-7061(97)00087-6; Tambone F, 2010, CHEMOSPHERE, V81, P577, DOI 10.1016/j.chemosphere.2010.08.034; Terhoeven-Urselmans T, 2009, APPL SOIL ECOL, V42, P297, DOI 10.1016/j.apsoil.2009.05.012; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Wentzel S, 2016, ENG LIFE SCI, V16, P231, DOI 10.1002/elsc.201400229; Wragge V., 2013, FACHTAGUNG PFLANZENB; Zirkler D, 2014, BIOMASS BIOENERG, V67, P89, DOI 10.1016/j.biombioe.2014.04.021	45	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0204121	10.1371/journal.pone.0204121	http://dx.doi.org/10.1371/journal.pone.0204121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312296	Green Submitted, Green Published, gold			2022-12-26	WOS:000447427300007
J	Wu, X; Du, J; Song, WT; Cao, MP; Chen, SD; Xia, RH				Wu, Xia; Du, Juan; Song, Weitao; Cao, Meiping; Chen, Shude; Xia, Ruohong			Weak power frequency magnetic fields induce microtubule cytoskeleton reorganization depending on the epidermal growth factor receptor and the calcium related signaling	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; INDUCED CELL-MIGRATION; CANCER-CELLS; CA2+ INFLUX; EGF; PHOSPHORYLATION; ACTIN; ACTIVATION; DYNAMICS; TAU	We have shown previously that a weak 50 Hz magnetic field (MF) invoked the actin-cytoskeleton, and provoked cell migration at the cell level, probably through activating the epidermal growth factor receptor (EGFR) related motility pathways. However, whether the MF also affects the microtubule (MT)-cytoskeleton is still unknown. In this article, we continuously investigate the effects of 0.4 mT, 50 Hz MF on the MT, and try to understand if the MT effects are also associated with the EGFR pathway as the actin-cytoskeleton effects were. Our results strongly suggest that the MF effects are similar to that of EGF stimulation on the MT cytoskeleton, showing that 1) the MF suppressed MT in multiple cell types including PC12 and FL; 2) the MF promoted the clustering of the EGFR at the protein and the cell levels, in a similar way of that EGF did but with higher sensitivity to PD153035 inhibition, and triggered EGFR phosphorylation on sites of Y1173 and S1046/1047; 3) these effects were strongly depending on the Ca2+ signaling through the L-type calcium channel (LTCC) phosphorylation and elevation of the intracellular Ca2+ level. Strong associations were observed between EGFR and the Ca2+ signaling to regulate the MF-induced-reorganization of the cytoskeleton network, via phosphorylating the signaling proteins in the two pathways, including a significant MT protein, tau. These results strongly suggest that the MF activates the overall cytoskeleton in the absence of EGF, through a mechanism related to both the EGFR and the LTCC/Ca2+ signaling pathways.	[Wu, Xia; Du, Juan; Song, Weitao; Cao, Meiping; Chen, Shude; Xia, Ruohong] East China Normal Univ, Phys Dept, Shanghai, Peoples R China; [Wu, Xia; Xia, Ruohong] East China Normal Univ, State Key Lab Precis Spect, Shanghai, Peoples R China	East China Normal University; East China Normal University	Xia, RH (corresponding author), East China Normal Univ, Phys Dept, Shanghai, Peoples R China.; Xia, RH (corresponding author), East China Normal Univ, State Key Lab Precis Spect, Shanghai, Peoples R China.	xrhwxecnu@163.com			973 National Natural Science Foundation of China [30770539]; open project of State Key Laboratory of Precision Spectroscopy, East China Normal University, Shanghai	973 National Natural Science Foundation of China; open project of State Key Laboratory of Precision Spectroscopy, East China Normal University, Shanghai	This work was supported by the 973 National Natural Science Foundation of China (No. 30770539 to RX) and the open project of State Key Laboratory of Precision Spectroscopy, East China Normal University, Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhshi TK, 2014, CYTOSKELETON, V71, P1, DOI 10.1002/cm.21150; Anfuso CD, 2009, MICROVASC RES, V78, P338, DOI 10.1016/j.mvr.2009.09.001; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Avner P, 2009, NANONEUROSCIENCE BIO; BADLEY R A, 1980, Journal of Muscle Research and Cell Motility, V1, P5, DOI 10.1007/BF00711922; BAUMGARTEN LB, 1992, J BIOL CHEM, V267, P10524; Bos M, 1997, CLIN CANCER RES, V3, P2099; Brubaker-Purkey BJ, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.6801; Chan AY, 1998, J CELL SCI, V111, P199; Che Q, 2002, HYPERTENSION, V40, P700, DOI 10.1161/01.HYP.0000035524.10948.93; Chu K, 2007, CHIN J RADIOL HEALTH, V16, P259; Chu Ke-ping, 2007, Zhonghua Yufang Yixue Zazhi, V41, P391; Churcher I, 2006, CURR TOP MED CHEM, V6, P579, DOI 10.2174/156802606776743057; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Correa Sonia A L, 2012, J Signal Transduct, V2012, P649079, DOI 10.1155/2012/649079; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; Du J, 2015, PROG BIOCHEM BIOPHYS, V42, P758; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Dumstrei K, 1998, DEVELOPMENT, V125, P3417; Elkabets M, 2015, CANCER CELL, V27, P533, DOI 10.1016/j.ccell.2015.03.010; Feng W, 1999, MOL PHARMACOL, V55, P821; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; FITZSIMMONS RJ, 1995, J BONE MINER RES, V10, P812; Foller M, 2009, FASEB J, V23, P1072, DOI 10.1096/fj.08-121772; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Ganguly A, 2012, J BIOL CHEM, V287, P43359, DOI 10.1074/jbc.M112.423905; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guo K, 2008, CANCER SCI, V99, P486, DOI 10.1111/j.1349-7006.2007.00702.x; Harms BD, 2005, BIOPHYS J, V88, P1479, DOI 10.1529/biophysj.104.047365; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Heo JS, 2006, AM J PHYSIOL-CELL PH, V290, pC123, DOI 10.1152/ajpcell.00142.2005; Hermle T, 2006, AM J PHYSIOL-CELL PH, V291, pC710, DOI 10.1152/ajpcell.00631.2005; HSU CYJ, 1991, J BIOL CHEM, V266, P603; Hutchinson TE, 2015, EUR J PHARMACOL, V755, P110, DOI 10.1016/j.ejphar.2015.02.042; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Jia CL, 2007, BIOELECTROMAGNETICS, V28, P197, DOI 10.1002/bem.20293; Jiang Q, 2006, J OCUL PHARMACOL TH, V22, P93, DOI 10.1089/jop.2006.22.93; Kadavath H, 2015, P NATL ACAD SCI USA, V112, P7501, DOI 10.1073/pnas.1504081112; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; KAVALIERS M, 1987, N-S ARCH PHARMACOL, V336, P308; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Komazaki S, 2007, J EXP ZOOL PART A, V307A, P156, DOI 10.1002/jez.a.359; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Lee JK, 2017, MOLECULES, V22, DOI 10.3390/molecules22081287; Liang H, 2012, J ANESTH, V26, P381, DOI 10.1007/s00540-011-1317-y; LINDSTROM E, 1993, J CELL PHYSIOL, V156, P395, DOI 10.1002/jcp.1041560223; Liu GF, 2014, NEUROSCI BULL, V30, P569, DOI 10.1007/s12264-014-1444-6; Liu LP, 2013, POWER FREQUENCY MAGN; MANDELKOW E, 1995, CURR OPIN CELL BIOL, V7, P72, DOI 10.1016/0955-0674(95)80047-6; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; Medina M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041160; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Mezi S, 2012, INT J ONCOL, V41, P2128, DOI 10.3892/ijo.2012.1642; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Muroyama A, 2017, DEVELOPMENT, V144, P3012, DOI 10.1242/dev.153171; Neltner BS, 2000, CELL SIGNAL, V12, P71, DOI 10.1016/S0898-6568(99)00065-0; Peiretti F, 1996, BLOOD, V87, P162; Purvis J, 2008, BIOTECHNOL PROGR, V24, P540, DOI 10.1021/bp070405o; Rea K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.353; Rodriguez-Martin T, 2013, NEUROBIOL AGING, V34, P2146, DOI 10.1016/j.neurobiolaging.2013.03.015; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; Sato H, 2005, CANCER GENE THER, V12, P757, DOI 10.1038/sj.cgt.7700827; Singh S, 2003, J BIOL CHEM, V278, P36410, DOI 10.1074/jbc.M306428200; Sturla LM, 2005, J BIOL CHEM, V280, P14597, DOI 10.1074/jbc.M413287200; Tomlins SA, 2005, EXP CELL RES, V308, P439, DOI 10.1016/j.yexcr.2005.04.032; Tsao HK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.274; WALLECZEK J, 1992, FEBS LETT, V314, P351, DOI 10.1016/0014-5793(92)81504-F; WALLECZEK J, 1990, FEBS LETT, V271, P157, DOI 10.1016/0014-5793(90)80396-Z; Wang F, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-65; Wayman GA, 2011, CELL CALCIUM, V50, P1, DOI 10.1016/j.ceca.2011.02.007; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Wills MKB, 2014, MOL BIOL CELL, V25, P739, DOI 10.1091/mbc.E13-08-0434; Woolf NJ, 2009, BIOL MED PHYS BIOMED, P85, DOI 10.1007/978-3-642-03584-5_3; Wu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087626; Yang F, 2018, J RAD RES RAD PROCES; Yoneda M, 2000, J ENDOCRINOL, V166, P677, DOI 10.1677/joe.0.1660677	79	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205569	10.1371/journal.pone.0205569	http://dx.doi.org/10.1371/journal.pone.0205569			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312357	Green Submitted, Green Published, gold			2022-12-26	WOS:000447427300038
J	Wu, WT; Chu, CY; Hsu, PC; Lee, WH; Su, HM; Yen, HW; Voon, WC; Lai, WT; Sheu, SH; Lin, TH				Wu, Wei-Tsung; Chu, Chun-Yuan; Hsu, Po-Chao; Lee, Wen-Hsien; Su, Ho-Ming; Yen, Hsueh-Wei; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung; Lin, Tsung-Hsien			Impact of the duration of the evidence-based medicine use in acute heart failure: A nationwide cohort study	PLOS ONE			English	Article							EJECTION FRACTION; MORTALITY; TRIAL; SPIRONOLACTONE; MORBIDITY; SURVIVAL; DIGOXIN	Background Several randomized control trials have established that drugs can decrease the heart failure (HF) rehospitalization in patients with HF. However, limited studies have investigated the duration of medicine use to decrease the rehospitalization period in the real world. Hence, this study aims to investigate whether the evidence-based medicine decreases the HF rehospitalization in different treatment intervals in the clinical practice. Method We examined patients admitted with acute HF from the National Health Insurance Research Database in Taiwan. In addition, the major adverse cardiovascular events (MACE) were the composite endpoints of the in-hospital mortality and rehospitalization after 1 year. Furthermore, we analyzed the medicine use to decrease 14 days and 1, 6, and 12 months' HF rehospitalization. Results Overall, we examined 11,012 patients. The use of the renin-angiotensin system (RAS) blockers [hazard ratio (HR), 0.58; P< 0.01], beta-blocker (HR, 0.67; P < 0.01), spironolactone (HR, 0.63; P < 0.01), and digitalis (HR, 0.67; P < 0.01) associated with the lower in-hospital mortality rate. The Cox regression analysis revealed that RAS blocker (HR, 0.86; P< 0.01) and 8-blocker (HR, 0.71; P< 0.01) were independent predictors for MACE. Although RAS blockers declined rehospitalization to 6 months, beta-blocker decreased the rehospitalization rate after 1 month use and the benefit persisted till 12 months. Furthermore, digitalis only lowered rehospitalization to 14 days. Conclusion This study suggests that the use of evidence-based medicine is associated with lower MACE for patients with HF, and these drugs could play vital roles in different periods to decrease the rehospitalization in the clinical setting.	[Wu, Wei-Tsung; Chu, Chun-Yuan; Hsu, Po-Chao; Lee, Wen-Hsien; Su, Ho-Ming; Yen, Hsueh-Wei; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung; Lin, Tsung-Hsien] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Chu, Chun-Yuan; Hsu, Po-Chao; Lee, Wen-Hsien; Su, Ho-Ming; Yen, Hsueh-Wei; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung; Lin, Tsung-Hsien] Kaohsiung Med Univ, Fac Med, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Lin, TH (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.; Lin, TH (corresponding author), Kaohsiung Med Univ, Fac Med, Dept Internal Med, Kaohsiung, Taiwan.	lth@kmu.edu.tw	蘇, 河名/AAE-9843-2019	Wu, Wei Tsung/0000-0003-3702-1406; Lin, Tsung-Hsien/0000-0002-7226-8730; Su, Ho-Ming/0000-0003-0247-3250; Chu, Chun-Yuan/0000-0001-5550-102X; Hsu, Po-Chao/0000-0001-6217-3036				Ahmed A, 2007, J GERONTOL A-BIOL, V62, P323, DOI 10.1093/gerona/62.3.323; Bourge RC, 2013, AM J MED, V126, P701, DOI 10.1016/j.amjmed.2013.02.001; Chamberlain AM, 2015, AM J MED, V128, P38, DOI 10.1016/j.amjmed.2014.08.024; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Eichhorn EJ, 2001, CURR CONTR TRIALS C, V2, P20, DOI 10.1186/CVM-2-1-020; Hjalmarson A, 2000, BASIC RES CARDIOL, V95, P98; Lechat P, 1999, LANCET, V353, P9; Perry G, 1997, NEW ENGL J MED, V336, P525; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	13	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205440	10.1371/journal.pone.0205440	http://dx.doi.org/10.1371/journal.pone.0205440			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308032	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500077
J	Yamada, K; Sasabe, M; Fujikawa, Y; Wada, T; Tominaga-Wada, R				Yamada, Koh; Sasabe, Michiko; Fujikawa, Yukichi; Wada, Takuji; Tominaga-Wada, Rumi			Amino acid substitutions in CPC-LIKE MYB reveal residues important for protein stability in Arabidopsis roots	PLOS ONE			English	Article							EPIDERMAL-CELL DIFFERENTIATION; TRICHOME DEVELOPMENT; CAPRICE; GENES; EXPRESSION; THALIANA; TRY; GL3; PHOSPHORYLATION; TRANSCRIPTION	TRYPTICHON (TRY) and ENHANCER OF TRY AND CPC2 (ETC2) encode R3-type MYB transcription factors that are involved in epidermal cell differentiation in Arabidopsis thaliana. TRY and ETC2 belong to the CPC-like MYB gene family, which includes seven homolog genes. Previously, we showed that among the CPC family members, TRY and ETC2 are characterized by rapid proteolysis compared with that of other members, and we demonstrated that this proteolysis is mediated by the proteasome-dependent pathway. In this study, we compared the functions of the wild-type TRY and ETC2 proteins and their amino acid-substituted versions. Our results showed that the substitution of amino acids in the C-terminal of TRY and ETC2 conferred them the ability to induce root hair formation. Furthermore, we confirmed that these mutations enhanced the stability of the TRY and ETC2 proteins. These results revealed that the amino acids, which are important for the functions of TRY and ETC2, mediate morphological pattern formation and can be useful in understanding the pathway determining the fate of root hair cells.	[Yamada, Koh] Hiroshima Univ, Sch Appl Biol Sci, Higashihiroshima, Japan; [Sasabe, Michiko] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Fujikawa, Yukichi; Wada, Takuji; Tominaga-Wada, Rumi] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Japan; [Yamada, Koh] Kyoto Univ, Inst Chem Res, Uji, Kyoto, Japan	Hiroshima University; Hirosaki University; Hiroshima University; Kyoto University	Tominaga-Wada, R (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Japan.	rtomi@hiroshima-u.ac.jp	Fujikawa, Yukichi/G-7627-2019; Fujikawa, Y./M-4553-2019	Fujikawa, Yukichi/0000-0003-1556-6173; Fujikawa, Y./0000-0003-1556-6173	JSPS KAKENHI [16K07644]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI, Grant number: 16K07644 to RT-W. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Champion A., 2004, Functional & Integrative Genomics, V4, P163, DOI 10.1007/s10142-003-0096-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DOLAN L, 1994, DEVELOPMENT, V120, P2465; DOLAN L, 1993, DEVELOPMENT, V119, P71; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; Esch JJ, 2004, PLANT J, V40, P860, DOI 10.1111/j.1365-313X.2004.02259.x; Gan LJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-176; Kirik V, 2004, PLANT MOL BIOL, V55, P389, DOI 10.1007/s11103-004-0893-8; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Koshino-Kimura Y, 2005, PLANT CELL PHYSIOL, V46, P817, DOI 10.1093/pcp/pci096; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; OKADA K, 1990, SCIENCE, V250, P274, DOI 10.1126/science.250.4978.274; Payne CT, 2000, GENETICS, V156, P1349; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Simon M, 2007, DEV BIOL, V311, P566, DOI 10.1016/j.ydbio.2007.09.001; Tominaga R, 2008, DEVELOPMENT, V135, P1335, DOI 10.1242/dev.017947; Tominaga-Wada R, 2017, DEVELOPMENT, V144, P2375, DOI 10.1242/dev.149542; Tominaga-Wada R, 2012, INT J MOL SCI, V13, P3478, DOI 10.3390/ijms13033478; Tominaga-Wada R, 2011, INT REV CEL MOL BIO, V286, P67, DOI 10.1016/B978-0-12-385859-7.00002-1; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wada T, 2015, PLANT SCI, V241, P260, DOI 10.1016/j.plantsci.2015.10.015; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Wang SC, 2007, DEVELOPMENT, V134, P3873, DOI 10.1242/dev.009597; Wang SC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-81	29	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205522	10.1371/journal.pone.0205522	http://dx.doi.org/10.1371/journal.pone.0205522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308079	Green Submitted, Green Published, gold			2022-12-26	WOS:000447173500095
J	Zhang, CQ; Deng, YW; Liu, YN; Xu, Y; Liu, YL; Zhang, L; Chen, XW; Xie, MX; Ge, S				Zhang, Chunquan; Deng, Yiwen; Liu, Yanna; Xu, Yan; Liu, Yanling; Zhang, Li; Chen, Xiongwen; Xie, Mingxing; Ge, Shuping			Preclinical cardiovascular changes in children with obesity: A real-time 3-dimensional speckle tracking imaging study	PLOS ONE			English	Article							MYOCARDIAL DEFORMATION CHANGES; LEFT-VENTRICULAR FUNCTION; QUANTITATIVE ASSESSMENT; 2-DIMENSIONAL STRAIN; SYSTOLIC STRAIN; HEART-DISEASE; RISK-FACTORS; ECHOCARDIOGRAPHY; CHILDHOOD; VALIDATION	The aims of this study were (1) to quantify changes in 3-dimensional (3D) strain in obese children using real-time 3D echocardiography (RT3DE) and 3D speckle tracking echocardiography (3DSTE), and (2) to investigate the utility of left ventricular (LV) strain variables in measuring early cardiovascular changes in children with obesity. A total of 181 obese children (study group) aged 4-18 years old were prospectively enrolled and compared with 229 healthy subjects (control group). We acquired demographic, clinical, biochemical, and 2D echocardiography/Doppler data. Also, RT3DE and 3DSTE were performed to measure LV volume, left ventricular ejection fraction (LVEF), LV mass (LVM), LV peak systolic global longitudinal strain (GLS), radial strain (GRS), circumferential strain (GCS), and global strain (GS). There were significant differences in anthropometric measurements, blood pressures, Cholesterol, C-reactive protein (CRP), Intima-media thickness (IMT), left atrium end-systolic dimension (LASD), interventricular septal end-diastolic dimension (IVSD), LV posterior wall end-diastolic dimension (LVPWD), LV end-diastolic dimension (LVEDD), LV end-systolic dimension (LVESD), LV end-diastolic volumes (LVEDV), and LV end-systolic volumes (LVESV), E and A velocities, E/A,e', e'/a', E/e', LVM, LV mass index (LVMI), GLS, GRS, GCS, and GS between the study and control groups. The receiver operating characteristic curves (ROC) for the statistically significant echocardiographic variables showed that the range of areas of ROC curves varied from 0.76 (GLS), 0.74 (GRS), 0.72 (LASD), to 0.58 (LVESD), respectively. In conclusion, LV 3D strain variables by RT3DE and 3DSTE decrease in obese children. LV 3D strain is more sensitive than other echocardiographic and vascular ultrasound variables in detecting cardiovascular changes in children with obesity.	[Zhang, Chunquan; Deng, Yiwen; Liu, Yanna; Xu, Yan] Nanchang Univ, Affiliated Hosp 2, Dept Ultrasound, Nanchang, Jiangxi, Peoples R China; [Liu, Yanling] Nanchang Univ, Affiliated Hosp 2, Dept Pediat, Nanchang, Jiangxi, Peoples R China; [Zhang, Li; Xie, Mingxing] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ultrasound, Wuhan, Hubei, Peoples R China; [Chen, Xiongwen] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA USA; [Ge, Shuping] St Christophers Hosp Children, Heart Ctr, Philadelphia, PA 19133 USA; [Ge, Shuping] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Nanchang University; Nanchang University; Huazhong University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Drexel University	Ge, S (corresponding author), St Christophers Hosp Children, Heart Ctr, Philadelphia, PA 19133 USA.; Ge, S (corresponding author), Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.	shuping.ge@americanacademic.com	Zhang, L/A-8465-2019; Zhang, L/ABG-4378-2020; liu, yan/HCI-5542-2022; Chen, Xiongwen/D-5988-2012; liu, yan/HGV-1365-2022	Zhang, L/0000-0003-1620-1512; Zhang, L/0000-0003-1620-1512; Chen, Xiongwen/0000-0002-3829-5815; Zhang, Chun-Quan/0000-0002-4709-1603	Jiangxi Province Department of Science and Technology [20152ACG70019]	Jiangxi Province Department of Science and Technology	This research received a grant from Jiangxi Province Department of Science and Technology (Grant number: 20152ACG70019). The grant provided salary support for 2 graduate students (YD and YX), but otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert MA, 2001, AM J MED SCI, V321, P225, DOI 10.1097/00000441-200104000-00003; Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040; Barbosa JAA, 2013, EUR HEART J-CARD IMG, V14, P882, DOI 10.1093/ehjci/jes294; DERVAN JP, 1991, CATHETER CARDIO DIAG, V22, P184, DOI 10.1002/ccd.1810220307; Di Salvo G, 2006, EUR HEART J, V27, P2689, DOI 10.1093/eurheartj/ehl163; Eidem BW, 2004, J AM SOC ECHOCARDIOG, V17, P212, DOI 10.1016/j.echo.2003.12.005; Galinier M, 2005, ARCH MAL COEUR VAISS, V98, P39; Gayat E, 2011, J AM SOC ECHOCARDIOG, V24, P878, DOI 10.1016/j.echo.2011.04.016; Gorcsan J, 1997, CIRCULATION, V95, P2423, DOI 10.1161/01.CIR.95.10.2423; Group of China Obesity Task Force, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P97; Juonala M, 2005, CIRCULATION, V112, P1486, DOI 10.1161/CIRCULATIONAHA.104.502161; Juonala M, 2006, ARTERIOSCL THROM VAS, V26, P1883, DOI 10.1161/01.ATV.0000228818.11968.7a; Kaku K, 2014, J AM SOC ECHOCARDIOG, V27, P55, DOI 10.1016/j.echo.2013.10.002; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kibar AE, 2015, BALK MED J, V32, P56, DOI 10.5152/balkanmedj.2015.15136; Korner A, 2013, INT J OBESITY, V37, P931, DOI 10.1038/ijo.2012.163; Korinek J, 2005, J AM SOC ECHOCARDIOG, V18, P1247, DOI 10.1016/j.echo.2005.03.024; Kozakova M, 2016, NUTR METAB CARDIOVAS, V26, P60, DOI 10.1016/j.numecd.2015.10.002; Labombarda F, 2013, EUR HEART J-CARD IMG, V14, P668, DOI 10.1093/ehjci/jes238; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Li XR, 2004, CIRCULATION, V110, P3488, DOI 10.1161/01.CIR.0000149713.48317.27; Lorch Steven M, 2007, J Cardiometab Syndr, V2, P30, DOI 10.1111/j.1559-4564.2007.06001.x; Luis SA, 2014, J AM SOC ECHOCARDIOG, V27, P285, DOI 10.1016/j.echo.2013.11.002; Mangner N, 2014, JACC-CARDIOVASC IMAG, V7, P1198, DOI 10.1016/j.jcmg.2014.08.006; Marcus KA, 2011, J AM SOC ECHOCARDIOG, V24, P625, DOI 10.1016/j.echo.2011.01.021; Moore CC, 2000, RADIOLOGY, V214, P453, DOI 10.1148/radiology.214.2.r00fe17453; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Oliveira OP, 2015, MINERVA GINECOL, V67, P307; Pacileo G, 2007, J CARDIOVASC MED, V8, P17, DOI 10.2459/01.JCM.0000247430.36581.c2; Peterson LR, 2004, J AM COLL CARDIOL, V43, P1399, DOI 10.1016/j.jacc.2003.10.062; REFSUM H, 1989, CLIN CHEM, V35, P1921; Rodriguez L, 1996, AM HEART J, V131, P982, DOI 10.1016/S0002-8703(96)90183-0; Saltijeral A, 2011, OBESITY, V19, P2268, DOI 10.1038/oby.2011.157; Simsek E, 2010, TURKISH J PEDIATR, V52, P602; Sorof J, 2002, HYPERTENSION, V40, P441, DOI 10.1161/01.HYP.0000032940.33466.12; SPAIN DM, 1946, AM HEART J, V32, P659, DOI 10.1016/0002-8703(46)90674-6; Vitarelli A, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000071; Wang Q, 2015, HERZ, V40, P260, DOI 10.1007/s00059-014-4186-y; Whincup PH, 2005, CIRCULATION, V112, P1789, DOI 10.1161/CIRCULATIONAHA.104.532663; Wong CY, 2004, CIRCULATION, V110, P3081, DOI 10.1161/01.CIR.0000147184.13872.0F; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; YOUNG AA, 1993, RADIOLOGY, V188, P101, DOI 10.1148/radiology.188.1.8511281; Zhang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158679; Zhang L, 2013, J AM SOC ECHOCARDIOG, V26, P853, DOI 10.1016/j.echo.2013.05.002	44	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205177	10.1371/journal.pone.0205177	http://dx.doi.org/10.1371/journal.pone.0205177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308043	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500044
J	Song, ZY; Wang, F; Cui, SX; Gao, ZH; Qu, XJ				Song, Zhi-Yu; Wang, Feng; Cui, Shu-Xiang; Gao, Zu-Hua; Qu, Xian-Jun			CXCR7/CXCR4 heterodimer-induced histone demethylation: a new mechanism of colorectal tumorigenesis	ONCOGENE			English	Article							SUPPRESSOR-CELLS; CHEMOKINE RECEPTOR; BETA-ARRESTIN; CANCER; CXCR7; REGULATORS; IMMUNE; TRIMETHYLATION; ACTIVATION; METASTASES	Both chemokine receptors (CXCRs) 7 and 4 can facilitate immune cell migration and mediate a vast array of physiological and pathological events. Herein we report, in both human and animal studies, that these two CXCRs can form heterodimers in vivo and promote colorectal tumorigenesis through histone demethylation. Compared with adjacent non-neoplastic tissue, human colorectal cancer (CRC) tissue showed a significant higher expression of CXCR4 and CXCR7, which was colocalized in the cancer cell epithelium. The CXCR/CXCR4 heterodimerization was associated with increased histone demethylase JMJD2A. Villin-CXCR7-CXCR4 transgenic mice demonstrated a greater degree of exacerbated colitis and tumorigenesis than villin-CXCR7 and villin-CXCR4 mice. The CXCR7/CXCR4 heterodimerization also promoted APC mutation-driven colorectal tumorigenesis in APC(Min/+)/villin-CXCR7-CXCR4 mice. Further analysis showed that the CXCR7/CXCR4 heterodimer induced nuclear beta arr1 recruitment and histone demethylase JMJD2A, leading to histone demethylation and resulting in transcription of inflammatory factors and oncogenes. This study uncovered a novel mechanism of colorectal tumorigenesis through the CXCR7/CXCR4 heterodimer-induced histone demethylation. Inhibition of CXCR7/CXCR4 heterodimer-induced histone demethylation could be an effective strategy for the prevention and treatment of colorectal cancer.	[Song, Zhi-Yu; Qu, Xian-Jun] Capital Med Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing, Peoples R China; [Wang, Feng; Cui, Shu-Xiang] McGill Univ, Dept Pathol, Montreal, PQ, Canada; [Gao, Zu-Hua] Capital Med Univ, Sch Publ Hlth, Toxicol & Sanit Chem, Beijing, Peoples R China; [Song, Zhi-Yu] Henan Prov Peoples Hosp, Dept Pharm, Zhengzhou, Henan, Peoples R China	Capital Medical University; McGill University; Capital Medical University; Zhengzhou University	Qu, XJ (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing, Peoples R China.; Gao, ZH (corresponding author), Capital Med Univ, Sch Publ Hlth, Toxicol & Sanit Chem, Beijing, Peoples R China.	zu-hua.gao@mcgill.ca; quxj@ccmu.edu.cn			Natural Science Foundation of China [81673449, 91629303]; Beijing Natural Science Foundation Program and Scientific Research Program of Municipal Commission of Education [KZ201710025020, KZ201810025033]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation Program and Scientific Research Program of Municipal Commission of Education	This work was supported by Natural Science Foundation of China (81673449 and 91629303) and Beijing Natural Science Foundation Program and Scientific Research Program of Municipal Commission of Education (KZ201710025020 and KZ201810025033).	Atreya I, 2008, EXPERT REV ANTICANC, V8, P561, DOI 10.1586/14737140.8.4.561; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Beaulieu JM, 2005, CELL, V123, P755, DOI 10.1016/j.cell.2005.11.010; Berry WL, 2013, CANCER RES, V73, P2936, DOI 10.1158/0008-5472.CAN-12-4300; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; COOPER HS, 1993, LAB INVEST, V69, P238; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Guerra-Calderas L, 2015, CANCER GENET-NY, V208, P215, DOI 10.1016/j.cancergen.2014.11.001; Haile LA, 2008, GASTROENTEROLOGY, V135, P871, DOI 10.1053/j.gastro.2008.06.032; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liu XQ, 2017, BIOMATERIALS, V127, P61, DOI 10.1016/j.biomaterials.2017.02.035; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Meidenbauer JJ, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-23; Saleiro D, 2012, INT J CANCER, V131, P2553, DOI 10.1002/ijc.27578; Salifou K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10174; Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Sun CC, 2014, PATHOL RES PRACT, V210, P668, DOI 10.1016/j.prp.2014.06.016; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Werner L, 2013, THERANOSTICS, V3, P40, DOI 10.7150/thno.5135; Werner L, 2011, J LEUKOCYTE BIOL, V90, P583, DOI 10.1189/jlb.0111101; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu T, 2016, ONCOTARGET, V7, P19548, DOI 10.18632/oncotarget.6969; Xu GL, 2015, J BIOL CHEM, V290, P5414, DOI 10.1074/jbc.M114.610345; Yang D, 2015, INT J CLIN EXP PATHO, V8, P13051; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhang L, 2016, ONCOGENE, V35, P5641, DOI 10.1038/onc.2016.100; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85; Zhou ZH, 2015, J PATHOL, V236, P467, DOI 10.1002/path.4541	42	26	26	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1560	1575		10.1038/s41388-018-0519-2	http://dx.doi.org/10.1038/s41388-018-0519-2			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30337690				2022-12-26	WOS:000459945800014
J	Sugita, S; Watanabe, K; Hashimoto, K; Niwa, T; Uemura, E; Taguchi, H; Watanabe, Y				Sugita, Saori; Watanabe, Kumiko; Hashimoto, Kana; Niwa, Tatsuya; Uemura, Eri; Taguchi, Hideki; Watanabe, Yo-hei			Electrostatic interactions between middle domain motif-1 and the AAA1 module of the bacterial ClpB chaperone are essential for protein disaggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; ATPases associated with diverse cellular activities (AAA); chaperone; protein conformation; protein cross-linking; protein dynamic; structure-function; mass spectrometry (MS); disaggregation; Hsp104	AMINO-TERMINAL DOMAIN; MOLECULAR CHAPERONE; DNAJ COMPLEX; ATP BINDING; HSP104; HSP70; GRPE; MUTAGENESIS; MECHANISM; SYSTEM	ClpB, a bacterial homologue of heat shock protein 104 (Hsp104), can disentangle aggregated proteins with the help of the DnaK, a bacterial Hsp70, and its co-factors. As a member of the expanded superfamily of ATPases associated with diverse cellular activities (AAA(+)), ClpB forms a hexameric ring structure, with each protomer containing two AAA(+) modules, AAA1 and AAA2. A long coiled-coil middle domain (MD) is present in the C-terminal region of the AAA1 and surrounds the main body of the ring. The MD is subdivided into two oppositely directed short coiled-coils, called motif-1 and motif-2. The MD represses the ATPase activity of ClpB, and this repression is reversed by the binding of DnaK to motif-2. To better understand how the MD regulates ClpB activity, here we investigated the roles of motif-1 in ClpB from Thermus thermophilus (TClpB). Using systematic alanine substitution of the conserved charged residues, we identified functionally important residues in motif-1, and using a photoreactive cross-linker and LC-MS/MS analysis, we further explored potential interacting residues. Moreover, we constructed TClpB mutants in which functionally important residues in motif-1 and in other candidate regions were substituted by oppositely charged residues. These analyses revealed that the intra-subunit pair Glu-401-Arg-532 and the inter-subunit pair Asp-404-Arg-180 are functionally important, electrostatically interacting pairs. Considering these structural findings, we conclude that the Glu-401-Arg-532 interaction shifts the equilibrium of the MD conformation to stabilize the activated form and that the Arg-180-Asp-404 interaction contributes to intersubunit signal transduction, essential for ClpB chaperone activities.	[Sugita, Saori; Watanabe, Kumiko; Hashimoto, Kana; Watanabe, Yo-hei] Konan Univ, Fac Sci & Engn, Dept Biol, Okamoto 8-9-1, Kobe, Hyogo 6588501, Japan; [Watanabe, Yo-hei] Konan Univ, Inst Integrat Neurobiol, Okamoto 8-9-1, Kobe, Hyogo 6588501, Japan; [Niwa, Tatsuya; Uemura, Eri; Taguchi, Hideki] Tokyo Inst Technol, Inst Innovat Res, Ctr Cell Biol, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan	Konan University; Konan University; Tokyo Institute of Technology	Watanabe, Y (corresponding author), Konan Univ, Fac Sci & Engn, Dept Biol, Okamoto 8-9-1, Kobe, Hyogo 6588501, Japan.	ywatanab@center.konan-u.ac.jp	Taguchi, Hideki/B-6946-2009; taguchi, hideki/AAM-2663-2021	Taguchi, Hideki/0000-0002-6612-9339; taguchi, hideki/0000-0002-6612-9339; Niwa, Tatsuya/0000-0002-1330-8974	JSPS KAKENHI Grants [24241048, 26440085]	JSPS KAKENHI Grants	This work was supported by JSPS KAKENHI Grants 24241048 and 26440085. The authors declare that they have no conflicts of interest with the contents of this article.	Acebron SP, 2009, FEBS LETT, V583, P2991, DOI 10.1016/j.febslet.2009.08.020; Fernandez-Higuero JA, 2011, J BIOL CHEM, V286, P25547, DOI 10.1074/jbc.M111.231365; Barnett ME, 2005, J BIOL CHEM, V280, P34940, DOI 10.1074/jbc.M505653200; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; Deville C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701726; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Hayashi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08917-8; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lipinska N, 2013, J BIOL CHEM, V288, P2857, DOI 10.1074/jbc.M112.387589; Masuda T, 2009, MOL CELL PROTEOMICS, V8, P2770, DOI 10.1074/mcp.M900240-MCP200; Mizuno S, 2012, FEBS J, V279, P1474, DOI 10.1111/j.1742-4658.2012.08540.x; Mizutani T, 2009, GENES CELLS, V14, P1405, DOI 10.1111/j.1365-2443.2009.01357.x; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Motohashi K, 1996, J BIOL CHEM, V271, P17343, DOI 10.1074/jbc.271.29.17343; Motohashi K, 1997, FEBS LETT, V412, P633, DOI 10.1016/S0014-5793(97)00847-8; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Thomas JG, 1998, J BACTERIOL, V180, P5165, DOI 10.1128/JB.180.19.5165-5172.1998; Uchihashi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04587-w; Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200; Watanabe Y, 2004, J BIOL CHEM, V279, P15723, DOI 10.1074/jbc.M308782200; Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Yamasaki T, 2015, J BIOL CHEM, V290, P9789, DOI 10.1074/jbc.M114.617696; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yokom AL, 2016, NAT STRUCT MOL BIOL, V23, P830, DOI 10.1038/nsmb.3277; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083	38	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19228	19239		10.1074/jbc.RA118.005496	http://dx.doi.org/10.1074/jbc.RA118.005496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30327424	Green Published, hybrid			2022-12-26	WOS:000453537300007
J	Mills, BB; Thomas, AD; Riddle, NC				Mills, Benjamin B.; Thomas, Andrew D.; Riddle, Nicole C.			HP1B is a euchromatic Drosophila HP1 homolog with links to metabolism	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; HETEROCHROMATIN PROTEIN-1 HP1; CHROME SHADOW DOMAIN; HISTONE H3; CHROMOSOMAL-PROTEIN; STRESS RESISTANCE; RNA INTERFERENCE; OXIDATIVE STRESS; MAMMALIAN-CELLS; LIFE-SPAN	Heterochromatin Protein 1 (HP1) proteins are an important family of chromosomal proteins conserved among all major eukaryotic lineages. While HP1 proteins are best known for their role in heterochromatin, many HP1 proteins function in euchromatin as well. As a group, HP1 proteins carry out diverse functions, playing roles in the regulation of gene expression, genome stability, chromatin structure, and DNA repair. While the heterochromatic HP1 proteins are well studied, our knowledge of HP1 proteins with euchromatic distribution is lagging behind. We have created the first mutations in HP1B, a Drosophila HP1 protein with euchromatic function, and the Drosophila homolog most closely related to mammalian HP1 alpha, HP1 beta, and HP1 gamma. We find that HP1B is a non-essential protein in Drosophila, with mutations affecting fertility and animal activity levels. In addition, animals lacking HP1B show altered food intake and higher body fat levels. Gene expression analysis of animals lacking HP1B demonstrates that genes with functions in various metabolic processes are affected primarily by HP1B loss. Our findings suggest that there is a link between the chromatin protein HP1B and the regulation of metabolism.	[Mills, Benjamin B.; Thomas, Andrew D.; Riddle, Nicole C.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Riddle, NC (corresponding author), Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.	riddlenc@uab.edu		Riddle, Nicole/0000-0003-1827-9145	National Science Foundation [1552586]; American Cancer Society; NIH [P30 DK079626/DK/NIDDK]; UAB Health Services Foundation General Endowment Fund Grant; UAB O'Brien Acute Kidney Injury Center [NIH P30 DK079337]; NIH Nutrition & Obesity Research Center [NIH P30DK056336]; UAB Diabetes Research Center [NIH P30DK079626]; Nathan Shock Center [NIH PAG050886A]; UAB Comprehensive Cancer Center [NIH NCI P30 CA13148]; UAB Center for AIDS Research [NIH P30 AI027767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, P30DK079626, P30DK079337] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Health Services Foundation General Endowment Fund Grant; UAB O'Brien Acute Kidney Injury Center; NIH Nutrition & Obesity Research Center; UAB Diabetes Research Center; Nathan Shock Center; UAB Comprehensive Cancer Center; UAB Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This material is based upon work supported by the National Science Foundation (www.nsf.gov) under Grant No. 1552586 (NCR). Additional funding was provided by an American Cancer Society (www.cancer.org) Institutional Research Grant to NCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was supported by the following UAB core facilities: Bio-Analytical Redox Biology core (supported by grant number P30 DK079626/DK/NIDDK from the NIH (www.nih.gov); Targeted Metabolomics and Proteomics Laboratory core (supported by the UAB Health Services Foundation General Endowment Fund Grant and the UAB O'Brien Acute Kidney Injury Center NIH P30 DK079337); UAB Small Animal Phenotyping Core (supported by the NIH Nutrition & Obesity Research Center NIH P30DK056336, UAB Diabetes Research Center NIH P30DK079626, and Nathan Shock Center NIH PAG050886A); and Heflin Center for Genomic Science Genomics Core Laboratory (supported by the UAB Comprehensive Cancer Center NIH NCI P30 CA13148 and the UAB Center for AIDS Research NIH P30 AI027767). Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study. The JLA20 monoclonal antibody developed by J. J. -C. Lin was obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242.	AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; Alekseyenko AA, 2014, GENE DEV, V28, P1445, DOI 10.1101/gad.241950.114; Aydin E, 2015, J BIOSCIENCES, V40, P325, DOI 10.1007/s12038-015-9520-x; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Baxley RM, 2011, DEV BIOL, V356, P398, DOI 10.1016/j.ydbio.2011.05.666; Boivin A, 2003, GENETICS, V164, P195; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Clough E, 2007, DEVELOPMENT, V134, P157, DOI 10.1242/dev.02698; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Cryderman DE, 1999, NUCLEIC ACIDS RES, V27, P3364, DOI 10.1093/nar/27.16.3364; Cryderman DE, 2011, TRANSCR-AUSTIN, V2, P95, DOI 10.4161/trns.2.2.14687; CSINK AK, 1994, GENETICS, V138, P153; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; DiMauro S, 2001, ANN MED, V33, P472, DOI 10.3109/07853890109002096; Doheny JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003864; EBERL DF, 1993, GENETICS, V134, P277; EISSENBERG JC, 1992, GENETICS, V131, P345; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Eissenberg JC, 2014, TRENDS GENET, V30, P103, DOI 10.1016/j.tig.2014.01.002; Elgin SCR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017780; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Font-Burgada J, 2008, GENE DEV, V22, P3007, DOI 10.1101/gad.481408; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Harrison DA, 1993, GENES DEV, V7; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HOWE M, 1995, GENETICS, V140, P1033; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Kessler R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8049; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; KHESIN RB, 1978, MOL GEN GENET, V162, P323, DOI 10.1007/BF00268858; Kwon SH, 2011, BIOESSAYS, V33, P280, DOI 10.1002/bies.201000138; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee DH, 2013, BIOCHEM BIOPH RES CO, V434, P820, DOI 10.1016/j.bbrc.2013.04.020; Leek BT, 2001, AM J PHYSIOL-REG I, V280, pR441, DOI 10.1152/ajpregu.2001.280.2.R441; Levine MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002729; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Linford NJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50068; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu BY, 2000, GENETICS, V155, P699; Meister P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r123; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Piacentini L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000670; Riddle NC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002954; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Ryu HW, 2014, J PROTEOMICS, V102, P137, DOI 10.1016/j.jprot.2014.03.016; Rzezniczak TZ, 2011, ANAL BIOCHEM, V419, P345, DOI 10.1016/j.ab.2011.08.023; SHAFFER CD, 1994, METHOD CELL BIOL, V44, P99, DOI 10.1016/S0091-679X(08)60908-5; Shanle EK, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0117-5; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Spencer CC, 2003, AGING CELL, V2, P123, DOI 10.1046/j.1474-9728.2003.00044.x; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Stabell M, 2006, HEREDITAS, V143, P177, DOI 10.1111/j.2006.0018-0661.01970.x; Sun FL, 2000, P NATL ACAD SCI USA, V97, P5340, DOI 10.1073/pnas.090530797; Team RC, 2015, R LANG ENV STAT COMP; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Therneau T., PACKAGE SURVIVAL ANA, DOI [10.1038/nprot.2012.016, DOI 10.1038/NPROT.2012.016]; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Tower J, 2011, EXP GERONTOL, V46, P355, DOI 10.1016/j.exger.2010.09.002; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Volpe AM, 2001, GENETICS, V159, P1117; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wang HD, 2004, P NATL ACAD SCI USA, V101, P12610, DOI 10.1073/pnas.0404648101; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Wood JG, 2010, AGING CELL, V9, P971, DOI 10.1111/j.1474-9726.2010.00624.x; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Zhang DY, 2011, CHROMOSOMA, V120, P97, DOI 10.1007/s00412-010-0294-5; Zhang RG, 2007, CELL CYCLE, V6, P784, DOI 10.4161/cc.6.7.4079	89	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205867	10.1371/journal.pone.0205867	http://dx.doi.org/10.1371/journal.pone.0205867			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346969	Green Published, Green Submitted, gold			2022-12-26	WOS:000447938400020
J	Rana, MJ; Goli, S				Rana, Md Juel; Goli, Srinivas			Tracing long-term trajectories of contraceptive practice across 185 countries	PLOS ONE			English	Article							GLOBAL DEMOGRAPHIC CONVERGENCE; TRENDS; WOMEN; DIVERGENCE; INEQUALITY; HEALTH; GROWTH; RATES; LIFE	Background Globally the trajectories of approaches in adoption and implementation of family planning programmes have varied subjecting to variation in cultural and political philosophies across the countries. Accordingly, the progress in family planning has varied over the time across the countries. Objective This study investigates long-term trajectories of demand for family planning and contraceptive prevalence rates and tests the hypothesis of convergence across the world countries. Methods This study used data from United Nations Population Prospects for 185 countries and regions during 1970-2015. Standard graphical, parametric and nonparametric convergence metrics have been used for testing of the convergence hypothesis. Results The results suggest a substantial increase in the global average of both demand and actual prevalence of contraceptive practice across the countries, but the actual contraceptive use is yet to catch up with the demand. Our findings suggest that there is a convergence in contraceptive use across the countries, particularly since the mid-1990s. Conclusion A major part of the convergence in demand for family planning and contraceptive prevalence rate is due to its stalling in both developed and many developing countries and its increase in several developing and least developed countries. Family planning has a greater role in human wellbeing particularly enhancing reproductive, maternal and child health outcomes than being a mere tool for fertility reduction. Therefore, the emphasis is needed on family planning efforts in the lagged behind countries for global convergence of family planning.	[Rana, Md Juel; Goli, Srinivas] Jawaharlal Nehru Univ, Ctr Study Reg Dev, Sch Social Sci, New Delhi, India	Jawaharlal Nehru University, New Delhi	Rana, MJ (corresponding author), Jawaharlal Nehru Univ, Ctr Study Reg Dev, Sch Social Sci, New Delhi, India.	jranajnu@gmail.com	Rana, MJ/AAE-5965-2020; Goli, Srinivas/J-7238-2012	Rana, MJ/0000-0001-8830-492X; Goli, Srinivas/0000-0002-8481-484X				Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; [Anonymous], 2017, B WORLD HEALTH ORGAN, V95, P614, DOI 10.2471/BLT.17.020917; [Anonymous], WORLD POP POL 2013; Barro R.J., 1997, J ECON GROWTH, V2, P1, DOI DOI 10.1023/A:1009746629269; BARRO RJ, 1992, J POLIT ECON, V100, P223, DOI 10.1086/261816; Becker GS, 2005, AM ECON REV, V95, P277, DOI 10.1257/0002828053828563; Bendix D, 2018, DEV CHANGE, V49, P259, DOI 10.1111/dech.12363; Blanc AK, 2009, INT PERSPECT SEX R H, V35, P63, DOI 10.1363/ipsrh.35.063.09; BONGAARTS J, 1987, POPUL DEV REV, V13, P323, DOI 10.2307/1973197; Bongaarts J, 2009, INT PERSPECT SEX R H, V35, P39, DOI 10.1363/ifpp.35.039.09; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Coale A.J., 1958, POPULATION GROWTH EC; CONNELLY M, 2008, FATAL MISCONCEPTION; Creanga AA, 2011, B WORLD HEALTH ORGAN, V89, P258, DOI 10.2471/BLT.10.083329; Dorius SF, 2008, POPUL DEV REV, V34, P519, DOI 10.1111/j.1728-4457.2008.00235.x; Doskoch P, 2013, INT PERSPECT SEX R H, V39, P103; Eberstadt N., 2006, WILSON Q, P27; ENKE S, 1960, ECON DEV CULT CHANGE, V8, P339, DOI 10.1086/449854; FRIEDMAN M, 1992, J ECON LIT, V30, P2129; Frost JJ, 2014, MILBANK Q, V92, P696, DOI 10.1111/1468-0009.12080; Goli S, 2014, GLOB PUBLIC HEALTH, V9, P342, DOI 10.1080/17441692.2014.890237; Goli S, 2014, HEALTH ECON POLICY L, V9, P143, DOI 10.1017/S1744133113000042; Guttmacher Institute, 2017, IND AB WORLDW; Joshi R, 2015, INT J GYNECOL OBSTET, V131, pS60, DOI 10.1016/j.ijgo.2015.04.024; MacQuarrie K.L.D., 2015, DHS ANAL STUDIES, V49; McMichael AJ, 2004, LANCET, V363, P1155, DOI 10.1016/S0140-6736(04)15902-3; Moser K, 2005, B WORLD HEALTH ORGAN, V83, P202; Myrdal G., 1973, ASIAN DRAMA INQUIRY; Neumayer E, 2004, POPUL DEV REV, V30, P727, DOI 10.1111/j.1728-4457.2004.00039.x; QUAH D, 1993, EUR ECON REV, V37, P426, DOI 10.1016/0014-2921(93)90031-5; Rah JH, 2008, J NUTR, V138, P1505, DOI 10.1093/jn/138.8.1505; Rana MJ, 2017, J BIOSOC SCI, V49, P773, DOI [10.1017/S0021932016000717, 10.1017/s0021932016000717]; Rey SJ, 1999, REG STUD, V33, P143, DOI 10.1080/00343409950122945; Robinson W. C., 2007, GLOBAL FAMILY PLANNI, P421; SalaiMartin XX, 1996, ECON J, V106, P1019, DOI 10.2307/2235375; Sedgh G, 2012, STUD FAMILY PLANN, V45, P301, DOI DOI 10.1111/J.1728-4465; Sedgh G, 2016, LANCET, V388, P258, DOI 10.1016/S0140-6736(16)30380-4; Sharan M, 2011, YES AFRICA CAN, V445; Speidel J., 2006, INT PARL C IMPL ICPD; Starrs AM, 2017, LANCET, V389, P485, DOI 10.1016/S0140-6736(17)30270-2; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; United Nations, 2017, WORLD CONTR US 2017; Wang, 2004, REGIONAL SECTORAL EC, V4, P5; Wilson C, 2011, POPUL DEV REV, V37, P375, DOI 10.1111/j.1728-4457.2011.00415.x; Young AT, 2008, J MONEY CREDIT BANK, V40, P1083, DOI 10.1111/j.1538-4616.2008.00148.x	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205927	10.1371/journal.pone.0205927	http://dx.doi.org/10.1371/journal.pone.0205927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX7HS	30346993	Green Published, gold, Green Submitted			2022-12-26	WOS:000447938400023
J	Harhala, M; Barylski, J; Huminska-Lisowska, K; Lecion, D; Wojciechowicz, J; Lahutta, K; Kus, M; Kropinski, AM; Nowak, S; Nowicki, G; Hodyra-Stefaniak, K; Dabrowska, K				Harhala, Marek; Barylski, Jakub; Huminska-Lisowska, Kinga; Lecion, Dorota; Wojciechowicz, Jacek; Lahutta, Karolina; Kus, Marta; Kropinski, Andrew M.; Nowak, Sylwia; Nowicki, Grzegorz; Hodyra-Stefaniak, Katarzyna; Dabrowska, Krystyna			Two novel temperate bacteriophages infecting Streptococcus pyogenes: Their genomes, morphology and stability	PLOS ONE			English	Article							ICTV BACTERIAL; GLOBAL BURDEN; SEARCH; TAXONOMY; UPDATE; PNEUMONIAE; DIVERSITY; SOFTWARE; SEQUENCE; DISEASES	Only 3% of phage genomes in NCBI nucleotide database represent phages that are active against Streptococcus sp. With the aim to increase general awareness of phage diversity, we isolated two bacteriophages, Str01 and Str03, active against health-threatening Group A Streptococcus (GAS). Both phages are members of the Siphoviridae, but their analysis revealed that Str01 and Str03 do not belong to any known genus. We identified their structural proteins based on LC-ESI29 MS/MS and list their basic thermal stability and physicochemical features including optimum pH. Annotated genomic sequences of the phages are deposited in GenBank (NCBI accession numbers KY349816 and KY363359, respectively).	[Harhala, Marek; Lecion, Dorota; Lahutta, Karolina; Hodyra-Stefaniak, Katarzyna; Dabrowska, Krystyna] Polish Acad Sci, Inst Immunol & Expt Therapy, Bacteriophage Lab, Weigla 12, Wroclaw, Poland; [Barylski, Jakub; Nowicki, Grzegorz] Adam Mickiewicz Univ, Fac Biol, Dept Mol Virol, Coll Biol, Umultowska 89, Poznan, Poland; [Huminska-Lisowska, Kinga; Wojciechowicz, Jacek; Kus, Marta] DNA Res Ctr, Inflancka 25, Poznan, Poland; [Kropinski, Andrew M.] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Kropinski, Andrew M.] Univ Guelph, Dept Food Sci, Guelph, ON, Canada; [Nowak, Sylwia] Wroclaw Univ, Fac Biol Sci, Kuznicza 35, Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Adam Mickiewicz University; University of Guelph; University of Guelph; University of Wroclaw	Dabrowska, K (corresponding author), Polish Acad Sci, Inst Immunol & Expt Therapy, Bacteriophage Lab, Weigla 12, Wroclaw, Poland.	dabrok@iitd.pan.wroc.pl	Huminska-Lisowska, Kinga/GRS-8404-2022; Huminska-Lisowska, Kinga/HHN-1095-2022; Humińska-Lisowska, Kinga/AGG-4978-2022; Harhala, Marek Adam/AAR-5437-2020	Huminska-Lisowska, Kinga/0000-0003-0034-0809; Huminska-Lisowska, Kinga/0000-0003-0034-0809; Harhala, Marek Adam/0000-0001-7018-6873; Barylski, Jakub/0000-0001-6630-6932; Dabrowska, Krystyna/0000-0002-1518-3183	National Science Centre in Poland [UMO-2015/18/M/NZ6/00412]	National Science Centre in Poland(National Science Centre, Poland)	This work was supported by the National Science Centre in Poland grant no. UMO-2015/18/M/NZ6/00412.	Adriaenssens EM, 2018, ARCH VIROL, V163, P1125, DOI 10.1007/s00705-018-3723-z; Adriaenssens EM, 2017, ARCH VIROL, V162, P1153, DOI 10.1007/s00705-016-3173-4; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2010, FASTQC QUALITY CONTR; BAILONE A, 1978, VIROLOGY, V84, P547, DOI 10.1016/0042-6822(78)90273-8; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Berngruber TW, 2010, J VIROL, V84, P10200, DOI 10.1128/JVI.00865-10; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chan WT, 2012, MICROBIOL MOL BIOL R, V76, P773, DOI 10.1128/MMBR.00030-12; Clark PF, 1927, P SOC EXP BIOL MED, V24, P635; Croucher NJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002394; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; DIAZ E, 1992, J BACTERIOL, V174, P5516; Fortier LC, 2006, J BACTERIOL, V188, P6101, DOI 10.1128/JB.00581-06; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Joshi NA, 2011, SICKLE SLIDING WINDO; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Krupovic M, 2016, ARCH VIROL, V161, P1095, DOI 10.1007/s00705-015-2728-0; Lavigne R, 2013, FUTURE VIROL, V8, P997, DOI 10.2217/fvl.13.84; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Mahony J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00007; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; McShan WM, 2016, STREPTOCOCCUS PYOGEN; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Sabri M, 2011, J BACTERIOL, V193, P551, DOI 10.1128/JB.01117-10; Tang F, 2013, GENOMICS, V101, P336, DOI 10.1016/j.ygeno.2013.04.005; Unterholzner Simon J, 2013, Mob Genet Elements, V3, pe26219; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Whitehead HR, 1935, OCCURRENCE BACTERIOP, P63	42	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205995	10.1371/journal.pone.0205995	http://dx.doi.org/10.1371/journal.pone.0205995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339682	Green Published, gold, Green Submitted			2022-12-26	WOS:000447761400032
J	Zhu, HY; Pan, Y; Cheng, KT; Huan, RH				Zhu, Huaiyu; Pan, Yun; Cheng, Kwang-Ting; Huan, Ruohong			A lightweight piecewise linear synthesis method for standard 12-lead ECG signals based on adaptive region segmentation	PLOS ONE			English	Article							ELECTROCARDIOGRAM; SYSTEM; MODEL	This paper presents a lightweight synthesis algorithm, named adaptive region segmentation based piecewise linear (ARSPL) algorithm, for reconstructing standard 12-lead electrocardiogram (ECG) signals from a 3-lead subset (I, II and V2). Such a lightweight algorithm is particularly suitable for healthcare mobile devices with limited resources for computing, communication and data storage. After detection of R-peaks, the ECGs are segmented by cardiac cycles. Each cycle is further divided into four regions according to different cardiac electrical activity stages. A personalized linear regression algorithm is then applied to these regions respectively for improved ECG synthesis. The proposed ARSPL method has been tested on 39 subjects randomly selected from the PTB diagnostic ECG database and achieved accurate synthesis of remaining leads with an average correlation coefficient of 0.947, an average root-mean-square error of 55.4 mu V, and an average runtime performance of 114ms. Overall, these results are significantly better than those of the common linear regression method, the back propagation (BP) neural network and the BP optimized using the genetic algorithm. We have also used the reconstructed ECG signals to evaluate the denivelation of ST segment, which is a potential symptom of intrinsic myocardial disease. After ARSPL, only 10.71% of the synthesized ECG cycles are with a ST-level synthesis error larger than 0.1mV, which is also better than those of the three above-mentioned methods.	[Zhu, Huaiyu; Pan, Yun] Zhejiang Univ, Coll Informat Sci & Elect Engn, Hangzhou, Zhejiang, Peoples R China; [Cheng, Kwang-Ting] Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Hong Kong, Hong Kong, Peoples R China; [Huan, Ruohong] Zhejiang Univ Technol, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Hong Kong University of Science & Technology; Zhejiang University of Technology	Pan, Y (corresponding author), Zhejiang Univ, Coll Informat Sci & Elect Engn, Hangzhou, Zhejiang, Peoples R China.	panyun@zju.edu.cn		Zhu, Huaiyu/0000-0001-6918-4088; Cheng, Kwang-Ting Tim/0000-0002-3885-4912	Zhejiang Provincial Nonprofit Technology Research Projects [2014C31045]; Hangzhou Proton Technology Co., Ltd.	Zhejiang Provincial Nonprofit Technology Research Projects; Hangzhou Proton Technology Co., Ltd.	This research was supported in part by the Zhejiang Provincial Nonprofit Technology Research Projects (No. 2014C31045) and in part by Hangzhou Proton Technology Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; [Anonymous], 2000, P GEN EV COMP C GECC; ARTHUR RM, 1971, J ELECTROCARDIOL, V4, P29, DOI 10.1016/S0022-0736(71)80047-X; Atoui H, 2010, IEEE T INF TECHNOL B, V14, P883, DOI 10.1109/TITB.2010.2047754; Baig MM, 2013, MED BIOL ENG COMPUT, V51, P485, DOI 10.1007/s11517-012-1021-6; Bousseljot R., 1995, BIOMED TECH, V40, P317, DOI DOI 10.1515/BMTE.1995.40.S1.317; BURGER HC, 1946, BRIT HEART J, V8, P157; Carley SD, 2002, EMERG MED J, V19, P126, DOI 10.1136/emj.19.2.126; Castells F, 2007, EURASIP J ADV SIG PR, DOI 10.1155/2007/74580; Chen FJ, 2015, 2015 SEVENTH INTERNATIONAL CONFERENCE ON ADVANCED COMPUTATIONAL INTELLIGENCE (ICACI), P289, DOI 10.1109/ICACI.2015.7184716; DONGARRA JJ, 1990, ACM T MATH SOFTWARE, V16, P1, DOI 10.1145/77626.79170; Dower G E, 1968, J Electrocardiol, V1, P101; Finlay DD, 2010, IEEE T INF TECHNOL B, V14, P69, DOI 10.1109/TITB.2009.2022933; FRANK E, 1956, CIRCULATION, V13, P737, DOI 10.1161/01.CIR.13.5.737; Goldenberg I, 2006, J CARDIOVASC ELECTR, V17, P333, DOI 10.1111/j.1540-8167.2006.00408.x; Guney ME, 2017, P S COMP ARITHM, P144, DOI 10.1109/ARITH.2017.19; Hadzievski L, 2004, IEEE T INF TECHNOL B, V8, P428, DOI 10.1109/TITB.2004.837869; Hsin-Yi Lin, 2013, 2013 IEEE 15th International Conference on e-Health Networking, Applications and Services (Healthcom 2013), P355, DOI 10.1109/HealthCom.2013.6720700; Jabaudon D, 2004, STROKE, V35, P1647, DOI 10.1161/01.STR.0000131269.69502.d9; Lachenbruch Peter A., 2008, WILEY ENCY CLIN TRIA, P1; Lenis G, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/9295029; LI CW, 1995, IEEE T BIO-MED ENG, V42, P21, DOI 10.1109/10.362922; Malmivuo J., 1995, BIOELECTROMAGNETISM, P320; McSharry PE, 2003, IEEE T BIO-MED ENG, V50, P289, DOI 10.1109/TBME.2003.808805; Nelwan SP, 2004, J ELECTROCARDIOL, V37, P11, DOI 10.1016/j.jelectrocard.2003.10.004; Sabatine MS, 2011, POCKET MED MASSACHUS, P1; Smith SW, 2006, ACAD EMERG MED, V13, P406, DOI 10.1197/j.aem.2005.10.019; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; TERZOPOULOS D, 1986, IEEE T PATTERN ANAL, V8, P413, DOI 10.1109/TPAMI.1986.4767807; THAKOR NV, 1984, IEEE T BIO-MED ENG, V31, P702, DOI 10.1109/TBME.1984.325393; Tomasic I, 2018, MED BIOL ENG COMPUT, V56, P547, DOI 10.1007/s11517-018-1798-z; Tomasic Ivan, 2014, IEEE Rev Biomed Eng, V7, P126, DOI 10.1109/RBME.2013.2264282; Toriello A, 2012, EUR J OPER RES, V219, P86, DOI 10.1016/j.ejor.2011.12.030; Trobec R., 2018, BODY SENSORS ELECTRO, P80; Trobec R, 2011, IEEE T INF TECHNOL B, V15, P615, DOI 10.1109/TITB.2011.2159236; Uijen GJH, 1988, ELECT CARDIOLOGY 198, P301; Williams RJ., 1990, NUCCS909, P433; Yapa RD, 2008, INT J COMPUT SCI NET, V8, P33	38	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0206170	10.1371/journal.pone.0206170	http://dx.doi.org/10.1371/journal.pone.0206170			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339673	Green Published, Green Submitted, gold			2022-12-26	WOS:000447761400042
J	De Groote, F; Blum, KP; Horslen, BC; Ting, LH				De Groote, Friedl; Blum, Kyle P.; Horslen, Brian C.; Ting, Lena H.			Interaction between muscle tone, short-range stiffness and increased sensory feedback gains explains key kinematic features of the pendulum test in spastic cerebral palsy: A simulation study	PLOS ONE			English	Article							HUMAN CALF MUSCLES; MODEL; CHILDREN	The pendulum test is a sensitive clinical assessment of spasticity where the lower leg is dropped from the horizontal position and features of limb motion are recorded. Three key kinematic features are associated with the degree of severity of spasticity in children with cerebral palsy: decreased initial limb excursion, reduced number of limb oscillations, and a non-vertical resting limb angle. While spasticity is attributed to increased velocity-dependent resistance to motion, prior models simulating increased sensorimotor feedback of muscle velocity fail to explain the key pendulum test kinematic outcomes in spastic individuals. Here we hypothesized that increased muscle tone, causing a transient increase in muscle force, i.e. short-range stiffness, could account for reduced first swing excursion and non-vertical resting limb angle. We further hypothesized that hyperreflexia modeled based on muscle fiber force, and not velocity, feedback would be necessary to reduce the number of oscillations because of its interaction with transiently increased muscle force due to short-range stiffness. We simulated the lower leg as a torque-driven single-link pendulum. Muscle tone was modeled as a constant baseline joint torque, short-range stiffness torque was dependent on the level of muscle tone, and delayed sensory feedback torque to simulate reflex activity was based on either muscle velocity or force. Muscle tone and transient short-range stiffness were necessary to simulate decreased initial swing excursion and non-vertical resting leg angle. Moreover, the reduction in the number of oscillations was best reproduced by simulating stretch reflex activity in terms of force, and not velocity, feedback. Varying only baseline muscle torque and reflex gain, we simulated a range of pendulum test kinematics observed across different levels of spasticity. Our model lends insight into physiological mechanisms of spasticity whose contributions can vary on an individual-specific basis, and potentially across different neurological disorders that manifest spasticity as a symptom.	[De Groote, Friedl] Katholieke Univ Leuven, Dept Movement Sci, Leuven, Belgium; [Blum, Kyle P.; Horslen, Brian C.; Ting, Lena H.] Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Blum, Kyle P.; Horslen, Brian C.; Ting, Lena H.] Georgia Inst Technol, Atlanta, GA 30332 USA; [Ting, Lena H.] Emory Univ, Dept Rehabil Med, Div Phys Therapy, Atlanta, GA 30322 USA	KU Leuven; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University	Ting, LH (corresponding author), Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.; Ting, LH (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.; Ting, LH (corresponding author), Emory Univ, Dept Rehabil Med, Div Phys Therapy, Atlanta, GA 30322 USA.	lting@emory.edu	Blum, Kyle P/P-2334-2018	Blum, Kyle P/0000-0002-9760-2053; De Groote, Friedl/0000-0002-4255-8673; Horslen, Brian/0000-0002-5566-5961	National Institute for Child Health and Human Development [R01 HD46922, R01 HD090642]; National Institute of Neurological Disorders and Stroke [F31NS093855]; Banting Postdoctoral Fellowship; Research Foundation - Flanders [V436017N]; KU Leuven [STG/16/032]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD090642, R01HD046922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS093855] Funding Source: NIH RePORTER	National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Banting Postdoctoral Fellowship; Research Foundation - Flanders(FWO); KU Leuven(KU Leuven); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute for Child Health and Human Development (https://www.nichd.nih.gov/Pages/index.aspx) grants R01 HD46922 and R01 HD090642 to LHT, the National Institute of Neurological Disorders and Stroke (https://www.ninds.nih.gov) F31NS093855 fellowship to KPB, Banting Postdoctoral Fellowship (http://bantingresearchfoundation.ca/) to BCH, and Research Foundation - Flanders (http://www.fwo.be/) travel grant V436017N and KU Leuven (https://www.kuleuven.be/onderzoek/ondersteuning/if) start-up grant STG/16/032 to FDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright L., 2009, IDENTIFICATION TREAT, P485; Bajd T, 1982, J BIOMED ENG; Bar-On L, 2013, GAIT POSTURE, V38, P141, DOI 10.1016/j.gaitpost.2012.11.003; Bianchi L, 1999, FUNCT NEUROL; Blum KP, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005767; Brown RA, 1988, DOES WAR TENBERG PEN, P1178; Campbell KS, 2002, BIOPHYS J, V82, P929, DOI 10.1016/S0006-3495(02)75454-4; CARTER RR, 1990, J NEUROPHYSIOL, V64, P105, DOI 10.1152/jn.1990.64.1.105; Casabona A, 2012, J APPL PHYSIOL, V113, P1747, DOI 10.1152/japplphysiol.00960.2012; Day J, 2017, J NEUROPHYSIOL, V117, P1489, DOI 10.1152/jn.00374.2016; De Groote F, 2017, J BIOMECH, V55, P71, DOI 10.1016/j.jbiomech.2017.02.008; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Fee JW, 2004, DEV MED CHILD NEUROL, V46, P273, DOI 10.1017/S001216220400043X; Fee JW, 2004, IEEE T NEUR SYS REH, V12, P55, DOI 10.1109/TNSRE.2003.819926; Feldmann RG, 1980, SPASTICITY DISORDERE, P485; Fleuren JFM, 2010, J NEUROL NEUROSUR PS, V81, P46, DOI 10.1136/jnnp.2009.177071; Fowler EG, 2000, DEV MED CHILD NEUROL, V42, P182; Getz EB, 1998, BIOPHYS J, V75, P2971, DOI 10.1016/S0006-3495(98)77738-0; He JP, 1997, IEEE T BIO-MED ENG, V44, P175, DOI 10.1109/10.554764; Hu X, 2011, J NEUROPHYSIOL, V105, P1633, DOI 10.1152/jn.00537.2010; Le Cavorzin P, 2003, MOVEMENT DISORD, V18, P1257, DOI 10.1002/mds.10532; Le Cavorzin P, 2001, MUSCLE NERVE, V24, P1612, DOI 10.1002/mus.1196; LIN DC, 1991, IEEE T BIO-MED ENG, V38, P906, DOI 10.1109/10.83611; Lin DC, 2001, J NEUROPHYSIOL, V85, P1059, DOI 10.1152/jn.2001.85.3.1059; Loram ID, 2007, J PHYSIOL-LONDON, V584, P677, DOI 10.1113/jphysiol.2007.140053; Loram ID, 2007, J PHYSIOL-LONDON, V584, P661, DOI 10.1113/jphysiol.2007.140046; McKay WB, 2011, SPINAL CORD, V49, P87, DOI 10.1038/sc.2010.73; NICHOLS TR, 1976, J NEUROPHYSIOL, V39, P119, DOI 10.1152/jn.1976.39.1.119; Pandyan AD, 2009, CONSTRUCT VALIDITY S, P8288; Pandyan AD, 2005, DISABIL REHABIL; van den Noort JC, 2010, ARCH PHYS MED REHAB, V91, P615, DOI 10.1016/j.apmr.2009.12.022	32	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205763	10.1371/journal.pone.0205763	http://dx.doi.org/10.1371/journal.pone.0205763			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335860	gold, Green Submitted, Green Published			2022-12-26	WOS:000447701300054
J	Dhahbi, W; Sellami, M; Chaouachi, A; Padulo, J; Milic, M; Mekki, I; Chamari, K				Dhahbi, Wissem; Sellami, Maha; Chaouachi, Anis; Padulo, Johnny; Milic, Mirjana; Mekki, Imed; Chamari, Karim			Seasonal weather conditions affect training program efficiency and physical performance among special forces trainees: A long-term follow-up study	PLOS ONE			English	Article							SPRINT EXERCISE PERFORMANCE; BODY-COMPOSITION; MILITARY; HEAT; FITNESS; TEMPERATURE; RESPONSES; HUMANS	The purpose of the present investigation was to follow-up the effect of specific commandos' training-cycles (SCTCs) on upper-body strength resistance and running endurance performance, as well as determine whether variation in seasonal parameters has any effect on physical performance. Fourteen SCTCs were held over eight years, involving 466 participants. Participants were assigned to four subgroups according to their distribution over the seasons: summer (n = 124), autumn (n = 145), winter (n = 52) and spring (n = 145). Before and after each SCTC, four tests (maximal pull-up, push-up and sit-up repetitions in 70-seconds for muscle strength resistance) and a 5-km cross-country run (endurance) were performed. Seasonal data were continuously recorded during all SCTCs. Body mass decreased significantly (p<0.05) in all groups following SCTCs. These training-cycles induced a significant increase (p<0.05) in the 70-seconds push-ups, pull-ups and sit-ups and a decrease (p<0.01) in the 5-km cross-country running time among all trainees. The main effect of the season was present in all tests (p<0.01). With regard to the percentage of changes, the results from the 70-seconds push-up, pull-up and sit-up tests were significantly higher in winter and spring (p<0.01) compared with the two other seasons, while 5-km cross-country performance improvements were significantly higher (p<0.01) in spring and summer, compared to the two other seasons. In summary, 14-week of SCTCs improved upper-body strength resistance and running endurance performance in the commandos. Improvements in strength resistance performance were greater during cool weather (winter and spring), while improvements in running endurance performance were higher during hotter (spring and summer) seasons.	[Dhahbi, Wissem; Chaouachi, Anis; Padulo, Johnny] Natl Ctr Med & Sci Sports CNMSS, Tunisian Res Lab Sport Performance Optimisat, Tunis, Tunisia; [Dhahbi, Wissem] Qatar Police Coll, Training Dept, Doha, Qatar; [Dhahbi, Wissem; Mekki, Imed] Tunisian Natl Guard Commandos Sch, Oued Zarga, Tunisia; [Dhahbi, Wissem; Sellami, Maha] Univ Qatar, Coll Arts & Sci Qu CAS, SSP, Doha, Qatar; [Padulo, Johnny] Univ eCampus, Novedrate, Italy; [Padulo, Johnny; Milic, Mirjana] Univ Split, Fac Kinesiol, Split, Croatia; [Chamari, Karim] Qatar Orthopaed & Sports Med Hosp, Athlete Hlth & Performance Res Ctr, ASPETAR, Doha, Qatar	Centre National de la Medecine Sciences des Sports; Qatar University; Universita Ecampus; University of Split; Aspetar Orthopaedic & Sports Medicine Hospital	Padulo, J (corresponding author), Natl Ctr Med & Sci Sports CNMSS, Tunisian Res Lab Sport Performance Optimisat, Tunis, Tunisia.; Padulo, J (corresponding author), Univ eCampus, Novedrate, Italy.; Padulo, J (corresponding author), Univ Split, Fac Kinesiol, Split, Croatia.	sportcinetic@gmail.com	milić, mirjana/C-1605-2012; Dhahbi, Wissem/A-1445-2019; CHAMARI, Karim/AAJ-7938-2021; Padulo, Johnny/AAK-2207-2020	milić, mirjana/0000-0002-6914-8666; Dhahbi, Wissem/0000-0001-6221-546X; CHAMARI, Karim/0000-0001-9178-7678; Padulo, Johnny/0000-0002-4254-3105; Sellami, Maha/0000-0003-1832-409X				Aharony S, 2008, SPINE J, V8, P578, DOI 10.1016/j.spinee.2007.01.001; Belcher CP, 2012, INT J EXERCISE SCI, V5, P7; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; Carlson Mark J, 2012, J Strength Cond Res, V26 Suppl 2, pS2, DOI 10.1519/JSC.0b013e31825d7ff9; Cheung SS, 2004, J SPORT SCI, V22, P605, DOI 10.1080/02640410310001655813; Cheuvront SN, 2001, SPORTS MED, V31, P743, DOI 10.2165/00007256-200131100-00004; Crandall CG, 2008, J PHYSIOL-LONDON, V586, P293, DOI 10.1113/jphysiol.2007.143057; Delvecchio L, 2016, J EXERC REHABIL, V12, P442, DOI 10.12965/jer.1632672.336; Dhahbi W, 2015, INT J SPORT PHYSIOL, V10, P509, DOI 10.1123/ijspp.2014-0334; Duffield R, 2007, EUR J APPL PHYSIOL, V100, P727, DOI 10.1007/s00421-007-0468-x; Fairbrother B, 1995, NUTR IMMUNOLOGICAL A; Hargreaves M, 2008, J SCI MED SPORT, V11, P66, DOI 10.1016/j.jsams.2007.07.002; Hayes M, 2014, INT J SPORT PHYSIOL, V9, P387, DOI [10.1123/ijspp.2012-0247, 10.1123/IJSPP.2012-0247]; Heinrich KM, 2012, MIL MED, V177, P1125, DOI 10.7205/MILMED-D-12-00143; Holcomb John, 2007, US Army Med Dep J, P24; Johnson JM, 2010, SCAND J MED SCI SPOR, V20, P29, DOI 10.1111/j.1600-0838.2010.01206.x; Klika B, 2013, ACSMS HEALTH FIT J, V17, P8, DOI 10.1249/FIT.0b013e31828cb1e8; Kraemer William J, 2012, J Strength Cond Res, V26 Suppl 2, pS107, DOI 10.1519/JSC.0b013e31825d8263; Kyrolainen H, 2017, J SCI MED SPORT; Lacerda ACR, 2007, EUR J APPL PHYSIOL, V99, P87, DOI 10.1007/s00421-006-0329-z; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; Locke M, 2014, CELL STRESS CHAPERON, V19, P519, DOI 10.1007/s12192-013-0478-z; Malavolti M, 2008, J STRENGTH COND RES, V22, P503, DOI 10.1519/JSC.0b013e318163441f; Martin RC, 2016, J STRENGTH COND RES, V30, P26, DOI 10.1519/JSC.0000000000001026; Montain SJ, 2003, APPETITE, V40, P255, DOI 10.1016/S0195-6663(03)00011-4; Nindl BC, 2007, MED SCI SPORT EXER, V39, P1380, DOI 10.1249/mss.0b013e318067e2f7; No M, 2016, INTEGR MED RES, V5, P216, DOI 10.1016/j.imr.2016.06.002; Pemrick MD, 1999, PHYS FITNESS 75 RANG; Prusaczyk WK, 1995, PHYS DEMANDS US NAVY; Ronnestad BR, 2014, SCAND J MED SCI SPOR, V24, P603, DOI 10.1111/sms.12104; Santtila M, 2015, J STRENGTH COND RES, V29, pS154, DOI 10.1519/JSC.0000000000001035; Shippee R., 1994, NUTR IMMUNOLOGICAL A; Smith CJ, 2016, AUTON NEUROSCI-BASIC, V196, P25, DOI 10.1016/j.autneu.2016.01.002; Sporis G, 2012, J STRENGTH COND RES, V26, P2872, DOI 10.1519/JSC.0b013e318242966c; Tharion WJ, 2005, APPETITE, V44, P47, DOI 10.1016/j.appet.2003.11.010; Vickers Jr RR, 1999, EFFECTS BASIC FITNES, V38	36	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206088	10.1371/journal.pone.0206088	http://dx.doi.org/10.1371/journal.pone.0206088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335826	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300095
J	Tong, J; Mou, S; Xiong, LY; Wang, ZX; Wang, RR; Weigand, A; Yuan, Q; Horch, RE; Sun, JM; Yang, J				Tong, Jing; Mou, Shan; Xiong, Lingyun; Wang, Zhenxing; Wang, Rongrong; Weigand, Annika; Yuan, Quan; Horch, Raymund E.; Sun, Jiaming; Yang, Jie			Adipose-derived mesenchymal stem cells formed acinar-like structure when stimulated with breast epithelial cells in three-dimensional culture	PLOS ONE			English	Article							IN-VIVO; ASSISTED LIPOTRANSFER; GRAFT-SURVIVAL; SUPPORTIVE USE; CANCER-CELLS; TISSUE; MOUSE; DIFFERENTIATION; COMPLICATIONS; AUGMENTATION	Lipotransfer has been applied in breast augmentation surgery for several years and the resident adipose-derived stem cells (ASCs) play an important role in enhancing fat graft survival. However, the interaction between ASCs and mammary epithelium is not fully understood. Many studies have shown that ASCs have a tumor-supportive effect in breast cancer. To the best of our knowledge, this is the first study on the effect of mammary epithelial cells on the human ASCs in 3D culture. ASCs were cultivated on matrigel in the conditioned medium (CM) prepared from a human breast epithelial cell line (HBL-100). The ASCs formed KRT18-positive acini-like structures after stimulation with breast epithelial cells. The expression of epithelial genes (CDH1 and KRT18) was up-regulated while the expression of mesenchymal specific genes (CDH2 and VIM) was down-regulated as determined by qRT-PCR. The stemness marker (CD29) and angiogenic factors (CD31 and VEGF) were also down-regulated as examined by immunofluorescence. In addition, the CM obtained from HBL-100 enhanced the migration and inhibited the adipogenic differentiation of ASCs. These results demonstrate that ASCs have the ability to transform into epithelial-like cells when cultured with mammary epithelial cells. Given these observations, we infer that ASCs have a positive effect on lipotransfer, not only due to their ability to secrete growth factors, but also due to their direct participation in the formation of new breast tissue.	[Tong, Jing; Mou, Shan; Xiong, Lingyun; Wang, Zhenxing; Wang, Rongrong; Yuan, Quan; Sun, Jiaming; Yang, Jie] Huazhong Univ Sci & Technol, Union Hosp, Dept Plast Surg, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Weigand, Annika; Horch, Raymund E.] FAU, Univ Hosp Erlangen, Dept Plast & Hand Surg, Erlangen, Germany; [Weigand, Annika; Horch, Raymund E.] FAU, Univ Hosp Erlangen, Lab Tissue Engn & Regenerat Med, Erlangen, Germany	Huazhong University of Science & Technology; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Sun, JM; Yang, J (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Plast Surg, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	sunjm1592@sina.com; abrams18@163.com	yuan, quan/GZM-5597-2022		special research grant for non-profit public service [201502029]; Science Foundation of Wuhan Union Hospital [02.03.2015-61, 2016ZYCX034]; National Natural Science Foundation of China [81701922, 81501688]; Natural Science Foundation of Hubei Province [2017CFB263]	special research grant for non-profit public service; Science Foundation of Wuhan Union Hospital; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported in part by the special research grant for non-profit public service (grant no. 201502029) to Jiaming Sun; the Science Foundation of Wuhan Union Hospital (02.03.2015-61) to Jie Yang. This work was also supported in part by the National Natural Science Foundation of China (no. 81701922), the Natural Science Foundation of Hubei Province (2017CFB263) and the Science Foundation of Wuhan Union Hospital (2016ZYCX034) to Zhenxing Wang and the National Natural Science Foundation of China (No. 81501688) to Quan Yuan.	Baer PC, 2011, STEM CELLS DEV, V20, P1805, DOI 10.1089/scd.2011.0086; Bertolini F, 2015, BRIT J CANCER, V112, P419, DOI 10.1038/bjc.2014.657; Booth BW, 2008, P NATL ACAD SCI USA, V105, P14891, DOI 10.1073/pnas.0803214105; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Boulanger CA, 2015, J MAMMARY GLAND BIOL, V20, P93, DOI 10.1007/s10911-015-9343-2; Brzoska M, 2005, BIOCHEM BIOPH RES CO, V330, P142, DOI 10.1016/j.bbrc.2005.02.141; Bussard KM, 2010, CANCER RES, V70, P6336, DOI 10.1158/0008-5472.CAN-10-0591; Campbell JJ, 2009, ORGANOGENESIS, V5, P43, DOI 10.4161/org.5.2.8321; Chai JY, 2010, BIOSCI TRENDS, V4, P130; Choi M, 2013, PLAST RECONSTR SURG, V131, P185, DOI 10.1097/PRS.0b013e3182789b13; De Matteis R, 2009, STEM CELLS, V27, P2761, DOI 10.1002/stem.197; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Domenis R, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt536; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eterno V, 2014, ONCOTARGET, V5, P613, DOI 10.18632/oncotarget.1359; Ferraro GA, 2013, J CELL BIOCHEM, V114, P1039, DOI 10.1002/jcb.24443; GAFFNEY EV, 1982, CELL TISSUE RES, V227, P563, DOI 10.1007/BF00204786; Gargiulo L, 2014, ONCOTARGET, V5, P10058, DOI 10.18632/oncotarget.2460; Kim HY, 2017, SEMIN CELL DEV BIOL, V67, P113, DOI 10.1016/j.semcdb.2016.05.011; Koellensperger E, 2014, J PLAST RECONSTR AES, V67, P844, DOI 10.1016/j.bjps.2014.02.021; Kolle SFT, 2013, LANCET, V382, P1113, DOI 10.1016/S0140-6736(13)61410-5; Krumboeck A, 2013, BREAST, V22, P579, DOI 10.1016/j.breast.2013.05.006; Kucerova L, 2013, BMC CANCER, V3, P362; Largo RD, 2014, J PLAST RECONSTR AES, V67, P437, DOI 10.1016/j.bjps.2013.11.011; Li HB, 2014, TISSUE ENG PT A, V20, P774, DOI 10.1089/ten.TEA.2013.0122; Lian XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060016; Locke M, 2011, STEM CELLS, V29, P404, DOI 10.1002/stem.593; Matsumoto D, 2006, TISSUE ENG, V12, P3375, DOI 10.1089/ten.2006.12.3375; Paino F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.308; Pal A, 2014, JOVE-J VIS EXP, DOI 10.3791/51311; Papaccio F, 2017, STEM CELL TRANSL MED, V6, P2115, DOI 10.1002/sctm.17-0138; Parmar H, 2002, ENDOCRINOLOGY, V143, P4886, DOI 10.1210/en.2002-220570; Petit JY, 2011, PLAST RECONSTR SURG, V128, P341, DOI 10.1097/PRS.0b013e31821e713c; Rauner G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068637; Rowan BG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089595; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Setiawan M, 2017, BIOCHEM BIOPH RES CO, V490, P1381, DOI 10.1016/j.bbrc.2017.07.036; Shamir ER, 2015, CURR TOP DEV BIOL, V112, P353, DOI 10.1016/bs.ctdb.2014.12.001; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132; Weigand A, 2017, HANDCHIR MIKROCHIR P, V49, P111, DOI 10.1055/s-0042-123706; Weigand A, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0688-2; Yang J, 2015, J CELL MOL MED; Yonemura S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112922; Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4	44	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0204077	10.1371/journal.pone.0204077	http://dx.doi.org/10.1371/journal.pone.0204077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335754	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300005
J	Souza, ACF; Santos, FC; Bastos, DSS; Sertorio, MN; Teixeira, JPG; Fernandes, KM; Machado-Neves, M				Ferreira Souza, Ana Claudia; Santos, Felipe Couto; Sena Bastos, Daniel Silva; Sertorio, Marcela Nascimento; Gusmao Teixeira, Joao Paulo; Fernandes, Kenner Morais; Machado-Neves, Mariana			Reproductive functions in Desmodus rotundus: A comparison between seasons in a morphological context	PLOS ONE			English	Article							SEMINIFEROUS EPITHELIUM CYCLE; INTERTUBULAR COMPARTMENT; LEYDIG-CELLS; VAMPIRE BAT; CHIROPTERA; TESTIS; PHYLLOSTOMIDAE; ORGANIZATION; RESERVES	Reproductive seasonality in Neotropical bats has been assessed to the better understand their reproductive behavior. This knowledge is especially important for the control of Desmodus rotundus population as it is a transmitter of rabies virus. Therefore, we aimed to evaluate the functional activity of testis and epididymis of D. rotundus in dry and rainy seasons under a morphological approach. We observed an increase in tubular diameter and epithelial height of the seminiferous tubules during the rainy season. In the latter, additionally, stereo logical analysis of the testis showed increased proportion of seminiferous epithelium and reduced percentage of lumen. The sperm number in caput/corpus epididymis increased in rainy season, whereas sperm count and transit time were reduced in cauda region. These alterations were probably related to the recovery of epithelium activities after mating season in dry season. Despite altered nuclear and cytoplasm parameters of Leydig cells between seasons, the volume and number of these cells were constant. Moreover, no change in serum testosterone levels, daily sperm production, and apoptotic index were observed, which indicates that the reproductive pattern in D. rotundus does not change between seasons. Our study offers a baseline for the management of vampire bat population as an attempt to control rabies disease.	[Ferreira Souza, Ana Claudia; Santos, Felipe Couto; Sena Bastos, Daniel Silva; Sertorio, Marcela Nascimento; Fernandes, Kenner Morais; Machado-Neves, Mariana] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Ferreira Souza, Ana Claudia] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Gusmao Teixeira, Joao Paulo] Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil; [Fernandes, Kenner Morais] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Machado-Neves, M (corresponding author), Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil.	mariana.mneves@ufv.br	Souza, Ana Cláudia/J-1375-2016; Bastos, Daniel/G-3161-2017; Souza, Ana Cláudia Ferreira/Q-4659-2019; NEVES, MARIANA MACHADO/B-8833-2015; Morais, Kenner/Z-1667-2019	Souza, Ana Cláudia/0000-0001-5840-2641; Bastos, Daniel/0000-0001-7442-8067; Souza, Ana Cláudia Ferreira/0000-0001-5840-2641; NEVES, MARIANA MACHADO/0000-0002-7416-3529; Morais, Kenner/0000-0003-0576-8185; Santos, Felipe/0000-0003-0475-0389	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais grant [APQ-02514-16]; Coordenacao de Aperfeicoamento de Pessoal de Avel Superior; Conselho Nacional de Desenvolvimento Cientofico e Tecnologico [448455/2014-5, 150333/2018-8]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais grant; Coordenacao de Aperfeicoamento de Pessoal de Avel Superior; Conselho Nacional de Desenvolvimento Cientofico e Tecnologico	This research was funded by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais grant APQ-02514-16 (M. M-N), Coordenacao de Aperfeicoamento de Pessoal de Avel Superior (PhD fellowship to A.C.F.S) and Conselho Nacional de Desenvolvimento Cientofico e Tecnologico grant 448455/2014-5 (M. M-N) and 150333/2018-8 (A.C.F.S).	Amann R.P., 1970, TESTIS, V1, P433, DOI DOI 10.1016/B978-0-12-386601-1.50013-5; Barros MS, 2013, BRAZ J BIOL, V73, P629, DOI 10.1590/S1519-69842013000300022; Beguelini MR, 2014, REPROD FERT DEVELOP, V26, P834, DOI 10.1071/RD13109; Beguelini MR, 2013, MICROSC RES TECHNIQ, V76, P1035, DOI 10.1002/jemt.22264; Beguelini MR, 2009, J MORPHOL, V270, P943, DOI 10.1002/jmor.10731; BRASS DA, 1994, RABIES BATS NATURAL; Burns R. J., 1975, SW NATURALIST, V19, P446, DOI [10.2307/3670407, DOI 10.2307/3670407]; Caldeira Bianca Cabral, 2010, Rev. Ceres, V57, P569; Costa KLC, 2011, ANIM REPROD SCI, V127, P202, DOI 10.1016/j.anireprosci.2011.07.016; Castro MM, 2017, HISTOCHEM CELL BIOL, V147, P39, DOI 10.1007/s00418-016-1477-9; Christante CM, 2015, REPROD FERT DEVELOP, V27, P313, DOI 10.1071/RD13232; Crichton E. G., 2000, LIFE HIST REPROD STR, P364; Cryan PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047586; de Castro MM, 2017, MICRON, V102, P35, DOI 10.1016/j.micron.2017.08.006; Delpietro HA, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160959; Farias TO, 2015, ANAT HISTOL EMBRYOL, V44, P361, DOI 10.1111/ahe.12148; Souza ACF, 2016, BIOL TRACE ELEM RES, V171, P354, DOI 10.1007/s12011-015-0523-0; FLEMING TH, 1972, ECOLOGY, V53, P555, DOI 10.2307/1934771; Franca LR, 1998, MALE REPROD MULTIDIS, V197, P219; Gardner AL, MUSEUM TEXAS TU SPEC; Godoy MSM, 2014, BRAZ J BIOL, V74, P913, DOI 10.1590/1519-6984.22612; Greenhall A. M., 1988, NATURAL HIST VAMPIRE; GUSTAFSON AW, 1987, AM J ANAT, V178, P312, DOI 10.1002/aja.1001780403; Heideman Paul D, 2003, BMC Ecol, V3, P11, DOI 10.1186/1472-6785-3-11; Cervantes MI, 2008, SYST BIOL REPROD MED, V54, P196, DOI 10.1080/19396360802334466; Karnovsky M. J., 1965, J CELL BIOL, V15, P127; KUNZ TH, 1982, J MAMMAL, V63, P23, DOI 10.2307/1380667; Lane JE, 2011, ANIM BEHAV, V81, P909, DOI 10.1016/j.anbehav.2011.02.003; LOH HSF, 1980, CELL TISSUE RES, V210, P339; LORD RD, 1992, J WILDLIFE DIS, V28, P292, DOI 10.7589/0090-3558-28.2.292; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; Morais DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101759; Morais DB, 2014, ANIM REPROD SCI, V147, P180, DOI 10.1016/j.anireprosci.2014.03.008; Morais DB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173856; Morais DB, 2013, MICROSC RES TECHNIQ, V76, P94, DOI 10.1002/jemt.22141; MORI H, 1980, J CELL BIOL, V84, P340, DOI 10.1083/jcb.84.2.340; Nunez HA, 1997, REV BIOL TROP, V45, P1231; OHATA M, 1979, ARCH HISTOL JAPON, V42, P103, DOI 10.1679/aohc1950.42.103; Oliveira RL, 2009, GEN COMP ENDOCR, V161, P283, DOI 10.1016/j.ygcen.2009.01.019; ORSI A M, 1990, Revista Brasileira de Biologia, V50, P221; Pacheco SE, 2012, J ANDROL, V33, P811, DOI 10.2164/jandrol.111.015131; Robaire B, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1071; ROBB GW, 1978, J REPROD FERTIL, V54, P103, DOI 10.1530/jrf.0.0540103; Ross MH, 2016, HISTOLOGIA TEXTO ATL; Russell L. D., 1990, HISTOLOGICAL HISTOPA; RUSSELL LD, 1996, LEYDIG CELL, P00043; Streicker DG, 2016, P NATL ACAD SCI USA, V113, P10926, DOI 10.1073/pnas.1606587113; Taboga SR, 1999, CYTOBIOS, V99, P39; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P111; Wilson D.E., 1979, Texas Tech University Museum Special Publications, P317; WING TY, 1982, AM J ANAT, V165, P13, DOI 10.1002/aja.1001650103; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; Witorsch RJ, 2016, CRIT REV TOXICOL, V46, P420, DOI 10.3109/10408444.2016.1140718	54	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205023	10.1371/journal.pone.0205023	http://dx.doi.org/10.1371/journal.pone.0205023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332444	Green Submitted, Green Published, gold			2022-12-26	WOS:000447638200046
J	Schick, R; Mekies, LN; Shemer, Y; Eisen, B; Hallas, T; Ben Jehuda, R; Ben-Ari, M; Szantai, A; Willi, L; Shulman, R; Gramlich, M; Pane, LS; My, I; Freimark, D; Murgia, M; Santamaria, G; Gherghiceanu, M; Arad, M; Moretti, A; Binah, O				Schick, Revital; Mekies, Lucy N.; Shemer, Yuval; Eisen, Binyamin; Hallas, Tova; Ben Jehuda, Ronen; Ben-Ari, Meital; Szantai, Agnes; Willi, Lubna; Shulman, Rita; Gramlich, Michael; Pane, Luna Simona; My, Ilaria; Freimark, Dov; Murgia, Marta; Santamaria, Gianluca; Gherghiceanu, Mihaela; Arad, Michael; Moretti, Alessandra; Binah, Ofer			Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; BEAT RATE VARIABILITY; SARCOPLASMIC-RETICULUM; MUTATIONS; PROTEIN; KINASE; IDENTIFICATION; GENETICS; FORCE; LINE	Aims Dilated cardiomyopathy (DCM), a myocardial disorder that can result in progressive heart failure and arrhythmias, is defined by ventricular chamber enlargement and dilatation, and systolic dysfunction. Despite extensive research, the pathological mechanisms of DCM are unclear mainly due to numerous mutations in different gene families resulting in the same outcome-decreased ventricular function. Titin (TTN) a giant protein, expressed in cardiac and skeletal muscles, is an important part of the sarcomere, and thus TTN mutations are the most common cause of adult DCM. To decipher the basis for the cardiac pathology in titin-mutated patients, we investigated the hypothesis that induced Pluripotent Stem Cell (iPSC)-derived cardiomyocytes (iPSC-CM) generated from patients, recapitulate the disease phenotype. The hypothesis was tested by 3 Aims: (1) Investigate key features of the excitation-contraction-coupling machinery; (2) Investigate the responsiveness to positive inotropic interventions; (3) Investigate the proteome profile of the AuP cardiomyocytes using mass-spectrometry (MS). Methods and results iPSC were generated from the patients' skin fibroblasts. The major findings were: (1) Sarcomeric organization analysis in mutated iPSC-CM showed defects in assembly and maintenance of sarcomeric structure. (2) Mutated iPSC-CM exhibited diminished inotropic and lusitropic responses to beta-adrenergic stimulation with isoproterenol, increased [Ca2+](out) and angiotensin-II. Additionally, mutated iPSC-CM displayed prolonged recovery in response to caffeine. These findings may result from defective or lack of interactions of the sarcomeric components with titin through its kinase domain which is absent in the mutated cells. Conclusions These findings show that the mutated cardiomyocytes from DCM patients recapitulate abnormalities of the inherited cardiomyopathies, expressed as blunted inotropic response.	[Schick, Revital; Mekies, Lucy N.; Shemer, Yuval; Eisen, Binyamin; Hallas, Tova; Ben Jehuda, Ronen; Ben-Ari, Meital; Szantai, Agnes; Willi, Lubna; Shulman, Rita; Binah, Ofer] Technion, Dept Physiol Biophys & Syst Biol, Haifa, Israel; [Schick, Revital; Mekies, Lucy N.; Shemer, Yuval; Eisen, Binyamin; Hallas, Tova; Ben Jehuda, Ronen; Ben-Ari, Meital; Szantai, Agnes; Willi, Lubna; Shulman, Rita; Binah, Ofer] Rappaport Inst, Haifa, Israel; [Schick, Revital; Mekies, Lucy N.; Shemer, Yuval; Eisen, Binyamin; Hallas, Tova; Ben Jehuda, Ronen; Ben-Ari, Meital; Szantai, Agnes; Willi, Lubna; Shulman, Rita; Binah, Ofer] Technion, Rappaport Fac Med, Haifa, Israel; [Ben Jehuda, Ronen] Technion, Dept Biotechnol, Haifa, Israel; [Szantai, Agnes] Univ Szeged, Dept Biochem, Szeged, Hungary; [Gramlich, Michael] Eberhard Karls Univ Tubingen, Dept Cardiol & Cardiovasc Dis, Tubingen, Germany; [Pane, Luna Simona] AstraZeneca, IMED Biotech Unit, Discovery Biol, Discovery Sci, Gothenburg, Sweden; [My, Ilaria; Moretti, Alessandra] Tech Univ Munich, Klinikum Rechts Isar, Med Dept Cardiol, Munich, Germany; [Freimark, Dov; Arad, Michael] Tel Aviv Univ, Heart Failure Inst, Tel Aviv, Israel; [Freimark, Dov; Arad, Michael] Tel Aviv Univ, Leviev Heart Ctr, Sheba Med Ctr, Tel Aviv, Israel; [Freimark, Dov; Arad, Michael] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Murgia, Marta] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Martinsried, Germany; [Murgia, Marta] Univ Padua, Dept Biomed Sci, Padua, Italy; [Santamaria, Gianluca] Univ Magna Grecia, Med Sch, Dept Expt & Clin Med, Catanzaro, Italy; [Gherghiceanu, Mihaela] Victor Babes Natl Inst Pathol, Bucharest, Romania; [Moretti, Alessandra] German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Szeged University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; AstraZeneca; Technical University of Munich; Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Max Planck Society; University of Padua; Magna Graecia University of Catanzaro; Victor Babes National Institute of Pathology; German Centre for Cardiovascular Research; Munich Heart Alliance	Binah, O (corresponding author), Technion, Dept Physiol Biophys & Syst Biol, Haifa, Israel.; Binah, O (corresponding author), Rappaport Inst, Haifa, Israel.; Binah, O (corresponding author), Technion, Rappaport Fac Med, Haifa, Israel.	binah@tx.technion.ac.il	Moretti, Alessandra/O-9271-2015; My, Ilaria/AAK-8169-2021; Gherghiceanu, Mihaela/G-4621-2016	Moretti, Alessandra/0000-0001-5782-7832; Gherghiceanu, Mihaela/0000-0001-6117-4328; Eisen, Binyamin/0000-0002-2185-5054; SANTAMARIA, Gianluca/0000-0001-9284-7492	Israel Science Foundation (ISF) [292/13]; Israeli Ministry of Science, Technology and Space [7-10772]; Niedersachsen Ministry of Science and Culture [1176251-99-16/14]; DZHK (German Centre) for Cardiovascular Research-partner site Munich Heart Alliance [81Z7600671]	Israel Science Foundation (ISF)(Israel Science Foundation); Israeli Ministry of Science, Technology and Space; Niedersachsen Ministry of Science and Culture; DZHK (German Centre) for Cardiovascular Research-partner site Munich Heart Alliance	This work was supported by the Israel Science Foundation (ISF) [grant number 292/13]; the Israeli Ministry of Science, Technology and Space [grant number 7-10772]; the Niedersachsen Ministry of Science and Culture [grant number 1176251-99-16/14]; and the DZHK (German Centre for Cardiovascular Research-partner site Munich Heart Alliance-grant number 81Z7600671).	Arvanitis DA, 2011, J MOL CELL CARDIOL, V50, P43, DOI 10.1016/j.yjmcc.2010.08.021; Ben Jehuda R, 2018, HEART RHYTHM, V15, P267, DOI 10.1016/j.hrthm.2017.09.024; Ben-Ari M, 2016, HEART RHYTHM, V13, P2379, DOI 10.1016/j.hrthm.2016.08.045; Ben-Ari M, 2014, HEART RHYTHM, V11, P1808, DOI 10.1016/j.hrthm.2014.05.037; Castro-Ferreira R, 2011, ARQ BRAS CARDIOL, V96, P332, DOI 10.1590/S0066-782X2011005000023; Chopra A, 2018, DEV CELL, V44, P87, DOI 10.1016/j.devcel.2017.12.012; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dolnikov K, 2006, STEM CELLS, V24, P236, DOI 10.1634/stemcells.2005-0036; Eisen B, 2018, STEM CELL RES, V29, P111, DOI 10.1016/j.scr.2018.03.023; Fatkin Diane, 2010, Heart Fail Clin, V6, P129, DOI 10.1016/j.hfc.2009.11.003; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Gerull B, 2015, CAN J CARDIOL, V31, P1351, DOI 10.1016/j.cjca.2015.08.016; Gherghiceanu M, 2011, J CELL MOL MED, V15, P2539, DOI 10.1111/j.1582-4934.2011.01417.x; Gramlich M, 2015, EMBO MOL MED, V7, P562, DOI 10.15252/emmm.201505047; Gramlich M, 2009, J MOL CELL CARDIOL, V47, P352, DOI 10.1016/j.yjmcc.2009.04.014; Hallas T, 2018, J CELL MOL MED, V22, P913, DOI 10.1111/jcmm.13392; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Jacoby D, 2012, EUR HEART J, V33, P296, DOI 10.1093/eurheartj/ehr260; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Kamakura T, 2013, CIRC J, V77, P1307, DOI 10.1253/circj.CJ-12-0987; Kamen PW, 1996, CLIN SCI, V91, P201, DOI 10.1042/cs0910201; Kimura A, 2016, J HUM GENET, V61, P41, DOI 10.1038/jhg.2015.83; Kruger M, 2009, J MOL CELL CARDIOL, V46, P490, DOI 10.1016/j.yjmcc.2009.01.004; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Mandel Y, 2012, CIRCULATION, V125, P883, DOI 10.1161/CIRCULATIONAHA.111.045146; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; Mestroni L, 2014, PROG PEDIATR CARDIOL, V37, P13, DOI 10.1016/j.ppedcard.2014.10.003; Novak A, 2015, J CELL MOL MED, V19, P2006, DOI 10.1111/jcmm.12581; Novak A, 2012, J CELL MOL MED, V16, P468, DOI 10.1111/j.1582-4934.2011.01476.x; Novak A, 2010, CELL REPROGRAM, V12, P665, DOI 10.1089/cell.2010.0027; Peng J, 2007, CIRCULATION, V115, P743, DOI 10.1161/CIRCULATIONAHA.106.645499; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Sedan O, 2008, STEM CELLS, V26, P3130, DOI 10.1634/stemcells.2008-0777; Stoehr A, 2014, AM J PHYSIOL-HEART C, V306, pH1353, DOI 10.1152/ajpheart.00705.2013; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Tonino P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01144-9; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Yoskovitz G, 2012, AM J CARDIOL, V109, P1644, DOI 10.1016/j.amjcard.2012.01.392; Zhang XF, 2018, NAT PROTOC, V13, P530, DOI 10.1038/nprot.2017.147	45	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205719	10.1371/journal.pone.0205719	http://dx.doi.org/10.1371/journal.pone.0205719			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332462	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000447638200065
J	Chimbindi, N; Mthiyane, N; Birdthistle, I; Floyd, S; McGrath, N; Pillay, D; Seeley, J; Zuma, T; Dreyer, J; Gareta, D; Mutevedzi, T; Fenty, J; Herbst, K; Smit, T; Baisley, K; Shahmanesh, M				Chimbindi, Natsayi; Mthiyane, Nondumiso; Birdthistle, Isolde; Floyd, Sian; McGrath, Nuala; Pillay, Deenan; Seeley, Janet; Zuma, Thembelihle; Dreyer, Jaco; Gareta, Dickman; Mutevedzi, Tinofa; Fenty, Justin; Herbst, Kobus; Smit, Theresa; Baisley, Kathy; Shahmanesh, Maryam			Persistently high incidence of HIV and poor service uptake in adolescent girls and young women in rural KwaZulu-Natal, South Africa prior to DREAMS	PLOS ONE			English	Article							CONTRACEPTIVE USE; PREVENTION; HEALTH; RISK; INFECTION; AREA; SEX	Background Adolescent girls and young women (AGYW) bear the brunt of the HIV epidemic in South Africa. 'DREAMS' aims to reduce HIV incidence through multi-level combination prevention. We describe HIV incidence and uptake of HIV and sexual reproductive health (SRH) by AGYW in KwaZulu-Natal (KZN), prior to DREAMS. Methods Longitudinal and cross-sectional analysis of women (15-24 year old) in a population-based HIV incidence cohort within a demographic surveillance site in KZN. Observation time for HIV incidence was person-years at risk while resident. "Current use of contraceptives" and "having an HIV test in the past 12 months" was compared between 2011 and 2015. Results In 2015, HIV prevalence was 11.0% and 34.1% and HIV incidence (2011-2015) was 4.54% (95% CI: 3.89-5.30) and 7.45% (95% CI: 6.51-8.51) per year in 15-19 and 20-24 year olds respectively, with no significant decline compared to 2006-2010. In 2015, 90.7% of 20-24 year- olds were unemployed, 36.4% and 51.7% of 15-19 and 20-24 year olds reported recent migration; 20.9% and 72.6% of 15-19 and 20-24 year olds had ever been pregnant. In 2015, less than 50% reported condom-use at last sex, 15.0% of 15-19 year olds and 48.9% of 20-24 year olds were currently using contraception and 32.0% and 66.7% of 15-19 and 20-24 year olds had tested for HIV in the past 12 months. There had been no improvement compared to 2011. Factors associated with AGYW testing for HIV in the past 12 months were, survey year-2011 more likely than 2015 (aOR = 0.50), number of partners (aOR = 3.25), ever been pregnant (aOR = 2.47) and knowing where to find ART (aOR = 1.54). Factors associated with contraception use were being older (aOR = 4.83); ever been pregnant (aOR = 12.62); knowing where to get ART (aOR = 1.79) and having had an HIV test in past 12 months (aOR = 1.74). Conclusion Prior to DREAMS, HIV incidence in AGYW was high. HIV and SRH service uptake did not improve and was suboptimal. Findings highlight the need for combination HIV prevention programmes for AGYW in this economically vulnerable area.	[Chimbindi, Natsayi; Mthiyane, Nondumiso; Pillay, Deenan; Seeley, Janet; Zuma, Thembelihle; Dreyer, Jaco; Gareta, Dickman; Mutevedzi, Tinofa; Herbst, Kobus; Smit, Theresa; Baisley, Kathy; Shahmanesh, Maryam] Africa Hlth Res Inst, Durban, South Africa; [Birdthistle, Isolde; Floyd, Sian; Seeley, Janet; Fenty, Justin; Baisley, Kathy] London Sch Hyg & Trop Med, London, England; [McGrath, Nuala] Southampton Univ, Southampton, Hants, England; [Pillay, Deenan; Shahmanesh, Maryam] UCL, London, England	Africa Health Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Southampton; University of London; University College London	Shahmanesh, M (corresponding author), Africa Hlth Res Inst, Durban, South Africa.; Shahmanesh, M (corresponding author), UCL, London, England.	m.shahmanesh@ucl.ac.uk	Herbst, Abraham J/E-4848-2010	Herbst, Abraham J/0000-0002-5436-9386; Seeley, Janet/0000-0002-0583-5272; Shahmanesh, Maryam/0000-0001-7129-8535; McGrath, Nuala/0000-0002-1039-0159	Bill & Melinda Gates Foundation [OPP1136774]; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under REA grant [612216]; Wellcome Trust [082384/Z/07/Z]; Bill and Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under REA grant; Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, Grant Number OPP1136774. The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under REA grant agreement no 612216. Africa Health Research Institute is supported by a grant from the Wellcome Trust (082384/Z/07/Z). BMGF did input into the early phase of the evaluation design. However, neither funder had any role in data collection, analysis, decision to publish or preparation of the manuscript.; The authors are grateful, to the communities of the Hlabisa sub-district who contributed their data to this study and to Africa Health Research Institute staff who collected the data, the DREAMS project management group who reviewed the paper. Africa Health Research Institute is supported by a grant from the Wellcome Trust (082384/Z/07/Z). The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's seventh Framework Programme FP7/2007-2013 under REA grant agreement no. 612216. The DREAMS IE Baseline Report received funding from the Bill and Melinda Gates Foundation.	Chang LW, 2013, LANCET INFECT DIS, V13, P65, DOI 10.1016/S1473-3099(12)70273-6; Chersich MF, 2017, SAMJ S AFR MED J, V107, P307, DOI 10.7196/SAMJ.2017.v107i4.12141; Chetty T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012088; Chimbindi N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-32; Cluver L, 2013, SAMJ S AFR MED J, V103, P910, DOI [10.7196/SAMJ.7045, 10.7196/samj.7045]; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Fielding-Miller R, 2016, SOC SCI MED, V158, P24, DOI 10.1016/j.socscimed.2016.04.005; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Herbst K, 2015, CURR OPIN HIV AIDS, V10, P483, DOI 10.1097/COH.0000000000000203; Magadi MA, 2011, SOCIOL HEALTH ILL, V33, P522, DOI 10.1111/j.1467-9566.2010.01304.x; McGrath N, 2009, SEX TRANSM INFECT, V85, pI49, DOI 10.1136/sti.2008.033324; Moshabela M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-182; MUHWAVA W, 2007, MONOGRAPH SERIES AFR, V1; Ngwenya N, 2018, AJAR-AFR J AIDS RES, V17, P72, DOI 10.2989/16085906.2017.1415214; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Peer N, 2013, SAMJ S AFR MED J, V103, P406, DOI [10.7196/SAMJ.6201, 10.7196/samj.6201]; Peltzer K, 2013, AFR HEALTH SCI, V13, P1012, DOI 10.4314/ahs.v13i4.22; Shisana O., 2014, AFRICAN NATL HIV P; Sia D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3783-5; South African National Department of Health, 2013, NAT ANT SENT HIV PRE; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Wood K, 2006, REPROD HEALTH MATTER, V14, P109, DOI 10.1016/S0968-8080(06)27231-8	23	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0203193	10.1371/journal.pone.0203193	http://dx.doi.org/10.1371/journal.pone.0203193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325932	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000447430800005
J	Nisbet, AI; Omuse, G; Revathi, G; Adam, RD				Nisbet, Audrey I.; Omuse, Geoffrey; Revathi, Gunturu; Adam, Rodney D.			Seroprevalence data at a private teaching hospital in Kenya: An examination of Toxoplasma gondii, cytomegalovirus, rubella, hepatitis A, and Entamoeba histolytica	PLOS ONE			English	Article							CONGENITAL CYTOMEGALOVIRUS; INFECTION; ENCEPHALITIS; EPIDEMIOLOGY; PREVENTION; DISEASE; WOMEN; AIDS	Background Relevant seroprevalence data for endemic pathogens in a given region provide insight not only into a population's susceptibility to acute infection or risk for reactivation disease but also into the potential need for policy initiatives aimed at reducing these risks. Data from sub-Saharan Africa are sparse and since Aga Khan University Hospital Nairobi is an internationally accredited hospital equipped with a laboratory electronic medical record system, analysis of pertinent local seroprevalence data has been made possible. Methods We have analyzed serology data from laboratory electronic records at a 300 bed tertiary private teaching hospital in Kenya for the dates, 2008 to 2017 for Toxoplasma gondii, cytomegalovirus, and rubella, which were used primarily for antenatal screening. We also analyzed the data from hepatitis A and amebiasis serologies, which were used primarily for diagnostic purposes. Results For T. gondii, cytomegalovirus, and rubella, we used IgG serology to determine seroprevalence, finding rates of 32%, 86%, and 89%, respectively. There was no significant agerelated difference in the 20 to 49 year old age range for any of these three pathogens. Of the Hepatitis A IgM tests that were ordered, 33% were positive with a peak positive rate of 70% in the five to nine year old age range. The seroprevalence of amebiasis was 4% and all cases of seropositivity were accompanied by compatible clinical illness (hepatic abscess). Conclusions These data provide insight into seroprevalence rates of selected pathogens that can be used to guide screening and diagnostic laboratory testing as well as private and public immunization practices.	[Nisbet, Audrey I.] Univ Arizona, Coll Med, Tucson, AZ USA; [Omuse, Geoffrey; Revathi, Gunturu; Adam, Rodney D.] Aga Khan Univ Hosp, Dept Pathol, Nairobi, Kenya; [Adam, Rodney D.] Aga Khan Univ Hosp, Dept Med, Nairobi, Kenya	University of Arizona	Adam, RD (corresponding author), Aga Khan Univ Hosp, Dept Pathol, Nairobi, Kenya.; Adam, RD (corresponding author), Aga Khan Univ Hosp, Dept Med, Nairobi, Kenya.	adamr@u.arizona.edu	OMUSE, GEOFFREY/EVF-7884-2022	OMUSE, GEOFFREY/0000-0002-3866-5118; Nisbet, Audrey Irene/0000-0003-1329-6843; Adam, Rodney/0000-0002-6665-4280				Bharti AR, 2016, CLIN INFECT DIS, V63, P1655, DOI 10.1093/cid/ciw655; Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Fotedar R, 2007, CLIN MICROBIOL REV, V20, P511, DOI 10.1128/CMR.00004-07; Franco E, 2012, WORLD J HEPATOL, V4, P68, DOI 10.4254/wjh.v4.i3.68; GRIFFIN L, 1983, T ROY SOC TROP MED H, V77, P763, DOI 10.1016/0035-9203(83)90283-3; Kibet E, 2014, AM J CLIN PATHOL, V141, P188, DOI 10.1309/AJCPV8A9MRWHGXEF; Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Lebo EJ, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv006; LUFT BJ, 1984, JAMA-J AM MED ASSOC, V252, P913, DOI 10.1001/jama.252.7.913; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Njeru D G, 2009, East Afr Med J, V86, pS58; Pandolfi E, 2017, EUR J PUBLIC HEALTH, V27, P530, DOI 10.1093/eurpub/ckw259; Pass RF, 2014, J PEDIATR INFECT DIS, V3, pS2, DOI 10.1093/jpids/piu069; Petri Jr WA, 2015, MANDELL DOUGLAS BENN; Pritt BS, 2008, MAYO CLIN PROC, V83, P1154, DOI 10.4065/83.10.1154; Raffi F, 1997, AIDS, V11, P177, DOI 10.1097/00002030-199702000-00007; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Siekmann JH, 2003, AM J CLIN NUTR, V77, P242, DOI 10.1093/ajcn/77.1.242; Stillwaggon E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001333	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0204867	10.1371/journal.pone.0204867	http://dx.doi.org/10.1371/journal.pone.0204867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325924	Green Published, Green Submitted, gold			2022-12-26	WOS:000447430800013
J	Pena, IP; Cheplygina, V; Paschaloudi, S; Vuust, M; Carl, J; Weinreich, UM; Ostergaard, LR; de Bruijne, M				Pena, Isabel Pino; Cheplygina, Veronika; Paschaloudi, Sofia; Vuust, Morten; Carl, Jesper; Weinreich, Ulla Moller; Ostergaard, Lasse Riis; de Bruijne, Marleen			Automatic emphysema detection using weakly labeled HRCT lung images	PLOS ONE			English	Article							TEXTURE-BASED QUANTIFICATION; COMPUTER-AIDED DIAGNOSIS; PULMONARY-EMPHYSEMA; COPD; CLASSIFICATION; TOMOGRAPHY; DISEASES	Purpose A method for automatically quantifying emphysema regions using High-Resolution Computed Tomography (HRCT) scans of patients with chronic obstructive pulmonary disease (COPD) that does not require manually annotated scans for training is presented. Methods HRCT scans of controls and of COPD patients with diverse disease severity are acquired at two different centers. Textural features from co-occurrence matrices and Gaussian filter banks are used to characterize the lung parenchyma in the scans. Two robust versions of multiple instance learning (MIL) classifiers that can handle weakly labeled data, miSVM and MILES, are investigated. Weak labels give information relative to the emphysema without indicating the location of the lesions. The classifiers are trained with the weak labels extracted from the forced expiratory volume in one minute (FEV1) and diffusing capacity of the lungs for carbon monoxide (DLCO). At test time, the classifiers output a patient label indicating overall COPD diagnosis and local labels indicating the presence of emphysema. The classifier performance is compared with manual annotations made by two radiologists, a classical density based method, and pulmonary function tests (PFTs). Results The miSVM classifier performed better than MILES on both patient and emphysema classification. The classifier has a stronger correlation with PFT than the density based method, the percentage of emphysema in the intersection of annotations from both radiologists, and the percentage of emphysema annotated by one of the radiologists. The correlation between the classifier and the PFT is only outperformed by the second radiologist. Conclusions The presented method uses MIL classifiers to automatically identify emphysema regions in HRCT scans. Furthermore, this approach has been demonstrated to correlate better with DLCO than a classical density based method or a radiologist, which is known to be affected in emphysema. Therefore, it is relevant to facilitate assessment of emphysema and to reduce inter-observer variability.	[Pena, Isabel Pino; Ostergaard, Lasse Riis] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Cheplygina, Veronika] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands; [Cheplygina, Veronika; de Bruijne, Marleen] Erasmus MC, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands; [Paschaloudi, Sofia; Vuust, Morten] Vendsyssel Hosp, Dept Diagnost Imaging, Fredrikshavn, Denmark; [Carl, Jesper; Weinreich, Ulla Moller] Aalborg Univ Hosp, Dept Clin Med, Aalborg, Denmark; [Weinreich, Ulla Moller] Aalborg Univ Hosp, Dept Pulm Med, Aalborg, Denmark; [de Bruijne, Marleen] Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark	Aalborg University; Eindhoven University of Technology; Erasmus University Rotterdam; Erasmus MC; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; University of Copenhagen	Pena, IP (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark.; Cheplygina, V (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands.; Cheplygina, V (corresponding author), Erasmus MC, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands.	ipino@hst.aau.dk; v.cheplygina@tue.nl	Weinreich, Ulla M/L-9069-2013; de Bruijne, Marleen/G-2662-2010; Ostergaard, Lars/AAA-3020-2020	Weinreich, Ulla M/0000-0003-1975-3654; de Bruijne, Marleen/0000-0002-6328-902X; Ostergaard, Lars/0000-0003-2459-0511; Paschaloudi, Sofia/0000-0002-7330-0392; stergaard, Lasse Riis/0000-0002-0524-6347; Cheplygina, Veronika/0000-0003-0176-9324; Ostergaard, Lars/0000-0002-7619-605X	Netherlands Organization for Scientific Research (NWO) [639.022.010]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	M.B and V.C. received financial support from the Netherlands Organization for Scientific Research (NWO), grant no. 639.022.010, www.nwo.nl/en.	Albregtsen F., 2008, IMAGE PROCESSING LAB, V5; Amores J, 2013, ARTIF INTELL, V201, P81, DOI 10.1016/j.artint.2013.06.003; Andrews S., 2002, ADV NEURAL INFORM PR, V15, P561; Bagci U, 2012, COMPUT MED IMAG GRAP, V36, P72, DOI 10.1016/j.compmedimag.2011.06.002; Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Chabat F, 2003, RADIOLOGY, V228, P871, DOI 10.1148/radiol.2283020505; Chen YX, 2006, IEEE T PATTERN ANAL, V28, P1931, DOI 10.1109/TPAMI.2006.248; Cheplygina V L, 2015, MED IMAGE COMPUTING; Cheplygina V, 2014, INT C PATT RECOG, P1508, DOI 10.1109/ICPR.2014.268; Cheplygina V, 2015, PATTERN RECOGN, V48, P264, DOI 10.1016/j.patcog.2014.07.022; de Bruijne M, 2016, MED IMAGE ANAL, V33, P94, DOI 10.1016/j.media.2016.06.032; Diaz AA, 2015, RESP MED, V109, P882, DOI 10.1016/j.rmed.2015.04.009; do Tragante O V, 2011, BEN C ART INT; Ginsburg SB, 2012, ACAD RADIOL, V19, P1241, DOI 10.1016/j.acra.2012.04.020; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2015, GLOB STRAT DIAGN MAN; Kandemir M, 2015, COMPUT MED IMAG GRAP, V42, P44, DOI 10.1016/j.compmedimag.2014.11.010; Kim N, 2009, J DIGIT IMAGING, V22, P136, DOI 10.1007/s10278-008-9147-7; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Lynch DA, 2009, J THORAC IMAG, V24, P189, DOI 10.1097/RTI.0b013e3181b31cf0; Mascalchi M, 2012, ACTA RADIOL, V53, P53, DOI 10.1258/ar.2011.110419; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matsuoka S, 2010, RADIOGRAPHICS, V30, P55, DOI 10.1148/rg.301095110; Melendez J, 2015, IEEE T MED IMAGING, V34, P179, DOI 10.1109/TMI.2014.2350539; Mets OM, 2012, LUNG, V190, P133, DOI 10.1007/s00408-011-9353-9; Nagao J, 2003, LECT NOTES COMPUT SC, V2878, P730; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nanni L, 2017, PATTERN RECOGN, V71, P158, DOI 10.1016/j.patcog.2017.05.025; Nishimura K, 1998, J THORAC IMAG, V13, P193, DOI 10.1097/00005382-199807000-00006; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Park YS, 2008, INVEST RADIOL, V43, P395, DOI 10.1097/RLI.0b013e31816901c7; Prasad M, 2009, PATTERN ANAL APPL, V12, P9, DOI 10.1007/s10044-007-0093-7; Schlkopf B., 2006, ADV NEURAL INFORM PR, V19, P1609; Sorensen L, 2012, IEEE T MED IMAGING, V31, P70, DOI 10.1109/TMI.2011.2164931; Sorensen L, 2010, IEEE T MED IMAGING, V29, P559, DOI 10.1109/TMI.2009.2038575; Sorensen L, 2009, LECT NOTES COMPUT SC, V5762, P699, DOI 10.1007/978-3-642-04271-3_85; Tan J, 2011, SPIE, P1; Uppaluri R, 1999, AM J RESP CRIT CARE, V160, P648, DOI 10.1164/ajrccm.160.2.9804094; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vanwinckelen G, 2016, DATA MIN KNOWL DISC, V30, P313, DOI 10.1007/s10618-015-0416-z; Voelkel NF, 2008, CHRONIC OBSTRUCTIVE; Wang ZM, 2013, EUR RADIOL, V23, P975, DOI 10.1007/s00330-012-2683-z; World Health Organization, TOP 10 CAUS DEATH; Yao JH, 2011, ACAD RADIOL, V18, P306, DOI 10.1016/j.acra.2010.11.013	43	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205397	10.1371/journal.pone.0205397	http://dx.doi.org/10.1371/journal.pone.0205397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321206	Green Submitted, Green Published, gold			2022-12-26	WOS:000447417900029
J	Kain, D; Simon, AJ; Greenberg, A; Ben Zvi, D; Gilburd, B; Schneiderman, J				Kain, David; Simon, Amos J.; Greenberg, Avraham; Ben Zvi, Danny; Gilburd, Boris; Schneiderman, Jacob			Cardiac leptin overexpression in the context of acute MI and reperfusion potentiates myocardial remodeling and left ventricular dysfunction	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; PERMEABILITY TRANSITION PORE; INFLAMMATORY-BOWEL-DISEASE; HEART-FAILURE; NATIONWIDE COHORT; TGF-BETA; INFARCTION; HYPERTROPHY; RISK; HYPERLEPTINEMIA	Background Acute MI induces leptin expression in the heart, however the role of myocardial leptin in cardiac ischemia and reperfusion (IR) remains unknown. To shed light on the effects of elevated levels of leptin in the myocardium, we overexpressed cardiac leptin and assessed local remodeling and myocardial function in this context. Methods and results Cardiac leptin overexpression was stimulated in mice undergoing IR by a single intraperitoneal injection of leptin antagonist (LepA). All mice exhibited a normal pattern of body weight gain. A rapid, long-term upregulation of leptin mRNA was demonstrated in the heart, adipose, and liver tissues in IR/LepA-treated mice. Overexpressed cardiac leptin mRNA extended beyond postoperative day (POD) 30. Plasma leptin peaked 7.5 hours postoperatively, especially in IR/LepA-treated mice, subsiding to normal levels by 24 hours. On POD-30 IR/LepA-treated mice demonstrated cardiomyocyte hypertrophy and perivascular fibrosis compared to IR/saline controls. Echocardiography on POD-30 demonstrated eccentric hypertrophy and systolic dysfunction in IR/LepA. We recorded reductions in Ejection Fraction (p<0.001), Fraction Shortening (p<0.01), and Endocardial Fraction Area Change (p<0.01), and an increase in Endocardial Area Change (p<0.01). Myocardial remodeling in the context of IR and cardiac leptin overexpression was associated with increased cardiac TGF beta ligand expression, activated Smad2, and downregulation of STAT3 activity. Conclusions Cardiac IR coinciding with increased myocardial leptin synthesis promotes cardiomyocyte hypertrophy and fibrosis and potentiates myocardial dysfunction. Plasma leptin levels do not reflect cardiac leptin synthesis, and may not predict leptin-related cardiovascular morbidity. Targeting cardiac leptin is a potential treatment for cardiac IR damage.	[Kain, David] Tel Aviv Univ, Dept Neurobiol, Tel Aviv, Israel; [Simon, Amos J.] Tel Aviv Univ, Canc Res, Sheba Med Ctr, Sackler Fac Med, Tel Aviv, Israel; [Simon, Amos J.] Tel Aviv Univ, Inst Hematol, Sheba Med Ctr, Sackler Fac Med, Tel Aviv, Israel; [Greenberg, Avraham; Ben Zvi, Danny] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel; [Gilburd, Boris] Tel Aviv Univ, Ctr Autoimmune Dis, Sheba Med Ctr, Sackler Fac Med, Tel Aviv, Israel; [Schneiderman, Jacob] Tel Aviv Univ, Dept Vasc Surg, Sheba Med Ctr, Sackler Fac Med, Tel Aviv, Israel	Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Schneiderman, J (corresponding author), Tel Aviv Univ, Dept Vasc Surg, Sheba Med Ctr, Sackler Fac Med, Tel Aviv, Israel.	jschneid@post.tau.ac.il		Ben-Zvi, Danny/0000-0002-8697-9744; kain, david/0000-0002-8410-9390				Ahren B, 2000, INT J OBESITY, V24, P1579, DOI 10.1038/sj.ijo.0801447; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Ben-Zvi D, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003474; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Desta L, 2015, JACC-HEART FAIL, V3, P234, DOI 10.1016/j.jchf.2014.10.007; Gao XM, 2000, CARDIOVASC RES, V45, P330, DOI 10.1016/S0008-6363(99)00274-6; Guo KY, 2007, ENDOCRINOLOGY, V148, P3987, DOI 10.1210/en.2007-0261; Hadi Khafaji HAR, BMC RES NOTES, V5, P262; Hall ME, 2015, WORLD J CARDIOL, V7, P511, DOI 10.4330/wjc.v7.i9.511; Hall ME, 2012, AM J PHYSIOL-REG I, V303, pR1241, DOI 10.1152/ajpregu.00292.2012; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hausenloy DJ, 2003, J MOL CELL CARDIOL, V35, P339, DOI 10.1016/S0022-2828(03)00043-9; Hayashi D, 2004, BIOCHEM BIOPH RES CO, V322, P310, DOI 10.1016/j.bbrc.2004.07.119; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Himms-Hagen J, 1999, CRIT REV CL LAB SCI, V36, P575, DOI 10.1080/10408369991239259; Hou N, 2011, CLIN EXP PHARMACOL P, V38, P905, DOI 10.1111/j.1440-1681.2011.05619.x; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Jafarzadeh SR, 2016, CLIN INFECT DIS, V63, P495, DOI 10.1093/cid/ciw320; Kaplan MJ, 2010, RHEUM DIS CLIN N AM, V36, P405, DOI 10.1016/j.rdc.2010.02.002; Kasama S, 2008, EUR HEART J, V29, P1485, DOI 10.1093/eurheartj/ehn206; Khafaji Hadi A R Hadi, 2012, BMC Res Notes, V5, P262, DOI 10.1186/1756-0500-5-262; Knight Richard A, 2012, JAKSTAT, V1, P111, DOI 10.4161/jkst.20078; Kristensen SL, 2014, CIRC-CARDIOVASC QUAL, V7, P857, DOI 10.1161/CIRCOUTCOMES.114.000918; Kristensen SL, 2014, CIRC-HEART FAIL, V7, P717, DOI 10.1161/CIRCHEARTFAILURE.114.001152; Lee Y, 2004, P NATL ACAD SCI USA, V101, P13624, DOI 10.1073/pnas.0405499101; Leifheit-Nestler M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-170; Liu RM, 2015, REDOX BIOL, V6, P565, DOI 10.1016/j.redox.2015.09.009; Maki T, 2000, BRIT J PHARMACOL, V131, P1204, DOI 10.1038/sj.bjp.0703679; McGaffin KR, 2011, CARDIOVASC RES, V89, P60, DOI 10.1093/cvr/cvq288; McGaffin KR, 2009, CIRC-HEART FAIL, V2, P676, DOI 10.1161/CIRCHEARTFAILURE.109.869909; Moro C, 2011, J CELL MOL MED, V15, P1688, DOI 10.1111/j.1582-4934.2010.01154.x; Pardali E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102157; Purdham DM, 2008, AM J PHYSIOL-HEART C, V295, pH441, DOI 10.1152/ajpheart.91537.2007; Rajapurohitam V, 2006, J MOL CELL CARDIOL, V41, P265, DOI 10.1016/j.yjmcc.2006.05.001; Schneiderman J, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001727; Shpilman M, 2011, J BIOL CHEM, V286, P4429, DOI 10.1074/jbc.M110.196402; Smith CCT, 2010, AM J PHYSIOL-HEART C, V299, pH1265, DOI 10.1152/ajpheart.00092.2010; Soderberg S, 2003, CEREBROVASC DIS, V15, P63, DOI 10.1159/000067128; Tao M, 2013, ARTERIOSCL THROM VAS, V33, P311, DOI 10.1161/ATVBAHA.112.300543; Voigt J, 2014, CLIN CARDIOL, V37, P312, DOI 10.1002/clc.22260; Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061	41	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0203902	10.1371/journal.pone.0203902	http://dx.doi.org/10.1371/journal.pone.0203902			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312306	Green Published, Green Submitted, gold			2022-12-26	WOS:000447427300006
J	Shu, LJ; Liao, JY; Lin, NC; Chung, CL				Shu, Lin-Jie; Liao, Jui-Yu; Lin, Nai-Chun; Chung, Chia-Lin			Identification of a strawberry NPR-like gene involved in negative regulation of the salicylic acid-mediated defense pathway	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; SPECTRUM DISEASE RESISTANCE; COLLETOTRICHUM-GLOEOSPORIOIDES; TRANSCRIPTION FACTORS; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS MUTANT; GENOME DATABASE; PLANT IMMUNITY; EXPRESSION; RESPONSES	Hormonal modulation plays a central role in triggering various resistant responses to biotic and abiotic stresses in plants. In cultivated strawberry (Fragaria x ananassa), the salicylic acid (SA)-dependent defense pathway has been associated with resistance to Colletotrichum spp. and the other pathogens. To better understand the SA-mediated defense mechanisms in strawberry, we analyzed two strawberry cultivars treated with SA for their resistance to anthracnose and gene expression profiles at 6, 12, 24, and 48 hr post-treatment. Strawberry genes related to SA biosynthesis, perception, and signaling were identified from SA-responsive transcriptomes of the two cultivars, and the induction of 17 candidate genes upon SA treatment was confirmed by qRT-PCR. Given the pivotal role of the non-expressor of pathogenesis-related (NPR) family in controlling the SA-mediated defense signaling pathway, we then analyzed NPR orthologous genes in strawberry. From the expression profile, FaNPRL-1 [ortholog of FvNPRL-1 (gene20070 in F. vesca)] was identified as an NPR-like gene significantly induced after SA treatment in both cultivars. With a conserved BTB/POZ domain, ankyrin repeat domain, and nuclear localization signal, FvNPRL-1 was found phylogenetically closer to NPR3/NPR4 than NPR1 in Arabidopsis. Ectopic expression of FvNPRL-1 in the Arabidopsis thaliana wild type suppressed the SA-mediated PR1 expression and the resistance to Pseudomonas syringae pv. tomato DC3000. Transient expression of FvNPRL-1 fused with green fluorescent protein in Arabidopsis protoplasts showed that SA affected nuclear translocation of FvNPRL-1. FvNPRL-1 likely functions similar to Arabidopsis NPR3/NPR4 as a negative regulator of the SA-mediated defense.	[Shu, Lin-Jie; Liao, Jui-Yu; Chung, Chia-Lin] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei, Taiwan; [Lin, Nai-Chun] Natl Taiwan Univ, Dept Agr Chem, Taipei, Taiwan	National Taiwan University; National Taiwan University	Chung, CL (corresponding author), Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei, Taiwan.; Lin, NC (corresponding author), Natl Taiwan Univ, Dept Agr Chem, Taipei, Taiwan.	nlin@ntu.edu.tw; clchung@ntu.edu.tw	Shu, Lin-Jie/AAI-5868-2020	CHUNG, CHIA-LIN/0000-0002-1612-0109; LIN, NAI-CHUN/0000-0002-6485-9776; Shu, Lin-Jie/0000-0002-9698-183X	Ministry of Science and Technology, Taiwan [NSC 101-2313-B-002-057-, MOST 107-2321-B-002-058-]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/?l=ch) (grants "NSC 101-2313-B-002-057-" to Chia-Lin Chung and "MOST 107-2321-B-002-058-" to Chia-Lin Chung and Nai-Chun Lin). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Hsin-Hung Yeh and Dr. Yu-Liang Yang (Agricultural Biotechnology Research Center, Academia Sinica, Taiwan) for providing miscellaneous resources and advising on plant resistance mechanisms. We thank Dr. Shih-Shun Lin (Institute of Biotechnology, NTU), Dr. Chien-Yu Chen (Department of Bio-Industrial Mechatronics Engineering, NTU), and Ms. Qiao-Juan Lai and Mr. Hsin-Han Lee (Department of Plant Pathology and Microbiology, NTU) for support with transcriptome analysis. We appreciate help from Dr. Kuo-Tan Li (Department of Horticulture, NTU) for providing strawberry materials and Ms. Pei-Che Chung (Miaoli District Agricultural Research and Extension Station, Council of Agriculture, Taiwan) for advising on strawberry cultivation. Thanks to Dr. Kevin Folta (University of Florida) for information on strawberry RNA extraction. We also thank Dr. Shean-Shong Tzean for providing miscellaneous resources when the lab was just established. The work was supported by the Ministry of Science and Technology, Taiwan (NSC 101-2313-B-002-057-; MOST 107-2321-B-002-058-).	Agrios G. N., 2005, PLANT PATHOL; Amil-Ruiz F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01036; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; Boatwright JL, 2013, MOL PLANT PATHOL, V14, P623, DOI 10.1111/mpp.12035; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Casado-Diaz A, 2006, PHYSIOL PLANTARUM, V128, P633, DOI 10.1111/j.1399-3054.2006.00798.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Darwish O, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-223; De Witt RN, 2013, THESIS; Ding YL, 2018, CELL, V173, P1454, DOI 10.1016/j.cell.2018.03.044; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Ellis C, 2002, MOL PLANT MICROBE IN, V15, P1025, DOI 10.1094/MPMI.2002.15.10.1025; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Endah R, 2008, PLANT PHYSIOL BIOCH, V46, P1007, DOI 10.1016/j.plaphy.2008.06.007; Folta KM, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-12; Folta KM, 2010, PLANT GENOME-US, V3, P90, DOI 10.3835/plantgenome2010.02.0003; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Gomez-Munoz N, 2017, MOL PLANT PATHOL, V18, P1253, DOI 10.1111/mpp.12488; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grellet-Bournonville CF, 2012, PLANT PHYSIOL BIOCH, V54, P10, DOI 10.1016/j.plaphy.2012.01.019; Guidarelli M, 2011, PLANT PATHOL, V60, P685, DOI 10.1111/j.1365-3059.2010.02423.x; Hanhineva K, 2009, J EXP BOT, V60, P2093, DOI 10.1093/jxb/erp085; Herrera-Vasquez A, 2015, PLANT MOL BIOL REP, V33, P624, DOI 10.1007/s11105-014-0782-5; Hukkanen AT, 2007, J AGR FOOD CHEM, V55, P1862, DOI 10.1021/jf063452p; Jung S, 2008, NUCLEIC ACIDS RES, V36, pD1034, DOI 10.1093/nar/gkm803; Jung S, 2014, NUCLEIC ACIDS RES, V42, pD1237, DOI 10.1093/nar/gkt1012; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Henanff G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-54; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Li J, 2013, GENE, V527, P215, DOI [10.1016/j.gene.2012.11.027, 10.1016/j.gene.2013.06.008]; Lin NC, 2005, MOL PLANT MICROBE IN, V18, P43, DOI 10.1094/MPMI-18-0043; Liu GS, 2005, PLANT J, V41, P304, DOI 10.1111/j.1365-313X.2004.02296.x; Liu GS, 2007, MOL PLANT MICROBE IN, V20, P1308, DOI 10.1094/MPMI-20-10-1308; Liu LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13099; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Zamora MGM, 2012, FUNCT PLANT BIOL, V39, P412, DOI 10.1071/FP11275; Moore JW, 2011, PLANT CELL, V23, P2809, DOI 10.1105/tpc.111.087346; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Mukhtar MS, 2009, CELL, V137, P804, DOI 10.1016/j.cell.2009.05.010; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Ndamukong I, 2007, PLANT J, V50, P128, DOI 10.1111/j.1365-313X.2007.03039.x; Osorio S, 2011, J EXP BOT, V62, P2855, DOI 10.1093/jxb/erq465; Pajerowska-Mukhtar KM, 2013, TRENDS PLANT SCI, V18, P402, DOI 10.1016/j.tplants.2013.04.004; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Rouhier N, 2006, J EXP BOT, V57, P1685, DOI 10.1093/jxb/erl001; Sandhu D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-105; Shearer HL, 2009, BOTANY, V87, P561, DOI 10.1139/B08-143; SHI Z, 2013, BMC PLANT BIOL, V13; Shi Z, 2013, MOL PLANT, V6, P802, DOI 10.1093/mp/sss091; Shi Z, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-248; Shirano Y, 2002, PLANT CELL, V14, P3149, DOI 10.1105/tpc.005348; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Silva KJP, 2015, TRANSGENIC RES, V24, P693, DOI 10.1007/s11248-015-9869-5; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Spoel SH, 2009, CELL, V137, P860, DOI 10.1016/j.cell.2009.03.038; Stupar RM, 2006, GENETICS, V172, P1263, DOI 10.1534/genetics.105.051219; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang QY, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.7; Zhang Y, 2008, BIOSCIENCE REP, V28, P7, DOI 10.1042/BSR20070028; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894; Zhang YL, 2006, PLANT J, V48, P647, DOI 10.1111/j.1365-313X.2006.02903.x; Zhang YH, 2007, J PLANT PHYSIOL, V164, P68, DOI 10.1016/j.jplph.2006.02.002	76	14	16	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205790	10.1371/journal.pone.0205790	http://dx.doi.org/10.1371/journal.pone.0205790			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312354	gold, Green Submitted, Green Published			2022-12-26	WOS:000447427300057
J	Wiersema, JR; Godefroid, E				Wiersema, Jan R.; Godefroid, Elke			Interoceptive awareness in attention deficit hyperactivity disorder	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; STATE-REGULATION; DECISION-MAKING; NEURAL ACTIVITY; ADULT ADHD; EVENT RATE; STRESS; SENSITIVITY; PERFORMANCE; DEPRESSION	ADHD is considered a disorder of self-regulation. Recent research has shown that awareness of bodily states, referred to as interoceptive awareness, crucially contributes to self-regulatory processes. Impaired self-regulation in ADHD has been explained in terms of arousal regulation deficits in ADHD (the state regulation deficit (SRD) account). There is now ample support for the SRD account, however the exact reason for arousal regulation difficulties is not yet known. The SRD account explicitly refers to the ability to monitor one's momentary bodily state as a prerequisite for effective state regulation. However, surprisingly, no study to date has tested the ability to become aware of bodily signals, i.e. interoceptive awareness, in ADHD. In the current study, we therefore compared interoceptive awareness between 24 adults with ADHD and 23 controls by means of both an objective (heartbeat perception task) and subjective measure (questionnaire) of interoceptive awareness. Results revealed a strikingly similar performance for both groups on both measures, suggesting preserved interoceptive awareness in adult ADHD.	[Wiersema, Jan R.; Godefroid, Elke] Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Clin & Hlth Psychol, Ghent, Belgium	Ghent University	Wiersema, JR (corresponding author), Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Clin & Hlth Psychol, Ghent, Belgium.	Roeljan.Wiersema@Ugent.be			Ghent University (Bijzonder Onderzoeksfonds) [B/11684/02]	Ghent University (Bijzonder Onderzoeksfonds)	This work was supported by Ghent University (Bijzonder Onderzoeksfonds, grant number B/11684/02) granted to J.R.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2003, MANUAL ASEBA ADULT F; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.1016/j.biopsych.2004.11.011, DOI 10.1016/J.BIOPSYCH.2004.11.011]; Baeyens D, 2012, ZVAH ZELFRAPPORTAGE; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Balogh L., 2014, J ATTEN DISORD; Borger N, 2000, BIOL PSYCHOL, V51, P247, DOI 10.1016/S0301-0511(99)00040-X; Cabrera A, 2018, INT J METH PSYCH RES, V27, DOI 10.1002/mpr.1596; Combs MA, 2012, J ATTEN DISORD; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Douglas VI, 1980, TREATMENT HYPERACTIV, P65; Furman DJ, 2013, J AFFECT DISORDERS, V151, P780, DOI 10.1016/j.jad.2013.06.044; Ganos C, 2015, MOVEMENT DISORD, V30, P1198, DOI 10.1002/mds.26228; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Garfinkel SN, 2013, PSYCHOPHYSIOLOGY, V50, P505, DOI 10.1111/psyp.12039; Godefroid E, 2016, BIOL PSYCHOL, V114, P49, DOI 10.1016/j.biopsycho.2015.12.005; Harshaw C, 2015, PSYCHOL BULL, V141, P311, DOI 10.1037/a0038101; Herbert BM, 2007, INT J PSYCHOPHYSIOL, V65, P214, DOI 10.1016/j.ijpsycho.2007.04.007; Herbert BM, 2011, J PERS, V79, P1149, DOI 10.1111/j.1467-6494.2011.00717.x; Herrmann MJ, 2009, SOC COGN AFFECT NEUR, V4, P340, DOI 10.1093/scan/nsp033; Hirvikoski T, 2009, HORM BEHAV, V55, P418, DOI 10.1016/j.yhbeh.2008.12.004; JONES GE, 1988, PSYCHOPHYSIOLOGY, V25, P547, DOI 10.1111/j.1469-8986.1988.tb01890.x; Khalsa SS, 2009, NAT NEUROSCI, V12, P1494, DOI 10.1038/nn.2411; Kooij JJS, 2005, PSYCHOL MED, V35, P817, DOI 10.1017/S003329170400337X; Kooij SJJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-67; Lackschewitz H, 2008, PSYCHONEUROENDOCRINO, V33, P612, DOI 10.1016/j.psyneuen.2008.01.016; Limmer J, 2015, J AFFECT DISORDERS, V185, P170, DOI 10.1016/j.jad.2015.07.010; Lopez-Larson MP, 2012, PSYCHIAT RES-NEUROIM, V204, P32, DOI 10.1016/j.pscychresns.2012.09.009; Luman M, 2010, NEUROSCI BIOBEHAV R, V34, P744, DOI 10.1016/j.neubiorev.2009.11.021; Matte B, 2015, PSYCHOL MED, V45, P361, DOI 10.1017/S0033291714001470; Metin B, 2015, J ABNORM PSYCHOL, V124, P208, DOI 10.1037/abn0000013; Metin B, 2012, BIOL PSYCHIAT, V72, P990, DOI 10.1016/j.biopsych.2012.08.023; Nigg JT, 2017, J CHILD PSYCHOL PSYC, V58, P361, DOI 10.1111/jcpp.12675; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1424, DOI 10.1016/j.biopsych.2004.11.011; O'Connell RG, 2009, NEUROPSYCHOLOGIA, V47, P1149, DOI 10.1016/j.neuropsychologia.2009.01.011; Paulus MP, 2010, BRAIN STRUCT FUNCT, P1; Pollatos O, 2007, J ANXIETY DISORD, V21, P931, DOI 10.1016/j.janxdis.2006.12.004; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V63, P117, DOI 10.1016/j.ijpsycho.2006.09.003; Porges, 1993, BODY PERCEPTION QUES; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; SANDERS AF, 1983, ACTA PSYCHOL, V53, P61, DOI 10.1016/0001-6918(83)90016-1; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Schauder KB, 2015, J EXP CHILD PSYCHOL, V131, P193, DOI 10.1016/j.jecp.2014.11.002; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Shaw P, 2014, AM J PSYCHIAT, V171, P276, DOI 10.1176/appi.ajp.2013.13070966; Sidlauskaite J, 2015, EUR ARCH PSYCHIAT CL; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Sonuga-Barke EJS, 2010, NEUROPSYCHOL REV, V20, P86, DOI 10.1007/s11065-009-9115-0; Sueyoshi T, 2014, INT J PSYCHOPHYSIOL, V94, P278, DOI 10.1016/j.ijpsycho.2014.10.001; Terasawa Y, 2013, HUM BRAIN MAPP, V34, P598, DOI 10.1002/hbm.21458; Ullsperger M., 2010, BRAIN STRUCTURE FUNC, P1; Van Cauwenberge V, 2015, RES DEV DISABIL, V47, P199, DOI 10.1016/j.ridd.2015.09.012; van der Meere J, 2005, STATE REGULATION ATT, P162; Wechsler D, 1997, WAIS 3 WACHSLER ADUL; Wender PH, 1993, SCALE AID RETROSPECT, P885; Werner NS, 2013, BIOL PSYCHOL, V94, P498, DOI 10.1016/j.biopsycho.2013.09.002; Wiebking C, 2010, WORLD J BIOL PSYCHIA, V11, P538, DOI 10.3109/15622970903563794; Wiersema JR, 2009, J NEURAL TRANSM, V116, P371, DOI 10.1007/s00702-008-0165-x; Wiersema R, 2006, J CLIN EXP NEUROPSYC, V28, P1113, DOI 10.1080/13803390500212896; Wiersema R, 2006, J CHILD PSYCHOL PSYC, V47, P560, DOI 10.1111/j.1469-7610.2005.01592.x; ZENTALL S, 1975, AM J ORTHOPSYCHIAT, V45, P549, DOI 10.1111/j.1939-0025.1975.tb01185.x	61	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205221	10.1371/journal.pone.0205221	http://dx.doi.org/10.1371/journal.pone.0205221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0UN	30312308	gold, Green Published, Green Submitted			2022-12-26	WOS:000447427300023
J	Bakhshinyan, D; Venugopal, C; Adile, AA; Garg, N; Manoranjan, B; Hallett, R; Wang, X; Mahendram, S; Vora, P; Vijayakumar, T; Subapanditha, M; Singh, M; Kameda-Smith, MM; Qazi, M; McFarlane, N; Mann, A; Ajani, OA; Yarascavitch, B; Ramaswamy, V; Farooq, H; Morrissy, S; Cao, LX; Sydorenko, N; Baiazitov, R; Du, W; Sheedy, J; Weetall, M; Moon, YC; Lee, CS; Kwiecien, JM; Delaney, KH; Doble, B; Cho, YJ; Mitra, S; Kaplan, D; Taylor, MD; Davis, TW; Singh, SK				Bakhshinyan, David; Venugopal, Chitra; Adile, Ashley A.; Garg, Neha; Manoranjan, Branavan; Hallett, Robin; Wang, Xin; Mahendram, Sujeivan; Vora, Parvez; Vijayakumar, Thusyanth; Subapanditha, Minomi; Singh, Mohini; Kameda-Smith, Michelle Masayo; Qazi, Maleeha; McFarlane, Nicole; Mann, Aneet; Ajani, Olufemi A.; Yarascavitch, Blake; Ramaswamy, Vijay; Farooq, Hamza; Morrissy, Sorana; Cao, Liangxian; Sydorenko, Nadiya; Baiazitov, Ramil; Du, Wu; Sheedy, Josephine; Weetall, Marla; Moon, Young-Choon; Lee, Chang-Sun; Kwiecien, Jacek M.; Delaney, Kathleen H.; Doble, Brad; Cho, Yoon-Jae; Mitra, Siddhartha; Kaplan, David; Taylor, Michael D.; Davis, Thomas W.; Singh, Sheila K.			BMI1 is a therapeutic target in recurrent medulloblastoma	ONCOGENE			English	Article							NEURAL STEM-CELLS; CHILDHOOD MEDULLOBLASTOMA; MOLECULAR SUBGROUPS; MALIGNANT GLIOMA; CANCER; CLASSIFICATION; PREDICTION; REGULATORS; MODEL	Medulloblastoma (MB) is the most frequent malignant pediatric brain tumor, representing 20% of newly diagnosed childhood central nervous system malignancies. Although advances in multimodal therapy yielded a 5-year survivorship of 80%, MB still accounts for the leading cause of childhood cancer mortality. In this work, we describe the epigenetic regulator BMI1 as a novel therapeutic target for the treatment of recurrent human Group 3 MB, a childhood brain tumor for which there is virtually no treatment option beyond palliation. Current clinical trials for recurrent MB patients based on genomic profiles of primary, treatment-naive tumors will provide limited clinical benefit since recurrent metastatic MBs are highly genetically divergent from their primary tumor. Using a small molecule inhibitor against BMI1, PTC-028, we were able to demonstrate complete ablation of self-renewal of MB stem cells in vitro. When administered to mice xenografted with patient tumors, we observed significant reduction in tumor burden in both local and metastatic compartments and subsequent increased survival, without neurotoxicity. Strikingly, serial in vivo re-transplantation assays demonstrated a marked reduction in tumor initiation ability of recurrent MB cells upon re-transplantation of PTC-028-treated cells into secondary recipient mouse brains. As Group 3 MB is often metastatic and uniformly fatal at recurrence, with no current or planned trials of targeted therapy, an efficacious targeted agent would be rapidly transitioned to clinical trials.	[Bakhshinyan, David; Venugopal, Chitra; Adile, Ashley A.; Garg, Neha; Manoranjan, Branavan; Mahendram, Sujeivan; Vora, Parvez; Vijayakumar, Thusyanth; Subapanditha, Minomi; Singh, Mohini; Kameda-Smith, Michelle Masayo; Qazi, Maleeha; McFarlane, Nicole; Mann, Aneet; Doble, Brad; Singh, Sheila K.] McMaster Univ, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8S 4L8, Canada; [Bakhshinyan, David; Adile, Ashley A.; Manoranjan, Branavan; Vijayakumar, Thusyanth; Singh, Mohini; Kameda-Smith, Michelle Masayo; Qazi, Maleeha; Doble, Brad; Singh, Sheila K.] McMaster Univ, Dept Biochem, Hamilton, ON L8S 4L8, Canada; [Bakhshinyan, David; Adile, Ashley A.; Manoranjan, Branavan; Vijayakumar, Thusyanth; Singh, Mohini; Kameda-Smith, Michelle Masayo; Qazi, Maleeha; Doble, Brad; Singh, Sheila K.] McMaster Univ, Dept Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Venugopal, Chitra; Garg, Neha; Mahendram, Sujeivan; Vora, Parvez; Subapanditha, Minomi; Kameda-Smith, Michelle Masayo; McFarlane, Nicole; Ajani, Olufemi A.; Yarascavitch, Blake; Singh, Sheila K.] McMaster Univ, Surg, Fac Hlth Sci, Hamilton, ON L8S 4L8, Canada; [Manoranjan, Branavan; Singh, Sheila K.] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON L8S 4L8, Canada; [Hallett, Robin] Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5S 1A1, Canada; [Wang, Xin; Ramaswamy, Vijay; Farooq, Hamza] Univ Toronto, Hosp Sick Children, Dev Stem Cell Biol Program, Toronto, ON M5S 1A1, Canada; [Wang, Xin; Farooq, Hamza; Taylor, Michael D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Ramaswamy, Vijay; Morrissy, Sorana] Hosp Sick Children, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada; [Cao, Liangxian; Sydorenko, Nadiya; Baiazitov, Ramil; Du, Wu; Sheedy, Josephine; Weetall, Marla; Moon, Young-Choon; Lee, Chang-Sun; Davis, Thomas W.] PTC Therapeut, 100 Corp Court, South Plainfield, NJ 07080 USA; [Kwiecien, Jacek M.; Delaney, Kathleen H.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada; [Kwiecien, Jacek M.] Med Univ Lublin, Dept Clin Pathomorphol, Lublin, Poland; [Cho, Yoon-Jae; Mitra, Siddhartha] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Cho, Yoon-Jae; Mitra, Siddhartha] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Kaplan, David] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X8, Canada; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; Medical University of Lublin; Stanford University; Stanford University; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Singh, SK (corresponding author), McMaster Univ, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8S 4L8, Canada.; Singh, SK (corresponding author), McMaster Univ, Dept Biochem, Hamilton, ON L8S 4L8, Canada.; Singh, SK (corresponding author), McMaster Univ, Dept Biomed Sci, Hamilton, ON L8S 4L8, Canada.; Singh, SK (corresponding author), McMaster Univ, Surg, Fac Hlth Sci, Hamilton, ON L8S 4L8, Canada.; Singh, SK (corresponding author), McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON L8S 4L8, Canada.	ssingh@mcmaster.ca	Doble, Bradley/V-7848-2019; Garg, Neha/AAG-5180-2020; Yarascavitch, Blake/AAR-8800-2021; Singh, Sheila K/W-2799-2018; Wang, Xin/O-8779-2019	Doble, Bradley/0000-0002-0260-2983; Garg, Neha/0000-0003-2227-8292; Yarascavitch, Blake/0000-0003-1810-1267; Singh, Sheila K/0000-0003-1272-5300; Wang, Xin/0000-0001-6292-3087; Ramaswamy, Vijay/0000-0002-6557-895X; Morrissy, Sorana/0000-0001-8526-562X; Adile, Ashley/0000-0002-3700-7527; Taylor, Michael/0000-0001-7009-3466	Canada Research Chair award; Canadian Institutes of Health Research (CIHR); Stem Cell Network; Ontario Institute for Cancer Research Cancer Stem Cell Program; Canadian Cancer Society Research Institute; Cancer Research Society; Brain Tumor Foundation of Canada	Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Stem Cell Network; Ontario Institute for Cancer Research Cancer Stem Cell Program; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Research Society; Brain Tumor Foundation of Canada	SKS is supported by Canada Research Chair award, and operating grants from Canadian Institutes of Health Research (CIHR), Stem Cell Network, the Ontario Institute for Cancer Research Cancer Stem Cell Program, the Canadian Cancer Society Research Institute, the Cancer Research Society, the Brain Tumor Foundation of Canada, and generous donations from the Box Run Foundation, Team Kelsey, and patients and their families.	ALKEMA MJ, 1993, HUM MOL GENET, V2, P1597, DOI 10.1093/hmg/2.10.1597; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Cavalli FMG, 2017, CANCER CELL, V31, P737, DOI 10.1016/j.ccell.2017.05.005; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cho JH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-117; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Ellison DW, 2010, ACTA NEUROPATHOL, V120, P305, DOI 10.1007/s00401-010-0726-6; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Hallett RM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-16; Hallett RM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00227; HE XM, 1991, LAB INVEST, V64, P833; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy V, 2013, LANCET ONCOL, V14, P1200, DOI 10.1016/S1470-2045(13)70449-2; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schwalbe EC, 2017, LANCET ONCOL, V18, P958, DOI 10.1016/S1470-2045(17)30243-7; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Venugopal C, 2015, CLIN CANCER RES, V21, P5324, DOI 10.1158/1078-0432.CCR-14-3147; Venugopal C, 2012, J NEURO-ONCOL, V109, P457, DOI 10.1007/s11060-012-0917-1; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang X, 2012, ONCOGENE, V31, P187, DOI 10.1038/onc.2011.232; Wang X, 2015, ACTA NEUROPATHOL, V129, P449, DOI 10.1007/s00401-015-1389-0; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Yong KJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6066	40	17	18	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2019	38	10					1702	1716		10.1038/s41388-018-0549-9	http://dx.doi.org/10.1038/s41388-018-0549-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN8DD	30348991				2022-12-26	WOS:000460423800010
J	Rani, R; Kumar, S; Sharma, A; Mohanty, SK; Donnelly, B; Tiao, GM; Gandhi, CR				Rani, Richa; Kumar, Sudhir; Sharma, Akanksha; Mohanty, Sujit K.; Donnelly, Bryan; Tiao, Gregory M.; Gandhi, Chandrashekhar R.			Mechanisms of concanavalin A-induced cytokine synthesis by hepatic stellate cells: Distinct roles of interferon regulatory factor-1 in liver injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KUPFFER CELLS; MEDIATED HEPATITIS; DNA-SYNTHESIS; T-CELLS; ENDOTOXIN; FIBROSIS; HEPATOCYTES; INDUCTION; INFLAMMATION; PATHWAY	Mice depleted of hepatic stellate cells (HSCs) are protected from concanavalin A (ConA)-induced liver injury that is mediated by the activation of interferon regulatory factor 1 (IRF1). The aim of this study was to determine the mechanisms of ConA-mediated signaling and synthesis/release of mediators by HSCs that damage hepatocytes. Primary cultures of wildtype (WT) and IRF1-knockout (KO) HSCs and hepatocytes were used, and ConA-induced liver damage in interferon (IFN) alpha beta receptor-deficient (IFN alpha beta R-KO) mice was determined. Specific binding of ConA to HSCs induced rapid activation of JAK2 and STAT1. ConA-induced expression of IRF1, IFN beta, tumor necrosis factor alpha, and CXCL1 was abrogated by selective inhibition of JAK2 and STAT1. Despite activating JAK2/STAT1, ConA failed to stimulate expression of inflammatory cytokines in HSCs from IRF1-KO mice. ConA-conditioned WT-HSC medium caused activation of JNK and caspase 3, and apoptosis of hepatocytes from WT but not from IRF1-KO or IFN alpha beta R-KO mice. Conversely, ConA-conditioned medium of IRF1-KO HSCs failed to cause apoptosis of WT or IRF1-KO hepatocytes. IFN alpha beta R-KO mice were protected from ConA-induced liver damage, and ConA-induced hepatic expression of IRF1 and pro-inflammatory cytokines and chemokines, and infiltration of neutrophils were significantly lower in IFN alpha beta R-KO than in WT mice. These results demonstrate distinct roles of IRF1 in hepatic inflammation (HSCs) and injury (hepatocytes) and can be an important target for intervention in acute liver injury.	[Rani, Richa; Kumar, Sudhir; Sharma, Akanksha; Mohanty, Sujit K.; Donnelly, Bryan; Tiao, Gregory M.; Gandhi, Chandrashekhar R.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Rani, Richa; Kumar, Sudhir; Gandhi, Chandrashekhar R.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH 45220 USA; [Gandhi, Chandrashekhar R.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45220 USA	Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati	Gandhi, CR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, 3333 Burnett Ave, Cincinnati, OH 45229 USA.	chandrashekhar.gandhi@cchmc.org	Sharma, Akanksha/ABI-4027-2020; Kumar, Sudhir/J-3844-2019	Sharma, Akanksha/0000-0001-6321-0564; Mohanty, Sujit/0000-0001-9559-4638	U.S. Department of Veterans Affairs (VA) Merit Review Award [1IO1BX001174]; U.S. Department of Defense (DOD) [W81XWH-14-PRMRP-IIRA]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001174] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs (VA) Merit Review Award(US Department of Veterans Affairs); U.S. Department of Defense (DOD)(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by U.S. Department of Veterans Affairs (VA) Merit Review Award 1IO1BX001174 (to C. R. G.) and U.S. Department of Defense (DOD) Grant W81XWH-14-PRMRP-IIRA. The authors declare that they have no conflicts of interest with the contents of this article.	Afonso V, 2006, FREE RADICAL BIO MED, V41, P709, DOI 10.1016/j.freeradbiomed.2006.05.014; [Anonymous], 2011, NAT RES COUNC GUID C, V8th; Bhattacharya A, 2015, IMMUNITY, V43, P974, DOI 10.1016/j.immuni.2015.10.013; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chen L, 2011, HEPATOB PANCREAT DIS, V10, P171, DOI 10.1016/S1499-3872(11)60027-1; Dangi A, 2016, J CELL PHYSIOL, V231, P94, DOI 10.1002/jcp.25055; Dangi A, 2012, J IMMUNOL, V188, P3667, DOI 10.4049/jimmunol.1102460; Deng SY, 2017, INT J MOL MED, V40, P1261, DOI 10.3892/ijmm.2017.3110; Dhupar R, 2011, SHOCK, V35, P293, DOI 10.1097/SHK.0b013e3181f6aab0; Ferayorni L. S, 1983, ISOLATION CHARACTERI, P271; Friedman SL, 2015, DIGEST DIS, V33, P504, DOI 10.1159/000374098; Gandhi CR, 2015, STELLATE CELLS IN HEALTH AND DISEASE, P209, DOI 10.1016/B978-0-12-800134-9.00013-0; Gandhi CR, 2015, STELLATE CELLS IN HEALTH AND DISEASE, P227, DOI 10.1016/B978-0-12-800134-9.00014-2; Goritzka M, 2014, J VIROL, V88, P6128, DOI 10.1128/JVI.00333-14; Harvey SAK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082159; Heymann F, 2015, LAB ANIM-UK, V49, P12, DOI 10.1177/0023677215572841; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Jaruga B, 2004, AM J PHYSIOL-GASTR L, V287, pG1044, DOI 10.1152/ajpgi.00184.2004; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Knolle PA, 1996, HEPATOLOGY, V24, P824, DOI 10.1002/hep.510240413; Kumar S, 2017, AM J PATHOL, V187, P1356, DOI 10.1016/j.ajpath.2017.01.021; Kumar S, 2017, J LEUKOCYTE BIOL, V101, P429, DOI 10.1189/jlb.2A0516-239R; Kumar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147864; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Leist M, 1996, J HEPATOL, V25, P948, DOI 10.1016/S0168-8278(96)80301-1; Mizuhara H, 1998, HEPATOLOGY, V27, P513, DOI 10.1002/hep.510270227; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Morita A, 2003, HEPATOL RES, V27, P143, DOI 10.1016/S1386-6346(03)00206-7; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Rani R, 2017, AM J PATHOL, V187, P2008, DOI 10.1016/j.ajpath.2017.05.015; Riera H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127571; ROTH RA, 1983, BIOCHEM BIOPH RES CO, V115, P245, DOI 10.1016/0006-291X(83)90996-8; Scharf JG, 1998, HEPATOLOGY, V27, P1275, DOI 10.1002/hep.510270513; Schumann J, 2000, AM J PATHOL, V157, P1671, DOI 10.1016/S0002-9440(10)64804-3; Schuppan D, 2015, CLIN RES HEPATOL GAS, V39, pS51, DOI 10.1016/j.clinre.2015.05.005; Siebler J, 2003, HEPATOLOGY, V38, P1573, DOI 10.1016/j.hep.2003.09.020; Stewart RK, 2014, J HEPATOL, V60, P298, DOI 10.1016/j.jhep.2013.09.013; Sumpter TL, 2012, J IMMUNOL, V189, P3848, DOI 10.4049/jimmunol.1200819; Thirunavukkarasu C, 2005, J CELL PHYSIOL, V204, P654, DOI 10.1002/jcp.20366; Thirunavukkarasu C, 2006, HEPATOLOGY, V44, P389, DOI 10.1002/hep.21254; Tiegs G, 2007, Z GASTROENTEROL, V45, P63, DOI 10.1055/s-2006-927397; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Tsung A, 2006, AM J PHYSIOL-GASTR L, V290, pG1261, DOI 10.1152/ajpgi.00460.2005; Uemura T, 2001, BRIT J PHARMACOL, V133, P1125, DOI 10.1038/sj.bjp.0704151; Vandenbon A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S10-S4; Vila-del Sol V, 2008, J IMMUNOL, V181, P4461, DOI 10.4049/jimmunol.181.7.4461; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011	48	16	16	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18466	18476		10.1074/jbc.RA118.005583	http://dx.doi.org/10.1074/jbc.RA118.005583			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30348900	hybrid, Green Published			2022-12-26	WOS:000458467300005
J	Araya, D; Paraje, G				Araya, Daniel; Paraje, Guillermo			The impact of prices on alcoholic beverage consumption in Chile	PLOS ONE			English	Article							DEMAND; INTERVENTIONS; METAANALYSIS; ADOLESCENTS	Introduction and objective Chile is among the countries with the highest alcohol consumption per capita in Latin America, but little has been done in the way of public policy and policy research to overcome this problem. The objective of the present study is to estimate demand elasticities (own-price, cross-price, expenditure and quality) for three groups of alcoholic beverages in Chile: spirits, wines, and beers. Data and methods The study uses data from the VII Encuesta de Presupuestos Familiares (Family Budget Survey) 2011-2012 conducted by the National Institute of Statistics. Because of problems with the quality of the measurement units, hot-deck imputation method was used with the alcohol purchases that presented problems. To estimate the demand elasticities, the Almost Ideal Demand System (AIDS) method proposed by Deaton was used. Quality decisions were estimated for each beverage separately using an equation proposed by Deaton in the three-step AIDS. Results The estimated elasticities were more inelastic for spirits (-0.14, P<0.01), followed by wines (-0.77, P<0.01) and beers (-0.93, P<0.01). Spirits reported less sensitivity to changes in the total budget, while wines reported the most sensitivity to changes in the total budget (expenditure elasticity). Wines also reported the most sensitivity related to quality for changes in the total budget (0,20, meaning that a 10% increase in a household's total expenditure increases the "quality" of purchased wines by 2%). Conclusions Own-price elasticities reported for spirits, wines and beers are consistently negative, and inelastic, in line with international evidence. Although own-price elasticities for spirits is more inelastic than found in most studies, its quality-elasticity is more positive and greater. This could be explained by the greater price dispersion of spirits, as well as spirits (and wine) being consumed more than beers in Chile. This in turn may be because consumers have the option of switching to cheaper, Chilean-produced spirits such as pisco and wines when prices rise. The existence of these relatively broad quality-elasticities points to the need for a change in the alcohol tax structure from the current ad-valorem tax to a specific tax that could reduce price dispersion and curb total consumption.	[Araya, Daniel] Univ Adolfo Ibanez, Santiago, Chile; [Paraje, Guillermo] Univ Adolfo Ibanez, Business Sch, Santiago, Chile	Universidad Adolfo Ibanez; Universidad Adolfo Ibanez	Araya, D (corresponding author), Univ Adolfo Ibanez, Santiago, Chile.	dan.araya.rios@gmail.com		Araya, Daniel/0000-0002-3459-1422; Paraje, Guillermo/0000-0002-7863-907X	International Development Research Centre [107206-001]	International Development Research Centre	International Development Research Centre Grant No. 107206-001, received by GP, helped to support this work.	Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Andridge RR, 2010, INT STAT REV, V78, P40, DOI 10.1111/j.1751-5823.2010.00103.x; Brown SA, 2000, ALCOHOL CLIN EXP RES, V24, P164, DOI 10.1111/j.1530-0277.2000.tb04586.x; Chaloupka FJ, 2002, ALCOHOL RES HEALTH, V26, P22; DEATON A, 1980, AM ECON REV, V70, P312; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; DEATON A, 1990, J ECONOMETRICS, V44, P281, DOI 10.1016/0304-4076(90)90060-7; Elder RW, 2010, AM J PREV MED, V38, P217, DOI 10.1016/j.amepre.2009.11.005; Euromonitor International, 2018, PASSP DAT 2018; Fogarty J, 2006, BRIT FOOD J, V108, P316, DOI 10.1108/00070700610657155; Food and Agricultural Organization of the United Nations, FAOSTAT DAT; Gallet CA, 2007, AUST J AGR RESOUR EC, V51, P121, DOI 10.1111/j.1467-8489.2007.00365.x; Golden SD, 2016, TOB CONTROL, V25, P377, DOI 10.1136/tobaccocontrol-2015-052294; Grossman M, 1993, W4385 NAT BUR EC RES; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MANNING WG, 1995, J HEALTH ECON, V14, P123, DOI 10.1016/0167-6296(94)00042-3; Margozzini P, 2015, CONSUMO RIESGOSO ALC; Martineau F, 2013, PREV MED, V57, P278, DOI 10.1016/j.ypmed.2013.06.019; Observatorio Chileno de Drogas Senda, 2017, 11 2 EST NAC DROG PO; Poi B P., 2012, EASY DEMAND SYSTEM E; RAY R, 1983, J PUBLIC ECON, V22, P89, DOI 10.1016/0047-2727(83)90058-0; Reardon DC, 2004, AM J DRUG ALCOHOL AB, V30, P369, DOI 10.1081/ADA-120037383; Rubin, 2002, STAT ANAL MISSING DA, P59, DOI DOI 10.1002/9781119013563.CH4; Sornpaisarn B, 2013, INT J ALCOHOL DRUG R, V2, DOI [10.7895/ijadr.v2i1.71, DOI 10.7895/IJADR.V2I1.71]; Stueve A, 2005, AM J PUBLIC HEALTH, V95, P887, DOI 10.2105/AJPH.2003.026567; Troncoso-Valverde Cristián, 2004, Rev. Econ. Sociol. Rural, V42, P487, DOI 10.1590/S0103-20032004000300005; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2011, ESTR MUND RED US NOC; Zeigler DW, 2005, PREV MED, V40, P23, DOI 10.1016/j.ypmed.2004.04.044	30	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205932	10.1371/journal.pone.0205932	http://dx.doi.org/10.1371/journal.pone.0205932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX7HS	30346989	Green Submitted, Green Published, gold			2022-12-26	WOS:000447938400026
J	Kuehn, R; Stoeckle, BC; Young, M; Popp, L; Taeubert, JE; Pfaffl, MW; Geist, J				Kuehn, Ralph; Stoeckle, Bernhard C.; Young, Marc; Popp, Lisa; Taeubert, Jens-Eike; Pfaffl, Michael W.; Geist, Juergen			Identification of a piscine reovirus-related pathogen in proliferative darkening syndrome (PDS) infected brown trout (Salmo trutta fario) using a next-generation technology detection pipeline	PLOS ONE			English	Article							ORTHOREOVIRUS PRV; ATLANTIC SALMON; DNA MICROARRAYS; DISCOVERY; VIRUSES; GENES; PCR; QUANTIFICATION; NORMALIZATION; METAGENOMICS	The proliferative darkening syndrome (PDS) is an annually recurring disease that causes species-specific die-off of brown trout (Salmo trutta fario) with a mortality rate of near 100% in pre-alpine rivers of central Europe. So far the etiology and causation of this disease is still unclear. The objective of this study was to identify the cause of PDS using a next-generation technology detection pipeline. Following the hypothesis that PDS is caused by an infectious agent, brown trout specimens were exposed to water from a heavily affected pre-alpine river with annual occurrence of the disease. Specimens were sampled over the entire time period from potential infection through death. Transcriptomic analysis (microarray) and RT-qPCR of brown trout liver tissue evidenced strong gene expression response of immune-associated genes. Messenger RNA of specimens with synchronous immune expression profiles were ultra-deep sequenced using next-generation sequencing technology (NGS). Bioinformatic processing of generated reads and gap-filling Sanger re-sequencing of the identified pathogen genome revealed strong evidence that a piscine-related reovirus is the causative organism of PDS. The identified pathogen is phylogenetically closely related to the family of piscine reoviruses (PRV) which are considered as the causation of different fish diseases in Atlantic and Pacific salmonid species such as Salmo salar and Onchorhynchus kisutch. This study also highlights that the approach of first screening immune responses along a timeline in order to identify synchronously affected stages in different specimens which subsequently were ultra-deep sequenced is an effective approach in pathogen detection. In particular, the identification of specimens with synchronous molecular immune response patterns combined with NGS sequencing and gap-filling re-sequencing resulted in the successful pathogen detection of PDS.	[Kuehn, Ralph; Stoeckle, Bernhard C.; Young, Marc; Popp, Lisa] Tech Univ Munich, Dept Zool, Unit Mol Zool, Freising Weihenstephan, Germany; [Kuehn, Ralph] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Stoeckle, Bernhard C.; Geist, Juergen] Tech Univ Munich, Dept Ecol & Ecosyst Management, Aquat Syst Biol Unit, Freising Weihenstephan, Germany; [Taeubert, Jens-Eike] Bezirk Niederbayern, Fachberatung Fischerei Niederbayern, Landshut, Germany; [Pfaffl, Michael W.] Tech Univ Munich, Dept Anim Physiol & Immunol, Freising Weihenstephan, Germany	Technical University of Munich; New Mexico State University; Technical University of Munich; Technical University of Munich	Kuehn, R (corresponding author), Tech Univ Munich, Dept Zool, Unit Mol Zool, Freising Weihenstephan, Germany.; Kuehn, R (corresponding author), New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA.	kuehn@wzw.tum.de	Geist, Juergen/C-4933-2008; Pfaffl, Michael/G-6622-2013	Geist, Juergen/0000-0001-7698-3443; Pfaffl, Michael/0000-0002-3192-1019; Kuehn, Ralph/0000-0001-9518-0590	Bayerisches Landesamt fur Umwelt [AZ: Z4-0734-24903/2008]; Bayerisches Staatsministerium fur Ernahrung, Landwirtschaft und Forsten (StMELF) [A/14/37, A/16/23]	Bayerisches Landesamt fur Umwelt; Bayerisches Staatsministerium fur Ernahrung, Landwirtschaft und Forsten (StMELF)	The first grant was provided by the "Bayerisches Landesamt fur Umwelt", https://www.lfu.bayern.de/index.htm; Grant number: AZ: Z4-0734-24903/2008. The second and third grants were provided by the "Bayerisches Staatsministerium fur Ernahrung, Landwirtschaft und Forsten (StMELF)", http://www.stmelf.bayern.de/, Grant numbers: A/14/37 AND A/16/23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2014, R LANG ENV STAT COMP; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Born O., 2003, SCHRIFTENREIHE LANDE, P15; Busse HJ, 2005, 11 INT C BACT APPL M, P23; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carissimo G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168397; Carissimo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153881; Cartagena J, 2018, AQUACULTURE, V493, P79, DOI 10.1016/j.aquaculture.2018.04.044; Di Cicco E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171471; DOANE FW, 1987, ULTRASTRUCT PATHOL, V11, P681, DOI 10.3109/01913128709048454; FAO, 2016, CONTRIBUTING FOOD SE; Garseth AH, 2013, J FISH DIS, V36, P483, DOI 10.1111/j.1365-2761.2012.01450.x; Godoy MG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0554-y; Gorgoglione B, 2016, DIS AQUAT ORGAN, V119, P117, DOI 10.3354/dao02993; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Haatveit HM, 2016, VET RES, V47, DOI 10.1186/s13567-015-0302-0; Hjeltnes B., 2016, FISH HLTH REPORT 201; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; Kondo H, 2014, FISH SHELLFISH IMMUN, V41, P437, DOI 10.1016/j.fsi.2014.09.038; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Kooperberg C, 2002, J COMPUT BIOL, V9, P55, DOI 10.1089/10665270252833190; Krasnov A, 2011, MOL IMMUNOL, V49, P163, DOI 10.1016/j.molimm.2011.08.007; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lahnsteiner F, 2011, J APPL ICHTHYOL, V27, P83, DOI 10.1111/j.1439-0426.2010.01621.x; LANDRY ML, 2000, CLIN VIROLOGY MANUAL, P27; Liu HP, 2011, DEV COMP IMMUNOL, V35, P716, DOI 10.1016/j.dci.2011.02.015; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Markussen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070075; Marty GD, 2015, J FISH DIS, V38, P713, DOI 10.1111/jfd.12285; Munang'andu HM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00406; Olsen AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131638; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purcell MK, 2018, J FISH DIS, V41, P347, DOI 10.1111/jfd.12740; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roingeard P, 2008, BIOL CELL, V100, P491, DOI 10.1042/BC20070173; Rose TM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-20; Schlaberg R, 2017, ARCH PATHOL LAB MED, V141, P776, DOI 10.5858/arpa.2016-0539-RA; Schwaiger J, 2006, BACHFORELLENSTERBEN; Schwaiger J, 2003, SCHRIFTENREIHE LANDE, P31; Siah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141475; SIMON R, 2003, DESIGN ANAL DNA MICR; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165424; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; Tengs T, 2017, DEV COMP IMMUNOL, V75, P109, DOI 10.1016/j.dci.2017.01.025; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wessel O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183781; Yanez JM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00415; Zhu LY, 2013, DEV COMP IMMUNOL, V39, P39, DOI 10.1016/j.dci.2012.04.001	58	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0206164	10.1371/journal.pone.0206164	http://dx.doi.org/10.1371/journal.pone.0206164			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346982	gold, Green Published, Green Submitted			2022-12-26	WOS:000447938400041
J	Kwon, SJ; Choi, GS; Choi, B; Seo, JK				Kwon, Sun-Jung; Choi, Gug-Seoun; Choi, Boram; Seo, Jang-Kyun			Molecular characterization of an unusual new plant RNA virus reveals an evolutionary link between two different virus families	PLOS ONE			English	Article							MOVEMENT PROTEINS; GENE; SUPPRESSION; TAXONOMY; GENOME; DISCOVERY; SEQUENCES; STRATEGY; DNA	An unusual novel plant virus provisionally named goji berry chlorosis virus (GBCV) was isolated from goji berry plants (Lycium chinense Miller) showing chlorosis symptoms and its complete genome sequence was determined. The viral genome consists of a positivesense single-stranded RNA of 10,100 ribonucleotides and contains six open reading frames (ORFs). Electron microscopy showed that the viral genome is packaged as a filamentous particle with an average length of approximately 850 nm. Phylogenetic analysis and amino acid similarity analysis of the encoded ORFs revealed that this new virus could be classified in an intermediate position between the families Benyviridae and Virgaviridae. The GBCV 200-kDa replicase (ORF1) is more similar to benyvirus replicases than to virgavirus replicases, while its 17-kDa coat protein (CP, ORF2) is more closely related with virgavirus CPs than benyvirus CPs. ORF3 was predicted to produce a C-terminally extended protein from ORF2 via frameshifting. While ORF4 (45-kDa), ORF5 (44-kDa), and ORF6 (16-kDa) have no apparent sequence homology with other known viruses, ORF5 is predicted to encode a movement protein (MP) that is phylogenetically related to the furovirus MP and ORF6 was experimentally proven to encode a viral suppressor of RNA silencing. These unusual characteristics suggest that GBCV may represent an evolutionary link between the families Benyviridae and Virgaviridae and indicate the existence of a novel, unidentified virus group.	[Kwon, Sun-Jung; Choi, Gug-Seoun] Natl Inst Hort & Herbal Sci, Hort & Herbal Crop Environm Div, Wonju, South Korea; [Choi, Boram; Seo, Jang-Kyun] Seoul Natl Univ, Dept Int Agr Technol, Pyeongchang, South Korea; [Choi, Boram; Seo, Jang-Kyun] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea	National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Seoul National University (SNU); Seoul National University (SNU)	Seo, JK (corresponding author), Seoul Natl Univ, Dept Int Agr Technol, Pyeongchang, South Korea.; Seo, JK (corresponding author), Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea.	jangseo@snu.ac.kr			Next-Generation BioGreen 21 Program - Rural Development Administration of Korea [PJ013129]; Young Researcher Program - National Research Foundation of Korea [2018R1C1B5029927]	Next-Generation BioGreen 21 Program - Rural Development Administration of Korea; Young Researcher Program - National Research Foundation of Korea	This research was supported in part by grants from the Next-Generation BioGreen 21 Program (PJ013129) funded by the Rural Development Administration of Korea, and by the Young Researcher Program (2018R1C1B5029927) funded by the National Research Foundation of Korea to JKS.	Adams MJ, 2017, J GEN VIROL, V98, P1999, DOI 10.1099/jgv.0.000884; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Botstein D, 1980, Ann N Y Acad Sci, V354, P484, DOI 10.1111/j.1749-6632.1980.tb27987.x; BRIERLEY I, 1995, J GEN VIROL, V76, P1885, DOI 10.1099/0022-1317-76-8-1885; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Claverie S, 2018, ADV VIRUS RES, V101, P55, DOI 10.1016/bs.aivir.2018.02.003; DEOM CM, 1992, CELL, V69, P221, DOI 10.1016/0092-8674(92)90403-Y; Dolja VV, 2018, VIRUS RES, V244, P36, DOI 10.1016/j.virusres.2017.10.020; Gao F, 2016, NUCLEIC ACIDS RES, V44, P878, DOI 10.1093/nar/gkv1241; Gilmer D, 2017, J GEN VIROL, V98, P1571, DOI 10.1099/jgv.0.000864; HERZOG E, 1995, VIROLOGY, V208, P215, DOI 10.1006/viro.1995.1145; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; King AMQ, 2018, ARCH VIROL, V163, P2601, DOI 10.1007/s00705-018-3847-1; Klupp BG, 2002, J VIROL, V76, P3065, DOI 10.1128/JVI.76.6.3065-3071.2002; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehmann AR, 2005, DNA REPAIR, V4, P309, DOI 10.1016/j.dnarep.2004.07.009; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lu R, 2004, P NATL ACAD SCI USA, V101, P15742, DOI 10.1073/pnas.0404940101; Massart S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00045; Melcher U, 2000, J GEN VIROL, V81, P257, DOI 10.1099/0022-1317-81-1-257; Morozov SY, 2003, J GEN VIROL, V84, P1351, DOI 10.1099/vir.0.18922-0; Muthukumar V, 2009, VIRUS RES, V141, P169, DOI 10.1016/j.virusres.2008.06.016; Nemchinov LG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178222; Roossinck MJ, 2015, PHYTOPATHOLOGY, V105, P716, DOI 10.1094/PHYTO-12-14-0356-RVW; Roossinck MJ, 2011, CURR OPIN VIROL, V1, P63, DOI 10.1016/j.coviro.2011.05.022; Roossinck MJ, 2010, MOL ECOL, V19, P81, DOI 10.1111/j.1365-294X.2009.04470.x; ROZANOV MN, 1992, J GEN VIROL, V73, P2129, DOI 10.1099/0022-1317-73-8-2129; Rubino L, 2012, ARCH VIROL, V157, P1629, DOI 10.1007/s00705-012-1342-7; Seo JK, 2017, ARCH VIROL, V162, P2885, DOI 10.1007/s00705-017-3405-2; Seo JK, 2017, ARCH VIROL, V162, P2457, DOI 10.1007/s00705-017-3374-5; Seo JK, 2012, VIROLOGY, V432, P296, DOI 10.1016/j.virol.2012.05.023; Seo JK, 2012, J VIROL, V86, P6210, DOI 10.1128/JVI.07184-11; Shi M, 2018, NATURE, V556, P197, DOI 10.1038/s41586-018-0012-7; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Tamm T, 2009, VIRUS RES, V146, P73, DOI 10.1016/j.virusres.2009.09.002; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Wylie SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079587; Wylie SJ, 2013, VIRUS RES, V171, P22, DOI 10.1016/j.virusres.2012.10.003; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Zheng Y, 2017, VIROLOGY, V500, P130, DOI 10.1016/j.virol.2016.10.017	44	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0206382	10.1371/journal.pone.0206382	http://dx.doi.org/10.1371/journal.pone.0206382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346992	Green Submitted, Green Published, gold			2022-12-26	WOS:000447938400044
J	O'Malley, KJ; Bowling, JL; Stinson, E; Cole, KS; Mann, BJ; Namjoshi, P; Hazlett, KRO; Barry, EM; Reed, DS				O'Malley, Katherine J.; Bowling, Jennifer L.; Stinson, Elizabeth; Cole, Kelly S.; Mann, Barbara J.; Namjoshi, Prachi; Hazlett, Karsten R. O.; Barry, Eileen M.; Reed, Douglas S.			Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis	PLOS ONE			English	Article							LIVE TULAREMIA VACCINE; B-CELL EPITOPES; PNEUMONIC TULAREMIA; O-POLYSACCHARIDE; ANTIBODIES; STRAIN; IMMUNIZATION; INFECTION; IMMUNITY; CHALLENGE	Tularemia, also known as rabbit fever, is a severe zoonotic disease in humans caused by the gram-negative bacterium Francisella tularensis (Ft). While there have been a number of attempts to develop a vaccine for Ft, few candidates have advanced beyond experiments in inbred mice. We report here that a prime-boost strategy with aerosol delivery of recombinant live attenuated candidate Ft S4 Delta aroD offers significant protection (83% survival) in an outbred animal model, New Zealand White rabbits, against aerosol challenge with 248 cfu (11 LD50) of virulent type A FtSCHU S4. Surviving rabbits given two doses of the attenuated strains by aerosol did not exhibit substantial post-challenge fevers, changes in erythrocyte sedimentation rate or in complete blood counts. At a higher challenge dose (3,186 cfu; 139 LD50), protection was still good with 66% of S4 Delta aroD-vaccinated rabbits surviving while 50% of S4 Delta guaBA vaccinated rabbits also survived challenge. Pre-challenge plasma IgG titers against Ft SCHU S4 corresponded with survival time after challenge. Western blot analysis found that plasma antibody shifted from predominantly targeting Ft O-antigen after the prime vaccination to other antigens after the boost. These results demonstrate the superior protection conferred by a live attenuated derivative of virulent F. tularensis, particularly when given in an aerosol prime-boost regimen.	[O'Malley, Katherine J.; Bowling, Jennifer L.; Stinson, Elizabeth; Cole, Kelly S.; Reed, Douglas S.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Mann, Barbara J.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA; [Namjoshi, Prachi; Hazlett, Karsten R. O.] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA; [Barry, Eileen M.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia; Albany Medical College; University System of Maryland; University of Maryland Baltimore	Reed, DS (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.	dsreed@pitt.edu	Reed, Douglas/AAA-2587-2020	Reed, Douglas/0000-0003-0076-9023; /0000-0002-1432-0211; Mann, Barbara J/0000-0002-5549-2562	National Institute of Allergy & Infectious Diseases at the National Institutes of Health [U01 AI077909-01, R01 A102966-01A1, AI 123129, AI 100138]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123129, R01AI100138] Funding Source: NIH RePORTER	National Institute of Allergy & Infectious Diseases at the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DSR, EB, KH were funded by the National Institute of Allergy & Infectious Diseases at the National Institutes of Health, for the work reported in this manuscript, Grants U01 AI077909-01, R01 A102966-01A1, AI 123129, and AI 100138, niaid. nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2011, VIROLOGY, V411, P206, DOI 10.1016/j.virol.2010.12.016; Barry EM, 2012, 7 INT C TUL BRECK CO; BURKE DS, 1977, J INFECT DIS, V135, P55, DOI 10.1093/infdis/135.1.55; Chu P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004439; De Pascalis R, 2016, INFECT IMMUN, V84, P1054, DOI 10.1128/IAI.01348-15; De Pascalis R, 2014, MBIO, V5, DOI 10.1128/mBio.00936-13; de Swart RL, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0022-8; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DRABICK JJ, 1994, AM J MED SCI, V308, P83, DOI 10.1097/00000441-199408000-00003; EIGELSBACH HT, 1962, J BACTERIOL, V84, P1020, DOI 10.1128/JB.84.5.1020-1027.1962; El Sahly HM, 2009, VACCINE, V27, P4905, DOI 10.1016/j.vaccine.2009.06.036; Elkins KL, 1999, INFECT IMMUN, V67, P6002, DOI 10.1128/IAI.67.11.6002-6007.1999; Eneslatt K, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00027; Faith SA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00126; FDA, 2014, GUID IND AN MOD ESS; Feldman KA, 2001, NEW ENGL J MED, V345, P1601, DOI 10.1056/NEJMoa011374; Fernandez-de Castro J, 1997, Salud Publica Mex, V39, P53; Glynn AR, 2015, COMP IMMUNOL MICROB, V39, P13, DOI 10.1016/j.cimid.2015.01.003; Gunn JS, 2007, ANN NY ACAD SCI, V1105, P202, DOI 10.1196/annals.1409.006; Holland KM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01158; Hornick R B, 1966, Antimicrob Agents Chemother (Bethesda), V6, P11; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; Hutt JA, 2017, AM J PATHOL, V187, P252, DOI 10.1016/j.ajpath.2016.09.021; Jackson LA, 1999, VACCINE, V17, P1905, DOI 10.1016/S0264-410X(98)00471-X; Jones BD, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00032; Kilmury SLN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00143; Kirimanjeswara GS, 2008, IMMUNOL REV, V225, P244, DOI 10.1111/j.1600-065X.2008.00689.x; Kirimanjeswara GS, 2007, J IMMUNOL, V179, P532, DOI 10.4049/jimmunol.179.1.532; Liashenko Vsevolod A., 1999, Human Antibodies, V9, P143; Lu ZH, 2014, CLIN VACCINE IMMUNOL, V21, P227, DOI 10.1128/CVI.00626-13; Lu ZH, 2012, IMMUNOLOGY, V136, P352, DOI 10.1111/j.1365-2567.2012.03589.x; Makara MA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003820; Mara-Koosham G, 2011, INFECT IMMUN, V79, P1770, DOI 10.1128/IAI.00605-10; Marohn ME, 2013, VACCINE, V31, P3485, DOI 10.1016/j.vaccine.2013.05.096; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Okan NA, 2013, MBIO, V4, DOI 10.1128/mBio.00638-12; Pasetti MF, 2008, VACCINE, V26, P1773, DOI 10.1016/j.vaccine.2008.01.005; PIKE RM, 1965, AM J PUBLIC HEALTH N, V55, P190, DOI 10.2105/AJPH.55.2.190; PULLEN RL, 1945, JAMA-J AM MED ASSOC, V129, P495, DOI 10.1001/jama.1945.02860410011003; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Reed DS, 2014, INFECT IMMUN, V82, P2098, DOI 10.1128/IAI.01498-14; Reed DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024654; Roche MI, 2011, HYBRIDOMA, V30, P19, DOI 10.1089/hyb.2010.0083; Roy CJ, 2005, BIODEFENSE RES METHO, P61; Ryden P, 2013, MOL IMMUNOL, V54, P58, DOI 10.1016/j.molimm.2012.10.043; Santiago AE, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv036; Santiago AE, 2009, VACCINE, V27, P2426, DOI 10.1016/j.vaccine.2009.02.073; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Skyberg JA, 2013, VIRULENCE, V4, P859, DOI 10.4161/viru.25454; Stenmark S, 2003, MICROB PATHOGENESIS, V35, P73, DOI 10.1016/S0882-4010(03)00095-0; Stinson E, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw079; Sulkin SE, 1951, AM J PUBLIC HEALTH N, V41, P769; TEUTSCH SM, 1979, NEW ENGL J MED, V301, P826, DOI 10.1056/NEJM197910113011507; TULIS JJ, 1969, P SOC EXP BIOL MED, V132, P893, DOI 10.3181/00379727-132-34331; van de Beek D, 2007, NEUROLOGY, V68, P531, DOI 10.1212/01.wnl.0000250246.01304.98; Zarrella TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022335	57	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205928	10.1371/journal.pone.0205928	http://dx.doi.org/10.1371/journal.pone.0205928			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346998	gold, Green Published, Green Submitted			2022-12-26	WOS:000447938400024
J	Todd, M; Schneper, L; Vasunilashorn, SM; Notterman, D; Ullman, MT; Goldman, N				Todd, Megan; Schneper, Lisa; Vasunilashorn, Sarinnapha M.; Notterman, Daniel; Ullman, Michael T.; Goldman, Noreen			Apolipoprotein E, cognitive function, and cognitive decline among older Taiwanese adults	PLOS ONE			English	Article							PRECLINICAL ALZHEIMER-DISEASE; MENTAL STATE EXAMINATION; E EPSILON-4 ALLELE; AFRICAN-AMERICANS; WORKING-MEMORY; APOE EPSILON-4; ASSOCIATION; RISK; POPULATION; VARIANTS	Apolipoprotein E (APOE) genotype is believed to play a role in the onset of dementia, though less is known about its relationship with non-pathogenic age-related cognitive decline. We assessed whether APOE was a risk factor for cognitive decline among older Taiwanese adults using nationally representative data. General cognition was measured longitudinally over eleven years; domain-specific cognitive assessments of working memory, declarative learning and three aspects of attention (executive function, alerting, and orientation) were performed once. Having at least one risky APOE allele was associated with more rapid longitudinal cognitive decline compared to those with no risky alleles. Some evidence from the cross-sectional analysis of domain-specific cognitive assessments suggested that APOE genotype may be more closely associated with working memory and declarative learning than with attention. Most genetic studies of cognition include only populations of European descent; extension is crucial. This study confirmed the association between APOE genotype and the rate of cognitive decline in a predominantly Han Chinese population. Additional studies on diverse populations are warranted.	[Todd, Megan] Columbia Univ, Columbia Aging Ctr, New York, NY 10027 USA; [Schneper, Lisa; Notterman, Daniel] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Vasunilashorn, Sarinnapha M.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Vasunilashorn, Sarinnapha M.] Harvard Med Sch, Boston, MA USA; [Ullman, Michael T.] Georgetown Univ, Dept Neurosci, Washington, DC USA; [Goldman, Noreen] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Goldman, Noreen] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Todd, Megan] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Ctr Hlth & Wellbeing, Princeton, NJ 08544 USA	Columbia University; Princeton University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Georgetown University; Princeton University; Princeton University; Princeton University	Todd, M (corresponding author), Columbia Univ, Columbia Aging Ctr, New York, NY 10027 USA.; Todd, M (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Ctr Hlth & Wellbeing, Princeton, NJ 08544 USA.	megan.todd@princeton.edu		Goldman, Noreen/0000-0003-2865-9491	National Institute on Aging [R01AG16790, R01AG16661, K01G057836, R25AG053227]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [P2CHD047879, P2CHD058486, R01HD076592]; Alzheimer's Association [AARF-18-560789]; Charles King Trust Postdoctoral Research Fellowship Program, Bank of America, N.A.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076592, P2CHD047879, P2CHD058486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG057836, R25AG053227] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Alzheimer's Association(Alzheimer's Association); Charles King Trust Postdoctoral Research Fellowship Program, Bank of America, N.A.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the National Institute on Aging (grants R01AG16790, R01AG16661, K01G057836 and R25AG053227) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (grants P2CHD047879, P2CHD058486, and R01HD076592) of the National Institutes of Health; The Alzheimer's Association (grant AARF-18-560789); and the Charles King Trust Postdoctoral Research Fellowship Program, Bank of America, N.A., Co-Trustee. There was no additional external or internal funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartres-Faz D, 1999, NEUROREPORT, V10, P2923, DOI 10.1097/00001756-199909290-00009; Bi R, 2014, NEUROBIOL AGING, V35, DOI [10.1016/j.neurobiolaging.2013.08.013, 10.1016/j.neurobiolaging.2013.12.021]; Boyle PA, 2013, ANN NEUROL, V74, P478, DOI 10.1002/ana.23964; Brier MR, 2014, NEUROLOGY, V83, P1613, DOI 10.1212/WNL.0000000000000939; Bunce D, 2004, NEUROLOGY, V63, P816, DOI 10.1212/01.WNL.0000137041.86153.42; Carrasquillo MM, 2015, NEUROBIOL AGING, V36, P60, DOI 10.1016/j.neurobiolaging.2014.07.042; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chang MC, 2012, SOCIAL ENV BIOMARKER; Chen CJ, 2013, AM J NEURORADIOL, V34, P1197, DOI 10.3174/ajnr.A3369; Chiao C, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0503-7; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Davies G, 2014, MOL PSYCHIATR, V19, P76, DOI 10.1038/mp.2012.159; De Jager PL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.033; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Hayden KM, 2011, AGE AGEING, V40, P684, DOI 10.1093/ageing/afr101; Hedenius M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063998; Herzog AR, 1997, J GERONTOL B-PSYCHOL, V52, P37, DOI 10.1093/geronb/52B.Special_Issue.37; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Kaufman AS., 1983, J PSYCHOEDUC ASSESS, V1, P309, DOI 10.1177/073428298300100310; Kim KW, 2002, INT J GERIATR PSYCH, V17, P635, DOI 10.1002/gps.664; Kim KW, 1999, NEUROSCI LETT, V277, P145, DOI 10.1016/S0304-3940(99)00867-8; Liu GY, 2013, NEUROMOL MED, V15, P384, DOI 10.1007/s12017-013-8225-2; Ma F, 2011, NEUROPSYCHOBIOLOGY, V64, P102, DOI 10.1159/000324991; Michaelson DM, 2014, ALZHEIMERS DEMENT, V10, P861, DOI 10.1016/j.jalz.2014.06.015; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Pliatsikas C, 2018, Q J EXP PSYCHOL; Poreh A., 2010, CORSINI ENCY PSYCHOL, DOI [10.1002/9780470479216.corpsy0796, DOI 10.1002/9780470479216.CORPSY0796]; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Reinvang I, 2010, NEUROPSYCHOLOGIA, V48, P566, DOI 10.1016/j.neuropsychologia.2009.10.018; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; Ridge PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079771; SALMON DP, 1989, ARCH NEUROL-CHICAGO, V46, P769, DOI 10.1001/archneur.1989.00520430063019; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Savitz J, 2006, BRAIN RES REV, V51, P125, DOI 10.1016/j.brainresrev.2005.10.006; Small BJ, 2004, PSYCHOL AGING, V19, P592, DOI 10.1037/0882-7974.19.4.592; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Sun SD, 2015, AM J ALZHEIMERS DIS, V30, P503, DOI 10.1177/1533317514566114; Tan L, 2013, ALZHEIMERS DEMENT, V9, P546, DOI 10.1016/j.jalz.2012.08.007; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Todd MA, 2017, BIODEMOGR SOC BIOL, V63, P309, DOI 10.1080/19485565.2017.1403305; Tractenberg Rochelle E, 2005, Am J Alzheimers Dis Other Demen, V20, P239, DOI 10.1177/153331750502000410; Vasunilashorn S, 2011, ATHEROSCLEROSIS, V219, P349, DOI 10.1016/j.atherosclerosis.2011.07.100; Verhaaren BFJ, 2013, BIOL PSYCHIAT, V73, P429, DOI 10.1016/j.biopsych.2012.04.009; Wang HZ, 2016, MOL NEUROBIOL, V53, P379, DOI 10.1007/s12035-014-9015-z; Ward A, 2012, NEUROEPIDEMIOLOGY, V38, P1, DOI 10.1159/000334607; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003	50	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0206118	10.1371/journal.pone.0206118	http://dx.doi.org/10.1371/journal.pone.0206118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX5DH	30339707	Green Published, Green Submitted, gold			2022-12-26	WOS:000447761400039
J	Huang, CH; Li, CL; Kor, CT; Chang, CC				Huang, Ching-Hui; Li, Cheng-Liang; Kor, Chew-Teng; Chang, Chia-Chu			Menopausal symptoms and risk of coronary heart disease in middle-aged women: A nationwide population-based cohort study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; VASOMOTOR SYMPTOMS; DIVERSE POPULATION; HEALTH; ASSOCIATION; TRANSITION; MIDLIFE; TAIWAN; STROKE	Objective To assess the relationship between coronary heart disease (CHD) and menopausal symptoms in middle-aged women in Taiwan. Patients and methods The present study identified 14,340 symptomatic menopausal women without a history of CHD from the Taiwan National Health Insurance Research Database from January 1, 2000, to December 31, 2013. A total of 14,340 age-and Charlson-comorbidity-index-score-matched asymptomatic women were used as controls. Possible comorbidity-attributable risks of CHD were surveyed to assess whether the symptomatic menopausal cohort had a higher incidence of CHD. Results The incidence of CHD was higher in the symptomatic menopausal cohort than in the control cohort (17.18 vs. 12.05 per 1000 person-years). After adjustment in multivariate Cox analysis, the risk of CHD was significantly higher in the symptomatic menopausal cohort (adjusted hazard ratio = 1.344, 95% confidence interval [CI] = 1.262-1.43, P < 0.001) than in the control cohort. In the symptomatic menopausal cohort, the risk of CHD was significantly higher in all subgroups, except for the hormone therapy (HT) subgroup. Patients undergoing HT had a nonsignificantly higher risk of CHD, regardless of the presence or absence of menopausal symptoms. Conclusion This large-scale longitudinal retrospective cohort study revealed that menopausal symptoms are an independent risk factor for CHD. Moreover, our findings indicate that HT has a nonsignificant effect on the risk of CHD.	[Huang, Ching-Hui; Li, Cheng-Liang] Changhua Christian Hosp, Dept Internal Med, Div Cardiol, Changhua, Taiwan; [Huang, Ching-Hui] Chien Kuo Technol Univ, Dept Beauty Sci, Changhua, Taiwan; [Huang, Ching-Hui] Chien Kuo Technol Univ, Grad Inst Beauty Sci Technol, Changhua, Taiwan; [Huang, Ching-Hui] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Kor, Chew-Teng] Changhua Christian Hosp, Dept Internal Med, Med Res Ctr, Changhua, Taiwan; [Chang, Chia-Chu] Kuang Tien Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Chang, Chia-Chu] Hungkuang Univ, Dept Nutr, Taichung, Taiwan	Changhua Christian Hospital; Chienkuo Technology University; Chienkuo Technology University; Kaohsiung Medical University; Changhua Christian Hospital; Hungkuang University	Chang, CC (corresponding author), Kuang Tien Gen Hosp, Dept Internal Med, Taichung, Taiwan.; Chang, CC (corresponding author), Hungkuang Univ, Dept Nutr, Taichung, Taiwan.	chiachuchang0312@gmail.com						Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059899; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gast GCM, 2011, MENOPAUSE, V18, P146, DOI 10.1097/gme.0b013e3181f464fb; Gold EB, 2006, AM J PUBLIC HEALTH, V96, P1226, DOI 10.2105/AJPH.2005.066936; Gurka MJ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003609; Harman SM, 2014, ANN INTERN MED, V161, P249, DOI 10.7326/M14-0353; Herber-Gast GCM, 2015, BJOG-INT J OBSTET GY, V122, P1560, DOI 10.1111/1471-0528.13163; Janssen I, 2008, ARCH INTERN MED, V168, P1568, DOI 10.1001/archinte.168.14.1568; KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447; Lien HM, 2008, J HEALTH ECON, V27, P1208, DOI 10.1016/j.jhealeco.2008.03.002; Lobo RA, 2017, NAT REV ENDOCRINOL, V13, P220, DOI 10.1038/nrendo.2016.164; Matthews KA, 2009, J AM COLL CARDIOL, V54, P2366, DOI 10.1016/j.jacc.2009.10.009; Muka T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157417; Reed SD, 2013, MATURITAS, V75, P152, DOI 10.1016/j.maturitas.2013.03.003; Reed SD, 2014, MENOPAUSE, V21, P153, DOI 10.1097/GME.0b013e3182952228; Szmuilowicz ED, 2011, MENOPAUSE, V18, P603, DOI 10.1097/gme.0b013e3182014849; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	22	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206036	10.1371/journal.pone.0206036	http://dx.doi.org/10.1371/journal.pone.0206036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4KR	30335825	Green Submitted, gold, Green Published			2022-12-26	WOS:000447701300090
J	Chen, LL; Wang, JX; Jiang, PP; Ren, FZ; Lei, XG; Guo, HY				Chen, Lingli; Wang, Jingxuan; Jiang, Pingping; Ren, Fazheng; Lei, Xingen; Guo, Huiyuan			Alteration of the colostrum whey proteome in mothers with gestational hypothyroidism	PLOS ONE			English	Article							SUBCLINICAL HYPOTHYROIDISM; HUMAN-MILK; HORMONAL-REGULATION; THYROID-HORMONES; LACTATING RATS; PREGNANCY; PROTEINS; DIFFERENTIATION	Background Gestational hypothyroidism (G-HypoT) is one of the most common thyroid diseases in pregnant women. Human milk, which closely links the mother with infant, is an important factor to the infant health. Here, we analyzed the colostrum whey proteome of women with or without G-HypoT. Methods and results Using high mass accuracy and high-resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS), 1055 proteins were identified. Tandem Mass Tags (TMT) analysis identified differentially expressed proteins between G-HypoT and non-G-HypoT mothers. Of 44 proteins identified, 15 proteins were significantly increased in G-HypoT colostrum whey, while 29 were significantly decreased. Analysis revealed that enzymes involved in carbohydrate metabolism, and that reflect the metabolic activities in breastfeeding women, including fructose-1, 6-bisphosphatase 1, phosphoglycerate mutase 1 were down-regulated. Cell structural proteins, biomarkers of mammary integrity development, including Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and actin were lower in G-HypoT colostrum whey. However, immune protein fragments like Ig gamma-3 chain C region increased in G-HypoT colostrum whey. Conclusion These results implied that G-HypoT may changed human colostrum whey protein in composition level, decreasing levels of metabolic proteins and cell-structure proteins, while increasing levels of immune-related proteins, which may compromise or reflect mothers' and infants' health.	[Chen, Lingli; Ren, Fazheng; Guo, Huiyuan] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [Wang, Jingxuan; Ren, Fazheng] China Agr Univ, Key Lab Funct Dairy, Minist Educ, Beijing, Peoples R China; [Wang, Jingxuan; Ren, Fazheng] China Agr Univ, Beijing Govt, Beijing, Peoples R China; [Jiang, Pingping] Univ Copenhagen, Dept Vet & Anim Sci, Frederiksberg, Denmark; [Lei, Xingen] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Guo, Huiyuan] Hebei Engn Res Ctr Anim Prod, Sanhe, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University; University of Copenhagen; Cornell University	Guo, HY (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing, Peoples R China.; Guo, HY (corresponding author), Hebei Engn Res Ctr Anim Prod, Sanhe, Peoples R China.	guohuiyuan@cau.edu.cn		Jiang, Pingping/0000-0002-7393-9719	Beijing Natural Science Foundation [S150009]; Beijing Municipal Commission of Education Co-constructed Program	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Commission of Education Co-constructed Program	This work was supported by the Beijing Natural Science Foundation (S150009 to HG) and the Beijing Municipal Commission of Education Co-constructed Program (to FR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalovich M, 2002, THYROID, V12, P63, DOI 10.1089/105072502753451986; ACOG, 2015, ACOG PRACT B, V125; Alexander EK, 2004, NEW ENGL J MED, V351, P241, DOI 10.1056/NEJMoa040079; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Capuco AV, 2008, EXP BIOL MED, V233, P1309, DOI 10.3181/0803-RM-85; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127788; Ferlin ML, J PERINAT MED, V2206, P251; Gao XL, 2012, J PROTEOME RES, V11, P3897, DOI 10.1021/pr3004002; Grapov D, 2015, J PROTEOME RES, V14, P512, DOI 10.1021/pr500818d; Hapon MB, 2003, REPRODUCTION, V126, P371, DOI 10.1530/rep.0.1260371; Hettinga KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122234; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Innis SM, 2007, P NUTR SOC, V66, P397, DOI 10.1017/S0029665107005666; Koletzko B, 1998, Curr Opin Clin Nutr Metab Care, V1, P171, DOI 10.1097/00075197-199803000-00005; Liao YL, 2011, J PROTEOME RES, V10, P3530, DOI 10.1021/pr200149t; Liao YL, 2011, J PROTEOME RES, V10, P1746, DOI 10.1021/pr101028k; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Martinez M, 2018, ENDOCRINOL DIAB NUTR, V65, P107, DOI 10.1016/j.endinu.2017.11.009; Molinari CE, 2012, J PROTEOME RES, V11, P1696, DOI 10.1021/pr2008797; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; MOTIL KJ, 1994, J NUTR, V124, P1248, DOI 10.1093/jn/124.8.1248; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Orosz F, 2006, IUBMB LIFE, V58, P703, DOI 10.1080/15216540601115960; Penin M, 2014, ENDOCRINOL NUTR, V61, P347, DOI 10.1016/j.endonu.2014.01.011; Peterson JA, 2001, ADV EXP MED BIOL, V501, P179; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; RStudioTeam, 2012, R STUD INT DEV R RST; Smolenski G, 2007, J PROTEOME RES, V6, P207, DOI 10.1021/pr0603405; Sokolowski JD, 2014, ACTA NEUROPATHOL COM, P2, DOI [10.1186/2051-5960-2-2, DOI 10.1186/2051-5960-2-2]; Taylor P., 2018, EENDOCRINOLOGY, P1; Team R Core, 2013, R LANG ENV STAT COMP; Thompson EJ, 2006, MOL CANCER RES, V4, P489, DOI 10.1158/1541-7786.MCR-06-0038; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Arbocco FCV, 2016, MOL CELL ENDOCRINOL, V419, P18, DOI 10.1016/j.mce.2015.09.023; VONDERHAAR BK, 1989, ANNU REV PHYSIOL, V51, P641, DOI 10.1146/annurev.ph.51.030189.003233; Wang JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129430; Zhang W, 2014, J BONE MINER RES, V29, P1232, DOI 10.1002/jbmr.2116; ZISKA SE, 1988, ENDOCRINOLOGY, V123, P2242, DOI 10.1210/endo-123-5-2242	45	6	6	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205987	10.1371/journal.pone.0205987	http://dx.doi.org/10.1371/journal.pone.0205987			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332478	gold, Green Submitted, Green Published			2022-12-26	WOS:000447638200080
J	Smith, TC; Saul, RG; Barton, ER; Luna, EJ				Smith, Tara C.; Saul, Richard G.; Barton, Elisabeth R.; Luna, Elizabeth J.			Generation and characterization of monoclonal antibodies that recognize human and murine supervillin protein isoforms	PLOS ONE			English	Article							MYOSIN-II ACTIVATION; F-ACTIN; ANDROGEN-RECEPTOR; FOCAL ADHESIONS; INTRINSIC DISORDER; BINDING DOMAINS; STRESS FIBERS; SMOOTH-MUSCLE; ARCHVILLIN; TRANSCRIPTION	Supervillin isoforms have been implicated in cell proliferation, actin filament-based motile processes, vesicle trafficking, and signal transduction. However, an understanding of the roles of these proteins in cancer metastasis and physiological processes has been limited by the difficulty of obtaining specific antibodies against these highly conserved membrane associated proteins. To facilitate research into the biological functions of supervillin, monoclonal antibodies were generated against the bacterially expressed human supervillin N-terminus. Two chimeric monoclonal antibodies with rabbit Fc domains (clones 1E2/CPTC-SVIL-1; 4A8/CPTC-SVIL-2) and two mouse monoclonal antibodies (clones 5A8/CPTC-SVIL-3; 5G3/CPTC-SVIL-4) were characterized with respect to their binding sites, affinities, and for efficacy in immunoblotting, immunoprecipitation, immunofluorescence microscopy and immunohistochemical staining. Two antibodies (1E2, 5G3) recognize a sequence found only in primate supervillins, whereas the other two antibodies (4A8, 5A8) are specific for a more broadly conserved conformational epitope(s). All antibodies function in immunoblotting, immunoprecipitation and in immunofluorescence microscopy under the fixation conditions identified here. We also show that the 5A8 antibody works on immunohistological sections. These antibodies should provide useful tools for the study of mammalian supervillins.	[Smith, Tara C.; Luna, Elizabeth J.] Univ Massachusetts, Sch Med, Dept Radiol, Div Cell Biol & Imaging, Worcester, MA 01655 USA; [Saul, Richard G.] Frederick Natl Lab Canc Res ATRF, Antibody Characterizat Lab, Canc Res Technol Program, Frederick, MD USA; [Barton, Elisabeth R.] Univ Florida, Coll Hlth & Human Performance, Appl Physiol & Kinesiol, Gainesville, FL USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University System of Florida; University of Florida	Luna, EJ (corresponding author), Univ Massachusetts, Sch Med, Dept Radiol, Div Cell Biol & Imaging, Worcester, MA 01655 USA.	Elizabeth.Luna@umassmed.edu		Luna, Elizabeth/0000-0002-0779-3379	National Cancer Institute's Clinical Proteomics Tumor Analysis Consortium (CPTAC)'s Antibody Characterization Program; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR069660]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069660] Funding Source: NIH RePORTER	National Cancer Institute's Clinical Proteomics Tumor Analysis Consortium (CPTAC)'s Antibody Characterization Program; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by the National Cancer Institute's Clinical Proteomics Tumor Analysis Consortium (CPTAC)'s Antibody Characterization Program (antibodies.cancer.gov) and, in part, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (www. niams.nih.gov) under the award number R01 AR069660 award to ERB and EJL. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Research in the Antibody Characterization Program was overseen by Leidos Biomedical Research, Inc. This commercial institution did not play a role in the funding, study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Bhuwania R, 2012, J CELL SCI, V125, P2300, DOI 10.1242/jcs.100032; Burridge K, 2016, EXP CELL RES, V343, P14, DOI 10.1016/j.yexcr.2015.10.029; Burstein HJ, 2017, J CLIN ONCOL, V35, P1341, DOI 10.1200/JCO.2016.71.5292; Chen XR, 2017, BIOCHEM BIOPH RES CO, V482, P43, DOI 10.1016/j.bbrc.2016.11.013; Chen XR, 2016, PROTEIN J, V35, P107, DOI 10.1007/s10930-016-9658-x; Chen Y, 2003, J BIOL CHEM, V278, P46094, DOI 10.1074/jbc.M305311200; Chin LK, 2016, CURR OPIN CHEM ENG, V11, P77, DOI 10.1016/j.coche.2016.01.011; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; Di Domenico M, 2017, ONCOTARGET, V8, P36869, DOI 10.18632/oncotarget.16300; Edelstein LC, 2012, CIRCULATION, V125, P2762, DOI 10.1161/CIRCULATIONAHA.112.091462; Fang ZY, 2013, J BIOL CHEM, V288, P7918, DOI 10.1074/jbc.M112.416842; Fang ZY, 2010, TRAFFIC, V11, P782, DOI 10.1111/j.1600-0854.2010.01062.x; Fedechkin SO, 2012, J BIOMOL STRUCT DYN; Francis JE, 2017, BEILSTEIN J NANOTECH, V8, P1238, DOI 10.3762/bjnano.8.125; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Fung HYJ, 2018, CURR OPIN STRUC BIOL, V49, P36, DOI 10.1016/j.sbi.2017.12.007; Gangopadhyay SS, 2009, J BIOL CHEM, V284, P17607, DOI 10.1074/jbc.M109.002386; Gangopadhyay SS, 2004, J CELL SCI, V117, P5043, DOI 10.1242/jcs.01378; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Goldenring JR, 2013, NAT REV CANCER, V13, P813, DOI 10.1038/nrc3601; Hasegawa H, 2013, J CELL SCI, V126, P3627, DOI 10.1242/jcs.124818; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laurent B, 2015, MOL CELL, V57, P957, DOI 10.1016/j.molcel.2015.01.010; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Livne A, 2016, J CELL SCI, V129, P1293, DOI 10.1242/jcs.180927; Mock A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1069941; Mock A, 2015, ONCOTARGET, V6, P13579, DOI 10.18632/oncotarget.3791; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Oh SW, 2003, J CELL SCI, V116, P2261, DOI 10.1242/jcs.00422; PESTONJAMASP K, 1995, MOL BIOL CELL, V6, P247, DOI 10.1091/mbc.6.3.247; Pestonjamasp KN, 1997, J CELL BIOL, V139, P1255, DOI 10.1083/jcb.139.5.1255; Pollock LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158349; Pope RK, 1998, GENOMICS, V52, P342, DOI 10.1006/geno.1998.5466; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Schirwitz C, 2013, ADV MATER, V25, P1598, DOI 10.1002/adma.201203853; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith TC, 2013, MOL BIOL CELL, V24, P3603, DOI 10.1091/mbc.E12-10-0714; Smith TC, 2010, CYTOSKELETON, V67, P346, DOI 10.1002/cm.20449; Son K, 2015, CYTOSKELETON, V72, P47, DOI 10.1002/cm.21210; Spinazzola JM, 2015, HUM MOL GENET, V24, P2470, DOI 10.1093/hmg/ddv008; Takizawa N, 2007, J CELL SCI, V120, P3792, DOI 10.1242/jcs.008219; Takizawa N, 2006, J CELL BIOL, V174, P447, DOI 10.1083/jcb.200512051; Ting HJ, 2005, ENDOCRINE, V26, P1, DOI 10.1385/ENDO:26:1:001; Ting HJ, 2004, BIOCHEM BIOPH RES CO, V319, P393, DOI 10.1016/j.bbrc.2004.04.186; Ting HJ, 2002, P NATL ACAD SCI USA, V99, P661, DOI 10.1073/pnas.022469899; Toth-Petroczy A, 2016, CELL, V167, P158, DOI 10.1016/j.cell.2016.09.010; Uhart M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00010; Vanaja DK, 2006, CLIN CANCER RES, V12, P1128, DOI 10.1158/1078-0432.CCR-05-2072; Wagner S, 2003, P NATL ACAD SCI USA, V100, P3269, DOI 10.1073/pnas.0438055100; Wulfkuhle JD, 1999, J CELL SCI, V112, P2125	54	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205910	10.1371/journal.pone.0205910	http://dx.doi.org/10.1371/journal.pone.0205910			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332471	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200076
J	Vedenin, A; Gusky, M; Gebruk, A; Kremenetskaia, A; Rybakova, E; Boetius, A				Vedenin, Andrey; Gusky, Manuela; Gebruk, Andrey; Kremenetskaia, Antonina; Rybakova, Elena; Boetius, Antje			Spatial distribution of benthic macrofauna in the Central Arctic Ocean	PLOS ONE			English	Article							DEEP-SEA MACROBENTHOS; KARA SEA; CONTINENTAL-SLOPE; BARENTS SEA; CANADA BASIN; NE ATLANTIC; DIVERSITY; BIOMASS; FAUNA; COMMUNITIES	Permanent sea-ice cover and low primary productivity in the mostly ice-covered Central Arctic ocean basins result in significantly lower biomass and density of macrobenthos in the abyssal plains compared to the continental slopes. However, little is known on bathymetric and regional effects on the macrobenthos diversity. This study synthesizes new and available macrobenthos data to provide a baseline for future studies of the effects of Arctic change on macrofauna community composition in the Arctic basins. Samples collected during three expeditions (in 1993,2012 and 2015) at 37 stations on the slope of the Barents and Laptev Seas and in the abyssal of the Nansen and Amundsen Basins in the depth range from 38 m to 4381 m were used for a quantitative analysis of species composition, abundance and biomass. Benthic communities clustered in five depth ranges across the slope and basin. A parabolic pattern of species diversity change with depth was found, with the diversity maximum for macrofauna at the shelf edge at depths of 100-300 m. This deviates from the typical species richness peak at mid-slope depths of 1500-3000 m in temperate oceans. Due to the limited availability of standardized benthos data, it remains difficult to assess if and how the significant sea-ice loss observed in the past decade has affected benthic community composition. The polychaete Ymerana pteropoda and the bryozoan Nolella sp. were found for the first time in the deep Nansen and Amundsen Basins.	[Vedenin, Andrey; Gebruk, Andrey; Kremenetskaia, Antonina; Rybakova, Elena] Russian Acad Sci, PP Shirshov Inst Oceanol, Moscow, Russia; [Gusky, Manuela; Boetius, Antje] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Boetius, Antje] Max Planck Inst Marine Microbiol, Bremen, Germany	Russian Academy of Sciences; Shirshov Institute of Oceanology; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society	Kremenetskaia, A (corresponding author), Russian Acad Sci, PP Shirshov Inst Oceanol, Moscow, Russia.	antoneene@gmail.com	Boetius, Antje/D-5459-2013; Kremenetskaia, Antonina/H-5654-2018; Vedenin, Andrey/ABB-9373-2021; Vedenin, Andrey A/B-1840-2017; Rybakova, Elena/AAD-1922-2019; Gebruk, Andrey/A-9041-2016	Boetius, Antje/0000-0003-2117-4176; Kremenetskaia, Antonina/0000-0001-8851-3318; Vedenin, Andrey/0000-0002-4457-8299; Vedenin, Andrey A/0000-0002-4457-8299; Rybakova, Elena/0000-0001-9695-149X	Alfred Wegener Institute (Polar Regions and Coasts in a Changing Earth System = PACES II program); European Research Council [294757]; Russian Science Foundation [14-50-00095]; Russian Foundation for Basic Research [17-05-00787, 18-05-60228]	Alfred Wegener Institute (Polar Regions and Coasts in a Changing Earth System = PACES II program); European Research Council(European Research Council (ERC)European Commission); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	Funding of this study was provided by the Alfred Wegener Institute (Polar Regions and Coasts in a Changing Earth System = PACES II program, https://www.hzg.de/institutes_platforms/coastal_research/research_topics/paces_2/index.php.de) and by the European Research Council Advanced Grant 294757 (https://erc.europa.eu/funding/advanced-grants) to Dr. Antje Boetius. This work was partly supported by the Russian Science Foundation Grant 14-50-00095 (http://rscf.ru/en) to Dr. Andrey Vedenin, Russian Foundation for Basic Research Grant 17-05-00787 (http://www.rfbr.ru/rffi/eng) to Dr. Andrey Vedenin, Dr. Elena Rybakova and Antonina Kremenetskaia, and 18-05-60228 (http://www.rfbr.ru/rffi/eng) to Dr. Andrey Gebruk (data analysis). The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Aldea C, 2008, DEEP-SEA RES PT I, V55, P350, DOI 10.1016/j.dsr.2007.12.002; Bluhm BA, 2015, PROG OCEANOGR, V139, P89, DOI 10.1016/j.pocean.2015.07.011; Bluhm BA, 2005, POLAR BIOL, V28, P218, DOI 10.1007/s00300-004-0675-4; Bluhm BA, 2009, SEA ICE, P149; Bodil Bluhm A., 2011, Marine Biodiversity, V41, P87, DOI 10.1007/s12526-010-0078-4; Boetius A., 2013, BERICHTE POLAR MEERE, DOI 10.2312/BzPM_0663_2013; Boetius A., 1996, REPORTS POLAR RES, V212, P213; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Brandt A, 1999, POLAR BIOL, V22, P75, DOI 10.1007/s003000050392; Brandt A, 2009, DEEP-SEA RES PT I, V56, P2013, DOI 10.1016/j.dsr.2009.06.007; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Clough LM, 1997, DEEP-SEA RES PT II, V44, P1683, DOI 10.1016/S0967-0645(97)00052-0; Cochrane SKJ, 2012, J MARINE SYST, V94, P204, DOI 10.1016/j.jmarsys.2011.12.001; Cochrane SKJ, 2009, J SEA RES, V61, P222, DOI 10.1016/j.seares.2009.01.003; d'Hondt J.-L., 1985, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V7, P39; Dahle S, 2009, POLAR BIOL, V32, P169, DOI 10.1007/s00300-008-0516-y; Degen R, 2015, POLAR RES, V34, DOI 10.3402/polar.v34.24008; Demidov AB, 2014, J MARINE SYST, V132, P130, DOI 10.1016/j.jmarsys.2014.01.014; Deubel H., 2003, P MARINE SCI, P237; Deubel H., 2000, REP POLAR RES, P370; DHONDT JL, 1981, CAH BIOL MAR, V22, P267; Diepenbroek M., 2000, PANMAP; Fernandez-Mendez M, 2015, BIOGEOSCIENCES, V12, P3525, DOI 10.5194/bg-12-3525-2015; Flach E, 1996, MAR ECOL PROG SER, V141, P55, DOI 10.3354/meps141055; Flach E, 1999, J SEA RES, V42, P303, DOI 10.1016/S1385-1101(99)00034-9; Frolova EA, 2003, FAUNA BESPOZVONOCHNY; Futterer D., 1992, REP POLAR RES, V107; Futterer D., 1994, REP POLAR RES, P149; Gage JD, 2000, HYDROBIOLOGIA, V440, P261, DOI 10.1023/A:1004143816391; Galeron J, 2000, MAR ECOL PROG SER, V197, P121, DOI 10.3354/meps197121; Gebruk AV, 2010, J MAR BIOL ASSOC UK, V90, P1, DOI 10.1017/S0025315409991111; Gerdes D., 1990, Polar Record, V26, P35; Gorbunov G.P., 1946, T DREIFUYUSHCHEI EKS, V3, P30; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; Gukov A. Y., 2002, BER POLARFORSCH, V70, P107; Harper DAT, 2008, PAST USER MANUAL; HOLTHE T, 1986, SARSIA, V71, P227, DOI 10.1080/00364827.1986.10419692; Hoppe G, 1987, EXPEDITIONEN YMER 80; Jorgensen LL, 1999, POLAR BIOL, V22, P395, DOI 10.1007/s003000050435; Klages M, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P139; KOLTUN V. M., 1964, TR ARKTICHESKOGO ANTARKT NAUCH ISSLED INST, V259, P13; Kroncke I, 1998, POLAR BIOL, V19, P383, DOI 10.1007/s003000050263; KRONCKE I, 1994, POLAR BIOL, V14, P519, DOI 10.1007/BF00238221; Levin LA, 1998, DEEP-SEA RES PT II, V45, P129, DOI 10.1016/S0967-0645(97)00085-4; Lisitzin A. P., 1955, Trudy Vsesoyuznogo Gidrobiologicheskogo Obshchestva, V6, P217; MacDonald IR, 2010, DEEP-SEA RES PT II, V57, P136, DOI 10.1016/j.dsr2.2009.08.012; Makkaveev PN, 2010, OCEANOLOGY+, V50, P698, DOI 10.1134/S0001437010050073; Maslanik J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047735; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Mironov A.N., 2013, Zoologiya Bespozvonochnykh, V10, P167; Moskalev LI, 1980, EKOLOGICHESKIE ISSLE, P73; Parapar J, 2014, POL POLAR RES, V35, P311, DOI 10.2478/popore-2014-0019; Parkinson CL, 2014, J CLIMATE, V27, P9377, DOI 10.1175/JCLI-D-14-00605.1; PAUL AZ, 1974, MAR BIOL, V27, P251, DOI 10.1007/BF00391950; Petryashov V.V., 2004, Issledovaniya Fauny Morei, V54, P9; Piepenburg D, 1996, POLAR BIOL, V16, P383, DOI 10.1007/BF02390420; Pivovarov S., 1999, LAND OCEAN SYSTEMS S, P251, DOI [10.1007/978-3-642-60134-7_23, DOI 10.1007/978-3-642-60134-7_23]; Rachor E., 1997, REPORTS POLAR RES; Renaud PE, 2015, PROG OCEANOGR, V139, P244, DOI 10.1016/j.pocean.2015.07.007; Renaud PE, 2006, J EXP MAR BIOL ECOL, V330, P297, DOI 10.1016/j.jembe.2005.12.035; Rex M.A., 1983, SEA, P453; Rex M.A., 2010, BIOSCIENCE; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; Rossel PE, 2015, DISSOLVED ORGANIC CA, DOI [10.1594/PANGAEA.849056, DOI 10.1594/PANGAEA.849056]; ROWE GT, 1982, DEEP-SEA RES, V29, P257, DOI 10.1016/0198-0149(82)90113-3; Sirenko B.I., 2004, FAUNA ECOSYSTEMS LAP, V54, P28; Sirenko BI, 2010, EXPLOR FAUNA SEAS, V66, P74; Smirnov AV, 1994, ISSLEDOVANIYA FAUNY, V49, P132; Sukhanova IN, 2017, OCEANOLOGY+, V57, P75, DOI 10.1134/S0001437017010209; Vedenin AA, 2015, POLAR BIOL, V38, P829, DOI 10.1007/s00300-014-1642-3; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Wlodarska-Kowalczuk M, 2004, DEEP-SEA RES PT I, V51, P1903, DOI 10.1016/j.dsr.2004.07.013; Zatsepin AG, 2010, OCEANOLOGY+, V50, P657, DOI 10.1134/S0001437010050036; Zenkevich L.A, 1963, BIOL SEAS USSR	74	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0200121	10.1371/journal.pone.0200121	http://dx.doi.org/10.1371/journal.pone.0200121			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332418	gold, Green Published, Green Submitted			2022-12-26	WOS:000447638200003
J	Skibiel, AL; Dado-Senn, B; Fabris, TF; Dahl, GE; Laporta, J				Skibiel, Amy L.; Dado-Senn, Bethany; Fabris, Thiago F.; Dahl, Geoffrey E.; Laporta, Jimena			In utero exposure to thermal stress has long-term effects on mammary gland microstructure and function in dairy cattle	PLOS ONE			English	Article							MATERNAL HEAT-STRESS; DRY PERIOD; CELL-PROLIFERATION; MILK ACCUMULATION; LATE-GESTATION; BOVINE UDDER; LACTATION; GROWTH; COWS; CALVES	Earth's rising temperature has substantial repercussions for food-producing animals by increasing morbidity and mortality, diminishing reproductive potential, and reducing productivity. In the dairy industry this equates to massive losses in milk yield, which occur when cows are exposed to heat stress during lactation or during the non-lactating period between lactations (i.e. dry period). Furthermore, milk yield is significantly lower in first-lactation heifers that experienced fetal heat stress. The mechanisms underlying intrauterine effects of heat stress on the offspring's future lactation have yet to be fully elucidated. We hypothesize that heat stress experienced through the intrauterine environment will alter the mammary gland microstructure and cellular processes involved in cell turnover during the cow's first lactation. Mammary biopsies were collected from first-lactation heifers that were exposed to heat stress or cooling conditions while developing in utero (IUHT and IUCL; respectively, n = 9-10). IUHT heifers produced less milk compared to IUCL. The mammary glands of IUHT heifers differed morphologically from IUCL, with the IUHT heifers having smaller alveoli and a greater proportion of connective tissue relative to their IUCL herdmates. However, intrauterine heat stress had little impact on the proliferation and apoptosis of mammary cells during lactation. Our results indicate that fetal exposure to heat stress impairs milk production in the first lactation, in part, by inducing aberrant mammary morphology. This may result from alterations in the developmental trajectory of the fetal mammary gland that persist through the first lactation rather than to alterations in the cellular processes controlling mammary cell turnover during lactation.	[Skibiel, Amy L.; Dado-Senn, Bethany; Fabris, Thiago F.; Dahl, Geoffrey E.; Laporta, Jimena] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Laporta, J (corresponding author), Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA.	jlaporta@ufl.edu	Laporta, Jimena/AAX-3093-2021; Dahl, Geoffrey/AAC-4953-2019	Dado-Senn, Bethany/0000-0002-6104-7334	University of Florida Institute of Food and Agricultural Sciences Climate Change; Florida's Agricultural, Natural Resource and Human Systems 2016 Seed Fund Grant; USDA NIFA AFRI Foundational Program [2015-67015-23409]	University of Florida Institute of Food and Agricultural Sciences Climate Change; Florida's Agricultural, Natural Resource and Human Systems 2016 Seed Fund Grant; USDA NIFA AFRI Foundational Program	Funding was provided through University of Florida Institute of Food and Agricultural Sciences Climate Change; and Florida's Agricultural, Natural Resource and Human Systems 2016 Seed Fund Grant awarded to Dr. Laporta. The authors acknowledge USDA NIFA AFRI Foundational Program (Award#2015-67015-23409) awarded to Dr. Dahl for additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed BMS, 2017, J ANIM SCI, V95, P3497, DOI [10.2527/jas2016.1298, 10.2527/jas.2016.1298]; Akers R.M., 2002, LACTATION MAMMARY GL, V1st; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; Baumgard LH, 2013, ANNU REV ANIM BIOSCI, V1, P311, DOI 10.1146/annurev-animal-031412-103644; Bernabucci U, 2010, ANIMAL, V4, P1167, DOI 10.1017/S175173111000090X; Burgos R, 2006, J ANIM SCI, V84, P399; Cai Y, ASIAN ASTRALAS J ANI; Capuco AV, 2012, ANIMAL, V6, P382, DOI 10.1017/S1751731111002369; Capuco AV, 2003, J ANIM SCI, V81, P18; Capuco AV, 2002, TISSUE CELL, V34, P143, DOI 10.1016/S0040-8166(02)00024-1; Capuco AV, 2001, J DAIRY SCI, V84, P2177, DOI 10.3168/jds.S0022-0302(01)74664-4; Castillo V, 2008, J DAIRY SCI, V91, P3403, DOI 10.3168/jds.2008-1097; COLLIER RJ, 1982, J ANIM SCI, V54, P309, DOI 10.2527/jas1982.542309x; Davis SR, 1998, J DAIRY RES, V65, P1, DOI 10.1017/S0022029997002562; do Amaral BC, 2009, J DAIRY SCI, V92, P5988, DOI 10.3168/jds.2009-2343; Du J, 2008, J THERM BIOL, V33, P37, DOI 10.1016/j.jtherbio.2007.06.002; Fabris TF, 2017, J DAIRY SCI, V100, P6733, DOI 10.3168/jds.2016-12313; Farr VC, 1996, J DAIRY SCI, V79, P543, DOI 10.3168/jds.S0022-0302(96)76398-1; Fernandez-Twinn DS, 2007, CARCINOGENESIS, V28, P545, DOI 10.1093/carcin/bgl166; Ferreira FC, 2016, J DAIRY SCI, V99, P9931, DOI 10.3168/jds.2016-11566; HilakiviClarke L, 1997, P NATL ACAD SCI USA, V94, P9372, DOI 10.1073/pnas.94.17.9372; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; Knight CH, 2001, REPRODUCTION, V122, P337, DOI 10.1530/rep.0.1220337; KNIGHT CH, 1994, J DAIRY RES, V61, P167, DOI 10.1017/S0022029900028181; Knight CH, 2000, LIVEST PROD SCI, V66, P169, DOI 10.1016/S0301-6226(00)00224-4; Li L, 2015, CELL STRESS CHAPERON, V20, P381, DOI 10.1007/s12192-014-0559-7; Monteiro APA, 2016, J DAIRY SCI, V99, P8443, DOI 10.3168/jds.2016-11072; Monteiro APA, 2016, J DAIRY SCI, V99, P3896, DOI 10.3168/jds.2015-10699; O'Neill KL, 1998, APOPTOSIS, V3, P369, DOI 10.1023/A:1009689407261; Rowson AR, 2012, SEMIN CELL DEV BIOL, V23, P557, DOI 10.1016/j.semcdb.2012.03.018; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skibiel AL, 2017, J DAIRY SCI, V100, P7659, DOI 10.3168/jds.2017-12619; Sorensen MT, 2006, J DAIRY SCI, V89, P4632, DOI 10.3168/jds.S0022-0302(06)72513-9; Tao S, 2012, J DAIRY SCI, V95, P7128, DOI 10.3168/jds.2012-5697; Tao S, 2011, J DAIRY SCI, V94, P5976, DOI 10.3168/jds.2011-4329; Thevenaz P., 2010, BIOMEDICAL IMAGING G; Thornton PK, 2009, AGR SYST, V101, P113, DOI 10.1016/j.agsy.2009.05.002; van der Linden DS, 2009, J ANIM SCI, V87, P3944, DOI 10.2527/jas.2009-2125; Wohlgemuth SE, 2016, J DAIRY SCI, V99, P4875, DOI 10.3168/jds.2015-10649; Zimbleman R. B., 2009, J DAIRY SCI, V92, P347	40	25	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0206046	10.1371/journal.pone.0206046	http://dx.doi.org/10.1371/journal.pone.0206046			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325972	gold, Green Published, Green Submitted			2022-12-26	WOS:000447430800052
J	Won, SJ; Minnella, AM; Wu, L; Eun, CH; Rome, E; Herson, PS; Shaw, AE; Bamburg, JR; Swanson, RA				Won, Seok Joon; Minnella, Angela M.; Wu, Long; Eun, Claire H.; Rome, Eric; Herson, Paco S.; Shaw, Alisa E.; Bamburg, James R.; Swanson, Raymond A.			Cofilin-actin rod formation in neuronal processes after brain ischemia	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; ADF/COFILIN; ATP; OCCLUSION; DYNAMICS; PROTEIN; MODELS	Functional impairment after brain ischemia results in part from loss of neuronal spines and dendrites, independent of neuronal death. Cofilin-actin rods are covalently linked aggregates of cofilin-1 and actin that form in neuronal processes (neurites) under conditions of ATP depletion and oxidative stress, and which cause neurite degeneration if not disassembled. ATP depletion and oxidative stress occur with differing severity, duration, and time course in different ischemic conditions. Here we evaluated four mouse models of brain ischemia to define the conditions that drive formation of cofilin-actin rods. Three of the models provide early reperfusion: transient middle cerebral artery occlusion (MCAo), transient bilateral common carotid artery occlusion (CCAo), and cardiac arrest/cardiopulmonary resuscitation (CA/CPR). Early reperfusion restores ATP generating capacity, but also induces oxidative stress. The fourth model, photothrombotic cortical infarction, does not provide reperfusion. Cofilin-actin rods were formed in each of these models, but with differing patterns. Where acute reperfusion occurred, rod formation was maximal within 4 hours after reperfusion. Where infarction occurred, rods continued to form for at least 24 hours after ischemic onset, and extended into the adjacent non-ischemic tissue. Interventions that limit cofilin-actin rod formation may help to preserve integrity of neuronal processes in permanent ischemia.	[Won, Seok Joon; Minnella, Angela M.; Wu, Long; Eun, Claire H.; Rome, Eric; Swanson, Raymond A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Won, Seok Joon; Minnella, Angela M.; Wu, Long; Eun, Claire H.; Rome, Eric; Swanson, Raymond A.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Herson, Paco S.] Univ Colorado, Neuronal Injury Program, Dept Anesthesiol, Anschutz Med Campus, Aurora, CO USA; [Herson, Paco S.] Univ Colorado, Dept Pharmacol, Anschutz Med Campus, Aurora, CO USA; [Shaw, Alisa E.; Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado State University	Won, SJ (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.; Won, SJ (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.	Seokjoon.won@va.gov		Wu, Long/0000-0003-1165-1784	National Institutes of Health [R01AG049668, R01NS081149]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG049668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health (R01AG049668, JRB; R01NS081149, RAS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; Alhadidi Q, 2016, TRANSL STROKE RES, V7, P33, DOI 10.1007/s12975-015-0438-2; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; Bamburg JR, 2016, CYTOSKELETON, V73, P477, DOI 10.1002/cm.21282; Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; Bernstein BW, 2012, J NEUROSCI, V32, P6670, DOI 10.1523/JNEUROSCI.6020-11.2012; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bernstein BW, 2003, J NEUROSCI, V23, P1; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Engl E, 2015, J PHYSIOL-LONDON, V593, P3417, DOI 10.1113/jphysiol.2014.282517; Flynn KC, 2009, DEV NEUROBIOL, V69, P761, DOI 10.1002/dneu.20734; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Gulati T, 2015, J NEUROSCI, V35, P8653, DOI 10.1523/JNEUROSCI.5007-14.2015; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Kanellos G, 2016, J CELL SCI, V129, P3211, DOI 10.1242/jcs.187849; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kofler J, 2004, J NEUROSCI METH, V136, P33, DOI 10.1016/j.jneumeth.2003.12.024; LIU T, 2017, SCI REP, P1; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Madineni A, 2016, MOL NEUROBIOL, V53, P867, DOI 10.1007/s12035-014-9056-3; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; MELDRUM BS, 1987, MED BIOL, V65, P153; Mi JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059430; Minamide LS, 2010, J BIOL CHEM, V285, P5450, DOI 10.1074/jbc.M109.063768; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Neumann JT, 2013, CURR DRUG TARGETS, V14, P20; Quillinan N, 2017, J CEREBR BLOOD F MET, V37, P3053, DOI 10.1177/0271678X16683691; Shaw AE, 2017, PHARMACOL THERAPEUT, V175, P17, DOI 10.1016/j.pharmthera.2017.02.031; Sheth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129735; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Shu L, 2019, J CEREBR BLOOD F MET, V39, P2181, DOI 10.1177/0271678X18785567; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Wang Q, 2006, BRAIN RES, V1090, P182, DOI 10.1016/j.brainres.2006.03.060; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Whiteman IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020878; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; Won SJ, 2015, J NEUROSCI, V35, P7143, DOI 10.1523/JNEUROSCI.4826-14.2015; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005	42	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0198709	10.1371/journal.pone.0198709	http://dx.doi.org/10.1371/journal.pone.0198709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325927	Green Published, Green Submitted, gold			2022-12-26	WOS:000447430800002
J	Wongkamhaeng, K; Dumrongrojwattana, P; Shin, MH				Wongkamhaeng, Koraon; Dumrongrojwattana, Pongrat; Shin, Myung-Hwa			Discovery of a new genus and species of dogielinotid amphipod (Crustacea: Amphipoda: Dogielinotidae) from the Nipa palm in Thailand, with an updated key to the genera	PLOS ONE			English	Article								During a scientific survey, a new genus of the dogielinotid amphipoda was found in the Nipa palm (Nypa fruticans) in Bang Krachao Urban Oasis, Samut Prakan Province, Thailand. We placed this new genus, Allorchestoides gen. nov., within the family Dogielinotidae. The new taxa can be easily distinguished from the remaining genera by differences in the incisor of the left and right mandibles, apical robust setae of the maxilla 1, and the large coxa and strong obtuse palm in the female gnathopod 1. The type species of Allorchestoides gen. nov., Allorchestoides rosea n. sp., is described here in, with an updated key to the genera of the family Dogielinotidae.	[Wongkamhaeng, Koraon] Kasetsart Univ, Dept Zool, Fac Sci, Bangkok, Thailand; [Wongkamhaeng, Koraon] Prince Songkla Univ, Coastal Oceanog & Climate Change Res Ctr, Hat Yai, Songkhla, Thailand; [Dumrongrojwattana, Pongrat] Burapha Univ, Dept Biol, Fac Sci, Bangsaen, Chonburi, Thailand; [Shin, Myung-Hwa] Natl Marine Biodivers Inst Korea, Seocheon, South Korea	Kasetsart University; Prince of Songkla University; Burapha University; Marine Biodiversity Institute of Korea (MABIK)	Wongkamhaeng, K (corresponding author), Kasetsart Univ, Dept Zool, Fac Sci, Bangkok, Thailand.; Wongkamhaeng, K (corresponding author), Prince Songkla Univ, Coastal Oceanog & Climate Change Res Ctr, Hat Yai, Songkhla, Thailand.	koraon.w@ku.ac.th	Dumrongrojwattana, Pongrat/AHE-5840-2022; wongkamhaeng, koraon/E-6244-2010; Dumrongrojwattana, Pongrat/GRO-1081-2022	wongkamhaeng, koraon/0000-0001-7671-8869; 	Research Grant of Burapha University through National Research Council of Thailand [185/2560, 136/2561]; National Marine Biodiversity Institute Research Program [2018M00100]; Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea [20170488]	Research Grant of Burapha University through National Research Council of Thailand; National Marine Biodiversity Institute Research Program; Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea	The first and second authors (KW and PD) is supported by Research Grant of Burapha University through National Research Council of Thailand (Grant no. 185/2560) and the second authors (MHS) is supported by National Marine Biodiversity Institute Research Program (2018M00100) and Marine Biotechnology Program(20170488) funded by the Ministry of Oceans and Fisheries, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Ed Bousfield (Canadian Museum of Nature), who discussed several aspects of the evolution of the Talitroidea. We are grateful to the Marine and Coastal Resources Institute for the use of their laboratory facilities. The senior author would like to thank Dr. Patchara Danaisawat, as she has been a tremendous source of inspiration for this work. We also thank Dr. Azman Abdul Rahim for producing a map of the sampling area. This work was financial supported by Research Grant of Burapha University through National Research Council of Thailand (Grant no. 136/2561), National Marine Biodiversity Institute Research Program(2018M00100) and Marine Biotechnology Program(20170488) funded by the Ministry of Oceans and Fisheries, Korea.	Barnard J.L., 1991, RECORDS AUSTR MUSE S, V13, P419, DOI DOI 10.3853/J.0812-7387.13.1991.367; Bousfield E.L., 2002, Amphipacifica, V3, P17; Bousfield E.L., 1982, Issledovaniya Fauny Morei, V29, P76; Bousfield E.L., 1996, B MUSEO CIVICO STORI, V20, P175, DOI DOI 10.5962/BHL.TITLE.58522; Bulycheva A.I., 1957, DOKL AKAD NAUK+, V65, P1; Coleman C.O., 2003, ORG DIVERS EVOL, V3, P1, DOI [10.1078/1439-6092-00081, DOI 10.1078/1439-6092-00081]; Derjavin A. N., 1937, EXPLORATIONS MERS UR, V23, P106; Garm A, 2004, J MORPHOL, V260, P85, DOI 10.1002/jmor.10213; GURJANOVA E., 1953, TRUD ZOOLOG INST SSSR, V13, P216; Hendrycks E.A., 2001, Amphipacifica, V3, P3; Holmquist C., 1989, FUNCTIONAL MORPHOLOG; Horton T., 2018, TALITROIDEA RAFINESQ; Just J., 1978, ZOOLOGICA SCRIPTA, V6, P229; Kamihira Y., 1977, NEW SAND BURROWING M, V28, P1; Lazo-Wasem E. A., 2001, B PEABODY MUS NAT HI, P1; Lowry JK, 2013, ZOOTAXA, V3610, DOI 10.11646/zootaxa.3610.1.1; OLDEVIG HUGO, 1958, ARKIV ZOOL, V11, P343; Serejo CS, 2004, ZOOL SCR, V33, P551, DOI 10.1111/j.0300-3256.2004.00163.x	18	0	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0204299	10.1371/journal.pone.0204299	http://dx.doi.org/10.1371/journal.pone.0204299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321188	Green Published, Green Submitted, gold			2022-12-26	WOS:000447417900004
J	Bradbury-Jones, C; Ogik, P; Betts, J; Taylor, J; Lund, P				Bradbury-Jones, Caroline; Ogik, Peter; Betts, Jane; Taylor, Julie; Lund, Patricia			Beliefs about people with albinism in Uganda: A qualitative study using the Common-Sense Model	PLOS ONE			English	Article							OCULOCUTANEOUS ALBINISM; RESEARCH METHODOLOGY; SURROUNDING PEOPLE; SOUTH-AFRICA; KNOWLEDGE; CHILDREN; UBUNTU; EDUCATION; TANZANIA; HEALTH	Albinism includes a group of inherited conditions that result in reduced melanin production. It has been documented across the world, with a high frequency in sub-Saharan Africa. There is very little published research about the lives of people with albinism, but available evidence shows that myths abound regarding their condition. They are feared, viewed with suspicion and believed to have supernatural powers. In this study we explored the links between beliefs, myths, traditions and positive/negative attitudes that surround people with albinism in Uganda. The study was located philosophically within Ubuntu-an-Afrocentric worldview-and theoretically within the Common-Sense Model of self-regulation of health and illness that originates from the work of Leventhal in 2003. This qualitative study took place in eight districts of Busoga sub-region, Uganda between 2015 and 2017. Data collection comprised eight group discussions and 17 individual interviews with a range of informants, capturing the viewpoints of 73 participants. Findings lend support to previous research, highlighting the lifetime discrimination and disadvantage experienced by many people with albinism. It shows that there is still much to be done to address the pervasive and potentially harmful beliefs and misconceptions about people with albinism.	[Bradbury-Jones, Caroline; Taylor, Julie] Univ Birmingham, Sch Nursing, Birmingham, W Midlands, England; [Ogik, Peter] Source Nile Union Persons Albinism, Head Off, Jinja, Uganda; [Betts, Jane] Advantage Africa, Olney, Bucks, England; [Taylor, Julie] Birmingham Womens & Childrens Hosp NHS Fdn Trust, Birmingham, W Midlands, England; [Lund, Patricia] Coventry Univ, Sch Life Sci, Albinism Africa Project, Coventry, W Midlands, England	University of Birmingham; Birmingham Women's Hospital; Coventry University	Bradbury-Jones, C (corresponding author), Univ Birmingham, Sch Nursing, Birmingham, W Midlands, England.	c.bradbury-jones@bham.ac.uk		bradbury-jones, caroline/0000-0002-5237-6777	FIRAH - Fondation Internationale de la Recherche Appliquee [AP2014-47]; Coventry University: International Foundation of Applied Disability Research (FIRAH); Simon Goodman (SG), Coventry University	FIRAH - Fondation Internationale de la Recherche Appliquee; Coventry University: International Foundation of Applied Disability Research (FIRAH); Simon Goodman (SG), Coventry University	This work was supported by FIRAH - Fondation Internationale de la Recherche Appliquee, grant number: FIRAH code AP2014-47. URL to their website: http://www.firah.org/, www.firah.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the funders of the original study led by Coventry University: International Foundation of Applied Disability Research (FIRAH). Simon Goodman (SG), Coventry University undertook an initial thematic analysis for the grant report submitted to the funder. Sincere thanks to Sarah Babirye, Fazira Kawuma, Faruk Kiiza and Sharifa Nabaggala from SNUPA who undertook the interviews and transcription in Uganda. We take this opportunity to thank the very many participants who came forward to share their experiences, insights and beliefs about albinism.	Baker C, 2010, J AFR CULT STUD, V22, P169, DOI 10.1080/13696815.2010.491412; Baker S. E., 2018, MANY QUALITATIVE INT; Barbour R., 2007, DOING FOCUS GROUPS; Braathen SH, 2006, DISABIL SOC, V21, P599, DOI 10.1080/09687590600918081; Brocco G, 2016, ANTHROPOL MED, V23, P229, DOI 10.1080/13648470.2016.1184009; Brocco G, 2015, DISABIL SOC, V30, P1143, DOI 10.1080/09687599.2015.1075869; Bucaro S, 2010, PUB INT LAW REP, V2, P15; Carlsen B, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-26; Chilisa B, 2017, SUSTAIN SCI, V12, P813, DOI 10.1007/s11625-017-0461-1; Dysli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158815; Franklin A., 2017, KNOWLEDGE BASED DESC; Franklin A, 2018, BMC INT HEALTH HUM R, V18, DOI 10.1186/s12914-018-0144-8; Gaigher R J, 2002, Curationis, V25, P4; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hong ES, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-212; Keane M, 2017, EDUC RES SOC CHANG, V6, P12, DOI 10.17159/2221-4070/2017/v6i1a2; Keane M, 2016, EDUC CHANGE, V20, P163, DOI 10.17159/1947-9417/2016/913; Khupe C, 2017, EDUC RES SOC CHANG, V6, P25, DOI [10.17159/2221-4070/2017/v6i1a3, 10.17159/2221-4070/2017/v6i1a3j]; Kovoch M., 2009, INDIGENOUS METHODOLO; Kromberg Jennifer, 2018, ALBINISM AFRICA HIST; Leventhal H, 2003, SELF REGULATION HLTH, P42, DOI DOI 10.1093/RHEUMATOLOGY/KEM060; Lund P., 1998, J SOC BIOL HUM AFF, V63, P3; Lund P.M., 2018, ALBINISM AFRICA; Lund PM, 2002, HEALTH EDUC RES, V17, P365, DOI 10.1093/her/17.3.365; Lund PM, 1996, J MED GENET, V33, P641, DOI 10.1136/jmg.33.8.641; Lund PM, 2001, HEALTH EDUC RES, V16, P1, DOI 10.1093/her/16.1.1; Lynch P, 2014, INT J EDUC DEV, V39, P226, DOI 10.1016/j.ijedudev.2014.07.002; Mabula JB, 2012, BMC DERMATOL, V12, DOI 10.1186/1471-5945-12-5; Masanja M. M., 2015, ASIAN J APPL SCI ENG, V3, P14; Metz T, 2010, J MORAL EDUC, V39, P273, DOI 10.1080/03057240.2010.497609; Miles S., 2011, INT J INCLUSIVE EDUC, V15, P1073; Mkabela Q, 2005, QUAL REP, V10, P178; Muwanga-Zake JWF, 2009, DISCOURSE-ABINGDON, V30, P413, DOI 10.1080/01596300903237198; Muwanga-Zake J.W.F, 2010, CURRENT NARRATIVES, V2, P68; National Organization for Albinism and Hypopigmentation (NOAH), 2018, INF B WHAT YOU CALL; Nkondo GM, 2007, INT J AFR RENAISS ST, V2, P88, DOI 10.1080/18186870701384202; Palmer C, 2007, BRIT J VISUAL IMPA, V25, P144, DOI 10.1177/0264619607075998; Penn C, 2010, J GENET COUNS, V19, P9, DOI 10.1007/s10897-009-9252-x; Phatoli R, 2015, AFR J DISABIL, V4, DOI 10.4102/ajod.v4i1.106; Pooe-Monyemore MBJ, 2012, HEALTH SA GESONDHEID, V17, DOI 10.4102/hsag.v17i1.592; Raliavhegwa M, 2001, J MED GENET, V38, pS35; Seehawer MK, 2018, INT J SOC RES METHOD, V21, P453, DOI 10.1080/13645579.2018.1432404; Smith LT, 2012, DECOLONIZING METHODO; Tanner R, 2010, ANTHROPOLOGIST, V12, P229, DOI 10.1080/09720073.2010.11891161; Under the Same Sun, 2018, ALB VS PERS ALB PWA; Under the Same Sun (UTSS), 2018, SUP WITCHCR; Yahalom C, 2012, BRIT J OPHTHALMOL, V96, P537, DOI 10.1136/bjophthalmol-2011-300072	47	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205774	10.1371/journal.pone.0205774	http://dx.doi.org/10.1371/journal.pone.0205774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0UN	30312349	Green Published, gold, Green Submitted			2022-12-26	WOS:000447427300056
J	Hogers, RCJ; de Ruiter, M; Huvenaars, KHJ; van der Poel, H; Janssen, A; van Eijk, MJT; van Orsouw, NJ				Hogers, Rene C. J.; de Ruiter, Marjo; Huvenaars, Koen H. J.; van der Poel, Hein; Janssen, Antoine; van Eijk, Michiel J. T.; van Orsouw, Nathalie J.			SNPSelect: A scalable and flexible targeted sequence-based genotyping solution	PLOS ONE			English	Article							MAIZE; LOCI	In plant breeding the use of molecular markers has resulted in tremendous improvement of the speed with which new crop varieties are introduced into the market. Single Nucleotide Polymorphism (SNP) genotyping is routinely used for association studies, Linkage Disequilibrium (LD) and Quantitative Trait Locus (QTL) mapping studies, marker-assisted back-crosses and validation of large numbers of novel SNPs. Here we present the KeyGene SNPSelect technology, a scalable and flexible multiplexed, targeted sequence-based, genotyping solution. The multiplex composition of SNPSelect assays can be easily changed between experiments by adding or removing loci, demonstrating their content flexibility. To demonstrate this versatility, we first designed a 1,056-plex maize assay and genotyped a total of 374 samples originating from an F2 and a Recombinant Inbred Line (RIL) population and a maize germplasm collection. Next, subsets of the most informative SNP loci were assembled in 384-plex and 768-plex assays for further genotyping. Indeed, selection of the most informative SNPs allows cost-efficient yet highly informative genotyping in a custom-made fashion, with average call rates between 88.1% (1,056-plex assay) and 99.4% (384-plex assay), and average reproducibility rates between duplicate samples ranging from 98.2% (1056-plex assay) to 99.9% (384-plex assay). The SNPSelect workflow can be completed from a DNA sample to a genotype dataset in less than three days. We propose SNPSelect as an attractive and competitive genotyping solution to meet the targeted genotyping needs in fields such as plant breeding.	[Hogers, Rene C. J.; de Ruiter, Marjo; Huvenaars, Koen H. J.; van der Poel, Hein; Janssen, Antoine; van Eijk, Michiel J. T.; van Orsouw, Nathalie J.] Keygene NV, Wageningen, Gelderland, Netherlands	Keygene N.V.	van Orsouw, NJ (corresponding author), Keygene NV, Wageningen, Gelderland, Netherlands.	nathalie.van-orsouw@keygene.com						Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; [Anonymous], 2010, SOILS PLANT GROWTH C; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bumgarner Roger, 2013, Curr Protoc Mol Biol, VChapter 22, DOI 10.1002/0471142727.mb2201s101; Buntjer J, 2002, PLANT AN MICR GEN C; Dobosy JR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-80; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Ghosh S. K., 2001, Journal of Intellectual Property Rights, V6, P377; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Hipi A, 2013, INT J APPL SCI TECHN, V3; Jamann TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168910; Macdonald SJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r105; Muraya MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132120; Prasanna BM, 2010, MOL BREEDING, V26, P339, DOI 10.1007/s11032-009-9387-3; Rousselle Y, 2015, CROP SCI, V55, P1170, DOI 10.2135/cropsci2014.09.0627; Samelak-Czajka A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00222; Semagn K, 2015, CROP SCI, V55, P1449, DOI 10.2135/cropsci2014.09.0646; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Stull GW, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200497; Tobler Andreas R, 2005, J Biomol Tech, V16, P398; Truong HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037565; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; van Eijk MJT, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh045; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; van Poecke RMP, 2013, PLANT BIOTECHNOL J, V11, P809, DOI 10.1111/pbi.12072; Xiao YJ, 2017, MOL PLANT, V10, P359, DOI 10.1016/j.molp.2016.12.008	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205577	10.1371/journal.pone.0205577	http://dx.doi.org/10.1371/journal.pone.0205577			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312324	Green Submitted, gold, Green Published			2022-12-26	WOS:000447427300039
J	Sauget, M; Bertrand, X; Hocquet, D				Sauget, Marlene; Bertrand, Xavier; Hocquet, Didier			Rapid antibiotic susceptibility testing on blood cultures using MALDI-TOF MS	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; RESISTANCE; ENTEROBACTERIACEAE; IDENTIFICATION; SYSTEM	Antibiotic resistance is a major public health problem requiring the early optimization of antibiotic prescriptions. Matrix-Assisted Laser Desorption Ionization-Time Of Flight Mass Spectrometry (MALDI-TOF MS) has been shown to accurately identify bacteria from positive blood culture. Here, we developed a rapid detection of Escherichia coli resistance to amoxicillin (AMX) and cefotaxime (CTX) from positive blood culture based on MALDI-TOF MS. Potential sparing of broad-spectrum antibiotics was also evaluated. We tested 103 E. coli-positive blood cultures. Blood cultures were subculture 1-hour in antibiotic-free rich liquid media before further incubation with and without AMX for 2.5 h or CTX for 2 h. Protein extracts associated with an internal control were spotted on a MALDI-TOF target and spectra were analyzed with the MBT-ASTRA prototype software (Bruker Daltonik GmbH, Bremen, Germany). Bacterial growth ratio was calculated from the AUC spectra obtained in the presence and absence of the antibiotic and compared to a threshold which classified E. coli as susceptible or resistant. Results were interpreted with MICs determined using agar dilution method as reference technique. MBT-ASTRA recognized 95% and 84% of the AMX-and CTX-susceptible isolates, respectively. Overall, quantitative analysis of mass spectra allows susceptibility testing within 4 hours after the positivity of blood culture with E. coll. At the first report of positive blood culture, MALDI-TOF MS would then provide the prescribers with the bacterial identification and the susceptibility to AMX and CTX, thus limiting the use of broad-spectrum compounds.	[Sauget, Marlene; Bertrand, Xavier; Hocquet, Didier] Ctr Hosp Reg Univ, Hyg Hosp, Besancon, France; [Sauget, Marlene; Hocquet, Didier] Ctr Hosp Reg Univ, Ctr Ressources Biol Filiere Microbiol Besancon, Besancon, France; [Sauget, Marlene; Bertrand, Xavier; Hocquet, Didier] Univ Bourgogne Franche Comte, UMR CNRS Chronoenvironm 6249, Besancon, France	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte	Sauget, M (corresponding author), Ctr Hosp Reg Univ, Hyg Hosp, Besancon, France.; Sauget, M (corresponding author), Ctr Hosp Reg Univ, Ctr Ressources Biol Filiere Microbiol Besancon, Besancon, France.; Sauget, M (corresponding author), Univ Bourgogne Franche Comte, UMR CNRS Chronoenvironm 6249, Besancon, France.	msauget@chu-besancon.fr	Bertrand, Xavier/AAK-3270-2021; Bertrand, Xavier/AAL-3809-2021; Hocquet, Didier/AAK-9107-2020	Bertrand, Xavier/0000-0002-8028-1396; Hocquet, Didier/0000-0002-4192-7238; Sauget, Marlene/0000-0003-4734-1075	European Grant "Fonds europeen de developpement regional" [34534]	European Grant "Fonds europeen de developpement regional"	This work was funded by a call for projects "Jeunes chercheurs, Groupement Interregional de Recherche Clinique et d'Innovation Est, France, 2015". This study was supported by a European Grant "Fonds europeen de developpement regional" (number 34534). Bruker Daltonik made MBT-ASTRA prototype software freely available for the experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, M100 PERFORMANCE STA; Ceyssens PJ, 2017, J CLIN MICROBIOL, V55, P624, DOI 10.1128/JCM.02089-16; EUCAST, 2018, BREAKP TABL INT MICS; Idelevich EA, 2018, CLIN MICROBIOL INFEC, V24, P738, DOI 10.1016/j.cmi.2017.10.016; Idelevich EA, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00913-18; Jung JS, 2016, J CLIN MICROBIOL, V54, P2820, DOI 10.1128/JCM.01131-16; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Lange C, 2014, J CLIN MICROBIOL, V52, P4155, DOI 10.1128/JCM.01872-14; Lasserre C, 2015, J CLIN MICROBIOL, V53, P2163, DOI 10.1128/JCM.03467-14; Marschal M, 2017, J CLIN MICROBIOL, V55, P2116, DOI [10.1128/jcm.00181-17, 10.1128/JCM.00181-17]; MCGREGOR A, 1995, PATHOLOGY, V27, P172, DOI 10.1080/00313029500169822; Morgenthaler Nils G, 2015, Int J Microbiol, V2015, P827416, DOI 10.1155/2015/827416; Pliakos EE, 2018, CLIN MICROBIOL REV, V31, DOI [10.1128/CMR.00095-17, 10.1128/cmr.00095-17]; Sauget M, 2017, TRENDS MICROBIOL, V25, P447, DOI 10.1016/j.tim.2016.12.006; Sparbier K, 2016, METHODS, V104, P48, DOI 10.1016/j.ymeth.2016.01.008; Sparbier K, 2012, J CLIN MICROBIOL, V50, P927, DOI 10.1128/JCM.05737-11; Stewardson AJ, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.33.30319; Woodford N, 2010, J CLIN MICROBIOL, V48, P2999, DOI 10.1128/JCM.00341-10	18	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205603	10.1371/journal.pone.0205603	http://dx.doi.org/10.1371/journal.pone.0205603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308072	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500108
J	Polianskyte-Prause, Z; Tolvanen, TA; Lindfors, S; Dumont, V; Van, M; Wang, H; Dash, SN; Berg, M; Naams, JB; Hautala, LC; Nisen, H; Mirtti, T; Groop, PH; Wahala, K; Tienari, J; Lehtonen, S				Polianskyte-Prause, Zydrune; Tolvanen, Tuomas A.; Lindfors, Sonja; Dumont, Vincent; Van, Mervi; Wang, Hong; Dash, Surjya N.; Berg, Mika; Naams, Jette-Britt; Hautala, Laura C.; Nisen, Harry; Mirtti, Tuomas; Groop, Per-Henrik; Wahala, Kristiina; Tienari, Jukka; Lehtonen, Sanna			Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity	FASEB JOURNAL			English	Article						diabetic kidney disease; insulin resistance; lipid phosphatase; podocyte; type 2 diabetes	ACTIVATED PROTEIN-KINASE; LIPID PHOSPHATASE SHIP2; INSULIN-RESISTANCE; PLASMA-MEMBRANE; METABOLISM; MECHANISM; PATHWAY; GLUT4; RAT; GLUCONEOGENESIS	Metformin, the first-line drug to treat type 2 diabetes (T2D), inhibits mitochondrial glycerolphosphate dehydrogenase in the liver to suppress gluconeogenesis. However, the direct target and the underlying mechanisms by which metformin increases glucose uptake in peripheral tissues remain uncharacterized. Lipid phosphatase Src homology 2 domain-containing inositol-5-phosphatase 2 (SHIP2) is upregulated in diabetic rodent models and suppresses insulin signaling by reducing Akt activation, leading to insulin resistance and diminished glucose uptake. Here, we demonstrate that metformin directly binds to and reduces the catalytic activity of the recombinant SHIP2 phosphatase domain in vitro. Metformin inhibits SHIP2 in cultured cells and in skeletal muscle and kidney of db/db mice. In SHIP2-overexpressing myotubes, metformin ameliorates reduced glucose uptake by slowing down glucose transporter 4 endocytosis. SHIP2 overexpression reduces Akt activity and enhances podocyte apoptosis, and both are restored to normal levels by metformin. SHIP2 activity is elevated in glomeruli of patients with T2D receiving nonmetformin medication, but not in patients receiving metformin, compared with people without diabetes. Furthermore, podocyte loss in kidneys of metformin-treated T2D patients is reduced compared with patients receiving nonmetformin medication. Our data unravel a novel molecular mechanism by which metformin enhances glucose uptake and acts renoprotectively by reducing SHIP2 activity.Polianskyte-Prause, Z., Tolvanen, T. A., Lindfors, S., Dumont, V., Van, M., Wang, H., Dash, S. N., Berg, M., Naams, J.-B., Hautala, L. C., Nisen, H., Mirtti, T., Groop, P.-H., Wahala, K., Tienari, J., Lehtonen, S. Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity.	[Polianskyte-Prause, Zydrune; Tolvanen, Tuomas A.; Lindfors, Sonja; Dumont, Vincent; Van, Mervi; Wang, Hong; Dash, Surjya N.; Naams, Jette-Britt; Hautala, Laura C.; Mirtti, Tuomas; Tienari, Jukka; Lehtonen, Sanna] Univ Helsinki, Dept Pathol, Haartmaninkatu 3,B241,POB 21, Helsinki 00014, Finland; [Berg, Mika; Wahala, Kristiina] Univ Helsinki, Dept Chem, Helsinki, Finland; [Groop, Per-Henrik] Univ Helsinki, Folkhalsan Inst Genet, Folkhalsan Res Ctr, Helsinki, Finland; [Groop, Per-Henrik] Univ Helsinki, Res Program Unit, Diabet & Obes, Helsinki, Finland; [Nisen, Harry] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland; [Groop, Per-Henrik] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland; [Groop, Per-Henrik] Helsinki Univ Hosp, Helsinki, Finland; [Groop, Per-Henrik] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Tienari, Jukka] Helsinki Univ Hosp, Hyvinkaa, Finland	University of Helsinki; University of Helsinki; Folkhalsan Research Center; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Monash University; University of Helsinki; Helsinki University Central Hospital	Lehtonen, S (corresponding author), Univ Helsinki, Dept Pathol, Haartmaninkatu 3,B241,POB 21, Helsinki 00014, Finland.	sanna.h.lehtonen@helsinki.fi	Lindfors, Sonja/AAP-2050-2021; Wang, Hong/AAW-6913-2020; Lehtonen, Sanna/GRJ-3642-2022; Lehtonen, Sanna/AAE-4545-2020	Lindfors, Sonja/0000-0002-2024-0760; Wang, Hong/0000-0001-5700-6786; Lehtonen, Sanna/0000-0003-4189-2415; Wahala, Kristiina/0000-0003-4082-8622; Mirtti, Tuomas/0000-0003-0455-9891; Polianskyte-Prause, Zydrune/0000-0002-0145-7032; Dumont, Vincent/0000-0002-2893-5479; Tolvanen, Tuomas Aleksi/0000-0002-3581-208X; Hautala, Laura/0000-0002-5501-2792	European Research Council [242820]; Academy of Finland [131255, 218021, 255551, 134379]; Jane and Aatos Erkko Foundation; European Foundation for the Study of Diabetes/Boehringer Ingelheim Research Programme; Sigrid Juselius Foundation; Paivikki and Sakari Sohlberg Foundation; Diabetes Research Foundation; Business Finland [1964/31/2017]; Helsinki University Hospital; Folkhalsan Research Foundation; Novo Nordisk Foundation; Eli Lilly; Roche; Faculty of Medicine, University of Helsinki; Doctoral Programme in Biomedicine	European Research Council(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); Jane and Aatos Erkko Foundation; European Foundation for the Study of Diabetes/Boehringer Ingelheim Research Programme; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Paivikki and Sakari Sohlberg Foundation; Diabetes Research Foundation; Business Finland; Helsinki University Hospital; Folkhalsan Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Eli Lilly(Eli Lilly); Roche(Roche Holding); Faculty of Medicine, University of Helsinki; Doctoral Programme in Biomedicine	The authors thank M. Saleem (Southmead Hospital, University of Bristol, Bristol United Kingdom) for kindly providing immortalized human podocytes, S. Cushman (National Institutes of Health, Bethesda, MD, USA) for the HA-GLUT4-GFP construct, and C. A. Mitchell (Monash University, Clayton, VIC, Australia) and G. Krystal (Terry Fox Laboratory, Vancouver, BC, Canada) for human SHIP2 (NP_001558) and SHIP1 (NP_005532) cDNA constructs, respectively. Leena Saikko, High Throughput Biomedicine Unit, Biomedicum Flow Cytometry Unit, Biochemical Analysis Core for Experimental Research, and Genome Biology Unit (University of Helsinki) are acknowledged for excellent technical assistance. This work was supported by the European Research Council (Grant 242820; to S.L.), Academy of Finland (Grants 131255, 218021, and 255551 to S.L.; Grant 134379 to P.-H.G.), Jane and Aatos Erkko Foundation (to S.L.), European Foundation for the Study of Diabetes/Boehringer Ingelheim Research Programme (to S.L.), Sigrid Juselius Foundation (to S.L.), Paivikki and Sakari Sohlberg Foundation (to S.L.), Diabetes Research Foundation (to S. L.), Business Finland (1964/31/2017 to S.L.), Faculty of Medicine, University of Helsinki (to S. L.), Helsinki University Hospital (to J.T.), Doctoral Programme in Biomedicine (to T.A.T. and V.D.), Folkhalsan Research Foundation (to P.-H. G.), and Novo Nordisk Foundation (to P.-H. G.). P.-H. G. has received research grants from Eli Lilly and Roche, and is an advisory board member for AbbVie, AstraZeneca, Boehringer-Ingelheim, Cebix, Eli Lilly, Janssen, Medscape, Musculoskeletal Diseases (MSD), and Novartis. P.-H. G. has received lecture honoraria from AstraZeneca, Boehringer-Ingelheim, Eli Lilly, Genzyme, MSD, Novartis, Novo Nordisk, and Sanofi. However, none of the above are relevant to the article. The remaining authors declare no conflicts of interest.	Aatsinki SM, 2014, BRIT J PHARMACOL, V171, P2351, DOI 10.1111/bph.12585; Ahlqvist E, 2018, LANCET DIABETES ENDO, V6, P361, DOI 10.1016/S2213-8587(18)30051-2; Alsahli M, 2017, DIABETES RES CLIN PR, V133, P1, DOI 10.1016/j.diabres.2017.07.033; Amador-Licona N, 2000, ARCH MED RES, V31, P571, DOI 10.1016/S0188-4409(00)00241-1; Amin J, 2015, INFLAMM BOWEL DIS, V21, P445, DOI 10.1097/MIB.0000000000000197; Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Dash SN, 2014, J CELL SCI, V127, P1476, DOI 10.1242/jcs.138495; Dutt V, 2015, PHARMACOL RES, V99, P86, DOI 10.1016/j.phrs.2015.05.010; Edimo WE, 2016, J CELL SCI, V129, P1101, DOI 10.1242/jcs.179663; Eisenreich A, 2017, CURR MED CHEM, V24, P3397, DOI 10.2174/0929867324666170404143102; Erneux C, 2011, J CELL BIOCHEM, V112, P2203, DOI 10.1002/jcb.23146; Eskens BJM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-175; Fery F, 1997, METABOLISM, V46, P227, DOI 10.1016/S0026-0495(97)90307-3; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gallo LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28124; Gallo LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26428; Guo JK, 2012, J AM SOC NEPHROL, V23, P429, DOI 10.1681/ASN.2011040396; Hale LJ, 2013, CLIN SCI, V124, P351, DOI 10.1042/CS20120378; Heikkila E, 2011, BIOCHEM J, V435, P619, DOI 10.1042/BJ20101599; Hoekstra E, 2016, ONCOTARGET, V7, P73525, DOI 10.18632/oncotarget.12321; Hori H, 2002, DIABETES, V51, P2387, DOI 10.2337/diabetes.51.8.2387; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Hyvonen ME, 2010, MOL CELL ENDOCRINOL, V328, P70, DOI 10.1016/j.mce.2010.07.016; Ichihara Y, 2013, EUR J MED CHEM, V62, P649, DOI 10.1016/j.ejmech.2013.01.014; Ishihara H, 1999, BIOCHEM BIOPH RES CO, V260, P265, DOI 10.1006/bbrc.1999.0888; Kagawa S, 2008, ENDOCRINOLOGY, V149, P642, DOI 10.1210/en.2007-0820; Kanzaki M, 2004, J BIOL CHEM, V279, P30622, DOI 10.1074/jbc.M401443200; Kim J, 2012, EXP DIABETES RES, DOI 10.1155/2012/210821; KLIP A, 1992, ENDOCRINOLOGY, V130, P2535, DOI 10.1210/en.130.5.2535; Langer S, 2016, J NEPHROL, V29, P765, DOI 10.1007/s40620-015-0258-1; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Marion E, 2002, DIABETES, V51, P2012, DOI 10.2337/diabetes.51.7.2012; Mills SJ, 2012, ACS CHEM BIOL, V7, P822, DOI 10.1021/cb200494d; Munshi PN, 2014, ONCOLOGIST, V19, P760, DOI 10.1634/theoncologist.2014-0178; Orchard TJ, 2002, KIDNEY INT, V62, P963, DOI 10.1046/j.1523-1755.2002.00507.x; Pan QR, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003247; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Rogacka D, 2014, INT J BIOCHEM CELL B, V51, P120, DOI 10.1016/j.biocel.2014.04.008; Saurus P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.125; Saurus P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10512-w; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Suwa A, 2009, BRIT J PHARMACOL, V158, P879, DOI 10.1111/j.1476-5381.2009.00358.x; Tang XQ, 2005, J BIOL CHEM, V280, P22523, DOI 10.1074/jbc.M501949200; Tolvanen TA, 2015, J CELL SCI, V128, P4588, DOI 10.1242/jcs.175075; Turban S, 2012, J BIOL CHEM, V287, P20088, DOI 10.1074/jbc.M111.330746; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; Viernes DR, 2014, MED RES REV, V34, P795, DOI 10.1002/med.21305; Wiernsperger NF, 1999, DIABETES METAB, V25, P110; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Yang J, 2006, ENDOCRINOLOGY, V147, P2728, DOI 10.1210/en.2005-1433; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	53	41	44	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2858	2869		10.1096/fj.201800529RR	http://dx.doi.org/10.1096/fj.201800529RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30321069	Green Published, hybrid			2022-12-26	WOS:000457296600106
J	del Cano-Ochoa, F; Grande-Garcia, A; Reverte-Lopez, M; D'Abramo, M; Ramon-Maiques, S				del Cano-Ochoa, Francisco; Grande-Garcia, Araceli; Reverte-Lopez, Maria; D'Abramo, Marco; Ramon-Maiques, Santiago			Characterization of the catalytic flexible loop in the dihydroorotase domain of the human multi-enzymatic protein CAD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ASPARTATE TRANSCARBAMOYLASE; NUCLEOTIDE BIOSYNTHESIS; PYRIMIDINE BIOSYNTHESIS; MULTIFUNCTIONAL PROTEIN; INHIBITORS; PURIFICATION; EFFICIENT; MOVEMENT; SYSTEM	The dihydroorotase (DHOase) domain of the multifunctional protein carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, and dihydroorotase (CAD) catalyzes the third step in the de novo biosynthesis of pyrimidine nucleotides in animals. The crystal structure of the DHOase domain of human CAD (huDHOase) revealed that, despite evolutionary divergence, its active site components are highly conserved with those in bacterial DHOases, encoded as monofunctional enzymes. An important element for catalysis, conserved from Escherichia coli to humans, is a flexible loop that closes as a lid over the active site. Here, we combined mutagenic, structural, biochemical, and molecular dynamics analyses to characterize the function of the flexible loop in the activity of CAD's DHOase domain. A huDHOase chimera bearing the E. coli DHOase flexible loop was inactive, suggesting the presence of distinctive elements in the flexible loop of huDHOase that cannot be replaced by the bacterial sequence. We pinpointed Phe-1563, a residue absolutely conserved at the tip of the flexible loop in CAD's DHOase domain, as a critical element for the conformational equilibrium between the two catalytic states of the protein. Substitutions of Phe-1563 with Ala, Leu, or Thr prevented the closure of the flexible loop and inactivated the protein, whereas substitution with Tyr enhanced the interactions of the loop in the closed position and reduced fluctuations and the reaction rate. Our results confirm the importance of the flexible loop in CAD's DHOase domain and explain the key role of Phe-1563 in configuring the active site and in promoting substrate strain and catalysis.	[del Cano-Ochoa, Francisco; Reverte-Lopez, Maria; Ramon-Maiques, Santiago] Ctr Biol Mol Severo Ochoa CSIC UAM, Dept Genome Dynam & Funct, Madrid 28049, Spain; [Grande-Garcia, Araceli] Spanish Natl Canc Res Ctr CNIO, Struct Biol Programme, Madrid 28029, Spain; [D'Abramo, Marco] Sapienza Univ Rome, Dept Chem, I-00185 Rome, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Centro Nacional de Investigaciones Oncologicas (CNIO); Sapienza University Rome	Ramon-Maiques, S (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, Dept Genome Dynam & Funct, Madrid 28049, Spain.	santiago.ramon@cbm.csic.es	Ramon-Maiques, Santiago/R-2533-2019; Grande-García, Araceli/ABH-3169-2020; Reverte-López, María/ABB-8276-2020; D'Abramo, Marco/B-7035-2008	Grande-García, Araceli/0000-0003-2619-5013; Reverte-López, María/0000-0002-6854-7446; D'Abramo, Marco/0000-0001-6020-8581; Ramon-Maiques, Santiago/0000-0001-9674-8088; del Cano-Ochoa, Francisco/0000-0003-3093-3103	Spanish Ministry of Science, Innovation and Universities (AEI/FEDER, UE) [BFU2016-80570-R]; European Community [283570]; Spanish National Cancer Research Centre (CNIO) Intramural Programme	Spanish Ministry of Science, Innovation and Universities (AEI/FEDER, UE); European Community(European Commission); Spanish National Cancer Research Centre (CNIO) Intramural Programme	This work was supported by the Spanish Ministry of Science, Innovation and Universities (BFU2016-80570-R; AEI/FEDER, UE), by the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (Grant 283570) and by the Spanish National Cancer Research Centre (CNIO) Intramural Programme. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; BROOKE J, 1990, CANCER RES, V50, P7793; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cassera MB, 2011, CURR TOP MED CHEM, V11, P2103; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; CHRISTOPHERSON RI, 1979, J BIOL CHEM, V254, P2506; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Evans HG, 2014, PROTEIN SCI, V23, P100, DOI 10.1002/pro.2396; Fields C., 1999, PATHS PYRIMIDINES, V7, P49; Grande-Garcia A, 2014, STRUCTURE, V22, P185, DOI 10.1016/j.str.2013.10.016; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koshland DE, 1998, NAT MED, V4, P1112, DOI 10.1038/2605; Lallous N, 2012, ACTA CRYSTALLOGR F, V68, P1341, DOI 10.1107/S1744309112038857; LEE L, 1985, P NATL ACAD SCI USA, V82, P6802, DOI 10.1073/pnas.82.20.6802; Lee M, 2005, J MOL BIOL, V348, P523, DOI 10.1016/j.jmb.2005.01.067; Lee M, 2007, BIOCHEMISTRY-US, V46, P10538, DOI 10.1021/bi701098e; Lee M, 2007, J MOL BIOL, V370, P812, DOI 10.1016/j.jmb.2007.05.019; Li YC, 2005, BIOORG CHEM, V33, P470, DOI 10.1016/j.bioorg.2005.08.001; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Porter TN, 2004, BIOCHEMISTRY-US, V43, P16285, DOI 10.1021/bi048308g; Rice AJ, 2016, BIOORGAN MED CHEM, V24, P4536, DOI 10.1016/j.bmc.2016.07.055; Ruiz-Ramos A, 2015, ENCY INORGANIC BIOIN, DOI [10.1002/9781119951438.eibc2321, DOI 10.1002/9781119951438.EIBC2321]; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schroeder PE, 2008, DRUG METAB DISPOS, V36, P1780, DOI 10.1124/dmd.108.021626; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Thoden JB, 2001, BIOCHEMISTRY-US, V40, P6989, DOI 10.1021/bi010682i; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Zhang PF, 2009, BIOCHEMISTRY-US, V48, P766, DOI 10.1021/bi801831r	40	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18903	18913		10.1074/jbc.RA118.005494	http://dx.doi.org/10.1074/jbc.RA118.005494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30315107	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000458467400008
J	Eswarappa, SM; Potdar, AA; Sahoo, S; Sankar, S; Fox, PL				Eswarappa, Sandeep M.; Potdar, Alka A.; Sahoo, Sarthak; Sankar, Santhosh; Fox, Paul L.			Metabolic origin of the fused aminoacyl-tRNA synthetase, glutamyl-prolyl-tRNA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; TRANSCRIPTION ANTITERMINATION; GENE-REGULATION; EVOLUTION; COMPLEX; EXPRESSION; COMPONENT; GROWTH; MODEL; CYCLE	About 1 billion years ago, in a single-celled holozoan ancestor of all animals, a gene fusion of two tRNA synthetases formed the bifunctional enzyme, glutamyl-prolyl-tRNA synthetase (EPRS). We propose here that a confluence of metabolic, biochemical, and environmental factors contributed to the specific fusion of glutamyl- (ERS) and prolyl- (PRS) tRNA synthetases. To test this idea, we developed a mathematical model that centers on the precursor-product relationship of glutamic acid and proline, as well as metabolic constraints on free glutamic acid availability near the time of the fusion event. Our findings indicate that proline content increased in the proteome during the emergence of animals, thereby increasing demand for free proline. Together, these constraints contributed to a marked cellular depletion of glutamic acid and its products, with potentially catastrophic consequences. In response, an ancient organism invented an elegant solution in which genes encoding ERS and PRS fused to form EPRS, forcing coexpression of the two enzymes and preventing lethal dysregulation. The substantial evolutionary advantage of this coregulatory mechanism is evidenced by the persistence of EPRS in nearly all extant animals.	[Eswarappa, Sandeep M.; Sahoo, Sarthak; Sankar, Santhosh] Indian Inst Sci, Dept Biochem, Bengaluru 560012, India; [Potdar, Alka A.] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel, Los Angeles, CA 90048 USA; [Potdar, Alka A.] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA	Indian Institute of Science (IISC) - Bangalore; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cleveland Clinic Foundation	Eswarappa, SM (corresponding author), Indian Inst Sci, Dept Biochem, Bengaluru 560012, India.; Fox, PL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.	sandeep@iisc.ac.in; foxp@ccf.org	Eswarappa, Sandeep/AFG-1997-2022	Fox, Paul/0000-0002-6033-1528	National Institutes of Health [P01HL029582, P01HL076491, R01GM115476]; Wellcome Trust-Department of Biotechnology, India Alliance Intermediate Fellowship [IA/I/15/1/501833]; Department of Science and Technology-Science and Engineering Research Board, India [YSS/2015/000989]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust-Department of Biotechnology, India Alliance Intermediate Fellowship; Department of Science and Technology-Science and Engineering Research Board, India; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01HL029582, P01HL076491, and R01GM115476 (to P. L. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of Wellcome Trust-Department of Biotechnology, India Alliance Intermediate Fellowship IA/I/15/1/501833 and Start-up Grant for Young Scientists YSS/2015/000989 from the Department of Science and Technology-Science and Engineering Research Board, India.	Arif A, 2017, NATURE, V542, P357, DOI 10.1038/nature21380; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; BAICH A, 1977, SOMAT CELL GENET, V3, P529, DOI 10.1007/BF01539123; BANDYOPADHYAY AK, 1971, J MOL BIOL, V60, P113, DOI 10.1016/0022-2836(71)90451-7; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Berthonneau E, 2000, FEBS LETT, V470, P300, DOI 10.1016/S0014-5793(00)01343-0; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; Condon C, 1996, BIOCHIMIE, V78, P381, DOI 10.1016/0300-9084(96)84744-4; Eswarappa SM, 2013, TRENDS BIOCHEM SCI, V38, P222, DOI 10.1016/j.tibs.2013.01.005; Exposito JY, 2002, ANAT RECORD, V268, P302, DOI 10.1002/ar.10162; Fidler AL, 2017, ELIFE, V6, DOI 10.7554/eLife.24176; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; GRUNDY FJ, 1993, CELL, V74, P475, DOI 10.1016/0092-8674(93)80049-K; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Han JM, 2006, J BIOL CHEM, V281, P38663, DOI 10.1074/jbc.M605211200; Havrylenko S, 2015, INT J MOL SCI, V16, P6571, DOI 10.3390/ijms16036571; Havrylenko S, 2011, J BIOL CHEM, V286, P28476, DOI 10.1074/jbc.M111.254037; Heino J, 2009, INT J BIOCHEM CELL B, V41, P341, DOI 10.1016/j.biocel.2008.08.021; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; LAZARD M, 1987, FEBS LETT, V216, P27, DOI 10.1016/0014-5793(87)80750-0; LAZARD M, 1987, J BIOL CHEM, V262, P3982; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Luo D, 1997, J BACTERIOL, V179, P2472, DOI 10.1128/jb.179.8.2472-2478.1997; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; MESTICHELLI LJJ, 1979, J BIOL CHEM, V254, P640; Mills DB, 2014, BIOESSAYS, V36, P1145, DOI 10.1002/bies.201400101; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nakano MM, 1998, J BACTERIOL, V180, P3304, DOI 10.1128/JB.180.13.3304-3311.1998; Norcum MT, 1998, PROTEIN SCI, V7, P79, DOI 10.1002/pro.5560070108; Perez-Arellano I, 2010, PROTEIN SCI, V19, P372, DOI 10.1002/pro.340; PUTZER H, 1995, MOL MICROBIOL, V16, P709, DOI 10.1111/j.1365-2958.1995.tb02432.x; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Ray PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098493; Ray PS, 2011, MOL BIOL EVOL, V28, P437, DOI 10.1093/molbev/msq246; Ryckelynck M, 2005, BIOCHIMIE, V87, P835, DOI 10.1016/j.biochi.2005.02.014; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sebe-Pedros A, 2013, ELIFE, V2, DOI 10.7554/eLife.01287; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Tekaia F, 2002, GENE, V297, P51, DOI 10.1016/S0378-1119(02)00871-5; TING SM, 1994, J BIOL CHEM, V269, P8993; VALLE D, 1973, BIOCHEM BIOPH RES CO, V54, P1418, DOI 10.1016/0006-291X(73)91144-3; van de Guchte MV, 2001, MICROBIOL-SGM, V147, P1223, DOI 10.1099/00221287-147-5-1223; Webster KA, 2003, J EXP BIOL, V206, P2911, DOI 10.1242/jeb.00516; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108	46	8	8	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19148	19156		10.1074/jbc.RA118.004276	http://dx.doi.org/10.1074/jbc.RA118.004276			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30309984	Green Published, hybrid			2022-12-26	WOS:000458467400027
J	Gong, X; Liu, WG; Wu, LL; Ma, ZF; Wang, YZ; Yu, SY; Zhang, J; Xie, H; Wei, GY; Ma, F; Lu, L; Chen, LM				Gong, Xue; Liu, Weiguang; Wu, Lele; Ma, Zhifang; Wang, Yuzhi; Yu, Shiyi; Zhang, Jun; Xie, Hao; Wei, Guanyun; Ma, Fei; Lu, Ling; Chen, Liming			Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; BREAST; SOX2; TRPS1; DIFFERENTIATION; GENES; MUTAGENESIS; MAINTAINS; NETWORK; FATE	Cancer stem cells (CSCs) have been reported in a variety of cancers. SRY-box 2 (SOX2) is a member of the SOX family of transcription factors and has been shown to play a critical role in maintaining the functions of CSCs and promoting tumor initiation. However, the underlying mechanisms for the transcriptional regulation of the SOX2 gene in CSCs are unclear. In this study, using in silico and experimental approaches, we identified transcriptional repressor GATA binding 1 (TRPS1), an atypical GATA-type transcription factor, as a critical transcriptional regulator that represses SOX2 expression and thereby suppresses cancer stemness and tumorigenesis. Mechanistically, TRPS1 repressed SOX2 expression by directly targeting the consensus GATA-binding element in the SOX2 promoter as elucidated by ChIP and luciferase reporter assays. Of note, in vitro mammosphere formation assays in culture and in vivo xenograft tumor initiation experiments in mouse models revealed that TRPS1-mediated repression of SOX2 expression suppresses CSC functions and tumor initiation. Taken together, our study provides detailed mechanistic insights into CSC functions and tumor initiation by the TRPS1-SOX2 axis.	[Gong, Xue; Wang, Yuzhi; Xie, Hao; Chen, Liming] Southeast Univ, Inst Life Sci, Nanjing 210096, Jiangsu, Peoples R China; [Gong, Xue; Liu, Weiguang; Wu, Lele; Ma, Zhifang; Wang, Yuzhi; Yu, Shiyi; Zhang, Jun; Wei, Guanyun; Ma, Fei; Chen, Liming] Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China; [Lu, Ling] Nanjing Med Univ, Dept Otolaryngol Head & Neck Surg, DrumTower Clin Med Coll, Nanjing 210008, Jiangsu, Peoples R China; [Lu, Ling] Nanjing Univ, Dept Otolaryngol Head & Neck Surg, Nanjing Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Southeast University - China; Nanjing Normal University; Nanjing Medical University; Nanjing University	Chen, LM (corresponding author), Southeast Univ, Inst Life Sci, Nanjing 210096, Jiangsu, Peoples R China.; Chen, LM (corresponding author), Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China.	chenliming1981@njnu.edu.cn	gong, xue/GYQ-8649-2022	Xie, Hao/0000-0002-0683-6883	National Natural Science Foundation of China [81772956, 81572712]; National Basic Research Program of China 973 Program [2015CB965000]; Key University Science Research Project of Jiangsu Province [17KJA320002]; Natural Science Foundation of Jiangsu Province [SBK2016030027]; Priority Academic Program and the Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Medical Youth Talent of the Project of Invigorating Health Care through Science, Technology and Education Grant [QNRC2016002]; National Science Foundation for Young Scientists of China [81700913]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); Key University Science Research Project of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program and the Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Medical Youth Talent of the Project of Invigorating Health Care through Science, Technology and Education Grant; National Science Foundation for Young Scientists of China	This work was supported by National Natural Science Foundation of China Grants 81772956 and 81572712, National Basic Research Program of China 973 Program Grant 2015CB965000, Key University Science Research Project of Jiangsu Province Grant 17KJA320002, Natural Science Foundation of Jiangsu Province Grant SBK2016030027, funds from the Priority Academic Program and the Development of Jiangsu Higher Education Institutions, Jiangsu Provincial Medical Youth Talent of the Project of Invigorating Health Care through Science, Technology and Education Grant QNRC2016002, and National Science Foundation for Young Scientists of China Grant 81700913. The authors declare that they have no conflicts of interest with the contents of this article.	Annovazzi L, 2011, CANCER GENOM PROTEOM, V8, P139; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen Jie Qing, 2011, Hormones & Cancer, V2, P132, DOI 10.1007/s12672-011-0067-5; Chen LM, 2017, P NATL ACAD SCI USA, V114, pE2215, DOI 10.1073/pnas.1701512114; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Fantauzzo KA, 2012, DEVELOPMENT, V139, P203, DOI 10.1242/dev.069971; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Itoh S, 2008, GENES CELLS, V13, P355, DOI 10.1111/j.1365-2443.2008.01170.x; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lentjes MHFM, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2016.2; Liu KC, 2013, CELL SIGNAL, V25, P1264, DOI 10.1016/j.cellsig.2013.02.013; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Piva M, 2014, EMBO MOL MED, V6, P66, DOI 10.1002/emmm.201303411; Rangel R, 2016, P NATL ACAD SCI USA, V113, pE7749, DOI 10.1073/pnas.1613859113; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Savinainen KJ, 2004, BRIT J CANCER, V90, P1041, DOI 10.1038/sj.bjc.6601648; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Turbendian HK, 2013, DEVELOPMENT, V140, P1639, DOI 10.1242/dev.093260; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Wang YZ, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-1018-7; Wu LL, 2014, ONCOTARGET, V5, P7677, DOI 10.18632/oncotarget.2291; Yu SY, 2017, INT J BIOL SCI, V13, P505, DOI 10.7150/ijbs.18834; Zhang C, 2007, STEM CELLS DEV, V16, P605, DOI 10.1089/scd.2006.0077; Zhao HX, 2010, DIFFERENTIATION, V80, P123, DOI 10.1016/j.diff.2010.03.002; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	40	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18646	18654		10.1074/jbc.RA118.003983	http://dx.doi.org/10.1074/jbc.RA118.003983			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30315105	Green Published, hybrid			2022-12-26	WOS:000458467300019
J	Jones, OY; Raschke, SU; Riches, PE				Jones, O. Yvette; Raschke, Silvia U.; Riches, Philip E.			Inertial properties of the German Shepherd Dog	PLOS ONE			English	Article							KINEMATIC GAIT ANALYSIS; CRUCIATE LIGAMENT DISEASE; BODY SEGMENT PARAMETERS; LABRADOR-RETRIEVERS; HIND-LIMB; HIP-DYSPLASIA; PELVIC LIMBS; TROT; HORSES; BIOMECHANICS	One of the most popular dog breeds deployed by both the police and military has been the German Shepherd yet little is known about the morphology or body segment parameters of this breed. Such measures are essential for developing biomechanical models which, in turn, may guide clinicians in developing surgical interventions, injury treatment and prevention procedures. This paper provides a complete set of body segment parameters and inertial properties for the German Shepherd. Morphometric measures and 3-dimensional inertial properties, including mass, centre of mass, moment of inertia and volume, were measured from 17 segments from 6 German Shepherd police service dog cadavers. Using whole body mass and geometric modelling, 11 regression equations were developed for predicting segment masses, and 33 equations were developed for predicting moments of inertia. Using these data, inverse dynamic analyses may be applied in future investigations of canine mechanics, guiding surgical procedures, rehabilitation and training especially for the German Shepherd breed but potentially for other breeds too.	[Jones, O. Yvette; Raschke, Silvia U.] British Columbia Inst Technol, Ctr Appl Res & Innovat, Burnaby, BC, Canada; [Jones, O. Yvette; Riches, Philip E.] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland	British Columbia Institute of Technology; University of Strathclyde	Riches, PE (corresponding author), Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland.	philip.riches@strath.ac.uk	Jones, Yvette/AAN-5188-2020; Raschke, Silvia/AAW-3331-2020	Riches, Philip/0000-0002-7708-4607; Jones, Yvette/0000-0001-6306-996X	Vancouver Police Foundation; British Columbia Institute of Technology Super PD Fund	Vancouver Police Foundation; British Columbia Institute of Technology Super PD Fund	This study was financially supported by the Vancouver Police Foundation and the British Columbia Institute of Technology Super PD Fund.	ALLEN K, 1994, VET COMP ORTHOPAED, V7, P148; Amit T, 2009, VET J, V182, P94, DOI 10.1016/j.tvjl.2008.05.024; Angle TC, 2012, AUST VET J, V90, P60, DOI 10.1111/j.1751-0813.2011.00892.x; Bennett RL, 1996, AM J VET RES, V57, P966; Borelli GA, 1681, MOTU ANIMALIUM PUOS; Buchner HHF, 1997, J BIOMECH, V30, P653, DOI 10.1016/S0021-9290(97)00005-5; Camomilla V, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0396-x; Chandler RF., 1975, INVESTIGATION INERTI; Cheng CK, 2000, CLIN BIOMECH, V15, P559, DOI 10.1016/S0268-0033(00)00016-4; Clauser C. E., 1969, WEIGHT VOLUME CTR MA, P1; Colborne GR, 2007, VET J, V173, P469, DOI 10.1016/j.tvjl.2006.01.002; Colborne GR, 2011, AM J VET RES, V72, P336, DOI 10.2460/ajvr.72.3.336; Colborne GR, 2005, AM J VET RES, V66, P1563, DOI 10.2460/ajvr.2005.66.1563; DeCamp CE, 1996, AM J VET RES, V57, P120; DeCamp CE, 1997, VET CLIN N AM-SMALL, V27, P825, DOI 10.1016/S0195-5616(97)50082-9; Dempster W.T., 1955, SPACE REQUIREMENTS S; DOGAN S, 1991, J BIOMECH, V24, P397, DOI 10.1016/0021-9290(91)90028-L; Dumas R, 2007, J BIOMECH, V40, P543, DOI 10.1016/j.jbiomech.2006.02.013; Faber M, 2001, AM J VET RES, V62, P757, DOI 10.2460/ajvr.2001.62.757; Gerhardt JJ, 1990, MEASURING RECORDING; Gillette RL, 1999, J AM ANIM HOSP ASSOC, V35, P515, DOI 10.5326/15473317-35-6-515; Griffon DJ, 2008, VET J, V178, P159, DOI 10.1016/j.tvjl.2008.05.002; HATZE H, 1980, J BIOMECH, V13, P833, DOI 10.1016/0021-9290(80)90171-2; Headrick JF, 2014, AM J VET RES, V75, P544, DOI 10.2460/ajvr.75.6.544; Hicks DA, 2014, VET COMP ORTHOPAED, V27, P453, DOI 10.3415/VCOT-14-04-0057; Hower R. O., 1970, Curator, V13, P135; Kubo K., 1992, Japanese Journal of Equine Science, V3, P149; Marsh AP, 2010, NEUROMUSCULAR DISORD, V20, P16, DOI 10.1016/j.nmd.2009.10.007; Martin P, 2016, J BIOMECH, V49, P1027, DOI 10.1016/j.jbiomech.2016.02.016; Nauwelaerts S, 2011, J ANAT, V218, P500, DOI 10.1111/j.1469-7580.2011.01353.x; Nielsen C, 2003, AM J VET RES, V64, P609, DOI 10.2460/ajvr.2003.64.609; Nova Scotia German Shepherd Dog Club, 2014, GERM SHEPH DOG BREED; Onar V, 1997, ANN ANAT, V179, P563, DOI 10.1016/S0940-9602(97)80022-2; Onar V, 1999, ANAT HISTOL EMBRYOL, V28, P253, DOI 10.1046/j.1439-0264.1999.00202.x; PEARSALL DJ, 1994, SPORTS MED, V18, P126, DOI 10.2165/00007256-199418020-00005; Poy NSJ, 2000, AM J VET RES, V61, P974, DOI 10.2460/ajvr.2000.61.974; Ragetly CA, 2008, AM J VET RES, V69, P1188, DOI 10.2460/ajvr.69.9.1188; Ragetly CA, 2010, VET SURG, V39, P513, DOI 10.1111/j.1532-950X.2010.00680.x; Reynolds HM., 1974, MEASUREMENT INERTIAL; RIGGS CM, 1993, AM J VET RES, V54, P1523; Schaefer SL, 1998, AM J VET RES, V59, P680; Silva GCA, 2014, PESQUI VET BRASIL, V34, P1265, DOI 10.1590/S0100-736X2014001200021; Sloane CF, 1955, J CRIM LAW CRIMINOL, V46, P385, DOI 10.2307/1139438; SPRIGINGS E, 1986, EQUINE VET J, V18, P43, DOI 10.1111/j.2042-3306.1986.tb03536.x; Strasser T, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0241-4; Torres BT, 2010, VET SURG, V39, P504, DOI 10.1111/j.1532-950X.2010.00666.x; VANDENBOGERT AJ, 1989, J BIOMECH, V22, P33, DOI 10.1016/0021-9290(89)90182-6; Zatsiorsky VM., 2002, KINETICS HUMAN MOTIO	48	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0206037	10.1371/journal.pone.0206037	http://dx.doi.org/10.1371/journal.pone.0206037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339688	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000447761400035
J	Nasanen-Gilmore, P; Sipola-Leppanen, M; Tikanmaki, M; Matinolli, HM; Eriksson, JG; Jarvelin, MR; Vaarasmaki, M; Hovi, P; Kajantie, E				Nasanen-Gilmore, Pieta; Sipola-Leppanen, Marika; Tikanmaki, Marjaana; Matinolli, Hanna-Maria; Eriksson, Johan G.; Jarvelin, Marjo-Riitta; Vaarasmaki, Marja; Hovi, Petteri; Kajantie, Eero			Lung function in adults born preterm	PLOS ONE			English	Article							BRONCHOPULMONARY DYSPLASIA; MATERNAL SMOKING; CHILDREN BORN; BIRTH-WEIGHT; PREGNANCY; ASTHMA; AGE; HEALTH; VARIABILITY; SPIROMETRY	Very preterm birth, before the gestational age (GA) of 32 weeks, increases the risk of obstructed airflow in adulthood. We examined whether all preterm births (GA<37 weeks) are associated with poorer adult lung function and whether any associations are explained by maternal, early life/neonatal, or current life factors. Participants of the ESTER Preterm Birth Study, born between 1985 and 1989 (during the pre-surfactant era), at the age of 23 years participated in a clinical study in which they performed spirometry and provided detailed medical history. Of the participants, 139 were born early preterm (GA<34 weeks), 239 late preterm (GA: 34-<37 weeks), and 341 full-term (GA >= 37 weeks). Preterm birth was associated with poorer lung function. Mean differences between individuals born early preterm versus full-term were -0.23 standard deviation (SD) (95% confidence interval (CI): -0.40, -0.05)) for forced vital capacity z-score (zFVC), -0.44 SD (95% CI -0.64, -0.25) for forced expiratory volume z-score (zFEV1), and -0.29 SD (95% CI -0.47, -0.10) for zFEV1/FVC. For late preterm, mean differences with full-term controls were -0.02 SD (95% CI -0.17, 0.13), -0.12 SD (95% CI -0.29, 0.04) and -0.13 SD (95% CI -0.29, 0.02) for zFVC, zFEV1, and zFEV1/FVC, respectively. Examination of finer GA subgroups suggested an inverse non-linear association between lung function and GA, with the greatest impact on zFEV1 for those born extremely preterm. The subgroup means were GA<28 weeks: -0.98 SD; 28-<32 weeks: -0.29 SD; 32-<34 weeks: -0.44 SD; 34-<36 weeks: -0.10 SD; 36<37weeks: -0.11 SD; term-born controls (>= 37weeks): 0.02 SD. Corresponding means for zFEV1/FVC were -1.79, -0.44, -0.47, -0.48, -0.29, and -0.02. Adjustment for maternal pregnancy conditions and socioeconomic and lifestyle factors had no major impact on the relationship. Preterm birth is associated with airflow limitation in adult life. The association appears to be attributable predominantly to those born most immature, with only a modest decrease among those born preterm at later gestational ages.	[Nasanen-Gilmore, Pieta; Sipola-Leppanen, Marika; Tikanmaki, Marjaana; Matinolli, Hanna-Maria; Eriksson, Johan G.; Jarvelin, Marjo-Riitta; Vaarasmaki, Marja; Hovi, Petteri; Kajantie, Eero] Natl Inst Hlth & Welf, Helsinki, Finland; [Nasanen-Gilmore, Pieta; Sipola-Leppanen, Marika; Tikanmaki, Marjaana; Matinolli, Hanna-Maria; Eriksson, Johan G.; Jarvelin, Marjo-Riitta; Vaarasmaki, Marja; Hovi, Petteri; Kajantie, Eero] Natl Inst Hlth & Welf, Oulu, Finland; [Sipola-Leppanen, Marika; Tikanmaki, Marjaana; Matinolli, Hanna-Maria; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Sipola-Leppanen, Marika; Vaarasmaki, Marja; Kajantie, Eero] Oulu Univ Hosp, Med Res Ctr Oulu, PEDEGO Res Unit, Oulu, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Vaasa Cent Hosp, Vaasa, Finland; [Jarvelin, Marjo-Riitta] Imperial Coll London, Sch Publ Hlth, Ctr Environm & Hlth, MRC Hlth Protect Agcy HPA, London, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Hovi, Petteri; Kajantie, Eero] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Kajantie, Eero] Norwegian Univ Hlth & Technol, Dept Clin & Mol Med, Trondheim, Norway	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; Folkhalsan Research Center; University of Helsinki; Vaasa Central Hospital; Imperial College London; University of Oulu; University of Oulu; University of Helsinki; Helsinki University Central Hospital	Nasanen-Gilmore, P (corresponding author), Natl Inst Hlth & Welf, Helsinki, Finland.; Nasanen-Gilmore, P (corresponding author), Natl Inst Hlth & Welf, Oulu, Finland.	pieta.nasanen-gilmore@thl.fi	Matinolli, Hanna-Maria/P-9477-2019; Paalanne, Marika/ABE-5008-2020	Paalanne, Marika/0000-0003-1626-9410; Matinolli, Hanna-Maria/0000-0001-8281-6801	Academy of Finland [127437, 129306, 130326, 134791, 263924]; Doctoral Program for Public Health, University of Tampere; Emil Aaltonen Foundation; European Commission [QLG1-CT-2000-001643, 733280]; Finnish Foundation for Paediatric Research; Finnish Government Special Subsidiary for Health Sciences; Finnish Medical Society Duodecim; Finska Lakaresallskapet; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; National Graduate School of Clinical Investigation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Research Foundation of the Pulmonary Diseases; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation	Academy of Finland(Academy of Finland); Doctoral Program for Public Health, University of Tampere; Emil Aaltonen Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Foundation for Paediatric Research; Finnish Government Special Subsidiary for Health Sciences; Finnish Medical Society Duodecim; Finska Lakaresallskapet; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; National Graduate School of Clinical Investigation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Research Foundation of the Pulmonary Diseases; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation	This study was funded by the Academy of Finland (SALVE programme for 2009-2012 and grants 127437, 129306, 130326, 134791, and 263924 to EK; The Doctoral Program for Public Health, University of Tampere (to MSL); Emil Aaltonen Foundation to EK; The European Commission (Framework 5 award QLG1-CT-2000-001643 and Horizon2020 award 733280 RECAP to EK) to Dr M-RJ; Finnish Foundation for Paediatric Research to EK; Finnish Government Special Subsidiary for Health Sciences (evo) (to JGE); Finnish Medical Society Duodecim to EK; Finska Lakaresallskapet to EK; Jalmari and Rauha Ahokas Foundation to EK and PGN; Juho Vainio Foundation to EK and MSL; National Graduate School of Clinical Investigation to MT; Novo Nordisk Foundation to EK and MV; Paivikki and Sakari Sohlberg Foundation to PNG; Research Foundation of the Pulmonary Diseases to PNG; Signe and Ane Gyllenberg Foundation to EK, JGE and PNG; Sigrid Juselius Foundation to EK; Yrjo Jahnsson Foundation to EK, MSL, and MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand D, 2003, ARCH DIS CHILD, V88, P135, DOI 10.1136/adc.88.2.135; Azad MB, 2017, PAEDIATR RESPIR REV, V21, P19, DOI 10.1016/j.prrv.2016.08.007; Barker DJP, 2013, ACTA PAEDIATR, V102, P732, DOI 10.1111/apa.12257; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Brostrom EB, 2013, EUR J EPIDEMIOL, V28, P79, DOI 10.1007/s10654-013-9761-7; Crump C, 2011, PEDIATRICS, V127, pE913, DOI 10.1542/peds.2010-2603; Doyle LW, 2006, PEDIATRICS, V118, P108, DOI 10.1542/peds.2005-2522; Drummond MB, 2012, AM J RESP CRIT CARE, V185, P1301, DOI 10.1164/rccm.201202-0223OC; Duke JW, 2018, EXP PHYSIOL, V103, P261, DOI 10.1113/EP086588; Filippone M, 2003, LANCET, V361, P753, DOI 10.1016/S0140-6736(03)12633-5; Friedrich L, 2007, AM J RESP CRIT CARE, V176, P1269, DOI 10.1164/rccm.200703-476OC; Global Chronic Obstructive Lung Disease Initiative, 2016, GLOB STRAT DIAGN MAN; Global Initiative for Chronic Obstructive Lung Disease Global Initiative for Asthma Diagnosis of Diseases of Chronic Airflow Limitation: Asthma COPD and Asthma-COPD Overlap Syndrome (ACOS), 2014, BAS GLOB STRAT ASTHM; GREEN M, 1974, J APPL PHYSIOL, V37, P67, DOI 10.1152/jappl.1974.37.1.67; Hamilton BE, 2006, PRELIMINARY DATA 200; Harju M, 2014, J PEDIATR-US, V164, P295, DOI 10.1016/j.jpeds.2013.09.057; Hines D, 2017, ACTA PAEDIATR, V106, P366, DOI 10.1111/apa.13672; Hogg JC, 2017, PHYSIOL REV, V97, P529, DOI 10.1152/physrev.00025.2015; Hollams EM, 2014, AM J RESP CRIT CARE, V189, P401, DOI 10.1164/rccm.201302-0323OC; Ioan I, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00650; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P136, DOI 10.2105/AJPH.94.1.136; Jaakkola JKJ, 2006, RESP RES, V7, P1; Jaakkola JJK, 2006, J ALLERGY CLIN IMMUN, V118, P823, DOI 10.1016/j.jaci.2006.06.043; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kalhan R, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.07.037; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Kotecha SJ, 2012, SEMIN FETAL NEONAT M, V17, P77, DOI 10.1016/j.siny.2012.01.004; Kotecha SJ, 2012, THORAX, V67, P54, DOI 10.1136/thoraxjnl-2011-200329; Lawlor DA, 2005, THORAX, V60, P851, DOI 10.1136/thx.2005.042408; Liu XQ, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-13; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Narang I, 2008, AM J RESP CRIT CARE, V178, P74, DOI 10.1164/rccm.200705-701OC; Pekkanen J, 2001, CLIN EXP ALLERGY, V31, P95, DOI 10.1046/j.1365-2222.2001.00930.x; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pihkala J, 1989, Duodecim, V105, P1540; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Raisanen S, 2014, PREV MED, V67, P6, DOI 10.1016/j.ypmed.2014.06.026; Saarenpaa HK, 2015, PEDIATRICS, V136, P642, DOI 10.1542/peds.2014-2651; Sipola-Leppanen M, 2015, AM J EPIDEMIOL, V181, P861, DOI 10.1093/aje/kwu443; Sipola-Leppanen M, 2015, HYPERTENSION, V65, P615, DOI 10.1161/HYPERTENSIONAHA.114.04717; Sipola-Leppanen M, 2014, PEDIATRICS, V134, pE1072, DOI 10.1542/peds.2013-4186; Sovijarvi A, 1994, KLIININEN FYSIOLOGIA, P99; Sovijarvi A, 2003, MOODI, V4, P113; Tikanmaki M, 2017, J PEDIATR-US, V189, P135, DOI 10.1016/j.jpeds.2017.06.068; Vaarasmaki M, 2009, AM J EPIDEMIOL, V169, P1209, DOI 10.1093/aje/kwp020; VILJANEN AA, 1982, SCAND J CLIN LAB INV, V42, P5; Vollsaeter M, 2013, THORAX, V68, P767, DOI 10.1136/thoraxjnl-2012-202980; Vrijlandt EJLE, 2013, AM J RESP CRIT CARE, V187, P1234, DOI 10.1164/rccm.201211-2070OC; Yammine S, 2016, EUR RESPIR J, V47, P147, DOI 10.1183/13993003.00478-2015	49	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205979	10.1371/journal.pone.0205979	http://dx.doi.org/10.1371/journal.pone.0205979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339699	Green Submitted, gold, Green Published			2022-12-26	WOS:000447761400030
J	Hsu, HC; Tai, YJ; Chen, YL; Chiang, YC; Chen, CA; Cheng, WF				Hsu, Heng-Cheng; Tai, Yi-Jou; Chen, Yu-Li; Chiang, Ying-Cheng; Chen, Chi-An; Cheng, Wen-Fang			Factors predicting parametrial invasion in patients with early-stage cervical carcinomas	PLOS ONE			English	Article							SPARING RADICAL HYSTERECTOMY; UTERINE CERVIX; SURGICAL-TREATMENT; BLADDER FUNCTION; IB-IIA; CANCER; SURGERY; INVOLVEMENT; IDENTIFICATION; PARAMETRECTOMY	We aimed to identify factors predicting parametrial invasion in early-stage cervical cancer patients undergoing radical hysterectomy. We recruited women with invasive cervical cancer who underwent radical hysterectomy at a single medical institute from 2000-2011. The clinical and pathological characteristics and outcomes were retrospectively recorded, and the risk factors for parametrial invasion were analyzed. We enrolled 339 patients, including 7 with stage IA1 carcinomas, 10 with stage IA2, 266 with stage IB1, 39 with stage IB2, 14 with stage IIA1, and 3 with stage IIA2. The majority (237/339, 69.9%) had squamous cell carcinoma, while 32 (12.4%) had parametrial invasion. The 16 patients with stage IB1 tumors and parametrial invasion were older (55.9 +/- 9.5vs. 49.0 +/- 9.9 years, p = 0.005, Mann-Whitney U test), and had deeper cervical stromal invasion (9.59 +/- 4.87 vs. 7.47 +/- 5.48 mm, p = 0.048, Mann-Whitney U test), larger tumor size (2.32 +/- 1.15 vs. 1.74 +/- 1.14cm, p = 0.043, Mann-Whitney U test), higher incidences of lymphovascular space invasion (87.5% vs. 28.8%, p<0.001, chi-square test), and greater lymph node metastasis (68.8% vs. 10.8%, p<0.001, chi-square test) than the 260 patients without parametrial invasion. Among the patients with stage IB1 tumor size >2 cm, 10% had parametrial invasion and 24.2% had lymph node metastasis compared with only 4% and 9.4% of stage IB1 patients with a tumor size <2 cm, respectively. Only one (0.9%) of the 109 patients aged less than 50 years had parametrial invasion compared with 6 (9.7%) of the 62 patients aged over 50 years. Patients with stage IA2 and IB1 tumors <2 cm may not need radical hysterectomy owing to the low incidence of parametrial invasion.	[Hsu, Heng-Cheng; Tai, Yi-Jou; Chen, Yu-Li; Chiang, Ying-Cheng; Chen, Chi-An; Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan; [Hsu, Heng-Cheng] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Obstet & Gynecol, Hsin Chu City, Taiwan; [Hsu, Heng-Cheng; Tai, Yi-Jou; Chiang, Ying-Cheng; Cheng, Wen-Fang] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chen, Yu-Li] Natl Taiwan Univ, Grad Inst Anat & Cell Biol, Coll Med, Taipei, Taiwan; [Cheng, Wen-Fang] Natl Taiwan Univ, Grad Inst Oncol, Coll Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Cheng, WF (corresponding author), Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan.; Cheng, WF (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.; Cheng, WF (corresponding author), Natl Taiwan Univ, Grad Inst Oncol, Coll Med, Taipei, Taiwan.	wenfangcheng@yahoo.com	Tai, Yi-Jou/AAB-8363-2019; Chiang, Ying-Cheng/T-3329-2019	Tai, Yi-Jou/0000-0003-1442-0850; Hsu, Heng-Cheng/0000-0002-6817-0693; CHEN, CHI-AN/0000-0001-6670-7939; CHIANG, YING-CHENG/0000-0002-8958-5222				Agnieszka K, 2011, BLAUSTEINS PATHOLOGY, P265; Aoun F, 2015, INT UROGYNECOL J, V26, P947, DOI 10.1007/s00192-014-2574-8; Bergmark K, 2006, INT J GYNECOL CANCER, V16, P1130, DOI 10.1111/j.1525-1438.2006.00601.x; Bisseling KCHM, 2007, GYNECOL ONCOL, V107, P424, DOI 10.1016/j.ygyno.2007.07.062; Broders AC, 1920, J AMER MED ASSOC, V74, P656, DOI 10.1001/jama.1920.02620100016007; Chang SJ, 2012, GYNECOL ONCOL, V126, P82, DOI 10.1016/j.ygyno.2012.04.016; Covens A, 2002, GYNECOL ONCOL, V84, P145, DOI 10.1006/gyno.2001.6493; Derks M, 2016, ACTA OBSTET GYN SCAN, V95, P166, DOI 10.1111/aogs.12819; Ditto A, 2011, ANN SURG ONCOL, V18, P3469, DOI 10.1245/s10434-011-1767-3; Fagotti A, 2011, FERTIL STERIL, V95, P1109, DOI 10.1016/j.fertnstert.2010.11.010; Fujii S, 2007, GYNECOL ONCOL, V107, P4, DOI 10.1016/j.ygyno.2007.08.076; Gemer O, 2013, EJSO-EUR J SURG ONC, V39, P76, DOI 10.1016/j.ejso.2012.10.013; GERBAULET AL, 1992, RADIOTHER ONCOL, V23, P66, DOI 10.1016/0167-8140(92)90337-T; Kasamatsu T, 2002, GYNECOL ONCOL, V85, P327, DOI 10.1006/gyno.2002.6624; KENTER GG, 1989, EUR J SURG ONCOL, V15, P55; Kim HS, 2015, J GYNECOL ONCOL, V26, P100, DOI 10.3802/jgo.2015.26.2.100; Kodama J, 2011, GYNECOL ONCOL, V122, P491, DOI 10.1016/j.ygyno.2011.05.038; Kuwabara Y, 2000, J Obstet Gynaecol Res, V26, P1; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Landoni F, 2012, EJSO-EUR J SURG ONC, V38, P203, DOI 10.1016/j.ejso.2011.12.017; Laterza RM, 2015, NEUROUROL URODYNAM, V34, P309, DOI 10.1002/nau.22570; Lee YJ, 2017, GYNECOL ONCOL, V144, P536, DOI 10.1016/j.ygyno.2017.01.001; Merz E, 1996, ULTRASOUND OBST GYN, V7, P38, DOI 10.1046/j.1469-0705.1996.07010038.x; Naik R, 2007, BJOG-INT J OBSTET GY, V114, P958, DOI 10.1111/j.1471-0528.2007.01408.x; PIVER MS, 1974, OBSTET GYNECOL, V44, P265; Puente R, 2004, INT J GYNECOL CANCER, V14, P832, DOI 10.1111/j.1048-891X.2004.14517.x; Reade CJ, 2013, GYNECOL ONCOL, V131, P222, DOI 10.1016/j.ygyno.2013.07.078; Rob L, 2010, LANCET ONCOL, V11, P292, DOI 10.1016/S1470-2045(09)70191-3; Sakuragi N, 2005, INT J GYNECOL CANCER, V15, P389, DOI 10.1111/j.1525-1438.2005.15236.x; SCOTTI RJ, 1986, OBSTET GYNECOL, V68, P111; Sood AK, 2002, J AM COLL SURGEONS, V195, P513, DOI 10.1016/S1072-7515(02)01311-X; Steed H, 2006, GYNECOL ONCOL, V103, P53, DOI 10.1016/j.ygyno.2006.01.027; Stegeman M, 2007, GYNECOL ONCOL, V105, P475, DOI 10.1016/j.ygyno.2007.01.016; Strnad P, 2008, GYNECOL ONCOL, V109, P280, DOI 10.1016/j.ygyno.2008.02.004; Toita Takafumi, 2012, Int J Radiat Oncol Biol Phys, V82, pe49, DOI 10.1016/j.ijrobp.2011.01.022; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; TOUBOUL E, 1992, RADIOTHER ONCOL, V24, P32, DOI 10.1016/0167-8140(92)90351-T; Wiebe E, 2012, INT J GYNECOL OBSTET, V119, pS100, DOI 10.1016/S0020-7292(12)60023-X; Wright JD, 2007, CANCER-AM CANCER SOC, V110, P1281, DOI 10.1002/cncr.22899	39	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0204950	10.1371/journal.pone.0204950	http://dx.doi.org/10.1371/journal.pone.0204950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335786	gold, Green Published, Green Submitted			2022-12-26	WOS:000447701300018
J	Lunghi, E; Cianferoni, F; Ceccolini, F; Veith, M; Manenti, R; Mancinelli, G; Corti, C; Ficetola, GF				Lunghi, Enrico; Cianferoni, Fabio; Ceccolini, Filippo; Veith, Michael; Manenti, Raoul; Mancinelli, Giorgio; Corti, Claudia; Ficetola, Gentile Francesco			What shapes the trophic niche of European plethodontid salamanders?	PLOS ONE			English	Article							SARDINIAN CAVE SALAMANDERS; SPATIAL SEGREGATION; DIET VARIATION; ECOLOGY; POPULATION; HABITAT; DISTRIBUTIONS; TEMPERATURE; CONSISTENCY; STRATEGIES	The trophic niche is a life trait that identifies the consumer's position in a local food web. Several factors, such as ontogeny, competitive ability and resource availability contribute in shaping species trophic niches. To date, information on the diet of European Hydromantes salamanders are only available for a limited number of species, no dietary studies have involved more than one species of the genus at a time, and there are limited evidences on how multiple factors interact in determining diet variation. In this study we examined the diet of multiple populations of six out of the eight European cave salamanders, providing the first data on the diet for five of them. In addition, we assessed whether these closely related generalist species show similar diet and, for each species, we tested whether season, age class or sex influence the number and the type of prey consumed. Stomach condition (empty/full) and the number of prey consumed were strongly related to seasonality and to the activity level of individuals. Empty stomachs were more frequent in autumn, in individuals far from cave entrance and in juveniles. Diet composition was significantly different among species. Hydromantes imperialis and H. supramontis were the most generalist species; H. flavus and H. sarrabusensis fed mostly on Hymenoptera and Coleoptera Staphylinidae, while H. genei and H. ambrosii mostly consumed Arachnida and Endopterygota larvae. Furthermore, we detected seasonal shifts of diet in the majority of the species examined. Conversely, within each species, we did not find diet differences between females, males and juveniles. Although being assumed to have very similar dietary habits, here Hydromantes species were shown to be characterized by a high divergence in diet composition and in the stomach condition of individuals.	[Lunghi, Enrico; Veith, Michael] Univ Trier, Dept Biogeog, Trier, Germany; [Lunghi, Enrico; Cianferoni, Fabio; Ceccolini, Filippo; Corti, Claudia] Univ Firenze, Sez Zool La Specola, Museo Storia Nat, Florence, Italy; [Lunghi, Enrico] Nat Oasis, Prato, Italy; [Cianferoni, Fabio] CNR, IBAF, Rome, Italy; [Manenti, Raoul; Ficetola, Gentile Francesco] Univ Milan, Dept Environm Sci & Policy, Milan, Italy; [Mancinelli, Giorgio] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lecce, Italy; [Ficetola, Gentile Francesco] Univ Grenoble Alpes, CNRS, Lab Ecol Alpine LECA, Grenoble, France	Universitat Trier; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Agroambientale e Forestale (IBAF-CNR); University of Milan; University of Salento; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie	Lunghi, E (corresponding author), Univ Trier, Dept Biogeog, Trier, Germany.; Lunghi, E (corresponding author), Univ Firenze, Sez Zool La Specola, Museo Storia Nat, Florence, Italy.; Lunghi, E (corresponding author), Nat Oasis, Prato, Italy.	enrico.arti@gmail.com	Cianferoni, Fabio/P-7826-2018; Lunghi, Enrico/AAL-3391-2020; Manenti, Raoul/O-5166-2017; Manenti, Raoul/D-4419-2013; Ficetola, Gentile Francesco/A-2813-2008; Mancinelli, Giorgio/A-7679-2013	Cianferoni, Fabio/0000-0003-3170-0774; Lunghi, Enrico/0000-0002-4228-2750; Manenti, Raoul/0000-0001-6071-8194; Ficetola, Gentile Francesco/0000-0003-3414-5155; Mancinelli, Giorgio/0000-0002-5833-7322; Corti, Claudia/0000-0001-6015-0092	Italian Ministry of Environment [9384/PNM of 12/05/2015]; Regione Autonoma della Sardegna [6312]	Italian Ministry of Environment; Regione Autonoma della Sardegna(Regione Sardegna)	Fieldwork was authorized by the Italian Ministry of Environment (9384/PNM of 12/05/2015) and by the Regione Autonoma della Sardegna (no 6312 of 27/03/2017). We thank two anonymous Reviewers for useful suggestions.	Adams DC, 2017, AM NAT, P190; Albano PG, 2014, J MOLLUS STUD, V80, P55, DOI 10.1093/mollus/eyt041; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; [Anonymous], 2000, NON TRADITIONAL REF; Araujo MS, 2008, ECOLOGY, V89, P1981, DOI 10.1890/07-0630.1; Arif S, 2007, EVOL ECOL RES, V9, P843; Baker NJ, 2015, ECOGRAPHY, V38, P130, DOI 10.1111/ecog.00913; Barzaghi B, 2017, FRESHWATER BIOL, V62, P1637, DOI 10.1111/fwb.12975; Basic T, 2016, ECOL EVOL, V6, P5093, DOI 10.1002/ece3.2272; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blasina G, 2017, POLAR RES, V36, DOI 10.1080/17518369.2017.1331558; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bradley JG, 1822, EURYCEA LUCIFUGA; Brunkow PE, 1996, ECOLOGY, V77, P1483, DOI 10.2307/2265545; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Chiari Y, 2013, AMPHIBIA-REPTILIA, V34, P136, DOI 10.1163/15685381-00002876; Chiari Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032332; Cicek K, 2017, ZOOLOGY MIDDLE E; Cloyed CS, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170060; Costa A, 2017, SALAMANDRA, V53, P148; Costa A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13260; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; de la Vega C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155727; Deban SM, 2004, J EXP BIOL, V207, P2071, DOI 10.1242/jeb.00978; Deban SM, 1999, J EXP BIOL, V202, P3699; Deban SM, 2011, J EXP ZOOL PART A, V315A, P618, DOI 10.1002/jez.708; Doebeli M, 1997, J THEOR BIOL, V188, P109, DOI 10.1006/jtbi.1997.0454; Evans MR, 2017, ECOLOGICAL INFORM; Felix ZI, 2006, NORTHEAST NAT, V13, P469, DOI 10.1656/1092-6194(2006)13[469:DOSBMA]2.0.CO;2; Ficetola GF, 2013, POPUL ECOL, V55, P217, DOI 10.1007/s10144-012-0350-5; Ficetola GF, 2012, AMPHIBIA-REPTILIA, V33, P251, DOI 10.1163/156853812X638536; Fox J., 2018, R COMPANION APPL REG, VThird; Grundel R, 2007, BIOL CONSERV, V135, P135, DOI 10.1016/j.biocon.2006.10.003; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Juares MA, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2886-y; Khalaman VV, 2015, INVERTEBR BIOL, V134, P38, DOI 10.1111/ivb.12075; Kohl M., 2016, MKMISC MISCELLANEOUS; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Laigle I, 2018, OIKOS, V127, P316, DOI 10.1111/oik.04712; Lanza B, 1999, HDB REPTILIEN AMPHIB; Lanza Benedetto, 2005, Atti del Museo Civico di Storia Naturale di Trieste, V52, P5; Lunghi E, SCI REPORTS; Lunghi E., SCI DATA; Lunghi E, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.83; Lunghi E, 2018, AMPHIBIA-REPTILIA, V39, P113, DOI 10.1163/15685381-00003137; Lunghi E, 2017, SALAMANDRA, V53, P541; Lunghi E, 2017, PEERJ, V5, DOI 10.7717/peerj.3169; Lunghi E, 2016, J THERM BIOL, V60, P79, DOI 10.1016/j.jtherbio.2016.06.010; Lunghi E, 2015, PEERJ, V3, DOI 10.7717/peerj.1122; Lunghi E, 2014, SALAMANDRA, V50, P105; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Manenti Raoul, 2017, Biogeographia, V32, P31; Manenti R, 2016, HERPETOZOA, V29, P27; Manenti R, 2015, INVERTEBR BIOL, V134, P242, DOI 10.1111/ivb.12092; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olalla-Tarraga MA, 2017, J BIOGEOGR, V44, P99, DOI 10.1111/jbi.12823; Pastorelli C, 2006, ATT 6 C NAZ SOC HERP, P45; Peers MJL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051488; Pekar S, 2015, ECOLOGICAL ENTOMOLOG; Pianka E. R, 2011, EVOL ECOL, V7; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Pough F, 2016, HERPETOLOGY; Pough FH, 2013, VERTEBRATE LIFE; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; R Core Team, 2021, R LANGUAGE ENV STAT; Ravenscraft A, 2016, OECOLOGIA, V181, P1, DOI 10.1007/s00442-015-3403-6; Rondinini C., 2013, LISTA ROSSA IUCN VER; Rosado BHP, 2016, ECOGRAPHY, V39, P1034, DOI 10.1111/ecog.01678; Ruedenauer FA, 2016, BEHAV ECOL SOCIOBIOL, V70, P1209, DOI 10.1007/s00265-016-2129-8; Ruggi Alessandra, 2005, Annali del Museo Civico di Storia Naturale Giacomo Doria, V97, P135; SALVIDIO S, 1992, Vie et Milieu, V42, P35; Salvidio S, 2002, AMPHIBIA-REPTILIA, V23, P505; Salvidio S, 2017, ANIM BIOL, V67, P1, DOI 10.1163/15707563-00002517; Salvidio S, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1443-y; Salvidio S, 2012, ACTA OECOL, V43, P42, DOI 10.1016/j.actao.2012.05.001; Salvidio Sebastiano, 1994, Amphibia-Reptilia, V15, P35, DOI 10.1163/156853894X00533; Santini L, 2018, GLOBAL ECOL BIOGEOGR, V27, P787, DOI 10.1111/geb.12756; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Showalter AM, 2016, FRESHWATER BIOL, V61, P800, DOI 10.1111/fwb.12751; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; SPOTILA JR, 1972, ECOL MONOGR, V42, P95, DOI 10.2307/1942232; Stewart AB, 2017, BIOTROPICA, DOI [10.1111/btp.12464, DOI 10.1111/BTP.12464]; Svanback R, 2002, OECOLOGIA, V131, P61, DOI 10.1007/s00442-001-0861-9; Svanback R, 2012, AM NAT, V180, P50, DOI 10.1086/666000; Taberlet P, 2018, ENVIRONMENTAL DNA: FOR BIODIVERSITY RESEARCH AND MONITORING; Tartu S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155980; Venables WN., 2002, MODERN APPL STAT S, V4; Vignoli L, 2006, J NAT HIST, V40, P1841, DOI 10.1080/00222930600973598; VOESENEK L A C J, 1987, Amphibia-Reptilia, V8, P307, DOI 10.1163/156853887X00081; Wake DB, 2013, AMPHIBIA-REPTILIA, V34, P323, DOI 10.1163/15685381-00002893; Wells KD., 2007, ECOLOGY BEHAV AMPHIB	94	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205672	10.1371/journal.pone.0205672	http://dx.doi.org/10.1371/journal.pone.0205672			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335776	Green Published, gold, Green Submitted			2022-12-26	WOS:000447701300042
J	Martino, GP; Perez, CE; Magni, C; Blancato, VS				Martino, Gabriela P.; Perez, Cristian E.; Magni, Christian; Blancato, Victor S.			Implications of the expression of Enterococcus faecalis citrate fermentation genes during infection	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; OXALOACETATE DECARBOXYLASE; LACTOCOCCUS-LACTIS; ACTIVATOR CITO; METABOLISM; RESISTANCE; VIRULENCE; FAMILY; TRANSPORTER; MUTATIONS	Citrate is an ubiquitous compound in nature. However, citrate fermentation is present only in a few pathogenic or nonpathogenic microorganisms. The citrate fermentation pathway includes a citrate transporter, a citrate lyase complex, an oxaloacetate decarboxylase and a regulatory system. Enterococcus faecalis is commonly present in the gastro-intestinal microbiota of warm-blooded animals and insect guts. These bacteria can also cause infection and disease in immunocompromised individuals. In the present study, we performed whole genome analysis in Enterococcus strains finding that the complete citrate pathway is present in all of the E. faecalis strains isolated from such diverse habitats as animals, hospitals, water, milk, plants, insects, cheese, etc. These results indicate the importance of this metabolic preservation for persistence and growth of E. faecalis in different niches. We also analyzed the role of citrate metabolism in the E. faecalis pathogenicity. We found that an E. faecalis citrate fermentation-deficient strain was less pathogenic for Galleria mellonella larvae than the wild type. Furthermore, strains with deletions in the oxaloacetate decarboxylase subunits or in the alpha-acetolactate synthase resulted also less virulent than the wild type strain. We also observed that citrate promoters are induced in blood, urine and also in the hemolymph of G. mellonella. In addition, we showed that citrate fermentation allows E. faecalis to grow better in blood, urine and G. mellonella. The results presented here clearly indicate that citrate fermentation plays an important role in E. faecalis opportunistic pathogenic behavior.	[Martino, Gabriela P.; Perez, Cristian E.; Magni, Christian; Blancato, Victor S.] UNR, CONICET, Inst Biol Mol & Celular Rosario IBR, Lab Fisiol & Genet Bacterias Lact, Rosario, Argentina; [Magni, Christian; Blancato, Victor S.] UNR, Lab Biotecnol & Inocuidad Alimentos, Fac Ciencias Bioquim & Farmaceut FBioyF, Municipalidad Granadero Baigorria, Granadero Baigorria, Argentina; [Magni, Christian; Blancato, Victor S.] UNR, FCByF, LCTA, Biotecnol Alimentos, Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario	Blancato, VS (corresponding author), UNR, CONICET, Inst Biol Mol & Celular Rosario IBR, Lab Fisiol & Genet Bacterias Lact, Rosario, Argentina.; Blancato, VS (corresponding author), UNR, Lab Biotecnol & Inocuidad Alimentos, Fac Ciencias Bioquim & Farmaceut FBioyF, Municipalidad Granadero Baigorria, Granadero Baigorria, Argentina.; Blancato, VS (corresponding author), UNR, FCByF, LCTA, Biotecnol Alimentos, Rosario, Argentina.	blancato@ibr-conicet.gov.ar	Magni, Christian/AAF-6476-2019; Blancato, Víctor/J-8976-2019	Blancato, Víctor/0000-0003-3945-2859; Magni, Christian/0000-0002-5179-9700; Perez, Cristian/0000-0003-0508-260X	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 11220150100855]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPyCT) [PICT 2014 - 3482]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPyCT)(ANPCyT)	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP 11220150100855) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPyCT, PICT 2014 - 3482). GM is a Doctoral fellow from CONICET. CM and VB are research members from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agudelo Higuita NI., 2014, ENTEROCOCCI COMMENSA; Zuljan FA, 2016, INT DAIRY J, V62, P53, DOI 10.1016/j.idairyj.2016.07.007; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Blancato VS, 2008, J BACTERIOL, V190, P7419, DOI 10.1128/JB.01704-07; Blancato VS, 2006, FEBS J, V273, P5121, DOI 10.1111/j.1742-4658.2006.05509.x; Blancato VS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00101; Chen YT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-168; Espariz M, 2011, FEBS J, V278, P2140, DOI 10.1111/j.1742-4658.2011.08131.x; Fedhila S, 2010, J INVERTEBR PATHOL, V103, P24, DOI 10.1016/j.jip.2009.09.005; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Frank KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115839; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Garcia-Cayuela T, 2012, APPL MICROBIOL BIOT, V96, P171, DOI 10.1007/s00253-012-4087-z; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Gaspar F, 2009, MICROBIOL-SGM, V155, P3564, DOI 10.1099/mic.0.030775-0; Giraffa G, 2003, INT J FOOD MICROBIOL, V88, P215, DOI 10.1016/S0168-1605(03)00183-1; Hidron AI, 2008, J ANTIMICROB CHEMOTH, V61, P1394, DOI 10.1093/jac/dkn105; Inoue M, 2015, PROTEIN EXPRES PURIF, V115, P34, DOI 10.1016/j.pep.2015.05.008; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Korithoski B, 2005, J BACTERIOL, V187, P4451, DOI 10.1128/JB.187.13.4451-4456.2005; Laetitia G., 2014, Food and Nutrition Sciences, V5, P953, DOI 10.4236/fns.2014.510106; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; LeBlanc DJ, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P175, DOI 10.1007/0-387-30744-3_6; Maadani A, 2007, INFECT IMMUN, V75, P2634, DOI 10.1128/IAI.01372-06; Magni C, 1999, MECH CITRATE METABOL, V181; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Marelli B, 2010, WORLD J MICROB BIOT, V26, P999, DOI 10.1007/s11274-009-0262-5; Martin MG, 2005, J BACTERIOL, V187, P5146, DOI 10.1128/JB.187.15.5146-5155.2005; Martino GP, 2018, INT J FOOD MICROBIOL, V277, P1, DOI 10.1016/j.ijfoodmicro.2018.04.012; Martino GP, 2016, INT J FOOD MICROBIOL, V218, P27, DOI 10.1016/j.ijfoodmicro.2015.11.004; Moreno MRF, 2006, INT J FOOD MICROBIOL, V106, P1, DOI 10.1016/j.ijfoodmicro.2005.06.026; Mortera P, 2013, APPL ENVIRON MICROB, V79, P4603, DOI 10.1128/AEM.00925-13; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Repizo GD, 2013, APPL ENVIRON MICROB, V79, P2882, DOI 10.1128/AEM.03980-12; Repizo GD, 2011, MICROBIOL-SGM, V157, P2708, DOI 10.1099/mic.0.047662-0; Riboulet E, 2007, J MOL MICROB BIOTECH, V13, P140, DOI 10.1159/000103605; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sender PD, 2004, FEBS LETT, V570, P217, DOI 10.1016/j.febslet.2004.06.038; Sobczak T, 2005, MICROBIOL MOL BIOL R, V69, P665, DOI 10.1128/MMBR.69.4.665-695.2005; Suarez CA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-227; Sugumaran M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101753; Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Yoon SS, 2006, INFECT IMMUN, V74, P6547, DOI 10.1128/IAI.00695-06; Yuen GJ, 2014, J MICROBIOL, V52, P200, DOI 10.1007/s12275-014-4011-6; Zuljan FA, 2014, INT J FOOD MICROBIOL, V188, P99, DOI 10.1016/j.ijfoodmicro.2014.07.017	50	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205787	10.1371/journal.pone.0205787	http://dx.doi.org/10.1371/journal.pone.0205787			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335810	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300056
J	Cusso, L; Desco, M				Cusso, Lorena; Desco, Manuel			Suppression of F-18-FDG signal in the bladder on small animal PET-CT	PLOS ONE			English	Article							FUROSEMIDE	Introduction Retention of 2-deoxy-2-[F-18]fluoro-D-glucose F-18-FDG in the bladder causes more problems in small animal research than in human research owing to the smaller size of the subject. Catheterization has been proposed to reduce bladder spillover both in human studies and in small animal research. Noninvasive alternatives such as hydration plus furosemide also seem to be a promising pre-imaging strategy for decreasing bladder spillover. Our main goal was to measure the effects of the combination of furosemide and hydration for reducing bladder signal directly on mouse bowel F-18-FDG-PET images. Methods Nine mice were divided into two groups: the control group (C, n = 4) and the treatment group (n = 5). The clearance protocol combines hyperhydration and a single furosemide dose during the F-18-FDG uptake period. Two images were acquired on different days in treated mice to evaluate two different furosemide doses (low dose, LD, 3.5 mg/kg; and high dose, HD, 7 mg/kg). A region of interest was drawn on each computed tomography image (bladder, kidneys, liver, muscle, and bone marrow). To quantify bladder spillover, two different areas of the colon were selected. Results A remarkable reduction in bladder spillover was achieved on F-18-FDG-PET in both groups. Our imaging findings were quantified, and both furosemide doses induced a decrease in mean standard uptake values (SUVmean) compared with the controls (LD 1.46 +/- 0.54 and HD 1.05 +/- 0.29; controls: 8.90 +/- 3.4 [p-value < 0.05]). Conclusion We validated a non-invasive, easy, and harmless pre-imaging alternative for decreasing F-18-FDG bladder spillover. Our study shows the effect of furosemide on bladder spillover directly on F-18-FDG-PET images by measuring SUVmean in the bladder, colon, liver, muscle, and bone marrow.	[Cusso, Lorena; Desco, Manuel] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain; [Cusso, Lorena; Desco, Manuel] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Cusso, Lorena; Desco, Manuel] Ctr Invest Biorned Red Salud Mental CIBERSAM, Madrid, Spain; [Cusso, Lorena; Desco, Manuel] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain	Universidad Carlos III de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Cusso, L (corresponding author), Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain.; Cusso, L (corresponding author), Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain.; Cusso, L (corresponding author), Ctr Invest Biorned Red Salud Mental CIBERSAM, Madrid, Spain.; Cusso, L (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain.	lcusso@hggm.es	cussó, lorena/R-6715-2019; Desco, Manuel/AAD-7137-2019	cussó, lorena/0000-0001-9298-0015; Desco, Manuel/0000-0003-0989-3231	Spanish Ministerio de Ciencia, Innovacion y Universidades (ISCIII grant) [PIE16/00055]; ERDF (FEDER) Funds from the European Commission; Comunidad de Madrid [S2017/BMD-3867 RENIM-CM]; European structural and investment funds; Ministerio de Ciencia, Innovacion y Universidades; Pro CNIC Foundation	Spanish Ministerio de Ciencia, Innovacion y Universidades (ISCIII grant); ERDF (FEDER) Funds from the European Commission; Comunidad de Madrid(Comunidad de Madrid); European structural and investment funds; Ministerio de Ciencia, Innovacion y Universidades; Pro CNIC Foundation	This work was partially supported by Spanish Ministerio de Ciencia, Innovacion y Universidades (ISCIII grant PIE16/00055) and co-financed by ERDF (FEDER) Funds from the European Commission, "A way of making Europe". It was also supported by the Comunidad de Madrid (S2017/BMD-3867 RENIM-CM) (MD) and cofunded with European structural and investment funds. The CNIC is supported by the Ministerio de Ciencia, Innovacion y Universidades and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505).	Abella M, 2012, COMPUT METH PROG BIO, V107, P218, DOI 10.1016/j.cmpb.2011.06.008; Agarwal KK, 2016, PET CLIN, V11, P39, DOI 10.1016/j.cpet.2015.07.005; Almuhaideb A, 2011, ANN SAUDI MED, V31, P3, DOI 10.4103/0256-4947.75771; Anjos DA, 2007, J NUCL MED, V48, P764, DOI 10.2967/jnumed.106.036350; Bettenworth D, 2013, J NUCL MED, V54, P748, DOI 10.2967/jnumed.112.112623; Bohnen NI, 2012, J NUCL MED, V53, P59, DOI 10.2967/jnumed.111.096578; Deleye S, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2014.00013; FOY JM, 1971, BRIT J PHARMACOL, V42, P287, DOI 10.1111/j.1476-5381.1971.tb07110.x; Gargiulo S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/541872; Glaudemans AWJM, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/623036; Harkirat S, 2010, Indian J Radiol Imaging, V20, P13, DOI 10.4103/0971-3026.59746; Hindryckx P, 2011, INFLAMM BOWEL DIS, V17, P2058, DOI 10.1002/ibd.21578; KLEINZELLER A, 1980, BIOCHIM BIOPHYS ACTA, V600, P513, DOI 10.1016/0005-2736(80)90453-8; Kosuda S, 1997, Ann Nucl Med, V11, P213; Kumar R, 2004, RADIOL CLIN N AM, V42, P1141, DOI 10.1016/j.rcl.2004.08.007; Lum Darren P, 2002, Mol Imaging Biol, V4, P232, DOI 10.1016/S1095-0397(01)00062-0; MCMURTRY RJ, 1977, TOXICOL APPL PHARM, V42, P285, DOI 10.1016/0041-008X(77)90005-9; Moran JK, 1999, J NUCL MED, V40, P1352; Nijjar S, 2010, NUCL MED COMMUN, V31, P167, DOI 10.1097/MNM.0b013e32833492eb; Pandit-Taskar N, 2005, J NUCL MED, V46, P1842; Shreve PD, 1999, RADIOGRAPHICS, V19, P61, DOI 10.1148/radiographics.19.1.g99ja0761; Yu JQ, 2012, PET CLIN, V7, P191, DOI 10.1016/j.cpet.2012.01.005	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205610	10.1371/journal.pone.0205610	http://dx.doi.org/10.1371/journal.pone.0205610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332442	Green Published, Green Submitted, gold			2022-12-26	WOS:000447638200058
J	Rogers, PC; McAvoy, DJ				Rogers, Paul C.; McAvoy, Darren J.			Mule deer impede Pando's recovery: Implications for aspen resilience from a single-genotype forest	PLOS ONE			English	Article							POPULUS-TREMULOIDES MICHX.; QUAKING ASPEN; TROPHIC CASCADE; NORTH-AMERICA; ELK; STANDS; COMMUNITIES; HERBIVORY; CONSERVATION; MANAGEMENT	Aspen ecosystems (upland Populus-dominated forests) support diverse species assemblages in many parts of the northern hemisphere, yet are imperiled by common stressors. Extended drought, fire suppression, human development, and chronic herbivory serve to limit the sustainability of this keystone species. Here we assess conditions at a renowned quaking aspen (Populus tremuloides) grove purportedly the largest living organism on earth with ramifications for aspen biogeography globally. The "Pando" clone is 43 ha and estimated to contain 47,000 genetically identical aspen ramets. This iconic forest is threatened in particular by herbivory, and current management activities aim to reverse the potential for type conversion, likely to a non-forest state. We set out to gauge agents affecting recent deterioration through a network of monitoring plots and by examining a chronosequence of historic aerial photos to better understand the timing of putative departure from a sustainable course. Sixty-five permanent forest monitoring plots were located in three management regimes existing within Pando: no fencing, fencing with active and passive treatments, fencing with passive-only treatment. At each sample plot we measured live and dead mature trees, stem recruitment and regeneration, forest and shrub cover, browse level, and feces counts as a surrogate for ungulate presence. Ordination results indicate that aspen regeneration was the strongest indicator of overall forest conditions at Pando, and that mule deer (Odocoileus hemionus) presence strongly impacts successful regeneration. Additionally, fencing with active/passive treatments yielded the most robust regeneration levels; however, a fence penetrable by ungulates in the passive-only treatment most likely played a role in this outcome. The aerial photo sequence depicts various human intrusions over the past seven decades, but perhaps most telling, a decline in self-replacement beginning 30-40 years ago. Aspen communities in many locations in North American and Europe are impacted by unchecked herbivory. The Pando clone presents a unique opportunity for understanding browse mechanisms in a forest where tree genotype, closely aligned with growth and chemical defense, is uniform.	[Rogers, Paul C.] Utah State Univ, Wildland Resources Dept, Western Aspen Alliance, Logan, UT 84322 USA; [Rogers, Paul C.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [McAvoy, Darren J.] Utah State Univ, Forestry Extens & Wildland Resources Dept, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Rogers, PC (corresponding author), Utah State Univ, Wildland Resources Dept, Western Aspen Alliance, Logan, UT 84322 USA.; Rogers, PC (corresponding author), Utah State Univ, Ctr Ecol, Logan, UT 84322 USA.	p.rogers@usu.edu		Rogers, Paul C./0000-0001-5978-8910	Secure Rural Schools program; US Forest Service, Fishlake National Forest; Utah State University Forestry Extension; Pando Fund; U.S. Bureau of Land Management grant [L16AC00175]	Secure Rural Schools program; US Forest Service, Fishlake National Forest; Utah State University Forestry Extension; Pando Fund; U.S. Bureau of Land Management grant	Funding for fence construction was provided by the Secure Rural Schools program and labor came from the US Forest Service, Fishlake National Forest. Additional funding was provided by Utah State University Forestry Extension, the Pando Fund, and the U.S. Bureau of Land Management grant no. L16AC00175 to PCR.; We would like to thank the U.S. Forest Service, Fishlake National Forest for their permission to conduct this research, as well as for providing housing for the field campaign. Utah State University Ecology Center and Wildland Resources Department aided with administrative and logistical work for this study. Funding for fence construction was provided by the Secure Rural Schools program and labor came from the U.S. Forest Service, Fishlake National Forest. Additional funding was provided by Utah State University Forestry Extension, the Pando Fund, and the U.S. Bureau of Land Management. Primary field work was conducted by Kasy Kliewer, Tiffany Thompson, Jody Gale, and Paul Rogers. We are grateful to the editors and three anonymous reviewers for their time and critical scrutiny devoted to improving this manuscript.	Angelstam P, 2017, ECOL APPL, V27, P1108, DOI 10.1002/eap.1506; [Anonymous], 2016, PC ORD MULTIVARIATE; Bailey JK, 2002, ECOLOGY, V83, P1701, DOI 10.1890/0012-9658(2002)083[1701:IAFAAE]2.0.CO;2; Beck JL, 1996, USDA INTERM, V343, P81; Bork EW, 2013, OECOLOGIA, V173, P895, DOI 10.1007/s00442-013-2676-x; Boudreault C, 2002, CAN J FOREST RES, V32, P1080, DOI [10.1139/x02-027, 10.1139/X02-027]; Bunnefeld N, 2006, J ZOOL, V270, P31, DOI 10.1111/j.1469-7998.2006.00107.x; Cavard X, 2011, ENVIRON REV, V19, P142, DOI [10.1139/a11-004, 10.1139/A11-004]; Chen L, 2017, GLOBAL CHANGE BIOL, V23, P2887, DOI 10.1111/gcb.13595; Chong GW, 2001, USDA ROCKY, P261; Conway AJ, 2017, FOREST ECOL MANAG, V391, P154, DOI 10.1016/j.foreco.2017.02.018; DeRose RJ, 2015, CAN J FOREST RES, V45, P1, DOI 10.1139/cjfr-2014-0382; Ding C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04871-7; Edenius L, 2007, BIOL CONSERV, V135, P293, DOI 10.1016/j.biocon.2006.10.052; Edenius L, 2015, SCAND J FOREST RES, V30, P283, DOI 10.1080/02827581.2014.999823; Eisenberg C, 2013, FOREST ECOL MANAG, V299, P70, DOI 10.1016/j.foreco.2013.01.014; Endress BA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1530; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Griffis-Kyle KL, 2003, BIOL CONSERV, V110, P375, DOI 10.1016/S0006-3207(02)00237-9; Haggerty JH, 2006, GEOFORUM, V37, P816, DOI 10.1016/j.geoforum.2005.12.004; HARNISS R.O., 1982, INTRP297 USDA FOR SE; Hedenas H, 2000, BIOL CONSERV, V93, P43, DOI 10.1016/S0006-3207(99)00113-5; Holeski LM, 2016, J ECOL, V104, P850, DOI 10.1111/1365-2745.12559; Jones BE, 2005, R5EMTP004 USDA FOR S; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; KEMPERMAN JA, 1976, CAN J BOT, V54, P2603, DOI 10.1139/b76-280; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P115, DOI 10.1007/BF02289694; Kuhn TJ, 2011, PLANT ECOL, V212, P1451, DOI 10.1007/s11258-011-9920-4; Kurzel BP, 2007, FOREST ECOL MANAG, V252, P176, DOI 10.1016/j.foreco.2007.06.027; Lindroth RL, 2013, FOREST ECOL MANAG, V299, P14, DOI 10.1016/j.foreco.2012.11.018; LOFT ER, 1991, J WILDLIFE MANAGE, V55, P16, DOI 10.2307/3809236; Martin TE, 2012, NAT CLIM CHANGE, V2, P195, DOI [10.1038/NCLIMATE1348, 10.1038/nclimate1348]; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Mittanck CM, 2014, ECOL MODEL, V288, P203, DOI 10.1016/j.ecolmodel.2014.06.010; Mitton JB, 1996, BIOSCIENCE, V46, P25, DOI 10.2307/1312652; Mock KE, 2008, MOL ECOL, V17, P4827, DOI 10.1111/j.1365-294X.2008.03963.x; Myking T, 2011, FORESTRY, V84, P61, DOI 10.1093/forestry/cpq044; Oaten DK, 2008, NORTHWEST SCI, V82, P276, DOI 10.3955/0029-344X-82.4.276; Olmsted C.E., 1979, P89; Osier TL, 2006, OECOLOGIA, V148, P293, DOI 10.1007/s00442-006-0373-8; Painter LE, 2015, ECOLOGY, V96, P252, DOI 10.1890/14-0712.1; Parsons EWR, 2013, J ANIM ECOL, V82, P459, DOI 10.1111/1365-2656.12009; Peck J. E., 2010, MULTIVARIATE ANAL CO; Rehfeldt GE, 2009, FOREST ECOL MANAG, V258, P2353, DOI 10.1016/j.foreco.2009.06.005; Rhodes AC, 2017, FOREST ECOL MANAG, V397, P39, DOI 10.1016/j.foreco.2017.04.014; Rogers PC, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1661; Rogers PC, 2014, FOREST SCI, V60, P345, DOI 10.5849/forsci.12-156; Rogers PC, 2014, J VEG SCI, V25, P457, DOI 10.1111/jvs.12099; Seager ST, 2013, FOREST ECOL MANAG, V299, P81, DOI 10.1016/j.foreco.2013.02.017; Shinneman DJ, 2013, FOREST ECOL MANAG, V299, P22, DOI 10.1016/j.foreco.2012.11.032; Swift CE, 2017, CAN J REMOTE SENS, V43, P231, DOI 10.1080/07038992.2017.1317205; Usoltsev V, 2018, J ECOL ENG, V19, P206, DOI 10.12911/22998993/79403; Wooley S. C., 2008, RANGELANDS, V30, P17; Worrall JJ, 2013, FOREST ECOL MANAG, V299, P35, DOI 10.1016/j.foreco.2012.12.033; Yang J, 2015, LANDSCAPE ECOL, V30, P1055, DOI 10.1007/s10980-015-0160-1; Zar JH, 1999, BIOSTATISTICAL ANAL	57	9	9	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0203619	10.1371/journal.pone.0203619	http://dx.doi.org/10.1371/journal.pone.0203619			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332420	Green Published, Green Submitted, gold			2022-12-26	WOS:000447638200005
J	Quax, S; van Gerven, M				Quax, Silvan; van Gerven, Marcel			Emergent mechanisms of evidence integration in recurrent neural networks	PLOS ONE			English	Article							DECISION-MAKING; NEURONS; MODELS	Recent advances in machine learning have enabled neural networks to solve tasks humans typically perform. These networks offer an exciting new tool for neuroscience that can give us insight in the emergence of neural and behavioral mechanisms. A big gap remains though between the very deep neural networks that have risen in popularity and outperformed many existing shallow networks in the field of computer vision and the highly recurrently connected human brain. This trend towards ever-deeper architectures raises the question why the brain has not developed such an architecture. Besides wiring constraints we argue that the brain operates under different circumstances when performing object recognition, being confronted with noisy and ambiguous sensory input. The role of time in the process of object recognition is investigated, showing that a recurrent network trained through reinforcement learning is able to learn the amount of time needed to arrive at an accurate estimate of the stimulus and develops behavioral and neural mechanisms similar to those found in the human and non-human primate literature.	[Quax, Silvan; van Gerven, Marcel] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	Radboud University Nijmegen	Quax, S (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	s.quax@donders.ru.nl	Quax, Silvan/Q-8683-2018	Quax, Silvan/0000-0001-6685-1789	VIDI of The Netherlands Organization for Scientific Research (NWO) [639.072.513]	VIDI of The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by VIDI grant number 639.072.513 of The Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by VIDI grant number 639.072.513 of The Netherlands Organization for Scientific Research (NWO). A special thanks to Sander Bosch for providing helpful feedback on the manuscript.	BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Cho K, 2014, ARXIV140610782014; Drugowitsch J, 2015, ELIFE, V4, DOI 10.7554/eLife.06678; Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Guergiuev J, 2016, ARXIV1610001612016; Hanks TD, 2014, ELIFE, V3, DOI 10.7554/eLife.02260; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang J, 2016, ARXIV1611100122016; Jones E., 2001, SCIPY OPEN SOURCE SC; Kayser C, 2003, NEUROCOMPUTING, V52-4, P117, DOI 10.1016/S0925-2312(02)00789-0; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Liao Q, 2016, ARXIV1604036402016; Lillicrap TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13276; Lotter W, 2016, ARXIV1605081042016; Malhotra G, 2018, PSYCHON B REV, V25, P971, DOI 10.3758/s13423-017-1340-6; Miconi T, 2017, ELIFE, V6, DOI 10.7554/eLife.20899; Mikolov T, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P1045; Mnih V, 2016, PR MACH LEARN RES, V48; MYERSON J, 1995, J EXP ANAL BEHAV, V64, P263, DOI 10.1901/jeab.1995.64-263; MYUNG IJ, 1989, AM J PSYCHOL, V102, P1, DOI 10.2307/1423113; Nayebi A, 2018, ARXIV1807000532018; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Pascanu R., 2013, INT C MACH LEARN, P1310; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Philiastides MG, 2006, CEREB CORTEX, V16, P509, DOI 10.1093/cercor/bhi130; Reinagel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068505; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roitman JD, 2002, J NEUROSCI, V22, P9475; RUMELHART DE, 1987, PARALLEL DISTRIBUTED, V1; Scellier B, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00024; Silver D, 2014, PR MACH LEARN RES, V32; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Song HF, 2017, ELIFE, V6, DOI [10.7554/elife.21492, 10.7554/eLife.21492]; Spoerer CJ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01551; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tokui Seiya, 2015, P WORKSH MACH LEARN, V5, P1; Wang JX, 2018, BIORXIV; WILLIAMS RJ, 1992, MACH LEARN, V8, P229, DOI 10.1007/BF00992696; Xu K, 2015, PR MACH LEARN RES, V37, P2048; Yang G. R., 2017, BIORXIV, P1, DOI [10.1101/183632, DOI 10.1101/183632]	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205676	10.1371/journal.pone.0205676	http://dx.doi.org/10.1371/journal.pone.0205676			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0VS	30325970	gold, Green Submitted, Green Published			2022-12-26	WOS:000447430800032
J	Kaiser, BLD; Hill, KK; Smith, TJ; Williamson, CHD; Keim, P; Sahl, JW; Wahl, KL				Kaiser, Brooke L. Deatherage; Hill, Karen K.; Smith, Theresa J.; Williamson, Charles H. D.; Keim, Paul; Sahl, Jason W.; Wahl, Karen L.			Proteomic analysis of four Clostridium botulinum strains identifies proteins that link biological responses to proteomic signatures	PLOS ONE			English	Article							NEUROTOXIN; ALGORITHM	Microorganisms alter gene and protein expression in response to environmental conditions to adapt and survive. Whereas the genetic composition of a microbe represents an organism's biological potential, the proteins expressed provide a functional readout of the organism's response to the environment. Understanding protein expression patterns in response to specific environmental conditions furthers fundamental knowledge about a microbe, which can be especially useful for understudied organisms such as Clostridium botulinum examined herein. In addition, protein expression patterns that reproducibly occur in certain growth conditions hold potential in fields such as microbial forensics, in which determination of conditions in which an unknown possible biothreat sample had been grown may be important. To investigate the identity and reproducibility of protein profile patterns for varied strains, we defined the proteomic profiles of four Group I strains of Clostridium botulinum, a Category A biothreat agent and the organism responsible for the production of the botulinum neurotoxin (BoNT), in two different culture media grown for five days. The four C. botulinum strains produced one of three neurotoxins (BoNT/A, /B, or /F), and their protein profiles were compared to that of a fifth non-toxigenic strain of C. sporogenes. These strains each had DNA sequences available to assist in accurate protein identification. Differing culture growth phase, bacterial strain, and growth medium resulted in reproducible protein profiles, which were used to calculate relative protein abundance ratios as an internally normalized metric of microbial growth in varying conditions. The resulting protein profiles provide functional information about how four Group I C. botulinum strains and a C. sporogenes strain respond to the culture environment during growth and explores the feasibility of using these proteins to characterize unknown samples.	[Kaiser, Brooke L. Deatherage; Wahl, Karen L.] Pacific Northwest Natl Lab, Chem & Biol Signature Sci Grp, Richland, WA 99354 USA; [Hill, Karen K.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Smith, Theresa J.; Williamson, Charles H. D.; Keim, Paul; Sahl, Jason W.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Northern Arizona University	Kaiser, BLD (corresponding author), Pacific Northwest Natl Lab, Chem & Biol Signature Sci Grp, Richland, WA 99354 USA.	brooke.kaiser@pnnl.gov		, Jason/0000-0002-2497-0138	Department of Homeland Security Science and Technology Directorate [HSHQPM-10-X-00077/4]	Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS))	Funding for this work was provided by the Department of Homeland Security Science and Technology Directorate (https://www.dhs.gov/science-and-technology) under contract HSHQPM-10-X-00077/4 to Pacific Northwest National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artin I, 2010, APPL ENVIRON MICROB, V76, P1168, DOI 10.1128/AEM.02247-09; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Budowle B, 2005, APPL ENVIRON MICROB, V71, P2209, DOI 10.1128/AEM.71.5.2209-2213.2005; Collins MD, 1998, J APPL MICROBIOL, V84, P5, DOI 10.1046/j.1365-2672.1997.00313.x; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Dorner MB, 2013, CURR TOP MICROBIOL, V364, P219, DOI 10.1007/978-3-642-33570-9_11; Dover N, 2014, J INFECT DIS, V209, P192, DOI 10.1093/infdis/jit450; Fonfria E, 2018, TOXINS, V10, DOI 10.3390/toxins10050208; Hill KK, 2013, CURR TOP MICROBIOL, V364, P1, DOI 10.1007/978-3-642-33570-9_1; Hill KK, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-66; Jacobson MJ, 2011, FOOD MICROBIOL FOOD, P95, DOI 10.1007/978-1-4419-7686-4_4; Kalb SR, 2017, TOXINS, V9, DOI 10.3390/toxins9060193; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kim BH, 2008, BACTERIAL PHYSIOLOGY AND METABOLISM, P1; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Liang WD, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/760904; Lin GY, 2010, APPL ENVIRON MICROB, V76, P40, DOI 10.1128/AEM.01882-09; NISMAN B, 1954, BACTERIOL REV, V18, P16, DOI 10.1128/MMBR.18.1.16-42.1954; Peck MW, 2017, TOXINS, V9, DOI 10.3390/toxins9010038; Pirazzini M, 2017, PHARMACOL REV, V69, P200, DOI 10.1124/pr.116.012658; Prevention CfDCa, 1998, HDB EP; Sahl JW, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000074; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Williamson CHD, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00806-17, 10.1128/aem.00806-17]	27	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205586	10.1371/journal.pone.0205586	http://dx.doi.org/10.1371/journal.pone.0205586			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321210	gold, Green Submitted, Green Published			2022-12-26	WOS:000447417900039
J	Li, YJ; Dungey, HS; Carson, M; Carson, S				Li, Yongjun; Dungey, Heidi S.; Carson, Mike; Carson, Sue			Genotype by environment interaction for growth and Dothistroma resistance and clonal connectivity between environments in radiata pine in New Zealand and Australia	PLOS ONE			English	Article							DON. ELDRIDGE COLLECTION; NEEDLE BLIGHT; BREEDING STRATEGY; PROVENANCE VARIATION; GENETIC-PARAMETERS; DIAMETER GROWTH; LOBLOLLY-PINE; WOOD DENSITY; FORM TRAITS; SELECTION	Twenty-eight clonal trials of radiata pine planted across Australia and New Zealand were used to investigate genetic variation and genotype by environment (GxE) interaction for diameter-at-breast-height (DBH), height and Dothistroma resistance (DO_R). The average narrow-sense heritabilities were 0.11, 0.21 and 0.30 while the average broad-sense heritabilities were 0.27, 0.34 and 0.40 for DBH, height and Dothistroma resistance, respectively. Dothistroma resistance was assessed as the percentage of needles that were not affected by Dothistroma needle blight. GxE interactions were analysed using an approximate reduced factor analytic model. Apparent GxE interactions were estimated for DBH, height and Dothistroma resistance. Estimates of GxE interactions and their standard errors were strongly influenced by the level of connectivity between trials, in terms of common clones and common parents. When there was sufficient connectivity between trials (more than 30% common clones between trials), a high level of GxE interaction was found for DBH and height but not for Dothistroma resistance. In two simulated clonal trials planted in two environments, low connectivity between environments resulted in a lower estimated genetic correlation between environments with an increased standard error. These results suggest that the number of clones in common between clonal trials is a key factor for inclusion in future experimental designs for estimating GxE interaction. When designing clonal trials for use in multiple environments for accurately estimating the level of GxE, if the resource for creating connectivity between environments is limited, at least 30% of the clones need to be in common between environments.	[Li, Yongjun; Dungey, Heidi S.] Scion New Zealand Forest Res Inst, Rotorua, New Zealand; [Li, Yongjun] Agr Victoria, AgriBio Ctr, Bundoora, Vic, Australia; [Carson, Mike; Carson, Sue] Forest Genet Ltd, Rotorua, New Zealand; [Carson, Mike; Carson, Sue] Carson Associates Ltd, Rotorua, New Zealand		Li, YJ (corresponding author), Scion New Zealand Forest Res Inst, Rotorua, New Zealand.; Li, YJ (corresponding author), Agr Victoria, AgriBio Ctr, Bundoora, Vic, Australia.	Yongjun.Li@ecodev.vic.gov.au		Dungey, Heidi/0000-0003-2589-3928	Scion Core Funding; Forest Genetics Ltd.; Scion and Forest Genetics Ltd.	Scion Core Funding; Forest Genetics Ltd.; Scion and Forest Genetics Ltd.	This manuscript was funded by Scion Core Funding and funding from Forest Genetics Ltd. Authors Yongjun Li and Heidi S. Dungey were working at Scion and authors Mike Carson and Sue Carson were working at Forest Genetics Ltd during the course of the study. This project was an incorporated project between Scion and Forest Genetics Ltd. Scion and Forest Genetics Ltd provided support for the authors in terms of working hours to conduct the study. The manuscript has been approved for publication by the funding bodies. The current affiliation of author YL is Agriculture Victoria. The simulation part of this manuscript was conducted by author YL when working in Agriculture Victoria. Agriculture Victoria provided support for author YL in terms of working hours to conduct the simulation but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. Forest Genetics Ltd did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. Mike Carson and Sue Carson are affiliated to Carson Associates Ltd. Carson Associates Ltd provided support in the form of salaries for authors MS and SC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Apiolaza LA, 2012, TREE GENET GENOMES, V8, P87, DOI 10.1007/s11295-011-0423-1; Baltunis BS, 2010, NEW FOREST, V40, P305, DOI 10.1007/s11056-010-9201-4; Bradshaw RE, 2004, FOREST PATHOL, V34, P163, DOI 10.1111/j.1439-0329.2004.00356.x; Bulman LS, 2004, NZ FOREST RES B, V229; Bulman LS, 1993, NZ FOR, V21, P21; BURDON R D, 1976, New Zealand Journal of Forestry Science, V5, P250; BURDON R D, 1971, Silvae Genetica, V20, P33; Burdon RD, 2008, AUST FORESTRY, V71, P263, DOI 10.1080/00049158.2008.10675045; BURDON RD, 1977, SILVAE GENET, V26, P168; Burdon RD, 2017, NZ J FORESTRY SCI, V47, DOI 10.1186/s40490-017-0087-1; Butler DG, 2018, ASREML R REFERENCE M; Carson S. D., 1991, New Zealand Journal of Forestry Science, V21, P32; CARSON S D, 1989, New Zealand Journal of Forestry Science, V19, P3; CARSON SD, 1989, ANNU REV PHYTOPATHOL, V27, P373, DOI 10.1146/annurev.py.27.090189.002105; Chen ZQ, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1103-6; Silva JCE, 2006, TREE GENET GENOMES, V2, P61, DOI 10.1007/s11295-005-0025-x; Cullis BR, 2014, THEOR APPL GENET, V127, P2193, DOI 10.1007/s00122-014-2373-0; DEJONG G, 1990, GENETICA, V81, P171, DOI 10.1007/BF00360862; Devey ME, 2004, THEOR APPL GENET, V108, P516, DOI 10.1007/s00122-003-1471-1; Dieters MJ, 1996, SILVAE GENET, V45, P235; Dieters MJ, 2007, WFGA SFTIC JOINT M 2; Ding M., 2008, New Zealand Journal of Forestry Science, V38, P143; Dungey HS, 2009, SILVAE GENET, V58, P28, DOI 10.1515/sg-2009-0004; ELDRIDGE KG, 1982, NEW ZEAL J FOR SCI, V12, P404; Falconer D. S., 1996, INTRO QUANTITATIVE G; FOA, 2012, TECHNICAL REPORT; FOA MPI, 2012, NZ FOR IND FACTS FIG; Ganley R. J., 2014, New Zealand Plant Protection, V67, P48; Gapare WJ, 2012, TREE GENET GENOMES, V8, P895, DOI 10.1007/s11295-012-0475-x; Gapare WJ, 2012, TREE GENET GENOMES, V8, P391, DOI 10.1007/s11295-011-0449-4; Gapare WJ, 2010, TREE GENET GENOMES, V6, P113, DOI 10.1007/s11295-009-0233-x; Hirst P., 1999, New Zealand Journal of Forestry Science, V29, P459; Ivkovic M, 2013, FOR GEN 2013 JOINT M; Ivkovic M, 2013, ANN FOREST SCI, V70, P525, DOI 10.1007/s13595-013-0290-z; Ivkovic M, 2010, CAN J FOREST RES, V40, P1653, DOI 10.1139/X10-097; Jayawickrama KJS, 2000, SILVAE GENET, V49, P82; JOHNSON GR, 1990, SILVAE GENET, V39, P55; Kennedy SG, 2014, NEW ZEAL J FOR SCI, V44, DOI 10.1186/s40490-014-0012-9; Kennedy SG, 2013, TREE GENET GENOMES, V9, P1313, DOI 10.1007/s11295-013-0639-3; Kimberley MO, 2015, CAN J FOREST RES, V45, P1676, DOI 10.1139/cjfr-2015-0191; LI B, 1989, SILVAE GENET, V38, P96; Li L, 2005, CAN J FOREST RES, V35, P2019, DOI [10.1139/x05-134, 10.1139/X05-134]; Li YJ, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1144-x; Li YJ, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1019-6; Li YJ, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0830-1; MATHESON AC, 1984, AUST FOREST RES, V14, P11; McDonald TM, 2009, 2 AUSTR FOR GEN C 20; Mead DJ, 2013, SUSTAINABLE MANAGEME, P246; PEDERICK LA, 1990, SILVAE GENET, V39, P134; RAYMOND CA, 1990, SILVAE GENET, V39, P110; Raymond CA, 2011, TREE GENET GENOMES, V7, P819, DOI 10.1007/s11295-011-0376-4; SHAW CG, 1977, PHYTOPATHOLOGY, V67, P1319, DOI 10.1094/Phyto-67-1319; Shelbourne CJA, 1986, FOREST RES I SPECIAL; SHELBOURNE CJA, 1972, IUFRO GEN SABRAO JOI; Sutton WRJ, 1999, NEW FOREST, V17, P95, DOI 10.1023/A:1006567221005; Vincent T. G., 1987, FRI Bulletin, Forest Research Institute, New Zealand; Watt M., 2011, New Zealand Journal of Forestry, V56, P20; WILCOX MD, 1982, NEW ZEAL J FOR SCI, V12, P14; Wilcox PL, 1996, P NATL ACAD SCI USA, V93, P3859, DOI 10.1073/pnas.93.9.3859; Wu H. X., 2007, Australian Forestry, V70, P215; Wu H. X., 2008, New Zealand Journal of Forestry Science, V38, P56; Wu HX, 2005, FOREST SCI, V51, P29	62	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205402	10.1371/journal.pone.0205402	http://dx.doi.org/10.1371/journal.pone.0205402			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312360	gold, Green Published, Green Submitted			2022-12-26	WOS:000447427300031
J	Mahalhal, A; Williams, JM; Johnson, S; Ellaby, N; Duckworth, CA; Burkitt, MD; Liu, X; Hold, GL; Campbell, BJ; Pritchard, DM; Probert, CS				Mahalhal, Awad; Williams, Jonathan M.; Johnson, Sophie; Ellaby, Nicholas; Duckworth, Carrie A.; Burkitt, Michael D.; Liu, Xuan; Hold, Georgina L.; Campbell, Barry J.; Pritchard, D. Mark; Probert, Chris S.			Oral iron exacerbates colitis and influences the intestinal microbiome	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GUT MICROBIOTA; DEFICIENCY ANEMIA; INTRAVENOUS IRON; BACTERIA; SUPPLEMENTATION; IBD; FORTIFICATION; HOMEOSTASIS; MANAGEMENT	Inflammatory bowel disease (IBD) is associated with anaemia and oral iron replacement to correct this can be problematic, intensifying inflammation and tissue damage. The intestinal microbiota also plays a key role in the pathogenesis of IBD, and iron supplementation likely influences gut bacterial diversity in patients with IBD. Here, we assessed the impact of dietary iron, using chow diets containing either 100, 200 or 400 ppm, fed ad libitum to adult female C57BL/6 mice in the presence or absence of colitis induced using dextran sulfate sodium (DSS), on (i) clinical and histological severity of acute DSS-induced colitis, and (ii) faecal microbial diversity, as assessed by sequencing the V4 region of 16S rRNA. Increasing or decreasing dietary iron concentration from the standard 200 ppm exacerbated both clinical and histological severity of DSS-induced colitis. DSS-treated mice provided only half the standard levels of iron ad libitum (i.e. chow containing 100 ppm iron) lost more body weight than those receiving double the amount of standard iron (i.e. 400 ppm); p<0.01. Faecal calprotectin levels were significantly increased in the presence of colitis in those consuming 100 ppm iron at day 8 (5.94-fold) versus day-10 group (4.14-fold) (p<0.05), and for the 400 ppm day-8 group (8.17-fold) versus day-10 group (4.44-fold) (p<0.001). In the presence of colitis, dietary iron at 400 ppm resulted in a significant reduction in faecal abundance of Firmicutes and Bacteroidetes, and increase of Proteobacteria, changes which were not observed with lower dietary intake of iron at 100 ppm. Overall, altering dietary iron intake exacerbated DSS-induced colitis; increasing the iron content of the diet also led to changes in intestinal bacteria diversity and composition after colitis was induced with DSS.	[Mahalhal, Awad; Johnson, Sophie; Duckworth, Carrie A.; Burkitt, Michael D.; Campbell, Barry J.; Pritchard, D. Mark; Probert, Chris S.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Gastroenterol Res Unit, Liverpool, Merseyside, England; [Mahalhal, Awad] Benghazi Univ, Fac Med, Dept Anat & Histol, Benghazi, Libya; [Williams, Jonathan M.] Royal Vet Coll, Pathobiol & Populat Sci, N Mymms, England; [Ellaby, Nicholas; Liu, Xuan] Univ Liverpool, Inst Integrat Biol, Dept Funct & Comparat Genom, Liverpool, Merseyside, England; [Hold, Georgina L.] Univ New South Wales, St George & Sutherland Clin Sch, Dept Med, Sydney, NSW, Australia	University of Liverpool; University of Benghazi; University of London; University of London Royal Veterinary College; University of Liverpool; University of New South Wales Sydney	Mahalhal, A (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Gastroenterol Res Unit, Liverpool, Merseyside, England.; Mahalhal, A (corresponding author), Benghazi Univ, Fac Med, Dept Anat & Histol, Benghazi, Libya.	awad.mahalhal@liverpool.ac.uk	Hold, Georgina Louise/AAG-9923-2020	Hold, Georgina Louise/0000-0001-7573-3397; Pritchard, David Mark/0000-0001-7971-3561; Williams, Jonathan/0000-0002-6617-0323; Probert, Christopher/0000-0003-4550-0239	Higher Education Ministry, Libyan Government, Tripoli - Libya	Higher Education Ministry, Libyan Government, Tripoli - Libya	This work was supported by a grant from the Higher Education Ministry, Libyan Government, Tripoli - Libya. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bik EM, 2009, NUTR REV, V67, pS164, DOI 10.1111/j.1753-4887.2009.00237.x; Bleich A, 2012, COMP IMMUNOL MICROB, V35, P81, DOI 10.1016/j.cimid.2011.12.006; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carrier J, 2001, ALIMENT PHARM THER, V15, P1989, DOI 10.1046/j.1365-2036.2001.01113.x; Carrier JC, 2006, INT J COLORECTAL DIS, V21, P381, DOI 10.1007/s00384-005-0011-7; Constante M, 2017, INFLAMM BOWEL DIS, V23, P753, DOI 10.1097/MIB.0000000000001089; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Erichsen K, 2005, INFLAMM BOWEL DIS, V11, P744, DOI 10.1097/01.MIB.0000174374.83601.86; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Guarner F, 2006, DIGESTION, V73, P5, DOI 10.1159/000089775; Henderson P, 2012, AM J GASTROENTEROL, V107, P941, DOI 10.1038/ajg.2012.33; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Hold GL, 2014, WORLD J GASTROENTERO, V20, P1192, DOI 10.3748/wjg.v20.i5.1192; Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720; Kopylov U, 2014, INFLAMM BOWEL DIS, V20, P742, DOI 10.1097/01.MIB.0000442681.85545.31; Kortman GAM, 2015, EUR J IMMUNOL, V45, P2553, DOI 10.1002/eji.201545642; Kulnigg S, 2009, AM J GASTROENTEROL, V104, P1460, DOI 10.1038/ajg.2009.114; Lee SH, 2008, BIOL TRACE ELEM RES, V126, pS57, DOI 10.1007/s12011-008-8209-5; Lee T, 2017, GUT, V66, P863, DOI 10.1136/gutjnl-2015-309940; Lee TW, 2012, J CROHNS COLITIS, V6, P267, DOI 10.1016/j.crohns.2011.09.010; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Manfred Wick W.P., 2011, CLIN ASPECTS LAB IRO, V6th ed.; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Matsuoka K, 2015, SEMIN IMMUNOPATHOL, V37, P47, DOI 10.1007/s00281-014-0454-4; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Ponka P, 1999, INT J BIOCHEM CELL B, V31, P1111, DOI 10.1016/S1357-2725(99)00070-9; Rastall RA, 2004, J NUTR, V134, p2022S, DOI 10.1093/jn/134.8.2022S; Reid CA, 1999, ANIM SCI, V68, P503, DOI 10.1017/S1357729800050529; Rizvi S, 2011, AM J GASTROENTEROL, V106, P1872, DOI 10.1038/ajg.2011.232; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Sartor RB, 2012, NAT REV GASTRO HEPAT, V9, P561, DOI 10.1038/nrgastro.2012.157; Schubert Mikkel, 2016, BMC Res Notes, V9, P88, DOI 10.1186/s13104-016-1900-2; Stein J, 2013, ANN GASTROENTEROL, V26, P104; Hung TV, 2016, J NUTR, V146, P1970, DOI 10.3945/jn.116.232538; Uritski R, 2004, J NUTR, V134, P2251, DOI 10.1093/jn/134.9.2251; WEISS G, 1995, IMMUNOL TODAY, V16, P495, DOI 10.1016/0167-5699(95)80034-4; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	47	44	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0202460	10.1371/journal.pone.0202460	http://dx.doi.org/10.1371/journal.pone.0202460			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308045	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000447173500003
J	Leong, TL; Gayevskiy, V; Steinfort, DP; De Massy, MR; Gonzalez-Rajal, A; Marini, KD; Stone, E; Chin, V; Havryk, A; Plit, M; Irving, LB; Jennings, BR; McCloy, RA; Jayasekara, WSN; Alamgeer, M; Boolell, V; Field, A; Russell, PA; Kumar, B; Gough, DJ; Szczepny, A; Ganju, V; Rossello, FJ; Cain, JE; Papenfuss, AT; Asselin-Labat, ML; Cowley, MJ; Watkins, DN				Leong, Tracy L.; Gayevskiy, Velimir; Steinfort, Daniel P.; De Massy, Marc R.; Gonzalez-Rajal, Alvaro; Marini, Kieren D.; Stone, Emily; Chin, Venessa; Havryk, Adrian; Plit, Marshall; Irving, Louis B.; Jennings, Barton R.; McCloy, Rachael A.; Jayasekara, W. Samantha N.; Alamgeer, Muhammad; Boolell, Vishal; Field, Andrew; Russell, Prudence A.; Kumar, Beena; Gough, Daniel J.; Szczepny, Anette; Ganju, Vinod; Rossello, Fernando J.; Cain, Jason E.; Papenfuss, Anthony T.; Asselin-Labat, Marie-Liesse; Cowley, Mark J.; Watkins, D. Neil			Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer	ONCOGENE			English	Article							INTRATUMOR HETEROGENEITY; MUTATIONAL SIGNATURES; FRAMEWORK; CANCERIZATION; HYPERMUTATION; EPIDEMIOLOGY; EVOLUTIONARY; LANDSCAPE; PROFILES; SMOKING	Our understanding of genomic heterogeneity in lung cancer is largely based on the analysis of early-stage surgical specimens. Here we used endoscopic sampling of paired primary and intrathoracic metastatic tumors from 11 lung cancer patients to map genomic heterogeneity inoperable lung cancer with deep whole-genome sequencing. Intra-patient heterogeneity in driver or targetable mutations was predominantly in the form of copy number gain. Private mutation signatures, including patterns consistent with defects in homologous recombination, were highly variable both within and between patients. Irrespective of histotype, we observed a smaller than expected number of private mutations, suggesting that ancestral clones accumulated large mutation burdens immediately prior to metastasis. Single-region whole-genome sequencing of from 20 patients showed that tumors in ever-smokers with the strongest tobacco signatures were associated with germline variants in genes implicated in the repair of cigarette-induced DNA damage. Our results suggest that lung cancer precursors in ever-smokers accumulate large numbers of mutations prior to the formation of frank malignancy followed by rapid metastatic spread. In advanced lung cancer, germline variants in DNA repair genes may interact with the airway environment to influence the pattern of founder mutations, whereas similar interactions with the tumor microenvironment may play a role in the acquisition of mutations following metastasis.	[Leong, Tracy L.; Asselin-Labat, Marie-Liesse] Walter & Eliza Hall Inst Med Res, ACRF Stem Cells & Canc Div, Parkville, Vic 3050, Australia; [Leong, Tracy L.; Steinfort, Daniel P.; Irving, Louis B.; Asselin-Labat, Marie-Liesse] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [Gayevskiy, Velimir; De Massy, Marc R.; Cowley, Mark J.] Garvan Inst Med Res, Kinghorn Ctr Clin Genom, Darlinghurst, NSW 2010, Australia; [Steinfort, Daniel P.; Irving, Louis B.] Royal Melbourne Hosp, Dept Resp Med, Parkville, Vic 3050, Australia; [Gonzalez-Rajal, Alvaro; Chin, Venessa; McCloy, Rachael A.; Watkins, D. Neil] Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW 2010, Australia; [Marini, Kieren D.; Stone, Emily; Jayasekara, W. Samantha N.; Alamgeer, Muhammad; Boolell, Vishal; Gough, Daniel J.; Szczepny, Anette; Ganju, Vinod; Cain, Jason E.] Hudson Inst Med Res, Clayton, Vic 3168, Australia; [Stone, Emily; Havryk, Adrian; Plit, Marshall; Watkins, D. Neil] St Vincents Hosp, Dept Thorac Med, Darlinghurst, NSW 2010, Australia; [Chin, Venessa; Havryk, Adrian; Plit, Marshall; Field, Andrew; Cowley, Mark J.; Watkins, D. Neil] UNSW Sydney, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia; [Chin, Venessa; Watkins, D. Neil] St Vincents Hosp, Dept Med Oncol, Darlinghurst, NSW 2010, Australia; [Jennings, Barton R.] Monash Hlth, Dept Resp & Sleep Med, Clayton, Vic 3168, Australia; [Field, Andrew] St Vincents Hosp, Dept Pathol, Sydney, NSW 2010, Australia; [Russell, Prudence A.] St Vincents Hosp Melbourne, Dept Pathol, Fitzroy, Vic 3000, Australia; [Kumar, Beena] Monash Hlth, Dept Pathol, Clayton, Vic 3168, Australia; [Gough, Daniel J.; Ganju, Vinod; Cain, Jason E.] Monash Univ, Dept Mol & Translat Sci, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Rossello, Fernando J.] Monash Univ, Dept Anat & Dev Biol, Fac Med Nursing & Hlth Sci, Clayton, Vic 3168, Australia; [Rossello, Fernando J.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3168, Australia; [Papenfuss, Anthony T.] Peter MacCallum Canc Ctr, Computat Canc Biol Program, Melbourne, Vic 3000, Australia; [Papenfuss, Anthony T.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Papenfuss, Anthony T.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Cowley, Mark J.] Childrens Canc Inst, Kensington, NSW 2750, Australia	Walter & Eliza Hall Institute; University of Melbourne; Garvan Institute of Medical Research; Royal Melbourne Hospital; Garvan Institute of Medical Research; Hudson Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincent's Hospital Melbourne; Monash University; Monash University; Australian Regenerative Medicine Institute; Monash University; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Walter & Eliza Hall Institute; Children's Cancer Institute	Asselin-Labat, ML (corresponding author), Walter & Eliza Hall Inst Med Res, ACRF Stem Cells & Canc Div, Parkville, Vic 3050, Australia.; Asselin-Labat, ML (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia.; Cowley, MJ (corresponding author), Garvan Inst Med Res, Kinghorn Ctr Clin Genom, Darlinghurst, NSW 2010, Australia.; Watkins, DN (corresponding author), Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW 2010, Australia.; Watkins, DN (corresponding author), St Vincents Hosp, Dept Thorac Med, Darlinghurst, NSW 2010, Australia.; Cowley, MJ; Watkins, DN (corresponding author), UNSW Sydney, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia.; Watkins, DN (corresponding author), St Vincents Hosp, Dept Med Oncol, Darlinghurst, NSW 2010, Australia.; Cowley, MJ (corresponding author), Childrens Canc Inst, Kensington, NSW 2750, Australia.	labat@wehi.edu.au; m.cowley@garvan.org.au; dr.neil.watkins@gmail.com	Rossello, Fernando/B-1208-2015; Papenfuss, Anthony T/C-6297-2008; Stone, Emily/AAP-1249-2021; Steinfort, Daniel/AAO-6898-2020; Gonzalez-Rajal, Alvaro/ABA-6874-2020; Alamgeer, Muhammad/AAM-4784-2021; Stone, Emily/GZL-2451-2022	Rossello, Fernando/0000-0003-3885-8777; Papenfuss, Anthony T/0000-0002-1102-8506; Stone, Emily/0000-0001-9021-8449; Steinfort, Daniel/0000-0002-8998-2949; Gonzalez-Rajal, Alvaro/0000-0002-9230-0339; McCloy, Rachael/0000-0001-7791-4044; Cowley, Mark/0000-0002-9519-5714; Robert de Massy, Marc/0000-0002-3048-1680; Gough, Daniel/0000-0001-5725-8668; Watkins, Neil/0000-0001-8218-4920; Chin, Venessa/0000-0002-4630-4451; Gough, Daniel/0000-0001-6479-1735	Victorian Cancer Agency [TS10-01]; Petre Foundation; Victorian Government's Operational Infrastructure Support Program; Baxter Charitable Foundation; St Vincent's Clinic Foundation; Tour de Cure; Australian Government NHMRC IRIISS; Victorian State Government Operational Infrastructure Support; Australian Cancer Therapeutics CRC; Australian Cancer Research Foundation; NHMRC Career Development Fellowship [GNT1063914]; Victoria Cancer Agency Mid-Career Fellowship [MCRF17014]; Viertel Foundation Senior Medical Researcher Fellowship; Cancer Institute NSW Early Career Fellowship [13ECF/1-46]; NSW Health Early-Mid-Career Fellowship; Kinghorn Foundation; NHMRC Senior Research Fellowship [GNT546107]	Victorian Cancer Agency; Petre Foundation; Victorian Government's Operational Infrastructure Support Program; Baxter Charitable Foundation; St Vincent's Clinic Foundation; Tour de Cure; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Cancer Therapeutics CRC; Australian Cancer Research Foundation; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victoria Cancer Agency Mid-Career Fellowship; Viertel Foundation Senior Medical Researcher Fellowship; Cancer Institute NSW Early Career Fellowship; NSW Health Early-Mid-Career Fellowship; Kinghorn Foundation; NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Victorian Cancer Agency, (TS10-01), the Petre Foundation, the Victorian Government's Operational Infrastructure Support Program, the Baxter Charitable Foundation, the St Vincent's Clinic Foundation, Tour de Cure, the Australian Government NHMRC IRIISS, the Victorian State Government Operational Infrastructure Support, the Australian Cancer Therapeutics CRC (TLL), the Australian Cancer Research Foundation, an NHMRC Career Development Fellowship (GNT1063914, DJG), a Victoria Cancer Agency Mid-Career Fellowship (MCRF17014, JEC), a Viertel Foundation Senior Medical Researcher Fellowship (M-LA-L), a Cancer Institute NSW Early Career Fellowship (13ECF/1-46) and NSW Health Early-Mid-Career Fellowship (MJC), the Kinghorn Foundation (MJC, VG), and an NHMRC Senior Research Fellowship (GNT546107, DNW). We thank the Victorian Cancer Biobank for technical support.	Adamo P, 2016, ONCOGENE, V35, P403, DOI 10.1038/onc.2015.109; Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299; Alioto TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10001; Amirouchene-Angelozzi N, 2017, CANCER DISCOV, V7, P805, DOI 10.1158/2159-8290.CD-17-0343; Bakhoum SF, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a029611; Campbell BB, 2017, CELL, V171, P1042, DOI 10.1016/j.cell.2017.09.048; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Cardarella S, 2013, AM J RESP CRIT CARE, V188, P770, DOI 10.1164/rccm.201305-0843PP; Chansky K, 2017, J THORAC ONCOL, V12, P1109, DOI 10.1016/j.jtho.2017.04.011; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gayevskiy V, 2019, BIOINFORMATICS, V35, P122, DOI 10.1093/bioinformatics/bty540; Gehring JS, 2015, BIOINFORMATICS, V31, P3673, DOI 10.1093/bioinformatics/btv408; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Grainge CL, 2013, CHEST, V144, P1906, DOI 10.1378/chest.12-1944; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Houghton AM, 2013, NAT REV CANCER, V13, P233, DOI 10.1038/nrc3477; Jakubek Y, 2016, CANCER RES, V76, P3676, DOI 10.1158/0008-5472.CAN-15-3064; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jin XR, 2017, ONCOTARGET, V8, P23130, DOI 10.18632/oncotarget.15506; Kadara H, 2016, CANCER PREV RES, V9, P518, DOI 10.1158/1940-6207.CAPR-15-0400; Kadara Humam, 2012, Proc Am Thorac Soc, V9, P38, DOI 10.1513/pats.201201-004MS; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Leong TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106862; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; Maley CC, 2017, NAT REV CANCER, V17, P605, DOI 10.1038/nrc.2017.69; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Meienberg J, 2016, HUM GENET, V135, P359, DOI 10.1007/s00439-015-1631-9; Nahar R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02584-z; Reiter JG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14114; Samet JM, 2009, CLIN CANCER RES, V15, P5626, DOI 10.1158/1078-0432.CCR-09-0376; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shields PG, 2002, ONCOGENE, V21, P6870, DOI 10.1038/sj.onc.1205832; Shugay M, 2013, BIOINFORMATICS, V29, P2539, DOI 10.1093/bioinformatics/btt445; TheGeneOntologyConsortium, 2017, Nucleic Acids Res, V45, pD331, DOI 10.1093/nar/gkw1108; Turajlic S, 2016, SCIENCE, V352, P169, DOI 10.1126/science.aaf2784; Um SW, 2016, CANCER RES, V76, P6568, DOI 10.1158/0008-5472.CAN-16-0873; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wiencke JK, 2002, ONCOGENE, V21, P7376, DOI 10.1038/sj.onc.1205799; Wu XF, 2004, ONCOGENE, V23, P6500, DOI 10.1038/sj.onc.1207811; Yu AM, 2016, ONCOTARGET, V7, P28624, DOI 10.18632/oncotarget.8721; Zappasodi R, 2018, CANCER CELL, V33, P581, DOI 10.1016/j.ccell.2018.03.005; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	52	13	13	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2019	38	10					1661	1675		10.1038/s41388-018-0536-1	http://dx.doi.org/10.1038/s41388-018-0536-1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN8DD	30348992	Green Published, hybrid			2022-12-26	WOS:000460423800007
J	Murata, H; Khine, CC; Nishikawa, A; Yamamoto, K; Kinoshita, R; Sakaguchi, M				Murata, Hitoshi; Khine, Cho Cho; Nishikawa, Akane; Yamamoto, Ken-ichi; Kinoshita, Rie; Sakaguchi, Masakiyo			c-Jun N-terminal kinase (JNK)-mediated phosphorylation of SARM1 regulates NAD(+) cleavage activity to inhibit mitochondrial respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL DEGENERATION; CELL-DEATH; ACTIVATION; INJURY; PINK1; DELETION; UBIQUITIN; TRIGGERS; PARKIN; LINKS	Mitochondrial dysfunction is a key pathological feature of many different types of neurodegenerative disease. Sterile alpha and Toll/interleukin receptor motif-containing protein 1 (SARM1) has been attracting much attention as an important molecule for inducing axonal degeneration and neuronal cell death by causing loss of NAD (NADH). However, it has remained unclear what exactly regulates the SARM1 activity. Here, we report that NAD(+) cleavage activity of SARM1 is regulated by its own phosphorylation at serine 548. The phosphorylation of SARM1 was mediated by c-jun N-terminal kinase (JNK) under oxidative stress conditions, resulting in inhibition of mitochondrial respiration concomitant with enhanced activity of NAD(+) cleavage. Nonphosphorylatable mutation of Ser-548 or treatment with a JNK inhibitor decreased SARM1 activity. Furthermore, neuronal cells derived from a familial Parkinson's disease (PD) patient showed a congenitally increased level of SARM1 phosphorylation compared with that in neuronal cells from a healthy person and were highly sensitive to oxidative stress. These results indicate that JNK-mediated phosphorylation of SARM1 at Ser-548 is a regulator of SARM1 leading to inhibition of mitochondrial respiration. These findings suggest that an abnormal regulation of SARM1 phosphorylation is involved in the pathogenesis of Parkinson's disease and possibly other neurodegenerative diseases.	[Murata, Hitoshi; Khine, Cho Cho; Nishikawa, Akane; Yamamoto, Ken-ichi; Kinoshita, Rie; Sakaguchi, Masakiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan; [Khine, Cho Cho] Univ Med, Hosp UM1, Yangon 11131, Myanmar	Okayama University	Sakaguchi, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	masa-s@md.okayama-u.ac.jp	MURATA, Hitoshi/B-2327-2011	Lin, Li Juan/0000-0003-2522-9306	Japan Science and Technology Agency Grant [16K19037]; Japan Agency for Medical Research and Development [JP17km0908001]	Japan Science and Technology Agency Grant; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by Japan Science and Technology Agency Grant 16K19037 and Japan Agency for Medical Research and Development Grant JP17km0908001 (to H.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Burke RE, 2013, EXP NEUROL, V246, P72, DOI 10.1016/j.expneurol.2012.01.011; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Deng H, 2018, AGEING RES REV, V42, P72, DOI 10.1016/j.arr.2017.12.007; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2016, BRAIN, V139, P3092, DOI 10.1093/brain/aww251; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Gilley J, 2017, CELL REP, V21, P10, DOI 10.1016/j.celrep.2017.09.027; Gilley J, 2015, CELL REP, V10, P1974, DOI 10.1016/j.celrep.2015.02.060; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803; Jin Y, 2012, ONCOL REP, V27, P695, DOI 10.3892/or.2011.1543; Kandan NM, 2013, EXP NEUROL, V246, P44, DOI 10.1016/j.expneurol.2012.06.003; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mukherjee P, 2015, J IMMUNOL, V195, P4913, DOI 10.4049/jimmunol.1500953; Mukherjee P, 2013, IMMUNITY, V38, P705, DOI 10.1016/j.immuni.2013.02.013; Murata H, 2013, MOL BIOL CELL, V24, P2772, DOI 10.1091/mbc.E13-01-0016; Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Panneerselvam P, 2013, CELL DEATH DIFFER, V20, P478, DOI 10.1038/cdd.2012.144; Panneerselvam P, 2012, BIOCHEM J, V442, P263, DOI 10.1042/BJ20111653; Peng J, 2010, EUR J IMMUNOL, V40, P1738, DOI 10.1002/eji.200940034; Sakaguchi M, 2014, MOL BIOTECHNOL, V56, P621, DOI 10.1007/s12033-014-9738-0; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Su KG, 2009, CURR NEUROL NEUROSCI, V9, P411, DOI 10.1007/s11910-009-0060-3; Summers DW, 2016, P NATL ACAD SCI USA, V113, pE6271, DOI 10.1073/pnas.1601506113; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Turkiew E, 2017, J PERIPHER NERV SYST, V22, P162, DOI 10.1111/jns.12219; Veriepe J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8319; Walker LJ, 2017, ELIFE, V6, DOI 10.7554/eLife.22540; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010	41	39	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18933	18943		10.1074/jbc.RA118.004578	http://dx.doi.org/10.1074/jbc.RA118.004578			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30333228	hybrid, Green Published			2022-12-26	WOS:000458467400010
J	Lv, JJ; Su, W; Yu, QY; Zhang, M; Di, CX; Lin, XL; Wu, M; Xia, ZW				Lv, Jiajia; Su, Wen; Yu, Qianying; Zhang, Meng; Di, Caixia; Lin, Xiaoliang; Wu, Min; Xia, Zhenwei			Heme oxygenase-1 protects airway epithelium against apoptosis by targeting the proinflammatory NLRP3-RXR axis in asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; CARBON-MONOXIDE SUPPRESS; NUCLEAR EXPORT; UP-REGULATION; CELLS; INFLAMMASOME; DIFFERENTIATION; RESPONSES; PATHWAY; HO-1	Asthma is thought to be caused by malfunction of type 2 T helper cell (Th2)-mediated immunity, causing excessive inflammation, mucus overproduction, and apoptosis of airway epithelial cells. Heme oxygenase-1 (HO-1) functions in heme catabolism and is both cytoprotective and anti-inflammatory. We hypothesized that this dual function may be related to asthma's etiology. Using primary airway epithelial cells (pAECs) and an asthma mouse model, we demonstrate that severe lung inflammation is associated with rapid pAEC apoptosis. Surprisingly, NOD-like receptor protein 3 (NLRP3) inhibition, retinoid X receptor (RXR) deficiency, and HO-1 induction were associated with abrogated apoptosis. MCC950, a selective small-molecule inhibitor of canonical and noncanonical NLRP3 activation, reduced RXR expression, leading to decreased pAEC apoptosis that was reversed by the RXR agonist adapalene. Of note, HO-1 induction in a mouse model of ovalbumin-induced eosinophilic asthma suppressed Th2 responses and reduced apoptosis of pulmonary pAECs. In vitro, HO-1 induction desensitized cultured pAECs to ovalbumin-induced apoptosis, confirming the in vivo observations. Critically, the HO-1 products carbon monoxide and bilirubin suppressed the NLRP3-RXR axis in pAECs. Furthermore, HO-1 impaired production of NLRP3-RXR-induced cytokines (interleukin [IL]-25, IL-33, thymic stromal lymphopoietin, and granulocyte-macrophage colony-stimulating factor) in pAECs and lungs. Finally, we demonstrate that HO-1 binds to the NACHT domain of NLRP3 and the RXR alpha and RXR beta subunits and that this binding is not reversed by Sn-protoporphyrin. Our findings indicate that HO-1 and its products are essential for pAEC survival to maintain airway epithelium homeostasis during NLRP3-RXR-mediated apoptosis and inflammation.	[Lv, Jiajia; Su, Wen; Yu, Qianying; Zhang, Meng; Di, Caixia; Lin, Xiaoliang; Xia, Zhenwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pediat, Shanghai 200025, Peoples R China; [Lv, Jiajia; Su, Wen; Yu, Qianying; Zhang, Meng; Di, Caixia; Lin, Xiaoliang; Xia, Zhenwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pulm & Crit Care Med, Shanghai 200025, Peoples R China; [Wu, Min] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of North Dakota Grand Forks	Xia, ZW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pediat, Shanghai 200025, Peoples R China.; Xia, ZW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pulm & Crit Care Med, Shanghai 200025, Peoples R China.	xzw10484@rjh.com.cn		Wu, Min/0000-0003-1205-982X; Lv, Jiajia/0000-0002-0016-7981	National Natural Science Foundation of China [91542202, 81470217, 81200016]; National Institutes of Health [R01 AI109317-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109317] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China Grants 91542202, 81470217, and 81200016 and by National Institutes of Health Grant R01 AI109317-01A1. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Anderson OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067263; Bakhautdin B, 2014, J HEPATOL, V61, P1029, DOI 10.1016/j.jhep.2014.06.007; Besnard AG, 2011, ALLERGY, V66, P1047, DOI 10.1111/j.1398-9995.2011.02586.x; Bi Y, 2010, DEV GROWTH DIFFER, V52, P419, DOI 10.1111/j.1440-169X.2010.01182.x; Bruder-Nascimento T, 2016, CIRCULATION, V134, P1866, DOI 10.1161/CIRCULATIONAHA.116.024369; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Decherf S, 2013, MOL CELL ENDOCRINOL, V381, P115, DOI 10.1016/j.mce.2013.07.016; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Grenningloh R, 2006, J IMMUNOL, V176, P5161, DOI 10.4049/jimmunol.176.9.5161; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Hu XY, 2017, INT IMMUNOPHARMACOL, V52, P185, DOI 10.1016/j.intimp.2017.09.007; Jiang L, 2016, INFLAMM RES, V65, P905, DOI 10.1007/s00011-016-0973-7; Kadoya H, 2015, FASEB J, V29, P3899, DOI 10.1096/fj.15-271734; Kim RY, 2017, AM J RESP CRIT CARE, V196, P283, DOI 10.1164/rccm.201609-1830OC; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2013, NEW ENGL J MED, V369, P1964, DOI 10.1056/NEJMcibr1311045; Li Y, 2017, J IMMUNOL, V199, P761, DOI 10.4049/jimmunol.1601416; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lin XL, 2017, ALLERGY, V72, P1972, DOI 10.1111/all.13216; Linhoff MW, 2001, MOL CELL BIOL, V21, P3001, DOI 10.1128/MCB.21.9.3001-3011.2001; Martinon F, 2008, J LEUKOCYTE BIOL, V83, P507, DOI 10.1189/jlb.0607362; Mridha AR, 2017, J HEPATOL, V66, P1037, DOI 10.1016/j.jhep.2017.01.022; Nakamura M, 2004, AM J PATHOL, V164, P1949, DOI 10.1016/S0002-9440(10)63755-8; Nunez V, 2010, P NATL ACAD SCI USA, V107, P10626, DOI 10.1073/pnas.0913545107; Ocker M, 2003, INT J CANCER, V107, P453, DOI 10.1002/ijc.11410; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Rushworth SA, 2008, BLOOD, V111, P3793, DOI 10.1182/blood-2007-07-104042; Rushworth SA, 2010, CANCER RES, V70, P2973, DOI 10.1158/0008-5472.CAN-09-3407; Saito-Hakoda A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141960; Saxon JA, 2016, J IMMUNOL, V196, P1891, DOI 10.4049/jimmunol.1501555; Schmitz N, 2003, EUR J IMMUNOL, V33, P991, DOI 10.1002/eji.200323801; Shankaranarayanan P, 2009, CANCER CELL, V16, P220, DOI 10.1016/j.ccr.2009.07.029; Tenaud I, 2007, EXP DERMATOL, V16, P500, DOI 10.1111/j.1600-0625.2007.00552.x; Tesfaigzi Y, 2006, AM J RESP CELL MOL, V34, P537, DOI 10.1165/rcmb.2006-0014OC; Tesfaigzi Y, 2002, J IMMUNOL, V169, P5919, DOI 10.4049/jimmunol.169.10.5919; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vignola AM, 1998, AM J RESP CRIT CARE, V157, P403, DOI 10.1164/ajrccm.157.2.96-08040; Vignola AM, 1999, J ALLERGY CLIN IMMUN, V103, P563, DOI 10.1016/S0091-6749(99)70225-3; Wadsworth SJ, 2010, J ALLERGY CLIN IMMUN, V126, P366, DOI 10.1016/j.jaci.2010.05.015; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Xia ZW, 2007, AM J PATHOL, V171, P1904, DOI 10.2353/ajpath.2007.070096; Xia ZW, 2006, J IMMUNOL, V177, P5936, DOI 10.4049/jimmunol.177.9.5936; Yang SM, 2014, DIABETOLOGIA, V57, P424, DOI 10.1007/s00125-013-3115-6; Yasui Y, 2007, BIOCHEM BIOPH RES CO, V354, P485, DOI 10.1016/j.bbrc.2006.12.228; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zimmerman TL, 2006, J BIOL CHEM, V281, P15434, DOI 10.1074/jbc.M508277200; Zwerina J, 2005, FASEB J, V19, P2011, DOI 10.1096/fj.05-4278fje	55	32	32	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18454	18465		10.1074/jbc.RA118.004950	http://dx.doi.org/10.1074/jbc.RA118.004950			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30333233	hybrid, Green Published			2022-12-26	WOS:000458467300004
J	Borzelli, D; Cesqui, B; Berger, DJ; Burdet, E; d'Avella, A				Borzelli, Daniele; Cesqui, Benedetta; Berger, Denise J.; Burdet, Etienne; d'Avella, Andrea			Muscle patterns underlying voluntary modulation of co-contraction	PLOS ONE			English	Article							MULTIJOINT ARM MOVEMENTS; END-POINT STIFFNESS; UNSTABLE DYNAMICS; REACHING MOVEMENTS; IMPEDANCE CONTROL; ADAPTIVE-CONTROL; ADAPTATION; HAND; MODEL; JOINT	Manipulative actions involving unstable interactions with the environment require controlling mechanical impedance through muscle co-contraction. While much research has focused on how the central nervous system (CNS) selects the muscle patterns underlying a desired movement or end-point force, the coordination strategies used to achieve a desired endpoint impedance have received considerably less attention. We recorded isometric forces at the hand and electromyographic (EMG) signals in subjects performing a reaching task with an external disturbance. In a virtual environment, subjects displaced a cursor by applying isometric forces and were instructed to reach targets in 20 spatial locations. The motion of the cursor was then perturbed by disturbances whose effects could be attenuated by increasing co-contraction. All subjects could voluntarily modulate co-contraction when disturbances of different magnitudes were applied. For most muscles, activation was modulated by target direction according to a cosine tuning function with an offset and an amplitude increasing with disturbance magnitude. Co-contraction was characterized by projecting the muscle activation vector onto the null space of the EMG-to-force mapping. Even in the baseline the magnitude of the null space projection was larger than the minimum magnitude required for non-negative muscle activations. Moreover, the increase in co-contraction was not obtained by scaling the baseline null space projection, scaling the difference between the null space projections in any block and the projection of the non-negative minimum-norm muscle vector, or scaling the difference between the null space projections in the perturbed blocks and the baseline null space projection. However, the null space projections in the perturbed blocks were obtained by linear combination of the baseline null space projection and the muscle activation used to increase co-contraction without generating any force. The failure of scaling rules in explaining voluntary modulation of arm co-contraction suggests that muscle pattern generation may be constrained by muscle synergies.	[Borzelli, Daniele; Cesqui, Benedetta; Berger, Denise J.; d'Avella, Andrea] IRCCS Fdn Santa Lucia, Lab Neuromotor Physiol, Rome, Italy; [Borzelli, Daniele; d'Avella, Andrea] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Cesqui, Benedetta] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy; [Burdet, Etienne] Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	IRCCS Santa Lucia; University of Messina; University of Rome Tor Vergata; Imperial College London	d'Avella, A (corresponding author), IRCCS Fdn Santa Lucia, Lab Neuromotor Physiol, Rome, Italy.; d'Avella, A (corresponding author), Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy.	a.davella@hsantalucia.it	d'Avella, Andrea/K-6856-2018; Berger, Denise J/K-3694-2018	d'Avella, Andrea/0000-0002-3393-4956; Berger, Denise J/0000-0002-4416-3659; Borzelli, Daniele/0000-0002-9456-0177; Burdet, Etienne/0000-0002-2123-0185	Italian Ministry of Health [RF-2011-02347869]; Italian Ministry of Education, University and Research (PRIN-2015-HFWRYY); Human Frontier Science Program Organization [RGP11/2008]; European Union's Seventh Framework programme [248311-AMARSi]; European Union's Horizon 2020 research and innovation programme [644727-Cogl Mon]	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Education, University and Research (PRIN-2015-HFWRYY); Human Frontier Science Program Organization(Human Frontier Science Program); European Union's Seventh Framework programme; European Union's Horizon 2020 research and innovation programme	This work was supported by the Italian Ministry of Health (RF-2011-02347869) to AdA (http://vowsalute.govit/polalettemi/p2_6.isp7ling ua=italiano&id,45178,area=Ricerca% 20sanitaria&menu=finalizzata), the Italian Ministry of Education, University and Research (PRIN-2015-HFWRYY) to AdA (http://attiministeriali.miur.itarino-2016inovembre/ti-07112016-(1).aspx), the Human Frontier Science Program Organization (program grant RGP11/2008) to AdA (http://www.hfsp.org/awardees/awards archive), the European Union's Seventh Framework programme (under Grant Agreement 248311-AMARSi, https://www.amarsi-projecteu/), and the European Union's Horizon 2020 research and innovation programme (under Grant Agreement 644727-Cogl Mon, https://cogimon.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artemiadis P. K., 2010, 2010 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2010), P3103, DOI 10.1109/IROS.2010.5652025; Berger DJ, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00046; Berger DJ, 2013, J NEUROSCI, V33, P12384, DOI 10.1523/JNEUROSCI.0122-13.2013; Bernstein N, 1967, COORDINATION REGULAT; Borzelli D, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00186; Borzelli D, 2012, P IEEE RAS-EMBS INT, P1241, DOI 10.1109/BioRob.2012.6290941; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Burdet E., 2013, HUMAN ROBOTICS; Darainy M, 2004, J NEUROPHYSIOL, V92, P3344, DOI 10.1152/jn.00596.2004; Darainy M, 2008, EXP BRAIN RES, V190, P153, DOI 10.1007/s00221-008-1457-y; de Rugy A, 2012, J NEUROSCI, V32, P7384, DOI 10.1523/JNEUROSCI.5792-11.2012; DESERRES SJ, 1991, EXP BRAIN RES, V86, P451, DOI 10.1007/BF00228972; Fagg AH, 2002, J NEUROPHYSIOL, V88, P3348, DOI 10.1152/jn.00621.2002; FLANDERS M, 1990, J NEUROPHYSIOL, V64, P1818, DOI 10.1152/jn.1990.64.6.1818; FLASH T, 1987, BIOL CYBERN, V57, P257, DOI 10.1007/BF00338819; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Franklin DW, 2003, EXP BRAIN RES, V152, P211, DOI 10.1007/s00221-003-1540-3; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; Gentner R, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00120; Gomi H, 1998, J NEUROSCI, V18, P8965; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; Hoppner H, 2017, FRONT NEUROROBOTICS, V11, DOI 10.3389/fnbot.2017.00017; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; Howard A., 2010, ELEMENTARY LINEAR AL; Inouye JM, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004737; LACQUANITI F, 1989, J NEUROSCI, V9, P134, DOI 10.1523/JNEUROSCI.09-01-00134.1989; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; LATASH ML, 1992, BIOL CYBERN, V67, P377, DOI 10.1007/BF02414893; LAWRENCE JH, 1983, J APPL PHYSIOL, V54, P1653, DOI 10.1152/jappl.1983.54.6.1653; McIntyre J, 1996, EXP BRAIN RES, V110, P248; Melendez-Calderon A, 2011, INVESTIGATING SENSOR; MILNER TE, 1993, EXP BRAIN RES, V94, P522; Milner TE, 1998, EXP BRAIN RES, V122, P309, DOI 10.1007/s002210050519; Milner TE, 2002, EXP BRAIN RES, V143, P406, DOI 10.1007/s00221-002-1001-4; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; Osu R, 1999, J NEUROPHYSIOL, V81, P1458, DOI 10.1152/jn.1999.81.4.1458; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Perreault EJ, 2002, J NEUROPHYSIOL, V87, P2808, DOI 10.1152/jn.2002.87.6.2808; Roh J, 2012, J NEUROPHYSIOL, V107, P2123, DOI 10.1152/jn.00173.2011; Selen LPJ, 2006, EXP BRAIN RES, V172, P129, DOI 10.1007/s00221-005-0320-7; Selen LPJ, 2009, J NEUROSCI, V29, P12606, DOI 10.1523/JNEUROSCI.2826-09.2009; SHADMEHR R, 1993, J NEUROSCI, V13, P45; STRANG G, 1993, AM MATH MON, V100, P848, DOI 10.2307/2324660; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Todorov E, 2002, NEURAL COMPUT, V14, P1233, DOI 10.1162/089976602753712918; TSUJI T, 1995, BIOL CYBERN, V72, P475, DOI 10.1007/BF00199890; Valero-Cuevas F.J., 2015, FUNDAMENTALS NEUROME; Valero-Cuevas FJ, 2009, J NEUROPHYSIOL, V102, P59, DOI 10.1152/jn.90324.2008; Wang T, 2001, BIOL CYBERN, V85, P437, DOI 10.1007/s004220100277	52	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205911	10.1371/journal.pone.0205911	http://dx.doi.org/10.1371/journal.pone.0205911			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339703	Green Published, Green Submitted, gold			2022-12-26	WOS:000447761400025
J	Slupecka-Ziemilska, M; Grzesiak, P; Jank, M; Majewska, A; Rak, A; Kowalczyk, P; Kato, I; Kuwahara, A; Wolinski, J				Slupecka-Ziemilska, Monika; Grzesiak, Paulina; Jank, Michal; Majewska, Alicja; Rak, Agnieszka; Kowalczyk, Pawel; Kato, Ikuo; Kuwahara, Atsukazu; Wolinski, Jaroslaw			Small intestinal development in suckling rats after enteral obestatin administration	PLOS ONE			English	Article							GHRELIN; EXPRESSION; REPAIR; CELLS; DNA; PROLIFERATION; PROTEIN; STRESS; GENE	This study investigated the effect of enteral administration of obestatin on the development of small intestine, as well as oxidative stress markers and trancriptomic profile of gastrointestinal genes. Suckling rats were assigned to 3 groups treated with: C-saline solution; OLobestatin (125 nmol/kg BW); OH-obestatin (250 nmol/kg BW) administered twice daily, from the 14th to the 21st day of life. Enteral administration of obestatin in both studied doses had no effect neither on the body weight of animals nor the BMI calculated in the day of euthanasia. Compared to the control group (C), treatment with obestatin resulted in significant changes in the histometry of the small intestinal wall as well as intestinal epithelial cell remodeling. The observed changes and their possible implications for intestinal development were dependent on the dosage of peptide. The enteral administration of high dose (OH) of obestatin significantly decreased its expression in the stomach and increased markers of oxidative stress. The gene profile revealed MAPK3 (mitogen-activated protein kinase-3) as the key regulator gene for obestatin action in the gastrointestinal track. In conclusion, we have showed that enteral administration of obestatin influences the gut mucosa remodeling. It is also suggested that the administration of high dose (OH) has inhibitory effect on the intestinal maturation of suckling rats.	[Slupecka-Ziemilska, Monika; Grzesiak, Paulina; Wolinski, Jaroslaw] Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Dept Anim Physiol, Jablonna, Poland; [Jank, Michal] Warsaw Univ Life Sci SGGW WULS, Fac Vet Sci, Dept Preclin Sci, Div Pharmacol & Toxicol, Warsaw, Poland; [Majewska, Alicja] Warsaw Univ Life Sci SGGW WULS, Fac Vet Sci, Dept Physiol Sci, Warsaw, Poland; [Rak, Agnieszka] Jagiellonian Univ Krakow, Inst Zool & Biomed Res, Dept Physiol & Toxicol Reprod, Krakow, Poland; [Kowalczyk, Pawel] Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Dept Anim Nutr, Jablonna, Poland; [Kato, Ikuo] Kobe Pharmaceut Univ, Dept Med Biochem, Kobe, Hyogo, Japan; [Kuwahara, Atsukazu] Univ Shizuoka, Inst Environm Sci, Lab Physiol, Shizuoka, Japan; [Kuwahara, Atsukazu] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Shizuoka, Japan	Polish Academy of Sciences; Kielanowski Institute of Animal Physiology & Nutrition of the Polish Academy of Sciences; Warsaw University of Life Sciences; Warsaw University of Life Sciences; Jagiellonian University; Polish Academy of Sciences; Kielanowski Institute of Animal Physiology & Nutrition of the Polish Academy of Sciences; Kobe Pharmaceutical University; University of Shizuoka; University of Shizuoka	Slupecka-Ziemilska, M (corresponding author), Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Dept Anim Physiol, Jablonna, Poland.	m.slupecka@ifzz.pl	Woliński, Jarosław/AAH-3109-2021	Woliński, Jarosław/0000-0001-8645-1045; Jank, Michal/0000-0003-1630-2938; Rak, Agnieszka/0000-0002-9572-7151; , Alicja/0000-0002-9815-7844; Kowalczyk, Pawel/0000-0003-4025-3750	National Science Center [2011/03/D/NZ9/03697]	National Science Center(National Science Centre, Poland)	This research was supported by National Science Center Grant no. 2011/03/D/NZ9/03697 MSZ received the funding.	Aydin S, 2008, NUTRITION, V24, P689, DOI 10.1016/j.nut.2008.03.020; Bartsch H, 2004, CANCER DETECT PREV, V28, P385, DOI 10.1016/j.cdp.2004.07.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camina JP, 2007, J CELL PHYSIOL, V211, P1, DOI 10.1002/jcp.20925; DAHLQVIST A, 1984, SCAND J CLIN LAB INV, V44, P169, DOI 10.3109/00365518409161400; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Font-Nieves M, 2012, J BIOL CHEM, V287, P6454, DOI 10.1074/jbc.M111.327874; Granata R, 2008, DIABETES, V57, P967, DOI 10.2337/db07-1104; Gregoraszczuk E, 2016, J PHYSIOL PHARMACOL, V67, P543; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kowalczyk P, 2016, J PHYSIOL PHARMACOL, V67, P277; Legler DF, 2010, INT J BIOCHEM CELL B, V42, P198, DOI 10.1016/j.biocel.2009.09.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAROUX S, 1973, BIOCHIM BIOPHYS ACTA, V321, P282, DOI 10.1016/0005-2744(73)90083-1; Meszarosova M, 2008, ANIM REPROD SCI, V108, P196, DOI 10.1016/j.anireprosci.2007.08.011; NAGATSU T, 1976, ANAL BIOCHEM, V74, P466, DOI 10.1016/0003-2697(76)90227-X; Obtulowicz T, 2010, FREE RADICAL BIO MED, V49, P1064, DOI 10.1016/j.freeradbiomed.2010.06.027; Pamukcu O, 2013, J PEDIATR GASTR NUTR, V57, P211, DOI 10.1097/MPG.0b013e318294711e; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; Slupecka M, 2017, GEN COMP ENDOCR, V248, P69, DOI 10.1016/j.ygcen.2017.02.006; Slupecka M, 2014, GEN COMP ENDOCR, V208, P109, DOI 10.1016/j.ygcen.2014.08.015; Slupecka M, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/5739763; Slupecka M, 2012, REGUL PEPTIDES, V174, P38, DOI 10.1016/j.regpep.2011.11.007; Slupecka-Ziemilska M, 2017, J PHYSIOL PHARMACOL, V68, P693; Speina E, 2003, MUTAT RES-FUND MOL M, V531, P205, DOI 10.1016/j.mrfmmm.2003.07.007; Tang SQ, 2014, ANN ENDOCRINOL-PARIS, V75, P1, DOI 10.1016/j.ando.2013.10.003; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zhang Q, 2017, MED SCI MONITOR, V23, P2127, DOI 10.12659/MSM.901361; Zhao CM, 2008, CELL TISSUE RES, V331, P575, DOI 10.1007/s00441-007-0514-3	30	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205994	10.1371/journal.pone.0205994	http://dx.doi.org/10.1371/journal.pone.0205994			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339696	Green Published, Green Submitted, gold			2022-12-26	WOS:000447761400031
J	Tasneem, S; Sarwar, MT; Bashir, MR; Hussain, H; Ahmed, J; Pervez, S				Tasneem, Shahida; Sarwar, Muhammad Tahir; Bashir, Muhammad Rizwan; Hussain, Hamid; Ahmed, Jawad; Pervez, Shahid			Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; CANCER; COX-2; SMOKING	Esophageal squamous cell carcinoma (ESCC) is one of the aggressive malignancies and mechanisms underlying its pathogenesis remain unclear. Cyclooxygenase-2 (COX-2) enzyme system plays a crucial role in many gastrointestinal malignancies and is an important regulator of cell growth, proliferation, apoptosis, differentiation and transformation. More precise outcome of COX-2 in ESCC is less investigated. In this study we investigated the risk factors of ESCC and expression of COX-2 in Carcinoma in situ (CIS) and ESCC compared to normal esophageal mucosa. ESCC relationship to clinico-pathological parameters using immunohistochemistry was also part of this investigation. Current study was conducted in the Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan. A total of 69 diagnosed patients of ESCC, both Pakistanis and Afghans were enrolled. Various risk factors associated with ESCC were recorded. Mean age at the time of diagnosis was 55 years. Out of 69 patients of ESCC 46 (67%) were users of dipping tobacco (Naswar). Expression of COX-2 was determined in normal esophageal mucosa, CIS and invasive ESCC using Immunohistochemistry (IHC). Differences of mean were computed using ANOVA followed by applying Post Hoc test. Patients were categorized as positive with high expression or negative with low to nil expression. ANOVA showed large differences in expression of COX-2 in normal healthy mucosa compared with CIS and ESCC with the mean difference of -9.529 and -7.370 respectively, p-value being <.05 at 95% confidence interval (CI). No significant difference was noticed in the expression of COX-2 in CIS compared with ESCC with p-value >.05 at 95% Cl. Our complete cohort (23-85 years) showed statistically significant difference in the expression of COX-2 gene in ESCC and CIS tissue samples compared with normal healthy mucosa. Results of this study indicate that over-expression of COX-2 is positively associated with ESCC.	[Tasneem, Shahida; Sarwar, Muhammad Tahir; Ahmed, Jawad] Khyber Med Univ, Inst Basic Med Sci, Peshawar, Pakistan; [Bashir, Muhammad Rizwan] Rehman Med Inst, Dept Pathol, Peshawar, Pakistan; [Bashir, Muhammad Rizwan] Dallah Hosp Lab, Riyadh, Saudi Arabia; [Hussain, Hamid] Khyber Med Univ, Inst Publ Hlth & Social Sci, Peshawar, Pakistan; [Pervez, Shahid] Aga Khan Univ Hosp, Dept Pathol & Lab Med, Karachi, Pakistan	Khyber Medical University; Khyber Medical University; Aga Khan University	Tasneem, S (corresponding author), Khyber Med Univ, Inst Basic Med Sci, Peshawar, Pakistan.	shahida_tasneem@hotmail.com	Ahmed, Jawad/AAC-6781-2020	Ahmed, Jawad/0000-0003-3074-1953	Higher Education Commission, Pakistan [NRPU4222]	Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	This work was supported by Higher Education Commission, Pakistan; Project Number: NRPU4222; Grant Recipient: Muhammad Tahir Sarwar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul M K, 2009, GJM SCI, V7, P58; Akhtar S, 2012, EUR J CANCER, V48, P655, DOI 10.1016/j.ejca.2011.06.008; Alici S, 2006, ADV THER, V23, P672, DOI 10.1007/BF02850306; Alidina A, 2004, ANN ONCOL, V15, P118, DOI 10.1093/annonc/mdh014; [Anonymous], 2016, PROT EX SPEC PAT CAR; Ashktorab H, 2011, DIGEST DIS SCI, V56, P3577, DOI 10.1007/s10620-011-1853-1; Asting AG, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-238; Badar Farhana, 2005, Asian Pac J Cancer Prev, V6, P139; Bhurgri Yasmin, 2006, J Pak Med Assoc, V56, P124; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Chakhachiro ZI, 2013, CANCER-AM CANCER SOC, V119, P3318, DOI 10.1002/cncr.28219; Chen MQ, 2014, J CHIN MED ASSOC, V77, P562, DOI 10.1016/j.jcma.2014.05.014; Coupland VH, 2012, BRIT J CANCER, V107, P1908, DOI 10.1038/bjc.2012.465; Cui Y, 2015, J CANCER RES THER, V11, pC44, DOI 10.4103/0973-1482.163838; Dar NA, 2012, BRIT J CANCER, V107, P1618, DOI 10.1038/bjc.2012.449; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Elston DM, 2010, NON-SURGICAL TREATMENT OF KERATINOCYTE SKIN CANCER, P9, DOI 10.1007/978-3-540-79341-0_2; Hashimoto Naoki, 2012, ISRN Gastroenterol, V2012, P914824, DOI 10.5402/2012/914824; Hu DX, 2016, THORAC CANCER, V7, P310, DOI 10.1111/1759-7714.12329; Huang JX, 2010, WORLD J GASTROENTERO, V16, P5975, DOI 10.3748/wjg.v16.i47.5975; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V89, P1; Jamal S., 2010, PAFMJ, V60; Janbaz KH, 2014, WSPOLCZESNA ONKOL, V18, P160, DOI 10.5114/wo.2014.40524; Kim GY, 2011, MODERN PATHOL, V24, P1336, DOI 10.1038/modpathol.2011.90; KT K, 2003, ANN THORAC SURG, V76, P909; Li BH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04811-5; Lian Y, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317715804; Lin YS, 2013, J EPIDEMIOL, V23, P233, DOI 10.2188/jea.JE20120162; Mirinezhad SK, 2012, ASIAN PAC J CANCER P, V13, P3451, DOI 10.7314/APJCP.2012.13.7.3451; Roelofs HMJ, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-1; Seyedmajidi M, 2014, J CANCER RES THER, V10, P1024, DOI 10.4103/0973-1482.138205; Shamma A, 2000, CLIN CANCER RES, V6, P1229; Takatori H, 2008, EJSO-EUR J SURG ONC, V34, P397, DOI 10.1016/j.ejso.2007.04.011; Vaiphei K, 2014, ASIAN PAC J CANCER P, V15, P3519, DOI 10.7314/APJCP.2014.15.8.3519; Wang F, 2014, ASIAN PAC J CANCER P, V15, P3613, DOI 10.7314/APJCP.2014.15.8.3613; Yu HP, 2004, J GASTROEN HEPATOL, V19, P638, DOI 10.1111/j.1440-1746.2004.03345.x; Zhai XH, 2012, J ZHEJIANG UNIV-SC B, V13, P964, DOI 10.1631/jzus.B1200066; Zhang HZ, 2012, CHIN J CANCER, V31, P281, DOI 10.5732/cjc.011.10390; Zhi HY, 2006, CARCINOGENESIS, V27, P1214, DOI 10.1093/carcin/bgi304; Zimmermann KC, 1999, CANCER RES, V59, P198	40	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205508	10.1371/journal.pone.0205508	http://dx.doi.org/10.1371/journal.pone.0205508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339710	Green Published, gold, Green Submitted			2022-12-26	WOS:000447761400014
J	Kratochwil, NA; Dueker, SR; Muri, D; Senn, C; Yoon, H; Yu, BY; Lee, GH; Dong, F; Otteneder, MB				Kratochwil, Nicole A.; Dueker, Stephen R.; Muri, Dieter; Senn, Claudia; Yoon, HyeJin; Yu, Byung-Yong; Lee, Gwan-Ho; Dong, Feng; Otteneder, Michael B.			Nanotracing and cavity-ring down spectroscopy: A new ultrasensitive approach in large molecule drug disposition studies	PLOS ONE			English	Article							ACCELERATOR MASS-SPECTROMETRY; LASER SPECTROSCOPY; RADIOCARBON; ANTIBODIES; PHARMACOKINETICS; C-14; PARAMETERS; DIOXIDE; SAMPLES; ADME	New therapeutic biological entities such as bispecific antibodies targeting tissue or specific cell populations form an increasingly important part of the drug development portfolio. However, these biopharmaceutical agents bear the risk of extensive target-mediated drug disposition or atypical pharmacokinetic properties as compared to canonical antibodies. Pharmacokinetics and bio-distribution studies become therefore more and more important during lead optimization. Biologics present, however, greater analytical challenges than small molecule drugs due to the mass and selectivity limitation of mass spectrometry and ligand-binding assay, respectively. Radiocarbon (C-14) and its detection methods, such as the emerging C-14 cavity ring down spectroscopy (CRDS), thus can play an important role in the large molecule quantitation where a C-14-tag is covalently bound through a stable linker. CRDS has the advantage of a simplified sample preparation and introduction system as compared to accelerator mass spectrometry (AMS) and can be accommodated within an ordinary research laboratory. In this study, we report on the labeling of an anti-IL17 IgG 1 model antibody with C-14 propionate tag and its detection by CRDS using it as nanotracer (2.1 nCi or 77.7 Bq blended with the therapeutic dose) in a pharmacokinetics study in a pre-clinical species. We compare these data to data generated by AMS in parallel processed samples. The derived concentration time profiles for anti-IL17 by CRDS were in concordance with the ones derived by AMS and gamma-counting of an I-125-labeled anti-IL17 radiotracer and were well described by a 2-compartment population pharmacokinetic model. In addition, antibody tissue distribution coefficients for anti-IL17 were determined by CRDS, which proved to be a direct and sensitive measurement of the extravascular tissue concentration of the antibody when tissue perfusion was applied. Thus, this proof-of-concept study demonstrates that trace C-14-radiolabels and CRDS are an ultrasensitive approach in (pre)clinical pharmacokinetics and bio-distribution studies of new therapeutic entities.	[Kratochwil, Nicole A.; Muri, Dieter; Senn, Claudia; Otteneder, Michael B.] Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Pharmaceut Sci & Therapeut Modal, Basel, Switzerland; [Dueker, Stephen R.; Yoon, HyeJin] BioCore Ltd, Seoul, South Korea; [Yu, Byung-Yong; Lee, Gwan-Ho] Korea Inst Sci & Technol, Seoul, South Korea; [Dong, Feng] Picarro Inc, Santa Clara, CA USA	Roche Holding; Korea Institute of Science & Technology (KIST)	Kratochwil, NA (corresponding author), Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Pharmaceut Sci & Therapeut Modal, Basel, Switzerland.	nicole_a.kratochwil@roche.com			Roche; BioCore Ltd.; Picarro Inc.; Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Switzerland	Roche(Roche Holding); BioCore Ltd.; Picarro Inc.; Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Switzerland	Roche funded the accelerator mass spectrometry work done at BioCore Ltd. and the Korea Institute of Science & Technology, Seoul, South Korea, which is shown in the paper for comparison. Apart from this, the author(s) received no specific further funding for this work. Roche, BioCore Ltd. and Picarro Inc. provided support in the form of salaries for authors NAK, DM, CS, MBO, SRD, HY and FD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors would like to thank Christelle Rapp, Marie Stella Gruyer, Veronique Dall' Asen, Peter Schrag, Thomas Thelly and Fabian Kaegi (Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Switzerland) for their radiolabeling and in vivo work and Miro Eigenmann (Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Switzerland) for providing the plasma and tissue concentration time profiles of the <SUP>125</SUP>I-labeled anti-IL17 and very valuable discussions. Sincere thanks to Stephen Fowler, Christoph Funk, Nicolas Frances and Nicolas Frey (Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Switzerland) for critical discussions and sponsorship. In addition, the authors would like to thank Joerg Benz (Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Switzerland) for providing the schematic view of the anti-IL17.	Boswell CA, 2014, MOL PHARMACEUT, V11, P1591, DOI 10.1021/mp400748t; Burt T, 2016, CTS-CLIN TRANSL SCI, V9, P74, DOI 10.1111/cts.12390; Crosson ER, 2008, APPL PHYS B-LASERS O, V92, P403, DOI 10.1007/s00340-008-3135-y; Cymer F, 2017, BIOANALYSIS, V9, P1305, DOI 10.4155/bio-2017-0109; Davidsson P, 2015, J PHARM SCI-US, V104, P1825, DOI 10.1002/jps.24368; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Deng R, 2011, MABS-AUSTIN, V3, P61, DOI 10.4161/mabs.3.1.13799; Dueker SR, 2011, ADV DRUG DELIVER REV, V63, P518, DOI 10.1016/j.addr.2010.10.009; Eigenmann MJ, 2017, J PHYSIOL-LONDON, V595, P7311, DOI 10.1113/JP274819; Enright HA, 2016, CHEM RES TOXICOL, V29, P1976, DOI 10.1021/acs.chemrestox.6b00234; Fleisher AJ, 2017, J PHYS CHEM LETT, V8, P4550, DOI 10.1021/acs.jpclett.7b02105; Fronton L, 2014, J PHARMACOKINET PHAR, V41, P87, DOI 10.1007/s10928-014-9349-1; Galli I, 2016, OPTICA, V3, P385, DOI 10.1364/OPTICA.3.000385; Genoud G, 2015, OPT LETT, V40, P1342, DOI 10.1364/OL.40.001342; Keck BD, 2010, BIOANALYSIS, V2, P469, DOI [10.4155/bio.10.14, 10.4155/BIO.10.14]; LABRIE D, 1981, APPL PHYS, V24, P381, DOI 10.1007/BF00899738; Lappin G, 2008, EXPERT OPIN DRUG MET, V4, P1021, DOI 10.1517/17425255.4.8.1021 ; Liu HY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00038; Lozac'h F, 2018, BIOANALYSIS, V10, P321, DOI 10.4155/bio-2017-0216; Marathe PH, 2004, CURR PHARM DESIGN, V10, P2991, DOI 10.2174/1381612043383494; McCartt AD, 2016, ANAL CHEM, V88, P8714, DOI 10.1021/acs.analchem.6b02054; Mohn J, 2014, RAPID COMMUN MASS SP, V28, P1995, DOI 10.1002/rcm.6982; Ognibene TJ, 2003, ANAL CHEM, V75, P2192, DOI 10.1021/ac026334j; OKEEFE A, 1988, REV SCI INSTRUM, V59, P2544, DOI 10.1063/1.1139895; Shah DK, 2013, MABS-AUSTIN, V5, P297, DOI 10.4161/mabs.23684; Sonnenschein V, 2018, J APP PHYS, V124, P3; van Duijn E, 2014, ANAL CHEM, V86, P7635, DOI 10.1021/ac5015035; Vlaming MLH, 2015, CLIN PHARMACOL THER, V98, P196, DOI 10.1002/cpt.131; Vogel JS, 2005, METHOD ENZYMOL, V402, P402, DOI 10.1016/S0076-6879(05)02013-6; WAHL RL, 1988, NUCL MED BIOL, V15, P611, DOI 10.1016/0883-2897(88)90051-7; Zare RN, 2012, NATURE, V482, P312, DOI 10.1038/482312a	31	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205435	10.1371/journal.pone.0205435	http://dx.doi.org/10.1371/journal.pone.0205435			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332475	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200054
J	Liu, CJ; Yu, KL; Bai, JB; Tian, DH; Liu, GL				Liu, Chunjie; Yu, Kunlun; Bai, Jiangbo; Tian, Dehu; Liu, Guoli			Experimental study of tendon sheath repair via decellularized amnion to prevent tendon adhesion	PLOS ONE			English	Article							SYNOVIAL-FLUID; IN-VIVO; MEMBRANE; PROLIFERATION; FIBROBLASTS; MIGRATION; INJURIES; WOUNDS; CELLS; MODEL	The adhesion of tendon and surrounding tissue is the most common complication after repairing an injured tendon. The injured flexor tendons in zone II are frequently accompanied by tendon sheath defects, which lead to poor recovery. A variety of biological and nonbiological materials have been recently used for repair or as substitute for tendon sheaths to prevent tendon adhesion. However, non-biological materials, such as polyethylene films, have been used to prevent tendon adhesions by mechanical isolation. The possibility of tendon necrosis and permanent foreign body remains due to the lack of permeability and the obstruction of nutrient infiltration. The natural macromolecule amniotic membrane derived from organisms is a semi-permeable membrane with the following characteristics: smooth; without vascular, nerve, and lymphatic; and rich in matrix, cytokines, enzymes, and other active ingredients. The unique structure of this membrane makes it an ideal biomaterial. In the experiment in Henry chicken, the model of tendon sheath defect and the flexor digitorum tendon in zone II was established and randomly divided into control group, medical membrane group, and decellularized amniotic membrane group. Samples were obtained at the 2nd, 4th, 8th, and 12th week after operation. General, histological, and biomechanical tests were performed to investigate the preventive effect of repaired tendon sheath by decallularized amniotic membrane. Experimental results showed the following: the amniotic membrane group and the medical membrane group had mild inflammatory reaction and tissue edema, and nearly no adhesion was observed in the surrounding tissue; the fibroblast-like cells were distributed in layers under the light microscope; the amniotic membrane group was denser than the medical membrane group cells, and numerous fibroblasts were disorganized in the control group. Biomechanical measurements showed that the sliding distance of tendon, the total flexion angle of the toes, and the tendon maximum tensile breaking strength at the early postoperative were significantly better than in the control group. Through this experiment, the amniotic membrane, as a natural biological substitute material in the construction of tendon sheath, can effectively inhibit exogenous healing and promote endogenous healing to prevent tendon adhesion.	[Liu, Chunjie] Tangshan Workers Hosp, Dept Orthoped, Tangshan City, Hebei, Peoples R China; [Liu, Chunjie; Yu, Kunlun; Bai, Jiangbo; Tian, Dehu] Hebei Med Univ, Affiliated Hosp 3, Dept Hand Surg, Shijiazhuang, Hebei, Peoples R China; [Liu, Guoli] Second Hosp Tangshan, Dept Orthoped, Tangshan City, Hebei, Peoples R China	Hebei Medical University	Tian, DH (corresponding author), Hebei Med Univ, Affiliated Hosp 3, Dept Hand Surg, Shijiazhuang, Hebei, Peoples R China.	tiandehu_1961@126.com						Baymurat AC, 2015, J BIOMED MATER RES A, V103, P84, DOI 10.1002/jbm.a.35151; Bunata RE, 2009, J HAND SURG-AM, V34A, P1436, DOI 10.1016/j.jhsa.2009.05.005; Chehelcheraghi F, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.25588; Donegan Ryan J, 2016, Foot Ankle Spec, V9, P438, DOI 10.1177/1938640016630057; Duan-Arnold Y, 2015, ADV WOUND CARE, V4, P523, DOI 10.1089/wound.2015.0636; Fong G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174101; Fouda MB, 2017, AM J TRANSL RES, V9, P4341; Go YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182716; Godoy-Santos AL, 2017, INJURY, V48, pS27, DOI 10.1016/S0020-1383(17)30772-6; Gonzalez-Andrades M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142099; Harrison RK, 2003, J HAND SURG-AM, V28A, P987, DOI 10.1016/S0363-5023(03)00380-0; Jamil S, 2017, MED SCI SPORT EXER, V49, P1769, DOI 10.1249/MSS.0000000000001294; Ji XX, 2015, J BONE JOINT SURG AM, V97A, P972, DOI 10.2106/JBJS.N.01100; Jiang SC, 2015, INT J MOL SCI, V16, P6932, DOI 10.3390/ijms16046932; Koob TJ, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-10; Kormpakis I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153822; Kshersagar J, 2018, CELL TISSUE BANK, V19, P423, DOI 10.1007/s10561-018-9688-z; Lorenz J, 2016, J ORAL IMPLANTOL, V42, P273, DOI 10.1563/aaid-joi-D-15-00133; McKenna B, 2018, CLIN PODIATR MED SUR, V35, P1, DOI 10.1016/j.cpm.2017.08.007; McQuilling JP., 2017, WOUNDS, V29, pE36; Mehdizadeh A, 2018, CONNECT TISSUE RES, V59, P396, DOI 10.1080/03008207.2018.1432605; Melville JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173572; Mousavi SR, 2009, J PEDIATR SURG, V44, P1662, DOI 10.1016/j.jpedsurg.2009.04.012; Rigo IZ, 2016, J HAND SURG-EUR VOL, V41, P793, DOI 10.1177/1753193416657758; Ryzhuk V, 2018, MAT SCI ENG C-MATER, V85, P191, DOI 10.1016/j.msec.2017.12.026; Shu J, 2015, BIOL RES, V48, DOI 10.1186/s40659-015-0062-3; Srinivasan R, 2007, CORNEA, V26, P1275, DOI 10.1097/ICO.0b013e31814b8b94; Tan JL, 2018, STEM CELL TRANSL MED, V7, P180, DOI 10.1002/sctm.17-0185; Tan JL, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt542; Tang JB, 1996, J HAND SURG-AM, V21A, P900, DOI 10.1016/S0363-5023(96)80212-7; Tang QM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05515; Temiz A, 2008, INT ORTHOP, V32, P389, DOI 10.1007/s00264-007-0335-8; Tenenhaus M, 2017, ANN PLAS SURG, V78, pS11, DOI 10.1097/SAP.0000000000000983; Wong JKF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112672; Wu F, 2017, EFORT OPEN REV, V2, P332, DOI 10.1302/2058-5241.2.160075; Xu L, 2010, BIOMATERIALS, V31, P3894, DOI 10.1016/j.biomaterials.2010.01.106; Xu Y, 2003, J HAND SURG-AM, V28A, P994, DOI 10.1016/S0363-5023(03)00428-3; Yagi M, 2010, J HAND SURG-AM, V35A, P791, DOI 10.1016/j.jhsa.2010.02.010; Yang TH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160301	39	27	29	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205811	10.1371/journal.pone.0205811	http://dx.doi.org/10.1371/journal.pone.0205811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325952	Green Submitted, gold, Green Published			2022-12-26	WOS:000447430800042
J	Lee, J; Kiuchi, T; Kawamoto, M; Shimada, T; Katsuma, S				Lee, Jung; Kiuchi, Takashi; Kawamoto, Munetaka; Shimada, Toru; Katsuma, Susumu			Accumulation of uric acid in the epidermis forms the white integument of Samia ricini larvae	PLOS ONE			English	Article							BOMBYX-MORI; SILKWORM; LEPIDOPTERA; GENES; ORGANELLES; MUTATION; HORMONE	The white color in the larval integument of the silkworm Bombyx mori is considered the result of uric acid accumulation in its epidermal cells. Larvae of the eri silkworm Samia ricini (Lepidoptera; Saturniidae) also have a white and opaque integument, but little is known about its coloration mechanism. In this study, we first performed a feeding assay of S. ricini larvae using allopurinol, an inhibitor of xanthine oxidase, which catalyzes the degradation of xanthine to uric acid. This treatment induced a clear translucent integument phenotype, indicating that the larval color of S. ricini is also determined by uric acid accumulation. Next, to investigate the genetic basis that controls uric acid accumulation in S. ricini larvae, we isolated and characterized the S. ricini homolog of mammalian biogenesis of lysosome-related organelles complex 1, subunit 2 (BLOS2), which is known to play a crucial role in urate granule biosynthesis. We created a transcription activator-like effector nuclease (TALEN)-mediated gene knockout of S. ricini BLOS2 (SrBLOS2) and succeeded in establishing SrBLOS2 knockout strains (SrBLOS2(KO)). SrBLOS2(KO) mutants exhibited a translucent larval integument phenotype and lacked uric acid in the epidermis, as also observed in allopurinol-fed larvae. In addition, electron microscopy revealed that urate granules were rarely observed in the epidermis of SrBLOS2(KO) larvae, whereas abundant granules were found in the epidermis of wild-type larvae. These results clearly demonstrated that larval S. ricini accumulates uric acid as urate granules in the epidermis and that the genetic basis that controls uric acid accumulation is evolutionarily conserved in S. ricini and B. mori.	[Lee, Jung; Kiuchi, Takashi; Kawamoto, Munetaka; Shimada, Toru; Katsuma, Susumu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Yayoi, Tokyo, Japan	University of Tokyo	Kiuchi, T; Katsuma, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Yayoi, Tokyo, Japan.	kiuchi@ss.ab.a.u-tokyo.ac.jp; katsuma@ss.ab.a.u-tokyo.ac.jp	Kiuchi, Takashi/AAG-4913-2020; Shimada, Toru/A-2033-2011; Shimada, Toru/AAZ-2703-2021	Kiuchi, Takashi/0000-0003-3616-1650; Shimada, Toru/0000-0002-5791-0000; Shimada, Toru/0000-0002-5791-0000; yun qiu, li/0000-0002-5295-0708; Kawamoto, Munetaka/0000-0003-3554-8407	Japan Society for the Promotion of Science [17J06249, 17H06431];  [15H02482]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	JL is a recipient of a fellowship from the Japan Society for the Promotion of Science (17J06249). https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-17J06249/. This work was supported by Grant-in-Aid for Scientific Research (A) (15H02482) to TK, TS, and SK. https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-15H02482/. Additional support for TK and SK from Japan Society for the Promotion of Science (17H06431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; BOWERS WILLIAM S., 1965, J INSECT PHYSIOL, V11, P1003, DOI 10.1016/0022-1910(65)90203-9; Cermak T, 2011, NUCLEIC ACIDS RES, V39, P7879, DOI 10.1093/nar/gkr739; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Fujii T, 2010, INSECT MOL BIOL, V19, P659, DOI 10.1111/j.1365-2583.2010.01020.x; Fujii T, 2008, INSECT BIOCHEM MOLEC, V38, P1072, DOI 10.1016/j.ibmb.2008.03.004; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; GILBERT LI, 1959, NATURE, V184, P171, DOI 10.1038/184171a0; Hu YG, 2013, ARCH INSECT BIOCHEM, V83, P41, DOI 10.1002/arch.21096; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kashima T, 2006, J INSECT PHYSIOL, V52, P816, DOI 10.1016/j.jinsphys.2006.05.003; KOBAYASHI M, 1962, NATURE, V194, P401, DOI 10.1038/194401a0; Komoto N, 2002, INSECT BIOCHEM MOLEC, V32, P591, DOI 10.1016/S0965-1748(01)00134-5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Maiuolo J, 2016, INT J CARDIOL, V213, P8, DOI 10.1016/j.ijcard.2015.08.109; Matsuo T, 1999, APPL ENTOMOL ZOOL, V34, P481, DOI 10.1303/aez.34.481; MIZOGUCHI A, 1982, P NATL ACAD SCI-BIOL, V79, P2726, DOI 10.1073/pnas.79.8.2726; NAGASAWA H, 1984, GEN COMP ENDOCR, V53, P143, DOI 10.1016/0016-6480(84)90234-X; Saitoh H., 2011, SANSHI KONCHU BIOTEC, V79, P153; Takasu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073458; TAMURA T, 1990, Cytologia (Tokyo), V55, P519, DOI 10.1508/cytologia.55.519; Tasaki E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167412; Timmermann Susanne, 1999, Journal of the Lepidopterists' Society, V53, P104; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tsujita M., 1964, J SERIC SCI JPN, V33, P447; Wang LY, 2013, INSECT BIOCHEM MOLEC, V43, P562, DOI 10.1016/j.ibmb.2013.03.011; WHITE JF, 1966, NATURE, V212, P314, DOI 10.1038/212314a0; Yang B, 2016, INSECT BIOCHEM MOLEC, V70, P53, DOI 10.1016/j.ibmb.2015.12.003; Zhu GH, 2017, J INSECT PHYSIOL, V103, P29, DOI 10.1016/j.jinsphys.2017.09.008	31	8	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205758	10.1371/journal.pone.0205758	http://dx.doi.org/10.1371/journal.pone.0205758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321229	gold, Green Published, Green Submitted			2022-12-26	WOS:000447417900050
J	Mubaiwa, J; Fogliano, V; Chidewe, C; Linnemann, AR				Mubaiwa, Juliet; Fogliano, Vincenzo; Chidewe, Cathrine; Linnemann, Anita R.			Bambara groundnut (Vigna subterranea (L.) Verdc.) flour: A functional ingredient to favour the use of an unexploited sustainable protein source	PLOS ONE			English	Article							CAJANUS-CAJAN FLOUR; PHYSICAL-PROPERTIES; PROXIMATE COMPOSITION; PHYSICOCHEMICAL PROPERTIES; THERMAL-CONDUCTIVITY; CHEMICAL-COMPOSITION; PARTICLE-SIZE; 2 VARIETIES; STARCH; SEED	Variability in dehulling efficiency, colour, chemical composition and selected functional properties of raw and pre-treated bambara groundnut (Vigna subterranea (L.) Verdc.) (BG) flour from red and black-eye varieties were studied. Functional properties were water and oil absorption, gelation, pasting, emulsification and foaming capacity. Pre-treatment of seeds (i.e. soaking, roasting and combined soaking and roasting) improved dehulling efficiency of BG varieties. Protein content of flour ranged from 15.6-19.6%, starch from 47.8-52.0% and sucrose from 1.9-5%. An improvement was observed for protein and ash content of pre-treated flour compared to raw flour. Heat treatments increased onset gelatinization temperature of flour. Black-eye BG flours that had higher starch content, also had better gelation capacity than red BG flours. All pre-treatment methods decreased flour emulsification capacity and stability. Dry-roasting caused a greater decline than other methods, whereas soaking had little effect on emulsion stability. Further, soaking increased foaming capacity, whilst a decline was observed in roasted flour. All pre-treatment methods increased oil absorption capacity of both BG flour varieties. Overall, soaked and combined soaked and roasted flour is recommended for BG flour to be incorporated in food products.	[Mubaiwa, Juliet] Chinhoyi Univ Technol, Dept Food Sci & Technol, Chinhoyi, Zimbabwe; [Chidewe, Cathrine] Univ Zimbabwe, Dept Biochem, Harare, Zimbabwe	University of Zimbabwe	Mubaiwa, J (corresponding author), Chinhoyi Univ Technol, Dept Food Sci & Technol, Chinhoyi, Zimbabwe.	anita.linnemann@wur.nl	fogliano, vincenzo/W-6885-2019; Fogliano, Vincenzo/M-8166-2019; Mubaiwa, Juliet/K-8392-2019; fogliano, vincenzo/A-1419-2009	fogliano, vincenzo/0000-0001-8786-9355; Mubaiwa, Juliet/0000-0001-9553-5830; fogliano, vincenzo/0000-0001-8786-9355	Netherlands Fellowship Programmes [CF9153/2013]	Netherlands Fellowship Programmes	The work was funded by Netherlands Fellowship Programmes (Grant award CF9153/2013 to JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiodun A. O., 2011, Advance Journal of Food Science & Technology, V3, P224; Abu JO, 2005, FOOD CHEM, V93, P103, DOI 10.1016/j.foodchem.2004.09.010; Adebowale A, 2011, 2 INT S UND PLANT SP, P979; Adebowale KO, 2004, FOOD RES INT, V37, P355, DOI 10.1016/j.foodres.2004.01.009; Adebowale KO, 2002, FOOD CHEM, V78, P305, DOI 10.1016/S0308-8146(02)00100-0; Afolabi TA, 2012, INT J FOOD SCI TECH, V47, P445, DOI 10.1111/j.1365-2621.2011.02860.x; AKPAPUNAM MA, 1994, PLANT FOOD HUM NUTR, V46, P147, DOI 10.1007/BF01088767; Akubor PI, 2000, FOOD RES INT, V33, P707, DOI 10.1016/S0963-9969(00)00116-2; Amarteifio J. O., 1998, Journal of Food Composition and Analysis, V11, P329, DOI 10.1006/jfca.1998.0595; Amonsou EO, 2009, J SCI FOOD AGR, V89, P1587, DOI 10.1002/jsfa.3628; [Anonymous], [No title captured]; AOAC, 1995, OFFICIAL METHODS ANA, V16th; Ashogbon A. O., 2014, African Journal of Food Science, V8, P322; Ashogbon A.O., 2013, INT J BIOTECHNOL FOO, V1, P72; Barimalaa IS, 1997, J SCI FOOD AGR, V73, P186, DOI [10.1002/(SICI)1097-0010(199702)73:2&lt;186::AID-JSFA643&gt;3.0.CO;2-M, 10.1002/(SICI)1097-0010(199702)73:2<186::AID-JSFA643>3.3.CO;2-D]; Baryeh EA, 2001, J FOOD ENG, V47, P321, DOI 10.1016/S0260-8774(00)00136-9; Boye J, 2010, FOOD RES INT, V43, P414, DOI 10.1016/j.foodres.2009.09.003; BRESSANI R, 1993, FOOD REV INT, V9, P237, DOI 10.1080/87559129309540960; BROUGH SH, 1993, FOOD CHEM, V47, P277, DOI 10.1016/0308-8146(93)90161-8; BROUGH SH, 1992, J SCI FOOD AGR, V60, P197, DOI 10.1002/jsfa.2740600207; Catsimpoolas N, 1971, CEREAL CHEM; Acuna SPC, 2012, CIENCIA TECNOL ALIME, V32, P98, DOI 10.1590/S0101-20612012005000007; COFFMANN CW, 1977, J FOOD TECHNOL, V12, P473, DOI 10.2174/0929866054395257; Copeland L, 2009, FOOD HYDROCOLLOID, V23, P1527, DOI 10.1016/j.foodhyd.2008.09.016; DESHPANDE SS, 1982, CEREAL CHEM, V59, P396; Diedericks CF, 2015, J FOOD SCI, V80, pC1933, DOI 10.1111/1750-3841.12981; Eltayeb A. R. S. M., 2011, African Journal of Food Science, V5, P82; Enwere NJ, 1996, INT J FOOD SCI NUTR, V47, P469, DOI 10.3109/09637489609031875; Evageliou V, 2000, CARBOHYD POLYM, V42, P261, DOI 10.1016/S0144-8617(99)00158-7; EVANS RJ, 1967, J AGR FOOD CHEM, V15, P439, DOI 10.1021/jf60151a011; Fekria Ali Mohamed I, 2015, NUTR FUNCTIONAL PROP; Ghavidel RA, 2007, LWT-FOOD SCI TECHNOL, V40, P1292, DOI 10.1016/j.lwt.2006.08.002; GIAMI SY, 1993, FOOD CHEM, V47, P153, DOI 10.1016/0308-8146(93)90237-A; HERMANSSON AM, 1986, J AM OIL CHEM SOC, V63, P658, DOI 10.1007/BF02638232; Hillocks RJ, 2011, AFRICAN CROP SCI J, V20, P1; HORIUCHI T, 1978, FOOD CHEM, V3, P35, DOI 10.1016/0308-8146(78)90045-6; James S, 2018, FOOD SCI NUTR; Kaptso KG, 2008, J FOOD ENG, V86, P91, DOI 10.1016/j.jfoodeng.2007.09.014; Kaptso KG, 2015, J FOOD SCI TECH MYS, V52, P4915, DOI 10.1007/s13197-014-1580-7; Karababa E, 2006, J FOOD ENG, V72, P100, DOI 10.1016/j.jfoodeng.2004.11.028; Kerr WL, 2000, CEREAL CHEM, V77, P213, DOI 10.1094/CCHEM.2000.77.2.213; Kim W, 2004, J CEREAL SCI, V40, P9, DOI 10.1016/j.jcs.2004.04.005; KINSELLA JE, 1979, J AM OIL CHEM SOC, V56, P242, DOI 10.1007/BF02671468; KRUEGER BR, 1987, J FOOD SCI, V52, P715, DOI 10.1111/j.1365-2621.1987.tb06709.x; Li S, 2014, J BIOPROCESSING BIOT, V4, P1; LIN MJY, 1974, J FOOD SCI, V39, P368, DOI 10.1111/j.1365-2621.1974.tb02896.x; Longland AC, 2011, VET REC, V168, DOI 10.1136/vr.d157; Mahala A. G., 2010, Journal of Applied Sciences Research, P383; Malik MA, 2016, COGENT FOOD AGR, V2; Matsa W, 2013, TRADITIONAL SCI SEED; Matsuura-Endo C, 2004, J PLANT RES, V117, P131, DOI 10.1007/s10265-003-0137-z; MCGUIRE RG, 1992, HORTSCIENCE, V27, P1254, DOI 10.21273/HORTSCI.27.12.1254; Modi SK, 2014, INT J HEAT MASS TRAN, V78, P354, DOI 10.1016/j.ijheatmasstransfer.2014.06.076; Mohsenin N. N., 1980, THERMAL PROPERTIES F; MOSSE J, 1990, J AGR FOOD CHEM, V38, P18, DOI 10.1021/jf00091a004; Mubaiwa J, UTILIZATION BAMBARA; Mubaiwa J, 2017, FOOD REV INT, V33, P167, DOI 10.1080/87559129.2016.1149864; Nti CA, 2009, INT J FOOD SCI TECH, V44, P2234, DOI 10.1111/j.1365-2621.2009.02064.x; Obatolu VA, 2007, J FOOD PROCESS PRES, V31, P240, DOI 10.1111/j.1745-4549.2007.00112.x; Ogundele OM, 2017, FOOD CHEM, V214, P655, DOI 10.1016/j.foodchem.2016.07.022; Olapade A, 2007, NIGERIAN FOOD J, V25; Olayinka B. U., 2016, Annals of West University of Timisoara, Series of Biology, V19, P177; Onimawo IA, 2006, J FOOD PROCESS PRES, V30, P742, DOI 10.1111/j.1745-4549.2006.00093.x; Onimawo IA, 1998, PLANT FOOD HUM NUTR, V53, P153, DOI 10.1023/A:1008027030095; OSHODI AA, 1989, FOOD CHEM, V34, P187, DOI 10.1016/0308-8146(89)90139-8; Plahar WA, 2004, DISSEMINATION IMPROV; POULTER NH, 1981, J SCI FOOD AGR, V32, P44, DOI 10.1002/jsfa.2740320108; Quinton LA, 2000, AM ASS CEREAL CHEMIS; Sahin S., 2006, PHYS PROPERTIES FOOD; Samira S, 2014, INT FOOD RES J, V21; SATHE SK, 1982, J FOOD SCI, V47, P491, DOI 10.1111/j.1365-2621.1982.tb10110.x; Schaafsma G, 2012, BRIT J NUTR, V108, pS333, DOI 10.1017/S0007114512002541; Sikorski Z.E., 2006, CHEM FUNCTIONAL PROP; Singh N, 2003, FOOD CHEM, V81, P219, DOI 10.1016/S0308-8146(02)00416-8; Sirivongpaisal P., 2008, SONGKLA J SCI TECHNO, V30, P51; SNOW P, 1981, AM J CLIN NUTR, V34, P2721, DOI 10.1093/ajcn/34.12.2721; SREENARAYANAN VV, 1986, J AGR ENG RES, V34, P115, DOI 10.1016/S0021-8634(86)80004-X; Sreerama YN, 2009, LWT-FOOD SCI TECHNOL, V42, P44, DOI 10.1016/j.lwt.2008.07.005; van der Linden E, 2009, MODERN BIOPOLYMER SCIENCE: BRIDGING THE DIVIDE BETWEEN FUNDAMENTAL TREATISE AND INDUSTRIAL APPLICATION, P29; WOLF WJ, 1970, J AGR FOOD CHEM, V18, P969, DOI 10.1021/jf60172a025; Yagoub A. E. A., 2007, Research Journal of Agriculture and Biological Sciences, V3, P24; Yusuf AA, 2008, FOOD CHEM, V111, P277, DOI 10.1016/j.foodchem.2007.12.014; Zia-ur-Rehman, 2005, INT J FOOD SCI TECH, V40, P695, DOI 10.1111/j.1365-2621.2005.00978.x	83	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205776	10.1371/journal.pone.0205776	http://dx.doi.org/10.1371/journal.pone.0205776			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321223	Green Published, Green Submitted, gold			2022-12-26	WOS:000447417900051
J	Dai, L; Hao, QH; Mao, LM				Dai, Lu; Hao, Qinghe; Mao, Limi			Morphological diversity of Quercus fossil pollen in the northern South China Sea during the last glacial maximum and its paleoclimatic implication	PLOS ONE			English	Article							LEIZHOU PENINSULA; CLIMATE-CHANGE; RECORD; VEGETATION; FAGACEAE; HOLOCENE; MARINE; PHYLOGENY; SEDIMENTS; JAPAN	We aimed to obtain high resolution vegetation data and climate information about the LGM in the inland of the northern SCS based on key pollen types. Dominant Quercus fossil pollen grains in the core from the continental shelf of the northern SCS have been identified at the infrageneric level by using scanning electron microscopy. Based on tectum ornamentation, we recognized five sculpture types of Quercus pollen, namely, rodlike, rodlike masked, rodlike vertical, verrucate and micro-verrucate. Such a high diversity of Quercus fossil pollen types indicated that broadleaved forests were widely distributed in the inland along the northern SCS and included species of the subgenera Cyclobalanopsis and Quercus, of which subgenus Cyclobalanopsis populations were highly dominant. Low abundance of deciduous Quercus pollen probably derived from temperate-subtropical forests, while abundant evergreen pollen types of subgenura Quercus and Cyclobalanopsis, as well as other pollen of broadleaved taxa in the pollen assemblages, strongly suggest that the inland has been covered by dense subtropical forests. Consequently, the warm and humid subtropical climate prevailed during the LGM in the inland along the northern SCS. Our results shed new light on regional climatic conditions during the LGM in eastern Asia based on high diversity of Quercus fossil pollen in marine deposits from northern SCS.	[Dai, Lu; Hao, Qinghe] Ningbo Univ, Dept Geog & Spatial Informat Tech, Ningbo, Zhejiang, Peoples R China; [Dai, Lu] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China; [Dai, Lu] Tongji Univ, State Key Lab Marine Geol, Shanghai, Peoples R China; [Mao, Limi] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Key Lab Econ Stratig & Palaeogeog, Nanjing, Jiangsu, Peoples R China	Ningbo University; Chinese Academy of Sciences; Tongji University; Chinese Academy of Sciences	Dai, L (corresponding author), Ningbo Univ, Dept Geog & Spatial Informat Tech, Ningbo, Zhejiang, Peoples R China.; Dai, L (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China.; Dai, L (corresponding author), Tongji Univ, State Key Lab Marine Geol, Shanghai, Peoples R China.	dailu2288@163.com			National Natural Science Foundation of China [41776063, 41877437]; State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) [163105]; K.C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS)(Chinese Academy of Sciences); K.C. Wong Magna Fund in Ningbo University	This work was funded by the National Natural Science Foundation of China (Grant No. 41776063 and 41877437), State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) (Grant No. 163105) and K.C. Wong Magna Fund in Ningbo University.	Cao H, 2013, DINGHUSHAN LOWER SUB; [常琳 Chang Lin], 2013, [科学通报, Chinese Science Bulletin], V58, P3079; COLOMBO PM, 1983, PLANT SYST EVOL, V141, P273, DOI 10.1007/BF00989007; Dai L, 2015, PALAEOGEOGR PALAEOCL, V440, P249, DOI 10.1016/j.palaeo.2015.08.041; Dai L, 2015, DEEP-SEA RES PT II, V122, P153, DOI 10.1016/j.dsr2.2015.06.011; Dai L, 2014, QUATERN INT, V325, P136, DOI 10.1016/j.quaint.2013.09.031; Deng Min, 2013, Guangxi Zhiwu / Guihaia, V33, P368; Denk T, 2017, TREE PHYSIOL-NETH, V7, P13, DOI 10.1007/978-3-319-69099-5_2; Denk T, 2014, GRANA, V53, P255, DOI 10.1080/00173134.2014.918647; Denk T, 2009, INT J PLANT SCI, V170, P926, DOI 10.1086/600134; Fu G.A., 1995, GUIHAIA, V15, P57; Hayashi R, 2012, QUATERN INT, V254, P99, DOI 10.1016/j.quaint.2010.08.011; Kershaw A, 2007, QUATERNARY HIST FAR, P77; Liew PM, 2006, QUATERN INT, V147, P16, DOI 10.1016/j.quaint.2005.09.003; Liu CYS, 2007, REV PALAEOBOT PALYNO, V145, P289, DOI 10.1016/j.revpalbo.2006.12.001; Manos PS, 1999, MOL PHYLOGENET EVOL, V12, P333, DOI 10.1006/mpev.1999.0614; Nakagawa T, 1996, REV PALAEOBOT PALYNO, V91, P317, DOI 10.1016/0034-6667(95)00072-0; Naryshkina NN, 2009, PALEONTOL J+, V43, P1309, DOI 10.1134/S0031030109100128; Nixon K.C., 1993, ANN SCI FORESTIERE S, V50, P25, DOI DOI 10.1051/F0REST:19930701; Punt W, 2007, REV PALAEOBOT PALYNO, V143, P1, DOI 10.1016/j.revpalbo.2006.06.008; Rowley JR, 2004, REV PALAEOBOT PALYNO, V132, P115, DOI 10.1016/j.revpalbo.2004.05.003; Sheng M, 2017, PALAEOGEOGR PALAEOCL, V472, P83, DOI 10.1016/j.palaeo.2017.01.038; Sun XJ, 2003, MAR GEOL, V201, P97, DOI 10.1016/S0025-3227(03)00211-1; Sun XJ, 1999, MAR GEOL, V156, P227, DOI 10.1016/S0025-3227(98)00181-9; Tekleva MV, 2014, PLANT SYST EVOL, V300, P1877, DOI 10.1007/s00606-014-1014-z; Wang P., 2004, POLLEN MORPHOLOGY BI; Wang SY, 2012, QUATERN INT, V248, P79, DOI 10.1016/j.quaint.2010.07.030; Wu, 1980, VEGETATION CHINA; Xu DK, 2013, P NATL ACAD SCI USA, V110, P9657, DOI 10.1073/pnas.1300025110; Xue JB, 2015, QUATERNARY RES, V84, P223, DOI 10.1016/j.yqres.2015.08.001; Yu SH, 2017, QUATERNARY SCI REV, V157, P114, DOI 10.1016/j.quascirev.2016.12.012; Yue YF, 2012, PALAEOGEOGR PALAEOCL, V365, P115, DOI 10.1016/j.palaeo.2012.09.018; Zheng Z, 1999, PALAEOGEOGR PALAEOCL, V145, P339, DOI 10.1016/S0031-0182(98)00107-2; Zheng Z, 2000, QUATERNARY RES, V53, P330, DOI 10.1006/qres.1999.2126; [Zheng Zhuo 郑卓], 2002, [古生物学报, Acta Palaeontologica Sinica], V41, P487; Zheng Z, 2014, J BIOGEOGR, V41, P1819, DOI 10.1111/jbi.12361	36	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205246	10.1371/journal.pone.0205246	http://dx.doi.org/10.1371/journal.pone.0205246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312322	gold, Green Submitted, Green Published			2022-12-26	WOS:000447427300024
J	Judd, A; Foster, C; Thompson, LC; Sturgeon, K; Le Prevost, M; Jungmann, E; Rowson, K; Castro, H; Gibb, DM				Judd, Ali; Foster, Caroline; Thompson, Lindsay C.; Sturgeon, Kate; Le Prevost, Marthe; Jungmann, Eva; Rowson, Katie; Castro, Hannah; Gibb, Diana M.		Adolescents Adults Living Perinat	Sexual health of young people with perinatal HIV and HIV negative young people in England	PLOS ONE			English	Article							DRUG-USE BEHAVIOR; RISK BEHAVIOR; REPRODUCTIVE HEALTH; INFECTED YOUTH; UNITED-KINGDOM; MENTAL-HEALTH; SUBSTANCE USE; ADOLESCENTS; CHILDREN; ADULTS	As adolescents with perinatal HIV (PHIV) survive into adulthood, gaining insight into sexual behaviour and risk-taking is important. Between 2013-2015, 296 PHIV aged 13-21 years and 96 HIV negative affected adolescents (13-23 years) were recruited to the Adolescents and Adults Living with Perinatal HIV (AALPHI) cohort in England. Sexual health data were collected through computer-assisted self-interview questionnaires. Quality of life and household deprivation were also measured. T-tests compared means, and chi(2) proportions; logistic regression examined predictors of ever having sex. 120(41%) PHIV and 31(32%) HIVyoung people were male, 254(86%) and 70(73%) were black, median age 16 [IQR 15,18] and 16 [14,18] years respectively. 77(26%) PHIV had a previous AIDS diagnosis. 93(32%) PHIV and 38(40%) HIV-had ever had sex; median number of partners was 3 [1,6] and 4 [1,6] respectively. 54 (41%) of 131 young people who were sexually active reported not always using condoms, including 32% (30/93) of PHIV. In multivariable analysis, older age, male sex, worse deprivation score, worse quality of life, and alcohol and/or drugs were associated with ever having sex, but not HIV status. 12/30 PHIV reporting unprotected sex had at least one HIV viral load >= 200c/ml in the previous 12 months. Age at first sex and number of sexual partners were similar among PHIV and HIV-, and comparable to normative data. In conclusion, small numbers of PHIV reported condomless sex with a detectable viral load, which could result in HIV transmission, indicating the need for targeted sexual health and ART adherence interventions for young people with perinatal HIV.	[Judd, Ali; Thompson, Lindsay C.; Sturgeon, Kate; Le Prevost, Marthe; Rowson, Katie; Castro, Hannah; Gibb, Diana M.] UCL, MRC Clin Trials Unit, London, England; [Foster, Caroline] Imperial Coll Healthcare NHS Trust, London, England; [Jungmann, Eva] Cent & North West London NHS Fdn Trust, London, England	Medical Research Council Clinical Trials Unit; University of London; University College London; Imperial College London	Judd, A (corresponding author), UCL, MRC Clin Trials Unit, London, England.	a.judd@ucl.ac.uk	Judd, Ali/B-5132-2009	Judd, Ali/0000-0003-3176-5295; Castro, Hannah/0000-0001-9086-8687; Gibb, Diana/0000-0002-9738-5490	Monument Trust; Medical Research Council programme grant [MC_UU_12023/26]; PENTA Foundation; MRC [MC_UU_12023/26, MC_UU_12023/17] Funding Source: UKRI	Monument Trust; Medical Research Council programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); PENTA Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Monument Trust and PENTA Foundation. This work was supported by the Medical Research Council programme grant MC_UU_12023/26 awarded to the MRC Clinical Trials Unit. The funding sources had no role in the study design, collection, analysis and interpretation of data, writing of the report or decision to submit the paper for publication.	Aicken CRH, 2011, J PUBLIC HEALTH-UK, V33, P262, DOI 10.1093/pubmed/fdq056; Bauermeister JA, 2012, J SEX RES, V49, P413, DOI 10.1080/00224499.2011.598248; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Center for Disease Control and prevention, 2017, HIV PREGN WOM INF CH; Children's HIV Association, 2015, VACC IND UNC INC IMM; Collins IJ, 2017, CLIN INFECT DIS, V64, P1105, DOI 10.1093/cid/cix063; Connery HS, 2014, OBSTET GYN CLIN N AM, V41, P191, DOI 10.1016/j.ogc.2014.02.011; Croucher AP, 2013, SEX TRANSM INFECT, V89, P392, DOI 10.1136/sextrans-2012-050831; Department for Communities and Local Government, 2015, ENGL IND DEPR 2015; Des Jarlais DC, 1999, LANCET, V353, P1657, DOI 10.1016/S0140-6736(98)07026-3; Dolezal C, 2014, J SEX RES, V51, P599, DOI 10.1080/00224499.2013.829797; Elkington KS, 2015, J PEDIATR PSYCHOL, V40, P442, DOI 10.1093/jpepsy/jsu103; Elkington KS, 2012, AIDS PATIENT CARE ST, V26, P411, DOI 10.1089/apc.2012.0005; Fakoya A, 2008, HIV MED, V9, P681, DOI 10.1111/j.1468-1293.2008.00634.x; Gibb DM, 2003, BMJ-BRIT MED J, V327, P1019, DOI 10.1136/bmj.327.7422.1019; Jacobson DL, 2010, AIDS, V24, P687, DOI 10.1097/QAD.0b013e328336095d; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Judd A, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.4.21577; Judd A, 2016, CLIN INFECT DIS, V63, P1380, DOI 10.1093/cid/ciw568; Kang E, 2011, J COMMUNITY PSYCHOL, V39, P956, DOI 10.1002/jcop.20483; Lolekha R, 2015, AIDS CARE, V27, P618, DOI 10.1080/09540121.2014.986046; Mbalinda SN, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0082-z; Mellins CA, 2011, AIDS PATIENT CARE ST, V25, P413, DOI 10.1089/apc.2011.0025; Mellins CA, 2009, J AM ACAD CHILD PSY, V48, P810, DOI 10.1097/CHI.0b013e3181a81346; Melvin D, 2007, Psychol Health Med, V12, P40, DOI 10.1080/13548500600731708; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Office for National Statistics, 2015, CRIM SURV ENGL WAL T, VOne; Patel K, 2008, CLIN INFECT DIS, V46, P507, DOI 10.1086/526524; Pilapil M, 2015, CURR OPIN PEDIATR, V27, P132, DOI 10.1097/MOP.0000000000000177; Public Health England, 2015, HUM PAP HPV VACC COV; Rehm J, 2012, ADDICTION, V107, P51, DOI 10.1111/j.1360-0443.2011.03621.x; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Sadarangani M, 2015, J INFECTION, V71, P495, DOI 10.1016/j.jinf.2015.06.003; Sales Jessica M, 2012, Curr Drug Abuse Rev, V5, P117; Scalese M, 2017, ADDICT BEHAV, V72, P93, DOI 10.1016/j.addbeh.2017.03.016; Slogrove AL, 2018, CURR OPIN HIV AIDS, V13, P170, DOI [10.1097/COH.0000000000000449, 10.1097/coh.0000000000000449]; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Tassiopoulos K, 2013, CLIN INFECT DIS, V56, P283, DOI 10.1093/cid/cis816; Tepper V, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.4.21490; UNAIDS, 2016, CHILDR HIV FACT SHEE; van Leeuwen AJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160257; VARNI JW, 2014, SCALING SCORING PEDI; Weintraub A, 2017, AIDS BEHAV, V21, P129, DOI 10.1007/s10461-016-1337-6; Writing group for the Kids to Adults Working Group and Data Management and Harmonisation Group in EuroCoord, 2016, Euro Surveill, V21, P30162, DOI 10.2807/1560-7917.ES.2016.21.10.30162; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	48	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205597	10.1371/journal.pone.0205597	http://dx.doi.org/10.1371/journal.pone.0205597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0UN	30312343	Green Published, Green Submitted, gold			2022-12-26	WOS:000447427300041
J	Ok, JM; Park, YB; Park, YJ				Ok, Ji-Myung; Park, Young-Bae; Park, Young-Jae			Association of dysfunctional breathing with health-related quality of life: A cross-sectional study in a young population	PLOS ONE			English	Article							HYPERVENTILATION SYNDROME; NIJMEGEN QUESTIONNAIRE; ASTHMA; CHILDREN	Symptomatic hyperventilation (SH) is a pathological condition that manifests with breathlessness, dyspnea, light-headedness, anxiety, and paresthesia. However, little is known about the prevalence of SH and its association with health-related quality of life (HRQoL) in a young population. The Nijmegen questionnaire (NQ), which measures severity of SH, had not previously been cross-culturally translated into Korean. In this study, the NQ was cross-culturally translated into Korean (KNQ), using translation and back-translation methods. To examine the reliability and validity levels of the KNQ, as well as its association with HRQoL, 237 college students (21.38 +/- 2.45 years) were asked to complete the KNQ, the Korean version of the general health questionnaire (K-GHQ-30) and the short form-36 (K-SF-36). The KNQ showed satisfactory reliability (Cronbach's alpha = 0.878). In the construct validity test, four factors (neuropsychological, respiratory, neurogastrointestinal, and neuromuscular) were extracted (% of total variance = 59.8). Using a KNQ cut-off score of 23 points, the prevalence of SH was 22.8%. Physical and mental HRQoL levels estimated by the K-GHQ-30 score and the 8 subscale scores of the K-SF-36 were lower in the SH group than in those of the non-SH group. It is concluded that the cross-culturally translated KNQ is reliable and valid, and management of SH may prevent a reduction in physical and mental HRQoL in a young population.	[Ok, Ji-Myung; Park, Young-Bae; Park, Young-Jae] Kyung Hee Univ, Grad Sch, Dept Human Informat Korean Med, Seoul, South Korea; [Park, Young-Bae; Park, Young-Jae] Kyung Hee Univ, Coll Korean Med, Dept Biofunct Med & Diagnost, Seoul, South Korea; [Park, Young-Jae] Kyung Hee Univ Hosp Gangdong, Dept Diag & Biofunct Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University Hospital	Park, YJ (corresponding author), Kyung Hee Univ, Grad Sch, Dept Human Informat Korean Med, Seoul, South Korea.; Park, YJ (corresponding author), Kyung Hee Univ, Coll Korean Med, Dept Biofunct Med & Diagnost, Seoul, South Korea.; Park, YJ (corresponding author), Kyung Hee Univ Hosp Gangdong, Dept Diag & Biofunct Med, Seoul, South Korea.	bmpomd@khu.ac.kr		Park, Young-Jae/0000-0002-1582-7858				Chenivesse C, 2014, RESP MED, V108, P517, DOI 10.1016/j.rmed.2013.10.024; de Groot EP, 2013, EUR RESPIR J, V41, P1068, DOI 10.1183/09031936.00130212; Gardner WN, 1996, CHEST, V109, P516, DOI 10.1378/chest.109.2.516; GARDNER WN, 1986, LANCET, V2, P826; Grammatopoulou EP, 2014, J ASTHMA, V51, P839, DOI 10.3109/02770903.2014.922190; Gridina I, 2013, ARCH PEDIATRIE, V20, P265, DOI 10.1016/j.arcped.2012.12.016; Han JN, 1996, J PSYCHOSOM RES, V41, P481, DOI 10.1016/S0022-3999(96)00220-6; Han SS, 2004, STAT ANAL NURSING PU; Hanna BC, 2012, CLIN OTOLARYNGOL, V37, P155, DOI 10.1111/j.1749-4486.2012.02466.x; Jeong JC, 2004, EVALUATION VALIDITY; Marriage Deborah, 2012, Nurs Child Young People, V24, P30; Park YA, 2013, STUDY USING CHINESE; Ravanbakhsh Majid, 2015, Tanaffos, V14, P121; Ristiniemi H, 2014, SCAND J CARING SCI, V28, P657, DOI 10.1111/scs.12090; SCHIMMENTI JM, 1953, J NERV MENT DIS, V118, P223, DOI 10.1097/00005053-195309000-00003; Shin SI, 2001, KOREAN J WELFARE, V46, P210; Ten Voorde M, 2012, QUAL LIFE RES, V21, P961, DOI 10.1007/s11136-011-0001-x; Thomas M, 2003, THORAX, V58, P110, DOI 10.1136/thorax.58.2.110; Thomas Mike, 2005, Prim Care Respir J, V14, P78, DOI 10.1016/j.pcrj.2004.10.007; van Dixhoorn Jan, 2015, ERJ Open Res, V1; VANDIXHOORN J, 1985, J PSYCHOSOM RES, V29, P199, DOI 10.1016/0022-3999(85)90042-X; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205634	10.1371/journal.pone.0205634	http://dx.doi.org/10.1371/journal.pone.0205634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW7TO	30308070	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500110
J	Wallner, S; Orso, E; Grandl, M; Konovalova, T; Liebisch, G; Schmitz, G				Wallner, Stefan; Orso, Evelyn; Grandl, Margot; Konovalova, Tatiana; Liebisch, Gerhard; Schmitz, Gerd			Phosphatidylcholine and phosphatidylethanolamine plasmalogens in lipid loaded human macrophages	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; LOW-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; FATTY-ACID SYNTHESIS; MYOCARDIAL-INFARCTION; BLOOD-CELLS; CHOLESTEROL; ATHEROSCLEROSIS; EXPRESSION	Background Plasmalogens are either phosphatidylcholine (PC P) or phosphatidylethanolamine (PE P) glycerophospholipids containing a vinyl ether moiety in sn-1-position and an esterified fatty acid in sn-2 position. Multiple functions have been proposed, including reservoir of precursors for inflammatory mediators, modulation of membrane fluidity, and anti-oxidative properties. They could therefore play a role under conditions of metabolic stress. Especially enzymatically modified LDL (eLDL) and oxidatively modified LDL (oxLDL) represent modifications of LDL that are taken up by macrophages in atherosclerotic plaques. The aim of this study was to analyze plasmalogen related effects of eLDL and oxLDL in human monocyte derived macrophages, as well as the effects of HDL3 mediated deloading. Methods Elutriated monocytes from nine healthy donors were differentiated in vitro for four days. Macrophages were then loaded with native LDL, eLDL and oxLDL for 24h and subsequently deloaded with HDL3 for another 24h. Lipidomic and transcriptomic profiles were obtained. Results Loading of macrophages with eLDL and oxLDL led to a transient but strong elevation of lysophosphatidylcholine (LPC) most likely through direct uptake. Only eLDL induced increased levels of total PC, presumably through an induction of PC synthesis. On the other hand treatment with oxLDL led to a significant increase in PC P. Analysis of individual lipid species showed lipoprotein and saturation specific effects for LPC, PC P and PE P species. Membrane fluidity was decreased by the large amount of FC contained in the lipoproteins, as indicated by a lower PC to FC ratio after lipoprotein loading. In contrast the observed changes in the saturated to mono-unsaturated fatty acid (SFA to MUFA) and saturated to poly-unsaturated fatty acid (SFA to PUFA) ratios in PE P could represent a cellular reaction to counteract this effect by producing more fluid membranes. Transcriptomic analysis showed considerable differences between eLDL and oxLDL treated macrophages. As a common feature of both lipoproteins we detected a strong downregulation of pathways for endogenous lipid synthesis as well as for exogenous lipid uptake. Deloading with HDL3 had only minor effects on total lipid class as well as on individual lipid species levels, most of the time not reaching significance. Interestingly treatment with HDL3 had no effect on membrane fluidity under these conditions, although incubation with HDL3 was partially able to counteract the oxLDL induced transcriptomic effects. To investigate the functional effect of lipoprotein treatment on macrophage polarization we performed surface marker flow cytometry. Under our experimental conditions oxLDL was able to partially shift the surface marker pattern towards a pro-inflammatory M1-like phenotype. This is consistent with the consumption of arachidonic acid containing PE P species in oxLDL treated cells, presumably for the synthesis of inflammatory mediators. Summary Our findings provide novel data on the lipoprotein induced, lipidomic and transcriptomic changes in macrophages. This can help us better understand the development of metabolic, inflammatory diseases as well as improve our background knowledge on lipid biomarkers in serum.	[Wallner, Stefan; Orso, Evelyn; Grandl, Margot; Konovalova, Tatiana; Liebisch, Gerhard; Schmitz, Gerd] Regensburg Univ, Med Ctr, Inst Clin Chem & Lab Med, Regensburg, Germany; [Grandl, Margot] Beckman Coulter GmbH, Berlin, Germany; [Konovalova, Tatiana] Thermo Fisher Sci, Regensburg, Germany	University of Regensburg; Beckman Coulter Inc.; Thermo Fisher Scientific	Wallner, S (corresponding author), Regensburg Univ, Med Ctr, Inst Clin Chem & Lab Med, Regensburg, Germany.	stefan.wallner@ukr.de	Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811; Wallner, Stefan/0000-0002-3365-9579	European Community's Seventh Framework Programme [202272]; Federal Ministry of Education and Research [FKZ01KU1216J]	European Community's Seventh Framework Programme; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 202272, IP-Project LipidomicNet to GS. The results of this publication were partly funded by the Federal Ministry of Education and Research under the Project Number FKZ01KU1216J (Deutsches Epigenom Programm, DEEP) to GS.	Anderson EK, 2012, ARTERIOSCL THROM VAS, V32, P1687, DOI 10.1161/ATVBAHA.112.250142; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; BHAKDI S, 1995, J EXP MED, V182, P1959, DOI 10.1084/jem.182.6.1959; Binder M, 2006, J BIOL CHEM, V281, P21869, DOI 10.1074/jbc.M603025200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Clarke MSF, 1996, ENDOTHELIUM, V4, P127, DOI DOI 10.3109/10623329609024689; COOPER RA, 1978, J SUPRAMOL STR CELL, V8, P413, DOI 10.1002/jss.400080404; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; DIANZANI MU, 1976, J PATHOL, V118, P193, DOI 10.1002/path.1711180402; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Felder TK, 2017, J SCI MED SPORT, V20, P700, DOI 10.1016/j.jsams.2016.11.011; George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Hanania R, 2012, J BIOL CHEM, V287, P8468, DOI 10.1074/jbc.M111.290676; Horejsi V, 2014, FEBS LETT; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kondrakhin Yury V, 2008, In Silico Biol, V8, P383; Lankinen M, 2016, J NUTR, V146, P662, DOI 10.3945/jn.115.220459; Leidl K, 2008, BBA-MOL CELL BIOL L, V1781, P655, DOI 10.1016/j.bbalip.2008.07.008; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2002, CLIN CHEM, V48, P2217; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; LINDGREN FT, 1975, LIPIDS, V10, P750, DOI 10.1007/BF02532316; Lohner K, 1996, CHEM PHYS LIPIDS, V81, P167, DOI 10.1016/0009-3084(96)02580-7; Mankidy R, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-62; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Moxon JV, 2017, ATHEROSCLEROSIS, V263, P301, DOI 10.1016/j.atherosclerosis.2017.06.925; MULLER G, 1993, ARTERIOSCLER THROMB, V13, P1317, DOI 10.1161/01.ATV.13.9.1317; Nishimukai M, 2014, CLIN CHIM ACTA, V437, P147, DOI 10.1016/j.cca.2014.07.024; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Orso E, 2015, BIOCH BIOPHYSICA ACT; Orso E, 2011, CHEM PHYS LIPIDS, V164, P479, DOI 10.1016/j.chemphyslip.2011.06.001; Pan A, 2012, AM J CLIN NUTR, V96, P1262, DOI 10.3945/ajcn.112.044040; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; QUINN MT, 1987, P NATL ACAD SCI USA, V84, P2995, DOI 10.1073/pnas.84.9.2995; Rasmiena AA, 2015, ATHEROSCLEROSIS, V241, pE10, DOI 10.1016/j.atherosclerosis.2015.04.051; Rasmiena AA, 2013, CLIN SCI, V124, P289, DOI 10.1042/CS20120268; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Sander PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056360; Schmitz G, 2009, BBA-MOL CELL BIOL L, V1791, P524, DOI 10.1016/j.bbalip.2008.12.007; SCHRAKAMP G, 1988, J LIPID RES, V29, P325; Shima H, 2010, INT IMMUNOL, V22, P149, DOI 10.1093/intimm/dxp121; Sigruener A, 2007, BIOCHEM BIOPH RES CO, V359, P723, DOI 10.1016/j.bbrc.2007.05.169; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEINBERG D, 1995, LANCET, V346, P36, DOI 10.1016/S0140-6736(95)92657-7; Sutter I, 2016, ATHEROSCLEROSIS, V246, P130, DOI 10.1016/j.atherosclerosis.2016.01.003; TOMECZKOWSKI J, 1993, ENZYME MICROB TECH, V15, P849, DOI 10.1016/0141-0229(93)90096-K; Torzewski M, 1998, ARTERIOSCL THROM VAS, V18, P369, DOI 10.1161/01.ATV.18.3.369; Tulodziecka K, 2016, MOL BIOL CELL, V27, P3480, DOI 10.1091/mbc.E16-06-0420; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Yuan Y, 2012, PROTEIN CELL, V3, P173, DOI 10.1007/s13238-012-2025-6	61	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205706	10.1371/journal.pone.0205706	http://dx.doi.org/10.1371/journal.pone.0205706			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308051	gold, Green Submitted, Green Published			2022-12-26	WOS:000447173500118
J	Aydin, E; Hallner, A; Wiktorin, HG; Staffas, A; Hellstrand, K; Martner, A				Aydin, Ebru; Hallner, Alexander; Wiktorin, Hanna Grauers; Staffas, Anna; Hellstrand, Kristoffer; Martner, Anna			NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; DNA-DAMAGE; GENOMIC INSTABILITY; HYDROGEN-PEROXIDE; NADPH OXIDASES; NK CELLS; ROS; HISTAMINE; MELANOMA; METASTASIS	Mutations leading to constitutive RAS activation contribute in myeloid leukemogenesis. RAS mutations in myeloid cells are accompanied by excessive formation of reactive oxygen species (ROS), but the source of ROS and their role for the initiation and progression of leukemia have not been clearly defined. To determine the role of NOX2-derived ROS in RAS-driven leukemia, double transgenic LSL-Kras(G12D) x Mx1-Cre mice expressing oncogenic KRAS in hematopoietic cells (M-Kras(G12D)) were treated with N-alpha-methyl-histamine (NMH) that targeted the production of NOX2-derived ROS in leukemic cells by agonist activity at histamine H-2 receptors. M-Kras(G12D) mice developed myeloid leukemia comprising mature CD11b(+)Gr1(+) myeloid cells that produced NOX2-derived ROS. Treatment of M-Kras(G12D) mice with NMH delayed the development of myeloproliferative disease and prolonged survival. In addition, NMH-treated M-Kras(G12D) mice showed reduction of intracellular ROS along with reduced DNA oxidation and reduced occurence of double-stranded DNA breaks in myeloid cells. The in vivo expansion of leukemia was markedly reduced in triple transgenic mice where KRAS was expressed in hematopoietic cells of animals with genetic NOX2 deficiency (Nox2(-/-) x LSL-Kras(G12D) x Mx1-Cre). Treatment with NMH did not alter in vivo expansion of leukemia in these NOX2-deficient transgenic mice. We propose that NOX2-derived ROS may contribute to the progression of KRAS-induced leukemia and that strategies to target NOX2 merit further evaluation in RAS-mutated hematopoietic cancer.	[Aydin, Ebru; Hallner, Alexander; Wiktorin, Hanna Grauers; Staffas, Anna; Hellstrand, Kristoffer; Martner, Anna] Univ Gothenburg, Sahlgrenska Canc Ctr, TIMM Lab, S-41390 Gothenburg, Sweden; [Staffas, Anna] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Chem & Transfus Med, S-41345 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Martner, A (corresponding author), Univ Gothenburg, Sahlgrenska Canc Ctr, TIMM Lab, S-41390 Gothenburg, Sweden.	anna.martner@gu.se		Aydin, Ebru/0000-0003-2395-7529; Martner, Anna/0000-0002-6598-5221; Hallner, Alexander/0000-0002-4973-5097; Hellstrand, Kristoffer/0000-0002-6617-5976				Aurelius J, 2017, J LEUKOCYTE BIOL, V102, P459, DOI 10.1189/jlb.5VMA1116-454R; Aurelius J, 2012, HAEMATOL-HEMATOL J, V97, P1904, DOI 10.3324/haematol.2012.066399; Aurelius J, 2012, BLOOD, V119, P5832, DOI 10.1182/blood-2011-11-391722; Aydin E, 2017, CANCER IMMUNOL RES, V5, P804, DOI 10.1158/2326-6066.CIR-16-0382; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Betten A, 2003, SCAND J IMMUNOL, V58, P321, DOI 10.1046/j.1365-3083.2003.01301.x; Bowen DT, 2005, BLOOD, V106, P2113, DOI 10.1182/blood-2005-03-0867; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; BRITTAIN RT, 1981, SCAND J GASTROENTERO, V16, P1; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; DeFlora S, 1996, INT J CANCER, V67, P842, DOI 10.1002/(SICI)1097-0215(19960917)67:6<842::AID-IJC14>3.0.CO;2-3; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Galadari S, 2017, FREE RADICAL BIO MED, V104, P144, DOI 10.1016/j.freeradbiomed.2017.01.004; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; Gritsman K, 2014, J CLIN INVEST, V124, P1794, DOI 10.1172/JCI69927; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hansson M, 1996, J IMMUNOL, V156, P42; HELLSTRAND K, 1994, J IMMUNOL, V153, P4940; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Kelkka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084148; Kiffin R, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00218; Kuo LJ, 2008, IN VIVO, V22, P305; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Ligtenberg MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129786; Loh ML, 2011, BRIT J HAEMATOL, V152, P677, DOI 10.1111/j.1365-2141.2010.08525.x; Lyubynska N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001069; Marlein CR, 2017, BLOOD, V130, P1649, DOI 10.1182/blood-2017-03-772939; Martner A, 2015, J IMMUNOL, V194, P5014, DOI 10.4049/jimmunol.1402991; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Quinlan MP, 2009, FUTURE ONCOL, V5, P105, DOI 10.2217/14796694.5.1.105; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Rassool FV, 2007, CANCER RES, V67, P8762, DOI 10.1158/0008-5472.CAN-06-4807; Saitoh T, 2002, GUT, V50, P786, DOI 10.1136/gut.50.6.786; Sallmyr A, 2008, CANCER LETT, V270, P1, DOI 10.1016/j.canlet.2008.03.036; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Scott AJ, 2016, CANCER J, V22, P165, DOI 10.1097/PPO.0000000000000187; Stanicka J, 2015, J BIOL CHEM, V290, P9348, DOI 10.1074/jbc.M113.510495; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Vachhani P, 2014, PHYSIOL GENOMICS, V46, P448, DOI 10.1152/physiolgenomics.00173.2013; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Van Etten RA, 2004, CANCER CELL, V6, P547, DOI 10.1016/j.ccr.2004.12.004; Ward AF, 2012, BLOOD, V120, P3397, DOI 10.1182/blood-2012-05-378596; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Wiktorin HG, 2018, BRIT J HAEMATOL, V182, P290, DOI 10.1111/bjh.14772; Will M, 2014, CANCER DISCOV, V4, P334, DOI 10.1158/2159-8290.CD-13-0611; Wu RF, 2009, FREE RADICAL BIO MED, V47, P1276, DOI 10.1016/j.freeradbiomed.2009.05.037; Zeng M, 2017, CELL CHEM BIOL, V24, P1005, DOI 10.1016/j.chembiol.2017.06.017	56	14	15	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1534	1543		10.1038/s41388-018-0528-1	http://dx.doi.org/10.1038/s41388-018-0528-1			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30323311	hybrid, Green Published			2022-12-26	WOS:000459945800012
J	Li, HW; Cui, Y; Wei, J; Liu, C; Chen, YH; Cui, CP; Li, L; Zhang, XL; Zhang, LQ				Li, Haiwen; Cui, Yu; Wei, Jun; Liu, Chao; Chen, Yuhan; Cui, Chun-Ping; Li, Lei; Zhang, Xueli; Zhang, Lingqiang			VCP/p97 increases BMP signaling by accelerating ubiquitin ligase Smurf1 degradation	FASEB JOURNAL			English	Article						PDB; osteoblast; E3 ubiquitin ligase	PAGETS-DISEASE; AAA-ATPASE; BONE; PROTEIN; DOMAIN; MUTATIONS; P97; FAM/USP9X; VCP	The bone morphogenetic protein (BMP)-Smad signaling pathway plays a crucial role in the control of bone homeostasis by regulating osteoblast activity. It is known that the ubiquitin ligase Smad ubiquitination regulatory factor (Smurf)1 is a master negative regulator of BMP signaling, but how its stability and activity are regulated remains poorly understood. Our study showed that valosin-containing protein/p97, the mutations of which lead to rare forms of Paget's disease of bone (PDB)-like syndromesuch as inclusion body myopathy (IBM) associated with Paget's disease of bone and frontotemporal dementia (IBM-PFD)together with its adaptor nuclear protein localization (NPL)4, specifically interact with Smurf1 and deliver the ubiquitinated Smurf1 for degradation. Depletion of either p97 or NPL4 resulted in the elevation of Smurf1 protein level and decreased BMP signaling accordingly. Mechanically, a typical proline, glutamic acid, serine, and threonine motif specifically existing in Smurf1 is necessary for its recognition and degradation by p97, and this process is dependent on p97 ATPase activity. More importantly, compared with p97 WT, PDB-associated mutation of p97 (mainly A232E) harboring the higher ATPase activity of p97 further promoted Smurf1 degradation, thus increasing BMP signaling activity. Our findings first establish a link between p97 and Smurf1, providing an in-depth understanding of how Smurf1 is regulated, as well as the mechanism of p97-related bone diseases.Li, H., Cui, Y., Wei, J., Liu, C., Chen, Y., Cui, C.-P., Li, L., Zhang, X., Zhang, L. VCP/p97 increases BMP signaling by accelerating ubiquitin ligase Smurf1 degradation.	[Li, Haiwen; Cui, Yu; Liu, Chao; Chen, Yuhan; Cui, Chun-Ping; Li, Lei; Zhang, Lingqiang] Beijing Inst Life, Natl Ctr Prot Sci, State Key Lab Prote, Beijing, Peoples R China; [Li, Haiwen] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Wei, Jun; Zhang, Xueli] Southern Med Univ, Fengxian Hosp, Shanghai Fengxian Cent Hosp, Dept Gen Surg,Grad Training Base, Shanghai 201400, Peoples R China	Case Western Reserve University; Southern Medical University - China	Zhang, XL (corresponding author), Southern Med Univ, Fengxian Hosp, Shanghai Fengxian Cent Hosp, Dept Gen Surg,Grad Training Base, Shanghai 201400, Peoples R China.; Zhang, LQ (corresponding author), Beijing Inst Life, 27 Taiping Rd, Beijing 100850, Peoples R China.	zhanglq@nic.bmi.ac.cn; zhanglq@nic.bmi.ac.cn		Chen, Yuhan/0000-0003-3674-1516	Chinese National Natural Science Foundation [81772959, 81521064]; Beijing Science Program for the Top Young Grant [2015000021223TD04]; Beijing Natural Science Foundation [Z151100003915083]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Science Program for the Top Young Grant; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	The authors thank their laboratory members for critical reading of the manuscript and helpful discussions, and Dr. Ping Wang (Tongji University, Shanghai, China) for generously providing the Smurf1 KO mice. This research was partially supported by Chinese National Natural Science Foundation Project Grants 81772959 (to X.Z.) and 81521064 (to L.Z.), Beijing Science Program for the Top Young Grant 2015000021223TD04, and Beijing Natural Science Foundation Project Grant Z151100003915083 (to L.Z.). The authors declare no conflicts of interest.	Al-Salihi MA, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120082; Albagha OME, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.125; Albagha OME, 2010, NAT GENET, V42, P520, DOI 10.1038/ng.562; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Baek G.H., 2013, J AMINO ACIDS, V2013, DOI DOI 10.1155/2013/183421; Belizario JE, 2008, CURR PROTEIN PEPT SC, V9, P210, DOI 10.2174/138920308784534023; Cao Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04965; Chan NC, 2014, J BIOL CHEM, V289, P19789, DOI 10.1074/jbc.M114.569392; Cui Y, 2011, EMBO J, V30, P2675, DOI 10.1038/emboj.2011.155; Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050; David D, 2013, BBA-REV CANCER, V1835, P119, DOI 10.1016/j.bbcan.2012.11.003; De Boeck M, 2012, UPSALA J MED SCI, V117, P153, DOI 10.3109/03009734.2012.654858; Divisato G, 2018, CLIN GENET, V93, P1240, DOI 10.1111/cge.13247; Divisato G, 2016, AM J HUM GENET, V98, P275, DOI 10.1016/j.ajhg.2015.12.016; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Gibbs-Seymour I, 2015, MOL CELL, V57, P150, DOI 10.1016/j.molcel.2014.12.001; Greenblatt MB, 2015, J EXP MED, V212, P1283, DOI 10.1084/jem.20150407; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kannan M, 2012, DEVELOPMENT, V139, P3600, DOI 10.1242/dev.081786; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Li HW, 2016, CELL SIGNAL, V28, P1186, DOI 10.1016/j.cellsig.2016.05.016; Li JM, 2014, MOL CELL BIOL, V34, P335, DOI 10.1128/MCB.01190-13; Li LY, 2004, MOL CELL BIOL, V24, P856, DOI 10.1128/MCB.24.2.856-864.2004; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Menaa C, 2000, J CLIN INVEST, V105, P1833, DOI 10.1172/JCI9133; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Moreno SP, 2014, SCIENCE, V346, P477, DOI 10.1126/science.1253585; Ralston SH, 2008, BONE, V43, P819, DOI 10.1016/j.bone.2008.06.015; Ralston SH, 2013, NEW ENGL J MED, V368, P644, DOI 10.1056/NEJMcp1204713; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; ROODMAN GD, 1992, J CLIN INVEST, V89, P46, DOI 10.1172/JCI115584; Sanchez-Duffhues G, 2015, BONE, V80, P43, DOI 10.1016/j.bone.2015.05.025; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Soysa NS, 2009, BIOCHEM BIOPH RES CO, V378, P1, DOI 10.1016/j.bbrc.2008.10.146; Wan LX, 2011, MOL CELL, V44, P721, DOI 10.1016/j.molcel.2011.09.024; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Xie Y, 2013, J BIOL CHEM, V288, P2976, DOI 10.1074/jbc.M112.430066; Xu PL, 2012, FEBS LETT, V586, P1871, DOI 10.1016/j.febslet.2012.05.010; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Zeng Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114475; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522; Zhang L, 2014, CELL RES, V24, P742, DOI 10.1038/cr.2014.53; Zhang YC, 2016, INT J INTERDISCIP TE, V8, P1, DOI 10.4018/IJITN.2016040101; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	54	6	6	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2928	2943		10.1096/fj.201801173R	http://dx.doi.org/10.1096/fj.201801173R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30335548	Bronze			2022-12-26	WOS:000457296600111
J	Meng, MY; Li, L; Li, RH; Wang, WJ; Chen, Y; Xie, YH; Han, R; Zhu, K; Huang, WW; Yang, LL; Li, S; Shi, JL; Tan, WW; Gao, H; Zhao, YY; Yang, L; Tan, J; Hou, ZL				Meng, Mingyao; Li, Lin; Li, Ruhong; Wang, Wenju; Chen, Yang; Xie, Yanhua; Han, Rui; Zhu, Kai; Huang, Wenwen; Yang, Lili; Li, Shuo; Shi, Jianlin; Tan, Weiwei; Gao, Hui; Zhao, Yiyi; Yang, Li; Tan, Jing; Hou, Zongliu			A dynamic transcriptomic atlas of cytokine-induced killer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunotherapy; tumor therapy; bioinformatics; immunology; computational biology; cytokine-induced killer cells; deep sequencing; cytotoxicity; WGCNA; safety; cytokine; CD8; anticancer treatment	TUMOR-INFILTRATING LYMPHOCYTES; SRC-FAMILY KINASES; ADOPTIVE TRANSFER; T-CELLS; CANCER; IMMUNOTHERAPY; ANTIGENS; PROTEIN; INTERLEUKIN-2; CYTOTOXICITY	Several clinical immunotherapy trials with cytokine-induced killer (CIK) cells have been reported. However, molecular evidence of cell expansion, acquisition of tumor cytotoxicity, and safety of CIK cells is required before putting them to clinical use. Here, we performed dynamic transcriptomic analyses of CIKs generated from primary peripheral blood mononuclear cells exposed to interferon-, OKT3, and interleukin-2. CIK mRNAs were extracted and sequenced at days 0, 1, 7, and 14 and subjected to bioinformatics analyses. Using weighted correlation network analysis (WGCNA), we identified two major gene modules that mediate immune cell activation and mitosis. We found that activation and cytotoxicity of CIK cells likely rely on cluster of differentiation 8 (CD8) and its protein partner LCK proto-oncogene, Src family tyrosine kinase (LCK). A time-course series analysis revealed that CIK cells have relatively low immunogenicity because of decreased expression of some self-antigens. Importantly, we identified several crucial activating receptors and auxiliary adhesion receptors expressed on CIK cells that may function as tumor sensors. Interestingly, cytotoxicity-associated genes, including those encoding PRF1, GZMB, FASL, and several cytokines, were up-regulated in mature CIK cells. Most immune-checkpoint molecules and inflammatory tumor-promoting factors were down-regulated in the CIK cells, suggesting efficacy and safety in future clinical trials. Notably, insulin-like growth factor 1 (IGF-1) was highly expressed in CIK cells and may promote cytotoxicity, although it also could facilitate tumorigenesis. The transcriptomic atlas of CIK cells presented here may inform efforts to improve CIK-associated tumor cytotoxicity and safety in clinical trials.	[Meng, Mingyao; Li, Lin; Li, Ruhong; Wang, Wenju; Xie, Yanhua; Han, Rui; Zhu, Kai; Huang, Wenwen; Yang, Lili; Li, Shuo; Shi, Jianlin; Tan, Weiwei; Gao, Hui; Zhao, Yiyi; Yang, Li; Tan, Jing; Hou, Zongliu] Kunming Med Univ, Yanan Affiliated Hosp, 245 East Renmin Rd, Kunming 650051, Yunnan, Peoples R China; [Meng, Mingyao; Li, Lin; Li, Ruhong; Wang, Wenju; Xie, Yanhua; Han, Rui; Zhu, Kai; Huang, Wenwen; Yang, Lili; Li, Shuo; Shi, Jianlin; Tan, Weiwei; Gao, Hui; Zhao, Yiyi; Yang, Li; Tan, Jing; Hou, Zongliu] Key Lab Tumor Immunol Prevent & Treatment Yunnan, Kunming 650051, Yunnan, Peoples R China; [Chen, Yang] Tsinghua Univ, Minist Educ MOE, Key Lab Bioinformat, Bioinformat Div, Beijing 100084, Peoples R China; [Chen, Yang] Tsinghua Univ, Ctr Synthet & Syst Biol, BNRist, Dept Automat, Beijing 100084, Peoples R China	Kunming Medical University; Tsinghua University; Tsinghua University	Tan, J; Hou, ZL (corresponding author), Kunming Med Univ, Yanan Affiliated Hosp, 245 East Renmin Rd, Kunming 650051, Yunnan, Peoples R China.	kmtjing@sina.com; hzl579@163.com	huang, wen/GXW-0661-2022; Huang, WW/GXH-0977-2022		National Natural Science Foundation of China [81360245, 81660477, 81460436]; Yunnan Province Science and Technology Department and Kunming Medical University [2015FA008]; Health and Family Planning Commission of Yunnan Province [2014NS212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province Science and Technology Department and Kunming Medical University; Health and Family Planning Commission of Yunnan Province	This work is supported by National Natural Science Foundation of China Grants 81360245, 81660477, and 81460436 and "Special and Joint Program" of Yunnan Province Science and Technology Department and Kunming Medical University Grant 2015FA008. This study is also funded by Health and Family Planning Commission of Yunnan Province Grant 2014NS212.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Basso S, 2011, J CANCER, V2, P341, DOI 10.7150/jca.2.341; Besser MJ, 2013, CLIN CANCER RES, V19, P4792, DOI 10.1158/1078-0432.CCR-13-0380; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Cantoni C, 1998, EUR J IMMUNOL, V28, P327, DOI 10.1002/(SICI)1521-4141(199801)28:01<327::AID-IMMU327>3.0.CO;2-O; Cappuzzello E, 2017, CYTOKINE GROWTH F R, V36, P99, DOI 10.1016/j.cytogfr.2017.06.003; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Chandran SS, 2017, LANCET ONCOL, V18, P792, DOI 10.1016/S1470-2045(17)30251-6; EISEMAN E, 1990, CANCER CELL-MON REV, V2, P303; Fisher JPH, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27572; Garfall AL, 2015, NEW ENGL J MED, V373, P1040, DOI 10.1056/NEJMoa1504542; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Jakel CE, 2014, EXPERT OPIN BIOL TH, V14, P905, DOI 10.1517/14712598.2014.900537; Jiang JT, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-83; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawasaki Y, 2010, GLYCOBIOLOGY, V20, P1373, DOI 10.1093/glycob/cwq116; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lankry D, 2013, EUR J IMMUNOL, V43, P2151, DOI 10.1002/eji.201343433; Li XD, 2012, CLIN TRANSL ONCOL, V14, P102, DOI 10.1007/s12094-012-0768-4; Linn YC, 2012, CYTOTHERAPY, V14, P851, DOI 10.3109/14653249.2012.694419; Lucas DP, 2015, TRANSPLANTATION, V99, P77, DOI 10.1097/TP.0000000000000355; Maher J, 2004, BRIT J CANCER, V91, P817, DOI 10.1038/sj.bjc.6602022; Matsumoto G, 1998, J IMMUNOL, V160, P5781; Mesiano G, 2017, MOL MED, V23, P235, DOI 10.2119/molmed.2017.00084; Musgrave BL, 2003, J INTERF CYTOK RES, V23, P67, DOI 10.1089/107999003321455462; Ni F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2484; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; OSHIMI K, 1990, J IMMUNOL, V144, P3312; Oykhman P, 2013, INFECT IMMUN, V81, P3912, DOI 10.1128/IAI.00533-13; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Poh SL, 2016, CANCER IMMUNOL IMMUN, V65, P525, DOI 10.1007/s00262-016-1815-8; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Sakhdari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040146; Schmidt-Wolf IGH, 1999, BRIT J CANCER, V81, P1009, DOI 10.1038/sj.bjc.6690800; SCHMIDTWOLF IGH, 1991, J EXP MED, V174, P139, DOI 10.1084/jem.174.1.139; Shao JY, 2016, SCAND J IMMUNOL, V84, P182, DOI 10.1111/sji.12455; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang WJ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-49; Watzl Carsten, 2010, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109bs90; Wordeman L, 2010, SEMIN CELL DEV BIOL, V21, P260, DOI 10.1016/j.semcdb.2010.01.018; Wright SE, 2012, J IMMUNOTHER, V35, P196, DOI 10.1097/CJI.0b013e318243f213; Zhao X, 2015, CANCER LETT, V362, P192, DOI 10.1016/j.canlet.2015.03.043; Zou C, 2017, ONCOTARGET, V8, P8900, DOI 10.18632/oncotarget.13051; Zwirner NW, 1998, IMMUNOGENETICS, V47, P139	50	7	7	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19600	19612		10.1074/jbc.RA118.003280	http://dx.doi.org/10.1074/jbc.RA118.003280			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30333226	Green Published, hybrid			2022-12-26	WOS:000454294900009
J	Sadleir, KR; Popovic, J; Vassar, R				Sadleir, Katherine R.; Popovic, Jelena; Vassar, Robert			ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; MEMORY DEFICITS; TRANSGENIC MICE; PATHOGENIC MUTATION; AMYLOID PLAQUES; BETA-SECRETASE; TAU PATHOLOGY; NEURON LOSS; PC12 CELLS	Alzheimer's disease mouse models that overexpress amyloid precursor protein (APP) and presenilin 1 (PS1) form beta-amyloid (A beta) plaques, a hallmark Alzheimer's disease lesion. It has been assumed that the neuroinflammation, synaptic dysfunction, neurodegeneration, and cognitive impairment observed in these mice are caused by cerebral A beta accumulation. However, it is also possible that accumulation of the overexpressed transmembrane proteins APP and PS1 in the endoplasmic reticulum (ER) triggers chronic ER stress and activation of the unfolded protein response (UPR). The 5XFAD mouse, a widely used amyloid pathology model, overexpresses APP and PS1, displays aggressive amyloid pathology, and has been reported to exhibit ER stress. To systematically evaluate whether 5XFAD mice have increased ER stress, here we used biochemical approaches to assess a comprehensive panel of UPR markers. We report that APPand PS1 levels are 1.8- and 1.5-fold, respectively, of those in 5XFAD compared with nontransgenic brains, indicating that transgenes are not massively overexpressed in 5XFAD mice. Using immunoblotting, we quantified UPR protein levels in nontransgenic, 5XFAD, and 5XFAD; BACE1(-/-) mice at 4, 6, and 9 months of age. Importantly, we did not observe elevation of the ER stress markers p-eIF2 alpha, ATF4, CHOP, p-IRE1 alpha, or BiP at any age in 5XFAD or 5XFAD; BACE1(-/-) compared with nontransgenic mice. Despite lacking A beta generation, 5XFAD; BACE1(-/-) mice still expressed APP and PS1 transgenes, indicating that their overexpression does not cause ER stress. These results reveal the absence of ER stress in 5XFAD mice, suggesting that artifactual phenotypes associated with overexpression-induced ER stress are not a concern in this model.	[Sadleir, Katherine R.; Popovic, Jelena; Vassar, Robert] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Vassar, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.	r-vassar@northwestern.edu	Sadleir, Katherine R/N-1199-2019	Sadleir, Katherine R/0000-0001-8310-841X	National Institutes of Health [R01 AG030142, R01 AG1022560]; NATIONAL INSTITUTE ON AGING [R01AG030142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01 AG030142 and R01 AG1022560. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; Briggs DI, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0025-17.2017; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Cisse M, 2017, MOL PSYCHIATR, V22, P1562, DOI 10.1038/mp.2016.152; Citron M, 1998, NEUROBIOL DIS, V5, P107, DOI 10.1006/nbdi.1998.0183; Devi L, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.59; Devi L, 2014, NEUROBIOL AGING, V35, P2272, DOI 10.1016/j.neurobiolaging.2014.04.031; Devi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077335; Devi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012974; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gerakis Y, 2018, FEBS J, V285, P995, DOI 10.1111/febs.14332; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guo Q, 1996, NEUROREPORT, V8, P379, DOI 10.1097/00001756-199612200-00074; Hashimoto S, 2018, J BIOL CHEM, V293, P3118, DOI 10.1074/jbc.M117.811315; Ho YS, 2012, J ALZHEIMERS DIS, V28, P839, DOI 10.3233/JAD-2011-111037; Hoozemans JJM, 2012, NEURODEGENER DIS, V10, P212, DOI 10.1159/000334536; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Kadowaki H, 2013, GENES-BASEL, V4, P306, DOI 10.3390/genes4030306; Kim S, 2016, MOL PSYCHIATR, V21, P707, DOI 10.1038/mp.2015.97; Kohler C, 2014, NEUROBIOL DIS, V71, P169, DOI 10.1016/j.nbd.2014.07.006; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nijholt DAT, 2012, J PATHOL, V226, P693, DOI 10.1002/path.3969; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Rodrigues EM, 2012, HUM MOL GENET, V21, P4587, DOI 10.1093/hmg/dds297; Rutten BR, 2003, NEUROBIOL DIS, V12, P110, DOI 10.1016/S0969-9961(02)00015-3; Sadleir KR, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-1; Sadleir KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101643; Sadleir KR, 2013, CURR ALZHEIMER RES, V10, P785; Saito T, 2016, J NEUROSCI, V36, P9933, DOI 10.1523/JNEUROSCI.1907-16.2016; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Scheper W, 2015, ACTA NEUROPATHOL, V130, P315, DOI 10.1007/s00401-015-1462-8; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Stutzbach LD, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-31; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Tanzi Rudolph E, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006296; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	52	25	25	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18434	18443		10.1074/jbc.RA118.005769	http://dx.doi.org/10.1074/jbc.RA118.005769			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30315100	hybrid, Green Published			2022-12-26	WOS:000458467300002
J	Kinoshita, M; Oka, S				Kinoshita, Mari; Oka, Shinichi			Migrant patients living with HIV/AIDS in Japan: Review of factors associated with high dropout rate in a leading medical institution in Japan	PLOS ONE			English	Review							ANTIRETROVIRAL THERAPY; FOLLOW-UP; RETENTION; CARE; ADHERENCE	The present study aimed to identify factors associated with retention in HIV/AIDS care among migrant patients who visited the outpatient clinic of the AIDS Clinical Center, National Center for Global Health and Medicine in Tokyo, Japan. We reviewed the records of 551 selected (78 non-Japanese and 473 Japanese) patients who started visiting our clinic between 2011 and 2014. A total of 390 patients (70.8%: 38 non-Japanese and 352 Japanese) continued their visits during the study: from the date of their first visit to the end of 2015. The difference in retention rate was not significant (Incidence Rate Ratio (IRR) = 0.89, p = 0.27), but the loss-to-follow-up cases were considerably high among non-Japanese patients (n = 13, Incidence rate (IR) = 24.6 per 100,000 person-days, IRR = 3.65, p<0.01 after adjusting for time since diagnosis). The results showed, nevertheless, that there was no apparent association between retention and factors peculiar to non-Japanese. Twelve out of thirteen lost-to-follow-up non-Japanese patients held legal status to reside in Japan and were eligible for public health services. Nine had limited fluency in Japanese language, and six used alternative verbal communication. Further studies are needed to identify the factors responsible for the high dropout rate and to improve the care of migrant patients living with HIV/AIDS.	[Kinoshita, Mari; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Shinjuku Ku, Tokyo, Japan	National Center for Global Health & Medicine - Japan	Kinoshita, M (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Shinjuku Ku, Tokyo, Japan.	mkinoshi@acc.ncgm.go.jp		Kinoshita, Mari/0000-0002-5429-3457	Ministry of Health, Labor and Welfare (Health Labor Sciences Research Grant)	Ministry of Health, Labor and Welfare (Health Labor Sciences Research Grant)	The authors received a research grant of the Ministry of Health, Labor and Welfare (Health Labor Science Research Grant).; This study is part of the research programs funded by the Ministry of Health, Labor, and Welfare (Health Labor Sciences Research Grant).	AIDS Control Section Infectious Disease Control Division Health and Safety Office Bureau of Social Welfare and Public Health, 2012, AIDS CONTR SECT INF, P28; Asai A, 1997, J ACQ IMMUN DEF SYND, V14, pS30, DOI 10.1097/00042560-199700002-00006; Been SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162800; Colasanti J, 2016, AIDS RES HUM RETROV, V32, P357, DOI [10.1089/AID.2015.0227, 10.1089/aid.2015.0227]; Cyrus E, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030285; Dang BN, 2016, AIDS BEHAV, V20, P2477, DOI 10.1007/s10461-016-1340-y; Fleishman JA, 2012, JAIDS-J ACQ IMM DEF, V60, P249, DOI 10.1097/QAI.0b013e318258c696; Lebouche B, 2006, HIV MED, V7, P140, DOI 10.1111/j.1468-1293.2006.00357.x; Purdue University, OR ENGL PROF PROGR; Schilkowsky Louise Bastos, 2011, Rev. bras. epidemiol., V14, P187, DOI 10.1590/S1415-790X2011000200001; Schneider J, 2004, J GEN INTERN MED, V19, P1096, DOI 10.1111/j.1525-1497.2004.30418.x; Sheehan D. M, 2015, INT J ENV RES PUB HE, V14, P120, DOI [10.3390/ijerph1402012028134795, DOI 10.3390/IJERPH1402012028134795]; Tariq S, 2016, SEX TRANSM DIS, V43, P283, DOI 10.1097/OLQ.0000000000000442; Tedaldi Ellen M, 2014, J Int Assoc Provid AIDS Care, V13, P232, DOI 10.1177/2325957413514631; The Ministry of Justice, CHOIC NAT; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Torian LV, 2014, AM J PUBLIC HEALTH, V104, pE24, DOI 10.2105/AJPH.2014.302080; XE, 2016, CURR RAT JAP YEN US; Yamamura J, 2002, J AIDS RES, V4, P53	19	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205184	10.1371/journal.pone.0205184	http://dx.doi.org/10.1371/journal.pone.0205184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX5DH	30339665	Green Published, Green Submitted, gold			2022-12-26	WOS:000447761400010
J	Zablotska, IB; Gray, R; Whittaker, B; Holt, M; Wright, E; Prestage, G; O'Donnell, D; Grulich, AE				Zablotska, Iryna B.; Gray, Richard; Whittaker, Bill; Holt, Martin; Wright, Edwina; Prestage, Garrett; O'Donnell, Darryl; Grulich, Andrew E.			The estimated number of potential PrEP users among gay-identifying men who have sex with men in Australia	PLOS ONE			English	Article							HIV PREEXPOSURE PROPHYLAXIS; HEALTH; INFECTION; RISK	We estimated the size of the population of gay-identified men who have sex with men (gay men) eligible for PrEP in Australia under the current national PrEP guidelines. Using input indicators from the Australian Bureau of Statistics, the national representative survey Second Australian Study of Health and Relationships, and national HIV-behavioural surveillance, we calculated the size of the population of sexually active gay men and estimated a range for the number eligible for PrEP using different scenarios based on the guidelines. In 2015, an estimated 108,850 sexually-active 16-69-year-old gay men were classified as at risk of acquiring HIV in Australia. Of these men, 10,558 to 30,913 (9.7%-28.4%) were classified as being at high risk and therefore eligible for PrEP, most commonly due to recent receptive condomless intercourse with casual partners (6.1% to 15.5%), STI infections (5.4% to 10.6%) or the use of crystal methamphetamine (1.4% to 9.4%). The higher estimates included men who may have been at HIV risk for shorter time periods or with fewer partners. Australian PrEP guidelines recommend targeting PrEP to people at high HIV risk. Our estimation of potential PrEP users informed PrEP implementation in Australia. The choice of PrEP eligibility criteria, and interpretation of the guidelines, strongly affects the population estimates. In the future, higher numbers of gay men may become eligible for PrEP, because the estimates are largely defined by and follow trends in condomless anal intercourse. Our estimation methods can be adapted to other settings.	[Zablotska, Iryna B.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Zablotska, Iryna B.; Gray, Richard; Prestage, Garrett; Grulich, Andrew E.] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Whittaker, Bill] Natl Assoc People HIV, Newtown, NSW, Australia; [Holt, Martin] UNSW Sydney, Ctr Social Res Hlth, Sydney, NSW, Australia; [Wright, Edwina] Monash Univ, Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia; [Wright, Edwina] Burnet Inst, Melbourne, Vic, Australia; [Wright, Edwina] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [O'Donnell, Darryl] Australian Federat AIDS Org, Newtown, NSW, Australia	University of Sydney; University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; Monash University; Burnet Institute; University of Melbourne	Zablotska, IB (corresponding author), Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia.; Zablotska, IB (corresponding author), UNSW Sydney, Kirby Inst, Sydney, NSW, Australia.	Iryna.Zablotska@sydney.edu.au	Wright, Edwina J/I-2950-2014; Holt, Martin/X-6482-2019	Wright, Edwina J/0000-0001-8626-782X; Holt, Martin/0000-0002-2586-8274; Prestage, Garrett/0000-0003-3917-8992; Gray, Richard/0000-0002-2885-0483	Gilead Sciences	Gilead Sciences(Gilead Sciences)	IBZ has received funding from Gilead Sciences. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ANN SURV REP 2016; ASHM, AUSTR NAT PREP GUID; Australian Bureau of Statistics (ABS), 2015, 31010DO002 201406 AU; Australian Government Department of Health Therapeutic Goods Administration, 2016, PRESCR MED NEW EXT U; Bekker LG, 2016, S AFR J HIV MED, V17, DOI 10.4102/sajhivmed.v17i1.455; Cambiano V, 2016, CURR OPIN HIV AIDS, V11, P56, DOI 10.1097/COH.0000000000000217; Centers for Disease Control and Prevention (CDC), MMWR, V60, P65; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Food and Drug Administration, 2012, TRUV APPR RED RISK S; Gilead Sciences, 2016, TRUV PACK INS; Grant R, 2015, CROI 2015; Grulich AE, 2014, SEX HEALTH, V11, P439, DOI 10.1071/SH14122; Holt M, 2017, SEX TRANSM INFECT, V93, P438, DOI 10.1136/sextrans-2016-052774; Holt M, 2017, SEX HEALTH, V14, P72, DOI 10.1071/SH16072; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mera R, 2016, INT AIDS C DURB 17 2; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; NSW Government Ministry of Health, PREEXP PROPH HIV ANT; Richters J, 2014, SEX HEALTH, V11, P383, DOI 10.1071/SH14115; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Swiss Federal Commission for Sexual Health (FCSH), 2016, REC SWISS FED COMM S; The Pharmaceutical Benefits Scheme, JUL 2017 PBAC M; US Public Health Service, PREEXP PROPH PREV HI; World Health Organization, 2015, GUID START ANT THER; Wright E, 2017, J VIRUS ERAD, V3, P168; Zablotska I.B., BMC PUBLIC HLTH; Zablotska IB, 2016, SEX HLTH; Zablotska IB, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-5018-9; Zablotska IB, 2011, SEX HEALTH, V8, P272, DOI 10.1071/SH10125	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0204138	10.1371/journal.pone.0204138	http://dx.doi.org/10.1371/journal.pone.0204138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335758	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300006
J	Bar El, Y; Kanner, S; Barzilai, A; Hanein, Y				Bar El, Yasmin; Kanner, Sivan; Barzilai, Ari; Hanein, Yael			Activity changes in neuron-astrocyte networks in culture under the effect of norepinephrine	PLOS ONE			English	Article							MOUSE ENTORHINAL CORTEX; RAT VISUAL-CORTEX; IN-VITRO; GLIAL-CELLS; MORPHOLOGICAL-CHANGES; ADRENERGIC-RECEPTORS; ASTROGLIAL CELLS; LOCUS-COERULEUS; CALCIUM WAVES; BRAIN	The concerted activity of neuron-glia networks is responsible for the fascinating dynamics of brain functions. Although these networks have been extensively investigated using a variety of experimental (in vivo and in vitro) and theoretical models, the manner by which neuronglia networks interact is not fully understood. In particular, how neuromodulators influence network-level signaling between neurons and astrocytes was poorly addressed. In this work, we investigated global effects of the neuromodulator norepinephrine (NE) on neuron-astrocyte network communication in co-cultures of neurons and astrocytes and in isolated astrocyte networks. Electrical stimulation was used to activate the neuron-astrocyte glutamate-mediated pathway. Our results showed dramatic changes in network activity under applied global perturbations. Under neuromodulation, there was a marked rise in calcium signaling in astrocytes, neuronal spontaneous activity was reduced, and the communication between neuron-astrocyte networks was perturbed. Moreover, in the presence of NE, we observed two astrocyte behaviors based on their coupling to neurons. There were also morphological changes in astrocytes upon application of NE, suggesting a physical cause underlies the change in signaling. Our results shed light on the role of NE in controlling sleep-wake cycles.	[Bar El, Yasmin] Tel Aviv Univ, Sch Phys & Astron, Tel Aviv, Israel; [Kanner, Sivan; Barzilai, Ari] Tel Aviv Univ, Dept Neurobiol, Fac Life Sci, Tel Aviv, Israel; [Barzilai, Ari; Hanein, Yael] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Hanein, Yael] Tel Aviv Univ, Sch Elect Engn, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University; Tel Aviv University	Hanein, Y (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.; Hanein, Y (corresponding author), Tel Aviv Univ, Sch Elect Engn, Tel Aviv, Israel.	yaelha@tauex.tau.ac.il	Hanein, Yael/A-7179-2008; Hanein, Yael/AAG-5980-2021	Hanein, Yael/0000-0002-4213-9575	European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC grant [FUNMANIA-306707]; Israel Society for Neuroscience [421/15]	European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC grant; Israel Society for Neuroscience	This work was supported by the European Research Council funding under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement FUNMANIA-306707 (YH). https://erc.europa.eu, and Israel Society for Neuroscience (421/15) (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNATI LF, 1995, NEUROSCIENCE, V69, P711, DOI 10.1016/0306-4522(95)00308-6; Amzica F, 2002, J PHYSIOL-PARIS, V96, P209, DOI 10.1016/S0928-4257(02)00008-6; Amzica F, 2000, J NEUROSCI, V20, P6648, DOI 10.1523/JNEUROSCI.20-17-06648.2000; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2010, PHILOS T R SOC B, V365, P2375, DOI 10.1098/rstb.2009.0313; Aston-Jones G, 2016, BRAIN RES, V1645, P75, DOI 10.1016/j.brainres.2016.03.001; ATKINSON BN, 1991, J NEUROCHEM, V56, P587, DOI 10.1111/j.1471-4159.1991.tb08190.x; Bai D, 1998, NEUROSCIENCE, V83, P905, DOI 10.1016/S0306-4522(97)00435-1; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Colombi I, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00315; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Corner MA, 2008, BRAIN RES REV, V59, P221, DOI 10.1016/j.brainresrev.2008.08.001; Ding FF, 2013, CELL CALCIUM, V54, P387, DOI 10.1016/j.ceca.2013.09.001; EBERSOLT C, 1981, J NEUROSCI RES, V6, P643, DOI 10.1002/jnr.490060509; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Feinstein DL, 2016, J NEUROCHEM, V139, P154, DOI 10.1111/jnc.13447; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Fitzgerald PJ, 2014, PSYCHIAT RES, V215, P497, DOI 10.1016/j.psychres.2014.01.011; GIAUME C, 1991, P NATL ACAD SCI USA, V88, P5577, DOI 10.1073/pnas.88.13.5577; Giorgi FS, 2004, NEUROSCI BIOBEHAV R, V28, P507, DOI 10.1016/j.neubiorev.2004.06.008; Grintal B, 2009, NEUROCHEM INT, V54, P535, DOI 10.1016/j.neuint.2009.02.018; GRUDT TJ, 1995, J PHYSIOL-LONDON, V485, P113, DOI 10.1113/jphysiol.1995.sp020716; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTON GI, 1991, BRAIN RES BULL, V26, P765, DOI 10.1016/0361-9230(91)90173-H; HERTZ L, 1984, PROG NEURO-PSYCHOPH, V8, P521, DOI 10.1016/0278-5846(84)90010-1; Herzog N, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056008; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Ji XH, 2008, NEUROPSYCHOPHARMACOL, V33, P2263, DOI 10.1038/sj.npp.1301603; Kamioka H, 1996, NEUROSCI LETT, V206, P109, DOI 10.1016/S0304-3940(96)12448-4; Kaufman M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0083-3; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Kobayashi M, 2000, EUR J NEUROSCI, V12, P264, DOI 10.1046/j.1460-9568.2000.00917.x; Kreda SM, 2001, ENDOCRINOLOGY, V142, P4839, DOI 10.1210/en.142.11.4839; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lei S, 2007, J NEUROPHYSIOL, V98, P2868, DOI 10.1152/jn.00679.2007; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; LLANO I, 1993, J PHYSIOL-LONDON, V468, P201, DOI 10.1113/jphysiol.1993.sp019767; Ma ZG, 2016, NATURE, V539, P428, DOI 10.1038/nature20145; Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010; Matsutani S, 1997, GLIA, V20, P1, DOI 10.1002/(SICI)1098-1136(199705)20:1<1::AID-GLIA1>3.0.CO;2-E; Mola MG, 2016, GLIA, V64, P139, DOI 10.1002/glia.22921; Molotkov D, 2013, CELL CALCIUM, V53, P338, DOI 10.1016/j.ceca.2013.03.001; Nam Y, 2007, J BIOMAT SCI-POLYM E, V18, P1091, DOI 10.1163/156856207781494430; Nam Yoonkey, 2011, Critical Reviews in Biomedical Engineering, V39, P45, DOI 10.1615/CritRevBiomedEng.v39.i1.40; NARUMI S, 1978, J NEUROCHEM, V31, P1479, DOI 10.1111/j.1471-4159.1978.tb06575.x; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Newman EA, 1998, J NEUROSCI, V18, P4022; O'Donnell John, 2015, Curr Sleep Med Rep, V1, P1; O'Donnell J, 2012, NEUROCHEM RES, V37, P2496, DOI 10.1007/s11064-012-0818-x; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; Perea G, 2002, J PHYSIOLOGY-PARIS, V96, P199, DOI 10.1016/S0928-4257(02)00007-4; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Porter JT, 1996, J NEUROSCI, V16, P5073; PRALONG E, 1994, NEUROSCI LETT, V179, P145, DOI 10.1016/0304-3940(94)90955-5; Pralong E, 1995, EUR J NEUROSCI, V7, P2370, DOI 10.1111/j.1460-9568.1995.tb01034.x; Rusakov DA, 2015, NAT REV NEUROSCI, V16, P226, DOI 10.1038/nrn3878; Salgado H, 2016, BRAIN RES, V1641, P163, DOI 10.1016/j.brainres.2016.01.033; SALM AK, 1990, GLIA, V3, P529, DOI 10.1002/glia.440030612; SEGAL M, 1974, BRAIN RES, V72, P79, DOI 10.1016/0006-8993(74)90652-0; SEGAL M, 1981, BRAIN RES, V206, P107, DOI 10.1016/0006-8993(81)90104-9; SHAIN W, 1987, J CELL BIOL, V105, P2307, DOI 10.1083/jcb.105.5.2307; Shein Idelson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014443; Sherpa AD, 2016, SYNAPSE, V70, P307, DOI 10.1002/syn.21908; Smythies John, 2005, Int Rev Neurobiol, V64, P173, DOI 10.1016/S0074-7742(05)64003-2; Stett A, 2003, ANAL BIOANAL CHEM, V377, P486, DOI 10.1007/s00216-003-2149-x; Szot P, 1999, J NEUROSCI, V19, P10985, DOI 10.1523/JNEUROSCI.19-24-10985.1999; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Vardjan N, 2014, GLIA, V62, P566, DOI 10.1002/glia.22626; Venance L, 1997, J NEUROSCI, V17, P1981; VOLTERRA A, 1992, J NEUROCHEM, V59, P600, DOI 10.1111/j.1471-4159.1992.tb09411.x; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wallach G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003964; Won CK, 2000, BRAIN RES, V887, P250, DOI 10.1016/S0006-8993(00)02922-X; Xiao ZY, 2009, J BIOL CHEM, V284, P10980, DOI 10.1074/jbc.M806760200; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	85	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0203761	10.1371/journal.pone.0203761	http://dx.doi.org/10.1371/journal.pone.0203761			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332429	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200006
J	Kielmann, K; Vidal, N; Riekstina, V; Krutikov, M; van der Werf, MJ; Biraua, E; Duric, P; Moore, DAJ				Kielmann, Karina; Vidal, Nicole; Riekstina, Vija; Krutikov, Maria; van der Werf, Marieke J.; Biraua, Evita; Duric, Predrag; Moore, David A. J.			"Treatment is of primary importance, and social assistance is secondary": A qualitative study on the organisation of tuberculosis (TB) care and patients' experience of starting and staying on TB treatment in Riga, Latvia	PLOS ONE			English	Article							TO-REACH POPULATIONS; STRUCTURAL VULNERABILITY; HEALTH; COUNTRIES; SERVICES	Background Vulnerable individuals with tuberculosis (TB) struggle to access and stay on treatment. While patient-related and social barriers to TB treatment adherence are well documented, less is known about how the organisation and delivery of TB care influences adherence behaviour. Aim To examine the influence of TB service organisation and culture on patients' experience of starting and staying on treatment in Riga, Latvia. Methods An intervention package to support adherence to TB treatment amongst vulnerable patients in Riga, Latvia was piloted between August 2016 and March 2017. Qualitative observations (5), interviews with staff (20) and with TB patients (10) were conducted mid-way and at the end of the intervention to understand perceptions, processes, and experiences of TB care. Results The organisation of TB services is strongly influenced by a divide between medical and social aspects of TB care. Communication and care practices are geared towards addressing individual risk factors for non-adherence rather than the structural vulnerabilities that patients experience in accessing care. Support for vulnerable patients is limited because of standardised programmatic approaches, resource constraints and restricted job descriptions for non-medical staff. Conclusion Providing support for vulnerable patients is challenged in this setting by the strict division between medical and social aspects of TB care, and the organisational focus on patient related rather than systems-related barriers to access and adherence. Potential systems interventions include the introduction of multi-disciplinary approaches and teams in TB care, strengthening patient literacy at the point of treatment initiation, as well as stronger linkages with social care organisations.	[Kielmann, Karina; Vidal, Nicole; Duric, Predrag] Queen Margaret Univ, Inst Global Hlth & Dev, Edinburgh, Midlothian, Scotland; [Riekstina, Vija; Biraua, Evita] Riga East Univ Hosp, Ctr TB & Lung Dis, Riga, Latvia; [Riekstina, Vija; Moore, David A. J.] Univ Latvia, Internal Med Dept, Fac Med, Riga, Latvia; [Krutikov, Maria] London Sch Hyg & Trop Med, TB Ctr, London, England; [van der Werf, Marieke J.] European Ctr Dis Prevent & Control, Stockholm, Sweden	Queen Margaret University; Riga East University Hospital; University of Latvia; University of London; London School of Hygiene & Tropical Medicine; European Centre for Disease Prevention & Control	Kielmann, K (corresponding author), Queen Margaret Univ, Inst Global Hlth & Dev, Edinburgh, Midlothian, Scotland.	kkielmann@qmu.ac.uk	Duric, Predrag/L-9002-2019	Duric, Predrag/0000-0001-5770-7224; Kielmann, Karina/0000-0001-5519-1658; Moore, David/0000-0002-3748-0154; Krutikov, Maria/0000-0002-3982-642X	LSHTM TB Centre [ECDC/2014/013, 4795]; European Centre for Disease Prevention & Control (ECDC project) [OCS-2015-0UT-2900-MCSaAI]	LSHTM TB Centre; European Centre for Disease Prevention & Control (ECDC project)	This research was funded through the European Centre for Disease Prevention & Control - see https://ecdc.europa.eu/en/home. The ECDC project ID was OCS-2015-0UT-2900-MCSaAI and the contract was made through and managed by the World Health Communication Associates - see http://www.whcaonline.org/. The European Centres for Disease Control (ECDC) issued a Request for Proposals (RFP) to "design a methodology and an implementation plan for interventions that will contribute to increased TB treatment adherence and improved treatment outcomes among specific hard-to-reach and vulnerable population groups in the EU/EEA". World Health Communication Associates (WHCA), with support from the LSHTM TB Centre, responded to this RFP under the framework contract ECDC/2014/013 "Communication support to ECDC" - LOT 3: "Provision of health communication experts for short term assignments" - ID 4795 with a successful bid and subsequently contracted the LSHTM TB Centre including Dr Karina Kielmann (formerly based at the LSHTM, currently at QMU Edinburgh) to undertake several of the packages of work involved. This manuscript is based on the process evaluation of the pilot study undertaken within this contract as one of the deliverables. The ECDC TB team in particular Dr Van der Werf, included as a co-author here, provided guidance on the pilot intervention protocol, feedback on the report of the pilot study, as well as substantive and editorial comments on the draft manuscript.; This research was funded through the European Centre for Disease Prevention & Control (ECDC project ID OCS-2015-0UT-2900-MCSaAI) and managed by the World Health Communication Associates. We gratefully acknowledge the tremendous help of Ms Liva Krieke and Dr Agita Luse, who assisted with conducting and translating the interviews and observations during the first and second rounds of data collection respectively. We wish to acknowledge the assistance and comments provided by the independent peer reviewers: Salla Atkins, Vladimir Milanov and Alistair Story; as well as colleagues at ECDC: Stefania De Angelis and Irina Ljungqvist Dinca, at each stage of the protocol development.	Bojorquez I, 2018, GLOB PUBLIC HEALTH, V13, P804, DOI 10.1080/17441692.2016.1240823; Bourgois P, 2017, ACAD MED, V92, P299, DOI 10.1097/ACM.0000000000001294; Craig GM, 2007, J ADV NURS, V58, P418, DOI 10.1111/j.1365-2648.2007.04257.x; Daftary A, 2015, AIDS, V29, P1, DOI 10.1097/QAD.0000000000000515; de Vries SG, 2017, LANCET INFECT DIS, V17, pE128, DOI 10.1016/S1473-3099(16)30531-X; Diez E, 1996, TUBERCLE LUNG DIS, V77, P420, DOI 10.1016/S0962-8479(96)90114-8; European Centre for Disease Prevention and Control (ECDC) /WHO Regional Office for Europe, 2018, TUB SURV MON EUR 201; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2016, TUB SURV MON EUR 201; Figueroa-Munoz JI, 2008, B WORLD HEALTH ORGAN, V86, P733, DOI 10.2471/BLT.06.038737; Garner P, 2007, B WORLD HEALTH ORGAN, V85, P325; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Harper Ian, 2010, Anthropol Med, V17, P201, DOI 10.1080/13648470.2010.493606; Heuvelings CC, 2017, LANCET INFECT DIS, V17, pE144, DOI 10.1016/S1473-3099(16)30532-1; Ivanovs A, 2016, UNIVERSAL J PUBLIC H, V4, P230; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Koch E, 2016, J BIOETHIC INQ, V13, P47, DOI 10.1007/s11673-015-9689-6; Leff MS, 2017, EUR J GEN PRACT, V23, P91, DOI 10.1080/13814788.2017.1291626; Lewin S, 2009, SOC SCI MED, V68, P1464, DOI 10.1016/j.socscimed.2009.02.013; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Lucenko I, 2014, PUBLIC HEALTH ACTION, V4, pS54, DOI 10.5588/pha.14.0040; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Potter JL, 2016, J PUBLIC HEALTH-UK, V38, P391, DOI 10.1093/pubmed/fdv052; Quesada J, 2011, MED ANTHROPOL, V30, P339, DOI 10.1080/01459740.2011.576725; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Rhodes T, 2012, RETHINKING SOCIAL EPIDEMIOLOGY: TOWARDS A SCIENCE OF CHANGE, P205, DOI 10.1007/978-94-007-2138-8_10; Ross E., 2004, PSYCHOSOCIAL APPROAC; Sheikh K, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-19; SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311; van Hest N A, 2014, Euro Surveill, V19; Wemrell M, 2016, SOCIOL COMPASS, V10, P153, DOI 10.1111/soc4.12345; [WHO Regional Office for Europe European Centre for Disease Prevention and Control], 2017, TUB SURV MON EUR 201; World Health Organization, 2017, PEOPL CTR MOD TB CAR; World Health Organization, 2014, END TB STRAT GLOB ST; World Health Organization, 2016, HLTH SYST STRENGTH G; Zachariah R, 2012, INT J TUBERC LUNG D, V16, P714, DOI 10.5588/ijtld.11.0635	35	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0203937	10.1371/journal.pone.0203937	http://dx.doi.org/10.1371/journal.pone.0203937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX3PM	30332406	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000447638200007
J	Liu, XL; Kong, DH; Fu, J; Zhang, YQ; Liu, YB; Zhao, YK; Lian, H; Zhao, XY; Yang, J; Fan, ZJ				Liu, Xiaole; Kong, Dehui; Fu, Jia; Zhang, Yongqiao; Liu, Yanbo; Zhao, Yakun; Lian, Hui; Zhao, Xiaoyi; Yang, Jun; Fan, Zhongjie			Association between extreme temperature and acute myocardial infarction hospital admissions in Beijing, China: 2013-2016	PLOS ONE			English	Article							COLD-INDUCED CONSTRICTION; AMBIENT-TEMPERATURE; WEATHER CONDITIONS; INCREASED RISK; STROKE; MORTALITY; RESPONSES	Over the past few decades, a growing body of epidemiological studies found the effects of temperature on cardiovascular disease, including the risk for acute myocardial infarction (AMI). Our study aimed to investigate whether there is an association between extremely temperature and acute myocardial infarction hospital admission in Beijng, China. We obtained 81029 AMI cases and daily temperature data from January 1, 2013 to December 31, 2016. We employed a time series design and modeled distributed lag nonlinear model (DLNM) to analyze effects of temperature on daily AMI cases. Compared with the 10th percentile temperature measured by daily mean temperature (Tmean), daily minimum temperature (Tmin) and daily minimum apparent temperature (Armin), the cumulative relative risks (CRR) at 1st percentile of Tmean, Tmin and ATmin for AMI hospitalization were 1.15(95% CI: 1.02, 1.30), 1.24(95% CI: 1.11, 1.38) and 1.41(95% CI: 1.18, 1.68), respectively. Moderate low temperature (10th vs 25th) also had adverse impact on AMI events. The susceptive groups were males and people 65 years and older. No associations were found between high temperature and AMI risk. The main limitation of the study is temperature exposure was not individualized. These findings on cold-associated AMI hospitalization helps characterize the public health burden of cold and target interventions to reduce temperature induced AMI occurrence.	[Liu, Xiaole; Kong, Dehui; Fu, Jia; Zhang, Yongqiao; Liu, Yanbo; Zhao, Yakun; Lian, Hui; Fan, Zhongjie] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Cardiol, Beijing, Peoples R China; [Zhao, Xiaoyi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Phys Med & Rehabil, Beijing, Peoples R China; [Yang, Jun] Jinan Univ, Inst Environm & Climate Res, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Jinan University	Fan, ZJ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Cardiol, Beijing, Peoples R China.	Fan@pumch.cn	Yang, Jun/Q-3037-2019; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Fu, Jia/0000-0003-1432-0323	National Environmental Protection Non-profit Project [201509062]; National Natural Science Foundation [41450006, 91643208]; Beijing Medical Health Science and Technology Key-support Project [2014-1-4016]; Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine [2017-I2M-2-001, CAMS 2016ZX310181-4/5]; National Key Research and Development Plan [2017YFC0211703]; National 973 Project [2015CB553400]; Beijing Municipal Science and Technology Commission [Z131107002213176]	National Environmental Protection Non-profit Project; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Medical Health Science and Technology Key-support Project; Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine; National Key Research and Development Plan; National 973 Project(National Basic Research Program of China); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by The National Environmental Protection Non-profit Project [201509062], National Natural Science Foundation [41450006, 91643208], Beijing Medical Health Science and Technology Key-support Project [2014-1-4016], Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine [2017-I2M-2-001, CAMS 2016ZX310181-4/5], National Key Research and Development Plan [2017YFC0211703], National 973 Project [2015CB553400], and Beijing Municipal Science and Technology Commission [Z131107002213176]. Zhongjie Fan received all the fundings.	Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Bai L, 2018, HEART, V104, P673, DOI 10.1136/heartjnl-2017-311821; Bailey SR, 2004, CIRC RES, V94, P1367, DOI 10.1161/01.RES.0000128407.45014.58; Bayentin L, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-5; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; Bhaskaran K, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8050; Bhaskaran K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3823; Chang CL, 2004, J CLIN EPIDEMIOL, V57, P749, DOI 10.1016/j.jclinepi.2003.10.016; Chen RJ, 2013, NEUROLOGY, V81, P1064, DOI 10.1212/WNL.0b013e3182a4a43c; Chen WW, 2016, EUR HEART J SUPPL, V18, pF2, DOI 10.1093/eurheartj/suw030; Danet S, 1999, Circulation, V100, pE1; Dilaveris P, 2006, HEART, V92, P1747, DOI 10.1136/hrt.2006.091884; Eid AH, 2007, AM J PHYSIOL-HEART C, V293, pH1955, DOI 10.1152/ajpheart.00306.2007; Fisher JA, 2017, J EXPO SCI ENV EPID, V27, P276, DOI 10.1038/jes.2016.83; FLAVAHAN NA, 1985, AM J PHYSIOL, V249, pH950, DOI 10.1152/ajpheart.1985.249.5.H950; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Goggins WB, 2013, INT J CARDIOL, V168, P243, DOI 10.1016/j.ijcard.2012.09.087; Hess KL, 2009, J APPL PHYSIOL, V107, P1076, DOI 10.1152/japplphysiol.00605.2009; Honda T, 2016, J CARDIOL, V67, P42, DOI 10.1016/j.jjcc.2015.02.013; Hopstock LA, 2012, J EPIDEMIOL COMMUN H, V66, P815, DOI 10.1136/jech.2010.131458; Intergovernmental Panel on Climate Change { IPCC, 2007, GENEBRA SUICA; Krstic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025101; KUNST AE, 1994, AM J PUBLIC HEALTH, V84, P1738, DOI 10.2105/AJPH.84.11.1738; MARCHANT B, 1993, BRIT HEART J, V69, P385; Ogbomo AS, 2017, INT J BIOMETEOROL, V61, P833, DOI 10.1007/s00484-016-1261-5; Panagiotakos DB, 2004, INT J CARDIOL, V94, P229, DOI 10.1016/j.ijcard.2003.04.050; Spencer FA, 1998, J AM COLL CARDIOL, V31, P1226, DOI 10.1016/S0735-1097(98)00098-9; Turner LR, 2012, EPIDEMIOLOGY, V23, P594, DOI 10.1097/EDE.0b013e3182572795; Wang XY, 2009, INT J BIOMETEOROL, V53, P535, DOI 10.1007/s00484-009-0241-4; Wichmann J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062059; Wichmann J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-19; Wolf K, 2009, CIRCULATION, V120, P735, DOI 10.1161/CIRCULATIONAHA.108.815860	34	22	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204706	10.1371/journal.pone.0204706	http://dx.doi.org/10.1371/journal.pone.0204706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332423	gold, Green Submitted, Green Published			2022-12-26	WOS:000447638200023
J	Zhen, LM; Li, X; Gao, X; Wei, HD; Lei, XM				Zhen, Luming; Li, Xiao; Gao, Xue; Wei, Haidong; Lei, Xiaoming			Dose determination of sufentanil for intravenous patient-controlled analgesia with background infusion in abdominal surgeries: A random study	PLOS ONE			English	Article							TARGET-CONTROLLED INFUSION; EPIDURAL ANALGESIA; PAIN MANAGEMENT; NATIONAL-SURVEY; PHARMACOKINETICS; LEVOBUPIVACAINE; EFFICACY; OPIOIDS; SAFETY	Objectives Sufentanil has been widely used in epidural PCA, while its use in intravenous PCA has rarely been reported. Based on its use in target controlled infusion, we reckoned that the effect-site concentration of sufentanil would be steady if background infusion is given in intravenous PCA. This prospective, single center, randomized study with a three arm parallel group design aims to find out the appropriate dose of sufentanil when used in intravenous PCA with background infusion in abdominal surgeries. Methods Patients diagnosed with gastrointestinal cancer and consented to the study were recruited. The analgesia pump with one of three different doses of sufentanil (1.5, 2.0 or 2.5 mu g/kg) was attached to the patient through peripheral venous line right after surgery. The primary endpoint was pain scale VAS up to 48 hours postoperatively. Results In our study 90 patients were analyzed. In group B (SF 2.0) and C (SF2.5), patients had better pain relief than in group A (SF 1.5). There was no difference between group B and C in pain intensity at rest. While in group C more patients got pain relived at activity than in group B. All three groups had low and similar incidence of adverse effects of sufentanil. Conclusion The dose 2.5 pg/kg of sufentanil with background infusion is preferred because of better pain alleviation at activity without increase of adverse effects up to 48 hours after surgery.	[Zhen, Luming; Li, Xiao; Gao, Xue; Wei, Haidong; Lei, Xiaoming] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Anesthesiol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Wei, HD; Lei, XM (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Anesthesiol, Xian, Shaanxi, Peoples R China.	weihdxj@xjtu.edu.cn; leixiaoming007@163.com	Wei, Haidong/GZG-6935-2022					Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E; Bastin R, 2005, ACTA ANAESTH BELG, V56, P31; Boselli E, 2004, ANESTHESIOLOGY, V100, P968, DOI 10.1097/00000542-200404000-00030; Brown C, 2013, PAIN MANAG NURS, V14, P184, DOI 10.1016/j.pmn.2010.12.002; Coller J, 2009, EUR J CLIN PHARMACOL, V65, P121, DOI 10.1007/s00228-008-0570-y; Ethuin F, 2003, INTENS CARE MED, V29, P1916, DOI 10.1007/s00134-003-1920-y; Gan TJ, 2014, ANESTH ANALG, V118, P85, DOI 10.1213/ANE.0000000000000002; Gan TJ, 2014, CURR MED RES OPIN, V30, P149, DOI 10.1185/03007995.2013.860019; GEPTS E, 1995, ANESTHESIOLOGY, V83, P1194, DOI 10.1097/00000542-199512000-00010; Gerbershagen HJ, 2013, ANESTHESIOLOGY, V118, P934, DOI 10.1097/ALN.0b013e31828866b3; Jeleazcov C, 2016, ANESTHESIOLOGY, V124, P56, DOI 10.1097/ALN.0000000000000937; Li W, 2016, PLOS ONE, V11; Macintyre PE, 2001, BRIT J ANAESTH, V87, P36, DOI 10.1093/bja/87.1.36; Mendola C, 2009, BRIT J ANAESTH, V102, P418, DOI 10.1093/bja/aep004; Oberhofer D, 2005, WORLD J SURG, V29, P446, DOI 10.1007/s00268-004-7612-0; Olivier P, 1999, J CARDIOTHOR VASC AN, V13, P3, DOI 10.1016/S1053-0770(99)90164-7; PARKER RK, 1991, JAMA-J AM MED ASSOC, V266, P1947, DOI 10.1001/jama.266.14.1947; SCHUG SA, 1993, PAIN, V55, P387, DOI 10.1016/0304-3959(93)90016-I; Sitsen E, 2012, ACTA ANAESTH BELG, V63, P169; Smet I, 2008, BRIT J ANAESTH, V100, P99, DOI 10.1093/bja/aem309; Wu CL, 2005, ANESTHESIOLOGY, V103, P1079, DOI 10.1097/00000542-200511000-00023; Zhang CH, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0003-2; Zhao Y, 2009, CHINESE MED J-PEKING, V122, P1979, DOI 10.3760/cmaj.issn.0366-6999.2009.17.004; Zhao Y, 2009, CHINESE MED J-PEKING, V122, P291, DOI 10.3760/cma.j.issn.0366-6999.2009.03.010	24	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205959	10.1371/journal.pone.0205959	http://dx.doi.org/10.1371/journal.pone.0205959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332482	gold, Green Published, Green Submitted			2022-12-26	WOS:000447638200078
J	Zevenbergen, L; Smith, CR; Van Rossom, S; Thelen, DG; Famaey, N; Vander Sloten, J; Jonkers, I				Zevenbergen, Lianne; Smith, Colin R.; Van Rossom, Sam; Thelen, Darryl G.; Famaey, Nele; Vander Sloten, Jos; Jonkers, Ilse			Cartilage defect location and stiffness predispose the tibiofemoral joint to aberrant loading conditions during stance phase of gait	PLOS ONE			English	Article							FOCAL ARTICULAR DEFECTS; FULL-THICKNESS; KNEE ARTHROSCOPIES; OSTEOCHONDRAL DEFECTS; CONTACT STRESS; CHONDROCYTE APOPTOSIS; RESURFACING IMPLANT; 3-DIMENSIONAL MODEL; CHONDRAL DEFECTS; NATURAL-HISTORY	Objectives The current study quantified the influence of cartilage defect location on the tibiofemoral load distribution during gait. Furthermore, changes in local mechanical stiffness representative for matrix damage or bone ingrowth were investigated. This may provide insights in the mechanical factors contributing to cartilage degeneration in the presence of an articular cartilage defect. Methods The load distribution following cartilage defects was calculated using a musculoskeletal model that included tibiofemoral and patellofemoral joints with 6 degrees-of-freedom. Circular cartilage defects of 100 mm 2 were created at different locations in the tibiofemoral contact geometry. By assigning different mechanical properties to these defect locations, softening and hardening of the tissue were evaluated. Results Results indicate that cartilage defects located at the load-bearing area only affect the load distribution of the involved compartment. Cartilage defects in the central part of the tibia plateau and anterior-central part of the medial femoral condyle present the largest influence on load distribution. Softening at the defect location results in overloading, i.e., increased contact pressure and compressive strains, of the surrounding tissue. In contrast, inside the defect, the contact pressure decreases and the compressive strain increases. Hardening at the defect location presents the opposite results in load distribution compared to softening. Sensitivity analysis reveals that the surrounding contact pressure, contact force and compressive strain alter significantly when the elastic modulus is below 7 MPa or above 18 MPa. Conclusion Alterations in local mechanical behavior within the high load bearing area resulted in aberrant loading conditions, thereby potentially affecting the homeostatic balance not only at the defect but also at the tissue surrounding and opposing the defect. Especially, cartilage softening predisposes the tissue to loads that may contribute to accelerated risk of cartilage degeneration and the initiation or progression towards osteoarthritis of the whole compartment.	[Zevenbergen, Lianne; Van Rossom, Sam; Jonkers, Ilse] Katholieke Univ Leuven, Dept Movement Sci, Human Movement Biomech Res Grp, Leuven, Belgium; [Smith, Colin R.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Smith, Colin R.; Thelen, Darryl G.] Univ Wisconsin, Dept Mech Engn, Madison, WI 53706 USA; [Thelen, Darryl G.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Thelen, Darryl G.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI USA; [Famaey, Nele; Vander Sloten, Jos] Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, Leuven, Belgium	KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; KU Leuven	Zevenbergen, L (corresponding author), Katholieke Univ Leuven, Dept Movement Sci, Human Movement Biomech Res Grp, Leuven, Belgium.	lianne.zevenbergen@kuleuven.be	Van+Rossom, Sam/L-2255-2019	Van+Rossom, Sam/0000-0002-3206-9796; Thelen, Darryl/0000-0002-7873-2477; Famaey, Nele/0000-0002-7374-8912; Smith, Colin/0000-0003-0884-5588; Zevenbergen, Willy Johanna/0000-0002-8891-7571	KU Leuven research council [OT/13/083]; Agency for Innovation by Science and Technology [IWT 131105]; Whitaker International Summer Program; NIH [EB015410]	KU Leuven research council(KU Leuven); Agency for Innovation by Science and Technology; Whitaker International Summer Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research was supported by funding of the KU Leuven research council OT/13/083 (IJ), PhD grant of the Agency for Innovation by Science and Technology IWT 131105 (LZ), Whitaker International Summer Program (CRS) and NIH Grant EB015410 (DGT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford JW, 2005, AM J SPORT MED, V33, P443, DOI 10.1177/0363546505274578; Alford JW, 2005, AM J SPORT MED, V33, P295, DOI 10.1177/0363546504273510; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Aroen A, 2004, AM J SPORT MED, V32, P211, DOI 10.1177/0363546503259345; Bader DL, 2011, ARTHRITIS, DOI 10.1155/2011/979032; Becher C, 2008, KNEE SURG SPORT TR A, V16, P56, DOI 10.1007/s00167-007-0416-7; Behery O, 2014, CLIN J SPORT MED, V24, P21, DOI 10.1097/JSM.0000000000000004; Bei YH, 2004, MED ENG PHYS, V26, P777, DOI 10.1016/j.medengphy.2004.07.004; Bingham JT, 2008, RHEUMATOLOGY, V47, P1622, DOI 10.1093/rheumatology/ken345; Biswal S, 2002, ARTHRITIS RHEUM-US, V46, P2884, DOI 10.1002/art.10573; BLANKEVOORT L, 1991, J BIOMECH, V24, P1019, DOI 10.1016/0021-9290(91)90019-J; BLANKEVOORT L, 1991, J BIOMECH ENG-T ASME, V113, P263, DOI 10.1115/1.2894883; BROWN TD, 1991, J ORTHOPAED RES, V9, P559, DOI 10.1002/jor.1100090412; Campbell AB, 2013, AM J SPORT MED, V41, P590, DOI 10.1177/0363546512472044; Chan DD, 2018, J BIOMECH, V66, P18, DOI 10.1016/j.jbiomech.2017.10.031; Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9; Custers RJH, 2010, OSTEOARTHR CARTILAGE, V18, P377, DOI 10.1016/j.joca.2009.10.009; D'Lima DD, 2001, J BONE JOINT SURG AM, V83A, P19, DOI 10.2106/00004623-200100021-00004; Davies-Tuck ML, 2008, OSTEOARTHR CARTILAGE, V16, P337, DOI 10.1016/j.joca.2007.07.005; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; de Windt TS, 2009, AM J SPORT MED, V37, p58S, DOI 10.1177/0363546509349765; Delp SL, 2000, COMPUT SCI ENG, V2, P46, DOI 10.1109/5992.877394; Devitt BM, 2017, KNEE, V24, P508, DOI 10.1016/j.knee.2016.12.002; Dong Yue-fu, 2011, Journal of Shanghai Jiaotong University (English Edition), V16, P620, DOI 10.1007/s12204-011-1199-z; Duffell LD, 2014, P I MECH ENG H, V228, P206, DOI 10.1177/0954411913518747; Ebenstein DM, 2004, J MATER RES, V19, P273, DOI 10.1557/jmr.2004.19.1.273; Eckstein F, 2001, OSTEOARTHR CARTILAGE, V9, P101, DOI 10.1053/joca.2000.0365; Edwards PK, 2014, J ORTHOP SPORT PHYS, V44, P102, DOI 10.2519/jospt.2014.5055; Favre J, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024629; Flanigan DC, 2010, ARTHROSCOPY, V26, P1655, DOI 10.1016/j.arthro.2010.05.017; Flanigan DC, 2010, MED SCI SPORT EXER, V42, P1795, DOI 10.1249/MSS.0b013e3181d9eea0; Franke O, 2007, ACTA BIOMATER, V3, P873, DOI 10.1016/j.actbio.2007.04.005; Fregly BJ, 2012, J ORTHOP RES, V30, P503, DOI 10.1002/jor.22023; Fuchs A, 2018, KNEE SURG SPORT TR A, V26, P2722, DOI 10.1007/s00167-017-4714-4; Gratz KR, 2008, BIORHEOLOGY, V45, P193, DOI 10.3233/BIR-2008-0475; Gratz KR, 2009, J ORTHOP RES, V27, P584, DOI 10.1002/jor.20762; Gudas R, 2005, ARTHROSCOPY, V21, P1066, DOI 10.1016/j.arthro.2005.06.018; Guermazi A, 2017, ARTHRITIS RHEUMATOL, V69, P560, DOI 10.1002/art.39970; Guess TM, 2015, J BIOMECH, V48, P1490, DOI 10.1016/j.jbiomech.2015.01.047; Guettler JH, 2004, AM J SPORT MED, V32, P1451, DOI 10.1177/0363546504263234; Hambly K, 2012, CARTILAGE, V3, p50S, DOI 10.1177/1947603511413569; Heir S, 2010, AM J SPORT MED, V38, P231, DOI 10.1177/0363546509352157; Henao-Murillo L, 2018, ANN BIOMED ENG, V46, P605, DOI 10.1007/s10439-018-1986-x; Henderson IJP, 2005, KNEE, V12, P435, DOI 10.1016/j.knee.2005.04.003; Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839; Hunt N, 2001, ARTHROSCOPY, V17, P481, DOI 10.1053/jars.2001.19977; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Jones DG, 2006, J BONE JOINT SURG AM, V88A, P2502, DOI 10.2106/00004623-200611000-00025; Kaiser J, 2016, MED ENG PHYS, V38, P1131, DOI 10.1016/j.medengphy.2016.06.016; Kaplan JT, 2017, J MECH BEHAV BIOMED, V65, P734, DOI 10.1016/j.jmbbm.2016.09.040; Kelly DJ, 2005, J BIOMECH, V38, P1413, DOI 10.1016/j.jbiomech.2004.06.026; Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003; Kutzner I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081036; Lenhart RL, 2015, ANN BIOMED ENG, V43, P2675, DOI 10.1007/s10439-015-1326-3; Lenhart RL, 2015, J BIOMECH, V48, P2871, DOI 10.1016/j.jbiomech.2015.04.036; Li G, 2005, CLIN BIOMECH, V20, P736, DOI 10.1016/j.clinbiomech.2005.04.001; Li G, 2001, J BIOMECH ENG-T ASME, V123, P341, DOI 10.1115/1.1385841; Li Y, 2013, OSTEOARTHR CARTILAGE, V21, P1933, DOI 10.1016/j.joca.2013.08.021; Loening AM, 2000, ARCH BIOCHEM BIOPHYS, V381, P205, DOI 10.1006/abbi.2000.1988; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Manda K, 2011, J BIOMECH, V44, P794, DOI 10.1016/j.jbiomech.2010.12.026; Martinez-Carranza N, 2016, OSTEOARTHR CARTILAGE, V24, P484, DOI 10.1016/j.joca.2015.09.009; Orth P, 2015, TISSUE ENG PART B-RE, V21, P504, DOI [10.1089/ten.teb.2015.0122, 10.1089/ten.TEB.2015.0122]; Orth P, 2013, EUR CELLS MATER, V25, P299, DOI 10.22203/eCM.v025a21; Papaioannou G, 2002, ORTHOPEADIC RES SOC, P1242; Papaioannou G, 2010, KNEE, V17, P61, DOI 10.1016/j.knee.2009.05.001; Pena E, 2007, COMPUT BIOL MED, V37, P376, DOI 10.1016/j.compbiomed.2006.04.004; Salzmann GM, 2013, ARCH ORTHOP TRAUM SU, V133, P303, DOI 10.1007/s00402-012-1660-y; Segal NA, 2012, OSTEOARTHR CARTILAGE, V20, P1120, DOI 10.1016/j.joca.2012.05.013; Segal NA, 2009, J ORTHOP RES, V27, P1562, DOI 10.1002/jor.20936; Shelbourne KD, 2003, J BONE JOINT SURG AM, V85A, P8, DOI 10.2106/00004623-200300002-00002; Shirazi R, 2009, J BIOMECH, V42, P2458, DOI 10.1016/j.jbiomech.2009.07.022; Smith C. R., 2016, COMPUT METHOD BIOMEC, V1163, P1, DOI DOI 10.1080/21681163.2016.1172346; Smith CR, 2015, 15 INT S COMP SIM BI, DOI [10.1080/21681163.2016.1172346, DOI 10.1080/21681163.2016.1172346]; Strauss EJ, 2005, AM J SPORT MED, V33, P1647, DOI 10.1177/0363546505275487; Sun HB, 2010, ANN NY ACAD SCI, V1211, P37, DOI 10.1111/j.1749-6632.2010.05808.x; Thoma LM, 2017, OSTEOARTHR CARTILAGE, V25, P1046, DOI 10.1016/j.joca.2017.02.794; Thoma LM, 2016, GAIT POSTURE, V48, P68, DOI 10.1016/j.gaitpost.2016.04.021; Van Rossom S., 2017, RELATING KNEE JOINT; van Rossom S, 2018, J ORTHOP SPORT PHYS, V48, P162, DOI 10.2519/jospt.2018.7459; Vanwanseele B, 2003, ARTHRITIS RHEUM, V48, P3377, DOI 10.1002/art.11367; Venalainen MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep37538; Wang Y, 2006, RHEUMATOLOGY, V45, P79, DOI 10.1093/rheumatology/kei108; Weber AE, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967117753572; Widuchowski W, 2007, KNEE, V14, P177, DOI 10.1016/j.knee.2007.02.001; Wiegant K, 2016, KNEE, V23, P487, DOI 10.1016/j.knee.2016.01.004; Wirth W, 2008, IEEE T MED IMAGING, V27, P737, DOI 10.1109/TMI.2007.907323; Yokota Hiroki, 2011, Curr Osteoporos Rep, V9, P237, DOI 10.1007/s11914-011-0067-y; Zevenbergen L, 2018, OSTEOARTHR CARTILAGE, V26, P1710, DOI 10.1016/j.joca.2018.08.013; Zevenbergen L, 2018, ORTHOP P B, V100-B, P41, DOI [10.1302/1358-992X.2018.3.041, DOI 10.1302/1358-992X.2018.3.041]	90	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205842	10.1371/journal.pone.0205842	http://dx.doi.org/10.1371/journal.pone.0205842			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325946	Green Published, gold, Green Submitted			2022-12-26	WOS:000447430800045
J	Rosen, MA; Dietz, AS; Lee, N; Wang, IJ; Markowitz, J; Wyskiel, RM; Yang, T; Priebe, CE; Sapirstein, A; Gurses, AP; Pronovost, PJ				Rosen, Michael A.; Dietz, Aaron S.; Lee, Nam; Wang, I-Jeng; Markowitz, Jared; Wyskiel, Rhonda M.; Yang, Ting; Priebe, Carey E.; Sapirstein, Adam; Gurses, Ayse P.; Pronovost, Peter J.			Sensor-based measurement of critical care nursing workload: Unobtrusive measures of nursing activity complement traditional task and patient level indicators of workload to predict perceived exertion	PLOS ONE			English	Article							ATTENDING PHYSICIAN WORKLOAD; WEARABLE DEVICES; BURNOUT; MORTALITY; BEHAVIOR; MODEL; UNIT; JOB; SATISFACTION; ASSOCIATION	Objective To establish the validity of sensor-based measures of work processes for predicting perceived mental and physical exertion of critical care nurses. Materials and methods Repeated measures mixed-methods study in a surgical intensive care unit. Wearable and environmental sensors captured work process data. Nurses rated their mental (ME) and physical exertion (PE) for each four-hour block, and recorded patient and staffing-level workload factors. Shift was the grouping variable in multilevel modeling where sensor-based measures were used to predict nursing perceptions of exertion. Results There were 356 work hours from 89 four-hour shift segments across 35 bedside nursing shifts. In final models, sensor-based data accounted for 73% of between-shift, and 5% of within-shift variance in ME; and 55% of between-shift, and 55% of within-shift variance in PE. Significant predictors of ME were patient room noise (beta = 0.30, p < .01), the interaction between time spent and activity levels outside main work areas (beta = 2.24, p < .01), and the interaction between the number of patients on an insulin drip and the burstiness of speaking (beta = 0.19, p <.05). Significant predictors of PE were environmental service area noise (beta = 0.18, p < .05), and interactions between: entropy and burstiness of physical transitions (beta = 0.22, p < .01), time speaking outside main work areas and time at nursing stations (beta = 0.37, p < .001), service area noise and time walking in patient rooms (beta = -0.19, p < .05), and average patient load and nursing station speaking volume (beta = 0.30, p < .05). Discussion Analysis yielded highly predictive models of critical care nursing workload that generated insights into workflow and work design. Future work should focus on tighter connections to psychometric test development methods and expansion to a broader variety of settings and professional roles. Conclusions Sensor-based measures are predictive of perceived exertion, and are viable complements to traditional task demand measures of workload.	[Rosen, Michael A.; Dietz, Aaron S.; Lee, Nam; Wyskiel, Rhonda M.; Yang, Ting; Sapirstein, Adam; Gurses, Ayse P.; Pronovost, Peter J.] Armstrong Inst Patient Safety & Qual, Baltimore, MD 21202 USA; [Rosen, Michael A.; Dietz, Aaron S.; Sapirstein, Adam; Gurses, Ayse P.; Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Rosen, Michael A.; Gurses, Ayse P.; Pronovost, Peter J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21218 USA; [Rosen, Michael A.; Pronovost, Peter J.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA; [Wang, I-Jeng; Markowitz, Jared] Johns Hopkins Univ, Appl Phys Lab, Baltimore, MD 21218 USA; [Wyskiel, Rhonda M.; Pronovost, Peter J.] Johns Hopkins Hlth Syst, Baltimore, MD USA; [Priebe, Carey E.] Johns Hopkins Univ, Dept Appl Math & Stat, Whiting Sch Engn, Baltimore, MD USA; [Gurses, Ayse P.] Johns Hopkins Univ, Whiting Sch Engn, Malone Ctr Engn Healthcare, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Rosen, MA (corresponding author), Armstrong Inst Patient Safety & Qual, Baltimore, MD 21202 USA.; Rosen, MA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.; Rosen, MA (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21218 USA.; Rosen, MA (corresponding author), Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA.	mrosen44@jhmi.edu		Rosen, Michael/0000-0002-6621-906X	Gordon and Betty Moore Foundation [113703]; Agency for Healthcare Research and Quality [P30HS023553-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P30HS023553] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by Gordon and Betty Moore Foundation (Grant #: 113703): https://www.moore.org/, and Agency for Healthcare Research and Quality (Grant #: P30HS023553-01): https://www.ahrq.gov/.	Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Aragon D, 2006, AM J CRIT CARE, V15, P370, DOI 10.4037/ajcc2006.15.4.370; Bliese P., 2013, MULTILEVEL MULTILEVE, P5; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Buerhaus PI, 2008, JAMA-J AM MED ASSOC, V300, P2422, DOI 10.1001/jama.2008.729; Carayon Pascale, 2005, Intensive Crit Care Nurs, V21, P284, DOI 10.1016/j.iccn.2004.12.003; Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Chaffin D, 2017, ORGAN RES METHODS, V20, P3, DOI 10.1177/1094428115617004; Dall T., 2020, COMPLEXITIES PHYS SU; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; DEWA CS, 2014, BMC HEALTH SERV RES, V14; DiDomenico A, 2008, INT J IND ERGONOM, V38, P977, DOI 10.1016/j.ergon.2008.01.012; Douglas S, 2013, NURS RES, V62, P50, DOI 10.1097/NNR.0b013e318270714b; Elliott DJ, 2014, JAMA INTERN MED, V174, P786, DOI 10.1001/jamainternmed.2014.300; Friedman J., 2009, GLMNET LASSO ELASTIC; Han K, 2015, J CLIN NURS, V24, P3224, DOI 10.1111/jocn.12987; Heisterkamp S., 2016, COMPUTER SOFTWARE, V3, P1, DOI DOI 10.1016/J.CR0PR0.2007.08.015; Hendrich Ann, 2008, Perm J, V12, P25; Hockey G.R.J., 1993, ATTENTION SELECTION; Hoonakker Peter, 2011, IIE Trans Healthc Syst Eng, V1, P131; Hugonnet S, 2007, CRIT CARE MED, V35, P76, DOI 10.1097/01.CCM.0000251125.08629.3F; Kanji S, 2004, INTENS CARE MED, V30, P804, DOI 10.1007/s00134-004-2252-2; Lim M, 2015, J COMPUT GRAPH STAT, V24, P627, DOI 10.1080/10618600.2014.938812; Malhotra S, 2007, J BIOMED INFORM, V40, P81, DOI 10.1016/j.jbi.2006.06.002; Mast MS, 2015, CURR DIR PSYCHOL SCI, V24, P154, DOI 10.1177/0963721414560811; Michtalik HJ, 2013, JAMA INTERN MED, V173, P1026, DOI 10.1001/jamainternmed.2013.405; Michtalik HJ, 2013, JAMA INTERN MED, V173, P375, DOI 10.1001/jamainternmed.2013.1864; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; Mohr DC, 2013, MED CARE, V51, P108, DOI 10.1097/MLR.0b013e318277f1cb; Morris R, 2007, J ADV NURS, V57, P463, DOI 10.1111/j.1365-2648.2006.04134.x; Neuraz A, 2015, CRIT CARE MED, V43, P1587, DOI 10.1097/CCM.0000000000001015; Olguin D. O., 2009, P 2009 3 INT C PERVA, P1; Olguin DO, 2009, IEEE T SYST MAN CY B, V39, P43, DOI 10.1109/TSMCB.2008.2006638; Overdyk FJ, 2016, BMJ QUAL SAF, V25, P947, DOI 10.1136/bmjqs-2015-004226; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Penoyer DA, 2010, CRIT CARE MED, V38, P1521, DOI 10.1097/CCM.0b013e3181e47888; Pronovost P J, 2001, Eff Clin Pract, V4, P199; R Core Team, 2013, R LANG ENV STAT COMP; Ream RS, 2007, PEDIATR CRIT CARE ME, V8, P366, DOI 10.1097/01.PCC.0000269379.40748.AF; Rosen MA, 2018, CAMB HANDB PSYCHOL, P142; Rosen MA, 2015, J AM MED INFORM ASSN, V22, P11, DOI 10.1136/amiajnl-2013-002606; Shanafelt TD, 2016, MAYO CLIN PROC, V91, P422, DOI 10.1016/j.mayocp.2016.02.001; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Sharma N, 2012, COMPUT METH PROG BIO, V108, P1287, DOI 10.1016/j.cmpb.2012.07.003; Szalma JL, 2011, PSYCHOL BULL, V137, P682, DOI 10.1037/a0023987; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Topf M, 2000, J ADV NURS, V31, P520, DOI 10.1046/j.1365-2648.2000.01307.x; Tucker AL, 2006, HEALTH SERV RES, V41, P643, DOI 10.1111/j.1475-6773.2006.00502.x; Yarkoni T, 2012, CURR DIR PSYCHOL SCI, V21, P391, DOI 10.1177/0963721412457362; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	51	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0204819	10.1371/journal.pone.0204819	http://dx.doi.org/10.1371/journal.pone.0204819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0UN	30312326	Green Published, gold, Green Submitted			2022-12-26	WOS:000447427300015
J	Lee, SY; Park, JH; Jeong, S; Kim, BY; Kang, YK; Xu, Y; Chung, SK				Lee, Seo-Young; Park, Jung-Hyun; Jeong, Sangkyun; Kim, Bu-Yeo; Kang, Yong-Kook; Xu, Yang; Chung, Sun-Ku			K120R mutation inactivates p53 by creating an aberrant splice site leading to nonsense-mediated mRNA decay	ONCOGENE			English	Article							CELL-CYCLE ARREST; ACETYLATION; APOPTOSIS; ACTIVATION; SURVIVAL; CANCERS; PREDICT; TP53; GENE	The point mutation that substitutes lysine with arginine at position 120 of human p53 has been characterized as a missense mutation. The K120R mutation renders the p53 protein disabled for acetylation and, as a result, defective for apoptotic function, which provides a mechanistic link between the missense mutation and tumorigenesis. However, we noticed the failures of tumorigenesis in mice with the mutation, and of the related studies to notice that it has arbitrarily reflected in amino acid change through a sequence modification (AGA) of the original tumor mutation (AGG) by codon degeneracy. Unlike this modified version, we also discovered a novel splicing site the original mutation, TP53 c.359A>G, may induce. Using a human induced pluripotent stem cell line that was engineered to be homozygous for the original mutation, we here identified that the accidental splicing site generates a defective transcript variant with a frame-shifted premature termination codon which is subjected to nonsense-mediated mRNA decay. The authentic splicing still occurs but in extremely low amounts. Taken together, this mutation causes depletion of cellular p53 via defective mRNA, suggesting a new link to tumorigenesis.	[Lee, Seo-Young; Park, Jung-Hyun; Jeong, Sangkyun; Kim, Bu-Yeo; Chung, Sun-Ku] Korea Inst Oriental Med, Div Clin Med, 1672 Yuseong Daero, Daejeon 34054, South Korea; [Kang, Yong-Kook] Korea Res Inst Biosci & Biotechnol, Dev & Differentiat Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea; [Kang, Yong-Kook] Korea Univ Sci & Technol, Dept Funct Genom, Daejeon, South Korea; [Xu, Yang] Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA	Korea Institute of Oriental Medicine (KIOM); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); University of California System; University of California San Diego	Chung, SK (corresponding author), Korea Inst Oriental Med, Div Clin Med, 1672 Yuseong Daero, Daejeon 34054, South Korea.	skchung@kiom.re.kr		Xu, Yang/0000-0001-5574-921X	National Research Foundation of Korea [NRF-2013M3A9B4076487]; Korea Institute of Oriental Medicine Grants [K18131]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Institute of Oriental Medicine Grants	We thank B-J. Park, K-S. Chae, and I. Horikawa for comments on the manuscript and Y-D. Kim for technical assistance. This research was supported in part by the National Research Foundation of Korea Grants (NRF-2013M3A9B4076487) and Korea Institute of Oriental Medicine Grants (K18131).	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chung SK, 2007, GASTROENTEROLOGY, V132, P2459, DOI 10.1053/j.gastro.2007.04.024; Deissler H, 2004, ONCOL REP, V11, P1281; Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043; Gong L, 2018, ONCOGENE, V37, P2150, DOI 10.1038/s41388-017-0117-8; Hashimoto T, 1999, CANCER RES, V59, P5572; Hayes VM, 1999, BRAIN PATHOL, V9, P463, DOI 10.1111/j.1750-3639.1999.tb00535.x; Jayasinghe RG, 2018, CELL REP, V23, P270, DOI 10.1016/j.celrep.2018.03.052; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim BY, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.43; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee SY, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2725670; Leitao MM, 2004, GYNECOL ONCOL, V93, P301, DOI 10.1016/j.ygyno.2004.01.043; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liebermann DA, 2007, CELL CYCLE, V6, P166, DOI 10.4161/cc.6.2.3789; Liu NS, 2013, CANCER RES, V73, P3749, DOI 10.1158/0008-5472.CAN-12-3684; Liu XF, 2016, EMBO REP, V17, P349, DOI 10.15252/embr.201540505; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; MEYERS FJ, 1993, J NATL CANCER I, V85, P1856, DOI 10.1093/jnci/85.22.1856; Monteith JA, 2016, MOL ONCOL, V10, P1207, DOI 10.1016/j.molonc.2016.05.007; Shinmen N, 2009, FEBS LETT, V583, P1916, DOI 10.1016/j.febslet.2009.04.041; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang J, 2000, J MICROBIOL METH, V39, P121, DOI 10.1016/S0167-7012(99)00107-4; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Yu H, 2009, GENOMICS, V94, P355, DOI 10.1016/j.ygeno.2009.08.004; Yun T, 2016, J BIOL CHEM, V291, P7386, DOI 10.1074/jbc.M115.706341	28	13	14	3	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2019	38	10					1597	1610		10.1038/s41388-018-0542-3	http://dx.doi.org/10.1038/s41388-018-0542-3			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN8DD	30348990				2022-12-26	WOS:000460423800002
J	Schmidt, K; Ralle, M; Schaffer, T; Jayakanthan, S; Bari, B; Muchenditsi, A; Lutsenko, S				Schmidt, Katharina; Ralle, Martina; Schaffer, Thomas; Jayakanthan, Samuel; Bari, Bilal; Muchenditsi, Abigael; Lutsenko, Svetlana			ATP7A and ATP7B copper transporters have distinct functions in the regulation of neuronal dopamine--hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper transport; vesicles; dopamine--hydroxylase; cellular regulation; intracellular trafficking; ATP7A; ATP7B; SH-SY5Y cells; noradrenergic; locus coeruleus; constitutive secretion; Wilson's disease; Menkes disease	WILSON DISEASE PROTEIN; BETA-HYDROXYLASE; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; NMDA RECEPTOR; ATPASE ATP7B; IN-VITRO; EXPRESSION; GENE; HOMEOSTASIS	The copper (Cu) transporters ATPase copper-transporting alpha (ATP7A) and ATPase copper-transporting beta (ATP7B) are essential for the normal function of the mammalian central nervous system. Inactivation of ATP7A or ATP7B causes the severe neurological disorders, Menkes disease and Wilson disease, respectively. In both diseases, Cu imbalance is associated with abnormal levels of the catecholamine-type neurotransmitters dopamine and norepinephrine. Dopamine is converted to norepinephrine by dopamine--hydroxylase (DBH), which acquires its essential Cu cofactor from ATP7A. However, the role of ATP7B in catecholamine homeostasis is unclear. Here, using immunostaining of mouse brain sections and cultured cells, we show that DBH-containing neurons express both ATP7A and ATP7B. The two transporters are located in distinct cellular compartments and oppositely regulate the export of soluble DBH from cultured neuronal cells under resting conditions. Down-regulation of ATP7A, overexpression of ATP7B, and pharmacological Cu depletion increased DBH retention in cells. In contrast, ATP7B inactivation elevated extracellular DBH. Proteolytic processing and the specific activity of exported DBH were not affected by changes in ATP7B levels. These results establish distinct regulatory roles for ATP7A and ATP7B in neuronal cells and explain, in part, the lack of functional compensation between these two transporters in human disorders of Cu imbalance.	[Schmidt, Katharina; Jayakanthan, Samuel; Muchenditsi, Abigael; Lutsenko, Svetlana] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Ralle, Martina] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Schaffer, Thomas] Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21205 USA; [Bari, Bilal] Johns Hopkins Univ, Brain Sci Inst, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Oregon Health & Science University; Johns Hopkins University; Johns Hopkins University	Lutsenko, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	lutsenko@jhmi.edu	Ralle, Martina/H-2936-2019	Bari, Bilal/0000-0002-8381-3802; Lutsenko, Svetlana/0000-0001-5275-2587	U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101502, T32GM007445] Funding Source: NIH RePORTER	U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Hippocampal neurons were provided by Dr. Kirill Gorshkov. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. We thank Evan Maxey and Dr. Stefan Vogt for user support and assistance at the Advanced Photon Source. We thank Dr. Betty Eipper for expert advice and the kind gift of the antibody. We thank members of the Lutsenko laboratory for critical reading of the manuscript and helpful comments.	ASH DE, 1984, J BIOL CHEM, V259, P3395; Banci L, 2005, J BIOL CHEM, V280, P38259, DOI 10.1074/jbc.M506219200; Banci L, 2009, J BIOL CHEM, V284, P9354, DOI 10.1074/jbc.M805981200; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Barthel H, 2001, EUR J NUCL MED, V28, P1656, DOI 10.1007/s002590100623; Benhamla T, 2007, ENCEPHALE, V33, P924, DOI 10.1016/j.encep.2006.08.009; Braiterman L, 2011, AM J PHYSIOL-GASTR L, V301, pG69, DOI 10.1152/ajpgi.00038.2011; Cunnane SC, 2014, J HUM EVOL, V77, P88, DOI 10.1016/j.jhevol.2014.05.001; Davies KM, 2014, NEUROBIOL AGING, V35, P858, DOI 10.1016/j.neurobiolaging.2013.09.034; Dodani SC, 2014, P NATL ACAD SCI USA, V111, P16280, DOI 10.1073/pnas.1409796111; Doreulee N, 1997, HIPPOCAMPUS, V7, P666, DOI 10.1002/(SICI)1098-1063(1997)7:6<666::AID-HIPO8>3.3.CO;2-6; Fu S, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00022; Gaier ED, 2014, J NEUROPHYSIOL, V111, P1927, DOI 10.1152/jn.00631.2013; Gaier ED, 2013, J NEUROSCI RES, V91, P2, DOI 10.1002/jnr.23143; Gaier ED, 2013, J NEUROCHEM, V127, P605, DOI 10.1111/jnc.12438; Gao C, 2014, J TRACE ELEM MED BIO, V28, P344, DOI 10.1016/j.jtemb.2014.04.004; Gerbasi V, 2003, NEUROCHEM RES, V28, P867, DOI 10.1023/A:1023219308890; Goldstein DS, 2009, NEUROCHEM RES, V34, P1464, DOI 10.1007/s11064-009-9933-8; Gupta A, 2011, P NATL ACAD SCI USA, V108, P5390, DOI 10.1073/pnas.1014959108; Han H, 2009, BIOL TRACE ELEM RES, V129, P130, DOI 10.1007/s12011-008-8293-6; Hasan NM, 2012, J BIOL CHEM, V287, P36041, DOI 10.1074/jbc.M112.370403; Hatori Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10640; Hegde S, 2010, NEUROL INDIA, V58, P708, DOI 10.4103/0028-3886.72172; Hendy GN, 2006, MOL ENDOCRINOL, V20, P1935, DOI 10.1210/me.2005-0398; Jayakanthan S, 2017, J BIOL CHEM, V292, P18760, DOI 10.1074/jbc.M117.807263; KALER SG, 1993, ANN NEUROL, V33, P171, DOI 10.1002/ana.410330206; KALER SG, 1993, J INHERIT METAB DIS, V16, P907, DOI 10.1007/BF00714295; Kaler SG, 2013, ADV PHARMACOL, V68, P223, DOI 10.1016/B978-0-12-411512-5.00011-7; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; MANGOLD JB, 1984, J BIOL CHEM, V259, P7772; Naeve GS, 1999, NEUROSCIENCE, V93, P1179, DOI 10.1016/S0306-4522(99)00175-X; NAGATSU T, 1972, CLIN CHEM, V18, P980; Niciu MJ, 2007, NEUROBIOL DIS, V27, P278, DOI 10.1016/j.nbd.2007.05.004; Nishihara E, 1998, NEUROREPORT, V9, P3259, DOI 10.1097/00001756-199810050-00023; OCONNOR DT, 1994, CLIN SCI, V86, P149, DOI 10.1042/cs0860149; OYARCE AM, 1991, ARCH BIOCHEM BIOPHYS, V290, P503, DOI 10.1016/0003-9861(91)90573-2; Pilankatta Rajendra, 2011, J Biol Chem, V286, P7389, DOI 10.1074/jbc.M110.171454; Popescu BFG, 2011, CNS NEUROSCI THER, V17, P256, DOI 10.1111/j.1755-5949.2010.00149.x; Qian YC, 1997, MOL BRAIN RES, V48, P60, DOI 10.1016/S0169-328X(97)00083-1; SABBAN EL, 1983, J BIOL CHEM, V258, P7812; Saito T, 1996, NEUROSCI LETT, V216, P195, DOI 10.1016/S0304-3940(96)13041-X; Salazar-Weber Nina L, 2011, Int J Alzheimers Dis, V2011, P864753, DOI 10.4061/2011/864753; SAXENA A, 1983, J BIOL CHEM, V258, P4147; Scheiber IF, 2014, PROG NEUROBIOL, V116, P33, DOI 10.1016/j.pneurobio.2014.01.002; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Slanina H, 2012, J MOL MICROB BIOTECH, V22, P245, DOI 10.1159/000342909; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Veldhuis NA, 2009, INT J BIOCHEM CELL B, V41, P2403, DOI 10.1016/j.biocel.2009.06.008; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; Woerwag-Mehta S, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.01.2010.2628; Xiao T, 2018, NAT CHEM BIOL, V14, P655, DOI 10.1038/s41589-018-0062-z; Zecca L, 2004, P NATL ACAD SCI USA, V101, P9843, DOI 10.1073/pnas.0403495101; Zhang JW, 2015, BIOCHEM BIOPH RES CO, V458, P82, DOI 10.1016/j.bbrc.2015.01.071	53	37	37	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20085	20098		10.1074/jbc.RA118.004889	http://dx.doi.org/10.1074/jbc.RA118.004889			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30341172	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000454685900018
J	Sorrentino, ZA; Vijayaraghavan, N; Gorion, KM; Riffe, CJ; Strang, KH; Caldwell, J; Giasson, BI				Sorrentino, Zachary A.; Vijayaraghavan, Niran; Gorion, Kimberly-Marie; Riffe, Cara J.; Strang, Kevin H.; Caldwell, Jason; Giasson, Benoit I.			Physiological C-terminal truncation of alpha-synuclein potentiates the prion-like formation of pathological inclusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUROBLASTOMA-CELLS; TRANSGENIC MOUSE MODEL; PARKINSONS-DISEASE; FIBRIL FORMATION; LEWY BODIES; IN-VITRO; AMYLOID FIBRILLOGENESIS; MEMBRANE-BINDING; CARBOXY-TERMINUS; AGGREGATION	alpha-Synuclein (alpha syn) aggregates into toxic fibrils in multiple neurodegenerative diseases where these fibrils form characteristic pathological inclusions such as Lewy bodies (LBs). The mechanisms initiating alpha syn aggregation into fibrils are unclear, but ubiquitous post-translational modifications of alpha syn present in LBs may play a role. Specific C-terminally (C)-truncated forms of alpha syn are present within human pathological inclusions and form under physiological conditions likely in lysosome-associated pathways, but the roles for these C-truncated forms of alpha syn in inclusion formation and disease are not well understood. Herein, we characterized the in vitro aggregation properties, amyloid fibril structures, and ability to induce full-length (FL) alpha syn aggregation through prion-like mechanisms for eight of the most common physiological C-truncated forms of alpha syn (1-115, 1-119, 1-122, 1-124, 1-125, 1-129, 1-133, and 1-135). In vitro, C-truncated alpha syn aggregated more readily than FL alpha syn and formed fibrils with unique morphologies. The presence of C-truncated alpha syn potentiated aggregation of FL alpha syn in vitro through co-polymerization. Specific C-truncated forms of alpha syn in cells also exacerbated seeded aggregation of alpha syn. Furthermore, in primary neuronal cultures, co-polymers of C-truncated and FL alpha syn were potent prion-like seeds, but polymers composed solely of the C-truncated protein were not. These experiments indicated that specific physiological C-truncated forms of alpha syn have distinct aggregation properties, including the ability to modulate the prion-like aggregation and seeding activity of FL alpha syn. Proteolytic formation of these C-truncated species may have an important role in both the initiation of alpha syn pathological inclusions and further progression of disease with strain-like properties.	[Sorrentino, Zachary A.; Vijayaraghavan, Niran; Gorion, Kimberly-Marie; Riffe, Cara J.; Strang, Kevin H.; Caldwell, Jason; Giasson, Benoit I.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Sorrentino, Zachary A.; Vijayaraghavan, Niran; Gorion, Kimberly-Marie; Riffe, Cara J.; Strang, Kevin H.; Caldwell, Jason; Giasson, Benoit I.] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Giasson, Benoit I.] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Giasson, BI (corresponding author), BMS J483 CTRND,1275 Ctr Dr, Gainesville, FL 32610 USA.	bgiasson@ufl.edu		Sorrentino, Zachary/0000-0001-8835-0432	National Institutes of Health [R01NS089022, R21NS102685]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089622, T32NS082168, R21NS102685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01NS089022 and R21NS102685. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmotilib H, 2017, NEUROBIOL DIS, V105, P84, DOI 10.1016/j.nbd.2017.05.014; Afitska K, 2017, BIOPHYS J, V113, P2182, DOI 10.1016/j.bpj.2017.08.027; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Ayers JI, 2018, J VIROL, V92, DOI 10.1128/JVI.00586-18; Baba M, 1998, AM J PATHOL, V152, P879; Bae EJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.283; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Choi DH, 2011, J BIOL CHEM, V286, P14168, DOI 10.1074/jbc.M111.222430; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Crystal AS, 2003, J NEUROCHEM, V86, P1359, DOI 10.1046/j.1471-4159.2003.01949.x; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Daher JPL, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-34; Deng H, 2018, AGEING RES REV, V42, P72, DOI 10.1016/j.arr.2017.12.007; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dhillon JKS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184731; Duda JE, 2000, J NEUROPATH EXP NEUR, V59, P830, DOI 10.1093/jnen/59.9.830; Duda JE, 2002, ANN NEUROL, V52, P205, DOI 10.1002/ana.10279; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; DUNN SD, 1986, ANAL BIOCHEM, V157, P144, DOI 10.1016/0003-2697(86)90207-1; El-Turk F, 2016, BIOCHEMISTRY-US, V55, P3116, DOI 10.1021/acs.biochem.6b00149; Emmer KL, 2011, J BIOL CHEM, V286, P35104, DOI 10.1074/jbc.M111.247965; Fernandes HJR, 2016, STEM CELL REP, V6, P342, DOI 10.1016/j.stemcr.2016.01.013; Garcia-Reitbock P, 2010, BRAIN, V133, P2032, DOI 10.1093/brain/awq132; Gath J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090659; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Grassi D, 2018, P NATL ACAD SCI USA, V115, pE2634, DOI 10.1073/pnas.1713849115; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Guerrero-Ferreira R, 2018, ELIFE, V7, DOI 10.7554/eLife.36402; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hall K, 2015, EXP NEUROL, V264, P8, DOI 10.1016/j.expneurol.2014.11.003; Hossain S, 2001, J ALZHEIMERS DIS, V3, P577, DOI 10.3233/JAD-2001-3608; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; Iljina M, 2016, P NATL ACAD SCI USA, V113, pE1206, DOI 10.1073/pnas.1524128113; Iyer A, 2017, J AM CHEM SOC, V139, P15392, DOI 10.1021/jacs.7b07403; Izawa Y, 2012, BRAIN BEHAV, V2, P595, DOI 10.1002/brb3.86; Jang A, 2010, J NEUROCHEM, V113, P1263, DOI 10.1111/j.1471-4159.2010.06695.x; Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6; Kellie J. F, 2014, SCI REP, V4, P5791; Khalaf O, 2014, J BIOL CHEM, V289, P21856, DOI 10.1074/jbc.M114.553297; Klein AD, 2018, BRAIN, V141, P2255, DOI 10.1093/brain/awy147; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Lemkau LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049750; Levitan K, 2011, J MOL BIOL, V411, P329, DOI 10.1016/j.jmb.2011.05.046; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Li YW, 2018, CELL RES, V28, P897, DOI 10.1038/s41422-018-0075-x; Lim S, 2016, BRAIN PATHOL, V26, P404, DOI 10.1111/bpa.12371; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Luk KC, 2016, CELL REP, V16, P3373, DOI 10.1016/j.celrep.2016.08.053; Masaracchia C, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0578-1; McGlinchey RP, 2015, P NATL ACAD SCI USA, V112, P9322, DOI 10.1073/pnas.1500937112; McLean PJ, 2002, NEUROSCI LETT, V323, P219, DOI 10.1016/S0304-3940(02)00154-4; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Michell AW, 2007, CELL TRANSPLANT, V16, P461, DOI 10.3727/000000007783464911; Mishizen-Eberz AJ, 2005, BIOCHEMISTRY-US, V44, P7818, DOI 10.1021/bi047846q; Muntane G, 2012, NEUROSCIENCE, V200, P106, DOI 10.1016/j.neuroscience.2011.10.042; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Park S, 2016, J BIOMOL STRUCT DYN, V34, P376, DOI 10.1080/07391102.2015.1033016; Park SM, 2002, BIOCHEMISTRY-US, V41, P4137, DOI 10.1021/bi015961k; Park SM, 2002, J BIOL CHEM, V277, P28512, DOI 10.1074/jbc.M111971200; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Pieri L, 2016, BBA-GEN SUBJECTS, V1860, P8, DOI 10.1016/j.bbagen.2015.10.007; Pinotsi D, 2014, NANO LETT, V14, P339, DOI 10.1021/nl4041093; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prasad K, 2012, BRAIN PATHOL, V22, P811, DOI 10.1111/j.1750-3639.2012.00597.x; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; Robak LA, 2017, BRAIN, V140, P3191, DOI 10.1093/brain/awx285; Rutherford NJ, 2017, HUM MOL GENET, V26, P4906, DOI 10.1093/hmg/ddx371; Sacino AN, 2017, J NEUROCHEM, V140, P662, DOI 10.1111/jnc.13743; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; Sacino AN, 2014, ACTA NEUROPATHOL, V127, P645, DOI 10.1007/s00401-014-1268-0; Sacino AN, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-38; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Sorrentino ZA, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0182-z; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Strang KH, 2018, J BIOL CHEM, V293, P2408, DOI 10.1074/jbc.M117.815357; Strang KH, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0458-0; Sugeno N, 2014, J BIOL CHEM, V289, P18137, DOI 10.1074/jbc.M113.529461; Terada M, 2018, J BIOL CHEM, V293, P13910, DOI 10.1074/jbc.RA118.001862; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Tsujimura A, 2015, NEUROBIOL DIS, V73, P244, DOI 10.1016/j.nbd.2014.10.011; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Uchihara T, 2016, ACTA NEUROPATHOL, V131, P49, DOI 10.1007/s00401-015-1485-1; Ulusoy A, 2010, EUR J NEUROSCI, V32, P409, DOI 10.1111/j.1460-9568.2010.07284.x; Valdinocci D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020469; Vamvaca K, 2011, J NEUROCHEM, V119, P389, DOI 10.1111/j.1471-4159.2011.07431.x; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wakamatsu M, 2008, NEUROBIOL AGING, V29, P574, DOI 10.1016/j.neurobiolaging.2006.11.017; Waxman EA, 2008, ACTA NEUROPATHOL, V116, P37, DOI 10.1007/s00401-008-0375-1; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Waxman EA, 2010, J NEUROCHEM, V113, P374, DOI 10.1111/j.1471-4159.2010.06592.x; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Wong YC, 2016, MOVEMENT DISORD, V31, P1610, DOI 10.1002/mds.26802; Yap TL, 2011, BIOCHEMISTRY-US, V50, P1963, DOI 10.1021/bi2000824; Zhang ZT, 2017, NAT STRUCT MOL BIOL, V24, P632, DOI 10.1038/nsmb.3433; Zibaee S, 2007, J MOL BIOL, V374, P454, DOI 10.1016/j.jmb.2007.09.039	110	47	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18914	18932		10.1074/jbc.RA118.005603	http://dx.doi.org/10.1074/jbc.RA118.005603			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30327435	hybrid, Green Published			2022-12-26	WOS:000458467400009
J	Pavesi, A; Vianelli, A; Chirico, N; Bao, YM; Blinkova, O; Belshaw, R; Firth, A; Karlin, D				Pavesi, Angelo; Vianelli, Alberto; Chirico, Nicola; Bao, Yiming; Blinkova, Olga; Belshaw, Robert; Firth, Andrew; Karlin, David			Overlapping genes and the proteins they encode differ significantly in their sequence composition from non-overlapping genes	PLOS ONE			English	Article							RNA SILENCING SUPPRESSOR; READING FRAMES; CRYSTAL-STRUCTURE; VIRAL-PROTEINS; MESSENGER-RNAS; VIRUS PROTEIN; NSS PROTEIN; EVOLUTION; GENOMES; EXPRESSION	Overlapping genes represent a fascinating evolutionary puzzle, since they encode two functionally unrelated proteins from the same DNA sequence. They originate by a mechanism of overprinting, in which point mutations in an existing frame allow the expression (the "birth") of a completely new protein from a second frame. In viruses, in which overlapping genes are abundant, these new proteins often play a critical role in infection, yet they are frequently overlooked during genome annotation. This results in erroneous interpretation of mutational studies and in a significant waste of resources. Therefore, overlapping genes need to be correctly detected, especially since they are now thought to be abundant also in eukaryotes. Developing better detection methods and conducting systematic evolutionary studies require a large, reliable benchmark dataset of known cases. We thus assembled a high-quality dataset of 80 viral overlapping genes whose expression is experimentally proven. Many of them were not present in databases. We found that overall, overlapping genes differ significantly from non-overlapping genes in their nucleotide and amino acid composition. In particular, the proteins they encode are enriched in high-degeneracy amino acids and depleted in low-degeneracy ones, which may alleviate the evolutionary constraints acting on overlapping genes. Principal component analysis revealed that the vast majority of overlapping genes follow a similar composition bias, despite their heterogeneity in length and function. Six proven mammalian overlapping genes also followed this bias. We propose that this apparently near-universal composition bias may either favour the birth of overlapping genes, or/and result from selection pressure acting on them.	[Pavesi, Angelo] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy; [Vianelli, Alberto; Chirico, Nicola] Univ Insubria, Dept Theoret & Appl Sci, Varese, Italy; [Bao, Yiming] Chinese Acad Sci, Beijing Inst Gen, BIG Data Ctr, Beijing, Peoples R China; [Blinkova, Olga] NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bldg 10, Bethesda, MD 20892 USA; [Belshaw, Robert] PUPSMD, Sch Biomed & Healthcare Sci, Plymouth, Devon, England; [Firth, Andrew] Univ Cambridge, Div Virol, Dept Pathol, Cambridge, England; [Karlin, David] Univ Oxford, Dept Zool, Oxford, England; [Karlin, David] Univ Oxford, Div Struct Biol, Oxford, England	University of Parma; University of Insubria; Chinese Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Cambridge; University of Oxford; University of Oxford	Pavesi, A (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy.; Vianelli, A (corresponding author), Univ Insubria, Dept Theoret & Appl Sci, Varese, Italy.	angelo.pavesi@unipr.it; alberto.vianelli@uninsubria.it	Vianelli, Alberto/A-6292-2010	Vianelli, Alberto/0000-0002-5206-3164; Firth, Andrew/0000-0002-7986-9520	Wellcome Trust [090005, 106207]; University of Insubria (Fondo di Ateneo per la Ricerca); University of Parma (Fondo di Ateneo per la Ricerca); Intramural Research Program of the National Institutes of Health, National Library of Medicine; 100 Talent Program of the Chinese Academy of Sciences; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); University of Insubria (Fondo di Ateneo per la Ricerca); University of Parma (Fondo di Ateneo per la Ricerca); Intramural Research Program of the National Institutes of Health, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); 100 Talent Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by Wellcome Trust (http://wellcome.ac.uk/funding) (grants 090005 to DGK and 106207 to AEF), by University of Insubria (http://www.uninsubria.it) (Fondo di Ateneo per la Ricerca to AV), by University of Parma (http://www.unipr.it) (Fondo di Ateneo per la Ricerca to AP), by the Intramural Research Program of the National Institutes of Health, National Library of Medicine (http://irp.nih.gov) (YB and OB). YB was supported by the 100 Talent Program of the Chinese Academy of Sciences (http://english.cas.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani VM, 2016, BIOESSAYS, V38, P21, DOI 10.1002/bies.201500131; Allison JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147619; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson DI, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a017996; Arias C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003847; BARRELL BG, 1976, NATURE, V264, P34, DOI 10.1038/264034a0; Baulcombe DC, 2004, TRENDS BIOCHEM SCI, V29, P279, DOI 10.1016/j.tibs.2004.04.007; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Belshaw R, 2007, GENOME RES, V17, P1496, DOI 10.1101/gr.6305707; Bergeron D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.472654; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Brandes N, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0128-3; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Cassan E, 2016, P NATL ACAD SCI USA, V113, P11537, DOI 10.1073/pnas.1605739113; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chirico N, 2010, P ROY SOC B-BIOL SCI, V277, P3809, DOI 10.1098/rspb.2010.1052; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Chung WY, 2007, PLOS COMPUT BIOL, V3, P855, DOI 10.1371/journal.pcbi.0030091; Cochran W.G., 1967, STAT METHODS; Davy C, 2009, VIROLOGY, V394, P266, DOI 10.1016/j.virol.2009.08.035; Delaye L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-31; DING SW, 1995, EMBO J, V14, P5762, DOI 10.1002/j.1460-2075.1995.tb00265.x; Dinman JD, 2012, ADV PROTEIN CHEM STR, V86, P129, DOI 10.1016/B978-0-12-386497-0.00004-9; Fellner L, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0558-z; Fernandes JD, 2016, CELL, V167, P1762, DOI 10.1016/j.cell.2016.11.031; Firth AE, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120109; Firth AE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-75; Firth AE, 2008, ARCH VIROL, V153, P1379, DOI 10.1007/s00705-008-0119-5; Firth AE, 2014, NUCLEIC ACIDS RES, V42, P12425, DOI 10.1093/nar/gku981; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-193; Govind K, 2014, FEBS OPEN BIO, V4, P362, DOI 10.1016/j.fob.2014.03.009; Guyader S, 2002, J GEN VIROL, V83, P1799, DOI 10.1099/0022-1317-83-7-1799; HEIN J, 1995, J MOL EVOL, V40, P181, DOI 10.1007/BF00167112; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Hughes AL, 2005, VIRUS RES, V113, P81, DOI 10.1016/j.virusres.2005.03.030; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/pnas.89.20.9489; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Krakauer DC, 2000, EVOLUTION, V54, P731, DOI 10.1111/j.0014-3820.2000.tb00075.x; Kuchibhatla DB, 2014, J VIROL, V88, P10, DOI 10.1128/JVI.02595-13; Lai GH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14558-8; LAMB RA, 1980, CELL, V21, P475, DOI 10.1016/0092-8674(80)90484-5; Lartey RT, 1996, MOL BIOL EVOL, V13, P1327, DOI 10.1093/oxfordjournals.molbev.a025579; Lingel A, 2005, EMBO REP, V6, P1149, DOI 10.1038/sj.embor.7400583; Lo MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090003; Mazur I, 2008, CELL MICROBIOL, V10, P1140, DOI 10.1111/j.1462-5822.2008.01116.x; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; McVeigh A, 2000, INFECT IMMUN, V68, P5710, DOI 10.1128/IAI.68.10.5710-5715.2000; Meier C, 2006, STRUCTURE, V14, P1157, DOI 10.1016/j.str.2006.05.012; Michel AM, 2012, GENOME RES, V22, P2219, DOI 10.1101/gr.133249.111; Mingot A, 2016, J VIROL, V90, P3543, DOI 10.1128/JVI.02360-15; MIYATA T, 1978, NATURE, V272, P532, DOI 10.1038/272532a0; Mizokami M, 1997, J MOL EVOL, V44, pS83, DOI 10.1007/PL00000061; Morrison D. F., 1976, MULTIVARIATE STAT ME; Mouilleron H, 2016, NUCLEIC ACIDS RES, V44, P14, DOI 10.1093/nar/gkv1218; Naumer M, 2012, J VIROL, V86, P13038, DOI 10.1128/JVI.01675-12; NOTEBORN MHM, 1994, J VIROL, V68, P346, DOI 10.1128/JVI.68.1.346-351.1994; Noteborn MHM, 1998, J GEN VIROL, V79, P3073, DOI 10.1099/0022-1317-79-12-3073; Olspert A, 2015, EMBO REP, V16, P995, DOI 10.15252/embr.201540509; Pavesi A, 1997, J MOL EVOL, V44, P625, DOI 10.1007/PL00006185; Pavesi A, 2000, J MOL EVOL, V50, P284, DOI 10.1007/s002399910033; Pavesi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003162; Peleg O, 2004, J MOL EVOL, V59, P520, DOI 10.1007/s00239-004-2644-5; Priyadarshini CGP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026929; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Rainsford EW, 2007, VIRUS RES, V130, P193, DOI 10.1016/j.virusres.2007.06.011; Rancurel C, 2009, J VIROL, V83, P10719, DOI 10.1128/JVI.00595-09; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; Ren Q, 2012, P NATL ACAD SCI USA, V109, pE630, DOI 10.1073/pnas.1111303109; Ribrioux S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-122; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Sabath N, 2012, MOL BIOL EVOL, V29, P3767, DOI 10.1093/molbev/mss179; Sabath N, 2010, J MOL EVOL, V71, P308, DOI 10.1007/s00239-010-9386-3; Schwemmle M, 1998, J BIOL CHEM, V273, P9007, DOI 10.1074/jbc.273.15.9007; Sealfon RS, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0603-7; SIEGEL S., 1956, NONPARAMETRIC STAT B; Simon-Loriere E, 2013, MOL BIOL EVOL, V30, P1916, DOI 10.1093/molbev/mst094; SOEDA E, 1982, ADV BIOPHYS, V15, P1, DOI 10.1016/0065-227X(82)90003-X; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Sorgeloos F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003474; Stern-Ginossar N, 2015, ANNU REV VIROL, V2, P335, DOI 10.1146/annurev-virology-100114-054854; Sun FF, 2018, VIROLOGY, V513, P188, DOI 10.1016/j.virol.2017.09.014; Torres-Vega MA, 2000, J GEN VIROL, V81, P821, DOI 10.1099/0022-1317-81-3-821; Tyagi S, 2002, J BIOL CHEM, V277, P22759, DOI 10.1074/jbc.M200185200; van Knippenberg I, 2010, J GEN VIROL, V91, P2002, DOI 10.1099/vir.0.021774-0; van Pesch V, 2001, J VIROL, V75, P7811, DOI 10.1128/JVI.75.17.7811-7817.2001; Vanderperre B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070698; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Vera-Otarola J, 2012, J VIROL, V86, P2176, DOI 10.1128/JVI.06223-11; Wieringa R, 2003, J VIROL, V77, P6216, DOI 10.1128/JVI.77.11.6216-6226.2003; Yang ZL, 2015, J VIROL, V89, P6874, DOI 10.1128/JVI.00528-15; Zhao XR, 2007, GENOMICS, V89, P502, DOI 10.1016/j.ygeno.2006.12.007	97	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0202513	10.1371/journal.pone.0202513	http://dx.doi.org/10.1371/journal.pone.0202513			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339683	Green Published, Green Submitted, gold			2022-12-26	WOS:000447761400003
J	Aparicio, D; Ribeiro, P; Silva, F				Aparicio, David; Ribeiro, Pedro; Silva, Fernando			Graphlet-orbit Transitions (GoT): A fingerprint for temporal network comparison	PLOS ONE			English	Article							DYNAMICS	Given a set of temporal networks, from different domains and with different sizes, how can we compare them? Can we identify evolutionary patterns that are both (i) characteristic and (ii) meaningful? We address these challenges by introducing a novel temporal and topological network fingerprint named Graphlet-orbit Transitions (GoT). We demonstrate that GoT provides very rich and interpretable network characterizations. Our work puts forward an extension of graphlets and uses the notion of orbits to encapsulate the roles of nodes in each subgraph. We build a transition matrix that keeps track of the temporal trajectory of nodes in terms of their orbits, therefore describing their evolution. We also introduce a metric (OTA) to compare two networks when considering these matrices. Our experiments show that networks representing similar systems have characteristic orbit transitions. GoT correctly groups synthetic networks pertaining to well-known graph models more accurately than competing static and dynamic state-of-the-art approaches by over 30%. Furthermore, our tests on real-world networks show that GoT produces highly interpretable results, which we use to provide insight into characteristic orbit transitions.	[Aparicio, David] Univ Porto, CRACS, Fac Ciencias, R Campo Alegre,1021, P-4169007 Porto, Portugal; Univ Porto, INESC TEC, Fac Ciencias, R Campo Alegre,1021, P-4169007 Porto, Portugal	Universidade do Porto; INESC TEC; Universidade do Porto	Aparicio, D (corresponding author), Univ Porto, CRACS, Fac Ciencias, R Campo Alegre,1021, P-4169007 Porto, Portugal.	daparicio@dcc.fc.up.pt	Silva, Fernando/C-5986-2009; Silva, Fernando/ABD-2062-2020; Ribeiro, Pedro/F-9537-2011	Silva, Fernando/0000-0001-8411-7094; Aparicio, David/0000-0001-8250-041X; Ribeiro, Pedro/0000-0002-5768-1383	North Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement [NORTE-01-0145-FEDER-000020]; European Regional Development Fund (ERDF); FCT/MAP-i PhD research grant [PD/BD/105801/2014]; ERDF through the COMPETE 2020 Programme [POCI-01-0145-FEDER-006961]; National Funds through the FCT [UID/EEA/50014/2013]	North Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement; European Regional Development Fund (ERDF)(European Commission); FCT/MAP-i PhD research grant(Portuguese Foundation for Science and Technology); ERDF through the COMPETE 2020 Programme; National Funds through the FCT(Portuguese Foundation for Science and Technology)	Project "NORTE-01-0145-FEDER-000020" is financed by the North Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, and through the European Regional Development Fund (ERDF). David Aparicio is supported by a FCT/MAP-i PhD research grant [PD/BD/105801/2014].; This work is partially funded by the ERDF through the COMPETE 2020 Programme within project "POCI-01-0145-FEDER-006961", and by National Funds through the FCT as part of project UID/EEA/50014/2013. David Aparicio is supported by a FCT/MAP-i PhD research grant (PD/BD/105801/2014). We would also like to thank the reviewer for his careful reading and insightful comments that helped improve this article.	Adhikari B., 2017, P SIAM INT C DAT MIN, P417; Aliakbarpour M, 2016, ARXIV160104233; Aparicio D, 2016, IEEE ACM T COMPUTATI; Aparicio D, 2014, IEEE INT SYMP PARAL, P34, DOI 10.1109/ISPA.2014.14; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Buriol L.S., 2006, P 25 ACM SIGACT SIGM, P253, DOI DOI 10.1145/1142351.1142388; Chirico M., 2018, PHILDELPHIA CRIME DA; Choobdar S, 2012, 2012 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P147, DOI 10.1109/ASONAM.2012.34; Cook SA, 1971, P 3 ANN ACM S THEOR, P151, DOI DOI 10.1145/800157.805047; Costa LD, 2011, ADV PHYS, V60, P329, DOI 10.1080/00018732.2011.572452; De Choudhury M., 2010, P INT AAAI C WEB SOC, V4; Doroud M, 2011, EVOLUTION EGO CENTRI, P172; ERDOS P, 1960, B INT STATIST INST, V38, P343; Faisal FE, 2014, BIOINFORMATICS, V30, P1721, DOI 10.1093/bioinformatics/btu089; Finocchi I, 2014, COUNTING SMALL CLIQU; Genois M, 2015, NETW SCI, V3, P326, DOI 10.1017/nws.2015.10; Hocevar T, 2014, BIOINFORMATICS, V30, P559, DOI 10.1093/bioinformatics/btt717; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hu HB, 2009, PHYS LETT A, V373, P1105, DOI 10.1016/j.physleta.2009.02.004; Hulovatyy Y, 2015, BIOINFORMATICS, V31, P171, DOI 10.1093/bioinformatics/btv227; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Jin RM, 2007, IEEE DATA MINING, P541, DOI 10.1109/ICDM.2007.92; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Kim MS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-31; Kobler J., 2012, GRAPH ISOMORPHISM PR; Kovanen L, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/11/P11005; Leskovec J., 2008, P 14 ACM SIGKDD INT, P462, DOI DOI 10.1145/1401890.1401948; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Martin AJM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163497; Michalski R, 2011, LECT NOTES BUS INF P, V87, P197; Milenkovic T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-70; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nicosia V., 2013, TEMPORAL NETWORKS, P15, DOI DOI 10.1007/978-3-642-36461-7_2; Paredes Pedro, 2013, 2013 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining (ASONAM), P264; Pavan A, 2013, PROC VLDB ENDOW, V6, P1870, DOI 10.14778/2556549.2556569; Pinar A, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P1431, DOI 10.1145/3038912.3052597; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Ribeiro P, 2014, DATA MIN KNOWL DISC, V28, P337, DOI 10.1007/s10618-013-0303-4; Ribeiro P, 2010, LECT N BIOINFORMAT, V6293, P238, DOI 10.1007/978-3-642-15294-8_20; Risdal M., 2018, MINNEAPOLIS INCIDENT; Rocha LEC, 2010, P NATL ACAD SCI USA, V107, P5706, DOI 10.1073/pnas.0914080107; Shah N, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1055, DOI 10.1145/2783258.2783321; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Viswanath B, 2009, 2ND ACM SIGCOMM WORKSHOP ON ONLINE SOCIAL NETWORKS (WOSN 09), P37; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu G, 2012, P 8 ANN INT S WIK OP, P12, DOI DOI 10.1145/2462932.2462948; Yu WC, 2017, WSDM'17: PROCEEDINGS OF THE TENTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING, P455, DOI 10.1145/3018661.3018669; Zhu DX, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-8	53	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205497	10.1371/journal.pone.0205497	http://dx.doi.org/10.1371/journal.pone.0205497			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335791	gold, Green Published, Green Submitted			2022-12-26	WOS:000447701300037
J	Asbell, PA; DeCory, HH				Asbell, Penny A.; DeCory, Heleen H.			Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study	PLOS ONE			English	Article							BESIFLOXACIN OPHTHALMIC SUSPENSION; CATARACT-SURGERY; PARALLEL-GROUP; 0.6-PERCENT; KERATITIS; CHILDREN; EFFICACY; TRENDS; SAFETY; SUSCEPTIBILITY	The Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study evaluates in vitro antibiotic resistance among Staphylococcus aureus, coagulase-negative staphylococci (CoNS), Streptococcus pneumoniae, Pseudomonas aeruginosa, and Haemophilus influenzae isolates from ocular infections. Here we report resistance rates and trends among conjunctival-sourced ocular isolates collected across the US from 2009 through 2016. A total of 1198 conjunctival isolates (483 S. aureus, 305 CoNS, 208 H. influenzae, 118 S. pneumoniae, and 84 P. aeruginosa) were collected from patients with presumed bacterial conjunctivitis from 57 sites across 40 states. A large proportion of staphylococci demonstrated resistance to oxacillin and azithromycin, while resistance was low against the majority of antibiotics tested for S. pneumoniae, P. aeruginosa, and H. influenzae. Multidrug resistance (>= 3 antibiotic classes) was found in 30.2% of S. aureus and 39.0% of CoNS isolates, and methicillin resistance more than doubled the rate of multi-drug resistance (methicillin-resistant S. aureus [MRSA], 76.5%; methicillin-resistant CoNS isolates, 72.8%). There was a pattern of increasing mean percent resistance with increasing age by decade of life among S. aureus, MRSA, and CoNS (P <= 0.038). Over the eight-year study period, there were small yet significant decreases in resistance rates among S. aureus to azithromycin, ciprofloxacin, tobramycin, trimethoprim, and oxacillin (P <= 0.003), and among CoNS and P. aeruginosa (both P<0.05) to ciprofloxacin. These data indicate that antibiotic resistance is high, but did not increase, among conjunctival-sourced isolates collected in the US from 2009 through 2016. For certain antibiotic/pathogen combinations, there was a trend of decreased resistance, including a decrease in oxacillin resistance among S. aureus.	[Asbell, Penny A.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [DeCory, Heleen H.] Bausch Lomb, Rochester, NY 14604 USA	Icahn School of Medicine at Mount Sinai; Bausch Health; Bausch + Lomb	DeCory, HH (corresponding author), Bausch Lomb, Rochester, NY 14604 USA.	heleen.decory@bausch.com			Bausch & Lomb Incorporated; Bausch + Lomb	Bausch & Lomb Incorporated; Bausch + Lomb	The ARMOR study is funded by Bausch & Lomb Incorporated. Knowledgeable individuals from Bausch + Lomb were involved in the study design, analyzing the data, and the decision to publish this analysis. One of the authors (HH DeCory) is an employee of Bausch + Lomb, and the funder provided support in the form of employee salary. The specific roles of all authors are articulated in the 'author contributions' section. Bausch + Lomb also funded the writing assistance, which was provided by Rachel Hathcock, RN of Churchill Communications at the direction of the authors.	Adebayo A, 2011, GRAEF ARCH CLIN EXP, V249, P111, DOI 10.1007/s00417-010-1426-6; Amato M, 2013, J AAPOS, V17, P243, DOI 10.1016/j.jaapos.2012.12.151; American Academy of Ophthalmology Cornea/External Disease Panel, 2013, PREF PRACT PATT GUID; [Anonymous], 2016, PRESCRIBING INFORM; [Anonymous], 2009, PERFORMANCE STANDARD, V19; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Asbell PA., 2017, US OPHTHALMIC REV, V10, P35, DOI [10.17925/USOR.2017.10.01.35, DOI 10.17925/USOR.2017.10.01.35]; Asbell PA, 2009, AM SOC CAT REFR SURG; Asbell PA, 2008, AM SOC CAT REFR SURG; Asbell PA, 2008, AM J OPHTHALMOL, V145, P951, DOI 10.1016/j.ajo.2008.01.025; Asbell PA, 2015, JAMA OPHTHALMOL, V133, P1445, DOI 10.1001/jamaophthalmol.2015.3888; Azari AA, 2013, JAMA-J AM MED ASSOC, V310, P1721, DOI 10.1001/jama.2013.280318; Bertino JS, 2009, CLIN OPHTHALMOL, V3, P507; Block SL, 2000, ANTIMICROB AGENTS CH, V44, P1650, DOI 10.1128/AAC.44.6.1650-1654.2000; Cavuoto K, 2008, OPHTHALMOLOGY, V115, P51, DOI 10.1016/j.ophtha.2007.03.076; Chang VS, 2015, CORNEA, V34, P698, DOI 10.1097/ICO.0000000000000431; Chatterjee S, 2016, INDIAN J OPHTHALMOL, V64, P153, DOI 10.4103/0301-4738.179721; Chen FV, 2018, J AAPOS, V22, P66, DOI 10.1016/j.jaapos.2017.08.008; Clinical and Laboratory Standards Institute, 2009, METHODS DILUTION ANT; Clinical and Laboratory Standards Institute (CLSI), 2009, M100S25 CLSI; Clinical and Laboratory Standards Institute (CLSI), 2009, M100S26 CLSI; Clinical and Laboratory Standards Institute (CLSI), 2009, M100S22 CLSI; Clinical and Laboratory Standards Institute (CLSI), 2009, M100S20 CLSI; Clinical and Laboratory Standards Institute (CLSI), 2009, M100S23 CLSI; Clinical Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V9th; CLSI, 2009, M100S21 CLSI; CLSI, 2009, M100S24 CLSI; Comstock Timothy L, 2010, Paediatr Drugs, V12, P105, DOI 10.2165/11534380-000000000-00000; Dave SB, 2011, OPHTHALMOLOGY, V118, P2035, DOI 10.1016/j.ophtha.2011.03.017; DeLeon J, 2012, CLIN DRUG INVEST, V32, P303, DOI 10.2165/11632470-000000000-00000; Epling J., 2012, CLIN EVID, V2, P704; Everitt HA, 2006, BMJ-BRIT MED J, V333, P321, DOI 10.1136/bmj.38891.551088.7C; Garg P, 1999, OPHTHALMOLOGY, V106, P1319, DOI 10.1016/S0161-6420(99)00717-4; Gentile RC, 2014, OPHTHALMOLOGY, V121, P1634, DOI 10.1016/j.ophtha.2014.02.001; Haas W, 2011, AM J OPHTHALMOL, V152, P567, DOI 10.1016/j.ajo.2011.03.010; Holland EJ, 2014, OPHTHALMOLOGY, V121, pS1, DOI 10.1016/j.ophtha.2014.06.049; Hovding G, 2008, ACTA OPHTHALMOL, V86, P5, DOI 10.1111/j.1600-0420.2007.01006.x; Hsu HY, 2013, AM J OPHTHALMOL, V155, P36, DOI 10.1016/j.ajo.2012.06.024; Karpecki P, 2009, CLIN THER, V31, P514, DOI 10.1016/j.clinthera.2009.03.010; Kowalski RP, 2005, OPHTHALMOLOGY, V112, P1987, DOI 10.1016/j.ophtha.2005.06.025; Malhotra R, 2013, DRUGS R&D, V13, P243, DOI 10.1007/s40268-013-0029-1; McDonald M, 2010, J CATARACT REFR SURG, V36, P1588, DOI 10.1016/j.jcrs.2010.06.028; McDonald MB, 2009, OPHTHALMOLOGY, V116, P1615, DOI 10.1016/j.ophtha.2009.05.014; Morris TW, 2011, CLIN OPHTHALMOL, V5, P1359, DOI 10.2147/OPTH.S23518; Moshirfar M, 2006, J CATARACT REFR SURG, V32, P515, DOI 10.1016/j.jcrs.2005.12.108; Moss JM, 2010, OPHTHALMOLOGY, V117, P2141, DOI 10.1016/j.ophtha.2010.02.030; Mueller JB, 2008, EMERG MED CLIN N AM, V26, P57, DOI 10.1016/j.emc.2007.10.004; Ni NN, 2015, CORNEA, V34, P296, DOI 10.1097/ICO.0000000000000352; Ohnsman CM, 2007, J PEDIAT OPHTH STRAB, V44, P101, DOI 10.3928/01913913-20070301-03; Olson R, 2010, CLIN OPHTHALMOL, V4, P1505, DOI 10.2147/OPTH.S14333; Patel PB, 2007, ACAD EMERG MED, V14, P1, DOI [10.1197/j.aem.2006.08.006, 10.1111/j.1553-2712.2007.tb00359.x]; Sharma S, 2011, INDIAN J MED MICROBI, V29, P218, DOI 10.4103/0255-0857.83903; Sheikh A., 2012, COCHRANE DB SYST REV, V9; Silverstein BE, 2011, CLIN THER, V33, P13, DOI 10.1016/j.clinthera.2010.12.004; Tepedino ME, 2009, CURR MED RES OPIN, V25, P1159, DOI [10.1185/03007990902837919, 10.1185/03007990902837919 ]; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Wilhelmus MR, 2003, ARCH OPHTHALMOL-CHIC, V121, P1229, DOI 10.1001/archopht.121.9.1229	58	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205814	10.1371/journal.pone.0205814	http://dx.doi.org/10.1371/journal.pone.0205814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335799	Green Submitted, Green Published, gold			2022-12-26	WOS:000447701300060
J	Inglis, PW; Pappas, MDR; Resende, LV; Grattapaglia, D				Inglis, Peter W.; Pappas, Marilia de Castro R.; Resende, Lucileide V.; Grattapaglia, Dario			Fast and inexpensive protocols for consistent extraction of high quality DNA and RNA from challenging plant and fungal samples for high-throughput SNP genotyping and sequencing applications	PLOS ONE			English	Article							POLYSACCHARIDE; PRIMERS; GENOME; PCR	Modern genotyping techniques, such as SNP analysis and genotyping by sequencing (GBS), are hampered by poor DNA quality and purity, particularly in challenging plant species, rich in secondary metabolites. We therefore investigated the utility of a pre-wash step using a buffered sorbitol solution, prior to DNA extraction using a high salt CTAB extraction protocol, in a high throughput or miniprep setting. This pre-wash appears to remove interfering metabolites, such as polyphenols and polysaccharides, from tissue macerates. We also investigated the adaptability of the sorbitol pre-wash for RNA extraction using a lithium chloride-based protocol. The method was successfully applied to a variety of tissues, including leaf, cambium and fruit of diverse plant species including annual crops, forest and fruit trees, herbarium leaf material and lyophilized fungal mycelium. We consistently obtained good yields of high purity DNA or RNA in all species tested. The protocol has been validated for thousands of DNA samples by generating high data quality in dense SNP arrays. DNA extracted from Eucalyptus spp. leaf and cambium as well as mycelium from Trichoderma spp. was readily digested with restriction enzymes and performed consistently in AFLP assays. Scaled-up DNA extractions were also suitable for long read sequencing. Successful RNA quality control and good RNA-Seq data for Eucalyptus and cashew confirms the effectiveness of the sorbitol buffer pre-wash for high quality RNA extraction.	[Inglis, Peter W.; Pappas, Marilia de Castro R.; Resende, Lucileide V.; Grattapaglia, Dario] Embrapa Genet Resources & Biotechnol, Plant Genet Lab, Brasilia, DF, Brazil; [Grattapaglia, Dario] Univ Catolica Brasilia, Genom Sci & Biotechnol Program, Brasilia, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Catolica de Brasilia	Grattapaglia, D (corresponding author), Embrapa Genet Resources & Biotechnol, Plant Genet Lab, Brasilia, DF, Brazil.; Grattapaglia, D (corresponding author), Univ Catolica Brasilia, Genom Sci & Biotechnol Program, Brasilia, DF, Brazil.	dario.grattapaglia@embrapa.br	Grattapaglia, Dario/AAB-6805-2020; Inglis, Peter/HGB-7460-2022; Grattapaglia, Dario/B-5864-2014	Grattapaglia, Dario/0000-0002-0050-970X; Inglis, Peter/0000-0002-5513-8918; Grattapaglia, Dario/0000-0002-0050-970X; Pappas, Marilia/0000-0002-4680-0199	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq competitive grant) [402659/2013-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq competitive grant)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was funded by a grant to D.G. from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq competitive grant 402659/2013-9). www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar-Mohammadian M, 2018, METHODSX, V5, P352, DOI 10.1016/j.mex.2018.03.008; Aljanabi SM, 1999, PLANT MOL BIOL REP, V17, P281, DOI 10.1023/A:1007692929505; Barman P, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0775-9; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Cheng T, 2016, MOL ECOL RESOUR, V16, P138, DOI 10.1111/1755-0998.12438; Couch J. A., 1990, Plant Molecular Biology Reporter, V8, P8, DOI 10.1007/BF02668875; Csaikl UM, 1998, PLANT MOL BIOL REP, V16, P69, DOI 10.1023/A:1007428009556; DEMEKE T, 1992, BIOTECHNIQUES, V12, P332; Desjardins P., 2010, JOVE-J VIS EXP, V45, P2565, DOI DOI 10.3791/2565; DO N, 1991, BIOTECHNIQUES, V10, P162; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Grattapaglia D., 2011, BMC P, V5, pP45, DOI DOI 10.1186/1753-6561-5-S7-P45; Grattapaglia D, 2017, PLANT ANIMAL GENOME; Guillemaut P, 1992, PLANT MOL BIOL REP, V10, P60, DOI 10.1007/BF02669265; Healey A, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-21; Inglis PW, 2016, EMBRAPA COMUNICADO T, V203; JOHN ME, 1992, NUCLEIC ACIDS RES, V20, P2381, DOI 10.1093/nar/20.9.2381; KATTERMAN FRH, 1983, PREP BIOCHEM, V13, P347, DOI 10.1080/00327488308068177; Lade BD, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-457; Li HaiWen, 2001, Plant Molecular Biology Reporter, V19, P183, DOI 10.1007/BF02772162; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Pandey RN, 1996, PLANT MOL BIOL REP, V14, P17, DOI 10.1007/BF02671898; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Pessoa-Filho M, 2018, PLANT ANIMAL GENOME, pP1156; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Russell A, 2010, TAXON, V59, P389, DOI 10.1002/tax.592005; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; Scott KD, 1996, BIOTECHNIQUES, V20, P974; Silva-Junior OB, 2017, PLANT ANIMAL GENOME; Silva OB, 2015, NEW PHYTOL, V206, P1527, DOI 10.1111/nph.13322; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Stielow JB, 2015, PERSOONIA, V35, P242, DOI 10.3767/003158515X689135; Storchova H, 2000, TAXON, V49, P79, DOI 10.2307/1223934; Tel-Zur N, 1999, PLANT MOL BIOL REP, V17, P249, DOI 10.1023/A:1007656315275; Xin ZG, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-26	37	66	68	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206085	10.1371/journal.pone.0206085	http://dx.doi.org/10.1371/journal.pone.0206085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335843	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300094
J	Tonoyama, Y; Tsukada, M; Imai, Y; Sanada, M; Aota, S; Oka, G; Sugiura, S; Hori, N; Kawachi, H; Shimizu, Y; Shimizu, N				Tonoyama, Yasuhiro; Tsukada, Masaki; Imai, Yoshimasa; Sanada, Matoki; Aota, Syota; Oka, Gouhei; Sugiura, Shozo; Hori, Nobuaki; Kawachi, Hiroyuki; Shimizu, Yoshiko; Shimizu, Nobuyoshi			Establishment of a quantitative in vivo method for estimating adipose tissue volumes and the effects of dietary soy sauce oil on adipogenesis in medaka, Oryzias latipes	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; 3T3-L1 ADIPOGENESIS; RAT ADIPOCYTES; FATTY-ACIDS; ALPHA; GENISTEIN; OBESITY; LIPOLYSIS	Adipose tissue, which is conserved in higher eukaryotes, plays central roles in controlling the body's energy balance, including excess energy storage and energy expenditure during starvation. In adipogenesis, intranuclear receptor, peroxisome proliferator-activated receptor gamma (PPAR gamma) is a key molecule, and PPAR gamma agonists can promote adipogenesis. Many studies on the in vitro screening of PPAR gamma agonists with compounds derived from various materials have been reported; however, in vivo assays for quick examination of these feeding effects have not been established. In this study, we developed a technique using a lipophilic fluorescent reagent, Nile red to quantitatively estimate the adipose tissue volumes by using Japanese rice fish, medaka (Oryzias latipes) and studied effects of dietary soy sauce oil (SSO), which is a discarded by-product from Japanese traditional food and is known to have PPAR gamma-agonistic activity, on adipogenesis. We found that SSO feeding increased the adipose tissue volumes, and the expression levels of adipogenesis-related genes increased in these medaka larvae. These results suggest that SSO feeding increases the adipose tissue volumes through adipogenesis promotion by PPAR gamma-agonistic activity in medaka, and medaka is a powerful model for studying adipogenesis. Furthermore, our study also demonstrates the availability of SSO as a dietary additive for farmed fish.	[Tonoyama, Yasuhiro; Tsukada, Masaki; Imai, Yoshimasa; Sanada, Matoki; Aota, Syota; Kawachi, Hiroyuki; Shimizu, Nobuyoshi] Nagahama Inst Biosci & Technol, Grad Sch Biosci, Nagahama, Shiga, Japan; [Oka, Gouhei] Nagahama Inst Biosci & Technol, Div Admiss Ctr, Nagahama, Shiga, Japan; [Sugiura, Shozo] Univ Shiga Prefecture, Sch Environm Sci, Hikone, Shiga, Japan; [Hori, Nobuaki] Nagahama Inst Biosci & Technol, Div Res Management & External Cooperat, Nagahama, Shiga, Japan; [Shimizu, Yoshiko] Kyorin Univ, Fac Hlth Sci, Mitaka, Tokyo, Japan; [Tonoyama, Yasuhiro] Keio Univ, Branch Lab Gene Med, Sch Med, Tsukuba, Ibaraki, Japan	University Shiga Prefecture; Kyorin University; Keio University	Tonoyama, Y; Kawachi, H (corresponding author), Nagahama Inst Biosci & Technol, Grad Sch Biosci, Nagahama, Shiga, Japan.; Tonoyama, Y (corresponding author), Keio Univ, Branch Lab Gene Med, Sch Med, Tsukuba, Ibaraki, Japan.	tonoyama@dmb.med.keio.ac.jp; hkawachi@nagahama-i-bio.ac.jp		KAWACHI, HIROYUKI/0000-0002-7508-5569; Tonoyama, Yasuhiro/0000-0003-3583-2248	local government of Nagahama-city, Shiga, Japan; JSPS KAKENHI Grant [26860197]	local government of Nagahama-city, Shiga, Japan; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors would like to thank the local government of Nagahama-city, Shiga, Japan, for funding. Additionally, this work was also supported by JSPS KAKENHI Grant Number 26860197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Dang ZC, 2003, J BIOL CHEM, V278, P962, DOI 10.1074/jbc.M209483200; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Flynn EJ, 2009, J LIPID RES, V50, P1641, DOI 10.1194/jlr.M800590-JLR200; Gorocica-Buenfil MA, 2007, J ANIM SCI, V85, P3355, DOI 10.2527/jas.2007-0172; Harmon AW, 2002, BIOCHEM J, V367, P203, DOI 10.1042/BJ20020300; Harmon AW, 2001, AM J PHYSIOL-CELL PH, V280, pC807, DOI 10.1152/ajpcell.2001.280.4.C807; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; JOHNSON PR, 1972, J LIPID RES, V13, P2; Kandulska K, 1999, REPROD NUTR DEV, V39, P497, DOI 10.1051/rnd:19990408; Kawachi H, 2009, TRACE NUTR RES, V26, P65; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kobayashi Daisuke, 2008, Briefings in Functional Genomics & Proteomics, V7, P415, DOI 10.1093/bfgp/eln044; Kogame M, 2006, J MED INVESTIG, V53, P238, DOI 10.2152/jmi.53.238; Kondo H, 2010, FISHERIES SCI, V76, P167, DOI 10.1007/s12562-009-0193-y; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lin F, 2015, GENE, V573, P296, DOI 10.1016/j.gene.2015.07.059; Lusis AJ, 2003, TRENDS CARDIOVAS MED, V13, P309, DOI 10.1016/j.tcm.2003.08.001; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mattson MP, 2010, AGEING RES REV, V9, P69, DOI 10.1016/j.arr.2009.11.004; Nakashimada Y, 2002, BIO IND, V60, P807; Naruse K, 2009, MEDAKA BIOL MANAGEME, P9; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Nishikawa K, 1999, JPN J SOC FOOD CHEM, V6, P135; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Okuyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066597; Ono S., 2009, AQUACULT SCI, V57, P149; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Shah N, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1055, DOI 10.1145/2783258.2783321; Sitepu IR, 2012, J MICROBIOL METH, V91, P321, DOI 10.1016/j.mimet.2012.09.001; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Sugiura S, 2015, AQUACULT SCI, V63, P291; Szkudelska K, 2000, J STEROID BIOCHEM, V75, P265, DOI 10.1016/S0960-0760(00)00172-2; Tabuchi K, 2013, J BREW SOC JPN, V108, P84; Takahashi N, 2002, FEBS LETT, V514, P315, DOI 10.1016/S0014-5793(02)02390-6; Takeda H, 2008, DEV GROWTH DIFFER, V50, pS157, DOI 10.1111/j.1440-169X.2008.00992.x; Taniguchi Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r116; Tiefenbach J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009797; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Torstensen BE, 2011, BRIT J NUTR, V106, P633, DOI 10.1017/S0007114511000729; WAKAMATSU Y, 1997, FISH BIOL J MEDAKA, V9, P49; Watkins AM, 2015, MOL CELL ENDOCRINOL, V400, P90, DOI 10.1016/j.mce.2014.10.020; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yogosawa S, 2013, DIABETES, V62, P115, DOI 10.2337/db12-0295; Zanella I, 2015, EUR J NUTR, V54, P1095, DOI 10.1007/s00394-014-0786-9	52	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205888	10.1371/journal.pone.0205888	http://dx.doi.org/10.1371/journal.pone.0205888			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335858	Green Submitted, Green Published, gold			2022-12-26	WOS:000447701300068
J	Zipori, AB; Colpa, L; Wong, AMF; Cushing, SL; Gordon, KA				Zipori, Anat Bachar; Colpa, Linda; Wong, Agnes M. F.; Cushing, Sharon L.; Gordon, Karen A.			Postural stability and visual impairment: Assessing balance in children with strabismus and amblyopia	PLOS ONE			English	Article							BRUININKS-OSERETSKY TEST; EARLY-ONSET STRABISMUS; SENSORY ORGANIZATION; MOTOR PROFICIENCY; EYE SURGERY; BODY SWAY; AGE; VISION; STABILIZATION; EQUILIBRIUM	Background Vision plays an important role in controlling posture and balance in children. Reduced postural control has been reported in children with strabismus, but little has been reported specifically in amblyopia. Objective To investigate whether children with amblyopia have reduced balance compared to both children with strabismus without amblyopia and healthy controls. Study design and methods In this cross-sectional study, a total of 56 patients and healthy controls were recruited from the Ophthalmology and Otolaryngology Clinics at The Hospital for Sick Children, Toronto. Participants were divided into three groups: (1) 18 with unilateral amblyopia (strabismic amblyopia or mixed mechanism); (2) 16 with strabismus only without amblyopia; and (3) 22 visually-normal controls. The primary outcome was the balance performance as measured by the balance subtest of the Bruininks-Oseretsky Test of Motor Proficiency 2 [BOT2]. Results The age and gender-adjusted BOT2 balance scores were significantly reduced in the amblyopia group (mean score 9.0 +/- 3.1 SD) and the strabismus without amblyopia group (mean score 8.6 +/- 2.4 SD) compared to visually normal controls (mean score 18.9 +/- 4.2) (p< 0.0001), but no statistical difference was demonstrated between the two patient groups (p = 0.907). Further subgroup analysis of the strabismus only group did not reveal a statistically significant difference in performance on BOT2 balance score between strabismus only patients with good stereopsis 60 sec or better (BOT2 mean score 9.8 +/- 3.0 SD) to patients with 3000 sec or no stereopsis (BOT2 mean score 7.9 +/- 1.7) (p = 0.144). Conclusion Our findings suggest that normal vision plays an important role in the development and maintenance of balance control. When normal binocular vision is disrupted in childhood in strabismus and/or amblyopia, not only is the vision affected, but balance is also reduced. Our results indicate that the presence of even mild binocular discordance/dysfunction (patients with intermittent strabismus and good stereopsis) may lead to postural instability.	[Zipori, Anat Bachar; Wong, Agnes M. F.] Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Zipori, Anat Bachar] Tel Aviv Univ, Sackler Fac Med, Dept Ophthalmol, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; [Colpa, Linda; Wong, Agnes M. F.] Hosp Sick Children, Eye Movement & Vis Neurosci Lab, Toronto, ON, Canada; [Cushing, Sharon L.] Hosp Sick Children, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Cushing, Sharon L.; Gordon, Karen A.] Hosp Sick Children, Archies Cochlear Implant Lab, Cochlear Implant Program, Toronto, ON, Canada; [Cushing, Sharon L.; Gordon, Karen A.] Hosp Sick Children, Commun Disorders, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Gordon, KA (corresponding author), Hosp Sick Children, Archies Cochlear Implant Lab, Cochlear Implant Program, Toronto, ON, Canada.; Gordon, KA (corresponding author), Hosp Sick Children, Commun Disorders, Toronto, ON, Canada.	karen.gordon@sickkids.ca		Bachar Zipori, Anat/0000-0003-2757-7996				Aki E, 2007, PERCEPT MOTOR SKILL, V104, P1328, DOI 10.2466/PMS.104.4.1328-1336; Anoh-Tanon MJ, 2000, PEDIATR NEUROL, V23, P49, DOI 10.1016/S0887-8994(00)00140-5; Borel L, 2001, NEUROREPORT, V12, P3137, DOI 10.1097/00001756-200110080-00031; BRANDT T, 1976, ARCH PSYCHIAT NERVEN, V223, P1, DOI 10.1007/BF00367449; Bucci MP, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3339/fnsys.2016.00067, 10.3389/fnsys.2016.00067]; Bucci MP, 2009, INVEST OPHTH VIS SCI, V50, P4678, DOI 10.1167/iovs.09-3537; Buckley JG, 2010, INVEST OPHTH VIS SCI, V51, P2487, DOI 10.1167/iovs.09-3858; BUISSERET P, 1995, PHYSIOL REV, V75, P323, DOI 10.1152/physrev.1995.75.2.323; Cushing SL, 2008, ARCH OTOLARYNGOL, V134, P34, DOI 10.1001/archoto.2007.16; Deitz Jean C, 2007, Phys Occup Ther Pediatr, V27, P87, DOI 10.1300/J006v27n04_06; Dickmann A, 2016, NEUROSCI LETT, V623, P28, DOI 10.1016/j.neulet.2016.04.041; Drover JR, 2008, J AAPOS, V12, P136, DOI 10.1016/j.jaapos.2007.08.013; Duger T, 1999, Pediatr Rehabil, V3, P125; EDWARDS AS, 1946, J EXP PSYCHOL, V36, P526, DOI 10.1037/h0059909; Engel-Yeger B, 2008, DISABIL REHABIL, V30, P243, DOI 10.1080/09638280701257221; FORSSBERG H, 1982, J NEUROSCI, V2, P545; FOUDRIAT BA, 1993, INT J PEDIATR OTORHI, V27, P255, DOI 10.1016/0165-5876(93)90231-Q; FOX CR, 1990, PERCEPT PSYCHOPHYS, V47, P409, DOI 10.3758/BF03208174; Gaertner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060341; Gaertner C, 2013, INVEST OPHTH VIS SCI, V54, P529, DOI 10.1167/iovs.12-10586; Gibbs J, 2007, ARCH DIS CHILD, V92, P534, DOI 10.1136/adc.2005.088054; Glaser SR, 2002, ARCH OPHTHALMOL-CHIC, V120, P268; Henriksson NG, 1966, ACTA OTOLARYNGO S224; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; Horak FB, 2010, RESTOR NEUROL NEUROS, V28, P57, DOI 10.3233/RNN-2010-0515; Jeon HS, 2017, GRAEF ARCH CLIN EXP, V255, P2487, DOI 10.1007/s00417-017-3798-3; Kapoula Z, 2006, EXP BRAIN RES, V173, P438, DOI 10.1007/s00221-006-0382-1; Largo RH, 2001, DEV MED CHILD NEUROL, V43, P436, DOI 10.1017/S0012162201000810; Le TT, 2006, VISION RES, V46, P3586, DOI 10.1016/j.visres.2006.06.018; Legrand A, 2012, GRAEF ARCH CLIN EXP, V250, P849, DOI 10.1007/s00417-011-1845-z; Legrand A, 2011, NEUROSCI LETT, V501, P96, DOI 10.1016/j.neulet.2011.06.056; LENNERSTRAND G, 1988, GRAEF ARCH CLIN EXP, V226, P172, DOI 10.1007/BF02173311; Lions C, 2013, GRAEF ARCH CLIN EXP, V251, P2219, DOI 10.1007/s00417-013-2372-x; LOSSE A, 1991, DEV MED CHILD NEUROL, V33, P55, DOI 10.1111/j.1469-8749.1991.tb14785.x; Lucas BR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-135; Matsuo T, 2006, ACTA MED OKAYAMA, V60, P13; Matsuo T, 2010, INVEST OPHTH VIS SCI, V51, P6341, DOI 10.1167/iovs.10-5840; Miller JM, 2012, PEDIATRICS, V130, P983, DOI 10.1542/peds.2012-2548; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Nolan L, 2005, DEV MED CHILD NEUROL, V47, P449, DOI 10.1017/S0012162205000873; ODENRICK P, 1984, DEV MED CHILD NEUROL, V26, P495; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Rajendran V, 2011, ITAL J PEDIATR, V37, P1824; Rutkowska I, 2015, J HUM KINET, V48, P99, DOI 10.1515/hukin-2015-0096; Steinbach M J, 1988, J Pediatr Ophthalmol Strabismus, V25, P115; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; VANPARYS JAP, 1976, AGRESSOLOGIE, V17, P95; Venetsanou F, 2007, DEV MED CHILD NEUROL, V49, P846, DOI 10.1111/j.1469-8749.2007.00846.x; Vertigo Brandt T., 2003, ITS MULTISENSORY SYN; WEISSLER PG, 1972, J SPEECH HEAR RES, V15, P665, DOI 10.1044/jshr.1503.665; Weisz S, 1938, J NERV MENT DIS, V88, P150, DOI 10.1097/00005053-193808000-00002	52	28	28	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205857	10.1371/journal.pone.0205857	http://dx.doi.org/10.1371/journal.pone.0205857			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335817	Green Published, gold, Green Submitted			2022-12-26	WOS:000447701300064
J	del Rey, J; Vidal, F; Ramirez, L; Borras, N; Corrales, I; Garcia, I; Martinez-Pasarell, O; Fernandez, SF; Garcia-Cruz, R; Pujol, A; Plaja, A; Salaverria, I; Oliver-Bonet, M; Benet, J; Navarro, J				del Rey, Javier; Vidal, Francisco; Ramirez, Lorena; Borras, Nina; Corrales, Irene; Garcia, Iris; Martinez-Pasarell, Olga; Fernandez, Silvia F.; Garcia-Cruz, Raquel; Pujol, Aida; Plaja, Alberto; Salaverria, Itziar; Oliver-Bonet, Maria; Benet, Jordi; Navarro, Joaquima			Novel Double Factor PGT strategy analyzing blastocyst stage embryos in a single NGS procedure	PLOS ONE			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; COMPARATIVE GENOMIC HYBRIDIZATION; SEQUENCING-BASED PROTOCOL; PHI-29 DNA-POLYMERASE; LIVE BIRTHS; IN-VITRO; ANEUPLOIDY; DISEASE; AMPLIFICATION; IMPLANTATION	In families at risk from monogenic diseases affected offspring, it is fundamental the development of a suitable Double Factor Preimplantation Genetic Testing (DF-PGT) method for both single-gene analysis and chromosome complement screening. Aneuploidy is not only a major issue in advanced-maternal-age patients and balanced translocation carriers, but also the aneuploidy rate is extremely high in patients undergoing in vitro fertilization (IVF), even in young donors. To adequate NGS technology to the DF-PGT strategy four different whole genome amplification systems (Sureplex, MALBAC, and two multiple displacement amplification systems-MDA) were tested using TruSight One panel on cell lines and blastocyst trophectoderm biopsies-TE. Embryo cytogenetic status was analyzed by Nexus software. Sureplex and MALBAC DNA products were considered not suitable for PGT diagnosis due to inconsistent and poor results on Trusight one (TSO) panel. Results obtained with both MDA based methods (GEH-MDA and RG-MDA) were appropriate for direct mutation detection by TSO NGS platform. Nevertheless, RG-MDA amplification products showed better coverage and lower ADO rates than GEH-MDA. The present work also demonstrates that the same TSO sequencing data is suitable not only for the direct mutation detection, but also for the indirect mutation detection by linkage analysis of informative SNPs. The present work also demonstrates that Nexus software is competent for the detection of CNV by using with TSO sequencing data from RG-MDA products, allowing for the whole cytogenetic characterization of the embryos. In conclusion, successfully development of an innovative and promising DF-PGT strategy using TSO-NGS technology in TE biopsies, performed in-house in a single laboratory experience, has been done in the present work. Additional studies should be performed before it could be used as a diagnostic alternative in order to validate this approach for the detection of chromosomal aneuploidies.	[del Rey, Javier; Pujol, Aida; Plaja, Alberto; Salaverria, Itziar; Oliver-Bonet, Maria; Benet, Jordi; Navarro, Joaquima] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular & Genet Med, Fac Med, Bellaterra, Spain; [Vidal, Francisco; Ramirez, Lorena; Borras, Nina; Corrales, Irene; Garcia, Iris] Blood & Tissue Bank, Congenital Coagulopathies, Barcelona, Spain; [Vidal, Francisco] UAB, VHIR, Vall dHebron Res Inst, Mol Diag & Therapy, Barcelona, Spain; [Vidal, Francisco] ISCIII, CIBER Enfermedades Cardiovasc CIBERCV, Madrid, Spain; [Martinez-Pasarell, Olga] Hosp St Pau & Santa Creu, Fundacio Puigvert, Barcelona, Spain; [Fernandez, Silvia F.; Garcia-Cruz, Raquel] Ctr Embryo Med, Barcelona, Spain; [Pujol, Aida] CIRH, Eugin Grp, Barcelona, Spain; [Plaja, Alberto] Hosp Valle De Hebron, Area Genet Clin & Mol, Barcelona, Spain; [Salaverria, Itziar] Ctr Invest Biomed Red Canc, Hosp Clin, Inst Invest Biomed August Pi Sunyer, Hematopathol Unit, Barcelona, Spain	Autonomous University of Barcelona; Fundacio Banc Sang Teixits de les Illes Balears; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Salud Carlos III; Fundacio Puigvert; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Navarro, J (corresponding author), Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular & Genet Med, Fac Med, Bellaterra, Spain.	joaquima.navarro@uab.cat		Benet, Jordi/0000-0001-6185-2555; Garcia Martinez, Iris/0000-0001-6656-3322; Oliver-Bonet, Maria/0000-0001-5635-6741; Corrales Insa, Irene/0000-0002-0647-0340; DEL REY AZPIRI, JAVIER/0000-0001-7887-7871; Vidal, Francisco/0000-0001-8089-4945	Fondo de Investigaciones Sanitarias, Instituto Carlos III-Fondo Europeo de Desarrollo Regional (FEDER) [PI 080012, PI 1100625]; Generalitat de Catalunya [2014SGR0903]	Fondo de Investigaciones Sanitarias, Instituto Carlos III-Fondo Europeo de Desarrollo Regional (FEDER); Generalitat de Catalunya(Generalitat de Catalunya)	This study was funded by the Fondo de Investigaciones Sanitarias, Instituto Carlos III-Fondo Europeo de Desarrollo Regional (FEDER) (PI 080012, PI 1100625) to JN and Grup de Suport a la Recerca of the Generalitat de Catalunya (2014SGR0903) to JB.	Baart EB, 2006, HUM REPROD, V21, P223, DOI 10.1093/humrep/dei291; Biesecker LG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-128; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Borgstrom E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171566; Capalbo A, 2015, EUR J HUM GENET, V23, P901, DOI 10.1038/ejhg.2014.222; Codina-Pascual M, 2006, MOL HUM REPROD, V12, P123, DOI 10.1093/molehr/gal007; Daina G, 2015, PRENATAL DIAG, V35, P1301, DOI 10.1002/pd.4691; Daina G, 2014, EUR J HUM GENET, V22, P202, DOI 10.1038/ejhg.2013.106; de Bourcy CFA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105585; De Rycke M, 2015, HUM REPROD, V30, P1763, DOI 10.1093/humrep/dev122; Deleye L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11711; Fan JM, 2015, REPROD BIOMED ONLINE, V31, P62, DOI 10.1016/j.rbmo.2015.03.010; Fiorentino F, 2014, FERTIL STERIL, V101, P1375, DOI 10.1016/j.fertnstert.2014.01.051; Fragouli E, 2010, FERTIL STERIL, V94, P875, DOI 10.1016/j.fertnstert.2009.04.053; Gimenez C, 2015, REPROD BIOMED ONLINE, V31, P770, DOI 10.1016/j.rbmo.2015.08.017; Handyside AH, 2010, J MED GENET, V47, P651, DOI 10.1136/jmg.2009.069971; Harton GL, 2013, FERTIL STERIL, V100, P1695, DOI 10.1016/j.fertnstert.2013.07.2002; Huang J, 2016, FERTIL STERIL, V105, P1532, DOI 10.1016/j.fertnstert.2016.01.040; Huang L, 2015, ANNU REV GENOM HUM G, V16, P79, DOI 10.1146/annurev-genom-090413-025352; Konstantinidis M, 2015, REPROD BIOMED ONLINE, V31, P394, DOI 10.1016/j.rbmo.2015.05.018; Kumar G, 2008, BIOTECHNIQUES, V44, P879, DOI 10.2144/000112755; Kung A, 2015, REPROD BIOMED ONLINE, V31, P760, DOI 10.1016/j.rbmo.2015.09.002; Natesan SA, 2014, REPROD BIOMED ONLINE, V29, P600, DOI 10.1016/j.rbmo.2014.07.007; Natesan SA, 2014, GENET MED, V16, P838, DOI 10.1038/gim.2014.45; Obradors A, 2008, HUM REPROD, V23, P1949, DOI 10.1093/humrep/den201; Obradors A, 2010, FERTIL STERIL, V93, P675, DOI 10.1016/j.fertnstert.2009.08.050; Peters BA, 2015, GENOME RES, V25, P426, DOI 10.1101/gr.181255.114; Ramos L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113223; Ramos L, 2014, FERTIL STERIL, V101, P488, DOI 10.1016/j.fertnstert.2013.10.031; Rius M, 2010, HUM REPROD, V25, P1824, DOI 10.1093/humrep/deq118; Rius M, 2011, FERTIL STERIL, V96, P134, DOI 10.1016/j.fertnstert.2011.04.052; Rubio C, 2003, HUM REPROD, V18, P182, DOI 10.1093/humrep/deg015; Scott RT, 2013, FERTIL STERIL, V100, P624, DOI 10.1016/j.fertnstert.2013.04.039; Strien J, 2013, MOL BIOTECHNOL, V54, P1048, DOI 10.1007/s12033-013-9660-x; Tortoriello DV, 2016, J ASSIST REPROD GEN, V33, P1467, DOI 10.1007/s10815-016-0766-5; Treff NR, 2017, ANNU REV GENOM HUM G, V18, P189, DOI 10.1146/annurev-genom-091416-035508; Treff NR, 2013, FERTIL STERIL, V99, P1377, DOI 10.1016/j.fertnstert.2012.12.018; Voullaire L, 2002, MOL HUM REPROD, V8, P1035, DOI 10.1093/molehr/8.11.1035; Yan LY, 2015, P NATL ACAD SCI USA, V112, P15964, DOI 10.1073/pnas.1523297113; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	40	6	6	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205692	10.1371/journal.pone.0205692	http://dx.doi.org/10.1371/journal.pone.0205692			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332465	Green Published, Green Submitted, gold			2022-12-26	WOS:000447638200061
J	Beydoun, MA; Fanelli-Kuczmarski, MT; Poti, J; Allen, A; Beydoun, HA; Evans, MK; Zonderman, AB				Beydoun, May A.; Fanelli-Kuczmarski, Marie T.; Poti, Jennifer; Allen, Allyssa; Beydoun, Hind A.; Evans, Michele K.; Zonderman, Alan B.			Longitudinal change in the diet's monetary value is associated with its change in quality and micronutrient adequacy among urban adults	PLOS ONE			English	Article							ENERGY-DENSE DIETS; UK WOMENS COHORT; UNITED-STATES; SOCIOECONOMIC-STATUS; NUTRITIONAL QUALITY; FOOD PURCHASES; FRENCH ADULTS; HEALTHY DIET; COST CONSTRAINT; US ADULTS	Background Reducing diet costs may lead to the selection of energy-dense foods, such as refined grains or foods high in added sugars and/or fats, which can lower overall dietary quality. We examined the longitudinal association between the monetary value of the diet (MVD) and the overall dietary quality across sex, race and income groups. Methods and findings Longitudinal data from 1,466 adult urban participants from Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study were used. Healthy Eating Index-2010 (HEI-2010) and Mean Adequacy Ratio (MAR) were computed and a national food price database was used to estimate MVD. Multiple linear regression analyses were conducted linking annual rates of change (Delta) in MVD to Delta HEI-2010 and Delta MAR, stratifying by sex, race and income groups. Among key findings, Delta HEI-2010 was comparable across socio-demographic groups, while Delta MAR was higher among women and individuals above poverty. Adjusting for key covariates, Delta MVD was positively associated with both Delta HEI-2010 and Delta MAR, and with a consistently stronger association among individuals above poverty, specifically for the total proteins and empty calories components of HEI-2010 and several nutrient adequacy ratios (NARs: vitamins C, E, B-6 and Zinc). Delta MVD-Delta MAR association was stronger in women, mainly influenced by Delta MVD's positive associations with B-vitamins, copper, calcium, magnesium and phosphorus NARs. Delta MVD-Delta vitamin D NAR's positive relationship was stronger among Whites, while Delta MVD-Delta vitamin B-12 NAR's association was stronger among African-Americans. Conclusions In sum, a potential increase in MVD may have a stronger impact on dietary quality among urban adult women and above-poverty individuals.	[Beydoun, May A.; Evans, Michele K.; Zonderman, Alan B.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Fanelli-Kuczmarski, Marie T.] Univ Delaware, Dept Behav Hlth & Nutr, Newark, DE USA; [Poti, Jennifer] Univ North Carolina Chapel Hill, Dept Nutr, Chapel Hill, NC USA; [Poti, Jennifer] Univ North Carolina Chapel Hill, Carolina Populat Ctr, Chapel Hill, NC USA; [Allen, Allyssa] Ctr Medicare & Medicaid Serv CMS, Woodlawn, MD USA; [Beydoun, Hind A.] Johns Hopkins Univ, Dept Med, Johns Hopkins Med Inst, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Delaware; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Centers for Medicare & Medicaid Services; Johns Hopkins University; Johns Hopkins Medicine	Beydoun, MA (corresponding author), NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	baydounm@mail.nih.gov	Evans, Michele Kim/AAE-4776-2019	Evans, Michele/0000-0002-8546-2831; Poti, Jennifer/0000-0002-7651-3625; Kuczmarski, Marie/0000-0001-6903-3386	Intramural Research Program of the NIH, National Institute on Aging; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000513] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported entirely by the Intramural Research Program of the NIH, National Institute on Aging.	Aggarwal A, 2011, EUR J CLIN NUTR, V65, P1059, DOI 10.1038/ejcn.2011.72; Aggarwal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037533; Agriculture. USDo, 2011, FOOD SPEND ADJ REC T; Andrieu E, 2006, EUR J CLIN NUTR, V60, P434, DOI 10.1038/sj.ejcn.1602331; Appelhans BM, 2012, AM J PREV MED, V42, P398, DOI 10.1016/j.amepre.2011.12.007; Banks Jonathan, 2012, Br J Gen Pract, V62, pe1, DOI 10.3399/bjgp12X616300; Bernstein AM, 2010, AM J CLIN NUTR, V92, P1197, DOI 10.3945/ajcn.2010.29854; Beydoun MA, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.180; Beydoun MA, 2008, SOC SCI MED, V66, P2218, DOI 10.1016/j.socscimed.2008.01.018; Beydoun MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140905; Beydoun MA, 2015, NEUROBIOL AGING, V36, P3056, DOI 10.1016/j.neurobiolaging.2015.08.002; Beydoun MA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.017; Beydoun MA, 2011, J NUTR, V141, P304, DOI 10.3945/jn.110.132613; Beydoun MA, 2009, PUBLIC HEALTH NUTR, V12, P369, DOI 10.1017/S1368980008002140; Cade J, 1999, PUBLIC HEALTH NUTR, V2, P505, DOI 10.1017/S1368980099000683; Caplovitz David., 1967, THE POOR PAY MORE; Carlson A, 2014, PHYSIOL BEHAV, V134, P20, DOI 10.1016/j.physbeh.2014.03.001; Chung CJ, 1999, J CONSUM AFF, V33, P276, DOI 10.1111/j.1745-6606.1999.tb00071.x; Cleary J, 2012, NUTRIENTS, V4, P1759, DOI 10.3390/nu4111759; Conforti P, 2000, PUBLIC HEALTH NUTR, V3, P367, DOI 10.1017/S1368980000000410; Darmon N, 2006, J NUTR EDUC BEHAV, V38, P82, DOI 10.1016/j.jneb.2005.11.028; Darmon N, 2004, PUBLIC HEALTH NUTR, V7, P21, DOI 10.1079/PHN2003512; Darmon N, 2003, APPETITE, V41, P315, DOI 10.1016/S0195-6663(03)00113-2; Darmon N, 2002, J NUTR, V132, P3764, DOI 10.1093/jn/132.12.3764; Darmon N, 2016, WORLD REV NUTR DIET, V115, P36, DOI 10.1159/000442069; Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027; Denny S, 2012, J ACAD NUTR DIET, V112, P1504, DOI 10.1016/j.jand.2012.07.018; Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Drewnowski A, 2015, J HUM HYPERTENS, V29, P14, DOI 10.1038/jhh.2014.38; Drewnowski A, 2009, EUR J CLIN NUTR, V63, P674, DOI 10.1038/ejcn.2008.16; Drewnowski A, 2007, J AM DIET ASSOC, V107, P1028, DOI 10.1016/j.jada.2007.03.013; Drewnowski A, 2010, AM J CLIN NUTR, V92, P1181, DOI 10.3945/ajcn.2010.29300; Drewnowski A, 2009, NUTR REV, V67, pS36, DOI 10.1111/j.1753-4887.2009.00157.x; Evans MK, 2010, ETHNIC DIS, V20, P267; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; *I MED FANB, 2000, DIET REF INT VIT C V; Kant AK, 2005, J AM COLL NUTR, V24, P294, DOI 10.1080/07315724.2005.10719477; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Kant AK, 1996, J AM DIET ASSOC, V96, P785, DOI 10.1016/S0002-8223(96)00217-9; Katz DL, 2011, PUBLIC HEALTH NUTR, V14, P1693, DOI 10.1017/S1368980011000048; Lipsky LM, 2009, AM J CLIN NUTR, V90, P1397, DOI 10.3945/ajcn.2008.27384; Lopez CN, 2009, J EPIDEMIOL COMMUN H, V63, P920, DOI 10.1136/jech.2008.081208; Maillot M, 2007, AM J CLIN NUTR, V86, P690; Marty L, 2015, AM J CLIN NUTR, V102, P190, DOI 10.3945/ajcn.114.104380; McDermott AJ, 2010, FAM MED, V42, P280; Moeller S. M., 2007, Journal of the American Dietetic Association, V107, P1233, DOI 10.1016/j.jada.2007.03.014; Monsivais P, 2013, EUR J CLIN NUTR, V67, P1220, DOI 10.1038/ejcn.2013.176; Monsivais P, 2013, JAMA INTERN MED, V173, P1922, DOI 10.1001/jamainternmed.2013.9479; Monsivais P, 2009, J AM DIET ASSOC, V109, P814, DOI 10.1016/j.jada.2009.02.002; Morris MA, 2014, J EPIDEMIOL COMMUN H, V68, P1043, DOI 10.1136/jech-2014-204039; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Murakami K, 2009, PUBLIC HEALTH NUTR, V12, P1290, DOI 10.1017/S1368980008003923; Murphy SP, 2006, J AM DIET ASSOC, V106, P425, DOI 10.1016/j.jada.2005.12.003; National Cancer Institute AR, 2014, HEI TOOLS RES; National Institute on Aging NNI Laboratory of Epidemiology and Population Sciences, 2014, HLTH EAT IND 2010 CA; Ng SW, 2014, AM J PREV MED, V47, P520, DOI 10.1016/j.amepre.2014.05.030; Ng SW, 2014, AM J CLIN NUTR, V99, P609, DOI 10.3945/ajcn.113.072892; Ng SW, 2012, J ACAD NUTR DIET, V112, P41, DOI 10.1016/j.jada.2011.09.015; Pechey R, 2016, PREV MED, V88, P203, DOI 10.1016/j.ypmed.2016.04.012; Poti JM, 2015, AM J CLIN NUTR, V101, P1251, DOI 10.3945/ajcn.114.100925; Powell LM, 2009, HEALTH PLACE, V15, P1064, DOI 10.1016/j.healthplace.2009.05.002; Raffensperger S, 2010, J NATL MED ASSOC, V102, P923, DOI 10.1016/S0027-9684(15)30711-2; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277; Raper N, 2004, J FOOD COMPOS ANAL, V17, P545, DOI 10.1016/j.jfca.2004.02.013; Rauber F, 2009, J PEDIAT-BRAZIL, V85, P536, DOI [10.2223/JPED.1955, 10.1590/S0021-75572009000600011]; Rehm CD, 2015, PREV MED, V73, P70, DOI 10.1016/j.ypmed.2015.01.019; Rehm CD, 2011, AM J CLIN NUTR, V94, P1333, DOI 10.3945/ajcn.111.015560; Ryden PJ, 2011, PUBLIC HEALTH NUTR, V14, P1680, DOI 10.1017/S1368980010003642; Schroder H, 2016, BRIT J NUTR, V115, P817, DOI 10.1017/S0007114515005048; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Slining MM, 2013, AM J PREV MED, V44, P174, DOI 10.1016/j.amepre.2012.09.064; STATA, 2015, STATISTICS DATA ANAL; Taillie LS, 2016, AM J PREV MED, V50, P171, DOI 10.1016/j.amepre.2015.07.015; Townsend MS, 2009, AM J CLIN NUTR, V89, P1220, DOI 10.3945/ajcn.2008.26916; U.S. Department of Health and Human Services, OFF DIS PREV HLTH PR; US Department of Agriculture US Department of Health and Human Services, 2020, DIET GUID AM 2020 20; US Department of Health and Human Services, 2015, HLTH PEOPL 2020; Wang J, 2010, PUBLIC HEALTH NUTR, V13, P1049, DOI 10.1017/S1368980009991595; Waterlander WE, 2010, PUBLIC HEALTH NUTR, V13, P1599, DOI 10.1017/S1368980009992989; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Wilson MM, 2016, J ACAD NUTR DIET, V116, P302, DOI 10.1016/j.jand.2015.09.020	83	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0204141	10.1371/journal.pone.0204141	http://dx.doi.org/10.1371/journal.pone.0204141			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0UN	30312298	Green Published, gold			2022-12-26	WOS:000447427300008
J	Karasik, A; Varadi, A; Szeri, F				Karasik, Agnes; Varadi, Andras; Szeri, Flora			In vitro transport of methotrexate by Drosophila Multidrug Resistance-associated Protein	PLOS ONE			English	Article							NUCLEOTIDE-BINDING DOMAINS; MALPIGHIAN TUBULES; MELANOGASTER; EXPRESSION; GENE; MRP1; SYSTEM; FAMILY; ATPASE; ABCG2	Methotrexate (MTX) is a widely used chemotherapeutic agent, immune suppressant and antimalarial drug. It is a substrate of several human ABC proteins that confer multidrug resistance to cancer cells and determine compartmentalization of a wide range of physiological metabolites and endo or xenobiotics, by their primary active transport across biological membranes. The substrate specificity and tissue distribution of these promiscuous human ABC transporters show a high degree of redundancy, providing robustness to these key physiological and pharmacological processes, such as the elimination of toxins, e. g. methotrexate from the body. A similar network of proteins capable of transporting methotrexate has been recently suggested to exist in Drosophila melanogaster. One of the key players of this putative network is Drosophila Multidrug-resistance Associated Protein (DMRP). DMRP has been shown to be a highly active and promiscuous ABC transporter, capable of transporting various organic anions. Here we provide the first direct evidence that DMRP, expressed alone in a heterologous system lacking other, potentially functionally overlapping D. melanogaster organic anion transporters, is indeed able to transport methotrexate. Our in vitro results support the hypothesized but debated role of DMRP in in vivo methotrexate excretion.	[Karasik, Agnes; Varadi, Andras; Szeri, Flora] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Szeri, Flora] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Jefferson University	Szeri, F (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.; Szeri, F (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA.	szeri.flora@ttk.mta.hu	Szeri, Flóra/L-6162-2019; Szeri, Flora/AAD-3907-2021	Szeri, Flóra/0000-0003-2572-6820; Szeri, Flora/0000-0003-2572-6820	Hungarian OTKA grants [104227, 114136]; Fulbright Visiting Scholar Program - U.S. Department of State	Hungarian OTKA grants; Fulbright Visiting Scholar Program - U.S. Department of State	This work was funded by the Hungarian OTKA grants 104227 and 114136 and by a grant from the Fulbright Visiting Scholar Program sponsored by the U.S. Department of State.	Affleck JG, 2006, TOXICOL SCI, V89, P495, DOI 10.1093/toxsci/kfj036; Bakos E, 2000, MOL PHARMACOL, V57, P760, DOI 10.1124/mol.57.4.760; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bridges CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073559; Burmester GR, 2017, LANCET, V389, P2338, DOI 10.1016/S0140-6736(17)31491-5; Chahine S, 2012, ARCH INSECT BIOCHEM, V81, P228, DOI 10.1002/arch.21066; Chahine S, 2012, J EXP BIOL, V215, P2601, DOI 10.1242/jeb.071100; Chahine S, 2011, J EXP BIOL, V214, P462, DOI 10.1242/jeb.048884; Chahine S, 2009, J INSECT PHYSIOL, V55, P927, DOI 10.1016/j.jinsphys.2009.06.005; Chen ZS, 2002, CANCER RES, V62, P3144; Chen ZS, 2003, CANCER RES, V63, P4048; Chilengi R, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-63; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Hooijberg JH, 1999, CANCER RES, V59, P2532; Ivanyuk A, 2017, CLIN PHARMACOKINET, V56, P825, DOI 10.1007/s40262-017-0506-8; Karasik A, 2017, FASEB J; Kusari F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12148-2; Muller M, 1996, J BIOL CHEM, V271, P1877; Norris MD, 1996, INT J CANCER, V65, P613; Ozvegy C, 2002, J BIOL CHEM, V277, P47980, DOI 10.1074/jbc.M207857200; Prince L, 2014, TOXICOL SCI, V140, P425, DOI 10.1093/toxsci/kfu095; Rajagopalan PTR, PROC NATL ACAD SCI U; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Szabo K, 1998, J BIOL CHEM, V273, P10132, DOI 10.1074/jbc.273.17.10132; Szeri F, 2009, BBA-BIOMEMBRANES, V1788, P402, DOI 10.1016/j.bbamem.2008.11.007; Tarnay JN, 2004, INSECT MOL BIOL, V13, P539, DOI 10.1111/j.0962-1075.2004.00512.x; Vasiliou V, HUM GENOMICS, P281; Volk EL, 2003, CANCER RES, V63, P5538; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Xia CQ, 2012, DRUG EFFLUX TRANSPOR; Zeng H, 2001, CANCER RES, V61, P7225	34	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205657	10.1371/journal.pone.0205657	http://dx.doi.org/10.1371/journal.pone.0205657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312334	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000447427300043
J	Lam, WK; Lee, KK; Park, SK; Ryue, J; Yoon, SH; Ryu, J				Lam, Wing-Kai; Lee, Ki-Kwang; Park, Sang-Kyoon; Ryue, Jaejin; Yoon, Suk-Hoon; Ryu, Jiseon			Understanding the impact loading characteristics of a badminton lunge among badminton players	PLOS ONE			English	Article							GENDER-DIFFERENCES; PHYSIOLOGICAL-CHARACTERISTICS; CUTTING MANEUVERS; SMASH STROKE; KNEE PAIN; INJURIES; PERFORMANCE; ELITE; KINEMATICS; FREQUENCY	Background The rapid and repetitive badminton lunges would produce strenuous impact loading on the lower extremities of players and these loading are thought to be the contributing factors of chronic knee injuries. This study examined the impact loading characteristics in various groups of badminton athletes performing extreme lunges. Methods Fifty-two participants classified into male skilled, female skilled, male unskilled, and female unskilled groups performed badminton lunge with their maximum-effort. Shoe-ground kinematics, ground reaction forces, and knee moments were measured by using synchronised force platform and motion analysis system. A 2 (gender) x 2 (skill-level) factorial ANOVA was performed to determine the effects of different gender and different playing levels, as well as the interaction of two factors on all variables. Results Male athletes had faster approaching speed (male 3.87 and female 1.08 m/s), longer maximum lunge distance (male 1.47 and female 1.16 m), larger maximum (male 215.7 and female 121.65 BW/s) and mean loading rate (male 178.43 and female 81.77 BW/s) and larger peak knee flexion moment (male 0.75 and female 0.69) compared with female athletes (P < 0.001). Unskilled athletes exhibited smaller footstrike angle (skilled 45.78 and unskilled 32.35 degrees), longer contact time (skilled 0.69 and unskilled 0.75 s), larger peak horizontal GRF (skilled 1.61 and unskilled 2.40 BW), smaller mean loading rate (skilled 150.15 and unskilled 110.05 BW/s) and larger peak knee flexion moment (P <.05; skilled 0.69 and unskilled 0.75 Nm/BW) than the skilled athletes. In addition, the interaction indicated greater peak GRF impact in female unskilled athletes compared with female skilled athletes (P < 0.001; female skilled 2.01 and female unskilled 2.95 BW), while there was no difference between male participants (P > 0.05; male skilled 2.19 and male unskilled 2.49 BW). Conclusions These data suggested that male athletes and/or unskilled athletes experience greater impact loading rates and peak knee flexion moment during lunge compared with female and skilled athletes, respectively. This may expose them to higher risk of overuse injuries. Furthermore, female unskilled athletes seemed to be more vulnerable to lower extremity injuries.	[Lam, Wing-Kai] Shenyang Sports Inst, Dept Kinesiol, Shenyang, Liaoning, Peoples R China; [Lam, Wing-Kai] Li Ning China Sports Goods Co Ltd, Li Ning Sports Sci Res Ctr, Beijing, Peoples R China; [Lee, Ki-Kwang; Ryue, Jaejin] Kookmin Univ, Biomech & Sport Engn Lab, Seoul, South Korea; [Park, Sang-Kyoon; Yoon, Suk-Hoon; Ryu, Jiseon] Korea Natl Sport Univ, Mot Innovat Ctr, Seoul, South Korea	Kookmin University; Korea National Sport University	Lam, WK (corresponding author), Shenyang Sports Inst, Dept Kinesiol, Shenyang, Liaoning, Peoples R China.; Lam, WK (corresponding author), Li Ning China Sports Goods Co Ltd, Li Ning Sports Sci Res Ctr, Beijing, Peoples R China.	gilbertlam@li-ning.com.cn	Lam, Wing Kai/W-4265-2018	Lam, Wing Kai/0000-0001-8692-2206	Li Ning (China) Sports Goods Co. Ltd, Beijing, China	Li Ning (China) Sports Goods Co. Ltd, Beijing, China	Li Ning (China) Sports Goods Co. Ltd, Beijing, China provided support in the form of salaries for author (Wing-Kai Lam) and the tested shoes for this study. The test shoe was selected as it is one of the commercially available models used in professional athletes. The author provided additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Li Ning (China) Sports Goods Co. Ltd, Beijing, China provided support in the form of salaries for author (Wing-Kai Lam) and the tested shoes for this study. The test shoe was selected as it is one of the commercially available models used in professional athletes. The author provided additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abian P, 2016, RES SPORTS MED, V24, P104, DOI 10.1080/15438627.2015.1076416; Abian-Vicen J, 2013, INT J PERF ANAL SPOR, V13, P310, DOI 10.1080/24748668.2013.11868650; Abian-Vicen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037821; Castanedo JAVA, 2014, INT J SPORT PHYSIOL, V9, P689, DOI [10.1123/ijspp.2013-0269, 10.1123/IJSPP.2013-0269]; Altman AR, 2012, GAIT POSTURE, V35, P298, DOI 10.1016/j.gaitpost.2011.09.104; Beaulieu ML, 2008, MED SCI SPORT EXER, V40, P1795, DOI 10.1249/MSS.0b013e31817b8e9e; Boesen AP, 2011, KNEE SURG SPORT TR A, V19, P30, DOI 10.1007/s00167-010-1208-z; Cabello Manrique D, 2003, BRIT J SPORT MED, V37, P62; Challis JH, 1999, J APPL BIOMECH, V15, P303, DOI 10.1123/jab.15.3.303; Chappell JD, 2005, AM J SPORT MED, V33, P1022, DOI 10.1177/0363546504273047; Chen B, 2015, PHYS THER SPORT, V16, P80, DOI 10.1016/j.ptsp.2014.06.005; Cong Y, 2014, J BIOMECH, V47, P3799, DOI 10.1016/j.jbiomech.2014.10.028; Fahlstrom M, 1998, SCAND J MED SCI SPOR, V8, P145; Fahlstrom M, 1998, AM J SPORT MED, V26, P467, DOI 10.1177/03635465980260032201; Faude O, 2007, EUR J APPL PHYSIOL, V100, P479, DOI 10.1007/s00421-007-0441-8; Fernandez-Fernandez J, 2013, J STRENGTH COND RES, V27, P2396, DOI 10.1519/JSC.0b013e31827fcc6a; Ford KR, 2005, MED SCI SPORT EXER, V37, P124, DOI 10.1249/01.MSS.0000150087.95953.C3; Grice T., 2008, BADMINTON STEP SUCCE; Heller J., 2010, BR J SPORTS MED S, V44, DOI [10.1136/bjsm.2010.078725.51, DOI 10.1136/BJSM.2010.078725.51]; Hong YL, 2014, J APPL BIOMECH, V30, P113, DOI 10.1123/jab.2012-0151; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Huang MT, 2014, J SPORT SCI, V32, P690, DOI 10.1080/02640414.2013.848998; Kimura Y, 2012, BRIT J SPORT MED, V46, P207, DOI 10.1136/bjsm.2010.080861; Kimura Y, 2010, BRIT J SPORT MED, V44, P1124, DOI 10.1136/bjsm.2010.074153; Kong PW, 2009, BRIT J SPORT MED, V43, P745, DOI 10.1136/bjsm.2008.047761; Kuntze G, 2010, J SPORT SCI, V28, P183, DOI 10.1080/02640410903428533; Lam WK, 2017, J SPORT SCI, V35, P587, DOI 10.1080/02640414.2016.1180420; Lam WK, 2018, PEERJ, V6, DOI 10.7717/peerj.4753; Lam WK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174604; Landry SC, 2009, J ELECTROMYOGR KINES, V19, P370, DOI DOI 10.1016/J.JELEKIN.2008.08.004; Lieshout KAV, 2003, AFRICAN J PHYS HLTH, V9, P191; Mei Q, 2016, J SPORTS SCI, V35, P1, DOI [10.1249/MSS.0b013e31817b8e9e, DOI 10.1249/MSS.0B013E31817B8E9E]; Miyake Eiji, 2016, Asian J Sports Med, V7, pe29637, DOI 10.5812/asjsm.29637; Nin DZ, 2016, J SPORT SCI, V34, P756, DOI 10.1080/02640414.2015.1069381; Ooi CH, 2009, J SPORT SCI, V27, P1591, DOI 10.1080/02640410903352907; Paquette MR, 2013, FOOTWEAR SCI, V5, P9, DOI 10.1080/19424280.2012.692724; Phomsoupha M, 2014, COMPUT METHOD BIOMEC, V17, P140, DOI 10.1080/10255842.2014.931550; Phomsoupha M, 2015, SPORTS MED, V45, P473, DOI 10.1007/s40279-014-0287-2; Poliszczuk T, 2009, STUDIES PHYS CULTURE, V16, P259; Quatman CE, 2006, AM J SPORT MED, V34, P806, DOI 10.1177/0363546505281916; Sakurai S, 2000, J SPORT SCI, V18, P901, DOI 10.1080/026404100750017832; Shariff AH, 2009, SINGAP MED J, V50, P1095; Tsai CL, 1998, P 16 INT S BIOM SPOR, V2, P259; Yung Patrick Shu-Hang, 2007, Res Sports Med, V15, P133, DOI 10.1080/15438620701405263	44	7	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205800	10.1371/journal.pone.0205800	http://dx.doi.org/10.1371/journal.pone.0205800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312359	Green Submitted, Green Published, gold			2022-12-26	WOS:000447427300058
J	Harmon, AC; Hebert, VY; Cormier, SA; Subramanian, B; Reed, JR; Backes, WL; Dugas, TR				Harmon, Ashlyn C.; Hebert, Valeria Y.; Cormier, Stephania A.; Subramanian, Balamurugan; Reed, James R.; Backes, Wayne L.; Dugas, Tammy R.			Particulate matter containing environmentally persistent free radicals induces AhR-dependent cytokine and reactive oxygen species production in human bronchial epithelial cells	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; DIESEL EXHAUST PARTICLES; AIR-POLLUTION; GENE-EXPRESSION; TERM EXPOSURE; ACTIVATION; COMBUSTION; AMBIENT; MODEL; INFLAMMATION	Particulate matter (PM) is emitted during the combustion of fuels and wastes. PM exposure exacerbates pulmonary diseases, and the mechanism may involve oxidative stress. At lower combustion temperatures such as occurs in the cool zone of a flame, aromatic compounds chemisorb to the surface of metal-oxide-containing PM, resulting in the formation of surface-stabilized environmentally persistent free radicals (EPFR). Prior studies showed that PM-containing EPFR redox cycle to produce reactive oxygen species (ROS), and after inhalation, EPFR induce pulmonary inflammation and oxidative stress. Our objective was to elucidate mechanisms linking EPFR-induced oxidant injury with increased cytokine production by pulmonary epithelial cells. We thus treated human bronchial epithelial cells with EPFR at sub-toxic doses and measured ROS and cytokine production. To assess aryl hydrocarbon receptor (AhR) activity, cells were transfected with a luciferase reporter for xenobiotic response element activation. To test whether cytokine production was dependent upon AhR activation or oxidative stress, some cells were co-treated with an antioxidant or an AhR antagonist. EPFR increased IL-6 release in an ROS and AhR- and oxidant-dependent manner. Moreover, EPFR induced an AhR activation that was dependent upon oxidant production, since antioxidant co-treatment blocked AhR activation. On the other hand, EPFR treatment increased a cellular ROS production that was at least partially attenuated by AhR knockdown using siRNA. While AhR activation was correlated with an increased expression of oxidant-producing enzymes like cytochrome P450 CYP1A1, it is possible that AhR activation is both a cause and effect of EPFR-induced ROS. Finally, lipid oxidation products also induced AhR activation. ROS-dependent AhR activation may be a mechanism for altered epithelial cell responses after EPFR exposure, potentially via formation of bioactive lipid or protein oxidation products.	[Harmon, Ashlyn C.; Dugas, Tammy R.] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Skip Beaman Dr, Baton Rouge, LA 70803 USA; [Hebert, Valeria Y.] LSU Hlth Sci Ctr Shreveport, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA USA; [Cormier, Stephania A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Subramanian, Balamurugan] Louisiana State Univ, Dept Environm Sci, Baton Rouge, LA 70803 USA; [Reed, James R.; Backes, Wayne L.] LSU Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Dugas, TR (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Skip Beaman Dr, Baton Rouge, LA 70803 USA.	tammydugas@lsu.edu	Cormier, Stephania A/I-7382-2017; Dugas, Tammy R/AGY-7952-2022	Cormier, Stephania A/0000-0002-6050-6172; Dugas, Tammy/0000-0002-4763-0603	National Institutes of Environmental Health Sciences [P42ES013648]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013648, R01ES015050] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by National Institutes of Environmental Health Sciences, P42ES013648.	Alaghmand M, 2007, ENVIRON SCI TECHNOL, V41, P2364, DOI 10.1021/es061902o; Balakrishna S, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-11; Beamer CA, 2013, SEMIN IMMUNOPATHOL, V35, P693, DOI 10.1007/s00281-013-0391-7; Brune K, 2015, AM J PHYSIOL-LUNG C, V308, pL731, DOI 10.1152/ajplung.00309.2014; Burn BR, 2015, AM J PHYSIOL-HEART C, V308, pH998, DOI 10.1152/ajpheart.00891.2014; Caiazzo F, 2013, ATMOS ENVIRON, V79, P198, DOI 10.1016/j.atmosenv.2013.05.081; Cesaroni G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7412; Chen H, 2014, CIRCULATION, V129, P562, DOI 10.1161/CIRCULATIONAHA.113.003532; Chen PH, 2012, ONCOGENE, V31, P2555, DOI 10.1038/onc.2011.438; Chiaro CR, 2008, MOL PHARMACOL, V74, P1649, DOI 10.1124/mol.108.049379; Chiaro CR, 2008, BIOCHEMISTRY-US, V47, P8445, DOI 10.1021/bi800712f; Clark NA, 2010, ENVIRON HEALTH PERSP, V118, P284, DOI 10.1289/ehp.0900916; Cormier SA, 2006, ENVIRON HEALTH PERSP, V114, P810, DOI 10.1289/ehp.8629; Costa C, 2010, TOXICOLOGY, V271, P83, DOI 10.1016/j.tox.2010.02.014; de Hoogh K, 2013, ENVIRON SCI TECHNOL, V47, P5778, DOI 10.1021/es400156t; Dellinger B, 2001, CHEM RES TOXICOL, V14, P1371, DOI 10.1021/tx010050x; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; DiStefano E, 2009, INHAL TOXICOL, V21, P731, DOI 10.1080/08958370802491433; Dong GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022470; Fang GD, 2014, ENVIRON SCI TECHNOL, V48, P1902, DOI 10.1021/es4048126; FITZGERALD GA, 1983, CIRCULATION, V67, P1174, DOI 10.1161/01.CIR.67.6.1174; Gasiewicz TA, 1996, BIOCHEM PHARMACOL, V52, P1787, DOI 10.1016/S0006-2952(96)00600-4; Gehling W, 2013, ENVIRON SCI TECHNOL, V47, P8172, DOI 10.1021/es401767m; Ishimura R, 2009, BIOCHEM PHARMACOL, V77, P660, DOI 10.1016/j.bcp.2008.10.030; Jaligama S, 2018, PART FIBRE TOXICOL, V15, DOI 10.1186/s12989-018-0255-3; Kelley MA, 2013, CHEM RES TOXICOL, V26, P1862, DOI 10.1021/tx400227s; Khachatryan L, 2011, ENVIRON SCI TECHNOL, V45, P9232, DOI 10.1021/es201702q; Kopf PG, 2010, TOXICOL APPL PHARM, V245, P91, DOI 10.1016/j.taap.2010.02.007; Lin PP, 2003, TOXICOL SCI, V71, P20, DOI 10.1093/toxsci/71.1.20; Lomnicki S, 2003, J PHYS CHEM A, V107, P4387, DOI 10.1021/jp026045z; Lomnicki S, 2008, ENVIRON SCI TECHNOL, V42, P4982, DOI 10.1021/es071708h; Mahne S, 2012, AM J PHYSIOL-HEART C, V303, pH1135, DOI 10.1152/ajpheart.00545.2012; Manea SA, 2015, REDOX BIOL, V5, P358, DOI 10.1016/j.redox.2015.06.012; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Oyana TJ, 2017, ENVIRON SCI TECHNOL, V51, P10663, DOI 10.1021/acs.est.7b03643; Pan CJG, 2004, TOXICOL SCI, V81, P225, DOI 10.1093/toxsci/kfh199; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Quay JL, 1998, AM J RESP CELL MOL, V19, P98, DOI 10.1165/ajrcmb.19.1.3132; Raysoni AU, 2017, ENVIRON POLLUT, V231, P681, DOI 10.1016/j.envpol.2017.08.065; Rice MB, 2013, AM J RESP CRIT CARE, V188, P1351, DOI 10.1164/rccm.201308-1414OC; Seidel SD, 2001, J BIOCHEM MOL TOXIC, V15, P187; Squadrito GL, 2001, FREE RADICAL BIO MED, V31, P1132, DOI 10.1016/S0891-5849(01)00703-1; Steerenberg PA, 1998, EXP LUNG RES, V24, P85, DOI 10.3109/01902149809046056; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Thevenot PT, 2013, AM J RESP CELL MOL, V48, P188, DOI 10.1165/rcmb.2012-0052OC; Tian LW, 2009, ENERG FUEL, V23, P2523, DOI 10.1021/ef8010096; U.S. Congress Office of Technology Assessment, 1995, OTABPENV164 US C; United States Environmental Protection Agency Agency UEP OSWER/Office of Communications Partnerships and Analysis, 2015, POP SURR 1388 SUP RE; US EPA, 2017, SUP REM REP; Valavanidis A, 2005, REDOX REP, V10, P37, DOI 10.1179/135100005X21606; Vasquez Alejandro, 2003, Cardiovasc Toxicol, V3, P153, DOI 10.1385/CT:3:2:153; Wang P, 2018, ENVIRON SCI TECHNOL, V52, P1054, DOI 10.1021/acs.est.7b05453; Wang PL, 2011, AM J RESP CELL MOL, V45, P977, DOI 10.1165/rcmb.2011-0001OC; Wei YD, 1998, CHEM-BIOL INTERACT, V110, P39, DOI 10.1016/S0009-2797(97)00111-7; Weinmayr G, 2010, ENVIRON HEALTH PERSP, V118, P449, DOI 10.1289/ehp.0900844; Yu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099368	56	26	27	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205412	10.1371/journal.pone.0205412	http://dx.doi.org/10.1371/journal.pone.0205412			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308017	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500071
J	Leroux, A; Egles, C; Migonney, V				Leroux, Amelie; Egles, Christophe; Migonney, Veronique			Impact of chemical and physical treatments on the mechanical properties of poly(epsilon-caprolactone) fibers bundles for the anterior cruciate ligament reconstruction	PLOS ONE			English	Article							ARTIFICIAL LIGAMENTS; STYRENE SULFONATE; HYALURONIC-ACID; BEHAVIOR; BIOCOMPATIBILITY; DEGRADATION; SCAFFOLDS; POLYMER; REPAIR	The anterior cruciate ligament rupture is one of the most common sport injuries. Due to ligaments' poor healing capacity, surgical intervention is often required. Nowadays, these injuries are managed using replacement autografts or to a lesser extent using artificial ligaments. With the expansion of tissue engineering, more recent researches focus on the development of biodegradable structures that could allow graft functioning while enhancing host integration. The main challenge is to develop a structure that gradually loses its mechanical properties when at the same time the neo-ligament gains in solidity. Mechanical behavior and reconstruction of natural tissue are the two key points for such a successful device. This article evaluates the mechanical consistency of poly(epsilon-caprolactone) fibers bundles grafted with sodium polystyrene sulfonate, as a candidate for ligament prosthesis. In order to be medically used, PCL fibers need to cope with multiple steps before implantation including extensive washings, knitting, grafting and sterilization processes. The evolution of mechanical properties at each step of the elaboration process has been investigated. The results show that PCL bundles have the same visco-elastic behavior than the native ACL. Nevertheless, when undergoing physical treatments such as ionizing radiations, like UV or beta-rays, the material endures a hardening, increasing its stiffness but also its fragility. At this opposite, the thermal radical grafting acts like an annealing step, increasing significantly the elasticity of the PCL fibers. With this chemical treatment, the stiffness is decreasing, leading to higher energy dissipation. Added to the observation of the structure of the material, this demonstrates the possibility of the PCL to modulate it microstructure. In case of orthopedic prosthesis, the need of such a construct is strongly required to avoid distension of the future prosthesis and to restore good knee stabilization, showing the promising future of PCL ligament prosthesis.	[Leroux, Amelie; Migonney, Veronique] Univ Paris 13, Sorbonne Paris Cite, Inst Galilee, Lab Biomat & Polymers Specialty,UMR CNRS 7244, Villetaneuse, France; [Egles, Christophe] Univ Technol Compiegne, Sorbonne Univ, UMR CNRS 7338, Lab Biomech & Bioengn, Compiegne, France	Universite Paris 13; Picardie Universites; Universite de Technologie de Compiegne; UDICE-French Research Universities; Sorbonne Universite	Migonney, V (corresponding author), Univ Paris 13, Sorbonne Paris Cite, Inst Galilee, Lab Biomat & Polymers Specialty,UMR CNRS 7244, Villetaneuse, France.	veronique.migonney@univ-paris13.fr	Migonney, Véronique/AAF-2825-2020	EGLES, Christophe/0000-0003-0982-7752; MIGONNEY, VERONIQUE/0000-0002-1055-3720	French Public Investment Bank; French state - PSPC application - Liga2bio project	French Public Investment Bank; French state - PSPC application - Liga2bio project	This work was funded as part of the "Future Investment Project" by the French Public Investment Bank (http://www.bpifrance.com/) and the French state - PSPC application - Liga2bio project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Sayed P, 2014, J MECH BEHAV BIOMED, V30, P123, DOI 10.1016/j.jmbbm.2013.10.025; Abdel-Sayed P, 2014, BIOMATERIALS, V35, P1890, DOI 10.1016/j.biomaterials.2013.11.048; Belleney J, 2002, EUR POLYM J, V38, P439, DOI 10.1016/S0014-3057(01)00205-1; Brulez B, 2004, Patent No. [WO2004067051 (A1), 2004067051]; Ciobanu M, 2006, BIOMACROMOLECULES, V7, P755, DOI 10.1021/bm050694+; Cooper JA, 2007, P NATL ACAD SCI USA, V104, P3049, DOI 10.1073/pnas.0608837104; Deepthi S, 2015, CHEM ENG J, V260, P478, DOI 10.1016/j.cej.2014.08.106; Djaker N, 2014, BIOMED OPT EXPRESS, V5, P149, DOI 10.1364/BOE.5.000149; Farah S, 2016, ADV DRUG DELIVER REV, V107, P367, DOI 10.1016/j.addr.2016.06.012; Felgueiras H, 2014, MAT SCI ENG C-MATER, V39, P196, DOI 10.1016/j.msec.2014.03.013; Freeman JW, 2007, J BIOMECH, V40, P2029, DOI 10.1016/j.jbiomech.2006.09.025; Guidoin MF, 2000, BIOMATERIALS, V21, P2461, DOI 10.1016/S0142-9612(00)00114-9; Haddad O, 2011, EXP CELL RES, V317, P1726, DOI 10.1016/j.yexcr.2011.05.007; Hoglund A, 2007, J MACROMOL SCI A, V44, P1041, DOI 10.1080/10601320701424487; Huang YP, 2007, COLLOID SURFACE A, V295, P75, DOI 10.1016/j.colsurfa.2006.08.034; IANNACE S, 1995, BIOMATERIALS, V16, P675, DOI 10.1016/0142-9612(95)99693-G; Kaeding CC, 2017, CLIN SPORT MED, V36, P1, DOI 10.1016/j.csm.2016.08.001; Kalaci A, 2014, J HARD TISSUE BIOL, V23, P317, DOI 10.2485/jhtb.23.317; Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002; KLEIN W, 1992, Arthroscopy, V8, P116, DOI 10.1016/0749-8063(92)90145-2; Laurencin CT, 2005, BIOMATERIALS, V26, P7530, DOI 10.1016/j.biomaterials.2005.05.073; Li H, 2012, ACTA BIOMATER, V8, P4007, DOI 10.1016/j.actbio.2012.07.008; MAROIS Y, 1993, BIOMATERIALS, V14, P255, DOI 10.1016/0142-9612(93)90115-I; Miculescu F, 2017, ACS SUSTAIN CHEM ENG, V5, P8491, DOI 10.1021/acssuschemeng.7b02314; Mollica F, 2006, COMPOS SCI TECHNOL, V66, P92, DOI 10.1016/j.compscitech.2005.05.022; Mowbray MAS, 1997, KNEE, V4, P35, DOI 10.1016/S0968-0160(96)00225-6; Murray MM, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116672176; Nelson MT, 2014, J MECH BEHAV BIOMED, V30, P150, DOI 10.1016/j.jmbbm.2013.11.004; Noroozi N, 2012, RHEOL ACTA, V51, P179, DOI 10.1007/s00397-011-0586-6; Pauly HM, 2016, J MECH BEHAV BIOMED, V61, P258, DOI 10.1016/j.jmbbm.2016.03.022; Pavon-Djavid G, 2007, BIOMACROMOLECULES, V8, P3317, DOI 10.1021/bm070344i; PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124; Proffen BL, 2015, J ORTHOP RES, V33, P1015, DOI 10.1002/jor.22855; Ratner B.D., 2004, BIOMATERIALS SCI INT; Rawal A, 2016, J MECH BEHAV BIOMED, V54, P305, DOI 10.1016/j.jmbbm.2015.09.018; Rohman G, 2015, J MATER SCI-MATER M, V26, DOI [10.1007/s10856-015-5635-8, DOI 10.1007/S10856-015-5635-8]; Seitz H, 1998, BIOMATERIALS, V19, P189, DOI 10.1016/S0142-9612(97)00201-9; Suart WM, 1988, PHYSIOTHERAPY, V74, P528, DOI [10.1016/S0031-9406(10)63401-3, DOI 10.1016/S0031-9406(10)63401-3]; Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019; Taylor KA, 2013, J BIOMECH, V46, P478, DOI 10.1016/j.jbiomech.2012.10.031; Thomson L, 1994, KNEE, V1, P139, DOI [DOI 10.1016/0968-0160(94)90028-0, 10.1016/0968-0160(94)90028-0]; Uchida M, 2013, INT J PLASTICITY, V49, P164, DOI 10.1016/j.ijplas.2013.03.007; van Dommelen JAW, 2003, J MECH PHYS SOLIDS, V51, P519, DOI 10.1016/S0022-5096(02)00063-7; Vaquette C, 2013, BIOMATERIALS, V34, P7048, DOI 10.1016/j.biomaterials.2013.05.058; Viateau V, 2011, IRBM, V32, P118, DOI 10.1016/j.irbm.2011.01.007; Viateau V, 2013, ARTHROSCOPY, V29, P1079, DOI 10.1016/j.arthro.2013.02.025; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002	47	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205722	10.1371/journal.pone.0205722	http://dx.doi.org/10.1371/journal.pone.0205722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308052	Green Submitted, gold, Green Published			2022-12-26	WOS:000447173500119
J	Deppe, JP; Rabbat, R; Hortensteiner, S; Keller, B; Martinoia, E; Lopez-Marques, RL				Deppe, Johannes P.; Rabbat, Ritta; Hortensteiner, Stefan; Keller, Beat; Martinoia, Enrico; Lopez-Marques, Rosa L.			The wheat ABC transporter Lr34 modifies the lipid environment at the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE FUNGAL PATHOGENS; PROTEIN-KINASE-C; PHOSPHATIDIC-ACID; ARABIDOPSIS-THALIANA; PLANT-GROWTH; CELL-DEATH; RESISTANCE; YEAST; EXPRESSION; DOMAINS	Phospholipids (PLs) are emerging as important factors that initiate signal transduction cascades at the plasma membrane. Their distribution within biological membranes is tightly regulated, e.g. by ATP-binding cassette (ABC) transporters, which preferably translocate PLs from the cytoplasmic to the exoplasmic membrane leaflet and are therefore called PL-floppases. Here, we demonstrate that a plant ABC transporter, Lr34 from wheat (Triticum aestivum), is involved in plasma membrane remodeling characterized by an intracellular accumulation of phosphatidic acid and enhanced outward translocation of phosphatidylserine. In addition, the content of phosphatidylinositol 4,5-bisphosphate in the cytoplasmic leaflet of the plasma membrane was reduced in the presence of the ABC transporter. When heterologously expressed in Saccharomyces cerevisiae, Lr34 promoted oil body formation in a mutant defective in PL-transfer in the secretory pathway. Our results suggest that PL redistribution by Lr34 potentially affects the membrane-bound proteome and contributes to the previously reported stimuli-independent activation of biotic and abiotic stress responses and neutral lipid accumulation in transgenic Lr34-expressing barley plants.	[Deppe, Johannes P.; Rabbat, Ritta; Hortensteiner, Stefan; Keller, Beat; Martinoia, Enrico] Univ Zurich UZH, Dept Plant & Microbial Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland; [Lopez-Marques, Rosa L.] Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark	University of Zurich; University of Copenhagen	Deppe, JP (corresponding author), Univ Zurich UZH, Dept Plant & Microbial Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.; Lopez-Marques, RL (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	johannes.deppe@botinst.uzh.ch; rlo@plen.ku.dk	Lopez-Marques, Rosa L/F-8536-2014; Martinoia, Enrico/AAH-8712-2021; Keller, Beat/K-3093-2019; Marques, Rosa Laura Lopez/AAI-8071-2020	Lopez-Marques, Rosa L/0000-0002-5663-7903; Keller, Beat/0000-0003-2379-9225; Marques, Rosa Laura Lopez/0000-0002-5663-7903	University of Zurich; ERC [249996]	University of Zurich; ERC(European Research Council (ERC)European Commission)	This work was supported by University of Zurich and ERC Advanced Grant Durable Resistance 249996. The authors declare that they have no conflicts of interest with the contents of this article.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Ananthanarayanan B, 2002, J BIOL CHEM, V277, P3568, DOI 10.1074/jbc.M109705200; Andjelic CD, 2008, MAR DRUGS, V6, P528, DOI 10.3390/md20080027; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bucher R. R., 2017, THESIS; Campos-Salinas J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002179; Chauhan H, 2015, PLANT J, V84, P202, DOI 10.1111/tpj.13001; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; Chung E, 2004, PLANTA, V220, P286, DOI 10.1007/s00425-004-1372-9; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393; Crouzet J, 2013, PLANT MOL BIOL, V82, P181, DOI 10.1007/s11103-013-0053-0; Dawson AP, 1997, CURR BIOL, V7, pR544, DOI 10.1016/S0960-9822(06)00277-6; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Hanson PK, 2003, J BIOL CHEM, V278, P36041, DOI 10.1074/jbc.M305263200; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Hulbert SH, 2007, PHYTOPATHOLOGY, V97, P1083, DOI 10.1094/PHYTO-97-9-1083; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jambunathan N, 2001, PLANT CELL, V13, P2225, DOI 10.1105/tpc.13.10.2225; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; KAISER WM, 1982, PLANTA, V154, P538, DOI 10.1007/BF00402997; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; Krattinger SG, 2016, PLANT BIOTECHNOL J, V14, P1261, DOI 10.1111/pbi.12491; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; MARKI F, 1991, BIOCHEM PHARMACOL, V42, P2027, DOI 10.1016/0006-2952(91)90604-4; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Mishra G, 2006, SCIENCE, V312, P264, DOI 10.1126/science.1123769; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Risk JM, 2013, PLANT BIOTECHNOL J, V11, P847, DOI 10.1111/pbi.12077; SAUER N, 1994, PLANT J, V6, P67, DOI 10.1046/j.1365-313X.1994.6010067.x; Simon MLA, 2014, PLANT J, V77, P322, DOI 10.1111/tpj.12358; Smriti, 2002, YEAST, V19, P303, DOI 10.1002/yea.818; Sucher J, 2017, PLANT BIOTECHNOL J, V15, P489, DOI 10.1111/pbi.12647; Testerink C, 2011, J EXP BOT, V62, P2349, DOI 10.1093/jxb/err079; Thompson JR, 1998, YEAST, V14, P565, DOI 10.1002/(SICI)1097-0061(19980430)14:6<565::AID-YEA251>3.0.CO;2-B; Wang XM, 2005, PLANT PHYSIOL, V139, P566, DOI 10.1104/pp.105.068809; Weingartner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042070; Woehlecke H, 2003, BIOCHEM J, V376, P489, DOI 10.1042/BJ20030886; Xue H, 2007, CURR OPIN PLANT BIOL, V10, P483, DOI 10.1016/j.pbi.2007.07.003; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhao J, 2015, J EXP BOT, V66, P1721, DOI 10.1093/jxb/eru540; Zou BH, 2016, GENOME, V59, P565, DOI 10.1139/gen-2016-0015	55	13	15	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18667	18679		10.1074/jbc.RA118.002532	http://dx.doi.org/10.1074/jbc.RA118.002532			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30327425	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000458467300021
J	Chacon, V; Paraje, G; Barnoya, J; Chaloupka, FJ				Chacon, Violeta; Paraje, Guillermo; Barnoya, Joaquin; Chaloupka, Frank J.			Own-price, cross-price, and expenditure elasticities on sugar-sweetened beverages in Guatemala	PLOS ONE			English	Article							SOFT DRINKS; FOOD; METAANALYSIS; DEMAND; TAXES; CONSUMPTION; OUTCOMES; CHILDREN; QUALITY; MEXICO	Background The obesity epidemic is spreading rapidly in Guatemala, a low/middle income country still struggling with undernutrition. Sugar sweetened beverages (SSBs) consumption is strongly associated with overweight, obesity, and non-communicable diseases. In Guatemala, SSBs are readily available and consumption is high, particularly among adolescents. SSB taxes have been proposed as a cost-effective way to reduce consumption and generate revenues for public health, as has been demonstrated in several countries around the world. Objective To estimate the price, expenditure, quality, and cross-price elasticity of beverage demand using household survey data. Method We conducted a secondary analysis on the 2014 Guatemala Living Conditions National Survey that includes national representative household data on expenditure. Own price, expenditure, quality, and cross-price elasticities of milk, soft drinks, packaged juices, and bottled water were estimated using Deaton's Almost Ideal Demand System (AIDS), controlling for goods' quality. Household characteristics and beverage expenditure are summarized for urban and rural locations using descriptive statistics. Results Positive expenditure on soft drinks was highest (50.9% of households). Positive expenditure on bottled water was next for urban households (43.8%) and lowest for rural households (10.8%). Own-price elasticities for all beverages are negative and statistically significant. Own-price elasticity of soft drinks is -1.39, suggesting that with a 10% increase in price, consumption would decrease by 13.9%. Expenditure elasticity for soft drinks (0.99) suggests that a 10% household expenditure increase would result in a 9.9% increase in demand. Milk (0.07) and soft drinks (0.07) have positive quality elasticity implying that, as household total expenditure increases, the quality of these beverages, measured by their unit values, also increases. Conclusion Soft drink demand is highly sensitive to changes in prices, suggesting that SSB taxes could significantly reduce consumption, which, in turn, could contribute to curbing the overweight/obesity epidemic.	[Chacon, Violeta; Barnoya, Joaquin] Cardiovasc Surg Unit Guatemala, Guatemala City, Guatemala; [Paraje, Guillermo] Univ Adolfo Ibanez, Santiago, Chile; [Paraje, Guillermo] Amer Canc Soc, Atlanta, GA 30329 USA; [Barnoya, Joaquin] Washington Univ, St Louis, MO 63130 USA; [Chaloupka, Frank J.] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL USA	Universidad Adolfo Ibanez; American Cancer Society; Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Barnoya, J (corresponding author), Cardiovasc Surg Unit Guatemala, Guatemala City, Guatemala.; Barnoya, J (corresponding author), Washington Univ, St Louis, MO 63130 USA.	barnoyaj@wustl.edu		Chacon, Violeta/0000-0003-0529-512X; Paraje, Guillermo/0000-0002-7863-907X	Centers for Disease Control and Prevention (CDC) through TEPHINET, a program of the Task Force for Global Health, Inc.; Foundation for Barnes-Jewish Hospital	Centers for Disease Control and Prevention (CDC) through TEPHINET, a program of the Task Force for Global Health, Inc.; Foundation for Barnes-Jewish Hospital	This publication was supported by a grant from the Centers for Disease Control and Prevention (CDC) through TEPHINET, a program of the Task Force for Global Health, Inc. Its contents are solely the responsibility of the authors and do not necessarily represent the views of The Task Force for Global Health, Inc., TEPHINET, or the CDC. Joaquin Barnoya receives additional support from The Foundation for Barnes-Jewish Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini C, 2018, EVALUACION APLICACIO; Alameda County, 2018, REG VOT NOV 4 2014 G; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Colchero MA, 2017, HEALTH AFFAIR, V36, P564, DOI 10.1377/hlthaff.2016.1231; Backholer K, 2017, PUBLIC HEALTH NUTR, V20, P3219, DOI 10.1017/S1368980017003329; Batis C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002057; Center for Science in the Public Interest, 2018, BIG SOD VS PUBL HLTH; Chacon V, 2015, CRIT PUBLIC HEALTH, V25, P291, DOI 10.1080/09581596.2014.953035; Claro RM, 2012, AM J PUBLIC HEALTH, V102, P178, DOI 10.2105/AJPH.2011.300313; Colchero MA, 2015, ECON HUM BIOL, V19, P129, DOI 10.1016/j.ehb.2015.08.007; Colen L, 2018, FOOD POLICY, V77, P116, DOI 10.1016/j.foodpol.2018.04.002; DEATON A, 1988, AM ECON REV, V78, P418; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; DEATON A, 1987, J ECONOMETRICS, V36, P7, DOI 10.1016/0304-4076(87)90041-8; DEATON A, 1990, J ECONOMETRICS, V44, P281, DOI 10.1016/0304-4076(90)90060-7; Delipalla S, 2001, INT J IND ORGAN, V19, P885, DOI 10.1016/S0167-7187(99)00057-0; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; Euromonitor International, 2018, PASSP DAT 2017; Ford CN, 2015, J NUTR, V145, P1835, DOI 10.3945/jn.115.210765; Gander, 2016, INDEPENDENT; Godin KM, 2017, PUBLIC HEALTH NUTR, V20, P2980, DOI 10.1017/S1368980017001926; Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329; Grogger J., 2015, NBER WORKING PAPERS, V21197; Guerrero-Lopez CM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4098-x; Guindon E, 2011, SOCIOECONOMIC DIFFER; Instituto Nacional de Estadistica, 2017, ENC NAC COND VID GUA; Instituto Nacional de Estadistica, 2017, IND POBR DES GUAT 20; Instituto Nacional de Estadistica, 2012, CAR EST REP GUAT 201; Leung CW, 2014, J ACAD NUTR DIET, V114, P1943, DOI 10.1016/j.jand.2014.06.353; Makkes S, 2011, MATERN CHILD NUTR, V7, P410, DOI 10.1111/j.1740-8709.2010.00249.x; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Sanchez-Romero LM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002158; Ministerio de Salud Publica y Asistencia Social Instituto Nacional de Estadistica, 2015, 4 ENC NAC SAL MAT IN; Ministry of Finance of Brunei, 2018, AM CUST IMP EXC DUT; Nagata JM, 2011, ECOL FOOD NUTR, V50, P297, DOI 10.1080/03670244.2011.568911; Nakhimovsky SS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0163358, 10.1371/jour]; National Cancer Institute, 2017, OB CANC FACT SHEET 2; National Cancer Institute World Health Organization, 2016, EC TOB TOB CONTR BET; National Treasury Republic of South Africa, 2018, TAX SUG SWEET BEV 20; Organizacion de las Naciones Unidas para la Alimentacion y la Agricultura, 2012, ESC LAT SEG AL ELCS; Pan American Health Organization, 2015, TAX SUG SWEET BEV PU; Paraje G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152260; Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002; Procurador de los Derechos Humanos, 2014, ACC AG POT COM DER; Purtle J, 2018, J PUBLIC HEALTH MAN, V24, P4, DOI 10.1097/PHH.0000000000000563; Ramirez-Zea M, 2014, AM J CLIN NUTR, V100, p1644S; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Silver LD, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002283; Singh GM, 2015, CIRCULATION, V132, P639, DOI 10.1161/CIRCULATIONAHA.114.010636; Singh GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124845; Singh GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065174; Superintendencia de Administracion Tributaria, 2017, REGL LEY IMP ESP DIS; Tomayko EJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4498-y; Vision 2030 Kingdom of Saudi Arabia, 2018, FISC BAL PROGR BAL B; Zhen C, 2014, AM J AGR ECON, V96, P1, DOI 10.1093/ajae/aat049	56	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205931	10.1371/journal.pone.0205931	http://dx.doi.org/10.1371/journal.pone.0205931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX7HS	30346999	Green Published, gold, Green Submitted			2022-12-26	WOS:000447938400025
J	Shin, JH; Joo, EY; Seo, DW; Shon, YM; Hong, SB; Hong, SC				Shin, Jong Hwa; Joo, Eun Yeon; Seo, Dae-Won; Shon, Young-Min; Hong, Seung Bong; Hong, Seung-Chyul			Prognostic factors determining poor postsurgical outcomes of mesial temporal lobe epilepsy	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS CLASSIFICATION; WHITE-MATTER ABNORMALITIES; HIPPOCAMPAL SCLEROSIS; INTERICTAL SPECT; DUAL PATHOLOGY; SEIZURE-FREE; FDG-PET; SURGERY; LOBECTOMY; RESECTION	Objectives To investigate the long-term postoperative outcomes and predictive factors associated with poor surgical outcomes in mesial temporal lobe epilepsy (MTLE). Materials and methods We enrolled patients with MTLE who underwent resective surgery at single university-affiliated hospital. Surgical outcomes were determined using a modified Engel classification at the 2nd and 5th years after surgery and the last time of follow-up. Results The mean duration of follow-up after surgery was 7.6 +/- 3.7 years (range, 5.0-21.0 years). 334 of 400 patients (83.5%) were seizure-free at the 5th postoperative year. Significant predictive factors of a poor outcome at the 5th year were a history of generalized tonic clonic (GTC) seizures (odds ratio, OR; 2.318), bi-temporal interictal epileptiform discharge (IED) (OR; 3.107), bilateral hippocampal sclerosis (HS) (OR; 5.471), unilateral HS and combined extra-hippocampal lesion (OR; 5.029), and bi-temporal hypometabolism (BTH) (OR; 4.438). Bi-temporal IED (hazard ratio, HR; 2.186), BTH (HR; 2.043), bilateral HS (HR; 2.541) and unilateral HS and combined extra-hippocampal lesion (HR; 2.75) were independently associated with seizure recurrence. We performed a subgroup analysis of 208 patients with unilateral HS, and their independent predictors of a poor outcome at the 5th year were BTH (OR; 5.838) and tailored hippocampal resection (OR; 11.053). Conclusion This study demonstrates that 16.5% of MTLE patients had poor long-term outcomes after surgery. Bilateral involvement in electrophysiological and imaging studies predicts poor surgical outcomes in MTLE patients.	[Shin, Jong Hwa; Joo, Eun Yeon; Seo, Dae-Won; Shon, Young-Min; Hong, Seung Bong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst,Neurosci Ctr,Dept Neurol, Seoul, South Korea; [Hong, Seung-Chyul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Joo, EY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst,Neurosci Ctr,Dept Neurol, Seoul, South Korea.	ejoo@skku.edu	Shon, Young-Min/GMX-1704-2022	Shon, Young-Min/0000-0001-5171-1695; JOO, EUN YEON/0000-0003-1233-959X	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning, Republic of Korea [2017R1A2B4003120]; Samsung Biomedical Research Institute grant [SMX1170571]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning, Republic of Korea; Samsung Biomedical Research Institute grant(Samsung)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning, Republic of Korea (2017R1A2B4003120) and by Samsung Biomedical Research Institute grant (SMX1170571).	Alvim MKM, 2016, EPILEPSIA, V57, P621, DOI 10.1111/epi.13334; AWAD IA, 1989, EPILEPSIA, V30, P756, DOI 10.1111/j.1528-1157.1989.tb05335.x; Bernhardt BC, 2015, EPILEPSY BEHAV, V50, P162, DOI 10.1016/j.yebeh.2015.06.005; Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220; Blum DE, 1998, EPILEPSIA, V39, P651, DOI 10.1111/j.1528-1157.1998.tb01434.x; Bonilha L, 2006, NEUROIMAGE, V32, P1070, DOI 10.1016/j.neuroimage.2006.05.038; Bonilha L, 2010, EPILEPSIA, V51, P1774, DOI 10.1111/j.1528-1167.2010.02576.x; Capraz IY, 2015, SEIZURE-EUR J EPILEP, V29, P63, DOI 10.1016/j.seizure.2015.03.015; Chassoux F, 2004, BRAIN, V127, P164, DOI 10.1093/brain/awh014; Cho JW, 2010, EPILEPSY RES, V88, P247, DOI 10.1016/j.eplepsyres.2009.12.002; Choi JY, 2003, EUR J NUCL MED MOL I, V30, P581, DOI 10.1007/s00259-002-1079-8; Coan AC, 2009, NEUROLOGY, V73, P834, DOI 10.1212/WNL.0b013e3181b783dd; Deleo F, 2016, EPILEPSIA, V57, P306, DOI 10.1111/epi.13277; Elsharkawy AE, 2009, J NEUROSURG, V110, P1135, DOI 10.3171/2008.6.JNS17613; Engel J, 1993, SURG TREATMENT EPILE, P609; Engel J, 2013, CURR OPIN NEUROL, V26, P186, DOI 10.1097/WCO.0b013e32835ee5b8; Gok B, 2013, NEURORADIOLOGY, V55, P541, DOI 10.1007/s00234-012-1121-x; Ho SS, 1997, BRAIN, V120, P1921, DOI 10.1093/brain/120.11.1921; Janszky J, 2005, BRAIN, V128, P395, DOI 10.1093/brain/awh358; Jeong SW, 2005, EPILEPSIA, V46, P1273, DOI 10.1111/j.1528-1167.2005.33504.x; Joo EY, 2005, SEIZURE-EUR J EPILEP, V14, P541, DOI 10.1016/j.seizure.2005.08.011; Joo EY, 2005, BRAIN, V128, P1802, DOI 10.1093/brain/awh534; Joo EY, 2004, EPILEPSIA, V45, P686, DOI 10.1111/j.0013-9580.2004.35003.x; Joo EY, 2004, ARCH NEUROL-CHICAGO, V61, P1074, DOI 10.1001/archneur.61.7.1074; Keller SS, 2007, EPILEPSY RES, V74, P131, DOI 10.1016/j.eplepsyres.2007.02.005; Labate A, 2015, EPILEPSIA, V56, P1109, DOI 10.1111/epi.13027; Labate A, 2010, EPILEPSIA, V51, P506, DOI 10.1111/j.1528-1167.2009.02310.x; LEVESQUE MF, 1991, J NEUROSURG, V75, P364, DOI 10.3171/jns.1991.75.3.0364; Li LM, 1999, BRAIN, V122, P799, DOI 10.1093/brain/122.5.799; Liu M, 2014, EPILEPSIA, V55, P674, DOI 10.1111/epi.12581; LoPinto-Khoury C, 2012, EPILEPSIA, V53, P342, DOI 10.1111/j.1528-1167.2011.03359.x; Lowe NM, 2010, SEIZURE-EUR J EPILEP, V19, P261, DOI 10.1016/j.seizure.2010.02.011; Mathon B, 2017, EPILEPSIA, V58, P1473, DOI 10.1111/epi.13831; McIntosh AM, 2001, EPILEPSIA, V42, P1288, DOI 10.1046/j.1528-1157.2001.02001.x; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Morgan VL, 2015, BRAIN CONNECT, V5, P35, DOI 10.1089/brain.2014.0251; Na M, 2015, SEIZURE-EUR J EPILEP, V25, P141, DOI 10.1016/j.seizure.2014.10.006; NAYEL MH, 1991, NEUROSURGERY, V29, P55, DOI 10.1227/00006123-199107000-00009; Pereira FRS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-66; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Ralph MAL, 2012, BRAIN, V135, P242, DOI 10.1093/brain/awr325; Schijns OEMG, 2011, NEUROSURGERY, V68, P98, DOI 10.1227/NEU.0b013e3181fc60ff; Schwartz TH, 2006, EPILEPSIA, V47, P567, DOI 10.1111/j.1528-1167.2006.00469.x; Tae WS, 2005, NEUROIMAGE, V24, P101, DOI 10.1016/j.neuroimage.2004.08.005; Uijl SG, 2008, EPILEPSIA, V49, P1317, DOI 10.1111/j.1528-1167.2008.01695.x; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wieser HG, 2003, J NEUROSURG, V98, P751, DOI 10.3171/jns.2003.98.4.0751; Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x; WYLER AR, 1995, NEUROSURGERY, V37, P982, DOI 10.1227/00006123-199511000-00019; Yasuda CL, 2010, NEUROIMAGE, V49, P71, DOI 10.1016/j.neuroimage.2009.08.014	50	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0206095	10.1371/journal.pone.0206095	http://dx.doi.org/10.1371/journal.pone.0206095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339697	Green Published, Green Submitted, gold			2022-12-26	WOS:000447761400038
J	Birmingham, E; Svard, J; Kanan, C; Fischer, H				Birmingham, Elina; Svard, Joakim; Kanan, Christopher; Fischer, Hakan			Exploring emotional expression recognition in aging adults using the Moving Window Technique	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; FACIAL EXPRESSIONS; FACE RECOGNITION; SCANNING PATTERNS; OWN-AGE; IDENTIFICATION; PERCEPTION; STIMULI; ATTENTION; AUTISM	Adult aging is associated with difficulties in recognizing negative facial expressions such as fear and anger. However, happiness and disgust recognition is generally found to be less affected. Eye-tracking studies indicate that the diagnostic features of fearful and angry faces are situated in the upper regions of the face (the eyes), and for happy and disgusted faces in the lower regions (nose and mouth). These studies also indicate age-differences in visual scanning behavior, suggesting a role for attention in emotion recognition deficits in older adults. However, because facial features can be processed extrafoveally, and expression recognition occurs rapidly, eye-tracking has been questioned as a measure of attention during emotion recognition. In this study, the Moving Window Technique (MWT) was used as an alternative to the conventional eye-tracking technology. By restricting the visual field to a moveable window, this technique provides a more direct measure of attention. We found a strong bias to explore the mouth across both age groups. Relative to young adults, older adults focused less on the left eye, and marginally more on the mouth and nose. Despite these different exploration patterns, older adults were most impaired in recognition accuracy for disgusted expressions. Correlation analysis revealed that among older adults, more mouth exploration was associated with faster recognition of both disgusted and happy expressions. As a whole, these findings suggest that in aging there are both attentional differences and perceptual deficits contributing to less accurate emotion recognition.	[Birmingham, Elina] Simon Fraser Univ, Fac Educ, Burnaby, BC, Canada; [Svard, Joakim; Fischer, Hakan] Stockholm Univ, Dept Psychol, Stockholm, Sweden; [Kanan, Christopher] Rochester Inst Technol, Chester F Carlson Ctr Imaging Sci, Rochester, NY 14623 USA	Simon Fraser University; Stockholm University; Rochester Institute of Technology	Birmingham, E (corresponding author), Simon Fraser Univ, Fac Educ, Burnaby, BC, Canada.	ebirming@sfu.ca		Fischer, Hakan/0000-0001-6710-1744	Swedish Research Council [421 2013-854]; Social Sciences and Humanities Research Council of Canada [639947]; John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development	Swedish Research Council(Swedish Research CouncilEuropean Commission); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development	This work was supported by Swedish Research Council (421 2013-854) awarded to H.F., https://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html; Social Sciences and Humanities Research Council of Canada grant (639947) to E.B., http://www.sshrccrsh.gc.ca/home-accueil-eng.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant from the Swedish Research Council (421 2013-854) awarded to H.F., and a Social Sciences and Humanities Research Council of Canada grant (639947) to E.B. The authors wish to thank Maja Johansson for assistance in data collection, and Dr. Natalie C. Ebner and Andrew Varan for constructive discussions regarding various aspects of the manuscript. The Development of the MacBrain Face Stimulus Set (NimStim) used in the present study was overseen by Nim Tottenham and supported by the John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development. Please contact Nim Tottenham at nlt7@columbia.edu for more information concerning the stimulus set.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Barrington L., 2008, J VISION, V8, P1, DOI [DOI 10.1167/8.14.17, 10.1167/8.14.17]; Bartzokis G, 2003, ARCH NEUROL-CHICAGO, V60, P393, DOI 10.1001/archneur.60.3.393; Birmingham E, 2013, CHILD DEV, V84, P1407, DOI 10.1111/cdev.12039; Butler S, 2005, NEUROPSYCHOLOGIA, V43, P52, DOI 10.1016/j.neuropsychologia.2004.06.005; Caldara R, 2011, BEHAV RES METHODS, V43, P864, DOI 10.3758/s13428-011-0092-x; Caldara R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009708; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Calvo MG, 2008, BEHAV RES METHODS, V40, P109, DOI 10.3758/BRM.40.1.109; Calvo MG, 2009, COGN AFFECT BEHAV NE, V9, P398, DOI 10.3758/CABN.9.4.398; Calvo MG, 2005, VIS COGN, V12, P13, DOI 10.1080/13506280444000094; Chan C. Y. H., PSYCHONOMIC B REV; Chiang CH, 2000, BRAIN COGNITION, V44, P415, DOI 10.1006/brcg.1999.1202; Chuk T, 2014, J VISION, V14, DOI 10.1167/14.11.8; Circelli KS, 2013, AGING NEUROPSYCHOL C, V20, P148, DOI 10.1080/13825585.2012.675427; Corden B, 2008, NEUROPSYCHOLOGIA, V46, P137, DOI 10.1016/j.neuropsychologia.2007.08.005; Ebner NC, 2011, COGNITION EMOTION, V25, P983, DOI 10.1080/02699931.2010.540817; Ebner NC, 2009, EMOTION, V9, P329, DOI 10.1037/a0015179; Firestone A, 2007, AGING NEUROPSYCHOL C, V14, P594, DOI 10.1080/13825580600899717; Folster M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00030; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gunning-Dixon FM, 2003, NEUROBIOL AGING, V24, P285, DOI 10.1016/S0197-4580(02)00099-4; Guo K, 2009, ANIM COGN, V12, P409, DOI 10.1007/s10071-008-0199-3; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Iidaka T, 2002, HIPPOCAMPUS, V12, P352, DOI 10.1002/hipo.1113; Isaacowitz DM, 2007, PSYCHOL AGING, V22, P147, DOI 10.1037/0882-7974.22.1.147; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KLEIN RM, 1994, ATTENTION PERFORM, V15, P333; Kohler CG, 2004, PSYCHIAT RES, V128, P235, DOI 10.1016/j.psychres.2004.07.003; Murphy NA, 2010, COGNITION EMOTION, V24, P436, DOI 10.1080/02699930802664623; Noh SR, 2013, EMOTION, V13, P238, DOI 10.1037/a0030234; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Raz N., 2000, HDB AGING COGNITION, V2nd, P1; Rhodes M.G., 2006, N AM J PSYCHOL, V8; Rhodes MG, 2012, PSYCHOL BULL, V138, P146, DOI 10.1037/a0025750; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Schurgin MW, 2014, J VISION, V14, DOI 10.1167/14.13.14; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Sullivan S, 2007, J GERONTOL B-PSYCHOL, V62, pP53, DOI 10.1093/geronb/62.1.P53; Tanaka JW, 2012, J CHILD PSYCHOL PSYC, V53, P1259, DOI 10.1111/j.1469-7610.2012.02571.x; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vaidya AR, 2014, COGNITION, V133, P443, DOI 10.1016/j.cognition.2014.07.004; Williams LM, 2006, J NEUROSCI, V26, P6422, DOI 10.1523/JNEUROSCI.0022-06.2006; Wong B, 2005, NEUROPSYCHOLOGY, V19, P739, DOI 10.1037/0894-4105.19.6.739	44	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205341	10.1371/journal.pone.0205341	http://dx.doi.org/10.1371/journal.pone.0205341			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4KR	30335767	Green Published, gold			2022-12-26	WOS:000447701300028
J	Cossellu, G; Fedele, L; Badaoui, B; Angiero, F; Farronato, G; Monti, E; Liverani, CA; Gorni, C; Botti, S				Cossellu, Gianguido; Fedele, Luigi; Badaoui, Bouabid; Angiero, Francesca; Farronato, Giampietro; Monti, Ermelinda; Liverani, Carlo Antonio; Gorni, Chiara; Botti, Sara			Prevalence and concordance of oral and genital HPV in women positive for cervical HPV infection and in their sexual stable partners: An Italian screening study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; OROPHARYNGEAL CANCER; UNITED-STATES; NEGATIVE WOMEN; MUCOSA; CAVITY; CARCINOMAS; EPIDEMIC; LESIONS; TRENDS	Objectives This cross-sectional study aimed to evaluate the prevalence and type of oral HPV-infection in women with a cervical HPV-lesion and in the oral and genital mucosa of their male partners. Methods The study group comprised 44 sexually-active women, 20-45 years with abnormal PAP smear, not more than 6 months prior to referral together with the male partners cohabiting in stable partnerships. A detailed questionnaire was administered concerning the HPV-related risk factors. Oral swabs, oral rinses, cervical swabs and urine samples were collected. HPV DNA was detected using two different polymerase chain reactions (PCRs): MY09-11 and FAP59-64. Positive samples were genotyped by Sanger sequencing and the INNO-LiPA HPV Genotyping Extra II probe assay. The association with risk factors was assessed by fitting a generalized model, using the General Linear Model function in the R-software; correlations were calculated between all data. Results HPV was detected in 84% of Cervical Samples, in 24.3% of oral samples and in one urine sample. Only 27% of the HPV-positive results were identical with both PCR DNA assays. 8 male had oral HPV-positive samples different from women cervical samples. In one couple the urine-male sample had the same HPV present in the female-cervical sample. A significant association resulted between women/oral sex practices and men/n. of partners. Conclusions This study reports that women (20.4%) with a diagnosis of cervical-HPV and their male partners (30,7%) are at high risk for subclinical oral HPV infection.	[Cossellu, Gianguido; Farronato, Giampietro] Univ Milan, Dept Biomed Surg & Dent Sci, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Milan, Italy; [Fedele, Luigi; Monti, Ermelinda; Liverani, Carlo Antonio] Fdn IRCCS Ca Granda, Dipartimento Donna Bambino Neonato, Ctr Riferimento Prevenz Diag & Cura Patol Gentita, Osped Maggiore Policlin, Milan, Italy; [Badaoui, Bouabid] Mohamed V Univ, Lab Biodivers Ecol & Genome, Rabat, Morocco; [Angiero, Francesca] Univ Genoa, Dept Med Sci & Diagnost Integrated, S Martino Hosp, Genoa, Italy; [Gorni, Chiara; Botti, Sara] Integrat Biol Grp, Parco Tecnol Padano CERSA, Lodi, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Mohammed V University in Rabat; University of Genoa; IRCCS AOU San Martino IST	Cossellu, G (corresponding author), Univ Milan, Dept Biomed Surg & Dent Sci, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Milan, Italy.	gianguido.cossellu@unimi.it	Badaoui, Bouabid/AAV-8968-2021	Cossellu, Gianguido/0000-0001-6442-5591				Adamopoulou M, 2013, GYNECOL ONCOL, V129, P395, DOI 10.1016/j.ygyno.2013.02.015; Badaracco G, 1998, J ORAL PATHOL MED, V27, P130; Castro Therezita M Peixoto Patury Galvao, 2009, Braz J Otorhinolaryngol, V75, P167; Centers for Disease Control and Prevention, 2014, MAN CANC AR LINK HPV; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Deschler DG, 2014, OTOLARYNG HEAD NECK, V151, P375, DOI 10.1177/0194599814538605; Fakhry C, 2006, J CLIN MICROBIOL, V44, P4479, DOI 10.1128/JCM.01321-06; Fuster-Rossello Liliana, 2014, Acta odontol. latinoam., V27, P82, DOI 10.1590/S1852-48342014000200007; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison Maura L., 1999, Current Opinion in Oncology, V11, P191, DOI 10.1097/00001622-199905000-00010; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Giraldo P, 2006, EUR J OBSTET GYN R B, V126, P104, DOI 10.1016/j.ejogrb.2005.09.009; Hong AM, 2010, VACCINE, V28, P3269, DOI 10.1016/j.vaccine.2010.02.098; KELLOKOSKI J, 1992, ORAL MICROBIOL IMMUN, V7, P19, DOI 10.1111/j.1399-302X.1992.tb00014.x; Kero K, 2016, EUR J CLIN MICROBIOL, V35, P697, DOI 10.1007/s10096-016-2589-9; Klussmann JP, 2003, AM J PATHOL, V162, P747, DOI 10.1016/S0002-9440(10)63871-0; Kocjan BJ, 2015, CLIN MICROBIOL INFEC; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Marais DJ, 2008, J MED VIROL, V80, P953, DOI 10.1002/jmv.21166; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Marques AEM, 2015, J ORAL PATHOL MED, V44, P453, DOI 10.1111/jop.12252; McIlwain WR, 2014, JAMA OTOLARYNGOL, V140, P441, DOI 10.1001/jamaoto.2014.141; Meyer MF, 2014, ORAL ONCOL, V50, P27, DOI 10.1016/j.oraloncology.2013.10.009; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Peixoto Andrea P, 2011, J Oral Sci, V53, P451; Ramqvist T, 2010, EMERG INFECT DIS, V16, P1671, DOI 10.3201/eid1611.100452; Saini R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-131; Sanchez-Vargas L, 2010, INFECT AGENTS CANCER, V5, P25, DOI DOI 10.1186/1750-9378-5-25; Smith E M, 2004, Infect Dis Obstet Gynecol, V12, P45; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Tatar TZ, 2015, J ORAL PATHOL MED, V44, P722, DOI 10.1111/jop.12302; Termine N, 2011, ORAL ONCOL, V47, P244, DOI 10.1016/j.oraloncology.2011.02.011; Termine N, 2009, J MED VIROL, V81, P1438, DOI 10.1002/jmv.21509; Uken RB, 2016, EUR ARCH OTO-RHINO-L, V273, P1933, DOI 10.1007/s00405-016-3953-1; van der Weele P, 2017, J VIROL, V91, DOI 10.1128/JVI.00844-17; Vidotti LR, 2014, J ORAL PATHOL MED, V43, P289, DOI 10.1111/jop.12141; Visalli G, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0096-3	40	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205574	10.1371/journal.pone.0205574	http://dx.doi.org/10.1371/journal.pone.0205574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335788	gold, Green Submitted, Green Published			2022-12-26	WOS:000447701300038
J	De Silva, D; Ranasinghe, W; Bandaragoda, T; Adikari, A; Mills, N; Iddamalgoda, L; Alahakoon, D; Lawrentschuk, N; Persad, R; Osipov, E; Gray, R; Bolton, D				De Silva, Daswin; Ranasinghe, Weranja; Bandaragoda, Tharindu; Adikari, Achini; Mills, Nishan; Iddamalgoda, Lahiru; Alahakoon, Damminda; Lawrentschuk, Nathan; Persad, Raj; Osipov, Evgeny; Gray, Richard; Bolton, Damien			Machine learning to support social media empowered patients in cancer care and cancer treatment decisions	PLOS ONE			English	Article							LOCALIZED PROSTATE-CANCER; COMPUTERIZED TEXT ANALYSIS; HEALTH-CARE; BREAST-CANCER; CENTERED CARE; BIG DATA; EMOTIONAL SUPPORT; ONLINE; INFORMATION; COMMUNICATION	Background A primary variant of social media, online support groups ( OSG) extend beyond the standard definition to incorporate a dimension of advice, support and guidance for patients. OSG are complementary, yet significant adjunct to patient journeys. Machine learning and natural language processing techniques can be applied to these large volumes of unstructured text discussions accumulated in OSG for intelligent extraction of patient-reported demographics, behaviours, decisions, treatment, side effects and expressions of emotions. New insights from the fusion and synthesis of such diverse patient-reported information, as expressed throughout the patient journey from diagnosis to treatment and recovery, can contribute towards informed decision-making on personalized healthcare delivery and the development of healthcare policy guidelines. Methods and findings We have designed and developed an artificial intelligence based analytics framework using machine learning and natural language processing techniques for intelligent analysis and automated aggregation of patient information and interaction trajectories in online support groups. Alongside the social interactions aspect, patient behaviours, decisions, demographics, clinical factors, emotions, as subsequently expressed over time, are extracted and analysed. More specifically, we utilised this platform to investigate the impact of online social influences on the intimate decision scenario of selecting a treatment type, recovery after treatment, side effects and emotions expressed over time, using prostate cancer as a model. Results manifest the three major decision-making behaviours among patients, Paternalistic group, Autonomous group and Shared group. Furthermore, each group demonstrated diverse behaviours in post-decision discussions on clinical outcomes, advice and expressions of emotion during the twelve months following treatment. Over time, the transition of patients from information and emotional support seeking behaviours to providers of information and emotional support to other patients was also observed. Conclusions Findings from this study are a rigorous indication of the expectations of social media empowered patients, their potential for individualised decision-making, clinical and emotional needs. The increasing popularity of OSG further confirms that it is timely for clinicians to consider patient voices as expressed in OSG. We have successfully demonstrated that the proposed platform can be utilised to investigate, analyse and derive actionable insights from patient-reported information on prostate cancer, in support of patient focused health-care delivery. The platform can be extended and applied just as effectively to any other medical condition.	[De Silva, Daswin; Ranasinghe, Weranja; Bandaragoda, Tharindu; Adikari, Achini; Mills, Nishan; Iddamalgoda, Lahiru; Alahakoon, Damminda] La Trobe Univ, Res Ctr Data Analyt & Cognit, Bundoora, Vic, Australia; [Ranasinghe, Weranja; Lawrentschuk, Nathan; Bolton, Damien] Austin Hosp, Heidelberg, Vic, Australia; [Persad, Raj] NHS Trust, North Bristol, Bristol, Avon, England; [Osipov, Evgeny] Lulea Univ Technol, Dept Comp Sci Elect & Space Engn, Lulea, Sweden; [Gray, Richard] La Trobe Univ, Sch Nursing & Midwifery, Bundoora, Vic, Australia	La Trobe University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Lulea University of Technology; La Trobe University	De Silva, D (corresponding author), La Trobe Univ, Res Ctr Data Analyt & Cognit, Bundoora, Vic, Australia.	d.desilva@latrobe.edu.au	des, d/GVU-7765-2022; PAN, ZEQIANG/X-6341-2018; Ranasinghe, Weranja/HHS-8150-2022; Ranasinghe, Weranja/AAV-5678-2021; Lawrentschuk, Nathan/AAL-8610-2021	Ranasinghe, Weranja/0000-0002-4006-0388; Lawrentschuk, Nathan/0000-0001-8553-5618; Bandaragoda, Tharindu/0000-0001-5047-3496; Adikari, Achini/0000-0001-5112-5063; Iddamalgodage Don, Lahiru Manohara/0000-0002-0849-6288				Aiken LH, 2002, INT J QUAL HEALTH C, V14, P5, DOI 10.1093/intqhc/14.1.5; Alpers GW, 2005, COMPUT HUM BEHAV, V21, P361, DOI 10.1016/j.chb.2004.02.008; American Cancer Society, 2017, AM CANC SOC; [Anonymous], 2015, WORLDW CANC STAT; [Anonymous], 1991, EMOTIONS; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Badawi O, 2014, JMIR MED INF, V2, P41, DOI 10.2196/medinform.3447; Bandaragoda T, 2018, ANN SURG ONCOL, V25, P1737, DOI 10.1245/s10434-018-6372-2; Bandaragoda TR, 2017, J ASSOC INF SCI TECH, V68, P2394, DOI 10.1002/asi.23896; Bandaragoda TR, 2018, J ASS INF SCI TECHNO; Bar-Lev S, 2008, QUAL HEALTH RES, V18, P509, DOI 10.1177/1049732307311680; Barak A, 2008, COMPUT HUM BEHAV, V24, P1867, DOI 10.1016/j.chb.2008.02.004; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Bates DW, 2014, HEALTH AFFAIR, V33, P1123, DOI 10.1377/hlthaff.2014.0041; Berry DL, 2003, UROL ONCOL-SEMIN O I, V21, P93, DOI 10.1016/S1078-1439(02)00209-0; Bird S., 2016, PROC ACL 02 WORK EFF, V1, DOI [10.3115/1225403.1225421, DOI 10.3115/1225403.1225421]; Blank TO, 2010, COMPUT HUM BEHAV, V26, P1400, DOI 10.1016/j.chb.2010.04.016; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; Chen AT, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4517; Chen AT, 2012, PATIENT EDUC COUNS, V87, P250, DOI 10.1016/j.pec.2011.08.017; Coulson NS, 2007, PATIENT EDUC COUNS, V68, P173, DOI 10.1016/j.pec.2007.06.002; Coulson NS, 2005, CYBERPSYCHOL BEHAV, V8, P580, DOI 10.1089/cpb.2005.8.580; Davis K, 2005, J GEN INTERN MED, V20, P953, DOI 10.1111/j.1525-1497.2005.0178.x; Demner-Fushman D, 2009, J BIOMED INFORM, V42, P760, DOI 10.1016/j.jbi.2009.08.007; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; DONOVAN JL, 1995, INT J TECHNOL ASSESS, V11, P443, DOI 10.1017/S0266462300008667; Elwyn G, 2000, BRIT J GEN PRACT, V50, P892; Evans M, 2012, PATIENT EDUC COUNS, V87, P405, DOI 10.1016/j.pec.2011.09.011; Fast E, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P4647, DOI 10.1145/2858036.2858535; Flood AB, 1996, J GEN INTERN MED, V11, P342, DOI 10.1007/BF02600045; Fox Susannah, 2011, SOCIAL LIFE HLTH INF; Gerteis M, 1993, EWEB124828; Gupta S, 2014, J AM MED INFORM ASSN, V21, P902, DOI 10.1136/amiajnl-2014-002669; Gwede CK, 2005, CANCER-AM CANCER SOC, V104, P1381, DOI 10.1002/cncr.21330; Hamilton William L, 2016, Proc Conf Empir Methods Nat Lang Process, V2016, P595, DOI 10.18653/v1/D16-1057; Harrison JD, 2009, SUPPORT CARE CANCER, V17, P1117, DOI 10.1007/s00520-009-0615-5; Hu XY, 2012, J HEALTH COMMUN, V17, P960, DOI 10.1080/10810730.2011.650828; Huber J, 2017, UROL ONCOL-SEMIN ORI, V35, DOI 10.1016/j.urolonc.2016.09.010; Huber J, 2011, BJU INT, V107, P1570, DOI 10.1111/j.1464-410X.2010.09859.x; Hutto CJ, 8 INT AAAI C WEBL SA; Ihrig A, 2011, BJU INT, V108, P1274, DOI 10.1111/j.1464-410X.2011.10082.x; Jayles B, 2017, P NATL ACAD SCI USA, V114, P12620, DOI 10.1073/pnas.1703695114; Kiss T, 2006, COMPUT LINGUIST, V32, P485, DOI 10.1162/coli.2006.32.4.485; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094186; Lieberman MA, 2006, PSYCHO-ONCOL, V15, P160, DOI 10.1002/pon.932; Lu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056221; Luxford K, 2011, INT J QUAL HEALTH C, V23, P510, DOI 10.1093/intqhc/mzr024; Mikolov T., 2013, ARXIV 160705368, P746, DOI DOI 10.3109/10826089109058901; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Miotto R, 2018, BRIEF BIOINFORM, V19, P1236, DOI 10.1093/bib/bbx044; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Mishra MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068563; Mnih Andriy, 2012, ARXIV12066426, P419; Mo PKH, 2008, CYBERPSYCHOL BEHAV, V11, P371, DOI 10.1089/cpb.2007.0118; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Murff HJ, 2011, JAMA-J AM MED ASSOC, V306, P848, DOI 10.1001/jama.2011.1204; Naslund JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110171; Niolon R, LIST FEELING WORDS; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Oh S, 2012, J AM SOC INF SCI TEC, V63, P543, DOI 10.1002/asi.21676; Pan HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059000; Plutchik R., 1980, EMOTION PSYCHOEVOLUT; Ranasinghe W, 2018, UROL ONCOL-SEMIN ORI, V36, DOI 10.1016/j.urolonc.2018.08.012; Ranasinghe W, 2017, BJU INT, V120, P59, DOI 10.1111/bju.14036; Ravi D, 2017, IEEE J BIOMED HEALTH, V21, P4, DOI 10.1109/JBHI.2016.2636665; Read J, 2012, P COLING 2012 POSTER, P985; Rehurek R., 2010, P LREC 2010 WORKSH N; Rumshisky A, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.182; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Ruthven I, 2018, J ASS INFORM SCI TEC; Shah ND, 2018, JAMA-J AM MED ASSOC, V320, P27, DOI 10.1001/jama.2018.5602; Shaikh AR, 2014, J MED INTERNET RES, V16, P143, DOI 10.2196/jmir.2496; Shim M, 2011, J COMMUN, V61, DOI 10.1111/j.1460-2466.2011.01555.x; Stewart M, 2000, J FAM PRACTICE, V49, P796; Stewart M, 2001, BRIT MED J, V322, P444, DOI 10.1136/bmj.322.7284.444; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Thelwall M, 2012, J AM SOC INF SCI TEC, V63, P163, DOI 10.1002/asi.21662; van Uden-Kraan CF, 2008, QUAL HEALTH RES, V18, P405, DOI 10.1177/1049732307313429; Wang YC, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3558; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278; Westerman D, 2014, J COMPUT-MEDIAT COMM, V19, P171, DOI 10.1111/jcc4.12041; White M, 2001, HEALTH EDUC RES, V16, P693, DOI 10.1093/her/16.6.693; Wright K, 2002, J APPL COMMUN RES, V30, P195, DOI 10.1080/00909880216586; Yates A., 2017, P 2017 C EMP METH NA, P2968, DOI DOI 10.18653/V1/D17-1322; Yim W, 2016, JAMA ONCOL, V2, P1, DOI DOI 10.1001/JAMA0NC0L.2016.0213	90	32	32	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205855	10.1371/journal.pone.0205855	http://dx.doi.org/10.1371/journal.pone.0205855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4KR	30335805	Green Published, gold			2022-12-26	WOS:000447701300063
J	Hawer, H; Utkur, K; Arend, M; Mayer, K; Adrian, L; Brinkmann, U; Schaffrath, R				Hawer, Harmen; Uetkuer, Koray; Arend, Meike; Mayer, Klaus; Adrian, Lorenz; Brinkmann, Ulrich; Schaffrath, Raffael			Importance of diphthamide modified EF2 for translational accuracy and competitive cell growth in yeast	PLOS ONE			English	Article							ELONGATION-FACTOR 2; KLUYVEROMYCES-LACTIS ZYMOCIN; ANTICODON LOOP MODIFICATIONS; TRANSFER-RNA MODIFICATION; ADP-RIBOSYLATING TOXINS; SACCHAROMYCES-CEREVISIAE; DIPHTHERIA-TOXIN; PROTEIN-SYNTHESIS; MOUSE DEVELOPMENT; BIOSYNTHESIS	In eukaryotes, the modification of an invariant histidine (His-699 in yeast) residue in translation elongation factor 2 (EF2) with diphthamide involves a conserved pathway encoded by the DPH1-DPH7 gene network. Diphthamide is the target for diphtheria toxin and related lethal ADP ribosylases, which collectively kill cells by inactivating the essential translocase function of EF2 during mRNA translation and protein biosynthesis. Although this notion emphasizes the pathological importance of diphthamide, precisely why cells including our own require EF2 to carry it, is unclear. Mining the synthetic genetic array (SGA) landscape from the budding yeast Saccharomyces cerevisiae has revealed negative interactions between EF2 (EFT1-EFT2) and diphthamide (DPH1-DPH7) gene deletions. In line with these correlations, we confirm in here that loss of diphthamide modification (dph.) on EF2 combined with EF2 undersupply (eft2.) causes synthetic growth phenotypes in the composite mutant (dph. eft2.). These reflect negative interference with cell performance under standard as well as thermal and/or chemical stress conditions, cell growth rates and doubling times, competitive fitness, cell viability in the presence of TOR inhibitors (rapamycin, caffeine) and translation indicator drugs (hygromycin, anisomycin). Together with significantly suppressed tolerance towards EF2 inhibition by cytotoxic DPH5 overexpression and increased ribosomal -1 frame-shift errors in mutants lacking modifiable pools of EF2 (dph., dph. eft2.), our data indicate that diphthamide is important for the fidelity of the EF2 translocation function during mRNA translation.	[Hawer, Harmen; Uetkuer, Koray; Arend, Meike; Schaffrath, Raffael] Univ Kassel, Inst Biol, Fachgebiet Mikrobiol, Kassel, Germany; [Mayer, Klaus; Brinkmann, Ulrich] Roche Innovat Ctr Munchen, Roche Pharma Res & Early Dev, Large Mol Res, Penzberg, Germany; [Adrian, Lorenz] Helmholtz Zentrum Umweltforsch GmbH UFZ, AG Geobiochem, Dept Isotopenbiogeochem, Leipzig, Germany; [Adrian, Lorenz] Tech Univ Berlin, Fachgebiet Geobiotechnol, Berlin, Germany	Universitat Kassel; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Berlin	Schaffrath, R (corresponding author), Univ Kassel, Inst Biol, Fachgebiet Mikrobiol, Kassel, Germany.	schaffrath@uni-kassel.de	Brinkmann, Ulrich/AAF-8216-2019; Adrian, Lorenz/A-4443-2012	Brinkmann, Ulrich/0000-0002-5558-0212; Adrian, Lorenz/0000-0001-8205-0842; Uetkuer, Koray/0000-0002-7506-9075; Arend, Meike/0000-0002-7561-1098; Schaffrath, Raffael/0000-0001-9484-5247	European regional development funds (EFRE-Europe Funds Saxony); University of Kassel research unit PhosMOrg [P/1082 232]; DFG [1927, AD178/7-1, SCHA750/21-1]	European regional development funds (EFRE-Europe Funds Saxony); University of Kassel research unit PhosMOrg; DFG(German Research Foundation (DFG))	This study was supported by European regional development funds (EFRE-Europe Funds Saxony) for the Centre for Chemical Microscopy (ProVIS) to Lorenz Adrian; University of Kassel research unit PhosMOrg (P/1082 232) to Raffael Schaffrath; DFG Priority Program 1927 Iron-Sulfur for Life: Cooperative Function of Iron-Sulfur Centers in Assembly, Biosynthesis, Catalysis and Disease to Lorenz Adrian (AD178/7-1) and to Raffael Schaffrath (SCHA750/21-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Fattah W, 2013, TOXINS, V5, P958, DOI 10.3390/toxins5050958; Abeyrathne PD, 2016, ELIFE, V5, DOI 10.7554/eLife.14874; Addinall SG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001362; Bar C, 2008, MOL MICROBIOL, V69, P1221, DOI 10.1111/j.1365-2958.2008.06350.x; Botet J, 2008, ANTIMICROB AGENTS CH, V52, P1623, DOI 10.1128/AAC.01603-07; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Chen CM, 2004, GENE DEV, V18, P320, DOI 10.1101/gad.1162204; CHEN JYC, 1985, MOL CELL BIOL, V5, P3357, DOI 10.1128/MCB.5.12.3357; CHEN JYC, 1988, J BIOL CHEM, V263, P11692; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2011, CURR OPIN BIOTECH, V22, P66, DOI 10.1016/j.copbio.2010.11.001; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Dever TE, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032649; Dominguez JM, 1999, J BIOL CHEM, V274, P22423, DOI 10.1074/jbc.274.32.22423; Dong M, 2018, SCIENCE, V359, P1247, DOI 10.1126/science.aao6595; Dong M, 2017, J AM CHEM SOC, V139, P5680, DOI 10.1021/jacs.7b01712; Dong M, 2014, J AM CHEM SOC, V136, P1754, DOI 10.1021/ja4118957; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Fichtner L, 2002, MOL MICROBIOL, V44, P865, DOI 10.1046/j.1365-2958.2002.02928.x; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gietz D, 2002, NUCLEIC ACIDS RES, V20, P1425; Glatt S, 2015, STRUCTURE, V23, P149, DOI 10.1016/j.str.2014.11.008; Greganova E, 2011, FEBS J, V278, P2613, DOI 10.1111/j.1742-4658.2011.08199.x; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Hekman KE, 2012, HUM MOL GENET, V21, P5472, DOI 10.1093/hmg/dds392; Horberg J, 2018, J CHEM INF MODEL, V58, P1406, DOI 10.1021/acs.jcim.8b00217; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Jablonowski D, 2001, YEAST, V18, P1285, DOI 10.1002/yea.776; KIMATA Y, 1994, J BIOL CHEM, V269, P13497; Klassen R, 2015, PLOS, DOI [10.1093/NAR/GKW705, DOI 10.1093/NAR/GKW705]; Klassen R, 2017, RNA BIOL, V14, P1252, DOI 10.1080/15476286.2016.1267098; Klassen R, 2016, NUCLEIC ACIDS RES, V44, P10946, DOI 10.1093/nar/gkw705; Kolaj-Robin O, 2015, FEBS J, V282, P819, DOI 10.1111/febs.13199; Kublik A, 2016, ENVIRON MICROBIOL, V18, P3044, DOI 10.1111/1462-2920.13200; Lin ZW, 2014, J AM CHEM SOC, V136, P6179, DOI 10.1021/ja5009272; Liu MH, 2017, CELL PHYSIOL BIOCHEM, V44, P505, DOI 10.1159/000485087; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu SH, 2006, MOL CELL BIOL, V26, P3835, DOI 10.1128/MCB.26.10.3835-3841.2006; Liu SH, 2012, P NATL ACAD SCI USA, V109, P13817, DOI 10.1073/pnas.1206933109; Mateyak MK, 2013, J BIOL CHEM, V288, P24647, DOI 10.1074/jbc.M113.488783; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; Murray J, 2016, ELIFE, V5, DOI 10.7554/eLife.13567; Nakajima J, 2018, J HUM GENET, V63, P529, DOI 10.1038/s10038-017-0399-2; Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022; Nobukuni Y, 2005, J BIOL CHEM, V280, P10572, DOI 10.1074/jbc.M413017200; Ortiz PA, 2005, NUCLEIC ACIDS RES, V33, P5740, DOI 10.1093/nar/gki882; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; Pellegrino S, 2018, J MOL BIOL, V430, P2677, DOI 10.1016/j.jmb.2018.06.006; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Schaffrath R, 2017, RNA BIOL, V14, P1209, DOI 10.1080/15476286.2017.1295204; Schaffrath R, 2014, MICROB CELL, V1, P203, DOI 10.15698/mic2014.06.151; Schaffrath R, 2014, MOL MICROBIOL, V94, P1213, DOI 10.1111/mmi.12845; Scheidt V, 2014, MICROB CELL, V1, P416, DOI 10.15698/mic2014.12.179; Seidel K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01130; Sekiguchi F, 2018, J HUM GENET, V63, P487, DOI 10.1038/s10038-017-0404-9; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sokolowski M, 2018, BBA-GENE REGUL MECH, V1861, P409, DOI 10.1016/j.bbagrm.2017.12.003; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Stahl S, 2015, P NATL ACAD SCI USA, V112, P10732, DOI 10.1073/pnas.1512863112; Su XY, 2013, CRIT REV BIOCHEM MOL, V48, P515, DOI 10.3109/10409238.2013.831023; Su XY, 2012, P NATL ACAD SCI USA, V109, P19983, DOI 10.1073/pnas.1214346109; Su XY, 2012, J AM CHEM SOC, V134, P773, DOI 10.1021/ja208870a; Susorov D, 2018, J BIOL CHEM, V293, P5220, DOI 10.1074/jbc.RA117.000761; Thakur A, 2012, J BIOL CHEM, V287, P13194, DOI 10.1074/jbc.M112.339655; Thatcher JW, 1998, P NATL ACAD SCI USA, V95, P253, DOI 10.1073/pnas.95.1.253; Tukenmez H, 2015, NUCLEIC ACIDS RES, V43, P9489, DOI 10.1093/nar/gkv832; Usaj M, 2017, G3-GENES GENOM GENET, V7, P1539, DOI 10.1534/g3.117.040220; Uthman S., 2011, SCI MICROBIOL PATHOG, V2, P1321; Uthman S., 2012, INSIGHT CONTROL INFE, P333; Uthman S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003334; VANNESS BG, 1980, J BIOL CHEM, V255, P710; Villahermosa D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07647-1; Webb TR, 2008, J CELL SCI, V121, P3140, DOI 10.1242/jcs.035550; Wei H, 2013, J BIOL CHEM, V288, P12305, DOI 10.1074/jbc.M113.461343; Zabel R, 2008, MOL MICROBIOL, V69, P175, DOI 10.1111/j.1365-2958.2008.06273.x; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138; Zhu XL, 2011, MOL BIOSYST, V7, P74, DOI 10.1039/c0mb00076k; Zhu XL, 2010, BIOCHEMISTRY-US, V49, P9649, DOI 10.1021/bi100812h	85	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205870	10.1371/journal.pone.0205870	http://dx.doi.org/10.1371/journal.pone.0205870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335802	gold, Green Submitted, Green Published			2022-12-26	WOS:000447701300066
J	Uselman, SM; Davison, J; Baughman, OW; Sullivan, BW; Miller, WW; Leger, EA				Uselman, Shauna M.; Davison, Jay; Baughman, Owen W.; Sullivan, Benjamin W.; Miller, W. Wally; Leger, Elizabeth A.			Restoring dryland old fields with native shrubs and grasses: Does facilitation and seed source matter?	PLOS ONE			English	Article							STRESS-GRADIENT HYPOTHESIS; LAND-USE LEGACIES; GREAT-BASIN; PLANT-COMMUNITIES; STATISTICAL INEVITABILITY; POSITIVE INTERACTIONS; SPECIES INTERACTIONS; RESTORATION ECOLOGY; SEMIARID GRASSLANDS; PERENNIAL GRASSES	Restoration of agricultural fields is challenging, especially in arid and semi-arid ecosystems. We conducted experiments in two fields in the Great Basin, USA, which differed in cultivation history and fertility. We tested the effects of different levels of functional diversity (planting grasses and shrubs together, vs. planting shrubs alone), seed source (cultivars, local or distant wild-collections), and irrigation regime (spring or fall and spring) on restoration outcomes. We sowed either: 1) grasses and shrubs in year one, 2) shrubs only, in year one, 3) grasses in year one with herbicide, shrubs in year two, or 4) shrubs alone in year two, after a year of herbicide. We irrigated for two years and monitored for three years. Shrub emergence was highest in the lower fertility field, where increasing functional diversity by seeding grasses had a neutral or facilitative effect on shrub emergence. In the higher fertility field, increasing functional diversity appeared to have a neutral to competitive effect. After declines in shrub densities after irrigation ceased, these effects did not persist. Grasses initially suppressed or had a neutral effect on weeds relative to an unseeded control, but had neutral or facilitative effects on weeds relative to shrub-only seeding. Initially, commercial grasses were either equivalent to or outperformed wild-collected grasses, but after irrigation ceased, commercial grasses were outperformed by wild-collected grasses in the higher fertility field. Local shrubs initially outperformed distant shrubs, but this effect did not persist. Fall and spring irrigation combined with local shrubs and wild-collected grasses was the most successful strategy in the higher fertility field, while in the lower fertility field, irrigation timing had fewer effects. Superior shrub emergence and higher grass persistence indicated that the use of wild and local seed sources is generally warranted, whereas the effects of functional diversity and irrigation regime were context-dependent. A bet-hedging approach that uses a variety of strategies may maximize the chances of restoration success.	[Uselman, Shauna M.; Baughman, Owen W.; Sullivan, Benjamin W.; Miller, W. Wally; Leger, Elizabeth A.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Davison, Jay] Univ Nevada Cooperat Extens, Fallon, NV USA; [Baughman, Owen W.] Nature Conservancy, Burns, OR USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nature Conservancy	Leger, EA (corresponding author), Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA.	eleger@cabnr.unr.edu		Leger, Elizabeth/0000-0003-0308-9496	United States Bureau of Reclamation [06FC204044]	United States Bureau of Reclamation	Funding for this work was provided by a grant under Public law 109-103, Section 208(a), through the United States Bureau of Reclamation (Cooperative Agreement 06FC204044). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas C, 2005, J ECOL, V93, P978, DOI 10.1111/j.1365-2745.2005.01033.x; Armas C, 2011, J VEG SCI, V22, P818, DOI 10.1111/j.1654-1103.2011.01301.x; Baer SG, 2014, EVOL APPL, V7, P323, DOI 10.1111/eva.12124; Banerjee MJ, 2006, RESTOR ECOL, V14, P339, DOI 10.1111/j.1526-100X.2006.00142.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Brown CS, 2008, INVAS PLANT SCI MANA, V1, P399, DOI 10.1614/IPSM-08-082.1; BURKE IC, 1995, ECOL APPL, V5, P793, DOI 10.2307/1941987; Chamberlain SA, 2014, ECOL LETT, V17, P881, DOI 10.1111/ele.12279; Chambers JC, 2000, ECOL APPL, V10, P1400, DOI 10.2307/2641294; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Davies KW, 2018, RANGELAND ECOL MANAG, V71, P19, DOI 10.1016/j.rama.2017.07.006; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; DOERR TB, 1983, J RANGE MANAGE, V36, P423, DOI 10.2307/3897931; DONOVAN LA, 1994, FUNCT ECOL, V8, P289, DOI 10.2307/2389821; DONOVAN LA, 1991, OECOLOGIA, V86, P594, DOI 10.1007/BF00318327; Elmore AJ, 2006, ECOSYSTEMS, V9, P1231, DOI 10.1007/s10021-005-0069-7; Espeland EK, 2007, ECOLOGY, V88, P2404, DOI 10.1890/06-1217.1; Forseth IN, 2001, J ECOL, V89, P670, DOI 10.1046/j.0022-0477.2001.00574.x; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Gasque M, 2004, FOREST ECOL MANAG, V189, P251, DOI 10.1016/j.foreco.2003.08.014; Gibson DJ, 2013, J VEG SCI, V24, P429, DOI 10.1111/j.1654-1103.2012.01475.x; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gomez-Aparicio L, 2009, J ECOL, V97, P1202, DOI 10.1111/j.1365-2745.2009.01573.x; Gustafson DJ, 2004, FUNCT ECOL, V18, P451, DOI 10.1111/j.0269-8463.2004.00850.x; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Hild AL, 2006, ARID LAND RES MANAG, V20, P183, DOI 10.1080/15324980600705586; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; Humphrey LD, 2002, RESTOR ECOL, V10, P88, DOI 10.1046/j.1526-100X.2002.10109.x; James JJ, 2011, J APPL ECOL, V48, P961, DOI 10.1111/j.1365-2664.2011.02009.x; Jensen K, 2001, ALL CURRENT PUBLICAT; JONES TA, 1990, J RANGE MANAGE, V43, P416, DOI 10.2307/3899003; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; le Roux PC, 2010, OECOLOGIA, V162, P733, DOI 10.1007/s00442-009-1484-9; Leger EA, 2015, NAT AREA J, V35, P54, DOI 10.3375/043.035.0108; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Liancourt P, 2011, PERSPECT PLANT ECOL, V13, P259, DOI 10.1016/j.ppees.2011.07.003; Lortie CJ, 2017, APPL VEG SCI, V20, P315, DOI 10.1111/avsc.12317; Low F, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10020159; Maestre FT, 2003, ECOLOGY, V84, P3186, DOI 10.1890/02-0635; Maestre FT, 2001, ECOL APPL, V11, P1641, DOI 10.1890/1051-0761(2001)011[1641:PFUFBG]2.0.CO;2; Monsen S.B., 2004, RESTORING W RANGES W, P121; Morris LR, 2011, RANGELAND ECOL MANAG, V64, P488, DOI 10.2111/REM-D-10-00147.1; Munroe DK, 2013, CURR OPIN ENV SUST, V5, P471, DOI 10.1016/j.cosust.2013.06.010; NAEEM S, 2006, FDN RESTORATION ECOL, P210; Noumi Z, 2015, APPL VEG SCI, V18, P391, DOI 10.1111/avsc.12158; Ogle D, 2012, PLANT MAT, P1; Perring MP, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00121.1; Porensky LM, 2014, AGR ECOSYST ENVIRON, V184, P135, DOI 10.1016/j.agee.2013.11.026; Pugnaire FI, 2011, J ARID ENVIRON, V75, P1310, DOI 10.1016/j.jaridenv.2011.01.016; PYKE DA, 1990, OECOLOGIA, V82, P537, DOI 10.1007/BF00319798; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; Rinella MJ, 2015, ECOL APPL, V25, P1044, DOI 10.1890/14-1110.1; Roundy BA, 2001, ARID LAND RES MANAG, V15, P23, DOI 10.1080/15324980121542; Rowe CLJ, 2012, WEST N AM NATURALIST, V72, P543, DOI 10.3398/064.072.0410; Seifan M, 2010, OIKOS, V119, P1601, DOI 10.1111/j.1600-0706.2010.18206.x; Smith S.D., 1997, PHYSIOLOGICAL ECOLOG; Standish RJ, 2014, BIOL CONSERV, V177, P43, DOI 10.1016/j.biocon.2014.06.008; Stuble KL, 2017, J APPL ECOL, V54, P1051, DOI 10.1111/1365-2664.12861; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Svejcar T, 2017, PLANT ECOL, V218, P81, DOI 10.1007/s11258-016-0648-z; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; Tilman D, 1998, AM NAT, V151, P277, DOI 10.1086/286118; USDA, 2014, 2012 CENS AGR NEV ST; Walker EA, 2015, APPL VEG SCI, V18, P368, DOI 10.1111/avsc.12153; Wang HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08016-8; Willand JE, 2015, J VEG SCI, V26, P421, DOI 10.1111/jvs.12257; Williams MI, 2002, RESTOR ECOL, V10, P385, DOI 10.1046/j.1526-100X.2002.01025.x; Wilsey BJ, 2010, RESTOR ECOL, V18, P628, DOI 10.1111/j.1526-100X.2008.00471.x	69	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205760	10.1371/journal.pone.0205760	http://dx.doi.org/10.1371/journal.pone.0205760			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335842	gold, Green Submitted, Green Published			2022-12-26	WOS:000447701300053
J	Al-Ani, A; Toms, D; Kondro, D; Thundathil, J; Yu, Y; Ungrin, M				Al-Ani, Abdullah; Toms, Derek; Kondro, Douglas; Thundathil, Jarin; Yu, Yang; Ungrin, Mark			Oxygenation in cell culture: Critical parameters for reproducibility are routinely not reported	PLOS ONE			English	Article							DIFFUSION-COEFFICIENTS; HELA-CELLS; RNA EXPRESSION; STEM-CELLS; HYPOXIA; HYPEROXIA; PRESSURE; ANGIOGENESIS; TEMPERATURE; LIMITATIONS	Mammalian cell culture is foundational to biomedical research, and the reproducibility of research findings across the sciences is drawing increasing attention. While many components contribute to reproducibility, the reporting of factors that impact oxygen delivery in the general biomedical literature has the potential for both significant impact, and immediate improvement. The relationship between the oxygen consumption rate of cells and the diffusive delivery of oxygen through the overlying medium layer means parameters such as medium depth and cell type can cause significant differences in oxygenation for cultures nominally maintained under the same conditions. While oxygenation levels are widely understood to significantly impact the phenotype of cultured cells in the abstract, in practise the importance of the above parameters does not appear to be well recognized in the non-specialist research community. On analyzing two hundred articles from high-impact journals we find a large majority missing at least one key piece of information necessary to ensure consistency in replication. We propose that explicitly reporting these values should be a requirement for publication.	[Al-Ani, Abdullah; Kondro, Douglas; Yu, Yang; Ungrin, Mark] Univ Calgary, Biomed Engn Grad Program, Calgary, AB, Canada; [Al-Ani, Abdullah; Toms, Derek; Kondro, Douglas; Yu, Yang; Ungrin, Mark] Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada; [Al-Ani, Abdullah; Kondro, Douglas; Yu, Yang; Ungrin, Mark] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Toms, Derek; Thundathil, Jarin; Ungrin, Mark] Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB, Canada	University of Calgary; University of Alberta; University of Calgary; University of Calgary	Ungrin, M (corresponding author), Univ Calgary, Biomed Engn Grad Program, Calgary, AB, Canada.; Ungrin, M (corresponding author), Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada.; Ungrin, M (corresponding author), Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada.; Ungrin, M (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB, Canada.	mark.ungrin@ucalgary.ca		Al-Ani, Abdullah/0000-0001-5057-7033; Yu, Yang/0000-0001-8986-6203; Ungrin, Mark/0000-0002-7410-1491	Natural Sciences and Engineering Research Council of Canada [RGPIN-201404874]; Canadian Institutes of Health Research [MOP-137095]; Alberta Diabetes Institute; Alberta Children's Hospital Research Institute	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Diabetes Institute; Alberta Children's Hospital Research Institute	Funding was provided by: Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) RGPIN-201404874 (MU), and PhD studentship (DK); Canadian Institutes of Health Research (http://cihr-irsc.gc.ca/) MOP-137095 (MU); Alberta Diabetes Institute (https://www.ualberta.ca/alberta-diabetes/) Graduate Studentship (YY); Alberta Children's Hospital Research Institute (https://research4kids.ucalgary.ca/) Graduate Studentship (AA), and Post Doctoral Fellowship (DT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CB, 2001, AM J PHYSIOL-LUNG C, V281, pL1021, DOI 10.1152/ajplung.2001.281.4.L1021; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; BALIN AK, 1976, J CELL PHYSIOL, V89, P235, DOI 10.1002/jcp.1040890207; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Berry JD, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0048-7; Bolli R, 2015, CIRC RES, V117, P665, DOI 10.1161/CIRCRESAHA.115.307496; Buchwald P, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-5; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Cassileth B, 2001, AM J PHYSIOL-LUNG C, V4, P261, DOI [10.1080/08858198909528020, DOI 10.1080/08858198909528020]; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Clayton JA, 2016, FASEB J, V30, P519, DOI 10.1096/fj.15-279554; CULLITON BJ, 1974, SCIENCE, V184, P1058, DOI 10.1126/science.184.4141.1058; Dachs GU, 2000, EUR J CANCER, V36, P1649, DOI 10.1016/S0959-8049(00)00159-3; Errington TM, 2014, ELIFE, V3, DOI 10.7554/eLife.04333; Fang FC, 2012, P NATL ACAD SCI USA, V109, P17028, DOI 10.1073/pnas.1212247109; FLEISCHAKER RJ, 1981, EUR J APPL MICROBIOL, V12, P193, DOI 10.1007/BF00499486; Florez-Vargas O, 2016, ELIFE, V5, DOI 10.7554/eLife.13615; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Freedman LP, 2015, NAT METHODS, V12, P493, DOI 10.1038/nmeth.3403; Freiberger J, 2004, UNDERSEA HYPERBAR M, V31, P227; FROESE G, 1962, BIOCHIM BIOPHYS ACTA, V57, P509, DOI 10.1016/0006-3002(62)91158-7; Gomes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161239; GRAHAM SV, 1985, LEUKEMIA RES, V9, P239, DOI 10.1016/0145-2126(85)90086-4; Guitart AV, 2010, EXP HEMATOL, V38, P847, DOI 10.1016/j.exphem.2010.06.002; Han P, 1996, J PHYS CHEM-US, V100, P5597, DOI 10.1021/jp952903y; Hartshorne JK, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hiorns LR, 2004, BRIT J CANCER, V90, P476, DOI 10.1038/sj.bjc.6601405; HO CS, 1986, BIOTECHNOL BIOENG, V28, P1086, DOI 10.1002/bit.260280720; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Ivanovic Z, 2009, EUR CYTOKINE NETW, V20, P7, DOI 10.1684/ecn.2009.0144; Jamnongwong M, 2010, CHEM ENG J, V165, P758, DOI 10.1016/j.cej.2010.09.040; Jez M, 2015, J CELL PHYSIOL, V230, P1999, DOI 10.1002/jcp.24953; JU LK, 1985, BIOTECHNOL BIOENG, V27, P1495, DOI 10.1002/bit.260271015; Kaiser J, 2018, SCIENCE, DOI [10.1126/science.aau9619, DOI 10.1126/SCIENCE.AAU9619]; Karp NA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005413; Kasinskas RW, 2014, INTEGR BIOL-UK, V6, P399, DOI 10.1039/c4ib00001c; Kim MC, 2013, MICROFLUID NANOFLUID, V15, P285, DOI 10.1007/s10404-013-1142-8; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lango T, 1996, UNDERSEA HYPERBAR M, V23, P247; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Macville M, 1999, CANCER RES, V59, P141; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Martin Y, 2005, BIOMATERIALS, V26, P7481, DOI 10.1016/j.biomaterials.2005.05.057; McKeown SR, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130676; MCLIMANS WF, 1968, BIOTECHNOL BIOENG, V10, P741, DOI 10.1002/bit.260100604; Mobley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063221; Muoio V, 2014, ACTA PHYSIOL, V210, P790, DOI 10.1111/apha.12250; Noman MZ, 2015, AM J PHYSIOL-CELL PH, V309, pC569, DOI 10.1152/ajpcell.00207.2015; Nugoli M, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-13; PAHL HL, 1994, BIOESSAYS, V16, P497, DOI 10.1002/bies.950160709; Place TL, 2017, FREE RADICAL BIO MED, V113, P311, DOI 10.1016/j.freeradbiomed.2017.10.003; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; RandersEichhorn L, 1996, BIOTECHNOL BIOENG, V51, P466, DOI 10.1002/(SICI)1097-0290(19960820)51:4<466::AID-BIT10>3.0.CO;2-G; Saltzman DJ, 2003, AM J PHYSIOL-HEART C, V285, pH1980, DOI 10.1152/ajpheart.00322.2002; SANGSTER WE, 1987, MON WEATHER REV, V115, P1358, DOI 10.1175/1520-0493(1987)115<1358:AITFCT>2.0.CO;2; SCHOONEN WGEJ, 1990, MUTAT RES, V237, P173; Tromans D, 1998, HYDROMETALLURGY, V48, P327, DOI 10.1016/S0304-386X(98)00007-3; Van Winkle AP, 2012, CELLS TISSUES ORGANS, V196, P34, DOI 10.1159/000330691; Vasilevsky NA, 2013, PEERJ, V1, DOI 10.7717/peerj.148; Vendruscolo F., 2012, ISRN CHEM ENG, V2012, P1, DOI [10.5402/2012/601458, DOI 10.5402/2012/601458]; Wagner BA, 2011, FREE RADICAL BIO MED, V51, P700, DOI 10.1016/j.freeradbiomed.2011.05.024; Wenger RH, 2000, J EXP BIOL, V203, P1253; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wenger RH, 2015, HYPOXIA, V3, P35, DOI 10.2147/HP.S92198; Wild JM, 2005, MAGNET RESON MED, V53, P1055, DOI 10.1002/mrm.20423; Witek P, 2016, CYTOTECHNOLOGY, V68, P2407, DOI 10.1007/s10616-016-9957-2; WITTENBERG BA, 1989, ANNU REV PHYSIOL, V51, P857, DOI 10.1146/annurev.physiol.51.1.857; YANG JD, 1992, BIOTECHNOL PROGR, V8, P244, DOI 10.1021/bp00015a010	72	60	61	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0204269	10.1371/journal.pone.0204269	http://dx.doi.org/10.1371/journal.pone.0204269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325922	Green Submitted, Green Published, gold			2022-12-26	WOS:000447430800006
J	Erickson, MA; Liang, WS; Fernandez, EG; Bullock, KM; Thysell, JA; Banks, WA				Erickson, Michelle A.; Liang, W. Sandy; Fernandez, Elizabeth G.; Bullock, Kristin M.; Thysell, Jarl A.; Banks, William A.			Genetics and sex influence peripheral and central innate immune responses and blood-brain barrier integrity	PLOS ONE			English	Article							NEUROVASCULAR UNIT; LIPOPOLYSACCHARIDE; MICE; DISRUPTION; NEUROINFLAMMATION; INFLAMMATION; DYSFUNCTION; DISEASE; ROLES; ENCEPHALOPATHY	Lipopolysaccharide (LPS) is a stimulator of the innate immune system and is routinely used in animal models to study blood-brain barrier (BBB) dysfunction under inflammatory conditions. It is appreciated that both humans and mice have sexually dimorphic immune responses, which could influence the brain's response to a systemic inflammatory insult. Mouse strain is also an important factor that can contribute to pathophysiological responses to inflammatory stimuli. Therefore, we aimed to test whether BBB disruption and the associated cytokine profiles in response to LPS differed in male and female mice from two mouse strains most commonly used in blood-brain barrier studies: CD-1 and C57BL6/J (C57). Mice were treated with saline, a single injection of 0.3, or 3mg/kg LPS, or three injections of 3mg/kg LPS, and studied 28 hours after the first LPS injection. To assay BBB disruption, we utilized the tracer 99mTc-DTPA. A 23-plex panel of cytokines was assayed in brain and blood of the same cohort of mice, which allowed us to compare differences in the levels of individual cytokines as well as correlations among cytokines and 99mTc-DTPA uptake. We found that only the three-injection dose of LPS induced significant BBB disruption in all sexes and strains. The treatment, strain, and sex, as well as treatment-by-strain and treatment-by-sex interactions significantly contributed to the variance. The mean brain/serum ratios of 99mTc-DTPA in the three-injection LPS group were ranked CD-1 male < CD-1 female < C57 male < C57 female. There were significant sex and strain differences in cytokine profiles in brain and blood, and pro-inflammatory cytokines and chemokines in brain were most strongly correlated with 99mTc-DTPA brain/serum ratios.	[Erickson, Michelle A.; Liang, W. Sandy; Fernandez, Elizabeth G.; Bullock, Kristin M.; Thysell, Jarl A.; Banks, William A.] Vet Adm Puget Sound Healthcare Syst, GRECC, Seattle, WA 98108 USA; [Erickson, Michelle A.; Banks, William A.] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Fernandez, Elizabeth G.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA	Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles	Erickson, MA (corresponding author), Vet Adm Puget Sound Healthcare Syst, GRECC, Seattle, WA 98108 USA.; Erickson, MA (corresponding author), Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA.	mericks9@uw.edu	Erickson, Michelle/AAR-8717-2021; Banks, William A/K-1330-2017; Erickson, Michelle/U-7754-2019; Erickson, Michelle/G-4815-2014	Banks, William A/0000-0002-0496-3619; Erickson, Michelle/0000-0002-2575-1594	United States Department of Veterans Affairs/Puget Sound Healthcare System	United States Department of Veterans Affairs/Puget Sound Healthcare System	This study was funded by the United States Department of Veterans Affairs/Puget Sound Healthcare System. The funders had no role in in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm AS, 2010, RESP PHYSIOL NEUROBI, V171, P157, DOI 10.1016/j.resp.2010.02.009; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Banks WA, 2015, BRAIN BEHAV IMMUN, V44, P1, DOI 10.1016/j.bbi.2014.08.007; Banks WA, 2018, J CEREBR BLOOD F MET, V38, P1104, DOI 10.1177/0271678X17740793; Banks WA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0434-1; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Berisavac II, 2016, CLIN NEUROL NEUROSUR, V148, P60, DOI 10.1016/j.clineuro.2016.06.013; Bohatschek M, 2001, EXP NEUROL, V172, P137, DOI 10.1006/exnr.2001.7764; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brown CM, 2010, ENDOCRINOLOGY, V151, P4916, DOI 10.1210/en.2010-0371; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cray C, 2009, COMPARATIVE MED, V59, P517; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Erickson MA, 2018, PHARMACOL REV, V70, P278, DOI 10.1124/pr.117.014647; Erickson MA, 2014, J PHARMACOL EXP THER, V349, P497, DOI 10.1124/jpet.114.213074; Erickson MA, 2011, BRAIN BEHAV IMMUN, V25, P1637, DOI 10.1016/j.bbi.2011.06.006; Galea I, 2018, BRAIN BEHAV IMMUN, V68, P11, DOI 10.1016/j.bbi.2017.10.014; Gilad R, 2012, J NEUROL, V259, P2041, DOI 10.1007/s00415-012-6445-2; Janigro D, 2012, EPILEPSIA, V53, P26, DOI 10.1111/j.1528-1167.2012.03472.x; Kadioglu A, 2011, J INFECT DIS, V204, P1971, DOI 10.1093/infdis/jir657; Li ZL, 2014, BRAIN BEHAV IMMUN, V38, P237, DOI 10.1016/j.bbi.2014.02.008; Lin KJ, 2009, NUCL MED BIOL, V36, P853, DOI 10.1016/j.nucmedbio.2009.04.011; Maggioli E, 2016, BRAIN BEHAV IMMUN, V51, P212, DOI 10.1016/j.bbi.2015.08.020; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; Michalak Z, 2012, J NEUROPATH EXP NEUR, V71, P826, DOI 10.1097/NEN.0b013e31826809a6; Minami T, 1998, ENVIRON TOXICOL PHAR, V5, P35, DOI 10.1016/S1382-6689(97)10004-7; Catorce MN, 2016, CURR NEUROPHARMACOL, V14, P155, DOI 10.2174/1570159X14666151204122017; Nishioku T, 2009, CELL MOL NEUROBIOL, V29, P309, DOI 10.1007/s10571-008-9322-x; Queen AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152289; Salameh TS, 2016, J PHARMACOL EXP THER, V359, P452, DOI 10.1124/jpet.116.237057; Saunders NR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3339/fnins.2015.00385, 10.3389/fnins.2015.00385]; Scotland RS, 2011, BLOOD, V118, P5918, DOI 10.1182/blood-2011-03-340281; Szigeti K, 2015, J CEREBR BLOOD F MET, V35, P1921, DOI 10.1038/jcbfm.2015.174; van Eijk LT, 2007, CRIT CARE MED, V35, P1464, DOI 10.1097/01.CCM.0000266534.14262.E8; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Winter C, 2015, NEUROL RES, V37, P599, DOI 10.1179/1743132815Y.0000000018	36	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205769	10.1371/journal.pone.0205769	http://dx.doi.org/10.1371/journal.pone.0205769			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325961	gold, Green Published, Green Submitted			2022-12-26	WOS:000447430800040
J	Kim, IY; Kim, JH; Kim, MJ; Lee, DW; Hwang, CG; Han, M; Rhee, H; Song, SH; Seong, EY; Lee, SB				Kim, Il Young; Kim, June Hyun; Kim, Min Jeong; Lee, Dong Won; Hwang, Cheol Gu; Han, Miyeun; Rhee, Harin; Song, Sang Heon; Seong, Eun Young; Lee, Soo Bong			Plasma neutrophil gelatinase-associated lipocalin is independently associated with left ventricular hypertrophy and diastolic dysfunction in patients with chronic kidney disease	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CHRONIC HEART-FAILURE; CARDIOVASCULAR-DISEASE; LEUKOCYTE ACTIVATION; NGAL; MORTALITY; MARKER; DAMAGE; CKD	Background Cardiovascular disease (CVD) is a leading cause of death in patients with chronic kidney disease (CKD). Left ventricular hypertrophy (LVH) and left ventricular diastolic dysfunction (LVDD) are known as predictors of CVD in these patients. Neutrophil gelatinase-associated lipocalin (NGAL) is a biomarker of acute kidney injury. Recently, elevated NGAL levels have been reported in patients with CVD. This study aimed to evaluate the association between plasma NGAL levels and LVH/LVDD in patients with CKD. Methods This study included 332 patients with pre-dialysis CKD (estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m(2)). Two-dimensional echocardiography was performed to measure the left ventricular mass index (LVMI). Tissue Doppler imaging was used to measure early mitral inflow velocity (E) and the peak early mitral annular velocity (E'). Diastolic function was estimated using E' and the ratio of E to E' (E/E'). The associations of echocardiographic index with clinical and laboratory variables (age, sex, diabetes, hypertension, eGFR, albumin, uric acid, calcium, phosphate, total cholesterol, hemoglobin, C-reactive protein, intact parathyroid hormone (PTH), the inferior vena cava collapse index (IVCCI) < 50%, and plasma NGAL) were investigated using univariate and multivariate analyses. Results In multivariate logistic regression analysis, plasma NGAL was an independent predictor of LVH (OR: 1.02, 95% CI: 1.01-1.02), P < 0.001). In addition, hypertension, intact PTH, and IVCCI < 50% were independent predictors of LVH. Plasma NGAL (OR: 1.02, 95% CI: 1.01-1.02, P < 0.001) was also an independent factor of LVDD. Furthermore, hypertension, intact PTH, and IVCCI < 50% were independent predictors of LVDD. Receiver operating characteristic curve analysis (area under the curve: 0.835, 95% CI: 0.792-0.879) showed the best cutoff value of plasma NGAL for identifying LVDD was >= 258 ng/ml with an associated sensitivity of 77.6% and a specificity of 87.6%. Conclusion Plasma NGAL levels were independent predictors of LVH and LVDD in patients with predialysis CKD, suggesting that plasma NGAL could be a biomarker for LVH and LVDD in these patients.	[Kim, Il Young; Kim, June Hyun; Kim, Min Jeong; Lee, Dong Won; Hwang, Cheol Gu; Han, Miyeun; Rhee, Harin; Song, Sang Heon; Seong, Eun Young; Lee, Soo Bong] Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan, South Korea; [Kim, Il Young; Kim, June Hyun; Kim, Min Jeong; Lee, Dong Won; Lee, Soo Bong] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea; [Hwang, Cheol Gu; Han, Miyeun; Rhee, Harin; Song, Sang Heon; Seong, Eun Young] Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Lee, SB (corresponding author), Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan, South Korea.; Lee, SB (corresponding author), Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea.	sbleemd@pusan.ac.kr	Han, Miyeun/AAE-7569-2022; Kim, Il Young/ABG-2153-2021; Kim, Il Young/ABG-2156-2021	Kim, Il Young/0000-0002-1731-6357; 				Alderson HV, 2016, CLIN J AM SOC NEPHRO, V11, P2141, DOI 10.2215/CJN.02670316; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Bolignano D, 2009, NEPHROL DIAL TRANSPL, V24, P3398, DOI 10.1093/ndt/gfp310; Bolignano D, 2009, REJUV RES, V12, P7, DOI 10.1089/rej.2008.0803; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; Choi KM, 2008, EUR J ENDOCRINOL, V158, P203, DOI 10.1530/EJE-07-0633; Cruz DN, 2012, CLIN CHEM LAB MED, V50, P1533, DOI 10.1515/cclm-2012-0307; Dyadyk OI, 1999, EUR J HEART FAIL, V1, P327, DOI 10.1016/S1388-9842(99)00057-4; Elneihoum AM, 1996, STROKE, V27, P1734, DOI 10.1161/01.STR.27.10.1734; Falke P, 2000, CEREBROVASC DIS, V10, P97, DOI 10.1159/000016037; Farshid A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-280; FOLEY RN, 1995, J AM SOC NEPHROL, V5, P2024; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hayashi SY, 2006, NEPHROL DIAL TRANSPL, V21, P125, DOI 10.1093/ndt/gfi075; Katagiri M, 2016, HEART VESSELS, V31, P1595, DOI 10.1007/s00380-015-0776-8; Kimura BJ, 2011, EUR J ECHOCARDIOGR, V12, DOI 10.1093/ejechocard/jeq157; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 1996, AM J KIDNEY DIS, V27, P347, DOI 10.1016/S0272-6386(96)90357-1; London GM, 2003, SEMIN DIALYSIS, V16, P85, DOI 10.1046/j.1525-139X.2003.16023.x; Maisel AS, 2011, NEPHROL DIAL TRANSPL, V26, P62, DOI 10.1093/ndt/gfq647; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Park M, 2012, J AM SOC NEPHROL, V23, P1725, DOI 10.1681/ASN.2012020145; Poniatowski B, 2009, KIDNEY BLOOD PRESS R, V32, P77, DOI 10.1159/000208989; Ronco C, 2014, HEART FAIL CLIN, V10, P251, DOI 10.1016/j.hfc.2013.12.003; Shrestha K, 2011, J CARD FAIL, V17, P472, DOI 10.1016/j.cardfail.2011.02.003; Yan AT, 2006, J CARD FAIL, V12, P514, DOI 10.1016/j.cardfail.2006.05.012; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yndestad A, 2009, EUR HEART J, V30, P1229, DOI 10.1093/eurheartj/ehp088	30	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205848	10.1371/journal.pone.0205848	http://dx.doi.org/10.1371/journal.pone.0205848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325973	Green Published, gold, Green Submitted			2022-12-26	WOS:000447430800046
J	Sage, EE; Jailani, N; Taib, AZM; Noor, NM; Said, MIM; Abu Bakar, M; Mackeen, MM				Sage, Edison Eukun; Jailani, Nashriq; Taib, Azney Zuhaily Md.; Noor, Normah Mohd; Said, Md. Ikram Mohd; Abu Bakar, Muntaz; Mackeen, Mukram Mohamed			From the Front or Back Door? Quantitative analysis of direct and indirect extractions of alpha-mangostin from mangosteen (Garcinia mangostana)	PLOS ONE			English	Article							PRENYLATED XANTHONES; PROSTATE-CANCER; PERICARP; FRUIT; CARBON; CONSTITUENTS; INHIBITION; SOLVENTS; CELLS; PARTS	The pulp and pericarp of mangosteen (Garcinia mangostana) fruit are popular food, beverage and health products whereby 60% of the fruit consist of the pericarp. The major metabolite in the previously neglected or less economically significant part of the fruit, the pericarp, is the prenylated xanthone alpha-mangostin. This highly bioactive secondary metabolite is typically isolated using solvent extraction methods that involve large volumes of halogenated solvents either via direct or indirect extraction. In this study, we compared the quantities of alpha-mangostin extracted using three different extraction methods based on the environmentally friendly solvents methanol and ethyl acetate. The three solvent extractions methods used were direct extractions from methanol (DM) and ethyl acetate (DEA) as well as indirect extraction of ethyl acetate obtained via solvent partitioning from an initial methanol extract (IEA). Our results showed that direct extraction afforded similar and higher quantities of alpha-mangostin than indirect extraction (DM: 318 mg; DEA: 305 mg; IEA: 209 mg per 5 g total dried pericarp). Therefore, we suggest that the commonly used method of indirect solvent extraction using halogenated solvents for the isolation of alpha-mangostin is replaced by single solvent direct extraction using the environmentally friendly solvents methanol or ethyl acetate.	[Sage, Edison Eukun; Said, Md. Ikram Mohd; Abu Bakar, Muntaz; Mackeen, Mukram Mohamed] Univ Kebangsaan Malaysia, Fac Sci & Technol, Ctr Adv Mat & Renewable Resources, Chem Programme, Bangi, Malaysia; [Jailani, Nashriq; Noor, Normah Mohd; Mackeen, Mukram Mohamed] Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi, UKM Bangi, Malaysia; [Taib, Azney Zuhaily Md.] Malaysia Genome Inst, Jalan Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Mackeen, MM (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Ctr Adv Mat & Renewable Resources, Chem Programme, Bangi, Malaysia.; Mackeen, MM (corresponding author), Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi, UKM Bangi, Malaysia.	mukram.mackeen@ukm.edu.my	Noor, Normah Mohd/X-1754-2019; Mackeen, Mukram Mohamed/AAN-6344-2020	Mackeen, Mukram Mohamed/0000-0001-7344-2932	Ministry of Higher Education [FRGS/1/2014/ST01/UKM/01/1]	Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR))	This work was supported by the Ministry of Higher Education under Grant FRGS/1/2014/ST01/UKM/01/1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdallah HM, 2017, J NAT MED-TOKYO, V71, P216, DOI 10.1007/s11418-016-1051-8; Abdalrahim F. A. A., 2012, J MED PLANTS RES, V6, P4526; Ahmad M, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-85; Alberti A, 2018, J PHARMACEUT BIOMED, V147, P13, DOI 10.1016/j.jpba.2017.08.051; Arunrattiyakorn P, 2014, J MOL CATAL B-ENZYM, V102, P174, DOI 10.1016/j.molcatb.2014.02.010; Arunrattiyakorn P, 2011, PHYTOCHEMISTRY, V72, P730, DOI 10.1016/j.phytochem.2011.02.007; Ashraf MA, 2017, SOILS OF MALAYSIA; Bundeesomchok K, 2016, LWT-FOOD SCI TECHNOL, V65, P297, DOI 10.1016/j.lwt.2015.08.036; Burkill I. H, 2015, DICT EC PRODUCTS MAL; Capello C, 2007, GREEN CHEM, V9, P927, DOI 10.1039/b617536h; Chaijaroenkul W, 2015, ACTA PARASITOL, V60, P105, DOI 10.1515/ap-2015-0013; Chen LG, 2008, FOOD CHEM TOXICOL, V46, P688, DOI 10.1016/j.fct.2007.09.096; Chen YD, 2011, J TAIWAN INST CHEM E, V42, P837, DOI 10.1016/j.jtice.2011.01.007; Chhouk K, 2016, J SUPERCRIT FLUID, V110, P167, DOI 10.1016/j.supflu.2015.11.016; Ee GCL, 2006, NAT PROD RES, V20, P1067, DOI 10.1080/14786410500463114; Fairchild D, 1915, J HERED, V6, P339, DOI 10.1093/oxfordjournals.jhered.a109140; Fei X, 2014, BIOORG MED CHEM LETT, V24, P2062, DOI 10.1016/j.bmcl.2014.03.047; Gross Paul M, 2009, SUPERFRUITS TOP 20 F; Guideline I.H.T., 2005, INT C HARM; Gutierrez-Orozco F, 2013, NUTRIENTS, V5, P3163, DOI 10.3390/nu5083163; He L, 2014, PHYTOCHEM LETT, V9, P175, DOI 10.1016/j.phytol.2014.06.009; Ho C-T, 2005, ASIAN FUNCTIONAL FOO; Ismail M, 2017, AIP C P, DOI [10.1063/1.4976594, DOI 10.1063/1.4976594]; Jantan I, 2011, J NAT MED-TOKYO, V65, P400, DOI 10.1007/s11418-010-0492-8; Johnson JJ, 2012, CARCINOGENESIS, V33, P413, DOI 10.1093/carcin/bgr291; Jung HA, 2006, J AGR FOOD CHEM, V54, P2077, DOI 10.1021/jf052649z; Kondo M, 2009, J AGR FOOD CHEM, V57, P8788, DOI 10.1021/jf901012f; Kunnumakkara AB, 2017, BRIT J PHARMACOL, V174, P1325, DOI 10.1111/bph.13621; Li GB, 2014, BIOCHEM BIOPH RES CO, V453, P75, DOI 10.1016/j.bbrc.2014.09.054; Li GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081572; Li GB, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00080; Li L, 2011, MOL NUTR FOOD RES, V55, pS67, DOI 10.1002/mnfr.201000511; Lin SM, 2017, J MED CHEM, V60, P10135, DOI 10.1021/acs.jmedchem.7b01348; Loo AEK, 2007, J AGR FOOD CHEM, V55, P9805, DOI 10.1021/jf071500f; MAHABUSARAKAM W, 1986, J SCI SOC THAILAND, V12, P239; Matsumoto K, 2004, BIOORGAN MED CHEM, V12, P5799, DOI 10.1016/j.bmc.2004.08.034; Mohamed GA, 2017, J ETHNOPHARMACOL, V198, P302, DOI 10.1016/j.jep.2017.01.030; Mohamed GA, 2014, FITOTERAPIA, V98, P215, DOI 10.1016/j.fitote.2014.08.014; Narasimhan S, 2017, MOLECULES, V22, DOI 10.3390/molecules22020275; Normah MN, 1997, SEED SCI RES, V7, P179, DOI 10.1017/S0960258500003512; Perry Lily M., 1980, MED PLANTS E SE ASIA; Pothitirat W, 2009, FUNCTIONAL PLANT SCI, V3, P16; Pothitirat W, 2010, MED PRIN PRACT, V19, P281, DOI 10.1159/000312714; Ramaiya A, 2012, CURR DRUG TARGETS, V13, P1698, DOI 10.2174/138945012804545524; Ryu HW, 2011, PHYTOCHEMISTRY, V72, P2148, DOI 10.1016/j.phytochem.2011.08.007; Sakagami Y, 2005, PHYTOMEDICINE, V12, P203, DOI 10.1016/j.phymed.2003.09.012; Samsir SA, 2016, DATA BRIEF, V8, P1, DOI 10.1016/j.dib.2016.04.062; Seesom W, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-182; Sosef M.S.M., 1998, PLANT RESOURCES S E; Suksamrarn S, 2003, CHEM PHARM BULL, V51, P857, DOI 10.1248/cpb.51.857; Tan GYT, 2017, FOOD BIOPROD PROCESS, V102, P233, DOI 10.1016/j.fbp.2016.12.016; Tarasuk M, 2017, VIRUS RES, V240, P180, DOI 10.1016/j.virusres.2017.08.011; Le TT, 2014, APPL MICROBIOL BIOT, V98, P8527, DOI 10.1007/s00253-014-5947-5; Win H, 2017, ANAL TROPICAL FRUITS; Yodhnu S, 2009, J CHROMATOGR SCI, V47, P185, DOI 10.1093/chromsci/47.3.185; Zarena AS, 2015, J FOOD SCI TECH MYS, V52, P6547, DOI 10.1007/s13197-014-1705-z; Zhang YC, 2015, SEP PURIF TECHNOL, V144, P215, DOI 10.1016/j.seppur.2015.02.038; Zhao Y, 2010, NAT PROD RES, V24, P1664, DOI 10.1080/14786419.2010.499539; Zhou XJ, 2015, NAT PROD RES, V29, P19, DOI 10.1080/14786419.2014.927873	59	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205753	10.1371/journal.pone.0205753	http://dx.doi.org/10.1371/journal.pone.0205753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321238	Green Published, gold, Green Submitted			2022-12-26	WOS:000447417900049
J	Shaikh, M; Miraldo, M; Renner, AT				Shaikh, Mujaheed; Miraldo, Marisa; Renner, Anna-Theresa			Waiting time at health facilities and social class: Evidence from the Indian caste system	PLOS ONE			English	Article							PATIENT-CENTERED COMMUNICATION; SOCIOECONOMIC-STATUS; PHYSICIAN GENDER; SERVICES; CARE; RESPONSIVENESS; ETHNICITY; INEQUALITIES; DISPARITIES; EXCLUSION	Waiting time for non-emergency medical care in developing countries is rarely of immediate concern to policy makers that prioritize provision of basic health services. However, waiting time as a measure of health system responsiveness is important because longer waiting times worsen health outcomes and affect utilization of services. Studies that assess socioeconomic inequalities in waiting time provide evidence from developed countries such as England and the United States; evidence from developing countries is lacking. In this paper, we assess the relationship between social class i.e. caste of an individual and waiting time at health facilities-a client orientation dimension of responsiveness. We use household level data from two rounds of the Indian Human Development Survey with a sample size of 27,251 households in each wave (2005 and 2012) and find that lower social class is associated with higher waiting time. This relationship is significant for individuals that visited a male provider but not so for those that visited a female provider. Further, caste is positively related to higher waiting time only if visiting a private facility; for individuals visiting a government facility the relationship between waiting time and caste is not significant. In general, caste related inequality in waiting time has worsened over time. The results are robust to different specifications and the inclusion of several confounders.	[Shaikh, Mujaheed; Renner, Anna-Theresa] Vienna Univ Econ & Business, Hlth Econ & Policy, Vienna, Austria; [Miraldo, Marisa] Imperial Coll London, Imperial Coll Business Sch, Dept Management, London, England; [Miraldo, Marisa] Imperial Coll London, Imperial Coll Business Sch, Ctr Hlth Econ & Policy Innovat, London, England	Vienna University of Economics & Business; Imperial College London; Imperial College London	Shaikh, M (corresponding author), Vienna Univ Econ & Business, Hlth Econ & Policy, Vienna, Austria.	mujaheed.shaikh@wu.ac.at	Miraldo, Marisa/ABF-2584-2020	Miraldo, Marisa/0000-0002-5772-7740; Shaikh, Mujaheed/0000-0002-4231-6631; Renner, Anna-Theresa/0000-0003-4591-3412				Adamson J, 2003, SOC SCI MED, V57, P895, DOI 10.1016/S0277-9536(02)00458-6; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Betancourt JR, 2003, PUBLIC HEALTH REP, V118, P293, DOI 10.1093/phr/118.4.293; Borooah VK, 2005, REV DEV ECON, V9, P399, DOI 10.1111/j.1467-9361.2005.00284.x; Borooah VK, 2005, J DEV STUD, V41, P1369, DOI 10.1080/00220380500186960; Burstrom B, 2002, HEALTH POLICY, V62, P117, DOI 10.1016/S0168-8510(02)00016-7; Cooper LA, 2003, ANN INTERN MED, V139, P907, DOI 10.7326/0003-4819-139-11-200312020-00009; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Coulter A, 2005, EUR J PUBLIC HEALTH, V15, P355, DOI 10.1093/eurpub/cki004; Desai S., 2018, India Human Development Survey (IHDS), 2005. ICPSR 22626, DOI 10.3886/ICPSR22626.v12; Desai S., **DATA OBJECT**, P2011, DOI [10.3886/ICPSR36151.v6, 10.3886/ICPSR36151. V6]; Desai Sonalde, 2012, Econ Polit Wkly, V46, P40; Deshpande A, 2000, AM ECON REV, V90, P322, DOI 10.1257/aer.90.2.322; Dunlop S, 2000, SOC SCI MED, V51, P123, DOI 10.1016/S0277-9536(99)00424-4; Habicht J, 2005, SOC SCI MED, V60, P777, DOI 10.1016/j.socscimed.2004.06.026; Johnson E., 2014, ENCY HLTH EC, V3, P77; Jones AM, 2011, J HEALTH ECON, V30, P616, DOI 10.1016/j.jhealeco.2011.05.003; Kaplan GA, 1996, BMJ-BRIT MED J, V312, P9; Kiwanuka SN, 2008, T ROY SOC TROP MED H, V102, P1067, DOI 10.1016/j.trstmh.2008.04.023; Koopmanschap MA, 2005, SOC SCI MED, V60, P2501, DOI 10.1016/j.socscimed.2004.11.022; Laudicella M, 2012, SOC SCI MED, V74, P1331, DOI 10.1016/j.socscimed.2011.12.049; Malhotra C, 2013, HEALTH POLICY PLANN, V28, P197, DOI 10.1093/heapol/czs051; Morris S, 2003, 27 U YORK CTR HLTH E; Moscelli G, 2016, SOC SCI MED, V161, P151, DOI 10.1016/j.socscimed.2016.05.043; Nayar KR, 2007, INDIAN J MED RES, V126, P355; Peltzer K, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-117; Rama Baru, 2010, Economic and Political Weekly, V45, P49; Robone S, 2011, HEALTH SERV RES, V46, P2079, DOI 10.1111/j.1475-6773.2011.01291.x; Roter DL, 2004, ANNU REV PUBL HEALTH, V25, P497, DOI 10.1146/annurev.publhealth.25.101802.123134; Sabin JA, 2009, J HEALTH CARE POOR U, V20, P896, DOI 10.1353/hpu.0.0185; Santana P, 2002, SOC SCI MED, V55, P33, DOI 10.1016/S0277-9536(01)00218-0; Siciliani L, 2014, ISR J HEALTH POLICY, V3, DOI 10.1186/2045-4015-3-38; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; Smaje C, 1997, SOC SCI MED, V45, P485, DOI 10.1016/S0277-9536(96)00380-2; Stith AY, 2003, UNEQUAL TREATMENT CO; STREET RL, 1991, SOC SCI MED, V32, P541, DOI 10.1016/0277-9536(91)90288-N; Subramanian SV, 2006, AM J PUBLIC HEALTH, V96, P818, DOI 10.2105/AJPH.2004.060103; Subramanian SV., 2008, BROWN J WORLD AFF, V14, P127; TEMKINGREENER H, 1988, SOC SCI MED, V26, P989, DOI 10.1016/0277-9536(88)90216-X; Thind A, 2004, J TROP PEDIATRICS, V50, P137, DOI 10.1093/tropej/50.3.137; van Doorslaer E, 2004, HEALTH ECON, V13, P629, DOI 10.1002/hec.919; WEISMAN CS, 1985, SOC SCI MED, V20, P1119, DOI 10.1016/0277-9536(85)90189-3; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; World Health Organization (WHO), HLTH IMP ASS	44	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205641	10.1371/journal.pone.0205641	http://dx.doi.org/10.1371/journal.pone.0205641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0RD	30321215	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000447417900042
J	Vollsaeter, M; Halvorsen, T; Markestad, T; Oymar, K; Ueland, PM; Meyer, K; Midttun, O; Bjorke-Monsen, AL				Vollsaeter, Maria; Halvorsen, Thomas; Markestad, Trond; Oymar, Knut; Ueland, Per Magne; Meyer, Klaus; Midttun, Oivind; Bjorke-Monsen, Anne-Lise			Renal function and blood pressure in 11 year old children born extremely preterm or small for gestational age	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; LONG-TERM RISK; BIRTH-WEIGHT; SERUM CREATININE; CYSTATIN-C; METAANALYSIS; INFANTS; FETAL; HYPERTENSION	Background Preterm birth and low birth weight are associated with reduced nephron numbers and increased risk of hypertension and kidney disease in later life. Aims We tested the hypothesis that extremely preterm birth and intrauterine growth restriction is associated with decreased renal function in mid childhood. Methods At 11 years of age the following measures were obtained in a regional cohort of children born extremely premature (EP, i.e. <28 weeks gestational age-GA) or with extremely low birth weight (ELBW, i.e. BW <1000 grams) and in matched controls born at term with appropriate BW (AGA): Height, weight, abdominal circumference, triceps and subscapular skin fold thicknesses, blood pressure, plasma levels of creatinine, cystatin C and symmetric dimethyl arginine (SDMA). Small for gestational age (SGA) was defined as a BW <10th percentile for GA. Glomerular filtration rate (GFR) was estimated according to the equations by Schwartz, Zappitelli and Gao. Results Fifty-seven of 61 eligible EP/ELBW children, 20 (35%) born SGA, and 54 controls, were assessed. Estimated GFR decreased while plasma SDMA increased from the children born AGA at term through those born preterm AGA to preterm SGA. Systolic BP was correlated to fat mass indices (p<0.03), but not to renal function (p>0.2) and did not differ between the groups. Conclusions Children born EP/ELBW, particularly those born SGA, had impaired renal function at age 11 years as judged from estimated GFRs and plasma levels of SDMA. Since reduced renal function is associated with an increased risk of later disease, these children should be followed in order to minimize additional risk factors.	[Vollsaeter, Maria; Halvorsen, Thomas] Haukeland Hosp, Dept Pediat, Bergen, Norway; [Vollsaeter, Maria; Halvorsen, Thomas; Markestad, Trond; Oymar, Knut; Ueland, Per Magne; Bjorke-Monsen, Anne-Lise] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Oymar, Knut] Stavanger Univ Hosp, Dept Pediat, Stavanger, Norway; [Ueland, Per Magne; Bjorke-Monsen, Anne-Lise] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway; [Meyer, Klaus; Midttun, Oivind] Bevital AS, Armauer Hansens Hus, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Stavanger University Hospital; University of Bergen; Haukeland University Hospital	Vollsaeter, M (corresponding author), Haukeland Hosp, Dept Pediat, Bergen, Norway.; Vollsaeter, M (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	maria.vollseter@helse-bergen.no	Ueland, Per M/C-7340-2013; Halvorsen, Thomas/P-6741-2015	Halvorsen, Thomas/0000-0003-1471-0225; Vollsaeter, Maria/0000-0003-2545-0190; Ueland, Per Magne/0000-0002-1903-0571	Western Norway health Authority; Foundation to promote research into functional vitamin B12-deficiency; Bevital	Western Norway health Authority; Foundation to promote research into functional vitamin B12-deficiency; Bevital	The study was supported by grants from 1) Western Norway health Authority and 2) the Foundation to promote research into functional vitamin B12-deficiency. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, writing of the report or in the decision to submit the paper for publication. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. Two of the authors are employed by a commercial company, Bevital A/S. Bevital as a funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of authors' salaries (KM, OM) and/or research materials. The specific roles of these authors are articulated in the "author's contributions" section.	Biosca M, 2011, NUTR HOSP, V26, P971, DOI [10.3305/nh.2011.26.5.5162, 10.1590/S0212-16112011000500008]; Black MJ, 2013, NEPHROLOGY, V18, P180, DOI 10.1111/nep.12028; Brooks ER, 2009, PEDIATR NEPHROL, V24, P129, DOI 10.1007/s00467-008-0972-1; Carmody JB, 2013, PEDIATRICS, V131, P1168, DOI 10.1542/peds.2013-0009; Cheung YF, 2004, ARCH DIS CHILD, V89, P217, DOI 10.1136/adc.2003.025999; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Delanaye P, 2017, NEPHRON, V136, P302, DOI 10.1159/000469669; Dolan MS, 2007, OBESITY, V15, P1600, DOI 10.1038/oby.2007.189; Elia M, 2007, AM J CLIN NUTR, V86, P618, DOI 10.1093/ajcn/86.3.618; Fanos V, 2012, CURR MED CHEM, V19, P4595, DOI 10.2174/092986712803306439; Freedman DS, 2009, PEDIATRICS, V123, P750, DOI 10.1542/peds.2008-1284; Gao AJ, 2013, KIDNEY INT, V83, P524, DOI 10.1038/ki.2012.388; HINCHLIFFE SA, 1992, BRIT J OBSTET GYNAEC, V99, P296, DOI 10.1111/j.1471-0528.1992.tb13726.x; Horbar JD, 2012, PEDIATRICS, V129, P1019, DOI 10.1542/peds.2011-3028; Hsu CY, 2011, CLIN J AM SOC NEPHRO, V6, P1813, DOI 10.2215/CJN.06040611; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Johansson S, 2005, CIRCULATION, V112, P3430, DOI 10.1161/CIRCULATIONAHA.105.540906; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Kramer MS, 2014, AM J CLIN NUTR, V100, P176, DOI 10.3945/ajcn.113.079590; Lackland DT, 2000, ARCH INTERN MED, V160, P1472, DOI 10.1001/archinte.160.10.1472; Leversen KT, 2011, PEDIATRICS, V127, pE630, DOI 10.1542/peds.2010-1001; Li S, 2008, KIDNEY INT, V73, P637, DOI 10.1038/sj.ki.5002747; Luyckx VA, 2015, NAT REV NEPHROL, V11, P135, DOI 10.1038/nrneph.2014.251; Luyckx VA, 2013, LANCET, V382, P273, DOI 10.1016/S0140-6736(13)60311-6; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Meyer K, 2014, ANAL CHEM, V86, P5807, DOI 10.1021/ac500704y; Moreno LA, 1997, J PEDIATR GASTR NUTR, V25, P175, DOI 10.1097/00005176-199708000-00008; Mu M, 2012, ARCH CARDIOVASC DIS, V105, P99, DOI 10.1016/j.acvd.2011.10.006; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Petrou S, 2011, ARCH DIS CHILD-FETAL, V96, pF225, DOI 10.1136/adc.2009.161117; Plantinga LC, 2010, ADV CHRONIC KIDNEY D, V17, P225, DOI 10.1053/j.ackd.2010.03.002; Pottel H, 2017, PEDIATR NEPHROL, V32, P249, DOI 10.1007/s00467-016-3373-x; Rink N, 2015, PEDIATR NEPHROL, V30, P1327, DOI 10.1007/s00467-015-3063-0; Rodriguez MM, 2004, PEDIATR DEVEL PATHOL, V7, P17, DOI 10.1007/s10024-003-3029-2; Ronkainen E, 2016, ARCH DIS CHILD-FETAL, V101, pF412, DOI 10.1136/archdischild-2015-308922; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Soeby K, 2015, CLIN CHEM LAB MED, V53, P1621, DOI 10.1515/cclm-2014-0949; Ueland PM, 2007, CLIN CHEM LAB MED, V45, P1737, DOI 10.1515/CCLM.2007.339; Uemura O, 2011, CLIN EXP NEPHROL, V15, P694, DOI 10.1007/s10157-011-0452-y; Vollsaeter M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144243; WHO MoD, PARTN MAT NEWB CHILD; Wilcox AJ, 2011, AM J EPIDEMIOL, V174, P1062, DOI 10.1093/aje/kwr230; Willemsen RH, 2008, J CLIN ENDOCR METAB, V93, P452, DOI 10.1210/jc.2007-1913; Zaffanello M, 2007, ANN CLIN LAB SCI, V37, P233	46	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205558	10.1371/journal.pone.0205558	http://dx.doi.org/10.1371/journal.pone.0205558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312323	Green Published, gold, Green Submitted			2022-12-26	WOS:000447427300035
J	Yu, HQ; Ding, MY; Zhang, XM; Wu, JB				Yu, Houqiang; Ding, Mingyue; Zhang, Xuming; Wu, Jinbo			PCANet based nonlocal means method for speckle noise removal in ultrasound images	PLOS ONE			English	Article							MODELS; DOMAIN	Speckle reduction remains a critical issue for ultrasound image processing and analysis. The nonlocal means (NLM) filter has recently attached much attention due to its competitive despeckling performance. However, the existing NLM methods usually determine the similarity between two patches by directly utilizing the gray-level information of the noisy image, which renders it difficult to represent the structural similarity of ultrasound images effectively. To address this problem, the NLM method based on the simple deep learning baseline named PCANet is proposed by introducing the intrinsic features of image patches extracted by this network rather than the pixel intensities into the pixel similarity computation. In this approach, the improved two-stage PCANet is proposed by using Parametric Rectified Linear Unit (PReLU) activation function instead of the binary hashing and block histograms in the original PCANet. This model is firstly trained on the ultrasound database to learn the convolution kernels. Then, the trained PCANet is utilized to extract the intrinsic features from the image patches in the pre-denoised version of the noisy image to be despeckled. These obtained features are concatenated together to determine the structural similarity between image patches in the NLM method, based on which the weighted mean of all pixels in a search window is computed to produce the final despeckled image. Extensive experiments have been conducted on a variety of images to demonstrate the superiority of the proposed method over several well-known despeckling algorithm and the PCANet based NLM method using ReLU function and sigmoid function. Visual inspection indicates that the proposed method outperforms the compared methods in reducing speckle noise and preserving image details. The quantitative comparisons show that among all the evaluated methods, our method produces the best structural similarity index metrics (SSIM) values for the synthetic image, as well as the highest equivalent number of looks (ENL) value for the simulated image and the clinical ultrasound images.	[Yu, Houqiang; Ding, Mingyue; Zhang, Xuming] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Mol Biophys,Minist Educ, Wuhan, Hubei, Peoples R China; [Wu, Jinbo] Huazhong Univ Sci & Technol, Sch Naval Architecture & Ocean Engn, 1037 Luoyu Rd, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, XM (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Mol Biophys,Minist Educ, Wuhan, Hubei, Peoples R China.; Wu, JB (corresponding author), Huazhong Univ Sci & Technol, Sch Naval Architecture & Ocean Engn, 1037 Luoyu Rd, Wuhan, Hubei, Peoples R China.	zxmboshi@hust.edu.cn; hustwjb@hust.edu.cn	Zhang, Xuming/AAS-7462-2020		National Key Research and Development Program of China [2017YFBI1303100]; National Natural Science Foundation of China [51679101]; Wuhan Science and Technology Project [2016060101010056]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Science and Technology Project	This work is supported by the National Key Research and Development Program of China (Grant No: 2017YFBI1303100), the National Natural Science Foundation of China (Grant No: 51679101) and Wuhan Science and Technology Project (Grant No: 2016060101010056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Chan TH, 2015, IEEE T IMAGE PROCESS, V24, P5017, DOI 10.1109/TIP.2015.2475625; Coupe P, 2009, IEEE T IMAGE PROCESS, V18, P2221, DOI 10.1109/TIP.2009.2024064; Divakar N, 2017, IEEE COMPUT SOC CONF, P1076, DOI 10.1109/CVPRW.2017.145; Dong FF, 2012, MATH COMPUT MODEL, V55, P939, DOI 10.1016/j.mcm.2011.09.021; Du WC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190069; FROST VS, 1982, IEEE T PATTERN ANAL, V4, P157, DOI 10.1109/TPAMI.1982.4767223; Girshick R, 2014, P IEEE C COMP VIS PA, DOI [DOI 10.1109/CVPR.2014.81, 10.1109/CVPR.2014.81]; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Kaur A, 2016, IMPERIAL J INTERDISC, V2, P29; Kervrann C, 2008, INT J COMPUT VISION, V79, P45, DOI 10.1007/s11263-007-0096-2; Kim J, 2016, PROC CVPR IEEE, P1646, DOI [10.1109/CVPR.2016.181, 10.1109/CVPR.2016.182]; Krizhevsky A., 2012, ADV NEURAL INF PROCE; KUAN DT, 1987, IEEE T ACOUST SPEECH, V35, P373, DOI 10.1109/TASSP.1987.1165131; LOUPAS T, 1989, IEEE T CIRCUITS SYST, V36, P129, DOI 10.1109/31.16577; Pizurica A, 2003, IEEE T MED IMAGING, V22, P323, DOI 10.1109/TMI.2003.809588; Rahman MM, 2012, INT J TOMOGRAPHY STA, V20, P91; Singh C, 2016, BIOMED SIGNAL PROCES, V30, P13, DOI 10.1016/j.bspc.2016.05.007; Slabaugh G., 2006, 2006 IEEE COMPUTER S, P45, DOI [10.1109/CVPR.2006.318, DOI 10.1109/CVPR.2006.318]; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Szkulmowski M, 2012, OPT EXPRESS, V20, P1337, DOI 10.1364/OE.20.001337; Tao Z, 2006, IEEE T MED IMAGING, V25, P1483, DOI 10.1109/TMI.2006.881376; Tay PC, 2010, IEEE T IMAGE PROCESS, V19, P1847, DOI 10.1109/TIP.2010.2044962; Wang X., 2017, NONLOCAL NEURAL NETW; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wen TX, 2016, ULTRASONIC IMAGING, V38, P254, DOI 10.1177/0161734615600676; Yang J, 2016, NEUROCOMPUTING, V195, P88, DOI 10.1016/j.neucom.2015.05.140; Yu YJ, 2002, IEEE T IMAGE PROCESS, V11, P1260, DOI 10.1109/TIP.2002.804279; Zaki F, 2017, BIOMED OPT EXPRESS, V8, P2720, DOI 10.1364/BOE.8.002720; Zeng D, 2016, IEEE T BIO-MED ENG, V63, P1044, DOI 10.1109/TBME.2015.2476371; Zhan Y, 2014, SIGNAL PROCESS, V103, P201, DOI 10.1016/j.sigpro.2013.12.019; Zhang F, 2007, IEEE T MED IMAGING, V26, P200, DOI 10.1109/TMI.2006.889735; Zhang KH, 2017, IEEE T IMAGE PROCESS, V26, P4193, DOI [10.1109/TIP.2016.2621478, 10.1109/TIP.2017.2689999]; Zhang XC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085241, 10.1371/journal.pone.0100240]; Zhu PF, 2017, PATTERN RECOGN, V66, P364, DOI 10.1016/j.patcog.2017.01.016; Zhu PF, 2016, INFORM SCIENCES, V370, P270, DOI 10.1016/j.ins.2016.08.004; Zielinski B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184554	38	15	15	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205390	10.1371/journal.pone.0205390	http://dx.doi.org/10.1371/journal.pone.0205390			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312331	Green Published, Green Submitted, gold			2022-12-26	WOS:000447427300030
J	Hsu, FF; Chou, YT; Chiang, MT; Li, FA; Yeh, CT; Lee, WH; Chau, LY				Hsu, Fu-Fei; Chou, Yi-Tai; Chiang, Ming-Tsai; Li, Fu-An; Yeh, Chi-Tai; Lee, Wei-Hwa; Chau, Lee-Young			Signal peptide peptidase promotes tumor progression via facilitating FKBP8 degradation	ONCOGENE			English	Article							INTRAMEMBRANE PROTEOLYSIS; HEME OXYGENASE-1; CLEAVAGE; PROTEIN; IDENTIFICATION; INHIBITOR; MECHANISM; BCL-2	Signal peptide peptidase (SPP) is an endoplasmic reticulum (ER)-resident aspartyl protease mediating intramembrane cleavage of type II transmembrane proteins. Increasing evidence has supported the role of SPP in ER-associated protein degradation. In the present study, we show that SPP expression is highly induced in human lung and breast cancers and correlated with disease outcome. Stable depletion of SPP expression in lung and breast cancer cell lines significantly reduced cell growth and migration/invasion abilities. Quantitative analysis of the proteomic changes of microsomal proteins in lung cancer cells by the stable isotope labeling with amino acids in cell culture (SILAC) approach revealed that the level of FKBP8, an endogenous inhibitor of mTOR, was significantly increased following SPP depletion. Co-immunoprecipitation assay and confocal immunofluorescence demonstrated that SPP interacted and colocalized with FKBP8 in ER, supporting that FKBP8 is a protein substrate of SPP. Cycloheximide chase and proteasome inhibition experiments revealed that SPP-mediated proteolysis facilitated FKBP8 protein degradation in cytosol. Further experiment demonstrated that the levels of phosphorylation in mTOR and its downstream effectors, S6K and 4E-BP1, were significantly lower in SPP-depleted cells. The reduced mTOR signaling and decreases of growth and migration/invasion abilities induced by SPP depletion in cancer cells could be reversed by FKBP8 downregulation. The implication of FKBP8 in SPP-mediated tumorigenicity was also observed in the xenograft model. Together, these findings disclose that SPP promotes tumor progression, at least in part, via facilitating the degradation of FKBP8 to enhance mTOR signaling.	[Hsu, Fu-Fei; Chou, Yi-Tai; Chiang, Ming-Tsai; Li, Fu-An; Chau, Lee-Young] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Yeh, Chi-Tai; Lee, Wei-Hwa] Taipei Med Univ, Shuang Ho Hosp, Canc Ctr, Taipei, Taiwan	Academia Sinica - Taiwan; Taipei Medical University; Shuang Ho Hospital	Chau, LY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	lyc@ibms.sinica.edu.tw	Chau, Lee-Young/N-7659-2018; Li, Fu-An/M-8506-2019	Chau, Lee-Young/0000-0002-6316-2328; Li, Fu-An/0000-0002-0580-7765	Ministry of Science and Technology Taiwan [MOST 103-2320-B-001-013-MY3]; Institute of Biomedical Sciences, Academia Sinica	Ministry of Science and Technology Taiwan(Ministry of Science and Technology, Taiwan); Institute of Biomedical Sciences, Academia Sinica(Academia Sinica - Taiwan)	This work was supported by the Ministry of Science and Technology Taiwan (MOST 103-2320-B-001-013-MY3) and Institute of Biomedical Sciences, Academia Sinica.	Avci D, 2015, TRENDS CELL BIOL, V25, P611, DOI 10.1016/j.tcb.2015.07.003; Avci D, 2014, MOL CELL, V56, P630, DOI 10.1016/j.molcel.2014.10.012; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chen CY, 2014, EMBO J, V33, P2492, DOI 10.15252/embj.201488208; Chen XL, 2015, PROTEOMICS, V15, P3175, DOI 10.1002/pmic.201500108; Choi MS, 2011, BIOCHEM BIOPH RES CO, V406, P305, DOI 10.1016/j.bbrc.2011.02.037; Das I, 2004, J BIOL CHEM, V279, P30771, DOI 10.1074/jbc.M309252200; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Fong S, 2003, P NATL ACAD SCI USA, V100, P14253, DOI 10.1073/pnas.2332307100; Guan M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09698; Hsu FF, 2015, ONCOGENE, V34, P2360, DOI 10.1038/onc.2014.166; Hwang HW, 2009, J BIOL CHEM, V284, P22672, DOI 10.1074/jbc.M109.028001; LAM E, 1995, GENE, V160, P297, DOI 10.1016/0378-1119(95)00216-S; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Mentrup T, 2017, EUR J CELL BIOL, V96, P372, DOI 10.1016/j.ejcb.2017.03.002; Murakami D, 2003, ONCOGENE, V22, P1511, DOI 10.1038/sj.onc.1206298; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Shi XH, 2016, P NATL ACAD SCI USA, V113, P8825, DOI 10.1073/pnas.1603364113; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Song W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9022; Targett-Adams P, 2006, J BIOL CHEM, V281, P29221, DOI 10.1074/jbc.M605373200; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Cespedes MV, 2010, AM J PATHOL, V177, P2067, DOI 10.2353/ajpath.2010.100079; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Wahlstrom AM, 2007, BLOOD, V109, P763, DOI 10.1182/blood-2006-05-024752; Wei JW, 2017, CNS NEUROSCI THER, V23, P257, DOI 10.1111/cns.12672; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200	32	17	18	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2019	38	10					1688	1701		10.1038/s41388-018-0539-y	http://dx.doi.org/10.1038/s41388-018-0539-y			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN8DD	30348988				2022-12-26	WOS:000460423800009
J	Simhadri, S; Vincelli, G; Huo, YY; Misenko, S; Foo, TK; Ahlskog, J; Sorensen, CS; Oakley, GG; Ganesan, S; Bunting, SF; Xia, B				Simhadri, Srilatha; Vincelli, Gabriele; Huo, Yanying; Misenko, Sarah; Foo, Tzeh Keong; Ahlskog, Johanna; Sorensen, Claus S.; Oakley, Gregory G.; Ganesan, Shridar; Bunting, Samuel F.; Xia, Bing			PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; BRCA1-PALB2 INTERACTION; CANCER; PHOSPHORYLATION; PROTEIN; PARTNER; SUPPRESSION; INSTABILITY; EXPRESSION	The G2/M checkpoint inhibits mitotic entry upon DNA damage, thereby preventing segregation of broken chromosomes and preserving genome stability. The tumor suppressor proteins BRCA1, PALB2 and BRCA2 constitute a BRCA1-PALB2-BRCA2 axis that is essential for homologous recombination (HR)-based DNA doublestrand break repair. Besides HR, BRCA1 has been implicated in both the initial activation and the maintenance of the G2/M checkpoint, while BRCA2 and PALB2 have been shown to be critical for its maintenance. Here we show that all three proteins can play a significant role in both checkpoint activation and checkpoint maintenance, depending on cell type and context, and that PALB2 links BRCA1 and BRCA2 in the checkpoint response. The BRCA1-PALB2 interaction can be important for checkpoint activation, whereas the PALB2-BRCA2 complex formation appears to be more critical for checkpoint maintenance. Interestingly, the function of PALB2 in checkpoint response appears to be independent of CHK1 and CHK2 phosphorylation. Following ionizing radiation, cells with disengaged BRCA1-PALB2 interaction show greatly increased chromosomal abnormalities due apparently to combined defects in HR and checkpoint control. These findings provide new insights into DNA damage checkpoint control and further underscore the critical importance of the proper cooperation of the BRCA and PALB2 proteins in genome maintenance.	[Simhadri, Srilatha; Vincelli, Gabriele; Huo, Yanying; Foo, Tzeh Keong; Ganesan, Shridar; Xia, Bing] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA; [Simhadri, Srilatha; Vincelli, Gabriele; Huo, Yanying; Foo, Tzeh Keong; Xia, Bing] Rutgers Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ 08903 USA; [Simhadri, Srilatha; Ganesan, Shridar] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA; [Misenko, Sarah; Bunting, Samuel F.] Rutgers State Univ, Sch Arts & Sci, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Ahlskog, Johanna; Sorensen, Claus S.] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Oakley, Gregory G.] Univ Nebraska, Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE 68583 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; University of Copenhagen; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center	Xia, B (corresponding author), Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA.; Xia, B (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ 08903 USA.	xiabi@cinj.rutgers.edu	Foo, Tzeh Keong/AAE-5830-2021	Foo, Tzeh Keong/0000-0003-0168-7054; Sorensen, Claus/0000-0001-6022-9710; HUO, YANYING/0000-0003-4747-4951	National Institutes of Health [R01CA138804, R01CA188096, R01CA190858, R01CA169182]; New Jersey Commission for Cancer Research (NJCCR); NATIONAL CANCER INSTITUTE [R01CA188096, R01CA138804, R01CA169182, R01CA190858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission for Cancer Research (NJCCR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. J. Jonkers (Netherlands Cancer Institute) and D. Boothman (UT Southwestern Medical Center) for provision of the KB2 mouse mammary tumor cells and isogenic HCT116 cells, respectively. This work was supported by the National Institutes of Health (R01CA138804 and R01CA188096 to BX, R01CA190858 to SFB and R01CA169182 to SG). GV was supported by a postdoctoral fellowship and SM by a predoctoral fellowship from the New Jersey Commission for Cancer Research (NJCCR).	Apostolou P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/747318; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cavanagh H, 2015, HERED CANCER CLIN PR, V13, DOI 10.1186/s13053-015-0038-x; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Cruz-Garcia A, 2014, CELL REP, V9, P451, DOI 10.1016/j.celrep.2014.08.076; Davis TW, 1998, CANCER RES, V58, P767; Evers B, 2010, CLIN CANCER RES, V16, P99, DOI 10.1158/1078-0432.CCR-09-2434; Foo TK, 2017, ONCOGENE, V36, P4161, DOI 10.1038/onc.2017.46; Huo YY, 2013, CANCER DISCOV, V3, P894, DOI 10.1158/2159-8290.CD-13-0011; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Juan G, 1998, CYTOMETRY, V32, P71, DOI 10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H; Lee M, 2004, ONCOGENE, V23, P865, DOI 10.1038/sj.onc.1207223; Lin HR, 2003, J BIOL CHEM, V278, P35979, DOI 10.1074/jbc.M210659200; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Lu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10086; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Menzel T, 2011, EMBO REP, V12, P705, DOI 10.1038/embor.2011.99; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Murphy AK, 2014, J CELL BIOL, V206, P493, DOI 10.1083/jcb.201404111; Oliver AW, 2009, EMBO REP, V10, P990, DOI 10.1038/embor.2009.126; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Shabbeer S, 2013, ONCOGENE, V32, P5005, DOI 10.1038/onc.2012.522; Simhadri S, 2014, J BIOL CHEM, V289, P24617, DOI 10.1074/jbc.M114.566141; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tischkowitz M, 2010, CANCER RES, V70, P7353, DOI 10.1158/0008-5472.CAN-10-1012; Venkitaraman AR, 2014, SCIENCE, V343, P1470, DOI 10.1126/science.1252230; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zhang F, 2009, MOL CANCER RES, V7, P1110, DOI 10.1158/1541-7786.MCR-09-0123; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	45	27	27	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2019	38	10					1585	1596		10.1038/s41388-018-0535-2	http://dx.doi.org/10.1038/s41388-018-0535-2			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN8DD	30337689	Green Accepted, Green Submitted			2022-12-26	WOS:000460423800001
J	Xu, WY; Jin, MM; Huang, WL; Wang, H; Hu, RK; Li, JY; Cao, Y				Xu, Wenyan; Jin, Miaomiao; Huang, Weilai; Wang, Hong; Hu, Ruikun; Li, Jingyu; Cao, Ying			Apical PtdIns(4,5)P-2 is required for ciliogenesis and suppression of polycystic kidney disease	FASEB JOURNAL			English	Article						cilium; Pip5k1; Inpp5e	PRIMARY CILIUM; PLASMA-MEMBRANE; BINDING-SITE; PHOSPHOINOSITIDES; INPP5E; MUTATIONS; TRAFFICKING; EZRIN; GENE; TRANSPORT	Cilia are hair-like structures that function like antennae to detect chemical and mechanical signals in the environment. Recently, phosphoinositides were shown to play an important role in cilia assembly and disassembly. However, the precise molecular and cellular mechanisms underlying this process remain unknown. Here, we report that suppression of apical phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P-2], by overexpressing apically targeted PtdIns(4,5)P-2 phosphatase or by knocking down type I phosphatidylinositol 4-phosphate 5-kinase (Pip5k1), leads to ciliogenesis defects and polycystic kidney disease (PKD) in zebrafish embryos that phenocopied inpp5e mutant, a Joubert syndrome model. We further demonstrate that decreased expression of apical PtdIns(4,5)P-2 disrupted apical ezrin recruitment, F-actin organization, and basal body docking. Moreover, the ciliogenesis and polycystic kidney defects in PtdIns(4,5)P-2-depleted embryos can be rescued by overexpression of ezrin. Finally, Pip5k1a overexpression rescued the ciliogenesis defects and PKD phenotypes in Inpp5e-depleted embryos. Taken together, our results reveal that apical PtdIns(4,5)P-2 is essential for ciliogenesis and the prevention of PKD and suggest a novel possibility for treating PKD and other human ciliopathies.Xu, W., Jin, M., Huang, W., Wang, H., Hu, R., Li, J., Cao, Y. Apical PtdIns(4,5)P-2 is required for ciliogenesis and suppression of polycystic kidney disease.	[Xu, Wenyan; Jin, Miaomiao; Huang, Weilai; Wang, Hong; Hu, Ruikun; Li, Jingyu; Cao, Ying] Tongji Univ, Matern & Infant Hosp 1, Sch Life Sci & Technol, Clin & Translat Res Ctr Shanghai, Shanghai, Peoples R China; [Xu, Wenyan] Yale Univ, Sch Med, New Haven, CT USA	Tongji University; Yale University	Cao, Y (corresponding author), Tongji Univ, 1239 Siping Rd,Med Bldg 1315, Shanghai 200092, Peoples R China.	yingcao@tongji.edu.cn	Li, Jing/GYU-5036-2022; Li, Jingyu/GSD-1924-2022		National Key Research and Development Program of China [2017YFA0104600]; National Natural Science Foundation of China [31771597, 31571515]; National Basic Research Program of China (973 Program) [2012CB966601, 2013CB945300]; Ministry of Science and Technology of China [2011DFB30010]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The authors thank Prof. Zhaoxia Sun (Yale University, New Haven, CT, USA), Dr. Kun Ling (Mayo Clinic, Rochester, MN, USA) and Dr. Lu Zhao (Zhejiang University, Hangzhou, China) for critically reading the manuscript, and the members of the Cao Laboratory for helpful discussions. This project was supported by grants from National Key Research and Development Program of China (2017YFA0104600), National Natural Science Foundation of China (31771597 and 31571515), National Basic Research Program of China (973 Program 2012CB966601 and 2013CB945300), and Ministry of Science and Technology of China (2011DFB30010). The authors declare no conflicts of interest.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; AUKEMA HM, 1995, J NUTR, V125, P1183; AUKEMA HM, 1992, EXP MOL PATHOL, V57, P39, DOI 10.1016/0014-4800(92)90047-F; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Cao Y, 2010, J AM SOC NEPHROL, V21, P1326, DOI 10.1681/ASN.2009091001; Castelli M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3658; Charron AJ, 2000, J CELL BIOL, V149, P111, DOI 10.1083/jcb.149.1.111; Chavez M, 2015, DEV CELL, V34, P338, DOI 10.1016/j.devcel.2015.06.016; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Epting D, 2015, DEVELOPMENT, V142, P174, DOI 10.1242/dev.112250; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Franco I, 2014, DEV CELL, V28, P647, DOI 10.1016/j.devcel.2014.01.022; Garcia-Gonzalo FR, 2015, DEV CELL, V34, P400, DOI 10.1016/j.devcel.2015.08.001; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hakim S, 2016, HUM MOL GENET, V25, P2295, DOI 10.1093/hmg/ddw097; Hasegawa H, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.110.089896; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jaulin F, 2007, DEV CELL, V13, P511, DOI 10.1016/j.devcel.2007.08.001; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Luo N, 2012, VISION RES, V75, P98, DOI 10.1016/j.visres.2012.09.011; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Phua SC, 2017, CELL, V168, P264, DOI 10.1016/j.cell.2016.12.032; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Skwarek LC, 2009, DEV CELL, V16, P12, DOI 10.1016/j.devcel.2008.12.006; Thisse B, 2004, METHOD CELL BIOL, V77, P505; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; Wei HC, 2008, J CELL SCI, V121, P1076, DOI 10.1242/jcs.024927; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Xu QW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10777; Xu WY, 2017, J AM SOC NEPHROL, V28, P118, DOI 10.1681/ASN.2015080906; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF55, DOI 10.1152/ajprenal.00043.2010	43	6	6	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2848	2857		10.1096/fj.201800385RRR	http://dx.doi.org/10.1096/fj.201800385RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30321068	Bronze			2022-12-26	WOS:000457296600105
J	Cai, YH; Yu, XH; Liu, Q; Liu, CJ; Shanklin, J				Cai, Yuanheng; Yu, Xiao-Hong; Liu, Qun; Liu, Chang-Jun; Shanklin, John			Two clusters of residues contribute to the activity and substrate specificity of Fm1, a bifunctional oleate and linoleate desaturase of fungal origin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structure-function; substrate specificity; fatty acid metabolism; dehydrogenase; lipid metabolism; 12 and 3 desaturases; Fm1; polyunsaturated fatty acid; structural determinants; substrate specificity; phospholipid; regioselectivity; bifunctional desaturase	FATTY-ACID DESATURASES; REGIOSELECTIVITY; CRYPTOREGIOCHEMISTRY; DELTA-12; SEQUENCE; ENZYME; BRAIN; TOOL	Polyunsaturated fatty acids (PUFAs) have important industrial, physiological, and nutritional properties. Plants use the sequential activities of FAD2 and FAD3 desaturases to convert 18:19 to the important PUFA 18:39,12,15, whereas the fungus Fusarium verticillioides 7600 uses the bifunctional desaturase Fm1 for both reactions. Here, we used a combination of sequence comparisons, structural modeling, and mutagenesis experiments to investigate Fm1's regioselectivity and identified two functionally relevant clusters of residues that contribute to Fm1 activity. We found that cluster I (Leu(153), Phe(157), and His(194)), located near the catalytic iron ions, predominantly affects activity, whereas cluster II (Tyr(280), His(284), and Leu(287)), located in a helix forming the entrance to the substrate-binding pocket, mainly specifies 15-desaturation. Individual or combined substitutions of cluster II residues substantially reduced 15-desaturation. The combination of F157W from cluster I with Y280L, H284V, and L287T from cluster II created an increased-activity variant that almost completely lost the ability to desaturate at C15 and acted almost exclusively as a 12-desaturase. No variants were identified in which 15-desaturation occurred in the absence of 12-desaturation. Fm1 displayed only traces of activity with C16 substrate, but several cluster I variants exhibited increased activity with both 18:1 and 16:1 substrates, converting 16:19 to 16:39,12,15, consistent with Fm1 performing sequential v + 3 desaturation reactions at C12 and then C15. We propose that cluster II residues interact with the substrate headgroup when the acyl chain contains both 9 and 12 double bonds, in which case C15 becomes positioned adjacent to the di-iron site enabling a second v + 3 desaturation.	[Cai, Yuanheng; Yu, Xiao-Hong; Shanklin, John] SUNY Stony Brook, Biochem & Cell Biol Dept, Stony Brook, NY 11794 USA; [Liu, Qun; Liu, Chang-Jun; Shanklin, John] Brookhaven Natl Lab, Biol Dept, Upton, NY 11973 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory	Shanklin, J (corresponding author), Brookhaven Natl Lab, Biol Dept, Upton, NY 11973 USA.	shanklin@bnl.gov	Liu, Qun/A-8757-2011	Liu, Qun/0000-0002-1179-290X; Yu, Xiao-Hong/0000-0003-2352-2023	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy [DOE KC0304000]; National Science Foundation Plant Genome Grant [IOS-1339385]; National Science Foundation [DBI 1117680]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation Plant Genome Grant; National Science Foundation(National Science Foundation (NSF))	This work was supported by Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy Grant DOE KC0304000 (to J.S.); National Science Foundation Plant Genome Grant IOS-1339385 (to J.S.); and National Science Foundation Grant DBI 1117680 (to Y.C. and X.Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Bai YH, 2015, NATURE, V524, P252, DOI 10.1038/nature14549; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; BROWSE J, 1993, J BIOL CHEM, V268, P16345; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; Burdge GC, 2006, PROSTAG LEUKOTR ESS, V75, P161, DOI 10.1016/j.plefa.2006.05.013; Christie W.W., 2012, LIPID ANAL, P145, DOI [10.1533/9780857097866.145, DOI 10.1533/9780857097866.145]; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Hoffmann M, 2007, J BIOL CHEM, V282, P26666, DOI 10.1074/jbc.M705068200; KEARNS EV, 1991, ARCH BIOCHEM BIOPHYS, V284, P431, DOI 10.1016/0003-9861(91)90319-E; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kumar R, 2006, PLANT J, V48, P920, DOI 10.1111/j.1365-313X.2006.02925.x; Kumar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031370; Lee JM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010023; Li DD, 2016, COMPUT STRUCT BIOTEC, V14, P341, DOI 10.1016/j.csbj.2016.08.003; Lou Y, 2014, J BIOL CHEM, V289, P17996, DOI 10.1074/jbc.M114.572883; Martinez M, 1995, J INHERIT METAB DIS, V18, P61, DOI 10.1007/BF00711429; Mayer KM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-284; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; Meesapyodsuk D, 2000, BIOCHEMISTRY-US, V39, P11948, DOI 10.1021/bi000756a; Meesapyodsuk D, 2000, BIOCHEM SOC T, V28, P632, DOI 10.1042/BST0280632; Meesapyodsuk D, 2007, J BIOL CHEM, V282, P20191, DOI 10.1074/jbc.M702196200; Pan ZQ, 2007, J BIOL CHEM, V282, P4326, DOI 10.1074/jbc.M606343200; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Racine RA, 2007, CURR OPIN CLIN NUTR, V10, P123, DOI 10.1097/MCO.0b013e3280129652; Sayanova O, 2006, J BIOL CHEM, V281, P36533, DOI 10.1074/jbc.M605158200; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; SMITH MA, 1990, BIOCHEM J, V272, P23, DOI 10.1042/bj2720023; Soucek MD, 2012, PROG ORG COAT, V73, P435, DOI 10.1016/j.porgcoat.2011.08.021; Stillwell W, 2005, REPROD NUTR DEV, V45, P559, DOI 10.1051/rnd:2005046; Wang H, 2015, NAT STRUCT MOL BIOL, V22, P581, DOI 10.1038/nsmb.3049	34	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19844	19853		10.1074/jbc.RA118.005972	http://dx.doi.org/10.1074/jbc.RA118.005972			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30348899	hybrid, Green Published			2022-12-26	WOS:000454294900028
J	Kang, YJ; Smith, M; Canfell, K				Kang, Yoon-Jung; Smith, Megan; Canfell, Karen			Anal cancer in high-income countries: Increasing burden of disease	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; INTRAEPITHELIAL NEOPLASIA; ANTIRETROVIRAL THERAPY; RISK-FACTORS; CARCINOMA; WOMEN; TRENDS; PREVALENCE; SEX; EXPERIENCE	Background Previous studies have reported that anal cancer incidence has increased in individual countries; however, age-specific trends were not examined in detail. This study describes pooled and country-specific anal cancer incidence trends by sex, age (all ages, <60 and 60+ years) and histological subtype (all subtypes, squamous cell carcinoma [SCC] and adenocarcinoma [ADC]). Methods Five-year incidence and population-at-risk data were obtained from IARC's Cancer Incidence in Five Continents for the years 1988-1992 to 2008-2012. The standardised rate ratios (SRRs) for 2008-2012 vs 1988-1992 and the 5-year average percent change (AvPC) during the period were used to assess changes in the age-standardised incidence rates. Results During the study period, there were significant increases in the incidence of SCC in both men and women of all age groups with significant increasing trend, and these increases were highest in those aged <60 years (SRR = 2.34 [95% CI:2.11-2.58] in men and SRR = 2.76 [95% CI:2.54-3.00] in women). By contrast, there were significant decreases in the incidence of ADC in men and women of all ages (SRR = 0.60 [95% CI:0.54-0.67]) and (SRR = 0.63 [95% CI:0.56-0.71], respectively), with similar decreases in those aged <60 years and 60+ years. These competing trends still resulted in significant increases in the overall incidence of anal cancer in men and women of all ages groups with significant increasing trend. The SRRs in men of all ages, <60 years and 60+ years were 1.35 (95% CI:1.28-1.42), 1.77 (95% CI:1.62-1.92) and 1.08 (95% CI:1.00-1.15), respectively. The corresponding SRRs in women were 1.75 (95% CI:1.67-1.83), 2.31 (95% CI:2.14-2.48) and 1.38 (95% CI 1.31-1.46), respectively. Conclusion Increases in the incidence of anal SCC has driven an overall increase in anal cancer incidence; this may be associated with changing sexual behaviours and increasing levels of HPV exposure in younger cohorts. The findings further reinforce the importance of HPV vaccination.	[Kang, Yoon-Jung; Smith, Megan; Canfell, Karen] Canc Council NSW, Canc Res Div, Sydney, NSW, Australia; [Canfell, Karen] Univ Sydney, Sydney Med Sch, Sch Publ Hlth, Sydney, NSW, Australia; [Canfell, Karen] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia	Cancer Council New South Wales; University of Sydney; University of New South Wales Sydney	Kang, YJ (corresponding author), Canc Council NSW, Canc Res Div, Sydney, NSW, Australia.	yoonjung.kang@nswcc.org.au		Canfell, Karen/0000-0002-6443-6618; Smith, Megan/0000-0002-0401-2653				Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Albero G, 20160225 ICO INF CTR; Alemany L, 2015, INT J CANCER, V136, P98, DOI 10.1002/ijc.28963; [Anonymous], 2016, JOINP REGR PROGR VER; [Anonymous], 2015, THE ANCHOR STUDY; Bajos N, 2010, AIDS, V24, P1185, DOI 10.1097/QAD.0b013e328336ad52; Barlow EL, 2015, INT J GYNECOL CANCER, V25, P1683, DOI 10.1097/IGC.0000000000000547; Borges AH, 2016, CLIN INFECT DIS, V63, P1668, DOI 10.1093/cid/ciw621; Boyle P., 1991, CANC REGISTRATION PR; Brewster DH, 2006, BRIT J CANCER, V95, P87, DOI 10.1038/sj.bjc.6603175; Chaturvedi AK, 2009, JNCI-J NATL CANCER I, V101, P1120, DOI 10.1093/jnci/djp205; Chiao EY, 2005, JAIDS-J ACQ IMM DEF, V40, P451, DOI 10.1097/01.qai.0000159669.80207.12; Clark MA, 2004, LANCET ONCOL, V5, P149, DOI 10.1016/S1470-2045(04)01410-X; Coffey K, 2015, BRIT J CANCER, V112, P1568, DOI 10.1038/bjc.2015.89; Colon-Lopez V, 2018, J CLIN ONCOL, V36, P68, DOI 10.1200/JCO.2017.74.9291; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; de Visser RO, 2003, AUST NZ J PUBL HEAL, V27, P146, DOI 10.1111/j.1467-842X.2003.tb00802.x; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Ferlay J, 2007, IARC SCI PUBLICATION; Ferlay J, CANC INCIDENCE 5 CON, VI; FRISCH M, 1994, AM J EPIDEMIOL, V140, P12, DOI 10.1093/oxfordjournals.aje.a117154; FRISCH M, 1993, BMJ-BRIT MED J, V306, P419, DOI 10.1136/bmj.306.6875.419; Frisch M, 1999, J NATL CANCER I, V91, P708, DOI 10.1093/jnci/91.8.708; Frisch M, 1997, NEW ENGL J MED, V337, P1350, DOI 10.1056/NEJM199711063371904; GOLDMAN S, 1989, ACTA CHIR SCAND, V155, P191; Hernandez BY, 2005, CANCER EPIDEM BIOMAR, V14, P2550, DOI 10.1158/1055-9965.EPI-05-0460; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; IARC, 2012, IARC MON EV CARC RIS, V100B; International Agency for Research on Cancer, 2009, IARC MNOGR EV CARC R, V100B; Islami F, 2017, INT J EPIDEMIOL, V46, P924, DOI 10.1093/ije/dyw276; Jin F, 2011, VACCINE, V2011, p1/19/2011; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; Joseph DA, 2008, CANCER-AM CANCER SOC, V113, P2892, DOI 10.1002/cncr.23744; Kang Y, 2017, INT J CANC, DOI 10.1002/ijc.30900; Leeds IL, 2016, WORLD J GASTRO SURG, V8, P41, DOI 10.4240/wjgs.v8.i1.41; Louchini R, 2008, CHRONIC DIS CAN, V28, P99; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Machalek DA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-946; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Nelson RA, 2013, J CLIN ONCOL, V31, P1569, DOI 10.1200/JCO.2012.45.2524; Nielsen A, 2012, INT J CANCER, V130, P1168, DOI 10.1002/ijc.26115; Oon SF, 2010, J MED SCREEN, V17, P44, DOI 10.1258/jms.2009.009058; Palefsky J M, 1998, J Natl Cancer Inst Monogr, P15; Pamnani SJ, 2016, J INFECT DIS, V214, P1180, DOI 10.1093/infdis/jiw334; Patel HS, 2007, INT J COLORECTAL DIS, V22, P1, DOI 10.1007/s00384-005-0023-3; RABKIN CS, 1992, AM J EPIDEMIOL, V136, P54, DOI 10.1093/oxfordjournals.aje.a116420; Read TRH, 2011, SEX TRANSM INFECT, V87, P544, DOI 10.1136/sextrans-2011-050234; Robinson D, 2009, BRIT J CANCER, V100, P527, DOI 10.1038/sj.bjc.6604871; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Simpson S, 2016, CANCER EPIDEMIOL, V42, P124, DOI 10.1016/j.canep.2016.04.001; Stier EA, 2015, AM J OBSTET GYNECOL, V213, P278, DOI 10.1016/j.ajog.2015.03.034; Tseng HF, 2003, CANCER CAUSE CONTROL, V14, P837, DOI 10.1023/B:CACO.0000003837.10664.7f	54	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205105	10.1371/journal.pone.0205105	http://dx.doi.org/10.1371/journal.pone.0205105			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339668	gold, Green Published, Green Submitted			2022-12-26	WOS:000447761400008
J	Marzullo, P; Minocci, A; Mele, C; Fessehatsion, R; Tagliaferri, M; Pagano, L; Scacchi, M; Aimaretti, G; Sartorio, A				Marzullo, Paolo; Minocci, Alessandro; Mele, Chiara; Fessehatsion, Rezene; Tagliaferri, Mariantonella; Pagano, Loredana; Scacchi, Massimo; Aimaretti, Gianluca; Sartorio, Alessandro			The relationship between resting energy expenditure and thyroid hormones in response to short-term weight loss in severe obesity	PLOS ONE			English	Article							FAT-FREE MASS; BODY-COMPOSITION; ADAPTIVE THERMOGENESIS; METABOLIC-RATE; FREE TRIIODOTHYRONINE; INSULIN-RESISTANCE; SERUM LEPTIN; ASSOCIATION; HYPOTHYROIDISM; DETERMINANT	Background Regulating thermogenesis is a major task of thyroid hormones (THs), and involves TH-responsive energetic processes at the central and peripheral level. In severe obesity, little is known on the relationship between THs and resting energy expenditure (REE) before and after weight loss. Methods We enrolled 100 euthyroid subjects with severe obesity who were equally distributed between genders. Each was examined before and after completion of a 4-wk inpatient multidisciplinary dieting program and subjected to measurement of thyroid function, REE, fatfree mass (FFM, kg) and percent fat mass (FM). Results Baseline REE was lower than predicted in 70 obese patients, and overall associated with BMI, FFM and FM but not thyroid-related parameters. By the study end, both BMI and REE decreased (5.5% and 4.1%, p<0.001 vs. baseline) and their percent changes were significantly associated (p<0.05), while no association related percent changes of REE and FFM or FM. Individually, REE decreased in 66 and increased in 34 patients irrespective of gender, BMI and body composition. Weight loss significantly impacted TSH (-6.3%), FT3 (-3.3%) and FT4 levels (3.9%; p<0.001 for all). By the study end, a significant correlation became evident between REE and FT4 (r = 0.42, p<0.001) as well as FT3 (r = 0.24, p<0.05). In stepwise multivariable regression analysis, however, neither THs nor body composition entered the regression equation for REE response to weight loss. Conclusions In severe obesity, short-term weight loss discloses a positive relationship between REE and THs.	[Marzullo, Paolo; Mele, Chiara; Tagliaferri, Mariantonella; Scacchi, Massimo] IRCCS Ist Auxol Italiano, Div Gen Med, Piancavallo, Verbania, Italy; [Marzullo, Paolo; Mele, Chiara; Aimaretti, Gianluca] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy; [Minocci, Alessandro; Fessehatsion, Rezene; Sartorio, Alessandro] IRCCS Ist Auxol Italiano, Div Metab Dis, Piancavallo, Verbania, Italy; [Pagano, Loredana] Univ Turin, Dept Med Sci, Turin, Italy; [Scacchi, Massimo] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Sartorio, Alessandro] IRCCS Ist Auxol Italiano, Expt Lab Auxoendocrinol Res, Piancavallo, Verbania, Italy	IRCCS Istituto Auxologico Italiano; University of Eastern Piedmont Amedeo Avogadro; IRCCS Istituto Auxologico Italiano; University of Turin; University of Milan; IRCCS Istituto Auxologico Italiano	Marzullo, P (corresponding author), IRCCS Ist Auxol Italiano, Div Gen Med, Piancavallo, Verbania, Italy.; Marzullo, P (corresponding author), Univ Piemonte Orientale, Dept Translat Med, Novara, Italy.	paolo.marzullo@med.uniupo.it	Sartorio, Alessandro/AAA-3581-2020; Minocci, Alessandro/AAA-5017-2020; Pagano, Loredana/AAK-9139-2020; Marzullo, Paolo/K-6371-2016; Mele, Chiara/ABG-2902-2020; Tagliaferri, Mariantonella/AAA-1726-2020	Sartorio, Alessandro/0000-0002-9620-4133; Marzullo, Paolo/0000-0003-3215-5747; SCACCHI, MASSIMO/0000-0002-4624-9114; Mele, Chiara/0000-0003-2880-9373				Agnihothri RV, 2014, THYROID, V24, P19, DOI 10.1089/thy.2013.0055; AlAdsani H, 1997, J CLIN ENDOCR METAB, V82, P1118, DOI 10.1210/jc.82.4.1118; Aoki Y, 2007, THYROID, V17, P1211, DOI 10.1089/thy.2006.0235; Drigo RAE, 2011, INT J BIOCHEM CELL B, V43, P1432, DOI 10.1016/j.biocel.2011.05.016; Astrup A, 1999, AM J CLIN NUTR, V69, P1117; Biondi B, 2010, J CLIN ENDOCR METAB, V95, P3614, DOI 10.1210/jc.2010-1245; Bosy-Westphal A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00047; Bosy-Westphal A, 2009, AM J CLIN NUTR, V90, P993, DOI 10.3945/ajcn.2008.27402; Camps SGJA, 2013, AM J CLIN NUTR, V97, P990, DOI 10.3945/ajcn.112.050310; Carneiro IP, 2016, ADV NUTR, V7, P476, DOI 10.3945/an.115.008755; CUNNINGHAM JJ, 1991, AM J CLIN NUTR, V54, P963, DOI 10.1093/ajcn/54.6.963; Curry SJ, 2018, JAMA-J AM MED ASSOC, V319, P2308, DOI 10.1001/jama.2018.6848; De Pergola G, 2007, CLIN ENDOCRINOL, V67, P265, DOI 10.1111/j.1365-2265.2007.02874.x; Dodd GT, 2014, CELL METAB, V20, P639, DOI 10.1016/j.cmet.2014.07.022; Ferrannini E, 2017, AM J PHYSIOL-ENDOC M, V312, pE429, DOI 10.1152/ajpendo.00464.2016; FISH LH, 1987, NEW ENGL J MED, V316, P764, DOI 10.1056/NEJM198703263161302; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; FROIDEVAUX F, 1993, AM J CLIN NUTR, V57, P35, DOI 10.1093/ajcn/57.1.35; Gambert S, 2007, CURR OPIN CLIN NUTR, V10, P664, DOI 10.1097/MCO.0b013e3282f0b69d; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Goglia F, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00528; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hermann GE, 2006, BRAIN RES, V1117, P118, DOI 10.1016/j.brainres.2006.08.018; Hoermann R, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00177; Johannsen DL, 2012, J CLIN ENDOCR METAB, V97, P248, DOI DOI 10.1093/AJCN/71.6.1421; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; Kim B, 2008, THYROID, V18, P141, DOI 10.1089/thy.2007.0266; Kim MS, 2000, J CLIN INVEST, V105, P1005, DOI 10.1172/JCI8857; Kiortsis DN, 1999, EUR J PEDIATR, V158, P446, DOI 10.1007/s004310051117; Kok P, 2005, J CLIN ENDOCR METAB, V90, P4659, DOI 10.1210/jc.2005-0920; LARN, 2014, LARN LIVELLI ASSUNZI; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Liuzzi A, 1999, INT J OBESITY, V23, P1066, DOI 10.1038/sj.ijo.0801036; Lopez M, 2013, TRENDS MOL MED, V19, P418, DOI 10.1016/j.molmed.2013.04.004; Mai S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050459; Maia AL, 2005, J CLIN INVEST, V115, P2524, DOI 10.1172/JCI25083; Major GC, 2007, INT J OBESITY, V31, P204, DOI 10.1038/sj.ijo.0803523; Makepeace AE, 2008, CLIN ENDOCRINOL, V69, P648, DOI 10.1111/j.1365-2265.2008.03239.x; Marzullo P, 2004, J CLIN ENDOCR METAB, V89, P936, DOI 10.1210/jc.2003-031328; Marzullo P, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0177-x; Marzullo P, 2010, J CLIN ENDOCR METAB, V95, P3965, DOI 10.1210/jc.2009-2798; Muller MJ, 2013, OBESITY, V21, P218, DOI 10.1002/oby.20027; Muller MJ, 2015, AM J CLIN NUTR, V102, P807, DOI 10.3945/ajcn.115.109173; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Neovius M, 2006, OBESITY, V14, P1731, DOI 10.1038/oby.2006.199; Nillni EA, 2010, FRONT NEUROENDOCRIN, V31, P134, DOI 10.1016/j.yfrne.2010.01.001; Onur S, 2005, EUR J ENDOCRINOL, V152, P179, DOI 10.1530/eje.1.01850; Pandit R, 2017, AM J PHYSIOL-REG I, V312, pR938, DOI 10.1152/ajpregu.00045.2016; RAVUSSIN E, 1985, AM J CLIN NUTR, V41, P753, DOI 10.1093/ajcn/41.4.753; Reinehr T, 2002, ARCH DIS CHILD, V87, P320, DOI 10.1136/adc.87.4.320; Rosenbaum M, 2010, INT J OBESITY, V34, pS47, DOI 10.1038/ijo.2010.184; Rosenbaum M, 2002, J CLIN ENDOCR METAB, V87, P2391, DOI 10.1210/jc.87.5.2391; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Rosenbaum M, 2000, AM J CLIN NUTR, V71, P1421; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Santini F, 2014, EUR J ENDOCRINOL, V171, pR137, DOI 10.1530/EJE-14-0067; Sari R, 2003, CLIN ENDOCRINOL, V59, P258, DOI 10.1046/j.1365-2265.2003.01836.x; Shin JA, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/104318; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Souza AD, 2011, EUR J ENDOCRINOL, V165, P11, DOI 10.1530/EJE-11-0261; Spadafranca A, 2015, CLIN NUTR, V34, P674, DOI 10.1016/j.clnu.2014.07.014; Tagliaferri M, 2001, OBES RES, V9, P196, DOI 10.1038/oby.2001.21; Vaitkus JA, 2015, INT J MOL SCI, V16, P16158, DOI 10.3390/ijms160716158; Volgyi E, 2008, OBESITY, V16, P700, DOI 10.1038/oby.2007.94; Wang ZM, 2000, AM J PHYSIOL-ENDOC M, V279, pE539, DOI 10.1152/ajpendo.2000.279.3.E539; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wolters B, 2013, EUR J ENDOCRINOL, V168, P323, DOI 10.1530/EJE-12-0981	68	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205293	10.1371/journal.pone.0205293	http://dx.doi.org/10.1371/journal.pone.0205293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339686	Green Published, gold, Green Submitted			2022-12-26	WOS:000447761400011
J	Brown, AC; Boesze-Battaglia, K; Balashova, NV; Gomez, NM; Speicher, K; Tang, HY; Duszyk, ME; Lally, ET				Brown, Angela C.; Boesze-Battaglia, Kathleen; Balashova, Nataliya V.; Gomez, Nestor Mas; Speicher, Kaye; Tang, Hsin-Yao; Duszyk, Margaret E.; Lally, Edward T.			Membrane localization of the Repeats-in-Toxin (RTX) Leukotoxin (LtxA) produced by Aggregatibacter actinomycetemcomitans	PLOS ONE			English	Article							PERTUSSIS ADENYLATE-CYCLASE; ESCHERICHIA-COLI HEMOLYSIN; MANNHEIMIA-HAEMOLYTICA LEUKOTOXIN; GRAM-NEGATIVE MICROORGANISM; HUMAN TARGET-CELLS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ACYLATION; CALCIUM; BINDING; CHOLESTEROL	The oral bacterium, Aggregatibacter actinomycetemcomitans, which is associated with localized aggressive periodontitis, as well as systemic infections including endocarditis, produces numerous virulence factors, including a repeats-in-toxin (RTX) protein called leukotoxin (LtxA), which kills human immune cells. The strains of A. actinomycetemcomitans most closely associated with disease have been shown to produce the most LtxA, suggesting that LtxA plays a significant role in the virulence of this organism. LtxA, like many of the RTX toxins, can be divided into four functional domains: an N-terminal hydrophobic domain, which contains a significant fraction of hydrophobic residues and has been proposed to play a role in the membrane interaction of the toxin; the central domain, which contains two lysine residues that are the sites of post-translational acylation; the repeat domain that is characteristic of the RTX toxins, and a C-terminal domain thought to be involved in secretion. In its initial interaction with the host cell, LtxA must bind to both cholesterol and an integrin receptor, lymphocyte function-associated antigen-1 (LFA-1). While both interactions are essential for toxicity, the domains of LtxA involved remain unknown. We therefore undertook a series of experiments, including tryptophan quenching and trypsin digestion, to characterize the structure of LtxA upon interaction with membranes of various lipid compositions. Our results demonstrate that LtxA adopts a U-shaped conformation in the membrane, with the N-and C-terminal domains residing outside of the membrane.	[Brown, Angela C.; Balashova, Nataliya V.; Gomez, Nestor Mas; Duszyk, Margaret E.; Lally, Edward T.] Univ Penn, Dept Pathol, Sch Dent Med, Philadelphia, PA 19104 USA; [Boesze-Battaglia, Kathleen] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA; [Speicher, Kaye; Tang, Hsin-Yao] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Brown, Angela C.] Lehigh Univ, Dept Chem & Biomol Engn, Bethlehem, PA 18015 USA	University of Pennsylvania; University of Pennsylvania; The Wistar Institute; Lehigh University	Lally, ET (corresponding author), Univ Penn, Dept Pathol, Sch Dent Med, Philadelphia, PA 19104 USA.	lally@upenn.edu		Tang, Hsin-Yao/0000-0003-1838-018X	National Institutes of Health [DE0022465, DE022795, DE025275, DE009517]; National Science Foundation [1554417]; National Institutes of Health, National Institute of Dental and Craniofacial Research; National Science Foundation, Division of Chemical, Bioengineering, Environmental, and Transport Systems; NATIONAL CANCER INSTITUTE [R50CA221838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE025275, R00DE022795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Science Foundation, Division of Chemical, Bioengineering, Environmental, and Transport Systems(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health, www.nih.gov: DE0022465 (KBB), DE022795 (ACB), DE025275 (ACB), DE009517 (ETL) National Science Foundation, www.nsf.gov: 1554417 (ACB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Our work was funded by the National Institutes of Health, specifically the National Institute of Dental and Craniofacial Research, and the National Science Foundation, specifically the Division of Chemical, Bioengineering, Environmental, and Transport Systems.	Atapattu DN, 2007, INFECT IMMUN, V75, P4719, DOI 10.1128/IAI.00534-07; BAEHNI P, 1979, INFECT IMMUN, V24, P233, DOI 10.1128/IAI.24.1.233-243.1979; BAEHNI PC, 1981, ARCH ORAL BIOL, V26, P671, DOI 10.1016/0003-9969(81)90164-3; Basar T, 2001, J BIOL CHEM, V276, P348, DOI 10.1074/jbc.M006463200; Batra SA, 2015, INFECT IMMUN, V83, P3982, DOI 10.1128/IAI.00733-15; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; Bauer ME, 1996, INFECT IMMUN, V64, P4665, DOI 10.1128/IAI.64.11.4665-4672.1996; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BOEHM DF, 1990, INFECT IMMUN, V58, P1959, DOI 10.1128/IAI.58.6.1959-1964.1990; Boyd AP, 2005, J IMMUNOL, V175, P730, DOI 10.4049/jimmunol.175.2.730; Brown AC, 2013, J BIOL CHEM, V288, P23607, DOI 10.1074/jbc.M113.486654; Brown AC, 2012, CELL MICROBIOL, V14, P869, DOI 10.1111/j.1462-5822.2012.01762.x; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; CHAKRABARTTY A, 1991, NATURE, V351, P586, DOI 10.1038/351586a0; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Dileepan T, 2007, INFECT IMMUN, V75, P4851, DOI 10.1128/IAI.00314-07; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Fine DH, 1999, MICROBIOL-SGM, V145, P1335, DOI 10.1099/13500872-145-6-1335; Fong KP, 2011, MOL ORAL MICROBIOL, V26, P262, DOI 10.1111/j.2041-1014.2011.00617.x; Fong KP, 2006, CELL MICROBIOL, V8, P1753, DOI 10.1111/j.1462-5822.2006.00746.x; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; HACKETT M, 1995, J BIOL CHEM, V270, P20250, DOI 10.1074/jbc.270.35.20250; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; JARCHAU T, 1994, MOL GEN GENET, V245, P53, DOI 10.1007/BF00279750; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; Kanonenberg K, TYPE I SECRETION SYS, P596; Kieba IR, 2007, CELL MICROBIOL, V9, P2689, DOI 10.1111/j.1462-5822.2007.00989.x; Koufos E, 2016, BIOCHEMISTRY-US, V55, P4787, DOI 10.1021/acs.biochem.6b00430; Krueger E, 2018, ACS INFECT DIS, V4, P1073, DOI 10.1021/acsinfecdis.7b00230; LALLY ET, 1994, J BIOL CHEM, V269, P31289; LALLY ET, 1989, J BIOL CHEM, V264, P15451; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Lilie H, 2000, FEBS LETT, V470, P173, DOI 10.1016/S0014-5793(00)01308-9; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; Meier R, 2007, J BIOL CHEM, V282, P31477, DOI 10.1074/jbc.M704942200; Miller CM, 2014, J PHYS CHEM B, V118, P13169, DOI 10.1021/jp5106423; Moayeri M, 1997, INFECT IMMUN, V65, P2233, DOI 10.1128/IAI.65.6.2233-2239.1997; Nygren P, AGGREGATIBACTER ACTI; PEREZ ACS, 2010, J MOL BIOL, V397, P534, DOI DOI 10.1016/J.JMB.2010.01.031; Sanchez-Magraner L, 2007, J BIOL CHEM, V282, P11827, DOI 10.1074/jbc.M700547200; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Sotomayor-Perez AC, 2015, TOXINS, V7, P1, DOI 10.3390/toxins7010001; Taichman N S, 1987, Oral Microbiol Immunol, V2, P97, DOI 10.1111/j.1399-302X.1987.tb00270.x; TSAI CC, 1979, INFECT IMMUN, V25, P427, DOI 10.1128/IAI.25.1.427-439.1979; Walters MJ, 2013, MOL ORAL MICROBIOL, V28, P342, DOI 10.1111/omi.12028; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; Wu CC, 2003, NAT BIOTECHNOL, V21, P262, DOI 10.1038/nbt0303-262	53	8	8	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205871	10.1371/journal.pone.0205871	http://dx.doi.org/10.1371/journal.pone.0205871			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335797	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300067
J	Mercante, JW; Caravas, JA; Ishaq, MK; Kozak-Muiznieks, NA; Raphael, BH; Winchell, JM				Mercante, Jeffrey W.; Caravas, Jason A.; Ishaq, Maliha K.; Kozak-Muiznieks, Natalia A.; Raphael, Brian H.; Winchell, Jonas M.			Genomic heterogeneity differentiates clinical and environmental subgroups of Legionella pneumophila sequence type 1	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY SUBGROUPS; SEROGROUP 1; LEGIONNAIRES-DISEASE; MOLECULAR CHARACTERIZATION; NEW-YORK; OUTBREAK; STRAINS; WATER; PREVALENCE; TOOL	Legionella spp. are the cause of a severe bacterial pneumonia known as Legionnaires' disease (LD). In some cases, current genetic subtyping methods cannot resolve LD outbreaks caused by common, potentially endemic L. pneumophila (Lp) sequence types (ST), which complicates laboratory investigations and environmental source attribution. In the United States (US), ST1 is the most prevalent clinical and environmental Lp sequence type. In order to characterize the ST1 population, we sequenced 289 outbreak and non-outbreak associated clinical and environmental ST1 and ST1-variant Lp strains from the US and, together with international isolate sequences, explored their genetic and geographic diversity. The ST1 population was highly conserved at the nucleotide level; 98% of core nucleotide positions were invariant and environmental isolates unassociated with human disease (n = 99) contained similar to 65% more nucleotide diversity compared to clinical-sporadic (n = 139) or outbreak-associated (n = 28) ST1 subgroups. The accessory pangenome of environmental isolates was also similar to 30-60% larger than other subgroups and was enriched for transposition and conjugative transfer-associated elements. Up to similar to 10% of US ST1 genetic variation could be explained by geographic origin, but considerable genetic conservation existed among strains isolated from geographically distant states and from different decades. These findings provide new insight into the ST1 population structure and establish a foundation for interpreting genetic relationships among ST1 strains; these data may also inform future analyses for improved outbreak investigations.	[Mercante, Jeffrey W.; Caravas, Jason A.; Ishaq, Maliha K.; Kozak-Muiznieks, Natalia A.; Raphael, Brian H.; Winchell, Jonas M.] Ctr Dis Control & Prevent, Pneumonia Response & Surveillance Lab, Resp Dis Branch, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Winchell, JM (corresponding author), Ctr Dis Control & Prevent, Pneumonia Response & Surveillance Lab, Resp Dis Branch, Atlanta, GA 30333 USA.	jwinchell@cdc.gov		Raphael, Brian/0000-0003-2778-2623	CDC Office of Advanced Molecular Detection	CDC Office of Advanced Molecular Detection	This study was supported by funding made available through the CDC Office of Advanced Molecular Detection. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Matawah Q, 2015, ENVIRON SCI POLLUT R, V22, P10235, DOI 10.1007/s11356-015-4226-z; Amemura-Maekawa J, 2012, APPL ENVIRON MICROB, V78, P4263, DOI 10.1128/AEM.06869-11; Amemura-Maekawa J, 2010, J MED MICROBIOL, V59, P653, DOI 10.1099/jmm.0.017509-0; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartley PB, 2016, CLIN INFECT DIS, V62, P273, DOI 10.1093/cid/civ870; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Benin AL, 2002, CLIN INFECT DIS, V35, P1039, DOI 10.1086/342903; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchi A, 2016, ANN AGR ENV MED, V23, P248, DOI 10.5604/12321966.1203885; Borchardt J, 2008, EUR J CLIN MICROBIOL, V27, P29, DOI 10.1007/s10096-007-0392-3; Brooks T, 2004, J TOXICOL ENV HEAL A, V67, P1845, DOI 10.1080/15287390490492449; Campese C, 2011, INT J INFECT DIS, V15, pE30, DOI 10.1016/j.ijid.2010.09.007; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Cazalet C, 2008, GENOME RES, V18, P431, DOI 10.1101/gr.7229808; Chiarini A, 2008, NEW MICROBIOL, V31, P217; COETZEE N, 2012, EURO SURVEILL, V17; Costa J, 2005, APPL ENVIRON MICROB, V71, P663, DOI 10.1128/AEM.71.2.663-671.2005; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; David S, 2016, GENOME RES; David S, 2017, CLIN INFECT DIS; David S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006855; David S, 2016, J CLIN MICROBIOL, V54, P2135, DOI 10.1128/JCM.00432-16; DeLeon-Rodriguez N, 2013, P NATL ACAD SCI USA, V110, P2575, DOI 10.1073/pnas.1212089110; Den Boer JW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-435; Doleans-Jordheim A, 2006, MICROBIOL-SGM, V152, P3561, DOI 10.1099/mic.0.29227-0; Euser SM, 2013, EUR J CLIN MICROBIOL, V32, P1017, DOI 10.1007/s10096-013-1841-9; Euser SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047437; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fontana S, 2014, INT J MED MICROBIOL, V304, P597, DOI 10.1016/j.ijmm.2014.04.004; Gardner SN, 2015, BIOINFORMATICS, V31, P2877, DOI 10.1093/bioinformatics/btv271; Garrison E., 2012, ARXIV E PRINTS; George Francisco, 2016, Rev. Port. Sau. Pub., V34, P199, DOI 10.1016/j.rpsp.2016.10.001; Ginevra C, 2011, J CLIN MICROBIOL; Ginevra C, 2008, EMERG INFECT DIS, V14, P673, DOI 10.3201/eid1404.070961; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Harrison TG, 2009, EUR J CLIN MICROBIOL, V28, P781, DOI 10.1007/s10096-009-0705-9; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Joseph SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33442; Kanatani J, 2017, J INFECT CHEMOTHER, V23, P265, DOI 10.1016/j.jiac.2017.01.002; Khan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067298; Kozak NA, 2009, J CLIN MICROBIOL, V47, P2525, DOI 10.1128/JCM.02410-08; Kozak-Muiznieks NA, 2014, J CLIN MICROBIOL, V52, P201, DOI 10.1128/JCM.01973-13; Kumar S, 2012, BIOINFORMATICS, V28, P2685, DOI 10.1093/bioinformatics/bts507; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lapierre P, 2017, EMERG INFECT DIS, V23, P1784, DOI 10.3201/eid2311.170308; Lee HK, 2010, APPL ENVIRON MICROB, V76, P6547, DOI 10.1128/AEM.00422-10; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Levesque S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163818; Lim YH, 2011, TROP BIOMED, V28, P149; Luneberg E, 2000, INT J MED MICROBIOL, V290, P37; Maisa A, 2013, EUROSURVEILLANCE, V20, P30064, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917.ES.2015.20.46.30064]; Massip C, 2017, J ANTIMICROB CHEMOTH, V72, P1327, DOI 10.1093/jac/dkw594; McAdam PR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0504-1; Mercante JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164074; Mercante JW, 2015, CLIN MICROBIOL REV, V28, P95, DOI 10.1128/CMR.00029-14; Moran-Gilad J, 2015, EUROSURVEILLANCE, V20; Moran-Gilad J, 2013, CLIN MICROBIOL INFEC, V2013; Nygard K, 2008, CLIN INFECT DIS, V46, P61, DOI 10.1086/524016; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Parks DH, 2009, GENOME RES, V19, P1896, DOI 10.1101/gr.095612.109; Peabody MA, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00246-17; Petzold M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.45.17-00137; Petzold M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-198; Qin T, 2016, SCI REP-UK, V6, DOI 10.1038/srep21356; Raphael BH, 2016, APPL ENVIRON MICROB, V82, P3582, DOI 10.1128/AEM.00362-16; Reimer AR, 2010, EUR J CLIN MICROBIOL, V29, P191, DOI 10.1007/s10096-009-0840-3; Ren J, 2017, TRENDS MICROBIOL, V25, P768, DOI 10.1016/j.tim.2017.04.001; Reuter S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002175; Sanchez-Buso L, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01556; Sanchez-Buso L, 2015, APPL ENVIRON MICROB, V81, P7106, DOI 10.1128/AEM.02196-15; Sanchez-Buso L, 2014, NAT GENET, V46, P1205, DOI 10.1038/ng.3114; Schjorring S., 2017, EURO SURVEILL, V22; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smets W, 2016, ATMOS ENVIRON, V139, P214, DOI 10.1016/j.atmosenv.2016.05.038; Tijet N, 2010, EMERG INFECT DIS, V16, P447, DOI 10.3201/eid1603.081689; Vandewalle-Capo M, 2017, INT J ANTIMICROB AG, V50, P684, DOI 10.1016/j.ijantimicag.2017.08.001; Vekens E, 2012, EUROSURVEILLANCE, V17, P9; Wedege E, 2013, SCAND J INFECT DIS, V45, P59, DOI 10.3109/00365548.2012.710855; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087; Yzerman E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-433; Zou CH, 1999, J BACTERIOL, V181, P4137, DOI 10.1128/JB.181.13.4137-4141.1999	87	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206110	10.1371/journal.pone.0206110	http://dx.doi.org/10.1371/journal.pone.0206110			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335848	gold, Green Submitted, Green Published			2022-12-26	WOS:000447701300097
J	Zhang, XP; Zhang, FF; Wang, DX; Fan, JX; Hu, YN; Kang, HB; Chang, MJ; Pang, Y; Yang, Y; Feng, Y				Zhang, Xinping; Zhang, Fangfang; Wang, Dexiang; Fan, Junxi; Hu, Youning; Kang, Haibin; Chang, Mingjie; Pang, Yue; Yang, Yang; Feng, Yang			Effects of vegetation, terrain and soil layer depth on eight soil chemical properties and soil fertility based on hybrid methods at urban forest scale in a typical loess hilly region of China	PLOS ONE			English	Article							MULTIPLE-LINEAR-REGRESSION; SPATIAL VARIABILITY; LAND-USE; LANDSCAPE POSITION; SMALL CATCHMENT; ORGANIC-MATTER; PLATEAU REGION; NUTRIENT; CARBON; PREDICTION	Although the spatial mapping and fertility assessment of soil chemical properties (SCPs) are well studied in the Loess Plateau region of China at farmland scale, little is known about spatial mapping the SCPs and their fertility and their influence factors at urban forest scale. The objectives of this study were to (1) compare the performance of two spatial interpolation methods, Ordinary kriging (OK) and regression kriging (RK), and (2) explain the relationships of the vegetation, terrain, and soil layer depth between the eight SCPs and their fertility, and (3) find the limiting factors of soil comprehensive fertility in this study area? The Yan'an urban forest was taken as study case, used hybrid spatial interpolation methods based on OK and RK to mapping eight SCPs and the soil fertility in each soil layer (0-20 cm, 20-40 cm, and 40-60 cm) for 285 soil samples. The results indicated that RK outperformed OK for total nitrogen (TN), available potassium (AK), organic matter (OM) in 0-60 cm profile and available phosphorus (AP) in the 0-20 cm and 40-60 cm soil layers because RK considered the impact of terrain. The terrain factors, comprising the relative terrain position, slope, aspect, and relative elevation significantly affected the SCPs and spatial heterogeneity of fertility, where the vegetation cover types determined the average SCPs to some extent. On average, the six SCPs (except total potassium and AP) and the fertility decreased as the soil layer depth increased. Ten vegetation cover types comprising broad-leaved mixed natural forest (BM), cultivated land (CL), economic forest (EF), grassland (GL), Platycladus orientalis natural forest (PON), Platycladus orientalis plantation (POP), Pinus tabuliformis plantation (PT), Quercus wutaishanica natural forest (QW), Robinia pseudoacacia plantation (RP), and Shrubwood (SW) were associated with significant differences in TN, OM, AN, AP, and AK, across the three soil layers. QW, PON, and BM also had higher content of TN, OM, AN, and AK contents than the other vegetation cover types. There were small differences in TK, AK, and pH among the 10 vegetation cover types. We concluded that AN, TN, and OM are the limiting factors of soil comprehensive fertility in this region. These results improve understanding of the spatial mapping, influence and limiting factors of SCPs and their fertility at urban forest scales.	[Zhang, Xinping; Wang, Dexiang; Kang, Haibin; Chang, Mingjie; Pang, Yue; Yang, Yang] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Zhang, Xinping] Shaanxi Vocat & Tech Coll, Tourism Dept, Xian, Shaanxi, Peoples R China; [Zhang, Xinping] Xian Univ Technol, Coll Arts & Design, Xian, Shaanxi, Peoples R China; [Zhang, Fangfang] Shaanxi Agr Broadcasting & Televis Sch, Branch Sch Gaoling Dist Xian City, Xian, Shaanxi, Peoples R China; [Fan, Junxi; Feng, Yang] Northwest A&F Univ, Coll Landscape Architecture & Arts, Yangling, Shaanxi, Peoples R China; [Hu, Youning] Xian Univ, Sch Biol & Environm Engn, Xian, Shaanxi, Peoples R China	Northwest A&F University - China; Xi'an University of Technology; Northwest A&F University - China; Xi'an University	Wang, DX (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	wangdx66@sohu.com	k, hb/AAR-3782-2021; Zhang, Fang/HHN-2153-2022	Feng, Yang/0000-0003-1594-6635	National 12th Five-Year Scientific and Technological Support Plan [2015BAD07B06]; Nonprofit Industry Special Research Fund of the State Forestry Administration of China [201104045]	National 12th Five-Year Scientific and Technological Support Plan; Nonprofit Industry Special Research Fund of the State Forestry Administration of China	This study was financially supported by the National 12th Five-Year Scientific and Technological Support Plan (grant no. 2015BAD07B06), and the Nonprofit Industry Special Research Fund of the State Forestry Administration of China (grant no. 201104045).	AHMED S, 1987, WATER RESOUR RES, V23, P1717, DOI 10.1029/WR023i009p01717; An SS, 2010, CATENA, V81, P226, DOI 10.1016/j.catena.2010.04.002; Barnes EM, 2003, PHOTOGRAMM ENG REM S, V69, P619, DOI 10.14358/PERS.69.6.619; Bell LW, 2012, AGR ECOSYST ENVIRON, V158, P156, DOI 10.1016/j.agee.2012.06.006; Berazneva J, 2018, WORLD DEV, V105, P367, DOI 10.1016/j.worlddev.2017.12.009; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Breiman L, 1997, J ROY STAT SOC B MET, V59, P3, DOI 10.1111/1467-9868.00054; Bremner JM, 1982, METHODS SOIL ANAL 2, P576; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Ceddia MB, 2009, SCI AGR, V66, P338, DOI 10.1590/S0103-90162009000300009; CHANG KT, 1991, CARTOGR GEOGR INFORM, V18, P69, DOI 10.1559/152304091783805626; Chang RY, 2012, ECOL RES, V27, P827, DOI 10.1007/s11284-012-0958-0; Chatterjee S, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4414-9; Chen XJ, 2017, RANGELAND ECOL MANAG, V70, P341, DOI 10.1016/j.rama.2016.10.005; Conforti M, 2016, CATENA, V144, P23, DOI 10.1016/j.catena.2016.04.023; Copeland SM, 2016, ANN BOT-LONDON, V118, P1187, DOI 10.1093/aob/mcw172; Cronan C. S., 2018, ECOSYSTEM BIOGEOCHEM, P141; Emamgholizadeh S, 2017, CHINESE GEOGR SCI, V27, P747, DOI 10.1007/s11769-017-0906-6; ESRI, 2011, ARCGIS DESKT REL 10; Fan HY, 2011, J NANYANG NORMAL U, V10, P66; Fitzpatrick BR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162489; Fraterrigo JM, 2005, ECOL MONOGR, V75, P16; Fu BJ, 2017, ANNU REV EARTH PL SC, V45, P223, DOI 10.1146/annurev-earth-063016-020552; Gao L, 2012, J SOIL SEDIMENT, V12, P128, DOI 10.1007/s11368-011-0438-0; Gomez K. A., 1976, STASTICAL PROCEDURES; Gong J, 2006, LAND DEGRAD DEV, V17, P453, DOI 10.1002/ldr.701; GREWAL J. S., 1966, Journal of the Indian Society of Soil Science, V14, P63; Haileslassie A, 2005, AGR ECOSYST ENVIRON, V108, P1, DOI 10.1016/j.agee.2004.12.010; Hengl T, 2004, GEODERMA, V120, P75, DOI 10.1016/j.geoderma.2003.08.018; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Hengl T, 2017, NUTR CYCL AGROECOSYS, V109, P77, DOI 10.1007/s10705-017-9870-x; Hou J, 2014, ENVIRON EARTH SCI, V72, P1721, DOI 10.1007/s12665-014-3076-1; Hu B, 2017, FOREST ECOL MANAG, V389, P46, DOI 10.1016/j.foreco.2016.12.011; Hu YN, 2015, ASSESSMENT URBAN FOR; Jackson ML, 2005, SOIL CHEM ANAL ADV C; Jeong GY, 2017, CATENA, V154, P73, DOI 10.1016/j.catena.2017.02.006; Jim CY, 2009, CITIES, V26, P187, DOI 10.1016/j.cities.2009.03.003; Joanes DN, 1998, J ROYAL STAT SOC D, V47, P7; Kan W.J., 1994, CHIN J SOIL SCI, V25, P245; Kleinman PJA, 1996, AGRON J, V88, P122, DOI 10.2134/agronj1996.00021962008800020002x; KNOTTERS M, 1995, GEODERMA, V67, P227, DOI 10.1016/0016-7061(95)00011-C; Kumar S, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-5098-8; Laliberte E, 2017, ECOL LETT, V20, P1273, DOI 10.1111/ele.12823; Li QQ, 2016, ARCH AGRON SOIL SCI, V62, P1541, DOI 10.1080/03650340.2016.1154543; Li QQ, 2013, CATENA, V104, P210, DOI 10.1016/j.catena.2012.11.012; Li XY, 2014, APPL MECH MATER, V535, P483, DOI 10.4028/www.scientific.net/AMM.535.483; Liu RM, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5130-9; Liu ZP, 2013, GEODERMA, V197, P67, DOI 10.1016/j.geoderma.2012.12.011; [吕金林 Lu Jinlin], 2017, [生态学报, Acta Ecologica Sinica], V37, P3385; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Lu YH, 2011, ENVIRON MANAGE, V48, P13, DOI 10.1007/s00267-011-9684-6; Ma YX, 2017, GEODERMA REG, V10, P144, DOI 10.1016/j.geodrs.2017.06.002; Martinez I, 2016, SOIL TILL RES, V163, P141, DOI 10.1016/j.still.2016.05.021; McLean E.O., 1982, METHODS SOIL ANAL, V2nd; Mudrak EL, 2014, LANDSCAPE ECOL, V29, P491, DOI 10.1007/s10980-013-9979-5; Mulder VL, 2011, GEODERMA, V162, P1, DOI 10.1016/j.geoderma.2010.12.018; ODEH IOA, 1995, GEODERMA, V67, P215, DOI 10.1016/0016-7061(95)00007-B; Olea RA, 2006, STOCH ENV RES RISK A, V20, P307, DOI 10.1007/s00477-005-0026-1; Qin CZ, 2009, GEOMORPHOLOGY, V110, P152, DOI 10.1016/j.geomorph.2009.04.003; Qiu WW, 2016, COMMUN SOIL SCI PLAN, V47, P2189, DOI 10.1080/00103624.2016.1228945; Qiu Y, 2003, CATENA, V54, P173, DOI 10.1016/S0341-8162(03)00064-X; [邱扬 Qiu Yang], 2002, [地理学报, Acta Geographica Sinica], V57, P587; Schloeder CA, 2001, SOIL SCI SOC AM J, V65, P470, DOI 10.2136/sssaj2001.652470x; SUBBIAH B. V., 1956, CURRENT SCI, V25, P259; Tarboton DG, 1997, WATER RESOUR RES, V33, P309, DOI 10.1029/96WR03137; Tian Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep45289; Vasat R, 2013, SOIL WATER RES, V8, P97, DOI 10.17221/62/2012-SWR; Vasu D, 2017, SOIL TILL RES, V169, P25, DOI 10.1016/j.still.2017.01.006; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; Wang J, 2001, J ARID ENVIRON, V48, P537, DOI 10.1006/jare.2000.0763; Wang JL, 2014, ENVIRON EARTH SCI, V72, P2683, DOI 10.1007/s12665-014-3175-z; Wang Rui, 2008, Acta Pedologica Sinica, V45, P550; Wigley BJ, 2013, ACTA OECOL, V51, P17, DOI 10.1016/j.actao.2013.05.007; Wu Bo, 2018, Yingyong Shengtai Xuebao, V29, P961, DOI 10.13287/j.1001-9332.201803.038; Xiong LY, 2016, EARTH SURF PROC LAND, V41, P1155, DOI 10.1002/esp.3883; Xu M, 2014, CATENA, V119, P116, DOI 10.1016/j.catena.2014.03.016; Xu YM, 2017, ISPRS J PHOTOGRAMM, V123, P1, DOI 10.1016/j.isprsjprs.2016.11.001; Yao XD, 2018, SCI TOTAL ENVIRON, V630, P96, DOI 10.1016/j.scitotenv.2018.02.155; Yuan F, 2015, LANDSCAPE ECOL, V30, P1737, DOI 10.1007/s10980-015-0154-z; ZEVENBERGEN LW, 1987, EARTH SURF PROCESSES, V12, P47, DOI 10.1002/esp.3290120107; Zhang JT, 2007, ECOL ENG, V31, P115, DOI 10.1016/j.ecoleng.2007.06.003; Zhang XP, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080840; Zhang ZQ, 2015, ENVIRON EARTH SCI, V73, P2287, DOI 10.1007/s12665-014-3580-3; Zhao WF, 2017, J MT SCI-ENGL, V14, P885, DOI 10.1007/s11629-016-4320-9; Zhao YT, 2014, SPATIAL CHARACTERIST; [周伟 Zhou Wei], 2017, [生态学报, Acta Ecologica Sinica], V37, P1211; Zhu Q, 2010, PEDOSPHERE, V20, P594, DOI 10.1016/S1002-0160(10)60049-5	87	6	8	6	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205661	10.1371/journal.pone.0205661	http://dx.doi.org/10.1371/journal.pone.0205661			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335794	Green Published, gold			2022-12-26	WOS:000447701300041
J	Luedde, M; Spehlmann, ME; Hippe, HJ; Loosen, SH; Roy, S; Cardenas, DV; Vucur, M; Frey, N; Koch, A; Luedde, T; Trautwein, C; Tacke, F; Roderburg, C				Luedde, Mark; Spehlmann, Martina E.; Hippe, Hans-Joerg; Loosen, Sven H.; Roy, Sanchari; Cardenas, David Vargas; Vucur, Mihael; Frey, Norbert; Koch, Alexander; Luedde, Tom; Trautwein, Christian; Tacke, Frank; Roderburg, Christoph			Serum levels of kisspeptin are elevated in critically ill patients	PLOS ONE			English	Article							REPRODUCTIVE AXIS; ARCUATE NUCLEUS; ADIPOSE-TISSUE; KISS-1; EXPRESSION; ACTIVATION; ADIPOKINES; PEPTIDE; SYSTEM; IMPACT	Introduction Members of the adipokine family such as resistin, adiponectin and omentin have recently been described as novel biomarkers with a diagnostic and prognostic role in the context of critically ill patients during intensive care unit (ICU) treatment. Kisspeptin represent another member of this family and has been shown to be closely correlated to different members of the adipokine family in manifold diseases. However, its role in critical illness and sepsis is currently unknown. Materials and methods Kisspeptin serum concentrations were measured in 133 ICU patients admitted to the medical ICU. Results were compared with 36 healthy controls. Results Kisspeptin serum levels were elevated in the serum of critically ill patients at admission to the ICU, when compared to healthy controls, and remained increased after 72 hours of ICU treatment. Notably, kisspeptin levels were independent of the presence of sepsis and etiology of critical illness. In line, serum concentrations of kisspeptin were not correlated to concentrations of inflammatory cytokines or established sepsis markers. Serum kisspeptin correlated inversely with the glomerular filtration rate. In contrast to the reported role of other members of the adipokine family, serum levels of kisspeptin were neither predictive for short term survival during ICU treatment nor for patients' overall survival. Kisspeptin levels did not correlate with other adipokines measured in serum, including leptin, resistin, ghrelin, or adiponectin. Conclusions Although circulating kisspeptin levels were strongly elevated in ICU-patients, elevated kisspeptin levels were not predictive for an impaired patients' survival.	[Luedde, Mark; Spehlmann, Martina E.; Hippe, Hans-Joerg; Frey, Norbert] Univ Clin Schleswig Holstein, Dept Internal Med 3, Kiel, Germany; [Loosen, Sven H.; Roy, Sanchari; Cardenas, David Vargas; Vucur, Mihael; Koch, Alexander; Luedde, Tom; Trautwein, Christian; Tacke, Frank; Roderburg, Christoph] Univ Hosp RWTH Aachen, Dept Med 3, Aachen, Germany	University of Kiel; Schleswig Holstein University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Roderburg, C (corresponding author), Univ Hosp RWTH Aachen, Dept Med 3, Aachen, Germany.	croderburg@ukaachen.de	Roderburg, Christoph/AAR-3051-2021; Tacke, Frank/ABF-2212-2020; Frey, Norbert/M-7749-2019; Luedde, Tom/AAE-9135-2022; Frey, Norbert/A-9695-2010; Roderburg, Christoph/AHC-8101-2022; Loosen, Sven/AHC-5236-2022	Frey, Norbert/0000-0001-7611-378X; Luedde, Tom/0000-0002-6288-8821; Roderburg, Christoph/0000-0002-1409-7697; Loosen, Sven/0000-0002-2799-2287	German Research Foundation [DFG RO 4317/4-1, SFB-TRR57 / P06]; START grant from the medical faculty RWTH Aachen; German Center for Cardiovascular Disease (DZHK) [B18-005Ext]	German Research Foundation(German Research Foundation (DFG)); START grant from the medical faculty RWTH Aachen; German Center for Cardiovascular Disease (DZHK)	This work was supported by project grants from the German Research Foundation (DFG RO 4317/4-1; SFB-TRR57 / P06) and a START grant from the medical faculty RWTH Aachen to C.R. and S.R. as well as a project grant of the German Center for Cardiovascular Disease (DZHK, B18-005Ext) to M.L., M.S. and C.R.	Backes Y, 2012, INTENS CARE MED, V38, P1418, DOI 10.1007/s00134-012-2613-1; Borges MD, 2018, ENDOCR METAB IMMUNE, V18, P260, DOI 10.2174/1871530318666180131094733; Castellano JM, 2010, AM J PHYSIOL-ENDOC M, V299, pE54, DOI 10.1152/ajpendo.00081.2010; Castellano JM, 2005, ENDOCRINOLOGY, V146, P3917, DOI 10.1210/en.2005-0337; Chudek J, 2006, CONTRIB NEPHROL, V151, P70, DOI 10.1159/000095320; Ciaramella V, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00115; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Dudek M, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00145; Hajri T, 2017, J TRAUMA ACUTE CARE, V83, P507, DOI 10.1097/TA.0000000000001610; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Iwasa T, 2008, J ENDOCRINOL INVEST, V31, P656, DOI 10.1007/BF03345620; Jayasena CN, 2011, J CLIN ENDOCR METAB, V96, pE1963, DOI 10.1210/jc.2011-1408; Kalamatianos T, 2008, J NEUROENDOCRINOL, V20, P1089, DOI 10.1111/j.1365-2826.2008.01757.x; Khattab AA, 2018, J PERINAT MED, V46, P919, DOI 10.1515/jpm-2018-0018; Koch A, 2011, J CRIT CARE, V26, P166, DOI 10.1016/j.jcrc.2010.07.015; Koch A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/473540; Koch A, 2009, CRIT CARE, V13, DOI 10.1186/cc7925; Kolodziejski PA, 2018, PHYSIOL RES, V67, P45, DOI 10.33549/physiolres.933467; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Luedde M, 2016, DIS MARKERS, V2016, P1, DOI 10.1155/2016/3149243; Maguire JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027601; MCKELVY JF, 1986, ANNU REV NEUROSCI, V9, P415; Navarro VM, 2004, J PHYSIOL-LONDON, V561, P379, DOI 10.1113/jphysiol.2004.072298; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Pinto FM, 2012, INT J ANDROL, V35, P63, DOI 10.1111/j.1365-2605.2011.01177.x; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Sawaki D, 2018, CIRCULATION, V138, P809, DOI 10.1161/CIRCULATIONAHA.117.031358; Shirshev S V, 2015, Dokl Biol Sci, V464, P267, DOI 10.1134/S0012496615050129; Shoji I, 2010, PEPTIDES, V31, P1920, DOI 10.1016/j.peptides.2010.07.001; Smith JT, 2018, J ENDOCRINOL, DOI [10.1530/JOE-18, DOI 10.1530/JOE-18]; Tang BMP, 2008, CRIT CARE MED, V36, P1125, DOI 10.1097/CCM.0b013e3181692c0b; Tang BMP, 2007, AM J RESP CRIT CARE, V176, P676, DOI 10.1164/rccm.200612-1819OC; Targonska-Stepniak B, 2010, RHEUMATOL INT, V30, P731, DOI 10.1007/s00296-009-1053-x; Tesema B, 2019, VACCINE, V37, P4630, DOI 10.1016/j.vaccine.2017.09.001; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Tsatsanis C, 2015, HORM-INT J ENDOCRINO, V14, P549, DOI 10.14310/horm.2002.1649; Wahab F, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00123; Yiannikouris F, 2010, CURR OPIN NEPHROL HY, V19, P195, DOI 10.1097/MNH.0b013e3283366cd0	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0206064	10.1371/journal.pone.0206064	http://dx.doi.org/10.1371/journal.pone.0206064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332461	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200082
J	Shaw, L; Mansfield, C; Colquitt, L; Lin, CL; Ferreira, J; Emmetsberger, J; Reed, DR				Shaw, Lauren; Mansfield, Corrine; Colquitt, Lauren; Lin, Cailu; Ferreira, Jaime; Emmetsberger, Jaime; Reed, Danielle R.			Personalized expression of bitter 'taste' receptors in human skin	PLOS ONE			English	Article							KERATINOCYTES; REVEALS; RANGES; CELLS; PCR	The integumentary (i.e., skin) and gustatory systems both function to protect the human body and are a first point of contact with poisons and pathogens. These systems may share a similar protective mechanism because, as we show here, both human taste and skin cells express mRNA for bitter 'taste' receptors (TAS2Rs). We used gene-specific methods to measure mRNA from all known bitter receptor genes in adult human skin from freshly biopsied samples and from samples collected at autopsy from the Genotype-Tissue Expression project. Human skin expressed some but not all TAS2Rs, and for those that were expressed, the relative amounts differed markedly among individuals. For some TAS2Rs, mRNA abundance was related to presumed sun exposure based on the location from which the skin sample was collected (TAS2R14, TAS2R30, TAS2R42, and TAS2R60), sex (TAS2R3, TAS2R4, TAS2R8, TAS2R9, TAS2R14, and TAS2R60), and age (TAS2R5), although these effects were not large. These findings contribute to our understanding of extraoral expression of chemosensory receptors.	[Shaw, Lauren; Mansfield, Corrine; Colquitt, Lauren; Lin, Cailu; Reed, Danielle R.] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA; [Ferreira, Jaime; Emmetsberger, Jaime] Estee Lauder Co Inc, Melville, NY USA	Monell Chemical Senses Center; Estee Lauder Companies	Reed, DR (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	reed@monell.org	Lin, Cailu/E-5316-2011; Lin, Cailu/ABD-7784-2021	Lin, Cailu/0000-0001-8909-7758; Lin, Cailu/0000-0001-8909-7758; Reed, Danielle/0000-0002-4374-6107; Shaw, Lauren/0000-0002-4104-2261	National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30-AR069589]; Monell Institutional Funds; Estee Lauder; Penn Skin Biology and Diseases Resource-based Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR069589] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Monell Institutional Funds; Estee Lauder; Penn Skin Biology and Diseases Resource-based Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was funded in part by the Penn Skin Biology and Diseases Resource-based Center with grant funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30-AR069589), Monell Institutional Funds, and a grant from Estee Lauder (https://www.elcompanies.com/). The funders provided feedback on study design, data collection and analysis, provided advice on the decision to publish, and helped prepare the manuscript.; Dr. Aimee Payne and the staff at the University of Pennsylvania Department of Dermatology are acknowledged for providing samples and technical assistance. This work was supported in part by the Penn Skin Biology and Diseases Resource-based Center with grant funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30-AR069589). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. We are thankful to Dr. Casey Trimmer for sharing her expertise and providing advice for the study. Dr. Mary Matsui, and Dr. Ed Pelle from the Estee Lauder Companies are also acknowledged for their contribution to our preliminary work and for their insight on the study. We are grateful to Nora Ruth from The Estee Lauder Companies for revising the manuscript.	Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; COTTEL WI, 1982, J DERMATOL SURG ONC, V8, P576, DOI 10.1111/j.1524-4725.1982.tb00316.x; Denda M, 2014, J INVEST DERMATOL, V134, P2677, DOI 10.1038/jid.2014.229; Edqvist PHD, 2015, J HISTOCHEM CYTOCHEM, V63, P129, DOI 10.1369/0022155414562646; Foster SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064579; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Lee RJ, 2015, CELL MOL LIFE SCI, V72, P217, DOI 10.1007/s00018-014-1736-7; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lion T, 1996, LEUKEMIA, V10, P1843; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lossow K, 2016, J BIOL CHEM, V291, P15358, DOI 10.1074/jbc.M116.718544; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Reed DR, 2010, PROG MOL BIOL TRANSL, V94, P213, DOI 10.1016/S1877-1173(10)94008-8; Reszka E, 2015, J CLIN RES BIOETHICS, V6; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Spielman Andrew I, 2010, J Vis Exp, DOI 10.3791/2201; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Tracy LE, 2016, ADV WOUND CARE, V5, P119, DOI 10.1089/wound.2014.0561; Wolfle U, 2015, SKIN PHARMACOL PHYS, V28, P137, DOI 10.1159/000367631; Zheng KZ, 2017, FASEB J, V31, P4037, DOI 10.1096/fj.201601323RR	21	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205322	10.1371/journal.pone.0205322	http://dx.doi.org/10.1371/journal.pone.0205322			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332676	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200050
J	Wei, WH; Li, G; Jiang, XL; Wang, YQ; Ma, ZH; Niu, ZP; Wang, ZW; Geng, XX				Wei, Wenhui; Li, Gan; Jiang, Xiaoling; Wang, Yuquan; Ma, Zhihui; Niu, Zhipeng; Wang, Zhiwei; Geng, Xinxin			Small RNA and degradome profiling involved in seed development and oil synthesis of Brassica napus	PLOS ONE			English	Article							IDENTIFIES MICRORNAS; WIDE IDENTIFICATION; PROTEIN FUNCTIONS; STRESS-RESPONSE; TARGETS; EXPRESSION; GENOME; BIOGENESIS; EVOLUTION; MIRNAS	MicroRNAs (miRNAs) play a prominent role in post-transcriptional gene expression regulation and have been involved in various biological and metabolic processes to regulate gene expression. For Brassica napus, improving seed-weight and oil-content is the main breeding goal. In order to better understand the regulation mechanism of miRNAs during seed-weight formation and oil-content accumulation in B. napus, in this study, a high-throughput sequencing technology was used to profile miRNAs expression of Brassica napus immature seeds from one to six weeks after flowering. A total of 1,276 miRNAs, including 1,248 novel and 28 known miRNAs, were obtained from both the high-seed-weight with low-oil-content RNA pool (S03) and the low-seed-weight with high-oil-content RNA pool (S04). Analysis of their expression profiles disclosed that 300 novel and two known miRNAs were differentially expressed between S03 and S04. For degradome analysis, 57 genes with 64 degradation sites were predicted to be targeted for degradation by these miRNAs. Further bioinformatics analysis indicated that these differentially expressed miRNAs might participate in regulation of myriad cellular and molecular processes, during seed development and oil synthesis. Finally, 6 target genes with potential roles in regulation of seed development and 9 other targets in seed oil synthesis, were further confirmed as candidate genes from small RNA and degradome sequencing.	[Wei, Wenhui; Li, Gan; Jiang, Xiaoling; Wang, Yuquan; Ma, Zhihui; Niu, Zhipeng; Wang, Zhiwei] Henan Inst Sci & Technol, Collaborat Innovat Ctr Modern Biol Breeding, Coll Life Sci & Technol, Xinxiang, Henan, Peoples R China; [Geng, Xinxin] Wuhan Inst Bioengn, Appl Biotechnol Ctr, Wuhan, Hubei, Peoples R China	Henan Institute of Science & Technology	Geng, XX (corresponding author), Wuhan Inst Bioengn, Appl Biotechnol Ctr, Wuhan, Hubei, Peoples R China.	creamxinxin111@sina.com			National Natural Science Foundation of China [31371664]; Key Project of Henan Natural Science Foundation [182300410002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Henan Natural Science Foundation	This work was funded by the National Natural Science Foundation of China (grant no. 31371664 to WW) and the Key Project of Henan Natural Science Foundation (grant no. 182300410002 to WW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Aryal R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-20; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Geng XX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191297; Geng XX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147580; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Huang DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-140; Huang J, 2016, J INTEGR PLANT BIOL, V58, P312, DOI 10.1111/jipb.12463; Jia XY, 2015, PLANT SCI, V233, P11, DOI 10.1016/j.plantsci.2014.12.020; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karlova R, 2013, J EXP BOT, V64, P1863, DOI 10.1093/jxb/ert049; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-264; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Liu HJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-433, 10.1186/1471-2164-15-25]; Liu NA, 2014, PLANT J, V80, P331, DOI 10.1111/tpj.12636; Liu Q, 2017, J INTEGR PLANT BIOL, V59, P774, DOI 10.1111/jipb.12571; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Meng YJ, 2010, PLANT SIGNAL BEHAV, V5, P252, DOI 10.4161/psb.5.3.10549; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Ortiz-Morea FA, 2013, J EXP BOT, V64, P2307, DOI 10.1093/jxb/ert089; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Paul S, 2014, J INTEGR PLANT BIOL, V56, P15, DOI 10.1111/jipb.12115; Peng T, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0196-4; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Pitzschke A, 2009, P NATL ACAD SCI USA, V106, P18414, DOI 10.1073/pnas.0905599106; Radoev M, 2008, GENETICS, V179, P1547, DOI 10.1534/genetics.108.089680; Shamimuzzaman M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-310; Shen EH, 2015, J EXP BOT, V66, P7241, DOI 10.1093/jxb/erv420; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thieme CJ, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.25, 10.1038/nplants.2015.25]; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01570; Wang Z, 2015, GENE, V619, P61; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Xu MY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-421; Xu ZH, 2009, GENOME, V52, P755, DOI [10.1139/G09-049, 10.1139/g09-049]; Ye YJ, 2016, PLANT J, V85, P3, DOI 10.1111/tpj.13086; Zhang BH, 2018, PLANT SCI, V274, P193, DOI 10.1016/j.plantsci.2018.05.031; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0271-x; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zheng Y, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1155/2012/360358, 10.1093/nar/gkr1092]; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhou ZS, 2012, J EXP BOT, V63, P4597, DOI 10.1093/jxb/ers136	61	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204998	10.1371/journal.pone.0204998	http://dx.doi.org/10.1371/journal.pone.0204998			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332454	Green Published, gold			2022-12-26	WOS:000447638200045
J	Wyman, SK; Avila-Herrera, A; Nayfach, S; Pollard, KS				Wyman, Stacia K.; Avila-Herrera, Aram; Nayfach, Stephen; Pollard, Katherine S.			A most wanted list of conserved microbial protein families with no known domains	PLOS ONE			English	Article								The number and proportion of genes with no known function are growing rapidly. To quantify this phenomenon and provide criteria for prioritizing genes for functional characterization, we developed a bioinformatics pipeline that identifies robustly defined protein families with no annotated domains, ranks these with respect to phylogenetic breadth, and identifies them in metagenomics data. We applied this approach to 271 965 protein families from the SFams database and discovered many with no functional annotation, including >118 000 families lacking any known protein domain. From these, we prioritized 6 668 conserved protein families with at least three sequences from organisms in at least two distinct classes. These Function Unknown Families (FUnkFams) are present in Tara Oceans Expedition and Human Microbiome Project metagenomes, with distributions associated with sampling environment. Our findings highlight the extent of functional novelty in sequence databases and establish an approach for creating a "most wanted" list of genes to prioritize for further characterization.	[Wyman, Stacia K.; Avila-Herrera, Aram; Nayfach, Stephen; Pollard, Katherine S.] Gladstone Inst, San Francisco, CA 94158 USA; [Wyman, Stacia K.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Avila-Herrera, Aram] Lawrence Livermore Natl Lab, Livermore, CA USA; [Nayfach, Stephen; Pollard, Katherine S.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Nayfach, Stephen] DOE Joint Genome Inst, Walnut Creek, CA USA; [Pollard, Katherine S.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California San Francisco; United States Department of Energy (DOE)	Pollard, KS (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.; Pollard, KS (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.; Pollard, KS (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	kpollard@gladstone.ucsf.edu			Gordon & Betty Moore Foundation [3300]; National Science Foundation [DMS-1563159]	Gordon & Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF))	This work was supported by the Gordon & Betty Moore Foundation, grant #3300, https://www.moore.org/initiative-strategy-detail? initiativeId=marine-microbiology-initiative (KSP); National Science Foundation, grant #DMS-1563159, https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5300 (KSP); Lab support from Gladstone Institutes (KSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Ellens KW, 2017, NUCLEIC ACIDS RES, V45, P11495, DOI 10.1093/nar/gkx937; Foster ZSL, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005404; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Lobb B, 2016, CURR OPIN STRUC BIOL, V38, P53, DOI 10.1016/j.sbi.2016.05.017; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Nayfach S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0611-7; Price MN, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00039-17; Sharpton TJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-264	13	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205749	10.1371/journal.pone.0205749	http://dx.doi.org/10.1371/journal.pone.0205749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332487	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200067
J	Jung, SM; Kwok, SK; Ju, JH; Lee, SW; Song, JJ; Yoon, CH; Park, YB; Park, SH				Jung, Seung Min; Kwok, Seung-Ki; Ju, Ji Hyeon; Lee, Sang-Won; Song, Jason Jungsik; Yoon, Chong-Hyeon; Park, Yong-Beom; Park, Sung-Hwan			Risk factors associated with inadequate control of disease activity in elderly patients with rheumatoid arthritis: Results from a nationwide KOrean College of Rheumatology BIOlogics (KOBIO) registry	PLOS ONE			English	Article							QUESTIONNAIRE-DISABILITY INDEX; AGGRESSIVE TREATMENT; ACTIVITY SCORE; ONSET; AGE; COMORBIDITIES; THERAPIES; ADHERENCE; OUTCOMES; IMPACT	Objective The proportion of elderly patients with rheumatoid arthritis (RA) is continuously growing as a result of the increasing aging population. We compared disease activity between different age groups, and evaluated the clinical factors associated with high disease activity. Methods This cross-sectional study analyzed the data of RA patients enrolled in the Korean College of Rheumatology Biologics registry (KOBIO-RA) between 2012 and 2014. Disease activity between elderly (age. 65 years) and non-elderly patients (age < 65 years) was compared, and the association of clinical factors with high disease activity was assessed using a multi-variate logistic regression model. Results Of 1,227 patients in KOBIO-RA, 244 patients with RA were aged 65 years or over. In elderly patients, the proportion of men was higher (P = 0.012), and the duration of disease was longer (P < 0.001) compared with non-elderly patients. The elderly group showed a higher incidence of comorbidity (P < 0.001), and less use of methotrexate (P = 0.004). Assessment of disease activity using various composite measures showed a higher proportion of high disease activity in elderly patients than non-elderly patients. Longer disease duration, presence of comorbidity, and non-use of methotrexate were independently associated with high disease activity (P = 0.002, P < 0.001, and P = 0.029, respectively). Conclusions At enrollment of KOBIO-RA, elderly patients showed higher disease activity compared with non-elderly patients. Disease duration, use of methotrexate, and comorbidity are associated with disease activity control in Korean patients with RA.	[Jung, Seung Min; Lee, Sang-Won; Song, Jason Jungsik; Park, Yong-Beom] Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Kwok, Seung-Ki; Ju, Ji Hyeon; Yoon, Chong-Hyeon; Park, Sung-Hwan] Catholic Univ Korea, Div Rheumatol, Dept Internal Med, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Catholic University of Korea	Park, SH (corresponding author), Catholic Univ Korea, Div Rheumatol, Dept Internal Med, Coll Med, Seoul, South Korea.	rapark@catholic.ac.kr		Song, Jason/0000-0003-0662-7704; Jung, Seung Min/0000-0003-3465-2181; Lee, Sang-Won/0000-0002-8038-3341	Korean College of Rheumatology	Korean College of Rheumatology	The registry was funded by the Korean College of Rheumatology. The funding source had no involvement in the study design, collection, analysis, and interpretation of the data; in writing the manuscript; and in the decision to submit the manuscript for publication.; We thank all investigators and patients participating in the KOBIO registry. The registry was funded by the Korean College of Rheumatology. The funding source had no involvement in the study design, collection, analysis, and interpretation of the data; in writing the manuscript; and in the decision to submit the manuscript for publication.	Arnold MB, 2014, RHEUMATOLOGY, V53, P1075, DOI 10.1093/rheumatology/ket449; Borah BJ, 2009, CURR MED RES OPIN, V25, P1365, DOI 10.1185/03007990902896386; Bukhari M, 2007, ANN RHEUM DIS, V66, P389, DOI 10.1136/ard.2006.055657; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cho SK, 2012, SEMIN ARTHRITIS RHEU, V42, P23, DOI 10.1016/j.semarthrit.2012.02.004; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Harrison MJ, 2005, J RHEUMATOL, V32, P1243; Idolazzi L, 2015, CLIN EXP RHEUMATOL, V33, P895; Kim HL, 2016, RHEUMATOL INT, V36, P505, DOI 10.1007/s00296-016-3427-1; Korean College of Rheumatology, 2016, BIOL REG; Krishnan E, 2005, ANN RHEUM DIS, V64, P1350, DOI 10.1136/ard.2005.037903; Lau CS, 2015, INT J RHEUM DIS, V18, P685, DOI 10.1111/1756-185X.12754; Lopez-Gonzalez R, 2015, CLIN EXP RHEUMATOL, V33, P559; Martin WJ, 2014, JCR-J CLIN RHEUMATOL, V20, P301, DOI 10.1097/RHU.0000000000000152; Ogasawara M, 2010, JCR-J CLIN RHEUMATOL, V16, P370, DOI 10.1097/RHU.0b013e3181fe8b37; Papadopoulos IA, 2003, RHEUMATOL INT, V23, P70, DOI 10.1007/s00296-002-0251-6; Pincus T, 2008, J RHEUMATOL, V35, P2136, DOI 10.3899/jrheum.080182; Putrik P, 2016, ANN RHEUM DIS, V75, P540, DOI 10.1136/annrheumdis-2014-206737; Radovits BJ, 2009, RHEUMATOLOGY, V48, P906, DOI 10.1093/rheumatology/kep129; Ranganath VK, 2013, RHEUMATOLOGY, V52, P1809, DOI 10.1093/rheumatology/ket224; Singh JA, 2016, ARTHRITIS RHEUMATOL, V68, P1, DOI 10.1002/art.39480; Smolen JS, 2016, ANN RHEUM DIS, V75, P3, DOI 10.1136/annrheumdis-2015-207524; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; SOX HC, 1986, ANN INTERN MED, V104, P515, DOI 10.7326/0003-4819-104-4-515; Statistics Korea, 2010, STAT AG; Suter LG, 2016, ARTHRIT CARE RES, V68, P1390, DOI 10.1002/acr.22936; Tan TC, 2017, INT J RHEUM DIS, V20, P737, DOI 10.1111/1756-185X.12861; Tutuncu Z, 2006, ANN RHEUM DIS, V65, P1226, DOI 10.1136/ard.2005.051144; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Widdifield J, 2014, ARTHRITIS RHEUMATOL, V66, P786, DOI 10.1002/art.38306	31	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205651	10.1371/journal.pone.0205651	http://dx.doi.org/10.1371/journal.pone.0205651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325962	gold, Green Published, Green Submitted			2022-12-26	WOS:000447430800030
J	Lee, YM; Kor, CT; Zhou, D; Lai, HC; Chang, CC; Ma, WL				Lee, Yang-Ming; Kor, Chew-Teng; Zhou, Diko; Lai, Hsueh-Chou; Chang, Chia-Chu; Ma, Wen-Lung			Impact of age at appendectomy on development of type 2 diabetes: A population-based cohort study	PLOS ONE			English	Article							DIET-INDUCED OBESITY; GUT MICROBIOTA; INTESTINAL MICROBIOTA; VERMIFORM APPENDIX; INCREASED RISK; INFLAMMATION; RESISTANCE; MICE	Aim Diabetes is a complex metabolic disease characterized by chronic low-grade inflammation in which genetic and environmental factors are involved. Growing evidence implicates that alterations of the gut microbiota potentially contribute to the emergence of metabolic diseases. The human appendix has more recently been recognized as a microbial reservoir for repopulating the gastrointestinal tract and an important part of the immune system. Thus, appendectomy may influence microbial ecology and immune function. This study investigated the association between appendectomy and type 2 diabetes risk. Methods We analyzed a cohort of 10954 patients who underwent appendectomy between 1998 and 2013 based on the Taiwan National Health Insurance Program database. A comparison cohort of 43815 persons without appendectomy was selected randomly and matched by sex, age, comorbidities, and index year. To ensure reliability of the results, a sensitivity analysis using a propensity score-matched study was performed. We observed the subsequent development of type 2 diabetes in both cohorts. Results Although the overall incidence of type 2 diabetes in the appendectomy patients was 7.9% higher than that in the non-appendectomy patients, it was not statistically significant (95% confidence interval [CI], 0.997-1.168) after the adjustment of confounding factors. Multivariate regression analysis revealed that the adjusted hazard ratio (HR) of type 2 diabetes was 1.347 for appendectomy patients < 30 years of age (95% CI, 1.009-1.798) compared to non-appendectomy patients. The incidence of type 2 diabetes was higher within 3 years of post-appendectomy follow-up than for non-appendectomy patients (HR, 2.017; 95% CI, 1.07-3.802). Age impacted the association between appendectomy and type 2 diabetes risk (P-interaction = 0.002); in contrast, sex did not affect the association between appendectomy and type 2 diabetes risk (P-interaction = 0.88). Conclusions Our study results suggest that appendectomy increases type 2 diabetes risk, particularly when performed prior to middle age.	[Lee, Yang-Ming; Ma, Wen-Lung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lee, Yang-Ming; Ma, Wen-Lung] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Lee, Yang-Ming; Kor, Chew-Teng; Chang, Chia-Chu] Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan; [Zhou, Diko; Ma, Wen-Lung] BenQ Med Ctr, Dept Surg, BioAct Lipid Res Ctr BALRC, Suzhou, Jiangsu, Peoples R China; [Lai, Hsueh-Chou; Ma, Wen-Lung] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan; [Lai, Hsueh-Chou; Ma, Wen-Lung] China Med Univ Hosp, Dept Gastroenterol, Taichung, Taiwan; [Chang, Chia-Chu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Changhua Christian Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University	Ma, WL (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.; Ma, WL (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Chang, CC (corresponding author), Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan.; Ma, WL (corresponding author), BenQ Med Ctr, Dept Surg, BioAct Lipid Res Ctr BALRC, Suzhou, Jiangsu, Peoples R China.; Ma, WL (corresponding author), China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan.; Ma, WL (corresponding author), China Med Univ Hosp, Dept Gastroenterol, Taichung, Taiwan.; Chang, CC (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	27509@cch.org.tw; maverick@mail.cmu.edu.tw	Lee, Yangming/AAB-2708-2021; Ma, Wen-Lung/O-2745-2015	Ma, Wen-Lung/0000-0002-5571-3302	Taiwan Ministry of Science and Technology [MOST104-2628-B-039-001-MY4]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; National Health Research Institute [NHRI-EX107-10705BI]; China Medical University [CMU105-S-41]; Internal Medicine Research Center of Changhua Christian Hospital	Taiwan Ministry of Science and Technology; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; National Health Research Institute(National Health Research Institutes - Taiwan); China Medical University(China Medical University); Internal Medicine Research Center of Changhua Christian Hospital	This work was supported by Taiwan Ministry of Science and Technology grant (MOST104-2628-B-039-001-MY4); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence grant (MOHW105-TDU-B-212-133019); National Health Research Institute (NHRI-EX107-10705BI); and China Medical University grant (CMU105-S-41).; We thank the Internal Medicine Research Center of Changhua Christian Hospital for supporting our study.	Andersson RE, 2003, GASTROENTEROLOGY, V124, P40, DOI 10.1053/gast.2003.50021; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Berry RJA, 1900, J ANAT PHYSIOL, V35, P83; Bollinger RR, 2007, J THEOR BIOL, V249, P826, DOI 10.1016/j.jtbi.2007.08.032; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Federation ID, 2016, IDF DIABETES ATLAS; Guinane CM, 2013, MBIO, V4, DOI 10.1128/mBio.00366-12; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Lai SW, 2014, EUR J CLIN MICROBIOL, V33, P1573, DOI 10.1007/s10096-014-2112-0; Laurin M, 2011, ANAT REC, V294, P567, DOI 10.1002/ar.21357; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liao KF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004015; Meadows Robin, 2011, PLoS Biol, V9, pe1001215, DOI 10.1371/journal.pbio.1001215; Moreno-Indias I, 2016, AM J TRANSL RES, V8, P5672; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Sanders NL, 2013, WORLD J GASTROENTERO, V19, P5607, DOI 10.3748/wjg.v19.i34.5607; SPENCER J, 1985, GUT, V26, P672, DOI 10.1136/gut.26.7.672; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tzeng YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126816; Verdam FJ, 2013, OBESITY, V21, pE607, DOI 10.1002/oby.20466; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wu SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118411	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205502	10.1371/journal.pone.0205502	http://dx.doi.org/10.1371/journal.pone.0205502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325958	gold, Green Submitted, Green Published			2022-12-26	WOS:000447430800022
J	Bywater, RP				Bywater, Robert P.			Why twenty amino acid residue types suffice(d) to support all living systems	PLOS ONE			English	Article							COMPUTATIONAL CHEMISTRY; PRIMITIVE EARTH; CHEMICAL SPACE; GENETIC-CODE; TRANSFER-RNA; LIFE; SELENOCYSTEINE; EUKARYOTES; PROTEINS; ORIGIN	It is well known that proteins are built up from an alphabet of 20 different amino acid types. These suffice to enable the protein to fold into its operative form relevant to its required functional roles. For carrying out these allotted functions, there may in some cases be a need for post-translational modifications and it has been established that an additional three types of amino acid have at some point been recruited into this process. But it still remains the case that the 20 residue types referred to are the major building blocks in all terrestrial proteins, and probably "universally". Given this fact, it is surprising that no satisfactory answer has been given to the two questions: "why 20?" and "why just these 20?". Furthermore, a suggestion is made as to how these 20 map to the codon repertoire which in principle has the capacity to cater for 64 different residue types. Attempts are made in this paper to answer these questions by employing a combination of quantum chemical and chemoinformatic tools which are applied to the standard 20 amino acid types as well as 3 "non-standard" types found in nature, a set of fictitious but feasible analog structures designed to test the need for greater coverage of function space and the collection of candidate alternative structures found either on meteorites or in experiments designed to reconstruct pre-life scenarios.	[Bywater, Robert P.] Francis Crick Inst, London, England	Francis Crick Institute	Bywater, RP (corresponding author), Francis Crick Inst, London, England.	robert.bywater@crick.ac.uk	Bywater, Robert Paul/AAY-1093-2020	Bywater, Robert Paul/0000-0002-3047-8123	Francis Crick Institute from Cancer Research UK [FC001179]; UK Medical Research Council [FC001179]; Wellcome Trust [FC001179]	Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (FC001179), the UK Medical Research Council (FC001179), and the Wellcome Trust (FC001179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bada JL, 2013, CHEM SOC REV, V42, P2186, DOI 10.1039/c3cs35433d; BERTZ SH, 1983, B MATH BIOL, V45, P849, DOI 10.1007/BF02460054; Bywater RP, 2012, NATURWISSENSCHAFTEN, V99, P167, DOI 10.1007/s00114-012-0892-6; Bywater RP, 2009, J THEOR BIOL, V261, P407, DOI 10.1016/j.jtbi.2009.08.001; Bywater RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119306; Bywater RP, 2005, ASTROBIOLOGY, V5, P568, DOI 10.1089/ast.2005.5.568; Cleaves HJ, 2014, ICARUS, V237, P182, DOI 10.1016/j.icarus.2014.04.042; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Emmert-Streib F, 2010, PLOS ONE, V10, DOI [10.1371/journal.pone0012256.g001, DOI 10.1371/JOURNAL.PONE0012256.G001]; Goesmann F, 2015, SCIENCE, V349, DOI 10.1126/science.aab0689; Higgs PG, 2009, ASTROBIOLOGY, V9, P483, DOI 10.1089/ast.2008.0280; Ilardo M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09414; Karlstrom G, 2003, COMP MATER SCI, V28, P222, DOI 10.1016/S0927-0256(03)00109-5; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kurland CG, 2010, BIOESSAYS, V32, P866, DOI 10.1002/bies.201000058; KVENVOLDEN K, 1970, NATURE, V228, P923, DOI 10.1038/228923a0; Lu Y, 2008, J THEOR BIOL, V250, P349, DOI 10.1016/j.jtbi.2007.10.007; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Mizushima S.-I., 1954, STRUCTURE MOL INTERN; ORO J, 1961, NATURE, V190, P442, DOI 10.1038/190442a0; Parker ET, 2011, P NATL ACAD SCI USA, V108, P5526, DOI 10.1073/pnas.1019191108; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; QUAYLE OR, 1953, CHEM REV, V53, P439, DOI 10.1021/cr60166a003; Reymond JL, 2010, MEDCHEMCOMM, V1, P30, DOI 10.1039/c0md00020e; Rode BM, 1999, PEPTIDES, V20, P773, DOI 10.1016/S0196-9781(99)00062-5; Rother M, 2010, ARCHAEA, V2010, DOI 10.1155/2010/453642; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; SJOSTROM M, 1985, J MOL EVOL, V22, P272, DOI 10.1007/BF02099756; STADTMAN TC, 1974, SCIENCE, V183, P915, DOI 10.1126/science.183.4128.915; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; TUFFERY P, 1991, J BIOMOL STRUCT DYN, V8, P1267, DOI 10.1080/07391102.1991.10507882; WEBER AL, 1981, J MOL EVOL, V17, P273, DOI 10.1007/BF01795749; Whanger PD, 2002, J AM COLL NUTR, V21, P223, DOI 10.1080/07315724.2002.10719214; Wong JTF, 2014, FRONT BIOSCI-LANDMRK, V19, P1117; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0204883	10.1371/journal.pone.0204883	http://dx.doi.org/10.1371/journal.pone.0204883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321190	Green Published, Green Submitted, gold			2022-12-26	WOS:000447417900015
J	Li, FF; Liu, YD; Wang, DW; Zhang, CS; Yang, ZH; Lu, SQ; Wang, YY				Li, Fangfang; Liu, Yidan; Wang, Diwei; Zhang, Chaosheng; Yang, Zhihui; Lu, Siqi; Wang, Yangyang			Biodegradation of di-(2-ethylhexyl) phthalate by a halotolerant consortium LF	PLOS ONE			English	Article							N-BUTYL PHTHALATE; COMPLETE DEGRADATION; BIOCHEMICAL COOPERATION; OCTYL PHTHALATE; RISK-ASSESSMENT; ACID-ESTERS; STRAIN; SEDIMENT; WATER; BIOREMEDIATION	A halotolerant bacterial consortium capable of degrading di-(2-ethylhexyl) phthalate (DEHP) was enriched from activated sludge. Community analysis revealed that LF contained seven families and seven genera of bacteria. The predominant species was Gordonia sp. (54.93%), Rhodococcus. sp. (9.92%) and Achromobacter sp. (8.47%). The consortium could degrade 93.84% of 1000 mg/l DEHP after 48 h incubation. The optimal temperature and pH for LF to degrade DEHP were 30 degrees C and 6.0, respectively. LF degraded more than 91% of DEHP with salt concentrations ranging from 0-3%. The inoculum size had great effects on DEHP degradation (incubation time < 24h). LF could degrade high concentrations of DEHP (from 100 to 2000 mg/l) with the degradation ratio above 92% after 72 h incubation. Kinetics analysis revealed that the degradation of DEHP by LF was best fitted by the first-order kinetics when the initial concentration ranged from 100 to 2000 mg/l. The main intermediates (2-ethylhexyl pentyl phthalate, butyl (2-ethylhexyl) phthalate (BEHP), mono-ethylhexyl phthalate (MEHP), mono-hexyl phthalate (MHP), mono-butyl phthalate (MBP)) in DEHP degradation process were identified using gas chromatography-mass spectrometry (GC-MS), and a new complex biochemical pathway was proposed. Furthermore, LF could also degrade dimethyl phthalate (DMP), diethyl phthalate (DEP), di-n-butyl phthalate (DBP), di-n-octyl phthalate (DOP) and phthalic acid (PA).	[Li, Fangfang; Liu, Yidan; Wang, Diwei; Wang, Yangyang] Henan Univ, Inst Sustainable Dev Agr & Rural Area, Kaifeng, Henan, Peoples R China; [Zhang, Chaosheng] Natl Univ Ireland, Sch Geog & Archaeol, Int Network Environm & Hlth, Galway, Ireland; [Yang, Zhihui] Cent S Univ, Sch Met & Environm, Dept Environm Engn, Changsha, Hunan, Peoples R China; [Yang, Zhihui] Chinese Natl Engn Res Ctr Control & Treatment Hea, Changsha, Hunan, Peoples R China; [Lu, Siqi] Jilin Univ, Coll Plant Sci, Changchun, Jilin, Peoples R China; [Wang, Yangyang] Henan Univ, Key Res Inst Yellow River Civilizat & Sustainable, Kaifeng, Peoples R China; [Wang, Yangyang] Henan Univ, Collaborat Innovat Ctr Yellow River Civilizat Hen, Kaifeng, Peoples R China	Henan University; Ollscoil na Gaillimhe-University of Galway; Central South University; Jilin University; Henan University; Henan University	Wang, YY (corresponding author), Henan Univ, Inst Sustainable Dev Agr & Rural Area, Kaifeng, Henan, Peoples R China.; Wang, YY (corresponding author), Henan Univ, Key Res Inst Yellow River Civilizat & Sustainable, Kaifeng, Peoples R China.; Wang, YY (corresponding author), Henan Univ, Collaborat Innovat Ctr Yellow River Civilizat Hen, Kaifeng, Peoples R China.	wangyangyangxyz@163.com			National Natural Science Foundation of China [51704093, 41430637, 21571051]; Opening Foundation of the Chinese National Engineering Research Center for Control and Treatment of Heavy Metal Pollution, Changsha, China [2015CNERC-CTHMP-]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [16IRTSTHN012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Foundation of the Chinese National Engineering Research Center for Control and Treatment of Heavy Metal Pollution, Changsha, China; Program for Innovative Research Team (in Science and Technology) in University of Henan Province	This work was supported by a grant from the National Natural Science Foundation of China (51704093, 41430637 and 21571051); Opening Foundation of the Chinese National Engineering Research Center for Control and Treatment of Heavy Metal Pollution, Changsha, 410083, China (No. 2015CNERC-CTHMP-); Program for Innovative Research Team (in Science and Technology) in University of Henan Province (16IRTSTHN012).	Abou-Elela SI, 2010, DESALINATION, V250, P1, DOI 10.1016/j.desal.2009.03.022; Babich MA, 2004, REGUL TOXICOL PHARM, V40, P151, DOI 10.1016/j.yrtph.2004.06.005; Benjamin S, 2015, J HAZARD MATER, V298, P58, DOI 10.1016/j.jhazmat.2015.05.004; Bergh C, 2011, INDOOR AIR, V21, P67, DOI 10.1111/j.1600-0668.2010.00684.x; Chen CY, 2009, BIORESOURCE TECHNOL, V100, P4531, DOI 10.1016/j.biortech.2009.04.020; Chen JA, 2006, APPL MICROBIOL BIOT, V74, P676; Chou K, 2006, J MED TOXICOL, V2, P126, DOI 10.1007/BF03161027; Gao DW, 2014, CHEMOSPHERE, V95, P24, DOI 10.1016/j.chemosphere.2013.08.009; He ZX, 2013, BIORESOURCE TECHNOL, V128, P526, DOI 10.1016/j.biortech.2012.10.107; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Huang PC, 2008, CHEMOSPHERE, V73, P539, DOI 10.1016/j.chemosphere.2008.06.019; Jin DC, 2013, INT J MOL SCI, V14, P24046, DOI 10.3390/ijms141224046; Jin DC, 2012, J HAZARD MATER, V221, P80, DOI 10.1016/j.jhazmat.2012.04.010; Josh MKS, 2014, J APPL TOXICOL, V34, P754, DOI 10.1002/jat.2902; Julinova M, 2012, J ENVIRON MANAGE, V94, P13, DOI 10.1016/j.jenvman.2011.09.006; Khalil MMH, 2014, J ESSENT OIL BEAR PL, V17, P1343, DOI 10.1080/0972060X.2014.952346; Kong SF, 2012, ENVIRON POLLUT, V170, P161, DOI 10.1016/j.envpol.2012.06.017; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Lertsirisopon R, 2009, J ENVIRON SCI-CHINA, V21, P285, DOI 10.1016/S1001-0742(08)62265-2; Li DD, 2016, INT BIODETER BIODEGR, V106, P34, DOI 10.1016/j.ibiod.2015.09.019; Li H, 2007, SCI TOTAL ENVIRON, V380, P181, DOI 10.1016/j.scitotenv.2006.12.033; Liang DW, 2008, APPL MICROBIOL BIOT, V80, P183, DOI 10.1007/s00253-008-1548-5; Liu YL, 2013, J NANOMATER, V2013, DOI [10.1155/2013/196521, 10.1155/2013/419349]; McCombie G, 2017, J ENVIRON SCI HEAL A, V52, P491, DOI 10.1080/10934529.2016.1274176; Meng XZ, 2014, SCI TOTAL ENVIRON, V476, P242, DOI 10.1016/j.scitotenv.2014.01.007; Meng XZ, 2015, BIORESOURCE TECHNOL, V180, P356, DOI 10.1016/j.biortech.2014.12.071; Net S, 2015, SCI TOTAL ENVIRON, V515, P162, DOI 10.1016/j.scitotenv.2015.02.013; Pradeep S, 2015, ECOTOX ENVIRON SAFE, V112, P114, DOI 10.1016/j.ecoenv.2014.10.035; [秦华 QIN Hua], 2006, [环境科学学报, Acta Scientiae Circumstantiae], V26, P1651; Qin X, 2012, LETT APPL MICROBIOL, V55, P210, DOI 10.1111/j.1472-765X.2012.03280.x; Romero-Franco M, 2011, ENVIRON INT, V37, P867, DOI 10.1016/j.envint.2011.02.014; Saratale RG, 2009, BIORESOURCE TECHNOL, V100, P2493, DOI 10.1016/j.biortech.2008.12.013; Sarkar J, 2013, CHEMOSPHERE, V90, P2571, DOI 10.1016/j.chemosphere.2012.10.101; Shailaja S, 2008, INT BIODETER BIODEGR, V62, P143, DOI 10.1016/j.ibiod.2008.01.002; Wang J, 2015, PEDOSPHERE, V25, P202, DOI 10.1016/S1002-0160(15)60005-4; Wang YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178213; Wang YY, 2012, PROCESS BIOCHEM, V47, P936, DOI 10.1016/j.procbio.2012.02.027; Wu XL, 2010, B ENVIRON CONTAM TOX, V85, P235, DOI 10.1007/s00128-010-0080-3; Wu XL, 2011, PROCESS BIOCHEM, V46, P1090, DOI 10.1016/j.procbio.2011.01.031; Wu XL, 2010, J HAZARD MATER, V176, P262, DOI 10.1016/j.jhazmat.2009.11.022; Xu JM, 2017, INT BIODETER BIODEGR, V117, P205, DOI 10.1016/j.ibiod.2017.01.004; Yamada N, 2013, WATER RES, V47, P2770, DOI 10.1016/j.watres.2013.02.023; Yan JL, 2014, MICROBIOL CHINA, V34, P2882; Zeng F, 2008, ENVIRON INT, V34, P372, DOI 10.1016/j.envint.2007.09.002; Zhao HM, 2016, SCI TOTAL ENVIRON, V562, P170, DOI 10.1016/j.scitotenv.2016.03.171	48	19	19	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0204324	10.1371/journal.pone.0204324	http://dx.doi.org/10.1371/journal.pone.0204324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321184	gold, Green Submitted, Green Published			2022-12-26	WOS:000447417900005
J	Yuan, D; Wen, J; Peng, LQ; Zhao, JC; Zheng, TH				Yuan, Ding; Wen, Jun; Peng, Liqing; Zhao, Jichun; Zheng, Tinghui			Precise plan of hybrid treatment for thoracoabdominal aortic aneurysm: Hemodynamics of retrograde reconstruction visceral arteries from the iliac artery	PLOS ONE			English	Article							ABDOMINAL-AORTA; WALL SHEAR; REPAIR; GRAFTS; SIMULATION	Hybrid visceral-renal debranching procedures with endovascular repair have been proposed as a less invasive alternative to conventional thoracoabdominal aortic aneurysm or dissection (TAAA or TAAD) surgery. Up to now, there has been no information about the hemodynamic effects of retrograde visceral reconstruction (RVR) for Crawford type II/III/IV TAAA patients undergoing hybrid treatment. The aim is to provide insights in the abnormal hemodynamics of RVR from unilateral or bilateral common iliac arteries (CIAs). Idealized three-dimensional AAs with RVR from unilateral CIA or bilateral CIAs were generated and computationally simulated. The results show that RVRs from CIA lead to a dramatic decrease in flow to the visceral organs compared with a healthy AA and that the anastomosis region is most dangerous to graft occlusion and the initiation of an aneurysm. In addition, compared with a quar-furcated graft, the employment of bilateral bi-furcated grafts have better performance in terms of the wall shear stress (WSS) and flow filed but result in less flow to the celiac and mesenteric arteries. This study has revealed the potential risks after an RVR operation, and points out the advantages and disadvantages of different approaches for the visceral reconstruction, which the vascular surgeons are not fully aware of. According to our results, bilateral bi-furcated grafts are recommended to the TAAA patients when the CIAs are unique inflow sites for visceral reconstruction. A precise plan with patient specific for TAAA or TAAD will be designed for better long-term outcome.	[Yuan, Ding; Zhao, Jichun] Sichuan Univ, West China Hosp, Dept Vasc Surg, Chengdu, Sichuan, Peoples R China; [Wen, Jun] Southwest Univ Sci & Technol, Sch Civil Engn & Architecture, Mianyang, Sichuan, Peoples R China; [Peng, Liqing] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Zheng, Tinghui] Sichuan Univ, Dept Appl Mech, Chengdu, Sichuan, Peoples R China	Sichuan University; Southwest University of Science & Technology - China; Sichuan University; Sichuan University	Zheng, TH (corresponding author), Sichuan Univ, Dept Appl Mech, Chengdu, Sichuan, Peoples R China.	tinghuizh@scu.edu.cn	peng, li/GQH-5153-2022	zheng, tinghui/0000-0002-0597-3245	Applying Basic Research Project of Sichuan Province, China [2017SZ0105, 2018JY0258]; National Natural Science Foundation of China [81770471, 11802253]; Doctoral Foundation of Southwest University of Science and Technology [15zx7151]	Applying Basic Research Project of Sichuan Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Foundation of Southwest University of Science and Technology	This study was funded by the Applying Basic Research Project of Sichuan Province, China (2017SZ0105, 2018JY0258), National Natural Science Foundation of China (nos. 81770471, 11802253), the Doctoral Foundation of Southwest University of Science and Technology (15zx7151). We confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boussel L, 2008, STROKE, V39, P2997, DOI 10.1161/STROKEAHA.108.521617; Boyd A. J., 2015, J VASC SURG; Choong AMTL, 2010, SURG-J R COLL SURG E, V8, P28, DOI 10.1016/j.surge.2009.10.016; Coppola G, 2009, J R SOC INTERFACE, V6, P519, DOI 10.1098/rsif.2008.0417; Drinkwater SL, 2009, EUR J VASC ENDOVASC, V38, P578, DOI 10.1016/j.ejvs.2009.07.002; Erbel R, 2014, EUR HEART J, V35, P2873, DOI 10.1093/eurheartj/ehu281; Guo W, 2014, ENDOVASCULAR TODAY, P76; Hathcock JJ, 2006, ARTERIOSCL THROM VAS, V26, P1729, DOI 10.1161/01.ATV.0000229658.76797.30; Huang B, 2012, SURG TODAY, V42, P1219, DOI 10.1007/s00595-012-0164-2; Ito T, 2009, EUR J CARDIO-THORAC, V35, P177, DOI 10.1016/j.ejcts.2008.09.032; Kanaoka Y, 2008, Minerva Chir, V63, P229; Kandail H, 2014, J BIOMECH, V47, P3546, DOI 10.1016/j.jbiomech.2014.08.011; Ku DN, 1975, ANNU REV FLUID MECH, V68, P399, DOI [10.1093/eurheartj/ehu281, DOI 10.1093/EURHEARTJ/EHU281]; Massoni CB, 2014, J VASC SURG, V59, P1265, DOI 10.1016/j.jvs.2013.11.064; MOORE JE, 1992, J BIOMECH ENG-T ASME, V114, P391, DOI 10.1115/1.2891400; Moulakakis KG, 2011, CIRCULATION, V124, P2670, DOI 10.1161/CIRCULATIONAHA.111.041582; Quinones-Baldrich WJ, 1999, J VASC SURG, V30, P555, DOI 10.1016/S0741-5214(99)70084-4; Setacci F, 2016, J VASC SURG, V64, P33, DOI 10.1016/j.jvs.2015.12.059; Shadden SC, 2013, BIOMECH MODEL MECHAN, V12, P467, DOI 10.1007/s10237-012-0417-4; Sheriff J, 2010, ANN BIOMED ENG, V38, P1442, DOI 10.1007/s10439-010-9936-2; Shimamoto T, 2009, ANN VASC SURG, V23, DOI 10.1016/j.avsg.2008.03.002; Sho E, 2004, ARTERIOSCL THROM VAS, V24, P1916, DOI 10.1161/01.ATV.0000142805.20398.74; Tanweer Omar, 2014, J Cerebrovasc Endovasc Neurosurg, V16, P335, DOI 10.7461/jcen.2014.16.4.335; Wen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23801; Wen J, 2015, COMPUT METHOD BIOMEC, V18, P760, DOI 10.1080/10255842.2013.845880; Wen J, 2014, ASAIO J, V60, P533, DOI 10.1097/MAT.0000000000000101; Yuan D, 2016, J VASC SURG, V64, P1138, DOI 10.1016/j.jvs.2014.10.105; Zheng TH, 2009, ASAIO J, V55, P192, DOI 10.1097/MAT.0b013e31819b34f2	28	4	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205679	10.1371/journal.pone.0205679	http://dx.doi.org/10.1371/journal.pone.0205679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321207	Green Published, Green Submitted, gold			2022-12-26	WOS:000447417900045
J	Hunter, MD; Moon, YP; DeCarli, C; Gutierrez, J; Wright, CB; Di Tullio, MR; Sacco, RL; Kamel, H; Elkind, MSV				Hunter, Madeleine D.; Moon, Yeseon Park; DeCarli, Charles; Gutierrez, Jose; Wright, Clinton B.; Di Tullio, Marco R.; Sacco, Ralph L.; Kamel, Hooman; Elkind, Mitchell S. V.			Electrocardiographic left atrial abnormality and silent vascular brain injury: The Northern Manhattan Study	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; CEREBROVASCULAR-DISEASE; CARDIOVASCULAR-ABNORMALITIES; CRYPTOGENIC STROKE; HEART-FAILURE; LESIONS CABL; RISK-FACTORS; FIBRILLATION; PREVALENCE; INFARCTION	Hypothesis We hypothesized that P wave terminal Force in the V1 lead (PTFV1) would be associated with leukoaraiosis and subclinical infarcts, especially cortical infarcts, in a population-based, multi-ethnic cohort. Methods PTFV1 was collected manually from baseline electrocardiograms of clinically stroke-free Northern Manhattan Study participants. Investigators read brain MRIs for superficial infarcts, deep infarcts, and white matter hyperintensity volume (WMHV). WMHV was adjusted for head size and log transformed, achieving a normal distribution. Logistic regression models investigated the association of PTFV1 with cortical and with all subclinical infarcts. Linear regression models examined logWMHV. Models were adjusted for demographics and risk factors. Results Among 1174 participants with PTFV1 measurements, the mean age at MRI was 70 +/- 9 years. Participants were 14.4% white, 17.6% black, and 65.8% Hispanic. Mean PTFV1 was 3587.35 +/- 2315.62 mu V-ms. Of the 170 subclinical infarcts, 40 were cortical. PTFV1 >= 5000 mu V-ms was associated with WMHV in a fully adjusted model (mean difference in logWMHV 0.15, 95% confidence interval 0.01 +/- 0.28). PTFV1 exhibited a trend toward an association with cortical infarcts (unadjusted OR per SD change logPTFV(1) 1.30, 95% CI 0.94 +/- 1.81), but not with all subclinical infarcts. Conclusion Electrocardiographic evidence of left atrial abnormality was associated with leukoaraiosis.	[Hunter, Madeleine D.; Moon, Yeseon Park; Gutierrez, Jose; Elkind, Mitchell S. V.] Columbia Univ, Dept Neurol, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Wright, Clinton B.] NINDS, Off Clin Res, NIH, Washington, DC USA; [Di Tullio, Marco R.] Columbia Univ, Dept Med, Vagelos Coll Phys & Surg, New York, NY USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Kamel, Hooman] Cornell Univ, Dept Neurol, Weill Cornell Med Sch, New York, NY USA; [Elkind, Mitchell S. V.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA	Columbia University; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Columbia University; University of Miami; University of Miami; University of Miami; University of Miami; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Columbia University	Hunter, MD; Elkind, MSV (corresponding author), Columbia Univ, Dept Neurol, Vagelos Coll Phys & Surg, New York, NY 10027 USA.; Elkind, MSV (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.	mdh2167@cumc.columbia.edu; mse13@cumc.columbia.edu	Sacco, Ralph/Y-9278-2019; Kamel, Hooman/AGG-9071-2022; Gutiérrez, José/GSJ-1846-2022; DeCarli, Charles/B-5541-2009	Hunter, Madeleine/0000-0002-2042-7947	National Institute of Neurological Disorders and Stroke [R01 29993, K23 NS 082367]; NIH; Boehringer-Ingelheim, Inc.; BMS-Pfizer Alliance; BioTelemetry/Cardionet; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS082367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer-Ingelheim, Inc.(Boehringer Ingelheim); BMS-Pfizer Alliance; BioTelemetry/Cardionet; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the National Institute of Neurological Disorders and Stroke (R01 29993 [Elkind/Sacco]; K23 NS 082367 [Kamel]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (NIH) provided support in the form of salaries for authors [MSVE, JG, HK, RLS] as did other funders (Boehringer-Ingelheim, Inc., BMS-Pfizer Alliance, and BioTelemetry/Cardionet) for an author [MSVE]. However, the funders but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alves TCTF, 2005, J NEUROIMAGING, V15, P150, DOI 10.1177/1051228404272880; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227; Debette S, 2010, STROKE, V41, P600, DOI 10.1161/STROKEAHA.109.570044; DeCarli C, 2005, STROKE, V36, P50, DOI 10.1161/01.STR.0000150668.58689.f2; Dickie DA, 2016, NEUROBIOL AGING, V42, P116, DOI 10.1016/j.neurobiolaging.2016.03.011; Elkind MSV, 2006, STROKE, V37, P13, DOI 10.1161/01.STR.0000195048.86810.5b; Elkind MSV, 2005, NEUROLOGY, V64, P2121, DOI 10.1212/01.WNL.0000165989.12122.49; Gutierrez J, 2015, J HYPERTENS, V33, P2115, DOI 10.1097/HJH.0000000000000686; JIN L, 1988, ARCH INTERN MED, V148, P1545, DOI 10.1001/archinte.148.7.1545; Kamel H, 2017, CIRC RES, V120, P514, DOI 10.1161/CIRCRESAHA.116.308407; Kamel H, 2015, STROKE, V46, P3208, DOI 10.1161/STROKEAHA.115.009989; Kamel H, 2015, FUTUR CARDIOL, V11, P323, DOI [10.2217/fca.15.22, 10.2217/FCA.15.22]; Kamel H, 2015, STROKE, V46, P711, DOI 10.1161/STROKEAHA.114.007762; Lattanzi S, 2017, J NEUROL SCI, V375, P175, DOI 10.1016/j.jns.2017.01.063; Lin J, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9372050; Longstreth WT, 2002, STROKE, V33, P2376, DOI 10.1161/01.STR.0000032241.58727.49; Magnani JW, 2010, ANN NONINVAS ELECTRO, V15, P77, DOI 10.1111/j.1542-474X.2009.00343.x; Mayasi Y, 2018, J NEUROL NEUROSUR PS, V89, P6, DOI 10.1136/jnnp-2016-315457; Nakanishi K, 2017, AM HEART J, V185, P85, DOI 10.1016/j.ahj.2016.11.010; Prabhakaran S, 2008, NEUROLOGY, V70, P425, DOI 10.1212/01.wnl.0000277521.66947.e5; Russo C, 2013, CIRCULATION, V128, P1105, DOI 10.1161/CIRCULATIONAHA.113.001984; Sachdev P, 2007, NEUROLOGY, V68, P214, DOI 10.1212/01.wnl.0000251302.55202.73; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Shimizu A, 2014, GERIATR GERONTOL INT, V14, P71, DOI 10.1111/ggi.12261; TARAZI RC, 1966, CIRCULATION, V34, P818, DOI 10.1161/01.CIR.34.5.818; Vermeer SE, 2002, STROKE, V33, P21, DOI 10.1161/hs0102.101629; Vogels RLC, 2007, EUR J HEART FAIL, V9, P1003, DOI 10.1016/j.ejheart.2007.07.006; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Willey JZ, 2011, NEUROLOGY, V76, P2112, DOI 10.1212/WNL.0b013e31821f4472; Wright CB, 2005, STROKE, V36, P1207, DOI 10.1161/01.STR.0000165923.02318.22; Wright CB, 2008, STROKE, V39, P800, DOI 10.1161/STROKEAHA.107.484147; Wright CB, 2009, STROKE, V40, P3466, DOI 10.1161/STROKEAHA.109.559567; Yaghi S, 2016, J STROKE CEREBROVASC, V25, P110, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.001; Yaghi S, 2015, STROKE, V46, P1488, DOI 10.1161/STROKEAHA.115.008711	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0203774	10.1371/journal.pone.0203774	http://dx.doi.org/10.1371/journal.pone.0203774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312297	Green Published, gold, Green Submitted			2022-12-26	WOS:000447427300005
J	Uesawa, Y; Tsuji, N				Uesawa, Yoshihiro; Tsuji, Naotaka			Bananas decrease acetaminophen potency in in vitro assays	PLOS ONE			English	Article							TYROSINASE	Edible portions of bananas contain high levels of polyphenol oxidase, which catalyzes reactions in the melanin formation pathway. Tyrosine, a physiological substrate of polyphenol oxidase, has an analogous structure to acetaminophen. We investigated whether banana extract causes structural changes in acetaminophen and a decrease in its potency. Acetaminophen concentration in banana extract was measured under different conditions to characterize incompatibility. Reaction products in solution were identified using liquid chromatography/ electrospray ionization/mass spectrometry (LC/ESI/MS). Acetaminophen potency decreased with time in the presence of banana extract. The reaction proceeded most efficiently in temperatures 30-37 degrees C and neutral to weakly acidic conditions. Molecular ion peaks derived from the oxidized catechol moiety of acetaminophen were identified in LC/ESI/MS spectra. Our findings suggest that incorporation or simultaneous administration of acetaminophen medication and banana juice may result in decreased efficacy of the clinically important drug. This interaction is likely due to the oxidation of acetaminophen by polyphenol oxidase activity in banana pulp. Therefore, we investigated and characterized a novel interaction between bananas and acetaminophen. To establish a safe and effective antipyretic analgesic regimen using acetaminophen, future studies of this interaction are expected to be performed in humans.	[Uesawa, Yoshihiro] Meiji Pharmaceut Univ, Med Mol Informat, Kiyose, Tokyo, Japan; [Tsuji, Naotaka] Sakae Pharm, Higashimurayama, Tokyo, Japan	Meiji Pharmaceutical University	Uesawa, Y (corresponding author), Meiji Pharmaceut Univ, Med Mol Informat, Kiyose, Tokyo, Japan.	uesawa@my-pharm.ac.jp	, uesawa/AAA-1691-2020	Uesawa, Yoshihiro/0000-0002-5773-991X	OTC Self-Medication Promotion Foundation	OTC Self-Medication Promotion Foundation	This work was supported by grant to YU from the OTC Self-Medication Promotion Foundation (2008) http://www.otc-spf.jp/symposium/080924.html.; This research was supported by the OTC Self-Medication Promotion Foundation. We thank our colleagues from Meiji Pharmaceutical University who provided insight and expertise that greatly assisted the research.	ALMEIDA MEM, 1995, PLANT FOOD HUM NUTR, V47, P245, DOI 10.1007/BF01088333; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; GRIFFITHS LA, 1959, NATURE, V184, P58, DOI 10.1038/1841475a0; NAGATSU I, 1972, ENZYMOLOGIA, V43, P25; Ogo Y, 2005, YAKUGAKU ZASSHI, V125, P1009, DOI 10.1248/yakushi.125.1009; Uesawa Y, 2010, PHARMACEUTICALS, V3, P441, DOI 10.3390/ph3030441; Uesawa Y, 2008, YAKUGAKU ZASSHI, V128, P62; Valero E, 2003, BIOTECHNOL PROGR, V19, P1632, DOI 10.1021/bp034075t; Valero E, 2002, BIOL CHEM, V383, P1931, DOI 10.1515/BC.2002.217	9	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205612	10.1371/journal.pone.0205612	http://dx.doi.org/10.1371/journal.pone.0205612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312340	Green Published, gold, Green Submitted			2022-12-26	WOS:000447427300042
J	Lee, SA; Kang, SB; Chang, CB; Chang, MJ; Kim, YJ; Song, MK; Jeong, JH				Lee, Seung Ah; Kang, Seung-Baik; Chang, Chong Bum; Chang, Moon Jong; Kim, Young Jun; Song, Min Kyu; Jeong, Jin Hwa			Does the severity or cause of preoperative stiffness affect the clinical results and range of motion after total knee arthroplasty?	PLOS ONE			English	Article							ANKYLOSED KNEES; FUSION; REPLACEMENT; TAKEDOWN; FLEXION	The purpose of this study was to assess the overall clinical results and range of motion (ROM) after total knee arthroplasty (TKA) in patients with preoperative stiffness. We also aimed to determine whether the severity or cause of the stiffness can affect the clinical outcome after surgery. This retrospective study included 122 knees (117 patients) with followup of more than 2 years (mean age, 64.3 years). TKA was performed using posterior-stabilized, varus-valgus constrained (VVC), and hinged prostheses. To determine the effect of the severity of stiffness on the clinical outcome, the subjects were divided into two groups: the severe group (preoperative ROM <= 50 degrees; 18 knees) and the moderate group (preoperative ROM, 50 degrees-90 degrees; 104 knees). Then, clinical results and ROM were compared according to the severity or cause of preoperative stiffness. After surgery, preoperative ROM (mean, 78 degrees; range, 25 degrees - 90 degrees) was improved (mean, 107 degrees; range, 70 degrees - 130 degrees). The severe group more frequently used the VVC or hinged prostheses (72% vs. 18%). Furthermore, the severe group had worse knee and function scores as well as more complications (33% vs. 13%), even though the severe group had a greater ROM increment (47 degrees vs. 27 degrees) after surgery. Patients with osteoarthritis and rheumatoid arthritis showed better ROM and clinical results compared to patients with infectious or traumatic arthritis. Although TKA in stiff knees can be successful, the results are inferior in knees with severe stiffness and knees with infectious or traumatic arthritis.	[Lee, Seung Ah] Kyung Hee Univ, Coll Med, Dept Phys Med & Rehabil, Seoul, South Korea; [Kang, Seung-Baik; Chang, Chong Bum; Chang, Moon Jong; Kim, Young Jun; Song, Min Kyu; Jeong, Jin Hwa] Seoul Natl Univ, SMG SNU Boramae Med Ctr, Dept Orthopaed Surg, Coll Med, Seoul, South Korea	Kyung Hee University; Seoul National University (SNU); Seoul National University Hospital	Kang, SB (corresponding author), Seoul Natl Univ, SMG SNU Boramae Med Ctr, Dept Orthopaed Surg, Coll Med, Seoul, South Korea.	ossbkang@gmail.com		Kang, Seung-Baik/0000-0002-1184-4482	Bio & Medical Technology Development Program of the National Research Foundation [2017M3A9D8063538]	Bio & Medical Technology Development Program of the National Research Foundation	Funding was provided by the Bio & Medical Technology Development Program of the National Research Foundation (grant # 2017M3A9D8063538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglietti P, 1989, J Arthroplasty, V4, P1, DOI 10.1016/S0883-5403(89)80046-4; Bae DK, 2005, J BONE JOINT SURG BR, V87B, P333, DOI 10.1302/0301-620X.87B3; Baldini A, 2015, BONE JOINT J, V97B, P30, DOI 10.1302/0301-620X.97B10.36920; Bhan S, 2006, CLIN ORTHOP RELAT R, P87, DOI 10.1097/01.blo.0000229313.20760.13; Cameron HU, 1996, J ARTHROPLASTY, V11, P732, DOI 10.1016/S0883-5403(96)80013-1; Choi Young-Joon, 2016, Knee Surg Relat Res, V28, P1, DOI 10.5792/ksrr.2016.28.1.1; Debette C, 2014, INT ORTHOP, V38, P285, DOI 10.1007/s00264-013-2252-3; Fosco M, 2011, Musculoskelet Surg, V95, P7, DOI 10.1007/s12306-011-0099-6; Gatha Nehal M, 2004, J Knee Surg, V17, P196; Henkel TR, 2001, J ARTHROPLASTY, V16, P768, DOI 10.1054/arth.2001.24375; Hsu C.-Y., 2011, J SPORT RECREATION R, V5, P1, DOI DOI 10.1016/J.AJEM.2011.05.001; Hwang Youn Soo, 2016, Knee Surg Relat Res, V28, P325, DOI 10.5792/ksrr.16.020; Kim YH, 1999, J BONE JOINT SURG BR, V81B, P296, DOI 10.1302/0301-620X.81B2.9183; Kim YH, 2000, J ARTHROPLASTY, V15, P453, DOI 10.1054/arth.2000.4640; Kim YH, 2003, J BONE JOINT SURG AM, V85A, P1047, DOI 10.2106/00004623-200306000-00009; Kim YH, 2009, CLIN ORTHOP RELAT R, V467, P1348, DOI 10.1007/s11999-008-0445-7; Lee BS, 2011, KNEE SURG SPORT TR A, V19, P936, DOI 10.1007/s00167-010-1272-4; McAuley JP, 2002, CLIN ORTHOP RELAT R, P203, DOI 10.1097/01.blo.0000030496.43495.76; Montgomery W H 3rd, 1998, Am J Knee Surg, V11, P20; Moon Young-Wan, 2010, Orthopedics, V33, DOI 10.3928/01477447-20100129-06; Naranja RJ, 1996, CLIN ORTHOP RELAT R, P234; Park KK, 2007, J BONE JOINT SURG BR, V89B, P604, DOI 10.1302/0301-620X.89B5.18117; Parvizi J, 2001, J BONE JOINT SURG AM, V83A, P1312, DOI 10.2106/00004623-200109000-00003; Rajgopal A, 2005, J ARTHROPLASTY, V20, P585, DOI 10.1016/j.arth.2005.04.002; RITTER MA, 1979, CLIN ORTHOP RELAT R, P115; Song Young Dong, 2016, Knee Surg Relat Res, V28, P118, DOI 10.5792/ksrr.2016.28.2.118; Van Onsem S, 2016, J ARTHROPLASTY, V31, P2660, DOI 10.1016/j.arth.2016.06.004	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205168	10.1371/journal.pone.0205168	http://dx.doi.org/10.1371/journal.pone.0205168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308050	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500042
J	Li, YP; Liu, FF; Du, X; Li, ZM; Wu, JX				Li, Yiping; Liu, Fangfang; Du, Xiao; Li, Zhumei; Wu, Junxiang			Ultrastructure of antennal sensilla of three fruit borers (Lepidoptera: Crambidae or Tortricidae)	PLOS ONE			English	Article							FEMALE HELICOVERPA-ARMIGERA; SEX-PHEROMONE; HYMENOPTERA; MORPHOLOGY; HEMIPTERA; RESPONSES; MOTH; COLEOPTERA	Three fruit borers Conogethes punctiferalis (Guenee) (Crambidae), Grapholita molesta Busck (Tortricidae), and Spilonota albicana Motschulsky (Tortricidae) are serious pests of fruit trees. In this study, their antennal morphology, types of sensilla, and distributions were observed by using SEM (Scanning Electron Microscope). Nine types of sensilla were found on the antennae of C. punctiferalis, while eight types of sensilla were presented on each of G. molesta and S. albicana. The sensilla trichodea with two subtypes were the most abundant sensilla among three fruit borers. Two subtypes of sensillum coeloconica (type I with spines and type II without spines) were observed on the antennae of C. punctiferalis and G. molesta. However, sensilla coeloconica (type I) were only found in S. albicana. Although the sensilla campaniformia were only found on the antennae of C. punctiferalis, our observations confirm sensilla campaniformia presence in the moths. In addition, the functions of these sensilla were discussed based on previously reported lepidopteran insects. As a result, our study may provide useful information for advanced electrophysiological and behavioral experiments to better understand the mechanisms related to pests control.	[Li, Yiping; Liu, Fangfang; Du, Xiao; Li, Zhumei; Wu, Junxiang] Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China; [Li, Yiping; Liu, Fangfang; Du, Xiao; Li, Zhumei; Wu, Junxiang] Key Lab Integrated Pest Management Crops Northwes, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wu, JX (corresponding author), Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China.; Wu, JX (corresponding author), Key Lab Integrated Pest Management Crops Northwes, Yangling, Shaanxi, Peoples R China.	junxw@nwsuaf.edu.cn		Li, Yiping/0000-0002-9461-813X	National Natural Science Foundation of China [31071693, 31871971, 31772503, 31272043]; Agro-Industry R and D Special Fund of China [2017YFD0200900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agro-Industry R and D Special Fund of China	This research was supported by National Natural Science Foundation of China (Grant Nos. 31071693, 31871971, 31772503, and 31272043 to Dr. Yiping Li and Prof. Junxiang Wu) and the Agro-Industry R and D Special Fund of China (Grant No. 2017YFD0200900 to Dr. Yiping Li).	Agrawal S, 2017, ARTHROPOD STRUCT DEV, V46, P215, DOI 10.1016/j.asd.2017.01.005; Ahmed T, 2013, MICRON, V50, P35, DOI 10.1016/j.micron.2013.04.003; Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; Ansebo L, 2005, J INSECT PHYSIOL, V51, P1066, DOI 10.1016/j.jinsphys.2005.05.003; Berg BG, 2002, J COMP NEUROL, V446, P123, DOI 10.1002/cne.10180; Bink-Moenen R.M., 1983, Monografieen van de Nederlandse Entomologische Vereniging, V10, P1; Bruce TJ, 2001, J CHEM ECOL, V27, P1119, DOI 10.1023/A:1010359811418; Burguiere L, 2001, J INSECT PHYSIOL, V47, P509, DOI 10.1016/S0022-1910(00)00119-0; Chang XQ, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev103; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Chinta S, 1997, INT J INSECT MORPHOL, V26, P21, DOI 10.1016/S0020-7322(96)00022-0; Consoli EL, 1999, MICROSC RES TECHNIQ, V45, P313, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<313::AID-JEMT15>3.0.CO;2-4; DIETZ A, 1971, ANN ENTOMOL SOC AM, V64, P919, DOI 10.1093/aesa/64.4.919; Domenichini G, 1982, MEMORIE SOC ENTOMOLO; [高希武 Gao Xiwu], 2010, [植物保护, Plant Protection], V36, P19; Gerling D., 1990, WHITEFLIES THEIR BIO; Godfray HCJ, 1994, ENVIRON ENTOMOL, V24; HALLBERG E, 1994, TISSUE CELL, V26, P489, DOI 10.1016/0040-8166(94)90002-7; Hora KH, 1999, PHYSIOL ENTOMOL, V24, P109, DOI 10.1046/j.1365-3032.1999.00120.x; Keil T. A., 1999, MORPHOLOGY DEV PERIP; [李倩 Li Qian], 2014, [植物保护, Plant Protection], V40, P70; [李欣 Li Xin], 2004, [河南农业大学学报, JOURNAL OF HENAN AGRICULTURAL UNIVERSITY], V38, P45; [鹿金秋 Lu Jinqiu], 2010, [植物保护, Plant Protection], V36, P31; Lu Peng-Fei, 2010, Acta Entomologica Sinica, V53, P1390; Ma M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40637; Ma Rui-Yan, 2000, Entomological Knowledge, V37, P179; Meng YF, 2017, ZOOL ANZ, V268, P64, DOI 10.1016/j.jcz.2017.04.002; Merivee E, 2000, ACTA ZOOL-STOCKHOLM, V81, P339, DOI 10.1046/j.1463-6395.2000.00068.x; Merivee E, 2002, MICRON, V33, P429, DOI 10.1016/S0968-4328(02)00003-3; Na J., 2008, J SHENYANG NORM U NA, V26, P213; OLSON DM, 1993, INT J INSECT MORPHOL, V22, P507, DOI 10.1016/0020-7322(93)90037-2; Onagbola EO, 2008, MICRON, V39, P1184, DOI 10.1016/j.micron.2008.05.002; Park KC, 2002, J INSECT PHYSIOL, V48, P527, DOI 10.1016/S0022-1910(02)00082-3; Romani R, 2009, ARTHROPOD STRUCT DEV, V38, P473, DOI 10.1016/j.asd.2009.08.002; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; Song Yue-Qin, 2014, Acta Entomologica Sinica, V57, P274; Sukontason K, 2007, MICRON, V38, P218, DOI 10.1016/j.micron.2006.07.018; van Naters WMV, 1998, CHEM SENSES, V23, P351, DOI 10.1093/chemse/23.3.351; [王安柱 Wang Anzhu], 2012, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V21, P203; Wang Gui-rong, 2002, Scientia Agricultura Sinica, V35, P1479; [王洪亮 Wang Hongliang], 2011, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V20, P174; Wang JL, 2010, MOD AGR SCI TECH, P219; Wang KQ, 2009, CHIN AGR SCI B, V25, P190; Wang Xia, 2008, Acta Entomologica Sinica, V51, P1225; Yang Xiao, 2012, Chinese Journal of Applied Entomology, V49, P1321; [余海忠 YU HaiZhong], 2007, [安徽农业科学, Journal of Anhui Agricultural Sciences], V35, P4238; Yuan XQ, 2014, ZOOKEYS, P17, DOI 10.3897/zookeys.399.7063; Zhang GuoHui, 2014, Journal of Northwest A & F University - Natural Science Edition, V42, P51; Zhao Xiao, 2012, Journal of Northwest A & F University - Natural Science Edition, V40, P119; Zhou H, 2013, MICRON, V44, P365, DOI 10.1016/j.micron.2012.09.001	50	9	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205604	10.1371/journal.pone.0205604	http://dx.doi.org/10.1371/journal.pone.0205604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308058	gold, Green Published, Green Submitted			2022-12-26	WOS:000447173500109
J	Perdices, A; Ozeren, CS; Erkakan, F; Freyhof, J				Perdices, Anabel; Ozeren, Cevher S.; Erkakan, Fusun; Freyhof, Joerg			Diversity of spined loaches from Asia Minor in a phylogenetic context (Teleostei: Cobitidae)	PLOS ONE			English	Article							SPECIES DELIMITATION; GENUS COBITIS; MOLECULAR PHYLOGENY; MITOCHONDRIAL-DNA; CENTRAL ANATOLIA; CYPRINIFORMES; COMPLEX; PISCES; INTROGRESSION; COLONIZATION	Accurate determination of species diversity in areas of high endemicity, particularly those lacking comprehensive systematic knowledge, represents a challenge for both taxonomists and conservationists. This need is particularly evident in areas greatly affected by anthropogenic disturbances such as the Eastern Mediterranean and its freshwater environments. To improve our knowledge of Eastern Mediterranean freshwater fishes, we phylogenetically studied Western Palearctic Cobitis species, focusing on those found in Turkey. Overall, our results provide a robust framework to assess the number of species of Cobitis. Phylogenetic reconstructions based on mitochondrial (cyt b) and nuclear (RAG1) sequences show seven major clades (Clades 1-7) grouping all Western Palearctic Cobitis species, except C. metanoleuca. In general, each major Glade comprises Cobitis species that inhabit geographically close areas and have similar secondary sexual characters. Multiple divergent lineages were identified in our analyses, some of which were highly divergent such as the ones inhabiting Turkish freshwaters. Moreover, in some analyses, several of the identified lineages were incongruent with a priori defined species. Furthermore, our analyses identified eight potentially new candidate species, six that had been suggested in previous studies and two that are reported here for the first time. Our results reveal Turkey as the area with the greatest diversity of spined loaches in the Mediterranean.	[Perdices, Anabel] CSIC, Museo Nacl Ciencias Nat, Dept Biodivers & Evolutionary Biol, Madrid, Spain; [Ozeren, Cevher S.] Univ Ankara, Fac Sci, Dept Biol, Ankara, Turkey; [Erkakan, Fusun] Hacettepe Univ, Fac Sci, Dept Biol, Beytepe Campus, Ankara, Turkey; [Freyhof, Joerg] Leibniz Inst Freshwater Ecol & Inland Fisheriers, Berlin, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Ankara University; Hacettepe University	Perdices, A (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Biodivers & Evolutionary Biol, Madrid, Spain.	aperdices@mncn.csic.es	Perdices, Anabel/K-5140-2014	Perdices, Anabel/0000-0003-0980-215X	Ministerio Ciencia e Innovacion [CGL2007-61010]; SYNTHESYS3 [CZ-TAF6293]; MINECO/FEDER [CGL2015-66571-P]; Intramural special project Fundacion General [200630l125]	Ministerio Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); SYNTHESYS3; MINECO/FEDER(Spanish Government); Intramural special project Fundacion General	This study was funded by project CGL2007-61010 by the Ministerio Ciencia e Innovacion, and partially supported by SYNTHESYS3 CZ-TAF6293, MINECO/FEDER CGL2015-66571-P, and Intramural special project Fundacion General 200630l125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Ahmadzadeh F, 2013, BIOL J LINN SOC, V110, P398, DOI 10.1111/bij.12129; Akin C, 2010, J BIOGEOGR, V37, P2111, DOI 10.1111/j.1365-2699.2010.02368.x; Bohlen J, 2006, MOL PHYLOGENET EVOL, V39, P552, DOI 10.1016/j.ympev.2005.12.007; Bohlen J, 2001, J FISH BIOL, V59, P75, DOI 10.1006/jfbi.2001.1751; Buj I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131580; Buj I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099833; Choleva L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080641; Costa-Silva GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135075; Culling MA, 2006, MOL ECOL, V15, P173, DOI 10.1111/j.1365-294X.2005.02790.X; Darwall W, 2014, FRESHWATER KEY BIODI; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Eagderi Soheil, 2017, FishTaxa-Journal of Fish Taxonomy, V2, P48; Economidis Panos S., 1996, Travaux du Museum National d'Histoire Naturelle "Grigore Antipa", V36, P295; Erk'akan Fusun, 2008, Journal of Fisheries International, V3, P112; Erkakan F, 1999, HYDROBIOLOGIA, V403, P13, DOI 10.1023/A:1003794726444; Erkakan Fusun, 2017, FishTaxa-Journal of Fish Taxonomy, V2, P82; Erkakan Fusun, 2014, HACETTEPE JOURNAL OF BIOLOGY AND CHEMISTRY, V42, P275; Freyhof J, 2005, MOL PHYLOGENET EVOL, V37, P347, DOI 10.1016/j.ympev.2005.07.018; Freyhof J, 2014, STATUS DISTRIBUTION, P19, DOI DOI 10.2305/IUCN.CH.2014.01.EN; Geiger MF, 2014, MOL ECOL RESOUR, V14, P1210, DOI 10.1111/1755-0998.12257; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt Godfrey M, 2004, Front Zool, V1, P4; Hrbek T, 2004, MOL PHYLOGENET EVOL, V32, P297, DOI 10.1016/j.ympev.2003.12.017; Hrbek T, 2002, MOL PHYLOGENET EVOL, V25, P125, DOI 10.1016/S1055-7903(02)00203-8; Janko K, 2007, J FISH BIOL, V71, P387, DOI 10.1111/j.1095-8649.2007.01663.x; Janko K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045384; Kapli P, 2017, BIOINFORMATICS, V33, P1630, DOI 10.1093/bioinformatics/btx025; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOSSWIG C, 1955, SYST ZOOL, V4, P49, DOI 10.2307/2411949; Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; Kottelat M, 2012, RAFFLES B ZOOL, P1; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Mousavi-Sabet H., 2011, J ICHTHYOL+, V51, P925, DOI DOI 10.1134/S0032945211100055; Mousavi-Sabet H, 2015, ZOOTAXA, V3914, P558, DOI 10.11646/zootaxa.3914.5.4; Perdices A, 2008, MOL PHYLOGENET EVOL, V46, P382, DOI 10.1016/j.ympev.2007.05.007; Perdices A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144628; Perdices A, 2012, ICHTHYOL RES, V59, P113, DOI 10.1007/s10228-011-0259-6; Plotner J, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P373, DOI 10.1007/978-3-642-12425-9_18; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Sanda R, 2008, FOLIA ZOOL, V57, P42; Schonhuth S, 2012, MOL PHYLOGENET EVOL, V62, P427, DOI 10.1016/j.ympev.2011.10.011; Seyrek A, 2008, GEOMORPHOLOGY, V97, P321, DOI 10.1016/j.geomorph.2007.08.014; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Slechtova V, 2008, MOL PHYLOGENET EVOL, V47, P812, DOI 10.1016/j.ympev.2007.12.018; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL, 2012, PAUP PHYLOGENETIC AN; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; Vasil'eva E.D., 2012, J ICHTHYOL+, V52, P200, DOI DOI 10.1134/S0032945212020154; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	53	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205678	10.1371/journal.pone.0205678	http://dx.doi.org/10.1371/journal.pone.0205678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308027	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500115
J	Michelsen, TM; Henriksen, T; Reinhold, D; Powell, TL; Jansson, T				Michelsen, Trond M.; Henriksen, Tore; Reinhold, Dominik; Powell, Theresa L.; Jansson, Thomas			The human placental proteome secreted into the maternal and fetal circulations in normal pregnancy based on 4-vessel sampling	FASEB JOURNAL			English	Article						placental physiology; proteomics; trophoblast; pregnancy proteins	GROWTH-FACTOR; GENE-EXPRESSION; PREECLAMPSIA; RAT; DIFFERENTIATION; TROPHOBLAST; RECEPTORS; SEROTONIN; DISCOVERY; HORMONE	We sought to identify proteins secreted by the human placenta into the maternal and fetal circulations. Blood samples from the maternal radial artery and uterine vein and umbilical artery and vein were obtained during cesarean section in 35 healthy women with term pregnancy. Slow off-rate modified aptamer (SOMA) protein-binding technology was used to quantify 1310 known proteins. The uteroplacental and umbilical venoarterial concentration differences were calculated. Thirty-four proteins were significantly secreted by the placenta into the maternal circulation, including placental growth factor, growth/differentiation factor 15, and matrix metalloproteinase 12. There were 341 proteins significantly secreted by the placenta into the fetal circulation. Only 7 proteins were secreted into both the fetal and maternal circulations, suggesting a distinct directionality in placental protein release. We examined changes across gestation in the proteins found to be significantly secreted by the placenta into the maternal circulation using serial blood samples from healthy women. Among the 34 proteins secreted into the maternal circulation, 8 changed significantly across gestation. The identified profiles of secreted placental proteins will allow us to identify novel minimally invasive biomarkers for human placental function across gestation and discover previously unknown proteins secreted by the human placenta that regulate maternal physiology and fetal development.Michelsen, T. M., Henriksen, T., Reinhold, D., Powell, T. L., Jansson, T. The human placental proteome secreted into the maternal and fetal circulations in normal pregnancy based on 4-vessel sampling.	[Michelsen, Trond M.; Jansson, Thomas] Univ Colorado, Dept Obstet & Gynecol, Div Reprod Sci, Anschutz Med Campus, Aurora, CO USA; [Powell, Theresa L.] Univ Colorado, Dept Pediat, Div Neonatol, Anschutz Med Campus, Aurora, CO USA; [Michelsen, Trond M.; Henriksen, Tore] Oslo Univ Hosp, Dept Obstet, Rikshosp, Div Obstet & Gynecol, Sognsvannsveien 20, N-0424 Oslo, Norway; [Reinhold, Dominik] PPD, Wilmington, NC USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Oslo; National Hospital Norway	Michelsen, TM (corresponding author), Oslo Univ Hosp, Dept Obstet, Rikshosp, Div Obstet & Gynecol, Sognsvannsveien 20, N-0424 Oslo, Norway.	trmi1@ous-hf.no	Powell, Theresa/AAE-4249-2020		South-Eastern Norway Regional Health Authority	South-Eastern Norway Regional Health Authority	T.M.M. received a research grant from The South-Eastern Norway Regional Health Authority. The funders had no role in designing the study, analyzing the data, writing the paper or the decision to publish the paper. The authors declare no conflicts of interest.	Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Alsat E, 1998, MOL CELL ENDOCRINOL, V140, P121, DOI 10.1016/S0303-7207(98)00040-9; Alsat E, 1997, AM J OBSTET GYNECOL, V177, P1526, DOI 10.1016/S0002-9378(97)70103-0; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2017, TISS ATL; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Burton GJ, 2009, REPRODUCTION, V138, P895, DOI 10.1530/REP-09-0092; Clark DE, 1996, HUM REPROD, V11, P1090; Cole LA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-24; Conde-Agudelo A, 2013, BJOG-INT J OBSTET GY, V120, P681, DOI 10.1111/1471-0528.12172; Costa MA, 2016, REPROD BIOMED ONLINE, V32, P14, DOI 10.1016/j.rbmo.2015.10.005; De Falco M, 2007, PLACENTA, V28, P118, DOI 10.1016/j.placenta.2006.03.010; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Ganz P, 2016, JAMA-J AM MED ASSOC, V315, P2532, DOI 10.1001/jama.2016.5951; Goeden N, 2016, J NEUROSCI, V36, P6041, DOI 10.1523/JNEUROSCI.2534-15.2016; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Haider S, 2016, P NATL ACAD SCI USA, V113, pE7710, DOI 10.1073/pnas.1612335113; Handwerger S, 2000, J PEDIATR ENDOCR MET, V13, P343, DOI 10.1515/JPEM.2000.13.4.343; Harris LK, 2010, AM J PATHOL, V177, P2103, DOI 10.2353/ajpath.2010.100182; Hathout Y, 2015, P NATL ACAD SCI USA, V112, P7153, DOI 10.1073/pnas.1507719112; Henson MC, 2006, BIOL REPROD, V74, P218, DOI 10.1095/biolreprod.105.045120; Hewitt DP, 2006, BIOL REPROD, V75, P75, DOI 10.1095/biolreprod.105.047647; Holm MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185760; Holme AM, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.07.056; Ishii H, 2001, CIRC RES, V89, P1240, DOI 10.1161/hh2401.101066; Jung JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044572; Leguy MC, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-129; Lowe WL, 2014, DIABETIC MED, V31, P254, DOI 10.1111/dme.12352; Lynch AM, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.001; Major HD, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.024; Michelsen TM, 2017, PLACENTA, V59, pS26, DOI 10.1016/j.placenta.2017.03.014; Mifsud W, 2014, FETAL DIAGN THER, V36, P117, DOI 10.1159/000359969; Mitchell MD, 2015, AM J OBSTET GYNECOL, V213, pS173, DOI 10.1016/j.ajog.2015.07.001; Moore AG, 2000, J CLIN ENDOCR METAB, V85, P4781, DOI 10.1210/jc.85.12.4781; Muyan M, 1997, PLACENTA, V18, P237, DOI 10.1016/S0143-4004(97)80056-2; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Romero R., 2017, AM J OBSTET GYNECOL, V217, P67; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Rosario FJ, 2011, ENDOCRINOLOGY, V152, P1119, DOI 10.1210/en.2010-1153; SASAKI A, 1987, J CLIN ENDOCR METAB, V64, P224, DOI 10.1210/jcem-64-2-224; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Shillingford JM, 2002, MOL ENDOCRINOL, V16, P563, DOI 10.1210/me.16.3.563; Sibley CP, 2005, PEDIATR RES, V58, P827, DOI 10.1203/01.PDR.0000181381.82856.23; Sircar M, 2015, CURR OPIN NEPHROL HY, V24, P131, DOI 10.1097/MNH.0000000000000105; Sugulle M, 2009, HYPERTENSION, V54, P106, DOI 10.1161/HYPERTENSIONAHA.109.130583; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tanaka Y, 2007, BRAIN RES, V1165, P135, DOI 10.1016/j.brainres.2007.06.039; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang A, 2015, J CLIN INVEST, V125, P4021, DOI 10.1172/JCI80457; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Xin H, 2012, THROMB RES, V129, P563, DOI 10.1016/j.thromres.2011.07.039; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	56	13	14	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2944	2956		10.1096/fj.201801193R	http://dx.doi.org/10.1096/fj.201801193R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30335547	Bronze			2022-12-26	WOS:000457296600112
J	Setty, TG; Mowers, JC; Hobbs, AG; Maiya, SP; Syed, S; Munson, RS; Apicella, MA; Subramanian, R				Setty, Thanuja Gangi; Mowers, Jonathan C.; Hobbs, Aaron G.; Maiya, Shubha P.; Syed, Sanaa; Munson, Robert S., Jr.; Apicella, Michael A.; Subramanian, Ramaswamy			Molecular characterization of the interaction of sialic acid with the periplasmic binding protein from Haemophilus ducreyi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; isothermal titration calorimetry (ITC); ABC transporter; energetics; sugar transport; enthalpy; entropy; nutrient sequestration; sialic acid; virulence; Haemophilus ducreyi; periplasmic binding protein	CYTOLETHAL DISTENDING TOXIN; HUMAN FORESKIN FIBROBLASTS; ABC TRANSPORTER; INFLUENZAE; EVOLUTION; LIPOPOLYSACCHARIDE; IDENTIFICATION; CYTOTOXIN; HEMOLYSIN; SUBSTRATE	The primary role of bacterial periplasmic binding proteins is sequestration of essential metabolites present at a low concentration in the periplasm and making them available for active transporters that transfer these ligands into the bacterial cell. The periplasmic binding proteins (SiaPs) from the tripartite ATP-independent periplasmic (TRAP) transport system that transports mammalian host-derived sialic acids have been well studied from different pathogenic bacteria, including Haemophilus influenzae, Fusobacterium nucleatum, Pasteurella multocida, and Vibrio cholerae. SiaPs bind the sialic acid N-acetylneuraminic acid (Neu5Ac) with nanomolar affinity by forming electrostatic and hydrogen-bonding interactions. Here, we report the crystal structure of a periplasmic binding protein (SatA) of the ATP-binding cassette (ABC) transport system from the pathogenic bacterium Haemophilus ducreyi. The structure of Hd-SatA in the native form and sialic acid-bound forms (with Neu5Ac and N-glycolylneuraminic acid (Neu5Gc)), determined to 2.2, 1.5, and 2.5 resolutions, respectively, revealed a ligand-binding site that is very different from those of the SiaPs of the TRAP transport system. A structural comparison along with thermodynamic studies suggested that similar affinities are achieved in the two classes of proteins through distinct mechanisms, one enthalpically driven and the other entropically driven. In summary, our structural and thermodynamic characterization of Hd-SatA reveals that it binds sialic acids with nanomolar affinity and that this binding is an entropically driven process. This information is important for future structure-based drug design against this pathogen and related bacteria.	[Setty, Thanuja Gangi; Maiya, Shubha P.; Syed, Sanaa; Subramanian, Ramaswamy] Inst Stem Cell Biol & Regenerat Med, GKVK Post, Bangalore 560065, Karnataka, India; [Mowers, Jonathan C.; Hobbs, Aaron G.; Subramanian, Ramaswamy] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Apicella, Michael A.] Univ Iowa, Carver Coll Med, Dept Microbiol & Immunol, Iowa City, IA 52242 USA; [Munson, Robert S., Jr.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Setty, Thanuja Gangi] Univ Trans Disciplinary Hlth Sci & Technol TDU, Bengaluru 560064, Karnataka, India	Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; University of Iowa; University of Iowa; University System of Ohio; Ohio State University	Subramanian, R (corresponding author), Inst Stem Cell Biol & Regenerat Med, GKVK Post, Bangalore 560065, Karnataka, India.	ramas@instem.res.in	Subramanian, Ramaswamy/Q-8671-2019	Subramanian, Ramaswamy/0000-0002-6709-190X; Hobbs, Aaron/0000-0002-4751-9681	Department of Biotechnology Grant [BT/INF/22/SP22660/2017]; DBT [BT/PR5081/INF/156/2012]	Department of Biotechnology Grant; DBT(Department of Biotechnology (DBT) India)	We thank the ESRF Access Program of RCB (supported by Department of Biotechnology Grant BT/INF/22/SP22660/2017). We thank the Advance Photon Source (IMCA-CAT beamline 17-ID) and Advanced Light Source (beamline 4.2.2, MBC) for providing the beam time for this project. The NCBS X-ray Facility was supported by Grant BT/PR5081/INF/156/2012 from the DBT.	Alfa MJ, 1997, MICROB PATHOGENESIS, V22, P39, DOI 10.1006/mpat.1996.0089; Alfa MJ, 1996, INFECT IMMUN, V64, P2349, DOI 10.1128/IAI.64.6.2349-2352.1996; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; [Anonymous], 2011, MOL IMMUNOLOGY COMPL, DOI 10.1007/978-1-4419-7877-6_28; [Anonymous], 2018, PYMOL MOL GRAPHICS S; Apicella MA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00019; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Ceelen LM, 2006, MICROBIOL RES, V161, P109, DOI 10.1016/j.micres.2005.04.002; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Cope LD, 1997, P NATL ACAD SCI USA, V94, P4056, DOI 10.1073/pnas.94.8.4056; Cortes-Bratti X, 1999, J CLIN INVEST, V103, P107, DOI 10.1172/JCI3831; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Du X, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020144; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; DUNTEN P, 1995, PROTEIN SCI, V4, P2327, DOI 10.1002/pro.5560041110; El Sahili A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005071; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Felder CB, 1999, AAPS PHARMSCI, V1; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Gibson BW, 1997, J BACTERIOL, V179, P5062, DOI 10.1128/jb.179.16.5062-5071.1997; Haines-Menges BL, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0005-2014; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; Hood DW, 2001, MOL MICROBIOL, V39, P341, DOI 10.1046/j.1365-2958.2001.02204.x; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Inamadar Arun C, 2002, Indian J Dermatol Venereol Leprol, V68, P5; Johnston JW, 2008, J BIOL CHEM, V283, P855, DOI 10.1074/jbc.M706603200; Kuzmanov U, 2013, GENOME MED, V5, DOI 10.1186/gm441; Levdikov VM, 2005, J MOL BIOL, V345, P879, DOI 10.1016/j.jmb.2004.10.089; Liu TY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002326; Maqbool A, 2015, BIOCHEM SOC T, V43, P1011, DOI 10.1042/BST20150135; Melaugh W, 1996, J BACTERIOL, V178, P564, DOI 10.1128/jb.178.2.564-570.1996; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; OH BH, 1993, J BIOL CHEM, V268, P11348; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Pawson T, 2000, GENE DEV, V14, P1027; Post DMB, 2005, INFECT IMMUN, V73, P6727, DOI 10.1128/IAI.73.10.6727-6735.2005; Saini R. D., 2017, J PROTEINS PROTEOMIC, V8, P205; Setty TG, 2014, ACTA CRYSTALLOGR D, V70, P1801, DOI 10.1107/S139900471400830X; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Sevimoglu T, 2014, COMPUT STRUCT BIOTEC, V11, P22, DOI 10.1016/j.csbj.2014.08.008; Spinola SM, 2002, INFECT IMMUN, V70, P1667, DOI 10.1128/IAI.70.4.1667-1676.2002; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thomas GH, 2016, BIOCHEM SOC T, V44, P760, DOI 10.1042/BST20160056; Thomson J, 1998, BIOPHYS CHEM, V70, P101, DOI 10.1016/S0301-4622(97)00113-0; Varki A, 2009, ESSENTIALS GLYCOBIOL, P1; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Vergauwen B, 2010, P NATL ACAD SCI USA, V107, P13270, DOI 10.1073/pnas.1005198107; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Wood GE, 1999, INFECT IMMUN, V67, P3740, DOI 10.1128/IAI.67.8.3740-3749.1999	54	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20073	20084		10.1074/jbc.RA118.005151	http://dx.doi.org/10.1074/jbc.RA118.005151			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30315109	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000454685900017
J	Choveau, FS; De la Rosa, V; Bierbower, SM; Hernandez, CC; Shapiro, MS				Choveau, Frank S.; De la Rosa, Victor; Bierbower, Sonya M.; Hernandez, Ciria C.; Shapiro, Mark S.			Phosphatidylinositol 4,5-bisphosphate (PIP2) regulates KCNQ3 K+ channels by interacting with four cytoplasmic channel domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium channel; phospholipid; structure-function; signal transduction; neuroscience; ion channel gating; ion channel modulation; KCNQ; lipid signaling; M current; PIP2	RECEPTOR-MEDIATED INHIBITION; GATED POTASSIUM CHANNELS; PROXIMAL C-TERMINUS; STRUCTURAL BASIS; VOLTAGE SENSOR; MUSCARINIC MODULATION; CRYSTAL-STRUCTURE; I-KS; SENSITIVITY; ACTIVATION	Phosphatidylinositol 4,5-bisphosphate (PIP2) in the plasma membrane regulates the function of many ion channels, including M-type (potassium voltage-gated channel subfamily Q member (KCNQ), K(v)7) K+ channels; however, the molecular mechanisms involved remain unclear. To this end, we here focused on the KCNQ3 subtype that has the highest apparent affinity for PIP2 and performed extensive mutagenesis in regions suggested to be involved in PIP2 interactions among the KCNQ family. Using perforated patch-clamp recordings of heterologously transfected tissue culture cells, total internal reflection fluorescence microscopy, and the zebrafish (Danio rerio) voltage-sensitive phosphatase to deplete PIP2 as a probe, we found that PIP2 regulates KCNQ3 channels through four different domains: 1) the A-B helix linker that we previously identified as important for both KCNQ2 and KCNQ3, 2) the junction between S6 and the A helix, 3) the S2-S3 linker, and 4) the S4-S5 linker. We also found that the apparent strength of PIP2 interactions within any of these domains was not coupled to the voltage dependence of channel activation. Extensive homology modeling and docking simulations with the WT or mutant KCNQ3 channels and PIP2 were consistent with the experimental data. Our results indicate that PIP2 modulates KCNQ3 channel function by interacting synergistically with a minimum of four cytoplasmic domains.	[Choveau, Frank S.; De la Rosa, Victor; Bierbower, Sonya M.; Shapiro, Mark S.] Univ Texas Hlth San Antonio, Dept Cell & Integrat Physiol, San Antonio, TX 78229 USA; [Hernandez, Ciria C.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Hernandez, Ciria C.] Univ Michigan, Inst Life Sci, Rm 6115,210 Washtenaw Ave, Ann Arbor, MI 48109 USA; [Bierbower, Sonya M.] William Paterson Univ, Dept Biol, Coll Sci & Hlth, Wayne, NJ 07470 USA	University of Texas System; University of Texas Health San Antonio; Vanderbilt University; University of Michigan System; University of Michigan	Hernandez, CC (corresponding author), Univ Michigan, Inst Life Sci, Rm 6115,210 Washtenaw Ave, Ann Arbor, MI 48109 USA.; Shapiro, MS (corresponding author), Univ Texas Hlth San Antonio, Dept Cell & Integrat Physiol, South Texas Res Facil, MC 8253,8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	ciria@umich.edu; shapirom@uthscsa.edu	De la Rosa, Victor/AAM-8583-2021; Choveau, Frank/AFI-6500-2022; Choveau, Frank/AAF-3858-2022	De la Rosa, Victor/0000-0001-5161-3083; 	National Institutes of Health [R01 NS150305, R01 NS094461, R56 NS153503]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 NS150305, R01 NS094461, and R56 NS153503 (to M. S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abderemane-Ali F, 2012, J BIOL CHEM, V287, P36158, DOI 10.1074/jbc.M112.382085; Aivar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047263; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Bender K, 2002, FEBS LETT, V529, P356, DOI 10.1016/S0014-5793(02)03426-9; Boyer Stephanie B, 2010, Commun Integr Biol, V3, P343; Chambard JM, 2005, PFLUG ARCH EUR J PHY, V450, P34, DOI 10.1007/s00424-004-1366-2; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Choveau FS, 2012, BIOPHYS J, V102, P2489, DOI 10.1016/j.bpj.2012.04.018; Choveau FS, 2011, J BIOL CHEM, V286, P707, DOI 10.1074/jbc.M110.146324; Cui JM, 2016, BIOPHYS J, V110, P14, DOI 10.1016/j.bpj.2015.11.023; Eckey K, 2014, J BIOL CHEM, V289, P22749, DOI 10.1074/jbc.M114.589796; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Hernandez CC, 2009, J GEN PHYSIOL, V134, P437, DOI 10.1085/jgp.200910313; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hou PP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01911-8; Itsuki K, 2012, CHANNELS, V6, P206, DOI 10.4161/chan.20883; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kasimova MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07474; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Kosenko A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082290; Kruse M, 2012, J GEN PHYSIOL, V140, P189, DOI 10.1085/jgp.201210806; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Li Y, 2011, P NATL ACAD SCI USA, V108, P9095, DOI 10.1073/pnas.1100872108; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lopes CMB, 2005, J PHYSIOL-LONDON, V564, P117, DOI 10.1113/jphysiol.2004.081935; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Nakajo K, 2005, J PHYSIOL-LONDON, V569, P59, DOI 10.1113/jphysiol.2005.094995; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; Sachyani D, 2014, STRUCTURE, V22, P1582, DOI 10.1016/j.str.2014.07.016; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selyanko AA, 1999, BIOPHYS J, V77, P701, DOI 10.1016/S0006-3495(99)76925-0; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Sun J, 2017, CELL, V169, P1042, DOI 10.1016/j.cell.2017.05.019; Telezhkin V, 2013, PFLUG ARCH EUR J PHY, V465, P945, DOI 10.1007/s00424-012-1199-3; Telezhkin V, 2012, J BIOL CHEM, V287, P10001, DOI 10.1074/jbc.M111.322552; Thomas AM, 2011, J BIOL CHEM, V286, P2088, DOI 10.1074/jbc.M110.153551; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobelaim WS, 2017, CHANNELS, V11, P686, DOI 10.1080/19336950.2017.1388478; Tobelaim WS, 2017, P NATL ACAD SCI USA, V114, pE869, DOI 10.1073/pnas.1612622114; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Zaika O, 2008, BIOPHYS J, V95, P5121, DOI 10.1529/biophysj.108.137604; Zaika O, 2007, J NEUROSCI, V27, P8914, DOI 10.1523/JNEUROSCI.1739-07.2007; Zaydman MA, 2014, ELIFE, V3, DOI 10.7554/eLife.03606; Zaydman MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00195; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang QS, 2013, P NATL ACAD SCI USA, V110, P20093, DOI 10.1073/pnas.1312483110; Zhou PZ, 2013, P NATL ACAD SCI USA, V110, P8726, DOI 10.1073/pnas.1302167110	73	24	24	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19411	19428		10.1074/jbc.RA118.005401	http://dx.doi.org/10.1074/jbc.RA118.005401			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30348901	Green Published, hybrid			2022-12-26	WOS:000453537300022
J	El Jellas, K; Johansson, BB; Fjeld, K; Antonopoulos, A; Immervoll, H; Choi, MH; Hoem, D; Lowe, ME; Lombardo, D; Njolstad, PR; Dell, A; Mas, E; Haslam, SM; Molven, A				El Jellas, Khadija; Johansson, Bente B.; Fjeld, Karianne; Antonopoulos, Aristotelis; Immervoll, Heike; Choi, Man H.; Hoem, Dag; Lowe, Mark E.; Lombardo, Dominique; Njolstad, Pal R.; Dell, Anne; Mas, Eric; Haslam, Stuart M.; Molven, Anders			The mucinous domain of pancreatic carboxyl-ester lipase (CEL) contains core 1/core 2 O-glycans that can be modified by ABO blood group determinants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreas; pancreatic cancer; glycomics; pathology; immunohistochemistry; lipase; glycoprotein; ABO blood group; carboxyl-ester lipase; O-glycans; Tn antigen; CEL; BSDL	SALT-STIMULATED LIPASE; N-LINKED OLIGOSACCHARIDES; GENOME-WIDE ASSOCIATION; ACTIVATED LIPASE; GENETIC-VARIANTS; SECRETOR STATUS; RISK-FACTORS; GLYCOSYLATION; PROTEIN; MILK	Carboxyl-ester lipase (CEL) is a pancreatic fat-digesting enzyme associated with human disease. Rare mutations in the CEL gene cause a syndrome of pancreatic exocrine and endocrine dysfunction denoted MODY8, whereas a recombined CEL allele increases the risk for chronic pancreatitis. Moreover, CEL has been linked to pancreatic ductal adenocarcinoma (PDAC) through a postulated oncofetal CEL variant termed feto-acinar pancreatic protein (FAPP). The monoclonal antibody mAb16D10 was previously reported to detect a glycotope in the highly O-glycosylated, mucin-like C terminus of CEL/FAPP. We here assessed the expression of human CEL in malignant pancreatic lesions and cell lines. CEL was not detectably expressed in neoplastic cells, implying that FAPP is unlikely to be a glycoisoform of CEL in pancreatic cancer. Testing of the mAb16D10 antibody in glycan microarrays then demonstrated that it recognized structures containing terminal GalNAc-1,3(Fuc-1,2)Gal (blood group A antigen) and also repeated protein sequences containing GalNAc residues linked to Ser/Thr (Tn antigen), findings that were supported by immunostainings of human pancreatic tissue. To examine whether the CEL glycoprotein might be modified by blood group antigens, we used high-sensitivity MALDI-TOF MS to characterize the released O-glycan pool of CEL immunoprecipitated from human pancreatic juice. We found that the O-glycome of CEL consisted mainly of core 1/core 2 structures with a composition depending on the subject's FUT2 and ABO gene polymorphisms. Thus, among digestive enzymes secreted by the pancreas, CEL is a glycoprotein with some unique characteristics, supporting the view that it could serve additional biological functions to its cholesteryl esterase activity in the duodenum.	[El Jellas, Khadija; Immervoll, Heike; Choi, Man H.; Molven, Anders] Univ Bergen, Dept Clin Med, Gade Lab Pathol, N-5020 Bergen, Norway; [El Jellas, Khadija; Choi, Man H.; Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [El Jellas, Khadija; Johansson, Bente B.; Fjeld, Karianne; Njolstad, Pal R.; Molven, Anders] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Diabet Res, N-5020 Bergen, Norway; [Johansson, Bente B.; Njolstad, Pal R.] Haukeland Hosp, Dept Pediat & Adolescent Med, N-5021 Bergen, Norway; [Fjeld, Karianne] Haukeland Hosp, Ctr Med Genet, N-5021 Bergen, Norway; [Antonopoulos, Aristotelis; Dell, Anne; Haslam, Stuart M.] Imperial Coll London, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England; [Immervoll, Heike] Alesund Hosp, Dept Pathol, N-6017 Alesund, Norway; [Hoem, Dag] Haukeland Hosp, Dept Gastrointestinal Surg, N-5021 Bergen, Norway; [Lowe, Mark E.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Lombardo, Dominique; Mas, Eric] Aix Marseille Univ, INSERM, Ctr Res Biol Oncol & Oncopharmacol, CRO2, F-13284 Marseille 07, France	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Imperial College London; University of Bergen; Haukeland University Hospital; Washington University (WUSTL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Molven, A (corresponding author), Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway.	anders.molven@uib.no	Mas, Eric/O-9569-2017; Mas, Eric/AAC-9837-2022; Fjeld, Karianne/Q-7122-2018; Johansson, Bente Berg/AAE-7666-2022	Mas, Eric/0000-0002-8925-9195; Fjeld, Karianne/0000-0003-0441-1475; Antonopoulos, Aristotelis/0000-0002-1592-4092; Choi, Man Hung/0000-0001-6204-1690	Western Norway Regional Health Authority (Helse Vest) [911831, 912057]; Stiftelsen Kristian Gerhard Jebsen; Research Council of Norway's FRIMEDBIO Program; Biotechnology and Biological Sciences Research Council [BB/K016164/1]; BBSRC [BB/K016164/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097241, U01DK108334] Funding Source: NIH RePORTER	Western Norway Regional Health Authority (Helse Vest); Stiftelsen Kristian Gerhard Jebsen; Research Council of Norway's FRIMEDBIO Program(Research Council of Norway); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Ph.D. fellowship 911831 (to K. E. J.) and Research Grant 912057 (to A. M.) from Western Norway Regional Health Authority (Helse Vest). The work was also supported by grants from the Gade Legacy (to K. E. J.), Stiftelsen Kristian Gerhard Jebsen (to P. R. N.), Research Council of Norway's FRIMEDBIO Program (to A. M.), and by Biotechnology and Biological Sciences Research Council Grant BB/K016164/1 (to A. D. and S. M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	ALBERS GHR, 1990, AM J CLIN PATHOL, V93, P14, DOI 10.1093/ajcp/93.1.14; ALBERS GHR, 1987, DIFFERENTIATION, V34, P210, DOI 10.1111/j.1432-0436.1987.tb00068.x; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; BABA T, 1991, BIOCHEMISTRY-US, V30, P500, DOI 10.1021/bi00216a028; Benkoel L, 2009, MOL CANCER THER, V8, P282, DOI 10.1158/1535-7163.MCT-08-0471; Bergstrom KSB, 2013, GLYCOBIOLOGY, V23, P1026, DOI 10.1093/glycob/cwt045; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen JCH, 1998, BIOCHEMISTRY-US, V37, P5107, DOI 10.1021/bi972989g; Childs EJ, 2015, NAT GENET, V47, P911, DOI 10.1038/ng.3341; Crescence L, 2012, J IMMUNOL, V189, P3386, DOI 10.4049/jimmunol.1102647; Dalva M, 2017, PANCREATOLOGY, V17, P83, DOI 10.1016/j.pan.2016.10.006; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; DOWNS D, 1994, BIOCHEMISTRY-US, V33, P7979, DOI 10.1021/bi00192a001; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; El Jellas K, 2017, CANCER MED-US, V6, P1531, DOI 10.1002/cam4.1097; ESCRIBANO MJ, 1985, BRIT J CANCER, V51, P187, DOI 10.1038/bjc.1985.28; ESCRIBANO MJ, 1986, INT J CANCER, V38, P155, DOI 10.1002/ijc.2910380202; Fjeld K, 2015, NAT GENET, V47, P518, DOI 10.1038/ng.3249; Greer JB, 2011, PANCREAS, V40, P1188, DOI 10.1097/MPA.0b013e3182232975; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; HANSSON L, 1993, J BIOL CHEM, V268, P26692; HERNELL O, 1994, J PEDIATR-US, V125, pS56, DOI 10.1016/S0022-3476(06)80737-7; Hofmann BT, 2014, CLIN CANCER RES, V20, P6117, DOI 10.1158/1078-0432.CCR-14-0716; Holmes RS, 2011, CHOLESTEROL, DOI 10.1155/2011/781643; Johansson BB, 2018, PANCREATOLOGY, V18, P12, DOI 10.1016/j.pan.2017.12.001; Johansson BB, 2011, J BIOL CHEM, V286, P34593, DOI 10.1074/jbc.M111.222679; Ju TZ, 2013, PROTEOM CLIN APPL, V7, P618, DOI 10.1002/prca.201300024; Kirsten H, 2016, GUT, V65, P184, DOI 10.1136/gutjnl-2015-309521; Kodvawala A, 2005, J BIOL CHEM, V280, P38592, DOI 10.1074/jbc.M502266200; Landberg E, 1997, ARCH BIOCHEM BIOPHYS, V344, P94, DOI 10.1006/abbi.1997.0188; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; LOMBARDO D, 1978, BIOCHIM BIOPHYS ACTA, V527, P142, DOI 10.1016/0005-2744(78)90263-2; Loomes KM, 1999, EUR J BIOCHEM, V266, P105, DOI 10.1046/j.1432-1327.1999.00824.x; Makivuokko H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-94; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Martinez E, 2017, ONCOTARGET, V8, P536, DOI 10.18632/oncotarget.11777; MAS E, 1993, BIOCHEM J, V289, P609, DOI 10.1042/bj2890609; MAS E, 1993, EUR J BIOCHEM, V216, P807, DOI 10.1111/j.1432-1033.1993.tb18201.x; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mechref Y, 1999, GLYCOBIOLOGY, V9, P227, DOI 10.1093/glycob/9.3.227; Molven A, 2016, GASTROENTEROLOGY, V150, P1515, DOI 10.1053/j.gastro.2016.04.019; Panicot-Dubois L, 2004, NEOPLASIA, V6, P713, DOI 10.1593/neo.04298; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Ragvin A, 2013, PANCREATOLOGY, V13, P29, DOI 10.1016/j.pan.2012.12.059; Reuss R, 2006, INT J ONCOL, V29, P649; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rossez Y, 2012, GLYCOBIOLOGY, V22, P1193, DOI 10.1093/glycob/cws072; Ruvoen-Clouet N, 2006, BIOCHEM J, V393, P627, DOI 10.1042/BJ20050898; Shindo K, 2017, ONCOTARGET, V8, P50824, DOI 10.18632/oncotarget.15137; SPRINGER GF, 1995, CANCER DETECT PREV, V19, P173; Stanley P, 2017, ESSENTIALS GLYCOBIOL, P161, DOI DOI 10.1101/GLYCOBIOLOGY.3E.014; Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438; SUGO T, 1993, EUR J BIOCHEM, V216, P799, DOI 10.1111/j.1432-1033.1993.tb18200.x; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Torsvik J, 2014, J BIOL CHEM, V289, P29097, DOI 10.1074/jbc.M114.574244; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; WANG CS, 1995, BIOCHEMISTRY-US, V34, P10639, DOI 10.1021/bi00033a039; Weiss FU, 2016, GUT, V65, P353, DOI 10.1136/gutjnl-2015-309682; Weiss FU, 2015, GUT, V64, P646, DOI 10.1136/gutjnl-2014-306930; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; Wolpin BM, 2014, NAT GENET, V46, P994, DOI 10.1038/ng.3052; Wolpin BM, 2010, CANCER EPIDEM BIOMAR, V19, P3140, DOI 10.1158/1055-9965.EPI-10-0751; Xiao XJ, 2016, J BIOL CHEM, V291, P23224, DOI 10.1074/jbc.M116.734384	66	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19476	19491		10.1074/jbc.RA118.001934	http://dx.doi.org/10.1074/jbc.RA118.001934			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30315106	Green Published, hybrid			2022-12-26	WOS:000453537300027
J	Amos, RA; Pattathil, S; Yang, JY; Atmodjo, MA; Urbanowicz, BR; Moremen, KW; Mohnen, D				Amos, Robert A.; Pattathil, Sivakumar; Yang, Jeong-Yeh; Atmodjo, Melani A.; Urbanowicz, Breeanna R.; Moremen, Kelley W.; Mohnen, Debra			A two-phase model for the non-processive biosynthesis of homogalacturonan polysaccharides by the GAUT1:GAUT7 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS SEROGROUP; CELL-WALL; FUNCTIONAL IDENTIFICATION; ARABIDOPSIS-THALIANA; POLYGALACTURONATE 4-ALPHA-GALACTURONOSYLTRANSFERASE; SUCCESSIVE GLYCOSYLTRANSFER; PECTIN BIOSYNTHESIS; HEPAROSAN SYNTHASE; CAPSULE POLYMERASE; GALACTURONIC ACID	Homogalacturonan (HG) is a pectic glycan in the plant cell wall that contributes to plant growth and development and cell wall structure and function, and interacts with other glycans and proteoglycans in the wall. HGis synthesized by the galacturonosyltransferase (GAUT) gene family. Two members of this family, GAUT1 and GAUT7, form a heteromeric enzyme complex in Arabidopsis thaliana. Here, we established a heterologous GAUT expression system in HEK293 cells and show that coexpression of recombinant GAUT1 with GAUT7 results in the production of a soluble GAUT1:GAUT7 complex that catalyzes elongation of HG products in vitro. The reaction rates, progress curves, and product distributions exhibited major differences dependent upon small changes in the degree of polymerization (DP) of the oligosaccharide acceptor. GAUT1:GAUT7 displayed >45-fold increased catalytic efficiency with DP11 acceptors relative to DP7 acceptors. Although GAUT1:GAUT7 synthesized high-molecular-weight polymeric HG (>100 kDa) in a substrate concentration-dependent manner typical of distributive (nonprocessive) glycosyltransferases with DP11 acceptors, reactions primed with short-chain acceptors resulted in a bimodal product distribution of glycan products that has previously been reported as evidence for a processive model of GT elongation. As an alternative to the processive glycosyltransfer model, a two-phase distributive elongation model is proposed in which a slow phase, which includes the de novo initiation of HG and elongation of short-chain acceptors, is distinguished from a phase of rapid elongation of intermediate- and long-chain acceptors. Upon reaching a critical chain length of DP11, GAUT1:GAUT7 elongates HG to high-molecular-weight products.	[Amos, Robert A.; Pattathil, Sivakumar; Yang, Jeong-Yeh; Atmodjo, Melani A.; Urbanowicz, Breeanna R.; Moremen, Kelley W.; Mohnen, Debra] Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA; [Amos, Robert A.; Atmodjo, Melani A.; Moremen, Kelley W.; Mohnen, Debra] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Pattathil, Sivakumar] Mascoma LLC, Lallemand Inc, 67 Etna Rd 200, Lebanon, NH 03766 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Mascoma Corporation	Mohnen, D (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	dmohnen@ccrc.uga.edu	Moremen, Kelley/AAD-4661-2019	Mohnen, Debra/0000-0001-5249-635X; , Breeanna/0000-0001-5247-4513	Office of Biological and Environmental Research in the Department of Energy's Office of Science; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-12ER16324]; National Science Foundation [DBI-0421683, RCN 009281]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM107012, P41GM103390] Funding Source: NIH RePORTER	Office of Biological and Environmental Research in the Department of Energy's Office of Science; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. A. Wood for technical support and guidance with enzyme kinetics experiments, M. G. Hahn for providing monoclonal antibodies, M. A. O'Neill for technical support, and the members of the Mohnen laboratory, including L. Tan, A. K Biswal, and K. A. Engle, for training and helpful research discussions. The BioEnergy Science Center and the Center for Bioenergy Innovation are United States Department of Energy Bioenergy Research Centers supported by the Office of Biological and Environmental Research in the Department of Energy's Office of Science. We also acknowledge the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy through Grant DE-FG02-12ER16324 for funding structural studies of pectin. Generation of the CCRC series of monoclonal antibodies used in this work was supported by National Science Foundation Plant Genome Program Grant DBI-0421683. Distribution of JIM antibodies used in this work was supported in part by National Science Foundation Grants DBI-0421683 and RCN 009281.	Akita K, 2002, PLANT PHYSIOL, V130, P374, DOI 10.1104/pp.005587; Atmodjo MA, 2013, ANNU REV PLANT BIOL, V64, P747, DOI 10.1146/annurev-arplant-042811-105534; Atmodjo MA, 2011, P NATL ACAD SCI USA, V108, P20225, DOI 10.1073/pnas.1112816108; Bambara RA, 1995, METHOD ENZYMOL, V262, P270; Basu D, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0670-7; Basu D, 2013, J BIOL CHEM, V288, P10132, DOI 10.1074/jbc.M112.432609; Benen JAE, 1999, EUR J BIOCHEM, V259, P577, DOI 10.1046/j.1432-1327.1999.00080.x; Biswal AK, 2018, NAT BIOTECHNOL, V36, P249, DOI 10.1038/nbt.4067; Biswal AK, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-017-1002-y; Biswal AK, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0218-y; Bloom L, 2001, MONOGR SOC RES CHILD, V66, pVII, DOI 10.1111/1540-5834.00162; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Chaikuad A, 2011, P NATL ACAD SCI USA, V108, P21028, DOI 10.1073/pnas.1113921108; Chavaroche AAE, 2010, APPL MICROBIOL BIOT, V85, P1881, DOI 10.1007/s00253-009-2214-2; Chiniquy D, 2012, P NATL ACAD SCI USA, V109, P17117, DOI 10.1073/pnas.1202079109; Chung D, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0147-1; Cornish-Bowden A., 2012, FUNDAMENTALS ENZYME, P210; Cosgrove DJ, 2016, F1000RESEARCH, V5, pF1000, DOI [10.12688/f1000research.7180.1, DOI 10.12688/F1000]; Culbertson A. T, 2015, JSM ENZYMOL PROTEIN, V1, P1004; Culbertson AT, 2016, PLANT PHYSIOL, V171, P1893, DOI 10.1104/pp.16.00361; Davis J, 2010, PLANT J, V64, P1028, DOI 10.1111/j.1365-313X.2010.04392.x; DeAngelis PL, 2002, J BIOL CHEM, V277, P7209, DOI 10.1074/jbc.M112130200; Dick-Perez M, 2011, BIOCHEMISTRY-US, V50, P989, DOI 10.1021/bi101795q; Dilokpimol A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-90; DOONG RL, 1995, PLANT PHYSIOL, V109, P141, DOI 10.1104/pp.109.1.141; Doong RL, 1998, PLANT J, V13, P363, DOI 10.1046/j.1365-313X.1998.00042.x; Fiebig T, 2018, J BIOL CHEM, V293, P953, DOI 10.1074/jbc.RA117.000488; Fiebig T, 2014, J BIOL CHEM, V289, P19395, DOI 10.1074/jbc.M114.575142; Fiebig T, 2014, GLYCOBIOLOGY, V24, P150, DOI 10.1093/glycob/cwt102; Forsee WT, 2006, J BIOL CHEM, V281, P6283, DOI 10.1074/jbc.M511124200; Geshi N, 2013, PLANT J, V76, P128, DOI 10.1111/tpj.12281; Gibbons BJ, 2002, J MOL BIOL, V319, P463, DOI 10.1016/S0022-2836(02)00305-4; Halmo SM, 2017, J BIOL CHEM, V292, P2101, DOI 10.1074/jbc.M116.764712; Ishii T, 2002, PLANT CELL PHYSIOL, V43, P1386, DOI 10.1093/pcp/pcf150; Jacobs A, 2001, ANAL CHEM, V73, P405, DOI 10.1021/ac001222i; Jiang N, 2016, PLANT PHYSIOL, V170, P1999, DOI 10.1104/pp.15.01777; Kellokumpu S, 2016, CELL MOL LIFE SCI, V73, P305, DOI 10.1007/s00018-015-2066-0; Keys TG, 2014, NAT CHEM BIOL, V10, P437, DOI 10.1038/nchembio.1501; Knoch E, 2013, PLANT J, V76, P1016, DOI 10.1111/tpj.12353; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laursen T, 2018, PLANT J, V94, P340, DOI 10.1111/tpj.13860; Lee C, 2012, PLANT CELL PHYSIOL, V53, P1204, DOI 10.1093/pcp/pcs064; Levengood MR, 2011, J AM CHEM SOC, V133, P12758, DOI 10.1021/ja204448t; LILJEBJELKE K, 1995, ANAL BIOCHEM, V225, P296, DOI 10.1006/abio.1995.1158; Lionetti V, 2010, P NATL ACAD SCI USA, V107, P616, DOI 10.1073/pnas.0907549107; Litschko C, 2015, J BIOL CHEM, V290, P24355, DOI 10.1074/jbc.M115.678094; Liwanag AJM, 2012, PLANT CELL, V24, P5024, DOI 10.1105/tpc.112.106625; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Ly HD, 2002, BIOCHEMISTRY-US, V41, P5075, DOI 10.1021/bi012031s; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Moremen KW, 2018, NAT CHEM BIOL, V14, P156, DOI [10.1038/NCHEMBIO.2539, 10.1038/nchembio.2539]; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; MORT AJ, 1991, CARBOHYD RES, V215, P219, DOI 10.1016/0008-6215(91)84022-7; NARDONE G, 1986, J BIOL CHEM, V261, P2128; Ogawa-Ohnishi M, 2015, PLANT J, V81, P736, DOI 10.1111/tpj.12764; Oikawa A, 2013, TRENDS PLANT SCI, V18, P49, DOI 10.1016/j.tplants.2012.07.002; Pattathil Sivakumar, 2012, Methods Mol Biol, V908, P61, DOI 10.1007/978-1-61779-956-3_6; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Pauly M, 2016, ANNU REV PLANT BIOL, V67, P235, DOI 10.1146/annurev-arplant-043015-112222; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Petersen BL, 2009, GLYCOCONJUGATE J, V26, P1235, DOI 10.1007/s10719-009-9242-0; Piszkiewicz D, 1977, KINETICS CHEM ENZYME, P97; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03943; Raga-Carbajal E, 2016, GLYCOBIOLOGY, V26, P377, DOI 10.1093/glycob/cwv112; Rennie EA, 2012, PLANT PHYSIOL, V159, P1408, DOI 10.1104/pp.112.200964; Scheller HV, 1999, PLANTA, V207, P512, DOI 10.1007/s004250050511; Sheikh MO, 2017, GLYCOBIOLOGY, V27, P206, DOI 10.1093/glycob/cww114; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; Sterling JD, 2005, ANAL BIOCHEM, V343, P231, DOI 10.1016/j.ab.2005.05.037; Subedi GP, 2015, JOVE-J VIS EXP, DOI 10.3791/53568; Tan L, 2013, PLANT CELL, V25, P270, DOI 10.1105/tpc.112.107334; Urbanowicz BR, 2017, PLANT J, V91, P931, DOI 10.1111/tpj.13628; Urbanowicz BR, 2014, PLANT J, V80, P197, DOI 10.1111/tpj.12643; Vionnet J, 2007, GLYCOBIOLOGY, V17, P735, DOI 10.1093/glycob/cwm032; Voxeur A, 2016, GLYCOBIOLOGY, V26, P950, DOI 10.1093/glycob/cww029; Vuttipongchaikij S, 2012, NEW PHYTOL, V195, P585, DOI 10.1111/j.1469-8137.2012.04196.x; Wang T, 2016, J EXP BOT, V67, P503, DOI 10.1093/jxb/erv416; Wang T, 2012, BIOCHEMISTRY-US, V51, P9846, DOI 10.1021/bi3015532; Weigel PH, 2017, GLYCOBIOLOGY, V27, P536, DOI 10.1093/glycob/cwx012; Weigel PH, 2015, GLYCOBIOLOGY, V25, P632, DOI 10.1093/glycob/cwv006; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715; Yasui K, 2009, PECTINS AND PECTINASES, P167; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; Zeng W, 2016, PLANT PHYSIOL, V171, P93, DOI 10.1104/pp.15.01919	85	24	24	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19047	19063		10.1074/jbc.RA118.004463	http://dx.doi.org/10.1074/jbc.RA118.004463			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30327429	hybrid, Green Published			2022-12-26	WOS:000458467400019
J	Hua, YW; Bi, RY; Zhang, Y; Xu, LC; Guo, JY; Li, YF				Hua, Yunwei; Bi, Ruiye; Zhang, Yue; Xu, Luchen; Guo, Jiaoyang; Li, Yunfeng			Different bone sites-specific response to diabetes rat models: Bone density, histology and microarchitecture	PLOS ONE			English	Article							IMPLANT OSSEOINTEGRATION; ALVEOLAR BONE; MELLITUS; OVARIECTOMY; FRACTURE; INSULIN; CELLS; HEALTH; RISK; MASS	Background and purpose Diabetes mellitus (DM) is the most common metabolic disorder that is characterized by hyperglycemia, it can be categorized by T1DM and T2DM. T1 DM is also reported to cause bone loss. However, most reports regarding this aspect of T1 DM have only investigated a single site; a comparison of bone loss from different areas of the body is still lacking. Methods Thirty-five 12-week-old Sprague Dawley (R) (SD) rats were separated to seven groups. Five rats were euthanized without any surgery at 0 weeks for histological examination and determination of baseline characteristics. In 15 of the rats, DM was induced via Streptozotocin (STZ)-injection, and they were separated to 3 groups (4 weeks, 8 weeks and 12 weeks after STZ-injection). The remaining 15 rats were used as the control group (4 weeks, 8 weeks and 12 weeks after saline-injection). We tested bone-mass loss at four skeletal sites, the tibia, the femur greater trochanter, the spine, and the mandibular bones using micro-computed tomography (CT) and histological tests. Results Tibia was influenced the most obvious(BV/TV decreased by 27.3%, 52.5%, and 81.2% at 4 weeks, 8 weeks, and 12 weeks, respectively. p<0.05). In contrast, the other three sites were influenced to a lesser extent and bone loss became prominent at a later time point according to the histological and micro-CT tests(Femur: BV/TV did not decrease significantly at the first month or second month. However, and decreased by 49.4% at the third month, P<0.05. Mandible: the BV/TV only decreased by 6.5% at 1 month after STZ-injection. There was still a significant difference between the second and third months. The BV/TV decreased by 47.0% and 68.1% at 2 months and 3 months, respectively, (p<0.05) Spine: the BV/TV only decreased by 6.7%. However, significant change was observed in the spine at the second month and third month after STZ injection. The BV/TV decreased by 45.4% and 64.3%, respectively, p<0.05). Conclusion The results indicate that T1 DM can severely influence the bone structure of the 4 skeletal sites. Further, areas with dense trabecular bones were influenced less and at a later time point in comparison to the tibial region.	[Hua, Yunwei; Bi, Ruiye; Zhang, Yue; Xu, Luchen; Guo, Jiaoyang; Li, Yunfeng] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China	Sichuan University	Li, YF (corresponding author), Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.	doctorlyf@163.com		Li, Yunfeng/0000-0003-2659-8074	National Natural Science Foundation of China [81300858]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the grant of National Natural Science Foundation of China (81300858 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaloo TL, 2010, J DENT RES, V89, P1293, DOI 10.1177/0022034510378427; Al-Hariri M., 2016, DIABETES RES, V2016; Andrade-Cetto A, 2005, J ETHNOPHARMACOL, V100, P319, DOI 10.1016/j.jep.2005.03.021; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bozkurt O, 2016, APPL SPECTROSC, V70, P2005, DOI 10.1177/0003702816671059; Burghardt AJ, 2010, J CLIN ENDOCR METAB, V95, P5045, DOI 10.1210/jc.2010-0226; Chan JCN, 2014, LANCET DIABETES ENDO, V2, P969, DOI 10.1016/S2213-8587(14)70144-5; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Epstein S, 2016, OSTEOPOROSIS INT, V27, P1931, DOI 10.1007/s00198-015-3454-x; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hasegawa H, 2008, INT J ORAL MAX IMPL, V23, P237; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Janghorbani M, 2006, DIABETES CARE, V29, P1573, DOI 10.2337/dc06-0440; Jee W. S. S., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P193; Jiao HL, 2015, CURR OSTEOPOROS REP, V13, P327, DOI 10.1007/s11914-015-0286-8; Tolosa MJ, 2013, DIABETES RES CLIN PR, V101, P177, DOI 10.1016/j.diabres.2013.05.016; Kume S, 2005, J BONE MINER RES, V20, P1647, DOI 10.1359/JBMR.050514; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Liu CT, 2018, J BONE MINER RES, V33, P1851, DOI 10.1002/jbmr.3472; Liu XL, 2015, CLIN ORAL IMPLAN RES, V26, P392, DOI 10.1111/clr.12360; Mavropoulos A, 2014, J BIOMECH, V47, P2666, DOI 10.1016/j.jbiomech.2014.05.012; McCarthy AD, 2004, INT J BIOCHEM CELL B, V36, P840, DOI 10.1016/j.biocel.2003.09.006; Moayeri A, 2017, THER CLIN RISK MANAG, V13, DOI 10.2147/TCRM.S131945; Napoli N, 2017, NAT REV ENDOCRINOL, V13, P208, DOI 10.1038/nrendo.2016.153; Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0; Piscitelli P, 2015, CURR OPIN ENDOCRINOL, V22, P439, DOI 10.1097/MED.0000000000000203; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schwartz AV, 2005, J BONE MINER RES, V20, P596, DOI 10.1359/JBMR.041219; Shanbhogue VV, 2015, J BONE MINER RES, V30, P2188, DOI 10.1002/jbmr.2573; Suzuki K, 2003, BONE, V33, P108, DOI 10.1016/S8756-3282(03)00169-8; Tanaka M, 2002, J PERIODONTAL RES, V37, P161, DOI 10.1034/j.1600-0765.2002.01601.x; Tanaka M, 2003, ORAL SURG ORAL MED O, V95, P495, DOI 10.1067/moe.2003.135; Tsiridis E, 2007, INJURY, V38, P704, DOI 10.1016/j.injury.2007.02.051; Verroken C, 2017, J CLIN ENDOCR METAB, V102, P2887, DOI 10.1210/jc.2017-00620; Wu YY, 2013, BONE, V52, P1, DOI 10.1016/j.bone.2012.09.005	35	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205503	10.1371/journal.pone.0205503	http://dx.doi.org/10.1371/journal.pone.0205503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346963	gold, Green Published, Green Submitted			2022-12-26	WOS:000447938400010
J	Ma, ZY; Wang, P; Gao, ZH; Wang, RB; Khalighi, K				Ma, Zhiyuan; Wang, Ping; Gao, Zehui; Wang, Ruobing; Khalighi, Koroush			Ensemble of machine learning algorithms using the stacked generalization approach to estimate the warfarin dose	PLOS ONE			English	Article							VKORC1; PHARMACOGENETICS; PREDICT; CYP2C9; POLYMORPHISM; RESISTANCE; GENOTYPES	Warfarin dosing remains challenging due to narrow therapeutic index and highly individual variability. Incorrect warfarin dosing is associated with devastating adverse events. Remarkable efforts have been made to develop the machine learning based warfarin dosing algorithms incorporating clinical factors and genetic variants such as polymorphisms in CYP2C9 and VKORC1. The most widely validated pharmacogenetic algorithm is the IWPC algorithm based on multivariate linear regression (MLR). However, with only a single algorithm, the prediction performance may reach an upper limit even with optimal parameters. Here, we present novel algorithms using stacked generalization frameworks to estimate the warfarin dose, within which different types of machine learning algorithms function together through a meta-machine learning model to maximize the prediction accuracy. Compared to the IWPC-derived MLR algorithm, Stack 1 and 2 based on stacked generalization frameworks performed significantly better overall. Subgroup analysis revealed that the mean of the percentage of patients whose predicted dose of warfarin within 20% of the actual stable therapeutic dose (mean percentage within 20%) for Stack 1 was improved by 12.7% (from 42.47% to 47.86%) in Asians and by 13.5% (from 22.08% to 25.05%) in the low-dose group compared to that for MLR, respectively. These data suggest that our algorithms would especially benefit patients requiring low warfarin maintenance dose, as subtle changes in warfarin dose could lead to adverse clinical events (thrombosis or bleeding) in patients with low dose. Our study offers novel pharmacogenetic algorithms for clinical trials and practice.	[Ma, Zhiyuan; Wang, Ping; Khalighi, Koroush] Easton Cardiovasc Associates, Easton, PA 18042 USA; [Ma, Zhiyuan] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Gao, Zehui] San Diego State Univ, Dept Math & Stat, La Mesa, CA USA; [Wang, Ruobing] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Wang, Ruobing] Duke Univ, Social Sci Res Inst, Durham, NC 27708 USA; [Wang, Ruobing] Sci Ctr Opera Solut LLC, San Diego, CA 92101 USA; [Khalighi, Koroush] Easton Hosp, Dept Med, Div Cardiol, Easton, PA 18042 USA; [Khalighi, Koroush] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Duke University; California State University System; San Diego State University; Duke University; Duke University; Drexel University	Ma, ZY; Khalighi, K (corresponding author), Easton Cardiovasc Associates, Easton, PA 18042 USA.; Ma, ZY (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA.; Wang, RB (corresponding author), Duke Univ, Dept Chem, Durham, NC 27706 USA.; Wang, RB (corresponding author), Duke Univ, Social Sci Res Inst, Durham, NC 27708 USA.; Wang, RB (corresponding author), Sci Ctr Opera Solut LLC, San Diego, CA 92101 USA.; Khalighi, K (corresponding author), Easton Hosp, Dept Med, Div Cardiol, Easton, PA 18042 USA.; Khalighi, K (corresponding author), Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.	zhiyuan.ma@duke.edu; ruobing.wang@duke.edu; koroushkhalighi@gmail.com	Ma, ZhiYuan/GWN-1061-2022; Ma, Zhiyuan/I-6678-2015	Ma, Zhiyuan/0000-0002-0381-7804	Science Center of Opera Solutions LLC	Science Center of Opera Solutions LLC	The funder Science Center of Opera Solutions LLC provided support in the form of salaries for the author [R.W.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Breiman L, 1996, MACH LEARN, V24, P49; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Gage BF, 2017, JAMA-J AM MED ASSOC, V318, P1115, DOI 10.1001/jama.2017.11469; Grossi E, 2014, PHARMACOGENOMICS, V15, P29, DOI 10.2217/pgs.13.212; Hu YH, 2012, ARTIF INTELL MED, V56, P27, DOI 10.1016/j.artmed.2012.04.001; Joffe HV, 2004, THROMB HAEMOSTASIS, V91, P1123, DOI 10.1160/TH04-02-0083; Johnson JA, 2012, CIRCULATION, V125, P1964, DOI 10.1161/CIRCULATIONAHA.112.100628; Ke Guolin, 2017, ADV NEURAL INFORM PR, P3146; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Liu K, 2013, METHOD INFORM MED, V52, P308, DOI 10.3414/ME12-01-0029; Liu R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135784; Ma Z, 2018, CLIN MODEL PRE UNPUB; Martin B, 2010, LECT NOTES ARTIF INT, V6304, P151, DOI 10.1007/978-3-642-15431-7_16; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Schalekamp T, 2006, CLIN PHARMACOL THER, V80, P13, DOI 10.1016/j.clpt.2006.04.006; Scott SA, 2008, AM J HUM GENET, V82, P495, DOI 10.1016/j.ajhg.2007.10.002; Shaw K, 2015, THER DRUG MONIT, V37, P428, DOI 10.1097/FTD.0000000000000192; Tao YY, 2019, IEEE J BIOMED HEALTH, V23, P395, DOI 10.1109/JBHI.2018.2812165; Ting KM, 1997, INT JOINT CONF ARTIF, P866; Wang RB, 2018, J PHYS CHEM C, V122, P8868, DOI 10.1021/acs.jpcc.8b03405; Wang SQ, 2006, J THEOR BIOL, V242, P941, DOI 10.1016/j.jtbi.2006.05.006; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1	29	44	45	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205872	10.1371/journal.pone.0205872	http://dx.doi.org/10.1371/journal.pone.0205872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339708	Green Published, gold, Green Submitted			2022-12-26	WOS:000447761400022
J	Duffy, S; Pearce, M				Duffy, Sam; Pearce, Marcus			What makes rhythms hard to perform? An investigation using Steve Reich's Clapping Music	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; BEAT PERCEPTION; BIG DATA; REVOLUTION; LISTENERS; LANGUAGE; SUPPORT; FRENCH	Clapping Music is a minimalist work by Steve Reich based on twelve phased variations of a rhythmic pattern. It has been reimagined as a game-based mobile application, designed with a dual purpose. First, to introduce new audiences to the Minimalist genre through interaction with the piece presented as an engaging game. Second, to use large-scale data collection within the app to address research questions about the factors determining rhythm production performance. The twelve patterns can be differentiated using existing theories of rhythmic complexity. Using performance indicators from the game such as tap accuracy we can determine which patterns players found most challenging and so assess hypotheses from theoretical models with empirical evidence. The app has been downloaded over 140,000 times since the launch in July 2015, and over 46 million rows of gameplay data have been collected, requiring a big data approach to analysis. The results shed light on the rhythmic factors contributing to performance difficulty and show that the effect of making a transition from one pattern to the next is as significant, in terms of pattern difficulty, as the inherent complexity of the pattern itself. Challenges that arose in applying this novel approach are discussed.	[Duffy, Sam; Pearce, Marcus] Queen Mary Univ London, Mus Cognit Lab, London, England	University of London; Queen Mary University London	Duffy, S; Pearce, M (corresponding author), Queen Mary Univ London, Mus Cognit Lab, London, England.	s.duffy@qmul.ac.uk; marcus.pearce@qmul.ac.uk		Pearce, Marcus/0000-0002-1282-431X	Digital R&D Fund for the Arts; Nesta; Arts Council England; Arts and Humanities Research Council (AHRC); London Sinfonietta and Touchpress; Engineering and Physical Sciences Research Council (EPSRC) [EP/K009559/1]; QMUL Research-IT; EPSRC [EP/K000128/1]	Digital R&D Fund for the Arts(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Nesta; Arts Council England(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council (AHRC)(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); London Sinfonietta and Touchpress; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); QMUL Research-IT; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by The Digital R&D Fund for the Arts (https://www.nesta.org.uk/archive-pages/steve-reichs-clapping-music/), a partnership between Nesta, the Arts Council England and the Arts and Humanities Research Council (AHRC) awarded to MP in partnership with The London Sinfonietta and Touchpress. Further data collection, outreach work in schools and analysis was funded by an award from the Engineering and Physical Sciences Research Council (EPSRC) Platform Grant EP/K009559/1 (http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/K009559/1; PI: Mark Sandler; MP is a co-investigator), held at Queen Mary University of London (QMUL). This research utilised QMUL's MidPlus computational facilities, supported by QMUL Research-IT and funded by EPSRC grant EP/K000128/1 (http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/K000128/1).	Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brown HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100662; Burke A, 2015, S REICHS CLAPPING MU; Cameron D., 2017, TIMING TIME PERCEPT, V5, P211, DOI [10.1163/22134468-00002085, DOI 10.1163/22134468-00002085]; Colannino J., 2009, PERSPECT NEW MUSIC, V47, P111; Drake C, 2000, MUSIC PERCEPT, V18, P1; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Griffiths TL, 2015, COGNITION, V135, P21, DOI 10.1016/j.cognition.2014.11.026; Haack J., 1991, COLL MATH J, V22, P224; Haack J., 1998, BRIDGES MATH CONNECT, P87; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; Hannon EE, 2005, PSYCHOL SCI, V16, P48, DOI 10.1111/j.0956-7976.2005.00779.x; Hannon EE, 2012, J EXP PSYCHOL HUMAN, V38, P543, DOI 10.1037/a0027225; Hannon EE, 2009, COGNITION, V111, P403, DOI 10.1016/j.cognition.2009.03.003; Hansen NC, 2016, MUSIC PERCEPT, V33, P414, DOI 10.1525/MP.2016.33.4.414; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Huron D, 2003, MUSIC PERCEPT, V21, P267, DOI 10.1525/mp.2003.21.2.267; Lee C.S., 1991, REPRESENTING MUSICAL, P59; Lerdahl F., 1983, GENERATIVE THEORY TO; London J, 2010, P 11 INT C MUSIC PER, P379; London J., 2012, HEARING TIME; McAdams S., 1979, Computer Music Journal, V3, P26; McAfee A, 2012, HARVARD BUS REV, V90, P60; McGowan RW, 2011, MUSIC PERCEPT, V28, P307, DOI 10.1525/MP.2011.28.3.307; McLachlan N, 2000, LEONARDO MUSIC J, V10, P61, DOI 10.1162/096112100570468; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2003, COGNITION, V87, pB35, DOI 10.1016/S0010-0277(02)00187-7; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Reich S., 1972, CLAPPING MUSIC; Reich Steve, 2002, WRITINGS MUSIC 1965; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Sethares WA, 2015, J NEW MUSIC RES, V44, P11, DOI 10.1080/09298215.2014.935736; Song Y, 2012, 9 INT S COMP MUS MOD, P19; Thaut M H, 2005, RHYTHM MUSIC BRAIN S, V7; Tones DM, 2007, ELEMENTS EWE MUSIC M; Toussaint G., 2002, P BRIDGES MATH CONN, P157; Toussaint GT, 2013, ANAL APPROACHES WORL, V2, P1; Tranchant P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160178; VanHandel L, 2010, J NEW MUSIC RES, V39, P1, DOI 10.1080/09298211003642498	42	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205847	10.1371/journal.pone.0205847	http://dx.doi.org/10.1371/journal.pone.0205847			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4KR	30335798	Green Submitted, Green Published, gold			2022-12-26	WOS:000447701300062
J	Horn, KJ; Thomas, RQ; Clark, CM; Pardo, LH; Fenn, ME; Lawrence, GB; Perakis, SS; Smithwick, EAH; Baldwin, D; Braun, S; Nordin, A; Perry, CH; Phelan, JN; Schaberg, PG; St Clair, SB; Warby, R; Watmough, S				Horn, Kevin J.; Thomas, R. Quinn; Clark, Christopher M.; Pardo, Linda H.; Fenn, Mark E.; Lawrence, Gregory B.; Perakis, Steven S.; Smithwick, Erica A. H.; Baldwin, Douglas; Braun, Sabine; Nordin, Annika; Perry, Charles H.; Phelan, Jennifer N.; Schaberg, Paul G.; St Clair, Samuel B.; Warby, Richard; Watmough, Shaun			Growth and survival relationships of 71 tree species with nitrogen and sulfur deposition across the conterminous U.S	PLOS ONE			English	Article							NORTHEASTERN UNITED-STATES; MANAGEMENT STRATEGIES; DECIDUOUS FORESTS; TEMPERATE FOREST; ECOSYSTEMS; PATTERNS; CLIMATE; LOADS; SOILS	Atmospheric deposition of nitrogen (N) influences forest demographics and carbon (C) uptake through multiple mechanisms that vary among tree species. Prior studies have estimated the effects of atmospheric N deposition on temperate forests by leveraging forest inventory measurements across regional gradients in deposition. However, in the United States (U.S.), these previous studies were limited in the number of species and the spatial scale of analysis, and did not include sulfur (S) deposition as a potential covariate. Here, we present a comprehensive analysis of how tree growth and survival for 71 species vary with N and S deposition across the conterminous U.S. Our analysis of 1,423,455 trees from forest plots inventoried between 2000 and 2016 reveals that the growth and/or survival of the vast majority of species in the analysis (n = 66, or 93%) were significantly affected by atmospheric deposition. Species co-occurred across the conterminous U. S. that had decreasing and increasing relationships between growth (or survival) and N deposition, with just over half of species responding negatively in either growth or survival to increased N deposition somewhere in their range (42 out of 71). Averaged across species and conterminous U.S., however, we found that an increase in deposition above current rates of N deposition would coincide with a small net increase in tree growth (1.7% per Delta kg N ha(-1) yr(-1)), and a small net decrease in tree survival (-0.22% per Delta kg N ha(-1) yr(-1)), with substantial regional and among species variation. Adding S as a predictor improved the overall model performance for 70% of the species in the analysis. Our findings have potential to help inform ecosystem management and air pollution policy across the conterminous U.S., and suggest that N and S deposition have likely altered forest demographics in the U.S.	[Horn, Kevin J.; Thomas, R. Quinn] Virginia Tech, Dept Forest Resources & Environm Conservat, Cheatham Hall, Blacksburg, VA 24060 USA; [Clark, Christopher M.] US EPA, Natl Ctr Environm Assessment, Washington, DC 20460 USA; [Pardo, Linda H.; Schaberg, Paul G.] US Forest Serv, USDA, Northern Res Stn, Burlington, VT USA; [Fenn, Mark E.] US Forest Serv, USDA, Pacific Southwest Res Stn, Riverside, CA USA; [Lawrence, Gregory B.] US Geol Survey, New York Water Sci Ctr, Troy, NY USA; [Perakis, Steven S.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA; [Smithwick, Erica A. H.; Baldwin, Douglas] Penn State Univ, Dept Geog, University Pk, PA 16802 USA; [Braun, Sabine] Inst Appl Plant Biol, Witterswil, Switzerland; [Nordin, Annika] Swedish Univ Agr Sci, Umea Plant Sci Ctr, Umea, Sweden; [Perry, Charles H.] US Forest Serv, USDA, Northern Res Stn, St Paul, MN USA; [Phelan, Jennifer N.] Res Triangle Inst RTI Int, Res Triangle Pk, NC USA; [St Clair, Samuel B.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Warby, Richard] Warby Grp LLC, North Attleboro, MA USA; [Watmough, Shaun] Trent Univ, Trent Sch Environm, Peterborough, ON, Canada	Virginia Polytechnic Institute & State University; United States Environmental Protection Agency; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Swedish University of Agricultural Sciences; Umea University; United States Department of Agriculture (USDA); United States Forest Service; Research Triangle Institute; Brigham Young University; Trent University	Thomas, RQ (corresponding author), Virginia Tech, Dept Forest Resources & Environm Conservat, Cheatham Hall, Blacksburg, VA 24060 USA.	rqthomas@vt.edu	St.Clair, Sam/GZA-4592-2022; Thomas, R Quinn/B-1611-2013	Thomas, R Quinn/0000-0003-1282-7825; Phelan, Jennifer/0000-0002-0931-3447; Pardo, Linda/0000-0001-5590-2683	U.S. Environmental Protection Agency [EP-W-11-029, 4-16]; U.S. Geologic Survey (U.S. Geologic Survey Powell Center Program); National Parks Service [P18AC01685]; Warby Group LLC	U.S. Environmental Protection Agency(United States Environmental Protection Agency); U.S. Geologic Survey (U.S. Geologic Survey Powell Center Program); National Parks Service; Warby Group LLC	Funding for this effort was provided by U.S. Environmental Protection Agency (Contract EP-W-11-029; Work Assignment No. 4-16), U.S. Geologic Survey (U.S. Geologic Survey Powell Center Program), and the National Parks Service (Task Agreement Number P18AC01685). CMC (EPA) and GBL (USGS) contributed to the study design, interpretation now the analysis, decision to publish, and preparation of the manuscript. The Warby Group LLC provided support in the form of salaries for author WB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Adams M. B., 2007, ACID RAIN DEPOSITION, P267; BINKLEY D, 1989, ACIDIC DEPOSITION FO; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Boggs JL, 2005, CAN J FOREST RES, V35, P1901, DOI 10.1139/x05-128; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burns DA, 2011, C 2011 INT ASS; Canham CD, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1701; Clark CM, 2018, ECOL APPL, V28, P978, DOI 10.1002/eap.1703; Crowley KF, 2012, ECOSYSTEMS, V15, P940, DOI 10.1007/s10021-012-9550-2; Dietze MC, 2011, GLOBAL CHANGE BIOL, V17, P3312, DOI 10.1111/j.1365-2486.2011.02477.x; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; Duarte N, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-012-1355-6; Eastaugh CS, 2011, TREE PHYSIOL, V31, P262, DOI 10.1093/treephys/tpr033; Fenn ME, 1998, ECOL APPL, V8, P706, DOI 10.1890/1051-0761(1998)008[0706:NEINAE]2.0.CO;2; Jenkins JC, 2003, FOREST SCI, V49, P12; Lovett GM, 2013, ECOSYSTEMS, V16, P980, DOI 10.1007/s10021-013-9662-3; McNulty SG, 2007, ENVIRON POLLUT, V149, P281, DOI 10.1016/j.envpol.2007.05.025; McRoberts RE, 2005, J FOREST, V103, P304; Morrison EW, 2016, FUNGAL ECOL, V23, P48, DOI 10.1016/j.funeco.2016.05.011; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Olson RK, 1992, RESPONSE W FORESTS A; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; Phillips RP, 2013, NEW PHYTOL, V199, P41, DOI 10.1111/nph.12221; Pukkala T, 2009, FOREST ECOL MANAG, V258, P207, DOI 10.1016/j.foreco.2009.03.052; Schwede D.B., 2014, ATMOS ENVIRON, V92, P207, DOI [DOI 10.1016/j.atmosenv.2014.04.008, 10.1016/j.atmosenv.2014.04.008]; Simkin SM, 2016, P NATL ACAD SCI USA, V113, P4086, DOI 10.1073/pnas.1515241113; Solberg S, 2009, FOREST ECOL MANAG, V258, P1735, DOI 10.1016/j.foreco.2008.09.057; St Clair SB, 2005, PLANT CELL ENVIRON, V28, P874, DOI 10.1111/j.1365-3040.2005.01337.x; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Sutton MA, 2008, GLOBAL CHANGE BIOL, V14, P2057, DOI 10.1111/j.1365-2486.2008.01636.x; Thomas RQ, 2010, NAT GEOSCI, V3, P13, DOI 10.1038/NGEO721; U. S. EPA, 2017, EPA600R16372; Vadeboncoeur MA, 2010, CAN J FOREST RES, V40, P1766, DOI 10.1139/X10-127; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	35	34	34	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205296	10.1371/journal.pone.0205296	http://dx.doi.org/10.1371/journal.pone.0205296			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335770	Green Published, gold, Green Submitted			2022-12-26	WOS:000447701300026
J	Jemere, KA; Melaku, MY; Jemeber, TH; Abate, MA				Jemere, Kassahun Atalele; Melaku, Mulat Yimer; Jemeber, Tadesse Hailu; Abate, Megbaru Alemu			Performance evaluation of laboratory professionals on malaria microscopy at health facilities in Bahir Dar city administration, Northwest Ethiopia	PLOS ONE			English	Article								Background Microscopic diagnosis of Giemsa stained thick and thin blood films by skilled microscopists has remained the gold standard laboratory method for the diagnosis of malaria. However, there is a scarcity of qualified laboratory professionals for correctly diagnosing malaria using microscopy. The aim of this study was to evaluate the performance of laboratory professionals on malaria microscopy at health facilities in Bahir Dar city administration, Northwest Ethiopia. Methods A cross-sectional study was conducted from January to March 2017 in Bahir Dar City. A total of 87 laboratory professionals participated in the selected health facilities, with a response rate of (100%). Standardized pre-validated slide panels and questionnaire were distributed to laboratory professionals by the principal investigator. The panel slides were comprised of 5 positives and 3 negative blood films. The laboratory professionals were requested to report the parasite density using semi-quantitative (+) and per micro-liter methods. Their performances of slide readings were compared with the experts' readings. Agreement in detecting malaria parasites between laboratory professionals and expert was estimated using the kappa score. Results The overall sensitivity and specificity of the laboratory professionals in detecting malaria parasites were 83% and 97%, respectively. Similarly, positive predictive values of 98.1% and negative predictive values of 77.7% were reported. The percent agreement between laboratory professionals and expert microscopist in the detection of malaria parasites was 88.5% with a Kappa index of 0.78. Percent agreement in species identification and reporting of Pf/Pv mixed infections were 27.2% and 22.4%, respectively. About 62.2% of the laboratory professionals reported parasite density using semi-quantitative method. While none of them reported per micro-liter method. Conclusions The current study showed that laboratory professionals had good performance in parasite detection. However, poor performance was seen in both species identification and reporting of Pf/Pv mixed infections.	[Jemere, Kassahun Atalele] Felege Hiwot Referral Specialized Hosp, Med Lab Serv, Bahir Dar, Ethiopia; [Melaku, Mulat Yimer; Jemeber, Tadesse Hailu; Abate, Megbaru Alemu] Bahir Dar Univ, Sch Hlth Sci, Dept Med Lab Sci, Coll Med & Hlth Sci, Bahir Dar, Ethiopia	Bahir Dar University	Jemere, KA (corresponding author), Felege Hiwot Referral Specialized Hosp, Med Lab Serv, Bahir Dar, Ethiopia.	jemerekassahun@gmail.com		Alemu, Megbaru/0000-0002-4851-1366				[Anonymous], 2010, BAS MAL MICR 1; [Anonymous], 2011, GLOB REP ANT DRUG EF, P2001; [Anonymous], 2009, MAL MICR QUAL ASS MA; [Anonymous], 2014, WORLD MALARIA REPORT; [Anonymous], 2016, MAL MICR QUAL MAN VE; Anthony VJ, 2005, FAM MED, V37, P360; Assefa AA, 2016, INT J INFECT DIS, V45, P351, DOI 10.1016/j.ijid.2016.02.758; Ayalew Freshwork, 2014, BMC Res Notes, V7, P839, DOI 10.1186/1756-0500-7-839; Bereket Z, 2015, CLIN MED RES, V4, P63; Chandler CIR, 2008, HEALTH POLICY PLANN, V23, P170, DOI 10.1093/heapol/czm046; EHNRI, 2009, MAL LAB DIAGN EXT QU; Federal Democratic Republic of Ethiopia, POP CENS COMM SUMM S; FMOH (Federal ministry of Health of Ethiopia), 2012, NAT MAL GUID; Kassahun Mitiku, 2003, Ethiopian Journal of Health Development, V17, P197; Lawrence B, 1999, AM J TROP MED HYG, V60, P1024; Le Roch KG, 2012, PARASITE IMMUNOL, V34, P50, DOI 10.1111/j.1365-3024.2011.01340.x; Lederman ER, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-108; Megbaru A, 2017, PARA RES J, P1; Mukadi P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-308; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Rosas A, 2010, PERU REV EXP MED PUB, V27, P540; William R, 2012, MALARIA J, V1, P1; Yitbarek T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166170	23	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0203420	10.1371/journal.pone.0203420	http://dx.doi.org/10.1371/journal.pone.0203420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335752	Green Submitted, Green Published, gold			2022-12-26	WOS:000447701300004
J	Melchior, EA; Smith, JK; Schneider, LG; Mulliniks, JT; Bates, GE; McFarlane, ZD; Flythe, MD; Klotz, JL; Goodman, JP; Ji, HH; Myer, PR				Melchior, Emily A.; Smith, Jason K.; Schneider, Liesel G.; Mulliniks, J. Travis; Bates, Gary E.; McFarlane, Zachary D.; Flythe, Michael D.; Klotz, James L.; Goodman, Jack P.; Ji, Huihua; Myer, Phillip R.			Effects of red clover isoflavones on tall fescue seed fermentation and microbial populations in vitro	PLOS ONE			English	Article							RUMINAL FERMENTATION; RUMEN FERMENTATION; CAUDAL ARTERY; BLOOD-FLOW; ENDOPHYTE; BIOCHANIN; EXTRACT; FIBER; PHYTOESTROGENS; DIGESTIBILITY	Negative impacts of endophyte-infected Lolium arundinaceum (Darbyshire) (tall fescue) are responsible for over $2 billion in losses to livestock producers annually. While the influence of endophyte-infected tall fescue has been studied for decades, mitigation methods have not been clearly elucidated. Isoflavones found in Trifolium pratense (red clover) have been the subject of recent research regarding tall fescue toxicosis mitigation. Therefore, the aim of this study was to determine the effect of ergovaline and red clover isoflavones on rumen microbial populations, fiber degradation, and volatile fatty acids (VFA) in an in vitro system. Using a dose of 1.10 mg x L-1, endophyte-infected or endophyte-free tall fescue seed was added to ANKOM fiber bags with or without 2.19 mg of isoflavones in the form of a control, powder, or pulverized tablet, resulting in a 2 x 3 factorial arrangements of treatments. Measurements of pH, VFA, bacterial taxa, as well as the disappearance of neutral detergent fiber (aNDF), acid detergent fiber (ADF), and crude protein (CP) were taken after 48 h of incubation. aNDF disappearance values were significantly altered by seed type (P = 0.003) and isoflavone treatment (P = 0.005), and ADF disappearance values were significantly different in a seed x isoflavone treatment interaction (P <= 0.05). A seed x isoflavone treatment interaction was also observed with respect to CP disappearance (P <= 0.05). Eighteen bacterial taxa were significantly altered by seed x isoflavone treatment interaction groups (P <= 0.05), eight bacterial taxa were increased by isoflavones (P <= 0.05), and ten bacterial taxa were altered by seed type (P <= 0.05). Due to the beneficial effect of isoflavones on tall fescue seed fiber degradation, these compounds may be viable options for mitigating fescue toxicosis. Further research should be conducted to determine physiological implications as well as microbiological changes in vivo.	[Melchior, Emily A.; Smith, Jason K.; Schneider, Liesel G.; Mulliniks, J. Travis; McFarlane, Zachary D.; Myer, Phillip R.] Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA; [Bates, Gary E.] Univ Tennessee, Dept Plant Sci, Knoxville, TN USA; [Flythe, Michael D.; Klotz, James L.] ARS, USDA, Forage Anim Prod Res Unit, Lexington, KY USA; [Goodman, Jack P.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Ji, Huihua] Univ Kentucky, Coll Agr Food & Environm, Lexington, KY USA; [Mulliniks, J. Travis] Univ Nebraska Lincoln, West Cent Res & Extens Ctr, North Platte, NE USA; [McFarlane, Zachary D.] Calif Polytech State Univ San Luis Obispo, Dept Anim Sci, San Luis Obispo, CA 93407 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; United States Department of Agriculture (USDA); University of Kentucky; University of Kentucky; University of Nebraska System; University of Nebraska Lincoln; California State University System; California Polytechnic State University San Luis Obispo	Myer, PR (corresponding author), Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA.	pmyer@utk.edu		Ji, Huihua/0000-0001-7528-1036; Melchior, Emily/0000-0003-4472-8047; Schneider, Liesel/0000-0002-9344-6495; Myer, Phillip/0000-0002-1980-2105; Flythe, Michael/0000-0002-8868-9169	UT Center of Excellence in Livestock Diseases and Human Health (COE); USDA-NIFA Hatch/Multistate Project [W2010-TEN00493]	UT Center of Excellence in Livestock Diseases and Human Health (COE); USDA-NIFA Hatch/Multistate Project	This work was supported by a grant from the UT Center of Excellence in Livestock Diseases and Human Health (COE). The authors acknowledge PharmaCare Inc. for providing the Promensil (R) product, as well as the USDA-NIFA Hatch/Multistate Project W2010-TEN00493-Integrated Approach to Enhance Efficiency of Feed Utilization in Beef Production Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNEY LK, 1993, J EQUINE VET SCI, V13, P334, DOI 10.1016/S0737-0806(06)81119-6; Aiken GE, 2007, J ANIM SCI, V85, P2337, DOI 10.2527/jas.2006-821; Aiken GE, 2009, J ANIM SCI, V87, P2142, DOI 10.2527/jas.2008-1562; Aiken GE, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00017; ALLISON MJ, 1985, ARCH MICROBIOL, V141, P1, DOI 10.1007/BF00446731; Ball D, 1991, TALL FESCUE ENDOPHYT; Beck VB, 2005, J STEROID BIOCHEM, V94, P499, DOI 10.1016/j.jsbmb.2004.12.038; Bush L., 1973, Special Publication, Crop Science Society of America, P99; BUSH LP, 1970, CROP SCI, V10, P108, DOI 10.2135/cropsci1970.0011183X001000010043x; CHEN GJ, 1989, APPL ENVIRON MICROB, V55, P1052, DOI 10.1128/AEM.55.5.1052-1057.1989; Contreras-Govea FE, 2016, J APPL MICROBIOL, V121, P333, DOI 10.1111/jam.13103; Cruz MN, 2006, AM J PHYSIOL-HEART C, V290, pH1969, DOI 10.1152/ajpheart.01065.2005; De Lorme MJM, 2007, J ANIM SCI, V85, P1199, DOI 10.2527/jas.2005-430; Flythe MD, 2010, J APPL MICROBIOL, V109, P1169, DOI 10.1111/j.1365-2672.2010.04739.x; Flythe M. D., 2013, AGR FOOD ANAL BACTER, V3, P176; Flythe M, 2010, CURR MICROBIOL, V61, P125, DOI 10.1007/s00284-010-9586-5; Foote AP, 2013, J ANIM SCI, V91, P5366, DOI 10.2527/jas.2013-6517; Green MA, 2017, J ANIM SCI, V95, P1537, DOI 10.2527/jas.2016.1309; HANNAH SM, 1990, J ANIM SCI, V68, P1693; Harlow BE, 2017, J APPL MICROBIOL, V122, P870, DOI 10.1111/jam.13397; Harlow BE, 2017, J ANIM SCI, DOI [10.2527/jas.2016.1059, DOI 10.2527/JAS.2016.1059]; Harlow BE, 2018, J APPL MICROBIOL, V124, P58, DOI 10.1111/jam.13632; Harlow BE, 2017, CROP SCI, V57, P506, DOI 10.2135/cropsci2016.07.0590; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; HERBEIN JH, 1978, J NUTR, V108, P994, DOI 10.1093/jn/108.6.994; JACKSON JA, 1984, J ANIM SCI, V58, P1057, DOI 10.2527/jas1984.5851057x; Jeyanathan J, 2016, J ANIM SCI, V94, P739, DOI 10.2527/jas.2015-9682; Kallenbach RL, 2015, J ANIM SCI, V93, P5487, DOI 10.2527/jas.2015-9229; Klotz JL, 2016, ANIM PROD SCI, V56, P1761, DOI 10.1071/AN14962; Koontz AF, 2012, J ANIM SCI, V90, P914, DOI 10.2527/jas.2011-4292; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kuhfeld W., 2010, EXPT DESIGN EFFICIEN; KUNG LM, 1995, J ANIM SCI, V73, P250; Luo JB, 2018, ANN MICROBIOL, V68, P153, DOI 10.1007/s13213-018-1322-6; LUSBY KS, 1990, J PROD AGRIC, V3, P103, DOI 10.2134/jpa1990.0103; Mantle PG, 2009, PHYTOCHEMISTRY, V70, P7, DOI 10.1016/j.phytochem.2008.11.004; MCDOUGALL EI, 1948, BIOCHEM J, V43, P99, DOI 10.1042/bj0430099; MCMURPHY WE, 1990, J PROD AGRIC, V3, P100, DOI 10.2134/jpa1990.0100; Mertens DR, 2002, J AOAC INT, V85, P1217; Myer PR, 2017, J ANIM SCI, V95, P3215, DOI 10.2527/jas.2016.1059; Myer PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129174; ORSKOV E.R., 1982, NEW YORK; Pan XH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01818; REDDY CA, 1978, J CLIN MICROBIOL, V7, P428; Reynolds CK, 2014, J DAIRY SCI, P97; Richards CJ, 2006, J ANIM SCI, V84, P678, DOI 10.2527/2006.843678x; Sari M, 2015, ANIM FEED SCI TECH, V200, P17, DOI 10.1016/j.anifeedsci.2014.11.011; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shappell NW, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00030; Strickland JR, 2011, J ANIM SCI, V89, P1603, DOI 10.2527/jas.2010-3478; Tedeschi LO, 2003, J ENVIRON QUAL, V32, P1591, DOI 10.2134/jeq2003.1591; van de Weijer PHM, 2002, MATURITAS, V42, P187, DOI 10.1016/S0378-5122(02)00080-4; van Gastelen S, 2015, J DAIRY SCI, V98, P1915, DOI 10.3168/jds.2014-8552; Vogel KP, 1999, CROP SCI, V39, P276, DOI 10.2135/cropsci1999.0011183X003900010042x; Weimer P, 2016, J ANIM SCI S5, V94, P807; Weimer PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00296; WESTENDORF ML, 1992, DRUG CHEM TOXICOL, V15, P351, DOI 10.3109/01480549209014162; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhuang J, 2005, AGRON J, V97, P711, DOI 10.2134/agronj2004.0108	59	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0201866	10.1371/journal.pone.0201866	http://dx.doi.org/10.1371/journal.pone.0201866			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335760	gold, Green Published			2022-12-26	WOS:000447701300001
J	Meragiaw, M; Woldu, Z; Martinsen, V; Singh, BR				Meragiaw, Misganaw; Woldu, Zerihun; Martinsen, Vegard; Singh, Bal Ram			Woody species composition and diversity of riparian vegetation along the Walga River, Southwestern Ethiopia	PLOS ONE			English	Article								The primary objective of this study was to examine the status of woody species composition and diversity along the Walga River of Wonchi, Southwestern Ethiopia. Fifty quadrats of 10 m x 50 m were laid at 500 m interval through systematic sampling method along the river line. Vegetation height (>= 2.5 m) and DBH (>= 2.5 cm) of only tree species were measured and altitude, ecological disturbances such as, grazing intensity and human impacts were included as main environmental variables at each of the sampled plots. The data was analyzed using different R statistical packages. Ninety-nine woody vascular plant species belonged to 81 genera and 45 familieswere recorded in Walga riparian vegetation. Only 10% of specieswere endemic to the Flora area. Asteraceae and Fabaceae had the highest number of species. Majority of the species (52.5%) were shrubs. Four major plant community types were identified: Euclea divinorum-Maytenus arbutifolia (1), Pterolobium stellatum-Calpurnia aurea (2), Brucea antidysenterica-Prunus africana (3), Erica arborea-Hagenia abyssinica (4). Species richness, true diversity and importance values were highestin community type 2(the lowest altitude ranges between 1976-2212 m a.s.l.) while evenness was highestin community type 3(mid altitude ranges between 2359-2676 m a.s.l.). Both community typeswere comprised of 56% of all recorded species and all endemic taxa except two. The highest percentage of species in lower frequency classes indicates a higher degree of floristic heterogeneity. There was a strong negative correlation (r = -0.65, p<0.001) between species richness and altitude with 42% of the variation in species richness per plot being explained by altitude. Our findings suggest that human disturbances and excessive livestock grazing are the main threats in community types1 and 2. We conclude that identifying major plant community types and underlying environmental conditions may help to manage and conserve forest resources in the area.	[Meragiaw, Misganaw; Woldu, Zerihun] Addis Ababa Univ, Natl Herbarium, Coll Nat & Computat Sci, Dept Plant Biol & Biodivers Management, Addis Ababa, Ethiopia; [Martinsen, Vegard; Singh, Bal Ram] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway	Addis Ababa University; Norwegian University of Life Sciences	Meragiaw, M (corresponding author), Addis Ababa Univ, Natl Herbarium, Coll Nat & Computat Sci, Dept Plant Biol & Biodivers Management, Addis Ababa, Ethiopia.	misganme@gmail.com	Meragiaw, Misganaw/W-1388-2019; Martinsen, Vegard/H-9406-2014	Martinsen, Vegard/0000-0002-7096-1806; /0000-0002-0751-9660	project "Regional Capacity Building for Sustainable Natural Resource Management and Agricultural Improvement under Climate Change" of the Norwegian Program for Capacity Building in Higher Education and Research for Development (NORHED); project "Regional Capacity Building for Sustainable Natural Resource Management and Agricultural Improvement under Climate Change (CAPSNAC)" of the Norwegian Program for Capacity Building in Higher Education and Research for Development (NORHED)	project "Regional Capacity Building for Sustainable Natural Resource Management and Agricultural Improvement under Climate Change" of the Norwegian Program for Capacity Building in Higher Education and Research for Development (NORHED); project "Regional Capacity Building for Sustainable Natural Resource Management and Agricultural Improvement under Climate Change (CAPSNAC)" of the Norwegian Program for Capacity Building in Higher Education and Research for Development (NORHED)	We are grateful to the project "Regional Capacity Building for Sustainable Natural Resource Management and Agricultural Improvement under Climate Change" of the Norwegian Program for Capacity Building in Higher Education and Research for Development (NORHED) for financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; The authors are grateful to the project "Regional Capacity Building for Sustainable Natural Resource Management and Agricultural Improvement under Climate Change (CAPSNAC)" of the Norwegian Program for Capacity Building in Higher Education and Research for Development (NORHED) for financial support for this study. We thank Mr. Melaku Wondafrash for his confirmation of plant specimens. Climate data of the study area was received from National Meteorology Agency. We also thank the editor and two anonymous reviewers for their constructive comments on the manuscript. Finally, we appreciate the people of Wonchi and field guides for providing field information relevant to our study.	Adugna F., 2010, THESIS; [Anonymous], 1994, THESIS; Beever EA, 2005, WEST N AM NATURALIST, V65, P382; BLM, 1990, REC DEC APPR RES MAN; Breugel PV Lilleso, 2011, POTENTIAL NATURAL VE, V6, P68; Carr CJ, 1998, PLANT ECOL, V135, P135, DOI 10.1023/A:1009704427916; Dibaba A, 2014, MOMONA ETHIOP J SCI, V6, P70; FRIIS I, 1986, Acta Universitatis Upsaliensis Symbolae Botanicae Upsalienses, V26, P31; Friis IB, 2010, BIOL SKR, V58, P1; Gardner PA, 1999, UTAH DIVISION WILDLI, V99-38; Gashaw T, 2015, POINT J AGR BIOTECHN, V1; Gemeda OD, 2016, J BIODIVERS ENVIRON, V8, P153; Hadera G, 2000, THESIS; Hedberg I, 2009, GEN PART INDEX, V1-7; IUCN, 2021, WIKIPEDIA; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kent M., 2012, VEGETATION DESCRIPTI; Laine CM, 2013, WEST N AM NATURALIST, V73, P337, DOI 10.3398/064.073.0307; Lovett S, 2010, PRINCIPLES RIPARIAN; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mekonnen A., 2009, THESIS; Meragiaw M, 2016, EVID-BASED COMPL ALT, V2016, P1; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; NASEM, 2002, RIP AR FUNCT STRAT M, P444, DOI [10.17226/10327, DOI 10.17226/10327]; NILSSON C, 1994, J ECOL, V82, P281, DOI 10.2307/2261296; Njue N., 2016, OPEN J FOR, V6, P373, DOI [10.4236/ojf.2016.65030, DOI 10.4236/OJF.2016.65030]; Oksanen J., 2016, VEGAN COMMUNITY ECOL, P4, DOI DOI 10.4135/9781412971874.N145; Person E, 2009, GEN PART INDEX, V8; PGRC, 1996, ETH COUNTR REP FAO I; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Rosell S, 2014, SCOT GEOGR J, V130, P51, DOI 10.1080/14702541.2013.820027; Sarmiento RT., 2017, J BIODIVERS ENVIRON, V10, P70; Soromessa Teshome, 2004, Tropical Ecology, V45, P209; Sunil C, 2016, TROP ECOL, V57, P343; Tabacchi E, 2000, HYDROL PROCESS, V14, P2959, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2959::AID-HYP129&gt;3.0.CO;2-B; VANDERMAAREL E, 1979, VEGETATIO, V39, P97, DOI 10.1007/BF00052021; Vivero JL., 2006, PROGR RED LIST ETHIO, P761; Wana D, 2010, J VEG SCI, V21, P617, DOI 10.1111/j.1654-1103.2010.01177.x; ZERIHUN W, 1991, J VEG SCI, V2, P173, DOI 10.2307/3235949; Zerihun Woldu, 1999, Sinet, an Ethiopian Journal of Science, V22, P235	40	11	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204733	10.1371/journal.pone.0204733	http://dx.doi.org/10.1371/journal.pone.0204733			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332486	Green Submitted, gold, Green Published			2022-12-26	WOS:000447638200027
J	Lipcius, RN; Burke, RP				Lipcius, Romuald N.; Burke, Russell P.			Successful recruitment, survival and long-term persistence of eastern oyster and hooked mussel on a subtidal, artificial restoration reef system in Chesapeake Bay	PLOS ONE			English	Article							CRASSOSTREA-VIRGINICA GMELIN; CONDITION INDEX; HABITAT; ASSEMBLAGES; POPULATION; ALGARVE; DISEASE; GROWTH; EXTENT; YIELD	Restoration efforts with native eastern oyster, Crassostrea virginica, in Chesapeake Bay and elsewhere have been limited by shell availability, necessitating the use of alternative structures as subtidal reefs, yet these have rarely been evaluated quantitatively. We quantified population structure, density, abundance and biomass of eastern oyster and hooked mussel, Ischadium recurvum, on a concrete modular reef (75 m(2) surface area over 5 m(2) of river bottom) deployed subtidally at 7 m depth in the Rappahannock River, Virginia during October, 2000. After nearly 5 y (May 2005), we took 120 stratified random samples over the reef. The reef was heavily colonized by 28-168 oysters and 14-2177 mussels m(-2) surface area. These densities translate to 1085 oysters and 8617 mussels m(-2) river bottom, which are the highest recorded for artificial oyster reefs. Size structure of oysters reflected four year classes, with over half of oysters more than 1 y old and of reproductive age. Oyster biomass (1663 g dry mass m(-2) river bottom) and condition index were equally high, whereas parasite prevalence and intensity were low. Oyster density correlated positively in a sigmoid fashion with mussel density up to high densities, then declined. This modular reef is one of the most successful artificial reefs for eastern oyster and hooked mussel restoration, and details features that are conducive for successful settlement, growth and survival in subtidal habitats.	[Lipcius, Romuald N.; Burke, Russell P.] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; [Burke, Russell P.] Christopher Newport Univ, Dept Organismal & Environm Biol, Newport News, VA 23606 USA	William & Mary; Virginia Institute of Marine Science	Lipcius, RN (corresponding author), Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA.	rom@vims.edu			Virginia Institute of Marine Science, College of William Mary; School of Marine Science; VIMS/School of Marine Science	Virginia Institute of Marine Science, College of William Mary; School of Marine Science; VIMS/School of Marine Science	Funding was provided by the Virginia Institute of Marine Science, College of William & Mary to RNL, and by a School of Marine Science doctoral fellowship to RPB by the Virginia Institute of Marine Science, College of William & Mary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express appreciation to Captain Robert W. Jensen, the Rappahannock Preservation Society, Reeftek-McLean, Commonwealth Pro Dive, and the VIMS Shellfish Pathology Group directed by Ryan Carnegie. In particular, McLean Construction Co. provided logistical support for sampling the modular reef. Special thanks to the entire Marine Conservation Biology and Marine Community Ecology programs at VIMS for their support of this research in both the field and the lab. RPB was supported by a VIMS/School of Marine Science doctoral fellowship. This publication is dedicated to the memory of Captain "Bob" Jensen, who recognized the potential of artificial reefs to advance oyster restoration. This is Contribution #3772 from the Virginia Institute of Marine Science.	Abbe GR, 2003, J SHELLFISH RES, V22, P747; ABBE GR, 1988, J SHELLFISH RES, V7, P57; Anderson D. R., 2008, MODEL BASED INFERENC; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Beck S, 2015, FISH B-NOAA, V113, P327, DOI 10.7755/FB.113.3.8; Benaglia T, 2009, J STAT SOFTW, V32, P1; Boaventura D, 2006, HYDROBIOLOGIA, V555, P335, DOI 10.1007/s10750-005-1133-1; Brown KM, 2011, INVERTEBR BIOL, V130, P43, DOI 10.1111/j.1744-7410.2011.00223.x; Carvalho S, 2013, MAR ENVIRON RES, V92, P170, DOI 10.1016/j.marenvres.2013.09.013; Cochran WG., 1963, SAMPLING TECHNIQUES; Encomio VG, 2005, J SHELLFISH RES, V24, P143; Ermgassen PSEZ, 2012, P ROY SOC B-BIOL SCI, V279, P3393, DOI 10.1098/rspb.2012.0313; Harding JM, 2013, J MAR BIOL ASSOC UK, V93, P519, DOI 10.1017/S002531541200032X; Jensen A., 2012, ARTIFICIAL REEFS EUR; La Peyre M.K., 2017, Living Shorelines: The Science and Management of Nature -Based Coastal Protection, P363; La Peyre M, 2014, OCEAN COAST MANAGE, V89, P20, DOI 10.1016/j.ocecoaman.2013.12.002; Lee MO, 2018, OCEAN COAST MANAGE, V154, P55, DOI 10.1016/j.ocecoaman.2018.01.010; Lipcius RN, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00065; Lv WW, 2016, MAR POLLUT BULL, V103, P137, DOI 10.1016/j.marpolbul.2015.12.029; Mercado-Silva N, 2005, J SHELLFISH RES, V24, P121; Monteiro CC, 2000, ARTIFICIAL REEFS IN EUROPEAN SEAS, P249; Powers SP, 2009, MAR ECOL PROG SER, V389, P159, DOI 10.3354/meps08164; R Core Team, 2017, R A LANGUAGE AND ENV; RAINER J S, 1992, Journal of Shellfish Research, V11, P55; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; Santos MN, 2007, HYDROBIOLOGIA, V580, P225, DOI 10.1007/s10750-006-0451-2; Santos MN, 1998, FISH RES, V39, P55; Schulte DM, 2009, SCIENCE, V325, P1124, DOI 10.1126/science.1176516; Schumacker Ervin J., 1998, Journal of Shellfish Research, V17, P338; Soniat TM, 2004, J EXP MAR BIOL ECOL, V310, P163, DOI 10.1016/j.jembe.2004.04.007; Southworth M., 2005, STATUS VIRGINIAS PUB; Southworth M, 2004, STATUS VIRGINIAS PUB; Southworth M, 2003, STATUS VIRGINIAS PUB; Southworth M, 2002, STATUS VIRGINIAS PUB; Southworth M, 2010, J SHELLFISH RES, V29, P271, DOI 10.2983/035.029.0202; Sustainable Fisheries Goal Implementation Team, 2011, REST GOALS QUANT MET; Walles B, 2016, J SEA RES, V108, P1, DOI 10.1016/j.seares.2015.11.007; Wilberg MJ, 2011, MAR ECOL PROG SER, V436, P131, DOI 10.3354/meps09161	38	15	17	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0204329	10.1371/journal.pone.0204329	http://dx.doi.org/10.1371/journal.pone.0204329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321191	Green Published, Green Submitted, gold			2022-12-26	WOS:000447417900006
J	Bastos, MM; Coelho, FC				Bastos, Marcio M.; Coelho, Flavio Codeco			Estimating under-observation and the full size of the 2016 Zika epidemic in Rio de Janeiro	PLOS ONE			English	Article							BASIC REPRODUCTION NUMBER; SEXUAL TRANSMISSION; VIRUS; COLOMBIA; HISTORY	The 2015-16 Zika epidemic spread quickly from north to south in Brazil. Two striking features were the much higher incidence in young adult women due to sexual transmission, and the serious congenital malformations and miscarriages associated to Zika infection in pregnant women. In this paper we use case reporting data along with live-birth records to reconstruct the full size of the epidemic through a Bayesian probabilistic graph model representing the Zika transmission probabilities of observation (case reporting) and of birth loss (through miscarriage or abortion). We find that the probability of observing (reporting) a Zika case is different between men and women and ranges between 10 to 13%. From these estimates we reconstruct the full size of the Zika epidemic in Rio de Janeiro in 2015-16.	[Bastos, Marcio M.; Coelho, Flavio Codeco] Fundacao Getulio Vargas, Escola Matemat Aplicada, Rio De Janeiro, RJ, Brazil	Escola de Pos-Graduacao em Economia (EPGE); Getulio Vargas Foundation	Bastos, MM (corresponding author), Fundacao Getulio Vargas, Escola Matemat Aplicada, Rio De Janeiro, RJ, Brazil.	marciomacielbastos@hotmail.com	; Coelho, Flavio/L-1089-2018	Bastos, Marcio/0000-0001-7431-3227; Coelho, Flavio/0000-0003-3868-4391	Fundacao Getulio Vargas	Fundacao Getulio Vargas	This project has received financial support in the form of a scholarship to Marcio Bastos from Fundacao Getulio Vargas, and equipment in the form of a TESLA GPU card from NVIDIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, CURR TRENDS BAYESIAN, DOI DOI 10.1201/B18502-5); Bastos L, 2016, BIORXIV, DOI DOI 10.1101/055475; Coelho FC, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00317; Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023; Coelho FC, 2015, SCI REP-UK, V5, DOI 10.1038/srep18455; Coimbra BM, 2017, BIORXIV; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016; Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112; Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003; Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358; Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274	18	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205001	10.1371/journal.pone.0205001	http://dx.doi.org/10.1371/journal.pone.0205001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312300	gold, Green Published, Green Submitted			2022-12-26	WOS:000447427300019
J	Chen, HM; Bi, YH; Ju, S; Gu, LX; Zhu, XY; Han, XW				Chen, Hongmei; Bi, Yonghua; Ju, Siyeong; Gu, Linxia; Zhu, Xiaoyan; Han, Xinwei			Hemodynamics and pathology of an enlarging abdominal aortic aneurysm model in rabbits	PLOS ONE			English	Article							SIMULTANEOUS INHIBITION; TOPICAL APPLICATION; KAPPA-B; ELASTASE; PERFORMANCE; STRESS; SHEAR; ETS	Hemodynamics may play an essential role in the initiation and progression of abdominal aortic aneurysm (AAA). We aimed to study the mechanism of self-healing process by the changes of hemodynamics and pathology in an enlarging AAA in rabbits. Seventy-two rabbits were randomly divided into three groups. Rabbits underwent extrinsic coarctation and received a 10-minute elastase incubation in Group A and Group B. Absorbable suture used in Group A was terminated by balloon dilation at week 4. Diameter was measured after 1, 3, 5, and 15 weeks, computational fluid dynamics analysis was performed at week 3 and week 15. Rabbits were sacrificed after 1, 5, and 15 weeks for pathological and quantitative studies. The higher velocity magnitude, intensified bulk flow and obvious vortex formation were observed in Group A at week 3 instead of week 15. Both low wall shear stress and high relative residence time increased in Group B, however, high oscillatory shear index had relatively less increase compared with Group A. Aortic diameter reached a plateau at 5 weeks in Group A, which was significantly lower than in week 15 in Group B. Intimal hyperplasia, intima-media thickness increased significantly in Group A at week 5, significantly higher than in week 15 in Group B. Marked destruction of elastin fibers and smooth muscle cells occurred at week 1, and increased significantly at week 15 in Group A. Aneurysm exhibited strong expression of matrix metalloproteinase 9 and mouse anti-rabbit macrophage 11 at week 1, and showed a tendency to decrease. Matrix metalloproteinase 2 expression decreased significantly in Group B at week 15 compared with week 5 and Group A. In conclusion, the self-healing of rabbit AAA may attributed to the regeneration of smooth muscle cells. The turbulence flow caused by coarctation is associated with continuous growth of rabbit AAA and prevents the self-healing phenomenon.	[Chen, Hongmei; Zhu, Xiaoyan] Zhengzhou Univ, Dept Histol & Embryol, Coll Basic Med, Zhengzhou, Henan, Peoples R China; [Chen, Hongmei] Zhengzhou Univ, Dept Ultrasound, Zhengzhou Cent Hosp, Zhengzhou, Henan, Peoples R China; [Bi, Yonghua; Han, Xinwei] Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Ju, Siyeong; Gu, Linxia] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE USA	Zhengzhou University; Zhengzhou University; Zhengzhou University; University of Nebraska System; University of Nebraska Lincoln	Zhu, XY (corresponding author), Zhengzhou Univ, Dept Histol & Embryol, Coll Basic Med, Zhengzhou, Henan, Peoples R China.; Han, XW (corresponding author), Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.	zhxy@zzu.edu.cn; dreamweaver08@126.com	gu, linxia/A-5645-2013; han, wei/ABG-2691-2021	gu, linxia/0000-0003-2637-0299; 	National Natural Science Foundation of China [81501569]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (81501569 to YB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi Y, 2013, EUR J VASC ENDOVASC, V45, P145, DOI 10.1016/j.ejvs.2012.11.015; Bi YH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198818; Bi YH, 2017, ANN MED SURG, V18, P24, DOI 10.1016/j.amsu.2017.05.004; Bi YH, 2016, CIRCULATION, V133, pE10, DOI 10.1161/CIRCULATIONAHA.115.017604; Bi YH, 2015, J VASC SURG, V62, P1054, DOI 10.1016/j.jvs.2014.02.062; Bi YH, 2014, CELL BIOCHEM BIOPHYS, V70, P819, DOI 10.1007/s12013-014-9985-5; Bi YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068476; Bi YH, 2012, J VASC INTERV RADIOL, V23, P1529, DOI 10.1016/j.jvir.2012.08.007; Chen HY, 2011, AM J PHYSIOL-HEART C, V301, pH2254, DOI 10.1152/ajpheart.00240.2011; Cockerill GW, 2013, EUR J VASC ENDOVASC, V45, P153, DOI 10.1016/j.ejvs.2012.11.018; Ekaterinaris JA, 2006, ANN VASC SURG, V20, P351, DOI 10.1007/s10016-006-9031-1; Ferreira JP, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003529; Himburg HA, 2004, AM J PHYSIOL-HEART C, V286, pH1916, DOI 10.1152/ajpheart.00897.2003; Isenburg JC, 2007, CIRCULATION, V115, P1729, DOI 10.1161/CIRCULATIONAHA.106.672873; Mata KM, 2011, INT J EXP PATHOL, V92, P26, DOI 10.1111/j.1365-2613.2010.00746.x; Meng H, 2014, AM J NEURORADIOL, V35, P1254, DOI 10.3174/ajnr.A3558; Miyake T, 2006, GENE THER, V13, P695, DOI 10.1038/sj.gt.3302704; Miyake T, 2007, CIRC RES, V101, P1175, DOI 10.1161/CIRCRESAHA.107.148668; Origuchi N, 1998, INT ANGIOL, V17, P113; Patelis N, 2017, PHYSIOL RES, V66, P899, DOI 10.33549/physiolres.933579; ROACH M R, 1970, Circulation Research, V27, P985; Sasaki K, 2004, NEUROL MED-CHIR, V44, P467, DOI 10.2176/nmc.44.467; Sasaki T, 2004, NEUROL MED-CHIR, V44, P473; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sinnott M, 2006, INVESTIGATION PULSAT	25	1	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205366	10.1371/journal.pone.0205366	http://dx.doi.org/10.1371/journal.pone.0205366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312321	Green Published, gold			2022-12-26	WOS:000447427300029
J	Stump, S; Mou, TC; Sprang, SR; Natale, NR; Beall, HD				Stump, Sascha; Mou, Tung-Chung; Sprang, Stephen R.; Natale, Nicholas R.; Beall, Howard D.			Crystal structure of the major quadruplex formed in the promoter region of the human c-MYC oncogene	PLOS ONE			English	Article							RELEVANT G-QUADRUPLEX; HUMAN TELOMERIC DNA; DOWN-REGULATION; FORMING REGION; K+ SOLUTION; MOTIF; GENE; TRACT; MODEL; LOOP	The c-MYC oncogene mediates multiple tumor cell survival pathways and is dysregulated or overexpressed in the majority of human cancers. The NHE III1 region of the c-MYC promoter forms a DNA quadruplex. Stabilization of this structure with small molecules has been shown to reduce expression of c-MYC, and targeting the c-MYC quadruplex has become an emerging strategy for development of antitumor compounds. Previous solution NMR studies of the c-MYC quadruplex have assigned the major conformer and topology of this important target, however, regions outside the G-quartet core were not as well-defined. Here, we report a high-resolution crystal structure (2.35 angstrom) of the major quadruplex formed in the NHE III1 region of the c-MYC promoter. The crystal structure is in general agreement with the solution NMR structure, however, key differences are observed in the position of nucleotides outside the G-quartet core. The crystal structure provides an alternative model that, along with comparisons to other reported quadruplex crystal structures, will be important to the rational design of selective compounds. This work will aid in development of ligands to target the c-MYC promoter quadruplex with the goal of creating novel anticancer therapies.	[Stump, Sascha; Natale, Nicholas R.; Beall, Howard D.] Univ Montana, Ctr Environm Hlth Sci, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Mou, Tung-Chung; Sprang, Stephen R.] Univ Montana, Div Biol Sci, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA	University of Montana System; University of Montana; University of Montana System; University of Montana	Beall, HD (corresponding author), Univ Montana, Ctr Environm Hlth Sci, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA.	howard.beall@umontana.edu	Natale, Nicholas Robert/AAA-1721-2022	Wang, Gangli/0000-0001-9204-7807; Beall, Howard/0000-0001-8601-1496	National Institutes of Health grant [P20ES017670]; National Institute of General Medical Sciences of the National Institutes of Health CoBRE [P20GM103546]; ALSAM Foundation Skaggs Scholar Program grant: AIMs as Novel G-Quadruplex DNA Binding Anticancer Agents [1000233768]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103546, P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institutes of Health CoBRE; ALSAM Foundation Skaggs Scholar Program grant: AIMs as Novel G-Quadruplex DNA Binding Anticancer Agents; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research described was supported by the National Institutes of Health grant #P20ES017670 (HDB, NRN), National Institute of General Medical Sciences of the National Institutes of Health CoBRE #P20GM103546 (SRS) and the ALSAM Foundation Skaggs Scholar Program grant: AIMs as Novel G-Quadruplex DNA Binding Anticancer Agents grant #1000233768 (HDB, NRN). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agrawal P, 2014, J AM CHEM SOC, V136, P1750, DOI 10.1021/ja4118945; Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya D, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00038; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Brown RV, 2011, J BIOL CHEM, V286, P41018, DOI 10.1074/jbc.M111.274720; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Campbell NH, 2007, METHODS, V43, P252, DOI 10.1016/j.ymeth.2007.08.005; Chen MC, 2018, NATURE, V558, P465, DOI 10.1038/s41586-018-0209-9; Dai JX, 2011, J AM CHEM SOC, V133, P17673, DOI 10.1021/ja205646q; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Dexheimer TS, 2006, J AM CHEM SOC, V128, P5404, DOI 10.1021/ja0563861; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; Han XC, 2009, BIOORGAN MED CHEM, V17, P1671, DOI 10.1016/j.bmc.2008.12.056; Heddi B, 2011, J AM CHEM SOC, V133, P9824, DOI 10.1021/ja200786q; Hu MH, 2018, J MED CHEM, V61, P2447, DOI 10.1021/acs.jmedchem.7b01697; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; Neidle S, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0041; Nicoludis JM, 2012, J AM CHEM SOC, V134, P20446, DOI 10.1021/ja3088746; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Phan AT, 2004, J AM CHEM SOC, V126, P8710, DOI 10.1021/ja048805k; Raiber EA, 2012, NUCLEIC ACIDS RES, V40, P1499, DOI 10.1093/nar/gkr882; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Schrodinger, 2015, PYMOL MOL GRAPH SYST; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Su LJ, 2014, BBA-GEN SUBJECTS, V1840, P3123, DOI 10.1016/j.bbagen.2014.07.004; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Weaver MJ, 2015, BIOORG MED CHEM LETT, V25, P1765, DOI 10.1016/j.bmcl.2015.02.063; Wei DG, 2015, NUCLEIC ACIDS RES, V43, P629, DOI 10.1093/nar/gku1282; Wei DG, 2012, NUCLEIC ACIDS RES, V40, P4691, DOI 10.1093/nar/gks023; Xue Y, 2007, J AM CHEM SOC, V129, P11185, DOI 10.1021/ja0730462; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913	45	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205584	10.1371/journal.pone.0205584	http://dx.doi.org/10.1371/journal.pone.0205584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312328	Green Published, gold, Green Submitted			2022-12-26	WOS:000447427300040
J	Ko, Y; Yun, SD; Hong, SM; Ha, Y; Choi, CH; Shah, NJ; Felder, J				Ko, YunKyoung; Yun, Seong Dae; Hong, Suk-Min; Ha, Yonghyun; Choi, Chang-Hoon; Shah, N. Jon; Felder, Joerg			MR-compatible, 3.8 inch dual organic light-emitting diode (OLED) in-bore display for functional MRI	PLOS ONE			English	Article							LUMINANCE CONTRAST; BOLD FMRI; STIMULUS; BRAIN; AREAS; TESLA	Purpose Functional MRI (fMRI) is a well-established method used to investigate localised brain activation by virtue of the blood oxygen level dependent (BOLD) effect. It often relies on visual presentations using beam projectors, liquid crystal display (LCD) screens, and goggle systems. In this study, we designed an MR compatible, low-cost display unit based on organic light-emitting diodes (OLED) and demonstrated its performance. Methods A 3.8 '' dual OLED module and an MIPI-to-HDMI converter board were used. The OLED module was enclosed using a shielded box to prevent noise emission from the display module and the potentially destructive absorption of high power RF from the MRI transmit pulses. The front of the OLED module was covered by a conductive, transparent mesh. Power was supplied from a non-magnetic battery. The shielding of the display was evaluated by directly measuring the electromagnetic emission with the aid of a pickup loop and a low noise amplifier, as well as by examining the signal-to-noise ratio (SNR) of phantom MRI data. The visual angle of the display was calculated and compared to standard solutions. As a proof of concept of the OLED display for fMRI, a healthy volunteer was presented with a visual block paradigm. Results The OLED unit was successfully installed inside a 3 T MRI scanner bore. Operation of the OLED unit did not degrade the SNR of the phantom images. The fMRI data suggest that visual stimulation can be effectively delivered to subjects with the proposed OLED unit without any significant interference between the MRI acquisitions and the display module itself. Discussion We have constructed and evaluated the MR compatible, dual OLED display for fMRI studies. The proposed OLED display provides the benefits of high resolution, wide visual angle, and high contrast video images during fMRI exams.	[Ko, YunKyoung; Yun, Seong Dae; Hong, Suk-Min; Ha, Yonghyun; Choi, Chang-Hoon; Shah, N. Jon; Felder, Joerg] Forschungszentrum Juelich, Inst Neurosci & Med 4, Julich, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Fac Med, JARA, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University	Felder, J (corresponding author), Forschungszentrum Juelich, Inst Neurosci & Med 4, Julich, Germany.	j.felder@fz-juelich.de	Shah, N. Jon/H-5849-2013; Choi, Chang-Hoon/S-9688-2019; Felder, Jörg/H-9707-2019	Shah, N. Jon/0000-0002-8151-6169; Choi, Chang-Hoon/0000-0003-3569-0905; Felder, Jörg/0000-0001-6431-4322; Yun, Seong Dae/0000-0001-7398-1899				Alliance M, 2011, APR, V5, P1; [Anonymous], 2008, 12008 NEMA MS; Ayama M, 1998, COLOR RES APPL, V23, P274, DOI 10.1002/(SICI)1520-6378(199810)23:5<274::AID-COL4>3.0.CO;2-T; Bai B, 2016, ELECTRON LETT, V52, P1292, DOI 10.1049/el.2016.1349; Brunner A, 2014, MAGN RESON MATER PHY, V27, P277, DOI 10.1007/s10334-013-0423-2; Cambridge Research System, BOLDSCREEN 32 LCD FM; Chee MWL, 2003, HUM BRAIN MAPP, V18, P186, DOI 10.1002/hbm.10092; Chen HW, 2018, LIGHT-SCI APPL, V7, DOI 10.1038/lsa.2017.168; Chun J, 2016, J NEUROSCI METH, V268, P78, DOI 10.1016/j.jneumeth.2016.05.011; Corney D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005091; Dempsey MF, 2001, J MAGN RESON IMAGING, V13, P627, DOI 10.1002/jmri.1088; Engstrom M, 2005, MAGN RESON IMAGING, V23, P695, DOI 10.1016/j.mri.2005.04.006; Fimreite V, 2015, BRAIN INJURY, V29, P1199, DOI 10.3109/02699052.2015.1035329; Giebink NC, 2009, J APPL PHYS, V105, DOI 10.1063/1.3151689; Goodyear BG, 1998, J NEUROPHYSIOL, V79, P2204, DOI 10.1152/jn.1998.79.4.2204; Groebner J, 2013, MAGN RESON MATER PHY, V26, P371, DOI 10.1007/s10334-012-0363-2; Han BH, 2008, IEEE ENG MED BIO, P3231, DOI 10.1109/IEMBS.2008.4649892; Jin DU, 2009, 2009 SID INTERNATIONAL SYMPOSIUM DIGEST OF TECHNICAL PAPERS, VOL XL, BOOKS I - III, P983; Kaiser PK, JOY VISUAL PERCEPTIO; Ko Y, 2018, ISMRM; Lee E, 2016, J INF DISP, V17, P151, DOI 10.1080/15980316.2016.1235622; Lee M.-K, 2017, U.S. Patent, DOI 10.3389/fonc.2017.00047, Patent No. [9541613B2, 9541613]; Liang CL, 2013, NEUROIMAGE, V64, P104, DOI 10.1016/j.neuroimage.2012.08.077; Marko K, 2009, J VISION, V9, DOI 10.1167/9.4.8; Mauler J, 2017, CASE REP NEUROL, V9, P131, DOI 10.1159/000475882; Michelson Albert A., 1927, STUDIES OPTICS; Mohamed FB, 2002, J MAGN RESON IMAGING, V16, P128, DOI 10.1002/jmri.10155; NEMA, 2008, 92008 NEMA MS; Nordic, NORD FMRI SOL; Park CI, 2018, J SOC INF DISPLAY, V26, P287, DOI 10.1002/jsid.663; Peterson DM, 2003, CONCEPT MAGN RESON B, V19B, P1, DOI 10.1002/cmr.b.10090; Reske M, 2015, NEUROIMAGE, V111, P602, DOI 10.1016/j.neuroimage.2015.02.013; Rosenberg J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137197; Smith JT, 2014, J DISP TECHNOL, V10, P514, DOI 10.1109/JDT.2014.2308436; Song JZ, 2015, ADV MATER, V27, P7162, DOI 10.1002/adma.201502567; Sreerama C, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON ELECTROMAGNETIC COMPATIBILITY, VOLS 1-3, PROCEEDINGS, P452, DOI 10.1109/ISEMC.2006.1706346; Teghtsoonian R, 1971, EXPONENTS STEVENS LA; Toshiba, NEW TECHN PROJ EXP V; Warbrick T, 2013, NEUROIMAGE, V77, P177, DOI 10.1016/j.neuroimage.2013.03.026; Wu JL, 2013, J NEUROSCI METH, V214, P126, DOI 10.1016/j.jneumeth.2013.01.021; Yun SD, 2013, NEUROIMAGE, V73, P135, DOI 10.1016/j.neuroimage.2013.01.070	41	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205325	10.1371/journal.pone.0205325	http://dx.doi.org/10.1371/journal.pone.0205325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308026	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500060
J	Natanov, R; Gueler, F; Falk, CS; Kuhn, C; Maus, U; Boyle, EC; Siemeni, T; Knoefel, AK; Cebotari, S; Haverich, A; Madrahimov, N				Natanov, Ruslan; Gueler, Faikah; Falk, Christine S.; Kuehn, Christian; Maus, Ulrich; Boyle, Erin C.; Siemeni, Thierry; Knoefel, Ann-Katrin; Cebotari, Serghei; Haverich, Axel; Madrahimov, Nodir			Blood cytokine expression correlates with early multi-organ damage in a mouse model of moderate hypothermia with circulatory arrest using cardiopulmonary bypass	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; END-ORGAN PROTECTION; ACUTE LUNG INJURY; ON-PUMP SURGERY; CARDIAC-SURGERY; INFLAMMATORY RESPONSE; GRAFT-SURGERY; CC-CHEMOKINE; RABBIT MODEL; TNF-ALPHA	Cardiopulmonary bypass (CPB) with moderate hypothermic cardiac arrest (MHCA) is essential for prolonged complex procedures in cardiac surgery and is associated with postoperative complications. Although cytokine release provoked through MHCA under CPB plays a pivotal role in postoperative organ damage, the pathomechanisms are unclear. Here, we investigated the cytokine release pattern and histological organ damage after MHCA using a recently described mouse CPB model. Eight BALB/c mice underwent 60 minutes of circulatory arrest under CPB, were successively rewarmed and reperfused. Blood cytokine concentrations and liver and kidney function parameters were measured and histological changes to these organs were compared to control animals. Our results showed a marked increase in proinflammatory cytokines and histological changes in the kidney, lung, and liver after CPB. Furthermore, clinical chemistry showed signs of hemolysis and acute kidney injury. These results suggest early onset of solid organ injury which correlates with increased leukocyte infiltration. A better understanding of the interplay between pro-inflammatory cytokine activation and solid organ injury in this model of CBP with MHCA will inform strategies to reduce organ damage during cardiac surgeries in the clinic.	[Natanov, Ruslan; Kuehn, Christian; Boyle, Erin C.; Siemeni, Thierry; Knoefel, Ann-Katrin; Cebotari, Serghei; Haverich, Axel; Madrahimov, Nodir] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Lower Saxony, Germany; [Gueler, Faikah] Hannover Med Sch, Dept Nephrol, Hannover, Lower Saxony, Germany; [Falk, Christine S.] Hannover Med Sch, Inst Transplant Immunol, Integrated Res & Treatment Ctr, Transplantat IFB Tx, Hannover, Lower Saxony, Germany; [Maus, Ulrich] Hannover Med Sch, Dept Pneumol, Hannover, Lower Saxony, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Madrahimov, N (corresponding author), Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Lower Saxony, Germany.	madrahimov.nodir@mh-hannover.de	Haverich, Axel/AAC-7552-2022; Falk, Christine/Q-4143-2016	Falk, Christine/0000-0003-1376-7318; Boyle, Erin C./0000-0002-5963-3633	DFG [SFB738]; IFB-Tx; Deutsche Forschungsgemeinschaft [KFO 311]	DFG(German Research Foundation (DFG)); IFB-Tx; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the DFG, SFB738 project B3 to CSF and the IFB-Tx. This research work was also supported by KFO 311 grant to UM and CK from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augoustides JGT, 2006, J CARDIOTHOR VASC AN, V20, P673, DOI 10.1053/j.jvca.2006.03.021; Baba O, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.11.46; Braun M, 2011, J INNATE IMMUN, V3, P420, DOI 10.1159/000322720; Chao YK, 2011, J SURG RES, V167, pE77, DOI 10.1016/j.jss.2009.10.041; Darby PJ, 2013, PERFUSION-UK, V28, P504, DOI 10.1177/0267659113490219; Day J R S, 2005, Int J Surg, V3, P129, DOI 10.1016/j.ijsu.2005.04.002; De Hert S, 2015, BEST PRACT RES-CLIN, V29, P137, DOI 10.1016/j.bpa.2015.03.002; De Somer F, 2013, MINERVA ANESTESIOL, V79, P285; Denizot Y, 2012, J THORAC CARDIOV SUR, V144, P743, DOI 10.1016/j.jtcvs.2012.05.080; Dhein S, 2015, N-S ARCH PHARMACOL, V388, P663, DOI 10.1007/s00210-015-1115-4; Dong LY, 2013, EUR REV MED PHARMACO, V17, P1789; Eggum R, 2010, INTERACT CARDIOV TH, V10, P76, DOI 10.1510/icvts.2009.213876; Fehrenbacher JW, 2007, ANN THORAC SURG, V83, P1041, DOI 10.1016/j.athoracsur.2006.09.088; Ferrandi C, 2007, J PHARMACOL EXP THER, V322, P923, DOI 10.1124/jpet.107.123026; Fiseha T, 2016, INT J NEPHROL, V2016, DOI 10.1155/2016/4647685; Francis M, 2017, TOXICOL SCI, V155, P182, DOI 10.1093/toxsci/kfw192; Franke A, 2006, EUR J CARDIO-THORAC, V30, P64, DOI 10.1016/j.ejcts.2006.03.029; Ghorbel MT, 2010, PHYSIOL GENOMICS, V42, P67, DOI 10.1152/physiolgenomics.00174.2009; Giordano P, 2013, PERFUSION-UK, V28, P496, DOI 10.1177/0267659113486827; Heise D, 2011, EUR J CARDIO-THORAC, V39, P38, DOI 10.1016/j.ejcts.2010.05.044; Heying R, 2012, ANN THORAC SURG, V93, P869, DOI 10.1016/j.athoracsur.2011.11.059; Hirao S, 2017, J THORAC CARDIOV SUR, V154, P1973, DOI 10.1016/j.jtcvs.2017.05.051; HISATOMI K, 1989, J THORAC CARDIOV SUR, V98, P580; Hueper K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162705; Jongman RM, 2014, SHOCK, V42, P121, DOI 10.1097/SHK.0000000000000190; Kazmierski J, 2014, INT PSYCHOGERIATR, V26, P845, DOI 10.1017/S1041610213002378; Khaladj N, 2011, EUR J CARDIO-THORAC, V40, P1492, DOI 10.1016/j.ejcts.2011.03.031; Kitaura M, 1996, J BIOL CHEM, V271, P7725, DOI 10.1074/jbc.271.13.7725; Liangos O, 2009, NEPHRON CLIN PRACT, V113, pC148, DOI 10.1159/000232595; Lotan D, 2001, ANN THORAC SURG, V71, P233, DOI 10.1016/S0003-4975(00)02020-8; Ma W, 2017, INFLAMMATION, V40, P1275, DOI 10.1007/s10753-017-0570-0; Madrahimov N, 2017, EUR J CARDIO-THORAC, V137, P1530, DOI [10.1093/ejcts/E7X237, DOI 10.1093/EJCTS/E7X237]; Martensson J, 2014, BLOOD PURIFICAT, V37, P304, DOI 10.1159/000364937; Montecucco F, 2012, EUR HEART J, V33, P1964, DOI 10.1093/eurheartj/ehr127; Morariu AM, 2005, CHEST, V128, P2677, DOI 10.1378/chest.128.4.2677; Mori Y, 2011, J ANESTH, V25, P799, DOI 10.1007/s00540-011-1210-8; Nathan N, 2000, J CARDIOTHOR VASC AN, V14, P156, DOI 10.1016/S1053-0770(00)90010-7; Onorati F, 2010, EUR J CARDIO-THORAC, V37, P897, DOI 10.1016/j.ejcts.2009.11.010; Pacini D, 2014, EUR J CARDIO-THORAC, V46, P438, DOI 10.1093/ejcts/ezt665; Parkunan SM, 2016, J LEUKOCYTE BIOL, V100, P1125, DOI 10.1189/jlb.3A0416-173R; Ranucci M, 2015, ANN THORAC SURG, V100, P95, DOI 10.1016/j.athoracsur.2015.02.034; Rasmussen BS, 2007, J CARDIOTHOR VASC AN, V21, P191, DOI 10.1053/j.jvca.2006.02.030; Roth-Isigkeit A, 1999, CLIN EXP IMMUNOL, V118, P242; Rubino AS, 2011, ANN THORAC SURG, V91, P534, DOI 10.1016/j.athoracsur.2010.09.077; Schultz JM, 2006, ANN THORAC SURG, V81, P474, DOI 10.1016/j.athoracsur.2005.06.041; Suleiman MS, 2008, BRIT J PHARMACOL, V153, P21, DOI 10.1038/sj.bjp.0707526; Szabo G, 2009, EUR J CARDIO-THORAC, V36, P657, DOI 10.1016/j.ejcts.2009.03.065; Tirilomis T, 2009, THORAC CARDIOV SURG, V57, P7, DOI 10.1055/s-2008-1039061; Vaidya VS, 2008, CTS-CLIN TRANSL SCI, V1, P200, DOI 10.1111/j.1752-8062.2008.00053.x; Welsby IJ, 2002, ANESTH ANALG, V94, P1072, DOI 10.1097/00000539-200205000-00004; Windsant ICV, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00340; Xing ZC, 2017, THORAX, V72, P245, DOI 10.1136/thoraxjnl-2015-208023; Yan YM, 2013, INT J MOL MED, V31, P637, DOI 10.3892/ijmm.2013.1228; Yoon SZ, 2009, J CARDIOTHOR VASC AN, V23, P646, DOI 10.1053/j.jvca.2009.03.004; Yu L, 2014, ANN SAUDI MED, V34, P532, DOI 10.5144/0256-4947.2014.532; Zhang JW, 2016, MOL MED REP, V13, P2918, DOI 10.3892/mmr.2016.4831; Zheng JH, 2010, PEDIATR CARDIOL, V31, P215, DOI 10.1007/s00246-009-9586-z	57	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205437	10.1371/journal.pone.0205437	http://dx.doi.org/10.1371/journal.pone.0205437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308065	gold, Green Submitted, Green Published			2022-12-26	WOS:000447173500076
J	van der Waals, LM; Rinkes, IHMB; Kranenburg, O				van der Waals, Lizet M.; Rinkes, Inne H. M. Borel; Kranenburg, Onno			ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 1A1; COLON-CANCER; STEM-CELLS; MOLECULAR SUBTYPES; MARKER; IMMUNOHISTOCHEMISTRY; CHEMOTHERAPY; METASTASIS; RECURRENCE; PROGNOSIS	Background Aldehyde dehydrogenase 1A1 (ALDH1A1) encodes an enzyme that oxidizes aldehydes to their corresponding carboxylic acids. In colorectal cancer ALDH1A1 marks cancer stem cells and plays putative roles in tumor progression and drug resistance. However, the potential value of ALDH1A1 as a diagnostic marker or target for therapy remains unclear. Here, we have analyzed ALDH1A1 mRNA and protein levels in relation to clinical, histopathological and molecular tumor features in large series of human colorectal cancer. Methods ALDH1A1 protein levels were determined by immunohistochemistry in a series of primary colorectal tumors and their corresponding liver metastases (n = 158). ALDH1A1 mRNA levels were analyzed in several large patient cohorts of colorectal cancer. ALDH1A1 mRNA and protein levels were then related to overall survival and to clinical, histopathological and molecular tumor features. Results High levels of ALDH1A1 were associated with a poorly differentiated histology and a right-sided tumor location, but not to a mesenchymal-like molecular subtype. Liver metastases contained significantly higher levels of ALDH1A1 compared to the corresponding primary tumors. Radio- and/or chemotherapy prior to tumor resection was associated with increased ALDH1A1 levels regardless of the molecular subtype. Finally, ALDH1A1 protein expression in primary tumors and metastases correlated with shorter overall survival. Conclusions ALDH1A1 expression is associated with features of poor prognosis, including a poorly differentiated histology and 'right-sidedness' of the primary tumor, and with shorter overall survival. ALDH1A1 is also highly expressed in therapy-surviving tumors and in liver metastases. These results warrant further research into the potential value of targeting ALDH1A1 in order to improve the efficacy of standard treatment and thereby preventing tumor recurrence.	[van der Waals, Lizet M.; Rinkes, Inne H. M. Borel; Kranenburg, Onno] UMC Utrecht, Lab Translat Oncol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Kranenburg, O (corresponding author), UMC Utrecht, Lab Translat Oncol, Utrecht, Netherlands.	o.kranenburg@umcutrecht.nl			Gieskes-Strijbis Foundation [UMCU2014]	Gieskes-Strijbis Foundation	This work was supported by the Gieskes-Strijbis Foundation grant UMCU2014 to L.M.W. ( https://gieskesstrijbisfonds.nl/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Cremolini C, 2015, NAT REV CLIN ONCOL, V12, P607, DOI 10.1038/nrclinonc.2015.129; Croker AK, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102039; Croker AK, 2012, BREAST CANCER RES TR, V133, P75, DOI 10.1007/s10549-011-1692-y; Dong Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187615; Douville J, 2009, STEM CELLS DEV, V18, P17, DOI 10.1089/scd.2008.0055; Emmink BL, 2013, J PROTEOMICS, V91, P84, DOI 10.1016/j.jprot.2013.06.027; Fitzgerald TL, 2014, J SURG RES, V192, P82, DOI 10.1016/j.jss.2014.05.054; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kahlert C, 2012, ANN SURG ONCOL, V19, P4193, DOI 10.1245/s10434-012-2518-9; Kahlert C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-275; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Lee A, 2018, PATHOL RES PRACT, V214, P619, DOI 10.1016/j.prp.2018.04.006; Loupakis F, 2014, NEW ENGL J MED, V371, P1609, DOI 10.1056/NEJMoa1403108; Lugli A, 2010, BRIT J CANCER, V103, P382, DOI 10.1038/sj.bjc.6605762; MacDonagh L, 2017, ONCOTARGET, V8, P72544, DOI 10.18632/oncotarget.19881; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; NEWLAND RC, 1994, CANCER, V73, P2076, DOI 10.1002/1097-0142(19940415)73:8<2076::AID-CNCR2820730811>3.0.CO;2-6; Oria VO, 2018, TRANSL ONCOL, V11, P1307, DOI 10.1016/j.tranon.2018.08.001; Planque C, 2016, ONCOTARGET, V7, P56558, DOI 10.18632/oncotarget.10646; Pors K, 2014, DRUG DISCOV TODAY, V19, P1953, DOI 10.1016/j.drudis.2014.09.009; Qian X, 2013, ONCOL REP, V29, P1777, DOI 10.3892/or.2013.2340; Rodriguez-Torres M, 2016, CLIN EXP METASTAS, V33, P97, DOI 10.1007/s10585-015-9755-9; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Snoeren N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049442; Stintzing S, 2017, EUR J CANCER, V84, P69, DOI 10.1016/j.ejca.2017.07.016; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; Trinh A, 2017, CLIN CANCER RES, V23, P387, DOI 10.1158/1078-0432.CCR-16-0680; Trumpi K, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.48; Van Cutsem E, 2014, ANN ONCOL, V25, P1, DOI 10.1093/annonc/mdu260; van der Waals LM, 2018, AM J PATHOL; vanDiest PJ, 1997, J CLIN PATHOL, V50, P801, DOI 10.1136/jcp.50.10.801; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Vishnubalaji Radhakrishnan, 2018, Oncotarget, V9, P13551, DOI 10.18632/oncotarget.24420; WIGGERS T, 1988, DIS COLON RECTUM, V31, P33, DOI 10.1007/BF02552567; Yang WS, 2018, MED SCI MONITOR, V24, P2864, DOI 10.12659/MSM.910109	42	23	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205536	10.1371/journal.pone.0205536	http://dx.doi.org/10.1371/journal.pone.0205536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308036	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500101
J	Sun, PC; Li, JL; Zhang, XL; Guan, ZY; Xiao, QJ; Zhao, CJ; Song, MX; Zhou, YX; Mou, LQ; Ke, M; Guo, L; Geng, J; Deng, D				Sun, Pengcheng; Li, Jialu; Zhang, Xialin; Guan, Zeyuan; Xiao, Qingjie; Zhao, Changjian; Song, Mengxiao; Zhou, Yanxia; Mou, Luqiu; Ke, Meng; Guo, Li; Geng, Jia; Deng, Dong			Crystal structure of the bacterial acetate transporter SatP reveals that it forms a hexameric channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structural biology; ion channel; organic anion channel; membrane protein; electrophysiology; protein structure; acetate uptake; SatP; hexamer; membrane channel; monocarboxylate transport	UREA CHANNEL; PERMEASE; IDENTIFICATION; PROTEIN; MODEL; ACID	Acetate is found ubiquitously in the natural environment and can be used as an exogenous carbon source by bacteria, fungi, and mammalian cells. A representative member of the acetate uptake transporter (AceTr) family named SatP (also yaaH) has been preliminarily identified as a succinate-acetate/proton symporter in Escherichia coli. However, the molecular mechanism of acetate uptake by SatP still remains elusive. Here, we report the crystal structure of SatP from E. coli at 2.8 resolution, determined with a molecular replacement approach using a previously developed predicted model algorithm, which revealed a hexameric UreI-like channel structure. Structural analysis identified six transmembrane (TM) helices surrounding the central channel pore in each protomer and three conserved hydrophobic residues, FLY, located in the middle of the TM region for pore constriction. According to single-channel conductance recordings, performed with purified SatP reconstituted into lipid bilayer, three conserved polar residues in the TM1 facing to the periplasmic side are closely associated with acetate translocation activity. These analyses provide critical insights into the mechanism of acetate translocation in bacteria and a first glimpse of a structure of an AceTr family transporter.	[Li, Jialu; Zhang, Xialin; Xiao, Qingjie; Zhao, Changjian; Song, Mengxiao; Zhou, Yanxia; Mou, Luqiu; Guo, Li; Geng, Jia; Deng, Dong] Sichuan Univ, West China Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Div Obstet,MOE,State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Xialin; Zhao, Changjian; Song, Mengxiao; Geng, Jia] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610041, Sichuan, Peoples R China; [Sun, Pengcheng; Ke, Meng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Guan, Zeyuan] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China; [Guan, Zeyuan] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan 430070, Hubei, Peoples R China	Sichuan University; Sichuan University; Tsinghua University; Huazhong Agricultural University; Huazhong Agricultural University	Geng, J; Deng, D (corresponding author), Sichuan Univ, West China Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Div Obstet,MOE,State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China.; Geng, J (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610041, Sichuan, Peoples R China.	geng.jia@scu.edu.cn; dengd@scu.edu.cn	li, jia/GVT-7587-2022; Geng, Jia/AAR-2192-2021; Geng, Jia/G-4332-2010	Geng, Jia/0000-0003-4753-1039; Zhang, Xialin/0000-0002-2234-3106; Sun, Pengcheng/0000-0002-7549-1161; Ke, Meng/0000-0002-9213-7439; Deng, Dong/0000-0002-8590-9525	National Key R&D Program of China [2016YFA0502700]; Scientific Department of Sichuan Province [2017JQ0007]	National Key R&D Program of China; Scientific Department of Sichuan Province	This work was supported by funds from National Key R&D Program of China Grant 2016YFA0502700 and Scientific Department of Sichuan Province Grant 2017JQ0007. The authors declare that they have no conflicts of interest with the contents of this article.	Accardi A, 2010, BBA-BIOMEMBRANES, V1798, P1457, DOI 10.1016/j.bbamem.2010.02.022; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AURORA R, 1994, SCIENCE, V264, P1126, DOI 10.1126/science.8178170; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernal V, 2016, APPL MICROBIOL BIOT, V100, P8985, DOI 10.1007/s00253-016-7832-x; Casal M, 1996, MICROBIOL-UK, V142, P1385, DOI 10.1099/13500872-142-6-1385; Casal M, 2008, FEMS MICROBIOL REV, V32, P974, DOI 10.1111/j.1574-6976.2008.00128.x; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gimenez R, 2003, J BACTERIOL, V185, P6448, DOI 10.1128/JB.185.21.6448-6455.2003; Gutsmann T, 2015, NAT PROTOC, V10, P188, DOI 10.1038/nprot.2015.003; Halestrap AP, 2013, COMPR PHYSIOL, V3, P1611, DOI 10.1002/cphy.c130008; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Huysmans GHM, 2012, BIOCHEM J, V445, P157, DOI 10.1042/BJ20120169; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Lee Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7112; Lyssiotis CA, 2014, CELL, V159, P1492, DOI 10.1016/j.cell.2014.12.009; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Ovchinnikov S, 2015, ELIFE, V4, DOI 10.7554/eLife.09248; Paiva S, 2004, YEAST, V21, P201, DOI 10.1002/yea.1056; Park E, 2018, ELIFE, V7, DOI 10.7554/eLife.36629; Qiu B, 2018, CELL RES, V28, P644, DOI 10.1038/s41422-018-0032-8; Sa-Pessoa J, 2013, BIOCHEM J, V454, P585, DOI 10.1042/BJ20130412; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Strugatsky D, 2013, NATURE, V493, P255, DOI 10.1038/nature11684; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005	32	19	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19492	19500		10.1074/jbc.RA118.003876	http://dx.doi.org/10.1074/jbc.RA118.003876			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30333234	hybrid, Green Published			2022-12-26	WOS:000453537300028
J	Menard, C; Folacci, M; Brunello, L; Charreton, M; Collet, C; Mary, R; Rousset, M; Thibaud, JB; Vignes, M; Charnet, P; Cens, T				Menard, Claudine; Folacci, Mathilde; Brunello, Lorene; Charreton, Mercedes; Collet, Claude; Mary, Rosanna; Rousset, Matthieu; Thibaud, Jean-Baptiste; Vignes, Michel; Charnet, Pierre; Cens, Thierry			Multiple combinations of RDL subunits diversify the repertoire of GABA receptors in the honey bee parasite Varroa destructor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; SMALL BROWN PLANTHOPPER; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; ANTENNAL LOBE; GENE FAMILY; RESISTANCE; MUTATION; CHLORIDE; INSECTICIDES	In insects, gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter, and GABA-gated ion channels are the target of different classes of insecticides, including fipronil. We report here the cloning of six subunits (four RDL, one LCCH3, and one GRD) that constitute the repertoire of the GABA-gated ion channel family of the Varroa mite (Varroa destructor), a honey bee ectoparasite. We also isolated a truncated GRD subunit with a premature stop codon. We found that when expressed in Xenopus laevis oocytes, three of the four RDL subunits (VdesRDL1, VdesRDL2, and VdesRDL3) formed functional, homomultimeric anionic receptors, whereas GRD and LCCH3 produced heteromultimeric cationic receptors. These receptors displayed specific sensitivities toward GABA and fipronil, and VdesRDL1 was the most resistant to the insecticide. We identified specific residues in the VdesRDL1 pore-lining region that explain its high resistance to fipronil. VdesRDL4 did not form a functional receptor when expressed alone, but it assembled with VdesRDL1 to form a heteromultimeric receptor with properties distinct from those of the VdesRDL1 homomultimeric receptor. Moreover, VdesRDL1 physically interacted with VdesRDL3, generating a heteromultimeric receptor combining properties of both subunits. On the other hand, we did not detect any functional interaction between VdesLCCH3 and the VdesRDL subunits, an observation that differed from what was previously reported for Drosophila melanogaster. In conclusion, this study provides insights relevant to improve our understanding of the precise role of GABAergic signaling in insects and new tools for the development of Varroa mite-specific insecticidal agents that do not harm honey bees.	[Menard, Claudine; Folacci, Mathilde; Brunello, Lorene; Mary, Rosanna; Rousset, Matthieu; Thibaud, Jean-Baptiste; Vignes, Michel; Charnet, Pierre; Cens, Thierry] Univ Montpellier, Inst Biomol Max Mousseron, CNRS, UMR5247, F-34095 Montpellier 5, France; [Charreton, Mercedes; Collet, Claude] INRA UR 406 Abeilles & Environm, F-84914 Avignon 9, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; INRAE	Cens, T (corresponding author), CRBM, 1919 Route Mende, F-34293 Montpellier, France.	thierry.cens@inserm.fr	Cens, Thierry/M-3337-2017; Vignes, Michel/AAA-7693-2019	Cens, Thierry/0000-0002-4109-2779; Vignes, Michel/0000-0003-0969-2966; THIBAUD, Jean-Baptiste/0000-0002-0824-6465; Folacci, Mathilde/0000-0001-8393-7517; Rousset, Matthieu/0000-0003-2064-2791	INSERM, CNRS; Universite de Montpellier; Agence Nationale de la Recherche [ANR-13-BSV7-0010]	INSERM, CNRS; Universite de Montpellier; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by INSERM, CNRS, the Universite de Montpellier, and Agence Nationale de la Recherche Grant ANR-13-BSV7-0010 (bee channel). The authors declare that they have no conflicts of interest with the contents of this article.	Aronstein K, 1996, INVERTEBR NEUROSCI, V2, P115, DOI 10.1007/BF02214114; Ashby JA, 2012, BIOPHYS J, V103, P2071, DOI 10.1016/j.bpj.2012.10.016; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; Casida JE, 2015, PESTIC BIOCHEM PHYS, V121, P22, DOI 10.1016/j.pestbp.2014.11.006; Cens T, 1996, FEBS LETT, V391, P232, DOI 10.1016/0014-5793(96)00704-1; Cens T, 2015, INSECT BIOCHEM MOLEC, V58, P12, DOI 10.1016/j.ibmb.2015.01.005; Choudhary AF, 2012, EUR J NEUROSCI, V35, P1718, DOI 10.1111/j.1460-9568.2012.08090.x; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Comitani F, 2016, J CHEM THEORY COMPUT, V12, P3398, DOI 10.1021/acs.jctc.6b00303; Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002; Dong XF, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix008; Dupuis JP, 2010, J NEUROPHYSIOL, V103, P458, DOI 10.1152/jn.00798.2009; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Feyereisen R, 2015, PESTIC BIOCHEM PHYS, V121, P61, DOI 10.1016/j.pestbp.2015.01.004; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Garrood WT, 2017, PESTIC BIOCHEM PHYS, V142, P1, DOI 10.1016/j.pestbp.2017.01.007; Gisselmann G, 2004, BRIT J PHARMACOL, V142, P409, DOI 10.1038/sj.bjp.0705818; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Jones Andrew K., 2006, Invertebrate Neuroscience, V6, P123, DOI 10.1007/s10158-006-0026-y; Knipple DC, 2010, PESTIC BIOCHEM PHYS, V97, P140, DOI 10.1016/j.pestbp.2009.09.002; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Nakao T, 2017, NEUROTOXICOLOGY, V60, P293, DOI 10.1016/j.neuro.2016.03.009; Nakao T, 2012, J PESTIC SCI, V37, P37, DOI 10.1584/jpestics.D11-018; Narusuye K, 2007, INSECT MOL BIOL, V16, P723, DOI 10.1111/j.1365-2583.2007.00766.x; Nicholl GCB, 2017, BRIT J PHARMACOL, V174, P781, DOI 10.1111/bph.13736; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Ozoe Y, 2013, ADV INSECT PHYSIOL, V44, P211, DOI 10.1016/B978-0-12-394389-7.00004-1; Price KL, 2014, INSECT BIOCHEM MOLEC, V55, P19, DOI 10.1016/j.ibmb.2014.10.002; Priestley CM, 2003, BRIT J PHARMACOL, V140, P1363, DOI 10.1038/sj.bjp.0705542; Raimondo JV, 2017, CURR OPIN NEUROBIOL, V43, P35, DOI 10.1016/j.conb.2016.11.012; Remnant EJ, 2014, INSECT BIOCHEM MOLEC, V54, P11, DOI 10.1016/j.ibmb.2014.08.008; Sheng CW, 2018, INSECT BIOCHEM MOLEC, V94, P18, DOI 10.1016/j.ibmb.2018.01.003; Shimizu K, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00030; Taylor-Wells J, 2017, NEUROTOXICOLOGY, V60, P207, DOI 10.1016/j.neuro.2016.06.007; Wei Q, 2017, PESTIC BIOCHEM PHYS, V136, P34, DOI 10.1016/j.pestbp.2016.08.007; Wei Q, 2015, ARCH INSECT BIOCHEM, V88, P249, DOI 10.1002/arch.21232; Wolff Mark A., 1998, Invertebrate Neuroscience, V3, P305, DOI 10.1007/BF02577690; Yu LL, 2010, GENOME, V53, P688, DOI [10.1139/g10-056, 10.1139/G10-056]; Yuan GR, 2010, ARCH INSECT BIOCHEM, V74, P81, DOI 10.1002/arch.20361; Yuan Q, 2014, NAT NEUROSCI, V17, P81, DOI 10.1038/nn.3581; ZHANG HG, 1995, MOL PHARMACOL, V48, P835; Zheng Y, 2003, INSECT BIOCHEM MOLEC, V33, P595, DOI 10.1016/S0965-1748(03)00038-9	43	14	14	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19012	19024		10.1074/jbc.RA118.005365	http://dx.doi.org/10.1074/jbc.RA118.005365			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30333227	Green Published, hybrid			2022-12-26	WOS:000458467400016
J	Watanabe, SM; Medina, GN; Eastep, GN; Ghanam, RH; Vlach, J; Saad, JS; Carter, CA				Watanabe, Susan M.; Medina, Gisselle N.; Eastep, Gunnar N.; Ghanam, Ruba H.; Vlach, Jiri; Saad, Jamil S.; Carter, Carol A.			The matrix domain of the Gag protein from avian sarcoma virus contains a PI(4,5)P-2-binding site that targets Gag to the cell periphery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLECKSTRIN HOMOLOGY DOMAINS; MEMBRANE-BINDING; PLASMA-MEMBRANE; TYPE-1 GAG; ESCRT-II; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; SPROUTY PROTEINS; UBIQUITINATION; PHOSPHOINOSITIDES	The Gag protein of avian sarcoma virus (ASV) lacks an N-myristoyl (myr) group, but contains structural domains similar to those of HIV-1 Gag. Similarly to HIV-1, ASV Gag accumulates on the plasma membrane (PM) before egress; however, it is unclear whether the phospholipid PI(4,5)P-2 binds directly to the matrix (MA) domain of ASV Gag, as is the case for HIV-1 Gag. Moreover, the role of PI(4,5)P-2 in ASV Gag localization and budding has been controversial. Here, we report that substitution of residues that define the PI(4,5)P-2-binding site in the ASV MA domain (reported in an accompanying paper) interfere with Gag localization to the cell periphery and inhibit the production of virus-like particles (VLPs). We show that co-expression of Sprouty2 (Spry2) or the pleckstrin homology domain of phospholipase C delta (PH-PLC), two proteins that bind PI(4,5)P-2, affects ASV Gag trafficking to the PM and budding. Replacement of the N-terminal 32 residues of HIV-1 MA, which encode its N-terminal myr signal and its PI(4,5)P-2-binding site, with the structurally equivalent N-terminal 24 residues of ASV MA created a chimera that localized at the PM and produced VLPs. In contrast, the homologous PI(4,5)P-2-binding signal in ASV MA could target HIV-1 Gag to the PM when substituted, but did not support budding. Collectively, these findings reveal a basic patch in both ASV and HIV-1 Gag capable of mediating PM binding and budding for ASV but not for HIV-1 Gag. We conclude that PI(4,5)P-2 is a strong determinant of ASV Gag targeting to the PM and budding.	[Watanabe, Susan M.; Medina, Gisselle N.; Carter, Carol A.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Life Sci Bldg,Rm 248, Stony Brook, NY 11794 USA; [Eastep, Gunnar N.; Ghanam, Ruba H.; Vlach, Jiri; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Alabama System; University of Alabama Birmingham	Carter, CA (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Life Sci Bldg,Rm 248, Stony Brook, NY 11794 USA.	carol.carter@stonybrook.edu	Medina, Gisselle N/AAO-3560-2021; Medina, Gisselle N/ACU-5726-2022	Vlach, Jiri/0000-0002-0874-2055; Eastep, Gunnar/0000-0003-3567-8500; Saad, Jamil/0000-0001-9503-6484	National Institutes of Health (NIH) [R01GM111028]; NIH [R01GM117837]; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048294, R01GM117837, R01GM111028] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health (NIH), Grant R01GM111028 and NIH Grants R01GM117837 (to C. A. C.) and R01GM117837 (to J. S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akbulut S, 2010, MOL BIOL CELL, V21, P3487, DOI 10.1091/mbc.E10-02-0123; Alfadhli A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00253; Ayada T, 2009, ONCOGENE, V28, P1076, DOI 10.1038/onc.2008.464; Cabrita MA, 2006, J BIOL CHEM, V281, P29201, DOI 10.1074/jbc.M603921200; Callahan EM, 2000, J VIROL, V74, P11222, DOI 10.1128/JVI.74.23.11222-11229.2000; Chan J, 2011, J VIROL, V85, P10851, DOI 10.1128/JVI.00760-11; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Dalton AK, 2005, J VIROL, V79, P6227, DOI 10.1128/JVI.79.10.6227-6238.2005; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dick RA, 2015, J VIROL, V89, P10371, DOI 10.1128/JVI.01628-15; Dick RA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00187; Dilley KA, 2010, J VIROL, V84, P6276, DOI 10.1128/JVI.00238-10; Doktorova M, 2017, BIOPHYS J, V113, P2004, DOI 10.1016/j.bpj.2017.08.055; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Ehrlich LS, 2011, J MOL BIOL, V410, P716, DOI 10.1016/j.jmb.2011.04.069; Fernandes F, 2011, TRAFFIC, V12, P438, DOI 10.1111/j.1600-0854.2010.01153.x; Ghanam RH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00055; Gottwein E, 2005, J VIROL, V79, P9134, DOI 10.1128/JVI.79.14.9134-9144.2005; Hahn S, 2011, J IMMUNOL, V186, P5706, DOI 10.4049/jimmunol.1003764; Hamard-Peron E, 2010, J VIROL, V84, P503, DOI 10.1128/JVI.01134-09; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Inlora J, 2014, MBIO, V5, DOI 10.1128/mBio.02202-14; Inlora J, 2011, J VIROL, V85, P3802, DOI 10.1128/JVI.02383-10; Jager S, 2007, J VIROL, V81, P9193, DOI 10.1128/JVI.00044-07; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Kolay S, 2016, BIOCHEM J, V473, P1681, DOI 10.1042/BCJ20160069; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Lim J, 2002, MOL CELL BIOL, V22, P7953, DOI 10.1128/MCB.22.22.7953-7966.2002; Maldonado JO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00302; Martin-Serrano J, 2004, J VIROL, V78, P5554, DOI 10.1128/JVI.78.11.5554-5563.2004; Medina GN, 2011, J VIROL, V85, P7353, DOI 10.1128/JVI.00141-11; Meng B, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0197-x; Murray PS, 2005, STRUCTURE, V13, P1521, DOI 10.1016/j.str.2005.07.010; Nadaraia-Hoke S, 2013, J VIROL, V87, P3609, DOI 10.1128/JVI.03059-12; Olety B, 2014, VIRUS RES, V193, P108, DOI 10.1016/j.virusres.2014.06.015; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Parent LJ, 1996, J VIROL, V70, P1016, DOI 10.1128/JVI.70.2.1016-1026.1996; Pincetic A, 2008, J BIOL CHEM, V283, P29822, DOI 10.1074/jbc.M804157200; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Vana ML, 2004, J VIROL, V78, P13943, DOI 10.1128/JVI.78.24.13943-13953.2004; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Vlach J, 2018, J BIOL CHEM, V293, P18828, DOI 10.1074/jbc.RA118.003944; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Wen Y, 2016, J VIROL, V90, P9518, DOI 10.1128/JVI.01102-16; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Zhang ZL, 2016, J VIROL, V90, P1824, DOI 10.1128/JVI.02814-15; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994; Zhou WJ, 1996, J VIROL, V70, P8540, DOI 10.1128/JVI.70.12.8540-8548.1996	51	6	6	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18841	18853		10.1074/jbc.RA118.003947	http://dx.doi.org/10.1074/jbc.RA118.003947			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30309982	hybrid, Green Published			2022-12-26	WOS:000458467400003
J	Thapa, D; Wu, KY; Stoner, MW; Xie, BX; Zhang, ML; Manning, JR; Lu, ZP; Li, JH; Chen, Y; Gucek, M; Playford, MP; Mehta, NN; Harmon, D; O'Doherty, RM; Jurczak, MJ; Sack, MN; Scott, I				Thapa, Dharendra; Wu, Kaiyuan; Stoner, Michael W.; Xie, Bingxian; Zhang, Manling; Manning, Janet R.; Lu, Zhongping; Li, Jian H.; Chen, Yong; Gucek, Marjan; Playford, Martin P.; Mehta, Nehal N.; Harmon, Daniel; O'Doherty, Robert M.; Jurczak, Michael J.; Sack, Michael N.; Scott, Iain			The protein acetylase GCN5L1 modulates hepatic fatty acid oxidation activity via acetylation of the mitochondrial beta-oxidation enzyme HADHA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; mitochondria; mitochondrial metabolism; fatty acid oxidation; post-translational modification (PTM); GCN5L1; HADHA; liver metabolism; lipid metabolism	SIRT3; METABOLISM; HYPERACETYLATION; SUCCINYLATION; BIOGENESIS; DISEASE; OBESITY; LIVER; HEART	Sirtuin 3 (SIRT3) deacetylates and activates several mitochondrial fatty acid oxidation enzymes in the liver. Here, we investigated whether the protein acetylase GCN5 general control of amino acid synthesis 5-like 1 (GCN5L1), previously shown to oppose SIRT3 activity, is involved in the regulation of hepatic fatty acid oxidation. We show that GCN5L1 abundance is significantly up-regulated in response to an acute high-fat diet (HFD). Transgenic GCN5L1 overexpression in the mouse liver increased protein acetylation levels, and proteomic detection of specific lysine residues identified numerous sites that are co-regulated by GCN5L1 and SIRT3. We analyzed several fatty acid oxidation proteins identified by the proteomic screen and found that hyperacetylation of hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit (HADHA) correlates with increased GCN5L1 levels. Stable GCN5L1 knockdown in HepG2 cells reduced HADHA acetylation and increased activities of fatty acid oxidation enzymes. Mice with a liver-specific deletion of GCN5L1 were protected from hepatic lipid accumulation following a chronic HFD and did not exhibit hyperacetylation of HADHA compared with WT controls. Finally, we found that GCN5L1-knockout mice lack HADHA that is hyperacetylated at three specific lysine residues (Lys-350, Lys-383, and Lys-406) and that acetylation at these sites is significantly associated with increased HADHA activity. We conclude that GCN5L1-mediated regulation of mitochondrial protein acetylation plays a role in hepatic metabolic homeostasis.	[Thapa, Dharendra; Stoner, Michael W.; Xie, Bingxian; Zhang, Manling; Manning, Janet R.; Scott, Iain] Univ Pittsburgh, Dept Med, Div Cardiol, BST E1256,200 Lothrop St, Pittsburgh, PA 15261 USA; [Thapa, Dharendra; Stoner, Michael W.; Xie, Bingxian; Zhang, Manling; Manning, Janet R.; Scott, Iain] Univ Pittsburgh, Dept Med, Vasc Med Inst, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Xie, Bingxian; Harmon, Daniel; O'Doherty, Robert M.; Jurczak, Michael J.] Univ Pittsburgh, Dept Med, Div Endocrinol, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Thapa, Dharendra; Stoner, Michael W.; Xie, Bingxian; Zhang, Manling; Manning, Janet R.; Harmon, Daniel; O'Doherty, Robert M.; Jurczak, Michael J.; Scott, Iain] Univ Pittsburgh, Ctr Metab & Mitochondrial Med, Pittsburgh, PA 15261 USA; [Wu, Kaiyuan; Lu, Zhongping; Li, Jian H.; Chen, Yong; Gucek, Marjan; Playford, Martin P.; Mehta, Nehal N.; Sack, Michael N.] NHLBI, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Lu, Zhongping] George Washington Univ, Vet Adm Med Ctr, Washington, DC 20422 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Scott, I (corresponding author), Univ Pittsburgh, Dept Med, Div Cardiol, BST E1256,200 Lothrop St, Pittsburgh, PA 15261 USA.	scotti2@upmc.edu	Xie, Bingxian/Y-6487-2019; Thapa, Dharendra/AAL-7293-2021; wu, kaiyuan/AAD-6635-2020; Mehta, Nehal N/W-4669-2019	Thapa, Dharendra/0000-0002-1157-5534; Mehta, Nehal N/0000-0003-4939-5130; wu, kaiyuan/0000-0001-7395-4524; chen, yong/0000-0003-1528-3456; Manning, Janet/0000-0001-5763-7713	National Institutes of Health Award [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005102, K22HL116728, ZIAHL006047, ZICHL005903, R56HL132917, T32HL110849, R01HL132917, ZIAHL005199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007052] Funding Source: NIH RePORTER	National Institutes of Health Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Liang Guo (University of Michigan) and Qi-Qun Tang (Fudan University) for the kind gift of the Ac-HADHA (Lys-350/Lys-383/Lys-406) antibody. This project used the UPMC Hillman Cancer Center and Tissue and Research Pathology/Health Sciences Tissue Bank shared resource, which is supported in part by National Institutes of Health Award P30CA047904.	Alrob OA, 2014, CARDIOVASC RES, V103, P485, DOI 10.1093/cvr/cvu156; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Carrico C, 2018, CELL METAB, V27, P497, DOI 10.1016/j.cmet.2018.01.016; Donato V, 2017, NAT CELL BIOL, V19, P341, DOI 10.1038/ncb3491; Fukushima A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99239; Fukushima A, 2016, AM J PHYSIOL-HEART C, V311, pH347, DOI 10.1152/ajpheart.00900.2015; Guo L, 2016, MOL CELL BIOL, V36, P2553, DOI 10.1128/MCB.00227-16; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Koliaki C, 2016, ANNU REV NUTR, V36, P337, DOI 10.1146/annurev-nutr-071715-050656; Lee J, 2016, CELL REP, V16, P201, DOI 10.1016/j.celrep.2016.05.062; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Mansouri A, 2018, GASTROENTEROLOGY, V155, P629, DOI 10.1053/j.gastro.2018.06.083; Nassir F, 2018, J LIPID RES, V59, P967, DOI 10.1194/jlr.M080952; Niwa S, 2017, CURR BIOL, V27, P2569, DOI 10.1016/j.cub.2017.07.013; Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Scott I, 2018, TRENDS CELL BIOL, V28, P346, DOI 10.1016/j.tcb.2018.01.007; Scott I, 2014, J BIOL CHEM, V289, P2864, DOI 10.1074/jbc.M113.521641; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Thapa D, 2017, AM J PHYSIOL-HEART C, V313, pH265, DOI 10.1152/ajpheart.00752.2016; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang LD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00521-8; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200	26	38	39	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17676	17684		10.1074/jbc.AC118.005462	http://dx.doi.org/10.1074/jbc.AC118.005462			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30323061	hybrid, Green Published			2022-12-26	WOS:000450409500002
J	Valenzuela, LM; Draibe, J; Ramos, MQ; Oliveras, XF; Melilli, E; Gerrit, JMC; Ambros, JT				Martinez Valenzuela, Laura; Draibe, Juliana; Quero Ramos, Maria; Fulladosa Oliveras, Xavier; Melilli, Edoardo; Cruzado Gerrit, Josep Maria; Torras Ambros, Juan			Calprotectin as a smoldering activity detection tool and renal prognosis biomarker in ANCA associated vasculitis	PLOS ONE			English	Article							ANTIBODY-ASSOCIATED VASCULITIS; ACUTE KIDNEY INJURY; URINARY CALPROTECTIN; DISEASE; RELAPSE; GLOMERULONEPHRITIS; MYELOPEROXIDASE; CLASSIFICATION; PROTEINASE-3; LEUKOCYTE	Background Calprotectin is produced by neutrophils and macrophages, and released during the acute phase of the ANCA vasculitis. The aim of our study was to determine if serum and urine calprotectin are disease activity and prognosis biomarkers in ANCA vasculitis patients during remission. Methods Forty-two ANCA vasculitis patients were included. Twenty-seven patients were in remission phase under immunosuppressive therapy, and 15 patients were in the acute phase. Four healthy controls were included. We determined calprotectin in serum and urine samples at the time of the inclusion. We recorded the incidence of relapse and the evolution of GFR, proteinuria, hematuria, and C reactive protein and ANCA titer during 24 months of follow-up. Results In remission phase, serum calprotectin was higher than in healthy controls but lower compared to acute patients (p = 0.05). Serum calprotectin at inclusion was higher in patients who increased proteinuria during follow-up (p = 0.04), with hematuria (p = 0.08), and with non-decreasing ANCA titer (p = 0.0019). Serum calprotectin at inclusion in stable patients who subsequently decreased GFR during follow-up was higher compared with those with a stable or improving GFR (p = 0.03). Urine calprotectin was lower in patients with sclerotic histology in remission (p = 0.03) and acute phase (p = 0.12) compared to the rest of histologies. Conclusions Worsening of renal function, hematuria, rising proteinuria and non-decreasing ANCA correlated with higher levels of serum calprotectin at recruitment. Low urine calprotectin was found in patients with sclerotic histology. Calprotectin during remission in ANCA vasculitis may be useful to identify subclinical inflammation and worse renal prognosis patients.	[Martinez Valenzuela, Laura; Draibe, Juliana; Quero Ramos, Maria; Fulladosa Oliveras, Xavier; Melilli, Edoardo; Cruzado Gerrit, Josep Maria; Torras Ambros, Juan] Bellvitge Univ Hosp, Nephrol Unit, Lhospitalet De Llobregat, Spain; [Martinez Valenzuela, Laura; Draibe, Juliana] IDIBELL Biomed Res Inst, Lhospitalet De Llobregat, Spain; [Cruzado Gerrit, Josep Maria; Torras Ambros, Juan] Barcelona Univ, Med Coll, Clin Sci Dept, Lhospitalet De Llobregat, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Ambros, JT (corresponding author), Bellvitge Univ Hosp, Nephrol Unit, Lhospitalet De Llobregat, Spain.; Ambros, JT (corresponding author), Barcelona Univ, Med Coll, Clin Sci Dept, Lhospitalet De Llobregat, Spain.	15268jta@comb.cat	Torras, Joan/AAH-8131-2021	Fulladosa, Xavier/0000-0003-1974-9874; QUERO RAMOS, MARIA/0000-0002-6515-4591	Programa Comite de Recerca-HUB de Formacio Post-Residencia en Recerca, Convocatoria d'Ajuts per la Recerca Clinica 2016 (IDIBELL Biomedical ResearchInstitute); European Regional Development Funds ISCIII, Red Tematica de Investigacion Cooperativa en Salud Red de Investigacion Renal [RD16/0009/0003]	Programa Comite de Recerca-HUB de Formacio Post-Residencia en Recerca, Convocatoria d'Ajuts per la Recerca Clinica 2016 (IDIBELL Biomedical ResearchInstitute); European Regional Development Funds ISCIII, Red Tematica de Investigacion Cooperativa en Salud Red de Investigacion Renal	This study was supported by Programa Comite de Recerca-HUB de Formacio Post-Residencia en Recerca, Convocatoria d'Ajuts per la Recerca Clinica 2016 (IDIBELL Biomedical ResearchInstitute) and European Regional Development Funds ISCIII, Red Tematica de Investigacion Cooperativa en Salud Red de Investigacion Renal; RD16/0009/0003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Programa Comite de Recerca-HUB de Formacio Post-Residencia en Recerca, Convocatoria d'Ajuts per la Recerca Clinica 2016 (IDIBELL Biomedical Research Institute) and European Regional Development Funds ISCIII, Red Tematica de Investigacion Cooperativa en Salud Red de Investigacion Renal; RD16/0009/0003.	Berden A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e26; Berden AE, 2010, J AM SOC NEPHROL, V21, P1628, DOI 10.1681/ASN.2010050477; Draibe JB, 2016, CLIN KIDNEY J, V9, P547, DOI 10.1093/ckj/sfw056; Hara A, 2018, J RHEUMATOL, V45, P521, DOI 10.3899/jrheum.170508; Heller F, 2011, CLIN J AM SOC NEPHRO, V6, P2347, DOI 10.2215/CJN.02490311; Hurnakova J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165498; Karras A, 2017, ANN RHEUM DIS, V76, P1662, DOI 10.1136/annrheumdis-2017-211123; Kemna MJ, 2015, J AM SOC NEPHROL, V26, P537, DOI 10.1681/ASN.2013111233; Kopec-Medrek Magdalena, 2016, Reumatologia (Warsaw), V54, P306, DOI 10.5114/reum.2016.64907; Lionaki S, 2012, ARTHRITIS RHEUM-US, V64, P3452, DOI 10.1002/art.34562; Little MA, 2005, BLOOD, V106, P2050, DOI 10.1182/blood-2005-03-0921; LUQMANI RA, 1994, Q J MED, V87, P671; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Ometto F, 2017, EXP BIOL MED, V242, P859, DOI 10.1177/1535370216681551; Pepper RJ, 2017, ARTHRITIS RHEUMATOL, V69, P185, DOI 10.1002/art.39814; Pepper RJ, 2013, KIDNEY INT, V83, P1150, DOI 10.1038/ki.2013.2; Sanders JSF, 2016, NEPHROL DIAL TRANSPL, V31, P1453, DOI 10.1093/ndt/gfw211; Striz I, 2004, PHYSIOL RES, V53, P245; Thieblemont N, 2016, SEMIN IMMUNOL, V28, P159, DOI 10.1016/j.smim.2016.03.004; Tomasson G, 2012, RHEUMATOLOGY, V51, P100, DOI 10.1093/rheumatology/ker280; Westhoff JH, 2017, EUR J PEDIATR, V176, P745, DOI 10.1007/s00431-017-2907-y; Yates M, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2017-000449	22	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205982	10.1371/journal.pone.0205982	http://dx.doi.org/10.1371/journal.pone.0205982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30347000	gold, Green Published, Green Submitted			2022-12-26	WOS:000447938400029
J	Numponsak, T; Kumla, J; Suwannarach, N; Matsui, K; Lumyong, S				Numponsak, Tosapon; Kumla, Jaturong; Suwannarach, Nakarin; Matsui, Kenji; Lumyong, Saisamorn			Biosynthetic pathway and optimal conditions for the production of indole-3-acetic acid by an endophytic fungus, Colletotrichum fructicola CMU-A109	PLOS ONE			English	Article							PLANT-GROWTH; BACTERIAL BIOSYNTHESIS; IAA BIOSYNTHESIS; DIVERSITY; ACID; TRYPTOPHAN; FUSARIUM	Endophytic fungi are known to produce indole-3-acetic acid (IAA), which can stimulate plant growth. Twenty-seven isolates of endophytic fungi were isolated from Coffea arabica in northern Thailand. Only one isolate (CMU-A109) produced IAA in vitro. This isolate was identified as Colletotrichum fructicola based on morphological characteristics and molecular phylogenetic analysis of a combined five loci (internal transcribed spacer of ribosomal DNA, actin, beta-tubulin 2, chitin synthase and glyceraldehyde-3-phosphate dehydrogenase genes). Identification of a fungal IAA production obtained from indole 3-acetamide (IAM) and tryptophan 2-monooxygenase activity is suggestive of IAM routed IAA biosynthesis. The highest IAA yield (1205.58 +/- 151.89 mu g/mL) was obtained after 26 days of cultivation in liquid medium supplemented with 8 mg/mL L-tryptophan at 30 degrees C. Moreover, the crude fungal IAA could stimulate coleoptile elongation of maize, rice and rye. This is the first report of IAA production by C. fructicola and its ability to produce IAA was highest when compared with previous reports on IAA produced by fungi.	[Numponsak, Tosapon; Kumla, Jaturong; Suwannarach, Nakarin; Lumyong, Saisamorn] Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand; [Matsui, Kenji] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Yamaguchi, Japan; [Lumyong, Saisamorn] Chiang Mai Univ, Ctr Excellence Renewable Energy, Chiang Mia, Thailand	Chiang Mai University; Yamaguchi University; Chiang Mai University	Lumyong, S (corresponding author), Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand.; Lumyong, S (corresponding author), Chiang Mai Univ, Ctr Excellence Renewable Energy, Chiang Mia, Thailand.	saisamorn.l@cmu.ac.th	Suwannarach, Nakarin/P-6078-2019	Suwannarach, Nakarin/0000-0002-2653-1913	Thailand Research Fund (TRF) under Research-Team Association Grant [RTA5580006]; Japan Society for the Promotion of Science (JSPS); Center of Excellence on Biodiversity (BDC), The Office of The Higher Education Commission [BDC-PG2-159010]; Center of Excellence for Renewable Energy, Chiang Mai University	Thailand Research Fund (TRF) under Research-Team Association Grant(Thailand Research Fund (TRF)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center of Excellence on Biodiversity (BDC), The Office of The Higher Education Commission; Center of Excellence for Renewable Energy, Chiang Mai University	This work was supported by Thailand Research Fund (TRF) under Research-Team Association Grant (RTA5580006) (http://www.trf.or.th); Japan Society for the Promotion of Science (JSPS) in Core-to-Core Program (http://www.jsps.go.jp/english/e-core_to_core); Center of Excellence on Biodiversity (BDC), The Office of The Higher Education Commission, (BDC-PG2-159010) (http://www.bdc-perdo.com); and The Center of Excellence for Renewable Energy, Chiang Mai University (http://www.cmu.ac.th).	Abd-Alla M. H., 2013, Journal of Biology and Earth Sciences, V3, pB182; Anjali Bose, 2013, Mycology - An International Journal on Fungal Biology, V4, P103, DOI 10.1080/21501203.2013.823891; Apine OA, 2011, J APPL MICROBIOL, V110, P1235, DOI 10.1111/j.1365-2672.2011.04976.x; Bae H, 2009, J EXP BOT, V60, P3279, DOI 10.1093/jxb/erp165; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; CARROLL G, 1988, ECOLOGY, V69, P2, DOI 10.2307/1943154; Chen XM, 2010, J PLANT GROWTH REGUL, V29, P328, DOI 10.1007/s00344-010-9139-y; Chung K. R., 2004, Journal of Biological Sciences, V4, P744; Chung KR, 2003, FEMS MICROBIOL LETT, V226, P23, DOI 10.1016/S0378-1097(03)00605-0; Chutima R, 2012, SYMBIOSIS, V56, P35, DOI 10.1007/s13199-012-0158-2; Dai CC, 2008, AFR J BIOTECHNOL, V7, P3505; Dasri K, 2014, KKU RES J, V19, P268; Dolatabadi H. K., 2012, African Journal of Biotechnology, V11, P1644; Duca D, 2014, ANTON LEEUW INT J G, V106, P85, DOI 10.1007/s10482-013-0095-y; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHMANN A, 1977, J CHROMATOGR, V132, P267, DOI 10.1016/S0021-9673(00)89300-0; Furukawa T, 1996, PLANT CELL PHYSIOL, V37, P899, DOI 10.1093/oxfordjournals.pcp.a029037; Guerber JC, 2003, MYCOLOGIA, V95, P872, DOI 10.2307/3762016; Hariharan Harikrishnan, 2014, International Journal of Current Microbiology and Applied Sciences, V3, P158; Hilbert M, 2012, NEW PHYTOL, V196, P520, DOI 10.1111/j.1469-8137.2012.04275.x; Khamna S., 2010, EURASIA J BIOSCI, V4, P23, DOI [DOI 10.5053/EJOBIOS.2010.4.0.4, 10.5053/ejobios.2010.4.0.4]; Khan AL, 2014, J PLANT INTERACT, V9, P731, DOI 10.1080/17429145.2014.917384; Khan AL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-3; Khan AR, 2015, WORLD J MICROB BIOT, V31, P1461, DOI 10.1007/s11274-015-1888-0; Kumla J, 2014, ANN MICROBIOL, V64, P707, DOI 10.1007/s13213-013-0706-x; Liu F, 2015, PERSOONIA, V35, P63, DOI 10.3767/003158515X687597; Mahmoud G.A.-E., 2017, EUR J BIOL RES, V7, P315, DOI [10.5281/zenodo.1012348, DOI 10.5281/ZENODO.1012348]; Maor R, 2004, APPL ENVIRON MICROB, V70, P1852, DOI 10.1128/AEM.70.3.1852-1854.2004; Morath Shannon U., 2012, Fungal Biology Reviews, V26, P73, DOI 10.1016/j.fbr.2012.07.001; Mujahid M, 2011, APPL MICROBIOL BIOT, V89, P1001, DOI 10.1007/s00253-010-2951-2; Nutaratat P, 2016, ARCH MICROBIOL, V198, P429, DOI 10.1007/s00203-016-1202-z; OBERHANSLI T, 1991, J GEN MICROBIOL, V137, P2273, DOI 10.1099/00221287-137-10-2273; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Page RD, 2001, TREEVIEW; Patten CL, 1996, CAN J MICROBIOL, V42, P207, DOI 10.1139/m96-032; Pedraza RO, 2004, FEMS MICROBIOL LETT, V233, P15, DOI 10.1016/j.femsle.2004.01.047; Pineda A, 2010, TRENDS PLANT SCI, V15, P507, DOI 10.1016/j.tplants.2010.05.007; Prihastuti H, 2009, FUNGAL DIVERS, V39, P89; Quint M, 2006, CURR OPIN PLANT BIOL, V9, P448, DOI [10.1016/j.pbi.2006.07.006, 10.1104/pp.17.00765]; Rao RP, 2010, GENETICS, V185, P211, DOI 10.1534/genetics.109.112854; Reineke G, 2008, MOL PLANT PATHOL, V9, P339, DOI [10.1111/j.1364-3703.2008.00470.x, 10.1111/J.1364-3703.2008.00470.X]; Robinson M, 1998, APPL ENVIRON MICROB, V64, P5030; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Ronquist F, 2006, WORLD J MICROB BIOT, V22, P1185, DOI [10.1007/s11274-006-9160-2, DOI 10.1007/S11274-006-9160-2]; Shilts T., 2005, Journal of Biological Sciences, V5, P205; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Spaepen S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001438; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stone JK., 2004, BIODIVERSITY FUNGI, P241, DOI [10.1016/B978-012509551-8/50015-5, DOI 10.1016/B978-012509551-8/50015-5]; Sun PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114196; Suwannarach N, 2015, BIOL CONTROL, V90, P25, DOI 10.1016/j.biocontrol.2015.05.008; Suwannarach N, 2012, CHIANG MAI J SCI, V39, P389; Syamsia, 2015, PROC FOOD SCI, V3, P96, DOI 10.1016/j.profoo.2015.01.009; Szkop M, 2013, ANTON LEEUW INT J G, V103, P683, DOI 10.1007/s10482-012-9838-4; Tsavkelova E, 2012, FUNGAL GENET BIOL, V49, P48, DOI 10.1016/j.fgb.2011.10.005; Tsavkelova EA, 2007, MICROBIOL RES, V162, P69, DOI 10.1016/j.micres.2006.07.014; Waqas M, 2014, J PLANT INTERACT, V9, P478, DOI 10.1080/17429145.2013.860562; Waqas M, 2012, MOLECULES, V17, P10754, DOI 10.3390/molecules170910754; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xin G, 2009, MYCOL RES, V113, P973, DOI 10.1016/j.mycres.2009.06.001; Yurekli F, 2003, MYCOL RES, V107, P305, DOI 10.1017/S0953756203007391; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	62	29	29	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205070	10.1371/journal.pone.0205070	http://dx.doi.org/10.1371/journal.pone.0205070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335811	gold, Green Published, Green Submitted			2022-12-26	WOS:000447701300021
J	Raimondi, F; Migliaro, F; Verdoliva, L; Gragnaniello, D; Poggi, G; Kosova, R; Sansone, C; Vallone, G; Capasso, L				Raimondi, Francesco; Migliaro, Fiorella; Verdoliva, Luisa; Gragnaniello, Diego; Poggi, Giovanni; Kosova, Roberta; Sansone, Carlo; Vallone, Gianfranco; Capasso, Letizia			Visual assessment versus computer-assisted gray scale analysis in the ultrasound evaluation of neonatal respiratory status	PLOS ONE			English	Article							LUNG ULTRASOUND; TEXTURE ANALYSIS; PULMONARY-EDEMA; VENTILATION	Background and aim Lung ultrasound has been used to describe common respiratory diseases both by visual and computer-assisted gray scale analysis. In the present paper, we compare both methods in assessing neonatal respiratory status keeping two oxygenation indexes as standards. Patients and methods Neonates admitted to the NICU for respiratory distress were enrolled. Two neonatologists not attending the patients performed a lung scan, built a single frame database and rated the images with a standardized score. The same dataset was processed using the gray scale analysis implemented with textural features and machine learning analysis. Both the oxygenation ratio (PaO2/FiO2) and the alveolar arterial oxygen gradient (A-a) were kept as reference standards. Results Seventy-five neonates with different respiratory status were enrolled in the study and a dataset of 600 ultrasound frames was built. Visual assessment of respiratory status correlated significantly with PaO2/FiO2 (r = -0.55; p<0.0001) and the A-a (r = 0.59; p<0.0001) with a strong interobserver agreement (K = 0.91). A significant correlation was also found between both oxygenation indexes and the gray scale analysis of lung ultrasound scans using regions of interest corresponding to 50K (r = -0.42; p<0.002 for PaO2/FiO2; r = 0.46 p<0.001 for A-a) and 100K (r = -0.35 p<0.01 for PaO2/FiO2; r = 0.58 p<0.0001 for A-a) pixels regions of interest. Conclusions A semi quantitative estimate of the degree of neonatal respiratory distress was demonstrated both by a validated scoring system and by computer assisted analysis of the ultrasound scan. This data may help to implement point of care ultrasound diagnostics in the NICU.	[Raimondi, Francesco; Migliaro, Fiorella; Kosova, Roberta; Capasso, Letizia] Univ Federico II, Div Neonatol, Sect Pediat, Dept Translat Med Sci, Naples, Italy; [Verdoliva, Luisa; Gragnaniello, Diego; Poggi, Giovanni; Sansone, Carlo] Univ Federico II, Dept Elect Engn & Informat Technol, Naples, Italy; [Vallone, Gianfranco] Univ Federico II, Dept Adv Biomed Sci, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Raimondi, F (corresponding author), Univ Federico II, Div Neonatol, Sect Pediat, Dept Translat Med Sci, Naples, Italy.	raimondi@unina.it	Sansone, Carlo/AGZ-8858-2022; capasso, letizia/AAX-1286-2020	Gragnaniello, Diego/0000-0003-4271-8160; capasso, letizia/0000-0002-0373-9201; Raimondi, Francesco/0000-0003-3250-1582				Bonet-Carne E, 2015, ULTRASOUND OBST GYN, V45, P427, DOI 10.1002/uog.13441; Brat R, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.1797; Cattarossi L, 2010, J PERINAT MED, V38, P557, DOI [10.1515/JPM.2010.096, 10.1515/jpm.2010.096]; Cisneros-Velarde P, 2016, IEEE ENG MED BIO, P4117, DOI 10.1109/EMBC.2016.7591632; Clausi DA, 2002, CAN J REMOTE SENS, V28, P45, DOI 10.5589/m02-004; Corradi F, 2016, CHEST, V150, P640, DOI 10.1016/j.chest.2016.04.013; Corradi F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/868707; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Piastra M, 2014, EARLY HUM DEV, V90, pS41, DOI 10.1016/S0378-3782(14)50011-4; Picano E, 2006, J AM SOC ECHOCARDIOG, V19, P356, DOI 10.1016/j.echo.2005.05.019; Raimondi F., 2014, NEOREVIEWS, V15, pe2, DOI [10.1542/neo.15-1-e2, DOI 10.1542/NEO.15-1-E2]; Raimondi F, 2016, J PEDIATR-US, V175, P74, DOI 10.1016/j.jpeds.2016.04.018; Raimondi F, 2014, PEDIATRICS, V134, pE1089, DOI 10.1542/peds.2013-3924; Rambhia SH, 2016, CURR PROBL DIAGN RAD; Raso R, 2015, JACC-CARDIOVASC IMAG, V8, P495, DOI 10.1016/j.jcmg.2014.06.022; Rodriguez-Fanjul J, 2016, NEONATOLOGY, V110, P198, DOI 10.1159/000445932; Soh LK, 1999, IEEE T GEOSCI REMOTE, V37, P780, DOI 10.1109/36.752194; Veeramani SK, 2016, J MATERN-FETAL NEO M, V29, P1844, DOI 10.3109/14767058.2015.1064888; Volpicelli G, 2012, INTENS CARE MED, V38, P577, DOI 10.1007/s00134-012-2513-4; Zanforlin A, 2014, JACC-CARDIOVASC IMAG, V7, P635, DOI 10.1016/j.jcmg.2013.12.018	20	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0202397	10.1371/journal.pone.0202397	http://dx.doi.org/10.1371/journal.pone.0202397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335753	Green Published, gold, Green Submitted			2022-12-26	WOS:000447701300002
J	Liang, LZ; Chen, F; Shi, L; Niu, SK				Liang, Lizhuang; Chen, Feng; Shi, Lei; Niu, Shukui			NDVI-derived forest area change and its driving factors in China	PLOS ONE			English	Article							GLOBAL LAND-COVER; DEFORESTATION; PHENOLOGY; MODIS; CLASSIFICATION; TRANSITION; LATITUDE; MODELS; IMPACT; GROWTH	China harbors diversified forest types, from tropical rainforest to boreal coniferous forest, and has implemented large-scale reforestation/afforestation programs over the past several decades. However, little information is available on changes in China's forest area and the causes. In this study, we used the classified forest distribution thematic map derived from Normalized Difference Vegetation Index (NDVI) datasets and a revised IPAT model to examine China's forest area change and the possible driving factors from 1982 to 2006. Overall, NDVI-derived forest areas were numerically consistent with those reported in the 3rd, 4th, 5th, and 6th National Forest Inventories, respectively. Over the past 25 years, China's forest area was estimated to have an average of 169.18 million hectares with an annual increase of 0.15 million hectares (c.a. a total net increment of 3.60 million hectares), which is equivalent to 0.089% of the relative annual change rate. However, a large difference in the changing rate and direction of forest area at the province level was found; for instance, forest area has declined in 10 provinces, mainly in Northeastern and Southern China, while 21 provinces showed an increase. The changes were most likely attributed to the policy regarding the import and export of timber and affluence (per capita gross domestic product), and both contributed more than 80% of the total contribution of the six factors of the revised IPAT model.	[Liang, Lizhuang; Chen, Feng; Niu, Shukui] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Shi, Lei] Int Ctr Bamboo & Rattan, State Forestry Adm, Key Lab Sci & Technol Bamboo & Rattan, Beijing, Peoples R China	Beijing Forestry University; International Centre for Bamboo & Rattan	Niu, SK (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.; Shi, L (corresponding author), Int Ctr Bamboo & Rattan, State Forestry Adm, Key Lab Sci & Technol Bamboo & Rattan, Beijing, Peoples R China.	leishi@icbr.ac.an; niushukui@bjfu.edu.cn	Shi, Lei/F-2820-2011	Shi, Lei/0000-0002-5569-8448	Special Fund for Basic Scientific Research of International Center for Bamboo and Rattan [1632015005]; Science & Technology Extension Project of State Forestry Administration [2015-04]; National Natural Science Foundation of China [31300177]	Special Fund for Basic Scientific Research of International Center for Bamboo and Rattan; Science & Technology Extension Project of State Forestry Administration; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially funded by the Special Fund for Basic Scientific Research of International Center for Bamboo and Rattan (1632015005), the Science & Technology Extension Project of State Forestry Administration (2015-04) and the National Natural Science Foundation of China (31300177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Special Fund for Basic Scientific Research of International Center for Bamboo and Rattan, the Science & Technology Extension Project of State Forestry Administration to and the National Natural Science Foundation of China. We also thank State Forestry Administration and International Center for Bamboo and Rattan who provided valuable support. We also want to express our gratitude to Dr. Marcelo Sacardi Biudes and two anonymous reviewers for their insightful suggestions in improving this manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; [Anonymous], 2001, EDITORIAL BOARD VEGE; [Anonymous], 2010, CHINA EC STAT DATABA; BAUER A, 1988, AGR FOREST METEOROL, V44, P131, DOI 10.1016/0168-1923(88)90012-3; Beresford AE, 2018, ENVIRON CONSERV, V45, P49, DOI [10.1017/S0376892917000157, 10.1017/s0376892917000157]; Channan S, 2014, GLOBAL MOSAICS STAND; Chertow MR., 2000, J IND ECOL, V4, P13, DOI [DOI 10.1162/10881980052541927, 10.1162/10881980052541927]; China Foreign Economic and Trade Yearbook Editorial Committee, 1984, CHINA FOREIGN EC TRA; Chinese Academy of Forest Inventory and Planning, 2004, 6 NATL FOREST INVENT; Culas RJ, 2007, ECOL ECON, V61, P429, DOI 10.1016/j.ecolecon.2006.03.014; EHRLICH PR, 1972, SCI PUBLIC AFF, V28, P16; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; FAO, 2010, GLOBAL FOREST RESOUR; FAO (Food and agriculture organization of the United Nations), 2016, STAT WORLDS FOR 2016; Fava F, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9010085; Food and Agriculture Organization-FAO, 2016, GLOB FOR RES ASS 201, V2nd; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Fritz S, 2008, GLOBAL CHANGE BIOL, V14, P1057, DOI 10.1111/j.1365-2486.2007.01519.x; Grainger A, 1995, AREA, V27, P242; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Herold M, 2008, REMOTE SENS ENVIRON, V112, P2538, DOI 10.1016/j.rse.2007.11.013; Hu HF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11203; Janssen TAJ, 2018, BIOL CONSERV, V218, P163, DOI 10.1016/j.biocon.2017.12.004; Li DQ, 2018, REMOTE SENS, V10, P22; Li Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07732-5; Liu ZH, 2018, INT J REMOTE SENS, V39, P1092, DOI 10.1080/01431161.2017.1381352; Magnussen S, 2017, EUR J FOREST RES, V136, P839, DOI 10.1007/s10342-017-1074-z; Massey R, 2017, REMOTE SENS ENVIRON, V198, P490, DOI 10.1016/j.rse.2017.06.033; MATHER AS, 1992, AREA, V24, P367; Mather AS, 1999, GEOGRAPHY, V84, P55; Mayer AL, 2005, SCIENCE, V308, P359, DOI 10.1126/science.1109476; Milodowski DT, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa7e1e; Moulin S, 1997, J CLIMATE, V10, P1154, DOI 10.1175/1520-0442(1997)010<1154:GSAOVP>2.0.CO;2; National Bureau of Statistics of China, 2009, CHIN STAT YB; National Bureau of Statistics Rural Social and Economic Investigation Division, 2009, COMP AGR STAT 30 YEA; National Bureau of Statistics Rural Social and Economic Survey Corp, 2000, NEW CHIN 50 YEAR AGR; Orlandi F, 2010, THEOR APPL CLIMATOL, V102, P265, DOI 10.1007/s00704-009-0239-1; Perz SG, 2007, PROF GEOGR, V59, P105, DOI 10.1111/j.1467-9272.2007.00594.x; Pfaff A, 2010, LAND USE POLICY, V27, P119, DOI 10.1016/j.landusepol.2009.07.010; Pinzon JE, 2005, INTERD MATH SCI, V5, P167; Shi L., 2011, P SPIE, V8203; State Forestry Administration, 1994, STAT FOR RES CHIN 19; State Forestry Administration, 2014, GEN SIT FOR RES CHIN; State Forestry Administration, 2000, STAT FOR RES CHIN 19; State Forestry Administration, 2008, CHINA FORESTRY STAT; State Forestry Administration, 1990, STAT FOR RES CHIN 19; State Forestry Administration P.s.R.o.C.S., 2005, STAT FOR RES CHIN 19; Tucker C.J., 2004, GLOBAL INVENTORY MOD; TUCKER CJ, 1981, REMOTE SENS ENVIRON, V11, P171, DOI 10.1016/0034-4257(81)90018-3; TUCKER CJ, 1985, SCIENCE, V227, P369, DOI 10.1126/science.227.4685.369; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Turner JA, 2006, SCAND J FOREST RES, V21, P73, DOI 10.1080/02827580500478506; Turner JA, 2008, SCAND J FOREST RES, V23, P154, DOI 10.1080/02827580801995307; Waggoner PE, 2002, P NATL ACAD SCI USA, V99, P7860, DOI 10.1073/pnas.122235999; Wang S, 2004, FOREST POLICY ECON, V6, P71, DOI 10.1016/S1389-9341(02)00078-3; Wardlow BD, 2008, REMOTE SENS ENVIRON, V112, P1096, DOI 10.1016/j.rse.2007.07.019; Wear DN, 1999, FOREST ECOL MANAG, V118, P107, DOI 10.1016/S0378-1127(98)00491-5; Xiong MZ, 2004, STUDY RELATIONSHIP W; Yin H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01582-x; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5; Zhang J, 2007, WORLD DEV, V35, P2150, DOI 10.1016/j.worlddev.2007.02.005; Zhang YB, 1997, FOREST PROD J, V47, P27; Zhao X, 2015, LANDSCAPE ECOL, V30, P1599, DOI 10.1007/s10980-014-0095-y; Zhao X, 2012, J INTEGR PLANT BIOL, V54, P713, DOI 10.1111/j.1744-7909.2012.01167.x	65	16	19	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205885	10.1371/journal.pone.0205885	http://dx.doi.org/10.1371/journal.pone.0205885			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX3PM	30332483	Green Submitted, gold, Green Published			2022-12-26	WOS:000447638200074
J	Mahpour, A; Scruggs, BS; Smiraglia, D; Ouchi, T; Gelman, IH				Mahpour, Amin; Scruggs, Benjamin S.; Smiraglia, Dominic; Ouchi, Toru; Gelman, Irwin H.			A methyl-sensitive element induces bidirectional transcription in TATA-less CpG island-associated promoters	PLOS ONE			English	Article							RNA-POLYMERASE-II; CORE PROMOTER; GENE-EXPRESSION; START SITES; GENOME-WIDE; CHROMATIN IMMUNOPRECIPITATION; HOUSEKEEPING GENES; DNA METHYLATION; ALPHA-AMANITIN; KEY COMPONENT	How TATA-less promoters such as those within CpG islands (CGI) control gene expression is still a subject of active research. Here, we have identified the "CGCG element", a ten base pair motif with a consensus sequence of TCTCGCGAGA present in a group of promoter-associated CGI-enriched in ribosomal protein and housekeeping genes. This element is evolutionarily conserved in vertebrates, found in DNase-accessible regions and employs RNA Pol II to activate gene expression. Through analysis of capped-nascent transcripts and supporting evidence from reporter assays, we demonstrate that this element activates bidirectional transcription through divergent start sites. Methylation of this element abrogates the associated promoter activity. When coincident with a TATA-box, directional transcription remains CGCG-dependent. Because the CGCG element is sufficient to drive transcription, we propose that its unmethylated form functions as a heretofore undescribed promoter element of a group of TATA-less CGI-associated promoters.	[Mahpour, Amin; Smiraglia, Dominic; Ouchi, Toru; Gelman, Irwin H.] Roswell Pk Comprehens Canc Ctr, Dept Canc Genet, Buffalo, NY 14263 USA; [Scruggs, Benjamin S.] NIEHS, Epigenet & Stem Cell Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA; [Mahpour, Amin] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Harvard Medical School; Massachusetts General Hospital	Mahpour, A; Gelman, IH (corresponding author), Roswell Pk Comprehens Canc Ctr, Dept Canc Genet, Buffalo, NY 14263 USA.; Mahpour, A (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA.	amahpour@mgh.harvard.edu; irwin.gelman@roswellpark.org	Smiraglia, Dominic/R-2069-2019; Mahpour, Amin/ABB-4994-2020	Smiraglia, Dominic/0000-0001-8852-1510; Mahpour, Amin/0000-0001-5885-1340; Gelman, Irwin/0000-0001-9204-207X	Roswell Park Comprehensive Cancer Center; National Cancer Institute (NCI) grant [P30CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Roswell Park Comprehensive Cancer Center; National Cancer Institute (NCI) grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Roswell Park Comprehensive Cancer Center and National Cancer Institute (NCI) grant P30CA016056 involving the use of the Genomics Shared Resource. The work was also funded by institutional funds provided to TO.	Anish R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005103; Brocks D, 2017, NAT GENET, V49, P1052, DOI 10.1038/ng.3889; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1998, COLD SPRING HARB SYM, V63, P75, DOI 10.1101/sqb.1998.63.75; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen Y, 2016, NAT GENET, V48, P984, DOI 10.1038/ng.3616; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Domcke S, 2015, NATURE, V528, P575, DOI 10.1038/nature16462; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Emami KH, 1997, GENE DEV, V11, P3007, DOI 10.1101/gad.11.22.3007; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guo G, 2013, GENE, V527, P448, DOI 10.1016/j.gene.2013.07.006; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; HAUN RS, 1993, J BIOL CHEM, V268, P8793; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; KEDINGER C, 1970, BIOCHEM BIOPH RES CO, V38, P165, DOI 10.1016/0006-291X(70)91099-5; Kovalskaya E, 2006, VIROLOGY, V346, P373, DOI 10.1016/j.virol.2005.11.007; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mikula M, 2010, DNA RES, V17, P245, DOI 10.1093/dnares/dsq016; Ndlovu MN, 2011, TRENDS BIOCHEM SCI, V36, P381, DOI 10.1016/j.tibs.2011.03.002; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Ohshima N, 2003, J BIOL CHEM, V278, P22928, DOI 10.1074/jbc.M303109200; Parry TJ, 2010, GENE DEV, V24, P2013, DOI 10.1101/gad.1951110; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raghav SK, 2012, MOL CELL, V46, P335, DOI 10.1016/j.molcel.2012.03.017; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; Rozenberg JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-67; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wyrwicz LS, 2007, ACTA BIOCHIM POL, V54, P89, DOI 10.18388/abp.2007_3273; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yamashita D, 2007, MOL CELL BIOL, V27, P2003, DOI 10.1128/MCB.01462-06; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Yang MQ, 2011, NUCLEIC ACIDS RES, V39, P2175, DOI 10.1093/nar/gkq1035; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	58	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205608	10.1371/journal.pone.0205608	http://dx.doi.org/10.1371/journal.pone.0205608			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332484	Green Published, Green Submitted, gold			2022-12-26	WOS:000447638200057
J	Sharma, A; Manolakos, ES				Sharma, Anuj; Manolakos, Elias S.			Multi-criteria protein structure comparison and structural similarities analysis using pyMCPSC	PLOS ONE			English	Article							STRUCTURE ALIGNMENT; HIGH-THROUGHPUT; CLASSIFICATION; SCOP	Protein Structure Comparison (PSC) is a well developed field of computational proteomics with active interest from the research community, since it is widely used in structural biology and drug discovery. With new PSC methods continuously emerging and no clear method of choice, Multi-Criteria Protein Structure Comparison (MCPSC) is commonly employed to combine methods and generate consensus structural similarity scores. We present pyMCPSC, a Python based utility we developed to allow users to perform MCPSC efficiently, by exploiting the parallelism afforded by the multi-core CPUs of today's desktop computers. We show how pyMCPSC facilitates the analysis of similarities in protein domain datasets and how it can be extended to incorporate new PSC methods as they are becoming available. We exemplify the power of pyMCPSC using a case study based on the Proteus_300 dataset. Results generated using pyMCPSC show that MCPSC scores form a reliable basis for identifying the true classification of a domain, as evidenced both by the ROC analysis as well as the Nearest-Neighbor analysis. Structure similarity based "Phylogenetic Trees" representation generated by pyMCPSC provide insight into functional grouping within the dataset of domains. Furthermore, scatter plots generated by pyMCPSC show the existence of strong correlation between protein domains belonging to SCOP Class C and loose correlation between those of SCOP Class D. Such analyses and corresponding visualizations help users quickly gain insights about their datasets. The source code of pyMCPSC is available under the GPLv3.0 license through a GitHub repository (https://githuthcom/xulesc/pymcpsc).	[Sharma, Anuj; Manolakos, Elias S.] Natl & Kapodistrian Univ Athens, Dept Informat & Telecommun, Athens, Greece; [Manolakos, Elias S.] Northeastern Univ, Boston, MA 02115 USA	National & Kapodistrian University of Athens; Northeastern University	Manolakos, ES (corresponding author), Natl & Kapodistrian Univ Athens, Dept Informat & Telecommun, Athens, Greece.; Manolakos, ES (corresponding author), Northeastern Univ, Boston, MA 02115 USA.	eliasm@di.uoa.gr	Manolakos, Elias/AAM-4957-2021	Manolakos, Elias/0000-0001-6376-0419	European Union (European Social Fund ESF); Greek national funds, through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program "Heracleitus II"	European Union (European Social Fund ESF)(European Social Fund (ESF)European Commission); Greek national funds, through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program "Heracleitus II"	This research was supported by the European Union (European Social Fund ESF) and Greek national funds, through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program "Heracleitus II."; The authors would like to acknowledge the support of this research by the European Union (European Social Fund ESF) and Greek national funds, through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program "Heracleitus II".	Andonov R, 2008, LECT N BIOINFORMAT, V5251, P162, DOI 10.1007/978-3-540-87361-7_14; Balaji S, 2007, J BIOSCIENCES, V32, P83, DOI 10.1007/s12038-007-0008-1; Barthel D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-416; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Cox T. F., 2000, MULTIDIMENSIONAL SCA; Csaba G, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-23; Dawson NL, 2017, NUCLEIC ACIDS RES, V45, pD289, DOI 10.1093/nar/gkw1098; Duran-Frigola M, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005522; Haupt VJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065894, 10.1371/journal.pone.0059937]; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Krasnogor N, 2004, BIOINFORMATICS, V20, P1015, DOI 10.1093/bioinformatics/bth031; Kufareva Irina, 2012, Methods Mol Biol, V857, P231, DOI 10.1007/978-1-61779-588-6_10; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Malod-Dognin N, 2014, BIOINFORMATICS, V30, P1259, DOI 10.1093/bioinformatics/btu020; Mattson T., 2010, P ACM IEEE INT C HIG, P1, DOI [10.1109/SC.2010.53, DOI 10.1109/SC.2010.53]; Mills CL, 2015, COMPUT STRUCT BIOTEC, V13, P182, DOI 10.1016/j.csbj.2015.02.003; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Page RDM, 2012, TRENDS ECOL EVOL, V27, P113, DOI 10.1016/j.tree.2011.12.002; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Poleksic A, 2009, BIOINFORMATICS, V25, P2751, DOI 10.1093/bioinformatics/btp530; Powers D. M, 2011, ARXIV201016061; Redfern OC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000485; Shah AA, 2010, IEEE T NANOBIOSCI, V9, P144, DOI 10.1109/TNB.2010.2043851; Sharma Anuj, 2013, 2013 IEEE International Symposium on Parallel and Distributed Processing, Workshops and PhD Forum (IPDPSW), P510, DOI 10.1109/IPDPSW.2013.222; Sharma A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/563674; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Teplitsky E, 2015, J STRUCT BIOL, V191, P49, DOI 10.1016/j.jsb.2015.05.006; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Van Rossum G., 1995, PYTHON TUTORIAL; Waskom M., 2014, **DATA OBJECT**, DOI [10.5281/zenodo.12710, DOI 10.5281/ZENODO.12710]; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhu JH, 2005, PROTEINS, V58, P618, DOI 10.1002/prot.20331	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204587	10.1371/journal.pone.0204587	http://dx.doi.org/10.1371/journal.pone.0204587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332415	Green Submitted, Green Published, gold			2022-12-26	WOS:000447638200018
J	Suwarto, S; Diahtantri, RA; Hidayat, MJ; Widjaya, B				Suwarto, Suhendro; Diahtantri, Riyanti Astrid; Hidayat, Mohammad Jauharsyah; Widjaya, Bing			Nonalcoholic fatty liver disease is associated with increased hemoconcentration, thrombocytopenia, and longer hospital stay in dengue-infected patients with plasma leakage	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; METABOLIC SYNDROME; VIRUS-REPLICATION; CHILDREN; PATHOGENESIS; INVOLVEMENT; SEVERITY; SIZE; SEROTYPE; FAILURE	A prominent histopathological feature of fatal dengue cases is hepatic steatosis. However, the association between hepatic steatosis and dengue severity is unknown. We conducted a study to determine the associations of nonalcoholic fatty liver disease (NAFLD) with laboratory markers of dengue severity and length of hospital stay (LOS). A retrospective study was conducted at a private hospital in Jakarta, Indonesia, from December 2011 to December 2016. Bivariate analysis was performed to analyze the associations of laboratory markers of dengue severity and LOS with the presence or absence of NAFLD in no-plasma-leakage (no leakage) and plasma-leakage (leakage) groups. There were 267 dengue-infected patients included in this study. Of these patients, 115 (43.1%) were classified as belonging to the no leakage group, and 152 (56.9%) were classified as belonging to the leakage group. Of the 115 patients belonging to the no leakage group, 53 (46.1%) did not have NAFLD, and 62 (53.9%) had NAFLD. Of the 152 patients belonging to the leakage group, 85 (55.9%) did not have NAFLD, and 67 (44.1%) had NAFLD. Leakage group patients with NAFLD experienced significantly higher hemoconcentration severity (p = 0.04), lower platelet count (p = 0.004) and higher LOS (p = 0.042) than did leakage group patients without NAFLD. The presence of NAFLD in dengue-infected patients with plasma leakage was associated with more severe hemoconcentration, thrombocytopenia and prolonged hospital stay.	[Suwarto, Suhendro] Pondok Indah Hosp, Jakarta, Indonesia; [Suwarto, Suhendro] Univ Indonesia, Div Trop & Infect Dis, Dept Internal Med, Fac Med,Cipto Mangunkusumo Natl Hosp RSCM, Jakarta, Indonesia; [Diahtantri, Riyanti Astrid] Univ Indonesia, Fac Med, Jakarta, Indonesia; [Hidayat, Mohammad Jauharsyah] Pondok Indah Hosp, Dept Radiol, Jakarta, Indonesia; [Widjaya, Bing] Pondok Indah Hosp, Dept Clin Pathol, Jakarta, Indonesia	University of Indonesia; University of Indonesia	Suwarto, S (corresponding author), Pondok Indah Hosp, Jakarta, Indonesia.; Suwarto, S (corresponding author), Univ Indonesia, Div Trop & Infect Dis, Dept Internal Med, Fac Med,Cipto Mangunkusumo Natl Hosp RSCM, Jakarta, Indonesia.	suhendro@ui.ac.id		, Suhendro/0000-0001-6394-0591				Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Aye KS, 2014, HUM PATHOL, V45, P1221, DOI 10.1016/j.humpath.2014.01.022; Balasubramanian S, 2006, INDIAN PEDIATR, V43, P334; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chen ZW, 2008, J ZHEJIANG UNIV-SC B, V9, P616, DOI 10.1631/jzus.B0720016; Dhanoa A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1731-8; Dinh TT, 2010, AM J TROP MED HYG, V83, P774, DOI 10.4269/ajtmh.2010.10-0090; Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014; Fernando S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1656-2; Gan VC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060946; Ghamar-Chehreh Mohammad Ebrahim, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P702, DOI 10.1016/S2221-1691(12)60213-5; Gowda S, 2009, PAN AFR MED J, V3, P1; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Hertzog MA, 2008, RES NURS HEALTH, V31, P180, DOI 10.1002/nur.20247; Huerre MR, 2001, VIRCHOWS ARCH, V438, P107; Hunsperger EA, 2016, J INFECT DIS, V214, P836, DOI 10.1093/infdis/jiw103; Jagadishkumar K, 2012, IRAN J PEDIATR, V22, P231; Kalayanarooj Siripen, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P378; Karyanti MR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-412; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Kitade H, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040387; Laoprasopwattana K, 2016, J TROP PEDIATRICS, V62, P200, DOI 10.1093/tropej/fmv099; Li L, 2016, OBES REV, V17, P510, DOI 10.1111/obr.12407; Lin YW, 2002, J VIROL, V76, P12242, DOI 10.1128/JVI.76.23.12242-12249.2002; Michels M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002277; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Obika M, 2012, EXP DIABETES RES, DOI 10.1155/2012/145754; Ojha A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41697; Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83; Paschos P, 2009, HIPPOKRATIA, V13, P9; Pichainarong Natchaporn, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P283; Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386; Ramachandran A, 2010, J OBES, V2010, DOI 10.1155/2010/868573; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Sourianarayanane Achuthan, 2013, J Crohns Colitis, V7, pe279, DOI 10.1016/j.crohns.2012.10.015; Srikiatkhachorn A, 2009, THROMB HAEMOSTASIS, V102, P1042, DOI 10.1160/TH09-03-0208; Suwarto S, 2017, J INFECT DIS; Suwarto S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1671-3; Tan VPK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200698; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vervaeke P, 2015, REV MED VIROL, V25, P50, DOI 10.1002/rmv.1818; Wang CC, 2007, AM J TROP MED HYG, V77, P151, DOI 10.4269/ajtmh.2007.77.151; Wang L, 2016, ONCOTARGET, V7, P73229, DOI 10.18632/oncotarget.12302; Wills BA, 2004, J INFECT DIS, V190, P810, DOI 10.1086/422754; World Health Organization, 2009, DENG GUID DIAGN TREA, P147, DOI DOI 10.7705/BIOMEDICA.V37I4.3370; Yacoub S., 2016, F1000RES, V5; Yoon HJ, 2014, WORLD J HEPATOL, V6, P800, DOI 10.4254/wjh.v6.i11.800	50	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205965	10.1371/journal.pone.0205965	http://dx.doi.org/10.1371/journal.pone.0205965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332476	Green Submitted, Green Published, gold			2022-12-26	WOS:000447638200079
J	Cardon, S; Sachon, E; Carlier, L; Drujon, T; Walrant, A; Aleman-Navarro, E; Martinez-Osorio, V; Guianvarc'h, D; Sagan, S; Fleury, Y; Marquant, R; Piesse, C; Rosenstein, Y; Auvynet, C; Lacombe, C				Cardon, Sebastien; Sachon, Emmanuelle; Carlier, Ludovic; Drujon, Thierry; Walrant, Astrid; Aleman-Navarro, Estefania; Martinez-Osorio, Veronica; Guianvarc'h, Dominique; Sagan, Sandrine; Fleury, Yannick; Marquant, Rodrigue; Piesse, Christophe; Rosenstein, Yvonne; Auvynet, Constance; Lacombe, Claire			Peptidoglycan potentiates the membrane disrupting effect of the carboxyamidated form of DMS-DA6, a Gram-positive selective antimicrobial peptide isolated from Pachymedusa dacnicolor skin	PLOS ONE			English	Article							C-TERMINAL AMIDATION; AMPHIBIAN SKIN; ANALOGS; PLASTICINS; MECHANISM; BACTERIAL; PROTEINS; DYNAMICS; MAGAININ; BEHAVIOR	The occurrence of nosocomial infections has been on the rise for the past twenty years. Notably, infections caused by the Gram-positive bacteria Staphylococcus aureus represent a major clinical problem, as an increase in antibiotic multi-resistant strains has accompanied this rise. There is thus a crucial need to find and characterize new antibiotics against Gram-positive bacteria, and against antibiotic-resistant strains in general. We identified a new dermaseptin, DMS-DA6, produced by the skin of the Mexican frog Pachymedusa dacnicolor, with specific antibacterial activity against Gram-positive bacteria. This peptide is particularly effective against two multiple drug-resistant strains Enterococcus faecium BM4147 and Staphylococcus aureus DAR5829, and has no hemolytic activity. DMS-DA6 is naturally produced with the C-terminal carboxyl group in either the free or amide forms. By using Gram-positive model membranes and different experimental approaches, we showed that both forms of the peptide adopt an a-helical fold and have the same ability to insert into, and to disorganize a membrane composed of anionic lipids. However, the bactericidal capacity of DMS-DA6-NH2 was consistently more potent than that of DMS-DA6-OH. Remarkably, rather than resulting from the interaction with the negatively charged lipids of the membrane, or from a more stable conformation towards proteolysis, the increased capacity to permeabilize the membrane of Gram-positive bacteria of the carboxyamidated form of DMS-DA6 was found to result from its enhanced ability to interact with peptidoglycan.	[Cardon, Sebastien; Sachon, Emmanuelle; Carlier, Ludovic; Drujon, Thierry; Walrant, Astrid; Guianvarc'h, Dominique; Sagan, Sandrine; Marquant, Rodrigue; Lacombe, Claire] Sorbonne Univ, PSL Univ, Ecole Normale Super, CNRS,Lab Biomol,LBM, Paris, France; [Sachon, Emmanuelle] Sorbonne Univ, CNRS, IBPS, Plate Forme Spectrometrie Masse & Proteo, Paris, France; [Aleman-Navarro, Estefania; Martinez-Osorio, Veronica; Rosenstein, Yvonne; Auvynet, Constance] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Fleury, Yannick] Univ Bretagne Occidentale, LUBEM EA, IUT Quimper, Quimper, France; [Piesse, Christophe] Sorbonne Univ, CNRS, IBPS, Plateforme Synth Peptid, Paris, France; [Lacombe, Claire] Univ Paris Est Creteil Val de Marne, Fac Sci & Technol, Creteil, France	Arts et Metiers Institute of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universidad Nacional Autonoma de Mexico; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Lacombe, C (corresponding author), Sorbonne Univ, PSL Univ, Ecole Normale Super, CNRS,Lab Biomol,LBM, Paris, France.; Auvynet, C (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.; Lacombe, C (corresponding author), Univ Paris Est Creteil Val de Marne, Fac Sci & Technol, Creteil, France.	constance@ibt.unam.mx; claire.lacombe@upmc.fr	QI, DANDAN/GVR-9324-2022; s, s/GYR-2278-2022; Sachon, Emmanuelle/AAR-6792-2020; Fleury, Yannick/AFG-2926-2022; Guianvarc'h, Dominique/AAE-5806-2022; SAGAN, Sandrine/AAA-8537-2022; s, s/HHD-0404-2022; S, SAGAN/I-8132-2013; s, s/HIK-1178-2022; FLEURY, Yannick/F-9480-2016	Guianvarc'h, Dominique/0000-0002-7722-370X; S, SAGAN/0000-0003-0083-4411; Walrant, Astrid/0000-0003-4054-905X; FLEURY, Yannick/0000-0002-1638-0963; Carlier, Ludovic/0000-0002-9036-6561	CONACYT (Consejo Nacional de Ciencia y tecnologia), Mexico [2015-02-853]	CONACYT (Consejo Nacional de Ciencia y tecnologia), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Grant number: 2015-02-853, Fronteras de la Ciencia 2015-2 issued by CONACYT (Consejo Nacional de Ciencia y tecnologia), Mexico, https://www.conacyt.gob.mx/, to YR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre S, 2015, ACS CHEM BIOL, V10, P2257, DOI 10.1021/acschembio.5b00495; Auvynet C, 2008, FEBS J, V275, P4134, DOI 10.1111/j.1742-4658.2008.06554.x; Auvynet C, 2009, FEBS J, V276, P6773, DOI 10.1111/j.1742-4658.2009.07392.x; BECHINGER B, 1993, PROTEIN SCI, V2, P2077, DOI 10.1002/pro.5560021208; Brannan AM, 2015, PEERJ, V3, DOI 10.7717/peerj.1516; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; Carlier L, 2015, BIOPHYS CHEM, V196, P40, DOI 10.1016/j.bpc.2014.09.004; Cerovsky V, 2009, CHEMBIOCHEM, V10, P2089, DOI 10.1002/cbic.200900133; CHEN HC, 1988, FEBS LETT, V236, P462, DOI 10.1016/0014-5793(88)80077-2; Conlon JM, 2011, CELL MOL LIFE SCI, V68, P2303, DOI 10.1007/s00018-011-0720-8; Conlon JM, 2009, ANN NY ACAD SCI, V1163, P75, DOI 10.1111/j.1749-6632.2008.03618.x; da Silva AVR, 2014, BBA-BIOMEMBRANES, V1838, P2357, DOI 10.1016/j.bbamem.2014.06.012; Dennison SR, 2015, BBA-BIOMEMBRANES, V1848, P1111, DOI 10.1016/j.bbamem.2015.01.014; Dennison SR, 2011, BIOCHEMISTRY-US, V50, P1514, DOI 10.1021/bi101687t; Dennison SR, 2009, MOL CELL BIOCHEM, V332, P43, DOI 10.1007/s11010-009-0172-8; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; El Amri C, 2006, BIOCHEMISTRY-US, V45, P14285, DOI 10.1021/bi060999o; Epand RM, 2011, J PEPT SCI, V17, P298, DOI 10.1002/psc.1319; Ghosh C, 2015, CHEMMEDCHEM, V10, P1606, DOI 10.1002/cmdc.201500299; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hawrani A, 2010, BBA-BIOMEMBRANES, V1798, P1254, DOI 10.1016/j.bbamem.2010.03.017; Joanne P, 2009, BIOCHEMISTRY-US, V48, P9372, DOI 10.1021/bi901222p; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kim JY, 2011, AMINO ACIDS, V40, P183, DOI 10.1007/s00726-010-0632-1; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Li JG, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00073; Li Y, 2017, MOLECULES, V22, DOI 10.3390/molecules22020328; Malanovic N, 2016, BBA-BIOMEMBRANES, V1858, P936, DOI 10.1016/j.bbamem.2015.11.004; Malanovic N, 2015, BBA-BIOMEMBRANES, V1848, P2437, DOI 10.1016/j.bbamem.2015.07.010; Marien E, 2015, INT J CANCER, V137, P1539, DOI 10.1002/ijc.29517; Meneses EP, 2011, AMINO ACIDS, V40, P113, DOI 10.1007/s00726-010-0564-9; Mura M, 2016, EUR BIOPHYS J BIOPHY, V45, P195, DOI 10.1007/s00249-015-1094-x; Neelay OP, 2017, J MOL STRUCT, V1146, P329, DOI 10.1016/j.molstruc.2017.06.018; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nguyen LT, 2010, PLOS ONE, P5; Nicolas P, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P295, DOI 10.1016/B978-012369442-3/50048-9; Niklison-Chirou MV, 2011, PEPTIDES, V32, P832, DOI 10.1016/j.peptides.2011.01.003; Ponti D, 1999, EUR J BIOCHEM, V263, P921, DOI 10.1046/j.1432-1327.1999.00597.x; Rinaldi AC, 2002, CURR OPIN CHEM BIOL, V6, P799, DOI 10.1016/S1367-5931(02)00401-5; Rinaldi AC, 2001, J PEPT RES, V58, P213, DOI 10.1034/j.1399-3011.2001.00896.x; Riordan J F, 1972, Methods Enzymol, V25, P494, DOI 10.1016/S0076-6879(72)25045-5; Roelants K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003662; Sani MA, 2015, J BIOL CHEM, V290, P19853, DOI 10.1074/jbc.M115.643262; Saravanan R, 2014, BIOTECHNOL BIOENG, V111, P37, DOI 10.1002/bit.25003; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shi DN, 2016, TOXINS, V8, DOI 10.3390/toxins8050144; Sun Y, 2015, BIOMATERIALS, V37, P299, DOI 10.1016/j.biomaterials.2014.10.041; Walrant A, 2011, BBA-BIOMEMBRANES, V1808, P382, DOI 10.1016/j.bbamem.2010.09.009; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558	50	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205727	10.1371/journal.pone.0205727	http://dx.doi.org/10.1371/journal.pone.0205727			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325956	Green Submitted, Green Published, gold			2022-12-26	WOS:000447430800037
J	Feger, S; Kendziorra, C; Lukas, S; Shaban, A; Bokeimann, B; Zimmermann, E; Rief, M; Dewey, M				Feger, Sarah; Kendziorra, Carsten; Lukas, Steffen; Shaban, Ahmed; Bokeimann, Bjorn; Zimmermann, Elke; Rief, Matthias; Dewey, Marc			Effect of iterative reconstruction and temporal averaging on contour sharpness in dynamic myocardial CT perfusion: Sub-analysis of the prospective 4D CT perfusion pilot study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; COMPUTED-TOMOGRAPHY; DIAGNOSTIC PERFORMANCE; FUNCTIONAL ASSESSMENT; CORE320 MULTICENTER; ANGIOGRAPHY; STENOSIS; METAANALYSIS	Purpose Myocardial computed tomography perfusion (CTP) allows the assessment of the functional relevance of coronary artery stenosis. This study investigates to what extent the contour sharpness of sequences acquired by dynamic myocardial CTP is influenced by the following noise reduction methods: temporal averaging and adaptive iterative dose reduction 3D (AIDR 3D). Materials and methods Dynamic myocardial CT perfusion was conducted in 29 patients at a dose level of 9.5 +/- 2.0 mSv and was reconstructed with both filtered back projection (FBP) and strong levels of AIDR 3D. Temporal averaging to reduce noise was performed as a post-processing step by combining two, three, four, six and eight original consecutive 3D datasets. We evaluated the contour sharpness at four distinct edges of the left-ventricular myocardium based on two different approaches: the distance between 25% and 75% of the maximal grey value (d) and the slope in the contour (m). Results Iterative reconstruction reduced contour sharpness: both measures of contour sharpness performed better for FBP than for AIDR 3D (d = 1.7 +/- 0.4 mm versus 2.0 +/- 0.5 mm, p>0.059 at all edges; m = 255.9 +/- 123.9 HU/mm versus 160.6 +/- 123.5 HU/mm; p<0.023 for all edges). Increasing levels of temporal averaging degraded contour sharpness. When FBP reconstruction was applied, contour sharpness was best without temporal averaging (d = 1.7 +/- 0.4 mm, m = 255.9 +/- 123.9 HU/mm) and poorest for the strongest levels of temporal averaging (d = 2.1 +/- 0.3 mm, m = 142.2 +/- 104.9 HU/mm; comparison between lowest and highest temporal averaging level: for d p>0.052 at all edges and for m p<0.001 at all edges). Conclusion The use of both temporal averaging and iterative reconstruction degrades objective contour sharpness parameters of dynamic myocardial CTP. Thus, further advances in image processing are needed to optimise contour sharpness of 4D myocardial CTP.	[Feger, Sarah; Kendziorra, Carsten; Lukas, Steffen; Shaban, Ahmed; Bokeimann, Bjorn; Zimmermann, Elke; Rief, Matthias; Dewey, Marc] Charite Univ Med Berlin, Dept Radiol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Feger, S (corresponding author), Charite Univ Med Berlin, Dept Radiol, Berlin, Germany.	sarah.feger@charite.de		Dewey, Marc/0000-0002-4402-2733; Bokelmann, Bjorn/0000-0001-9049-2755	FP7 Program of the European Commission [603266-2, HEALTH-2012.2.4.-2]; Heisenberg Program of the DFG [DE 1361/14-1]; Digital Health Accelerator of the Berlin Institute of Health; Canon Medical Systems; Guerbet; Cardiac MR Academy Berlin	FP7 Program of the European Commission; Heisenberg Program of the DFG(German Research Foundation (DFG)); Digital Health Accelerator of the Berlin Institute of Health; Canon Medical Systems; Guerbet; Cardiac MR Academy Berlin	Prof. Dewey has received grant support from the FP7 Program of the European Commission for the randomized multicenter DISCHARGE trial (603266-2, HEALTH-2012.2.4.-2). He also received grant support from the Heisenberg Program of the DFG (DE 1361/14-1) and the Digital Health Accelerator of the Berlin Institute of Health. Prof. Dewey has received lecture fees from Canon Medical Systems, Guerbet, Cardiac MR Academy Berlin, and Bayer. Prof. Dewey is also the editor of Cardiac CT, published by Springer, and offers hands-on workshops on CT imaging (www.ct-kurs.de). Institutional master research agreements exist with Siemens Medical Solutions, Philips Medical Systems, and Toshiba Medical Systems. The terms of these arrangements are managed by the legal department of Charite - Universitatsmedizin Berlin.	Bamberg F, 2014, JACC-CARDIOVASC IMAG, V7, P267, DOI 10.1016/j.jcmg.2013.06.008; Caruso D, 2016, EUR J RADIOL, V85, P1893, DOI 10.1016/j.ejrad.2016.07.017; De Cecco CN, 2015, RADIOL CLIN N AM, V53, P317, DOI 10.1016/j.rcl.2014.11.009; de Roos A, 2014, RADIOLOGY, V273, pS142, DOI 10.1148/radiol.14140432; Enders J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083427; Farzaneh-Far A, 2013, CORONARY ARTERY DIS, V24, P606, DOI 10.1097/MCA.0000000000000027; Feger S, 2017, INT J CARDIOVAS IMAG, V33, P371, DOI 10.1007/s10554-016-1011-0; Feger S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125943; Flohr TG, 2015, RADIOL CLIN N AM, V53, P271, DOI 10.1016/j.rcl.2014.11.011; George RT, 2014, RADIOLOGY, V272, P407, DOI 10.1148/radiol.14140806; Kendziorra C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116103; Kikuchi Y, 2014, EUR RADIOL, V24, P1547, DOI 10.1007/s00330-014-3164-3; Ko SM, 2012, AM J ROENTGENOL, V198, P512, DOI 10.2214/AJR.11.7029; Ponte M, 2014, INT J CARDIOVAS IMAG, V30, P1589, DOI 10.1007/s10554-014-0492-y; Rochitte CE, 2014, EUR HEART J, V35, P1120, DOI 10.1093/eurheartj/eht488; Rossi A, 2014, RADIOLOGY, V270, P24, DOI 10.1148/radiol.13112739; Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008; Shen HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142185; Sorgaard MH, 2016, J CARDIOVASC COMPUT, V10, P450, DOI 10.1016/j.jcct.2016.09.003; Tatsugami F, 2015, EUR RADIOL, V25, P41, DOI 10.1007/s00330-014-3381-9; Varga-Szemes A, 2015, AM J ROENTGENOL, V204, P487, DOI 10.2214/AJR.14.13546; Vavere AL, 2011, J CARDIOVASC COMPUT, V5, P370, DOI 10.1016/j.jcct.2011.11.001; Williams MC, 2016, CLIN RADIOL, V71, P739, DOI 10.1016/j.crad.2016.03.006	23	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205922	10.1371/journal.pone.0205922	http://dx.doi.org/10.1371/journal.pone.0205922			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325969	Green Published, gold, Green Submitted			2022-12-26	WOS:000447430800051
J	Kallberg, C; Ardal, C; Blix, HS; Klein, E; Martinez, EM; Lindbaek, M; Outterson, K; Rottingen, JA; Laxminarayan, R				Kallberg, Cecilia; Ardal, Christine; Blix, Hege Salvesen; Klein, Eili; Martinez, Elena M.; Lindbaek, Morten; Outterson, Kevin; Rottingen, John-Arne; Laxminarayan, Ramanan			Introduction and geographic availability of new antibiotics approved between 1999 and 2014	PLOS ONE			English	Article							MULTIDRUG-RESISTANT BACTERIA; ANTIBACTERIAL AGENTS; UNITED-STATES; MARKET; INNOVATION; SALES; DRUGS; US	Background Despite the urgent need for new, effective antibiotics, few antibiotics of value have entered the market during the past decades. Therefore, incentives have been developed to stimulate antibiotic R&D. For these incentives to be effective, geographic availability for recently approved antibiotics needs to be better understood. In this study, we analyze geographic availability and market introduction of antibiotics approved between 1999 and 2014. Material and method We identified antibiotics, considered new chemical entities (NCEs) for systemic use approved globally between 1999 and 2014, from national medicine agencies' lists of approved drugs, and data from the WHO Collaborating Center for Drug Statistics. Geographic availability was mapped using sales data from IQVIA, and analyzed with regards to class, indication, safety, and origin. Results Of the 25 identified NCEs, only 12 had registered sales in more than 10 countries. NCEs with the widest geographic availability had registered sales in more than 70 countries within a ten-year timeframe and 30 countries within a three-year timeframe, spreading across five different geographic regions and three country income classes. Half (52%) of the NCEs had an indication for infections caused by antibiotic-resistant bacteria, little diversity was seen regarding target pathogen and indication. Antibiotics originated from and/or marketed by companies from the US or Europe had greater geographic availability compared to Japanese antibiotics, which seldom reached outside of Asia. For 20 NCEs developers chose to fully or partially sublicense marketing rights to a number of companies of different sizes. Conclusion Our findings show great variation in geographic availability of antibiotics, indicating that availability in multiple regions and country income classes is possible, but rarely seen within a few years of market authorization. Sublicensing agreements between multiple companies was common practice. Moreover, differences were seen between countries regarding benefit/risk evaluations and company behavior. These findings could be a potential source of uncertainties, and create barriers to assure that working antibiotics are developed and made available according to public health needs.	[Kallberg, Cecilia; Lindbaek, Morten; Rottingen, John-Arne] Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway; [Kallberg, Cecilia; Ardal, Christine; Blix, Hege Salvesen; Rottingen, John-Arne] Norwegian Inst Publ Hlth, Oslo, Norway; [Blix, Hege Salvesen] Univ Oslo, Sch Pharm, Oslo, Norway; [Klein, Eili; Martinez, Elena M.; Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Klein, Eili] Johns Hopkins Sch Med, Dept Emergency Med, Baltimore, MD USA; [Klein, Eili] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Outterson, Kevin] Boston Univ, Sch Law, Boston, MA 02215 USA; [Outterson, Kevin] CARB X, Boston, MA USA; [Rottingen, John-Arne] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Laxminarayan, Ramanan] Princeton Environm Inst, Princeton, NJ USA; [Martinez, Elena M.] Int Food Policy Res Inst, Washington, DC 20036 USA; [Rottingen, John-Arne] Res Council Norway, Lysaker, Norway	University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Princeton University; CGIAR; International Food Policy Research Institute (IFPRI); Research Council of Norway	Kallberg, C (corresponding author), Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway.; Kallberg, C (corresponding author), Norwegian Inst Publ Hlth, Oslo, Norway.	ceciliakallberg@gmail.com	Martinez, Elena/AAG-4976-2019; Laxminarayan, Ramanan/ABD-5050-2021	Kaallberg, Cecilia/0000-0003-1078-3128; Klein, Eili/0000-0002-1304-5289; Outterson, Kevin/0000-0003-2513-3216; Blix, Hege Salvesen/0000-0002-4890-7555; Martinez, Elena/0000-0001-9800-6651	DRIVE-AB Consortium; IMI Joint Undertaking under the DRIVE-AB [115618]; European Union's 7th Framework Programme; European Federation of Pharmaceutical Industries and Associations; Research Council of Norway through the Global Health and Vaccination Programme (GLOBVAC) [234608]; Biomedical Advanced Research and Development Authority (BARDA) under US Department of Health and Human Services [NOA 06-IDSET160030]; Wellcome Trust	DRIVE-AB Consortium; IMI Joint Undertaking under the DRIVE-AB; European Union's 7th Framework Programme; European Federation of Pharmaceutical Industries and Associations; Research Council of Norway through the Global Health and Vaccination Programme (GLOBVAC); Biomedical Advanced Research and Development Authority (BARDA) under US Department of Health and Human Services; Wellcome Trust(Wellcome TrustEuropean Commission)	CK was funded by the DRIVE-AB Consortium, which also partly funded CA, JR and RL. DRIVE-AB aims to transform the way policymakers stimulate innovation, sustainable use, and equitable availability of antibiotics to meet unmet public health needs. DRIVE-AB is supported by the IMI Joint Undertaking under the DRIVE-AB grant agreement number 115618, the resources of which are composed of financial contribution from the European Union's 7th Framework Programme and the European Federation of Pharmaceutical Industries and Associations companies' in-kind contribution. CA was also partly supported by the Research Council of Norway through the Global Health and Vaccination Programme (GLOBVAC), project number 234608. KO is supported by NOA 06-IDSET160030 from the Biomedical Advanced Research and Development Authority (BARDA) under the Assistant Secretary for Preparedness and Response (ASPR) in the US Department of Health and Human Services and an award from the Wellcome Trust. The funders provided support in the form of salaries for authors, according to the statement above, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, TACKLING DRUG RESIST; [Anonymous], 2017, ATC DDD IND 2017; Ardal C., 2018, REVITALIZING ANTIBIO; Bax R, 2015, J ANTIMICROB CHEMOTH, V70, P1281, DOI 10.1093/jac/dku572; Bernardelli P, 2002, ANNU REP MED CHEM, V37, P257, DOI 10.1016/S0065-7743(02)37027-1; Boyer-Joubert C, 2003, ANNU REP MED CHEM, V38, P347, DOI 10.1016/S0065-7743(03)38034-0; Bronson J, 2012, ANN REPORTS MED CHEM, V48; Bronson J, 2014, ANNU REP MED CHEM, V49, P437, DOI 10.1016/B978-0-12-800167-7.00027-4; Bronson J, 2012, ANNU REP MED CHEM, V47, P499, DOI 10.1016/B978-0-12-396492-2.00031-X; Bronson J, 2011, ANNU REP MED CHEM, V46, P433, DOI 10.1016/B978-0-12-386009-5.00002-3; Butler MS, 2017, J ANTIBIOT, V70, P3, DOI 10.1038/ja.2016.72; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; Central Drugs Standard Control Organization, LIST APPR NEW DRUGS; Datapharm, EL MED COMP; Deak D, 2016, ANN INTERN MED, V165, P363, DOI 10.7326/M16-0291; Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; ECDC/ EMEA Joint Working Group, 2009, BACT CHALL TIM REACT, P13; European Commission, WHAT IS AN SME; European Medicines Agency, MEDICINES; Evans SR, 2015, STAT BIOPHARM RES, V7, P331, DOI 10.1080/19466315.2015.1094406; Freire-Moran L, 2011, DRUG RESIST UPDATE, V14, P118, DOI 10.1016/j.drup.2011.02.003; Gaudilliere B, 2001, ANNU REP MED CHEM, V36, P293, DOI 10.1016/S0065-7743(01)36068-2; Goossens H, 2007, CLIN INFECT DIS, V44, P1091, DOI 10.1086/512810; Government of Canada, DRUG PROD DAT ACC DA; Hahn Seokyung, 2012, Korean J Pediatr, V55, P403, DOI 10.3345/kjp.2012.55.11.403; Hegde S, 2005, ANNU REP MED CHEM, V40, P443, DOI 10.1016/S0065-7743(05)40029-9; Hegde S, 2004, ANNU REP MED CHEM, V39, P337, DOI 10.1016/S0065-7743(04)39025-1; Hegde S, 2008, ANNU REP MED CHEM, V43, P455, DOI 10.1016/S0065-7743(08)00025-0; Hegde S, 2007, ANNU REP MED CHEM, V42, P505, DOI 10.1016/S0065-7743(07)42032-2; Hegde S, 2006, ANNU REP MED CHEM, V41, P439, DOI 10.1016/S0065-7743(06)41030-7; Hegde S, 2010, ANNU REP MED CHEM, V45, P467, DOI 10.1016/S0065.7743(10)45028.9; Hegde S, 2009, ANNU REP MED CHEM, V44, P577, DOI 10.1016/S0065-7743(09)04428-5; Humphries RM, 2015, ANTIMICROB AGENTS CH, V59, P6605, DOI 10.1128/AAC.01165-15; IQVIA, WELC TO IQVIA; Kinch MS, 2014, DRUG DISCOV TODAY, V19, P1283, DOI 10.1016/j.drudis.2014.07.005; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Laxminarayan R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001974; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Livermore DM, 2011, J ANTIMICROB CHEMOTH, V66, P1941, DOI 10.1093/jac/dkr262; Morel CM, 2010, BMJ-BRIT MED J, P340; National Institutes of Health, LIVERTOX; O'Niell J., 2015, SECURING NEW DRUGS F; Okeke I, 2003, AFR HLTH, V25, P10; Outterson K, 2015, HEALTH AFFAIR, V34, P277, DOI 10.1377/hlthaff.2014.1003; Outterson K, 2013, J LAW MED ETHICS, V41, P688, DOI 10.1111/jlme.12079; Pharmaceuticals and Medical Devices Agency, LIST APPR PROD; Pignatti Francesco, 2004, J Ambul Care Manage, V27, P89; Powell M, 2000, INT J ANTIMICROB AG, V16, P199, DOI 10.1016/S0924-8579(00)00229-6; Renwick MJ, 2016, HLTH POLICY SERIES E; Rex JH, 2016, LANCET INFECT DIS, V16, P500, DOI 10.1016/S1473-3099(15)00500-9; Rogers BA, 2012, INT J INFECT DIS, V16, pE830, DOI 10.1016/j.ijid.2012.08.001; So AD, 2014, UPSALA J MED SCI, V119, P176, DOI 10.3109/03009734.2014.898717; Stern S, 2017, BREAKING WALL CALL C; *SWED MED PROD AG, LAK; The World Bank, WORLD BANK COUNTR LE; Tsuji K, 2010, J CLIN PHARM THER, V35, P289, DOI 10.1111/j.1365-2710.2009.01099.x; U.S. Food and Drug Administration, APPR DRUG PROD THER, V42; US Food and Drug Administration, DRUGS FDA FDA APPR D; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; WHO Collaborating Centre for Drug Statistics Methodology, INT LANG DRUG UT RES; WHOCollaborating Centre for Drug Statistics Methodology, STRUCT PRINC; World Health Organization, 2017, ANT AG CLIN DEV 2017	63	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205166	10.1371/journal.pone.0205166	http://dx.doi.org/10.1371/journal.pone.0205166			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325963	Green Published, Green Submitted, gold			2022-12-26	WOS:000447430800017
J	Osorio-Canadas, S; Arnan, X; Bassols, E; Vicens, N; Bosch, J				Osorio-Canadas, Sergio; Arnan, Xavier; Bassols, Emili; Vicens, Narcis; Bosch, Jordi			Seasonal dynamics in a cavity-nesting bee-wasp community: Shifts in composition, functional diversity and host-parasitoid network structure	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; TEMPORAL VARIABILITY; ECOLOGICAL NETWORKS; SPECIES COMPOSITION; LANDSCAPE CONTEXT; FLORAL TRAITS; BODY-SIZE; HABITAT; POPULATIONS; PHENOLOGY	Ecological communities are composed of species that interact with each other forming complex interaction networks. Although interaction networks have been usually treated as static entities, interactions show high levels of temporal variation, mainly due to temporal species turnover. Changes in taxonomic composition are likely to bring about changes in functional trait composition. Because functional traits influence the likelihood that two species interact, temporal changes in functional composition and structure may ultimately affect interaction network structure. Here, we study the seasonality (spring vs. summer) in a community of cavity-nesting solitary bees and wasps ('hosts') and their nest associates ('parasitoids'). We analyze seasonal changes in taxonomic compostion and structure, as well as in functional traits, of the host and parasitoid communities. We also analyze whether these changes result in changes in percent parasitism and interaction network structure. Our host and parasitoid communities are strongly seasonal. Host species richness increases from spring to summer. This results in important seasonal changes in functional composition of the host community. The spring community (almost exclusively composed of bees) is characterized by large, univoltine, adult-wintering host species. The summer community (composed of both bees and wasps) is dominated by smaller, bivoltine, prepupa-wintering species. Host functional diversity is higher in summer than in spring. Importantly, these functional changes are not only explained by the addition of wasp species in summer. Functional changes in the parasitoid community are much less pronounced, probably due to the lower parasitoid species turnover. Despite these important taxonomic and functional changes, levels of parasitism did not change across seasons. Two network metrics (generality and interaction evenness) increased from spring to summer. These changes can be explained by the seasonal increase in species richness (and therefore network size). The seasonal shift from a bee-dominated community in spring to a wasp-dominated community in summer suggests a change in ecosystem function, with emphasis on pollination in spring to emphasis on predation in summer.	[Osorio-Canadas, Sergio; Arnan, Xavier; Bosch, Jordi] CREAF, Barcelona, Spain; [Bassols, Emili] Parc Nat Zona Volcan Garrotxa, Olot, Spain; [Vicens, Narcis] Serv Medi Ambient Diputacio Girona, Pujada St Marti 4-5, Girona, Spain	Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Barcelona	Osorio-Canadas, S (corresponding author), CREAF, Barcelona, Spain.	s.osorio.canadas@gmail.com	ramon, anna/O-1249-2019; Arnan, Xavier/N-7829-2013; Bosch, Jordi/K-8752-2016	Arnan, Xavier/0000-0002-9904-274X; Osorio-Canadas, Sergio/0000-0002-0650-5566; Bosch, Jordi/0000-0002-8088-9457	'Ciutat d'Olot' grant, City Council of Olot; Spanish Ministerio de Ciencia e Innovacion [CICYT CGL2009-12646, CONSOLIDER CSD2008-0040]; Generalitat de Catalunya, Agencia de Gestio d'ajudes per a Universitats i Recerca [2012 FISO080484]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil [CNPq PDS-167533/2013-4, 165623/2015-2]; Spanish Ministerio de Economia y Competitividad [RYC-2015-18448]	'Ciutat d'Olot' grant, City Council of Olot; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya, Agencia de Gestio d'ajudes per a Universitats i Recerca; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Spanish Ministerio de Economia y Competitividad(Spanish Government)	This study was supported by 'Ciutat d'Olot' grant, City Council of Olot, (https://www.olotcultura.cat/projecte/beques-ciutat-olot/) (NV, EB); Projects CICYT CGL2009-12646 and CONSOLIDER CSD2008-0040, by the Spanish Ministerio de Ciencia e Innovacion (www.idi.mineco.gob.es/) (JB); FI fellowship (2012 FISO080484) from the Generalitat de Catalunya, Agencia de Gestio d'ajudes per a Universitats i Recerca (agaur.gencat.cat/es/inici) (SO); Projects CNPq PDS-167533/2013-4 and 165623/2015-2 by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil (http://www.cnpq.br/web) (XA); 'Ramon y Cajal' grant (RYC-2015-18448) from the Spanish Ministerio de Economia y Competitividad (www.mineco.gob.es/) (XA).	Albrecht M, 2007, J ANIM ECOL, V76, P1015, DOI 10.1111/j.1365-2656.2007.01264.x; Maglianesi MA, 2014, ECOLOGY, V95, P3325, DOI 10.1890/13-2261.1; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 1967, TRAP NESTING WASPS B; Barrientos Jose A., 2014, Revista Iberica de Aracnologia, V24, P3; Bartomeus I, 2016, FUNCT ECOL, V30, P1894, DOI 10.1111/1365-2435.12666; Barton K., 2016, MUMIN MULTIMODEL INF; Bascompte J, 2010, SCIENCE, V329, P765, DOI 10.1126/science.1194255; Basilio AM, 2006, AUSTRAL ECOL, V31, P975, DOI 10.1111/j.1442-9993.2006.01666.x; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bishop JA, 1999, FUNCT ECOL, V13, P711, DOI 10.1046/j.1365-2435.1999.00351.x; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bosch J, 1997, OECOLOGIA, V109, P583, DOI 10.1007/s004420050120; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; Cardoso P, 2007, ECOL ENTOMOL, V32, P516, DOI 10.1111/j.1365-2311.2007.00894.x; Dehling DM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2444; Deidda A, 2016, IFOREST, V9, P883, DOI 10.3832/ifor1805-009; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Eklof A, 2013, ECOL LETT, V16, P577, DOI 10.1111/ele.12081; Elekcioglul NZ, 2013, PAK J ZOOL, V45, P1393; Fabian Y, 2013, J ANIM ECOL, V82, P1203, DOI 10.1111/1365-2656.12103; Flo V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191268; Forrest JRK, 2017, ECOLOGY, V98, P359, DOI 10.1002/ecy.1655; Forrest JRK, 2015, J APPL ECOL, V52, P706, DOI 10.1111/1365-2664.12433; Foster RG, 2009, SEASONS OF LIFE: THE BIOLOGICAL RHYTHMS THAT ENABLE LIVING THINGS TO THRIVE AND SURVIVE, P1; Gagic V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157674; Gagic V, 2012, OECOLOGIA, V170, P1099, DOI 10.1007/s00442-012-2366-0; Gagic V, 2011, P ROY SOC B-BIOL SCI, V278, P2946, DOI 10.1098/rspb.2010.2645; Hall CR, 2016, AUSTRAL ECOL, V41, P145, DOI 10.1111/aec.12283; Harvey E, 2017, J APPL ECOL, V54, P371, DOI 10.1111/1365-2664.12769; Hawkins B. A., 1994, PATTERN PROCESS HOST; HAWKINS CP, 1981, ECOLOGY, V62, P387, DOI 10.2307/1936713; Heinrich B., 1993, HOT BLOODED INSECTS; Hinners SJ, 2012, ECOL APPL, V22, P1923, DOI 10.1890/11-1590.1; Hoiss B, 2012, P ROY SOC B-BIOL SCI, V279, P4447, DOI 10.1098/rspb.2012.1581; Holzschuh A, 2009, ECOL APPL, V19, P123, DOI 10.1890/08-0384.1; Holzschuh A, 2010, J ANIM ECOL, V79, P491, DOI 10.1111/j.1365-2656.2009.01642.x; Jenkins DA, 2004, J KANSAS ENTOMOL SOC, V77, P203, DOI 10.2317/0212.18a.1; Kaartinen R, 2011, J ANIM ECOL, V80, P622, DOI 10.1111/j.1365-2656.2011.01811.x; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kendall LK, 2016, BIODIVERS CONSERV, V25, P1955, DOI 10.1007/s10531-016-1174-y; Laliberte E., 2014, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Macek J, 2010, BLANOKRIDLI CESKE RE; Maunsell SC, 2015, J ANIM ECOL, V84, P353, DOI 10.1111/1365-2656.12285; Moretti M, 2009, J ANIM ECOL, V78, P98, DOI 10.1111/j.1365-2656.2008.01462.x; Morris RJ, 2015, ECOGRAPHY, V38, P792, DOI 10.1111/ecog.01078; Morris RJ, 2014, ECOL LETT, V17, P340, DOI 10.1111/ele.12235; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Osorio S, 2015, ECOL APPL, V25, P1869, DOI 10.1890/14-2476.1; Osorio-Canadas S, 2016, ECOL LETT, V19, P1395, DOI 10.1111/ele.12687; PETANIDOU T, 1995, BIOL J LINN SOC, V55, P261, DOI 10.1111/j.1095-8312.1995.tb01064.x; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Pons X, 2005, EUR J ENTOMOL, V102, P519, DOI 10.14411/eje.2005.074; Ramirez SR, 2015, ECOL EVOL, V5, P1896, DOI 10.1002/ece3.1466; Romo CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058136; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Samnegard U, 2015, AGR ECOSYST ENVIRON, V211, P185, DOI 10.1016/j.agee.2015.06.010; Santos AMC, 2016, GLOBAL ECOL BIOGEOGR, V25, P869, DOI 10.1111/geb.12340; Shaw MR, 2006, J INSECT CONSERV, V10, P117, DOI 10.1007/s10841-006-6288-1; Staab M, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0275; Stefanescu C, 2012, EUR J ENTOMOL, V109, P85, DOI 10.14411/eje.2012.011; Steffan-Dewenter I, 2003, CONSERV BIOL, V17, P1036, DOI 10.1046/j.1523-1739.2003.01575.x; Stephen WP, 1969, BIOL EXTERNAL MORPHO; STONE GN, 1989, J EXP BIOL, V147, P303; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; TOWNSEND CR, 1994, FRESHWATER BIOL, V31, P265, DOI 10.1111/j.1365-2427.1994.tb01740.x; Turner JW, 2009, ISME J, V3, P1082, DOI 10.1038/ismej.2009.50; Tylianakis JM, 2006, ECOLOGY, V87, P3047, DOI 10.1890/0012-9658(2006)87[3047:DEFASO]2.0.CO;2; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Veddeler D, 2010, OECOLOGIA, V162, P755, DOI 10.1007/s00442-009-1491-x; Visser ME, 2010, PHILOS T R SOC B, V365, P3113, DOI 10.1098/rstb.2010.0111; Watts S, 2016, ANN BOT-LONDON, V118, P415, DOI 10.1093/aob/mcw114; Westrich P, 1989, WILDBIENEN BADEN WUR; WITT R, 1998, WESPEN BEOBACHTEN BE; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	78	10	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205854	10.1371/journal.pone.0205854	http://dx.doi.org/10.1371/journal.pone.0205854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325966	Green Published, Green Submitted, gold			2022-12-26	WOS:000447430800047
J	Alhabbar, Z; Yang, RC; Juhasz, A; Xin, H; She, MY; Anwar, M; Sultana, N; Diepeveen, D; Ma, WJ; Islam, S				Alhabbar, Zaid; Yang, Rongchang; Juhasz, Angela; Xin, Hu; She, Maoyun; Anwar, Masood; Sultana, Nigarin; Diepeveen, Dean; Ma, Wujun; Islam, Shahidul			NAM gene allelic composition and its relation to grain-filling duration and nitrogen utilisation efficiency of Australian wheat	PLOS ONE			English	Article							DURUM-WHEAT; PROTEIN-CONTENT; DRY-MATTER; STAY-GREEN; YIELD; CULTIVARS; TRAITS; TRANSLOCATION; ACCUMULATION; IMPROVEMENT	Optimising nitrogen fertiliser management in combination with using high nitrogen efficient wheat cultivars is the most effective strategy to maximise productivity in a cost-efficient manner. The present study was designed to investigate the associations between nitrogen utilisation efficiency (NUtE) and the allelic composition of the NAM genes in Australian wheat cultivars. As results, the non-functional NAM-B1 allele was more responsive to the nitrogen levels and increased NUtE significantly, leading to a higher grain yield but reduced grain protein content. Nitrogen application at different developmental stages (mid-tillering, booting, and flowering) did not show significant differences in grain yield and protein content. The NAM-A1 allelic variation is significantly associated with the length of the grain-filling period. While the NAM-A1 allele a was associated with a short to moderate grain-filling phase, the alleles c and d were related to moderate to long grain-filling phase. Thus, selection of appropriate combinations of NAM gene alleles can fine-tune the duration of growth phases affecting sink-source relationships which offers an opportunity to develop high NUtE cultivars for target environments.	[Alhabbar, Zaid; Yang, Rongchang; Juhasz, Angela; Xin, Hu; She, Maoyun; Anwar, Masood; Sultana, Nigarin; Ma, Wujun; Islam, Shahidul] Murdoch Univ, Sch Vet & Life Sci, Australia China Ctr Wheat Improvement, Murdoch, WA, Australia; [Alhabbar, Zaid] Univ Mosul, Dept Field Crops, Coll Agr & Forestry, Mosul, Iraq; [Xin, Hu] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Diepeveen, Dean] Dept Primary Ind & Reg Dev, S Perth, WA, Australia; [Diepeveen, Dean] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia	Murdoch University; University of Mosul; Huazhong Agricultural University; Murdoch University	Ma, WJ; Islam, S (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Australia China Ctr Wheat Improvement, Murdoch, WA, Australia.	W.Ma@murdoch.edu.au; s.islam@murdoch.edu.au	Yang, Rongchang/AAJ-4557-2020; Juhasz, Angela/P-7169-2019; Ma, Wujun/F-5957-2010; Juhasz, Angela/B-9727-2019; Diepeveen, Dean/Q-8026-2019	Juhasz, Angela/0000-0002-4317-2027; Ma, Wujun/0000-0002-1264-866X; Juhasz, Angela/0000-0002-4317-2027; Diepeveen, Dean/0000-0002-1535-8019; Islam, Shahidul/0000-0001-5994-0521; anwar, masood/0000-0001-8132-9016; Yang, Rongchang/0000-0003-2563-2015	Iraqi government	Iraqi government	The authors wishes to thank the Iraqi government represented by the Ministry of Higher Education and Scientific Research / University of Mosul / College of Agriculture and Forestry for providing a Ph.D. scholarship.	ALAGARSWAMY G, 1985, FIELD CROP RES, V11, P265, DOI 10.1016/0378-4290(85)90108-X; Arduini I, 2006, EUR J AGRON, V25, P309, DOI 10.1016/j.eja.2006.06.009; Asplund L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059704; Avivi L., 1978, P 5 INT WHEAT GEN S, P372; Balotf S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190269; Barraclough PB, 2010, EUR J AGRON, V33, P1, DOI 10.1016/j.eja.2010.01.005; Borrell A, 2001, ANN APPL BIOL, V138, P91, DOI 10.1111/j.1744-7348.2001.tb00088.x; Borrill P, 2015, PLANT PHYSIOL, V2016; Borrill PG, 2014, THESIS; Borrill P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134947; Christopher JT, 2008, AUST J AGR RES, V59, P354, DOI 10.1071/AR07193; Cormier F, 2015, AGRONOMY-BASEL, V5, P143, DOI 10.3390/agronomy5020143; CSBP, 2012, FLEX N RANG IS LOC D; Department of Agriculture and Food WA DAFWA, 2016, AR SOWN WHEAT VAR W; Eagles HA, 2014, CROP PASTURE SCI, V65, P854, DOI 10.1071/CP14106; Fageria NK, 2014, J PLANT NUTR, V37, P795, DOI 10.1080/01904167.2014.881855; Fischer RA, 2016, FIELD CROP RES, V198, P188, DOI 10.1016/j.fcr.2016.06.019; Gaju O, 2011, FIELD CROP RES, V123, P139, DOI 10.1016/j.fcr.2011.05.010; GEBEYEHOU G, 1982, CROP SCI, V22, P337, DOI 10.2135/cropsci1982.0011183X002200020033x; GEBEYEHOU G, 1982, CROP SCI, V22, P287, DOI 10.2135/cropsci1982.0011183X002200020021x; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Guarda G, 2004, EUR J AGRON, V21, P181, DOI 10.1016/j.eja.2003.08.001; Hagenblad J, 2012, THEOR APPL GENET, V125, P1677, DOI 10.1007/s00122-012-1943-2; Haile D, 2012, J SOIL SCI PLANT NUT, V12, P389, DOI 10.4067/S0718-95162012005000002; Hawkesford MJ, 2013, FOOD ENERGY SECUR, V2, P34, DOI 10.1002/fes3.15; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Hitz K, 2017, FIELD CROP RES, V200, P1, DOI 10.1016/j.fcr.2016.10.001; JENNER CF, 1991, AUST J PLANT PHYSIOL, V18, P211, DOI 10.1071/PP9910211; Lea PJ, 2006, ANN APPL BIOL, V149, P243, DOI 10.1111/j.1744-7348.2006.00101.x; Limon-Ortega A, 2000, AGRON J, V92, P303, DOI 10.1007/s100870050037; Macnack N, 2014, COMMUN SOIL SCI PLAN, V45, P2480, DOI 10.1080/00103624.2014.904337; Martre P, 2007, FRONTIS, V21, P179; Masclaux-Daubresse C, 2008, PLANT BIOLOGY, V10, P23, DOI 10.1111/j.1438-8677.2008.00097.x; Millet E, 2013, EUPHYTICA, V190, P1, DOI 10.1007/s10681-012-0725-x; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; Nyikako J, 2014, EUPHYTICA, V199, P3, DOI 10.1007/s10681-014-1201-6; Phillip B, 2008, WHEAT GROWTH DEV; Przulj N, 2001, EUR J AGRON, V15, P255, DOI 10.1016/S1161-0301(01)00108-3; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Richards RA, 2000, J EXP BOT, V51, P447, DOI 10.1093/jexbot/51.suppl_1.447; SIDDIQUE KHM, 1989, FIELD CROP RES, V21, P59, DOI 10.1016/0378-4290(89)90041-5; Tao FL, 2012, EUR J AGRON, V43, P201, DOI 10.1016/j.eja.2012.07.005; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Uauy C, 2006, J EXP BOT, V57, P2785, DOI 10.1093/jxb/erl047; Waters BM, 2009, J EXP BOT, V60, P4263, DOI 10.1093/jxb/erp257; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Yang R, 2018, MOL CHARACTERI UNPUB; Yang RC, 2014, INT J PARASITOL, V44, P1105, DOI 10.1016/j.ijpara.2014.08.004; YEOH HH, 1994, FOOD CHEM, V49, P245, DOI 10.1016/0308-8146(94)90167-8; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	51	14	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205448	10.1371/journal.pone.0205448	http://dx.doi.org/10.1371/journal.pone.0205448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321195	Green Published, gold			2022-12-26	WOS:000447417900032
J	Byczek, C; Longaretti, PY; Renaud, J; Lavorel, S				Byczek, Coline; Longaretti, Pierre-Yves; Renaud, Julien; Lavorel, Sandra			Benefits of crowd-sourced GPS information for modelling the recreation ecosystem service	PLOS ONE			English	Article							OUTDOOR RECREATION; DECISION-MAKING; BIODIVERSITY; CONSERVATION; INDICATORS; STATISTICS; MANAGEMENT; FRAMEWORK; SUPPORT; VALUES	Modelling cultural ecosystem services is an enduring challenge, raising issues about the integration and spatialization of immaterial values and benefits, and their contingency on local preferences. Building on the Recreation Opportunity Spectrum framework, we present a novel methodology for assessing the recreation service using GPS tracks downloaded from crowd-sourced websites: the Grelou model (Georeferencing REcreation in Local OUt-doors), here applied to the Grenoble living area (French Alps). GPS tracks revealed the complete spatial extent of visitor presence and enabled modelling visitation networks for ten recreation activities with great spatial accuracy, thus providing a spatial estimate of recreational multifunctionality-expressed as the sum of networks. After coupling track networks with landscape preference and proximity factors, Grelou assessed the recreation service as a combination of opportunity and preferences, and identified recreation hotspots of different profiles such as aroundoor leisure or outdoor sport. We performed an online survey among local sports associations using an interactive map to select districts visited by respondents (similar to 1000 people). The declared visitor presence for recreation purposes was highly spatially congruent with Grelou outputs (R-2 = 0.89). Detailed analysis of responses on selection criteria for recreationists validates our choice of critical factors underlying both the recreation opportunity potential and the expected visitation frequency over the whole study area. We also analyzed outputs of the InVESt recreation model against the same visitation explanatory factors. Differences between the two models allowed us to pinpoint biases and weaknesses in the InVESt recreation modelling framework based on crowd-sourced photographs. By making use of an increasingly available data source (GPS tracks), Grelou offers a standardized and flexible way to assess the recreation service associated with multiple recreation practices. Its high spatial accuracy supports the analysis of spatial relationships with other ecoystems services and the integration of recreation into environmental assessments, land management and planning.	[Byczek, Coline; Renaud, Julien; Lavorel, Sandra] Univ Grenoble Alpes, CNRS, Lab Ecol Alpine, CS, Grenoble, France; [Longaretti, Pierre-Yves] Univ Grenoble Alpes, Grenoble INPINP Inst Engn, CNRS, Inria,LJK, Grenoble, France; [Longaretti, Pierre-Yves] Univ Grenoble Alpes, CNRS, INSU, IPAG,CS, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Inria; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Lavorel, S (corresponding author), Univ Grenoble Alpes, CNRS, Lab Ecol Alpine, CS, Grenoble, France.	sandra.lavorel@unv-grenoble-alpes.fr	BITOUN, RACHEL Elisabeth/AAC-9538-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Renaud, Julien/0000-0001-5991-4657	ONEMA (Office national de l'Eau et des Milieux Aquatiques); EU [FP7-ENV-2012-two-stage-308393]	ONEMA (Office national de l'Eau et des Milieux Aquatiques); EU(European Commission)	This research is part of the ESNET project, funded by ONEMA (Office national de l'Eau et des Milieux Aquatiques) and EU FP7 project OPERAs FP7-ENV-2012-two-stage-308393 (SL).	Akaike H., 1976, MATH SCI ENG, V126, P27, DOI DOI 10.1016/S0076-5392(08)60869-3; Ala-Hulkko T, 2016, ECOL INDIC, V66, P416, DOI 10.1016/j.ecolind.2016.02.013; Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 2014, ECOL INDIC, DOI DOI 10.1016/j.ecolind.2012.06.025; [Anonymous], 2017, R LANG ENV STAT COMP; Beeco JA, 2013, THESIS; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Blicharska M, 2018, ECOSYST SERV, V30, P181, DOI 10.1016/j.ecoser.2018.03.001; Bourdeau P., 2002, Current Issues in Tourism, V5, P22, DOI 10.1080/13683500208667905; Brown P.J., 1978, FOREST MANAGEMENT FA, V31; Casalegno S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068437; Cavin DA, 2004, USDA NE EXP, V326, P39; Chadefaud M., 1988, CAHIERS U PAU; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Clark R. N., 1979, PNWGTR098 USDA FOR S; Cowling RM, 2008, P NATL ACAD SCI USA, V105, P9483, DOI 10.1073/pnas.0706559105; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; Diaz S, 2018, SCIENCE, V359, P270, DOI 10.1126/science.aap8826; Dramstad WE, 2006, LANDSCAPE URBAN PLAN, V78, P465, DOI 10.1016/j.landurbplan.2005.12.006; Fisher B, 2011, BIODIVERS CONSERV, V20, P2461, DOI 10.1007/s10531-011-9998-y; Frank S, 2017, MAPPING ECOSYSTEM SERVICES, P81; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gimona A, 2007, LANDSCAPE ECOL, V22, P1255, DOI 10.1007/s10980-007-9105-7; Gret-Regamey A, 2015, ECOSYST SERV, V13, P16, DOI 10.1016/j.ecoser.2014.10.008; Hammitt W. E., 2015, WILDLAND RECREATION, V2nd; Hautbois C, 2009, LOISIR SOC-SOC LEIS, V32, P299, DOI 10.1080/07053436.2009.10707794; Hernandez-Morcillo M, 2013, ECOL INDIC, V29, P434, DOI 10.1016/j.ecolind.2013.01.013; Joyce K, 2009, APPL GEOGR, V29, P409, DOI 10.1016/j.apgeog.2008.11.006; Kienast F, 2012, LANDSCAPE URBAN PLAN, V105, P385, DOI 10.1016/j.landurbplan.2012.01.015; Maes J, 2017, MAPPING ECOSYSTEM SERVICES, P87; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; MANFREDO MJ, 1983, J LEISURE RES, V15, P263, DOI 10.1080/00222216.1983.11969562; Martinez-Harms MJ, 2018, SCI TOTAL ENVIRON, V636, P1128, DOI 10.1016/j.scitotenv.2018.04.353; McLaughlin W, 1980, ED SERIES U MINNESOT, V2-3, P64; Monz CA, 2010, ENVIRON MANAGE, V45, P551, DOI 10.1007/s00267-009-9406-5; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Paracchini ML, 2014, ECOL INDIC, V45, P371, DOI 10.1016/j.ecolind.2014.04.018; Perez-Verdin G, 2008, RECREATION VISITOR R, P23; Plieninger T, 2015, CURR OPIN ENV SUST, V14, P28, DOI 10.1016/j.cosust.2015.02.006; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; Queiroz C, 2015, AMBIO, V44, pS89, DOI 10.1007/s13280-014-0601-0; Raymond CM, 2009, ECOL ECON, V68, P1301, DOI 10.1016/j.ecolecon.2008.12.006; Rech Y., 2010, THESIS; Rech Y, 2011, LOISIR SOC-SOC LEIS, V34, P19, DOI 10.1080/07053436.2011.10707825; Reyers B, 2012, BIOSCIENCE, V62, P503, DOI 10.1525/bio.2012.62.5.12; Schirpke U, 2018, ECOSYSTEM SERVICES; Schirpke U, 2013, LANDSCAPE URBAN PLAN, V111, P1, DOI 10.1016/j.landurbplan.2012.11.010; Sharp R., INVEST 3 2 0 USERS G; Tallis H, 2008, P NATL ACAD SCI USA, V105, P9457, DOI 10.1073/pnas.0705797105; Tenerelli P, 2016, ECOL INDIC, V64, P237, DOI 10.1016/j.ecolind.2015.12.042; Vannier C, 2016, CYBERGEO, DOI 10.4000/cybergeo.27800; Wolff S, 2015, ECOL INDIC, V55, P159, DOI 10.1016/j.ecolind.2015.03.016; Wood SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02976	54	17	17	6	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0202645	10.1371/journal.pone.0202645	http://dx.doi.org/10.1371/journal.pone.0202645			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0RD	30321173	Green Published, Green Submitted, gold			2022-12-26	WOS:000447417900003
J	Liu, JJ; Guo, C; Wang, B; Shi, MX; Yang, Y; Yu, Z; Meng, XH; Xu, DX				Liu, Ji-Jie; Guo, Ce; Wang, Bo; Shi, Meng-Xing; Yang, Yang; Yu, Zhen; Meng, Xiu-Hong; Xu, De-Xiang			Maternal fenvalerate exposure during pregnancy impairs growth and neurobehavioral development in mouse offspring	PLOS ONE			English	Article							PYRETHROID METABOLITES; BEHAVIORAL-DEVELOPMENT; RESIDENTIAL PROXIMITY; RISK-ASSESSMENT; SEX-DIFFERENCES; MECHANISMS; PESTICIDES; ATTENTION; TOXICITY; ORIGINS	Although use of fenvalerate has increased dramatically over the past decade, little is known about their potential adverse effects on growth and development. The purpose of this study was to examine the effects of maternal fenvalerate exposure during pregnancy on growth and neurobehavioral development in the offspring. Pregnant mice were orally administered to fenvalerate (0.2, 2.0, and 20 mg/kg) daily throughout pregnancy. The tests of growth and neurobehavioral development were performed during lactation period. A series of neurobehavioral tasks were carried out from lactation to puberty. Anxiety-related behaviors were evaluated by open-field and elevated plus maze. Morris Water Maze was used to assess spatial learning and memory ability. Results showed that maternal fenvalerate exposure during pregnancy markedly delayed growth development of neonatal offspring during lactation. In addition, anxiety-like behaviors were increased in fenvalerate-exposed male offspring. Moreover, spatial learning and memory was severely impaired in female offspring. Taken together, maternal fenvalerate exposure during pregnancy delayed growth and neurobehavioral development in a gender-dependent manner. Additional study is required to explore the underlying mechanism through which maternal fenvalerate exposure during pregnancy induces impairment of growth and neurobehavioral development.	[Liu, Ji-Jie; Guo, Ce; Wang, Bo; Shi, Meng-Xing; Yang, Yang; Meng, Xiu-Hong] Anhui Med Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Hefei, Anhui, Peoples R China; [Yu, Zhen; Xu, De-Xiang] Anhui Med Univ, Sch Publ Hlth, Dept Toxicol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Meng, XH (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Hefei, Anhui, Peoples R China.; Xu, DX (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Toxicol, Hefei, Anhui, Peoples R China.	mengxiuhong@163.com; xudex@126.com			National Natural Science Foundation of China [81102155, 81773442]; Major projects of Natural Scientific Research in Universities and Colleges, Anhui, China [KJ2016SD27]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major projects of Natural Scientific Research in Universities and Colleges, Anhui, China	This work was supported by National Natural Science Foundation of China (81102155, 81773442) and Major projects of Natural Scientific Research in Universities and Colleges, Anhui, China (KJ2016SD27).	Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bedi JS, 2015, ARCH ENVIRON CON TOX, V69, P230, DOI 10.1007/s00244-015-0163-6; Brander SM, 2016, ENVIRON SCI TECHNOL, V50, P8977, DOI 10.1021/acs.est.6b02253; Corcellas C, 2012, ENVIRON INT, V47, P17, DOI 10.1016/j.envint.2012.05.007; Ding GD, 2015, J EXPO SCI ENV EPID, V25, P264, DOI 10.1038/jes.2014.86; Du GZ, 2010, TOXICOL SCI, V116, P58, DOI 10.1093/toxsci/kfq120; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Gaspar FW, 2015, ENVIRON INT, V85, P206, DOI 10.1016/j.envint.2015.09.004; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gunier RB, 2017, ENVIRON RES, V158, P358, DOI 10.1016/j.envres.2017.06.036; Han JJ, 2017, J TOXICOL ENV HEAL A, V80, P1331, DOI 10.1080/15287394.2017.1384167; Heindel JJ, 2015, ENDOCRINOLOGY, V156, P3416, DOI 10.1210/EN.2015-1394; Hill Joanna M., 2008, V39, P131, DOI 10.1007/978-1-60327-099-1_10; Li ZX, 2016, FOOD CHEM TOXICOL, V96, P234, DOI 10.1016/j.fct.2016.08.012; Liu P, 2011, TOXICOL LETT, V201, P181, DOI 10.1016/j.toxlet.2010.12.024; McEwen BS, 2017, J NEUROSCI RES, V95, P24, DOI 10.1002/jnr.23809; Meng XH, 2011, TOXICOL LETT, V203, P245, DOI 10.1016/j.toxlet.2011.03.024; Morgenstern R, 2017, ENVIRON INT, V106, P11, DOI 10.1016/j.envint.2017.05.007; Paus T, 2017, J NEUROSCI RES, V95, P362, DOI 10.1002/jnr.23825; Qi XJ, 2012, INT J HYG ENVIR HEAL, V215, P487, DOI 10.1016/j.ijheh.2011.12.003; Quiros-Alcala L, 2014, ENVIRON HEALTH PERSP, V122, P1336, DOI 10.1289/ehp.1308031; Shelton JF, 2014, ENVIRON HEALTH PERSP, V122, P1103, DOI 10.1289/ehp.1307044; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang B, 2017, TOXICOL SCI, V157, P377, DOI 10.1093/toxsci/kfx052; Wang H, 2010, TOXICOL LETT, V192, P245, DOI 10.1016/j.toxlet.2009.10.030; Ye M, 2015, INT J HYG ENVIR HEAL, V218, P616, DOI 10.1016/j.ijheh.2015.06.006; Zhang H, 2010, FOOD CHEM TOXICOL, V48, P1160, DOI 10.1016/j.fct.2010.02.003; Zhang H, 2009, TOXICOL LETT, V191, P47, DOI 10.1016/j.toxlet.2009.08.007; Zhang Q, 2017, CHEMOSPHERE, V185, P1173, DOI 10.1016/j.chemosphere.2017.07.091; Zhao XF, 2011, ARCH TOXICOL, V85, P1101, DOI 10.1007/s00204-011-0654-9	31	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205403	10.1371/journal.pone.0205403	http://dx.doi.org/10.1371/journal.pone.0205403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321209	Green Published, Green Submitted, gold			2022-12-26	WOS:000447417900030
J	Zafar, N; Krishnasamy, SS; Shah, J; Rai, SN; Riggs, DW; Bhatnagar, A; O'Toole, TE				Zafar, Nagma; Krishnasamy, Sathya S.; Shah, Jasmit; Rai, Shesh N.; Riggs, Daniel W.; Bhatnagar, Aruni; O'Toole, Timothy E.			Circulating angiogenic stem cells in type 2 diabetes are associated with glycemic control and endothelial dysfunction	PLOS ONE			English	Article							PROGENITOR CELLS; INDUCED MOBILIZATION; EXPOSURE; DISEASE	Circulating angiogenic cells (CACs) of various described phenotypes participate in the regeneration of the damaged endothelium, but the abundance of these cells is highly influenced by external cues including diabetes. It is not entirely clear which CAC populations are most reflective of endothelial function nor which are impacted by diabetes. To answer these questions, we enrolled a human cohort with variable CVD risk and determined relationships between stratified levels of CACs and indices of diabetes and vascular function. We also determined associations between CAC functional markers and diabetes and identified proangiogenic molecules which are impacted by diabetes. We found that subjects with low levels of CD34(+)/AC133(+)/CD31(+)/CD45(dim) cells (CAC-3) had a significantly higher incidence of diabetes (p = 0.004), higher HbA1c levels (p = 0.049) and higher CVD risk scores. Furthermore, there was an association between low CAC-3 levels and impaired vascular function (p = 0.023). These cells from diabetics had reduced levels of CXCR4 and VEGFR2, while diabetics had higher levels of certain cytokines and pro-angiogenic molecules. These results suggest that quantitative and functional defects of CD34(+)/AC133(+)/CD31(+)/CD45(dim) cells are associated with diabetes and vascular impairment and that this cell type may be a prognostic indicator of CVD and vascular dysfunction.	[Zafar, Nagma; Riggs, Daniel W.; Bhatnagar, Aruni; O'Toole, Timothy E.] Univ Louisville, Dept Med, Diabet & Obes Ctr, Louisville, KY 40292 USA; [Zafar, Nagma] Univ Louisville, Dept Med, Div Gen Pediat, Louisville, KY 40292 USA; [Krishnasamy, Sathya S.] Univ Louisville, Dept Med, Div Endocrinol Metab & Diabet, Louisville, KY 40292 USA; [Shah, Jasmit] Aga Khan Univ, Dept Internal Med, Nairobi, Kenya; [Rai, Shesh N.; Riggs, Daniel W.] Univ Louisville, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [Riggs, Daniel W.; Bhatnagar, Aruni; O'Toole, Timothy E.] Univ Louisville, Envirome Inst, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; Aga Khan University; University of Louisville; University of Louisville	O'Toole, TE (corresponding author), Univ Louisville, Envirome Inst, Louisville, KY 40292 USA.	teotoo01@louisville.edu		O'Toole, Timothy/0000-0003-1773-1523; Shah, Jasmit/0000-0002-7957-5426	Wellpoint Foundation; National Institutes of Health [ES019217, GM103492]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM127607, P20GM103492] Funding Source: NIH RePORTER	Wellpoint Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was also supported by a grant from the Wellpoint Foundation, and by National Institutes of Health (ES019217 to TO), (GM103492 to AB) https://www.nih.gov/grants-funding.	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Abplanalp WT, 2016, DIABETES, V65, P3505, DOI 10.2337/db16-0634; Abrahamsen JF, 1998, EUR J HAEMATOL, V60, P7; Albiero M, 2014, DIABETES, V63, P1353, DOI 10.2337/db13-0894; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Barrett EJ, 2017, J CLIN ENDOCR METAB, V102, P4343, DOI 10.1210/jc.2017-01922; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Chade AR, 2009, CIRCULATION, V119, P547, DOI 10.1161/CIRCULATIONAHA.108.788653; Cubbon RM, 2010, ARTERIOSCL THROM VAS, V30, P878, DOI 10.1161/ATVBAHA.109.201012; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fadini GP, 2013, DIABETES CARE, V36, P943, DOI 10.2337/dc12-1084; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Friedrich EB, 2006, CIRC RES, V98, pE20, DOI 10.1161/01.RES.0000205765.28940.93; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Haberzettl P, 2012, ENVIRON HEALTH PERSP, V120, P848, DOI 10.1289/ehp.1104206; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Jeong JO, 2009, CIRCULATION, V119, P699, DOI 10.1161/CIRCULATIONAHA.108.789297; Jiamsripong Panupong, 2008, Prev Cardiol, V11, P155; Kady N, 2017, J CLIN LIPIDOL, V11, P694, DOI 10.1016/j.jacl.2017.03.007; Kahn MB, 2011, DIABETES, V60, P1295, DOI 10.2337/db10-1080; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Lathief S, 2016, TRENDS CARDIOVAS MED, V26, P165, DOI 10.1016/j.tcm.2015.05.005; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Fernandez JM, 2012, CLIN SCI, V123, P361, DOI 10.1042/CS20110477; Marin C, 2011, AM J CLIN NUTR, V93, P267, DOI 10.3945/ajcn.110.006866; Murphy C, 2007, ARTERIOSCL THROM VAS, V27, P936, DOI 10.1161/01.ATV.0000258788.11372.d0; O'Toole TE, 2010, CIRC RES, V107, P200, DOI 10.1161/CIRCRESAHA.110.222679; Sambataro M, 2014, INT J VASC MED, V2014, DOI 10.1155/2014/589412; Sangidorj O, 2010, AM J PHYSIOL-RENAL, V299, pF325, DOI 10.1152/ajprenal.00019.2010; Schwarz TM, 2012, ARTERIOSCL THROM VAS, V32, pE13, DOI 10.1161/ATVBAHA.111.239822; Shantsila E, 2012, J THROMB HAEMOST, V10, P1252, DOI 10.1111/j.1538-7836.2012.04753.x; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Sibal L, 2009, DIABETOLOGIA, V52, P1464, DOI 10.1007/s00125-009-1401-0; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699; Ueno H, 2010, NEPHROL DIAL TRANSPL, V25, P581, DOI 10.1093/ndt/gfp358; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Wang CY, 2008, CIRCULATION, V118, P2166, DOI 10.1161/CIRCULATIONAHA.108.790469; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Westerweel PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060357; Wheat LA, 2011, ARTERIOSCL THROM VAS, V31, P1598, DOI 10.1161/ATVBAHA.111.227124; World Health Organization, 2008, WIAST CIRCUMFERENCE; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	46	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205851	10.1371/journal.pone.0205851	http://dx.doi.org/10.1371/journal.pone.0205851			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321232	Green Published, Green Submitted, gold			2022-12-26	WOS:000447417900060
J	Nam, BH; Jang, J; Caetano-Anolles, K; Kim, YO; Park, JY; Sohn, H; Yoon, SH; Kim, H; Kwak, W				Nam, Bo-Hye; Jang, Jisung; Caetano-Anolles, Kelsey; Kim, Young-Ok; Park, Jung Youn; Sohn, Hawsun; Yoon, Sook Hee; Kim, Heebal; Kwak, Woori			Microbial community and functions associated with digestion of algal polysaccharides in the visceral tract of Haliotis discus hannai: Insights from metagenome and metatranscriptome analysis	PLOS ONE			English	Article							GUT MICROFLORA; ABALONE; ALGINATE; PHYLOGENIES; ALIGNMENT; BACTERIA; LYASE	Haliotis discus hannai, a species of Pacific abalone, is a highly valuable food source throughout Northeast Asia. As H. discus hannai primarily feed on brown algae and largely extract their energy from algal polysaccharides, understanding the mechanisms by which they digest algal polysaccharides is essential for elucidating their energy metabolism. Gut microbes, as well as the host animal, are involved in the process of polysaccharide degradation. To identify algal polysaccharide-digestion mechanisms and their origin, we analyzed the metagenome and metatranscriptome of abalone visceral extracts. Microbial communities were characterized using the 16S rRNA gene sequences in the metagenome and our results differed significantly from those of previous studies using traditional microbiological methods such as bacterial cultivation and cloning. A greater diversity of bacterial taxa was identified here than was previously identified using cultivation methods. Furthermore, the most abundant bacterial taxa also differed from previous studies, which is not common when comparing the results of bacterial culturing with those of molecular methodologies. Based on the metatranscriptome, overall functions were identified and additional analyses were performed on the coding sequences of algal polysaccharide-digestive enzymes, including alginate lyase. Results of the transcriptomic analyses suggest that alginate lyase in the visceral extracts of H. discus hannai was produced by the host itself, not by visceral bacteria. This is the first next-generation sequencing study performed on abalone to characterize the visceral microbiota and the source of the ability to digest algal polysaccharides by analyzing the metagenome and metatranscriptome together.	[Nam, Bo-Hye; Kim, Young-Ok; Park, Jung Youn] Natl Inst Fisheries Sci, Biotechnol Res Div, Busan, South Korea; [Jang, Jisung; Kim, Heebal] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Jang, Jisung; Kim, Heebal; Kwak, Woori] C&K Genom, Seoul, South Korea; [Caetano-Anolles, Kelsey; Yoon, Sook Hee; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Caetano-Anolles, Kelsey; Yoon, Sook Hee; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Sohn, Hawsun] Natl Inst Fisheries Sci, Cetacean Res Inst, Ulsan, South Korea	National Institute of Fisheries Science; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Institute of Fisheries Science	Kwak, W (corresponding author), C&K Genom, Seoul, South Korea.	asleo@cnkgenomics.com	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Jang, Jisung/0000-0002-2643-1330; Caetano-Anolles, Kelsey/0000-0001-6310-6679	National Institute of Fisheries Science [R2018021, PJ01115901]; CK genomics	National Institute of Fisheries Science; CK genomics	This research was supported by grants from National Institute of Fisheries Science (Grant Number: R2018021, URL: www.nifs.go.kr (B-HN)) and Rural Development Administration (Grant number: PJ01115901, URL: www.rda.go.kr (SHY)). The two funding source contributed to this study with the same proportions. The C&K genomics provided support in the form of salaries for Jisung Jang, Woori Kwak and Heebal Kim, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbot R. T., 2000, COMPENDIUM SEASHELLS; Andrews S., 2010, FASTQC QUALITY CONTR; Bansemer MS, 2016, REV AQUACULT, V8, P121, DOI 10.1111/raq.12085; BENNETT KW, 1993, J MED MICROBIOL, V39, P246, DOI 10.1099/00222615-39-4-246; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bouchet P, 2017, 1758 WORLD REGISTER; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chi WJ, 2012, APPL MICROBIOL BIOT, V94, P917, DOI 10.1007/s00253-012-4023-2; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Erasmus JH, 1997, AQUACULTURE, V155, P377, DOI 10.1016/S0044-8486(97)00112-9; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Glass Elizabeth M, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5368; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Haas B., 2016, TRANSDECODER; Hall T.A., 1999, NUCL ACIDS S SERIES; HARRIS JM, 1993, MICROB ECOL, V25, P195, DOI 10.1007/BF00171889; Huang ZB, 2010, AQUAC RES, V41, pe760, DOI 10.1111/j.1365-2109.2010.02577.x; Hugenholtz P, 2002, GENOME BIOL, V3; Kang SW, 2016, MOL GENET GENOMICS, V291, P1999, DOI 10.1007/s00438-016-1233-9; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Korea Meteorological Administration, 2016, AN GEOM S KOR DEC 20; Korea Meteorological Administration, MAR BUOY COSM 2016; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee MJ, 2016, INT J FOOD MICROBIOL, V234, P45, DOI 10.1016/j.ijfoodmicro.2016.06.032; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Munasinghe H, 2006, J WORLD AQUACULT SOC, V37, P96, DOI 10.1111/j.1749-7345.2006.00012.x; Ojima T, 2013, WOODH PUB SER BIOMED, P333, DOI 10.1533/9781908818355.3.333; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ruperez P, 2003, J SCI FOOD AGR, V83, P1267, DOI 10.1002/jsfa.1536; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawabe T, 2003, AQUACULTURE, V219, P671, DOI 10.1016/S0044-8486(02)00618-X; SAWABE T, 1995, MICROB ECOL, V30, P193; Schink B, 2011, BERGEYS MANUAL SYSTE, V4, P759; Shimizu E, 2003, CARBOHYD RES, V338, P2841, DOI 10.1016/j.carres.2003.08.009; Sim SJ, 2012, J IND MICROBIOL BIOT, V39, P585, DOI 10.1007/s10295-011-1054-0; Suzuki H, 2006, CARBOHYD RES, V341, P1809, DOI 10.1016/j.carres.2006.04.032; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tanaka R, 2004, AQUACULTURE, V241, P453, DOI 10.1016/j.aquaculture.2004.08.032; Tanaka R, 2016, AQUAC RES, V47, P2899, DOI 10.1111/are.12740; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; Wells ML, 2017, J APPL PHYCOL, V29, P949, DOI 10.1007/s10811-016-0974-5; Westreich S. T., 2017, BIORXIV; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhao J, 2012, AQUACULTURE, V338, P147, DOI 10.1016/j.aquaculture.2012.01.016	49	6	8	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205594	10.1371/journal.pone.0205594	http://dx.doi.org/10.1371/journal.pone.0205594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308038	Green Submitted, Green Published, gold			2022-12-26	WOS:000447173500105
J	Niemirowicz, GT; Cazzulo, JJ; Alvarez, VE; Bouvier, LA				Niemirowicz, Gabriela T.; Cazzulo, Juan J.; Alvarez, Vanina E.; Bouvier, Leon A.			Simplified inducible system for Trypanosoma brucei	PLOS ONE			English	Article							TUBULIN GENE-CLUSTER; MESSENGER-RNA; EXPRESSION SYSTEM; BLOOD-STREAM; FUNCTIONAL GENOMICS; STABLE TRANSFECTION; PROMOTER; PROTEIN; REGION; VECTORS	Nowadays, most reverse genetics approaches in Trypanosoma brucei, a protozoan parasite of medical and veterinary importance, rely on pre-established cell lines. Consequently, inducible experimentation is reduced to a few laboratory strains. Here we described a new transgene expression system based exclusively on endogenous transcription activities and a minimum set of regulatory components that can easily been adapted to different strains. The pTbFIX vectors are designed to contain the sequence of interest under the control of an inducible rRNA promoter along with a constitutive dicistronic unit encoding a nucleus targeted tetracycline repressor and puromycin resistance genes in a tandem "head-to-tail" configuration. Upon doxycycline induction, the system supports regulatable GFP expression (170 to 400 fold) in both bloodstream and procyclic T. brucei forms. Furthermore we have adapted the pTbFIX plasmid to perform RNAi experimentation. Lethal phenotypes, including alpha-tubulin and those corresponding to the enolase and clathrin heavy chain genes, were successfully recapitulated in procyclic and bloodstream parasites thus showing the versatility of this new tool.	[Niemirowicz, Gabriela T.; Cazzulo, Juan J.; Alvarez, Vanina E.; Bouvier, Leon A.] Univ Nacl San Martin UNSAM, Inst Invest Biotecnol IIB Dr Rodolfo A Ugalde, CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bouvier, LA (corresponding author), Univ Nacl San Martin UNSAM, Inst Invest Biotecnol IIB Dr Rodolfo A Ugalde, CONICET, Buenos Aires, DF, Argentina.	lbouvier@gmail.com		Alvarez, Vanina/0000-0002-9890-6980; Niemirowicz, Gabriela/0000-0002-1286-5832	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, MinCyT) [PICT 2014-3029]; Fundacion Bunge y Born;  [PICT 2014-3510];  [PICT 2017-3447];  [PIP CONICET 112-201301-00303]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, MinCyT); Fundacion Bunge y Born; ; ; 	This study was supported by PICT 2014-3029 from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, MinCyT) to LAB; PICT 2014-3510 to GTN; PICT 2017-3447 to VEA and JJC; PIP CONICET 112-201301-00303 to GTN and LAB and Fundacion Bunge y Born to LAB. GTN, JJC, VEA and LAB are members of the research career of the Argentinean National Research Council (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Alsford S, 2008, MOL BIOCHEM PARASIT, V161, P76, DOI 10.1016/j.molbiopara.2008.05.006; BERBEROF M, 1995, EMBO J, V14, P2925, DOI 10.1002/j.1460-2075.1995.tb07292.x; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Clayton CE, 2016, CURR OPIN MICROBIOL, V32, P46, DOI 10.1016/j.mib.2016.04.018; Clayton CE, 2014, MOL BIOCHEM PARASIT, V195, P96, DOI 10.1016/j.molbiopara.2014.06.005; Cruz-Bustos T, 2018, J EUKARYOT MICROBIOL, V65, P412, DOI 10.1111/jeu.12493; EID J, 1991, P NATL ACAD SCI USA, V88, P2118, DOI 10.1073/pnas.88.6.2118; Hannaert V, 2003, EUR J BIOCHEM, V270, P3205, DOI 10.1046/j.1432-1033.2003.03692.x; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Horn D, 1997, EMBO J, V16, P7422, DOI 10.1093/emboj/16.24.7422; Hotz HR, 1997, NUCLEIC ACIDS RES, V25, P3017, DOI 10.1093/nar/25.15.3017; IMBODEN MA, 1987, NUCLEIC ACIDS RES, V15, P7357, DOI 10.1093/nar/15.18.7357; Jones NG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003886; Kalidas S, 2011, MOL BIOCHEM PARASIT, V178, P51, DOI 10.1016/j.molbiopara.2011.03.002; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kolev NG, 2014, CELL MICROBIOL, V16, P482, DOI 10.1111/cmi.12268; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Kraeva N, 2014, MOL BIOCHEM PARASIT, V198, P11, DOI 10.1016/j.molbiopara.2014.11.002; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Lee MGS, 1998, NUCLEIC ACIDS RES, V26, P4025, DOI 10.1093/nar/26.17.4025; LEE MGS, 1990, SCIENCE, V250, P1583, DOI 10.1126/science.2177225; Li FJ, 2017, MOL BIOCHEM PARASIT, V214, P101, DOI 10.1016/j.molbiopara.2017.04.007; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; McAllaster MR, 2016, MOL BIOCHEM PARASIT, V210, P13, DOI 10.1016/j.molbiopara.2016.08.001; McLatchie AP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002571; MUHICH ML, 1988, MOL CELL BIOL, V8, P3837, DOI 10.1128/MCB.8.9.3837; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Poon SK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110037; Price HP, 2010, MOL BIOCHEM PARASIT, V173, P123, DOI 10.1016/j.molbiopara.2010.05.016; Sunter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035167; Sunter JD, 2016, MOL BIOCHEM PARASIT, V207, P45, DOI 10.1016/j.molbiopara.2016.04.001; Taylor MC, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-32; TENASBROEK ALMA, 1990, NATURE, V348, P174, DOI 10.1038/348174a0; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Vasquez JJ, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky517; Wen LM, 2001, EXP PARASITOL, V97, P196, DOI 10.1006/expr.2001.4612; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; WIRTZ E, 1994, NUCLEIC ACIDS RES, V22, P3887, DOI 10.1093/nar/22.19.3887; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WIRTZ E, 1995, SCIENCE, V268, P1179, DOI 10.1126/science.7761835; Yan SF, 2002, MOL BIOCHEM PARASIT, V119, P217, DOI 10.1016/S0166-6851(01)00418-2; Yan SF, 2001, MOL BIOCHEM PARASIT, V112, P61, DOI 10.1016/S0166-6851(00)00345-5; Yao CQ, 2007, EXP PARASITOL, V116, P205, DOI 10.1016/j.exppara.2007.01.001; ZOMERDIJK JCBM, 1990, EMBO J, V9, P2791, DOI 10.1002/j.1460-2075.1990.tb07467.x	48	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205527	10.1371/journal.pone.0205527	http://dx.doi.org/10.1371/journal.pone.0205527			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308039	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500096
J	Zou, GZ; Kosikova, M; Kim, SR; Kotian, S; Wu, WW; Shen, RF; Powers, DN; Agarabi, C; Xie, H; Ju, TZ				Zou, Guozhang; Kosikova, Martina; Kim, Su-Ryun; Kotian, Shweta; Wu, Wells W.; Shen, Rongfong; Powers, David N.; Agarabi, Cyrus; Xie, Hang; Ju, Tongzhong			Comprehensive analysis of N-glycans in IgG purified from ferrets with or without influenza A virus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; IgG; glycosylation; influenza; MS; ferret; fucosylation; immunity; UPLC; vaccine development	FC-GAMMA-RIII; VACCINE EFFECTIVENESS; GLYCOMIC CHARACTERIZATION; RECEPTOR-BINDING; IMMUNOGLOBULIN-G; LINKED GLYCANS; LC-MS/MS; ANTIBODY; FRAGMENTATION; GLYCOFORMS	Influenza viruses cause contagious respiratory infections, resulting in significant economic burdens to communities. Production of influenza-specific Igs, specifically IgGs, is one of the major protective immune mechanisms against influenza viruses. In humans, N-glycosylation of IgGs plays a critical role in antigen binding and effector functions. The ferret is the most commonly used animal model for studying influenza pathogenesis, virus transmission, and vaccine development, but its IgG structure and functions remain largely undefined. Here we show that ferret IgGs are N-glycosylated and that their N-glycan structures are diverse. Using a comprehensive strategy based on MS and ultra-HPLC analyses in combination with exoglycosidase digestions, we assigned 42 N-glycan structures in ferret IgGs. We observed that N-glycans of ferret IgGs consist mainly of complex-type glycans, including some high-mannose and hybrid glycans, similar to those observed in human IgG. The complex-type glycans of ferret IgGs were primarily core-fucosylated. Furthermore, a fraction of N-glycans carried bisecting GlcNAc. Ferret IgGs also had a minor fraction of glycans carrying 2-6Neu5Ac(s). We noted that, unlike human IgG, ferret IgGs have Gal epitopes on some N-glycans. Interestingly, influenza A infection caused prominent changes in the N-glycans of ferret IgG, mainly because of an increase in bisecting GlcNAc and F1A2G0 and a corresponding decrease in F1A2G1. This suggests that the glycosylation of virus-specific IgG may play a role in its functionality. Our study highlights the need to further elucidate the structure-function relationships of IgGs in universal influenza vaccine development.	[Zou, Guozhang; Kim, Su-Ryun; Kotian, Shweta; Powers, David N.; Agarabi, Cyrus; Ju, Tongzhong] US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Kosikova, Martina; Xie, Hang] US FDA, Off Vaccines Res & Review, Silver Spring, MD 20993 USA; [Wu, Wells W.; Shen, Rongfong] US FDA, Facil Biotechnol Resources, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Ju, TZ (corresponding author), US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.; Xie, H (corresponding author), US FDA, Off Vaccines Res & Review, Silver Spring, MD 20993 USA.	hang.xie@fda.hhs.gov; tongzhong.ju@fda.hhs.gov	Kotian, Shweta/GMX-3418-2022; Xie, Hang/AAC-9092-2019	Xie, Hang/0000-0001-8318-5554; Ju, Tongzhong/0000-0002-4429-1976	Food and Drug Administration intramural funds	Food and Drug Administration intramural funds	This work is supported by Food and Drug Administration intramural funds. This project was supported in part by an appointment to the Internship/Research Participation Program at the Office of Biotechnology Products, Food and Drug Administration, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the Department of Energy and Food and Drug Administration. The authors declare that they have no conflicts of interest with the contents of this article. The views expressed in this article are those of the authors, and do not necessarily reflect the official policy or position of the U.S. Food and Drug Administration and the Dept. of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; Ackerman ME, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005315; Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708; Adamczyk B, 2014, CARBOHYD RES, V389, P174, DOI 10.1016/j.carres.2014.01.018; Alley WR, 2010, ANAL CHEM, V82, P5095, DOI 10.1021/ac100131e; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; DiLillo DJ, 2016, J CLIN INVEST, V126, P605, DOI 10.1172/JCI84428; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Flannery B, 2015, MMWR-MORBID MORTAL W, V64, P10; FUJII S, 1990, J BIOL CHEM, V265, P6009; GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519; Gornik O, 2009, GLYCOBIOLOGY, V19, P1547, DOI 10.1093/glycob/cwp134; Halim A, 2014, J PROTEOME RES, V13, P6024, DOI 10.1021/pr500898r; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P647, DOI 10.1016/j.jasms.2005.01.006; Harvey DJ, 2004, RAPID COMMUN MASS SP, V18, P2997, DOI 10.1002/rcm.1709; Hensley SE, 2014, CURR OPIN VIROL, V8, P85, DOI 10.1016/j.coviro.2014.07.007; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Jennewein MF, 2017, TRENDS IMMUNOL, V38, P358, DOI 10.1016/j.it.2017.02.004; Jia N, 2014, J BIOL CHEM, V289, P28489, DOI 10.1074/jbc.M114.588541; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kang P, 2005, RAPID COMMUN MASS SP, V19, P3421, DOI 10.1002/rcm.2210; Kirchenbaum GA, 2017, J IMMUNOL, V199, P3798, DOI 10.4049/jimmunol.1701174; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Kosikova M, 2018, CLIN INFECT DIS, V67, P1523, DOI 10.1093/cid/ciy327; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Li TZ, 2017, P NATL ACAD SCI USA, V114, P3485, DOI 10.1073/pnas.1702173114; Li Y, 2013, J EXP MED, V210, P1493, DOI 10.1084/jem.20130212; Maamary J, 2017, P NATL ACAD SCI USA, V114, P10172, DOI 10.1073/pnas.1707950114; Mucha E, 2018, ANGEW CHEM INT EDIT, V57, P7440, DOI 10.1002/anie.201801418; Nesspor TC, 2014, INFLUENZA OTHER RESP, V8, P596, DOI 10.1111/irv.12273; Ng PSK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6750; Popova L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041895; Pucic M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010090; Raju TS, 2000, GLYCOBIOLOGY, V10, P477, DOI 10.1093/glycob/10.5.477; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; SANDRIN MS, 1993, P NATL ACAD SCI USA, V90, P11391, DOI 10.1073/pnas.90.23.11391; Selman MHJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014563; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shivatare VS, 2018, J AM CHEM SOC, V140, P5202, DOI 10.1021/jacs.8b00896; Skowronski DM, 2016, CLIN INFECT DIS, V63, P21, DOI 10.1093/cid/ciw176; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Sullivan SG, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.43.17-00707; Tripp RA, 2009, CURR TOP MICROBIOL, V333, P397, DOI 10.1007/978-3-540-92165-3_19; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xie H, 2017, CLIN INFECT DIS, V65, P259, DOI 10.1093/cid/cix269; Xie H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15279; Zhou SY, 2017, ANAL CHEM, V89, P6590, DOI 10.1021/acs.analchem.7b00747; Zhou SY, 2017, ANAL BIOANAL CHEM, V409, P453, DOI 10.1007/s00216-016-9996-8; Zou GZ, 2017, ANAL CHEM, V89, P5364, DOI 10.1021/acs.analchem.7b00062; Zou GZ, 2011, J AM CHEM SOC, V133, P18975, DOI 10.1021/ja208390n	56	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19277	19289		10.1074/jbc.RA118.005294	http://dx.doi.org/10.1074/jbc.RA118.005294			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30315103	Green Published, hybrid			2022-12-26	WOS:000453537300011
J	Schoepp, KR; Schofield, JS; Home, D; Dawson, MR; Lou, E; Keri, M; Marasco, PD; Hebert, JS				Schoepp, Katherine R.; Schofield, Jonathon S.; Home, David; Dawson, Michael R.; Lou, Edmond; Keri, McNiel; Marasco, Paul D.; Hebert, Jacqueline S.			Real time monitoring of transtibial elevated vacuum prostheses: A case series on socket air pressure	PLOS ONE			English	Article							RESIDUAL LIMB WOUNDS; ASSISTED SUSPENSION; SWING PHASE; AMPUTEES; AMPUTATION; SUCTION; GAIT; PERFORMANCE; INTERFACE; VALUES	Prosthetic elevated vacuum is a suspension method used to reduce daily volume changes of the residual limb. Evaluation of the effectiveness of these systems is limited due to a lack of correlation to actual socket air pressure, particularly during unconstrained movements. This may explain some of the variability in functional outcomes reported in the literature. Our objective was to develop a light-weight portable socket measurement system to quantify internal socket air pressure, temperature, and acceleration; and to present preliminary results from implementation with three transtibial prosthesis users with mechanical elevated vacuum pumps. Participants completed five functional tasks with and without the vacuum pumps actively connected, including the 2-Minute Walk test, 5-Times Sit-to-Stand test, 4-Square Step test, L-Test, and Figure-8 test. Results demonstrated different gait profiles and pressure ranges for each user. Two of the participants demonstrated substantially lower air pressure (higher vacuum) over time while the pump was active compared to inactive. The minimum air pressure measured for all participants was -34.6 +/- 7.7 kPa. One participant did not show substantial changes in pressure over time for either pump condition. Functional task performance was not significantly different between pump conditions. Correlation with accelerometer readings indicated peak positive pressures occurred just following initial contact of the foot in early stance, and the most negative pressures (highest vacuum) were observed throughout swing. This study has demonstrated the use of a portable data logging tool that may serve the clinical and research communities to quantify the operation of elevated vacuum systems, and better understand the variability of mechanical pump operation and overall system performance.	[Schoepp, Katherine R.; Dawson, Michael R.; Keri, McNiel; Hebert, Jacqueline S.] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada; [Schofield, Jonathon S.; Marasco, Paul D.] Lerner Res Inst, Dept Biomed Engn, Cleveland, OH USA; [Home, David] Glenrose Rehabil Hosp, Prosthet & Orthot Dept, Edmonton, AB, Canada; [Lou, Edmond] Univ Alberta, Fac Engn, Dept Elect & Comp Engn, Edmonton, AB, Canada; [Marasco, Paul D.] Vet Affairs Med Ctr, Adv Platform Technol Ctr Excellence, Louis Stokes Cleveland Dept, Cleveland, OH USA	University of Alberta; Cleveland Clinic Foundation; University of Alberta; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Hebert, JS (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada.	jhebert@ualberta.ca	Hebert, Jacqueline/E-1881-2016	Hebert, Jacqueline/0000-0003-0788-0568; Dawson, Michael/0000-0003-3258-535X; Marasco, Paul/0000-0002-1689-7161	Congressionally Directed Medical Research Programs [W81XWH-15-1-0575]	Congressionally Directed Medical Research Programs(United States Department of Defense)	Partial funding for this project was provided through the Congressionally Directed Medical Research Programs (award number W81XWH-15-1-0575); PDM and JSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt B., 2011, JPO J PROSTHET ORTHO, V23, P82, DOI [10.1097/JPO.0b013e318217e5f7, DOI 10.1097/JPO.0B013E318217E5F7]; Arwert HJ, 2007, J REHABIL RES DEV, V44, P717, DOI 10.1682/JRRD.2006.05.0047; Beil TL, 2002, J REHABIL RES DEV, V39, P693; Board WJ, 2001, PROSTHET ORTHOT INT, V25, P202, DOI 10.1080/03093640108726603; Bohannon RW, 2006, PERCEPT MOTOR SKILL, V103, P215, DOI 10.2466/PMS.103.1.215-222; Bohannon RW, 2015, ARCH PHYS MED REHAB, V96, P472, DOI 10.1016/j.apmr.2014.10.006; Brunelli S, 2009, ORTHOPADIE TECHNIK Q, V2, P2; CHINO N, 1975, ARCH PHYS MED REHAB, V56, P22; Darter BJ, 2016, PROSTHET ORTHOT INT, V40, P552, DOI 10.1177/0309364615605372; Deathe AB, 2005, PHYS THER, V85, P626, DOI 10.1093/ptj/85.7.626; Dite W, 2002, ARCH PHYS MED REHAB, V83, P1566, DOI 10.1053/apmr.2002.35469; Gerschutz MJ., 2015, J PROSTHET ORTHOT, V27, P161, DOI [10.1097/JPO.0000000000000077, DOI 10.1097/JPO.0000000000000077]; Gerschutz MJ, 2010, J PROSTHET ORTHOT, V22, P172, DOI DOI 10.1097/JP0.0B013E3181E8FEAA; Gholizadeh H, 2016, CLIN BIOMECH, V37, P108, DOI 10.1016/j.clinbiomech.2016.06.005; Goswami J, 2003, PROSTHET ORTHOT INT, V27, P107, DOI 10.1080/03093640308726666; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hafner BJ, 2014, J REHABIL RES DEV, V51, P1, DOI 10.1682/JRRD.2013.01.0024; Heinemann AW, 2003, PROSTHET ORTHOT INT, V27, P191, DOI 10.1080/03093640308726682; Hess RJ, 2010, PHYS THER, V90, P89, DOI 10.2522/ptj.20080121; Hoskins RD, 2014, PROSTHET ORTHOT INT, V38, P68, DOI 10.1177/0309364613487547; Kahle JT, 2013, TECHNOL INNOV, V15, P333, DOI 10.3727/194982413X13844488879177; Klute GK, 2011, ARCH PHYS MED REHAB, V92, P1570, DOI 10.1016/j.apmr.2011.05.019; Klute GK, 2009, J REHABIL RES DEV, V46, P293, DOI 10.1682/JRRD.2008.02.0031; Komolafe O, 2013, J REHABIL RES DEV, V50, P1069, DOI 10.1682/JRRD.2012.11.0204; Ferreira AEK, 2015, GAIT POSTURE, V41, P683, DOI 10.1016/j.gaitpost.2015.01.026; Lang M, 2008, P MEC 08 C UNB; Legro MW, 1999, J REHABIL RES DEV, V36, P155; Levy SW., 2002, ATLAS LIMB PROSTHETI, P681; Major MJ, 2015, J MED DEVICES, V9, DOI 10.1115/1.4030507; Major MJ., 2015, J PROSTHET ORTHOT, V27, P149, DOI [10.1097/JPO.0000000000000073, DOI 10.1097/JPO.0000000000000073]; Mak AFT, 2001, J REHABIL RES DEV, V38, P161; Redfield MT, 2013, J REHABIL RES DEV, V50, P1201, DOI 10.1682/JRRD.2012.12.0233; Rink Cameron, 2016, J Rehabil Res Dev, V53, P1121, DOI 10.1682/JRRD.2015.07.0145; Safari MR, 2015, J REHABIL RES DEV, V52, P509, DOI 10.1682/JRRD.2014.08.0184; Safari MR, 2015, J REHABIL RES DEV, V52, P491, DOI 10.1682/JRRD.2014.08.0183; Samitier CB, 2016, PROSTHET ORTHOT INT, V40, P83, DOI 10.1177/0309364614546927; Sanders JE, 2011, J REHABIL RES DEV, V48, P1231, DOI 10.1682/JRRD.2010.11.0219; Shirley Ryan AbilityLab, 2015, SAT DEV SCOR; Traballesi M, 2012, EUR J PHYS REHAB MED, V48, P613; Wernke MM, 2017, ADV WOUND CARE, V6, P233, DOI 10.1089/wound.2016.0719; WILLEMSEN ATM, 1990, IEEE T BIO-MED ENG, V37, P1201, DOI 10.1109/10.64463; Xu H, 2017, CLIN BIOMECH, V43, P95, DOI 10.1016/j.clinbiomech.2017.02.008; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	43	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0202716	10.1371/journal.pone.0202716	http://dx.doi.org/10.1371/journal.pone.0202716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX7HS	30346953	Green Submitted, Green Published, gold			2022-12-26	WOS:000447938400003
J	Akbarian, M; Yousefi, R				Akbarian, Mohsen; Yousefi, Reza			Human alpha B-crystallin as fusion protein and molecular chaperone increases the expression and folding efficiency of recombinant insulin	PLOS ONE			English	Article							ESCHERICHIA-COLI; A-CHAIN; DISULFIDE-ISOMERASE; MONOMERIC INSULIN; INCLUSION-BODIES; FIBRILLATION; AGGREGATION; PROINSULIN; MECHANISM; PATHOMECHANISM	Low expression and instability are significant challenges in the recombinant production of therapeutic peptides. The current study introduces a novel expression and purification system for human insulin production using the molecular chaperone alpha B-crystallin (alpha B-Cry) as a fusion partner protein. Insulin is composed of A- and B-chain containing three disulfide bonds (one intarchain and two interchains). We have constructed two plasmids harboring the A- or B-chain of insulin joined with human alpha B-Cry. This system is suitable for cloning of the genes and for directing the synthesis of large amounts of the fusion proteins alpha B-Cry/Achain (alpha B-AC) and alpha B-Cry/B-chain (alpha B-BC). The construction of vectors, their efficient expression in Escherichia coli and simple purification of the fusion proteins and two insulin chains are described. A large amount of the recombinant fusion proteins with high purity was obtained by applying a single step anion exchange chromatography or metal chelate affinity. The insulin A- and B-chain were released from the fusion proteins using cyanogen bromide cleavage. The insulin peptides were obtained with an appreciable yield and high purity using one-step gel filtration chromatography. To increase efficiency of chain combination to produce insulin, alpha B-Cry was used under oxidative conditions. The purification of natively folded insulin was performed by phenyl sepharose hydrophobic interaction chromatography. Finally, using an insulin tolerance test in mice and various biophysical methods, the structure and function of purified human recombinant insulin was compared with authentic insulin, to verify folding of insulin to its native state. Overall, the novel expression system using alpha B-Cry is highly demanding for producing human insulin and functional protein. The procedure for alpha B-Cry-mediated insulin folding could be also applicable for the large-scale production of this highly important therapeutic peptide hormone.	[Akbarian, Mohsen; Yousefi, Reza] Shiraz Univ, Dept Biol, Coll Sci, Prot Chem Lab, Shiraz, Iran	Shiraz University	Yousefi, R (corresponding author), Shiraz Univ, Dept Biol, Coll Sci, Prot Chem Lab, Shiraz, Iran.	ryousefi@shirazu.ac.ir	Akbarian, Mohsen/AAF-1110-2020; Yousefi, Reza/S-8243-2017	Yousefi, Reza/0000-0001-7396-7720; Akbarian, Mohsen/0000-0002-2684-1727	INSF [96008461]; Shiraz University research council	INSF(Iran National Science Foundation (INSF)); Shiraz University research council	This work was supported by INSF (grant number 96008461) and Shiraz University research council to RY.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Ahmad A, 2004, J BIOL CHEM, V279, P14999, DOI 10.1074/jbc.M313134200; Baeshen NA, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0141-0; Bekard IB, 2009, BIOPHYS J, V97, P2521, DOI 10.1016/j.bpj.2009.07.064; Brange J, 1993, Pharm Biotechnol, V5, P315; CHAKRABARTY AM, 1975, P NATL ACAD SCI USA, V72, P3647, DOI 10.1073/pnas.72.9.3647; Cho C.W., 2001, BIOTECHNOL BIOPROC E, V6, P144, DOI [10.1007/BF02931961, DOI 10.1007/BF02931961]; DIXON GH, 1960, NATURE, V188, P721, DOI 10.1038/188721a0; ENFORS SO, 1992, TRENDS BIOTECHNOL, V10, P310, DOI 10.1016/0167-7799(92)90256-U; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Gan Z-R., 2005, CHAPERONE PROTEIN CO; Ghahghaei Arezou, 2008, American Journal of Biochemistry and Biotechnology, V4, P317, DOI 10.3844/ajbbsp.2008.317.324; Giannini C, 2009, DIABETES METABOLISM, V25; GOEDDEL DV, 1979, P NATL ACAD SCI USA, V76, P106, DOI 10.1073/pnas.76.1.106; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; GUO LH, 1984, GENE, V29, P251, DOI 10.1016/0378-1119(84)90186-0; Hall Stephen S., 1987, INVISIBLE FRONTIERS; HANSEN JF, 1991, BIOPHYS CHEM, V39, P107, DOI 10.1016/0301-4622(91)85011-E; Hartman JR, 2007, GENERATION HUMAN INS; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; HEATH WF, 1992, J BIOL CHEM, V267, P419; Hong DP, 2006, BIOCHEMISTRY-US, V45, P9342, DOI 10.1021/bi0604936; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hua QX, 2010, PROTEIN CELL, V1, P537, DOI 10.1007/s13238-010-0069-z; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Inouye M, 2014, EXPT MANIPULATION GE; Jonasson P, 1996, EUR J BIOCHEM, V236, P656, DOI 10.1111/j.1432-1033.1996.00656.x; KATSOYAN.PG, 1966, P NATL ACAD SCI USA, V55, P1554, DOI 10.1073/pnas.55.6.1554; KATSOYANNIS PG, 1964, DIABETES, V13, P339, DOI 10.2337/diab.13.4.339; Khazaei S, 2012, PROTEIN J, V31, P717, DOI 10.1007/s10930-012-9451-4; Khoshaman K, 2017, BBA-PROTEINS PROTEOM, V1865, P604, DOI 10.1016/j.bbapap.2017.02.003; Khoshaman K, 2015, FREE RADICAL BIO MED, V89, P819, DOI 10.1016/j.freeradbiomed.2015.09.013; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Krizkova K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112883; KRUGER P, 1990, BIOL CHEM H-S, V371, P669, DOI 10.1515/bchm3.1990.371.2.669; LADISCH MR, 1992, BIOTECHNOL PROGR, V8, P469, DOI 10.1021/bp00018a001; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Maltesen MJ, 2012, AAPS PHARMSCITECH, V13, P747, DOI 10.1208/s12249-012-9796-1; Maltesen MJ, 2011, AAPS PHARMSCITECH, V12, P627, DOI 10.1208/s12249-011-9618-x; MARKUSSEN J, 1971, INT J PROT RES, V3, P149; MILLICAN RL, 1994, BIOCHEMISTRY-US, V33, P1116, DOI 10.1021/bi00171a010; Moafian Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164139; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nilsson J, 1996, J BIOTECHNOL, V48, P241, DOI 10.1016/0168-1656(96)01514-3; Nykiforuk CL, 2006, PLANT BIOTECHNOL J, V4, P77, DOI 10.1111/j.1467-7652.2005.00159.x; Pandey A, 2011, J PHARM BIOALLIED SC, V3, P504, DOI 10.4103/0975-7406.90103; Panse VG, 2000, J BIOL CHEM, V275, P18698, DOI 10.1074/jbc.275.25.18698; Pi-Sunyer FX, 2000, DIABETES CARE, V23, P1451, DOI 10.2337/diacare.23.10.1451; Queiroz JA, 2001, J BIOTECHNOL, V87, P143, DOI 10.1016/S0168-1656(01)00237-1; Rasmussen T, 2010, PHARM RES-DORDR, V27, P1337, DOI 10.1007/s11095-010-0116-8; Rege NK, 2018, J BIOL CHEM; RHEE HJ, 1990, J BIOTECHNOL, V13, P293, DOI 10.1016/0168-1656(90)90077-O; Schmidt M, 1999, J BIOTECHNOL, V68, P71, DOI 10.1016/S0168-1656(98)00189-8; STRANDBERG L, 1991, APPL ENVIRON MICROB, V57, P1669, DOI 10.1128/AEM.57.6.1669-1674.1991; TALMADGE K, 1982, P NATL ACAD SCI-BIOL, V79, P1830, DOI 10.1073/pnas.79.6.1830; TANG JG, 1988, BIOCHEM J, V255, P451, DOI 10.1042/bj2550451; TANG JG, 1990, BIOCHEM J, V268, P429, DOI 10.1042/bj2680429; THOMPSON EO, 1966, AUST J BIOL SCI, V19, P1139, DOI 10.1071/BI9661139; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862; WEI J, 1992, BIOCHIM BIOPHYS ACTA, V1120, P69, DOI 10.1016/0167-4838(92)90425-D; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200	66	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0206169	10.1371/journal.pone.0206169	http://dx.doi.org/10.1371/journal.pone.0206169			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339677	Green Submitted, Green Published, gold			2022-12-26	WOS:000447761400041
J	Lu, ZH; Shi, P; You, HJ; Liu, YQ; Chen, SJ				Lu, Zenghui; Shi, Ping; You, Huajian; Liu, Yanqi; Chen, Shijiang			Transcriptomic analysis of the salivary gland of medicinal leech Hirudo nipponia	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; LEUKOCYTE ELASTASE INHIBITOR; CDNA CLONING; CARBOXYPEPTIDASE INHIBITOR; MOLECULAR CHARACTERIZATION; HIRUDINARIA-MANILLENSIS; PROTEINASE-INHIBITOR; PROTEASE INHIBITOR; THROMBIN INHIBITOR; KAZAL-TYPE	Hirudo nipponia (known as Shui Zhi in Chinese) is a well-known Chinese medicine with numerous active ingredients in its body, especially in its saliva. This native Chinese blood-sucking leech has been used for therapeutic purposes since before 100 AD. Modern Chinese physicians use it for a wide range of diseases. Genomic data and molecular information about the pharmacologically active substances produced by this medicinal leech are presently unavailable despite this organism's medicinal importance. In this study, we performed transcriptome profiling of the salivary glands of medicinal leech H. nipponia using the Illumina platform. In total, 84,657,362 clean reads were assembled into 50,535 unigenes. The obtained unigenes were compared to public databases. Furthermore, a unigene sequence similarity search and comparisons with the whole transcriptome of medical leech were performed to identify potential proteins. Finally, more than 21 genes were predicted to be involved in anticoagulatory, antithrombotic, antibacterial, anti-inflammatory and antitumor processes, which might play important roles in the treatment of various diseases. This study is the first analysis of a sialotranscriptome in H. nipponia. The transcriptome profile will shed light on its genetic background and provide a useful tool to deepen our understanding of the medical value of H. nipponia.	[Lu, Zenghui; Shi, Ping; You, Huajian; Liu, Yanqi; Chen, Shijiang] Chongqing Acad Chinese Mat Med, Chongqing, Peoples R China; [Lu, Zenghui; Shi, Ping; Chen, Shijiang] China Acad Chinese Med Sci, Chongqing Subctr Natl Resource Ctr Chinese Mat Me, Chongqing, Peoples R China; [Lu, Zenghui; You, Huajian; Liu, Yanqi; Chen, Shijiang] Chongqing Key Lab Chinese Med Resources, Chongqing, Peoples R China	China Academy of Chinese Medical Sciences	Chen, SJ (corresponding author), Chongqing Acad Chinese Mat Med, Chongqing, Peoples R China.; Chen, SJ (corresponding author), China Acad Chinese Med Sci, Chongqing Subctr Natl Resource Ctr Chinese Mat Me, Chongqing, Peoples R China.; Chen, SJ (corresponding author), Chongqing Key Lab Chinese Med Resources, Chongqing, Peoples R China.	305616415@qq.com			Traditional Chinese Medicine Science and Technology Project of Chongqing Health and Family Planning Commission in China [zy201602097]; Natural Science Foundation of Chongqing [cstc2018jcyjAX0674]; Science and Technology Innovation Funds by the Chongqing Science and Technology Commission of China [cstc2016shmszx1247]; Fundamental Research Funds for the Chongqing Academy of Chinese Material Medica [2016csts-jbky-01910]	Traditional Chinese Medicine Science and Technology Project of Chongqing Health and Family Planning Commission in China; Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing); Science and Technology Innovation Funds by the Chongqing Science and Technology Commission of China; Fundamental Research Funds for the Chongqing Academy of Chinese Material Medica	This study was founded by the Traditional Chinese Medicine Science and Technology Project of Chongqing Health and Family Planning Commission in China (zy201602097 to PS), Natural Science Foundation of Chongqing (cstc2018jcyjAX0674 to PS), Science and Technology Innovation Funds by the Chongqing Science and Technology Commission of China (cstc2016shmszx1247 to SC), and the Fundamental Research Funds for the Chongqing Academy of Chinese Material Medica (2016csts-jbky-01910 to ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arolas JL, 2005, J MOL BIOL, V352, P961, DOI 10.1016/j.jmb.2005.07.065; Baskova I, 2000, PLATELETS, V11, P83, DOI 10.1080/09537100075689; Brankamp RG, 1995, PROTEIN EXPRES PURIF, V6, P813, DOI 10.1006/prep.1995.0013; Cho JH, 1998, BBA-MOL BASIS DIS, V1408, P67, DOI 10.1016/S0925-4439(98)00058-1; Dong H, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7895935; Dunwiddie Christopher T., 1993, Methods in Enzymology, V223, P291; El-Safory NS, 2010, CARBOHYD POLYM, V81, P165, DOI 10.1016/j.carbpol.2010.02.047; ELECTRICWALA A, 1993, J PROTEIN CHEM, V12, P365, DOI 10.1007/BF01028198; FINK E, 1986, BIOL CHEM H-S, V367, P1235, DOI 10.1515/bchm3.1986.367.2.1235; GASIC GJ, 1984, CANCER RES, V44, P5670; Ge CJ, 2014, CHIN J INTEGR MED, V20, P88, DOI 10.1007/s11655-013-1580-x; Gil-Bernabe AM, 2013, BRIT J HAEMATOL, V162, P433, DOI 10.1111/bjh.12381; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greinacher A, 2008, THROMB HAEMOSTASIS, V99, P819, DOI 10.1160/TH07-11-0693; Gronwald W, 2008, J MOL BIOL, V381, P913, DOI 10.1016/j.jmb.2008.06.034; HAN JH, 1989, GENE, V75, P47, DOI 10.1016/0378-1119(89)90382-X; Jin P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04471; Jo YJ, 2008, INT IMMUNOPHARMACOL, V8, P959, DOI 10.1016/j.intimp.2008.02.014; Joskova R, 2009, DEV COMP IMMUNOL, V33, P932, DOI 10.1016/j.dci.2009.03.002; JUNG HI, 1995, J BIOL CHEM, V270, P13879, DOI 10.1074/jbc.270.23.13879; Karalliedde LD, 2009, AM J PHYSIOL-HEART C, V297, pH1967, DOI 10.1152/ajpheart.00944.2009; Kim DR, 1998, EUR J BIOCHEM, V254, P692, DOI 10.1046/j.1432-1327.1998.2540692.x; Kim H, 2008, J MOL BIOL, V376, P184, DOI 10.1016/j.jmb.2007.11.089; Kim YH, 2001, J BIOCHEM, V130, P431, DOI 10.1093/oxfordjournals.jbchem.a003003; Kvist S, 2014, INVERTEBR BIOL, V133, P74, DOI 10.1111/ivb.12039; Leong JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-279; Li YB, 2008, HELV CHIM ACTA, V91, P303, DOI 10.1002/hlca.200890035; LINKER A, 1957, NATURE, V180, P810, DOI 10.1038/180810b0; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021416; Liu F, 2013, BIOCHEM SYST ECOL, V51, P215, DOI 10.1016/j.bse.2013.08.020; Lu Yu-Xi, 2017, Zhongguo Zhong Yao Za Zhi, V42, P2443, DOI 10.19540/j.cnki.cjcmm.20170614.014; MARKWARDT F, 1989, SEMIN THROMB HEMOST, V15, P269, DOI 10.1055/s-2007-1002719; Merzouk A., 2012, PHARM APPL ACTA, V15, P1, DOI DOI 10.4172/2153-2435; Min GS, 2010, J PARASITOL, V96, P1211, DOI 10.1645/GE-2496.1; Moser M, 1998, EUR J BIOCHEM, V253, P212, DOI 10.1046/j.1432-1327.1998.2530212.x; NODA N, 1995, CHEM PHARM BULL, V43, P567; NODA N, 1993, CHEM PHARM BULL, V41, P1366; Reverter D, 1998, J BIOL CHEM, V273, P32927, DOI 10.1074/jbc.273.49.32927; Salzet M, 2000, J BIOL CHEM, V275, P30774, DOI 10.1074/jbc.M000787200; Sanglas L, 2008, MOL CELL, V31, P598, DOI 10.1016/j.molcel.2008.05.031; SCACHERI E, 1993, EUR J BIOCHEM, V214, P295, DOI 10.1111/j.1432-1033.1993.tb17924.x; Schikorski D, 2008, J IMMUNOL, V181, P1083, DOI 10.4049/jimmunol.181.2.1083; Shi P, 2015, CHIN MED MAT, V38, P1144; Siddall ME, 2016, J PARASITOL, V102, P143, DOI 10.1645/15-802; Sig AK, 2017, INTEGR MED RES, V6, P337, DOI 10.1016/j.imr.2017.08.001; Sobczak Natalia, 2014, Annals of Parasitology, V60, P89; SOLLNER C, 1994, EUR J BIOCHEM, V219, P937, DOI 10.1111/j.1432-1033.1994.tb18575.x; SOMMERHOFF CP, 1994, BIOL CHEM H-S, V375, P685, DOI 10.1515/bchm3.1994.375.10.685; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; Tasiemski A, 2004, J BIOL CHEM, V279, P30973, DOI 10.1074/jbc.M312156200; Wei JG, 2012, FISH SHELLFISH IMMUN, V33, P916, DOI 10.1016/j.fsi.2012.08.001; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252; Xiao L, 2015, PHARMACOGN MAG, V11, P32, DOI 10.4103/0973-1296.149699; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X; Zaidi SMA, 2011, ALTERN MED REV, V16, P59; Zavalova L, 1996, MOL GEN GENET, V253, P20, DOI 10.1007/s004380050291; Zavalova LL, 2006, CHEMOTHERAPY, V52, P158, DOI 10.1159/000092904; Zhang YH, 2009, J ETHNOPHARMACOL, V124, P125, DOI 10.1016/j.jep.2009.04.012; Zhong XH, 2016, NEW PHYTOL, V210, P76, DOI 10.1111/nph.13540	59	7	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205875	10.1371/journal.pone.0205875	http://dx.doi.org/10.1371/journal.pone.0205875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339694	gold, Green Published, Green Submitted			2022-12-26	WOS:000447761400023
J	Miller, LJ; Fetterer, DP; Garza, NL; Lackemeyer, MG; Donnelly, GC; Steffens, JT; Van Tongeren, SA; Fiallos, JO; Moore, JL; Marko, ST; Lugo-Roman, LA; Fedewa, G; DeRisi, JL; Kuhn, JH; Stahl, SJ				Miller, Lynn J.; Fetterer, David P.; Garza, Nicole L.; Lackemeyer, Matthew G.; Donnelly, Ginger C.; Steffens, Jesse T.; Van Tongeren, Sean A.; Fiallos, Jimmy O.; Moore, Joshua L.; Marko, Shannon T.; Lugo-Roman, Luis A.; Fedewa, Greg; DeRisi, Joseph L.; Kuhn, Jens H.; Stahl, Scott J.			A fixed moderate-dose combination of tiletamine plus zolazepam outperforms midazolam in induction of short-term immobilization of ball pythons (Python regius)	PLOS ONE			English	Article							INCLUSION-BODY DISEASE; THAMNOPHIS-SIRTALIS-PARIETALIS; LIFE-HISTORY ECOTYPES; IGUANA IGUANA-IGUANA; SIDED GARTER SNAKE; MOLURUS-BIVITTATUS; BURMESE PYTHONS; ANESTHESIA; REPTILES; ARENAVIRUSES	Laboratory animals are commonly anesthetized to prevent pain and distress and to provide safe handling. Anesthesia procedures are well-developed for common laboratory mammals, but not as well established in reptiles. We assessed the performance of intramuscularly injected tiletamine (dissociative anesthetic) and zolazepam (benzodiazepine sedative) in fixed combination (2 mg/kg and 3 mg/kg) in comparison to 2 mg/kg of midazolam (benzodiazepine sedative) in ball pythons (Python regius). We measured heart and respiratory rates and quantified induction parameters (i.e., time to loss of righting reflex, time to loss of withdrawal reflex) and recovery parameters (i.e., time to regain righting reflex, withdrawal reflex, normal behavior). Mild decreases in heart and respiratory rates (median decrease of <10 beats per minute and <5 breaths per minute) were observed for most time points among all three anesthetic dose groups. No statistically significant difference between the median time to loss of righting reflex was observed among animals of any group (p = 0.783). However, the withdrawal reflex was lost in all snakes receiving 3mg/kg of tiletamine+zolazepam but not in all animals of the other two groups (p= 0.0004). In addition, the time for animals to regain the righting reflex and resume normal behavior was longer in the drug combination dose groups compared to the midazolam group (p = 0.0055). Our results indicate that midazolam is an adequate sedative for ball pythons but does not suffice to achieve reliable immobilization or anesthesia, whereas tiletamine+zolazepam achieves short-term anesthesia in a dose-dependent manner.	[Miller, Lynn J.; Fetterer, David P.; Garza, Nicole L.; Donnelly, Ginger C.; Steffens, Jesse T.; Van Tongeren, Sean A.; Fiallos, Jimmy O.; Moore, Joshua L.; Marko, Shannon T.; Lugo-Roman, Luis A.] US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Lackemeyer, Matthew G.; Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick, NIH, Ft Detrick, MD 21702 USA; [Fedewa, Greg; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Stahl, Scott J.] Stahl Exot Anim Vet Serv, Fairfax, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco	Miller, LJ (corresponding author), US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.; Kuhn, JH (corresponding author), NIAID, Integrated Res Facil Ft Detrick, NIH, Ft Detrick, MD 21702 USA.	lynn.j.miller.mil@mail.mil; kuhnjens@mail.nih.gov	Kuhn, Jens H./B-7615-2011	Kuhn, Jens H./0000-0002-7800-6045; Lackemeyer, Matthew/0000-0002-2174-9630	Battelle Memorial Institute's; US National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200700016I]; Chan Zuckerberg Biohub	Battelle Memorial Institute's; US National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Chan Zuckerberg Biohub	This research was in part supported through Battelle Memorial Institute's prime contract with the US National Institute of Allergy and Infectious Diseases (NIAID) under Contract No. HHSN272200700016I (M.G.L., J.H.K.). Additional funding was provided by the Chan Zuckerberg Biohub and administered by The Geneva Foundation to USAMRIID (all authors). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNE W, 1987, ARCH VIROL, V94, P135, DOI 10.1007/BF01313731; Allender MC, 2015, FUNGAL ECOL, V17, P187, DOI 10.1016/j.funeco.2015.05.003; Arnett-Chinn Elizabeth R., 2016, Journal of Herpetological Medicine and Surgery, V26, P59, DOI 10.5818/1529-9651-26.1-2.59; Barker DG, 2006, BALL PYTHONS HIST NA, V2; Bertelsen MF, 2011, VET ANAESTH ANALG, V38, P461, DOI 10.1111/j.1467-2995.2011.00640.x; Bisetto SP, 2018, VET ANAESTH ANALG, V45, P320, DOI 10.1016/j.vaa.2017.12.004; Bodewes R, 2013, J GEN VIROL, V94, P1206, DOI 10.1099/vir.0.051995-0; Boyer Thomas H., 2006, Veterinary Clinics of North America Exotic Animal Practice, V9, P269, DOI 10.1016/j.cvex.2006.03.006; Carpenter J, 2017, EXOTIC ANIMAL FORMUL, V5th; Chang L, 2016, VET J, V218, P13, DOI 10.1016/j.tvjl.2016.10.006; Cinelli AR, 2002, J NEUROPHYSIOL, V87, P1449, DOI 10.1152/jn.00651.2001; CLARK HF, 1979, J GEN VIROL, V44, P405, DOI 10.1099/0022-1317-44-2-405; Dervas E, 2017, J VIROL, V91, DOI [10.1128/JVI.00718-17, 10.1128/jvi.00718-17]; Dhananjaya BL, 2015, CURR TOP MED CHEM, V15, P649, DOI 10.2174/1568026615666150225113402; Divers S, 2006, REPTILE MED SURG E B; Farkas SL, 2004, J GEN VIROL, V85, P555, DOI 10.1099/vir.0.19616-0; Alves JRF, 2012, ACTA CIR BRAS, V27, P144, DOI 10.1590/S0102-86502012000200008; Gangloff EJ, 2016, J EXP BIOL, V219, P2944, DOI 10.1242/jeb.143107; Ghazaryan NA, 2015, EUR J PHARMACOL, V764, P340, DOI 10.1016/j.ejphar.2015.07.011; Grace MS, 2001, BRAIN RES, V919, P250, DOI 10.1016/S0169-328X(01)00248-0; Guenette SA, 2013, EXP ANIM TOKYO, V62, P87; Guerreiro I, 2014, INT J DEV BIOL, V58, P727, DOI 10.1387/ijdb.150026dd; Hack JB, 2011, J EMERG MED, V41, P102, DOI 10.1016/j.jemermed.2010.04.027; HARDING KA, 1977, VET REC, V100, P289, DOI 10.1136/vr.100.14.289; Harms CA, 2014, J ZOO WILDLIFE MED, V45, P86, DOI 10.1638/2013-0183R.1; Hedley J, 2014, VET RADIOL ULTRASOUN, V55, P380, DOI 10.1111/vru.12140; HELLYER P, 1989, VET SURG, V18, P160, DOI 10.1111/j.1532-950X.1989.tb01063.x; Hepojoki J, 2015, J VIROL, V89, P1119, DOI 10.1128/JVI.03119-14; Hetzel U, 2013, J VIROL, V87, P10918, DOI 10.1128/JVI.01123-13; Hoon-Hanks LL, 2018, VIROLOGY, V517, P77, DOI 10.1016/j.virol.2017.12.008; HUBBELL JAE, 1989, AM J VET RES, V50, P737; Hyndman TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006881; Hyndman TH, 2012, INFECT GENET EVOL, V12, P1436, DOI 10.1016/j.meegid.2012.04.022; Jacob-Ferreira AL, 2017, INT J BIOL MACROMOL, V95, P263, DOI 10.1016/j.ijbiomac.2016.11.063; James LE, 2018, VET ANAESTH ANALG, V45, P329, DOI 10.1016/j.vaa.2017.12.003; Krohmer RW, 2004, ILAR J, V45, P65, DOI 10.1093/ilar.45.1.65; Kumar A, 2014, XENOBIOTICA, V44, P379, DOI 10.3109/00498254.2013.833362; LAWRENCE K, 1983, VET REC, V112, P26, DOI 10.1136/vr.112.2.26; Lee Jae-il, 2003, J Vet Sci, V4, P187; Lind CM, 2018, J WILDLIFE DIS, V54, P352, DOI 10.7589/2017-05-109; Lopes IG, 2017, AUTON NEUROSCI-BASIC, V208, P103, DOI 10.1016/j.autneu.2017.10.008; Marschang RE, 2017, TIERAERZTL PRAX K H, V45, P22, DOI 10.15654/TPK-151067; MASON RT, 1993, BRAIN BEHAV EVOLUT, V41, P261, DOI 10.1159/000113848; McCurley K., 2005, COMPLETE BALL PYTHON; McFadden MS, 2011, JAVMA-J AM VET MED A, V239, P803, DOI 10.2460/javma.239.6.803; Mosley CAE, 2005, SEMIN AVIAN EXOT PET, V14, P243, DOI 10.1053/j.saep.2005.09.005; OGAWA M, 1992, J VET MED B, V39, P732, DOI 10.1111/j.1439-0450.1992.tb01228.x; Olsson A, 2013, J WILDLIFE DIS, V49, P560, DOI 10.7589/2012-06-160; Oppenheim YC, 1995, J ZOO WILDLIFE MED, V26, P409; Palacios MG, 2011, J ANIM ECOL, V80, P431, DOI 10.1111/j.1365-2656.2010.01785.x; Read MR, 2004, JAVMA-J AM VET MED A, V224, P547, DOI 10.2460/javma.2004.224.547; Saha DC, 2007, J AM ASSOC LAB ANIM, V46, P74; Schildger B.-J., 1993, Tieraerztliche Praxis, V21, P361; Shepard MK, 2013, VET ANAESTH ANALG, V40, P590, DOI 10.1111/vaa.12061; Sigler L, 2013, J CLIN MICROBIOL, V51, P3338, DOI 10.1128/JCM.01465-13; Sladky KK, 2012, J EXOT PET MED, V21, P17, DOI 10.1053/j.jepm.2011.11.013; Snyder PS, 1999, VET RADIOL ULTRASOUN, V40, P66, DOI 10.1111/j.1740-8261.1999.tb01840.x; Stenglein MD, 2017, J VIROL, V91, DOI 10.1128/JVI.00451-17; Stenglein MD, 2014, MBIO, V5, DOI 10.1128/mBio.01484-14; Stenglein MD, 2012, MBIO, V3, DOI 10.1128/mBio.00180-12; Stenglein MD, 2014, GENOME ANNOUNCEMENTS, V2; Stirl R, 1998, KLEINTIERPRAXIS, V43, P839; Stirl R., 1997, THESIS; Strahl-Heldreth D, 2017, VET ANAESTH ANALG, V44, DOI [10.1016/j.vaa.2017.09.008, DOI 10.1016/J.VAA.2017.09.008]; Treggiari MM, 2008, RESP CARE, V53, P1280; Uccellini L, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-144; von Degerfeld MM, 2004, VET RES COMMUN, V28, P351, DOI 10.1023/B:VERC.0000045444.84631.36; Woo PCY, 2017, INFECT GENET EVOL, V51, P239, DOI 10.1016/j.meegid.2017.04.008; Young LA, 1997, J ZOO WILDLIFE MED, V28, P71; Zuri I, 2003, BEHAV NEUROSCI, V117, P169, DOI 10.1037/0735-7044.117.1.169	70	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0199339	10.1371/journal.pone.0199339	http://dx.doi.org/10.1371/journal.pone.0199339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339670	Green Published, Green Submitted, gold			2022-12-26	WOS:000447761400001
J	Bestehorn, M; Weigold, S; Kern, WV; Chitimia-Dobler, L; Mackenstedt, U; Dobler, G; Borde, JP				Bestehorn, Malena; Weigold, Sebastian; Kern, Winfried V.; Chitimia-Dobler, Lidia; Mackenstedt, Ute; Dobler, Gerhard; Borde, Johannes P.			Phylogenetics of tick-borne encephalitis virus in endemic foci in the upper Rhine region in France and Germany	PLOS ONE			English	Article							DERMACENTOR-RETICULATUS TICKS; TBEV RNA; CENTRAL-EUROPE; WILD BOAR; EPIDEMIOLOGY; PREVALENCE; POLAND; GAME	Objective Tick-borne encephalitis (TBE) caused by the tick-borne encephalitis virus (TBEV) is the most important tick-borne arboviral disease in Europe and Asia. The Upper Rhine Valley is thought to be the very western border of TBEV distribution in Europe. The aim of our study was to identify natural foci and isolate TBEV from ticks, to determine the prevalence of TBEV in local tick populations and to study the phylogenetic relatedness of circulating TBEV strains in this region. Material and methods Ticks were collected between 2016, 2017 and 2018 by flagging. TBEV was isolated from collected ticks and phylogenetic analyses were performed. Minimal infection rates (MIR) of the collected ticks were calculated. Results At 12 sampling sites, a total of 4,064 Ixodes ticks were collected in 2016 and 2017 -(and one single collection 2018). 953 male, 856 female adult ticks and 2,255 nymphs were identified. The MIR rates were 0,17% (1/595) for Schiltach (Germany) and 0,11% (1/944) for Foret de la Robertsau (France), respectively. Overall, the three newly described TBEV strains, isolated in the years 2016 and 2017 from the Upper Rhine Valley have no close phylogenetic relation and show a genetic relationship with strains from eastern Europe. The 2018 TBEV strain from Aubachstrasse (Germany), however, is closely related to the TBEV found in Schiltach (Germany). Conclusion In conclusion, we demonstrate, to our knowledge for the first time, the phylogenetic relations of the newly isolated TBEV strains on both sides of the upper Rhine river.	[Bestehorn, Malena; Chitimia-Dobler, Lidia; Mackenstedt, Ute; Dobler, Gerhard] Univ Hohenheim, Parasitol Unit, D Stuttgart, Germany; [Weigold, Sebastian; Kern, Winfried V.; Borde, Johannes P.] Univ Freiburg, Med Ctr, Div Infect Dis, Dept Med 2, Freiburg, Germany; [Weigold, Sebastian; Kern, Winfried V.; Borde, Johannes P.] Fac Med, Freiburg, Germany; [Chitimia-Dobler, Lidia; Dobler, Gerhard] German Ctr Infect Res DZIF, Bundeswehr Inst Microbiol, Partner Site Munich, Neuherbergstr 11, Munich, Germany; [Borde, Johannes P.] Praxis Dr J Borde Gesundheitszentrum Oberkirch, Marktpl 8, Oberkirch, Germany	University Hohenheim; University of Freiburg; Bundeswehr Institute of Microbiology (IMB); German Center for Infection Research	Borde, JP (corresponding author), Univ Freiburg, Med Ctr, Div Infect Dis, Dept Med 2, Freiburg, Germany.; Borde, JP (corresponding author), Fac Med, Freiburg, Germany.; Borde, JP (corresponding author), Praxis Dr J Borde Gesundheitszentrum Oberkirch, Marktpl 8, Oberkirch, Germany.	johannes.borde@web.de	Borde, Johannes/AAT-6827-2020	Chitimia-Dobler, Lidia/0000-0001-8544-1945; Bestehorn-Willmann, Malena/0000-0003-1904-8461; Dobler, Gerhard/0000-0001-7461-293X	Pfizer Germany	Pfizer Germany(Pfizer)	The study was supported by Pfizer Germany with a IIR Grant ("Epidemiology of tickborne encephalitis (TBE) and its implications on potential vaccination strategies in the Upper Rhine Region"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balling A, 2014, TICKS TICK-BORNE DIS, V5, P805, DOI 10.1016/j.ttbdis.2014.06.007; Bastin R, 1971, LYON MED, V225, P109; Biernat B, 2016, ACTA PARASITOL, V61, P130, DOI 10.1515/ap-2016-0017; Biernat B, 2014, EXP APPL ACAROL, V64, P543, DOI 10.1007/s10493-014-9836-5; Bingsohn L, 2013, TICKS TICK-BORNE DIS, V4, P207, DOI 10.1016/j.ttbdis.2012.11.012; Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430; Brockmann SO, 2018, EUROSURVEILLANCE, V23, P8, DOI 10.2807/1560-7917.ES.2018.23.15.17-00336; Dobler G, 2012, WIEN MED WOCHENSCHR, V162, P230, DOI 10.1007/s10354-012-0100-5; Dorko E, 2014, CENT EUR J PUBL HEAL, V22, P277, DOI 10.21101/cejph.a3939; Frey S, 2012, VIRUS GENES, V45, P413, DOI 10.1007/s11262-012-0795-9; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HANNOUN C, 1971, CR ACAD SCI D NAT, V272, P766; Kriz B, 2009, EPIDEMIOL MIKROBI IM, V58, P98; Kriz B, 2014, VECTOR-BORNE ZOONOT, V14, P801, DOI 10.1089/vbz.2013.1569; Kupca AM, 2010, TICKS TICK-BORNE DIS, V1, P44, DOI 10.1016/j.ttbdis.2009.11.002; Levy M, 2016, ARCH PEDIATRIE, V23, P1055, DOI 10.1016/j.arcped.2016.06.018; Markovinovic L, 2016, INFECTION, V44, P661, DOI 10.1007/s15010-016-0917-8; Mierzejewska EJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1099-4; Roelandt Sophie, 2016, Infection Ecology & Epidemiology, V6, P31099, DOI 10.3402/iee.v6.31099; Schwaiger M, 2003, J CLIN VIROL, V27, P136, DOI 10.1016/S1386-6532(02)00168-3; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stefanoff P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-180; Suss J, 2002, INT J MED MICROBIOL, V291, P34; Van Der Poel WHM, 2005, VECTOR-BORNE ZOONOT, V5, P58; Velay A, 2018, TICKS TICK-BORNE DIS, V9, P120, DOI 10.1016/j.ttbdis.2017.09.015; Waldenstrom J, 2007, EMERG INFECT DIS, V13, P1215, DOI 10.3201/eid1308.061416; Wallner G, 1996, J GEN VIROL, V77, P1035, DOI 10.1099/0022-1317-77-5-1035; Weidmann M, 2011, J GEN VIROL, V92, P1906, DOI 10.1099/vir.0.032417-0; Weidmann M, 2013, J GEN VIROL, V94, P2129, DOI 10.1099/vir.0.054478-0; Weststrate AC, 2017, EUROSURVEILLANCE, V22, P6, DOI 10.2807/1560-7917.ES.2017.22.11.30482	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0204790	10.1371/journal.pone.0204790	http://dx.doi.org/10.1371/journal.pone.0204790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335778	Green Submitted, Green Published, gold			2022-12-26	WOS:000447701300014
J	Bretz, CL; Kim, J				Bretz, Corey L.; Kim, Joomyeong			Trans-allelic mutational effects at the Peg3 imprinted locus	PLOS ONE			English	Article							GENE-EXPRESSION; BINDING-SITES; METHYLATION; REGION; YY1; CIS	How one allele interacts with the other for the function of a gene is not well understood. In this study, we tested potential allelic interaction at the Peg3 imprinted locus with several mutant alleles targeting an Imprinting Control Region, the Peg3-DMR. According to the results, maternal deletion of the Peg3-DMR resulted in 2-fold up-regulation of two paternally expressed genes, Peg3 and Usp29. These trans-allelic mutational effects were observed consistently throughout various tissues with different developmental stages. These effects were also associated mainly with the genetic manipulation of the Peg3-DMR, but not with the other genomic changes within the Peg3 locus. The observed trans-allelic effects were unidirectional with the maternal influencing the paternal allele, but not with the opposite direction. Overall, the observed mutational effects suggest the presence of previously unrecognized trans-allelic regulation associated with the Peg3-DMR.	[Bretz, Corey L.; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Kim, Joomyeong/0000-0001-6577-5526	NIH (National Institute of General Medical Sciences) [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097074] Funding Source: NIH RePORTER	NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the NIH (National Institute of General Medical Sciences; R01-GM066225 and R01-GM097074 to J.K.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bretz CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197069; Bretz CL, 2017, EPIGENETICS-US, V12, P945, DOI 10.1080/15592294.2017.1377869; Davidson EH, 2006, REG GEN GEN REG; Do Kim J, 2006, GENOME RES, V16, P901, DOI 10.1101/gr.5091406; Duvillie B, 1998, GENOMICS, V47, P52, DOI 10.1006/geno.1997.5070; Forne T, 1997, P NATL ACAD SCI USA, V94, P10243, DOI 10.1073/pnas.94.19.10243; Frey WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144459; Fukaya T, 2017, CURR BIOL, V27, pR1047, DOI 10.1016/j.cub.2017.08.001; Gjuvsland AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009379; He HZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06817-5; He HZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38136; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Herman H, 2003, NAT GENET, V34, P199, DOI 10.1038/ng1162; Hollick JB, 2017, NAT REV GENET, V18, P5, DOI 10.1038/nrg.2016.115; Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025174; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2008, EPIGENETICS-US, V3, P115, DOI 10.4161/epi.3.3.6176; Kim J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181591; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lim B, 2018, MOL CELL, V70, P287, DOI 10.1016/j.molcel.2018.02.029; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Tsai TF, 2003, GENESIS, V37, P151, DOI 10.1002/gene.10237; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206112	10.1371/journal.pone.0206112	http://dx.doi.org/10.1371/journal.pone.0206112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335829	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300098
J	Covarrubias, G; Cha, A; Rahmy, A; Lorkowski, M; Perera, V; Erokwu, BO; Flask, C; Peiris, PM; Schiemann, WP; Karathanasis, E				Covarrubias, Gil; Cha, Anthony; Rahmy, Abdelrahman; Lorkowski, Morgan; Perera, Vindya; Erokwu, Bernadette O.; Flask, Chris; Peiris, Pubudu M.; Schiemann, William P.; Karathanasis, Efstathios			Imaging breast cancer using a dual-ligand nanochain particle	PLOS ONE			English	Article							CHAIN-LIKE NANOPARTICLE; BRAIN-TUMORS; IN-VIVO; P-SELECTIN; CARCINOMA MUCINS; METASTASIS; PLATELETS; FIBRONECTIN; EXPRESSION; HEPARIN	Nanoparticles often only exploit the upregulation of a receptor on cancer cells to enhance intratumoral deposition of therapeutic and imaging agents. However, a single targeting moiety assumes that a tumor is homogenous and static. Tumoral microenvironments are both heterogenous and dynamic, often displaying variable spatial and temporal expression of targetable receptors throughout disease progression. Here, we evaluated the in vivo performance of an iron oxide nanoparticle in terms of targeting and imaging of orthotropic mouse models of aggressive breast tumors. The nanoparticle, a multi-component nanochain, was comprised of 3-5 iron oxide nanoparticles chemically linked in a linear chain. The nanoparticle's surface was decorated with two types of ligands each targeting two different upregulated biomarkers on the tumor endothelium, P-selectin and fibronectin. The nanochain exhibited improved tumor deposition not only through vascular targeting but also through its elongated structure. A single-ligand nanochain exhibited a similar to 2.5-fold higher intratumoral deposition than a spherical nanoparticle variant. Furthermore, the dual-ligand nanochain exhibited higher consistency in generating detectable MR signals compared to a single-ligand nanochain. Using a 7T MRI, the dual-ligand nanochains exhibited highly detectable MR signal within 3h after injection in two different animal models of breast cancer.	[Covarrubias, Gil; Cha, Anthony; Rahmy, Abdelrahman; Lorkowski, Morgan; Perera, Vindya; Peiris, Pubudu M.; Karathanasis, Efstathios] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Erokwu, Bernadette O.; Flask, Chris; Karathanasis, Efstathios] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA; [Erokwu, Bernadette O.; Flask, Chris; Karathanasis, Efstathios] Case Western Reserve Univ, Case Ctr Imaging Res, Cleveland, OH 44106 USA; [Flask, Chris; Schiemann, William P.; Karathanasis, Efstathios] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Karathanasis, E (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.; Karathanasis, E (corresponding author), Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA.; Karathanasis, E (corresponding author), Case Western Reserve Univ, Case Ctr Imaging Res, Cleveland, OH 44106 USA.; Karathanasis, E (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	stathis@case.edu		Flask, Chris/0000-0002-1066-333X; Karathanasis, Efstathios/0000-0001-7484-7552	National Cancer Institute [R01CA177716, U01CA198892]; Alex's Lemonade Stand Foundation; Angie Fowler AYA Cancer Research Initiative of the Case Comprehensive Cancer Center; NIH Interdisciplinary Biomedical Imaging Training Program [T32EB007509]; NATIONAL CANCER INSTITUTE [R01CA177716, U01CA198892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB007509] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alex's Lemonade Stand Foundation; Angie Fowler AYA Cancer Research Initiative of the Case Comprehensive Cancer Center; NIH Interdisciplinary Biomedical Imaging Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by grants from the National Cancer Institute (R01CA177716, U01CA198892), the Alex's Lemonade Stand Foundation and the Angie Fowler AYA Cancer Research Initiative of the Case Comprehensive Cancer Center (E.K.). G.C. was supported by a fellowship from the NIH Interdisciplinary Biomedical Imaging Training Program (T32EB007509) administered by the Department of Biomedical Engineering, Case Western Reserve University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann BC, 2013, ONCOTARGET, V4, P64, DOI 10.18632/oncotarget.777; Borsi L, 2002, INT J CANCER, V102, P75, DOI 10.1002/ijc.10662; Borsig L, 2001, P NATL ACAD SCI USA, V98, P3352, DOI 10.1073/pnas.061615598; Danhier F, 2009, J CONTROL RELEASE, V140, P166, DOI 10.1016/j.jconrel.2009.08.011; Doolittle E, 2015, ACS NANO, V9, P8012, DOI 10.1021/acsnano.5b01552; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Gavze E, 1998, J FLUID MECH, V371, P59, DOI 10.1017/S0022112098002109; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gentile F, 2008, J BIOMECH, V41, P2312, DOI 10.1016/j.jbiomech.2008.03.021; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Huebschman Michael L, 2015, Breast Cancer (Dove Med Press), V7, P231, DOI 10.2147/BCTT.S87041; Karathanasis E, 2009, RADIOLOGY, V250, P398, DOI 10.1148/radiol.2502080801; Kim YJ, 1999, AM J PATHOL, V155, P461, DOI 10.1016/S0002-9440(10)65142-5; Laubli H, 2010, SEMIN CANCER BIOL, V20, P169, DOI 10.1016/j.semcancer.2010.04.005; Lee SY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/49/495101; Ludwig RJ, 2004, CANCER RES, V64, P2743, DOI 10.1158/0008-5472.CAN-03-1054; Martinez-Revollar G, 2015, EXP CELL RES, V339, P67, DOI 10.1016/j.yexcr.2015.10.006; Modery CL, 2011, BIOMATERIALS, V32, P9504, DOI 10.1016/j.biomaterials.2011.08.067; Molenaar TJM, 2002, BLOOD, V100, P3570, DOI 10.1182/blood-2002-02-0641; Mousa SA, 2009, THROMB HAEMOSTASIS, V102, P258, DOI 10.1160/TH08-12-0832; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Norton KA, 2015, AM J CANCER RES, V5, P1295; Ohnishi T, 1998, CLIN EXP METASTAS, V16, P729, DOI 10.1023/A:1006532812408; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Peiris PM, 2018, NANOSCALE, V10, P6861, DOI 10.1039/c8nr02513d; Peiris PM, 2015, J PHARM SCI-US, V104, P2600, DOI 10.1002/jps.24518; Peiris PM, 2015, CANCER RES, V75, P1356, DOI 10.1158/0008-5472.CAN-14-1540; Peiris PM, 2014, J CONTROL RELEASE, V173, P51, DOI 10.1016/j.jconrel.2013.10.031; Peiris PM, 2012, ACS NANO, V6, P8783, DOI 10.1021/nn303833p; Peiris PM, 2012, ACS NANO, V6, P4157, DOI 10.1021/nn300652p; Perera VS, 2017, NANOSCALE, V9, P9659, DOI 10.1039/c7nr02370g; Pilch J, 2006, P NATL ACAD SCI USA, V103, P2800, DOI 10.1073/pnas.0511219103; Reardon DA, 2008, EXPERT OPIN INV DRUG, V17, P1225, DOI 10.1517/13543784.17.8.1225 ; Reddy GR, 2006, CLIN CANCER RES, V12, P6677, DOI 10.1158/1078-0432.CCR-06-0946; Saul JM, 2006, J CONTROL RELEASE, V114, P277, DOI 10.1016/j.jconrel.2006.05.028; Schnell O, 2009, NEURO-ONCOLOGY, V11, P861, DOI 10.1215/15228517-2009-024; Serres E, 2014, ONCOGENE, V33, P3451, DOI 10.1038/onc.2013.305; Shamay Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7374; Simberg D, 2007, P NATL ACAD SCI USA, V104, P932, DOI 10.1073/pnas.0610298104; Toy R, 2014, ADV DRUG DELIVER REV, V76, P79, DOI 10.1016/j.addr.2014.08.002; Toy R, 2014, NANOMEDICINE-UK, V9, P121, DOI 10.2217/nnm.13.191; Toy R, 2013, ACS NANO, V7, P3118, DOI 10.1021/nn3053439; Zhou ZX, 2017, ADV DRUG DELIVER REV, V113, P24, DOI 10.1016/j.addr.2016.07.012	44	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0204296	10.1371/journal.pone.0204296	http://dx.doi.org/10.1371/journal.pone.0204296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335750	Green Submitted, gold, Green Published			2022-12-26	WOS:000447701300008
J	Mathew, E; Zhu, H; Connelly, SM; Sullivan, MA; Brewer, MG; Piepenbrink, MS; Kobie, JJ; Dewhurst, S; Dumont, ME				Mathew, Elizabeth; Zhu, Hong; Connelly, Sara M.; Sullivan, Mark A.; Brewer, Matthew G.; Piepenbrink, Michael S.; Kobie, James J.; Dewhurst, Stephen; Dumont, Mark E.			Display of the HIV envelope protein at the yeast cell surface for immunogen development	PLOS ONE			English	Article							BROADLY NEUTRALIZING ANTIBODY; HUMAN MONOCLONAL-ANTIBODIES; VIRUS TYPE-1 HIV-1; STRUCTURAL BASIS; SACCHAROMYCES-CEREVISIAE; POTENT NEUTRALIZATION; 4E10 RECOGNIZES; BINDING MODE; V3 PEPTIDES; EPITOPE	As a step toward the development of variant forms of Env with enhanced immunogenic properties, we have expressed the glycoprotein in the yeast surface display system in a form that can be subjected to random mutagenesis followed by screening for forms with enhanced binding to germline antibodies. To optimize the expression and immunogenicity of the yeast-displayed Env protein, we tested different approaches for cell wall anchoring, expression of gp120 and gp140 Env from different viral strains, the effects of introducing mutations designed to stabilize Env, and the effects of procedures for altering N-linked glycosylation of Env. We find that diverse forms of HIV envelope glycoprotein can be efficiently expressed at the yeast cell surface and that gp140 forms of Env are effectively cleaved by Kex2p, the yeast furin protease homolog. Multiple yeast-displayed gp120 and gp140 proteins are capable of binding to antibodies directed against the V3-variable loop, CD4 binding site, and gp41 membrane-proximal regions, including some antibodies whose binding is known to depend on Env conformation and N-linked glycan. Based on antibody recognition and sensitivity to glycosidases, yeast glycosylation patterns partially mimic high mannose-type N-glycosylation in mammalian cells. However, yeast-displayed Env is not recognized by some anti-Env antibodies sensitive to quaternary structure, suggesting either that the displayed protein exists in a monomeric state or that for these antibodies, yeast glycosylation in certain regions hinders recognition or access. Consistent with studies in other systems, reconstructed predicted unmutated precursors to anti-Env antibodies exhibit little affinity for the yeast-displayed envelope protein.	[Mathew, Elizabeth; Zhu, Hong; Connelly, Sara M.; Dumont, Mark E.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Sullivan, Mark A.; Brewer, Matthew G.; Dewhurst, Stephen] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Piepenbrink, Michael S.; Kobie, James J.] Univ Rochester, Med Ctr, Infect Dis Div, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Dumont, ME (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA.	Mark_Dumont@urmc.rochester.edu	Piepenbrink, Michael/GPK-5944-2022		NIH [R01 AI102730]; University of Rochester; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102730] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R01 AI102730 to MD and Interim Funding from the University of Rochester to MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2017, AIDS, V31, P1505, DOI [10.1097/QAD.0000000000001521, 10.1097/qad.0000000000001521]; Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Brewer MG, 2017, VACCINE, V35, P774, DOI 10.1016/j.vaccine.2016.12.049; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; Bruun TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109196; Burke V, 2009, STRUCTURE, V17, P1538, DOI 10.1016/j.str.2009.09.012; Cai H, 2017, CHEM COMMUN, V53, P5453, DOI 10.1039/c7cc02059g; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Celic Andjelka, 2003, V237, P105; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Charles-Nino C, 2011, VACCINE, V29, P5313, DOI 10.1016/j.vaccine.2011.05.007; Davenport TM, 2011, J VIROL, V85, P7095, DOI 10.1128/JVI.00411-11; De Pourcq K, 2010, APPL MICROBIOL BIOT, V87, P1617, DOI 10.1007/s00253-010-2721-1; DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Du SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020927; FISHER RA, 1988, NATURE, V331, P76, DOI 10.1038/331076a0; Georgiev IS, 2014, J IMMUNOL, V192, P1100, DOI 10.4049/jimmunol.1302515; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; GORNY MK, 1993, J IMMUNOL, V150, P635; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Grimm SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117227; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Hager-Braun C, 2006, J IMMUNOL, V176, P7471, DOI 10.4049/jimmunol.176.12.7471; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huber M, 2010, J VIROL, V84, P10700, DOI 10.1128/JVI.01111-10; Humbert M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003937; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Kieke MC, 1997, PROTEIN ENG, V10, P1303, DOI 10.1093/protein/10.11.1303; Killikelly A, 2013, BIOCHEMISTRY-US, V52, P6249, DOI 10.1021/bi400645e; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lee JH, 2017, IMMUNITY, V46, P690, DOI 10.1016/j.immuni.2017.03.017; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Luallen RJ, 2008, J VIROL, V82, P6447, DOI 10.1128/JVI.00412-08; Luallen RJ, 2009, J VIROL, V83, P4861, DOI 10.1128/JVI.02537-08; Macbeth MR, 2007, METHOD ENZYMOL, V424, P319, DOI 10.1016/S0076-6879(07)24015-7; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; Mattiacio J, 2011, VACCINE, V29, P2637, DOI 10.1016/j.vaccine.2011.01.038; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; McGuire AT, 2014, J VIROL, V88, P2645, DOI 10.1128/JVI.03228-13; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mester B, 2009, BIOCHEMISTRY-US, V48, P7867, DOI 10.1021/bi900146g; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Murai T, 1999, APPL MICROBIOL BIOT, V51, P65, DOI 10.1007/s002530051364; Nelson JD, 2008, VIROLOGY, V377, P170, DOI 10.1016/j.virol.2008.04.005; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; OKennedy RD, 1997, J IND MICROBIOL BIOT, V18, P319, DOI 10.1038/sj.jim.2900387; Orwenyo J, 2017, ACS CHEM BIOL, V12, P1566, DOI 10.1021/acschembio.7b00319; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pantophlet R, 2008, VIROLOGY, V381, P251, DOI 10.1016/j.virol.2008.08.032; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Patel MB, 2008, J VIROL, V82, P903, DOI 10.1128/JVI.01444-07; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reynolds MR, 2010, J VIROL, V84, P9190, DOI 10.1128/JVI.00041-10; Safrit JT, 2016, VACCINE, V34, P2921, DOI 10.1016/j.vaccine.2016.02.074; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Sanders RD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003788; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; SCHREUDER MP, 1993, YEAST, V9, P399, DOI 10.1002/yea.320090410; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Soto C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157409; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sullivan MA, 2013, BIOCHEMISTRY-US, V52, P1802, DOI 10.1021/bi3016668; TARENTINO AL, 1974, J BIOL CHEM, V249, P811; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tian Y, 2002, J PEPT RES, V59, P264, DOI 10.1034/j.1399-3011.2002.02988.x; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang Z, 2005, PROTEIN ENG DES SEL, V18, P337, DOI 10.1093/protein/gzi036; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wibmer CK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006074; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yamada R, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-32; Yamakawa S, 2012, ENZYME MICROB TECH, V50, P343, DOI 10.1016/j.enzmictec.2012.03.005; Yuan TT, 2011, MABS-AUSTIN, V3, P402, DOI 10.4161/mabs.3.4.15740; Zhang H, 2015, VACCINE, V33, P5140, DOI 10.1016/j.vaccine.2015.08.012; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 1999, J VIROL, V73, P4042, DOI 10.1128/JVI.73.5.4042-4051.1999; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005	105	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205756	10.1371/journal.pone.0205756	http://dx.doi.org/10.1371/journal.pone.0205756			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335821	Green Submitted, Green Published, gold			2022-12-26	WOS:000447701300052
J	Sadeghian, M; Sadeghi, O; Keshteli, AH; Daghaghzadeh, H; Esmaillzadeh, A; Adibi, P				Sadeghian, Mehdi; Sadeghi, Omid; Keshteli, Ammar Hassanzadeh; Daghaghzadeh, Hamed; Esmaillzadeh, Ahmad; Adibi, Peyman			Physical activity in relation to irritable bowel syndrome among Iranian adults	PLOS ONE			English	Article							LIFE-STYLE FACTORS; HEALTH-CARE; PREVALENCE; SYMPTOMS; RISK; DIETARY; HABITS	Background Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal disorder worldwide. Physical activity in relation to IBS has been investigated in few studies and data in this regard are conflicting. Aim To investigate the association between physical activity and IBS in a large sample of Iranian adults. Methods This cross-sectional study was done on 4763 Iranian adults in the framework of SEPAHAN (The Study on the Epidemiology of Psycho-Alimentary Health and Nutrition) project. The physical activity of study participants was assessed using the General Practice Physical Activity Questionnaire (GPPAQ). Using a validated self-administered modified Rome III questionnaire, functional gastrointestinal disorders including irritable bowel syndrome was assessed. Results The mean age of study participants was 36.5 years. Irritable bowel syndrome was prevalent among 21.5% of participants. Compared with physically active individuals (>= 1 hour/wk), those with sedentary physical activity (<1 hour/wk) had 1.27 times greater probability of suffering from IBS (OR: 1.27, 95% CI: 1.08-1.49). However, this association was attenuated after adjusting for age, sex, cigarette smoking and medical history of colitis and diabetes. When the analysis was additionally adjusted for diet-related practices and body mass index BMI), a non-significant association was found between sedentary physical activity and IBS (OR: 1.18, 95% CI: 0.98-1.41). Gender-stratified analysis revealed similar findings in women either before (OR: 1.29, 95% CI: 1.04-1.61) or after controlling for covariates (OR: 1.27, 95% CI: 0.99-1.62). In BMI-stratified analysis, a significant positive association was seen between sedentary physical activity and IBS among individuals with normal BMI (OR: 1.38, 95% CI: 1.07-1.79). Conclusion We found a significant positive association between sedentary physical activity and IBS, particularly among women and individuals of normal weight.	[Sadeghian, Mehdi] Isfahan Univ Med Sci, Food Secur Res Ctr, Esfahan, Iran; [Sadeghian, Mehdi; Esmaillzadeh, Ahmad] Isfahan Univ Med Sci, Sch Nutr & Food Sci, Dept Community Nutr, Esfahan, Iran; [Sadeghi, Omid] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran; [Sadeghi, Omid; Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran; [Keshteli, Ammar Hassanzadeh] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Daghaghzadeh, Hamed; Adibi, Peyman] Isfahan Univ Med Sci, Integrat Funct Gastroenterol Res Ctr, Esfahan, Iran; [Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Obes & Eating Habits Res Ctr, Endocrinol & Metab Mol Cellular Sci Inst, Tehran, Iran	Isfahan University Medical Science; Isfahan University Medical Science; Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of Alberta; Isfahan University Medical Science; Tehran University of Medical Sciences	Esmaillzadeh, A (corresponding author), Isfahan Univ Med Sci, Sch Nutr & Food Sci, Dept Community Nutr, Esfahan, Iran.; Esmaillzadeh, A (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.; Esmaillzadeh, A (corresponding author), Univ Tehran Med Sci, Obes & Eating Habits Res Ctr, Endocrinol & Metab Mol Cellular Sci Inst, Tehran, Iran.	a-esmaillzadeh@sina.tums.ac.ir	Sedeh, Peyman Adibi/AAJ-4582-2020; Esmaillzadeh, Ahmad/N-5704-2014; Sadeghi, Omid/AAM-9006-2020	Sedeh, Peyman Adibi/0000-0001-6411-5235; Esmaillzadeh, Ahmad/0000-0002-8735-6047; Hassanzadeh Keshteli, Ammar/0000-0001-7375-6210	Isfahan University of Medical Sciences, Isfahan, Iran [189069, 189082, 189086]	Isfahan University of Medical Sciences, Isfahan, Iran	The study was provided funding by Isfahan University of Medical Sciences, Isfahan, Iran (www.mui.ac.ir) (projects numbers #189069 to PA, #189082 to AE, and #189086 to AE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi P, 2012, J RES MED SCI, V17; Al Saadi T, 2016, J EPIDEMIOL GLOB HEA, V6, P285, DOI 10.1016/j.jegh.2016.07.001; Asare Fredrick, 2012, Curr Gastroenterol Rep, V14, P283, DOI 10.1007/s11894-012-0268-2; Chang FY, 2007, J GASTROEN HEPATOL, V22, P4, DOI 10.1111/j.1440-1746.2006.04672.x; Chatila R, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0698-2; Chen Y, 2013, INT J MOL MED, V31, P607, DOI 10.3892/ijmm.2013.1252; Chirila I, 2012, J GASTROINTEST LIVER, V21, P357; Cremonini F, 2005, GASTROENTEROL CLIN N, V34, P189, DOI 10.1016/j.gtc.2005.02.008; Dainese R, 2004, AM J MED, V116, P536, DOI 10.1016/j.amjmed.2003.12.018; Daley AJ, 2008, INT J SPORTS MED, V29, P778, DOI 10.1055/s-2008-1038600; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Esmaillzadeh A, 2013, WORLD J GASTROENTERO, V19, P6465, DOI 10.3748/wjg.v19.i38.6465; Guo YB, 2015, GUT LIVER, V9, P649, DOI 10.5009/gnl13437; Hungin APS, 2003, ALIMENT PHARM THER, V17, P643, DOI 10.1046/j.1365-2036.2003.01456.x; Jahangiri P, 2012, INT J PREVENTIVE MED, V3, pS1; Johannesson E, 2011, AM J GASTROENTEROL, V106, P915, DOI 10.1038/ajg.2010.480; Khayyatzadeh SS, 2018, J GASTROEN HEPATOL, V33, P404, DOI 10.1111/jgh.13908; Kim YJ, 2005, INT J NURS STUD, V42, P247, DOI 10.1016/j.ijnursta.2004.06.015; Lean MEJ, 2016, INT J OBESITY, V40, P622, DOI 10.1038/ijo.2015.220; Lustyk M K, 2001, Gastroenterol Nurs, V24, P129, DOI 10.1097/00001610-200105000-00006; Morlin E, 2008, GASTROENTEROLOGY, V134, pA416; NICE, PROM CREAT BUILT NAT; Nyrop KA, 2007, ALIMENT PHARM THERAP, V26, P237, DOI 10.1111/j.1365-2036.2007.03370.x; Okami Y, 2011, J GASTROENTEROL, V46, P1403, DOI 10.1007/s00535-011-0454-2; Omagari K, 2013, INTERNAL MED, V52, P1295, DOI 10.2169/internalmedicine.52.0248; Son YJ, 2009, INT J NURS STUD, V46, P77, DOI 10.1016/j.ijnurstu.2008.07.006; Toghiani A, 2016, J RES MED SCI, V21, DOI 10.4103/1735-1995.193175; Torres SJ, 2014, OBESITY FACTS, V7, P339, DOI 10.1159/000369854; Wang YT, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-104; Zheng ZL, 2007, GASTROENTEROLOGY, V132, P87, DOI 10.1053/j.gastro.2006.11.019	31	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205806	10.1371/journal.pone.0205806	http://dx.doi.org/10.1371/journal.pone.0205806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335859	Green Published, gold, Green Submitted			2022-12-26	WOS:000447701300057
J	Jeong, I; Cho, YS; Lee, KJ; Park, JB				Jeong, Inchul; Cho, Yun-Sik; Lee, Kyung-Jong; Park, Jae Bum			Impact of near work on perceived stress according to working hours: The Korea National Health and Nutrition Examination Survey VI (2013-2015)	PLOS ONE			English	Article							NECK/SHOULDER SYMPTOMS; UNPUBLISHED DATA; LONG WORKHOURS; COMPUTER USERS; RISK; METAANALYSIS; INDIVIDUALS; DISCOMFORT; COMPLAINTS; MANAGERS	The purpose of this study was to investigate the relationships among working hours, near work time, and perceived stress. In total, data of 3,776 workers from the Korea National Health and Nutrition Examination Survey VI were examined. The workers' working hours per week, daily near work time, and complaints of perceived stress were analyzed in conjunction with other sociodemographic and occupation-related variables. Multivariate logistic analysis found that workers with 3 and >= 4 hours of near work were more likely to report high perceived stress than were the reference group who had <1 hour per day of near work, with odds ratios (ORs) (95% confidence intervals [as]) of 1.34 (1.01-1.78) and 1.94 (1.53-2.46), respectively. Additionally, those working 50 and more hours a week were more likely to report high perceived stress with ORs of 1.51 (1.19-1.90) and 1.88 (1.42-2.48), respectively. When stratified by working hours, workers with daily near work time of >= 4 hours were more likely to report high perceived stress with ORs of 2.21 (1.45-3.37), 2.27 (1.30-3.97), and 3.47 (1.80-6.69), among the workers with 40-49, 50-59, and >= 60 weekly working hours, respectively. Workers with greater near work time are at risk for high perceived stress. Moreover, this risk was found to be higher among workers with longer working hours. Therefore, work cycle modification and reductions in near work time are necessary to prevent stress -related health outcomes.	[Jeong, Inchul; Lee, Kyung-Jong; Park, Jae Bum] Ajou Univ, Sch Med, Dept Occupat & Environm Med, Suwon, South Korea; [Jeong, Inchul; Cho, Yun-Sik; Lee, Kyung-Jong; Park, Jae Bum] Ajou Univ Hosp, Dept Occupat & Environm Med, Suwon, South Korea	Ajou University; Ajou University; Ajou University Hospital	Park, JB (corresponding author), Ajou Univ, Sch Med, Dept Occupat & Environm Med, Suwon, South Korea.; Park, JB (corresponding author), Ajou Univ Hosp, Dept Occupat & Environm Med, Suwon, South Korea.	jbpark@ajou.ac.kr		Jeong, Inchul/0000-0002-8619-5034				Balci R, 2003, ERGONOMICS, V46, P455, DOI 10.1080/0014013021000047557; BOUCSEIN W, 1995, HUM FAC ERG SOC P, P785; Caruso CC, 2006, AM J IND MED, V49, P930, DOI 10.1002/ajim.20373; Harma M, 2006, SCAND J WORK ENV HEA, V32, P502; Hobson J, 2000, OCCUP MED-OXFORD, V50, P518, DOI 10.1093/occmed/50.7.518; Hu NC, 2016, J OCCUP ENVIRON MED, V58, P514, DOI 10.1097/JOM.0000000000000715; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Kivimaki M, 2015, LANCET DIABETES ENDO, V3, P27, DOI 10.1016/S2213-8587(14)70178-0; Kivimaki M, 2017, EUR HEART J, V38, P2621, DOI 10.1093/eurheartj/ehx324; Kivimaki M, 2015, LANCET, V386, P1739, DOI 10.1016/S0140-6736(15)60295-1; Larsman P, 2006, EUR J APPL PHYSIOL, V96, P127, DOI 10.1007/s00421-004-1263-6; Larsman P, 2013, INT ARCH OCC ENV HEA, V86, P57, DOI 10.1007/s00420-012-0744-x; Lee K, 2017, IND HEALTH, V55, P46, DOI 10.2486/indhealth.2015-0173; Lodin C, 2012, WORK, V41, P3388, DOI 10.3233/WOR-2012-0613-3388; Marchand A, 2013, INT ARCH OCC ENV HEA, V86, P553, DOI 10.1007/s00420-012-0788-y; Maruyama S, 1996, SCAND J WORK ENV HEA, V22, P353, DOI 10.5271/sjweh.153; Melamed S, 2006, PSYCHOL BULL, V132, P327, DOI 10.1037/0033-2909.132.3.327; Nakazawa T, 2002, AM J IND MED, V42, P421, DOI 10.1002/ajim.10133; OECD, 2016, OECD FACT BOOK 2015, DOI [10.1787/18147364, DOI 10.1787/18147364]; Park J, 2010, AM J IND MED, V53, P1135, DOI 10.1002/ajim.20877; Sato Y, 2009, OCCUP MED-OXFORD, V59, P14, DOI 10.1093/occmed/kqn141; van der Hulst M, 2003, SCAND J WORK ENV HEA, V29, P171, DOI 10.5271/sjweh.720; Virtanen M, 2011, PSYCHOL MED, V41, P2485, DOI 10.1017/S0033291711000171; Virtanen M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7772; Wolkoff P, 2005, OCCUP ENVIRON MED, V62, P4, DOI 10.1136/oem.2004.016030; Yan Z, 2008, COMPUT HUM BEHAV, V24, P2026, DOI 10.1016/j.chb.2007.09.004; Ye Zhaojia, 2007, Journal of Physiological Anthropology, V26, P69, DOI 10.2114/jpa2.26.69; Yu RF, 2017, ERGONOMICS, V60, P680, DOI 10.1080/00140139.2016.1192226; Zetterberg C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182439	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204360	10.1371/journal.pone.0204360	http://dx.doi.org/10.1371/journal.pone.0204360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX3PM	30332424	Green Submitted, Green Published, gold			2022-12-26	WOS:000447638200013
J	Morozova, KN; Suldina, LA; Malankhanova, TB; Grigor'eva, EV; Zakian, SM; Kiseleva, E; Malakhova, AA				Morozova, Ksenia N.; Suldina, Lyubov A.; Malankhanova, Tuyana B.; Grigor'eva, Elena V.; Zakian, Suren M.; Kiseleva, Elena; Malakhova, Anastasia A.			Introducing an expanded CAG tract into the huntingtin gene causes a wide spectrum of ultrastructural defects in cultured human cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MUTANT HUNTINGTIN; MITOCHONDRIAL DYNAMICS; LYSOSOMAL ACTIVITY; NUCLEAR-MEMBRANE; DISEASE; AUTOPHAGY; BRAIN; PATHOGENESIS; MITOPHAGY	Modeling of neurodegenerative diseases in vitro holds great promise for biomedical research. Human cell lines harboring a mutations in disease-causing genes are thought to recapitulate early stages of the development an inherited disease. Modern genome-editing tools allow researchers to create isogenic cell clones with an identical genetic background providing an adequate "healthy" control for biomedical and pharmacological experiments. Here, we generated isogenic mutant cell clones with 150 CAG repeats in the first exon of the huntingtin (HTT) gene using the CRISPR/Cas9 system and performed ultrastructural and morphometric analyses of the internal organization of the mutant cells. Electron microscopy showed that deletion of three CAG triplets or an HTT gene knockout had no significant influence on the cell structure. The insertion of 150 CAG repeats led to substantial changes in quantitative and morphological parameters of mitochondria and increased the association of mitochondria with the smooth and rough endoplasmic reticulum while causing accumulation of small autolysosomes in the cytoplasm. Our data indicate for the first time that expansion of the CAG repeat tract in HTT introduced via the CRISPR/Cas9 technology into a human cell line initiates numerous ultrastructural defects that are typical for Huntington's disease.	[Morozova, Ksenia N.; Suldina, Lyubov A.; Malankhanova, Tuyana B.; Grigor'eva, Elena V.; Zakian, Suren M.; Kiseleva, Elena; Malakhova, Anastasia A.] Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Fed Res Ctr, Novosibirsk, Russia; [Morozova, Ksenia N.; Malankhanova, Tuyana B.; Grigor'eva, Elena V.; Zakian, Suren M.; Malakhova, Anastasia A.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia; [Malankhanova, Tuyana B.; Grigor'eva, Elena V.; Zakian, Suren M.; Malakhova, Anastasia A.] Minist Hlth Russian Federat, E Meshalkin Natl Med Res Ctr, Novosibirsk, Russia; [Malankhanova, Tuyana B.; Grigor'eva, Elena V.; Zakian, Suren M.; Malakhova, Anastasia A.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University; Meshalkin National Medical Research Center; Ministry of Health of the Russian Federation; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Morozova, KN (corresponding author), Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Fed Res Ctr, Novosibirsk, Russia.; Morozova, KN (corresponding author), Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia.	morozko@bionet.nsc.ru	Malakhova, Anastasia A/R-2640-2017; Morozova, Ksenia N./N-4990-2019; Grigor'eva, Elena V/V-5416-2018; Tuyana, Malankhanova/AAD-5620-2020	Malakhova, Anastasia A/0000-0003-1916-1333; Morozova, Ksenia N./0000-0003-3307-8819; 	Russian Scientific Foundation [16-15-10128]; Russian Science Foundation [16-15-10128] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the Russian Scientific Foundation (project 16-15-10128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by the Russian Scientific Foundation (project 16-15-10128).	Aki T, 2013, TOXICOLOGY, V311, P205, DOI 10.1016/j.tox.2013.07.001; Ayala-Pena S, 2013, FREE RADICAL BIO MED, V62, P102, DOI 10.1016/j.freeradbiomed.2013.04.017; Bard J, 2014, J BIOMOL SCREEN, V19, P191, DOI 10.1177/1087057113510320; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P189, DOI 10.1016/j.brainresbull.2011.03.014; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; BRENNAN WA, 1985, J NEUROCHEM, V44, P1948, DOI 10.1111/j.1471-4159.1985.tb07192.x; Camnasio S, 2012, NEUROBIOL DIS, V46, P41, DOI 10.1016/j.nbd.2011.12.042; Carroll JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118467; Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243; Ciarmiello A, 2006, J NUCL MED, V47, P215; Covill-Cooke C, 2017, NEUROCHEM INT; Csordas G, 2018, TRENDS CELL BIOL; Currais A, 2017, FASEB J, V31, P5, DOI 10.1096/fj.201601184; Feigin A, 2001, J NUCL MED, V42, P1591; Filadi R, 2017, CELL CALCIUM, V62, P1, DOI 10.1016/j.ceca.2017.01.003; Franco- Iborra S, 2018, FRONTIERS NEUROSCIEN, P12, DOI [10.3389/fnins.2018.00012, DOI 10.3389/FNINS.2018.00012]; Grigor'eva EV, 2015, ACTA NATURAE, V7, P56, DOI 10.32607/20758251-2015-7-4-56-69; Guedes-Dias P, 2016, NEUROBIOL DIS, V90, P51, DOI 10.1016/j.nbd.2015.09.008; Herst PM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00296; Hwang S, 2015, EMBO MOL MED, V7, P1307, DOI 10.15252/emmm.201505256; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kiriyama Y, 2015, INT J MOL SCI, V16, P26797, DOI 10.3390/ijms161125990; Kruglova AA, 2008, CELL TISSUE RES, V334, P371, DOI 10.1007/s00441-008-0702-9; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Liu KY, 2015, HUM MOL GENET, V24, P1602, DOI 10.1093/hmg/ddu574; Liu Y, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0092-6; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Malakhova A.A., 2016, GENES CELLS, V11, P106; Malankhanova TB, 2017, J HUNTINGTONS DIS, V6, P19, DOI 10.3233/JHD-160222; Martin DDO, 2015, TRENDS NEUROSCI, V38, P26, DOI 10.1016/j.tins.2014.09.003; Naia L, 2016, NEUROPEPTIDES, V58, P73, DOI 10.1016/j.npep.2016.01.009; Nekrasov ED, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0092-5; Nixon RA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008839; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Quintanilla RA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-45; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reipert S, 2014, MICROSCOPY ADV SCI R, P1131; ROOS RAC, 1983, J NEUROL SCI, V61, P37, DOI 10.1016/0022-510X(83)90053-9; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Sahoo B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155747; Sanchez AME, 2008, ARCH MED RES, V39, P265, DOI 10.1016/j.arcmed.2007.11.011; [Шарипова Д.В. Sharipova D.V.], 2017, [Вавиловский журнал генетики и селекции, VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII = VAVILOV JOURNAL OF GENETICS AND BREEDING, Vavilovskii zhurnal genetiki i selektsii], V21, P856, DOI 10.18699/VJ17.306; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Squitieri F, 2010, J NEURAL TRANSM, V117, P77, DOI 10.1007/s00702-009-0328-4; Suldina LA, 2018, PROTOPLASMA, P1, DOI [10.1007/s00709-017-1193-x, DOI 10.1007/S00709-017-1193-X]; Sunwoo JS, 2010, J MOV DISORD, V3, P45, DOI 10.14802/jmd.10012; TELLEZNAGEL I, 1974, J NEUROPATH EXP NEUR, V33, P308, DOI 10.1097/00005072-197404000-00008; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Tu ZC, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0031-x; Wong YC, 2014, J NEUROSCI, V34, P1293, DOI 10.1523/JNEUROSCI.1870-13.2014; Xu XH, 2017, STEM CELL REP, V8, P619, DOI 10.1016/j.stemcr.2017.01.022; Yager LM, 2015, NEUROSCIENCE, V301, P529, DOI 10.1016/j.neuroscience.2015.06.033; Yoo SM, 2018, MOL CELLS, V41, P18, DOI 10.14348/molcells.2018.2277; Zhu JH, 2013, AUTOPHAGY, V9, P1663, DOI 10.4161/auto.24135	57	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204735	10.1371/journal.pone.0204735	http://dx.doi.org/10.1371/journal.pone.0204735			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332437	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200028
J	Suarez-Arrones, L; de Villarreal, ES; Nunez, FJ; Di Salvo, V; Petri, C; Buccolini, A; Maldonado, RA; Torreno, N; Mendez-Villanueva, A				Suarez-Arrones, Luis; Saez de Villarreal, Eduardo; Javier Nunez, Francisco; Di Salvo, Valter; Petri, Cristian; Buccolini, Alessandro; Maldonado, Rafael Angel; Torreno, Nacho; Mendez-Villanueva, Alberto			In-season eccentric-overload training in elite soccer players: Effects on body composition, strength and sprint performance	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; ENGLISH PREMIER LEAGUE; CRUCIATE LIGAMENT INJURY; SKELETAL-MUSCLE MASS; RUGBY LEAGUE; PROFESSIONAL SOCCER; PLAYING POSITION; FOOTBALL PLAYERS; POWER; INTENSITY	The aim of this study was to describe the changes in body composition, strength and sprint performance in response to an entire competitive season of football training supplemented with 2 inertial eccentric-overload training sessions a week in young male professional soccer players. Whole body and regional composition (assessed using dual-energy X-ray absorptiometry), power output in half-squat and 40-m sprinting performance were evaluated in fourteen players. The eccentric-overload training consisted of training sessions a week of 1-2 sets of 10 exercises of upper-body and core (Day 1) and lower-body (Day 2), during the entire competitive season (27 weeks). Whole body fat mass decreased (-6.3 +/- 3.6%, ES = -0.99 +/- 0.54) substantially while lean mass increased (2.5 +/- 0.8%, ES = 0.25 +/- 0.09), with some regional differences. There was a substantial increase in half-squat power output (from 3% to 14%, ES from 0.45 to 1.73) and sprint performance (from 1.1% to 1.8%, ES from -0.33 to -0.44), however performance changes were not correlated with changes in body composition. A combined soccer and eccentric-overload training program was able to promote positive changes in body composition and physical factors relevant to both on-field performance and injury prevention in elite soccer players.	[Suarez-Arrones, Luis; Saez de Villarreal, Eduardo; Javier Nunez, Francisco] Pablo Olavide Univ, Sect Phys Educ & Sport, Dept Sport & Informat, Seville, Spain; [Suarez-Arrones, Luis; Di Salvo, Valter; Mendez-Villanueva, Alberto] ASPIRE Acad, Football Performance & Sci Dept, Doha, Qatar; [Di Salvo, Valter] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Petri, Cristian] Univ Florence, Dept Expt & Clin Med, Sports & Exercise Med Unit, Florence, Italy; [Buccolini, Alessandro; Maldonado, Rafael Angel; Torreno, Nacho] ACF Fiorentina SpA, Sport Sci Dept, Florence, Italy	Universidad Pablo de Olavide; Aspire Academy for Sports Excellence; Foro Italico University of Rome; University of Florence	Suarez-Arrones, L (corresponding author), Pablo Olavide Univ, Sect Phys Educ & Sport, Dept Sport & Informat, Seville, Spain.; Suarez-Arrones, L (corresponding author), ASPIRE Acad, Football Performance & Sci Dept, Doha, Qatar.	ljsuamor@upo.es	Sánchez, Francisco Javier Núñez/F-4501-2016	Sánchez, Francisco Javier Núñez/0000-0002-4166-3877; Suarez Moreno-Arrones, Luis Jesus/0000-0002-5432-4786	NPRP from the Qatar National Research Fund (a member of Qatar Foundation) [NPRP 6-1526-3-363]	NPRP from the Qatar National Research Fund (a member of Qatar Foundation)	This study was made possible by NPRP grant # NPRP 6-1526-3-363 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors. The funder provided support in the form of salaries for author LSA but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Askling C, 2003, SCAND J MED SCI SPOR, V13, P244, DOI 10.1034/j.1600-0838.2003.00312.x; Bardella P, 2017, SPORT BIOMECH, V16, P102, DOI 10.1080/14763141.2016.1205652; Barry DW, 2008, J BONE MINER RES, V23, P484, DOI 10.1359/JBMR.071203; Bilsborough JC, 2017, INT J SPORT PHYSIOL, V12, P10, DOI 10.1123/ijspp.2015-0666; Bilsborough JC, 2014, J SPORT SCI, V32, P1821, DOI 10.1080/02640414.2014.926380; Brito J, 2014, J HUM KINET, V40, P121, DOI 10.2478/hukin-2014-0014; Buchheit M, 2012, INT J SPORT PHYSIOL, V7, P76, DOI 10.1123/ijspp.7.1.76; Bush M, 2015, HUM MOVEMENT SCI, V39, P1, DOI 10.1016/j.humov.2014.10.003; Carling C, 2010, J STRENGTH COND RES, V24, P1332, DOI 10.1519/JSC.0b013e3181cc6154; Castagna C, 2003, J STRENGTH COND RES, V17, P775; Cormie P, 2007, J APPL BIOMECH, V23, P103, DOI 10.1123/jab.23.2.103; Cvetkovic N, 2018, SCAND J MED SCI SPOR, V28, P18, DOI 10.1111/sms.13241; de Hoyo M, 2015, INT J SPORTS MED, V36, P308, DOI 10.1055/s-0034-1395521; de Hoyo M, 2016, J SPORT SCI, V34, P1380, DOI 10.1080/02640414.2016.1157624; de Hoyo M, 2015, INT J SPORT PHYSIOL, V10, P46, DOI 10.1123/ijspp.2013-0547; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Faude O, 2013, J SPORT SCI, V31, P1460, DOI 10.1080/02640414.2013.796065; Fredericson M, 2007, BRIT J SPORT MED, V41, P664, DOI 10.1136/bjsm.2006.030783; Friedmann B, 2004, ACTA PHYSIOL SCAND, V182, P77, DOI 10.1111/j.1365-201X.2004.01337.x; Friedmann-Bette B, 2010, EUR J APPL PHYSIOL, V108, P821, DOI 10.1007/s00421-009-1292-2; Gabbett TJ, 2005, J SPORT SCI, V23, P961, DOI 10.1080/02640410400023381; Gonzalez-Badillo JJ, 2010, INT J SPORTS MED, V31, P347, DOI 10.1055/s-0030-1248333; Gonzalo-Skok O, 2017, INT J SPORT PHYSIOL, V12, P951, DOI 10.1123/ijspp.2016-0251; Harley JA, 2011, J STRENGTH COND RES, V25, P1024, DOI 10.1519/JSC.0b013e3181cc21fb; Hewett TE, 2009, BRIT J SPORT MED, V43, P417, DOI 10.1136/bjsm.2009.059162; Hoff J, 2004, SPORTS MED, V34, P165, DOI 10.2165/00007256-200434030-00003; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Iaia FM, 2009, INTJ SPORT PHYSIOL, V4, P291, DOI 10.1123/ijspp.4.3.291; Iga J, 2014, INT J SPORTS MED, V35, P994, DOI 10.1055/s-0034-1371833; Nunez FJ, 2017, INT J SPORT PHYSIOL, V12, P527, DOI 10.1123/ijspp.2016-0059; Nunez FJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193841; Kim J, 2004, J APPL PHYSIOL, V97, P655, DOI 10.1152/japplphysiol.00260.2004; Kim J, 2006, AM J CLIN NUTR, V84, P1014, DOI 10.1093/ajcn/84.5.1014; Kotzamanidis C, 2005, J STRENGTH COND RES, V19, P369; Kraemer WJ, 2004, J STRENGTH COND RES, V18, P121; Lee MG, 2012, APPL PHYSIOL NUTR ME, V37, P1019, DOI [10.1139/H2012-084, 10.1139/h2012-084]; Maroto-Izquierdo S, 2017, J SCI MED SPORT, V20, P943, DOI 10.1016/j.jsams.2017.03.004; McMaster DT, 2013, SPORTS MED, V43, P367, DOI 10.1007/s40279-013-0031-3; Melegati G, 2014, MUSCLES LIGAMENTS TE, V3, P324; Milanese C, 2015, J SPORT SCI, V33, P1219, DOI 10.1080/02640414.2015.1022573; Milsom J, 2015, J SPORT SCI, V33, P1799, DOI 10.1080/02640414.2015.1012101; Nana A, 2016, INT J SPORT NUTR EXE, V26, P259, DOI 10.1123/ijsnem.2013-0111; Norrbrand L, 2010, EUR J APPL PHYSIOL, V110, P997, DOI 10.1007/s00421-010-1575-7; Owen AL, 2013, J STRENGTH COND RES, V27, P3275, DOI 10.1519/JSC.0b013e318290cb3a; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; Rico-Sanz J, 1998, INT J SPORT NUTR, V8, P113, DOI 10.1123/ijsn.8.2.113; Rodriguez-Sanchez N, 2015, INT J SPORT NUTR EXE, V25, P60, DOI 10.1123/ijsnem.2014-0067; Sabido R, 2017, EUR J SPORT SCI, V17, P530, DOI 10.1080/17461391.2017.1282046; de Villarreal ES, 2015, J STRENGTH COND RES, V29, P1894, DOI 10.1519/JSC.0000000000000838; Sanchez-Medina L, 2014, INT J SPORTS MED, V35, P209, DOI 10.1055/s-0033-1351252; Silva JR, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0006-z; Silvestre R, 2006, J STRENGTH COND RES, V20, P962; Suarez-Arrones L, 2018, SCI MED FOOTBALL, P1; Suarez-Arrones L, 2016, INT J SPORT PHYSIOL, V11, P495, DOI 10.1123/ijspp.2014-0523; Suarez-Arrones L, 2014, INT J SPORT PHYSIOL, V9, P667, DOI [10.1123/ijspp.2013-0238, 10.1123/IJSPP.2013-0238]; Suarez-Arrones L, 2014, INT J SPORT PHYSIOL, V9, P316, DOI [10.1123/ijspp.2013-0069, 10.1123/IJSPP.2013-0069]; Sugimoto D, 2015, BRIT J SPORT MED, V49, P282, DOI 10.1136/bjsports-2014-093461; Sutton L, 2009, J SPORT SCI, V27, P1019, DOI 10.1080/02640410903030305; Tous-Fajardo J, 2016, INT J SPORT PHYSIOL, V11, P66, DOI 10.1123/ijspp.2015-0010; Wittich A, 2001, J CLIN DENSITOM, V4, P51, DOI 10.1385/JCD:4:1:51; Young WB, 2006, INT J SPORT PHYSIOL, V1, P74, DOI 10.1123/ijspp.1.2.74; Zazulak BT, 2007, AM J SPORT MED, V35, P1123, DOI 10.1177/0363546507301585	62	34	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205332	10.1371/journal.pone.0205332	http://dx.doi.org/10.1371/journal.pone.0205332			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325935	Green Published, gold, Green Submitted			2022-12-26	WOS:000447430800019
J	Falvo, MJ; Lindheimer, JB; Serrador, JM				Falvo, Michael J.; Lindheimer, Jacob B.; Serrador, Jorge M.			Dynamic cerebral autoregulation is impaired in Veterans with Gulf War Illness: A case-control study	PLOS ONE			English	Article							NEURALLY-MEDIATED HYPOTENSION; BLOOD-FLOW; ARTERY DIAMETER; NITRIC-OXIDE; BAROREFLEX; DYSFUNCTION; PERFUSION; HUMANS; CHEMOREGULATION; ASSOCIATION	Neurological dysfunction has been reported in Gulf War Illness (GWI), including abnormal cerebral blood flow (CBF) responses to physostigmine challenge. However, it is unclear whether the CBF response to normal physiological challenges and regulation is similarly dysfunctional. The goal of the present study was to evaluate the CBF velocity response to orthostatic stress (i.e., sit-to-stand maneuver) and increased fractional concentration of carbon dioxide. 23 cases of GWI (GWI+) and 9 controls (GWI) volunteered for this study. Primary variables of interest included an index of dynamic autoregulation and cerebrovascular reactivity. Dynamic autoregulation was significantly lower in GWI+ than GWI-both for autoregulatory index (2.99 +/- 1.5 vs 4.50 +/- 1.5, p = 0.017). In addition, we observed greater decreases in CBF velocity both at the nadir after standing (-18.5 +/- 6.0 vs -9.8 +/- 4.9%, p = 0.001) and during steady state standing (-5.7 +/- 7.1 vs -1.8 +/- 3.2%, p = 0.042). In contrast, cerebrovascular reactivity was not different between groups. In our sample of Veterans with GWI, dynamic autoregulation was impaired and consistent with greater cerebral hypoperfusion when standing. This reduced CBF may contribute to cognitive difficulties in these Veterans when upright.	[Falvo, Michael J.; Serrador, Jorge M.] War Related Illness & Injury Study Ctr, Dept Vet Affairs, E Orange, NJ 07018 USA; [Falvo, Michael J.; Serrador, Jorge M.] Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, New Jersey Med Sch, Newark, NJ 07102 USA; [Falvo, Michael J.] Rutgers State Univ, Dept Phys Med & Rehabil, New Jersey Med Sch, Newark, NJ 07102 USA; [Lindheimer, Jacob B.] William S Middleton Mem Vet Adm Med Ctr, Dept Vet Affairs, Madison, WI 53705 USA; [Lindheimer, Jacob B.] Univ Wisconsin, Dept Kinesiol, Madison, WI USA; [Serrador, Jorge M.] Natl Univ Ireland Galway, Dept Cardiovasc Elect, Galway, Connacht, Ireland	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; Ollscoil na Gaillimhe-University of Galway	Serrador, JM (corresponding author), War Related Illness & Injury Study Ctr, Dept Vet Affairs, E Orange, NJ 07018 USA.; Serrador, JM (corresponding author), Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, New Jersey Med Sch, Newark, NJ 07102 USA.; Serrador, JM (corresponding author), Natl Univ Ireland Galway, Dept Cardiovasc Elect, Galway, Connacht, Ireland.	Jorge.Serrador@rutgers.edu	Lindheimer, Jacob/O-7935-2016	Lindheimer, Jacob/0000-0002-1581-3210; Falvo, Michael/0000-0001-9348-6676	US Dept. of Veterans Affairs [1I01CX001329, 1I21CX000797]; U.S. Department of Veterans Affairs [1K2CX001679]; New Jersey War Related Illness and Injury Study Center, Dept of Veteran Affairs	US Dept. of Veterans Affairs; U.S. Department of Veterans Affairs(US Department of Veterans Affairs); New Jersey War Related Illness and Injury Study Center, Dept of Veteran Affairs	This work was funded by 1I01CX001329 (US Dept. of Veterans Affairs), https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fprojectreporter.nih.gov%2Fproject_info_details.cfm%3Faid%3D8925290& 1I21CX000797 (US Dept. of Veterans Affairs) https://na01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fgrantome.com%2Fgrant%2FNIH%2FI21-CX000797-01A1&data=02%7C01%7Cserradjo%40njms.rutgers.edu%7C1ffea257d7f147e6267b08d624a9d502% 7Cb92d2b234d35447093ff69aca6632ffe%7C1%7C0%7C636736710337379458& 1K2CX001679, U.S. Department of Veterans Affairs, Dr. Jacob Lindheimer. Please find the link below for this funding information. https://projectreporter.nih.gov/project_info_description.cfm?aid=9559970&icde=41405162&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC&pball=. Dr. Serrador did not have outside funding for this study. This study was primarily supported by the New Jersey War Related Illness and Injury Study Center, Dept of Veteran Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aengevaeren VL, 2013, J APPL PHYSIOL, V114, P195, DOI 10.1152/japplphysiol.00402.2012; Bertsch K, 2009, BRAIN RES, V1267, P77, DOI 10.1016/j.brainres.2009.02.053; Binnewijzend MAA, 2016, EUR RADIOL, V26, P506, DOI 10.1007/s00330-015-3834-9; Bresseleers J, 2010, PSYCHOSOM MED, V72, P672, DOI 10.1097/PSY.0b013e3181e68e94; Brothers RM, 2016, J PHYSIOL-LONDON, V594, P4077, DOI 10.1113/JP271884; Bunegin L, 2001, TOXICOL IND HEALTH, V17, P128, DOI 10.1191/0748233701th100oa; Camm AJ, 1996, EUR HEART J, V17, P354; Claassen JAHR, 2016, J CEREBR BLOOD F MET, V36, P665, DOI 10.1177/0271678X15626425; Clifford GD, 2005, IEEE T BIO-MED ENG, V52, P630, DOI 10.1109/TBME.2005.844028; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Coverdale NS, 2014, J APPL PHYSIOL, V117, P1090, DOI 10.1152/japplphysiol.00285.2014; Davis SD, 2000, AM J MED SCI, V319, P89, DOI 10.1097/00000441-200002000-00004; Dawson SL, 2000, CEREBROVASC DIS, V10, P126, DOI 10.1159/000016041; Deegan BM, 2011, MED ENG PHYS, V33, P553, DOI 10.1016/j.medengphy.2010.12.007; Deegan BM, 2009, IEEE ENG MED BIO, P2859, DOI 10.1109/IEMBS.2009.5333604; Dursa EK, 2016, J OCCUP ENVIRON MED, V58, P41, DOI 10.1097/JOM.0000000000000627; Haley RN, 2004, AM J MED, V117, P469, DOI 10.1016/j.amjmed.2004.03.041; Haley RW, 2013, JAMA NEUROL, V70, P191, DOI 10.1001/jamaneurol.2013.596; Haley RW, 2009, PSYCHIAT RES-NEUROIM, V171, P207, DOI 10.1016/j.pscychresns.2008.05.004; Haley RW, 1997, JAMA-J AM MED ASSOC, V277, P223, DOI 10.1001/jama.277.3.223; Haley RW, 1997, JAMA-J AM MED ASSOC, V277, P215, DOI 10.1001/jama.277.3.215; Hamner JW, 2012, J PHYSIOL-LONDON, V590, P6343, DOI 10.1113/jphysiol.2012.245100; Iannacchione VG, 2011, NEUROEPIDEMIOLOGY, V37, P129, DOI 10.1159/000331478; Immink RV, 2014, J APPL PHYSIOL, V116, P844, DOI 10.1152/japplphysiol.00637.2013; Lange G, 2001, J CLIN EXP NEUROPSYC, V23, P240, DOI 10.1076/jcen.23.2.240.1208; Lavi S, 2003, CIRCULATION, V107, P1901, DOI 10.1161/01.CIR.0000057973.99140.5A; Lavi S, 2006, AM J PHYSIOL-HEART C, V291, pH1856, DOI 10.1152/ajpheart.00014.2006; Li XF, 2011, RADIOLOGY, V261, P218, DOI 10.1148/radiol.11101715; Liu PY, 2011, NEUROTOXICOLOGY, V32, P242, DOI 10.1016/j.neuro.2010.12.004; Lucas KE, 2005, AM J MED, V118, P1421, DOI 10.1016/j.amjmed.2005.06.034; MAEDA H, 1994, J HYPERTENS, V12, P191; Marshall RS, 2012, J ALZHEIMERS DIS, V32, P633, DOI 10.3233/JAD-2012-120949; Marshall RS, 2001, BRAIN, V124, P1208, DOI 10.1093/brain/124.6.1208; McGrath RE, 2006, PSYCHOL METHODS, V11, P386, DOI 10.1037/1082-989X.11.4.386; Medow MS, 2014, J APPL PHYSIOL, V117, P1157, DOI 10.1152/japplphysiol.00527.2014; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Nasr N, 2014, CIRC J, V78, P2460, DOI 10.1253/circj.CJ-14-0445; Novak P, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00022; Paksoy Y, 2004, MED SCI MONITOR, V10, pCR316; Persson PB, 2001, J HYPERTENS, V19, P1699, DOI 10.1097/00004872-200110000-00001; Poulin MJ, 1996, J APPL PHYSIOL, V81, P1084, DOI 10.1152/jappl.1996.81.3.1084; Rayhan RU, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058493, 10.1371/journal.pone.0063903]; Roland PS, 2000, OTOLARYNG HEAD NECK, V122, P319, DOI 10.1016/S0194-5998(00)70041-6; Roloff EVL, 2016, J PHYSIOL-LONDON, V594, P6463, DOI 10.1113/JP272450; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Serrador JM, 2005, J APPL PHYSIOL, V98, P151, DOI 10.1152/japplphysiol.00471.2004; SERRADOR JM, 2017, FRONT NEUROL, V8, DOI DOI 10.3389/FNEUR.2017; Serrador JM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-119; Sorond FA, 2009, ULTRASOUND MED BIOL, V35, P21, DOI 10.1016/j.ultrasmedbio.2008.08.001; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Stein PK, 2004, ARTHRIT RHEUM-ARTHR, V51, P700, DOI 10.1002/art.20687; Sullivan K, 2003, J PSYCHOPATHOL BEHAV, V25, P95, DOI 10.1023/A:1023342915425; Thompson BG, 1996, J NEUROSURG, V84, P71, DOI 10.3171/jns.1996.84.1.0071; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Toomey R, 2009, J INT NEUROPSYCH SOC, V15, P717, DOI 10.1017/S1355617709990294; Tzeng YC, 2010, J APPL PHYSIOL, V108, P1162, DOI 10.1152/japplphysiol.01390.2009; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; White RP, 1997, STROKE, V28, P1340, DOI 10.1161/01.STR.28.7.1340; Witter T, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00457	59	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205393	10.1371/journal.pone.0205393	http://dx.doi.org/10.1371/journal.pone.0205393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0RD	30321200	Green Submitted, gold, Green Published			2022-12-26	WOS:000447417900028
J	Tentaku, A; Shimohata, T; Hatayama, S; Kido, J; Nguyen, AQ; Kenda, Y; Fukushima, S; Uebanso, T; Iwata, T; Mawatari, K; Harada, N; Takahashi, A				Tentaku, Aya; Shimohata, Takaaki; Hatayama, Sho; Kido, Junko; Anh Quoc Nguyen; Kenda, Yuna; Fukushima, Shiho; Uebanso, Takashi; Iwata, Taketoshi; Mawatari, Kazuaki; Harada, Nagakatsu; Takahashi, Akira			Host cellular unfolded protein response signaling regulates Campylobacter jejuni invasion	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INTESTINAL EPITHELIAL-CELLS; ER STRESS; TRANSMEMBRANE PROTEIN; MESSENGER-RNA; TRANSLATIONAL CONTROL; TRANSCRIPTION FACTOR; MAMMALIAN HOMOLOG; KINASE; ATF6	Campylobacter jejuni is a major cause of bacterial foodborne illness in humans worldwide. Bacterial entry into a host eukaryotic cell involves the initial steps of adherence and invasion, which generally activate several cell-signaling pathways that induce the activation of innate defense systems, which leads to the release of proinflammatory cytokines and induction of apoptosis. Recent studies have reported that the unfolded protein response (UPR), a system to clear unfolded proteins from the endoplasmic reticulum (ER), also participates in the activation of cellular defense mechanisms in response to bacterial infection. However, no study has yet investigated the role of UPR in C. jejuni infection. Hence, the aim of this study was to deduce the role of UPR signaling via induction of ER stress in the process of C. jejuni infection. The results suggest that C. jejuni infection suppresses global protein translation. Also, 12 h of C. jejuni infection induced activation of the eIF2 alpha pathway and expression of the transcription factor CHOP. Interestingly, bacterial invasion was facilitated by knockdown of UPR-associated signaling factors and treatment with the ER stress inducers, thapsigargin and tunicamycin, decreased the invasive ability of C. jejuni. An investigation into the mechanism of UPR-mediated inhibition of C. jejuni invasion showed that UPR signaling did not affect bacterial adhesion to or survival in the host cells. Further, Salmonella Enteritidis or FITC-dextran intake were not regulated by UPR signaling. These results indicated that the effect of UPR on intracellular intake was specifically found in C. jejuni infection. These findings are the first to describe the role of UPR in C. jejuni infection and revealed the participation of a new signaling pathway in C. jejuni invasion. UPR signaling is involved in defense against the early step of C. jejuni invasion and thus presents a potential therapeutic target for the treatment of C. jejuni infection.	[Tentaku, Aya; Shimohata, Takaaki; Hatayama, Sho; Kido, Junko; Anh Quoc Nguyen; Kenda, Yuna; Fukushima, Shiho; Uebanso, Takashi; Mawatari, Kazuaki; Takahashi, Akira] Tokushima Univ, Dept Prevent Environm & Nutr, Inst Biomed Sci, Tokushima, Japan; [Iwata, Taketoshi] Natl Agr & Food Res Org, Bacterial & Parasit Dis Res Div, Natl Inst Anim Hlth, Ibaraki, Japan; [Harada, Nagakatsu] Tokushima Univ, Inst Biomed Sci, Dept Nutr & Metab, Tokushima, Japan; [Harada, Nagakatsu] Univ Shimane, Dept Hlth & Nutr, Fac Nursing & Nutr, Matsue, Shimane, Japan	Tokushima University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Tokushima University; Shimane University	Shimohata, T (corresponding author), Tokushima Univ, Dept Prevent Environm & Nutr, Inst Biomed Sci, Tokushima, Japan.	shimohata@tokushima-u.ac.jp	Mawatari, Kazuaki/AAW-7266-2020	Mawatari, Kazuaki/0000-0003-2880-3801; Quoc Anh, Nguyen/0000-0001-7298-8060	JSPS Kakenhi [JP 15K00819]	JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a grant-in-aid for scientific research from JSPS Kakenhi (https://www.jsps.go.jp/j-grantsinaid/, grant number JP 15K00819).	[Anonymous], CELL COMMUN SIGNAL; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Ashgar SSA, 2007, J BACTERIOL, V189, P1856, DOI 10.1128/JB.01427-06; Bachoual R, 2001, MICROB DRUG RESIST, V7, P257, DOI 10.1089/10766290152652800; Baruch M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00105; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chang CL, 2017, BBA-MOL CELL RES, V1864, P1494, DOI 10.1016/j.bbamcr.2017.05.018; Cho JA, 2018, CELL HOST MICROBE, V23, P571, DOI 10.1016/j.chom.2018.03.005; Choi HH, 2010, FEBS LETT, V584, P2445, DOI 10.1016/j.febslet.2010.04.050; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Dalton LE, 2012, PROG MOL BIOL TRANSL, V106, P189, DOI 10.1016/B978-0-12-396456-4.00003-1; di Sario G, 2017, PROCEEDINGS OF 19 TH; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Friedman C.R., 2000, CAMPYLOBACTER, P121; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Heimesaat MM, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-16; Hickey TE, 2000, INFECT IMMUN, V68, P6535, DOI 10.1128/IAI.68.12.6535-6541.2000; Hofreuter D, 2008, CELL HOST MICROBE, V4, P425, DOI 10.1016/j.chom.2008.10.002; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hu L, 2005, MICROBIOL-SGM, V151, P3097, DOI 10.1099/mic.0.27866-0; Iwata T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056900; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kalischuk LD, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-2; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; KAUR R, 1993, FEMS MICROBIOL LETT, V111, P327; Konkel ME, 1997, MOL MICROBIOL, V24, P953, DOI 10.1046/j.1365-2958.1997.4031771.x; Krause-Gruszczynska M, 2007, CELL MICROBIOL, V9, P2431, DOI 10.1111/j.1462-5822.2007.00971.x; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee SY, 2008, CELL MICROBIOL, V10, P770, DOI 10.1111/j.1462-5822.2007.01083.x; Li YP, 2011, VET MICROBIOL, V148, P75, DOI 10.1016/j.vetmic.2010.08.009; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; MacCallum A, 2005, MICROBIOL-SGM, V151, P2765, DOI 10.1099/mic.0.27979-0; MORI K, 1993, CELL, V74, P743; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Pillich Helena, 2016, Mol Cell Pediatr, V3, P9, DOI 10.1186/s40348-016-0037-7; Pillich H, 2012, CELL MICROBIOL, V14, P949, DOI 10.1111/j.1462-5822.2012.01769.x; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Samuel CE, 1997, INT J HEMATOL, V65, P227; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sood R, 2000, GENETICS, V154, P787; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tareen AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081069; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Treacy-Abarca S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8887; van Vliet AR, 2017, MOL CELL, V65, P885, DOI 10.1016/j.molcel.2017.01.020; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 1998, J BIOL CHEM, P273; Zaas DW, 2005, BBA-MOL CELL RES, V1746, P305, DOI 10.1016/j.bbamcr.2005.10.003	59	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205865	10.1371/journal.pone.0205865	http://dx.doi.org/10.1371/journal.pone.0205865			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321237	Green Published, gold, Green Submitted			2022-12-26	WOS:000447417900062
J	Nagata, T; Nakajima, S; Fujiya, A; Sobajima, H; Yamaguchi, M				Nagata, Takanobu; Nakajima, Shoko; Fujiya, Atsushi; Sobajima, Hiroshi; Yamaguchi, Makoto			Prevalence of hypothyroidism in patients with hyponatremia: A retrospective cross-sectional study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; IMPAIRED WATER-EXCRETION; CHRONIC KIDNEY-DISEASE; THYROID-FUNCTION; VASOPRESSIN; MANAGEMENT; MYXEDEMA	Objective Hypothyroidism has been suggested to be an uncommon cause of hyponatremia. However, little is known about the prevalence of hypothyroidism in patients with different levels of hyponatremia. The objective of this study was to investigate the prevalence of hypothyroidism among patients with hyponatremia of varying severity while taking into consideration potential confounders associated with thyroid function. Methods All data on thyrotropin (TSH), free thyroxine (T4), and serum sodium (Na) levels were retrospectively collected from medical records at two Japanese tertiary hospitals. The main outcome measure was overt hypothyroidism, defined as TSH > 10.0 mu lU/mL and free T4 < 1.01 ng/dL. Results Of 71,817 patients, 964 patients (1.3%) had overt hypothyroidism. The prevalence of overt hypothyroidism in each category of hyponatremia (Na >= 136, 130-135, and <= 129 mEq/L) was 1.2% (787/65,051), 2.4% (124/5,254) and 3.5% (53/1,512), respectively. A significant increase in prevalence was observed as the severity of hyponatremia increased (P < 0.001 for trend). Multivariate logistic regression with adjustment for age, sex, kidney function, and serum albumin level showed that the odds ratios for overt hypothyroidism increased with increasing severity of hyponatremia when compared with Na >= 136 mEq/L (130-135 mEq/L: 1.43, 95% confidence interval [CI], 1.15 to 1.78, P = 0.001; <= 129 mEq/L: 1.87, 95% CI, 1.32 to 2.63, P < 0.001; P < 0.001 for trend). Conclusion The prevalence of overt hypothyroidism was significantly higher as the severity of hyponatremia progressed, even after adjusting for potential confounders. Hypothyroidism should be differentiated in patients with hyponatremia.	[Nagata, Takanobu; Yamaguchi, Makoto] Yokkaichi Municipal Hosp, Dept Nephrol, Yokaichi, Japan; [Nakajima, Shoko] Yokkaichi Municipal Hosp, Dept Diabetol, Yokaichi, Japan; [Fujiya, Atsushi; Sobajima, Hiroshi] Ogaki Municipal Hosp, Dept Diabetol & Nephrol, Ogaki, Japan	Ogaki Municipal Hospital	Nagata, T (corresponding author), Yokkaichi Municipal Hosp, Dept Nephrol, Yokaichi, Japan.	nagata-t@hotmail.co.jp						Asvold BO, 2011, EUR J ENDOCRINOL, V164, P101, DOI 10.1530/EJE-10-0705; Aylwin S, 2015, CURR MED RES OPIN, V31, P1755, DOI 10.1185/03007995.2015.1072706; Chaker L, 2017, LANCET, V390, P1550, DOI 10.1016/S0140-6736(17)30703-1; Chonchol M, 2008, CLIN J AM SOC NEPHRO, V3, P1296, DOI 10.2215/CJN.00800208; Croal BL, 1997, LANCET, V350, P1402, DOI 10.1016/S0140-6736(05)65181-1; DERUBERTIS FR, 1971, AM J MED, V51, P41, DOI 10.1016/0002-9343(71)90322-6; FEINSTEIN EI, 1982, AM J NEPHROL, V2, P70, DOI 10.1159/000166587; Hanna FWF, 1997, LANCET, V350, P755, DOI 10.1016/S0140-6736(05)62563-9; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Liamis G, 2017, EUR J ENDOCRINOL, V176, pR15, DOI 10.1530/EJE-16-0493; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Pantalone KM, 2015, J CLIN MED, V4, P32, DOI 10.3390/jcm4010032; Rhee CM, 2015, NEPHROL DIAL TRANSPL, V30, P282, DOI 10.1093/ndt/gfu303; Schwarz C, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13669; SKOWSKY WR, 1978, AM J MED, V64, P613, DOI 10.1016/0002-9343(78)90581-8; Spasovski G, 2014, NEPHROL DIAL TRANSPL, V29, P1, DOI 10.1093/ndt/gfu040; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Warner MH, 2006, CLIN ENDOCRINOL, V64, P598, DOI 10.1111/j.1365-2265.2006.02489.x; Wolf P, 2017, THYROID, V27, P611, DOI 10.1089/thy.2016.0597	19	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205687	10.1371/journal.pone.0205687	http://dx.doi.org/10.1371/journal.pone.0205687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308047	gold, Green Submitted, Green Published			2022-12-26	WOS:000447173500116
J	Ariaeenejad, S; Mousivand, M; Dezfouli, PM; Hashemi, M; Kavousi, K; Salekdeh, GH				Ariaeenejad, Shohreh; Mousivand, Maryam; Dezfouli, Parinaz Moradi; Hashemi, Maryam; Kavousi, Kaveh; Salekdeh, Ghasem Hosseini			A computational method for prediction of xylanase enzymes activity in strains of Bacillus subtilis based on pseudo amino acid composition features	PLOS ONE			English	Article							SEQUENCE-BASED PREDICTOR; FLEXIBLE WEB SERVER; FEATURE-SELECTION; SUBCELLULAR-LOCALIZATION; MYCOBACTERIAL PROTEINS; ENSEMBLE CLASSIFIER; GENE CLONING; IDENTIFICATION; PURIFICATION; PSEKNC	Xylanases are hydrolytic enzymes which based on physicochemical properties, structure, mode of action and substrate specificities are classified into various glycoside hydrolase (GH) families. The purpose of this study is to show that the activity of the members of the xylanase family in the specified pH and temperature conditions can be computationally predicted. The proposed computational regression model was trained and tested with the Pseudo Amino Acid Composition (PseAAC) features extracted solely from the amino acid sequences of enzymes. The xylanases with experimentally determined activities were used as the training dataset to adjust the model parameters. To develop the model, 41 strains of Bacillus subtilis isolated from field soil were screened. From them, 28 strains with the highest halo diameter were selected for further studies. The performance of the model for prediction of xylanase activity was evaluated in three different temperature and pH conditions using stratified cross-validation and jackknife methods. The trained model can be used for determining the activity of newly found xylanases in the specified condition. Such computational models help to scale down the experimental costs and save time by identifying enzymes with appropriate activity for scientific and industrial usage. Our methodology for activity prediction of xylanase enzymes can be potentially applied to the members of the other enzyme families. The availability of sufficient experimental data in specified pH and temperature conditions is a prerequisite for training the learning model and to achieve high accuracy.	[Ariaeenejad, Shohreh; Salekdeh, Ghasem Hosseini] Agr Res Educ & Extens Org AREO, ABRII, Dept Syst Biol, Karaj, Iran; [Mousivand, Maryam; Dezfouli, Parinaz Moradi; Hashemi, Maryam] Agr Res Educ & Extens Org AREO, ABRII, Dept Microbial Biotechnol, Karaj, Iran; [Kavousi, Kaveh] Univ Tehran, IBB, Tehran, Iran	University of Tehran	Ariaeenejad, S (corresponding author), Agr Res Educ & Extens Org AREO, ABRII, Dept Syst Biol, Karaj, Iran.	Sh.ariaee@abrii.ac.ir	Hashemi, Maryam/S-4140-2016; Salekdeh, Ghasem Hosseini/E-4198-2012; Mousivand, Maryam/AAZ-9782-2020; Hashemi, Maryam/AAC-7314-2020	Hashemi, Maryam/0000-0001-6961-7402; Salekdeh, Ghasem Hosseini/0000-0002-5124-4721; Hashemi, Maryam/0000-0001-6961-7402; Mousivand, Maryam/0000-0002-6120-3771				Basu M, 2018, CURR PROTEIN PEPT SC, V19, P87, DOI 10.2174/1389203718666161122110200; BERNIER R, 1983, APPL ENVIRON MICROB, V46, P511, DOI 10.1128/AEM.46.2.511-514.1983; BERNIER R, 1983, GENE, V26, P59, DOI 10.1016/0378-1119(83)90036-7; Chen W, 2014, BIOMED RES INT; Chen W, 2017, BIOINFORMATICS; Chen W, 2017, J BIOMOL STRUCT DYN, V35, P683, DOI 10.1080/07391102.2016.1157761; Chen W, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.37; Chen W, 2015, ANAL BIOCHEM, V490, P26, DOI 10.1016/j.ab.2015.08.021; Chen W, 2015, BIOINFORMATICS, V31, P119, DOI 10.1093/bioinformatics/btu602; Chen W, 2014, ANAL BIOCHEM, V462, P76, DOI 10.1016/j.ab.2014.06.022; Chen W, 2014, ANAL BIOCHEM, V456, P53, DOI 10.1016/j.ab.2014.04.001; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843; Chen X, 1996, PROTEIN SCI, V5, P705; Chen XX, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1654623; Chou KC, 2000, BIOCHEM BIOPH RES CO, V278, P477, DOI 10.1006/bbrc.2000.3815; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 1997, PROTEINS, V28, P99, DOI 10.1002/(SICI)1097-0134(199705)28:1<99::AID-PROT10>3.0.CO;2-C; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Cintra LC, 2017, CHARACTERIZATION REC; COUGHLAN MP, 1993, BIOTECHNOL APPL BIOC, V17, P259; Cuesta SM, 2015, BIOPHYS J, V109, P1082, DOI 10.1016/j.bpj.2015.04.020; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Ding H, 2016, VIROL SIN, V31, P350, DOI 10.1007/s12250-016-3740-6; Ding H, 2015, AMINO ACIDS, V47, P329, DOI 10.1007/s00726-014-1862-4; Ding H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/286419; Ding H, 2014, MOL BIOSYST, V10, P2229, DOI 10.1039/c4mb00316k; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; ELEGIR G, 1994, APPL ENVIRON MICROB, V60, P2609, DOI 10.1128/AEM.60.7.2609-2615.1994; Feng PM, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/530696; Feng PM, 2017, MOL THER-NUCL ACIDS, V7, P155, DOI 10.1016/j.omtn.2017.03.006; GILBERT HJ, 1993, J GEN MICROBIOL, V139, P187, DOI 10.1099/00221287-139-2-187; Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083; Hediger MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049849; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Huang JL, 2006, BIORESOURCE TECHNOL, V97, P802, DOI 10.1016/j.biortech.2005.04.011; Huo HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06195-y; Jacobson MP, 2014, TRENDS BIOCHEM SCI, V39, P363, DOI 10.1016/j.tibs.2014.05.006; Jalal A, 2009, J BIOSCI BIOENG, V107, P360, DOI 10.1016/j.jbiosc.2008.12.005; Jeffries TW, 1996, CURR OPIN BIOTECH, V7, P337, DOI 10.1016/S0958-1669(96)80041-3; Jiang ZQ, 2006, CARBOHYD POLYM, V66, P88, DOI 10.1016/j.carbpol.2006.02.030; Kavousi K, 2012, MATH BIOSCI, V240, P148, DOI 10.1016/j.mbs.2012.07.001; Kavousi K, 2011, COMPUT BIOL CHEM, V35, P1, DOI 10.1016/j.compbiolchem.2010.12.001; Khandeparker R, 2011, NEW BIOTECHNOL, V28, P814, DOI 10.1016/j.nbt.2011.08.001; Kumar VD, 2018, MED TEACH, V40, P1314, DOI 10.1080/0142159X.2018.1485885; Lai HY, 2017, ONCOTARGET, V8, P28169, DOI 10.18632/oncotarget.15963; Li WC, 2015, CHEMOMETR INTELL LAB, V141, P100, DOI 10.1016/j.chemolab.2014.12.011; Li Z, 2017, GENE, V618, P8, DOI 10.1016/j.gene.2017.03.011; Liang ZY, 2017, BIOINFORMATICS, V33, P467, DOI 10.1093/bioinformatics/btw630; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2019, IEEE ACM T COMPUT BI, V16, P1316, DOI 10.1109/TCBB.2017.2666141; Lin H, 2014, NUCLEIC ACIDS RES, V42, P12961, DOI 10.1093/nar/gku1019; Lin H, 2011, J MICROBIOL METH, V84, P67, DOI 10.1016/j.mimet.2010.10.013; Liu B, 2017, MOL THER-NUCL ACIDS, V7, P267, DOI 10.1016/j.omtn.2017.04.008; Liu B, 2017, ONCOTARGET, V8, P13338, DOI 10.18632/oncotarget.14524; Liu B, 2016, BIOINFORMATICS, V32, P2411, DOI 10.1093/bioinformatics/btw186; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; NAKAMURA S, 1993, APPL ENVIRON MICROB, V59, P2311, DOI 10.1128/AEM.59.7.2311-2316.1993; Ohmiya K, 1997, BIOTECHNOL GENET ENG, V14, P365, DOI 10.1080/02648725.1997.10647949; Sa-Pereira P, 2003, MOL BIOTECHNOL, V24, P257, DOI 10.1385/MB:24:3:257; Sa-Pereira P, 2002, ENZYME MICROB TECH, V30, P924, DOI 10.1016/S0141-0229(02)00034-0; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; Shukla P, 2018, CURR PROTEIN PEPT SC, V19, P3, DOI 10.2174/138920371901171121142734; Song JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007072; Tang HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30529; Tang H, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3267325; Tang H, 2016, BIOCHEM BIOPH RES CO, V477, P150, DOI 10.1016/j.bbrc.2016.06.035; Tang H, 2016, MOL BIOSYST, V12, P1269, DOI 10.1039/c5mb00883b; Tariq R, 2018, PAK J BOT, V50, P807; Thomas L, 2014, BIORESOURCE TECHNOL, V165, P309, DOI 10.1016/j.biortech.2014.03.037; VIIKARI L, 1994, FEMS MICROBIOL REV, V13, P335, DOI 10.1016/0168-6445(94)90090-6; Yang H, 2016, BIOMED RES INT; Yuan LF, 2013, TOXICOL IN VITRO, V27, P852, DOI 10.1016/j.tiv.2012.12.024; Zhang CJ, 2016, ONCOTARGET, V7, P69783, DOI 10.18632/oncotarget.11975; Zhang T, 2017, NUCLEIC ACIDS RES, V45, pD135, DOI 10.1093/nar/gkw728; Zhao Y-W, 2016, SCI REPORTS, V6, DOI [10.1016/j.tiv.2012.12.024, DOI 10.1016/J.TIV.2012.12.024]; Zhao YW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091838; Zheng HC, 2014, J IND MICROBIOL BIOT, V41, P153, DOI 10.1007/s10295-013-1363-6; Zhu PP, 2015, MOL BIOSYST, V11, P558, DOI 10.1039/c4mb00645c; Zuo YC, 2015, MOL BIOSYST, V11, P950, DOI 10.1039/c4mb00681j	85	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205796	10.1371/journal.pone.0205796	http://dx.doi.org/10.1371/journal.pone.0205796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346964	Green Published, gold, Green Submitted			2022-12-26	WOS:000447938400018
J	Morgounov, A; Sonder, K; Abugalieva, A; Bhadauria, V; Cuthbert, RD; Shamanin, V; Zelenskiy, Y; DePauw, RM				Morgounov, Alexey; Sonder, Kai; Abugalieva, Aygul; Bhadauria, Vijai; Cuthbert, Richard D.; Shamanin, Vladimir; Zelenskiy, Yuriy; DePauw, Ronald M.			Effect of climate change on spring wheat yields in North America and Eurasia in 1981-2015 and implications for breeding	PLOS ONE			English	Article							EASTERN-EUROPE; GRAIN-YIELD; TRAITS; IMPROVEMENT; TILLAGE; IMPACT	Wheat yield dynamic in Canada, USA, Russia and Kazakhstan from 1981 till 2015 was related to air temperature and precipitation during wheat season to evaluate the effects of climate change. The study used yield data from the provinces, states and regions and average yield from 19 spring wheat breeding/research sites. Both at production and research sites grain yield in Eurasia was two times lower compared to North America. The yearly variations in grain yield in North America and Eurasia did not correlate suggesting that higher yield in one region was normally associated with lower yield in another region. Minimum and maximum air temperature during the wheat growing season (April-August) had tendency to increase. While precipitation in April-August increased in North American sites from 289 mm in 1981-1990 to 338 mm in 2006-2015 it remained constant and low at Eurasian sites (230 and 238 mm, respectively). High temperature in June and July negatively affected grain yield in most of the sites at both continents. Climatic changes resulted in substantial changes in the dates of planting and harvesting normally leading to extension of growing season. Longer planting-harvesting period was positively associated with the grain yield for most of the locations. The climatic changes since 1981 and spring wheat responses suggest several implications for breeding. Gradual warming extends the wheat growing season and new varieties need to match this to utilize their potential. Higher rainfall during the wheat season, especially in North America, will require varieties with higher yield potential responding to moisture availability. June is a critical month for spring wheat in both regions due to the significant negative correlation of grain yield with maximum temperature and positive correlation with precipitation. Breeding for adaptation to higher temperatures during this period is an important strategy to increase yield.	[Morgounov, Alexey] Int Maize & Wheat Improvement Ctr CIMMYT, Ankara, Turkey; [Sonder, Kai] CIMMYT, Texcoco, Mexico; [Abugalieva, Aygul] Kazakh Res Inst Farming, Alma Ata, Kazakhstan; [Bhadauria, Vijai; Cuthbert, Richard D.] AAFC Swift Current Res & Dev Ctr, Swift Current, SK, Canada; [Shamanin, Vladimir] Omsk State Agrarian Univ, Omsk, Russia; [Zelenskiy, Yuriy] CIMMYT, Astana, Kazakhstan; [DePauw, Ronald M.] Advancing Wheat Technol, Swift Current, SK, Canada	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Ministry of Food, Agriculture & Livestock - Turkey; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Omsk State Agrarian University	Morgounov, A (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Ankara, Turkey.	a.morgounov@cgiar.org	Morgunov, Alexey/AGD-7910-2022; Shamanin, Vladimir/AAS-3913-2020	Morgunov, Alexey/0000-0001-7082-5655; Sonder, Kai/0000-0001-9672-5361	CRP WHEAT; Bill and Melinda Gates Foundation (BMGF); UK Department for International Development (DFID) [OPP1133199]; Western Grains Research Foundation; Agriculture and AgriFood Canada; Russian Science Foundation [16-1610005]; Russian Science Foundation [16-16-10005] Funding Source: Russian Science Foundation	CRP WHEAT; Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); UK Department for International Development (DFID); Western Grains Research Foundation; Agriculture and AgriFood Canada(Agriculture & Agri Food Canada); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	CIMMYT is supported by CRP WHEAT. CIMMYT thanks the Bill and Melinda Gates Foundation (BMGF) and UK Department for International Development (DFID) for providing financial support through the grant OPP1133199. Western Canadian wheat breeding research has been funded by a producer levy managed by the Western Grains Research Foundation and by grants from Agriculture and AgriFood Canada. Omsk State Agrarian University is supported by the Russian Science Foundation (project No. 16-1610005 signed 10.05.2016).	Angus, 2001, WORLD WHEAT BOOK HIS, P479; Balkovic J, 2014, GLOBAL PLANET CHANGE, V122, P107, DOI 10.1016/j.gloplacha.2014.08.010; Braun HJ, 2010, CABI CLIM CHANGE SER, V1, P115, DOI 10.1079/9781845936334.0115; BUSCH RH, 2001, WORLD WHEAT BOOK A H, P431; Chen H, 2016, EUPHYTICA, V208, P377, DOI 10.1007/s10681-015-1615-9; CRP W, 2016, WHEAT AGR SYST PROP; Cuthbert RD, 2017, CAN J PLANT SCI, V97, P393, DOI 10.1139/cjps-2016-0150; DePauw RM, 2007, EUPHYTICA, V157, P409, DOI 10.1007/s10681-007-9379-5; DePauw RM, 2011, CAN J PLANT SCI, V91, P529, DOI [10.4141/CJPS10187, 10.4141/cjps10187]; Gan YT, 2010, RECENT TRENDS SOIL S, P277; Grise J, 2015, J EARTH SCI CLIM CHA, V07, P332; He YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046900; Iqbal M, 2016, CROP SCI, V56, P613, DOI 10.2135/cropsci2015.06.0348; Kuhling I, 2017, SOIL TILL RES, V170, P43, DOI 10.1016/j.still.2017.02.009; Lanning SP, 2010, CROP SCI, V50, P835, DOI 10.2135/cropsci2009.06.0314; Liu B, 2016, NAT CLIM CHANGE, V6, P1130, DOI 10.1038/NCLIMATE3115; Lobell DB, 2007, AGRON J, V99, P469, DOI 10.2134/agronj2006.0209; McCaig TN, 1996, CAN J PLANT SCI, V76, P337, DOI 10.4141/cjps96-059; McCaig TN, 1997, CAN J PLANT SCI, V77, P215, DOI 10.4141/P96-144; McCallum BD, 2008, CAN J PLANT SCI, V88, P649, DOI 10.4141/CJPS07159; Merezhko A.F., 2001, WORLD WHEAT BOOK HIS, VVolume 1, P257; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Morgounov A, 2013, EUPHYTICA, V194, P277, DOI 10.1007/s10681-013-0968-1; Morgounov A, 2010, FIELD CROP RES, V117, P101, DOI 10.1016/j.fcr.2010.02.001; Morgounov A., 2001, WORLD WHEAT BOOK HIS, P755; Navabi A, 2006, CROP SCI, V46, P1107, DOI 10.2135/cropsci2005.06-0159; Qian BD, 2016, THEOR APPL CLIMATOL, V123, P651, DOI 10.1007/s00704-015-1378-1; Sommer R, 2013, AGR ECOSYST ENVIRON, V178, P78, DOI 10.1016/j.agee.2013.06.011; Swinnen J, 2017, GLOB FOOD SECUR-AGR, V14, P38, DOI 10.1016/j.gfs.2017.03.005; Thomas JB, 2014, CAN J PLANT SCI, V94, P1, DOI [10.4141/CJPS2013-160, 10.4141/cjps2013-160]; Trethowan RM, 2006, EUPHYTICA, V152, P303, DOI 10.1007/s10681-006-9217-1; Underdahl JL, 2008, CROP SCI, V48, P158, DOI 10.2135/cropsci2007.01.0018; Wang H, 2007, CAN J SOIL SCI, V87, P3, DOI 10.4141/S06-016; Wang H, 2012, CAN J PLANT SCI, V92, P421, DOI [10.4141/CJPS2011-192, 10.4141/cjps2011-192]	34	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204932	10.1371/journal.pone.0204932	http://dx.doi.org/10.1371/journal.pone.0204932			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332438	gold, Green Published, Green Submitted			2022-12-26	WOS:000447638200042
J	Ha, HJ; Kwon, S; Jeong, EM; Kim, CM; Lee, KB; Kim, IG; Park, HH				Ha, Hyun Ji; Kwon, Sunghark; Jeong, Eui Man; Kim, Chang Min; Lee, Ki Baek; Kim, In-Gyu; Park, Hyun Ho			Structure of natural variant transglutaminase 2 reveals molecular basis of gaining stability and higher activity	PLOS ONE			English	Article							GTP-BINDING PROTEIN; TISSUE TRANSGLUTAMINASE; CELIAC-DISEASE; CALCIUM-IONS; IDENTIFICATION; ACTIVATION; AUTOANTIBODIES; TRIPHOSPHATE; MODEL; SITE	Multi-functional transglutaminase 2 (TG2), which possesses protein cross-linking and GTP hydrolysis activities, is involved in various cellular processes, including apoptosis, angiogenesis, wound healing, and neuronal regeneration, and is associated with many human diseases, including inflammatory disease, celiac disease, neurodegenerative disease, diabetes, tissue fibrosis, and cancers. Although most biochemical and cellular studies have been conducted with the TG2 (G224) form, the TG2 (G224V) form has recently emerged as a putative natural variant of TG2. In this study, we characterized the putative natural form of TG2, TG2 (G224V), and through a new crystal structure of TG2 (G224V), we revealed how TG2 (G224V) gained stability and higher Ca2+-dependent activity than an artificial variant of TG2 (G224).	[Ha, Hyun Ji; Kwon, Sunghark; Kim, Chang Min; Park, Hyun Ho] Chung Ang Univ, Sch Pharm, Seoul, South Korea; [Jeong, Eui Man; Lee, Ki Baek; Kim, In-Gyu] Seoul Natl Univ, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea	Chung Ang University; Seoul National University (SNU)	Park, HH (corresponding author), Chung Ang Univ, Sch Pharm, Seoul, South Korea.; Kim, IG (corresponding author), Seoul Natl Univ, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea.	igkim@snu.ac; xrayleox@cau.ac.kr		park, hyun ho/0000-0001-9928-0847; Lee, Ki Baek/0000-0002-0208-272X; Jeong, Eui Man/0000-0003-0692-2033	Basic Science Research Program through National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology [NRF-2017M3A9D8062960, NRF-2017R1D1A1B03035059, NRF-2018R1A2B3008541]; Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI17C0155]; Brain Korea 21 (BK21) PLUS program of the Korean Ministry of Education, Science, and Technology	Basic Science Research Program through National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology; Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Brain Korea 21 (BK21) PLUS program of the Korean Ministry of Education, Science, and Technology	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (NRF-2017M3A9D8062960, NRF-2017R1D1A1B03035059, and NRF-2018R1A2B3008541) and a grant from the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI17C0155). E.M.J. was supported by the Brain Korea 21 (BK21) PLUS program of the Korean Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; Ahvazi B, 2002, EMBO J, V21, P2055, DOI 10.1093/emboj/21.9.2055; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Chen X, 2015, J BIOL CHEM, V290, P21365, DOI 10.1074/jbc.M115.669895; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; EITAN S, 1994, SCIENCE, V264, P1764, DOI 10.1126/science.7911602; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grenard P, 2001, J BIOL CHEM, V276, P33066, DOI 10.1074/jbc.M102553200; GRIFFIN M, 1979, BRIT J EXP PATHOL, V60, P653; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Han BG, 2010, INT J BIOL MACROMOL, V47, P190, DOI 10.1016/j.ijbiomac.2010.04.023; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Hasegawa G, 2003, BIOCHEM J, V373, P793, DOI 10.1042/BJ20021084; Hoffner G, 2005, FRONT BIOSCI-LANDMRK, V10, P3078, DOI 10.2741/1764; Im MJ, 1997, CELL SIGNAL, V9, P477, DOI 10.1016/S0898-6568(97)00049-1; Jang TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107005; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Jung SH, 2016, BIOSENS BIOELECTRON, V79, P930, DOI 10.1016/j.bios.2016.01.034; Kanchan K, 2013, BIOCHEM J, V455, P261, DOI 10.1042/BJ20130696; Kim SY, 2006, FRONT BIOSCI-LANDMRK, V11, P3026, DOI 10.2741/2030; Kiraly R, 2009, FEBS J, V276, P7083, DOI 10.1111/j.1742-4658.2009.07420.x; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mangala LS, 2005, PROG EXP TUMOR RES, V38, P125; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MIAN S, 1995, FEBS LETT, V370, P27, DOI 10.1016/0014-5793(95)00782-5; PIACENTINI M, 1991, EUR J CELL BIOL, V54, P246; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Piovesan D, 2016, NUCLEIC ACIDS RES, V44, pW367, DOI 10.1093/nar/gkw315; Porzio O, 2007, Hum Mutat, V28, P1150, DOI 10.1002/humu.9511; Shin DM, 2004, J BIOL CHEM, V279, P15032, DOI 10.1074/jbc.M308734200; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0204707	10.1371/journal.pone.0204707	http://dx.doi.org/10.1371/journal.pone.0204707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321187	gold, Green Published, Green Submitted			2022-12-26	WOS:000447417900010
J	Roba, AA; Dasa, TT; Weldegebreal, F; Asfaw, A; Mitiku, H; Teklemariam, Z; Naganuri, M; Geddugol, BJ; Mesfin, F; Befikadu, H; Tesfaye, E				Roba, Aklilu Abrham; Dasa, Tamirat Tesfaye; Weldegebreal, Fitsum; Asfaw, Abyot; Mitiku, Habtamu; Teklemariam, Zelalem; Naganuri, Mahantash; Geddugol, Bahubali Jinnappa; Mesfin, Frehiwot; Befikadu, Hilina; Tesfaye, Eden			Tuberculosis patients are physically challenged and socially isolated: A mixed methods case-control study of Health Related Quality of Life in Eastern Ethiopia	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; PULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; TB; DISABILITY; REGION; SF-36	Introduction Pulmonary tuberculosis (TB) impairs respiratory physiology and functional ability, resulting in economic and social dependence upon others. Patients with tuberculosis especially multi drug resistant (MDR-TB) suffer from social isolation, stigma, lack of support and economic constraints. In Ethiopia, the trend of MDR TB is increasing and becoming a serious public health problem. However, little is known about patients except treatment outcomes, financial burden and psychological distress with serious deficiency of data on Health Related Quality of Life (HRQOL). Hence, the aim of this study was to assess HRQOL of MDR TB patients in comparison with drug sensitive pulmonary TB (DSTB) patients. Methods We included 100 cases of MDR and 300 controls with DSTB who were matched by sex. Data were collected using SF- 36v2 TM questionnaire and analysed with SPSS version 20. Independent t-test and conditional logistic regression analysis was done considering P-values of less than 0.05 statistically significant. Eight in-depth interviews were also conducted with both groups and represented with verbatim quotations and narrative texts. Results There were no statistically significant differences in mean scores for health related quality of life between cases and controls (57.61 +/- 16.42 and 59.13 +/- 22.10) nor were there significant differences in physical functioning, role disruption due to physical problems, vitality, social functioning, role disruption due to emotional distress, or overall mental health. Individuals with MDR-TB were significantly more likely to be single, a current student, and with lower education and families with more than 5 people than individuals with Drug sensitive TB, all of which were significantly associated with poorer HRQOL (p<0.05). There was good internal consistency of the scale scores, with a Cronbach's alpha value of 0.73. Conclusion Individuals with MDR-TB reported statistically worse general health but less bodily pain than individuals with Drug sensitive TB. To regain the role function they lost, we recommend that health facilities, media and all other stakeholders educate the community, households and students about pulmonary tuberculosis, treatment, prevention methods and therapeutic approaches towards TB patients, specifically MDR-TB.	[Roba, Aklilu Abrham; Dasa, Tamirat Tesfaye; Weldegebreal, Fitsum; Asfaw, Abyot; Mitiku, Habtamu; Teklemariam, Zelalem; Naganuri, Mahantash; Geddugol, Bahubali Jinnappa; Mesfin, Frehiwot] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia; [Befikadu, Hilina] Haramaya Univ, Coll Social Sci & Humanities, Dire Dawa, Ethiopia; [Tesfaye, Eden] Haramaya Univ, Coll Nat & Computat Sci, Dire Dawa, Ethiopia	Haramaya University; Haramaya University; Haramaya University	Roba, AA (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia.	akliltimnathserah@gmail.com	Weldegebreal, Fitsum/AAU-4318-2021; Roba, Aklilu/ABF-4860-2021; Dasa, Tamirat/AAC-7138-2020; ROBA, AKLILU ABRHAM/K-9642-2018	Weldegebreal, Fitsum/0000-0002-7867-1483; Roba, Aklilu/0000-0002-1166-9207; Dasa, Tamirat/0000-0001-8499-5057; ROBA, AKLILU ABRHAM/0000-0002-1166-9207; GEDDUGOL, BAHUBALI/0000-0002-2282-5818	Haramaya University office of Research Affairs [HUGR-2016-02-02]	Haramaya University office of Research Affairs	This work was supported by Haramaya University office of Research Affairs by thematic code- HUGR-2016-02-02.	Abate Dereje, 2012, BMC Res Notes, V5, P462, DOI 10.1186/1756-0500-5-462; Ahmad N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159560; Al-Qahtani MF, 2014, J TAIBAH UNIV MED SC, V9, P311, DOI 10.1016/j.jtumed.2014.04.005; Alene KA, 2017, TROP MED INT HEALTH, V22, P351, DOI 10.1111/tmi.12826; Ambaw F, 2018, B WORLD HEALTH ORGAN, V96, P243, DOI 10.2471/BLT.17.192658; Babikako HM, 2010, HLTH QUALITY LIFE OU, V8; Wilches EC, 2009, COLOMB MEDICA, V40, P436; Cremers AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119861; de Andrade ED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137572; de Grass D, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.14; Deribew A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-105; Fantahun Biadglegne, 2014, ANTIMICROB RESIST IN, V3, DOI [10.3402/gha.v8.29019, DOI 10.3402/GHA.V8.29019]; Fuady A, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-017-0382-3; Gebreweld FH, 2018, J HEALTH POPUL NUTR, V37, DOI 10.1186/s41043-017-0132-y; Godoy MDP, 2012, RESP CARE, V57, P1949, DOI 10.4187/respcare.01532; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; Hamusse SD, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25382; Hutchison C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4089-y; Javed H, 2016, INT J MYCOBACT, V5, P128, DOI 10.1016/j.ijmyco.2015.12.004; Julia Louw, 2012, HLTH QUALITY LIFE OU, V10; Kakhki AD, 2015, TUBERC RESPIR DIS, V78, P309, DOI 10.4046/trd.2015.78.4.309; Karapet Davtyan, 2015, PUBLIC HLTH PANORAMA, V1, P253; Kastien-Hilka T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174605; Kastien-Hilka T, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0442-6; Kebede D, 2004, ETHIOPIAN MED J, V42, P289; Li CT, 2017, J INT MED RES, V45, P610, DOI 10.1177/0300060517694491; Maguire GP, 2009, INT J TUBERC LUNG D, V13, P1500; Melissa Bauer, 2015, HLTH RELATED QUALITY, V13; Ministry of Health/ Ethiopian Public Heath Institute, 2014, IMPL GUID GENEXPERT; Mulisa G, 2015, INT J INFECT DIS, V39, P57, DOI 10.1016/j.ijid.2015.08.013; Onazi O, 2015, PUBLIC HEALTH ACTION, V5, P127, DOI 10.5588/pha.15.0002; Power M, 1999, HLTH PSYCHOL; Sagwa EL, 2016, PATIENT PREFER ADHER, V10, P2369, DOI 10.2147/PPA.S116860; Shah R, 2018, INDIAN J PSYCHIAT, V60, P105; Sharma Raman, 2014, Acta Med Iran, V52, P448; Singla R, 2018, LUNG INDIA, V35, P4, DOI 10.4103/lungindia.lungindia_269_16; Skevington SM, 1999, J PSYCHOSOM RES, V47, P449, DOI 10.1016/S0022-3999(99)00051-3; Tesfay K, 2016, INT J MYCOBACT, V5, P324, DOI 10.1016/j.ijmyco.2016.07.007; Thomas BE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147397; Tola HH, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29019; van den Hof S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1802-x; van der Westhuizen H, 2017, SAMJ S AFR MED J, V107, P475, DOI [10.7196/SAMJ.2017.v107i6.12260, 10.7196/samj.2017.v107i6.12260]; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; WHO, 2015, GLOB TUB REP; WHO, 2018, WEEKLY EPIDEMIOLOGIC; Yesuf EA, 2016, EUROPEAN J EPIDEMIOL, V31, pS236; Zhang SR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-174; Zhou CC, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0100-6; Ziyada MM, 2010, EXPLORING TUBERCULOS	50	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0204697	10.1371/journal.pone.0204697	http://dx.doi.org/10.1371/journal.pone.0204697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0RD	30321189	gold, Green Submitted, Green Published			2022-12-26	WOS:000447417900009
J	van Hulten, MHA; Paulo, MJ; Kruijer, W; Blankestijn-De Vries, H; Kemperman, B; Becker, FFM; Yang, JM; Lauss, K; Stam, ME; van Eeuwijk, FA; Keurentjes, JJB				van Hulten, Marieke H. A.; Paulo, Maria-Joao; Kruijer, Willem; Blankestijn-De Vries, Hetty; Kemperman, Brend; Becker, Frank F. M.; Yang, Jiaming; Lauss, Kathrin; Stam, Maike E.; van Eeuwijk, Fred A.; Keurentjes, Joost J. B.			Assessment of heterosis in two Arabidopsis thaliana common-reference mapping populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; FLOWERING-TIME; HYBRID VIGOR; UNDERSTANDING HETEROSIS; GENETIC ARCHITECTURE; FREEZING TOLERANCE; ALLELIC VARIATION; DNA METHYLATION; MAIZE	Hybrid vigour, or heterosis, has been of tremendous importance in agriculture for the improvement of both crops and livestock. Notwithstanding large efforts to study the phenomenon of heterosis in the last decades, the identification of common molecular mechanisms underlying hybrid vigour remain rare. Here, we conducted a systematic survey of the degree of heterosis in Arabidopsis thaliana hybrids. For this purpose, two overlapping Arabidopsis hybrid populations were generated by crossing a large collection of naturally occurring accessions to two common reference lines. In these Arabidopsis hybrid populations the range of heterosis for several developmental and yield related traits was examined, and the relationship between them was studied. The traits under study were projected leaf area at 17 days after sowing, flowering time, height of the main inflorescence, number of side branches from the main stem or from the rosette base, total seed yield, seed weight, seed size and the estimated number of seeds per plant. Predominantly positive heterosis was observed for leaf area and height of the main inflorescence, whereas mainly negative heterosis was observed for rosette branching. For the other traits both positive and negative heterosis was observed in roughly equal amounts. For flowering time and seed size only low levels of heterosis were detected. In general the observed heterosis levels were highly trait specific. Furthermore, no correlation was observed between heterosis levels and the genetic distance between the parental lines. Since all selected lines were a part of the Arabidopsis genome wide association (GWA) mapping panel, a genetic mapping approach was applied to identify possible regions harbouring genetic factors causal for heterosis, with separate calculations for additive and dominance effects. Our study showed that the genetic mechanisms underlying heterosis were highly trait specific in our hybrid populations and greatly depended on the genetic background, confirming the elusive character of heterosis.	[van Hulten, Marieke H. A.; Blankestijn-De Vries, Hetty; Kemperman, Brend; Becker, Frank F. M.; Yang, Jiaming; Keurentjes, Joost J. B.] Wageningen Univ & Res, Lab Genet, Wageningen, Netherlands; [Paulo, Maria-Joao; Kruijer, Willem; van Eeuwijk, Fred A.] Wageningen Univ & Res, Biometris, Wageningen, Netherlands; [Lauss, Kathrin; Stam, Maike E.] Univ Amsterdam, Swammerdam Inst Life Sci, Fac Sci, Plant Dev & Epi Genet, Amsterdam, Netherlands; [van Hulten, Marieke H. A.] Univ Amsterdam, Swammerdam Inst Life Sci, Mol Plant Pathol, Fac Sci, Amsterdam, Netherlands; [Yang, Jiaming] Liaoning Acad Agr Sci, Shenyang, Liaoning, Peoples R China	Wageningen University & Research; Wageningen University & Research; University of Amsterdam; University of Amsterdam	Keurentjes, JJB (corresponding author), Wageningen Univ & Res, Lab Genet, Wageningen, Netherlands.	Joost.Keurentjes@wur.nl	Kruijer, Willem/AAJ-7245-2020	Caldas Paulo, Maria Joao/0000-0002-4180-0763; Keurentjes, Joost/0000-0001-8918-0711	Netherlands Genomics Initiative [050-040-213]	Netherlands Genomics Initiative	This research was supported by a booster grant (050-040-213) of the Netherlands Genomics Initiative to the Consortium for Improving Plant Yield.	Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Barber WT, 2012, P NATL ACAD SCI USA, V109, P10444, DOI 10.1073/pnas.1202073109; Barth S, 2003, HEREDITY, V91, P36, DOI 10.1038/sj.hdy.6800276; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birchler JA, 2010, PLANT CELL, V22, P2105, DOI 10.1105/tpc.110.076133; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Darwin CR, 1876, EFFECTS CROSS SELF F; Duvick DN, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P19; East EM, 1936, GENETICS, V21, P375; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; El-Lithy ME, 2004, PLANT PHYSIOL, V135, P444, DOI 10.1104/pp.103.036822; Flint-Garcia SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007433; Fujimoto R, 2012, P NATL ACAD SCI USA, V109, P7109, DOI 10.1073/pnas.1204464109; Goldman IL, 1998, CSSA SPEC PUBL, P1; Griffing B., 1963, STATISTICAL GENETICS, P368; Groszmann M, 2013, TRENDS GENET, V29, P684, DOI 10.1016/j.tig.2013.07.004; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Hochholdinger F, 2007, TRENDS PLANT SCI, V12, P427, DOI 10.1016/j.tplants.2007.08.005; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Huang XH, 2016, NATURE, V537, P629, DOI 10.1038/nature19760; Huang XH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7258; Huang XQ, 2013, NEW PHYTOL, V199, P843, DOI 10.1111/nph.12306; Huard-Chauveau C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003766; Jiang Y, 2017, NAT GENET, V49, P1741, DOI 10.1038/ng.3974; Joosen RVL, 2010, PLANT J, V62, P148, DOI 10.1111/j.1365-313X.2009.04116.x; Kempe K, 2014, P NATL ACAD SCI USA, V111, P9097, DOI 10.1073/pnas.1402836111; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Kooke R, 2016, PLANT PHYSIOL, V170, P2187, DOI 10.1104/pp.15.00997; Kooke R, 2015, PLANT CELL, V27, P337, DOI 10.1105/tpc.114.133025; Korn M, 2008, PLANT CELL ENVIRON, V31, P813, DOI 10.1111/j.1365-3040.2008.01800.x; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Kruijer W, 2015, GENETICS, V199, P379, DOI 10.1534/genetics.114.167916; Lauss K, 2018, PLANT PHYSIOL, V176, P1627, DOI 10.1104/pp.17.01054; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lisec J, 2009, PLANT J, V59, P777, DOI 10.1111/j.1365-313X.2009.03910.x; Longin CFH, 2012, THEOR APPL GENET, V125, P1087, DOI 10.1007/s00122-012-1967-7; Melamed-Bessudo C, 2005, PLANT J, V43, P458, DOI 10.1111/j.1365-313X.2005.02466.x; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Melchinger AE, 1998, CSSA SPEC PUBL, P29; Meyer RC, 2004, PLANT PHYSIOL, V134, P1813, DOI 10.1104/pp.103.033001; Meyer RC, 2012, PLANT J, V71, P669, DOI 10.1111/j.1365-313X.2012.05021.x; Meyer RC, 2010, THEOR APPL GENET, V120, P227, DOI 10.1007/s00122-009-1074-6; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; MITCHELLOLDS T, 1995, GENETICS, V140, P1105; Moore S, 2011, G3-GENES GENOM GENET, V1, P571, DOI 10.1534/g3.111.001156; Narang RA, 2001, PLANT SOIL, V234, P91, DOI 10.1023/A:1010545101345; Oakley CG, 2015, HEREDITY, V115, P73, DOI 10.1038/hdy.2015.18; REDEI GP, 1962, Z VEREBUNGSL, V93, P164; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Rohde P, 2004, PLANT J, V38, P790, DOI 10.1111/j.1365-313X.2004.02080.x; Schnable PS, 2013, ANNU REV PLANT BIOL, V64, P71, DOI 10.1146/annurev-arplant-042110-103827; Seren U, 2012, PLANT CELL, V24, P4793, DOI 10.1105/tpc.112.108068; Seymour DK, 2016, P NATL ACAD SCI USA, V113, pE7317, DOI 10.1073/pnas.1615268113; SHARMA RK, 1979, THEOR APPL GENET, V54, P11, DOI 10.1007/BF00265702; Shen HS, 2012, PLANT CELL, V24, P875, DOI 10.1105/tpc.111.094870; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Shivaprasad PV, 2012, EMBO J, V31, P257, DOI 10.1038/emboj.2011.458; SHULL GH, 1948, GENETICS, V33, P439; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Stokes D, 2007, EUPHYTICA, V156, P157, DOI 10.1007/s10681-007-9362-1; Strange A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019949; Syed NH, 2005, HEREDITY, V94, P295, DOI 10.1038/sj.hdy.6800558; Troyer AF, 2006, CROP SCI, V46, P528, DOI 10.2135/cropsci2005.0065; Ungerer MC, 2002, GENETICS, V160, P1133; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; VANDERVEEN JH, 1968, EUPHYTICA, V17, P371, DOI 10.1007/BF00056238; Wallace JG, 2014, HEREDITY, V112, P30, DOI 10.1038/hdy.2013.6; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Wu JW, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-439; Yang M, 2017, P NATL ACAD SCI USA, V114, P8101, DOI 10.1073/pnas.1705423114	78	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205564	10.1371/journal.pone.0205564	http://dx.doi.org/10.1371/journal.pone.0205564			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312352	gold, Green Published, Green Submitted			2022-12-26	WOS:000447427300036
J	Villanueva, JE; Gao, L; Chew, HC; Hicks, M; Doyle, A; Qui, MR; Dhital, KK; Macdonald, PS; Jabbour, A				Villanueva, Jeanette E.; Gao, Ling; Chew, Hong C.; Hicks, Mark; Doyle, Aoife; Qui, Min Ru; Dhital, Kumud K.; Macdonald, Peter S.; Jabbour, Andrew			Functional recovery after dantrolene-supplementation of cold stored hearts using an ex vivo isolated working rat heart model	PLOS ONE			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; RYANODINE RECEPTOR; MALIGNANT HYPERTHERMIA; SARCOPLASMIC-RETICULUM; CA2+ RELEASE; MYOCARDIAL REPERFUSION; GLYCERYL TRINITRATE; THERAPEUTIC AGENT; SKELETAL-MUSCLE; IN-VIVO	The ryanodine receptor antagonist dantrolene inhibits calcium release from the sarcoplasmic reticulum and reduces cardiac ischaemia-reperfusion injury (IRI) in global warm ischaemia models however the cardioprotective potential of dantrolene under hypothermic conditions is unknown. This study addresses whether the addition of dantrolene during cardioplegia and hypothermic storage of the donor heart can improve functional recovery and reduce IRI. Using an ex vivo isolated working heart model, Wistar rat (3 month and 12 month) hearts were perfused to acquire baseline haemodynamic measurements of aortic flow, coronary flow, cardiac output, pulse pressure and heart rate. Hearts were arrested and stored in Celsior preservation solution supplemented with 0.2-40 mu M dantrolene for 6 hours at 4 degrees C, then reperfused (15 min Langendorff, 30 min working mode). In 3-month hearts, supplementation with 1 mu M dantrolene significantly improved aortic flow and cardiac output compared to unsupplemented controls however lactate dehydrogenase (LDH) release and contraction bands were comparable. In contrast, 40 mu M dantrolene-supplementation yielded poor cardiac recovery, increased post-reperfusion LDH but reduced contraction bands. All 3-month hearts stored in dantrolene displayed significantly reduced cleaved-caspase 3 intensities compared to controls. Analysis of cardioprotective signalling pathways showed no changes in AMPK alpha however dantrolene increased STAT3 and ERK1/2 signaling in a manner unrelated to functional recovery and AKT activity was reduced in 1 mu M dantrolene-stored hearts. In contrast to 3-month hearts, no significant improvements were observed in the functional recovery of 12-month hearts following prolonged storage in 1 mu M dantrolene. Conclusions: Dantrolene supplementation at 1 mu M during hypothermic heart preservation improved functional recovery of young, but not older (12 month) hearts. Although the molecular mechanisms responsible for dantrolene-mediated cardioprotection are unclear, our studies show no correlation between improved functional recovery and SAFE and RISK pathway activation.	[Villanueva, Jeanette E.; Gao, Ling; Chew, Hong C.; Hicks, Mark; Doyle, Aoife; Dhital, Kumud K.; Macdonald, Peter S.; Jabbour, Andrew] Victor Chang Cardiac Res Inst, Cardiac Physiol & Transplantat, Darlinghurst, NSW, Australia; [Villanueva, Jeanette E.; Hicks, Mark; Dhital, Kumud K.; Macdonald, Peter S.; Jabbour, Andrew] Univ New South Wales, Randwick, NSW, Australia; [Hicks, Mark] St Vincents Hosp, Dept Clin Pharmacol & Toxicol, Darlinghurst, NSW, Australia; [Qui, Min Ru] St Vincents Hosp, Dept Anat Pathol, SydPath, Darlinghurst, NSW, Australia; [Dhital, Kumud K.; Macdonald, Peter S.; Jabbour, Andrew] St Vincents Hosp, Heart & Lung Transplant Unit, Darlinghurst, NSW, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney	Jabbour, A (corresponding author), Victor Chang Cardiac Res Inst, Cardiac Physiol & Transplantat, Darlinghurst, NSW, Australia.; Jabbour, A (corresponding author), Univ New South Wales, Randwick, NSW, Australia.; Jabbour, A (corresponding author), St Vincents Hosp, Heart & Lung Transplant Unit, Darlinghurst, NSW, Australia.	Andrew.Jabbour@svha.org.au	Macdonald, Peter/Q-3188-2019	Villanueva, Jeanette/0000-0002-6856-6778	National Health and Medical Research Council Australia Program Grant [1074386]; Royal Australasian College of Physicians Career Development Award	National Health and Medical Research Council Australia Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Royal Australasian College of Physicians Career Development Award	This study was funded by a National Health and Medical Research Council Australia Program Grant (1074386) awarded to PM and a Royal Australasian College of Physicians Career Development Award awarded to AJ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikel M, 2005, INT J CARDIOL, V98, P389, DOI 10.1016/j.ijcard.2003.10.054; DAVIDENKO J, 1986, J PHARMACOL EXP THER, V238, P206; Domeier TL, 2014, AM J PHYSIOL-HEART C, V307, pH818, DOI 10.1152/ajpheart.00287.2014; Egawa T, 2011, J APPL PHYSIOL, V111, P1629, DOI 10.1152/japplphysiol.00249.2011; Fratea S, 1997, ANESTHESIOLOGY, V86, P205, DOI 10.1097/00000542-199701000-00025; Gao L, 2005, AM J TRANSPLANT, V5, P1820, DOI 10.1111/j.1600-6143.2005.00967.x; Gao L, 2011, BRIT J PHARMACOL, V162, P633, DOI 10.1111/j.1476-5381.2010.01071.x; Gao L, 2007, TRANSPLANTATION, V84, P380, DOI 10.1097/01.tp.0000276924.08343.78; Garcia-Dorado D, 2012, CARDIOVASC RES, V94, P168, DOI 10.1093/cvr/cvs116; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; Hartmann N, 2017, HEART RHYTHM, V14, P412, DOI 10.1016/j.hrthm.2016.09.014; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Jabbour A, 2011, TRANSPLANTATION, V91, P961, DOI 10.1097/TP.0b013e3182115b4b; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V293, pE286, DOI 10.1152/ajpendo.00693.2006; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; Kobayashi S, 2010, CIRC J, V74, P2579, DOI 10.1253/circj.CJ-10-0680; Kobayashi S, 2009, J AM COLL CARDIOL, V53, P1993, DOI 10.1016/j.jacc.2009.01.065; Kondratiev TV, 2008, CRYOBIOLOGY, V56, P15, DOI 10.1016/j.cryobiol.2007.09.005; Kumarasinghe G, 2016, J HEART LUNG TRANSPL, V35, P636, DOI 10.1016/j.healun.2015.12.020; Kwan JC, 2015, HEART LUNG CIRC, V24, P306, DOI 10.1016/j.hlc.2014.10.001; Maxwell JT, 2012, AM J PHYSIOL-HEART C, V302, pH953, DOI 10.1152/ajpheart.00936.2011; Mertens-Walker I, 2010, ENDOCR-RELAT CANCER, V17, P335, DOI 10.1677/ERC-09-0152; MEYLER WJ, 1976, EUR J PHARMACOL, V39, P127, DOI 10.1016/0014-2999(76)90120-5; MITCHELL MB, 1993, J SURG RES, V54, P411, DOI 10.1006/jsre.1993.1065; Oda T, 2015, J MOL CELL CARDIOL, V85, P240, DOI 10.1016/j.yjmcc.2015.06.009; Paul-Pletzer K, 2005, BIOCHEM J, V387, P905, DOI 10.1042/BJ20041336; Piper HM, 2006, CARDIOVASC RES, V70, P170, DOI 10.1016/j.cardiores.2006.03.010; Preckel B, 2000, ACTA ANAESTH SCAND, V44, P194, DOI 10.1034/j.1399-6576.2000.440211.x; Schwanke U, 2002, AM J PHYSIOL-HEART C, V283, pH1740, DOI 10.1152/ajpheart.00442.2002; Shintani-Ishida K, 2007, AM J PHYSIOL-HEART C, V293, pH1714, DOI 10.1152/ajpheart.00022.2007; Siegmund B, 1997, CIRCULATION, V96, P4372; Wang RW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194316; Wold RM, 2013, ACTA PHYSIOL, V207, P460, DOI 10.1111/apha.12003; Yeager M, 1998, J STRUCT BIOL, V121, P231, DOI 10.1006/jsbi.1998.3972; Yu GY, 2000, BASIC RES CARDIOL, V95, P137, DOI 10.1007/s003950050175; Zamiri N, 2014, CIRCULATION, V129, P875, DOI 10.1161/CIRCULATIONAHA.113.005443	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205850	10.1371/journal.pone.0205850	http://dx.doi.org/10.1371/journal.pone.0205850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312353	Green Submitted, Green Published, gold			2022-12-26	WOS:000447427300059
J	Yu, A; Mansure, JJ; Solanki, S; Siemens, DR; Koti, M; Dias, ABT; Burnier, MM; Brimo, F; Kassouf, W				Yu, Alice; Mansure, Jose Joao; Solanki, Shraddha; Siemens, D. Robert; Koti, Madhuri; Dias, Ana B. T.; Burnier, Miguel M.; Brimo, Fadi; Kassouf, Wassim			Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3(+), CD8(+), and immunoscore as prognostic marker in patients after radical cystectomy	PLOS ONE			English	Article							INVASIVE BLADDER-CANCER; UROTHELIAL CARCINOMA; COLORECTAL-CANCER; LUMINAL SUBTYPES; CELLS; METASTASIS; SURVIVAL; TUMORS; BASAL	Tumor-Infiltrating Lymphocytes (TILs) has been shown to be essential to predict disease outcome in several types of cancers. Moreover, the distribution of cytotoxic T lymphocytes (CD8+) and T cells in general (CD3+) have been used to establish an Immunoscore, as a new cancer prognosticator for survival in colon and lung cancer. In bladder cancer, immune activation has been shown to be associated with genomic subtypes of muscle invasive bladder cancer (MIBC). We sought to evaluate the prognostic impact of these immune cell types in MIBC patients treated with radical cystectomy. For this purpose, cystectomy sections (n = 67) with identifiable invasive margin were selected and stained for CD8(+) and CD3(+) tumour infiltrating lymphocytes (TILs); both tumor core (CT) and invasive margin (IM) were assessed. Immunoscore was calculated based on previously defined criteria and used to illustrate differences in survival. High density of CD8(IM) TILs was associated with better disease-free (DFS) (P = 0.01) and overall survival (OS) (P = 0.02) whereas CD3 im TILs were associated with better OS (P = 0.05). Immunoscore was associated with improved DFS (P = 0.02) and OS (P = 0.05). The expression of cytotoxic T cells (CD8+ T cells) in TCGA bladder cancer was also investigated from RNA-Seq profiles of 344 cases. T cell cytotoxicity associated genes (n = 113) were derived from MSig GSEA database. Luminal (n = 121) and basal (n = 68) samples were used to evaluate expression differences. Differential expression (P<0.05) of cytotoxic T cell genes was noted across different molecular subsets of bladder cancer within TCGA analysis. Our data suggests host immune system appears to play a valuable prognostic role in MIBC.	[Yu, Alice; Mansure, Jose Joao; Solanki, Shraddha; Kassouf, Wassim] McGill Univ, Dept Surg, Div Urol, Montreal, PQ, Canada; [Siemens, D. Robert] Queens Univ, Dept Urol, Kingston, ON, Canada; [Koti, Madhuri] Queens Univ, Biomed & Mol Sci, Kingston, ON, Canada; [Dias, Ana B. T.; Burnier, Miguel M.] McGill Univ, Henry C Witelson Ocular Pathol Lab, Montreal, PQ, Canada; [Brimo, Fadi] McGill Univ, Dept Pathol, Montreal, PQ, Canada	McGill University; Queens University - Canada; Queens University - Canada; McGill University; McGill University	Kassouf, W (corresponding author), McGill Univ, Dept Surg, Div Urol, Montreal, PQ, Canada.	wassim.kassouf@muhc.mcgill.ca	brimo, fadi/AAE-9987-2022; brimo, fadi/AFF-8172-2022; Solanki, Sami/E-2487-2013	Solanki, Sami/0000-0002-3418-8449; Mansure, Jose Joao/0000-0002-3467-7752	Canadian Urological Association-Pfizer urology resident grant 2016	Canadian Urological Association-Pfizer urology resident grant 2016	This project was supported by the Canadian Urological Association-Pfizer urology resident grant 2016 awarded to Alice Yu.	Anitei MG, 2014, CLIN CANCER RES, V20, P1891, DOI 10.1158/1078-0432.CCR-13-2830; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Choi W, 2014, NAT REV UROL, V11, P400, DOI 10.1038/nrurol.2014.129; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Faraj SF, 2015, UROLOGY, V85, DOI 10.1016/j.urology.2014.10.020; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205; Horn T, 2016, WORLD J UROL, V34, P181, DOI 10.1007/s00345-015-1615-3; Ingels A, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.486; Kroeger DR, 2016, CLIN CANCER RES, V22, P3005, DOI 10.1158/1078-0432.CCR-15-2762; Laghi L, 2009, LANCET ONCOL, V10, P877, DOI 10.1016/S1470-2045(09)70186-X; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Mo QX, 2018, JNCI-J NATL CANCER I, V110, P448, DOI 10.1093/jnci/djx243; Nanos-Webb A, 2012, BREAST CANCER RES TR, V132, P575, DOI 10.1007/s10549-011-1638-4; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Ren R, 2017, ONCOTARGET; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Siemens D, 2017, J UROLOGY, V197, pE1175, DOI 10.1016/j.juro.2017.02.2730; Sjodahl G, 2014, UROL ONCOL-SEMIN ORI, V32, P791, DOI 10.1016/j.urolonc.2014.02.007; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Sun C, 2015, ONCOTARGET, V6, P35602, DOI 10.18632/oncotarget.5801; Wang B, CD103 TUMOR INFILTRA, P1527; Wang B, 2015, J UROLOGY, V194, P556, DOI 10.1016/j.juro.2015.02.2941; Wang E, 2002, CANCER RES, V62, P3581; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965	30	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205746	10.1371/journal.pone.0205746	http://dx.doi.org/10.1371/journal.pone.0205746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308033	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500121
J	Zhang, YL; Kang, SC; Li, G; Gao, TG; Chen, PF; Li, XF; Liu, YJ; Hu, ZF; Sun, SW; Guo, JM; Wang, K; Chen, XT; Sillanpaa, M				Zhang, Yulan; Kang, Shichang; Li, Gang; Gao, Tanguang; Chen, Pengfei; Li, Xiaofei; Liu, Yajun; Hu, Zhaofu; Sun, Shiwei; Guo, Junming; Wang, Kun; Chen, Xintong; Sillanpaa, Mika			Dissolved organic carbon in glaciers of the southeastern Tibetan Plateau: Insights into concentrations and possible sources	PLOS ONE			English	Article							LIGHT-ABSORBING IMPURITIES; GREENLAND ICE-SHEET; BLACK CARBON; CHEMICAL-COMPOSITION; ALBEDO REDUCTION; CLIMATE-CHANGE; BROWN CLOUDS; SNOW; MATTER; HIMALAYAS	Dissolved organic carbon (DOC) released from glaciers has an important role in the biogeochemistry of glacial ecosystems. This study focuses on DOC from glaciers of the southeastern Tibetan Plateau, where glaciers are experiencing rapid shrinkage. We found that concentrations of DOC in snowpits (0.16 +/- 0.054 mu g g(-1)), aged snow (0.16 +/- 0.048 mu g g(-1)), and bare ice (0.18 +/- 0.082 mu g g(-1)) were similar across the southeastern Tibetan Plateau, but were slightly lower than those in other glaciers on the Tibetan Plateau. Vertical variations of DOC, particulate organic carbon, black carbon, and total nitrate in snowpit showed no systematic variations in the studied glaciers, with high values of DOC occurring in the ice or dusty layers. We estimated the export of DOC and particulate organic carbon from glaciers to be 1.96 +/- 0.66 Gg yr(-1) and 5.88 +/- 2.15 Gg yr(-1) in this region, respectively, indicating that organic carbon released from glacier meltwater may be affecting downstream ecosystems. Potential sources of the air masses arriving at the southeastern Tibetan glaciers include South Asia, Central Asia, Middle East, and northwest China. Emissions from biomass burning of South Asia played an important role in the deposition of DOC to the glacier, which can be evidenced by backward trajectories and fire spot distributions from MODIS and CALIPSO images. Our findings suggest that anthropogenic aerosols contribute abundant DOC to glaciers on the southeastern Tibetan Plateau. The pronounced rate of glacial melting in the region may be delivering increased quantities of relic DOC to downstream rivers.	[Zhang, Yulan; Kang, Shichang; Chen, Pengfei; Li, Xiaofei; Liu, Yajun; Hu, Zhaofu; Sun, Shiwei; Guo, Junming; Wang, Kun; Chen, Xintong] Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, State Key Lab Cryospher Sci, Lanzhou, Gansu, Peoples R China; [Zhang, Yulan; Sillanpaa, Mika] Lappeenranta Univ Technol, Lab Green Chem, Mikkeli, Finland; [Kang, Shichang; Hu, Zhaofu; Sun, Shiwei; Wang, Kun; Chen, Xintong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Kang, Shichang] CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China; [Li, Gang] Lanzhou Meteorol Bur, Arid Meteorol Res Inst, Lanzhou, Gansu, Peoples R China; [Gao, Tanguang] Lanzhou Univ, Coll Earth & Environm Sci, Minist Educ, Key Lab Western Chinas Environm Syst, Lanzhou, Gansu, Peoples R China	Chinese Academy of Sciences; Lappeenranta University of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Lanzhou University	Kang, SC (corresponding author), Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, State Key Lab Cryospher Sci, Lanzhou, Gansu, Peoples R China.; Kang, SC (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Kang, SC (corresponding author), CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China.	shichang.kang@lzb.ac.cn	Guo, Jianping/K-1497-2017; Guo, Jianping/A-2378-2019; Gao, Tanguang/ABG-7175-2021; Hu, zhaofu/AAD-3701-2020; Li, xiaofei/GXF-7187-2022; Sillanpää, Mika E T/G-1366-2011; Kang, Shichang/I-6830-2018	Guo, Jianping/0000-0001-8530-8976; Guo, Jianping/0000-0001-8530-8976; Sillanpää, Mika E T/0000-0003-3247-5337; Kang, Shichang/0000-0003-2115-9005; Guo, Junming/0000-0002-3133-5597	National Natural Science Foundation of China [41630754, 41671067, 41721091]; Chinese Academy of Sciences [QYZDJ-SSW-DQC039]; State Key Laboratory of Cryospheric Science; China Scholarship Council; NASA/HQ	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Cryospheric Science; China Scholarship Council(China Scholarship Council); NASA/HQ	This work received support from the National Natural Science Foundation of China (41630754, 41671067 and 41721091), Chinese Academy of Sciences (QYZDJ-SSW-DQC039), State Key Laboratory of Cryospheric Science (SKLCS-ZZ-2018), and the China Scholarship Council.; We acknowledge the use of data products or imagery from the Land, Atmosphere Near real-time Capability for EOS (LANCE) system operated by the NASA/GSFC/Earth Science Data and Information System (ESDIS) with funding provided by NASA/HQ. We would also like to thank for NOAA Air Resources Laboratory for HYPSLIT backward trajectory analysis. The minimal data set necessary to replicate the study findings is in the paper and the Supporting Information files.	Antony R, 2017, ENVIRON SCI TECHNOL, V51, P4328, DOI 10.1021/acs.est.6b05780; Antony R, 2014, ENVIRON SCI TECHNOL, V48, P6151, DOI 10.1021/es405246a; Antony R, 2011, ENVIRON SCI TECHNOL, V45, P9944, DOI 10.1021/es203512t; Baccolo G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10220-5; Benning LG, 2014, NAT GEOSCI, V7, P691, DOI 10.1038/ngeo2260; Bhardwaj P, 2016, ENVIRON SCI POLLUT R, V23, P4397, DOI 10.1007/s11356-015-5629-6; Cao J., 2003, PARTICUOLOGY, V1, P33; Cong ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09580; CONG ZY, 2010, ENVIRON MONIT ASSESS, V160, P323, DOI [DOI 10.1007/s10661-008-0698-3, DOI 10.1007/S10661-008-0698-3]; Cook J, 2016, PROG PHYS GEOG, V40, P66, DOI 10.1177/0309133315616574; Doherty SJ, 2013, J GEOPHYS RES-ATMOS, V118, P5553, DOI 10.1002/jgrd.50235; Dong ZW, 2017, ATMOS ENVIRON, V156, P24, DOI 10.1016/j.atmosenv.2017.02.029; Fellman JB, 2015, ENVIRON SCI TECHNOL, V49, P11492, DOI 10.1021/acs.est.5b02685; Feng L, 2016, ENVIRON SCI TECHNOL, V50, P13215, DOI 10.1021/acs.est.6b03971; Franzetti A, 2006, ISME, V10, P2984; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Gustafsson O, 2009, SCIENCE, V323, P495, DOI 10.1126/science.1164857; Han HD, 2010, ENVIRON EARTH SCI, V61, P665, DOI 10.1007/s12665-009-0378-9; Hood E, 2008, NAT GEOSCI, V1, P583, DOI 10.1038/ngeo280; Hood E, 2015, NAT GEOSCI, V8, P91, DOI [10.1038/ngeo2331, 10.1038/NGEO2331]; Hood E, 2009, NATURE, V462, P1044, DOI 10.1038/nature08580; Hu ZF, 2018, SCI TOTAL ENVIRON, V627, P579, DOI 10.1016/j.scitotenv.2018.01.265; Huntington TG, 2016, J GEOPHYS RES-BIOGEO, V121, P2700, DOI 10.1002/2015JG003314; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Kaab A, 2015, CRYOSPHERE, V9, P557, DOI 10.5194/tc-9-557-2015; Kang SC, 2004, ATMOS ENVIRON, V38, P2819, DOI 10.1016/j.atmosenv.2004.02.043; Kim Y, 2005, ATMOS ENVIRON, V39, P3513, DOI 10.1016/j.atmosenv.2005.02.050; Lawson EC, 2014, BIOGEOSCIENCES, V11, P4015, DOI 10.5194/bg-11-4015-2014; Legrand M, 2013, CLIM PAST, V9, P2195, DOI 10.5194/cp-9-2195-2013; Li CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12574; Li QL, 2018, SCI TOTAL ENVIRON, V612, P1340, DOI 10.1016/j.scitotenv.2017.08.267; Li XF, 2017, SCI TOTAL ENVIRON, V587, P482, DOI 10.1016/j.scitotenv.2017.02.169; Liu YM, 2016, J GLACIOL, V62, P402, DOI 10.1017/jog.2016.47; Luthi ZL, 2015, ATMOS CHEM PHYS, V15, P6007, DOI 10.5194/acp-15-6007-2015; Milner AM, 2017, P NATL ACAD SCI USA, V114, P9770, DOI 10.1073/pnas.1619807114; Muller-Tautges C, 2016, ATMOS CHEM PHYS, V16, P1029, DOI 10.5194/acp-16-1029-2016; Niu HW, 2017, SCI TOTAL ENVIRON, V574, P889, DOI 10.1016/j.scitotenv.2016.09.114; Pfeffer WT, 2014, J GLACIOL, V60, P537, DOI 10.3189/2014JoG13J176; Pritchard HD, 2017, NATURE, V545, P169, DOI 10.1038/nature22062; Radic V, 2014, CLIM DYNAM, V42, P37, DOI 10.1007/s00382-013-1719-7; Shi Y, 2005, CONCISE CHINA GLACIE, P1; Singer GA, 2012, NAT GEOSCI, V5, P710, DOI [10.1038/ngeo1581, 10.1038/NGEO1581]; Singh P, 2005, HYDROL PROCESS, V19, P1445, DOI 10.1002/hyp.5583; Spencer RGM, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/5/055005; Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1; Stibal M, 2012, GLOBAL CHANGE BIOL, V18, P3332, DOI 10.1111/j.1365-2486.2012.02763.x; Stibal M, 2010, ANN GLACIOL, V51, P1, DOI 10.3189/172756411795931958; Stubbins A, 2012, NAT GEOSCI, V5, P198, DOI [10.1038/ngeo1403, 10.1038/NGEO1403]; Su F, 2016, GLOBAL PLANET CHANGE, V136, P82, DOI 10.1016/j.gloplacha.2015.10.012; Sun SW, 2016, J ENVIRON SCI, V44, P213, DOI 10.1016/j.jes.2015.09.017; Takeuchi N, 2006, ANN GLACIOL-SER, V43, P378, DOI 10.3189/172756406781812113; Vadrevu KP, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/10/105003; Winker DM, 2010, B AM METEOROL SOC, V91, P1211, DOI 10.1175/2010BAMS3009.1; Xu BQ, 2009, P NATL ACAD SCI USA, V106, P22114, DOI [10.1073/pnas.0910444106, 10.1073/pnas.pnas.0910444106]; Xu JZ, 2013, ENVIRON SCI TECHNOL, V47, P6181, DOI 10.1021/es4009882; Yan FP, 2016, CRYOSPHERE, V10, P2611, DOI 10.5194/tc-10-2611-2016; Yan W, 2006, CAN J PLANT SCI, V86, P623, DOI 10.4141/P05-169; Yanai M, 2006, ASIAN MONSOON, P513, DOI [DOI 10.1007/3-540-37722-0_13, 10.1007/3-540-37722-0_13]; Yang S, 2015, ATMOS ENVIRON, V111, P71, DOI 10.1016/j.atmosenv.2015.03.016; Yang W, 2016, CLIM DYNAM, V47, P805, DOI 10.1007/s00382-015-2872-y; Yao TD, 2012, ENVIRON DEV, V3, P52, DOI 10.1016/j.envdev.2012.04.002; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; Yasunari TJ, 2015, J GEOPHYS RES-ATMOS, V120, P5485, DOI 10.1002/2014JD022977; Zhang YL, 2019, SCI TOTAL ENVIRON, V647, P1385, DOI 10.1016/j.scitotenv.2018.07.417; Zhang YL, 2017, J GEOPHYS RES-ATMOS, V122, P6915, DOI 10.1002/2016JD026397; Zhang YL, 2017, SCI TOTAL ENVIRON, V607, P1237, DOI 10.1016/j.scitotenv.2017.07.100; Zhang YL, 2017, SCI COLD ARID REG, V9, P97, DOI 10.3724/SP.J.1226.2017.00097; Zhang YL, 2016, J ASIAN EARTH SCI, V131, P62, DOI 10.1016/j.jseaes.2016.09.007; Zhang YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155232	69	6	6	7	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205414	10.1371/journal.pone.0205414	http://dx.doi.org/10.1371/journal.pone.0205414			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308022	Green Submitted, Green Published, gold			2022-12-26	WOS:000447173500072
J	Paulsen, ME; Rosario, FJ; Wesolowski, SR; Powell, TL; Jansson, T				Paulsen, Megan E.; Rosario, Fredrick J.; Wesolowski, Stephanie R.; Powell, Theresa L.; Jansson, Thomas			Normalizing adiponectin levels in obese pregnant mice prevents adverse metabolic outcomes in offspring	FASEB JOURNAL			English	Article						fetal programming; insulin resistance; fatty liver	FULL-LENGTH ADIPONECTIN; INSULIN-RESISTANCE; FETAL OVERNUTRITION; MATERNAL OBESITY; UNITED-STATES; MOUSE MODEL; TRANSPORT; GLUCOSE; WOMEN; BIRTH	Infants of obese mothers have an increased risk of developing obesity, insulin resistance, and type 2 diabetes. The underlying mechanisms remain elusive, and no effective interventions to limit the transmission of metabolic disease from the obese mother to her infant are currently available. Obese pregnant women have decreased circulating levels of adiponectin, which is associated with increased placental nutrient transport and fetal overgrowth. We have reported that normalization of adiponectin levels during late gestation reversed placental dysfunction and fetal overgrowth in a mouse model of maternal obesity in pregnancy. In the current study, we hypothesized that adiponectin supplementation during pregnancy in obese mice attenuates the adverse metabolic outcomes in adult offspring. Adult male offspring of obese mice developed obesity, fatty liver, and insulin resistance, with adult female offspring of obese mice having a less pronounced metabolic phenotype. These metabolic abnormalities in offspring born to obese mice were largely prevented by normalization of maternal adiponectin levels in late pregnancy. We provide evidence that low circulating maternal adiponectin is a critical mechanistic link between maternal obesity and the development of metabolic disease in offspring. Strategies aimed at improving maternal adiponectin levels may prevent long-term metabolic dysfunction in offspring of obese mothers.Paulsen, M. E., Rosario, F. J., Wesolowski, S. R., Powell, T. L., Jansson, T. Normalizing adiponectin levels in obese pregnant mice prevents adverse metabolic outcomes in offspring.	[Paulsen, Megan E.; Wesolowski, Stephanie R.; Powell, Theresa L.] Univ Colorado, Dept Pediat, Sect Neonatol, Anschutz Med Campus, Aurora, CO USA; [Rosario, Fredrick J.; Powell, Theresa L.; Jansson, Thomas] Univ Colorado, Dept Obstet & Gynecol, Div Reprod Sci, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Paulsen, ME (corresponding author), Univ Minnesota, Med Sch, Dept Pediat, Div Neonatol, 2450 Riverside Ave,6th Floor,East Bldg, Minneapolis, MN 55455 USA.	mgosslin@umn.edu	Powell, Theresa/AAE-4249-2020	Paulsen, Megan/0000-0001-9187-4966	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK59630]; NIH Office of the Director [R24OD016724]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD065007, T32HD07186]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065007, T32HD007186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059630, R01DK108910] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD016724] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank A. Kramer and N. Anderson (University of Colorado) for providing technical assistance in the acquisition of data, and the Mouse Metabolic Phenotyping Center at the University of Cincinnati (Cincinnati, OH, USA) [U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases; Grant DK59630] for performing colorimetric assay of serum triglycerides. This work was supported by NIH Office of the Director Grant R24OD016724, and NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grants R01HD065007 and T32HD07186. The authors declare no conflicts of interest.	Acosta O, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.009; Ahlsson FSE, 2007, PEDIATRICS, V120, P958, DOI 10.1542/peds.2007-0165; Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; Ategbo JM, 2006, J CLIN ENDOCR METAB, V91, P4137, DOI 10.1210/jc.2006-0980; Aye ILMH, 2013, PLACENTA, V34, pS40, DOI 10.1016/j.placenta.2012.11.024; Aye ILMH, 2015, P NATL ACAD SCI USA, V112, P12858, DOI 10.1073/pnas.1515484112; Aye ILMH, 2014, MOL ENDOCRINOL, V28, P512, DOI 10.1210/me.2013-1401; Bellatorre A, 2018, J PEDIATR-US, V192, P165, DOI 10.1016/j.jpeds.2017.09.008; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bomba-Opon DA, 2009, NEUROENDOCRINOL LETT, V30, P729; Branca F., 2007, CHALLENGE OBESITY WH; Brumbaugh DE, 2013, J PEDIATR-US, V162, P930, DOI 10.1016/j.jpeds.2012.11.017; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Dearden L, 2018, MOL METAB, V15, P8, DOI 10.1016/j.molmet.2018.04.007; Diaz P, 2015, AM J PHYSIOL-REG I, V309, pR1569, DOI 10.1152/ajpregu.00385.2015; Evagelidou EN, 2006, DIABETES CARE, V29, P1197, DOI 10.2337/dc05-2401; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Fisher SC, 2013, PREV MED, V56, P372, DOI 10.1016/j.ypmed.2013.02.015; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Hendler I, 2005, AM J OBSTET GYNECOL, V193, P979, DOI 10.1016/j.ajog.2005.06.041; Jansson N, 2008, AM J CLIN NUTR, V87, P1743, DOI 10.1093/ajcn/87.6.1743; Jansson N, 2013, J CLIN ENDOCR METAB, V98, P105, DOI 10.1210/jc.2012-2667; Jansson T, 2013, CLIN OBSTET GYNECOL, V56, P591, DOI 10.1097/GRF.0b013e3182993a2e; Johansson K, 2015, NEW ENGL J MED, V372, P2267, DOI 10.1056/NEJMc1503863; Jones HN, 2010, DIABETES, V59, P1161, DOI 10.2337/db09-0824; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Lanoix D, 2012, PLACENTA, V33, P151, DOI 10.1016/j.placenta.2011.12.008; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Lekva T, 2017, J CLIN ENDOCR METAB, V102, P2552, DOI 10.1210/jc.2017-00289; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Nien JK, 2007, J PERINAT MED, V35, P522, DOI 10.1515/JPM.2007.123; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Qiao LP, 2017, DIABETES, V66, P1126, DOI 10.2337/db16-1096; Qiao LP, 2016, DIABETOLOGIA, V59, P2417, DOI 10.1007/s00125-016-4061-x; Ramirez VI, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000010; Retnakaran R, 2010, DIABETOLOGIA, V53, P268, DOI 10.1007/s00125-009-1600-8; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Rosario FJ, 2015, OBESITY, V23, P1663, DOI 10.1002/oby.21165; Rosario FJ, 2012, J PHYSIOL-LONDON, V590, P1495, DOI 10.1113/jphysiol.2011.226399; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Soheilykhah S, 2009, GYNECOL ENDOCRINOL, V25, P593, DOI 10.1080/09513590902972109; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Stocker C, 2004, INT J OBESITY, V28, P129, DOI 10.1038/sj.ijo.0802476; Stocker CJ, 2007, AM J PHYSIOL-REG I, V292, pR1810, DOI 10.1152/ajpregu.00676.2006; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Thorn SR, 2014, DIABETES, V63, P2702, DOI 10.2337/db14-0276; Thornburg KL, 2016, PLACENTA, V48, pS47, DOI 10.1016/j.placenta.2016.10.012; Tsai PJ, 2005, NUTRITION, V21, P1095, DOI 10.1016/j.nut.2005.03.008; Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112; Wang XM, 2007, INDIAN J PEDIATR, V74, P561, DOI 10.1007/s12098-007-0108-9; Wesolowski SR, 2017, NAT REV GASTRO HEPAT, V14, P81, DOI 10.1038/nrgastro.2016.160; YOGEV Y, 2010, AM J OBSTET GYNECOL, V202, pe1	57	18	18	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2899	2909		10.1096/fj.201801015R	http://dx.doi.org/10.1096/fj.201801015R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30346829	Green Published, Bronze			2022-12-26	WOS:000457296600109
J	Godbole, M; Togar, T; Patel, K; Dharavath, B; Yadav, N; Janjuha, S; Gardi, N; Tiwary, K; Terwadkar, P; Desai, S; Prasad, R; Dhamne, H; Karve, K; Salunkhe, S; Kawle, D; Chandrani, P; Dutt, S; Gupta, S; Badwe, RA; Dutt, A				Godbole, Mukul; Togar, Trupti; Patel, Kuldeep; Dharavath, Bhasker; Yadav, Neelima; Janjuha, Sharan; Gardi, Nilesh; Tiwary, Kanishka; Terwadkar, Prachi; Desai, Sanket; Prasad, Ratnam; Dhamne, Hemant; Karve, Kunal; Salunkhe, Sameer; Kawle, Dhananjay; Chandrani, Pratik; Dutt, Shilpee; Gupta, Sudeep; Badwe, Rajendra A.; Dutt, Amit			Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1-NDRG1 axis in both PR-positive and -negative breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						progesterone; breast cancer; functional genomics; cell signaling; microRNA (miRNA); N-Myc-downstream regulated gene 1 (NDRG1); post-transcriptional regulation; Serum- and glucocorticoid-regulated kinase 1 (SGK1); transcription factor AP-1	METASTASIS SUPPRESSOR NDRG1; GROWTH-STIMULATING FACTOR; PRIMARY TUMOR REMOVAL; READ ALIGNMENT; RECEPTOR; TRANSCRIPTION; SERUM; PROLIFERATION; PATHWAYS; PROSTATE	Preoperative progesterone intervention has been shown to confer a survival benefit to breast cancer patients independently of their progesterone receptor (PR) status. This observation raises the question how progesterone affects the outcome of PR-negative cancer. Here, using microarray and RNA-Seq-based gene expression profiling and ChIP-Seq analyses of breast cancer cells, we observed that the serum- and glucocorticoid-regulated kinase gene (SGK1) and the tumor metastasis-suppressor gene N-Myc downstream regulated gene 1 (NDRG1) are up-regulated and that the microRNAs miR-29a and miR-101-1 targeting the 3-UTR of SGK1 are down-regulated in response to progesterone. We further demonstrate a dual-phase transcriptional and post-transcriptional regulation of SGK1 in response to progesterone, leading to an up-regulation of NDRG1 that is mediated by a set of genes regulated by the transcription factor AP-1. We found that NDRG1, in turn, inactivates a set of kinases, impeding the invasion and migration of breast cancer cells. In summary, we propose a model for the mode of action of progesterone in breast cancer. This model helps decipher the molecular basis of observations in a randomized clinical trial of the effect of progesterone on breast cancer and has therefore the potential to improve the prognosis of breast cancer patients receiving preoperative progesterone treatment.	[Godbole, Mukul; Togar, Trupti; Patel, Kuldeep; Dharavath, Bhasker; Yadav, Neelima; Janjuha, Sharan; Gardi, Nilesh; Tiwary, Kanishka; Terwadkar, Prachi; Desai, Sanket; Prasad, Ratnam; Dhamne, Hemant; Karve, Kunal; Kawle, Dhananjay; Chandrani, Pratik; Dutt, Amit] Tata Mem Hosp, Tata Mem Ctr, Integrated Canc Genom Lab, Navi Mumbai 410210, Maharashtra, India; [Salunkhe, Sameer; Dutt, Shilpee] Tata Mem Hosp, Tata Mem Ctr, Shilpee Lab, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai 410210, Maharashtra, India; [Gupta, Sudeep] Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Navi Mumbai 410210, Maharashtra, India; [Badwe, Rajendra A.] Tata Mem Hosp, Tata Mem Ctr, Dept Surg Oncol, Navi Mumbai 410210, Maharashtra, India; [Godbole, Mukul; Togar, Trupti; Dharavath, Bhasker; Yadav, Neelima; Gardi, Nilesh; Desai, Sanket; Salunkhe, Sameer; Dutt, Shilpee; Dutt, Amit] Homi Bhabha Natl Inst, Training Sch Complex, Bombay 400094, Maharashtra, India	Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Homi Bhabha National Institute	Dutt, A (corresponding author), Tata Mem Hosp, Integrated Canc Genom Lab, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai 410210, Maharashtra, India.	adutt@actrec.gov.in	Dutt, Amit/I-1911-2013; Godbole, Mukul S./AAT-4330-2021; Chandrani, Pratik/AAV-9081-2021	Dutt, Amit/0000-0002-1119-4774; Godbole, Mukul S./0000-0003-0711-8696; Chandrani, Pratik/0000-0003-2572-0189; Janjuha, Sharan/0000-0002-5910-2912; Desai, Sanket/0000-0002-7929-8684; patel, kuldeep/0000-0003-4323-4264	Wellcome Trust/Department of Biotechnology India Alliance [IA/I/11/2500278]; Department of Biotechnology Grant [BT/MED/30/VNCI-Hr-RCA/2015]; Homi Bhabha National Institute (HBNI), ACTREC-TMC; intramural grants (IRB project) [2712]	Wellcome Trust/Department of Biotechnology India Alliance(Wellcome Trust DBT India Alliance); Department of Biotechnology Grant; Homi Bhabha National Institute (HBNI), ACTREC-TMC; intramural grants (IRB project)	This work was supported by Wellcome Trust/Department of Biotechnology India Alliance Grant IA/I/11/2500278 (to A. D.), intramural grants (IRB project 2712 to A. D.), and Department of Biotechnology Grant BT/MED/30/VNCI-Hr-RCA/2015 (to A. D.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a research fellowship from the Homi Bhabha National Institute (HBNI), ACTREC-TMC.	Azeez JM, 2015, DRUG DES DEV THER, V9, P5987, DOI 10.2147/DDDT.S89390; Badwe R, 2011, J CLIN ONCOL, V29, P2845, DOI 10.1200/JCO.2010.33.0738; Bandyopadhyay S, 2004, CANCER RES, V64, P7655, DOI 10.1158/0008-5472.CAN-04-1623; Bartlett JMS, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2604; Bethke A, 2009, SCIENCE, V324, P95, DOI 10.1126/science.1164899; Blaes J, 2014, J NEURO-ONCOL, V117, P25, DOI 10.1007/s11060-013-1357-2; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Catalanotto C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101712; Chatterjee S, 2018, BREAST CANCER RES TR, V170, P431, DOI 10.1007/s10549-018-4749-3; Cochrane DR, 2012, MOL CELL ENDOCRINOL, V355, P15, DOI 10.1016/j.mce.2011.12.020; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; FISHER B, 1989, CANCER RES, V49, P2002; FISHER B, 1989, CANCER RES, V49, P1996; Godbole M, 2017, CANCER BIOL THER, V18, P801, DOI 10.1080/15384047.2017.1373216; Godbole M, 2017, CELL ONCOL, V40, P411, DOI 10.1007/s13402-017-0330-z; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hahn MW, 2002, EVOL DEV, V4, P73, DOI 10.1046/j.1525-142X.2002.01069.x; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hosoya N, 2013, BBA-PROTEINS PROTEOM, V1834, P2630, DOI 10.1016/j.bbapap.2013.08.009; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Kondili M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02464-y; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma W, 2015, MOL MED REP, V12, P1050, DOI 10.3892/mmr.2015.3492; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Malet C, 2000, J STEROID BIOCHEM, V73, P171, DOI 10.1016/S0960-0760(00)00061-3; Mansley MK, 2010, BRIT J PHARMACOL, V161, P571, DOI 10.1111/j.1476-5381.2010.00898.x; Marzook H, 2017, ONCOGENE, V36, P5263, DOI 10.1038/onc.2017.19; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Menezes SV, 2017, J BIOL CHEM, V292, P12772, DOI 10.1074/jbc.R117.776393; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Need EF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1819-3; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Salnikow K, 2002, MOL CELL BIOL, V22, P1734, DOI 10.1128/MCB.22.6.1734-1741.2002; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Singhal H, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501924; Sun J, 2013, CARCINOGENESIS, V34, P1943, DOI 10.1093/carcin/bgt163; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Zhang P, 2007, CANCER RES, V67, P9125, DOI 10.1158/0008-5472.CAN-07-1525	47	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19263	19276		10.1074/jbc.RA118.002894	http://dx.doi.org/10.1074/jbc.RA118.002894			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30337371	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000453537300010
J	Zhang, JX; Chen, SR; Chen, H; Pan, HL				Zhang, Jixiang; Chen, Shao-Rui; Chen, Hong; Pan, Hui-Lin			RE1-silencing transcription factor controls the acute-to-chronic neuropathic pain transition and Chrm2 receptor gene expression in primary sensory neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD; HISTONE DEACETYLASE; ALZHEIMERS-DISEASE; GLUTAMATE RELEASE; UP-REGULATION; ANALGESIA; SUBTYPES; PROTEIN; REST; REPRESSION	Neuropathic pain is associated with persistent changes in gene expression in primary sensory neurons, but the underlying epigenetic mechanisms that cause these changes remain unclear. The muscarinic cholinergic receptors (mAChRs), particularly the M2 subtype (encoded by the cholinergic receptor muscarinic 2 (Chrm2) gene), are critically involved in the regulation of spinal nociceptive transmission. However, little is known about how Chrm2 expression is transcriptionally regulated. Here we show that nerve injury persistently increased the expression of RE1-silencing transcription factor (REST, also known as neuron-restrictive silencing factor [NRSF]), a gene-silencing transcription factor, in the dorsal root ganglion (DRG). Remarkably, nerve injury-induced chronic but not acute pain hypersensitivity was attenuated in mice with Rest knockout in DRG neurons. Also, siRNA-mediated Rest knockdown reversed nerve injury-induced chronic pain hypersensitivity in rats. Nerve injury persistently reduced Chrm2 expression in the DRG and diminished the analgesic effect of muscarine. The RE1 binding site on the Chrm2 promoter is required for REST-mediated Chrm2 repression, and nerve injury increased the enrichment of REST in the Chrm2 promoter in the DRG. Furthermore, Rest knockdown or genetic ablation in DRG neurons normalized Chrm2 expression and augmented muscarine's analgesic effect on neuropathic pain and fully reversed the nerve injury-induced reduction in the inhibitory effect of muscarine on glutamatergic input to spinal dorsal horn neurons. Our findings indicate that nerve injury-induced REST up-regulation in DRG neurons plays an important role in the acute-to-chronic pain transition and is essential for the transcriptional repression of Chrm2 in neuropathic pain.	[Zhang, Jixiang; Chen, Shao-Rui; Chen, Hong; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Zhang, Jixiang/T-9327-2019	Pan, Hui-Lin/0000-0001-8444-3770; Zhang, Jixiang/0000-0002-1641-8650	National Institutes of Health [GM120844, NS101880]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS101880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (GM120844 and NS101880) and by the N. G. and Helen T. Hawkins Endowment (to H.-L. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Cai YQ, 2009, J NEUROCHEM, V111, P1000, DOI 10.1111/j.1471-4159.2009.06396.x; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen JJ, 2018, CELL REP, V22, P2307, DOI 10.1016/j.celrep.2018.02.021; Chen SR, 2014, J BIOL CHEM, V289, P14321, DOI 10.1074/jbc.M114.550384; Chen SR, 2005, J PHARMACOL EXP THER, V313, P765, DOI 10.1124/jpet.104.082537; Chen SR, 2004, NEUROSCIENCE, V125, P141, DOI 10.1016/j.neuroscience.2004.01.015; Chen SR, 2001, ANESTHESIOLOGY, V95, P525, DOI 10.1097/00000542-200108000-00039; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; da Silva S, 2011, P NATL ACAD SCI USA, V108, P3395, DOI 10.1073/pnas.1014411108; Duttaroy A, 2002, MOL PHARMACOL, V62, P1084, DOI 10.1124/mol.62.5.1084; FRANCEL PC, 1987, J NEUROCHEM, V48, P1624, DOI 10.1111/j.1471-4159.1987.tb05711.x; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Garriga J, 2018, J NEUROSCI, V38, P6090, DOI 10.1523/JNEUROSCI.2616-17.2018; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gonzalez-Castaneda RE, 2013, GENET MOL BIOL, V36, P28, DOI 10.1590/S1415-47572013000100005; Hood DD, 1997, J PHARMACOL EXP THER, V282, P86; Hoover DB, 1996, HISTOCHEM J, V28, P771, DOI 10.1007/BF02272150; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kohno T, 1999, J PHYSIOL-LONDON, V518, P803, DOI 10.1111/j.1469-7793.1999.0803p.x; Laedermann CJ, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-19; LANGE KW, 1992, J NEUROL, V239, P103, DOI 10.1007/BF00862983; Laumet G, 2015, NAT NEUROSCI, V18, P1746, DOI 10.1038/nn.4165; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; Li LY, 2016, CELL REP, V15, P1376, DOI 10.1016/j.celrep.2016.04.039; Luo MC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-29; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; MASH DC, 1985, SCIENCE, V228, P1115, DOI 10.1126/science.3992249; McClelland S, 2014, ELIFE, V3, DOI 10.7554/eLife.01267; Mieda M, 1997, J BIOL CHEM, V272, P5854, DOI 10.1074/jbc.272.9.5854; Mori N, 2002, NEUROBIOL AGING, V23, P255, DOI 10.1016/S0197-4580(01)00286-X; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Noh KM, 2012, P NATL ACAD SCI USA, V109, pE962, DOI 10.1073/pnas.1121568109; O'Hern PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.20752; Palm K, 1998, J NEUROSCI, V18, P1280; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; RINNE JO, 1989, BRAIN RES, V483, P402, DOI 10.1016/0006-8993(89)90188-1; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Rose K, 2011, PAIN, V152, P742, DOI 10.1016/j.pain.2010.12.028; Saffen D, 1999, LIFE SCI, V64, P479, DOI 10.1016/S0024-3205(98)00591-8; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Tian B, 2012, METHODS MOL BIOL, V809, P105, DOI 10.1007/978-1-61779-376-9_7; Uchida H, 2010, NEUROSCIENCE, V166, P1, DOI 10.1016/j.neuroscience.2009.12.021; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Wang L, 2018, J NEUROCHEM, V147, P526, DOI 10.1111/jnc.14588; Weng YL, 2017, NEURON, V94, P337, DOI 10.1016/j.neuron.2017.03.034; Wess J, 2004, ANNU REV PHARMACOL, V44, P423, DOI 10.1146/annurev.pharmtox.44.101802.121622; Wood IC, 1996, J BIOL CHEM, V271, P14221, DOI 10.1074/jbc.271.24.14221; Zhang HM, 2007, J NEUROPHYSIOL, V97, P102, DOI 10.1152/jn.00586.2006; Zhang YH, 2016, J BIOL CHEM, V291, P8475, DOI 10.1074/jbc.M115.711812; Zhang YH, 2015, J BIOL CHEM, V290, P14647, DOI 10.1074/jbc.M115.650218; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107; ZHUO M, 1991, PAIN, V46, P211, DOI 10.1016/0304-3959(91)90078-C; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	62	20	20	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19078	19091		10.1074/jbc.RA118.005846	http://dx.doi.org/10.1074/jbc.RA118.005846			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30327427	hybrid, Green Published			2022-12-26	WOS:000458467400021
J	Banger, K; Nafziger, ED; Wang, JM; Muhammad, U; Pittelkow, CM				Banger, Kamaljit; Nafziger, Emerson D.; Wang, Junming; Muhammad, Umar; Pittelkow, Cameron M.			Simulating nitrogen management impacts on maize production in the US Midwest	PLOS ONE			English	Article							CORN-SOYBEAN ROTATION; TEXAS HIGH-PLAINS; SUBSURFACE DRAINAGE; SPRING APPLICATION; NITRATE-NITROGEN; CROPPING SYSTEMS; USE EFFICIENCY; CLIMATE-CHANGE; WATER-QUALITY; MODEL	Nutrient loss reduction strategies have recently been developed in the U.S. Midwest to decrease the environmental footprint associated with nitrogen (N) fertilizer use. Although these strategies generally suggest decreasing N rates and shifting the timing of N application from fall to spring, the spatiotemporal impacts of these practices on maize yield and fertilizer N use efficiency (NUE, kg grain yield increase per kg N applied) have not been assessed at the watershed scale using crop simulation models. We simulated the effects of N fertilizer rate (0, 168, 190, 224 kg N ha(-1)) and application timing [fall-applied N (FN): 100% N applied on 1 December; spring-applied N (SN): 100% N applied 10 days before planting; split N: 66% N applied on 1 December + 34% N applied 10 days before planting] on maize grain yield (GY) across 3042 points in Illinois during 2011-2015 using the DSSAT-CERESMaize model. When simulations were scaled up to the watershed level, results suggest that increases in average maize GY for SN compared to FN occurred in years with higher than average winter rainfall (2011, 2013), whereas yields were similar (+/-4%) in 2012, 2014, and 2015. Accordingly, differences in NUE for SN compared to FN were small (0.0-1.4 kg GY/kg N) when cumulative winter rainfall was < 300 mm, but increased to 0.1-9.2 kg GY/kg N when winter rainfall was > 500 mm at both 168 kg N ha(-1) and 224 kg N ha(-1). The combined practice of reducing N fertilizer amounts from 224 kg N ha(-1) to 190 kg N ha' andshifting from FN to SN resulted in a wide range of yield responses during 2011-2015, with the probability of increasing yields varying from <10% to >70% of simulation points within a watershed. Positive impacts on both GY and NUE occurred in only 60% of simulations for this scenario, highlighting the challenge of simultaneously improving yield and NUE with a 15% N rate reduction in this region.	[Banger, Kamaljit; Nafziger, Emerson D.; Pittelkow, Cameron M.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Wang, Junming; Muhammad, Umar] Univ Illinois, Prairie Res Inst, Illinois State Water Survey, Climate & Atmospher Sci Sect, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; Illinois State Water Survey; University of Illinois System; University of Illinois Urbana-Champaign	Pittelkow, CM (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	cmpitt@illinois.edu		Pittelkow, Cameron/0000-0001-8654-9552	Illinois Nutrient Research and Education Council; National Institute of Food and Agriculture, US Department of Agriculture, Hatch project [ILLU-802-949]	Illinois Nutrient Research and Education Council; National Institute of Food and Agriculture, US Department of Agriculture, Hatch project	This study was supported by the Illinois Nutrient Research and Education Council and the National Institute of Food and Agriculture, US Department of Agriculture, Hatch project (No. ILLU-802-949).	Adhikari P, 2016, AGR WATER MANAGE, V164, P317, DOI 10.1016/j.agwat.2015.10.011; [Anonymous], 2013, FERT CONS STAT; Attia A, 2016, AGR WATER MANAGE, V165, P50, DOI 10.1016/j.agwat.2015.11.002; Attia A, 2015, SOIL SCI SOC AM J, V79, P1693, DOI 10.2136/sssaj2015.05.0200; Balkcom KS, 2003, J ENVIRON QUAL, V32, P1015, DOI 10.2134/jeq2003.1015; Banger K, SIMULATING SOIL NITR; Bannayan M, 2009, FIELD CROP RES, V111, P290, DOI 10.1016/j.fcr.2009.01.007; BOSWELL FC, 1974, AGRON J, V66, P374, DOI 10.2134/agronj1974.00021962006600030011x; Bouma J, 2001, AGR SYST, V70, P355, DOI 10.1016/S0308-521X(01)00051-8; BUNDY LG, 1986, J FERT ISSUES, V3, P99; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Ciampitti IA, 2014, AGRON J, V106, P2107, DOI 10.2134/agronj14.0025; Ciampitti IA, 2013, CROP SCI, V53, P366, DOI 10.2135/cropsci2012.07.0439; Ciampitti IA, 2012, FIELD CROP RES, V133, P48, DOI 10.1016/j.fcr.2012.03.008; Clay DE, 2004, J ENVIRON QUAL, V33, P338, DOI 10.2134/jeq2004.3380; Davis DM, 2000, J ENVIRON QUAL, V29, P1568, DOI 10.2134/jeq2000.00472425002900050026x; Decock C, 2014, ENVIRON SCI TECHNOL, V48, P4247, DOI 10.1021/es4055324; Ewing PM, 2015, ECOL SOC, V20, DOI 10.5751/ES-06767-200118; Fernandez F.G., 2009, ILLINOIS AGRONOMY HD, P113; Gabrielle B, 1996, SOIL SCI SOC AM J, V60, P142, DOI 10.2136/sssaj1996.03615995006000010023x; Gentry LE, 1998, AGR ECOSYST ENVIRON, V68, P85, DOI 10.1016/S0167-8809(97)00139-4; Gentry LE, 2014, J ENVIRON QUAL, V43, P1467, DOI 10.2134/jeq2013.12.0499; Gijsman AJ, 2002, AGRON J, V94, P462, DOI 10.2134/agronj2002.4620; Goolsby DA, 2001, HYDROL PROCESS, V15, P1209, DOI 10.1002/hyp.210; Hanson JD, 1998, AGR SYST, V57, P161, DOI 10.1016/S0308-521X(98)00002-X; He J, 2009, T ASABE, V52, P1907, DOI 10.13031/2013.29218; He JQ, 2012, AGR WATER MANAGE, V109, P61, DOI 10.1016/j.agwat.2012.02.007; Heiman P, 2012, AGR SYST, V106, P59, DOI 10.1016/j.agsy.2011.10.010; Hoben JP, 2011, GLOBAL CHANGE BIOL, V17, P1140, DOI 10.1111/j.1365-2486.2010.02349.x; INLRS, 2016, ILLINOIS NUTR LOSS R; INREC, 2016, ANN REPORT; INRS, 2014, IOW NUTR RED STRAT S; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Kadiyala MDM, 2015, SCI TOTAL ENVIRON, V521, P123, DOI 10.1016/j.scitotenv.2015.03.097; Keating BA, 2003, EUR J AGRON, V18, P267, DOI 10.1016/S1161-0301(02)00108-9; Kim KI, 2008, AGRON J, V100, P551, DOI 10.2134/agronj2007.0064; Ladha JK, 2005, ADV AGRON, V87, P85, DOI 10.1016/S0065-2113(05)87003-8; Lee EA, 2007, CROP SCI, V47, pS202, DOI 10.2135/cropsci2007.04.0010IPBS; Li ZT, 2015, NUTR CYCL AGROECOSYS, V101, P401, DOI 10.1007/s10705-015-9688-3; Liu HL, 2011, NUTR CYCL AGROECOSYS, V89, P313, DOI 10.1007/s10705-010-9396-y; LOAGUE K, 1991, Journal of Contaminant Hydrology, V7, P51, DOI 10.1016/0169-7722(91)90038-3; Lopez-Cedron FX, 2005, EUR J AGRON, V23, P89, DOI 10.1016/j.eja.2005.01.001; Minnesota Pollution Control Agency (MPCA), 2014, MINN NUTR RED STRAT; O'Neill PM, 2004, AGRON J, V96, P1660, DOI 10.2134/agronj2004.1660; PICKERING NB, 1994, AGRON J, V86, P332, DOI 10.2134/agronj1994.00021962008600020023x; Randall G.W., 1998, P 1998 WIS FERT AG P, P90; Randall GW, 2001, J ENVIRON QUAL, V30, P337, DOI 10.2134/jeq2001.302337x; Randall GW, 2005, J ENVIRON QUAL, V34, P590, DOI 10.2134/jeq2005.0590; Randall GW, 2005, AGRON J, V97, P472, DOI 10.2134/agronj2005.0472; Randall GW, 2003, J ENVIRON QUAL, V32, P1764, DOI 10.2134/jeq2003.1764; Ritchie J.T., 1998, UNDERSTANDING OPTION, V7; Ritchie J.T., 1998, CEREAL GROWTH DEV YI; Ritchie JT, 2003, AGRON J, V95, P4, DOI 10.2134/agronj2003.0004; Ritchie JT, 1993, GENETIC SPECIFIC DAT; Seligman N. G., 1981, Simulation of nitrogen behaviour of soil-plant systems., P192; Sindelar AJ, 2015, AGRON J, V107, P2241, DOI 10.2134/agronj15.0085; Soler CMT, 2007, EUR J AGRON, V27, P165, DOI 10.1016/j.eja.2007.03.002; Staff SS. Natural Resources Conservation Service United States Department of Agriculture, 2016, NATL VALUE ADDED LOO; Vetsch JA, 2004, AGRON J, V96, P502, DOI 10.2134/agronj2004.0502; Wang ZG, 2014, AGRON J, V106, P1243, DOI 10.2134/agronj13.0487; WELCH LF, 1971, AGRON J, V63, P119, DOI 10.2134/agronj1971.00021962006300010037x; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2; Wortmann CS, 2011, AGRON J, V103, P76, DOI 10.2134/agronj2010.0189	63	13	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0201825	10.1371/journal.pone.0201825	http://dx.doi.org/10.1371/journal.pone.0201825			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346957	Green Published, gold, Green Submitted			2022-12-26	WOS:000447938400002
J	Oliveira, JAD; Ribeiro, ALP; Ribeiro, DD; Nobre, V; Rocha, MOD; Martins, MAP				de Queiroz Oliveira, Joao Antonio; Pinho Ribeiro, Antonio Luiz; Ribeiro, Daniel Dias; Nobre, Vandack; da Costa Rocha, Manoel Otavio; Parreiras Martins, Maria Auxiliadora			Predictive ability of scores for bleeding risk in heart disease outpatients on warfarin in Brazil	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; ANTICOAGULANT; VALIDATION; THERAPY; PERFORMANCE; HEMORRHAGE; PREVENTION; THROMBOSIS; INTENSITY; EVENTS	Introduction Bleeding is a common complication in patients taking warfarin. We sought to compare the performance of nine prediction models for bleeding risk in warfarin-treated Brazilian outpatients. Methods The dataset was derived from a clinical trial conducted to evaluate the efficacy of an anticoagulation clinic at a public hospital in Brazil. Overall, 280 heart disease outpatients taking warfarin were enrolled. The prediction models OBRI, Kuijer et al., Kearon et al., HEM-ORR(2)HAGES, Shireman et al., RIETE, HAS-BLED, ATRIA and ORBIT were compared to evaluate the overall model performance by Nagelkerke's R-2 estimation, discriminative ability based on the concordance (c) statistic and calibration based on the Hosmer-Lemeshow goodness-of-fit statistic. The primary outcomes were the first episodes of major bleeding, clinically relevant non-major bleeding and non-major bleeding events within 12 months of follow-up. Results Major bleeding occurred in 14 participants (5.0%), clinically relevant non-major bleeding in 29 (10.4%), non-major bleeding in 154 (55.0%) and no bleeding at all in 115 (41.1%). Most participants with major bleeding had their risk misclassified. All the models showed low overall performance (R 2 0.6-9.3%) and poor discriminative ability for predicting major bleeding (c <0.7), except Shireman et al. and ORBIT models (c 0.725 and 0.719, respectively). Results were not better for predicting other bleedings. All models showed good calibration for major bleeding. Conclusions Only two models (Shireman et al. and ORBIT) showed at least acceptable performance in the prediction of major bleeding in warfarin-treated Brazilian patients. Accurate models warrant further investigation to be used in similar populations.	[de Queiroz Oliveira, Joao Antonio; Pinho Ribeiro, Antonio Luiz; Nobre, Vandack; da Costa Rocha, Manoel Otavio; Parreiras Martins, Maria Auxiliadora] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [de Queiroz Oliveira, Joao Antonio; Pinho Ribeiro, Antonio Luiz; Ribeiro, Daniel Dias; Nobre, Vandack; da Costa Rocha, Manoel Otavio; Parreiras Martins, Maria Auxiliadora] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil; [Parreiras Martins, Maria Auxiliadora] Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Martins, MAP (corresponding author), Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.; Martins, MAP (corresponding author), Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.; Martins, MAP (corresponding author), Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil.	auxiliadorapmartins@hotmail.com	Martins, Maria Auxiliadora P/I-6136-2018; Oliveira, João Antonio Queiroz/O-1999-2019; Rocha, Manoel Otávio C/H-4776-2013; Ribeiro, Daniel/AAD-1362-2020	Martins, Maria Auxiliadora P/0000-0002-5211-411X; Oliveira, João Antonio Queiroz/0000-0003-3116-4713; 	Pro - Reitoria de Pesquisa da Universidade Federal de Minas Gerais - PRPq UFMG; Programa de Pos-Graduacao em Infectologia e Medicina Tropical da Universidade Federal de Minas Gerais; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq	Pro - Reitoria de Pesquisa da Universidade Federal de Minas Gerais - PRPq UFMG; Programa de Pos-Graduacao em Infectologia e Medicina Tropical da Universidade Federal de Minas Gerais; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Pro - Reitoria de Pesquisa da Universidade Federal de Minas Gerais - PRPq UFMG; and was partially supported by the Programa de Pos-Graduacao em Infectologia e Medicina Tropical da Universidade Federal de Minas Gerais and by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Apostolakis S, 2012, J AM COLL CARDIOL, V60, P861, DOI 10.1016/j.jacc.2012.06.019; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; Burgess S, 2013, J THROMB HAEMOST, V11, P1647, DOI 10.1111/jth.12352; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Donze J, 2012, AM J MED, V125, P1095, DOI 10.1016/j.amjmed.2012.04.005; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Hosmer Jr DW, 2013, APPLIED LOGISTIC REG; Kaatz S, 2015, J THROMB HAEMOST, V13, P2119, DOI 10.1111/jth.13140; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kuijer PMM, 1999, ARCH INTERN MED, V159, P457, DOI 10.1001/archinte.159.5.457; LANDEFELD CS, 1987, AM J MED, V82, P703, DOI 10.1016/0002-9343(87)90004-0; LANDEFELD CS, 1989, AM J MED, V87, P144; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Martins MA, 2014, CIRCULATION, V130; O'Brien EC, 2015, EUR HEART J, V36, P3258, DOI 10.1093/eurheartj/ehv476; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Roldan V, 2013, CHEST, V143, P179, DOI 10.1378/chest.12-0608; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruiz-Gimenez N, 2008, THROMB HAEMOSTASIS, V100, P26, DOI 10.1160/TH08-03-0193; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; Shireman TI, 2006, CHEST, V130, P1390, DOI 10.1378/chest.130.5.1390; Wells PS, 2003, ARCH INTERN MED, V163, P917, DOI 10.1001/archinte.163.8.917	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205970	10.1371/journal.pone.0205970	http://dx.doi.org/10.1371/journal.pone.0205970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339702	Green Published, Green Submitted, gold			2022-12-26	WOS:000447761400029
J	Nora, RL; Sitompul, R; Bakker, M; Versnel, MA; Swagemakers, SMA; van der Spek, PJ; Susiyanti, M; Edwar, L; Sjamsoe, S; Singh, G; Handayani, RRD; Rothova, A; van Hagen, PM; Dik, WA				Nora, Rina La Distia; Sitompul, Ratna; Bakker, Marleen; Versnel, Marjan A.; Swagemakers, Sigrid M. A.; van der Spek, Peter J.; Susiyanti, Made; Edwar, Lukman; Sjamsoe, Soedarman; Singh, Gurmeet; Handayani, R. R. Diah; Rothova, Aniki; van Hagen, P. Martin; Dik, Willem A.			Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis?	PLOS ONE			English	Article							DENDRITIC CELL SUBSETS; TERTIARY EYE CENTER; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; OCULAR TUBERCULOSIS; AUTOIMMUNE-DISEASES; SJOGRENS-SYNDROME; SIGNATURE; INFLAMMATION; MONOCYTES	QuantiFERON-Gold TB (QFT)-positive patients with undetermined cause of uveitis are problematic in terms of whether to diagnose and treat them for tuberculosis (TB). Here, we investigated whether peripheral blood expression of type 1 interferon (IFN)-inducible genes may be of use to stratify QFT-positive patients with uveitis into groups of high versus low risk of having active TB-associated uveitis. We recruited all new uveitis patients in Cipto Mangunkusumo Hospital, Jakarta, Indonesia for one year. We included 12 patients with uveitis and clinically diagnosed active pulmonary TB, 58 QFT-positive patients with uveitis of unknown cause, 10 newly diagnosed sputum-positive active pulmonary TB patients without uveitis and 23 QFT-negative healthy controls. Expression of 35 type 1 IFN-inducible genes was measured in peripheral blood cells from active pulmonary TB patients without uveitis and healthy controls. Differentially expressed genes were identified and used for further clustering analyses of the uveitis groups. A type-1 IFN gene signature score was calculated and the optimal cut-off value for this score to differentiate active pulmonary TB from healthy controls was determined and applied to QFT-positive patients with uveitis of unknown cause. Ten type 1 IFN-inducible genes were differentially expressed between active pulmonary TB and healthy controls. Expression of these 10 genes in QFT-positive patients with uveitis of unknown cause revealed three groups: 1); patients resembling active pulmonary TB, 2); patients resembling healthy controls, and 3); patients displaying an in-between gene expression pattern. A type 1 IFN gene signature score >= 5.61 displayed high sensitivity (100%) and specificity (91%) for identification of active TB. Application of this score to QFT-positive patients with uveitis of unknown cause yielded two groups with expected different likelihood (high vs. low) of having active-TB uveitis, and therefore may be useful in clinical management decisions.	[Nora, Rina La Distia; Sitompul, Ratna; Susiyanti, Made; Edwar, Lukman; Sjamsoe, Soedarman] Univ Indonesia, Dept Ophthalmol, Jakarta, Indonesia; [Nora, Rina La Distia; Sitompul, Ratna; Susiyanti, Made; Edwar, Lukman; Sjamsoe, Soedarman; Singh, Gurmeet] Cipto Mangunkusumo Hosp Kirana, Jakarta, Indonesia; [Nora, Rina La Distia; Dik, Willem A.] Erasmus MC, Lab Med Immunol, Rotterdam, Netherlands; [Bakker, Marleen] Erasmus MC, Dept Pulm Dis, Rotterdam, Netherlands; [Versnel, Marjan A.; van Hagen, P. Martin; Dik, Willem A.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Swagemakers, Sigrid M. A.; van der Spek, Peter J.] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Swagemakers, Sigrid M. A.; van der Spek, Peter J.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Singh, Gurmeet] Univ Indonesia, Dept Internal Med, Respirol & Crit Illness Div, Jakarta, Indonesia; [Handayani, R. R. Diah] Persahabatan Hosp, Dept Pulmonol, Jakarta, Indonesia; [Rothova, Aniki] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [van Hagen, P. Martin] Erasmus MC, Dept Internal Med, Sect Clin Immunol, Rotterdam, Netherlands	University of Indonesia; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Indonesia; Persahabatan Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Nora, RL (corresponding author), Univ Indonesia, Dept Ophthalmol, Jakarta, Indonesia.; Nora, RL (corresponding author), Cipto Mangunkusumo Hosp Kirana, Jakarta, Indonesia.; Nora, RL (corresponding author), Erasmus MC, Lab Med Immunol, Rotterdam, Netherlands.	rina.ladistia@ui.ac.id	La Distia Nora, Rina/ABA-9940-2021	La Distia Nora, Rina/0000-0002-7026-5341; van der Spek, Peter/0000-0002-2203-0652	Indonesian Ministry of Research Technology and Higher Education; Global Research Initiative Program Universitas Indonesia (BOPTN UI) in the year 2014	Indonesian Ministry of Research Technology and Higher Education(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Global Research Initiative Program Universitas Indonesia (BOPTN UI) in the year 2014(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This project was funded by the Indonesian Ministry of Research Technology and Higher Education for Rina La Distia Nora's PhD program in Erasmus MC and was partially funded by the Global Research Initiative Program Universitas Indonesia (BOPTN UI) in the year 2014 to RS. This project also received internal support from Internal Medicine and Immunology Departments, Erasmus MC, for laboratory platform (equipment, reagents and consumables). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Brkic Z, 2016, ANN RHEUM DIS, V75, P1567, DOI 10.1136/annrheumdis-2015-207392; Brkic Z, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4499; Brkic Z, 2013, ANN RHEUM DIS, V72, P728, DOI 10.1136/annrheumdis-2012-201381; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Eloranta ML, 2013, ARTHRITIS RHEUM-US, V65, P853, DOI 10.1002/art.37821; Gineys R, 2011, AM J OPHTHALMOL, V152, P433, DOI 10.1016/j.ajo.2011.02.006; Gupta A, 2015, OCUL IMMUNOL INFLAMM, V23, P7, DOI 10.3109/09273948.2014.967358; Gupta V, 2010, HUM IMMUNOL, V71, P682, DOI 10.1016/j.humimm.2010.03.010; HELM CJ, 1993, SURV OPHTHALMOL, V38, P229, DOI 10.1016/0039-6257(93)90076-J; Indonesian Society of Respirology, 2011, DIAGN TREATM GUID TU; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; Lichtner M, 2006, CLIN EXP IMMUNOL, V143, P329, DOI 10.1111/j.1365-2249.2005.02994.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozza L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00324; Lu YB, 2017, MOL IMMUNOL, V91, P86, DOI 10.1016/j.molimm.2017.08.007; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Manandhar A, 2017, OCUL IMMUNOL INFLAMM, V25, pS54, DOI 10.3109/09273948.2016.1161804; Maria NI, 2014, ANN RHEUM DIS, V73, P1052, DOI 10.1136/annrheumdis-2012-202552; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Mourik BC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00294; Nora RL, 2018, EYE, V32, P546, DOI 10.1038/eye.2017.231; Nora RL, 2018, INVEST OPHTH VIS SCI, V59, P1384, DOI 10.1167/iovs.17-23246; Nora RL, 2014, AM J OPHTHALMOL, V157, P754, DOI 10.1016/j.ajo.2013.11.013; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Rao NA, 2006, ARCH OPHTHALMOL-CHIC, V124, P1777, DOI 10.1001/archopht.124.12.1777; Ronnblom L, 2013, CURR OPIN RHEUMATOL, V25, P248, DOI 10.1097/BOR.0b013e32835c7e32; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Singh Ramandeep, 2004, Indian Journal of Ophthalmology, V52, P121; The Directorate General of Disease Control and Environmental Health Ministry of Health Republic of Indonesia, 2014, NAT GUID TUB CONTR; Triasih R, 2015, TROP MED INT HEALTH, V20, P737, DOI 10.1111/tmi.12484; Vos AG, 2013, INT J INFECT DIS, V17, pE993, DOI 10.1016/j.ijid.2013.03.019; Win MZA, 2017, OCUL IMMUNOL INFLAMM, V25, pS69, DOI 10.3109/09273948.2015.1133839; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; Wroblewski KJ, 2011, OPHTHALMOLOGY, V118, P772, DOI 10.1016/j.ophtha.2010.08.011; Yeo TK, 2013, OCUL IMMUNOL INFLAMM, V21, P264, DOI 10.3109/09273948.2013.774424; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206073	10.1371/journal.pone.0206073	http://dx.doi.org/10.1371/journal.pone.0206073			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30336493	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300092
J	Perlaki, G; Molnar, D; Smeets, PAM; Ahrens, W; Wolters, M; Eiben, G; Lissner, L; Erhard, P; van Meer, F; Herrmann, M; Janszky, J; Orsi, G				Perlaki, Gabor; Molnar, Denes; Smeets, Paul A. M.; Ahrens, Wolfgang; Wolters, Maike; Eiben, Gabriele; Lissner, Lauren; Erhard, Peter; van Meer, Floor; Herrmann, Manfred; Janszky, Jozsef; Orsi, Gergely		I Family Consortium	Volumetric gray matter measures of amygdala and accumbens in childhood overweight/obesity	PLOS ONE			English	Article							BODY-MASS INDEX; VOXEL-BASED MORPHOMETRY; METABOLIC SYNDROME; REWARD-SYSTEM; HUMAN BRAIN; HIPPOCAMPAL VOLUMES; CORTICAL THICKNESS; OBESE ADOLESCENTS; NUCLEUS-ACCUMBENS; CHILDREN	Objectives Neuroimaging data suggest that pediatric overweight and obesity are associated with morphological alterations in gray matter (GM) brain structures, but previous studies using mainly voxel-based morphometry (VBM) showed inconsistent results. Here, we aimed to examine the relationship between youth obesity and the volume of predefined reward system structures using magnetic resonance (MR) volumetry. We also aimed to complement volumetry with VBM-style analysis. Methods Fifty-one Caucasian young subjects (32 females; mean age: 13.8 +/- 1.9, range: 10.2-16.5 years) were included. Subjects were selected from a subsample of the I. Family study examined in the Hungarian center. A T-1-weighted 1 mm(3) isotropic resolution image was acquired. Age- and sex-standardized body mass index (zBMI) was assessed at the day of MRI and similar to 1.89 years (mean +/- SD: 689 +/- 188 days) before the examination. Obesity related GM alterations were investigated using MR volumetry in five predefined brain structures presumed to play crucial roles in body weight regulation (hippocampus, amygdala, accumbens, caudate, putamen), as well as whole-brain and regional VBM. Results The volumes of accumbens and amygdala showed significant positive correlations with zBMI, while their GM densities were inversely related to zBMI. Voxel-based GM mass also showed significant negative correlation with zBMI when investigated in the predefined amygdala region, but this relationship was mediated by GM density. Conclusions Overweight/obesity related morphometric brain differences already seem to be present in children/adolescents. Our work highlights the disparity between volume and VBM-derived measures and that GM mass (combination of volume and density) is not informative in the context of obesity related volumetric changes. To better characterize the association between childhood obesity and GM morphometry, a combination of volumetric segmentation and VBM methods, as well as future longitudinal studies are necessary. Our results suggest that childhood obesity is associated with enlarged structural volumes, but decreased GM density in the reward system.	[Perlaki, Gabor; Janszky, Jozsef; Orsi, Gergely] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Perlaki, Gabor; Janszky, Jozsef; Orsi, Gergely] Univ Pecs, Med Sch, Dept Neurol, Pecs, Hungary; [Molnar, Denes] Univ Pecs, Med Sch, Dept Pediat, Pecs, Hungary; [Smeets, Paul A. M.; van Meer, Floor] Univ Utrecht, Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Smeets, Paul A. M.] Wageningen Univ & Res, Div Human Nutr, Wageningen, Netherlands; [Ahrens, Wolfgang; Wolters, Maike] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Eiben, Gabriele; Lissner, Lauren] Univ Gothenburg, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Eiben, Gabriele] Univ Skovde, Dept Biomed & Publ Hlth, Sch Hlth & Educ, Skovde, Sweden; [Erhard, Peter; Herrmann, Manfred] Univ Bremen, Ctr Cognit Sci, Bremen, Germany; [Erhard, Peter; Herrmann, Manfred] Univ Bremen, Dept Neuropsychol & Behav Neurobiol, Bremen, Germany	University of Pecs; University of Pecs; University of Pecs; Utrecht University; Utrecht University Medical Center; Wageningen University & Research; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Gothenburg; University of Skovde; University of Bremen; University of Bremen	Perlaki, G (corresponding author), MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary.; Perlaki, G (corresponding author), Univ Pecs, Med Sch, Dept Neurol, Pecs, Hungary.	petzinger.gabor@gmail.com	Smeets, Paul AM/B-7979-2010; Herrmann, Manfred/H-3931-2011; van Meer, Floor/S-3268-2018; Molnár, Dénes/AAB-6820-2022	Smeets, Paul AM/0000-0002-8695-9612; Herrmann, Manfred/0000-0003-1872-8406; van Meer, Floor/0000-0002-6804-4101; 	European Commission within the Seventh RTD Framework Programme [266044]; Hungarian Brain Research Program [2017-1.2.1-NKP-2017-00002, EFOP-3.6.2-16-2017-00008]; New National Excellence Program of the Ministry of Human Capacities [UNKP-17-4-I-PTE-76, UNKP-17-4-I-PTE-93]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences;  [PTE AOK-KA-2017-05];  [PTE AOK-KA-2017-06]	European Commission within the Seventh RTD Framework Programme; Hungarian Brain Research Program; New National Excellence Program of the Ministry of Human Capacities; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); ; 	This work was done as part of the I. Family Study (http://www.ifamilystudy.eu/). We gratefully acknowledge the financial support of the European Commission within the Seventh RTD Framework Programme Contract No. 266044. The study was supported by the Hungarian Brain Research Program (2017-1.2.1-NKP-2017-00002) government-based fund (http://www.agykutatas.com/) and EFOP-3.6.2-16-2017-00008, The role of neuro-inflammation in neurodegeneration: from molecules to clinics" (https://pte.hu/sites/pte.hu/files/files/Sajtoszoba/Sajtokozlemenyek/2017/sajtokozlemeny_idegtudomany_2017november.doc). G.P. was supported by the UNKP-17-4-I-PTE-76 New National Excellence Program of the Ministry of Human Capacities, the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, and PTE AOK-KA-2017-05. G.O. was supported by the UNKP-17-4-I-PTE-93 New National Excellence Program of the Ministry of Human Capacities, the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, and PTE AOK-KA-2017-06.	Acevedo BP, 2012, SOC COGN AFFECT NEUR, V7, P145, DOI 10.1093/scan/nsq092; Ahima RS, 2008, ENDOCRIN METAB CLIN, V37, P811, DOI 10.1016/j.ecl.2008.08.005; Ahrens W, 2017, INT J EPIDEMIOL, V46, P1394, DOI 10.1093/ije/dyw317; Ahrens W, 2014, INT J OBESITY, V38, pS4, DOI 10.1038/ijo.2014.130; Ahrens W, 2014, INT J OBESITY, V38, pS99, DOI 10.1038/ijo.2014.140; Allcock Darren M, 2009, Int J Pediatr Endocrinol, V2009, P108187, DOI 10.1155/2009/108187; Alonso-Alonso M, 2015, NUTR REV, V73, P296, DOI 10.1093/nutrit/nuv002; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bauer CCC, 2015, PEDIATR OBES, V10, P196, DOI 10.1111/ijpo.241; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Begg DP, 2013, NAT REV ENDOCRINOL, V9, P584, DOI 10.1038/nrendo.2013.136; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Chan Y. H., 2004, SMJ Singapore Medical Journal, V45, P55; Chung S, 2017, AM J NEURORADIOL, V38, P726, DOI 10.3174/ajnr.A5053; Clark KA, 2014, BRAIN, V137, P3136, DOI 10.1093/brain/awu229; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Coveleskie K, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2014.45; de Groot C, 2015, OBESITY, V23, P2118, DOI 10.1002/oby.21191; DICHIARA G, 1992, ANN NY ACAD SCI, V654, P207, DOI 10.1111/j.1749-6632.1992.tb25969.x; Dietrich A, 2016, INT J OBESITY, V40, P982, DOI 10.1038/ijo.2016.28; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Eriksson SH, 2009, J NEUROSCI METH, V181, P111, DOI 10.1016/j.jneumeth.2009.05.001; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fonseca H, 2009, INT J PEDIATR OBES, V4, P166, DOI 10.1080/17477160802464495; Friedemann C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4759; Gennatas ED, 2017, J NEUROSCI, V37, P5065, DOI 10.1523/JNEUROSCI.3550-16.2017; Guegan T, 2013, EUR NEUROPSYCHOPHARM, V23, P146, DOI 10.1016/j.euroneuro.2012.04.004; Gupta N, 2013, INDIAN J PEDIATR, V80, pS28, DOI 10.1007/s12098-012-0923-5; Gutierrez-Martos M, 2018, ADDICT BIOL, V23, P735, DOI 10.1111/adb.12541; Hajnal A, 2001, BRAIN RES, V904, P76, DOI 10.1016/S0006-8993(01)02451-9; Hannon TS, 2005, PEDIATRICS, V116, P473, DOI 10.1542/peds.2004-2536; Hashimoto T, 2015, DEV NEUROSCI-BASEL, V37, P153, DOI 10.1159/000370064; HERNANDEZ L, 1988, PHYSIOL BEHAV, V44, P599, DOI 10.1016/0031-9384(88)90324-1; Horstmann A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00058; Kennedy JT, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00413; l'Allemand-Jander D, 2010, INT J OBESITY, V34, pS32, DOI 10.1038/ijo.2010.237; LeDoux JE, 1999, COGNITIVE NEUROSCIEN, P1067; Liang J, 2014, INT J OBESITY, V38, P494, DOI 10.1038/ijo.2013.142; Lockwood-Estrin G, 2012, J NEUROSCI METH, V205, P182, DOI 10.1016/j.jneumeth.2011.12.014; Maayan L, 2011, OBESITY, V19, P1382, DOI 10.1038/oby.2011.15; Markowitsch HJ, 1998, BEHAV NEUROL, V11, P233; McCarthy CS, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00379; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Mehta S, 2012, AM J CLIN NUTR, V96, P989, DOI 10.3945/ajcn.112.042341; Mole TB, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw039; Moreno-Lopez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049185; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Nouwen A, 2017, NEUROIMAGE-CLIN, V16, P43, DOI 10.1016/j.nicl.2017.07.004; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Organisation for Economic Co-Operation and Development, 2014, OB UPD; Orsi G, 2011, BRAIN IMAGING BEHAV, V5, P149, DOI 10.1007/s11682-011-9119-2; Ou XW, 2015, J MAGN RESON IMAGING, V42, P1205, DOI 10.1002/jmri.24912; Perlaki G, 2014, NEUROSCI LETT, V570, P119, DOI 10.1016/j.neulet.2014.04.013; Petrovich GD, 2005, J NEUROSCI, V25, P8295, DOI 10.1523/JNEUROSCI.2480-05.2005; PFAUS JG, 1995, BRAIN RES, V693, P21, DOI 10.1016/0006-8993(95)00679-K; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Rapuano KM, 2017, P NATL ACAD SCI USA, V114, P160, DOI 10.1073/pnas.1605548113; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Schoemaker D, 2016, NEUROIMAGE, V129, P1, DOI 10.1016/j.neuroimage.2016.01.038; Scofield MD, 2014, NEUROSCIENTIST, V20, P610, DOI 10.1177/1073858413520347; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Srinivasan SR, 1996, METABOLISM, V45, P235, DOI 10.1016/S0026-0495(96)90060-8; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Phan TV, 2018, DEV COGN NEUROS-NETH, V33, P206, DOI 10.1016/j.dcn.2017.08.009; Tirsi A, 2013, OBESITY, V21, pE577, DOI 10.1002/oby.20450; van Bloemendaal L, 2014, DIABETES, V63, P4186, DOI 10.2337/db14-0849; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Widya RL, 2011, AM J CLIN NUTR, V93, P1190, DOI 10.3945/ajcn.110.006304; Wilson SJ, 2008, J ABNORM PSYCHOL, V117, P428, DOI 10.1037/0021-843X.117.2.428; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yau PL, 2014, OBESITY, V22, P1865, DOI 10.1002/oby.20801; Yau PL, 2012, PEDIATRICS, V130, pE856, DOI 10.1542/peds.2012-0324; Yokum S, 2017, OBESITY, V25, P401, DOI 10.1002/oby.21728	87	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205331	10.1371/journal.pone.0205331	http://dx.doi.org/10.1371/journal.pone.0205331			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335775	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000447701300027
J	Scheidler, AM; Kinnett-Hopkins, D; Learmonth, YC; Motl, R; Lopez-Ortiz, C				Scheidler, Andrew M.; Kinnett-Hopkins, Dominique; Learmonth, Yvonne C.; Motl, Robert; Lopez-Ortiz, Citlali			Targeted ballet program mitigates ataxia and improves balance in females with mild-to-moderate multiple sclerosis	PLOS ONE			English	Article							INTERNATIONAL COOPERATIVE ATAXIA; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; RATING-SCALE; MINI-BESTEST; DANCERS; EXERCISE; VALIDITY; ADULTS; COORDINATION	Background Multiple sclerosis (MS) is a disease of the central nervous system that causes ataxia and deficits in balance. Exercise-based therapies have been identified as integral to the recovery of motor function in MS, but few studies have investigated non-traditional movement interventions. We examined a targeted ballet program (TBP) designed to mitigate ataxia and improve balance in females with mild-to-moderate relapsing-remitting MS. Methods and findings Twelve females with mild-to-moderate disability due to MS were assessed for study eligibility for the study. Ten participants met the inclusion criteria. Two were lost to unrelated health complications. Eight participants completed the TBP. The TBP met twice a week for 60 minutes for 16 weeks. Assessments included (a) the International Cooperative Ataxia Rating Scale (ICARS), (b) the Mini-Balance Evaluations Systems Test (Mini-BESTest), (c) smoothness of movement during a five-meter walk, and (d) balance in a step to stand task before and after the TBP. There were no TBP-related adverse events. Single-tailed paired samples t-tests and Wilcoxon tests were conducted. Improvements were observed in ICARS (p = 7.11E-05), Mini-BESTest (p = 0.001), smoothness of movement in the left (p = 0.027) and right (p = 0.028) sides of the body, and balance in a step-to-stand task in the back (p = 0.025) direction. Results yielded 42% and 58% improvements in the mean Mini-BESTest and ICARS scores, respectively. Conclusions This study adds to current research by providing support for a TBP intervention targeting ataxia and balance in MS. The TBP was well tolerated, improved balance, and mitigated ataxia. Clinical improvements were larger than those of previous studies on physical rehabilitation in MS with similar outcome measures.	[Scheidler, Andrew M.; Kinnett-Hopkins, Dominique; Learmonth, Yvonne C.; Motl, Robert; Lopez-Ortiz, Citlali] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Lopez-Ortiz, Citlali] Joffrey Ballet Acad, Official Sch Joffrey Ballet, Chicago, IL 60601 USA; [Kinnett-Hopkins, Dominique] Northwestern Univ, Ctr Educ Hlth Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Learmonth, Yvonne C.] Murdoch Univ, Sch Psychol & Exercise Sci, Murdoch, WA, Australia; [Motl, Robert] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL USA	University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Feinberg School of Medicine; Murdoch University; University of Alabama System; University of Alabama Birmingham	Lopez-Ortiz, C (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.; Lopez-Ortiz, C (corresponding author), Joffrey Ballet Acad, Official Sch Joffrey Ballet, Chicago, IL 60601 USA.	lopezort@illinois.edu	Kinnett-Hopkins, Dominique/AAC-9255-2022	Lopez-Ortiz, Citlali/0000-0002-2969-3184; Kinnett-Hopkins, Dominique/0000-0003-1793-3977; Learmonth, Yvonne/0000-0002-4857-8480	National Multiple Sclerosis Society [PP3418]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	The National Multiple Sclerosis Society Pilot Grant #PP3418 funded this study http://www.nationalmssociety.org/ awarded to C.L-O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	America TCCo, 1991, GRAD LESS CLASS BALL; Arbib M. A., 2011, HDB PHYSL NERVOUS SY, P1449, DOI [DOI 10.1016/J.JPHYSPARIS.2008.03.001, 10.1002/cphy.cp010233]; Balasubramanian S, 2012, IEEE T BIO-MED ENG, V59, P2126, DOI 10.1109/TBME.2011.2179545; Blasing B, 2012, ACTA PSYCHOL, V139, P300, DOI 10.1016/j.actpsy.2011.12.005; dAvella A., 2015, FRONTIERS COMPUTATIO, V1, P8; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Godi M, 2013, PHYS THER, V93, P158, DOI 10.2522/ptj.20120171; Golomer E, 2000, INT J NEUROSCI, V105, P15, DOI 10.3109/00207450009003262; Gosney JL, 2007, FAM COMMUNITY HEALTH, V30, P144, DOI 10.1097/01.FCH.0000264411.20766.0c; Gunn H, 2015, ARCH PHYS MED REHAB, V96, P1898, DOI 10.1016/j.apmr.2015.05.018; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Heesen C, 2008, MULT SCLER, V14, P988, DOI 10.1177/1352458508088916; Hoff M, 2015, EUR J NEUROSCI, V41, P1475, DOI 10.1111/ejn.12899; Jola C, 2011, EXP BRAIN RES, V213, P257, DOI 10.1007/s00221-011-2743-7; Kiefer Adam W, 2013, J Dance Med Sci, V17, P126; Kilby MC, 2014, GAIT POSTURE, V40, P701, DOI 10.1016/j.gaitpost.2014.08.002; King L, 2013, PHYS THER, V93, P571, DOI 10.2522/ptj.2013.93.4.571; King LA, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/375419; Kraft GH, 1999, LANCET, V354, P2016, DOI 10.1016/S0140-6736(99)90035-1; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LaRocca NG, 2011, PATIENT, V4, P189, DOI 10.2165/11591150-000000000-00000; Latimer-Cheung AE, 2013, ARCH PHYS MED REHAB, V94, P1800, DOI 10.1016/j.apmr.2013.04.020; Latimer-Cheung AE, 2013, ARCH PHYS MED REHAB, V94, P1829, DOI 10.1016/j.apmr.2013.05.015; Lepelley MC, 2006, EXP BRAIN RES, V175, P321, DOI 10.1007/s00221-006-0552-1; Lopez-Ortiz C, 2013, SOC NEUR PROGR 43 AN; Lopez-Ortiz C, 2016, SAGE OPEN MED, V4, DOI 10.1177/2050312116670926; Lopez-Ortiz Citlali, 2012, Arts Health, V4, P39; Lublin FD, 2014, EUR NEUROL, V72, P1, DOI 10.1159/000367614; Mandelbaum R, 2016, DISABIL REHABIL, V38, P218, DOI 10.3109/09638288.2015.1035457; Saute JAM, 2012, CEREBELLUM, V11, P488, DOI 10.1007/s12311-011-0316-8; Motl RW, 2017, LANCET NEUROL, V16, P848, DOI 10.1016/S1474-4422(17)30281-8; Potter K, 2018, PHYSIOTHERAPY, V104, P142, DOI 10.1016/j.physio.2017.06.001; Ramsay JRE, 2001, CLIN REHABIL, V15, P324, DOI 10.1191/026921501666288152; RAo Dancing, 1984, CHILDRENS EXAMINATIO; Salci Y, 2017, MULT SCLER RELAT DIS, V18, P135, DOI 10.1016/j.msard.2017.09.032; Salgado R, 2010, AM J DANCE THER, V32, P53, DOI 10.1007/s10465-010-9087-x; Schmit JM, 2005, EXP BRAIN RES, V163, P370, DOI 10.1007/s00221-004-2185-6; Snook EM, 2009, NEUROREHAB NEURAL RE, V23, P108, DOI 10.1177/1545968308320641; Solomon SR, 2009, J MOD APPL STAT METH, V8, P448, DOI 10.22237/jmasm/1257034080; Sternad D, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00090; Tarakci E, 2013, CLIN REHABIL, V27, P813, DOI 10.1177/0269215513481047; Thullier F, 2004, NEUROSCI LETT, V369, P80, DOI 10.1016/j.neulet.2004.08.011; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Vaganova A., 1965, BASIC PRINCIPLES CLA; Winser S, 2017, ARCH PHYS MED REHAB, V98, P270, DOI 10.1016/j.apmr.2016.07.023; Woolard A., 1999, VICON 512 MANUAL VER; Zurawski J, 2018, AM J MED, V131, P464, DOI 10.1016/j.amjmed.2017.11.044	47	9	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205382	10.1371/journal.pone.0205382	http://dx.doi.org/10.1371/journal.pone.0205382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4KR	30335774	Green Submitted, gold, Green Published			2022-12-26	WOS:000447701300031
J	Polio, SR; Kundu, AN; Dougan, CE; Birch, NP; Aurian-Blajeni, DE; Schiffman, JD; Crosby, AJ; Peyton, SR				Polio, Samuel R.; Kundu, Aritra Nath; Dougan, Carey E.; Birch, Nathan P.; Aurian-Blajeni, D. Ezra; Schiffman, Jessica D.; Crosby, Alfred J.; Peyton, Shelly R.			Cross-platform mechanical characterization of lung tissue	PLOS ONE			English	Article							CAVITATION RHEOLOGY; PARENCHYMA; MODEL; ELASTOGRAPHY; HYDROGELS; SYSTEM	Published data on the mechanical strength and elasticity of lung tissue is widely variable, primarily due to differences in how testing was conducted across individual studies. This makes it extremely difficult to find a benchmark modulus of lung tissue when designing synthetic extracellular matrices (ECMs). To address this issue, we tested tissues from various areas of the lung using multiple characterization techniques, including micro-indentation, small amplitude oscillatory shear (SAOS), uniaxial tension, and cavitation rheology. We report the sample preparation required and data obtainable across these unique but complimentary methods to quantify the modulus of lung tissue. We highlight cavitation rheology as a new method, which can measure the modulus of intact tissue with precise spatial control, and reports a modulus on the length scale of typical tissue heterogeneities. Shear rheology, uniaxial, and indentation testing require heavy sample manipulation and destruction; however, cavitation rheology can be performed in situ across nearly all areas of the lung with minimal preparation. The Young's modulus of bulk lung tissue using micro-indentation (1.4 +/-0.4 kPa), SAOS (3.3+/-0.5 kPa), uniaxial testing (3.4+/-0.4 kPa), and cavitation rheology (6.1 +/-1.6 kPa) were within the same order of magnitude, with higher values consistently reported from cavitation, likely due to our ability to keep the tissue intact. Although cavitation rheology does not capture the non-linear strains revealed by uniaxial testing and SAOS, it provides an opportunity to measure mechanical characteristics of lung tissue on a microscale level on intact tissues. Overall, our study demonstrates that each technique has independent benefits, and each technique revealed unique mechanical features of lung tissue that can contribute to a deeper understanding of lung tissue mechanics.	[Polio, Samuel R.; Kundu, Aritra Nath; Dougan, Carey E.; Birch, Nathan P.; Aurian-Blajeni, D. Ezra; Schiffman, Jessica D.; Peyton, Shelly R.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA; [Crosby, Alfred J.] Univ Massachusetts, Polymer Sci & Engn Dept, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Peyton, SR (corresponding author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.	speyton@umass.edu		Dougan, Carey/0000-0002-2165-771X; Crosby, Alfred/0000-0001-8850-8869; Aurian-Blajeni, D. Ezra/0000-0001-8997-1732; Schiffman, Jessica/0000-0002-1265-5392	NIH New Innovator Award [1DP2CA186573-01]; NSF [DMR-1454806, DMR-1304724]; BRC award from the ONR [N00014-17-1-2056]; Pew Charitable Trusts; Barry and Afsaneh Siadat Faculty Development Award; Professor James M. Douglas Career Development Faculty Award; Armstrong Fund for Science; NATIONAL CANCER INSTITUTE [DP2CA186573] Funding Source: NIH RePORTER	NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); BRC award from the ONR; Pew Charitable Trusts; Barry and Afsaneh Siadat Faculty Development Award; Professor James M. Douglas Career Development Faculty Award; Armstrong Fund for Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	S. Polio, S. Peyton, and D. Aurian-Blajeni were funded by an NIH New Innovator Award (1DP2CA186573-01) and a grant from the NSF (DMR-1454806). C. Dougan, A. Crosby, and S. Peyton were supported by a BRC award from the ONR (N00014-17-1-2056). S. Peyton is a Pew Biomedical Scholar supported by the Pew Charitable Trusts, and was supported by a Barry and Afsaneh Siadat Faculty Development Award. N. Birch and J. Schiffman were partially supported by the Professor James M. Douglas Career Development Faculty Award and the Armstrong Fund for Science. A. Crosby was funded by a grant from the NSF (DMR-1304724).; We would like to acknowledge Mike Imburgia, Shruti Rattan, and Lauren Jansen for their help with uniaxial testing, micro-indentation, and cavitation rheology. Igor Kheyfets helped with preparing the protocols for cavitation testing. S. Polio, S. Peyton, and D. Aurian-Blajeni were funded by an NIH New Innovator Award (1DP2CA186573-01) and a grant from the NSF (DMR-1454806). C. Dougan, A. Crosby, and S. Peyton were supported by a BRC award from the ONR (N00014-17-1-2056). S. Peyton is a Pew Biomedical Scholar supported by the Pew Charitable Trusts, and was supported by a Barry and Afsaneh Siadat Faculty Development Award. N. Birch and J. Schiffman were partially supported by the Professor James M. Douglas Career Development Faculty Award and the Armstrong Fund for Science. A. Crosby was funded by a grant from the NSF (DMR-1304724).	Asano S, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13281; Black LD, 2008, BIOPHYS J, V94, P1916, DOI 10.1529/biophysj.107.107144; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; BUTLER JP, 1986, JPN J PHYSIOL, V36, P91, DOI 10.2170/jjphysiol.36.91; Chin MS, 2013, PLAST RECONSTR SURG, V131, p303E, DOI 10.1097/PRS.0b013e318278d79f; Cui J, 2011, SOFT MATTER, V7, P7827, DOI 10.1039/c1sm05340j; Dai ZJ, 2015, MED ENG PHYS, V37, P752, DOI 10.1016/j.medengphy.2015.05.003; GIBSON GJ, 1976, BRIT J DIS CHEST, V70, P143, DOI 10.1016/0007-0971(76)90027-9; Graham HK, 2010, MATRIX BIOL, V29, P254, DOI 10.1016/j.matbio.2010.01.008; Hutchens SB, 2014, SOFT MATTER, V10, P3679, DOI 10.1039/c3sm52689e; Ito S, 2005, J APPL PHYSIOL, V98, P503, DOI 10.1152/japplphysiol.00590.2004; Jansen LE, 2015, J MECH BEHAV BIOMED, V50, P299, DOI 10.1016/j.jmbbm.2015.06.023; Killion JA, 2011, J MECH BEHAV BIOMED, V4, P1219, DOI 10.1016/j.jmbbm.2011.04.004; Kundu S, 2009, SOFT MATTER, V5, P3963, DOI 10.1039/b909237d; Lai-Fook SJ, 2000, J APPL PHYSIOL, V89, P163, DOI 10.1152/jappl.2000.89.1.163; Litzlbauer HD, 2010, ANAT REC, V293, P1607, DOI 10.1002/ar.21161; Liu F, 2011, J MED CHEM, P1; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Luque T, 2013, ACTA BIOMATER, V9, P6852, DOI 10.1016/j.actbio.2013.02.044; Maksym GN, 1997, J APPL PHYSIOL, V82, P32, DOI 10.1152/jappl.1997.82.1.32; Mariappan YK, 2012, MAGN RESON MED, V67, P210, DOI 10.1002/mrm.22976; Nichols JE, 2013, TISSUE ENG PT A, V19, P2045, DOI [10.1089/ten.tea.2012.0250, 10.1089/ten.TEA.2012.0250]; Nonaka PN, 2014, J BIOMED MATER RES A, V102, P413, DOI 10.1002/jbm.a.34708; O'Neill JD, 2013, ANN THORAC SURG, V96, P1046, DOI 10.1016/j.athoracsur.2013.04.022; Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012; Shull KR, 1998, MACROMOL CHEM PHYS, V199, P489, DOI 10.1002/(SICI)1521-3935(19980401)199:4<489::AID-MACP489>3.3.CO;2-1; Sicard D, 2018, AM J PHYSIOL-LUNG C, V314, pL946, DOI 10.1152/ajplung.00415.2017; STAMENOVIC D, 1990, PHYSIOL REV, V70, P1117, DOI 10.1152/physrev.1990.70.4.1117; Suki B, 2005, J APPL PHYSIOL, V98, P1892, DOI 10.1152/japplphysiol.01087.2004; Suki B, 2008, RESP PHYSIOL NEUROBI, V163, P33, DOI 10.1016/j.resp.2008.03.015; Suki B, 2014, J CELL PHYSIOL, V229, P1134, DOI 10.1002/jcp.24600; Suki B, 2011, COMPR PHYSIOL, V1, P1317, DOI 10.1002/cphy.c100033; Zhang XM, 2016, ULTRASONICS, V71, P183, DOI 10.1016/j.ultras.2016.06.012; Zimberlin JA, 2007, SOFT MATTER, V3, P763, DOI 10.1039/b617050a; Zimberlin JA, 2010, J POLYM SCI POL PHYS, V48, P1423, DOI 10.1002/polb.21968	35	37	37	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204765	10.1371/journal.pone.0204765	http://dx.doi.org/10.1371/journal.pone.0204765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332434	Green Published, Green Submitted, gold			2022-12-26	WOS:000447638200032
J	Skelsey, P; Humphris, SN; Campbell, EJ; Toth, IK				Skelsey, Peter; Humphris, Sonia N.; Campbell, Emma J.; Toth, Ian K.			Threat of establishment of non-indigenous potato blackleg and tuber soft rot pathogens in Great Britain under climate change	PLOS ONE			English	Article							ERWINIA-CAROTOVORA; TEMPERATURE; MODEL; EPIDEMIOLOGY; INFECTION; DISEASE; GROWTH; PLANTS; PROTEIN; STRAIN	Potato blackleg and soft rot caused by Pectobacterium and Dickeya species are among the most significant bacterial diseases affecting potato production globally. In this study we estimate the impact of future temperatures on establishment of non-indigenous but confirmed Pectobacterium and Dickeya species in Great Britain (GB). The calculations are based on probabilistic climate change data and a model fitted to disease severity data from a controlled environment tuber assay with the dominant potato blackleg and soft rot-causing species in GB (P. atrosepticum), and three of the main causative agents in Europe (P. carotovorum subsp. brasiliense, P. parmentieri, Dickeya solani). Our aim was to investigate if the European strains could become stronger competitors in the GB potato ecosystem as the climate warms, on the basis of their aggressiveness in tubers at different temperatures. Principally, we found that the tissue macerating capacity of all four pathogens will increase in GB under all emissions scenarios. The predominant Pectobacterium and Dickeya species in Europe are able to cause disease in tubers under field conditions currently seen in GB but are not expected to become widely established in the future, at least on the basis of their aggressiveness in tubers relative to P. atrosepticum under GB conditions. Our key takehome messages are that the GB potato industry is well positioned to continue to thrive via current best management practices and continued reinforcement of existing legislation.	[Skelsey, Peter] James Hutton Inst, Informat & Computat Sci, Dundee, Scotland; [Humphris, Sonia N.; Campbell, Emma J.; Toth, Ian K.] James Hutton Inst, Cell & Mol Sci, Dundee, Scotland	James Hutton Institute; James Hutton Institute	Skelsey, P (corresponding author), James Hutton Inst, Informat & Computat Sci, Dundee, Scotland.	peter.skelsey@hutton.ac.uk	Skelsey, Peter/L-7786-2013	Skelsey, Peter/0000-0002-7316-1951	Rural and Environment Science and Analytical Services (RESAS) Division of the Scottish Government	Rural and Environment Science and Analytical Services (RESAS) Division of the Scottish Government	We (PS, SH, EC, IT) are grateful for financial support for this work in part from the Rural and Environment Science and Analytical Services (RESAS) Division of the Scottish Government under its Environmental Change and Food, Land and People Strategic Research Programmes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali HF, 2012, PAK J BOT, V44, P825; [Anonymous], 1989, P NATO ADV RES WORKS; [Anonymous], 2016, CLIMATE CHANGE RISK; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cahill G, 2010, RECENT FINDINGS DICK; Czajkowski R, 2011, PLANT PATHOL, V60, P999, DOI 10.1111/j.1365-3059.2011.02470.x; Czajkowski R, 2010, PHYTOPATHOLOGY, V100, P134, DOI 10.1094/PHYTO-100-2-0134; Czajkowski R, 2009, EUR J PLANT PATHOL, V125, P263, DOI 10.1007/s10658-009-9480-9; Davey T, 2016, IDENTIFICATION FACTO; de Haan EG, 2008, EUR J PLANT PATHOL, V122, P561, DOI 10.1007/s10658-008-9325-y; de Werra P, 2015, AGRARFORSCH SCHWEIZ+, V6, P256; du Raan S, 2016, EUR J PLANT PATHOL, V144, P361, DOI 10.1007/s10658-015-0773-x; Elphinstone J. G., 1987, TECHNICAL INFORM B, V21, P1; Elphinstone JG, 2018, MANAGING RISK BLACKL; Elphinstone JG, 2018, BLACKLEG SURVEY ENGL; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Guyader S, 2013, EUR J PLANT PATHOL, V136, P535, DOI 10.1007/s10658-013-0185-8; Kery M., 2010, INTRO WINBUGS ECOLOG; Knox DJW, 2010, CLIMATE CHANGE IMPAC; Laurent P, 2000, APPL ENVIRON MICROB, V66, P1538, DOI 10.1128/AEM.66.4.1538-1543.2000; Laurent P, 2001, BIOTECHNOL LETT, V23, P753, DOI 10.1023/A:1010392624650; Lewis CM, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0013-y; Lizaso JI, 2017, FIELD CROP RES, V214, P239, DOI 10.1016/j.fcr.2017.09.019; LOJKOWSKA E, 1994, AM POTATO J, V71, P99, DOI 10.1007/BF02849113; Magarey RD, 2005, PHYTOPATHOLOGY, V95, P92, DOI 10.1094/PHYTO-95-0092; MOLINA JJ, 1980, AM POTATO J, V57, P351, DOI 10.1007/BF02854325; MOLINA JJ, 1977, AM POTATO J, V54, P587, DOI 10.1007/BF02855286; Nykyri J, 2014, PLANT PATHOL, V63, P747, DOI 10.1111/ppa.12159; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P2388, DOI 10.1099/ijs.0.009258-0; PEROMBELON M C M, 1974, Potato Research, V17, P187, DOI 10.1007/BF02360386; PEROMBELON MCM, 1979, PHYTOPATHOLOGY, V69, P167, DOI 10.1094/Phyto-69-167; PEROMBELON MCM, 1980, ANNU REV PHYTOPATHOL, V18, P361, DOI 10.1146/annurev.py.18.090180.002045; PEROMBELON MCM, 1987, J APPL BACTERIOL, V63, P73, DOI 10.1111/j.1365-2672.1987.tb02420.x; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; PEROMBELON MCM, 1992, NETH J PLANT PATHOL, V98, P135, DOI 10.1007/BF01974480; Sjoblom S, 2008, MOL PLANT MICROBE IN, V21, P967, DOI 10.1094/MPMI-21-7-0967; Skelsey P, 2016, PLANT PATHOL, V65, P570, DOI 10.1111/ppa.12455; Smadja B, 2004, CAN J MICROBIOL, V50, P19, DOI 10.1139/W03-099; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Toth I, 2016, UPDATE POTATO COUNCI; Toth I, 2017, INVESTIGATING BIOL A; Toth IK, 2011, PLANT PATHOL, V60, P385, DOI 10.1111/j.1365-3059.2011.02427.x; Tsror L, 2013, PLANT PATHOL, V62, P1097, DOI 10.1111/ppa.12030; Tsror L, 2009, EUR J PLANT PATHOL, V123, P311, DOI 10.1007/s10658-008-9368-0; van der Wolf JM, 2017, PLANT PATHOL, V66, P571, DOI 10.1111/ppa.12600; van der Wolf JM, 2014, INT J SYST EVOL MICR, V64, P768, DOI 10.1099/ijs.0.052944-0; Viswanath K, 2017, CLIMATIC CHANGE, V142, P155, DOI 10.1007/s10584-017-1942-z; Yan WK, 1999, ANN BOT-LONDON, V84, P607, DOI 10.1006/anbo.1999.0955; YIN XY, 1995, AGR FOREST METEOROL, V77, P1, DOI 10.1016/0168-1923(95)02236-Q	50	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205711	10.1371/journal.pone.0205711	http://dx.doi.org/10.1371/journal.pone.0205711			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312341	Green Published, Green Submitted, gold			2022-12-26	WOS:000447427300049
J	Farrow, JM; Wells, G; Pesci, EC				Farrow, John M., III; Wells, Greg; Pesci, Everett C.			Desiccation tolerance in Acinetobacter baumannii is mediated by the two-component response regulator BfmR	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; BIOFILM FORMATION; ESCHERICHIA-COLI; STRESS TOLERANCE; SURVIVAL; OUTBREAK; CALCOACETICUS; SEQUENCE; SYSTEM; TEMPERATURE	For the opportunistic pathogen Acinetobacter baumannii, desiccation tolerance is thought to contribute significantly to the persistence of these bacteria in the healthcare environment. We investigated the ability of A. baumannii to survive rapid drying, and found that some strains exhibited a profoundly desiccation-resistant phenotype, characterized by the ability of a large proportion of cells to survive on a dry surface for an extended period of time. However, this phenotype was only displayed during the stationary phase of growth. Most interestingly, we found that drying resistance could be lost after extended cultivation in liquid medium. Genome sequencing of isolates that became drying-sensitive identified mutations in bfmR, which encodes a two-component response regulator that is important for A. baumannii virulence. Additionally, BfmR was necessary for the expression of stress-related proteins during stationary phase, and one of these, KatE, was important for long-term drying survival. These results suggested that BfmR may control stress responses, and we demonstrated that the Delta bfmR mutant was more sensitive to hydrogen peroxide, nutrient starvation, and increased osmolarity. We also found that cross-protection against drying could be stimulated by either starvation, which required BfmR, or increased osmolarity. These results imply that BfmR plays a role in controlling stress responses in A. baumannii which help protect cells during desiccation, and they provide a regulatory link between this organism's ability to persist in the environment and pathogenicity.	[Farrow, John M., III; Wells, Greg; Pesci, Everett C.] East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Pesci, EC (corresponding author), East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA.	pescie@ecu.edu		Farrow, John/0000-0003-1619-2388; Pesci, Everett/0000-0002-7490-7591				Aranda J, 2011, J BACTERIOL, V193, P3740, DOI 10.1128/JB.00389-11; Berleman JE, 2004, MICROBIOL-SGM, V150, P383, DOI 10.1099/mic.0.26846-0; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boll JM, 2015, MBIO, V6, DOI 10.1128/mBio.00478-15; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; Chapartegui-Gonzalez I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201961; Chen AI, 2018, ENVIRON MICROBIOL, V20, P1283, DOI 10.1111/1462-2920.14074; Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Draughn GL, 2018, J MOL BIOL, V430, P806, DOI 10.1016/j.jmb.2018.02.002; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Farrow JM, 2007, J BACTERIOL, V189, P3425, DOI 10.1128/JB.00209-07; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Gayoso CM, 2014, J PROTEOME RES, V13, P460, DOI 10.1021/pr400603f; Gebhardt MJ, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00066-17; Gebhardt MJ, 2015, MBIO, V6, DOI 10.1128/mBio.01660-15; Geisinger E, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007030; Geisinger E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004691; Giannouli M, 2013, BMC INFECT DIS, V13, DOI [10.1186/1471-2334-13-470, 10.1186/1471-2334-13-282]; Gruzdev N, 2011, APPL ENVIRON MICROB, V77, P1667, DOI 10.1128/AEM.02156-10; Harding CM, 2018, NAT REV MICROBIOL, V16, P91, DOI 10.1038/nrmicro.2017.148; Hengge R, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P251; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Jacobs AC, 2014, MBIO, V5, DOI 10.1128/mBio.01076-14; Jawad A, 1996, J CLIN MICROBIOL, V34, P2881, DOI 10.1128/JCM.34.12.2881-2887.1996; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Lebre PH, 2017, NAT REV MICROBIOL, V15, P285, DOI 10.1038/nrmicro.2017.16; LEMCKE RUTH M., 1959, Journal of Applied Bacteriology, V22, P253, DOI 10.1111/j.1365-2672.1959.tb00158.x; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liou ML, 2014, J MICROBIOL IMMUNOL, V47, P275, DOI 10.1016/j.jmii.2012.12.004; LOEWEN PC, 1985, ARCH BIOCHEM BIOPHYS, V243, P144, DOI 10.1016/0003-9861(85)90782-9; Moultrie Denise, 2011, AORN J, V94, P27, DOI 10.1016/j.aorn.2010.12.026; MULVEY MR, 1990, J BACTERIOL, V172, P6713, DOI 10.1128/jb.172.12.6713-6720.1990; Nocker A, 2012, J MICROBIOL METH, V90, P86, DOI 10.1016/j.mimet.2012.04.015; Oncul O, 2002, J HOSP INFECT, V51, P47, DOI 10.1053/jhin.2002.1205; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Russo TA, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00082-16; Scott P, 2007, CLIN INFECT DIS, V44, P1577, DOI 10.1086/518170; Ramirez MS, 2010, J CLIN MICROBIOL, V48, P1488, DOI 10.1128/JCM.01264-09; Stockwell VO, 2005, MICROBIOL-SGM, V151, P3001, DOI 10.1099/mic.0.28077-0; Sun DQ, 2016, LIFE SCI, V148, P31, DOI 10.1016/j.lfs.2016.02.015; Tipton KA, 2015, J BACTERIOL, V197, P2593, DOI 10.1128/JB.00188-15; Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0; Umland TC, 2012, MBIO, V3, DOI 10.1128/mBio.00113-12; Vriezen JAC, 2006, LETT APPL MICROBIOL, V42, P172, DOI 10.1111/j.1472-765X.2005.01808.x; Wang ND, 2014, MBIO, V5, DOI 10.1128/mBio.01163-14; Wang SH, 2003, J HOSP INFECT, V53, P97, DOI 10.1053/jhin.2002.1348; Wattam AR, 2017, NUCLEIC ACIDS RES, V45, pD535, DOI 10.1093/nar/gkw1017; Weber BS, 2015, P NATL ACAD SCI USA, V112, P9442, DOI 10.1073/pnas.1502966112; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; Wilks M, 2006, INFECT CONT HOSP EP, V27, P654, DOI 10.1086/507011; Wolfe J, 1999, CRYOBIOLOGY, V39, P103, DOI 10.1006/cryo.1999.2195; Wong D, 2017, CLIN MICROBIOL REV, V30, P409, DOI 10.1128/CMR.00058-16; Wright MS, 2017, MBIO, V8, DOI [10.1128/mBio.02193-16, 10.1128/mbio.02193-16]; Zeidler S, 2017, ENVIRON MICROBIOL, V19, P5088, DOI 10.1111/1462-2920.13987	61	43	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205638	10.1371/journal.pone.0205638	http://dx.doi.org/10.1371/journal.pone.0205638			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308034	Green Submitted, Green Published, gold			2022-12-26	WOS:000447173500111
J	Petric, T; Kiferle, C; Perata, P; Gonzali, S				Petric, Tina; Kiferle, Claudia; Perata, Pierdomenico; Gonzali, Silvia			Optimizing shelf life conditions for anthocyanin-rich tomatoes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; LOW-TEMPERATURE; FRUIT; BIOSYNTHESIS; ACCUMULATION; LYCOPENE; LIGHT; AFT; ARABIDOPSIS; FLAVONOIDS	Shelf life is the time a product can be stored without losing its qualitative characteristics. It represents one of the most critical quality traits for food products, particularly for fleshy fruits, including tomatoes. Tomatoes' shelf life is usually shortened due to fast over-ripening caused by several different factors, among which changes in temperature, respiration and pathogen exposure. Although tomatoes usually do not contain anthocyanins, varieties enriched in these antioxidant compounds have been recently developed. The anthocyanin-rich tomatoes have been shown to possess a significantly extended shelf life by delayed over-ripening and reduction of the susceptibility to certain pathogens. In the present work, we compared different conditions of postharvest storage of anthocyanin-rich tomato fruits with the aim to understand if the added value represented by the presence of the anthocyanins in the fruit peel can be affected in postharvest. For this purpose we used an anthocyanin-enriched tomato line derived from conventional breeding and took into consideration different light and temperature conditions, known to affect fruit physiology during postharvest as well as anthocyanin production. Several quality traits related to the fruit ripening were measured, including anthocyanin and carotenoid content, pH, titratable acidity and total soluble solids. In this way we identified that the most suitable fruit storage and postharvest anthocyanin accumulation were obtained through exposure to cool temperature (12 degrees C), particularly in the presence of light. Under these parameters, tomato fruits showed increased anthocyanin content and unchanged flavour-related features up to three weeks after harvesting.	[Petric, Tina; Kiferle, Claudia; Perata, Pierdomenico; Gonzali, Silvia] Scuola Super Sant Anna, PlantLab, Inst Life Sci, Pisa, Italy	Scuola Superiore Sant'Anna	Gonzali, S (corresponding author), Scuola Super Sant Anna, PlantLab, Inst Life Sci, Pisa, Italy.	s.gonzali@santannapisa.it	Perata, Pierdomenico/L-2253-2019; Kiferle, Claudia/AAI-7391-2020	Kiferle, Claudia/0000-0002-4881-7066; Gonzali, Silvia/0000-0003-3671-4999	Scuola Superiore Sant'Anna	Scuola Superiore Sant'Anna	This work was supported by Scuola Superiore Sant'Anna.	[Anonymous], 2009, 6 ISHS POSTH S; AOAC, 1995, OFFICIAL METHODS ANA, V16th; Azari R, 2010, BIOTECHNOL ADV, V28, P108, DOI 10.1016/j.biotechadv.2009.10.003; Baranska M, 2006, ANAL CHEM, V78, P8456, DOI 10.1021/ac061220j; Bassolino L, 2013, NEW PHYTOL, V200, P650, DOI 10.1111/nph.12524; Biehler E, 2010, J FOOD SCI, V75, pC55, DOI 10.1111/j.1750-3841.2009.01417.x; Biswas P, 2014, POSTHARVEST BIOL TEC, V87, P140, DOI 10.1016/j.postharvbio.2013.08.018; Boches P, 2007, HORTSCIENCE, V42, P856; Borghesi E, 2016, PLANT GROWTH REGUL, V80, P207, DOI 10.1007/s10725-016-0158-y; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Cao X, 2017, J EXP BOT, V68, P5745, DOI 10.1093/jxb/erx382; Colanero S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00830; Conesa MA, 2014, POSTHARVEST BIOL TEC, V93, P114, DOI 10.1016/j.postharvbio.2014.02.014; Fish WW, 2002, J FOOD COMPOS ANAL, V15, P309, DOI 10.1006/jfca.2002.1069; Gao YF, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0032-3; Georgiev C, 1972, REP TOMATO GENET COO, P10; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Giusti MM., 2005, HDB FOOD ANAL CHEM, P19, DOI DOI 10.1002/0471709085.CH18; Gonzali S, 2009, TRENDS PLANT SCI, V14, P237, DOI 10.1016/j.tplants.2009.02.001; Huan C, 2017, POSTHARVEST BIOL TEC, V126, P1, DOI 10.1016/j.postharvbio.2016.11.018; Javanmardi J, 2006, POSTHARVEST BIOL TEC, V41, P151, DOI 10.1016/j.postharvbio.2006.03.008; Ji K, 2014, J EXP BOT, V65, P5243, DOI 10.1093/jxb/eru288; Jimenez A, 2002, PLANTA, V214, P751, DOI 10.1007/s004250100667; Jones CM, 2003, J HERED, V94, P449, DOI 10.1093/jhered/esg093; Kadomura-Ishikawa Y, 2015, PLANTA, V241, P953, DOI 10.1007/s00425-014-2228-6; Kiferle C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136365; Klee HJ, 2013, TRENDS GENET, V29, P257, DOI 10.1016/j.tig.2012.12.003; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Kubota C, 2012, HORTSCIENCE, V47, P1698, DOI 10.21273/HORTSCI.47.12.1698; Lin-Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI 10.1111/j.1365-3040.2011.02316.x; Liu CN, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf8823; Liu CC, 2018, PLANT CELL ENVIRON, V41, P1762, DOI 10.1111/pce.13171; Liu LH, 2009, FOOD CHEM, V115, P495, DOI 10.1016/j.foodchem.2008.12.042; Luengwilai K., 2013, Journal of Stored Products and Postharvest Research, V4, P35; Maier A, 2013, PLANT J, V74, P638, DOI 10.1111/tpj.12153; Majidi H., 2011, Australian Journal of Basic and Applied Sciences, V5, P1723; Man YP, 2015, PHYSIOL PLANTARUM, V153, P565, DOI 10.1111/ppl.12263; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; Najera C, 2018, POSTHARVEST BIOL TEC, V145, P151, DOI 10.1016/j.postharvbio.2018.07.008; Pataro G, 2015, INNOV FOOD SCI EMERG, V30, P103, DOI 10.1016/j.ifset.2015.06.003; Paul V, 2010, J FOOD SCI TECH MYS, V47, P519, DOI 10.1007/s13197-010-0090-5; Povero G., 2011, THESIS; Povero G, 2011, J PLANT PHYSIOL, V168, P270, DOI 10.1016/j.jplph.2010.07.022; PRICE CL, 1995, J FOOD SCI, V60, P369, DOI 10.1111/j.1365-2621.1995.tb05675.x; Qiu ZK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151067; Rick C.M., 1968, REP TOMATO GENET COO, V18, P34; Schreiber G, 2012, THEOR APPL GENET, V124, P295, DOI 10.1007/s00122-011-1705-6; Scott J, 2012, PURPLE TOMATO DEBUTS; Tsuda T, 2012, MOL NUTR FOOD RES, V56, P159, DOI 10.1002/mnfr.201100526; Xie XB, 2012, PLANT CELL ENVIRON, V35, P1884, DOI 10.1111/j.1365-3040.2012.02523.x; Xu WJ, 2015, TRENDS PLANT SCI, V20, P176, DOI 10.1016/j.tplants.2014.12.001; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zhang Y, 2015, PLANT PHYSIOL, V169, P1568, DOI 10.1104/pp.15.00346; Zhang Y, 2013, CURR BIOL, V23, P1094, DOI 10.1016/j.cub.2013.04.072; Zoratti L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00534; Zuluaga DL, 2008, FUNCT PLANT BIOL, V35, P606, DOI 10.1071/FP08021	56	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205650	10.1371/journal.pone.0205650	http://dx.doi.org/10.1371/journal.pone.0205650			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308054	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500114
J	Tan, C; Hansen, MS; Cohen, G; Boyle, K; Yang, A; Rishu, A; Pinto, R; Adhikari, NKJ; Daneman, N				Tan, Charlie; Hansen, Mark S.; Cohen, Gideon; Boyle, Karl; Yang, Alvin; Rishu, Asgar; Pinto, Ruxandra; Adhikari, Neill K. J.; Daneman, Nick			Case conferences for infective endocarditis: A quality improvement initiative	PLOS ONE			English	Article							6-MONTH MORTALITY; VALVE SURGERY; MANAGEMENT; IMPACT; ASSOCIATION; DIAGNOSIS; ADULTS; RISK	Background A multidisciplinary approach has been recommended for the management of patients with infective endocarditis. We evaluated the impact of multidisciplinary case conferences on morbidity, mortality, and quality of care for these patients. Methods We conducted a quasi-experimental study of consecutive patients admitted for infective endocarditis before (2013/10/1-2015/10/12, n = 97) and after (2015/10/13-2017/11/30, n = 80) implementation of case conferences to discuss medical and surgical management. These occurred as face-to-face discussions or electronically (for non-complex patients), and included physicians from cardiac surgery, cardiology, critical care, infectious diseases and neurology. We assessed process-of-care and clinical outcomes, with the primary outcome being complications up to 90 days after hospital discharge. Results A case conference was held for 80/80 (100%) of patients in the post-intervention group. After the intervention, more patients received inpatient cardiology assessment (81.3% [post-intervention] vs. 63.9% [pre-intervention], p = 0.01), and more patients with definite infective endocarditis underwent cardiac surgery treatment (44.6% vs. 21.7%, p = 0.007). All pre-intervention and post-intervention patients received guideline-concordant antimicrobial therapy. There was no difference in rates of complications (40.0% vs. 51.5%, p = 0.13) or mortality up to 90 days after hospital discharge (26.3% vs. 17.5%, p = 0.20). In multivariable analyses, the intervention was not associated with differences in mortality (odds ratio 87, 95% confidence interval 0.88-3.99) or a composite measure of complications and mortality (odds ratio 0.86, 95% confidence interval 0.46-1.58). Conclusion We successfully implemented a standardized multidisciplinary case conference protocol for patients with infective endocarditis. This intervention had no detectable effect on complications or mortality.	[Tan, Charlie] London Hlth Sci Ctr, Dept Med, London, ON, Canada; [Hansen, Mark S.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Cardiol, Toronto, ON, Canada; [Cohen, Gideon] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Div Cardiac Surg, Toronto, ON, Canada; [Boyle, Karl] Beaumont Hosp, Div Neurol, Dublin, Ireland; [Yang, Alvin] Univ Toronto, Dept Med, Toronto, ON, Canada; [Rishu, Asgar; Pinto, Ruxandra] Sunnybrook Hlth Sci Ctr, Crit Care Res Unit, Toronto, ON, Canada; [Adhikari, Neill K. J.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada; [Adhikari, Neill K. J.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Daneman, Nick] Sunnybrook Res Inst, Toronto, ON, Canada; [Daneman, Nick] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Infect Dis, Toronto, ON, Canada; [Daneman, Nick] Inst Clin Evaluat Sci, Toronto, ON, Canada	London Health Sciences Centre; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Daneman, N (corresponding author), Sunnybrook Res Inst, Toronto, ON, Canada.; Daneman, N (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Infect Dis, Toronto, ON, Canada.; Daneman, N (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	nick.daneman@sunnybrook.ca		Yang, Alvin/0000-0001-9444-4304				Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Botelho-Nevers E, 2009, ARCH INTERN MED, V169, P1290, DOI 10.1001/archinternmed.2009.192; Cahill TJ, 2016, LANCET, V387, P882, DOI 10.1016/S0140-6736(15)00067-7; Carrasco-Chinchilla F, 2014, REV ESP CARDIOL, V67, P380, DOI [10.1016/j.rec.2013.09.010, 10.1016/j.recesp.2013.09.012]; Castillo JC, 2000, HEART, V83, P525, DOI 10.1136/heart.83.5.525; Chirillo F, 2013, AM J CARDIOL, V112, P1171, DOI 10.1016/j.amjcard.2013.05.060; Chu VH, 2015, CIRCULATION, V131, P131, DOI 10.1161/CIRCULATIONAHA.114.012461; Delahaye F, 2007, SCAND J INFECT DIS, V39, P849, DOI 10.1080/00365540701393088; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Hill EE, 2007, EUR HEART J, V28, P196, DOI 10.1093/eurheartj/ehl427; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Kang DH, 2012, NEW ENGL J MED, V366, P2466, DOI 10.1056/NEJMoa1112843; Kiefer T, 2011, JAMA-J AM MED ASSOC, V306, P2239, DOI 10.1001/jama.2011.1701; Kim DH, 2010, CIRCULATION, V122, pS17, DOI 10.1161/CIRCULATIONAHA.109.927665; Lalani T, 2013, JAMA INTERN MED, V173, P1495, DOI 10.1001/jamainternmed.2013.8203; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Narayanan MA, 2016, HEART, V102, P950, DOI 10.1136/heartjnl-2015-308589; Nomura A, 2010, EUR J CLIN MICROBIOL, V29, P1355, DOI 10.1007/s10096-010-1006-z; Park LP, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003016; Pericart L, 2016, ANN THORAC SURG, V102, P496, DOI 10.1016/j.athoracsur.2016.02.010; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Sy RW, 2011, EUR HEART J, V32, P2016, DOI 10.1093/eurheartj/ehp085; Tan C, 2016, INT J CARDIOL, V224, P162, DOI 10.1016/j.ijcard.2016.09.030; Tleyjeh IM, 2007, CIRCULATION, V115, P1721, DOI 10.1161/CIRCULATIONAHA.106.658831; Vikram HR, 2003, JAMA-J AM MED ASSOC, V290, P3207, DOI 10.1001/jama.290.24.3207	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205528	10.1371/journal.pone.0205528	http://dx.doi.org/10.1371/journal.pone.0205528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308071	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500097
J	Jiang, Q; Sun, BF; Liu, Q; Cai, M; Wu, RF; Wang, FQ; Yao, YX; Wang, YZ; Wang, XX				Jiang, Qin; Sun, Baofa; Liu, Qing; Cai, Min; Wu, Ruifan; Wang, Fengqin; Yao, Yongxi; Wang, Yizhen; Wang, Xinxia			MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m(6)A-YTHDF1-dependent mechanism	FASEB JOURNAL			English	Article						mRNA m(6)A; porcine model; intramuscular fat; meRIP-seq; longissimus dorsi muscle	ADIPOSE-TISSUE; NUCLEAR-RNA; FAT; OBESITY; ASSOCIATION; EXPRESSION; MUSCLE; GENES; TRANSLATION; PIG	Intramuscular fat is considered a potential factor that is associated with meat quality in animal production and insulin resistance in humans. N-6-methyladenosine (m(6)A) modification of mRNA plays an important role in regulating adipogenesis. However, the effects of m(6)A on the adipogenesis of intramuscular preadipocytes and associated mechanisms remain unknown. Here, we performed m(6)A sequencing to compare m(6)A methylome of the longissimus dorsi muscles (LDMs) between Landrace pigs (lean-type breed) and Jinhua pigs (obese-type breed with higher levels of intramuscular fat). Transcriptome-wide m(6)A profiling of porcine LDMs was highly conserved with humans and mice. Furthermore, we identified a unique methylated gene in Jinhua pigs named mitochondrial carrier homology 2 (MTCH2). The m(6)A levels of MTCH2 mRNA were reduced by introducing a synonymous mutation, and adipogenesis test results showed that the MTCH2 mutant was inferior with regard to adipogenesis compared with the MTCH2 wild-type. We then found that MTCH2 protein expression was positively associated with m(6)A levels, and an YTH domain family protein 1-RNA immunoprecipitation-quantitative PCR assay indicated that MTCH2 mRNA was a target of the YTH domain family protein 1. This study provides comprehensive m(6)A profiles of LDM transcriptomes in pigs and suggests an essential role for m(6)A modification of MTCH2 in intramuscular fat regulation.Jiang, Q., Sun, B., Liu, Q., Cai, M., Wu, R., Wang, F., Yao, Y., Wang, Y., Wang, X. MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m(6)A-YTHDF1-dependent mechanism.	[Jiang, Qin; Liu, Qing; Cai, Min; Wu, Ruifan; Wang, Fengqin; Yao, Yongxi; Wang, Yizhen; Wang, Xinxia] Zhejiang Univ, Coll Anim Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Sun, Baofa] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genom & Precis Med, Beijing, Peoples R China; [Wang, Fengqin; Wang, Yizhen; Wang, Xinxia] Minist Agr, Key Lab Anim Nutr & Feed Sci Eastern China, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Ministry of Agriculture & Rural Affairs	Wang, XX (corresponding author), Zhejiang Univ, Coll Anim Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	xinxiawang@zju.edu.cn	Wu, Ruifan/AHH-6097-2022; dong, wang/T-9093-2019	Wu, Ruifan/0000-0003-4917-5197; wang, yizhen/0000-0002-3908-7102	Special Fund for Cultivation and Breeding of New Transgenic Organism [2014ZX0800949B]; National Natural Science Foundation of China [31572413, 31630075]; Natural Science Foundation of Zhejiang Province [LZ17C1700001]	Special Fund for Cultivation and Breeding of New Transgenic Organism; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the Special Fund for Cultivation and Breeding of New Transgenic Organism (Grant 2014ZX0800949B), the National Natural Science Foundation of China (Grants 31572413 and 31630075), and the Natural Science Foundation of Zhejiang Province (Grant LZ17C1700001). The authors declare no conflicts of interest.	Bassols A, 2014, PROTEOM CLIN APPL, V8, P715, DOI 10.1002/prca.201300099; Bernhard F, 2013, DIABETOLOGIA, V56, P311, DOI 10.1007/s00125-012-2773-0; Buzaglo-Azriel L, 2016, CELL REP, V14, P1602, DOI 10.1016/j.celrep.2016.01.046; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Chen FF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102101; Dodson MV, 2010, J FOOD SCI, V75, pR1, DOI 10.1111/j.1750-3841.2009.01396.x; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Guo J, 2011, J ANIM SCI, V89, P185, DOI 10.2527/jas.2010-2983; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hilton TN, 2008, PHYS THER, V88, P1336, DOI 10.2522/ptj.20080079; Huang YZ, 2014, SCI REP-UK, V4, P1, DOI 10.1038/srep06546; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kulyte A, 2011, J CLIN ENDOCR METAB, V96, pE1661, DOI 10.1210/jc.2010-3050; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Luo GZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6630; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Peng Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122047; Rottiers V, 2017, OBESITY, V25, P616, DOI 10.1002/oby.21751; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Sodhi SS, 2014, MOL BIOL REP, V41, P6305, DOI 10.1007/s11033-014-3513-y; Sorci M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0843-z; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vettor R, 2009, AM J PHYSIOL-ENDOC M, V297, pE987, DOI 10.1152/ajpendo.00229.2009; Walters EM, 2017, LAB ANIMAL, V46, P167, DOI 10.1038/laban.1215; Wang HY, 2013, MOL BIOSYST, V9, P2154, DOI 10.1039/c3mb70084d; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang XX, 2018, INT J OBESITY, V42, P1912, DOI 10.1038/s41366-018-0027-z; Wang XX, 2015, BIOCHEM BIOPH RES CO, V459, P201, DOI 10.1016/j.bbrc.2015.02.048; Wang YD, 2017, BMC GENOMICS, V18, DOI [10.1186/s12864-017-4201-9, 10.1186/s12863-017-0550-2]; Wang Z., 2015, PLOS ONE, V12; Wang ZX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141138; Wu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053181; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Yamada T, 2010, J VET MED SCI, V72, P991, DOI 10.1292/jvms.10-0031; Zhang GH, 2014, BIOCHEM CELL BIOL, V92, P259, DOI 10.1139/bcb-2014-0019; Zhang SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep35063; Zhang T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172389; Zhao CZ, 2016, EXP CELL RES, V344, P11, DOI 10.1016/j.yexcr.2016.02.019; Zhao SM, 2012, GENET MOL BIOL, V35, P783, DOI 10.1590/S1415-47572012005000079; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	47	41	46	9	51	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2971	2981		10.1096/fj.201801393RRR	http://dx.doi.org/10.1096/fj.201801393RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30339471	Green Published			2022-12-26	WOS:000457296600114
J	Feng, Y; Liang, Y; Zhu, XW; Wang, MJ; Gui, Y; Lu, QM; Gu, MR; Xue, X; Sun, XL; He, WC; Yang, JW; Johnson, RL; Dai, CS				Feng, Ye; Liang, Yan; Zhu, Xingwen; Wang, Mingjie; Gui, Yuan; Lu, Qingmiao; Gu, Mengru; Xue, Xian; Sun, Xiaoli; He, Weichun; Yang, Junwei; Johnson, Randy L.; Dai, Chunsun			The signaling protein Wnt5a promotes TGF1-mediated macrophage polarization and kidney fibrosis by inducing the transcriptional regulators Yap/Taz	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; fibrosis; Wnt signaling; Hippo pathway; macrophage; cell signaling; macrophage polarization; transforming growth factor; Wnt5a; Yap; Taz	FIBROBLAST ACTIVATION; HIPPO PATHWAY; TAZ; YAP; CANCER; CONTRIBUTES; TARGET; INJURY; CELLS; STAT6	M2 macrophage polarization is known to underlie kidney fibrosis. We previously reported that most of the members of the Wnt family of signaling proteins are induced in fibrotic kidneys. Dysregulation of the signaling protein Wnt5a is associated with fibrosis, but little is known about the role of Wnt5a in regulating M2 macrophage activation that results in kidney fibrosis. Here, using murine Raw 264.7 cells and bone marrow-derived macrophages, we found that Wnt5a enhanced transforming growth factor 1 (TGF1)-induced macrophage M2 polarization as well as expression of the transcriptional regulators Yes-associated protein (Yap)/transcriptional coactivator with PDZ-binding motif (Taz). Verteporfin blockade of Yap/Taz inhibited both Wnt5a- and TGF1-induced macrophage M2 polarization. In mouse models of kidney fibrosis, shRNA-mediated knockdown of Wnt5a expression diminished kidney fibrosis, macrophage Yap/Taz expression, and M2 polarization. Moreover, genetic ablation of Taz in macrophages attenuated kidney fibrosis and macrophage M2 polarization in mice. Collectively, these results indicate that Wnt5a promotes kidney fibrosis by stimulating Yap/Taz-mediated macrophage M2 polarization.	[Feng, Ye; Liang, Yan; Zhu, Xingwen; Wang, Mingjie; Gui, Yuan; Lu, Qingmiao; Gu, Mengru; Xue, Xian; Sun, Xiaoli; He, Weichun; Yang, Junwei; Dai, Chunsun] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Nanjing Medical University; University of Texas System; UTMD Anderson Cancer Center	Dai, CS (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China.	daichunsun@njmu.edu.cn			National Science Foundation of China [81570611/H0503, 81770675/H0503]; Science Foundation of Jiangsu Province [BK20140048]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Jiangsu Province	This work was supported by National Science Foundation of China Grants 81570611/H0503 and 81770675/H0503 and Science Foundation of Jiangsu Province Grant BK20140048 (to C. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraityte A, 2017, J MOL MED, V95, P767, DOI 10.1007/s00109-017-1529-1; Anorga S, 2018, FASEB J, V32, P2644, DOI 10.1096/fj.201700722R; Bergenfelz C, 2012, J IMMUNOL, V188, P5448, DOI 10.4049/jimmunol.1103378; Clements M, 2016, J AM SOC NEPHROL, V27, P159, DOI 10.1681/ASN.2014111138; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Feng Y, 2018, J AM SOC NEPHROL, V29, P182, DOI 10.1681/ASN.2017040391; Fu V, 2017, CURR OPIN CELL BIOL, V49, P99, DOI 10.1016/j.ceb.2017.12.012; Gao B, 2012, CURR TOP DEV BIOL, V101, P263, DOI 10.1016/B978-0-12-394592-1.00008-9; Geng J, 2017, NAT IMMUNOL, V18, P800, DOI 10.1038/ni.3748; Huang YJ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0421-3; Kapoor N, 2015, J IMMUNOL, V194, P6011, DOI 10.4049/jimmunol.1402797; Kawakami T, 2013, J PATHOL, V229, P221, DOI 10.1002/path.4121; Li X, 2013, GENES CELLS, V18, P608, DOI 10.1111/gtc.12064; Liang M, 2017, J AM SOC NEPHROL, V28, P3277, DOI 10.1681/ASN.2015121354; Liang N, 2014, J EXP MED, V211, P2249, DOI 10.1084/jem.20140341; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Maiti G, 2012, P NATL ACAD SCI USA, V109, P16600, DOI 10.1073/pnas.1207789109; Martin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12502; Miranda MZ, 2017, J BIOL CHEM, V292, P14902, DOI 10.1074/jbc.M117.780502; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Naskar D, 2014, J IMMUNOL, V192, P4386, DOI 10.4049/jimmunol.1302817; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Piccolo V, 2017, NAT IMMUNOL, V18, P530, DOI 10.1038/ni.3710; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rashid ST, 2012, J PROTEOME RES, V11, P4052, DOI 10.1021/pr3000927; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Rydell-Tormanen K, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12727; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Tariq M, 2017, ACTA PHARMACOL SIN, V38, P1501, DOI 10.1038/aps.2017.124; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Wong JS, 2016, AM J PHYSIOL-RENAL, V311, pF241, DOI 10.1152/ajprenal.00500.2015; Xu J, 2016, CLIN SCI, V130, P349, DOI 10.1042/CS20150385; Zhao F, 2018, IMMUNITY, V48, P147, DOI 10.1016/j.immuni.2017.12.004; Zhao Y, 2014, J BIOL CHEM, V289, P21028, DOI 10.1074/jbc.M113.546523; Zhou D, 2017, J AM SOC NEPHROL, V28, P2322, DOI 10.1681/ASN.2016080902	44	67	72	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19290	19302		10.1074/jbc.RA118.005457	http://dx.doi.org/10.1074/jbc.RA118.005457			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30333225	hybrid, Green Published			2022-12-26	WOS:000453537300012
J	Paul, S; Ghosh, S; Mandal, S; Sau, S; Pal, M				Paul, Soumyadip; Ghosh, Suvranil; Mandal, Sukhendu; Sau, Subrata; Pal, Mahadeb			NRF2 transcriptionally activates the heat shock factor 1 promoter under oxidative stress and affects survival and migration potential of MCF7 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heat shock factor protein 1 (HSF1); Nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); gene regulation; oxidative stress; breast cancer; antioxidant response element; transcription factor; transcriptional regulation; heat shock factor 1; NRF2; heat shock response; arsenic stress	HEAT-SHOCK FACTOR-1; MESENCHYMAL TRANSITION; ANTIOXIDANT RESPONSE; MOLECULAR CHAPERONES; HEME OXYGENASE-1; HSF1; GENE; INDUCTION; EXPRESSION; MUTATIONS	Functional up-regulation of heat shock factor 1 (HSF1) activity through different posttranslational modifications has been implicated in the survival and proliferation of various cancers. It is increasingly recognized that the HSF1 gene is also up-regulated at the transcriptional level, a phenomenon correlated with poor prognosis for patients with different cancers, including breast cancer. Here, we analyzed the transcriptional up-regulation of HSF1 in human cells upon arsenite- or peroxide-induced oxidative stress. Sequential promoter truncation coupled with bioinformatics analysis revealed that this activation is mediated by two antioxidant response elements (AREs) located between 1707 and 1530 bp upstream of the transcription start site of the HSF1 gene. Using shRNA-mediated down-regulation, ChIP of NRF2, site-directed mutagenesis of the AREs, and DNase I footprinting of the HSF1 promoter, we confirmed that nuclear factor erythroid-derived 2-like 2 (NRF2, also known as NFE2L2) interacts with these AREs and up-regulates HSF1 expression. We also found that BRM/SWI2-related gene 1 (BRG1), a catalytic subunit of SWI2/SNF2-like chromatin remodeler, is involved in this process. We further show that NRF2-dependent HSF1 gene regulation plays a crucial role in cancer cell biology, as interference with NRF2-mediated HSF1 activation compromised survival, migration potential, and the epithelial-to-mesenchymal transition and autophagy in MCF7 breast cancer cells exposed to oxidative stress. Taken together, our findings unravel the mechanistic basis of HSF1 gene regulation in cancer cells and provide molecular evidence supporting a direct interaction between HSF1 and NRF2, critical regulators of two cytoprotective mechanisms exploited by cancer cells.	[Paul, Soumyadip; Ghosh, Suvranil; Pal, Mahadeb] Bose Inst, Div Mol Med, P1-12 CIT Scheme VIIM, Kolkata 700054, India; [Mandal, Sukhendu; Sau, Subrata] Bose Inst, Dept Biochem, P1-12 CIT Scheme VIIM, Kolkata 700054, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Pal, M (corresponding author), Bose Inst, Div Mol Med, P1-12 CIT Scheme VIIM, Kolkata 700054, India.	palmahadeb@gmail.com	Mandal, Sukhendu/AAX-6423-2021	Mandal, Sukhendu/0000-0002-7752-0982; GHOSH, SUVRANIL/0000-0002-0003-349X; Paul, Dr Soumyadip/0000-0001-5207-9425	Science and Engineering Research Board (SERB); Department of Biotechnology (DBT), Ministry of Science and Technology; Bose Institute plan program IV	Science and Engineering Research Board (SERB); Department of Biotechnology (DBT), Ministry of Science and Technology(Department of Biotechnology (DBT) India); Bose Institute plan program IV(Department of Science & Technology (India))	This work was supported by the Science and Engineering Research Board (SERB) and the Department of Biotechnology (DBT), Ministry of Science and Technology and Bose Institute plan program IV. The authors declare that they have no conflicts of interest with the contents of this article.	Almeida DV, 2010, FISH PHYSIOL BIOCHEM, V36, P347, DOI 10.1007/s10695-008-9299-x; Arfmann-Knubel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132978; Calderwood SK, 2012, CURR MOL MED, V12, P1102, DOI 10.2174/156652412803306675; Carey Michael F, 2013, Cold Spring Harb Protoc, V2013, P469, DOI 10.1101/pdb.prot074328; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai CK, 2012, J CELL PHYSIOL, V227, P2982, DOI 10.1002/jcp.24017; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Desai S, 2013, J BIOL CHEM, V288, P9165, DOI 10.1074/jbc.M112.422071; Dokladny K, 2015, AUTOPHAGY, V11, P200, DOI 10.1080/15548627.2015.1009776; Fang F, 2012, CANCER-AM CANCER SOC, V118, P1782, DOI 10.1002/cncr.26482; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gokmen-Polar Y, 2016, ONCOTARGET, V7, P84239, DOI 10.18632/oncotarget.12438; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Gugnoni M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.415; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hazra J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168165; Hensen SMM, 2013, BIOCHIMIE, V95, P1245, DOI 10.1016/j.biochi.2013.01.017; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Imhoff BR, 2010, CELL BIOL TOXICOL, V26, P541, DOI 10.1007/s10565-010-9162-6; Ishiwata J, 2012, INT J ONCOL, V40, P47, DOI 10.3892/ijo.2011.1178; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kimura M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706863200; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lau A, 2013, J BIOCHEM MOL TOXIC, V27, P99, DOI 10.1002/jbt.21463; Li J, 2017, TRENDS CELL BIOL, V27, P895, DOI 10.1016/j.tcb.2017.08.002; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Maines MD, 1996, BIOL REPROD, V54, P1070, DOI 10.1095/biolreprod54.5.1070; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Manda G, 2015, REDOX BIOL, V5, P347, DOI 10.1016/j.redox.2015.06.014; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; Meakin PJ, 2014, MOL CELL BIOL, V34, P3305, DOI [10.1128/MCB.00677-14, 10.1128/MCB.00677-1]; Moloney JN, 2018, SEMIN CELL DEV BIOL, V80, P50, DOI 10.1016/j.semcdb.2017.05.023; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Naidu SD, 2015, TRENDS PHARMACOL SCI, V36, P6, DOI 10.1016/j.tips.2014.10.011; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nelson VK, 2016, ONCOTARGET, V7, P78281, DOI 10.18632/oncotarget.12930; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; PRESTERA T, 1995, MOL MED, V1, P827, DOI 10.1007/BF03401897; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Sasi BK, 2014, J MOL BIOL, V426, P116, DOI 10.1016/j.jmb.2013.09.008; Sekine H, 2016, MOL CELL BIOL, V36, P407, DOI 10.1128/MCB.00785-15; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Taguchi K, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00085; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Thomson S, 2004, MOL CELL, V15, P585, DOI 10.1016/j.molcel.2004.08.002; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Wang XJ, 2007, TOXICOL APPL PHARM, V225, P206, DOI 10.1016/j.taap.2007.07.016; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; Yoo NJ, 2012, HISTOPATHOLOGY, V60, P943, DOI 10.1111/j.1365-2559.2012.04178.x; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06; Zhang LF, 2011, PROTEOMICS, V11, P4638, DOI 10.1002/pmic.201100242	71	27	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19303	19316		10.1074/jbc.RA118.003376	http://dx.doi.org/10.1074/jbc.RA118.003376			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30309986	hybrid, Green Published			2022-12-26	WOS:000453537300013
J	Camilleri, ET; Dudakovic, A; Riester, SM; Galeano-Garces, C; Paradise, CR; Bradley, EW; McGee-Lawrence, ME; Im, HJ; Karperien, M; Krych, AJ; Westendorf, JJ; Larson, AN; van Wijnen, AJ				Camilleri, Emily T.; Dudakovic, Amel; Riester, Scott M.; Galeano-Garces, Catalina; Paradise, Christopher R.; Bradley, Elizabeth W.; McGee-Lawrence, Meghan E.; Im, Hee-Jeong; Karperien, Marcel; Krych, Aaron J.; Westendorf, Jennifer J.; Larson, A. Noelle; van Wijnen, Andre J.			Loss of histone methyltransferase Ezh2 stimulates an osteogenic transcriptional program in chondrocytes but does not affect cartilage development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-FORMATION; SKELETAL GROWTH; CRE RECOMBINASE; DIFFERENTIATION; EXPRESSION; OSTEOARTHRITIS; PROLIFERATION; SPECIFICATION; INHIBITION; CHROMATIN	Ezh2 is a histone methyltransferase that suppresses osteoblast maturation and skeletal development. We evaluated the role of Ezh2 in chondrocyte lineage differentiation and endochondral ossification. Ezh2 was genetically inactivated in the mesenchymal, osteoblastic, and chondrocytic lineages in mice using the Prrx1-Cre, Osx1-Cre, and Col2a1-Cre drivers, respectively. WT and conditional knockout mice were phenotypically assessed by gross morphology, histology, and micro-CT imaging. Ezh2-deficient chondrocytes in micromass culture models were evaluated using RNA-Seq, histologic evaluation, and Western blotting. Aged mice with Ezh2 deficiency were also evaluated for premature development of osteoarthritis using radiographic analysis. Ezh2 deficiency in murine chondrocytes reduced bone density at 4 weeks of age but caused no other gross developmental effects. Knockdown of Ezh2 in chondrocyte micromass cultures resulted in a global reduction in trimethylation of histone 3 lysine 27 (H3K27me3) and altered differentiation in vitro. RNA-Seq analysis revealed enrichment of an osteogenic gene expression profile in Ezh2-deficient chondrocytes. Joint development proceeded normally in the absence of Ezh2 in chondrocytes without inducing excessive hypertrophy or premature osteoarthritis in vivo. In summary, loss of Ezh2 reduced H3K27me3 levels, increased the expression of osteogenic genes in chondrocytes, and resulted in a transient post-natal bone phenotype. Remarkably, Ezh2 activity is dispensable for normal chondrocyte maturation and endochondral ossification in vivo, even though it appears to have a critical role during early stages of mesenchymal lineage commitment.	[Camilleri, Emily T.; Dudakovic, Amel; Riester, Scott M.; Galeano-Garces, Catalina; Paradise, Christopher R.; Bradley, Elizabeth W.; Krych, Aaron J.; Westendorf, Jennifer J.; Larson, A. Noelle; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55901 USA; [Paradise, Christopher R.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55901 USA; [Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55901 USA; [McGee-Lawrence, Meghan E.] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Im, Hee-Jeong] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Karperien, Marcel] Univ Twente, Dept Dev BioEngn, NL-7522 NB Enschede, Netherlands; [Camilleri, Emily T.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Twente; University of Minnesota System; University of Minnesota Twin Cities	van Wijnen, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg, Med Sci Bldg,Rm 3-69,200 1st St SW, Rochester, MN 55905 USA.	vanwijnen.andre@mayo.edu	Larson, A. Noelle/AAC-7158-2019; van Wijnen, Andre J./AAG-3578-2019; Galeano-Garces, Catalina/I-9155-2019; Karperien, Marcel/R-3270-2018	van Wijnen, Andre J./0000-0002-4458-0946; Karperien, Marcel/0000-0003-0751-0604; Camilleri, Emily/0000-0001-8982-6770; Dudakovic, Amel/0000-0002-8850-3977; Krych, Aaron/0000-0003-3248-8007; Bradley, Elizabeth/0000-0002-8814-5524	National Institutes of Health [R01 AR049069, R03 AR066342, F32 AR066508, K01 AR065397, R01 AR068103]; Center for Regenerative Medicine at the Mayo Clinic and Mayo Graduate School (Clinical and Translational Sciences Track); Center for Clinical and Translational Science [UL1 TR000135]; NIAMS; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR066508, R03AR066342, R01AR049069, R01AR068103, K01AR065397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Regenerative Medicine at the Mayo Clinic and Mayo Graduate School (Clinical and Translational Sciences Track); Center for Clinical and Translational Science; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health Grants R01 AR049069 (to A. J. v. W.), R03 AR066342 (to A. N. L.), F32 AR066508 (to A. D.), K01 AR065397 (to E. W. B.), and R01 AR068103 (to J. J. W.) as well as by intramural grants from the Center for Regenerative Medicine at the Mayo Clinic and Mayo Graduate School (Clinical and Translational Sciences Track) and the Center for Clinical and Translational Science (UL1 TR000135). We also appreciate generous philanthropic support from William H. and Karen J. Eby and the charitable foundation in their name. A. J. K. is a paid consultant for Arthrex, Inc., and M. K. is a founder and chair holder of Hy2Care B.V. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Barter MJ, 2012, OSTEOARTHR CARTILAGE, V20, P339, DOI 10.1016/j.joca.2011.12.012; Bradley EW, 2015, PHYSIOL REV, V95, P1359, DOI 10.1152/physrev.00004.2015; Bradley EW, 2015, J BIOL CHEM, V290, P118, DOI 10.1074/jbc.M114.596247; Bradley EW, 2013, J BIOL CHEM, V288, P9572, DOI 10.1074/jbc.M112.423723; Camilleri ET, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0370-8; Caplan AI, 2016, J CELL PHYSIOL, V231, P1413, DOI 10.1002/jcp.25255; Carpio LR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf3273; Chen LW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29176; Cohen ASA, 2016, HUM MUTAT, V37, P301, DOI 10.1002/humu.22946; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Dudakovic A, 2018, J BIOL CHEM, V293, P12894, DOI 10.1074/jbc.RA118.002983; Dudakovic A, 2017, GENE, V609, P28, DOI 10.1016/j.gene.2017.01.019; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Dudakovic A, 2015, J CELL PHYSIOL, V230, P52, DOI 10.1002/jcp.24680; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Fang C, 2016, J IMMUNOL, V196, P4452, DOI 10.4049/jimmunol.1501466; Goldring MB, 2012, TRENDS MOL MED, V18, P109, DOI 10.1016/j.molmed.2011.11.005; Gordon JAR, 2015, BONE, V81, P739, DOI 10.1016/j.bone.2015.03.011; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hemming S, 2017, FASEB J, V31, P1011, DOI 10.1096/fj.201600748R; Hemming S, 2016, STEM CELLS DEV, V25, P909, DOI 10.1089/scd.2015.0384; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ideno H, 2013, GENE EXPR PATTERNS, V13, P84, DOI 10.1016/j.gep.2013.01.002; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Khani F, 2017, J CELL BIOCHEM, V118, P1262, DOI 10.1002/jcb.25787; Lawson KA, 2013, J BIOL CHEM, V288, P32119, DOI 10.1074/jbc.M113.473827; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lui JC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13685; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Meyer MB, 2016, J BIOL CHEM, V291, P17829, DOI 10.1074/jbc.M116.736538; Mirzamohammadi F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12047; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakatani T, 2016, BONE, V90, P142, DOI 10.1016/j.bone.2016.06.010; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Pike JW, 2015, BONE, V81, P757, DOI 10.1016/j.bone.2015.03.012; Riester SM, 2017, STEM CELL TRANSL MED, V6, P910, DOI 10.5966/sctm.2016-0097; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; Spaapen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058083; Wang HR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36988; Wu H, 2017, BBA-GENE REGUL MECH, V1860, P438, DOI 10.1016/j.bbagrm.2017.01.003; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180; Zhang F, 2015, J MOL CELL BIOL, V7, P23, DOI 10.1093/jmcb/mjv003	49	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19001	19011		10.1074/jbc.RA118.003909	http://dx.doi.org/10.1074/jbc.RA118.003909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30327434	Green Published, hybrid			2022-12-26	WOS:000458467400015
J	Cai, BY; Zhong, T; Chen, PZ; Fu, J; Jin, YB; Liu, YL; Huang, R; Tan, LJ				Cai, Baoyi; Zhong, Tian; Chen, Peizhou; Fu, Jia; Jin, Yuanbao; Liu, Yinglei; Huang, Ran; Tan, Lianjiang			Preparation, characterization and in vitro release study of drug-loaded sodium carboxy-methylcellulose/chitosan composite sponge	PLOS ONE			English	Article							CHITOSAN; CELLULOSE; ALGINATE; SUBSTITUTION; SCAFFOLDS; HYDROGELS	A sodium carboxy-methylcellulose (CMC)/chitosan (CS) composite sponge as drug carrier was prepared, and its structure and functions were investigated. Samples with different CMC/chitosan ratios and under different pH conditions were synthesized via a freeze-drying method. The microstructure of the dried sponges was analyzed by Scanning Electron Microscope (SEM). Molecule interactions between polymers were confirmed by Fourier transform infrared (FTIR) spectra and Thermal gravimetric analyze (TGA). The swelling degree, weight loss, in vitro drug release behavior and antibacterial property of the sponges were determined as well. The results showed that the CMC/chitosan ratio and the pH value significantly affected the appearance of the blending solution and the microstructure of the final product, and also affected the sponge's degradation behavior, drug-loading capacity and the antibacterial activity. Gentamicin (GEN) as a hydrophilic model drug was remarkably superior to the other two hydrophobic drugs, ibuprofen (IBU) and roxithromycin (ROX), with respect to in vitro releasing. Moreover, higher CMC content and lower pH value of the sponge were confirmed to lead a larger loading for GEN. The bacteriostatic experiment showed a strong antimicrobial ability of GEN-loaded sponges on inhibiting Escherichia coli.	[Cai, Baoyi; Zhong, Tian; Chen, Peizhou; Jin, Yuanbao; Liu, Yinglei] Jilin Univ, Zhuhai Coll, Sch Pharm & Food Sci, Zhuhai, Guangdong, Peoples R China; [Zhong, Tian; Huang, Ran; Tan, Lianjiang] Zhejiang Univ Taizhou, Res Inst, Dept Mat Technol & Engn, Taizhou, Zhejiang, Peoples R China; [Fu, Jia] Jilin Univ, Zhuhai Coll, Sch Hlth, Zhuhai, Guangdong, Peoples R China; [Huang, Ran] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China; [Huang, Ran] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China	Jilin University; Taizhou University; Jilin University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhong, T (corresponding author), Jilin Univ, Zhuhai Coll, Sch Pharm & Food Sci, Zhuhai, Guangdong, Peoples R China.; Zhong, T; Huang, R (corresponding author), Zhejiang Univ Taizhou, Res Inst, Dept Mat Technol & Engn, Taizhou, Zhejiang, Peoples R China.; Huang, R (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China.; Huang, R (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China.	zhongtiancc@foxmail.com; ranhuang84@outlook.com	Huang, Ran/AAL-8076-2020	Huang, Ran/0000-0001-7778-0920; Zhong, Tian/0000-0002-8319-9144	National Natural Science Foundation of China [11505110]; China Postdoctoral Science Foundation [2016M591666]; Shanghai Pujiang Talent Grant [16PJ1431900]; Innovation Project by the Education Bureau of Guangdong Province [2016KTSCX175]; Taizhou Municipal Science and Technology Program [1701GY15, 2017CLS01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Pujiang Talent Grant; Innovation Project by the Education Bureau of Guangdong Province; Taizhou Municipal Science and Technology Program	This work was supported by: National Natural Science Foundation of China (Grant No. 11505110) to RH (URL: http://www.nsfc.gov.cn/); China Postdoctoral Science Foundation (Grant No. 2016M591666) to RH (URL: http://jj.chinapostdoctor.org.cn/); Shanghai Pujiang Talent Grant (Grant No. 16PJ1431900) to RH (URL: N/A); Innovation Project by the Education Bureau of Guangdong Province (Grant No. 2016KTSCX175) to TZ (URL: N/A); Taizhou Municipal Science and Technology Program (Grant No. 1701GY15 to RH and 2017CLS01 to LT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admane P, 2017, INT J PHARMACEUT, V520, P284, DOI 10.1016/j.ijpharm.2017.01.071; Archana D, 2013, CARBOHYD POLYM, V95, P530, DOI 10.1016/j.carbpol.2013.03.034; Archana D, 2013, INT J BIOL MACROMOL, V57, P193, DOI 10.1016/j.ijbiomac.2013.03.002; Archana D., 2013, CHITOSAN PECTIN ALGI; Cai Z, 2009, J APPL POLYM SCI, V114, P288, DOI 10.1002/app.30456; Cai ZJ, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/3/035028; Chang CY, 2010, CARBOHYD POLYM, V82, P122, DOI 10.1016/j.carbpol.2010.04.033; Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002; Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X; Cui WX, 2001, CELL TRANSPLANT, V10, P499; Deng CM, 2007, CARBOHYD POLYM, V69, P583, DOI 10.1016/j.carbpol.2007.01.014; Dubey V, 2005, J MEMBRANE SCI, V251, P131, DOI 10.1016/j.memsci.2004.11.009; Ferro M, 2017, CARBOHYD POLYM, V169, P16, DOI 10.1016/j.carbpol.2017.03.097; Hu SH, 2007, J CONTROL RELEASE, V121, P181, DOI 10.1016/j.jconrel.2007.06.002; Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Kuhn KD, 2008, J PHARMACEUT BIOMED, V48, P612, DOI 10.1016/j.jpba.2008.05.041; Lai HL, 2003, INT J PHARMACEUT, V251, P175, DOI 10.1016/S0378-5173(02)00590-2; Lee YM, 2000, J PERIODONTOL, V71, P410, DOI 10.1902/jop.2000.71.3.410; Lv FB, 2014, CELLULOSE, V21, P4405, DOI 10.1007/s10570-014-0440-y; Mi FL, 2002, CARBOHYD POLYM, V48, P61, DOI 10.1016/S0144-8617(01)00212-0; Miculescu F, 2017, ACS SUSTAIN CHEM ENG, V5, P8491, DOI 10.1021/acssuschemeng.7b02314; Muhulet A, 2018, MATER TODAY ENERGY, V9, P154, DOI 10.1016/j.mtener.2018.05.002; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Novotna K, 2013, CELLULOSE, V20, P2263, DOI 10.1007/s10570-013-0006-4; Park YJ, 2000, BIOMATERIALS, V21, P153; Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X; SHALABY WSW, 1991, J CONTROL RELEASE, V16, P355, DOI 10.1016/0168-3659(91)90013-4; Thakur S, 2017, VACUUM, V146, P342, DOI 10.1016/j.vacuum.2017.08.011; Thakur VK, 2016, CARBOHYD POLYM, V146, P148, DOI 10.1016/j.carbpol.2016.03.030; Twu YK, 2003, CARBOHYD POLYM, V54, P425, DOI 10.1016/j.carbpol.2003.03.001; Wu YB, 2004, CARBOHYD POLYM, V57, P435, DOI 10.1016/j.carbpol.2004.05.013; Xiong XP, 2010, J MEMBRANE SCI, V363, P96, DOI 10.1016/j.memsci.2010.07.031	33	22	22	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0206275	10.1371/journal.pone.0206275	http://dx.doi.org/10.1371/journal.pone.0206275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346976	Green Published, gold, Green Submitted			2022-12-26	WOS:000447938400043
J	Hung, YH; Liu, SA; Wang, CC; Wang, CP; Jiang, RS; Wu, SH				Hung, Yu-Hsuan; Liu, Shih-An; Wang, Chen-Chi; Wang, Ching-Ping; Jiang, Rong-San; Wu, Shang-Heng			Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck	PLOS ONE			English	Article							LYMPH-NODE METASTASES; PRIMARY TUMORS; CANCER; SURVIVAL; CHEMOTHERAPY; CRITERIA	Background Treatment modality of unknown primary squamous cell carcinoma of the head and neck (SCCHN) remains controversial. Objectives To evaluate the treatment outcomes and prognostic factors of unknown primary SCCHN. Materials and methods Patients with unknown primary SCCHN from April 1995 to March 2013 were recruited retrospectively. Results Sixty-nine patients were enrolled. The median time of follow-up was 55.5 months. The 2-year loco-regional control rate of all the patients was 60.4%. Multivariate Cox regression analysis revealed that N3 stage, extracapsular spread, distant metastasis, and treatment modality were significantly associated with neck recurrence. The actuarial 5-year disease-specific survival rates of neck dissection, neck dissection plus adjuvant therapy, radiotherapy alone, and combined therapy were 80.0%, 61.7%, 33.3%, and 68.8%, respectively (p = 0.046). The 5-year disease-specific survival rates of N1/N2a, N2b/N2c, and N3 stage were 83.9%, 64.3%, and 36.7%, respectively (p = 0.013). Univariate regression analysis revealed that neck recurrence, supraclavicular node involvement, distant metastasis, N3 stage, and unhealthy lifestyle habits were correlated with disease-specific mortality, especially the first three parameters. Patient's occupation and comorbidity were not significantly correlated with survival. Conclusions Composite therapy is mandatory for advanced unknown primary SCCHN. Supraclavicular node involvement and unhealthy lifestyle habits, such as betel nut chewing, indicate a poor prognosis.	[Hung, Yu-Hsuan; Liu, Shih-An; Wang, Chen-Chi; Wang, Ching-Ping; Jiang, Rong-San; Wu, Shang-Heng] Taichung Vet Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taichung, Taiwan; [Liu, Shih-An; Wang, Chen-Chi] Natl Yang Ming Univ, Sch Med, Dept Otolaryngol, Taipei, Taiwan; [Wang, Chen-Chi; Wang, Ching-Ping; Jiang, Rong-San] Chung Shan Med Univ, Sch Speech Language Pathol & Audiol, Taichung, Taiwan; [Jiang, Rong-San] Chung Shan Med Univ, Sch Med, Taichung, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; Chung Shan Medical University	Wu, SH (corresponding author), Taichung Vet Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taichung, Taiwan.	entwsh@gmail.com						ABBRUZZESE JL, 1993, SEMIN ONCOL, V20, P238; Adams Jeff R, 2002, Asian J Surg, V25, P188, DOI 10.1016/S1015-9584(09)60172-X; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Briasoulis, 1997, Oncologist, V2, P142; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Chien CY, 2008, ORAL ONCOL, V44, P174, DOI 10.1016/j.oraloncology.2007.01.018; COMESS MS, 1957, SURG GYNECOL OBSTET, V104, P607; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Datema FR, 2010, HEAD NECK-J SCI SPEC, V32, P728, DOI 10.1002/hed.21245; DEBRAUD F, 1989, CANCER, V64, P510, DOI 10.1002/1097-0142(19890715)64:2<510::AID-CNCR2820640225>3.0.CO;2-2; Farshadpour F, 2011, HEAD NECK-J SCI SPEC, V33, P817, DOI 10.1002/hed.21549; FROST P, 1992, LANCET, V339, P1458, DOI 10.1016/0140-6736(92)92040-M; Grau C, 2000, RADIOTHER ONCOL, V55, P121, DOI 10.1016/S0167-8140(00)00172-9; Guntinas-Lichius O, 2006, ACTA OTO-LARYNGOL, V126, P536, DOI 10.1080/00016480500417304; Iganej S, 2002, HEAD NECK-J SCI SPEC, V24, P236, DOI 10.1002/hed.10017; Jensen DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110456; Jereczek-Fossa BA, 2004, CANCER TREAT REV, V30, P153, DOI 10.1016/j.ctrv.2003.10.001; Keller LM, 2014, HEAD NECK-J SCI SPEC, V36, P1677, DOI 10.1002/hed.23514; Kimura Y, 2008, AM J NEURORADIOL, V29, P1355, DOI 10.3174/ajnr.A1088; Patel RS, 2007, ARCH OTOLARYNGOL, V133, P1282, DOI 10.1001/archotol.133.12.1282; Petti S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078999, 10.1371/journal.pone.0073827]; VANDENBREKEL MWM, 1990, RADIOLOGY, V177, P379, DOI 10.1148/radiology.177.2.2217772	23	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205365	10.1371/journal.pone.0205365	http://dx.doi.org/10.1371/journal.pone.0205365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335795	Green Submitted, gold, Green Published			2022-12-26	WOS:000447701300029
J	Jiang, ZX; Xiu, CZ; Yang, J; Zhang, XJ; Liu, MH; Chen, XL; Liu, DC				Jiang, Zhenxia; Xiu, Cuizhen; Yang, Jun; Zhang, Xijiang; Liu, Minghua; Chen, Xinlong; Liu, Dianchang			HIV test uptake and related factors amongst heterosexual drug users in Shandong province, China	PLOS ONE			English	Article							CONTROLLED-TRIAL; INFECTION; METHAMPHETAMINE; TRANSMISSION; SEX	Background In China, the mode of HIV transmission and the types and routes of drug use have changed in the past decade. HIV testing amongst drug users needs further improvement. Methods Interviewer-administered questionnaires were used for data collection amongst 600 heterosexual drug users from the community and a municipal detention centre, where criminal suspects are supervised. Descriptive statistics, univariate analysis and multilevel logistic regression analysis were used to identify the factors associated with HIV testing amongst heterosexual drug users. All participants were screened HIV and sexually transmitted infections. Results Amongst 600 participants, 554 (92.3%) were methamphetamine users, and 155 (25.8%) underwent HIV testing in the past year. Multivariate analysis results revealed that drug users who were single (adjusted odds ratio(AOR) = 1.923, 95% confidence interval(CI) = 1.189-3.109), had less knowledge of HIV (AOR = 1.706, 95% CI = 1.074-2.711), used only one kind of drug (AOR = 2.649, 95% CI = 1.155-6.077), used drug via a non-injection route (AOR = 2.121, 95% CI = 1.103-4.078), did not receive free condoms (AOR = 2.307, 95% CI = 1.129-4.715) and who did not receive free publicity material from health workers in the past year (AOR = 2.828, 95% CI = 1.757-4.552) were less likely to undergo HIV testing. A total of 594 participants underwent HIV and syphilis screening in this survey. Amongst these participants, 2 (0.3%) were HIV antibody positive, and 88 (14.8%) showed positive results in both non-treponemal test (rapid plasma regain test) and treponemal test (Treponema pallidum particle agglutination test) for the first time. Conclusions The rate of HIV test uptake amongst heterosexual drug users in China remains low. Thus, more specific interventions are urgently needed to improve the utilisation of HIV testing amongst heterosexual drug users, particularly amongst non-injection drug users in China.	[Jiang, Zhenxia; Xiu, Cuizhen; Zhang, Xijiang; Liu, Minghua] Qingdao Municipal Ctr Dis Control & Prevent, Dept HIV STI Prevent & Control, Qingdao, Shandong, Peoples R China; [Yang, Jun] Jining Hosp Skin Dis Control & Prevent, Dept STI & Leprosy Prevent & Control, Jining, Shandong, Peoples R China; [Chen, Xinlong; Liu, Dianchang] Shandong Prov Inst Dermatol & Venereol, Dept STI & Leprosy Prevent & Control, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences	Liu, DC (corresponding author), Shandong Prov Inst Dermatol & Venereol, Dept STI & Leprosy Prevent & Control, Jinan, Shandong, Peoples R China.	dianchangliu@163.com			Shandong Provincial Key RD Plan [2018GSF118062]; Shandong Provincial Institute of Dermatology and Venereology; Qingdao Centers for Disease Control and Prevention	Shandong Provincial Key RD Plan; Shandong Provincial Institute of Dermatology and Venereology; Qingdao Centers for Disease Control and Prevention	This study was supported by the Shandong Provincial Key R&D Plan (2018GSF118062). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all participants for their contribution in data collection, and thank Shandong Provincial Institute of Dermatology and Venereology and Qingdao Centers for Disease Control and Prevention for supporting this survey.	Bernstein E, 2012, ACAD EMERG MED, V19, P386, DOI 10.1111/j.1553-2712.2012.01314.x; Chen HT, 2007, AIDS BEHAV, V11, P778, DOI 10.1007/s10461-007-9215-x; China national narcotics control commission office, 2017, 2017 REP DRUG CONTR; China national narcotics control commission office, 2005, 2005 REP DRUG CONTR; Du J, 2012, INT J INFECT DIS, V16, pE498, DOI 10.1016/j.ijid.2012.02.013; Fonner VA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001224.pub4; Grusky O, 2006, INT J STD AIDS, V17, P354, DOI 10.1258/095646206776790196; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Kyle TL, 2015, AIDS BEHAV, V19, P536, DOI 10.1007/s10461-014-0864-2; Liu DC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-30; Mansergh G, 2006, SEX TRANSM INFECT, V82, P131, DOI 10.1136/sti.2005.017129; Molitor F, 1998, WESTERN J MED, V168, P93; National Health and Family Planning Commission of the People's Republic of China, 2016, 2015 CHIN AIDS RESP; NCAIDS/ STD Chinese CDC, 6 OUT EV 10000 PEOPL; NCAIDS/ STD Chinese CDC, 2016, CHINESE J AIDS STD, V22, P585; Saw YM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002747; Shain RN, 1999, NEW ENGL J MED, V340, P93, DOI 10.1056/NEJM199901143400203; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; United Nations Office on Drugs and Crime (UNODC), 2018, WORLD DRUG REPORT 20; Wang L, 2015, ADDICTION, V110, P20, DOI 10.1111/add.12779; Xing JianNan, 2013, Disease Surveillance, V28, P823; Zhang, 2010, CHIN J DIS CONTROL P, V14, P300; Zhao YJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000534; Zhou L, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-23; Zhuang X, 2012, DRUG ALCOHOL DEPEN, V126, P286, DOI 10.1016/j.drugalcdep.2012.05.028	26	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0204489	10.1371/journal.pone.0204489	http://dx.doi.org/10.1371/journal.pone.0204489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335766	gold, Green Published, Green Submitted			2022-12-26	WOS:000447701300009
J	Neparaczki, E; Maroti, Z; Kalmar, T; Kocsy, K; Maar, K; Bihari, P; Nagy, I; Fothi, E; Pap, I; Kustar, A; Palfi, G; Rasko, I; Zink, A; Torok, T				Neparaczki, Endre; Maroti, Zoltan; Kalmar, Tibor; Kocsy, Klaudia; Maar, Kitti; Bihari, Peter; Nagy, Istvan; Fothi, Erzsebet; Pap, Ildiko; Kustar, Agnes; Palfi, Gyorgy; Rasko, Istvan; Zink, Albert; Torok, Tibor			Mitogenomic data indicate admixture components of Central-Inner Asian and Srubnaya origin in the conquering Hungarians	PLOS ONE			English	Article							CHROMOSOME HAPLOGROUP-N; EURASIAN ANCESTRY; GENOMES SUGGEST; POPULATION; ANCIENT; MTDNA; DIVERSITY; MIDDLE; PHYLOGEOGRAPHY; EUROPE	It has been widely accepted that the Finno-Ugric Hungarian language, originated from proto Uralic people, was brought into the Carpathian Basin by the conquering Hungarians. From the middle of the 19th century this view prevailed against the deep-rooted Hungarian Hun tradition, maintained in folk memory as well as in Hungarian and foreign written medieval sources, which claimed that Hungarians were kinsfolk of the Huns. In order to shed light on the genetic origin of the Conquerors we sequenced 102 mitogenomes from early Conqueror cemeteries and compared them to sequences of all available databases. We applied novel population genetic algorithms, named Shared Haplogroup Distance and MITOMIX, to reveal past admixture of maternal lineages. Our results show that the Conquerors assembled from various nomadic groups of the Eurasian steppe. Population genetic results indicate that they had closest connection to the Onogur-Bulgar ancestors of Volga Tatars. Phylogenetic results reveal that more than one third of the Conqueror maternal lineages were derived from Central-Inner Asia and their most probable ultimate sources were the Asian Scythians and Asian Huns, giving support to the Hungarian Hun tradition. The rest of the lineages most likely originated from the Bronze Age Potapovka-Poltavka-Srubnaya cultures of the Pontic-Caspian steppe. Available data imply that the Conquerors did not have a major contribution to the gene pool of the Carpathian Basin.	[Neparaczki, Endre; Kocsy, Klaudia; Maar, Kitti; Torok, Tibor] Univ Szeged, Dept Genet, Szeged, Hungary; [Maroti, Zoltan; Kalmar, Tibor] Univ Szeged, Dept Pediat, Szeged, Hungary; [Maroti, Zoltan; Kalmar, Tibor] Univ Szeged, Pediat Hlth Ctr, Szeged, Hungary; [Bihari, Peter; Nagy, Istvan] SeqOm Biotechnol Ltd, Morahalom, Hungary; [Nagy, Istvan] Biol Res Ctr, Inst Biochem, Szeged, Hungary; [Fothi, Erzsebet; Pap, Ildiko; Kustar, Agnes] Hungarian Nat Hist Museum, Dept Anthropol, Budapest, Hungary; [Palfi, Gyorgy] Univ Szeged, Dept Biol Anthropol, Szeged, Hungary; [Rasko, Istvan] Biol Res Ctr, Inst Genet, Szeged, Hungary; [Zink, Albert] EURAC, Inst Mummies & Iceman, Bolzano, Italy	Szeged University; Szeged University; Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; European Academy of Bozen-Bolzano	Torok, T (corresponding author), Univ Szeged, Dept Genet, Szeged, Hungary.	torokt@bio.u-szeged.hu	Zink, Albert/P-4024-2015; Neparáczki, Endre/L-8186-2018; Pálfi, György/AAL-7268-2020	Zink, Albert/0000-0002-1461-747X; Neparáczki, Endre/0000-0003-3466-0368; Pap, Ildiko/0000-0001-6601-1616; Maroti, Zoltan/0000-0002-0515-117X; Kalmar, Tibor/0000-0002-0419-2009	National Research, Development and Innovation Office [K-124350]; Bolyai Research Scholarship of the Hungarian Academy of Sciences; Avicennna Middle East Research Institute (GF/JSZF) [814/ 9/2015]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Avicennna Middle East Research Institute (GF/JSZF)	This work was supported by grants from the National Research, Development and Innovation Office (K-124350 to TT), Bolyai Research Scholarship of the Hungarian Academy of Sciences (to IN), and the Avicennna Middle East Research Institute (GF/JSZF, Award Number: 814/ 9/2015 to IR). The Bolyai Research Scholarship provided support in the form of salaries for one of the authors (IN). The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2013, P NATL ACAD SCI USA, V110, P14308, DOI 10.1073/pnas.1306290110; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Anke B., 2007, ATTILA HUNNEN; Bakay K., 2002, AZ ARPADOK ORSZAGA O; Bakay K., 1997, OSTORTENETUNK REGESZ; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Becker R.A., 2018, MAPS DRAW GEOGRAPHIC; Bereczki Z, 2015, INT J OSTEOARCHAEOL, V25, P322, DOI 10.1002/oa.2304; Bermisheva MA, 2002, MOL BIOL+, V36, P802, DOI 10.1023/A:1021677708482; Biro A, 2015, FORENSIC SCI INT-GEN, V15, P121, DOI 10.1016/j.fsigen.2014.11.007; Bona I., 1993, HUNOK NAGYKIRALYAIK; Botalov SG, 2000, HUNNO SARMATIANS URA; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Budenz J., 1997, COMP DICT FINNO UGRI; Csanyi B, 2008, ANN HUM GENET, V72, P519, DOI 10.1111/j.1469-1809.2008.00440.x; Csosz A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33446; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; Derenko M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0217-9; Derenko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032179; Derenko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015214; Dreisziger N, 2013, HUNG CULT STUD, V6, P18, DOI 10.5195/ahea.2013.110; Egyed B, 2007, FORENSIC SCI INT-GEN, V1, P158, DOI 10.1016/j.fsigen.2007.03.001; Ery KK, 1994, HONFOGLALAS REGESZET, p[217, 291]; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fedorova SA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-127; Feher T, 2015, MOL GENET GENOMICS, V290, P377, DOI 10.1007/s00438-014-0925-2; Fothi E., 2006, A MAGYAR OSTORTENETI, P49; Fothi E., 2014, MAGYAR OSTORTENET TU, P151; Gerasimov M., 1971, THE FACE FINDER; Golden Peter B., 2011, STUDIES PEOPLES CULT; Gonzalez Fortes G, 2015, METHODS MOL BIOL, V1347, P179, DOI 10.1007/978-1-4939-2990-0_13; Gonzalez-Ruiz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048904; Grosheva AN, 2014, RUSS J GENET+, V50, P975, DOI 10.1134/S1022795414090063; Grousset R., 1970, EMPIRE STEPPES HIST; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Hollard C, 2014, FORENSIC SCI INT-GEN, V12, P199, DOI 10.1016/j.fsigen.2014.05.012; Homan B., 1925, MAGYAR HUN HAGYOMANY; Ilumae AM, 2016, AM J HUM GENET, V99, P163, DOI 10.1016/j.ajhg.2016.05.025; Ismagulov O., 1982, ETHNIC ANTHR KAZAKHS; JORDANOV J, 1988, ACTA NEUROCHIR, V92, P15, DOI 10.1007/BF01401967; Juhasz P., 2015, BELVEDERE MERIDIONAL, V27, P66, DOI [10.14232/belv.2015.3.7, DOI 10.14232/BELV.2015.3.7]; Juras A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43950; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kivisild T, 2015, INVESTIG GENET, V6, DOI 10.1186/s13323-015-0022-2; Kovacsics J., 1997, KOZPONTI STATISZTIKA; Kristo G., HUNGARIAN HIST 9 CEN; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kustar A., 1996, SAVARIA, V22, P179; Kustar A., 1996, MAGYARORSZAG HONFOGL, P395; Lahermo P, 2000, HEREDITAS, V132, P35, DOI 10.1111/j.1601-5223.2000.00035.x; Lalueza-Fox C, 2004, P ROY SOC B-BIOL SCI, V271, P941, DOI 10.1098/rspb.2004.2698; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Liptak P., 1983, AVARS ANCIENT HUNGAR; Liptak P., 1980, PHYS ANTHR EUROPEAN, P366; Llamas B, 2017, SCI TECHNOL ARCHAEOL, V3, P1, DOI 10.1080/20548923.2016.1258824; Malyarchuk B, 2010, MOL BIOL EVOL, V27, P2220, DOI 10.1093/molbev/msq065; Maroti Z., 2018, MITOMIX ALGORITHM RE, V13, P247395, DOI [10.1101/247395, DOI 10.1101/247395]; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Mittnik A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02825-9; Molodin V. I., 2012, POPULATION DYNAMICS, P93, DOI DOI 10.1515/9783110266306.93; Neparaczki E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174886; Neparaczki E, 2017, MOL GENET GENOMICS, V292, P201, DOI 10.1007/s00438-016-1267-z; Palanichamy MG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-304; Pamjav H, 2017, MOL GENET GENOMICS, V292, P883, DOI 10.1007/s00438-017-1319-z; Pankratov V, 2016, SCI REP-UK, V6, DOI 10.1038/srep30197; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pilipenko AS, 2018, ARCHAEOL ANTHROP SCI, V10, P1557, DOI 10.1007/s12520-017-0481-x; Pimenoff VN, 2008, EUR J HUM GENET, V16, P1254, DOI 10.1038/ejhg.2008.101; Pohl Walter, 2002, AWAREN STEPPENVOLK M; Posth C, 2016, CURR BIOL, V26, P827, DOI 10.1016/j.cub.2016.01.037; Prag J., 1997, MAKING FACES USING F; QGIS Development Team, 2015, QGIS GEOGR INF SYST; R Core Team, 2015, R LANG ENV STAT COMP, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Revesz L., 1996, KAROSI HONFOGLALASKO; Ricaut FX, 2004, HUM BIOL, V76, P109, DOI 10.1353/hub.2004.0025; Rogers L.L., 2016, BRONZE AGE IRON AGE; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Rohrer-Ertl O, GEGENBAURS MORPHOLOG, V130; Rona-Tas A., 2011, W OLD TURKIC TURKIC; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Runciman Steven., 1930, HIST 1 BULGARIAN EMP; Semino O, 2000, EUR J HUM GENET, V8, P339, DOI 10.1038/sj.ejhg.5200468; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066102; SLATKIN M, 1995, GENETICS, V139, P457; Stoljarova M, 2016, INT J LEGAL MED, V130, P67, DOI 10.1007/s00414-015-1249-4; Sugar Peter F., 1994, HIST HUNGARY; Szasz B., 1943, HUNOK TORTENETE ATTI; Szentpetery Imre, 1937, SCRIPTORES RERUM HUN; Taylor K.T., 2001, FORENSIC ART ILLUSTR; Tomory G, 2007, AM J PHYS ANTHROPOL, V134, P354, DOI 10.1002/ajpa.20677; Tumen D., 2008, MONGOLIAN J ANTHR AR, V4, P162; Turk A., 2009, AVARS BULGARS MAGYAR; Unterlander M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14615; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vianello D, 2013, HUM MUTAT, V34, P1189, DOI 10.1002/humu.22356; Volgyi A, 2009, FORENSIC SCI INT-GEN, V3, pE27, DOI 10.1016/j.fsigen.2008.04.006; Wong ENM, 2017, GENOME RES, V27, P1, DOI 10.1101/gr.202945.115	101	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205920	10.1371/journal.pone.0205920	http://dx.doi.org/10.1371/journal.pone.0205920			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335830	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000447701300075
J	Milano, S; Nehrke, G				Milano, Stefania; Nehrke, Gernot			Microstructures in relation to temperature-induced aragonite-to-calcite transformation in the marine gastropod Phorcus turbinatus	PLOS ONE			English	Article							ANISOTROPIC LATTICE-DISTORTIONS; MOLLUSK SHELL; MECHANICAL CHARACTERIZATION; ARCTICA-ISLANDICA; PHASE-CONTRAST; NACRE; IMPACT; GROWTH; CRYSTALLIZATION; RECONSTRUCTION	Mollusk shells represent important archives for paleoclimatic studies aiming to reconstruct environmental conditions at high temporal resolution. However, the shells, made of calcium carbonate in the form of aragonite and /or calcite, can be altered through time which may undermine the suitability for any reconstruction based on geochemical proxies (i.e., stable isotopes, radiocarbon). At present, the diagenetic processes involved in this chemical and physical deterioration are still poorly understood. The present study aims to shed light on the onset and development of diagenetic alteration in the aragonitic shell of Phorcus turbinatus. To artificially mimic diagenesis, shells of P. turbinatus were exposed to elevated temperatures. The transformation of the mineral phase was monitored by means of Confocal Raman Microscopy whereas the structural changes were investigated using Scanning Electron Microscopy and Atomic Force Microscopy. The results indicate that the two distinct shell layers (prismatic layer and nacre) respond differently to the elevated temperatures, suggesting that the different microstructural organization and organic content may drive the onset and spread of the aragonite-to-calcite transformation. Furthermore, changes in the microstructural arrangement became visible prior to the mineralogical transition. Our results demonstrate that the specific physico-chemical characteristics of structurally different areas within the biogenic carbonates have to be taken into account when studying the phase transformation occurring during diagenesis.	[Milano, Stefania] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Milano, Stefania; Nehrke, Gernot] Zentrum Polar & Meeresforsch, Alfred Wegener Inst Helmholtz, Bremerhaven, Germany	Max Planck Society; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Milano, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.; Milano, S (corresponding author), Zentrum Polar & Meeresforsch, Alfred Wegener Inst Helmholtz, Bremerhaven, Germany.	stefania_milano@eva.mpg.de		Milano, Stefania/0000-0002-7173-5819; Nehrke, Gernot/0000-0002-2851-3049	Alfred Wegener Institute for Polar and Marine Research	Alfred Wegener Institute for Polar and Marine Research(Helmholtz Association)	Funded by Alfred Wegener Institute for Polar and Marine Research.	Anderson GM, 2014, CHEM GEOL, V384, P10, DOI 10.1016/j.chemgeo.2014.06.020; Balmain J, 1999, J BIOMED MATER RES, V48, P749, DOI 10.1002/(SICI)1097-4636(1999)48:5<749::AID-JBM22>3.0.CO;2-P; Barthelat F, 2006, J MATER RES, V21, P1977, DOI 10.1557/JMR.2006.0239; Bhushan B, 2003, NANOTECHNOLOGY, V14, P886, DOI 10.1088/0957-4484/14/8/309; Bonadonna F, 1995, HOLOCENE, V5, P461, DOI 10.1177/095968369500500409; Bourrat X, 2007, CRYSTENGCOMM, V9, P1205, DOI 10.1039/b709388h; Colonese AC, 2009, J ARCHAEOL SCI, V36, P1935, DOI 10.1016/j.jas.2009.04.021; CARLSON WD, 1981, J GEOL, V89, P615, DOI 10.1086/628626; Carter J.G., 1985, University of Tennessee Department of Geological Sciences Studies in Geology, P50; Carter J. G., 2012, TREATISE ONLINE, V1, P209; Casella LA, 2016, BIOGEOSCIENCES, P1, DOI [10.5194/bg-2016-355, DOI 10.5194/BG-2016-355]; Chec AG, 2009, P NATL ACAD SCI USA, V106, P38, DOI 10.1073/pnas.0808796106; Checa AG, 2013, J STRUCT BIOL, V183, P368, DOI 10.1016/j.jsb.2013.07.014; Checa AG, 2011, J STRUCT BIOL, V176, P330, DOI 10.1016/j.jsb.2011.09.011; Crothers J. H., 2001, Field Studies, V10, P115; Cuif JP, 2012, MINERALS-BASEL, V2, P11, DOI 10.3390/min2010011; Cuif JP, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000783; Cuif JP., 2010, BIOMINERALS FOSSILS, p490 pp; Dashkovskiy S, 2007, COMP MATER SCI, V41, P96, DOI 10.1016/j.commatsci.2007.03.015; Dauphin Y, 2008, MINERAL MAG, V72, P243, DOI 10.1180/minmag.2008.072.1.243; Dauphin Y, 2005, AM MINERAL, V90, P1748, DOI 10.2138/am.2005.1640; Dauphin Y, 2003, AQUAT LIVING RESOUR, V16, P95, DOI 10.1016/S0990-7440(03)00022-6; Dauphin Y, 2003, J STRUCT BIOL, V142, P272, DOI 10.1016/S1047-8477(03)00054-6; DAUPHIN Y, 1989, Bulletin of the Geological Institutions of the University of Uppsala, V15, P7; Dauphin Y, 2006, CHEM GEOL, V231, P26, DOI 10.1016/j.chemgeo.2005.12.010; Dauphin Y, 2013, MICRON, V44, P373, DOI 10.1016/j.micron.2012.09.002; DODD JR, 1966, J SEDIMENT PETROL, V36, P733; Donald KM, 2012, MOL PHYLOGENET EVOL, V62, P35, DOI 10.1016/j.ympev.2011.09.002; Fyfe W. S., 1965, SOC ECON PALEONTOL M, V13, P3; Garcia R, 1999, SURF INTERFACE ANAL, V27, P312, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<312::AID-SIA496>3.0.CO;2-Y; Gomez-Villalba LS, 2012, CRYST GROWTH DES, V12, P4844, DOI 10.1021/cg300628m; Hovden R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10097; Huang ZW, 2009, MAT SCI ENG C-MATER, V29, P1803, DOI 10.1016/j.msec.2009.02.007; Hubbard F., 1981, GEO-MAR LETT, V1, P267, DOI [10.1007/BF02462445, DOI 10.1007/BF02462445]; JONES DS, 1983, AM SCI, V71, P384; Koga N, 2013, CRYST GROWTH DES, V13, P2238, DOI 10.1021/cg400350w; KUNZLER RH, 1970, AM J SCI, V269, P360, DOI 10.2475/ajs.269.4.360; Lecuyer C, 1996, CHEM GEOL, V129, P173, DOI 10.1016/0009-2541(96)00005-8; Leitmeier H., 1934, Z KRIST MINERAL PETR, V45, P447, DOI DOI 10.1007/BF02943377; Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k; Li XD, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.075502; Lowenstam HA, 1989, BIOMINERALIZATION; MACHEL HG, 1985, GEOSCI CAN, V12, P139; Mannino MA, 2003, J ARCHAEOL SCI, V30, P667, DOI 10.1016/S0305-4403(02)00238-8; Marin F., 2013, RECENTS ADV PEARL RE, V149; Marin Frederic, 2012, Front Biosci (Schol Ed), V4, P1099; Maritan L, 2007, ARCHAEOMETRY, V49, P529, DOI 10.1111/j.1475-4754.2007.00318.x; MCTIGUE JW, 1985, AM MINERAL, V70, P1253; Merkel C, 2009, J STRUCT BIOL, V168, P396, DOI 10.1016/j.jsb.2009.08.014; Milano S, 2016, J ARCHAEOL SCI-REP, V7, P14, DOI 10.1016/j.jasrep.2016.03.045; Milano S, 2017, PALAEOGEOGR PALAEOCL, V465, P395, DOI 10.1016/j.palaeo.2015.09.051; Mutvei H., 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V13, P163; Nehrke G, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003996; Nouet J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137162; Pagel M, 2000, CATHODOLUMINESCENCE IN GEOSCIENCES, P1; Parker JE, 2010, CRYSTENGCOMM, V12, P1590, DOI 10.1039/b921487a; Perdikouri C, 2013, EUR J MINERAL, V25, P123, DOI 10.1127/0935-1221/2013/0025-2261; Perdikouri C, 2011, GEOCHIM COSMOCHIM AC, V75, P6211, DOI 10.1016/j.gca.2011.07.045; Pokroy B, 2004, NAT MATER, V3, P900, DOI 10.1038/nmat1263; Pokroy B, 2006, J STRUCT BIOL, V155, P96, DOI 10.1016/j.jsb.2006.03.008; Prendergast AL, 2013, CHEM GEOL, V345, P77, DOI 10.1016/j.chemgeo.2013.02.026; Putnis A, 2002, MINERAL MAG, V66, P689, DOI 10.1180/0026461026650056; Riechelmann S, 2016, CHEM GEOL, V440, P191, DOI 10.1016/j.chemgeo.2016.07.020; Ritter A-C, 2017, SEDIMENTOLOGY, DOI [10.1111/ijlh.12426, DOI 10.1111/IJLH.12426]; Rousseau M, 2005, BIOMATERIALS, V26, P6254, DOI 10.1016/j.biomaterials.2005.03.028; Saylor CH, 1928, J PHYS CHEM-US, V32, P1441, DOI 10.1021/j150292a001; SCHAFFER HE, 1991, J CHEM PHYS, V94, P4161, DOI 10.1063/1.460649; Schone BR, 2003, GEOLOGY, V31, P1037, DOI 10.1130/G20013.1; Shirai K, 2014, GEOCHIM COSMOCHIM AC, V126, P307, DOI 10.1016/j.gca.2013.10.050; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Stemmer K, 2014, J MOLLUS STUD, V80, P365, DOI 10.1093/mollus/eyu033; Stevens RE, 2012, PALAEOGEOGR PALAEOCL, V319, P16, DOI 10.1016/j.palaeo.2011.12.012; Waters DJ, 2002, J METAMORPH GEOL, V20, P135, DOI 10.1046/j.0263-4929.2001.00350.x; Webb GE, 2007, GEOLOGY, V35, P803, DOI 10.1130/G23823A.1; Wheeler A.P., 1992, P179; Wolf SE, 2016, J STRUCT BIOL, V196, P244, DOI 10.1016/j.jsb.2016.07.016; YOSHIOKA S, 1985, GEOCHEM J, V19, P245, DOI 10.2343/geochemj.19.245; YOSHIOKA S, 1986, MAR CHEM, V18, P35, DOI 10.1016/0304-4203(86)90074-5; Zaremba CM, 1998, CHEM MATER, V10, P3813, DOI 10.1021/cm970785g; Zolotoyabko E, 2007, CRYSTENGCOMM, V9, P1156, DOI 10.1039/b708704g	80	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204577	10.1371/journal.pone.0204577	http://dx.doi.org/10.1371/journal.pone.0204577			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332413	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200016
J	Whaite, AD; Wang, TF; Macdnald, J; Cummins, SF				Whaite, Alessandra D.; Wang, Tianfang; Macdnald, Joanne; Cummins, Scott F.			Major ampullate silk gland transcriptomes and fibre proteomes of the golden orb-weavers, Nephila plumipes and Nephila pilipes (Araneae: Nephilidae)	PLOS ONE			English	Article							WESTERN BLACK-WIDOW; SPIDER SILK; SEQUENCE CONSERVATION; MECHANICAL-PROPERTIES; PROTEINS; FIBROIN; PERFORMANCE; MORPHOLOGY; SPIDROIN; DOMAIN	Natural spider silk is one of the world's toughest proteinaceous materials, yet a truly biomimetic spider silk is elusive even after several decades of intense focus. In this study, Next Generation Sequencing was utilised to produce transcriptomes of the major ampullate gland of two Australian golden orb-weavers, Nephila plumipes and Nephila pilipes, in order to identify highly expressed predicted proteins that may co-factor in the construction of the final polymer. Furthermore, proteomics was performed by liquid chromatography tandem mass spectroscopy to analyse the natural solid silk fibre of each species to confirm highly expressed predicted proteins within the silk gland are present in the final silk product. We assembled the silk gland transcriptomes of N. plumipes and N. pilipes into 69,812 and 70,123 contigs, respectively. Gene expression analysis revealed that silk gene sequences were among the most highly expressed and we were able to procure silk sequences from both species in excess of 1,300 amino acids. However, some of the genes with the highest expression values were not able to be identified from our proteomic analysis. Proteome analysis of "reeled" silk fibres of N. plumipes and N. pilipes revealed 29 and 18 proteins, respectively, most of which were identified as silk fibre proteins. This study is the first silk gland specific transcriptome and proteome analysis for these species and will assist in the future development of a biomimetic spider silk.	[Whaite, Alessandra D.; Wang, Tianfang; Macdnald, Joanne; Cummins, Scott F.] Univ Sunshine Coast, GeneCol Res Ctr, Sippy Downs, Qld, Australia; [Whaite, Alessandra D.; Wang, Tianfang; Macdnald, Joanne; Cummins, Scott F.] Univ Sunshine Coast, Sch Sci & Engn, Sippy Downs, Qld, Australia; [Macdnald, Joanne] Columbia Univ, Div Expt Therapeut, New York, NY 10027 USA	University of the Sunshine Coast; University of the Sunshine Coast; Columbia University	Macdnald, J; Cummins, SF (corresponding author), Univ Sunshine Coast, GeneCol Res Ctr, Sippy Downs, Qld, Australia.; Macdnald, J; Cummins, SF (corresponding author), Univ Sunshine Coast, Sch Sci & Engn, Sippy Downs, Qld, Australia.; Macdnald, J (corresponding author), Columbia Univ, Div Expt Therapeut, New York, NY 10027 USA.	jmacdon1@uso.edu.au; scummins@usc.edu.au	Wang, Tianfang/GRO-0844-2022; Wang, Tianfang/AAG-4290-2020; Wang, Tianfang/L-5192-2016; Cummins, Scott/I-6420-2016	Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Whaite, Alessandra/0000-0002-7361-0673; Cummins, Scott/0000-0002-1454-2076				Andersson M, 2017, NAT CHEM BIOL, V13, P262, DOI [10.1038/NCHEMBIO.2269, 10.1038/nchembio.2269]; dos Santos-Pinto JRA, 2016, J PROTEOME RES, V15, P1179, DOI 10.1021/acs.jproteome.5b01056; dos Santos-Pinto JRA, 2015, J PROTEOME RES, V14, P3859, DOI 10.1021/acs.jproteome.5b00243; Augsten K, 2000, SCANNING, V22, P12; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Babb PL, 2017, NAT GENET, V49, P895, DOI 10.1038/ng.3852; BECKWITT R, 1994, J BIOL CHEM, V269, P6661; Blamires SJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081294; Blamires SJ, 2015, BIOMACROMOLECULES, V16, P1218, DOI 10.1021/acs.biomac.5b00006; Blasingame E, 2009, J BIOL CHEM, V284, P29097, DOI 10.1074/jbc.M109.021378; Brown CP, 2015, J MATER RES, V30, P108, DOI 10.1557/jmr.2014.365; Casem ML, 2010, J ARACHNOL, V38, P99, DOI 10.1636/Sh09-20.1; Chaw RC, 2017, INSECT BIOCH MOL BIO; Chaw RC, 2015, J PROTEOME RES, V14, P4223, DOI 10.1021/acs.jproteome.5b00353; Clarke TH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07388-1; Clarke TH, 2015, GENOME BIOL EVOL, V7, P1856, DOI 10.1093/gbe/evv110; Clarke TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-365; Collin MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21589; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Correa-Garhwal SM, 2016, ZOOLOGY; Davies GJG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073225; Foelix R., 2011, BIOL SPIDERS, V3; Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0; Gosline JM, 1999, J EXP BIOL, V202, P3295; GRIFFITHS JR, 1980, J MATER SCI, V15, P491, DOI 10.1007/BF02396800; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936; Harvey MS, 2007, INVERTEBR SYST, V21, P407, DOI 10.1071/IS05016; Herrera E, 2015, INVERTEBR BIOL, V134, P332, DOI 10.1111/ivb.12106; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Holland C, 2012, ADV MATER, V24, P105, DOI 10.1002/adma.201103664; Kameda T, 2010, BIOMACROMOLECULES, V11, P1009, DOI 10.1021/bm901472a; Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002; Lane AK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-846; Larracas C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091537; Li X, 2017, BIOL OPEN, V6, P333, DOI 10.1242/bio.022665; Lowe EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105480; MELLO CM, 1994, ACS SYM SER, V544, P67; Prenter J, 2010, FUNCT ECOL, V24, P400, DOI 10.1111/j.1365-2435.2009.01633.x; Prosdocimi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021634; Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273; Sanggaard KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4765; Schneider JM, 2008, AUST J ZOOL, V56, P233, DOI 10.1071/ZO08041; Schwager EE, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0399-x; Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880; Tai PL, 2004, INT J BIOL MACROMOL, V34, P295, DOI 10.1016/j.ijbiomac.2004.08.002; Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109; Pham T, 2014, BIOMACROMOLECULES, V15, P4073, DOI 10.1021/bm5011239; Tokareva O, 2013, ACTA BIOMATER; Vasanthavada K, 2012, J BIOL CHEM, V287, P35986, DOI 10.1074/jbc.M112.399816; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wang TF, 2016, J PROTEOMICS, V146, P195, DOI 10.1016/j.jprot.2016.07.002; Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107; Zhang Y, 2013, COMP BIOCHEM PHYS B, V164, P151, DOI 10.1016/j.cbpb.2012.12.002	55	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204243	10.1371/journal.pone.0204243	http://dx.doi.org/10.1371/journal.pone.0204243			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332416	Green Published, Green Submitted, gold			2022-12-26	WOS:000447638200012
J	Boekel, W; Hsieh, S				Boekel, Wouter; Hsieh, Shulan			Cross-sectional white matter microstructure differences in age and trait mindfulness	PLOS ONE			English	Article							MONTREAL COGNITIVE ASSESSMENT; OLDER-ADULTS; MEDITATION; CONNECTIVITY; METAANALYSIS; SENSITIVITY; INHIBITION; INTEGRITY; HEALTH	The process of aging can be characterized by a decline in cognitive performance, which may be accompanied by deterioration in specific structural properties of the brain. In this study we sought to investigate to what extent mindfulness changes over the aging process, and which alterations in brain structure can be associated to aging and concomitant changes in mindfulness. We collected Mindful Attention Awareness Scale questionnaire data to assess trait mindfulness and acquired diffusion-weighted imaging data fitted to the diffusion tensor model (DTI) in a group of 97 middle-aged to elderly participants. Our results showed that trait mindfulness increased with age. In terms of white matter structure our results suggested that there was a general increase of omnidirectional diffusion, which favored radial over axial diffusivity, leading to a decrease in fractional anisotropy (FA) in older participants. We further showed that trait mindfulness mediated the FA-age effect in a localized area consisting of the internal and external capsule, as well as the corona radiata. The implication of this mediation analysis is that trait mindfulness may deter age-associated neurocognitive decline, perhaps by preventing age-associated microlesions specifically in cortico-subcortical white matter tracts. This study can be considered a pioneer of using DTI studies to investigate the relationship between age and trait mindfulness.	[Boekel, Wouter; Hsieh, Shulan] Natl Cheng Kung Univ, Coll Scoial Sci, Dept Psychol, Control Aging Sleep Emot CASE Lab, Tainan, Taiwan	National Cheng Kung University	Hsieh, S (corresponding author), Natl Cheng Kung Univ, Coll Scoial Sci, Dept Psychol, Control Aging Sleep Emot CASE Lab, Tainan, Taiwan.	psyhsl@mail.ncku.edu.tw		Hsieh, Shulan/0000-0001-6247-244X	Ministry of Science Technology (MOST) of the Republic of China, Taiwan [MOST104-2410-H-006-021-MY2, MOST106-2410-H-006-031-MY2]	Ministry of Science Technology (MOST) of the Republic of China, Taiwan	This work was supported by the Ministry of Science Technology (MOST) of the Republic of China, Taiwan, for financially supporting this research (Contract No. MOST104-2410-H-006-021-MY2; MOST106-2410-H-006-031-MY2).	Allen SC, 2003, AGE AGEING, V32, P299, DOI 10.1093/ageing/32.3.299; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Berk L, 2017, AGING MENT HEALTH, V21, P1113, DOI 10.1080/13607863.2016.1247423; Bilevicius E, 2018, BRAIN CONNECT, V8, P40, DOI 10.1089/brain.2017.0520; Black DS, 2012, ASSESSMENT, V19, P42, DOI 10.1177/1073191111415365; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Cullen M., 2011, MINDFULNESS, V2, P186, DOI [10.1007/s12671-011-0058-1, DOI 10.1007/S12671-011-0058-1]; Eberth J, 2012, MINDFULNESS, V3, P174, DOI 10.1007/s12671-012-0101-x; Fayed N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058476; Fox KCR, 2016, NEUROSCI BIOBEHAV R, V65, P208, DOI 10.1016/j.neubiorev.2016.03.021; Fox KCR, 2014, NEUROSCI BIOBEHAV R, V43, P48, DOI 10.1016/j.neubiorev.2014.03.016; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Grant JA, 2010, EMOTION, V10, P43, DOI 10.1037/a0018334; Grecucci A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/670724; Grigsby J, 1998, J AM GERIATR SOC, V46, P590, DOI 10.1111/j.1532-5415.1998.tb01075.x; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jolly TAD, 2016, PSYCHOPHYSIOLOGY, V53, P258, DOI 10.1111/psyp.12565; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kramer AF, 1999, ACTA PSYCHOL, V101, P339, DOI 10.1016/S0001-6918(99)00011-6; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Luders E, 2016, ANN NY ACAD SCI, V1373, P38, DOI 10.1111/nyas.13082; Luders E, 2011, NEUROIMAGE, V57, P1308, DOI 10.1016/j.neuroimage.2011.05.075; Ly A, 2016, J MATH PSYCHOL, V72, P43, DOI 10.1016/j.jmp.2016.01.003; MacKillop J, 2007, J PSYCHOPATHOL BEHAV, V29, P289, DOI 10.1007/s10862-007-9045-1; Mahoney CT, 2015, INT J AGING HUM DEV, V81, P217, DOI 10.1177/0091415015621309; Malinowski P, 2017, MINDFULNESS, V8, P78, DOI 10.1007/s12671-015-0482-8; Mayr U, 2001, PSYCHOL AGING, V16, P96, DOI 10.1037/0882-7974.16.1.96; Moore A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00018; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nuijten MB, 2015, BEHAV RES METHODS, V47, P85, DOI 10.3758/s13428-014-0470-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park Denise C, 2013, Dialogues Clin Neurosci, V15, P109; Prakash RS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00120; Raes AK, 2015, J GERONTOL B-PSYCHOL, V70, P179, DOI 10.1093/geronb/gbt074; Roser M., 2020, OUR WORLD DATA; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; SALTHOUSE TA, 1994, DEV PSYCHOL, V30, P240, DOI 10.1037/0012-1649.30.2.240; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sperduti M, 2017, GERIATR PSYCHOL NEUR, V15, P205, DOI 10.1684/pnv.2017.0672; Sullivan EV, 2010, NEUROBIOL AGING, V31, P464, DOI 10.1016/j.neurobiolaging.2008.04.007; Tanay G, 2013, PSYCHOL ASSESSMENT, V25, P1286, DOI 10.1037/a0034044; Tang YY, 2012, P NATL ACAD SCI USA, V109, P10570, DOI 10.1073/pnas.1207817109; Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.1011043107; Vernooij MW, 2008, NEUROIMAGE, V43, P470, DOI 10.1016/j.neuroimage.2008.07.052; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wetzels R, 2012, PSYCHON B REV, V19, P1057, DOI 10.3758/s13423-012-0295-x; Yaffe K, 2009, NEUROLOGY, V72, P2029, DOI 10.1212/WNL.0b013e3181a92c36; Zeidan F, 2010, CONSCIOUS COGN, V19, P597, DOI 10.1016/j.concog.2010.03.014	58	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205718	10.1371/journal.pone.0205718	http://dx.doi.org/10.1371/journal.pone.0205718			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0RD	30321218	Green Submitted, Green Published, gold			2022-12-26	WOS:000447417900047
J	Kularatne, RS; Niit, R; Rowley, J; Kufa-Chakezha, T; Peters, RPH; Taylor, MM; Johnson, LF; Korenromp, EL				Kularatne, Ranmini S.; Niit, Ronelle; Rowley, Jane; Kufa-Chakezha, Tendesayi; Peters, Remco P. H.; Taylor, Melanie M.; Johnson, Leigh F.; Korenromp, Eline L.			Adult gonorrhea, chlamydia and syphilis prevalence, incidence, treatment and syndromic case reporting in South Africa: Estimates using the Spectrum-STI model, 1990-2017	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HIV-INFECTION; SENTINEL SURVEILLANCE; NEISSERIA-GONORRHOEAE; BACTERIAL VAGINOSIS; URETHRAL DISCHARGE; MALE CIRCUMCISION; TRACT INFECTIONS; PREGNANT-WOMEN; HEALTH-CARE	Objectives To estimate trends in prevalence and incidence of syphilis, gonorrhea and chlamydia in adult men and women in South Africa. Methods The Spectrum-STI tool estimated trends in prevalence and incidence of active syphilis, gonorrhea and chlamydia, fitting South African prevalence data. Results were used, alongside programmatic surveillance data, to estimate trends in incident gonorrhea cases resistant to first-line treatment, and the reporting gap of symptomatic male gonorrhea and chlamydia cases treated but not reported as cases of urethritis syndrome. Results In 2017 adult (15-49 years) the estimated female and male prevalences for syphilis were 0.50% (95% CI: 0.32-0.80%) and 0.97% (0.19-2.28%), for gonorrhea 6.6% (3.8-10.8%) and 3.5% (1.7-6.1%), and for chlamydia 14.7% (9.9-21%) and 6.0% (3.8-10.4%), respectively. Between 1990 and 2017 the estimated prevalence of syphilis declined steadily in women and men, probably in part reflecting improved treatment coverage. For gonorrhea and chlamydia, estimated prevalence and incidence showed no consistent time trend in either women or men. Despite growing annual numbers of gonorrhea cases - reflecting population growth - the estimated number of first line treatment-resistant gonorrhea cases did not increase between 2008 and 2017, owing to changes in first-line antimicrobial treatment regimens for gonorrhea in 2008 and 2014/5. Case reporting completeness among treated male urethritis syndrome episodes was estimated at 10-28% in 2017. Conclusion South Africa continues to suffer a high STI burden. Improvements in access and quality of maternal, STI and HIV health care services likely contributed to the decline in syphilis prevalence. The lack of any decline in gonorrhea and chlamydia prevalence highlights the need to enhance STI services beyond clinic-based syndromic case management, to reinvigorate primary STI and HIV prevention and, especially for women, to screen for asymptomatic infections.	[Kularatne, Ranmini S.; Kufa-Chakezha, Tendesayi] Natl Inst Communicable Dis, Ctr HIV & STI, Johannesburg, South Africa; [Kularatne, Ranmini S.] Univ Witwatersrand, Dept Clin Microbiol & Infect Dis, Fac Hlth Sci, Johannesburg, South Africa; [Niit, Ronelle] Hlth Informat Syst Programme, Pretoria, South Africa; [Peters, Remco P. H.] Anova Hlth Inst, Johannesburg, South Africa; [Peters, Remco P. H.] Univ Pretoria, Dept Med Microbiol, Fac Hlth Sci, Pretoria, South Africa; [Taylor, Melanie M.] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland; [Taylor, Melanie M.] USA Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA; [Johnson, Leigh F.] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Korenromp, Eline L.] Avenir Hlth, Geneva, Switzerland	National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Pretoria; World Health Organization; University of Cape Town	Korenromp, EL (corresponding author), Avenir Hlth, Geneva, Switzerland.	ekorenromp@avenirhealth.org		Peters, Remco Petrus Hendricus/0000-0003-2124-7275; Kufa, Tendesayi/0000-0002-9797-616X	World Health Organization, Department of Reproductive Health and Research	World Health Organization, Department of Reproductive Health and Research(World Health Organization)	The project was funded by the World Health Organization, Department of Reproductive Health and Research. The views expressed in this paper are those of the authors and do not necessarily represent the position of the World Health Organization, or other affiliated organizations.	Adams EJ, 2004, SEX TRANSM INFECT, V80, P354, DOI 10.1136/sti.2003.005454; [Anonymous], 2018, EUROPEAN COMMITTEE A; [Anonymous], 2018, M100 PERFORMANCE STA; [Anonymous], 2016, GUIDELINES TREATMENT; Auvert B, 2004, JAIDS-J ACQ IMM DEF, V36, P613, DOI 10.1097/00126334-200405010-00010; Auvert B, 2001, AIDS, V15, pS31, DOI 10.1097/00002030-200108004-00004; Badrakh J, 2017, WEST PAC SURVEILL RE, V8, DOI 10.5365/wpsar.2017.8.2.007; Barnabas SL, 2018, INT J STD AIDS, V29, P531, DOI 10.1177/0956462417740487; Bennani A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181498; Black V, 2008, SEX TRANSM INFECT, V84, P254, DOI 10.1136/sti.2007.028464; Bronzan RN, 2007, SEX TRANSM DIS, V34, pS55, DOI 10.1097/01.olq.0000245987.78067.0c; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Coetzee N., 1994, SYPHILIS WOMEN ATTEN; Colvin M, 1998, INT J STD AIDS, V9, P548, DOI 10.1258/0956462981922683; CRONJE HS, 1994, S AFR MED J, V84, P602; Dawadi B. R., 2001, Southern African Journal of Epidemiology & Infection, V16, P117; De Jongh M, 2010, J OBSTET GYNAECOL, V30, P480, DOI 10.3109/01443611003797687; Department of Health Republic of South Africa, 2008, SEXUALLY TRANSMITTED; Department of Health Republic of South Africa, 2018, S AFR RAP INT PERF D; Devjee J, 2006, SAMJ S AFR MED J, V96, P1182; DIETRICH M, 1992, GENITOURIN MED, V68, P39; DONDERS GGG, 1993, GENITOURIN MED, V69, P98; El-Kettani A, 2017, SEX TRANSM DIS, V44, P557, DOI 10.1097/OLQ.0000000000000647; Enkhbat E, 2018, INFECT DIS MODEL, V3, P13, DOI 10.1016/j.idm.2018.03.003; Fehler H. G., 1998, Southern African Journal of Epidemiology & Infection, V13, P79; Francis SC, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002512; Friedman B, 2016, CLIN MICROBIOL INFEC, V22, P768, DOI 10.1016/j.cmi.2016.07.030; Frohlich JA, 2007, J ADV NURS, V60, P377, DOI 10.1111/j.1365-2648.2007.04405.x; Funk M., 1996, Southern African Journal of Epidemiology & Infection, V11, P74; GALLANT AR, 1973, J AM STAT ASSOC, V68, P144, DOI 10.2307/2284158; Giuliano AR, 2015, JAIDS-J ACQ IMM DEF, V68, P227, DOI 10.1097/QAI.0000000000000425; Govender L, 1996, INT J GYNECOL OBSTET, V55, P23, DOI 10.1016/0020-7292(96)02744-0; Grund JM, 2017, LANCET GLOB HEALTH, V5, pE1113, DOI 10.1016/s2214-109x(17)30369-8; Guffey MB, 2014, SEX TRANSM INFECT, V90, P363, DOI 10.1136/sextrans-2014-051537; Ham D Cal, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS10, DOI 10.1016/j.ijgo.2015.04.012; Ham DC, 2016, SEX TRANSM DIS, V43, P23, DOI 10.1097/OLQ.0000000000000383; Hoffman CM, PROVISION STI SERVIC; Htun Y, 2007, SAMJ S AFR MED J, V97, P1155; Hurkchand HP, 2004, 15 INT AIDS C BANGK; ICAP project at Columbia University Centers for Disease Control USA Westat, 2017, UG POP BAS HIV IMP A; ICAP project at Columbia University Centers for Disease Control USA Zimbabwe National AIDS Council (NAC) Zimbabwe National Statistics Agency (ZIMSTAT), 2016, ZIMB POP BAS HIV IMP; Jespers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109670; Johnson LF, 2016, SEX TRANSM DIS, V43, P139, DOI 10.1097/OLQ.0000000000000412; Johnson LF, 2012, J R SOC INTERFACE, V9, P1544, DOI 10.1098/rsif.2011.0826; Johnson LF, 2011, SEX REPROD HEALTHC, V2, P13, DOI 10.1016/j.srhc.2010.08.006; Johnson LF, 2010, SEX TRANSM INFECT, V86, P169, DOI 10.1136/sti.2009.037341; Johnson LF, 2005, SEX TRANSM INFECT, V81, P287, DOI 10.1136/sti.2004.013904; Kapiga S, 2009, SEX TRANSM DIS, V36, P199, DOI 10.1097/OLQ.0b013e318191ba01; Kenyon CR, 2015, INT J STD AIDS, V26, P556, DOI 10.1177/0956462414546392; Kharsany A. B. M., 1997, Journal of Obstetrics and Gynaecology (Abingdon), V17, P171; Kleinschmidt I, 2007, CONTRACEPTION, V75, P461, DOI 10.1016/j.contraception.2007.02.002; Kleppa E, 2015, SEX TRANSM INFECT, V91, P124, DOI 10.1136/sextrans-2014-051674; Kohler PK, 2017, SEX TRANSM INFECT, V93, P247, DOI 10.1136/sextrans-2016-052930; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Korenromp EL, 2001, SEX TRANSM DIS, V28, P613, DOI 10.1097/00007435-200111000-00001; Korenromp EL, 2018, PAN AM J PUBLIC HLTH, V42, pe118, DOI DOI 10.26633/RPSP.2018.118; Korenromp EL, 2012, GLOBAL BURDEN MATERN; Korenromp EL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29805-9; Korenromp EL, 2017, SEX TRANSM INFECT, V93, P599, DOI 10.1136/sextrans-2016-052953; Kularatne R., 2017, NICD B, V15, P114; Kularatne R, 2017, SENTINEL SURVEILLANC; Kularatne R, SENTINEL SURVEILLANC; Kularatne RMV, 2016, COMMUNICABLE DIS SUR, V14, P56; Lewis DA, 2008, SEX TRANSM INFECT, V84, P352, DOI 10.1136/sti.2007.029611; Lewis D. A., 2009, Southern African Journal of Epidemiology & Infection, V24, P6; Lewis DA, 2013, J ANTIMICROB CHEMOTH, V68, P1267, DOI 10.1093/jac/dkt034; Mashiane Y, 1999, S AFR J EPIDEMIOL IN, V14, P13; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; McKinnon L, 2016, INT AIDS C DURB S AF; Meyer-Weitz A, 2000, PATIENT EDUC COUNS, V41, P263, DOI 10.1016/S0738-3991(99)00103-2; Mhlongo S, 2010, SEX TRANSM DIS, V37, P566, DOI 10.1097/OLQ.0b013e3181d877b7; Moodley D, 2015, SEX TRANSM DIS, V42, P43, DOI 10.1097/OLQ.0000000000000219; Mothupi R, 2007, 2 JOINT C FED INF DI; Myer L, 2003, SEX TRANSM INFECT, V79, P208, DOI 10.1136/sti.79.3.208; National Department of Health, 2015, SEX TRANSM INF MAN G; Ndhlovu L, 2005, REDUCING TRANSMISSIO; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; O'Leary A, 2015, SEX TRANSM DIS, V42, P135, DOI 10.1097/OLQ.0000000000000247; Odendaal HJ, 2006, SAJOG-S AFR J OBSTET, V12, P146; OFARRELL N, 1989, GENITOURIN MED, V65, P276; Omori R, 2019, SEX TRANSM INFECT, V95, P115, DOI 10.1136/sextrans-2018-053543; OPAITETTEH ET, 1993, S AFR MED J, V83, P725; Orroth KK, 2003, SEX TRANSM INFECT, V79, P98, DOI 10.1136/sti.79.2.98; Palanee-Phillips T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128857; PARK SH, 1978, TECHNOMETRICS, V20, P151; Perti Tara, 2014, Infect Dis Obstet Gynecol, V2014, P258291, DOI 10.1155/2014/258291; Peters RPH, 2014, SEX TRANSM DIS, V41, P564, DOI 10.1097/OLQ.0000000000000175; Pettifor AE, 2005, TROP MED INT HEALTH, V10, P971, DOI 10.1111/j.1365-3156.2005.01483.x; QOLOHLE DC, 1995, GENITOURIN MED, V71, P65; Rebe K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138315; Rours G. I. J. G., 2006, Southern African Journal of Epidemiology & Infection, V21, P14; Rowley J, 2017, TECHNICAL REPORT; Schneider H, 1998, SEX TRANSM INFECT, V74, pS147; Schwartz S, 2017, SEX TRANSM INFECT, V93, P286, DOI 10.1136/sextrans-2016-052773; Sebitloane HM, 2011, SAMJ S AFR MED J, V101, P466; Smolak A, 2018, CLIN INFECT DIS, V66, P1184, DOI 10.1093/cid/cix975; Solomon W, 2016, HLTH SYST TRUST C 20; South Africa Dept. of Health, 2000, NAT HIV SYPH ANT SER; South Africa National Department of Health, 2017, 2015 NAT ANT SENT HI; South Africa National Department of Health, NAT INT DISTR HLTH I; South African National AIDS Council, 2017, NAT STRAT PLAN HIV T; Sturm A, 2003, S AFR AIDS C DURB; Sturm AW, 1998, AM J PUBLIC HEALTH, V88, P1243, DOI 10.2105/AJPH.88.8.1243; Sturm PDJ, 2004, INT J STD AIDS, V15, P94, DOI 10.1258/095646204322764271; Dinh TH, 2013, SEX TRANSM DIS, V40, P846, DOI 10.1097/OLQ.0000000000000042; Unemo M, 2017, LANCET INFECT DIS, V17, pE235, DOI [10.1016/s1473-3099(17)30310-9, 10.1016/S1473-3099(17)30310-9]; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; University of California San Francisco (UCSF) Anova Health Institute Wits Reproductive Health and HIV Research Institute (WRHI), 2016, S AFR HLTH MON SURV; USA Centers for Disease Control and Prevention, 2011, SEX TRANSM DIS SURV; Vickerman P, 2006, SEX TRANSM DIS, V33, pS122, DOI 10.1097/01.olq.0000221351.55097.36; Williams BG, 2003, AIDS, V17, P2099, DOI 10.1097/00002030-200309260-00011; WILLIAMS BG, 2000, NATURAL HIST HIV AID; World Health Organization, GON ANT SURV PROGR G; World Health Organization (WHO), GLOB HLTH SECT STRAT; Zambia Ministry of Communicable Diseases Maternal and Child Health United States of America Centers for Disease Control and Prevention ICAP at Columbia University Zambia Central Statistical Office Zambia Tropical Diseases Research Centre University of Zambia University Teaching Hospital Zambia National HIV/AIDS/STI/TB Council Zambian National Public Health Institute WESTAT. Zambia Population-based HIV impact assessment (ZAMPHIA), 2016, ZAMB POP BAS HIV IMP	115	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205863	10.1371/journal.pone.0205863	http://dx.doi.org/10.1371/journal.pone.0205863			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0RD	30321236	gold, Green Published, Green Submitted			2022-12-26	WOS:000447417900061
J	Stea, TH; Tveter, ET; te Velde, SJ; Vik, FN; Klepp, KI; Bere, E				Stea, Tonje Holte; Tveter, Eline Tonnesson; te Velde, Saskia J.; Vik, Froydis Nordgard; Klepp, Knut-Inge; Bere, Elling			The effect of an extra piece of fruit or vegetables at school on weight status in two generations-14 years follow-up of the Fruit and Vegetables Makes the Marks study	PLOS ONE			English	Article							MATERNAL OBESITY; HEALTH; OVERWEIGHT; PROGRAM; INTERVENTIONS; PREVENTION; CHILDREN; GAIN	Background The obesity epidemic presents a major public health challenge, and a poor diet quality has been identified as one of the most important contributing factors. Whereas a sufficient fruit and vegetable consumption has been associated with several positive health outcomes, the long-term effect on overweight and obesity is unclear. Thus, the aims of this study were to investigate if one year with free school fruit had any effect on weight status 14 years later, and if it affected the birth weight of the participants' children. Methods In 2001, 10-12-year old Norwegian children, received one year of free school fruit in the intervention study "Fruits and Vegetables Make the Marks" (FVMM) and in 2016, a total of 1081 participants of 2049 eligible responded to a follow-up survey. Multilevel logistic regression was used to investigate if one year of free school fruit was associated with weight status and with birthweight status of the offspring. The analyses were adjusted for gender, educational level, and the offspring analysis also for parents' weight status, and the nested design (child/parent). Results The odds ratios of being overweight (OR: 0.93, 95% CI: 0.70, 1.24) or having a child with high or low birth weight (OR: 0.52, 95% CI: 0.21, 1.30) in the intervention group compared to the control group were not statistically significant, 14 years after the intervention period. Conclusions One year of free school fruit did not have an effect on weight status on the participants or birth weight of their offspring, 14 years after the intervention period. Although, results from the present study contribute to fill the knowledge gaps concerning long-term effects of public health efforts on weight status, more follow-up studies with larger samples are warranted.	[Stea, Tonje Holte; Tveter, Eline Tonnesson; te Velde, Saskia J.; Vik, Froydis Nordgard; Bere, Elling] Univ Agder, Dept Publ Hlth Sport & Nutr, Kristiansand, Norway; [Klepp, Knut-Inge] Univ Oslo, Dept Nutr, Oslo, Norway	University of Agder; University of Oslo	Stea, TH (corresponding author), Univ Agder, Dept Publ Hlth Sport & Nutr, Kristiansand, Norway.	tonje.h.stea@uia.no		te Velde, Saskia/0000-0002-4674-8052	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was funded by the Norwegian Research Council. Free school fruit for the nine schools was made possible by the Norwegian Fruit and Vegetable Marketing Board through the collective agricultural agreement between Norway's farmers and the agricultural authorities to reduce the price and the administration of the School Fruit Programme. The study was initiated and analyzed by the investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adane AA, 2018, INT J OBESITY, V42, P1265, DOI 10.1038/s41366-018-0078-1; [Anonymous], 2005, PREV CHRON DIS VIT I; Bere E, 2006, HEALTH EDUC RES, V21, P268, DOI 10.1093/her/cyh063; Bere E, 2006, HEALTH EDUC RES, V21, P258, DOI 10.1093/her/cyh062; Bere E, 2005, PREV MED, V41, P463, DOI 10.1016/j.ypmed.2004.11.024; Bere E, 2004, PUBLIC HEALTH NUTR, V7, P991, DOI 10.1079/PHN2004619; Bere E, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-5; Bere E, 2008, PUBLIC HEALTH NUTR, V11, P321, DOI 10.1017/S1368980007000729; Bere E, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.23194; Bere E, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0301-6; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Boggs DA, 2011, AM J CLIN NUTR, V94, P86, DOI 10.3945/ajcn.111.013482; Brown EC, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4902714; Brown J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011970.pub2; Castillo-Laura H, 2015, CAD SAUDE PUBLICA, V31, P2073, DOI 10.1590/0102-311X00159914; Catalano P, 2015, INT J OBESITY, V39, P642, DOI 10.1038/ijo.2015.15; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Sa J, 2008, EUR J PUBLIC HEALTH, V18, P558, DOI 10.1093/eurpub/ckn061; de Vet E, 2011, OBES REV, V12, pe130, DOI 10.1111/j.1467-789X.2010.00784.x; Dodd JM, 2010, BJOG-INT J OBSTET GY, V117, P1316, DOI 10.1111/j.1471-0528.2010.02540.x; Dumville JC, 2006, BMJ-BRIT MED J, V332, P969, DOI 10.1136/bmj.332.7547.969; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jaime PC, 2009, PREV MED, V48, P45, DOI 10.1016/j.ypmed.2008.10.018; Jones R, 2011, AUSTRALAS PSYCHIATRY, V19, P325, DOI 10.3109/10398562.2011.579613; Kaiser KA, 2014, AM J CLIN NUTR, V100, P567, DOI 10.3945/ajcn.114.090548; Larson MR, 2000, INT J OBESITY, V24, P663, DOI 10.1038/sj.ijo.0801233; Marchi J, 2015, OBES REV, V16, P621, DOI 10.1111/obr.12288; Newby PK, 2009, AM J CLIN NUTR, V89, pS1572, DOI 10.3945/ajcn.2009.26736G; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Overby NC, 2012, AM J CLIN NUTR, V96, P1100, DOI 10.3945/ajcn.111.033399; Reinehr T, 2007, INT J OBESITY, V31, P1074, DOI 10.1038/sj.ijo.0803637; Robertson W, 2012, CHILD CARE HLTH DEV, V38, P229, DOI 10.1111/j.1365-2214.2011.01237.x; Schwingshackl L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140846; Shaya FT, 2008, J SCHOOL HEALTH, V78, P189, DOI 10.1111/j.1746-1561.2008.00285.x; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Taylor RW, 2008, AM J CLIN NUTR, V88, P1371, DOI 10.3945/ajcn.2007.25749; Vioque J, 2008, OBESITY, V16, P664, DOI 10.1038/oby.2007.121; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WHO, 2016, REP COMM END CHILDH; World Cancer Research Fund / American Institute for Cancer Research, 2018, DIET NUTR PHYS ACT C; World Health Organization Europe, 2007, CHALLENGE OBESITY WH; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627	44	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205498	10.1371/journal.pone.0205498	http://dx.doi.org/10.1371/journal.pone.0205498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0RD	30321202	Green Submitted, Green Published, gold			2022-12-26	WOS:000447417900034
J	Kumar, V; Denis, M; Gregory, A; Bayat, M; Mehrmohammadi, M; Fazzio, R; Fatemi, M; Alizad, A				Kumar, Viksit; Denis, Max; Gregory, Adriana; Bayat, Mahdi; Mehrmohammadi, Mohammad; Fazzio, Robert; Fatemi, Mostafa; Alizad, Azra			Viscoelastic parameters as discriminators of breast masses: Initial human study results	PLOS ONE			English	Article							SHEAR-WAVE ELASTOGRAPHY; MR ELASTOGRAPHY; RADIATION FORCE; LIVER FIBROSIS; ULTRASOUND; ELASTICITY; DISPERSION; VISCOSITY	Shear wave elastography is emerging as a clinically valuable diagnostic tool to differentiate between benign and malignant breast masses. Elastography techniques assume that soft tissue can be modelled as a purely elastic medium. However, this assumption is often violated as soft tissue exhibits viscoelastic properties. In order to explore the role of viscoelastic parameters in suspicious breast masses, a study was conducted on a group of patients using shear wave dispersion ultrasound vibrometry in the frequency range of 50 +/- 400 Hz. A total of 43 female patients with suspicious breast masses were recruited before their scheduled biopsy. Of those, 15 patients did not meet the data selection criteria. Voigt model based shear elasticity showed a significantly (p = 7.88x10(-6)) higher median value for the 13 malignant masses (16.76 +/- 13.10 kPa) compared to 15 benign masses (1.40 +/- 1.12 kPa). Voigt model based shear viscosity was significantly different (p = 4.13x10(-5)) between malignant (8.22 +/- 3.36 Pa-s) and benign masses (2.83 +/- 1.47 Pa-s). Moreover, the estimated time constant from the Voigt model, which is dependent on both shear elasticity and viscosity, differed significantly (p = 6.13x10(-5)) between malignant (0.68 +/- 0.33 ms) and benign masses (3.05 +/- 1.95 ms). Results suggest that besides elasticity, viscosity based parameters like shear viscosity and time constant can also be used to differentiate between malignant and benign breast masses.	[Kumar, Viksit; Bayat, Mahdi; Mehrmohammadi, Mohammad; Fatemi, Mostafa] Mayo Clin, Coll Med & Sci, Dept Physiol & Biomed Engn, Rochester, MN USA; [Denis, Max; Gregory, Adriana; Fazzio, Robert; Alizad, Azra] Mayo Clin, Coll Med & Sci, Dept Radiol, Rochester, MN 55905 USA; [Denis, Max] Phys & Life Sci Solut LLC, Randolph, MA USA; [Mehrmohammadi, Mohammad] Wayne State Univ, Dept Biomed Engn, Detroit, MI USA	Mayo Clinic; Mayo Clinic; Wayne State University	Alizad, A (corresponding author), Mayo Clin, Coll Med & Sci, Dept Radiol, Rochester, MN 55905 USA.	alizad.azra@mayo.edu		Alizad, Azra/0000-0002-7658-1572; Mehrmohammadi, Mohammad/0000-0002-9264-9354; Fatemi, Mostafa/0000-0002-6603-9077; Bayat, Mahdi/0000-0001-9069-0823; Kumar, Viksit/0000-0003-0056-5223	NIH-National Cancer Institute [R01CA148994, R01CA148994-S1, R01CA168575, R01CA195527, R01CA174723]; National Institute of Biomedical Imaging and Bioengineering [R01EB17213]; NATIONAL CANCER INSTITUTE [R01CA174723, R01CA148994, R01CA168575, R01CA195527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017213] Funding Source: NIH RePORTER	NIH-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Research reported in this publication was supported in parts by NIH grants R01CA148994, R01CA148994-S1, R01CA168575, R01CA195527 and R01CA174723 from the NIH-National Cancer Institute and R01EB17213 from National Institute of Biomedical Imaging and Bioengineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Cynthia Andrist, our clinical coordinator, and Jennifer Poston for administrative support, and Desiree Lanzino, PT, PhD, for help in editing the manuscript. Research reported in this publication was supported in parts by NIH grants R01CA148994, R01CA148994-S1, R01CA168575, R01CA195527 and R01CA174723 from the NIH-National Cancer Institute and R01EB17213 from National Institute of Biomedical Imaging and Bioengineering.	Bayat M., 2017, IEEE T BIOMEDICAL EN; Bayat M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179598; Bayat M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172801; Bercoff J, 2003, ULTR 2003 IEEE S; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; Chen S, 2009, ENG MED BIOL SOC 200; Chen S, 2008, ULTR S 2008 IUS 2008; Chen SG, 2004, J ACOUST SOC AM, V115, P2781, DOI 10.1121/1.1739480; Chen SG, 2013, RADIOLOGY, V266, P964, DOI 10.1148/radiol.12120837; Chen SG, 2009, IEEE T ULTRASON FERR, V56, P55, DOI 10.1109/TUFFC.2009.1005; Denis Max, 2014, Journal of the Acoustical Society of America, V136, DOI 10.1121/1.4899813; Fatemi M., 2016, J ACOUST SOC AM, V139, P2028; Gruber IV, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-328; Hossain MM, 2016, ULTR S IUS 2016 IEEE; Huwart L, 2006, NMR BIOMED, V19, P173, DOI 10.1002/nbm.1030; Mellema DC, 2016, IEEE T MED IMAGING, V35, P2098, DOI 10.1109/TMI.2016.2550007; Moore CJ, 2016, ULTR S IUS 2016 IEEE; Nam K, 2011, ULTRASONIC IMAGING, V33, P233, DOI 10.1177/016173461103300403; Nenadic Ivan, 2013, Journal of the Acoustical Society of America, V134, DOI 10.1121/1.4830632; Nightingale KR, 2015, IEEE T ULTRASON FERR, V62, P165, DOI 10.1109/TUFFC.2014.006653; Palmeri ML, 2014, 2014 IEEE INTERNATIO; Pinton GF, 2006, IEEE T ULTRASON FERR, V53, P1103, DOI 10.1109/TUFFC.2006.1642509; Qiu YP, 2008, ACAD RADIOL, V15, P1526, DOI 10.1016/j.acra.2008.05.023; Reiter R, 2014, J BIOMECH, V47, P1665, DOI 10.1016/j.jbiomech.2014.02.034; Rouze NC, 2014, ULTR S IUS 2014 IEEE; Salameh N, 2007, J MAGN RESON IMAGING, V26, P956, DOI 10.1002/jmri.21099; Selzo MR, 2013, IEEE T ULTRASON FERR, V60, P2488, DOI 10.1109/TUFFC.2013.2848; Selzo MR, 2016, QUANTITATIVE POTENTI; Siegel RL, 2015, CANC STAT 2016 CA CA; Sinkus R, 2005, MAGN RESON IMAGING, V23, P159, DOI 10.1016/j.mri.2004.11.060; Song PF, 2012, IEEE T MED IMAGING, V31, P1821, DOI 10.1109/TMI.2012.2205586; Sridhar M, 2007, MED PHYS, V34, P4757, DOI 10.1118/1.2805258; Viola F, 2003, IEEE T ULTRASON FERR, V50, P736, DOI 10.1109/TUFFC.2003.1209564; Xie H, 2010, ULTR S IUS 2010 IEEE	35	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205717	10.1371/journal.pone.0205717	http://dx.doi.org/10.1371/journal.pone.0205717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312358	Green Published, Green Submitted, gold			2022-12-26	WOS:000447427300050
J	Davies, M; Ecroyd, H; Robinson, SA; French, K				Davies, Michael; Ecroyd, Heath; Robinson, Sharon A.; French, Kristine			Stress in native grasses under ecologically relevant heat waves	PLOS ONE			English	Article							SHOCK PROTEINS; CLIMATE-CHANGE; CHLOROPHYLL FLUORESCENCE; HIGH-TEMPERATURE; LEAF SENESCENCE; PLANT-RESPONSES; ELEVATED CO2; DROUGHT; TOLERANCE; EXPRESSION	Future increases in the intensity of heat waves (high heat and low water availability) are predicted to be one of the most significant impacts on organisms. Using six native grasses from Eastern Australia, we assessed their capacity to tolerate heat waves with low water availability. We were interested in understanding differential response between native grasses of differing photosynthetic pathways in terms of physiological and some molecular parameters to ecologically relevant summer heat waves that are associated with low rainfall. We used a simulation heatwave event in controlled temperature cabinets and investigated effects of the different treatments on four stress indicators: leaf senescence, leaf water content, photosynthetic efficiency and the relative expression of two heat shock proteins, Hsp70 and smHsp17.6. Leaf senescence was significantly greater under the combined stress treatment, while declines in leaf water content and photosynthetic efficiency were much larger for C3 than C4 plants, particularly under the combined stress treatment. Species showed an increase in expression of Hsp70 associated with heat treatment, rather than drought stress. In contrast Hsp17.6 was only detected in two species, responding to heat rather than drought, although species' responses were variable. Overall, the C3 species were less tolerant than C4 species. Variation in individual plants within species was evident, especially under multiple stresses, and indicates that losses of individual plants may occur during a heat wave associated with this variability in tolerance. Heat waves will impose significant stress on plant communities that would not otherwise occur when heat and drought stress are experienced singly. Using ecologically relevant heat stress is likely to yield better predictability of how native plants will cope under a hotter, drier future.	[Davies, Michael; Robinson, Sharon A.; French, Kristine] Univ Wollongong, Ctr Sustainable Ecosyst Serv, Wollongong, NSW, Australia; [Davies, Michael; Ecroyd, Heath; Robinson, Sharon A.; French, Kristine] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Ecroyd, Heath] Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia	University of Wollongong; University of Wollongong; University of Wollongong	French, K (corresponding author), Univ Wollongong, Ctr Sustainable Ecosyst Serv, Wollongong, NSW, Australia.; French, K (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	kris@uow.edu.au	Davies, Michael/GWV-2527-2022; Robinson, Sharon/B-2683-2008; French, Kris/I-8202-2012	Robinson, Sharon/0000-0002-7130-9617; Davies, Michael/0000-0001-8084-7401; Ecroyd, Heath/0000-0001-7574-0044; French, Kris/0000-0001-6938-2017				Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Augustine SM, 2015, PLANT SCI, V232, P23, DOI 10.1016/j.plantsci.2014.12.012; Barua D, 2008, J INTEGR PLANT BIOL, V50, P1440, DOI 10.1111/j.1744-7909.2008.00756.x; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Cao ZX, 2015, ECOL INDIC, V54, P96, DOI 10.1016/j.ecolind.2015.02.027; Curtis EM, 2016, J BIOGEOGR, V43, P1156, DOI 10.1111/jbi.12713; Curtis EM, 2014, OECOLOGIA, V175, P1051, DOI 10.1007/s00442-014-2988-5; Darai C, 2007, ADV ROBUST NONPARAME; De Boeck HJ, 2010, GLOBAL CHANGE BIOL, V16, P1992, DOI 10.1111/j.1365-2486.2009.02049.x; Djanaguiraman M, 2011, ENVIRON EXP BOT, V71, P215, DOI 10.1016/j.envexpbot.2010.12.006; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Evans L., 1975, PHOTOSYNTHESIS PRODU, P501; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Filewod B, 2014, GLOBAL CHANGE BIOL, V20, P360, DOI 10.1111/gcb.12354; Fischer EM, 2015, NAT CLIM CHANGE, V5, P560, DOI 10.1038/nclimate2617; Forseth I.N., 2010, NATURE ED KNOWL, V3, P4; French K, 2017, CONSERV PHYSIOL, V5, DOI 10.1093/conphys/cox029; Ghosh R, 2014, EXPERT REV PROTEOMIC, V11, P549, DOI 10.1586/14789450.2014.939635; Grigorova B, 2011, BIOL PLANTARUM, V55, P105, DOI 10.1007/s10535-011-0014-x; Hamilton EW, 2008, J INTEGR PLANT BIOL, V50, P1375, DOI 10.1111/j.1744-7909.2008.00747.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Intergovernmental Panel on Climate Change, 2014, IPCC CLIMATE CHANGE; Knight CA, 2003, INT J PLANT SCI, V164, P53, DOI 10.1086/344554; Knight CA, 2001, AM J BOT, V88, P411, DOI 10.2307/2657105; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lipiec J, 2013, INT AGROPHYS, V27, P463, DOI 10.2478/intag-2013-0017; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; SMILLIE RM, 1983, PLANT PHYSIOL, V72, P1043, DOI 10.1104/pp.72.4.1043; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Vile D, 2012, PLANT CELL ENVIRON, V35, P702, DOI 10.1111/j.1365-3040.2011.02445.x; Waller S, 1997, J RANGE MANAGE, V32, P12; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Warren JM, 2011, TREE PHYSIOL, V31, P117, DOI 10.1093/treephys/tpr002; Waters ER, 2013, J EXP BOT, V64, P391, DOI 10.1093/jxb/ers355	48	4	4	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0204906	10.1371/journal.pone.0204906	http://dx.doi.org/10.1371/journal.pone.0204906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308074	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500031
J	Park, M; Moon, WJ; Moon, Y; Choi, JW; Han, SH; Wang, Y				Park, Mina; Moon, Won-Jin; Moon, Yeonsil; Choi, Jin Woo; Han, Seol-Heui; Wang, Yi			Region-specific susceptibility change in cognitively impaired patients with diabetes mellitus	PLOS ONE			English	Article							BASAL GANGLIA CALCIFICATION; MAGNETIC-SUSCEPTIBILITY; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; IRON ACCUMULATION; MAPPING QSM; MRI; NEURODEGENERATION; ABNORMALITIES; INFLAMMATION	Emerging evidence suggests that diabetes mellitus (DM) is associated with iron and calcium metabolism. However, few studies have investigated the presence of DM in cognitively impaired patients and its effect on brain iron and calcium accumulation. Therefore, we assessed the effects of DM on cognitively impaired patients using quantitative susceptibility mapping (QSM). From June 2012 to Feb 2014, 92 eligible cognitively impaired patients underwent 3T magnetic resonance imaging (MRI). There were 46 patients with DM (DM+) and 46 aged matched patients without DM (DM-). QSM was obtained from gradient echo data and analyzed by drawing regions of interest around relevant anatomical structures. Clinical factors and vascular pathology were also evaluated. Measurement differences between DM+ and DM- patients were assessed by ttests. A multiple regression analysis was performed to identify independent predictors of magnetic susceptibility. DM+ patients showed lower susceptibility values, indicative of lower brain iron content, than DM- patients, which was significant in the hippocampus (4.80 +/- 8.31 ppb versus 0.22 +/- 10.60 ppb, p = 0.024) and pulvinar of the thalamus (36.30 +/- 19.88 ppb versus 45.90 +/- 20.02 ppb, p = 0.023). On multiple regression analysis, microbleed number was a predictor of susceptibility change in the hippocampus (F = 4.291, beta = 0.236, p = 0.042) and DM was a predictor of susceptibility change in the pulvinar of the thalamus (F = 4.900, beta = - 0.251, p = 0.030). In cognitively impaired patients, presence of DM was associated with lower susceptibility change in the pulvinar of the thalamus and hippocampus. This suggests that there may be region-specific alterations of calcium deposition in cognitively impaired subjects with DM.	[Park, Mina; Moon, Won-Jin; Choi, Jin Woo] Konkuk Univ, Sch Med, Med Ctr, Dept Radiol, Seoul, South Korea; [Moon, Yeonsil; Han, Seol-Heui] Konkuk Univ, Sch Med, Med Ctr, Dept Neurol, Seoul, South Korea; [Wang, Yi] Weill Cornell Med Coll, Dept Radiol, New York, NY USA	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Cornell University	Moon, WJ (corresponding author), Konkuk Univ, Sch Med, Med Ctr, Dept Radiol, Seoul, South Korea.	mdmoonwj@kuh.ac.kr	Wang, Yi/GRS-4287-2022	Choi, Jin Woo/0000-0002-0716-5137; PARK, MINA/0000-0002-2005-7560; Moon, Won-Jin/0000-0002-8925-7376; Wang, Yi/0000-0003-1404-8526	National Research Foundation of Korea(NRF) grant - Korea government (MSIP) [2017R1A2B4010634]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI18C1038]	National Research Foundation of Korea(NRF) grant - Korea government (MSIP); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government (MSIP) (No. 2017R1A2B4010634). This research was also supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI18C1038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abner EL, 2016, ALZHEIMERS DEMENT, V12, P882, DOI 10.1016/j.jalz.2015.12.006; Aggarwal M, 2018, J MAGN RESON IMAGING, V47, P554, DOI 10.1002/jmri.25777; Bernasconi N, 2003, BRAIN, V126, P462, DOI 10.1093/brain/awg034; Blasco G, 2014, DIABETES CARE, V37, P3076, DOI 10.2337/dc14-0664; Boccardi M, 2011, J ALZHEIMERS DIS, V26, P61, DOI 10.3233/JAD-2011-0004; Bryan RN, 2014, RADIOLOGY, V272, P210, DOI 10.1148/radiol.14131494; Chen WW, 2014, RADIOLOGY, V271, P183, DOI 10.1148/radiol.13130353; Chew APT, 2012, RADIOLOGY, V265, P504, DOI 10.1148/radiol.12110636; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Gattringer T, 2016, NEUROBIOL AGING, V45, P61, DOI 10.1016/j.neurobiolaging.2016.05.008; Ghadery C, 2015, NEUROBIOL AGING, V36, P925, DOI 10.1016/j.neurobiolaging.2014.09.013; Hagemeier J., 2017, NEUROIMAGE CLIN; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; HARRINGTON MG, 1981, J NEUROL NEUROSUR PS, V44, P1168, DOI 10.1136/jnnp.44.12.1168; Hegde AN, 2011, RADIOGRAPHICS, V31, P5, DOI 10.1148/rg.311105041; Hopkins JA, 1997, MAGNET RESON MED, V37, P494, DOI 10.1002/mrm.1910370404; Kockelkoren R, 2018, EUR RADIOL, V28, P3811, DOI 10.1007/s00330-018-5372-8; Kockelkoren R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167444; Lammie GA, 2005, J CLIN NEUROSCI, V12, P49, DOI 10.1016/j.jocn.2004.03.026; Liu CL, 2015, TOMOGRAPHY, V1, P3, DOI 10.18383/j.tom.2015.00136; Liu JY, 2011, MATER ENG, V8, P82, DOI DOI 10.1016/J.NEUR0IMAGE.2011.08.082; Liu T, 2013, MAGN RESON MED, V69, P467, DOI 10.1002/mrm.24272; Liu T, 2012, RADIOLOGY, V262, P269, DOI 10.1148/radiol.11110251; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; MANN DMA, 1988, ACTA NEUROPATHOL, V76, P595, DOI 10.1007/BF00689598; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Moon WJ, 2012, KOREAN J RADIOL, V13, P674, DOI 10.3348/kjr.2012.13.6.674; Moon Y, 2016, J ALZHEIMERS DIS, V51, P737, DOI 10.3233/JAD-151037; Moore DF, 2003, AM J NEURORADIOL, V24, P1096; Moran C, 2015, NEUROLOGY, V85, P1123, DOI 10.1212/WNL.0000000000001982; Oakley AE, 2007, NEUROLOGY, V68, P1820, DOI 10.1212/01.wnl.0000262033.01945.9a; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Prins ND, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.10; Reske-Nielsen E, 1966, Diabetologia, V1, P233, DOI 10.1007/BF01257917; Schweser F, 2018, NEUROIMAGE, V167, P438, DOI 10.1016/j.neuroimage.2017.10.063; Straub S, 2017, MAGN RESON MED, V78, P204, DOI 10.1002/mrm.26369; Stuber C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010100; Su L, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0321-9; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; Ward R, 2014, LANCET NEUROL, V13, P1045, DOI 10.1016/S1474-4422(14)70117-6; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Yamada N, 1996, RADIOLOGY, V198, P171, DOI 10.1148/radiology.198.1.8539373; Yatomi Y, 2015, NEUROSCIENCE, V289, P214, DOI 10.1016/j.neuroscience.2014.12.054; Zhu WZ, 2009, RADIOLOGY, V253, P497, DOI 10.1148/radiol.2532082324	46	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205797	10.1371/journal.pone.0205797	http://dx.doi.org/10.1371/journal.pone.0205797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308069	Green Submitted, Green Published, gold			2022-12-26	WOS:000447173500124
J	Wofford, JD; Bolaji, N; Dziuba, N; Outten, FW; Lindahl, PA				Wofford, Joshua D.; Bolaji, Naimah; Dziuba, Nathaniel; Outten, F. Wayne; Lindahl, Paul A.			Evidence that a respiratory shield in Escherichia coli protects a low-molecular-mass Fe-II pool from O-2-dependent oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mossbauer spectroscopy; metal homeostasis; mitochondria; electron paramagnetic resonance (EPR); iron metabolism; chemiosmotic coupling; cyanide; labile iron pool; cyanide; iron homeostasis; ferric uptake regulator; ferritin	SACCHAROMYCES-CEREVISIAE CELLS; SULFUR CLUSTER BIOGENESIS; FERRIC UPTAKE REGULATOR; MOSSBAUER-SPECTROSCOPY; IRON-METABOLISM; MAGNETIC-PROPERTIES; DNA-DAMAGE; FUR; GROWTH; COMPLEXES	Iron is critical for virtually all organisms, yet major questions remain regarding the systems-level understanding of iron in whole cells. Here, we obtained Mossbauer and EPR spectra of Escherichia coli cells prepared under different nutrient iron concentrations, carbon sources, growth phases, and O-2 concentrations to better understand their global iron content. We investigated WT cells and those lacking Fur, FtnA, Bfr, and Dps proteins. The coarse-grain iron content of exponentially growing cells consisted of iron-sulfur clusters, variable amounts of nonheme high-spin Fe-II species, and an unassigned residual quadrupole doublet. The iron in stationary-phase cells was dominated by magnetically ordered Fe-III ions due to oxyhydroxide nanoparticles. Analysis of cytosolic extracts by size-exclusion chromatography detected by an online inductively coupled plasma mass spectrometer revealed a low-molecular-mass (LMM) Fe-II pool consisting of two iron complexes with masses of approximate to 500 (major) and approximate to 1300 (minor) Da. They appeared to be high-spin Fe-II species with mostly oxygen donor ligands, perhaps a few nitrogen donors, and probably no sulfur donors. Surprisingly, the iron content of E. coli and its reactivity with O-2 were remarkably similar to those of mitochondria. In both cases, a respiratory shield composed of membrane-bound iron-rich respiratory complexes may protect the LMM Fe-II pool from reacting with O-2. When exponentially growing cells transition to stationary phase, the shield deactivates as metabolic activity declines. Given the universality of oxidative phosphorylation in aerobic biology, the iron content and respiratory shield in other aerobic prokaryotes might be similar to those of E. coli and mitochondria.	[Wofford, Joshua D.; Lindahl, Paul A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Dziuba, Nathaniel; Lindahl, Paul A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Bolaji, Naimah; Outten, F. Wayne] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of South Carolina System; University of South Carolina Columbia	Lindahl, PA (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	lindahl@chem.tamu.edu		Outten, Franklin/0000-0002-9095-0194	National Institutes of Health [R35 GM127021, R01 GM112919]; Robert A. Welch Foundation [A1170]; Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112919, R35GM127021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35 GM127021 (to P.A.L.) and R01 GM112919 (to F.W.O.) and Robert A. Welch Foundation Grant A1170 (to P.A.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Welch Foundation.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Al-Attar S, 2013, COORDIN CHEM REV, V257, P64, DOI 10.1016/j.ccr.2012.05.022; Arras T, 1998, J BACTERIOL, V180, P2133, DOI 10.1128/JB.180.8.2133-2136.1998; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; BAUMINGER ER, 1980, BIOCHIM BIOPHYS ACTA, V623, P237, DOI 10.1016/0005-2795(80)90252-4; Beauchene NA, 2017, P NATL ACAD SCI USA, V114, P12261, DOI 10.1073/pnas.1707189114; Beilschmidt LK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15124; Benda R, 2002, BIOCHEMISTRY-US, V41, P15000, DOI 10.1021/bi026590q; BOHNKE R, 1995, BIOMETALS, V8, P223; Boughammoura A, 2008, J BACTERIOL, V190, P1518, DOI 10.1128/JB.01640-07; Bradley JM, 2016, J BIOL INORG CHEM, V21, P13, DOI 10.1007/s00775-016-1336-0; Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101; Carvalho DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134988; Clemente-Juan JM, 2002, INORG CHEM, V41, P1478, DOI 10.1021/ic010787+; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ferreira IGD, 2016, BIOMETALS, V29, P851, DOI 10.1007/s10534-016-9956-y; DICKSON DPE, 1979, EUR J BIOCHEM, V101, P291, DOI 10.1111/j.1432-1033.1979.tb04242.x; Dziuba N, 2018, METALLOMICS, V10, P802, DOI 10.1039/c8mt00055g; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; FONTECAVE M, 1991, BIOL MET, V4, P133, DOI 10.1007/BF01141302; Gutlich P, 2011, MOSSBAUER SPECTROSCOPY AND TRANSITION METAL CHEMISTRY: FUNDAMENTALS AND APPLICATIONS, P1; HAMED MY, 1993, J INORG BIOCHEM, V50, P193, DOI 10.1016/0162-0134(93)80025-5; Hohle TH, 2016, MOL MICROBIOL, V101, P152, DOI 10.1111/mmi.13381; Hristova D, 2008, BIOCHEMISTRY-US, V47, P3989, DOI 10.1021/bi702408k; HUDSON AJ, 1993, EUR J BIOCHEM, V218, P985, DOI 10.1111/j.1432-1033.1993.tb18457.x; Jacques JF, 2006, MOL MICROBIOL, V62, P1181, DOI 10.1111/j.1365-2958.2006.05439.x; Jhurry ND, 2012, BIOCHEMISTRY-US, V51, P5276, DOI 10.1021/bi300382d; KADIR FHA, 1991, J INORG BIOCHEM, V43, P753, DOI 10.1016/0162-0134(91)80046-K; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; Lane N, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015982; Lau CKY, 2016, FEMS MICROBIOL REV, V40, P273, DOI 10.1093/femsre/fuv049; Lemercier G, 2004, INORG CHEM, V43, P2105, DOI 10.1021/ic034907k; Lopez-Torrejon G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11426; Ma Z, 2012, MOL MICROBIOL, V86, P1144, DOI 10.1111/mmi.12049; MATZANKE BF, 1989, EUR J BIOCHEM, V183, P371, DOI 10.1111/j.1432-1033.1989.tb14938.x; McCormick SP, 2015, BIOCHEMISTRY-US, V54, P3442, DOI 10.1021/bi5015437; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Mettert EL, 2015, ANNU REV MICROBIOL, V69, P505, DOI 10.1146/annurev-micro-091014-104457; Miao R, 2011, BIOCHEMISTRY-US, V50, P2660, DOI 10.1021/bi102015s; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Moore MJ, 2018, BIOCHEMISTRY-US, V57, P672, DOI 10.1021/acs.biochem.7b01034; Munck E., 2000, PHYS METHODS BIOINOR, P287; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Outten FW, 2009, ANTIOXID REDOX SIGN, V11, P1029, DOI [10.1089/ars.2008.2296, 10.1089/ARS.2008.2296]; Paalme T, 1997, ANTON LEEUW INT J G, V71, P217, DOI 10.1023/A:1000198404007; Papaefthymiou GC, 2010, BBA-GEN SUBJECTS, V1800, P886, DOI 10.1016/j.bbagen.2010.03.018; Park J, 2013, BIOCHEMISTRY-US, V52, P9413, DOI 10.1021/bi4010304; POOLE RK, 1994, ANTON LEEUW INT J G, V65, P289, DOI 10.1007/BF00872215; Popescu CV, 1998, P NATL ACAD SCI USA, V95, P13431, DOI 10.1073/pnas.95.23.13431; REIFF WM, 1973, CHEM PHYS LETT, V22, P124, DOI 10.1016/0009-2614(73)80549-4; Reisner E, 2007, INORG CHEM, V46, P10754, DOI 10.1021/ic701663j; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wofford JD, 2016, METALLOMICS, V8, P692, DOI 10.1039/c6mt00070c; Wofford JD, 2015, J BIOL CHEM, V290, P26968, DOI 10.1074/jbc.M115.676668; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Woodmansee AN, 2002, METHOD ENZYMOL, V349, P3, DOI 10.1016/S0076-6879(02)49316-0	61	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					50	62		10.1074/jbc.RA118.005233	http://dx.doi.org/10.1074/jbc.RA118.005233			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30337367	hybrid, Green Published			2022-12-26	WOS:000455105500006
J	Chen, YS; Kozlov, G; Fakih, R; Funato, Y; Miki, H; Gehring, K				Chen, Yu Seby; Kozlov, Guennadi; Fakih, Rayan; Funato, Yosuke; Miki, Hiroaki; Gehring, Kalle			The cyclic nucleotide-binding homology domain of the integral membrane protein CNNM mediates dimerization and is required for Mg2+ efflux activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						magnesium; transporter; crystal structure; dimerization; biophysics; structural biology; X-ray crystallography; analytical ultracentrifugation; CNNM; cyclic nucleotide-binding homology domain	CARBOXY-TERMINAL REGION; CONE-ROD DYSTROPHY; STRUCTURAL BASIS; NA+/MG2+ EXCHANGERS; JALILI SYNDROME; MAGNESIUM; ULTRACENTRIFUGATION; REFINEMENT; MUTATIONS; FEATURES	Proteins of the cyclin M family (CNNMs; also called ancient conserved domain proteins, or ACDPs) are represented by four integral membrane proteins that have been proposed to function as Mg2+ transporters. CNNMs are associated with a number of genetic diseases affecting ion movement and cancer via their association with highly oncogenic phosphatases of regenerating liver (PRLs). Structurally, CNNMs contain an N-terminal extracellular domain, a transmembrane domain (DUF21), and a large cytosolic region containing a cystathionine--synthase (CBS) domain and a putative cyclic nucleotide-binding homology (CNBH) domain. Although the CBS domain has been extensively characterized, little is known about the CNBH domain. Here, we determined the first crystal structures of the CNBH domains of CNNM2 and CNNM3 at 2.6 and 1.9 resolutions. Contrary to expectation, these domains did not bind cyclic nucleotides, but mediated dimerization both in crystals and in solution. Analytical ultracentrifugation experiments revealed an inverse correlation between the propensity of the CNBH domains to dimerize and the ability of CNNMs to mediate Mg2+ efflux. CNBH domains from active family members were observed as both dimers and monomers, whereas the inactive member, CNNM3, was observed only as a dimer. Mutational analysis revealed that the CNBH domain was required for Mg2+ efflux activity of CNNM4. This work provides a structural basis for understanding the function of CNNM proteins in Mg2+ transport and associated diseases.	[Chen, Yu Seby; Kozlov, Guennadi; Fakih, Rayan; Gehring, Kalle] McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler,Rm 469, Montreal, PQ H3G 0B1, Canada; [Chen, Yu Seby; Kozlov, Guennadi; Fakih, Rayan; Gehring, Kalle] McGill Univ, Struct Biol Ctr, Montreal, PQ H3G 0B1, Canada; [Funato, Yosuke; Miki, Hiroaki] Osaka Univ, Microbial Dis Res Inst, Dept Cellular Regulat, Suita, Osaka 5650871, Japan	McGill University; McGill University; Osaka University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler,Rm 469, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013	Gehring, Kalle/0000-0001-6500-1184; Chen, Yu/0000-0002-0793-2391	National Science Foundation [DMR-0225180]; National Institutes of Health/NCRR Grant [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/NCRR Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Veronique Sauve and Jean-Francois Trempe for assistance,with crystallographic data collection, Nadeem Siddiqui for advice on AUC data processing, and Alexei Gorelik for advice on crystallographic data processing. Crystallographic data were acquired at the Canadian Light Source (CLS) and at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron,Source (CHESS). CHESS is supported by National Science Foundation award DMR-0225180 and National Institutes of Health/NCRR Grant RR-01646.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Corral-Rodriguez MA, 2014, BIOCHEM J, V464, P23, DOI 10.1042/BJ20140409; Arjona FJ, 2018, J PHYSIOL-LONDON, V596, P747, DOI 10.1113/JP275249; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brookes E, 2010, MACROMOL BIOSCI, V10, P746, DOI 10.1002/mabi.200900474; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; de Baaij JHF, 2012, J BIOL CHEM, V287, P13644, DOI 10.1074/jbc.M112.342204; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Funato Y, 2018, J PHYSIOL-LONDON, V596, P743, DOI 10.1113/JP275248; Funato Y, 2014, J CLIN INVEST, V124, P5398, DOI 10.1172/JCI76614; Gimenez-Mascarell P, 2017, J BIOL CHEM, V292, P786, DOI 10.1074/jbc.M116.759944; Goddard D., 2008, SPARKY 3; Gulerez I, 2016, EMBO REP, V17, P1890, DOI 10.15252/embr.201643393; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Hardy S, 2015, ONCOGENE, V34, P986, DOI 10.1038/onc.2014.33; Hirata Y, 2014, J BIOL CHEM, V289, P14731, DOI 10.1074/jbc.M114.551176; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; James ZM, 2018, J GEN PHYSIOL, V150, P225, DOI 10.1085/jgp.201711898; Kesters D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116369; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T., 1993, ANAL ULTRACENTRIFUGA, P90; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Payandeh J, 2013, BBA-BIOMEMBRANES, V1828, P2778, DOI 10.1016/j.bbamem.2013.08.002; Pessoa J, 2014, J GEN PHYSIOL, V144, P39, DOI 10.1085/jgp.201311145; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Rude RK, 1998, J BONE MINER RES, V13, P749, DOI 10.1359/jbmr.1998.13.4.749; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Schaffers OJM, 2018, AM J PHYSIOL-RENAL, V314, pF1027, DOI 10.1152/ajprenal.00634.2017; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Topcu V, 2017, OPHTHALMIC GENET, V38, P161, DOI 10.3109/13816810.2016.1164192; VanSchouwen B., 2016, NONCANONICAL CYCLIC, P123; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Wong K, 2015, J BIOL CHEM, V290, P24727, DOI 10.1074/jbc.M115.671263; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang HZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00147-2	50	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					19998	20007		10.1074/jbc.RA118.005672	http://dx.doi.org/10.1074/jbc.RA118.005672			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30341174	Green Published, hybrid			2022-12-26	WOS:000454685900006
J	Nagel, S; Spuler, M				Nagel, Sebastian; Spueler, Martin			Modelling the brain response to arbitrary visual stimulation patterns for a flexible high-speed Brain-Computer Interface	PLOS ONE			English	Article							POTENTIALS	Visual evoked potentials (VEPs) can be measured in the EEG as response to a visual stimulus. Commonly, VEPs are displayed by averaging multiple responses to a certain stimulus or a classifier is trained to identify the response to a certain stimulus. While the traditional approach is limited to a set of predefined stimulation patterns, we present a method that models the general process of VEP generation and thereby can be used to predict arbitrary visual stimulation patterns from EEG and predict how the brain responds to arbitrary stimulation patterns. We demonstrate how this method can be used to model single-flash VEPs, steady state VEPs (SSVEPs) or VEPs to complex stimulation patterns. It is further shown that this method can also be used for a high-speed BCI in an online scenario where it achieved an average information transfer rate (ITR) of 108.1 bit/min. Furthermore, in an offline analysis, we show the flexibility of the method allowing to modulate a virtually unlimited amount of targets with any desired trial duration resulting in a theoretically possible ITR of more than 470 bit/min.	[Nagel, Sebastian; Spueler, Martin] Univ Tubingen, Wilhelm Schickard Inst Comp Sci, Dept Comp Engn, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Nagel, S (corresponding author), Univ Tubingen, Wilhelm Schickard Inst Comp Sci, Dept Comp Engn, D-72076 Tubingen, Germany.	nagels@informatik.uni-tuebingen.de			Deutsche Forschungsgemeinschaft (DFG) [SP-1533\2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG; grant SP-1533\2-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, MATLAB VERS 9 3 R201, DOI [10.1016/j.jneumeth.2017.11.018, DOI 10.1016/J.JNEUMETH.2017.11.018]; Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Capilla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014543; Cardona J, 2016, IEEE SYS MAN CYBERN, P4477, DOI 10.1109/SMC.2016.7844937; Chen XG, 2015, P NATL ACAD SCI USA, V112, pE6058, DOI 10.1073/pnas.1508080112; Chirapapaisan N, 2015, DOC OPHTHALMOL, V130, P25, DOI 10.1007/s10633-014-9466-6; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Lalor EC, 2006, NEUROIMAGE, V32, P1549, DOI 10.1016/j.neuroimage.2006.05.054; Liu YH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202478; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Nagel S, 2018, P 7 INT BRAIN COMP I, P164; Nagel S, 2017, P 7 INT BRAIN COMP I, P349; Nagel S, 2018, J NEUROSCI METH, V295, P45, DOI 10.1016/j.jneumeth.2017.11.018; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Spuler M, 2014, IEEE T NEUR SYS REH, V22, P1097, DOI 10.1109/TNSRE.2013.2290870; Spuler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051077; Spuler M, 2012, P 20 EUR S ART NEUR, P103, DOI [10.13140/2.1.2186.7526, DOI 10.13140/2.1.2186.7526]; Sutter E. E., 1984, Proceedings of the Symposium on Biosensors (Cat. No. 84CH2068-5), P95; Thielen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133797; Tong JJ, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-5; Walter A, 2014, NEUROCOMPUTING, V141, P46, DOI 10.1016/j.neucom.2014.01.048; Wei QG, 2018, IEEE T NEUR SYS REH, V26, P1178, DOI 10.1109/TNSRE.2018.2837501; Wolpaw J R, 1998, IEEE Trans Rehabil Eng, V6, P326, DOI 10.1109/86.712231; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038603	27	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0206107	10.1371/journal.pone.0206107	http://dx.doi.org/10.1371/journal.pone.0206107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346983	Green Published, gold, Green Submitted			2022-12-26	WOS:000447938400035
J	Widinugraheni, S; Nino-Sanchez, J; van der Does, HC; van Dam, P; Garcia-Bastidas, FA; Subandiyah, S; Meijer, HJG; Kistler, HC; Kema, GHJ; Rep, M				Widinugraheni, S.; Nino-Sanchez, J.; van der Does, H. C.; van Dam, P.; Garcia-Bastidas, F. A.; Subandiyah, S.; Meijer, H. J. G.; Kistler, H. C.; Kema, G. H. J.; Rep, M.			A SIX1 homolog in Fusarium oxysporum f.sp cubense tropical race 4 contributes to virulence towards Cavendish banana	PLOS ONE			English	Article							F-SP CUBENSE; I-3-MEDIATED RESISTANCE; MEDIATED TRANSFORMATION; PANAMA-DISEASE; TOMATO; GENE; PROTEINS; GENOMICS; REVEALS	The fungus Fusarium oxysporum f.sp. cubense (Focub) causes Fusarium wilt of banana. Focub strains are divided into races according to their host specificity, but which virulence factors underlie these interactions is currently unknown. In the F. oxysporum f.sp. lycopersici (Fop-tomato system, small secreted fungal proteins, called Six proteins, were identified in the xylem sap of infected plants. The Fol Six1 protein contributes to virulence and has an avirulence function by activating the 1-3 immune receptor of tomato. The Focub tropical race 4 (TR4) genome harbors three SIX1 homologs: SIX1a, band c. In this study, the role of Focub-SIX1a in pathogenicity was evaluated since this homolog is present in not only TR4 but also in other races. A deletion mutant of the S1X1a gene from Focub TR4 strain II5 was generated (Focub Delta SIX1a) and tested in planta. Mutants were found to be severely compromised in their virulence. Ectopic integration of the Focub-SIX1a gene in the Focub Delta SIX1a strain restored virulence to wild type levels. We conclude that Focub-SIX1a is required for full virulence of Focub TR4 towards Cavendish banana.	[Widinugraheni, S.; van der Does, H. C.; van Dam, P.; Rep, M.] Univ Amsterdam, Swammerdam Inst Life Sci, Mol Plant Pathol, Amsterdam, Netherlands; [Widinugraheni, S.] Nusa Cendana Univ, Fac Agr, Kupang, Indonesia; [Nino-Sanchez, J.; Kistler, H. C.] Univ Minnesota, ARS, USDA, Cereal Dis Lab, St Paul, MN 55108 USA; [Garcia-Bastidas, F. A.; Meijer, H. J. G.; Kema, G. H. J.] Wageningen Univ & Res, Wageningen Plant Res, Wageningen, Netherlands; [Subandiyah, S.] Gadjah Mada Univ, Fac Agr, Dept Plant Protect, Yogyakarta, Indonesia; [Subandiyah, S.] Gadjah Mada Univ, Res Ctr Biotechnol, Yogyakarta, Indonesia	University of Amsterdam; Universitas Nusa Cendana; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; Wageningen University & Research; Gadjah Mada University; Gadjah Mada University	Rep, M (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Mol Plant Pathol, Amsterdam, Netherlands.	m.rep@uva.nl	Subandiyah, Siti/AEX-6339-2022; Meijer, Harold/S-3891-2019; Widinugraheni, Sri/GPK-0117-2022; Niño Sánchez, Jonatan/AAX-9723-2021; Kistler, Harold/AAC-1645-2019; Garcia-Bastidas, Fernando/AGR-2366-2022; Meijer, HJG/AFN-5216-2022	Subandiyah, Siti/0000-0002-7718-2362; Meijer, Harold/0000-0002-0883-219X; Widinugraheni, Sri/0000-0001-9775-9096; Niño Sánchez, Jonatan/0000-0002-0356-9871; Kistler, Harold/0000-0001-5312-6297; Meijer, HJG/0000-0002-0883-219X; van Dam, Peter/0000-0002-7366-2860; Rep, Martijn/0000-0003-3608-6283; Garcia-Bastidas, Fernando/0000-0001-6435-1174	KNAW-SPIN Project [SPIN3-JRP-34]; Netherlands Organization for Scientific Research (nwo.nl) through Veni grant [016.121.067]; Dioraphte Foundation; World Class Professor (WCP) Program A-UGM [168.A10/D2/KP/2017]	KNAW-SPIN Project; Netherlands Organization for Scientific Research (nwo.nl) through Veni grant; Dioraphte Foundation; World Class Professor (WCP) Program A-UGM	This study was made possible by the support of KNAW-SPIN Project SPIN3-JRP-34 (www.Fusariumwilt.org). HCvdD was supported by the Netherlands Organization for Scientific Research (nwo.nl) through Veni grant 016.121.067. HJGM and GHJK are supported by the Dioraphte Foundation, and SS is supported by the World Class Professor (WCP) Program A-UGM ((168.A10/D2/KP/2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank to Prof. Ben Cornelissen and Like Fokkens for their critical input and suggestions. We also thank UNIFARM, Wageningen in which the green house experiments were conducted. Bert Essenstam, Fajarudin Ahmad, Nani M. Martawi and Sarah Schmidt are acknowledged for their help during the green house work. This study was made possible by the support of a KNAW-SPIN Project (www.Fusariumwilt.org). HCvdD was supported by the Netherlands Organization for Scientific Research (nwo.nl) through Veni grant 016.121.067. HJGM and GHJK are supported by the Dioraphte Foundation, and SS is supported by the World Class Professor (WCP) Program A-UGM ((168.A10/D2/KP/2017).	Catanzariti AM, 2015, NEW PHYTOL, V207, P106, DOI 10.1111/nph.13348; Catanzariti AM, 2010, FUNCT PLANT BIOL, V37, P901, DOI 10.1071/FP10077; Covert SF, 2001, MYCOL RES, V105, P259, DOI 10.1017/S0953756201003872; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Czislowski E, 2018, MOL PLANT PATHOL, V19, P1155, DOI 10.1111/mpp.12594; Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; Garcia-Bastidas F, 2014, PLANT DIS, V98, P694, DOI 10.1094/PDIS-09-13-0954-PDN; Gawehns F, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00967; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Guo LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095543; Houterman PM, 2007, MOL PLANT PATHOL, V8, P215, DOI 10.1111/J.1364-3703.2007.00384.X; Houterman PM, 2009, PLANT J, V58, P970, DOI 10.1111/j.1365-313X.2009.03838.x; Houterman PM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000061; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Li EZ, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1407-8; Lievens B, 2009, FEMS MICROBIOL LETT, V300, P201, DOI 10.1111/j.1574-6968.2009.01783.x; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Meldrum RA, 2012, AUSTRALAS PLANT PATH, V41, P551, DOI 10.1007/s13313-012-0122-x; Michielse CB, 2009, MOL PLANT PATHOL, V10, P311, DOI [10.1111/J.1364-3703.2009.00538.X, 10.1111/j.1364-3703.2009.00538.x]; Michielse CB, 2005, CURR GENET, V48, P1, DOI 10.1007/s00294-005-0578-0; Molina AB, 2009, ACTA HORTIC, V828, P109; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; Ordonez N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005197; Paz Z, 2011, FUNGAL GENET BIOL, V48, P677, DOI 10.1016/j.fgb.2011.02.003; Perez-Vicente L., 2014, W DIAG FUS WILT, V4, P1; Ploetz RC, 2015, CROP PROT, V73, P7, DOI 10.1016/j.cropro.2015.01.007; Ploetz RC, 2000, DIS BANAN ABACA ENSE, P544; Punt PJ, 1992, TRANSFORMATION FILAM, P447, DOI [10.1016/0076-6879(92)16041-H, DOI 10.1016/0076-6879(92)16041-H]; Rep M, 2005, FEMS MICROBIOL LETT, V253, P19, DOI 10.1016/j.femsle.2005.09.014; Rep M, 2005, MOL PLANT MICROBE IN, V18, P15, DOI 10.1094/MPMI-18-0015; Rep M, 2004, MOL MICROBIOL, V53, P1373, DOI 10.1111/j.1365-2958.2004.04177.x; Schmidt SM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-119; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STOVER RH, 1986, FRUITS, V41, P175; SU HJ, 1986, PLANT DIS, V70, P814, DOI 10.1094/PD-70-814; Takken F, 2010, MOL PLANT PATHOL, V11, P309, DOI 10.1111/j.1364-3703.2009.00605.x; Taylor A, 2015, SP CEPAE, V7, P1032; van Dam P, 2016, ENVIRON MICROBIOL, V18, P4087, DOI 10.1111/1462-2920.13445; van der Does HC, 2008, FUNGAL GENET BIOL, V45, P1257, DOI 10.1016/j.fgb.2008.06.002; WAITE B. H., 1963, TROP AGRIC, V40, P299	40	30	32	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205896	10.1371/journal.pone.0205896	http://dx.doi.org/10.1371/journal.pone.0205896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346962	Green Published, gold, Green Submitted			2022-12-26	WOS:000447938400022
J	Kim, SI; Hwang, S; Lee, M				Kim, Sung-il; Hwang, Suyoung; Lee, Minhye			The benefits of negative yet informative feedback	PLOS ONE			English	Article							VENTROLATERAL PREFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; DECLARATIVE MEMORY TASK; NUCLEUS-ACCUMBENS; REWARD; MOTIVATION; PERFORMANCE; DOPAMINE; ANTICIPATION; ACHIEVEMENT	We investigated whether negative feedback with information could benefit both behavioral and neural responses. Fifteen participants were scanned with functional magnetic resonance imaging (fMRI) while receiving various feedbacks in a novel perceptual task. Behavioral data showed that reaction times of task performance were faster after receiving negative informative feedback compared to negative confirmatory feedback. The fMRI analysis of the interaction contrast between feedback type (informative vs. confirmatory) and valence (negative vs. positive) showed greater activation in the ventrolateral prefrontal cortex (vIPFC) and the ventral striatum in response to negative informative compared to confirmatory feedback. The psychophysiological interactions (PPI) analyses showed that the vIPFC activation was positively correlated with the amygdala and the rostral cingulate zone (RCZ). The ventral striatum activation was negatively correlated with the dorsolateral prefrontal cortex (dIPFC). These results suggest that negative but informative feedback benefits subsequent performance and its primary function is to elicit positive prediction error (instructive signal) and to induce cognitive control to guide subsequent goal-directed behavior.	[Kim, Sung-il; Lee, Minhye] Korea Univ, Brain & Motivat Res Inst, Dept Educ, Seoul, South Korea; [Hwang, Suyoung] Dankook Univ, Dept Teaching Educ, Yongin, South Korea	Korea University; Dankook University	Kim, SI (corresponding author), Korea Univ, Brain & Motivat Res Inst, Dept Educ, Seoul, South Korea.	sungkim@korea.ac.kr		Kim, Sung-il/0000-0002-3861-7036	College of Education, Korea University Grant in 2017	College of Education, Korea University Grant in 2017	This research was supported by the College of Education, Korea University Grant in 2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the College of Education, Korea University Grant in 2017.	Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Audia P.G., 2003, HUM RESOUR MANAGE R, V13, P631, DOI [10.1016/j.hrmr.2003.11.006, DOI 10.1016/J.HRMR.2003.11.006]; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; BAUMEISTER RF, 1990, BASIC APPL SOC PSYCH, V11, P131, DOI 10.1207/s15324834basp1102_2; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Bischoff-Grethe A, 2009, NEUROIMAGE, V44, P243, DOI 10.1016/j.neuroimage.2008.08.038; CARVER CS, 1990, PSYCHOL REV, V97, P19, DOI 10.1037/0033-295X.97.1.19; Cohen J, 2002, CURR OPIN NEUROBIOL, V12, P223, DOI 10.1016/S0959-4388(02)00314-8; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Floresco SB, 2015, ANNU REV PSYCHOL, V66, P25, DOI 10.1146/annurev-psych-010213-115159; Forster J, 2001, J EXP SOC PSYCHOL, V37, P253, DOI 10.1006/jesp.2000.1455; Goodman JS, 2004, J APPL PSYCHOL, V89, P248, DOI 10.1037/0021-9010.89.2.248; Hattie J, 2007, REV EDUC RES, V77, P81, DOI 10.3102/003465430298487; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; Hull CL, 1952, BEHAV SYSTEM INTRO B; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Jimura K, 2004, NEUROIMAGE, V22, P1578, DOI 10.1016/j.neuroimage.2004.04.012; Jung J, 2010, HUM BRAIN MAPP, V31, P1217, DOI 10.1002/hbm.20930; Kim SI, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00098; Kim SI, 2010, CONTEMP EDUC PSYCHOL, V35, P141, DOI 10.1016/j.cedpsych.2010.04.002; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kohn N, 2014, NEUROIMAGE, V87, P345, DOI 10.1016/j.neuroimage.2013.11.001; Kulhavy RW, 1989, EDUC PSYCHOL REV, V1, P279, DOI 10.1007/BF01320096; Lee W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107254; Lempert KM, 2016, J COGNITIVE NEUROSCI, V28, P261, DOI 10.1162/jocn_a_00892; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Narciss S, 2004, EXP PSYCHOL, V51, P214, DOI 10.1027/1618-3169.51.3.214; O'Reilly RC, 2010, TRENDS NEUROSCI, V33, P355, DOI 10.1016/j.tins.2010.05.002; Ozyurt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036509; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Rodriguez PF, 2006, HUM BRAIN MAPP, V27, P306, DOI 10.1002/hbm.20186; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Shute VJ, 2008, REV EDUC RES, V78, P153, DOI 10.3102/0034654307313795; Talairach J., 1988, COPLANAR STEREOTAXIC; Tricomi E, 2008, NEUROIMAGE, V41, P1154, DOI 10.1016/j.neuroimage.2008.02.066; Tricomi E, 2012, COGN AFFECT BEHAV NE, V12, P361, DOI 10.3758/s13415-011-0077-3; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Ullsperger M, 2014, PHYSIOL REV, V94, P35, DOI 10.1152/physrev.00041.2012; van den Bos W, 2007, COGN AFFECT BEHAV NE, V7, P337, DOI 10.3758/CABN.7.4.337; van den Bos W, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.052.2009; van Leijenhorst L, 2006, NEUROPSYCHOLOGIA, V44, P2158, DOI 10.1016/j.neuropsychologia.2006.02.002; Woo YK, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00378; Yanagisawa K, 2016, J EXP PSYCHOL GEN, V145, P273, DOI 10.1037/xge0000121; Zanolie K, 2008, NEUROPSYCHOLOGIA, V46, P117, DOI 10.1016/j.neuropsychologia.2007.08.009	54	5	5	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205183	10.1371/journal.pone.0205183	http://dx.doi.org/10.1371/journal.pone.0205183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX5DH	30339666	Green Published, Green Submitted, gold			2022-12-26	WOS:000447761400009
J	Yao, LL; Li, DH; Liu, LL				Yao, Lele; Li, Donghui; Liu, Lingling			An improved large signal model of full-bridge LLC converter	PLOS ONE			English	Article							DC-DC CONVERTERS; RESONANT CONVERTERS; DC/DC CONVERTER; HIGH-EFFICIENCY; AVERAGE MODEL; DESIGN; ALGORITHM; STRATEGY; MPPT	For the full-bridge LLC converter, it is necessary to establish a large signal model with low-complexity and high-precision when the current of filter inductor works under the continuous conduction mode (CCM) situation. In terms of low complexity, peak values of resonant state variables and average values of slow state variables are taken as the measured indexes between models and actual converter. Models based on the first harmonic approximation (FHA) are studied in depth because they have lower complexity than the existing models. From prospective of high precision, deficiencies of typical FHA model are explained in the light of harmonic generation mechanism of primary current and influence of Fourier series on the typical equivalent circuit. Therefore, transient process of each metallic oxide semiconductor field effect transistor (MOSFET) and its related fast recovery diode, transient process of Schottky rectifier diodes, piecewise equivalent circuit, appropriate selection of variables, and simplified modified dynamic equations are all considered. Furthermore, the unified proposed model is achieved according to the equivalent principle of indexes between aforementioned improved analyses and proposed model. Numerical results of typical FHA model and proposed model are given in accordance with the key indexes. Then, corresponding experimental results are also presented. Differences of indexes between the two models and the actual converter are compared respectively. Though complexity of proposed model is the same as that of typical FHA model, precision of proposed model is higher than that of typical FHA model.	[Yao, Lele; Li, Donghui; Liu, Lingling] Tianjin Univ, Sch Elect & Informat Engn, Tianjin, Peoples R China	Tianjin University	Yao, LL (corresponding author), Tianjin Univ, Sch Elect & Informat Engn, Tianjin, Peoples R China.	746267853@qq.com						Berger M, 2018, IEEE T POWER DELIVER, V33, P2020, DOI 10.1109/TPWRD.2018.2817878; Buccella C, 2015, IEEE T POWER ELECTR, V30, P5881, DOI 10.1109/TPEL.2014.2371137; Chen MJ, 2019, IEEE INTERNET THINGS, V6, P1410, DOI 10.1109/JIOT.2018.2856241; Chen Y, 2017, IEEE J EM SEL TOP P, V5, P124, DOI 10.1109/JESTPE.2016.2615071; Degioanni F, 2018, IEEE T POWER ELECTR, V33, P9875, DOI 10.1109/TPEL.2017.2786044; Deng JJ, 2014, IEEE T VEH TECHNOL, V63, P1581, DOI 10.1109/TVT.2013.2287379; Di Capua G, 2015, IEEE T POWER ELECTR, V30, P1567, DOI 10.1109/TPEL.2014.2314241; Fang X, 2012, IEEE T POWER ELECTR, V27, P1985, DOI 10.1109/TPEL.2011.2168545; Fang ZJ, 2018, IEEE T POWER ELECTR, V33, P887, DOI 10.1109/TPEL.2017.2672731; Fang ZJ, 2015, IEEE T POWER ELECTR, V30, P5469, DOI 10.1109/TPEL.2014.2379278; Feng WY, 2013, IEEE T POWER ELECTR, V28, P2415, DOI 10.1109/TPEL.2012.2212213; Hu ZY, 2016, IEEE T POWER ELECTR, V31, P5435, DOI 10.1109/TPEL.2015.2496333; Hu ZY, 2016, IEEE T POWER ELECTR, V31, P5448, DOI 10.1109/TPEL.2015.2496179; Huang C, 2018, IEEE T SUSTAIN ENERG, V9, P45, DOI 10.1109/TSTE.2017.2714705; Jahromi MG, 2017, IEEE T IND APPL, V53, P5105, DOI 10.1109/TIA.2017.2712118; Jeyaprabha SB, 2017, IEEE T SUSTAIN ENERG, V8, P1763, DOI 10.1109/TSTE.2017.2710302; Kim JW, 2017, IEEE T IND ELECTRON, V64, P1178, DOI 10.1109/TIE.2016.2618338; Kim KW, 2018, IEEE T POWER ELECTR, V33, P7252, DOI 10.1109/TPEL.2017.2760902; Kundu U, 2017, IEEE T IND ELECTRON, V64, P9311, DOI 10.1109/TIE.2017.2711520; Lai CM, 2018, IEEE T VEH TECHNOL, V67, P1036, DOI 10.1109/TVT.2017.2763157; Lai YS, 2014, IEEE T POWER ELECTR, V29, P4763, DOI 10.1109/TPEL.2013.2283747; Li X, 2018, IEEE T POWER ELECTR, V33, P7071, DOI 10.1109/TPEL.2017.2752419; Liu C, 2017, IEEE T IND ELECTRON, V64, P6970, DOI 10.1109/TIE.2017.2682784; Liu JQ, 2017, IEEE T POWER ELECTR, V32, P6716, DOI 10.1109/TPEL.2016.2623418; Sosa JL, 2012, IEEE T IND ELECTRON, V59, P1554, DOI 10.1109/TIE.2011.2161253; Luo X, 2019, FUTURE GENER COMP SY, V93, P1023, DOI 10.1016/j.future.2018.04.085; Mohammadi M, 2018, IEEE T POWER ELECTR, V33, P777, DOI 10.1109/TPEL.2017.2666803; Mohammadi M, 2016, IEEE T POWER ELECTR, V31, P6738, DOI 10.1109/TPEL.2015.2504489; Mosa M, 2017, IET RENEW POWER GEN, V11, P1401, DOI 10.1049/iet-rpg.2017.0018; Mostacciuolo E, 2018, IEEE T POWER ELECTR, V33, P3472, DOI 10.1109/TPEL.2017.2702389; Mueller JA, 2018, IEEE T POWER ELECTR, V33, P9975, DOI 10.1109/TPEL.2018.2797966; Noah M, 2018, IET POWER ELECTRON, V11, P339, DOI 10.1049/iet-pel.2017.0485; Pahlevaninezhad M, 2013, IEEE T POWER ELECTR, V28, P5293, DOI 10.1109/TPEL.2013.2243759; Park HP, 2017, IEEE T POWER ELECTR, V32, P7770, DOI 10.1109/TPEL.2016.2635261; Ryu SH, 2015, ELECTRON LETT, V51, P928, DOI 10.1049/el.2015.0572; Sun L, 2017, IEEE T POWER ELECTR, V32, P9364, DOI 10.1109/TPEL.2017.2653842; Sun XF, 2017, IEEE T POWER ELECTR, V32, P69, DOI 10.1109/TPEL.2016.2530748; Wang YJ, 2015, IEEE T IND ELECTRON, V62, P5446, DOI 10.1109/TIE.2015.2416341; Yang DD, 2016, IEEE T POWER ELECTR, V31, P7996, DOI 10.1109/TPEL.2016.2514399; Yang G, 2015, IEEE T POWER ELECTR, V30, P1876, DOI 10.1109/TPEL.2014.2328554; Yao C, 2015, IEEE T POWER ELECTR, V30, P1668, DOI 10.1109/TPEL.2014.2317795; Yeung RSC, 2017, SOL ENERGY, V141, P145, DOI 10.1016/j.solener.2016.11.017; Yu RY, 2012, IEEE T POWER ELECTR, V27, P3243, DOI 10.1109/TPEL.2011.2179562; Zhang K, 2017, IEEE T POWER ELECTR, V32, P1964, DOI 10.1109/TPEL.2016.2555929; Zhang ZL, 2018, IEEE T POWER ELECTR, V33, P1303, DOI 10.1109/TPEL.2017.2683798; Zong S, 2015, IEEE T IND ELECTRON, V62, P4170, DOI 10.1109/TIE.2014.2385661	46	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2018	13	10							e0205904	10.1371/journal.pone.0205904	http://dx.doi.org/10.1371/journal.pone.0205904			56	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX5DH	30339681	Green Submitted, gold, Green Published			2022-12-26	WOS:000447761400024
J	de Lima, FCG; Porpino, KD				Guimaraes de Lima, Fabio Cunha; Porpino, Kleberson de Oliveira			Ectoparasitism and infections in the exoskeletons of large fossil cingulates	PLOS ONE			English	Article							OSTEODERMS; XENARTHRA; TAXONOMY; FLEAS; HOST; WILD	Studies on paleopathological alterations in fossil vertebrates, including damages caused by infections and ectoparasites, are important because they are potential sources of paleo-ecological information. Analyzing exoskeleton material (isolated osteoderms, carapace and caudal tube fragments) from fossil cingulates of the Brazilian Quaternary Megafauna, we identified damages that were attributed to attacks by fleas and dermic infections. The former were compatible with alterations produced by one species of flea of the genus Tunga, which generates well-delimited circular perforations with a patterned distribution along the carapace; the latter were attributable to pathogenic microorganisms, likely bacteria or fungi that removed the ornamentation of osteoderms and, in certain cases, generated craters or pittings. Certain bone alterations observed in this study represent the first record of flea attack and pitting in two species of large glyptodonts (Panochthus and Glyptotherium) and in 9a non-glyptodontid large cingulate (Pachyarmatherium) from the Quaternary of the Brazilian Intertropical Region. These new occurrences widen the geographic distribution of those diseases during the Cenozoic and provide more evidence for the co-evolutionary interaction between cingulates and parasites registered to date only for a small number of other extinct and extant species.	[Guimaraes de Lima, Fabio Cunha; Porpino, Kleberson de Oliveira] Univ Fed Rural Semi Arido, Programa Posgrad Ecol & Coservacao, Mossoro, Brazil; [Porpino, Kleberson de Oliveira] Univ Estado Rio Grande do Norte, Dept Ciencias Biol, Mossoro, Brazil	Universidade Federal Rural do Semi-Arido (UFERSA); Universidade do Estado do Rio Grande do Norte (UERN)	Porpino, KD (corresponding author), Univ Fed Rural Semi Arido, Programa Posgrad Ecol & Coservacao, Mossoro, Brazil.; Porpino, KD (corresponding author), Univ Estado Rio Grande do Norte, Dept Ciencias Biol, Mossoro, Brazil.	kleporpino@yahoo.com.br	Porpino, Kleberson O./B-7328-2014	Porpino, Kleberson O./0000-0003-2081-3722	National Council for Scientific and Technological Development (CNPq) [308013/2015-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The National Council for Scientific and Technological Development (CNPq, http://cnpq.br/) provided support for KOP (Scholarship in Research Productivity #308013/2015-8). The study was also funded by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior: N/A: MSc Fabio Cunha Guimaraes Lima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramayo SA, 2006, 3 CONGR ARG CAUT GEO, P737; Araujo-Junior Herminio I., 2011, Pesquisas em Geociencias, V38, P67; Araujo-Junior HI, 2017, J S AM EARTH SCI, DOI [10.1016/j.jsames.2017.07.006, DOI 10.1016/J.JSAMES.2017.07.006]; AUDY JR, 1972, J MED ENTOMOL, V9, P487, DOI 10.1093/jmedent/9.6.487; Auler AS, 2006, PALAEOGEOGR PALAEOCL, V240, P508, DOI 10.1016/j.palaeo.2006.03.002; Barbosa F. H. S., 2014, REV MUSEO PROVINCEAL, V1, P9; Burmeister C, 1864, ANN MAGAZINE NATURAL, V14, p81 97; Cartelle C., 1999, MAMMALS NEOTROPICALS, V3, P27; de Araujo HI, 2013, PALAEOGEOGR PALAEOCL, V378, P52, DOI 10.1016/j.palaeo.2013.04.001; Barbosa FHD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088646; Dominato VH, 2009, REV BRAS PALEONTOLOG, V12, P77, DOI 10.4072/rbp.2009.1.07; Druetta HS, 2012, ARGENTINA AMEGHINIAN, V49, P45; Druetta HS, 2009, 3 C AS PAL SUD RES, V86; Blanco RE, 2009, P ROY SOC B-BIOL SCI, V276, P3971, DOI 10.1098/rspb.2009.1144; Ezquiaga MC, 2015, MED VET ENTOMOL, V29, P196, DOI 10.1111/mve.12106; Ezquiaga M.C., 2013, THESIS; Faure M, 1999, COMPTES RENDUS ACA 2, DOI [10.1016/S1251-8050(00), DOI 10.1016/S1251-8050(00)]; Fernandes, 2007, ICNOLOGIA, P88; Fernandez M., 1922, REV MUSEO LA PLATA, V26, P215; Gaudin Timothy J., 2006, P1; Gillette DD, 2016, J MAMM EVOL, V23, P133, DOI 10.1007/s10914-015-9309-6; Gonzalez A, 2003, ECTOPARASITOSIS HUMA, P284; Hammond H., 2014, ATEK NA, V4, P9; Hill RV, 2006, J MORPHOL, V267, P1441, DOI 10.1002/jmor.10490; Hubbe A, 2013, EARTH-SCI REV, V118, P1, DOI 10.1016/j.earscirev.2013.01.003; Jesus JM, 2017, 25 C BRAS PAL B RES, P148; Linardi PM, 2014, PARASITOL RES, V113, P3517, DOI 10.1007/s00436-014-4081-8; Matthias AE, 2016, INT J PALEOPATHOL, V13, P82, DOI 10.1016/j.ijpp.2016.02.006; McKenna MC, 1997, CLASSIFICATION MAMMA; Mikulas Radek, 2006, Ichnos, V13, P113, DOI 10.1080/10420940600850729; Montalvo CI, 2016, QUATERN INT, V391, P90, DOI 10.1016/j.quaint.2015.08.017; Neves DP., 2004, PARASITOLOGIA HUMANA, V11th; Neto VDP, 2016, PALAEOGEOGR PALAEOCL, V453, P30, DOI 10.1016/j.palaeo.2016.03.026; PALMER AN, 1991, GEOL SOC AM BULL, V103, P1, DOI 10.1130/0016-7606(1991)103<0001:OAMOLC>2.3.CO;2; Paula Couto C., 1979, TRATADO PALEOMASTOZO; Paula Couto C, 1980, ANAIS ACAD BRASILEIR, V52, P141; Pirrone CA, 2014, ICHNOS, V21, P251, DOI 10.1080/10420940.2014.958225; Pirrone CA, 2014, J PALEONTOL, V88, P195, DOI 10.1666/11-058; Porpino KD, 2014, J VERTEBR PALEONTOL, V34, P1165, DOI 10.1080/02724634.2014.863203; Porpino KD, 2009, J VERTEBR PALEONTOL, V29, P881; Porpino Kleberson de Oliveira, 2002, Revista Brasileira de Paleontologia, V4, P51; Ribeiro RC, 2013, QUATERN INT, V305, P91, DOI 10.1016/j.quaint.2012.07.017; Sanz Santos M. A., 2001, THESIS; Silva F.M., 2010, QUATERNARY ENV GEOSC, V2, P1, DOI [10.5380/abequa.v2i1-2.14182, DOI 10.5380/ABEQUA.V2I1-2.14182]; Sinibaldi RW, 2010, WHAT YOUR FOSSIL CAN; Tomassini RL, 2016, INT J PALEOPATHOL, V15, P65, DOI 10.1016/j.ijpp.2016.08.004; Dantas MAT, 2016, SPRING EARTH SYST SC, P207, DOI 10.1007/978-3-319-40000-6_12; Truman R, 2005, LEPROSY REV, V76, P198; Waldron T, 2009, CAMB MAN ARCHAEOL, P1; Wenker CJW, 1998, J ZOO WILDLIFE MED, V29, P474; Whiting MF, 2008, CLADISTICS, V24, P677, DOI 10.1111/j.1096-0031.2008.00211.x; Zhu QY, 2015, MOL PHYLOGENET EVOL, V90, P129, DOI 10.1016/j.ympev.2015.04.027	52	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205656	10.1371/journal.pone.0205656	http://dx.doi.org/10.1371/journal.pone.0205656			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335796	Green Published, gold, Green Submitted			2022-12-26	WOS:000447701300039
J	Lamarca, A; Galdy, S; Barriuso, J; Moghadam, S; Beckett, E; Rogan, J; Backen, A; Billington, C; McNamara, MG; Hubner, RA; Cramer, A; Valle, JW				Lamarca, Angela; Galdy, Salvatore; Barriuso, Jorge; Moghadam, Sharzad; Beckett, Elizabeth; Rogan, Jane; Backen, Alison; Billington, Catherine; McNamara, Mairead G.; Hubner, Richard A.; Cramer, Angela; Valle, Juan W.			The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; POOR-PROGNOSIS; ERBB RECEPTORS; OVEREXPRESSION; THERAPY; COEXPRESSION; EXPRESSION; FAMILY; EGFR; IMMUNOHISTOCHEMISTRY	Introduction Expression of human epidermal growth factor receptor (HER) 2 and HER3 have been investigated in small BTC studies using variable scoring systems. Methods HER2 and HER3 overexpression/amplification were explored following internationally agreed guidelines using immunohistochemistry (IHC) and fluorescent in-situ hybridisation (FISH), respectively. Logistic regression and survival analysis (Kaplan Meier, Log rank test and Cox Regression) were used for statistical analysis. Results Sixty-seven eligible patients with Stage I/II (31.3%) or III/IV (68.7%) disease at diagnosis were included. Membrane HER2 overexpression/amplification was identified in 1 patient (1%). HER3 overexpression was predominantly cytoplasmic; the rate of overexpression/amplification of HER3 in membrane and cytoplasm was 16% [ampullary cancer (AMP) (1/13; 8%), gallbladder cancer (GBC) (1/10; 10%), intra-hepatic cholangiocarcinoma (ICC) (6/26; 23%), extra-hepatic cholangiocarcinoma (ECC) (3/18; 17%)] and 24% [AMP (1/13; 8%), GBC (1/10; 10%), ICC (10/26; 38%), ECC (4/18; 22%)], respectively. Conclusions A significant subset of patients with BTC expressed HER3. Inhibition of HER3 warrants further investigation. A better understanding of the downstream effects of HER3 in BTC requires further mechanistic investigations to identify new biomarkers and improve patient selection for future clinical trials.	[Lamarca, Angela; Galdy, Salvatore; Barriuso, Jorge; Backen, Alison; McNamara, Mairead G.; Hubner, Richard A.; Valle, Juan W.] Christie NHS Fdn Trust Manchester, Dept Med Oncol, Manchester, Lancs, England; [Galdy, Salvatore] European Inst Oncol, Unit Gastrointestinal Med Oncol & Neuroendocrine, Milan, Italy; [Barriuso, Jorge; McNamara, Mairead G.; Valle, Juan W.] Univ Manchester, Div Canc Sci, Sch Med Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Moghadam, Sharzad; Rogan, Jane] Univ Manchester, Manchester Canc Res Ctr Biobank, Manchester, Lancs, England; [Beckett, Elizabeth; Billington, Catherine; Cramer, Angela] Christie NHS Fdn Trust, Christie Pathol Partnership, Manchester, Lancs, England	IRCCS European Institute of Oncology (IEO); University of Manchester; University of Manchester; Christie NHS Foundation Trust	Lamarca, A; Valle, JW (corresponding author), Christie NHS Fdn Trust Manchester, Dept Med Oncol, Manchester, Lancs, England.; Valle, JW (corresponding author), Univ Manchester, Div Canc Sci, Sch Med Sci, Fac Biol Med & Hlth, Manchester, Lancs, England.	angela.lamarca@christie.nhs.uk; juan.valle@manchester.ac.uk	; Mcnamara, Mairead/J-1621-2015	Lamarca, Angela/0000-0001-9696-6122; Mcnamara, Mairead/0000-0002-2272-3678; Barriuso, Jorge/0000-0002-5641-9105	European Society for Medical Oncology (ESMO) Translational Fellowship Programme; Spanish Society of Medical Oncology (SEOM) Fellowship Programme; American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation Young Investigator Award; 'Clinical Unit Visit' ESMO Fellowship	European Society for Medical Oncology (ESMO) Translational Fellowship Programme; Spanish Society of Medical Oncology (SEOM) Fellowship Programme; American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation Young Investigator Award; 'Clinical Unit Visit' ESMO Fellowship	Angela Lamarca was part-funded by the European Society for Medical Oncology (ESMO) Translational Fellowship Programme, by the Spanish Society of Medical Oncology (SEOM) Fellowship Programme and by the American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation Young Investigator Award. Salvatore Galdy was part-funded by 'Clinical Unit Visit' ESMO Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto N, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3329; Aloysius MM, 2009, HISTOPATHOLOGY, V55, P236, DOI 10.1111/j.1365-2559.2009.03351.x; Anagnostou VK, 2010, CANCER EPIDEM BIOMAR, V19, P982, DOI 10.1158/1055-9965.EPI-10-0097; Bae SY, 2013, BREAST CANCER RES TR, V139, P741, DOI 10.1007/s10549-013-2570-6; Bang YJ, 2010, LANCET, V376, P1302; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; COLLIER JD, 1992, J HEPATOL, V14, P377, DOI 10.1016/0168-8278(92)90186-S; Debska-Szmich S, 2015, POSTEP HIG MED DOSW, V69, P586, DOI 10.5604/17322693.1151339; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; El-Khoueiry AB, 2014, BRIT J CANCER, V110, P882, DOI 10.1038/bjc.2013.801; Elebro J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153533; Galdy S, 2017, CANCER METAST REV, V36, P141, DOI 10.1007/s10555-016-9645-x; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Goyal L., CANC DISCOV; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hyman DM, 2018, NATURE, V554, P189, DOI 10.1038/nature25475; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Javle MM, 2016, J CLIN ONCOL S4S, V34; Jusakul A, 2017, CANCER DISCOV, V7, P1116, DOI 10.1158/2159-8290.CD-17-0368; Kawamoto T, 2015, J GASTROENTEROL, V50, P467, DOI 10.1007/s00535-014-0984-5; Kol A, 2014, PHARMACOL THERAPEUT, V143, P1, DOI 10.1016/j.pharmthera.2014.01.005; Krahn G, 2001, EUR J CANCER, V37, P251, DOI 10.1016/S0959-8049(00)00364-6; Lamarca A., ANN ONCOL; Lamarca A., 2014, ANN ONCOL         S4, V25, DOI [10.1093/annonc/mdu334.133, DOI 10.1093/ANNONC/MDU334.133]; Lamarca A, 2018, ILCA ANN M SEPT; Lee HJ, 2012, VIRCHOWS ARCH, V461, P521, DOI 10.1007/s00428-012-1321-0; Mazzaferro V, 2016, PATIENTS ADV METASTA; Mitri Zahi, 2012, Chemother Res Pract, V2012, P743193, DOI 10.1155/2012/743193; Mota JM, 2017, ONCOTARGET, V8, P89284, DOI 10.18632/oncotarget.18467; Ocana A, 2013, JNCI-J NATL CANCER I, V105, P266, DOI 10.1093/jnci/djs501; Peck J, 2012, ONCOLOGY-BASEL, V82, P175, DOI 10.1159/000336488; Pellat A., HEPATOLOGY, V10; Ramanathan RK, 2009, CANCER CHEMOTH PHARM, V64, P777, DOI 10.1007/s00280-009-0927-7; Saha S. K., CANC DISCOV; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Sirica AE, 2008, WORLD J GASTROENTERO, V14, P7033, DOI 10.3748/wjg.14.7033; Spears M, 2012, BREAST CANCER RES TR, V132, P463, DOI 10.1007/s10549-011-1606-z; Tanner KG, 1999, J BIOL CHEM, V274, P35985, DOI 10.1074/jbc.274.50.35985; te Velde EA, 2009, EJSO-EUR J SURG ONC, V35, P1098, DOI 10.1016/j.ejso.2009.02.013; Thomas G, 2014, ONCOTARGET, V5, P7138, DOI 10.18632/oncotarget.2231; Vaidya P, 1996, J PATHOL, V178, P140, DOI 10.1002/(SICI)1096-9896(199602)178:2<140::AID-PATH450>3.0.CO;2-U; Valle JW, 2016, ANN ONCOL, V27, pv28, DOI 10.1093/annonc/mdw324; Valle JW, 2009, BRIT J CANCER, V101, P621, DOI 10.1038/sj.bjc.6605211; Valle J. W., CANC DISCOV; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Vollmann-Zwerenz A, 2010, CYTOM PART A, V77A, P387, DOI 10.1002/cyto.a.20868; Wang L, 2013, PROSTATE CANCER P D, V16, P301, DOI 10.1038/pcan.2013.25; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yan M, 2015, CANCER METAST REV, V34, P157, DOI 10.1007/s10555-015-9552-6; Yang JJ, 2014, EXPERT OPIN THER TAR, V18, P1011; Yang XQ, 2014, ONCOL REP, V32, P700, DOI 10.3892/or.2014.3261; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoshida H, 2016, VIRCHOWS ARCH, V468, P431, DOI 10.1007/s00428-015-1898-1; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zhang NY, 2016, ACTA BIOCH BIOPH SIN, V48, P39, DOI 10.1093/abbs/gmv103; Zhao S, 2016, ONCOTARGETS THER, V9, P6695, DOI 10.2147/OTT.S110926	60	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206007	10.1371/journal.pone.0206007	http://dx.doi.org/10.1371/journal.pone.0206007			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335866	gold, Green Submitted, Green Published			2022-12-26	WOS:000447701300086
J	Anitua, E; de la Fuente, M; Muruzabal, F; Sanchez-Avila, RM; Merayo-Lloves, J; Azkargorta, M; Elortza, F; Orive, G				Anitua, Eduardo; de la Fuente, Maria; Muruzabal, Francisco; Mauricio Sanchez-Avila, Ronald; Merayo-Lloves, Jesus; Azkargorta, Mikel; Elortza, Felix; Orive, Gorka			Differential profile of protein expression on human keratocytes treated with autologous serum and plasma rich in growth factors (PRGF)	PLOS ONE			English	Article							OCULAR SURFACE DISEASES; 3 BLOOD DERIVATIVES; LARGE GENE LISTS; EYE DROPS; IN-VITRO; SURGERY; MYODIFFERENTIATION; PROLIFERATION; REGENERATION; FIBROBLASTS	Purpose The main objective of this study is to compare the protein expression of human keratocytes treated with Plasma rich in growth factors (PRGF) or autologous serum (AS) and previously induced to myofibroblast by TGF-beta 1 treatment. Methods Blood from healthy donor was collected and processed to obtain AS and PRGF eye drops. Blood derivates were aliquoted and stored at-80 degrees C until use. Keratocyte cells were pretreated for 60 minutes with 2.5 ng/ml TGF-beta 1. After that, cells were treated with PRGF, AS or with TGF-beta 1 (control). To characterize the proteins deregulated after PRGF and AS treatment, a proteomic approach that combines 1D-SDS-PAGE approach followed by LC-MS/MS was carried out. Results Results show a catalogue of key proteins in close contact with a myofibroblastic differentiated phenotype in AS treated-cells, whereas PRGF-treated cells show attenuation on this phenotype. The number of proteins downregulated after PRGF treatment or upregulated in AS-treated cells suggest a close relationship between AS-treated cells and cytoskeletal functions. On the other hand, proteins upregulated after PRGF-treatment or downregulated in AS-treated cells reveal a greater association with processes such as protein synthesis, proliferation and cellular motility. Conclusion This proteomic analysis helps to understand the molecular events underlying AS and PRGF-driven tissue regeneration processes, providing new evidence that comes along with the modulation of TGF-beta 1 activity and the reversion of the myofibroblastic phenotype by PRGF.	[Anitua, Eduardo; de la Fuente, Maria; Muruzabal, Francisco; Orive, Gorka] BTI Biotechnol Inst, Vitoria, Spain; [Anitua, Eduardo; de la Fuente, Maria; Muruzabal, Francisco; Orive, Gorka] UPV EHU Fdn Eduardo Anitua, Univ Inst Regenerat Med & Oral Implantol UIRMI, Vitoria, Spain; [Mauricio Sanchez-Avila, Ronald; Merayo-Lloves, Jesus] Univ Oviedo, Inst Univ Fernandez Vega, Oviedo, Spain; [Azkargorta, Mikel; Elortza, Felix] ProteoRed ISCIII, CIBERehd, CIC BioGUNE, Prote Platform, Bizkaia Sci & Technol Pk, Derio, Spain; [Orive, Gorka] Univ Basque Country UPV EHU, Sch Pharm, Lab Pharmaceut, NanoBioCel Grp, Paseo Univ 7, Vitoria, Spain; [Orive, Gorka] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Vitoria, Spain	University of Oviedo; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Anitua, E; Orive, G (corresponding author), BTI Biotechnol Inst, Vitoria, Spain.; Anitua, E; Orive, G (corresponding author), UPV EHU Fdn Eduardo Anitua, Univ Inst Regenerat Med & Oral Implantol UIRMI, Vitoria, Spain.; Orive, G (corresponding author), Univ Basque Country UPV EHU, Sch Pharm, Lab Pharmaceut, NanoBioCel Grp, Paseo Univ 7, Vitoria, Spain.; Orive, G (corresponding author), Biomed Res Networking Ctr Bioengn Biomat & Nanome, Vitoria, Spain.	eduardo@fundacioneduardoanitua.org; gorka.orive@bti-implant.es	Elortza, Felix/ABG-4183-2020; Merayo-Lloves, Jesús/ABG-8863-2020; Azkargorta, Mikel/AAA-8047-2019; Anitua, Eduardo/O-1154-2018; Muruzabal, Francisco Jose/N-7814-2018	Elortza, Felix/0000-0001-8839-5438; Anitua, Eduardo/0000-0002-8386-5303; Muruzabal, Francisco Jose/0000-0001-7359-1698; ORIVE, GORKA/0000-0002-0773-300X	BTI Biotechnology Institute	BTI Biotechnology Institute	This study was fully supported by BTI Biotechnology Institute, a dental implant company that investigates in the fields of oral implantology and PRGF-Endoret technology. MF and FM received a salary as scientists from BTI Biotechnology Institute. EA is the Scientific Director and president of BTI Biotechnology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella JVG, 2016, NAT CELL BIOL, V18, P76, DOI 10.1038/ncb3286; Anitua E, 2016, EXP EYE RES, V151, P115, DOI 10.1016/j.exer.2016.08.012; Anitua E, 2015, EXP EYE RES, V135, P118, DOI 10.1016/j.exer.2015.02.016; Anitua E, 2013, EXP EYE RES, V115, P153, DOI 10.1016/j.exer.2013.07.007; Anitua E, 2016, CURR EYE RES, V41, P875, DOI 10.3109/02713683.2015.1104362; Anitua E, 2015, ACTA OPHTHALMOL, V93, pE605, DOI 10.1111/aos.12710; Anitua E, 2015, CORNEA, V34, P1144, DOI 10.1097/ICO.0000000000000489; Anitua E, 2012, J PERIODONTOL, V83, P1028, DOI 10.1902/jop.2011.110505; Anitua E, 2012, J CONTROL RELEASE, V157, P29, DOI 10.1016/j.jconrel.2011.07.004; Anitua E, 2011, INVEST OPHTH VIS SCI, V52, P6066, DOI 10.1167/iovs.11-7302; Bartlett AH, 2015, OPTOMETRY VISION SCI, V92, P939, DOI 10.1097/OPX.0000000000000659; Marquez EB, 2011, CUTAN OCUL TOXICOL, V30, P7, DOI 10.3109/15569527.2010.498398; Bonini S, 2000, OPHTHALMOLOGY, V107, P1347, DOI 10.1016/S0161-6420(00)00163-9; Bron AJ, 2015, PROG RETIN EYE RES, V44, P36, DOI 10.1016/j.preteyeres.2014.10.001; Chaurasia SS, 2009, EXP EYE RES, V89, P133, DOI 10.1016/j.exer.2009.02.022; Eslani M, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/196827; Freire V, 2014, CORNEA, V33, P614, DOI 10.1097/ICO.0000000000000109; Freire V, 2012, INVEST OPHTH VIS SCI, V53, P5571, DOI 10.1167/iovs.11-7340; Fullwood MJ, 2012, PROG MOL BIOL TRANSL, V106, P75, DOI 10.1016/B978-0-12-396456-4.00005-5; Garcia-Zalisnak D, 2014, CURR OPIN OPHTHALMOL, V25, P264, DOI 10.1097/ICU.0000000000000077; Geerling G, 2004, BRIT J OPHTHALMOL, V88, P1467, DOI 10.1136/bjo.2004.044347; Gire A, 2013, OPHTHAL PLAST RECONS, V29, pE38, DOI 10.1097/IOP.0b013e3182674069; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inatomi T, 2006, AM J OPHTHALMOL, V142, P757, DOI 10.1016/j.ajo.2006.06.004; Izzotti A, 2012, EXPERT REV MOL DIAGN, V12, P629, DOI [10.1586/erm.12.57, 10.1586/ERM.12.57]; Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008; Manni L, 2013, GROWTH FACTORS, V31, P115, DOI 10.3109/08977194.2013.804073; Matsuoka M, 2015, INT J MOL SCI, V16, P16275, DOI 10.3390/ijms160716275; Sanchez-Avila RM, 2018, INT OPHTHALMOL, V38, P1193, DOI 10.1007/s10792-017-0582-7; Sanchez-Avila RM, 2017, J OCUL PHARMACOL TH, V33, P391, DOI 10.1089/jop.2016.0166; Merayo-Lloves J, 2016, OPHTHALMIC RES, V56, P68, DOI 10.1159/000444496; Merayo-Lloves J, 2016, OPHTHALMIC RES, V55, P53, DOI 10.1159/000439280; Merrick WC, 2015, J BIOL CHEM, V290, P24091, DOI 10.1074/jbc.R115.675280; Milner MS, 2017, CURR OPIN OPHTHALMOL, V28, P3, DOI 10.1097/01.icu.0000512373.81749.b7; Nugent RB, 2015, SURV OPHTHALMOL, V60, P406, DOI 10.1016/j.survophthal.2015.03.003; Pan Q, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009327.pub2; Poulsen ET, 2016, PROTEOMICS, V16, P539, DOI 10.1002/pmic.201500287; Raab-Graham KF, 2017, FEBS LETT, V591, P1540, DOI 10.1002/1873-3468.12675; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Soni NG, 2016, BRIT J OPHTHALMOL, V100, P22, DOI 10.1136/bjophthalmol-2015-306842; Taliana L, 2005, INVEST OPHTH VIS SCI, V46, P96, DOI 10.1167/iovs.04-0145; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zeng H, 2017, CURR OPIN IMMUNOL, V46, P103, DOI 10.1016/j.coi.2017.04.005; Zhou L, 2012, PROG RETIN EYE RES, V31, P527, DOI 10.1016/j.preteyeres.2012.06.002	45	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205073	10.1371/journal.pone.0205073	http://dx.doi.org/10.1371/journal.pone.0205073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312303	Green Published, gold, Green Submitted			2022-12-26	WOS:000447427300020
J	Davis, SM; Davidov, D; Kristjansson, AL; Zullig, K; Baus, A; Fisher, M				Davis, Stephen M.; Davidov, Danielle; Kristjansson, Alfgeir L.; Zullig, Keith; Baus, Adam; Fisher, Melanie			Qualitative case study of needle exchange programs in the Central Appalachian region of the United States	PLOS ONE			English	Article							C VIRUS-INFECTION; INJECTION-DRUG USE; HEPATITIS-C; SYRINGE EXCHANGE; ECONOMIC BURDEN; IMPLEMENTATION; PARTICIPATION; PREVENTION; EPIDEMIC	Background The Central Appalachian region of the United States is in the midst of a hepatitis C virus epidemic driven by injection of opioids, particularly heroin, with contaminated syringes. In response to this epidemic, several needle exchange programs (NEP) have opened to provide clean needles and other supplies and services to people who inject drugs (PWID). However, no studies have investigated the barriers and facilitators to implementing, operating, and expanding NEPs in less populous areas of the United States. Methods This qualitative case study consisted of interviews with program directors, police chiefs, law enforcement members, and PWID affiliated with two NEPs in the rural state of West Virginia. Interview transcripts were coded inductively and analyzed using qualitative data analysis software. Final common themes related to barriers and facilitators of past program openings, current program operations, and future program plans, were derived through a consensus of two data coders. Results Both NEPs struggled to find existing model programs, but benefited from broad community support that facilitated implementation. The largest operational barrier was the legal conundrum created by paraphernalia laws that criminalize syringe possession. However, both PWID and law enforcement appreciated the comprehensive services provided by these programs. Program location and transportation difficulties were additional noted barriers. Future program operations are threatened by funding shortages and bans, but necessitated by unexpected program demand. Conclusion Despite broad community support, program operations are threatened by growing participant volumes, funding shortages, and the federal government's prohibition on the use of funds to purchase needles. Paraphernalia laws create a legal conundrum in the form of criminal sanctions for the possession of needles, which may inadvertently promote needle sharing and disease transmission. Future studies should examine additional barriers to using clean needles provided by rural NEPs that may blunt the effectiveness of NEPs in preventing disease transmission.	[Davis, Stephen M.] West Virginia Univ, Dept Hlth Policy Management & Leadership, Morgantown, WV 26506 USA; [Davis, Stephen M.; Davidov, Danielle] West Virginia Univ, Dept Emergency Med, Morgantown, WV 26506 USA; [Davidov, Danielle; Kristjansson, Alfgeir L.; Zullig, Keith; Baus, Adam] West Virginia Univ, Dept Social & Behav Sci, Morgantown, WV USA; [Fisher, Melanie] West Virginia Univ, Sect Infect Dis, Dept Med, Morgantown, WV USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University	Davis, SM (corresponding author), West Virginia Univ, Dept Hlth Policy Management & Leadership, Morgantown, WV 26506 USA.; Davis, SM (corresponding author), West Virginia Univ, Dept Emergency Med, Morgantown, WV 26506 USA.	smdavis@hsc.wvu.edu	Baus, Adam/AAR-3336-2020	Davis, Stephen/0000-0003-0392-3364	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER; NIGMS NIH HHS [U54 GM104942] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON W, 1991, AM J PUBLIC HEALTH, V81, P1506, DOI 10.2105/AJPH.81.11.1506; [Anonymous], 2016, CASE STUDY RES DESIG; Atchan M, 2016, J ADV NURS, V72, P2259, DOI 10.1111/jan.12946; Beheshti Annahita, 2015, Am Med J, V6, P9; Beletsky L, 2013, J URBAN HEALTH, V90, P284, DOI 10.1007/s11524-012-9741-3; Beletsky L, 2011, AM J PUBLIC HEALTH, V101, P2012, DOI 10.2105/AJPH.2011.300254; Brinkmann S., 2015, INTERVIEWS LEARNING; Campbell CA, 2017, MMWR-MORBID MORTAL W, V66, P465, DOI 10.15585/mmwr.mm6618a2; CDC, 2015, VIR HEP SURV; Clarke K, 2016, CRIT SOC POLICY, V36, P289, DOI 10.1177/0261018315608726; Creswell J. W., 2013, QUALITATIVE INQUIRY; Davis SM, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0156-z; Des Jarlais DC, 2015, MMWR-MORBID MORTAL W, V64, P1337, DOI 10.15585/mmwr.mm6448a3; DHHR W, 2017, INC RAT AC HEP C PER; Downing M, 2005, AIDS EDUC PREV, V17, P68, DOI 10.1521/aeap.17.1.68.58688; Estes C, 2015, ALIMENT PHARM THER, V42, P696, DOI 10.1111/apt.13316; Golding N. J, 2017, INDIANA HLTH LAW REV, V14, P173; Gray J, 1998, SUBST USE MISUSE, V33, P1075, DOI 10.3109/10826089809062208; HAGAN H, 1991, Journal of Addictive Diseases, V10, P81, DOI 10.1300/J069v10n04_06; Harry B., 2005, ED RES, V34, P3, DOI [10.3102/0013189X034002003, DOI 10.3102/0013189X034002003]; Havens Jennifer R, 2013, Am J Public Health, V103, pe44, DOI 10.2105/AJPH.2012.300874; Henman AR, 1998, SUBST USE MISUSE, V33, P1213, DOI 10.3109/10826089809062215; Henman AR, 1998, AIDS CARE, V10, P397, DOI 10.1080/09540129850123939; KAPLAN EH, 1993, INTERFACES, V23, P7, DOI 10.1287/inte.23.1.7; Keeshin SW, 2016, AM J MED SCI, V352, P609, DOI 10.1016/j.amjms.2016.10.002; Macworld, 2016, REC VOIC MEM IPOD IP; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; North American Syringe Exchange Network, 2018, DIR SYR EXCH PROGR; NVIVO, 2016, NVIVO SOFTW; Page K, 2013, CLIN INFECT DIS, V57, pS32, DOI 10.1093/cid/cit300; Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824; Pollini RA, 2008, ADDICTION, V103, P101, DOI 10.1111/j.1360-0443.2007.02051.x; Pouget ER, 2012, ADDICTION, V107, P1057, DOI 10.1111/j.1360-0443.2011.03765.x; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Rich JD, 1999, J ACQ IMMUN DEF SYND, V21, P396; Saldana J, 2016, CODING MANUAL QUALIT; Sandelowski M., 2007, HDB SYNTHESIZING QUA; Saranga A, 2008, INT J DRUG POLICY, V19, pS25, DOI 10.1016/j.drugpo.2007.11.008; Sherman SG, 2001, WASHINGTON INT J DRU, V12, P45; Smith BD, 2012, ANN INTERN MED, V157, P817, DOI 10.7326/0003-4819-157-9-201211060-00529; Somlai AM, 1999, AIDS EDUC PREV, V11, P187; Stake R. E., 1995, ART CASE STUDY RES; Stepanova M, 2017, CLIN LIVER DIS, V21, P579, DOI 10.1016/j.cld.2017.03.012; Strathdee SA, 2015, NEW ENGL J MED, V373, P397, DOI 10.1056/NEJMp1507252; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; TASCAM, 2016, DR05 TASCAM; Thrift AP, 2017, NAT REV GASTRO HEPAT, V14, P122, DOI 10.1038/nrgastro.2016.176; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; U. S. Census Bureau, 2017, QUICK FACTS W VIRG; VLAHOV D, 1994, AM J PUBLIC HEALTH, V84, P303, DOI 10.2105/AJPH.84.2.303; Ward John W, 2013, Top Antivir Med, V21, P15; WATTERS JK, 1994, JAMA-J AM MED ASSOC, V271, P115, DOI 10.1001/jama.271.2.115; Zibbell JE, 2015, MMWRMORBIDITY MORTAL, V64; Zibbell JE, 2018, AM J PUBLIC HEALTH, V108, P175, DOI 10.2105/AJPH.2017.304132	54	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205466	10.1371/journal.pone.0205466	http://dx.doi.org/10.1371/journal.pone.0205466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0UN	30312333	Green Published, gold			2022-12-26	WOS:000447427300034
J	Belcher, JD; Gomperts, E; Nguyen, J; Chen, CS; Abdulla, F; Kiser, ZM; Gallo, D; Levy, H; Otterbein, LE; Vercellotti, GM				Belcher, John D.; Gomperts, Edward; Nguyen, Julia; Chen, Chunsheng; Abdulla, Fuad; Kiser, Zachary M.; Gallo, David; Levy, Howard; Otterbein, Leo E.; Vercellotti, Gregory M.			Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia	PLOS ONE			English	Article							HEME OXYGENASE-1; MITOCHONDRIAL RESPIRATION; LUNG INJURY; MICE; HEMOGLOBIN; ACTIVATION; REJECTION; SUPPRESSES; MODULATOR; HEMOLYSIS	Carbon monoxide (CO) at low, non-toxic concentrations has been previously demonstrated to exert anti-inflammatory protection in murine models of sickle cell disease (SCD). However CO delivery by inhalation, CO-hemoglobin infusion or CO-releasing molecules presents problems for daily CO administration. Oral administration of a CO-saturated liquid avoids many of these issues and potentially provides a platform for self-administration to SCD patients. To test if orally-delivered CO could modulate SCD vaso-occlusion and inflammation, a liquid CO formulation (HBI-002) was administered by gavage (10 ml/kg) once-daily to NY1DD and Townes-SS transgenic mouse models of SCD. Baseline CO-hemoglobin (CO-Hb) levels were 1.6% and 1.8% in NY1DD and Townes-SS sickle mice and 0.6% in Townes-AS control mice. CO-Hb levels reached 5.4%, 4.7% and 3.0% within 5 minutes in NY1DD, SS and AS mice respectively after gavage with HBI-002. After ten treatments, each once-daily, hemoglobin levels rose from 5.3g/dL in vehicle-treated Townes-SS mice to 6.3g/dL in HBI-002-treated. Similarly, red blood cell (RBC) counts rose from 2.36 x 10(6)/mu L in vehicle-treated SS mice to 2.89 x 10(6)/mu L in HBI-002-treated mice. In concordance with these findings, hematocrits rose from 26.3% in vehicle-treated mice to 30.0% in HBI-002-treated mice. Reticulocyte counts were not significantly different between vehicle and HBI-002-treated SS mice implying less hemolysis and not an increase in RBC production. White blood cell counts decreased from 29.1 x 10(3)/mu L in vehicle-treated versus 20.3 x 10(3)/mu L in HBI-002-treated SS mice. Townes-SS mice treated with HBI-002 had markedly increased Nrf2 and HO-1 expression and decreased NF-kappa B activation compared to vehicle-treated mice. These anti-inflammatory effects were examined for the ability of HBI-002 (administered orally once-daily for up to 5 days) to inhibit vaso-occlusion induced by hypoxia-reoxygenation. In NY1DD and Townes-SS sickle mice, HBI-002 decreased microvascular stasis in a duration-dependent manner. Collectively, these findings support HBI-002 as a useful anti-inflammatory agent to treat SCD and warrants further development as a therapeutic.	[Belcher, John D.; Nguyen, Julia; Chen, Chunsheng; Abdulla, Fuad; Kiser, Zachary M.; Vercellotti, Gregory M.] Univ Minnesota, Dept Med, Vasc Res Ctr, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA; [Gomperts, Edward; Levy, Howard] Hillhurst Biopharmaceut Inc, Montrose, CA USA; [Gallo, David; Otterbein, Leo E.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Belcher, JD (corresponding author), Univ Minnesota, Dept Med, Vasc Res Ctr, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA.	belcher@umn.edu	Abdulla, Fuad/AHB-7032-2022	Belcher, John D/0000-0001-5536-2752; Gomperts, Edward/0000-0001-5904-265X	NIH SBIR grant [NHLBI 1 R43 HL131065-01A1]; University of Minnesota; National Heart, Lung, and Blood Institute [R01 HL114567, T32 HL007062]; National Institute of Diabetes and Digestive and Kidney Diseases [R44 DK111260-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114567, T32HL007062] Funding Source: NIH RePORTER	NIH SBIR grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was supported by an NIH SBIR grant NHLBI 1 R43 HL131065-01A1 to Hillhurst Biopharmaceuticals, Inc., as a prime grantee and with the University of Minnesota as a subawardee, with EG and JDB as Principal Investigators, and which provided partial salary support for EG, HL, JDB, and GMV. The grant provided resources for the manufacture, testing, and shipping of the test product and placebo control to the research laboratory at the University of Minnesota. The grant also provided resources for the conduct of the research activities. The research was conducted at the University of Minnesota. This research was also supported by the National Heart, Lung, and Blood Institute (R01 HL114567 to GMV and T32 HL007062 to GMV), the National Institute of Diabetes and Digestive and Kidney Diseases (R44 DK111260-01 to LEO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aban I, 2017, BLOOD, V129, P385, DOI 10.1182/blood-2016-09-738104; Abeyrathna N, 2017, ORG BIOMOL CHEM, V15, P8692, DOI 10.1039/c7ob01674c; Alayash AI, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010002; Ballas SK, 2006, TRANSFUSION, V46, P105, DOI 10.1111/j.1537-2995.2006.00679.x; Beckman JD, 2009, AM J PHYSIOL-HEART C, V297, pH1243, DOI 10.1152/ajpheart.00327.2009; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belcher John D, 2013, ISRN Oxidative Med, V2013; Belcher JD, 2013, BLOOD, V122, P2757, DOI 10.1182/blood-2013-02-486282; Belcher JD, 2010, J MOL MED, V88, P665, DOI 10.1007/s00109-010-0613-6; BEUTLER E, 1975, BLOOD, V46, P253; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Darbari DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079923; DeBaun MR, 2012, BLOOD, V119, P3684, DOI 10.1182/blood-2011-05-349621; Du MT, 2018, BLOOD CELL MOL DIS, V72, P1, DOI 10.1016/j.bcmd.2018.05.001; Dubert M, 2017, BLOOD, V130, P2215, DOI 10.1182/blood-2016-12-755777; FABRY ME, 1992, P NATL ACAD SCI USA, V89, P12150, DOI 10.1073/pnas.89.24.12150; Fujita T, 2001, NAT MED, V7, P598, DOI 10.1038/87929; Kalambur VS, 2004, AM J HEMATOL, V77, P117, DOI 10.1002/ajh.20143; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Kuramitsu K, 2011, HEPATOLOGY, V53, P2016, DOI 10.1002/hep.24317; Lo Iacono L, 2011, FREE RADICAL BIO MED, V50, P1556, DOI 10.1016/j.freeradbiomed.2011.02.033; Metere A, 2014, ANTIOXID REDOX SIGN, V20, P403, DOI 10.1089/ars.2012.5102; Miller ST, 2000, NEW ENGL J MED, V342, P83, DOI 10.1056/NEJM200001133420203; Minamoto K, 2005, J EXP MED, V202, P283, DOI 10.1084/jem.20050377; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Otterbein LE, 1999, AM J PHYSIOL-LUNG C, V276, pL688; Otterbein LE, 2003, NAT MED, V9, P183, DOI 10.1038/nm817; Reiter CEN, 2012, FEBS OPEN BIO, V2, P113, DOI 10.1016/j.fob.2012.05.003; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Schallner N, 2015, J CLIN INVEST, V125, P2609, DOI 10.1172/JCI78443; SIRS JA, 1963, LANCET, V1, P971; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812	34	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205194	10.1371/journal.pone.0205194	http://dx.doi.org/10.1371/journal.pone.0205194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308028	gold, Green Submitted, Green Published			2022-12-26	WOS:000447173500046
J	Periasamy, P; Tran, V; O'Neill, HC				Periasamy, Pravin; Tran, Vinson; O'Neill, Helen C.			Identification of genes which regulate stroma-dependent in vitro hematopoiesis	PLOS ONE			English	Article							DENDRITIC-LIKE CELLS; BONE-MARROW; STEM-CELLS; SUPPORT HEMATOPOIESIS; PROGENITOR CELLS; CD34(+) CELLS; SPLEEN; NICHE; CULTURES; INTEGRIN	Cultured splenic stroma has been shown to support in vitro hematopoiesis in overlaid bone marrow and spleen progenitors. These co-cultures support longterm production of a novel dendritic-like cell type along with transient production of myeloid cells. They also maintain a progenitor cell population. The splenic stromal lines 5G3 and 3B5 have been identified as a supporter and a non-supporter of hematopoiesis. Based on their gene expression profile, both 5G3 and 3B5 express genes related to hematopoiesis, while 5G3 cells express several unique genes, and show upregulation of some genes over 3B5. Based on gene expression studies, specific inhibitors were tested for capacity to inhibit hematopoiesis in co-cultures. Addition of specific antibodies and small molecule inhibitors identified VCAM1, CXCL12, CSF1 and SPP1 as potential regulators of hematopoiesis, although both are expressed by 5G3 and 3B5. Through inhibition of function, SVEP1 and ALDH1 are also shown here to be deterministic of 5G3 hematopoietic support capacity, since these are uniquely expressed by 5G3 and not 3B5. The achievement of inhibition is notable given the dynamic, longterm nature of co-cultures which involve only small numbers of cells. The alternate plan, to add recombinant soluble factors produced by 5G3 back into 3B5 co-cultures in order to recover in vitro hematopoiesis, proved ineffective. Out of 6 different factors added to 3B5, only IGF2 showed any effect on cell production. The identification of differentially expressed or upregulated genes in 5G3 has provided an insight into potential pathways involved in in vitro hematopoiesis leading to production of dendritic-like cells.	[Periasamy, Pravin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Tran, Vinson] Australian Natl Univ, Res Sch Biol, Div Biomed Sci, Canberra, ACT, Australia; [O'Neill, Helen C.] Bond Univ, Fac Hlth Sci & Med, Clem Jones Ctr Regenerat Med, Gold Coast, Qld, Australia	National University of Singapore; Australian National University; Bond University	O'Neill, HC (corresponding author), Bond Univ, Fac Hlth Sci & Med, Clem Jones Ctr Regenerat Med, Gold Coast, Qld, Australia.	honeill@bond.edu.au	O'NEILL, Helen/AAW-8921-2021	O'NEILL, Helen/0000-0002-9506-284X	Australian Research Council [DP130101703]; National Health and Medical Research Council of Australia [585443]; Australian National University Postgraduate Scholarship; Australian Postgraduate Award	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian National University Postgraduate Scholarship; Australian Postgraduate Award(Australian Government)	This work was supported by project grants from the Australian Research Council (#DP130101703 to Helen C.O'Neill) and the National Health and Medical Research Council of Australia (#585443 to Helen C.O'Neill). Pravin Periasamy was supported by an Australian National University Postgraduate Scholarship. Vinson Tran was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Despars G, 2004, EXP HEMATOL, V32, P1182, DOI 10.1016/j.exphem.2004.08.013; Despars G, 2006, IN VITRO CELL DEV-AN, V42, P208; Despars G, 2006, STEM CELLS, V24, P1496, DOI 10.1634/stemcells.2005-0530; Fancke B, 2008, BLOOD, V111, P150, DOI 10.1182/blood-2007-05-089292; Furuya M, 2010, J IMMUNOL, V185, P5769, DOI 10.4049/jimmunol.1002226; Galli LM, 2006, DEV DYNAM, V235, P681, DOI 10.1002/dvdy.20681; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hey YY, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00652; Hoang ATN, 2010, J IMMUNOL, V185, P2360, DOI 10.4049/jimmunol.0903673; Hoye Anette M., 2012, Advances in Biological Regulation, V52, P326, DOI 10.1016/j.jbior.2012.03.004; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kleiman A, 2013, EXP MOL PATHOL, V94, P126, DOI 10.1016/j.yexmp.2012.09.023; Kummer D, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7040025; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Miller-Delaney SFC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014565; Mizukami T, 2008, STEM CELLS DEV, V17, P67, DOI 10.1089/scd.2007.0077; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI 10.1586/EHM.10.16; Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007; Nakajima H, 2009, BIOCHEM BIOPH RES CO, V390, P65, DOI 10.1016/j.bbrc.2009.09.067; Ni KP, 1997, BRIT J HAEMATOL, V97, P710, DOI 10.1046/j.1365-2141.1997.00135.x; Ni KP, 1999, BRIT J HAEMATOL, V105, P58, DOI 10.1046/j.1365-2141.1999.01294.x; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; O'Neill HC, 2004, STEM CELLS, V22, P475, DOI 10.1634/stemcells.22-4-475; O'Neill HC, 2012, NICHE J, V1, P12, DOI DOI 10.5152/NICHE.2012.03; O'Neill HC, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/954275; Papathanasiou P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176345; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Periasamy P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00073; Periasamy P, 2013, EXP HEMATOL, V41, P281, DOI 10.1016/j.exphem.2012.11.003; Periasamy P, 2013, J LEUKOCYTE BIOL, V93, P63, DOI 10.1189/jlb.0512260; Periasamy P, 2009, EXP HEMATOL, V37, P1060, DOI 10.1016/j.exphem.2009.06.001; Petvises S, 2018, BMC IMMUNOL, V19, DOI 10.1186/s12865-018-0255-y; Petvises S, 2016, CELL MOL IMMUNOL, V13, P443, DOI 10.1038/cmi.2015.16; Petvises S, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00501; Petvises S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088311; Powerski MJ, 2011, LANGENBECK ARCH SURG, V396, P379, DOI 10.1007/s00423-010-0626-1; Prince SN, 2007, MOL CANCER THER, V6, P607, DOI 10.1158/1535-7163.MCT-06-0509; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; Quah B, 2004, INT IMMUNOL, V16, P567, DOI 10.1093/intimm/dxh060; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rice KL, 2008, LEUKEMIA RES, V32, P873, DOI 10.1016/j.leukres.2007.11.001; Sato-Nishiuchi R, 2012, J BIOL CHEM, P1; Schreiber Thomas D, 2010, Haematologica, DOI 10.3324/haematol.006072; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shur I, 2006, J CELL PHYSIOL, V206, P420, DOI 10.1002/jcp.20497; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Tan JKH, 2012, J CELL MOL MED, V16, P1924, DOI 10.1111/j.1582-4934.2011.01490.x; Tan JKH, 2011, J CELL MOL MED, V15, P1189, DOI 10.1111/j.1582-4934.2010.01089.x; Ulyanova T, 2005, BLOOD, V106, P86, DOI 10.1182/blood-2004-09-3417; von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V400, P299, DOI 10.1016/j.bbrc.2010.08.043; Wilson A, 2006, NATURE REV, V6; Wilson HL, 2000, P NATL ACAD SCI USA, V97, P4784, DOI 10.1073/pnas.080278897; Winkler IG, 2005, J EXP MED, V201, P1077, DOI 10.1084/jem.20042299; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130	58	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205583	10.1371/journal.pone.0205583	http://dx.doi.org/10.1371/journal.pone.0205583			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308055	Green Published, Green Submitted, gold			2022-12-26	WOS:000447173500104
J	Liu, XJ; Bao, YH; Meng, W; Yang, P; An, Y; Ma, J; Tang, YJ; Liu, ZG; Lu, Y; Zhou, JF; Zhang, Y; Feng, JF; Gao, XF; Su, ZD; Pu, YY; He, C				Liu, Xiujie; Bao, Yinghui; Meng, Wei; Yang, Ping; An, Yi; Ma, Jie; Tang, Yujie; Liu, Zhigang; Lu, Yan; Zhou, Jianfeng; Zhang, Yong; Feng, Jifeng; Gao, Xiaofei; Su, Zhida; Pu, Yingyan; He, Cheng			TROY interacts with RKIP to promote glioma development	ONCOGENE			English	Article							NF-KAPPA-B; KINASE INHIBITOR PROTEIN; RECEPTOR FAMILY-MEMBER; GENOME-WIDE ASSOCIATION; THERAPEUTIC TARGET; TYROSINE KINASES; EXPRESSION; GLIOBLASTOMA; CANCER; TNF	TROY is a component of the Nogo receptor complex and plays the key role in neuronal survival, migration, and differentiation. Here, we show the up-regulation of TROY in human glioma tissues and cells. Inhibition of TROY expression slowed glioma development in vivo and in vitro. Raf kinase inhibitor (RKIP) was found to interact with TROY. The physical interaction of TROY/RKIP was confirmed via co-immunoprecipitation (co-IP) assays. Furthermore, we found that the TROY/RKIP interaction was enhanced by fetal bovine serum (FBS) exposure, and TROY knockdown also led to down-regulation of NF-kappa B. Finally, disruption of the TROY/RKIP interaction using the TAT-TROY (234-371 aa) protein reduced the glioma development in xenografted mice. This suggests the TROY/RKIP interaction is a potential target for therapy of gliomas.	[Liu, Xiujie; Lu, Yan; Zhou, Jianfeng; Zhang, Yong; Feng, Jifeng; Gao, Xiaofei; Su, Zhida; Pu, Yingyan; He, Cheng] Second Mil Med Univ, Minist Educ, Key Lab Mol Neurobiol, Inst Neurosci, Shanghai 200433, Peoples R China; [Liu, Xiujie; Lu, Yan; Zhou, Jianfeng; Zhang, Yong; Feng, Jifeng; Gao, Xiaofei; Su, Zhida; Pu, Yingyan; He, Cheng] Second Mil Med Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200433, Peoples R China; [Bao, Yinghui] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai 200127, Peoples R China; [Meng, Wei; Ma, Jie] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Neurosurg, Shanghai 200092, Peoples R China; [Yang, Ping] Fudan Univ, Sch Pharm, Instrumental Anal Ctr, Shanghai 201203, Peoples R China; [An, Yi] Yale Univ, Sch Med, Dept Therapeut Oncol, New Haven, CT USA; [Tang, Yujie] Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Natl Minist Educ,Dept Pathophysiol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China; [Liu, Zhigang] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Radiat Oncol, Zhuhai 519001, Guangdong, Peoples R China; [Liu, Zhigang] Sun Yat Sen Univ, Affiliated Hosp 5, Phase Clin Trial Ward 1, Zhuhai 519001, Guangdong, Peoples R China	Naval Medical University; Naval Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Yale University; Shanghai Jiao Tong University; Sun Yat Sen University; Sun Yat Sen University	Liu, XJ; He, C (corresponding author), Second Mil Med Univ, Minist Educ, Key Lab Mol Neurobiol, Inst Neurosci, Shanghai 200433, Peoples R China.; Liu, XJ; He, C (corresponding author), Second Mil Med Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200433, Peoples R China.	LXJ186517@126.com; chenghe@smmu.edu.cn	Su, Zhida/G-6094-2015		National Key Basic Research Program [2011CB504401]; National Natural Science Foundation of China [81572500]; Natural Science Foundation of Shanghai City [13ZR1448500]; Hunan Young Talents [2016RS3036]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai City(Natural Science Foundation of Shanghai); Hunan Young Talents	This work was supported by the National Key Basic Research Program (2011CB504401), the National Natural Science Foundation of China (31070922; 31130024; 81471224) and the Natural Science Foundation of Shanghai City (13ZR1448500). This work was partially supported by National Natural Science Foundation of China (NO. 81572500); Hunan Young Talents (NO. 2016RS3036).	Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Carrasco-Garcia E, 2014, CELLS-BASEL, V3, P199, DOI 10.3390/cells3020199; Chumbalkar VC, 2005, PROTEOMICS, V5, P1167, DOI 10.1002/pmic.200401202; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Fafilek B, 2013, GASTROENTEROLOGY, V144, P381, DOI 10.1053/j.gastro.2012.10.048; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Granovsky AE, 2008, CELL RES, V18, P452, DOI 10.1038/cr.2008.43; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashimoto T, 2008, CELL CYCLE, V7, P106, DOI 10.4161/cc.7.1.5135; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hisaoka T, 2006, BRAIN RES, V1110, P81, DOI 10.1016/j.brainres.2006.06.068; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; Lee HC, 2006, GASTROENTEROLOGY, V131, P1208, DOI 10.1053/j.gastro.2006.07.012; Loftus JC, 2013, MOL CANCER RES, V11, P865, DOI 10.1158/1541-7786.MCR-13-0008; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu Y, 2013, J BIOL CHEM, V288, P34276, DOI 10.1074/jbc.M113.519744; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Maresch J, 2011, CANCER-AM CANCER SOC, V117, P2499, DOI 10.1002/cncr.25799; Mi S, 2008, CYTOKINE GROWTH F R, V19, P245, DOI 10.1016/j.cytogfr.2008.04.007; Nogueira L, 2011, ONCOTARGET, V2, P646, DOI 10.18632/oncotarget.322; Ohazama A, 2004, DEV DYNAM, V229, P131, DOI 10.1002/dvdy.10400; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Paulino VM, 2010, MOL CANCER RES, V8, P1558, DOI 10.1158/1541-7786.MCR-10-0334; Pispa J, 2008, HUM MOL GENET, V17, P3380, DOI 10.1093/hmg/ddn232; Purow B, 2009, NAT REV NEUROL, V5, P419, DOI 10.1038/nrneurol.2009.96; Reyes SB, 2013, MOL BIOL CELL, V24, P474, DOI 10.1091/mbc.E12-07-0521; Satoh J, 2007, NEUROPATH APPL NEURO, V33, P99, DOI 10.1111/j.1365-2990.2006.00787.x; Schuierer MM, 2004, CANCER RES, V64, P5186, DOI 10.1158/0008-5472.CAN-03-3861; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Spanjaard RA, 2007, INT J CANCER, V120, P1304, DOI 10.1002/ijc.22367; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; Trakul N, 2005, CELL RES, V15, P19, DOI 10.1038/sj.cr.7290258; Trakul N, 2005, J BIOL CHEM, V280, P24931, DOI 10.1074/jbc.M413929200; Wan JH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0556-3; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Yu ZW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009956; Ziegler DS, 2008, J CLIN INVEST, V118, P3109, DOI 10.1172/JCI34120; Zwick E, 2002, TRENDS MOL MED, V8, P17, DOI 10.1016/S1471-4914(01)02217-1	54	2	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1544	1559		10.1038/s41388-018-0503-x	http://dx.doi.org/10.1038/s41388-018-0503-x			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30337686	Green Published, hybrid			2022-12-26	WOS:000459945800013
J	Yarychkivska, O; Shahabuddin, Z; Comfort, N; Boulard, M; Bestor, TH				Yarychkivska, Olya; Shahabuddin, Zoha; Comfort, Nicole; Boulard, Mathieu; Bestor, Timothy H.			BAH domains and a histone-like motif in DNA methyltransferase 1 (DNMT1) regulate de novo and maintenance methylation in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA enzyme; DNA methylation; chromatin; chromatin modification; chromatin regulation; epigenetics; 5-methylcytosine; DNA methylation; DNA methyltransferase; DNA methyltransferase-1 (DNMT1); genomic imprinting; acetylation; histone; BAH domain; gene regulation	MOUSE CELLS; SRA DOMAIN; GERM-CELLS; UHRF1; EXPRESSION; PROTEINS; REVEALS; DIFFERENTIATION; ESTABLISHMENT; REPLICATION	DNA methyltransferase 1 (DNMT1) is a multidomain protein believed to be involved only in the passive transmission of genomic methylation patterns via maintenance methylation. The mechanisms that regulate DNMT1 activity and targeting are complex and poorly understood. We used embryonic stem (ES) cells to investigate the function of the uncharacterized bromo-adjacent homology (BAH) domains and the glycine-lysine (GK) repeats that join the regulatory and catalytic domains of DNMT1. We removed the BAH domains by means of a CRISPR/Cas9-mediated deletion within the endogenous Dnmt1 locus. The internally deleted protein failed to associate with replication foci during S phase in vivo and lost the ability to mediate maintenance methylation. The data indicate that ablation of the BAH domains causes DNMT1 to be excluded from replication foci even in the presence of the replication focus-targeting sequence (RFTS). The GK repeats resemble the N-terminal tails of histones H2A and H4 and are normally acetylated. Substitution of lysines within the GK repeats with arginines to prevent acetylation did not alter the maintenance activity of DNMT1 but unexpectedly activated de novo methylation of paternal imprinting control regions (ICRs) in mouse ES cells; maternal ICRs remained unmethylated. We propose a model under which DNMT1 deposits paternal imprints in male germ cells in an acetylation-dependent manner. These data reveal that DNMT1 responds to multiple regulatory inputs that control its localization as well as its activity and is not purely a maintenance methyltransferase but can participate in the de novo methylation of a small but essential compartment of the genome.	[Yarychkivska, Olya; Shahabuddin, Zoha; Bestor, Timothy H.] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168t St, New York, NY 10032 USA; [Comfort, Nicole] Columbia Univ Coll Phys & Surg, Dept Environm Hlth Sci, New York, NY 10032 USA; [Boulard, Mathieu] European Mol Biol Lab, I-00015 Rome, Italy	Columbia University; Columbia University; European Molecular Biology Laboratory (EMBL)	Bestor, TH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168t St, New York, NY 10032 USA.	THB12@cumc.columbia.edu	Comfort, Nicole/AAY-6714-2020; Boulard, Matthieu/H-8923-2017	Comfort, Nicole/0000-0002-6827-3043; Shahabuddin, Zoha/0000-0003-4641-7146; Boulard, Matthieu/0000-0001-5135-8529	National Institutes of Health [5R21 HG009187]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG009187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant 5R21 HG009187 (to T. H. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bewick AJ, 2017, MOL BIOL EVOL, V34, P654, DOI 10.1093/molbev/msw264; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2006, CYTOGENET GENOME RES, V113, P36, DOI 10.1159/000090813; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Cheng JD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8023; Damelin M, 2007, MOL CELL BIOL, V27, P3891, DOI 10.1128/MCB.00036-07; Edwards JR, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0130-8; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Ishiyama S, 2017, MOL CELL, V68, P350, DOI 10.1016/j.molcel.2017.09.037; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kim J, 2014, MOL PLANT, V7, P1470, DOI 10.1093/mp/ssu079; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, COLD SPRING HARB SYM, V58, P297, DOI 10.1101/SQB.1993.058.01.035; Li T, 2018, NUCLEIC ACIDS RES, V46, P3218, DOI 10.1093/nar/gky104; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; Long HK, 2013, BIOCHEM SOC T, V41, P727, DOI 10.1042/BST20130028; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; McGraw S, 2015, NUCLEIC ACIDS RES, V43, P1485, DOI 10.1093/nar/gku1386; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Proudhon C, 2012, MOL CELL, V47, P909, DOI 10.1016/j.molcel.2012.07.010; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Sakai Y, 2001, CELL STRUCT FUNCT, V26, P685, DOI 10.1247/csf.26.685; Schulz R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001214; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Takebayashi S, 2007, MOL CELL BIOL, V27, P8243, DOI 10.1128/MCB.00899-07; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Yang N, 2013, CRIT REV BIOCHEM MOL, V48, P211, DOI 10.3109/10409238.2012.742035; Yarychkivska O, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0179-z; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Zhang ZM, 2015, J MOL BIOL, V427, P2520, DOI 10.1016/j.jmb.2015.06.001	52	27	29	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19466	19475		10.1074/jbc.RA118.004612	http://dx.doi.org/10.1074/jbc.RA118.004612			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30341171	Green Published, hybrid			2022-12-26	WOS:000453537300026
J	Jinesh, GG; Flores, ER; Brohl, AS				Jinesh, Goodwin G.; Flores, Elsa R.; Brohl, Andrew S.			Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers	PLOS ONE			English	Article							BLEBBISHIELD EMERGENCY PROGRAM; ENHANCER-BLOCKING ACTIVITY; STEM-CELLS; TRANSCRIPTION FACTOR; HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; GENE-EXPRESSION; RESISTANCE; C19MC; TRANSFORMATION	Triple negative breast cancers (TNBCs) are known to express low PGR, ESR1, and ERBB2, and high KRT5, KRT14, and KRT17. However, the reasons behind the increased expressions of KRT5, KRT14, KRT17 and decreased expressions of PGR, ESR1, and ERBB2 in TNBCs are not fully understood. Here we show that, expression of chromosome 19 miRNA cluster (C19MC) specifically marks human TNBCs. Low REST and high CEBPB correlate with expression of C19MC, KRT5, KRT14, and KRT17 and enhancers of these genes/cluster are regulated by CEBPB and REST binding sites. The C19MC miRNAs in turn can potentially target REST to offer a positive feedback loop, and might target PGR, ESR1, ERBB2, GATA3, SCUBE2, TFF3 mRNAs to contribute towards TNBC phenotype. Thus our study demonstrates that C19MC miRNA expression marks TNBCs and that C19MC miRNAs and CEBPB might together determine the TNBC marker expression pattern.	[Jinesh, Goodwin G.; Flores, Elsa R.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Jinesh, Goodwin G.; Brohl, Andrew S.] H Lee Moffitt Canc Ctr & Res Inst, Sarcoma Dept, Tampa, FL 33612 USA; [Flores, Elsa R.] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL USA; [Flores, Elsa R.] H Lee Moffitt Canc Ctr & Res Inst, Canc Biol & Evolut Program, Tampa, FL USA; [Brohl, Andrew S.] H Lee Moffitt Canc Ctr & Res Inst, Chem Biol & Mol Med Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Jinesh, GG (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA.; Jinesh, GG; Brohl, AS (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Sarcoma Dept, Tampa, FL 33612 USA.; Brohl, AS (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Chem Biol & Mol Med Program, Tampa, FL 33612 USA.	goodwinjinesh@gmail.com; Andrew.Brohl@moffitt.org	Brohl, Andrew/ABB-6710-2020; Jinesh, Goodwin G./M-5956-2013	Jinesh, Goodwin G./0000-0002-2170-3245	NATIONAL CANCER INSTITUTE [R35CA197452] Funding Source: NIH RePORTER; NCI NIH HHS [R35 CA197452] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afghahi A, 2017, CLIN CANCER RES, V23, P3365, DOI 10.1158/1078-0432.CCR-16-2174; American Cancer Society, 2017, BREAST CANC FACTS FI; Augello C, 2012, LIVER INT, V32, P772, DOI 10.1111/j.1478-3231.2012.02795.x; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Flor I, 2016, CANCER GENOM PROTEOM, V13, P281; Fornari F, 2012, J PATHOL, V227, P275, DOI 10.1002/path.3995; Franco HL, 2018, GENOME RES, V28, P159, DOI 10.1101/gr.226019.117; Gade P, 2008, MOL CELL BIOL, V28, P2528, DOI 10.1128/MCB.00784-07; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Jakobsen JS, 2013, GENOME RES, V23, P592, DOI 10.1101/gr.146399.112; Jinesh GG, 2018, ONCOGENE, V37, P839, DOI 10.1038/onc.2017.377; Jinesh GG, 2016, CELL DEATH DIFFER, V23, P757, DOI 10.1038/cdd.2016.26; Jinesh GG, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2015.69; Jinesh GG, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.3; Jinesh GG, 2013, CELL DEATH DIFFER, V20, P382, DOI 10.1038/cdd.2012.140; Jinesh Goodwin G, 2017, Oncoscience, V4, P124, DOI 10.18632/oncoscience.369; Jinesh GG, 2017, CANCER RES, V77, P6144, DOI 10.1158/0008-5472.CAN-17-0522; Jinesh GG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08796-z; Jinesh GG, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.23; Jinesh GG, 2017, BIOFACTORS, V43, P181, DOI 10.1002/biof.1335; Jinesh GG, 2016, APOPTOSIS, V21, P1203, DOI 10.1007/s10495-016-1289-3; Jinesh GG, 2016, SCI REP-UK, V6, DOI 10.1038/srep23965; Jinesh GG, 2016, BIOCHEM J, V473, P99, DOI 10.1042/BJ20150877; Jinesh GG, 2014, CURR STEM CELL RES T, V9, P89; Karlin KL, 2014, CELL REP, V9, P1318, DOI 10.1016/j.celrep.2014.10.011; Kleinman CL, 2014, NAT GENET, V46, P39, DOI 10.1038/ng.2849; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li W, 2018, CELL METAB, V28, P87, DOI 10.1016/j.cmet.2018.04.022; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Liu YJ, 2017, CLIN CANCER RES, V23, P514, DOI 10.1158/1078-0432.CCR-15-1348; Loi S, 2013, P NATL ACAD SCI USA, V110, P11091, DOI 10.1073/pnas.1222251110; Lund MJ, 2009, BREAST CANCER RES TR, V113, P357, DOI 10.1007/s10549-008-9926-3; Lynch VJ, 2011, NATURE, V480, P383, DOI 10.1038/nature10595; Mudvari P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074993; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; Prat A, 2014, BRIT J CANCER, V111, P1532, DOI 10.1038/bjc.2014.444; Rippe V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009485; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Strub GM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88856; Taoka R, 2017, APOPTOSIS, V22, P719, DOI 10.1007/s10495-017-1359-1; Vaira V, 2012, J MOL ENDOCRINOL, V49, P115, DOI 10.1530/JME-11-0189; Wagoner MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000979; Ward A, 2014, J PATHOL, V233, P368, DOI 10.1002/path.4363; Zhang DH, 2017, NUCLEIC ACIDS RES, V45, P3102, DOI 10.1093/nar/gkw1258; Zhang Y, 2015, J BIOL CHEM, V290, P6215, DOI 10.1074/jbc.M114.620252; Zheng DY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r9; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	53	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206008	10.1371/journal.pone.0206008	http://dx.doi.org/10.1371/journal.pone.0206008			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335837	Green Submitted, Green Published, gold			2022-12-26	WOS:000447701300087
J	Nyirenda, D; Gooding, K; Lora, W; Kumwenda, M; McMorrow, M; Everett, D; Desmond, N				Nyirenda, Deborah; Gooding, Kate; Lora, Wezzie; Kumwenda, Moses; McMorrow, Meredith; Everett, Dean; Desmond, Nicola			Complexities and dilemmas in community consultation on the design of a research project logo in Malawi	PLOS ONE			English	Article							BIOMEDICAL-RESEARCH; VACCINE TRIAL; AFRICA; EXPERIENCES; ENGAGEMENT; COUNTRIES; INFLUENZA; SCIENCE; ENROLL; GAMBIA	Background Community engagement on research design is widely highlighted as an important approach for ethical research. This article reports the experience of consulting with communities on the logo used for an influenza study in Malawi. The logo was designed for use on badges worn by study researchers, participant information sheets and other project documents, and could affect perceptions of the study and consequent engagement in the research. Methods Four focus group discussions were conducted with populations targeted by the influenza study: pregnant women, people with HIV, mothers and community members. The focus groups incorporated a participatory matrix exercise focusing on key themes emerging from the discussions such as: attractiveness, comprehension, acceptability and suggestions for improvement. Findings from the focus groups were analyzed according to these key themes. Results The consultation highlighted important benefits of discussion with communities on research design, including providing new perspectives and helping to avoid harm. For example, people living with HIV felt that one of the possible logos could increase stigma within communities. The experience also indicated potential challenges of consultation. In particular, there were contrasting perspectives among the groups, such that the consultation did not provide a clear answer about which logo should be selected. Conclusions Our experience adds to current evidence on community engagement by reporting on an area where there is less discussion of community consultation for design of a study logo. The consultation exercise reaffirmed the value of community engagement, but also the difficulty of relying on a brief consultation for decision-making in research design. Further ethical guidance is required on how to negotiate contradictory views during consultations.	[Nyirenda, Deborah; Gooding, Kate; Lora, Wezzie; Kumwenda, Moses; Everett, Dean; Desmond, Nicola] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Nyirenda, Deborah; Kumwenda, Moses] Univ Malawi, Coll Med, Blantyre, Malawi; [Nyirenda, Deborah; Gooding, Kate; Lora, Wezzie; Desmond, Nicola] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [McMorrow, Meredith] US Ctr Dis Control & Prevent South Africa, Influenza Program, Pretoria, South Africa; [McMorrow, Meredith] US PHS, Rockville, MD USA; [Everett, Dean] Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; United States Public Health Service; University of Edinburgh	Nyirenda, D (corresponding author), Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.; Nyirenda, D (corresponding author), Univ Malawi, Coll Med, Blantyre, Malawi.; Nyirenda, D (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.	dnyirenda@mlw.mw	Desmond, Nicola/ABA-6504-2020; Desmond, Nicola/GYQ-8574-2022	Desmond, Nicola/0000-0002-2874-8569; Nyirenda, Deborah/0000-0002-5867-4687; Everett, Dean/0000-0002-8458-6779; Kumwenda, Moses Kelly/0000-0003-3091-7330; McMorrow, Meredith/0000-0001-6363-4033	U.S Centers for Disease Control and Prevention [U01IP000848]	U.S Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the U.S Centers for Disease Control and Prevention, grant number U01IP000848 to DE. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amuyunzu-Nyamongo M, 2013, GLOB HEALTH PROMOT, V20, P97, DOI 10.1177/1757975913500682; Angwenyi V, 2013, DEV WORLD BIOETH, V13, P38, DOI 10.1111/dewb.12015; Cohn S, 2016, HEALTH-LONDON, V20, P203, DOI 10.1177/1363459315574117; Council for International Organizations of Medical Sciences, 2016, INT ETH GUID HLTH RE; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Dickert N, 2005, AM J PUBLIC HEALTH, V95, P1123, DOI 10.2105/AJPH.2004.058933; Dudley L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128817; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Fairhead J, 2006, J BIOSOC SCI, V38, P103, DOI 10.1017/S0021932005000945; Fairhead J, 2006, SOC SCI MED, V63, P1109, DOI 10.1016/j.socscimed.2006.02.018; Girard T, 2015, ENTREPRENEURIAL EXEC, V18, P7; Group SW, 2012, BACKGR PAP INFL VACC; Holzer JK, 2015, J INVEST MED, V62, P851; Involve, 2015, APPR PUBL INV RES; Ives J, 2013, J MED ETHICS, V39, P181, DOI 10.1136/medethics-2011-100150; Marsh V, 2008, SOC SCI MED, V67, P721, DOI 10.1016/j.socscimed.2008.02.007; Masiye F, 2008, MALAWI MED J, V20, P50; McMorrow ML, 2015, J INFECT DIS; Mfutso-Bengo J, 2008, MALAWI MED J, V20, P64; Mfutso-Bengo J, 2008, MALAWI MED J, V20, P57, DOI 10.4314/mmj.v20i2.10958; Mfutso-Bengo J, 2008, MALAWI MED J, V20, P37, DOI 10.4314/mmj.v20i2.10898; Molyneux S, 2010, AM J BIOETHICS, V10, P24, DOI 10.1080/15265161003708623; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; SanJoaquin MA, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001400; Taylor RM, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0014-1; The World Bank, 2016, MAL COUNTR GLANC; Tindana PO, 2007, PLOS MED, V4, P1451, DOI 10.1371/journal.pmed.0040273; WHO, 2014, COUNTR PROF AN SUMM; World Health Organization, 2016, INFL SEAS; World Health Organization, 2015, MAL WHO STAT PROF; Yazdanbakhsh M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000182	33	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205737	10.1371/journal.pone.0205737	http://dx.doi.org/10.1371/journal.pone.0205737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4KR	30335816	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000447701300049
J	Verma, SP; Das, P				Verma, Shiv Prakash; Das, Parimal			Novel splicing in IGFN1 intron 15 and role of stable G-quadruplex in the regulation of splicing in renal cell carcinoma	PLOS ONE			English	Article							MESSENGER-RNA; BREAKPOINT REGION; DNA STRUCTURES; TRANSLOCATION; BINDS; POLYMORPHISMS; EXPRESSION; STABILITY; TARGET; MYC	The IGFN1 (Immunoglobulin-Like And Fibronectin Type III Domain Containing 1) gene has a role in skeletal muscle function and is also involved in metastatic breast cancer, and the isoforms with three N-terminal globular domains are sufficient for its function in skeletal muscle. Two novel splicing isoforms of IGFN1 have been identified in renal cell carcinoma (RCC), one with 5'exon extension and an isoform with a novel exon. The role of G-quadruplex, a non-B DNA, was explored for the splicing alteration of IGFN1 in RCC. G-quadruplexes are the secondary structures acquired by stacking of G-quartets by Hoogsteen hydrogen bonding in DNA and RNA. IGFN1 has intronic potential G-quadruplex forming sequence (PQS) folding into G-quadruplex and is studied for its involvement in aberrant splicing. A PQS in the intron 15 of IGFN1 gene was observed in our in silico analysis by QGRS mapper and non BdB web servers. We observed PQS folds into stable G-quadruplex structure in gel shift assay and circular dichroism (CD) spectroscopy in the presence of G-quadruplex stabilizing agents Pyridostatin (PDS) and KCl, respectively. G-quadruplex formation site with single base resolution was mapped by Sanger sequencing of the plasmid constructs harbouring the cloned PQS and its mutant. This stable G-quadruplex inhibits reverse transcriptase and taq polymerase in reverse transcriptase & PCR stop assays. PDS changes the different splicing isoforms of IGFN1 in UOK146 cell line, displaying involvement of intronic G-quadruplex in IGFN1 splicing. These results lead us to propose that a stable G-quadruplex structure is formed in IGFN1 intron and a reason behind IGFN1 aberrant splicing which could be targeted for therapeutic intervention.	[Verma, Shiv Prakash; Das, Parimal] Banaras Hindu Univ, Ctr Genet Disorders, Inst Sci, Varanasi, Uttar Pradesh, India	Banaras Hindu University (BHU)	Das, P (corresponding author), Banaras Hindu Univ, Ctr Genet Disorders, Inst Sci, Varanasi, Uttar Pradesh, India.	parimal@bhu.ac.in	Verma, Shiv Prakash/X-5316-2019; Verma, Shiv Prakash/AAP-7137-2021		Indian Council of Medical Research (ICMR), Government of India, New Delhi	Indian Council of Medical Research (ICMR), Government of India, New Delhi(Indian Council of Medical Research (ICMR))	This work was funded by the Indian Council of Medical Research (ICMR), Government of India, New Delhi for JRF and SRF fellowship support to Shiv Prakash Verma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Baker J, 2010, EXP CELL RES, V316, P1856, DOI 10.1016/j.yexcr.2010.02.027; Biffi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102711; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Blice-Baum AC, 2014, RNA, V20, P103, DOI 10.1261/rna.041442.113; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Cammas A, 2017, NUCLEIC ACIDS RES, V45, P1584, DOI 10.1093/nar/gkw1280; Cer RZ, 2011, NUCLEIC ACIDS RES, V39, pD383, DOI 10.1093/nar/gkq1170; Cimino-Reale G, 2016, CURR PHARM DESIGN, V22, P6612, DOI 10.2174/1381612822666160831101031; Collie GW, 2011, CHEM SOC REV, V40, P5867, DOI 10.1039/c1cs15067g; Conlon EG, 2016, ELIFE, V5, DOI 10.7554/eLife.17820; Decorsiere A, 2011, GENE DEV, V25, P220, DOI 10.1101/gad.607011; Duquette ML, 2005, ONCOGENE, V24, P5791, DOI 10.1038/sj.onc.1208746; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Fisette JF, 2012, J NEUROCHEM, V121, P763, DOI 10.1111/j.1471-4159.2012.07680.x; Gomez D, 2004, NUCLEIC ACIDS RES, V32, P371, DOI 10.1093/nar/gkh181; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Han HY, 2000, TRENDS PHARMACOL SCI, V21, P136, DOI 10.1016/S0165-6147(00)01457-7; Kang HJ, 2016, J AM CHEM SOC, V138, P13673, DOI 10.1021/jacs.6b07598; Kikin O, 2016, NUCLEIC ACIDS RES, V34, pW676; Kumari S, 2008, BIOCHEMISTRY-US, V47, P12664, DOI 10.1021/bi8010797; Lefebvre C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002201; Mansilla F, 2008, J CELL BIOCHEM, V105, P847, DOI 10.1002/jcb.21880; Marcel V, 2011, CARCINOGENESIS, V32, P271, DOI 10.1093/carcin/bgq253; Matsumura K, 2017, ONCOGENE, V36, P1191, DOI 10.1038/onc.2016.282; McCullough AJ, 2000, MOL CELL BIOL, V20, P9225, DOI 10.1128/MCB.20.24.9225-9235.2000; Miao CL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09079; Nambiar M, 2013, MOL CELL BIOL, V33, P4266, DOI 10.1128/MCB.00540-13; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Perriaud L, 2014, CARCINOGENESIS, V35, P2706, DOI 10.1093/carcin/bgu206; Petr M, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160232; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Ribeiro MM, 2015, HUM GENET, V134, P37, DOI 10.1007/s00439-014-1485-6; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Sagne C, 2014, CARCINOGENESIS, V35, P807, DOI 10.1093/carcin/bgt381; Shin YJ, 2015, ONCOGENE, V34, P1292, DOI 10.1038/onc.2014.65; Simone R, 2015, FEBS LETT, V589, P1653, DOI 10.1016/j.febslet.2015.05.003; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Smargiasso N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-362; Verma SP, 2018, BBA-GEN SUBJECTS, V1862, P630, DOI 10.1016/j.bbagen.2017.11.011	42	12	13	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205660	10.1371/journal.pone.0205660	http://dx.doi.org/10.1371/journal.pone.0205660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335789	gold, Green Published, Green Submitted			2022-12-26	WOS:000447701300040
J	Benito-Vicente, A; Uribe, KB; Siddiqi, H; Jebari, S; Galicia-Garcia, U; Larrea-Sebal, A; Cenarro, A; Stef, M; Ostolaza, H; Civeira, F; Palacios, L; Martin, C				Benito-Vicente, A.; Uribe, K. B.; Siddiqi, H.; Jebari, S.; Galicia-Garcia, U.; Larrea-Sebal, A.; Cenarro, A.; Stef, M.; Ostolaza, H.; Civeira, F.; Palacios, L.; Martin, C.			Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; LIGAND-BINDING DOMAIN; FAMILIAL HYPERCHOLESTEROLEMIA; FUNCTIONAL-CHARACTERIZATION; MONOCLONAL-ANTIBODIES; GENE; POPULATION; VARIANTS; DISEASE; CHOLESTEROL	Background and aims Pathogenic mutations in the Low Density Lipoprotein Receptor gene (LDLR) cause Familial Hypercholesterolemia (FH), one of the most common genetic disorders with a prevalence as high as 1 in 200 in some populations. FH is an autosomal dominant disorder of lipoprotein metabolism characterized by high blood cholesterol levels, deposits of cholesterol in peripheral tissues such as tendon xanthomas and accelerated atherosclerosis. To date, 2500 LDLRvariants have been identified in the LDLR gene; however, only a minority of them have been experimentally characterized and proven to be pathogenic. Here we investigated the role of Cys46 located in the first repeat of the LDL receptor binding domain in recognition of apolipoproteins. Methods Activity of the p.(Cys46Gly) LDLR variant was assessed by immunoblotting and flow cytometry in CHO-/d/A7 expressing the receptor variant. Affinity of p.(Cys46Gly) for LDL and VLDL was determined by solid-phase immunoassays and in silico analysis was used to predict mutation effects. Results and conclusion Functional characterization of p.(Cys46Gly) LDLRvariant showed impaired LDL and VLDL binding and uptake activity. Consistent with this, solid-phase immunoassays showed the p. (Cys46Gly) LDLR variant has decreased binding affinity for apolipoproteins. These results indicate the important role of Cys46 in LDL receptor activity and highlight the role of LR1 in LDLr activity modulation. This study reinforces the significance of in vitro functional characterization of LDL receptor activity in developing an accurate approach to FH genetic diagnosis. This is of particular importance because it enables clinicians to tailor personalized treatments for patients' mutation profile.	[Benito-Vicente, A.; Uribe, K. B.; Siddiqi, H.; Jebari, S.; Galicia-Garcia, U.; Larrea-Sebal, A.; Ostolaza, H.; Martin, C.] Univ Basque Country, Inst Biofis, CSIC, UPV EHU, Bilbao, Spain; [Benito-Vicente, A.; Uribe, K. B.; Siddiqi, H.; Jebari, S.; Galicia-Garcia, U.; Larrea-Sebal, A.; Ostolaza, H.; Martin, C.] Univ Basque Country, Dept Bioquim, Bilbao, Spain; [Cenarro, A.; Civeira, F.] Hosp Univ Miguel Servet, IACS, Unidad Libidos, Zaragoza, Spain; [Cenarro, A.; Civeira, F.] Hosp Univ Miguel Servet, IACS, Lab Invest Mol, Zaragoza, Spain; [Stef, M.; Palacios, L.] Progenika Biopharm, Derio, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Miguel Servet University Hospital; Miguel Servet University Hospital	Martin, C (corresponding author), Univ Basque Country, Inst Biofis, CSIC, UPV EHU, Bilbao, Spain.; Martin, C (corresponding author), Univ Basque Country, Dept Bioquim, Bilbao, Spain.	cesar.martin@ehu.eus	Uribe, Kepa B./AGZ-5717-2022; Uribe, Kepa B./AAC-2163-2019; marttin, cesar/GWC-4638-2022; martin, cesar/L-1303-2014	Uribe, Kepa B./0000-0002-4502-4853; Uribe, Kepa B./0000-0002-4502-4853; Civeira, Fernando/0000-0001-7043-0952; Larrea, Asier/0000-0001-9107-4299; OSTOLAZA ECHABE, ELENA AMAYA/0000-0003-2933-9975; martin, cesar/0000-0002-4087-8729	Progenika Biopharma SA; Gobernio Vasco; ELKARTEK BIOGUNE 2015 [KK-2015/0000089]; Basque Government [IT849-13]; Eusko Jaurlaritza [PIF 2014/2015, PIF 2018/2019]	Progenika Biopharma SA; Gobernio Vasco; ELKARTEK BIOGUNE 2015; Basque Government(Basque Government); Eusko Jaurlaritza	Progenika Biopharma SA, is an Spanish biotech company founded in 2000 with headquarters in Derio, Bizkaia (SPAIN). Progenika Biopharma SA did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries to M.S. and L.P. This work was supported by Gobernio Vasco, ELKARTEK BIOGUNE 2015 (Codigo KK-2015/0000089) and Basque Government (Grupos Consolidados IT849-13). A. B-V. was supported by a grant (PIF 2014/2015) Eusko Jaurlaritza and S.J. was supported by grant (PIF 2018/2019) Eusko Jaurlaritza. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benito-Vicente A, 2015, GENET MED, V17, P980, DOI 10.1038/gim.2015.14; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; BIERI S, 1995, BIOCHEMISTRY-US, V34, P13059, DOI 10.1021/bi00040a017; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; Dardik R, 2000, THROMB HAEMOSTASIS, V83, P338; Di Taranto MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15543-x; ESSER V, 1988, J BIOL CHEM, V263, P13282; Etxebarria A, 2015, ATHEROSCLEROSIS, V238, P304, DOI 10.1016/j.atherosclerosis.2014.12.026; Etxebarria A, 2015, HUM MUTAT, V36, P129, DOI 10.1002/humu.22721; Etxebarria A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112677; Etxebarria A, 2012, HUM MUTAT, V33, P232, DOI 10.1002/humu.21630; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; FIELDING PE, 1986, J BIOL CHEM, V261, P5233; Goldberg AC, 2011, J CLIN LIPIDOL, V5, pS1, DOI 10.1016/j.jacl.2011.04.003; Guttman M, 2011, BIOCHEMISTRY-US, V50, P11001, DOI 10.1021/bi2014486; Guttman M, 2010, BIOCHEMISTRY-US, V49, P1207, DOI 10.1021/bi9017208; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Holla OL, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-9; Huang S, 2010, J LIPID RES, V51, P297, DOI 10.1194/jlr.M000422; Hughes DP, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0723-z; ISHIKAWA Y, 1988, J BIOL CHEM, V263, P2744; Iwasaki T, 2004, J HUM GENET, V49, P622, DOI 10.1007/s10038-004-0198-4; Martinez-Olivan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132141; Martinez-Olivan J, 2014, FEBS J, V281, P1534, DOI 10.1111/febs.12721; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Raussens V, 2002, J BIOL CHEM, V277, P29172, DOI 10.1074/jbc.M204043200; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Sacks FM, 2000, CIRCULATION, V102, P1886, DOI 10.1161/01.CIR.102.16.1886; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Takahashi M, 2001, CLIN GENET, V59, P290, DOI 10.1034/j.1399-0004.2001.590414.x; Tosi I, 2007, ATHEROSCLEROSIS, V194, P102, DOI 10.1016/j.atherosclerosis.2006.10.003; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; VANDRIEL IR, 1989, J BIOL CHEM, V264, P9533; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Wonderling David, 2004, Semin Vasc Med, V4, P97; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yu WX, 2002, ATHEROSCLEROSIS, V165, P335, DOI 10.1016/S0021-9150(02)00249-6	39	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204771	10.1371/journal.pone.0204771	http://dx.doi.org/10.1371/journal.pone.0204771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332439	Green Published, gold			2022-12-26	WOS:000447638200033
J	Colin, T; Bruce, J; Meikle, WG; Barron, AB				Colin, Theotime; Bruce, Jake; Meikle, William G.; Barron, Andrew B.			The development of honey bee colonies assessed using a new semi-automated brood counting method: CombCount	PLOS ONE			English	Article							APIS-MELLIFERA; PATTERN-FORMATION; VARROA-DESTRUCTOR; COMBS; NECTAR; HYMENOPTERA; LANDSCAPE; EXPOSURE; MARKER; APIDAE	Precise, objective data on brood and honey levels in honey bee colonies can be obtained through the analysis of hive frame photographs. However, accurate analysis of all the frame photographs from medium-to large-scale experiments is time-consuming. This limits the number of hives than can be practically included in honeybee studies. Faster estimation methods exist but they significantly decrease precision and their use requires a larger sample size to maintain statistical power. To resolve this issue, we created 'CombCount' a python program that automatically detects uncapped cells to speed up measurements of capped brood and capped honey on photos of frames. CombCount does not require programming skills, it was designed to facilitate colony-level research in honeybees and to provide a fast, free, and accurate alternative to older methods based on visual estimations. Six observers measured the same photos of thirty different frames both with CombCount and by manually outlining the entire capped areas with ImageJ. The results obtained were highly similar between both the observers and the two methods, but measurements with CombCount were 3.2 times faster than with ImageJ (4 and 13 min per side of the frame, respectively) and all observers were faster when using CombCount rather than ImageJ. CombCount was used to measure the proportions of capped brood and capped honey on each frame of 16 hives over a year as they developed from packages to full-size colonies over about 60 days. Our data describe the formation of brood and honey stores during the establishment of a new colony.	[Colin, Theotime; Barron, Andrew B.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [Bruce, Jake] Queensland Univ Technol, Sch Elect Engn & Comp Sci, Brisbane, Qld, Australia; [Meikle, William G.] USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ USA	Macquarie University; Queensland University of Technology (QUT); United States Department of Agriculture (USDA)	Colin, T (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia.	theotime.colin@mq.edu.au	Meikle, William/AAC-2481-2022; Colin, Theotime/AAW-7734-2020	Meikle, William/0000-0002-1759-6950; Barron, Andrew/0000-0002-8135-6628; Colin, Theotime/0000-0003-0223-4479	iMQRES scholarship from Macquarie University; USDA Agricultural Research Service [58-5342-3-004F]	iMQRES scholarship from Macquarie University; USDA Agricultural Research Service(United States Department of Agriculture (USDA))	This research was funded by an iMQRES scholarship from Macquarie University for TC. WM, AB and TC received funding from USDA Agricultural Research Service Special Cooperative Agreement no: 58-5342-3-004F. There was no additional external funding received for this study.	Alburaki M, 2017, APIDOLOGIE, V48, P556, DOI 10.1007/s13592-017-0497-3; Alburaki M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125790; Baines D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10489-6; Bertrand B, 2015, MOL ECOL RESOUR, V15, P673, DOI 10.1111/1755-0998.12339; Bohme F, 2017, APIDOLOGIE, V48, P353, DOI 10.1007/s13592-016-0479-x; Brown MJF, 2016, PEERJ, V4, DOI 10.7717/peerj.2249; CAMAZINE S, 1991, BEHAV ECOL SOCIOBIOL, V28, P61, DOI 10.1007/BF00172140; CAMAZINE S, 1990, J THEOR BIOL, V147, P553, DOI 10.1016/S0022-5193(05)80264-4; Carroll MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175933; Chang LH, 2015, J EXP BIOL, V218, P1715, DOI 10.1242/jeb.119198; Colin T, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2322-4; de Mattos IM, 2017, APIDOLOGIE, V48, P483, DOI 10.1007/s13592-017-0491-9; DeGrandi-Hoffman G, 2000, INSECT SOC, V47, P302, DOI 10.1007/PL00001720; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Emsen B., 2006, Journal of Animal and Veterinary Advances, V5, P1229; Eyer M, 2015, INSECT SOC, V63, P51; Fewell JH, 2003, SCIENCE, V301, P1867, DOI 10.1126/science.1088945; Floris I, 2004, J ECON ENTOMOL, V97, P187, DOI 10.1603/0022-0493-97.2.187; FRESNAYE J., 1961, ANN ABEILLE [PARIS], V4, P369, DOI 10.1051/apido:19610404; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; He XJ, 2013, APIDOLOGIE, V44, P38, DOI 10.1007/s13592-012-0156-7; Holland JG, 2015, FUNCT ECOL, V29, P1209, DOI 10.1111/1365-2435.12480; IMDORF A, 1987, APIDOLOGIE, V18, P137, DOI 10.1051/apido:19870204; Imdorf A., 1999, LEHRGANG ERFASSUNG V; Johnson BR, 2007, INSECT SOC, V54, P351, DOI 10.1007/s00040-007-0953-6; Johnson BR, 2009, P ROY SOC B-BIOL SCI, V276, P255, DOI 10.1098/rspb.2008.0793; Lundin H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137535; Matsumoto T, 2013, J APIC SCI, V57, P21, DOI 10.2478/JAS-2013-0014; Meikle WG, 2016, APIDOLOGIE, V47, P1, DOI 10.1007/s13592-015-0370-1; Meikle WG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197589; Meikle WG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168603; Meikle WG, 2008, APIDOLOGIE, V39, P694, DOI 10.1051/apido:2008055; Melathopoulos AP, 2000, J ECON ENTOMOL, V93, P559, DOI 10.1603/0022-0493-93.3.559; Modlmeier AP, 2012, P ROY SOC B-BIOL SCI, V279, P2142, DOI 10.1098/rspb.2011.2376; Montovan KJ, 2013, J THEOR BIOL, V336, P75, DOI 10.1016/j.jtbi.2013.07.010; Odoux JF, 2014, J APICULT RES, V53, P57, DOI 10.3896/IBRA.1.53.1.05; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; SEELEY TD, 1989, BEHAV ECOL SOCIOBIOL, V24, P181, DOI 10.1007/BF00292101; SEELEY TD, 1976, INSECT SOC, V23, P495, DOI 10.1007/BF02223477; Winkelmann R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097953; Woodcock BA, 2017, SCIENCE, V356, P1393, DOI 10.1126/science.aaa1190; WSC Regexpert, 2016, PHOT HON BROOD TRIAL; Wu-Smart J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32108; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Yoshiyama M, 2011, J APICULT RES, V50, P170, DOI 10.3896/IBRA.1.50.2.10; YUEN HK, 1990, IMAGE VISION COMPUT, V8, P71, DOI 10.1016/0262-8856(90)90059-E; 2013, EFSA J, V11, DOI DOI 10.2903/J.EFSA.2013.3295	47	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205816	10.1371/journal.pone.0205816	http://dx.doi.org/10.1371/journal.pone.0205816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325960	Green Published, Green Submitted, gold			2022-12-26	WOS:000447430800044
J	Martinez-Garcia, M; Cyriac, P; Batard, T; Bertalmio, M; Malo, J				Martinez-Garcia, M.; Cyriac, P.; Batard, T.; Bertalmio, M.; Malo, J.			Derivatives and inverse of cascaded linear plus nonlinear neural models	PLOS ONE			English	Article							NATURAL IMAGES; NEURONAL RESPONSES; COLOR-VISION; DISCRIMINATION; RECONSTRUCTION; ADAPTATION; REPRESENTATION; VISIBILITY; TRANSFORM; SCENES	In vision science, cascades of Linear+Nonlinear transforms are very successful in modeling a number of perceptual experiences. However, the conventional literature is usually too focused on only describing the forward input-output transform. Instead, in this work we present the mathematics of such cascades beyond the forward transform, namely the Jacobian matrices and the inverse. The fundamental reason for this analytical treatment is that it offers useful analytical insight into the psychophysics, the physiology, and the function of the visual system. For instance, we show how the trends of the sensitivity (volume of the discrimination regions) and the adaptation of the receptive fields can be identified in the expression of the Jacobian w.r.t. the stimulus. This matrix also tells us which regions of the stimulus space are encoded more efficiently in multi-information terms. The Jacobian w.r.t. the parameters shows which aspects of the model have bigger impact in the response, and hence their relative relevance. The analytic inverse implies conditions for the response and model parameters to ensure appropriate decoding. From the experimental and applied perspective, (a) the Jacobian w.r.t. the stimulus is necessary in new experimental methods based on the synthesis of visual stimuli with interesting geometrical properties, (b) the Jacobian matrices w.r.t. the parameters are convenient to learn the model from classical experiments or alternative goal optimization, and (c) the inverse is a promising model-based alternative to blind machine-learning methods for neural decoding that do not include meaningful biological information. The theory is checked by building and testing a vision model that actually follows a modular Linear+Nonlinear program. Our illustrative derivable and invertible model consists of a cascade of modules that account for brightness, contrast, energy masking, and wavelet masking. To stress the generality of this modular setting we show examples where some of the canonical Divisive Normalization modules are substituted by equivalent modules such as the Wilson-Cowan interaction model (at the V1 cortex) or a tone-mapping model (at the retina).	[Martinez-Garcia, M.; Malo, J.] Univ Valencia, Image Proc Lab, Valencia, Spain; [Martinez-Garcia, M.] CSIC, Inst Neurociencias, Alicante, Spain; [Cyriac, P.; Batard, T.; Bertalmio, M.] Univ Pompeu Fabra, Informat & Commun Technol Dept, Barcelona, Spain	University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Pompeu Fabra University	Malo, J (corresponding author), Univ Valencia, Image Proc Lab, Valencia, Spain.	jesus.malo@uv.es	Malo, Jesus/K-9235-2017; Bertalmío, Marcelo/A-4341-2012; Batard, Thomas/AAA-4122-2020	Malo, Jesus/0000-0002-5684-8591; Batard, Thomas/0000-0001-9335-0314; Martinez Garcia, marina/0000-0002-2228-4396	Spanish Ministerio de Economia y Competitividad [CICYT TEC2013-50520-EXP, CICYT BFU2014-59776-R]; European Research Council [306337]; Spanish government; FEDER Fund (MINECO/FEDER,UE) [TIN2015-71537-P]; FEDER Fund [1021]; ICREA Academia Award	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Research Council(European Research Council (ERC)European Commission); Spanish government(Spanish GovernmentEuropean Commission); FEDER Fund (MINECO/FEDER,UE); FEDER Fund; ICREA Academia Award(ICREA)	This work was partially funded by the Spanish Ministerio de Economia y Competitividad projects CICYT TEC2013-50520-EXP and CICYT BFU2014-59776-R, by the European Research Council, Starting Grant ref. 306337, by the Spanish government and FEDER Fund, grant ref. TIN2015-71537-P(MINECO/FEDER,UE), 1021, and by the ICREA Academia Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHUMADA AJ, 1987, J OPT SOC AM A, V4, P2372, DOI 10.1364/JOSAA.4.002372; Antolik J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004927; Balle A J, 2017, INT CONF LEARN REPRE, V5; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Baydin Atilim Gunes, 2015, CORR; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Berardino A, 2017, ADV NEUR INF P NIPS; Bertalmio M, 2017, J VISION, V17, P657, DOI [10.1167/17.10.657, DOI 10.1167/17.10.657]; Bertalmio M, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00071; Bimbo A. del, 1999, VISUAL INFORM RETRIE; BROWN WRJ, 1949, J OPT SOC AM, V39, P808, DOI 10.1364/JOSA.39.000808; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Capilla P, 2004, J OPT SOC AM A, V21, P176, DOI 10.1364/JOSAA.21.000176; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Coen-Cagli R, 2013, J VISION, V13, DOI 10.1167/13.8.13; Cowan JD, 2016, J MATH NEUROSCI, V6, DOI 10.1186/s13408-015-0034-5; Cui Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19460; Cyriac P, 2016, IST ELECT IMAGING C, V13, P1, DOI [10.2352/ISSN.2470-1173.2016.13.IQSP-012, DOI 10.2352/ISSN.2470-1173.2016.13.IQSP-012]; Cyriac P, 2015, P IS T SPIE ELECT IM, P9394; Cyriac P, 2016, SMPTE 2016 ANN TECH, P1; da Fonseca M, 2016, NEURAL COMPUT, V28, P2628, DOI 10.1162/NECO_a_00903; Dubrovin B, 1982, MODERN GEOMETRY METH; Epifanio I, 2003, PATTERN RECOGN, V36, P1799, DOI 10.1016/S0031-3203(02)00325-4; Fairchild M, 2013, WILEY IS T SERIES IM; Fairchild M.D., 2013, COLOUR APPEARANCE MO, DOI DOI 10.1002/9781118653128; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Gatys L., 2015, J VISUAL-JAPAN; Georgeson MA, 2006, VISION RES, V46, P4294, DOI 10.1016/j.visres.2005.08.024; Golub GH., 2013, MATRIX COMPUTATIONS; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Gutierrez J, 2006, IEEE T IMAGE PROCESS, V15, P189, DOI 10.1109/TIP.2005.860345; Gutmann MU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086481; Hillis JM, 2005, J OPT SOC AM A, V22, P2090, DOI 10.1364/JOSAA.22.002090; Jinggang Huang, 1999, Proceedings. 1999 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No PR00149), P541, DOI 10.1109/CVPR.1999.786990; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kandel E.R., 1991, PRINC NEUROSCI, V3rd ed.; Kane D, 2016, J VISION, V16, DOI 10.1167/16.6.4; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kay KN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003079; Klindt D., 2017, ADV NEURAL INF PROCE, P3509; Laparra V, 2017, J OPT SOC AM A, V34, P1511, DOI 10.1364/JOSAA.34.001511; Laparra V, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00557; Laparra V, 2012, NEURAL COMPUT, V24, P2751, DOI 10.1162/NECO_a_00336; Laparra V, 2010, J MACH LEARN RES, V11, P873; Laparra V, 2010, J OPT SOC AM A, V27, P852, DOI 10.1364/JOSAA.27.000852; Laughlin S.B., 1983, PHYS BIOLOGICAL PROC, P42; LEGALL D, 1991, COMMUN ACM, V34, P46, DOI 10.1145/103085.103090; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; Legge GE, 1981, VISION RES, V18, P68, DOI DOI 10.1016/0042-6989(81)90092-4; Ma K, 2016, IEEE ICCV; MacLeod D., 2003, COLOR PERCEPTION LIG; Mahendran Aravindh, 2014, CORR; Malo J, 2006, IEEE T IMAGE PROCESS, V15, P68, DOI 10.1109/TIP.2005.860325; Malo J, 2000, IMAGE VISION COMPUT, V18, P233, DOI 10.1016/S0262-8856(99)00010-4; Malo J, 2000, LECT NOTES COMPUT SC, V1876, P658; Malo J, 2001, IEEE T IMAGE PROCESS, V10, P1411, DOI 10.1109/83.951528; Malo J, 2016, J VISION, V16, P822, DOI [10.1167/16.12.822, DOI 10.1167/16.12.822]; Malo J, 2015, INT SOC OPTICS PHOTO; Malo J, 2018, QUANT BIOL; Malo J., 2002, COLORLAB MATLAB TOOL; Malo J, 2006, NETWORK-COMP NEURAL, V17, P85, DOI 10.1080/09548980500439602; Malo J, 2010, NEURAL COMPUT, V22, P3179, DOI 10.1162/NECO_a_00046; Mantiuk R, 2000, ACM T APPL PERCEPT, V3, P286, DOI [10.1145/1166087, DOI 10.1145/1166087]; Marre A O, 2017, PLOS COMPUT BIOL, V11; Martinez-Garcia M, 2016, PERCEPTION, V45, P46; McFarland JM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003143; Minka TP, 2001, OLD NEW MATRIX ALGEB; Miyawaki Y, 2008, NEURON, V60, P915, DOI 10.1016/j.neuron.2008.11.004; MULLEN KT, 1985, J PHYSIOL-LONDON, V359, P381, DOI 10.1113/jphysiol.1985.sp015591; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; P Stocker AA, 2009, NEURAL COMPUT, V21, P3271, DOI [10.1162/neco.2009.09-08-869, DOI 10.1162/NECO.2009.09-08-869]; Palma-Amestoy R, 2009, IEEE T PATTERN ANAL, V31, P458, DOI 10.1109/TPAMI.2008.86; Pelli DG, 1991, COMPUTATIONAL MODELS, P147; Petersen K.B., 2012, MATRIX COOKBOOK; Ponomarenko N, 2008, 2008 IEEE 10TH WORKSHOP ON MULTIMEDIA SIGNAL PROCESSING, VOLS 1 AND 2, P407; Pons AM, 1999, DISPLAYS, V20, P93, DOI 10.1016/S0141-9382(99)00009-8; Press W. H., 2007, ART SCI COMPUTING; Regan D., 1991, SPATIAL VISION; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; SAKRISON DJ, 1977, IEEE T COMMUN, V25, P1251, DOI 10.1109/TCOM.1977.1093773; Schutt HH, 2017, J VISION, V17, DOI 10.1167/17.12.12; Schwartz G, 2011, J GEN PHYSIOL, V138, P283, DOI 10.1085/jgp.201110629; Schwartz GW, 2012, NAT NEUROSCI, V15, P1572, DOI 10.1038/nn.3225; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Spivak M., 1965, MATH MONOGRAPH SERIE; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Studeny M., 1998, MULTIINFORMATION FUN, P261; Tekalp AM, 1995, DIGITAL VIDEO PROCES; TEO PC, 1994, P SOC PHOTO-OPT INS, V2179, P127, DOI 10.1117/12.172664; Thomas MC, 2006, ELEMENTS INFORM THEO; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Vintch B, 2015, J NEUROSCI, V35, P14829, DOI 10.1523/JNEUROSCI.2815-13.2015; WALLACE GK, 1991, COMMUN ACM, V34, P30, DOI 10.1145/103085.103089; Wandell B.A., 1995, FDN VISION; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang Z., 2006, Modern Image Quality Assessment, DOI 10.2200/S00010ED1V01Y200508IVM003; Wang Z, 2008, J VISION, V8, DOI 10.1167/8.12.8; Wang Z, 2009, IEEE SIGNAL PROC MAG, V26, P98, DOI 10.1109/MSP.2008.930649; Watson AB, 2002, 2002 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL III, PROCEEDINGS, P41, DOI 10.1109/ICIP.2002.1038898; Watson AB, 1997, J OPT SOC AM A, V14, P2379, DOI 10.1364/JOSAA.14.002379; Watson Andrew B., 1993, DIGITAL IMAGES HUMAN; WILSON HR, 1993, VISION RES, V33, P1133, DOI 10.1016/0042-6989(93)90248-U; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117	107	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0201326	10.1371/journal.pone.0201326	http://dx.doi.org/10.1371/journal.pone.0201326			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321175	Green Submitted, Green Published, gold			2022-12-26	WOS:000447417900002
J	Misumi, T; Tanabe, K; Fujikuni, N; Ohdan, H				Misumi, Toshihiro; Tanabe, Kazuaki; Fujikuni, Nobuaki; Ohdan, Hideki			Stimulation of natural killer cells with rhCD137 ligand enhances tumor-targeting antibody efficacy in gastric cancer	PLOS ONE			English	Article							HER2-POSITIVE BREAST-CANCER; PHASE-III TRIAL; RECEPTOR POLYMORPHISMS; MONOCLONAL-ANTIBODIES; OVEREXPRESSING HER2; 1ST-LINE TREATMENT; IN-VIVO; TRASTUZUMAB; CETUXIMAB; THERAPY	Although many anticancer agents for gastric cancer have been developed, the prognosis for many patients remains poor. Recently, costimulatory immune molecules that reactivate antitumor immune responses by utilizing the host immune system have attracted attention as new therapeutic strategies. CD137 is a costimulatory molecule that reportedly potentiates the antitumor activity of tumor-targeting monoclonal antibodies (mAbs) by enhancing antibody- dependent cellular cytotoxicity. However, it remains unclear whether CD137 stimulates tumor-regulatory activity in gastric cancer. In this study, we investigated the antitumor effects of CD137 stimulation on gastric cancer cells administered tumor-targeting mAbs. Our results showed that human natural killer (NK) cells were activated by expressing CD137 after encountering trastuzumab-coated gastric cancer cells, and that stimulation of activated NK cells in the presence of trastuzumab and recombinant human CD137 ligand (rhCD137L) enhanced cytotoxicity and release of cytokines (IFN-gamma, TNF, granzyme A, or granzyme B) as compared with activated NK cells with trastuzumab alone (p < 0.05). By combination treatment with rhCD137L, similar effects were obtained regarding cancer cell cytotoxicity in the presence of cetuximab (p < 0.01). Moreover, we revealed that CD137 expression was dependent upon the affinity between the Fc portion of the antibodies and Fc.RIIIa of NK cells based on results indicating that human IgG1 and IgG3 subclasses enhanced CD137 expression (p < 0.001). These results confirmed that Fc gamma RIIIA polymorphisms (158 V/V) enhanced CD137 expression to a greater degree than 158 F polymorphisms (p = 0.014). Our results suggested that CD137 stimulation could promote the effects of tumor-targeting mAbs in gastric cancer, and that further investigation of antibody binding affinity and in vivo activities might improve therapeutic strategies related to the treatment of gastric cancer patients.	[Misumi, Toshihiro; Tanabe, Kazuaki; Fujikuni, Nobuaki; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Appl Life Sci, Hiroshima, Japan	Hiroshima University	Tanabe, K (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Appl Life Sci, Hiroshima, Japan.	ktanabe2@hiroshima-u.ac.jp	Ohdan, Hideki/G-4719-2019; tanabe, kazuaki/S-6282-2019	Ohdan, Hideki/0000-0002-9066-1288; tanabe, kazuaki/0000-0002-8650-2735	Japan Society for the Promotion of Science (JSPS) KAKENHI [25462023]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Japan Society for the Promotion of Science (JSPS) KAKENHI (grant No. 25462023) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003578; Atmaca A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-524; Bang YJ, 2010, LANCET, V376, P1302; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Chong KT, 2007, BRIT J CLIN PHARMACO, V63, P328, DOI 10.1111/j.1365-2125.2006.02771.x; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Gennari R, 2004, CLIN CANCER RES, V10, P5650, DOI 10.1158/1078-0432.CCR-04-0225; Gollob JA, 2000, CLIN CANCER RES, V6, P1678; Hoff P, 2013, ANN ONCOL         S4, V24, piv67, DOI DOI 10.1093/ANNONC/MDT203.109; Janunger KG, 2002, EUR J SURG, V168, P597, DOI 10.1080/11024150201680005; Kajitani K, 2012, BREAST CANCER RES TR, V134, P139, DOI 10.1007/s10549-011-1944-x; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kang YK, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.TPS4138; Kohrt HE, 2014, J CLIN INVEST, V124, P2668, DOI 10.1172/JCI73014; Kohrt HE, 2012, J CLIN INVEST, V122, P1066, DOI 10.1172/JCI61226; Kohrt HE, 2011, BLOOD, V117, P2423, DOI 10.1182/blood-2010-08-301945; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Lim CM, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24677; Lin W, 2008, BLOOD, V112, P699, DOI 10.1182/blood-2007-11-122465; Liu LD, 2010, CANCER CHEMOTH PHARM, V65, P849, DOI 10.1007/s00280-009-1090-x; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Makkouk A, 2017, ANN ONCOL, V28, P415, DOI 10.1093/annonc/mdw570; Matsusaka S, 2016, GASTRIC CANCER, V19, P839, DOI 10.1007/s10120-015-0518-8; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Moehler M, 2011, ANN ONCOL, V22, P1358, DOI 10.1093/annonc/mdq591; Murillo O, 2008, CLIN CANCER RES, V14, P6895, DOI 10.1158/1078-0432.CCR-08-0285; Musolino A, 2016, PHARMACOGENOMICS J, V16, P472, DOI 10.1038/tpj.2016.51; Narazaki H, 2010, BLOOD, V115, P1941, DOI 10.1182/blood-2008-12-192591; Oboshi W, 2016, HUM IMMUNOL, V77, P165, DOI 10.1016/j.humimm.2015.11.001; Peipp M, 2008, BLOOD, V112, P2390, DOI 10.1182/blood-2008-03-144600; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Schabowsky RH, 2009, VACCINE, V28, P512, DOI 10.1016/j.vaccine.2009.09.127; Shimizu S, 2016, AM J TRANSPLANT, V16, P625, DOI 10.1111/ajt.13492; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X; Takeda K, 2010, J IMMUNOL, V184, P5493, DOI 10.4049/jimmunol.0903033; Tamura K, 2011, ANN ONCOL, V22, P1302, DOI 10.1093/annonc/mdq585; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Varchetta S, 2007, CANCER RES, V67, P11991, DOI 10.1158/0008-5472.CAN-07-2068; Vilgelm AE, 2016, J LEUKOCYTE BIOL, V100, P275, DOI 10.1189/jlb.5RI0116-013RR; Wilcox RA, 2002, J IMMUNOL, V168, P4262, DOI 10.4049/jimmunol.168.9.4262; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yamashita-Kashima Y, 2011, CLIN CANCER RES, V17, P5060, DOI 10.1158/1078-0432.CCR-10-2927; Zalevsky J, 2009, BLOOD, V113, P3735, DOI 10.1182/blood-2008-10-182048	50	10	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0204880	10.1371/journal.pone.0204880	http://dx.doi.org/10.1371/journal.pone.0204880			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321186	Green Submitted, Green Published, gold			2022-12-26	WOS:000447417900014
J	Alizad, K; Hagen, SC; Medeiros, SC; Bilskie, MV; Morris, JT; Balthis, L; Buckel, CA				Alizad, Karim; Hagen, Scott C.; Medeiros, Stephen C.; Bilskie, Matthew V.; Morris, James T.; Balthis, Len; Buckel, Christine A.			Dynamic responses and implications to coastal wetlands and the surrounding regions under sea level rise	PLOS ONE			English	Article							GULF-OF-MEXICO; LAND-COVER DATABASE; STORM-SURGE; TIDAL MARSH; VEGETATION; MODEL; BAY; HYDRODYNAMICS; RESTORATION; MISSISSIPPI	Two distinct microtidal estuarine systems were assessed to advance the understanding of the coastal dynamics of sea level rise in salt marshes. A coupled hydrodynamic-marsh model (Hydro-MEM) was applied to both a marine-dominated (Grand Bay, Mississippi) and a mixed fluvial/marine (Weeks Bay, Alabama) system to compute marsh productivity, marsh migration, and potential tidal inundation from the year 2000 to 2100 under four sea level rise scenarios. Characteristics of the estuaries such as geometry, sediment availability, and topography, were compared to understand their role in the dynamic response to sea level rise. The results show that the low sea level rise scenario (20 cm) approximately doubled high-productivity marsh coverage in the marine-dominated estuary by the year 2100 due to an equilibrium between the rates of sea level rise and marsh platform accretion. Under intermediate-low sea level rise (50 cm), high-productivity marsh coverage in the year 2100 increased (doubled in the marine-dominated estuary and a seven-fold increase in the mixed estuary) by expanding into higher lands followed by the creation of interior ponds. The results also indicate that marine-dominated estuaries are vulnerable to collapse as a result of low, relatively uniform topography and lack of sediment sources, whereas mixed estuaries are able to expand due to higher elevations and sediment inputs. The results from the higher sea level rise scenarios (the intermediate-high (120 cm) and high (200 cm)) showed expansion of the bays along with marsh migration to higher land, producing a five-fold increase in wetland coverage for the mixed estuary and virtually no net change for the marine-dominated estuary. Additionally, hurricane storm surge simulations showed that under higher sea level rise scenarios, the marine-dominated estuary demonstrated weaker peak stage attenuation indicating that the marsh's ability to dissipate storm surge is sensitive to productivity changes and bay expansion / marsh loss.	[Alizad, Karim; Bilskie, Matthew V.] Louisiana State Univ, Ctr Coastal Resiliency, Baton Rouge, LA 70803 USA; [Hagen, Scott C.] Louisiana State Univ, Dept Civil & Environm Engn, Ctr Coastal Resiliency, Ctr Computat & Technol, Baton Rouge, LA 70803 USA; [Medeiros, Stephen C.] Univ Cent Florida, Dept Civil Environm & Construct Engn, Orlando, FL 32816 USA; [Morris, James T.] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Morris, James T.] Univ South Carolina, Belle W Baruch Inst, Columbia, SC 29208 USA; [Balthis, Len; Buckel, Christine A.] NOAA, Natl Ocean Serv, Natl Ctr Coastal Ocean Sci, Silver Spring, MD USA; [Alizad, Karim] Univ South Carolina, Belle W Baruch Inst Marine & Coastal Sci, Columbia, SC 29208 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; State University System of Florida; University of Central Florida; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); University of South Carolina System; University of South Carolina Columbia	Alizad, K (corresponding author), Louisiana State Univ, Ctr Coastal Resiliency, Baton Rouge, LA 70803 USA.; Alizad, K (corresponding author), Univ South Carolina, Belle W Baruch Inst Marine & Coastal Sci, Columbia, SC 29208 USA.	Alizad@SC.edu	morris, james/AAQ-5605-2020; Alizad, Karim/I-4736-2019; morris, james/ABC-8111-2020	morris, james/0000-0002-0511-642X; Alizad, Karim/0000-0002-9174-0164; Bilskie, Matthew/0000-0002-7697-7403; Medeiros, Stephen/0000-0003-0264-5868	National Oceanic and Atmospheric Administration (NOAA) Ecological Effects of Sea Level Rise (EESLR) Program [NA10NOS4780146, NA16NOS4780208]; National Science Foundation [NSF DEB 1052636, ACI-1053575]	National Oceanic and Atmospheric Administration (NOAA) Ecological Effects of Sea Level Rise (EESLR) Program; National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Oceanic and Atmospheric Administration (NOAA) Ecological Effects of Sea Level Rise (EESLR) Program: Award No. NA10NOS4780146 to Scott C. Hagen, Award No. NA16NOS4780208 to Scott C. Hagen; National Science Foundation: Award No. NSF DEB 1052636 to James T. Morris, Award No. ACI-1053575 to Scott C. Hagen. Scott C. Hagen's role in manuscript preparation was the study design, methodology, analysis and supervision as well as review and correction. James T. Morri's role in manuscript preparation was the study design, data collection and analysis as well as review and correction.	Alizad K, 2016, EARTHS FUTURE, V4, P483, DOI 10.1002/2016EF000385; Alizad K, 2016, ECOL MODEL, V327, P29, DOI 10.1016/j.ecolmodel.2016.01.013; [Anonymous], [No title captured]; [Anonymous], 1999, RES MDOM MISS COAST; Arcement G, 1989, S GEOL SURV WATER SU, DOI [10.3133/wsp2339, DOI 10.3133/WSP2339]; Augustin LN, 2009, COAST ENG, V56, P332, DOI 10.1016/j.coastaleng.2008.09.004; Barbier EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058715; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bilskie MV, 2016, J GEOPHYS RES-OCEANS, V121, P3625, DOI 10.1002/2015JC011400; Bilskie MV, 2016, EARTHS FUTURE, V4, P177, DOI 10.1002/2015EF000347; Bilskie MV, 2015, ADV WATER RESOUR, V86, P102, DOI 10.1016/j.advwatres.2015.09.020; Bilskie MV, 2013, ADV WATER RESOUR, V52, P165, DOI 10.1016/j.advwatres.2012.09.003; BROOME SW, 1988, AQUAT BOT, V32, P1, DOI 10.1016/0304-3770(88)90085-X; Clough JS, 2011, SLAMM ANAL GRAND BAY; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Crosby SC, 2016, ESTUAR COAST SHELF S, V181, P93, DOI 10.1016/j.ecss.2016.08.018; D'Alpaos A, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000537; Dalrymple R. W., 1992, J SEDIMENTARY RES, V62; Day J, 2011, ESTUAR COAST, V34, P483, DOI 10.1007/s12237-011-9390-x; DAY JW, 1995, ESTUARIES, V18, P636, DOI 10.2307/1352382; Donnelly JP, 2001, P NATL ACAD SCI USA, V98, P14218, DOI 10.1073/pnas.251209298; Eleuterius CK, 1991, POINT CHENES PRESENT; Enwright NM, 2016, FRONT ECOL ENVIRON, V14, P307, DOI 10.1002/fee.1282; Esri, 2012, WORLD IM BAS; Esri, 2012, NAT GEOGR WORLD BAS; Feagin RA, 2010, ECOLOGY SOC; Foster-Martinez MR, 2018, COAST ENG, V136, P26, DOI 10.1016/j.coastaleng.2018.02.001; FRIEDRICHS CT, 1990, COAST ESTUAR STUD, V38, P105; Ganju NK, 2016, ESTUAR COAST, V39, P311, DOI 10.1007/s12237-015-0011-y; Gilmer B., 2011, INFORM CONSERVATION; Guerreiro M, 2015, REV GESTAO COSTEIRA, V15; Hagen SC, 2013, J WATERW PORT C, V139, P118, DOI 10.1061/(ASCE)WW.1943-5460.0000177; Hammer-Klose E.S, 1999, 00179 NAT ASS COAST; Hearn C. J., 2001, SEA LEVEL CHANGES TH, P25; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Hughes Z.J., 2012, PRINCIPLES TIDAL SED, P269, DOI DOI 10.1007/978-94-007-0123-6_11; Jin SM, 2013, REMOTE SENS ENVIRON, V132, P159, DOI 10.1016/j.rse.2013.01.012; Kastner K, 2017, J GEOPHYS RES-EARTH, V122, P696, DOI 10.1002/2016JF004075; Kirwan ML, 2007, P NATL ACAD SCI USA, V104, P6118, DOI 10.1073/pnas.0700958104; Kirwan ML, 2016, GEOPHYS RES LETT, V43, P4366, DOI 10.1002/2016GL068507; Kirwan ML, 2012, J ECOL, V100, P764, DOI 10.1111/j.1365-2745.2012.01957.x; Knutson P., 1987, ROLE COASTAL MARSHES, P161; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leonard LA, 1995, LIMNOL OCEANOGR, V40, P1474, DOI 10.4319/lo.1995.40.8.1474; Leorri E., 2011, J INTEGR COAST ZONE, V11, P307, DOI DOI 10.5894/RGCI277; Linhoss AC, 2015, J COASTAL RES, V31, P36, DOI 10.2112/JCOASTRES-D-13-00215.1; Lovelace JK, 1992, STORM TIDE ELEVATION, P94; Lu Z, 1992, ESTUARINE COASTAL MO, P418; Luettich R., 2006, USERS MANUAL VERSION; Mariotti G, 2017, WATER RESOUR RES, V53, P7029, DOI 10.1002/2017WR020461; Mariotti G, 2016, J GEOPHYS RES-EARTH, V121, P1391, DOI 10.1002/2016JF003900; Medeiros S, 2015, REMOTE SENS-BASEL, V7, P3507, DOI 10.3390/rs70403507; Medeiros SC, 2013, INT J NUMER METH FL, V71, P473, DOI 10.1002/fld.3668; Medeiros SC, 2012, J HYDROL, V452, P139, DOI 10.1016/j.jhydrol.2012.05.043; Miller-Way T., 1996, 9601 DAUPH ISL SEA L; Moller I, 2002, J COASTAL RES, P506; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Morris J, 2013, AGU FALL M; Morris JT, 2013, OCEANOGRAPHY, V26, P78, DOI 10.5670/oceanog.2013.48; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Morton RA, 2008, J COASTAL RES, V24, P1587, DOI 10.2112/07-0953.1; Mudd SM, 2009, ESTUAR COAST SHELF S, V82, P377, DOI 10.1016/j.ecss.2009.01.028; National Oceanic and Atmospheric Administration Center for Operational Oceanographic Products and Services. COOPS, 2017, MEAN SEA LEV TREND D; Neubauer SC, 2008, ESTUAR COAST SHELF S, V78, P78, DOI 10.1016/j.ecss.2007.11.011; Nicholls RJ, 1999, GLOBAL ENVIRON CHANG, V9, pS69, DOI 10.1016/S0959-3780(99)00019-9; NWI, 2008, MISS COAST UPD NWI B; Osland MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183431; OSullivan W.T., 1998, 62 ANN M MISS AC SCI; Parris A., 2012, GLOBAL SEA LEVEL RIS; Passeri DL, 2016, EARTHS FUTURE, V4, P159, DOI 10.1002/2015EF000332; Passeri DL, 2015, CONT SHELF RES, V111, P150, DOI 10.1016/j.csr.2015.08.001; Passeri DL, 2015, EARTHS FUTURE, V3, P159, DOI 10.1002/2015EF000298; Passeri DL, 2015, NAT HAZARDS, V75, P1599, DOI 10.1007/s11069-014-1386-y; Peterson M.S., 2007, GRAND BAY NATL ESTUA; Pitchford JL, 2017, HIGH RESOLUTION LAND; Resio DT, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.2982120; Rilo A, 2013, J COASTAL RES, P820, DOI 10.2112/SI65-139.1; Rodriguez JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16094; Savenije H.H., 2006, SALINITY TIDES ALLUV; Schepers L, 2017, LIMNOL OCEANOGR, V62, P137, DOI 10.1002/lno.10381; Schieder NW, 2018, ESTUAR COAST, V41, P940, DOI 10.1007/s12237-017-0336-9; Schile LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088760; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Shirley LJ, 2006, WETLANDS, V26, P1057, DOI 10.1672/0277-5212(2006)26[1057:AVCICL]2.0.CO;2; Siverd CG, 2018, COAST ENG, V137, P28, DOI 10.1016/j.coastaleng.2018.03.006; Spalding EA, 2007, ESTUAR COAST, V30, P214, DOI 10.1007/BF02700165; Stark J, 2015, LIMNOL OCEANOGR, V60, P1371, DOI 10.1002/lno.10104; Stralberg D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027388; Townend I, 2002, PHILOS T R SOC A, V360, P1477, DOI 10.1098/rsta.2002.1011; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; Turner RE, 1997, ESTUARIES, V20, P1, DOI 10.2307/1352716; Turner RE, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P583; US Army Corps of Engineers, 1963, INT SURV REP, V63; van de Koppel J, 2012, J EXP BIOL, V215, P962, DOI 10.1242/jeb.060467; Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018; Wamsley TV, 2009, NAT HAZARDS, V51, P207, DOI 10.1007/s11069-009-9378-z; Weeks Bay National Estuarine Research Reserve, 2007, WEEKS BAY NAT EST RE; Wolanski E, 1996, J MARINE SYST, V7, P267, DOI 10.1016/0924-7963(95)00002-X; Yoskowitz D, 2017, INTEGR ENVIRON ASSES, V13, P431, DOI 10.1002/ieam.1798	100	54	54	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205176	10.1371/journal.pone.0205176	http://dx.doi.org/10.1371/journal.pone.0205176			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312304	Green Published, Green Submitted, gold			2022-12-26	WOS:000447427300022
J	Kim, DY; Woo, YM; Lee, S; Oh, S; Shin, Y; Shin, JO; Park, EY; Ko, JY; Lee, EJ; Bok, J; Yoo, KH; Park, JH				Kim, Do Yeon; Woo, Yu Mi; Lee, Sunyoung; Oh, Sumin; Shin, Yubin; Shin, Jeong-Oh; Park, Eun Young; Ko, Je Yeong; Lee, Eun Ji; Bok, Jinwoong; Yoo, Kyung Hyun; Park, Jong Hoon			Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease	FASEB JOURNAL			English	Article						ADPKD; DNA methylation; microRNA; ZEB2; N-cadherin	EPITHELIAL-CELLS; MICRORNAS; GENES; EXPRESSION; METHYLATION; PROGRESSION; MECHANISM; MODEL; DNA; INACTIVATION	Altered miRNA (miR) expression occurs in various diseases. However, the therapeutic effect of miRNAs in autosomal dominant polycystic kidney disease (ADPKD) is unclear. Genome-wide analyses of miRNA expression and DNA methylation status were conducted to identify crucial miRNAs in end-stage ADPKD. miR-192 and -194 levels were down-regulated with hypermethylation at these loci, mainly in the intermediate and late stages, not in the early stage, of cystogenesis, suggesting their potential impact on cyst expansion. Cyst expansion has been strongly associated with endothelial-mesenchymal transition (EMT). Zinc finger E-box-binding homeobox-2 and cadherin-2, which are involved in EMT, were directly regulated by miR-192 and -194. The therapeutic effect of miR-192 and -194 in vivo and in vitro were assessed. Restoring these miRs by injection of precursors influenced the reduced size of cysts in Pkd1 conditional knockout mice. miR-192 and -194 may act as potential therapeutic targets to control the expansion and progression of cysts in patients with ADPKD.Kim, D. Y., Woo, Y. M., Lee, S., Oh, S., Shin, Y., Shin, J.-O., Park, E. Y., Ko, J. Y., Lee, E. J., Bok, J., Yoo, K. H., Park, J. H. Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease.	[Kim, Do Yeon; Woo, Yu Mi; Lee, Sunyoung; Oh, Sumin; Shin, Yubin; Park, Eun Young; Ko, Je Yeong; Lee, Eun Ji; Yoo, Kyung Hyun; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Cheongpa Ro 47 Gil 100, Seoul 04310, South Korea; [Kim, Do Yeon; Woo, Yu Mi; Lee, Sunyoung; Oh, Sumin; Shin, Yubin; Park, Eun Young; Ko, Je Yeong; Lee, Eun Ji; Yoo, Kyung Hyun; Park, Jong Hoon] Sookmyung Womens Univ, Res Inst Womens Hlth, Cheongpa Ro 47 Gil 100, Seoul 04310, South Korea; [Shin, Jeong-Oh; Bok, Jinwoong] Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea; [Bok, Jinwoong] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea	Sookmyung Women's University; Sookmyung Women's University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoo, KH; Park, JH (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Cheongpa Ro 47 Gil 100, Seoul 04310, South Korea.; Yoo, KH; Park, JH (corresponding author), Sookmyung Womens Univ, Res Inst Womens Hlth, Cheongpa Ro 47 Gil 100, Seoul 04310, South Korea.	khryu@sookmyung.ac.kr; parkjh@sookmyung.ac.kr	Bok, Jinwoong/B-8982-2016	Bok, Jinwoong/0000-0003-1958-1872	Bio and Medical Technology Development Program [2015M3A9B6027557]; Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation [2014M3C9A2067613]; National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2016R1A5A1011974]; Sookmyung Women's University [1-1703-2021]	Bio and Medical Technology Development Program; Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation; National Research Foundation of Korea (NRF) - Korean Government (MSIP); Sookmyung Women's University	This work was supported by Bio and Medical Technology Development Program Grant 2015M3A9B6027557 (to J.H.P.); Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation Grant 2014M3C9A2067613 (to J.H.P.); National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP) 2016R1A5A1011974 (to J.H.P.); and Sookmyung Women's University Grant 1-1703-2021 (to K.H.Y.). The authors declare no conflicts of interest.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; Chiang YP, 2012, EXP THER MED, V3, P560, DOI 10.3892/etm.2011.436; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Delgado M, 2008, ARTHRITIS RHEUM-US, V58, P1026, DOI 10.1002/art.23283; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GABOW PA, 1993, AM J KIDNEY DIS, V22, P511, DOI 10.1016/S0272-6386(12)80921-8; GABOW PA, 1990, AM J KIDNEY DIS, V16, P403, DOI 10.1016/S0272-6386(12)80051-5; Grantham JJ, 1996, AM J KIDNEY DIS, V28, P788, DOI 10.1016/S0272-6386(96)90378-9; Hajarnis S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14395; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Happe H, 2014, NAT REV NEPHROL, V10, P587, DOI 10.1038/nrneph.2014.137; Happe H, 2013, KIDNEY INT, V83, P1099, DOI 10.1038/ki.2013.13; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ibraghimov-Beskrovnaya O, 2008, CELL MOL LIFE SCI, V65, P605, DOI 10.1007/s00018-007-7362-x; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Khella HWZ, 2013, CARCINOGENESIS, V34, P2231, DOI 10.1093/carcin/bgt184; Kocyigit I, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0600-z; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Lakhia R, 2016, J AM SOC NEPHROL, V27, P2319, DOI 10.1681/ASN.2015060634; Lee DBN, 2006, AM J PHYSIOL-RENAL, V290, pF20, DOI 10.1152/ajprenal.00052.2005; Lee SO, 2008, J CLIN INVEST, V118, P3714, DOI 10.1172/JCI34922; Lennox KA, 2011, GENE THER, V18, P1111, DOI 10.1038/gt.2011.100; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20856-6; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Loghman-Adham M, 2003, AM J PHYSIOL-RENAL, V285, pF397, DOI 10.1152/ajprenal.00310.2002; Lopez-Serra P, 2012, ONCOGENE, V31, P1609, DOI 10.1038/onc.2011.354; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Norman J, 2011, BBA-MOL BASIS DIS, V1812, P1327, DOI 10.1016/j.bbadis.2011.06.012; Pandey P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-56; Pandey P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-624; Park JH, 2014, BMB REP, V47, P417, DOI 10.5483/BMBRep.2014.47.8.109; Patel V, 2013, P NATL ACAD SCI USA, V110, P10765, DOI 10.1073/pnas.1301693110; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Raphael KL, 2009, KIDNEY INT, V75, P626, DOI 10.1038/ki.2008.659; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Roitbak T, 2004, MOL BIOL CELL, V15, P1334, DOI 10.1091/mbc.E03-05-0296; Schieren G, 2006, NEPHROL DIAL TRANSPL, V21, P1816, DOI 10.1093/ndt/gfl071; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Shin Y, 2018, FASEB J, V32, P3574, DOI 10.1096/fj.201700923R; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Torres VE, 2007, J INTERN MED, V261, P17, DOI 10.1111/j.1365-2796.2006.01743.x; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wessely O, 2012, J AM SOC NEPHROL, V23, P1909, DOI 10.1681/ASN.2012101026; Woo YM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14083-8; Woo Y, 2014, HUM GENET, V133, P281, DOI 10.1007/s00439-013-1378-0; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yang Y, 2018, J AM SOC NEPHROL, V29, P2310, DOI 10.1681/ASN.2018010074; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	56	21	21	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2870	2884		10.1096/fj.201800563RR	http://dx.doi.org/10.1096/fj.201800563RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30332302				2022-12-26	WOS:000457296600107
J	Lu, Y; Zhang, XS; Zhou, XM; Gao, YY; Chen, CL; Liu, JP; Ye, ZN; Zhang, ZH; Wu, LY; Li, W; Hang, CH				Lu, Yue; Zhang, Xiang-Sheng; Zhou, Xiao-Ming; Gao, Yong-Yue; Chen, Chun-Lei; Liu, Jing-Peng; Ye, Zhen-Nan; Zhang, Zi-Huan; Wu, Ling-Yun; Li, Wei; Hang, Chun-Hua			Peroxiredoxin 1/2 protects brain against H2O2-induced apoptosis after subarachnoid hemorrhage	FASEB JOURNAL			English	Article						hydroperoxide; oxidative stress; inflammation; ASK1	OXIDATIVE STRESS; INJURY; ACTIVATION; ADENANTHIN; PROTEINS; INFLAMMATION; MODULATORS; PATHWAY; STROKE	Recent studies suggest that peroxiredoxin1/2 (Prx1/2) may be involved in the pathophysiology of postischemic inflammatory responses in the brain. In this study, we assessed the distribution and function of Prx1/2 in mice after experimental subarachnoid hemorrhage (SAH). We investigated the distribution of Prx1/2 in the brains of mice both in vivo and in vitro using immunofluorescence staining. The expression of Prx1/2 after SAH was determined by Western blot. Adenanthin was used to inhibit Prx1/2 function, and Prx1/2 overexpression was achieved by injecting adeno-associated virus. Oxidative stress and neuronal apoptosis were assessed both in vivo and in vitro. The neurologic function, inflammatory response, and related cellular signals were analyzed. The results showed that Prx1 was mainly expressed in astrocytes, and Prx2 was abundant in neurons. The expression of Prx1/2 was elevated after SAH, and their expression levels peaked before proinflammatory cytokines. Inhibiting Prx1/2 promoted neuronal apoptosis by increasing the hydrogen peroxide (H2O2) levels via the apoptosis signal-regulating kinase 1/p38 pathway. By contrast, overexpression of Prx1/2 attenuated oxidative stress and neuronal apoptosis after SAH. Thus, early expression of Prx1/2 may protect the brain from oxidative damage after SAH and may provide a novel target for treating SAH.Lu, Y., Zhang, X.-S., Zhou, X.-M., Gao, Y.-Y., Chen, C.-L., Liu, J.-P., Ye, Z.-N., Zhang, Z.-H., Wu, L.-Y., Li, W., Hang, C.-H. Peroxiredoxin 1/2 protects brain against H2O2-induced apoptosis after subarachnoid hemorrhage.	[Lu, Yue; Zhang, Xiang-Sheng; Gao, Yong-Yue; Wu, Ling-Yun; Li, Wei; Hang, Chun-Hua] Nanjing Univ, Drum Tower Hosp, Dept Neurosurg, Med Sch, 321 Zhongshan Rd, Nanjing 210006, Jiangsu, Peoples R China; [Zhang, Xiang-Sheng; Zhou, Xiao-Ming] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Chen, Chun-Lei] Nanjing Med Univ, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Liu, Jing-Peng; Ye, Zhen-Nan] South Med Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Zhang, Zi-Huan] Zhongdu Hosp, Dept Neurosurg, Bengbu, Peoples R China	Nanjing University; Naval Medical University; Nanjing Medical University; Southern Medical University - China	Li, W; Hang, CH (corresponding author), Nanjing Univ, Drum Tower Hosp, Dept Neurosurg, Med Sch, 321 Zhongshan Rd, Nanjing 210006, Jiangsu, Peoples R China.	lwxzlw@126.com; hang_neurosurgery@163.com	Wu, Ling/GZN-2235-2022; Li, Wei/ABE-4301-2021	LU, Yue/0000-0001-9111-5943	National Natural Science Foundation of China (NSFC) [81771291, 81371294, 81501022, 81401029]; National Science Foundation of Jiangsu Province [BK20141375]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Science Foundation of Jiangsu Province	This work was supported by National Natural Science Foundation of China (NSFC) Grants 81771291 (to C.-H.H.), 81371294 (to C.-H.H.), 81501022 (to X.-S.Z.), and 81401029 (to W.L.), and National Science Foundation of Jiangsu Province Grant BK20141375. The authors declare no conflicts of interest.	Attia Mohammed Sabri, 2015, Acta Neurochir Suppl, V120, P311, DOI 10.1007/978-3-319-04981-6_53; Cao SL, 2016, STROKE, V47, P1626, DOI 10.1161/STROKEAHA.116.013146; Connor David E Jr, 2017, Pathophysiology, V24, P169, DOI 10.1016/j.pathophys.2017.04.003; Gan Y, 2012, ANTIOXID REDOX SIGN, V17, P719, DOI 10.1089/ars.2011.4298; Garcia-Bonilla L, 2012, NAT MED, V18, P858, DOI 10.1038/nm.2797; Gules I, 2003, ACT NEUR S, V86, P483; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Kamalvand G, 2003, AMYLOID, V10, P151, DOI 10.3109/13506120308998997; Kim SY, 2008, FEBS LETT, V582, P1913, DOI 10.1016/j.febslet.2008.05.015; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Leak RK, 2013, STROKE, V44, P1124, DOI 10.1161/STROKEAHA.111.680157; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Li W, 2014, MOL NEUROBIOL, V49, P187, DOI 10.1007/s12035-013-8509-4; Liu CX, 2012, NAT CHEM BIOL, V8, P486, DOI [10.1038/NCHEMBIO.935, 10.1038/nchembio.935]; Liu DL, 2016, INT IMMUNOPHARMACOL, V41, P82, DOI 10.1016/j.intimp.2016.10.025; Lu Y, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1118-4; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Muchowicz A, 2014, BIOCHEM PHARMACOL, V89, P210, DOI 10.1016/j.bcp.2014.02.022; Park MH, 2016, PHARMACOL THERAPEUT, V163, P1, DOI 10.1016/j.pharmthera.2016.03.018; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Rhee SG, 2016, MOL CELLS, V39, P1, DOI 10.14348/molcells.2016.2368; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Sabri M, 2008, BRAIN RES, V1238, P163, DOI 10.1016/j.brainres.2008.08.031; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Shichita T, 2017, NAT MED, V23, P723, DOI 10.1038/nm.4312; Shichita T, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00319; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Soethoudt M, 2014, FREE RADICAL BIO MED, V77, P331, DOI 10.1016/j.freeradbiomed.2014.09.025; Stolzing A, 2004, FASEB J, V18, P743, DOI 10.1096/fj.03-0374fje; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhang Feng, 2009, P187, DOI 10.1007/978-1-60327-185-1_15; Zhang M, 2015, ONCOL LETT, V10, P1841, DOI 10.3892/ol.2015.3424; Zhang XS, 2014, J NEUROSURG, V121, P42, DOI 10.3171/2014.2.JNS13730; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609	37	32	35	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					3051	3062		10.1096/fj.201801150R	http://dx.doi.org/10.1096/fj.201801150R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30351993	Bronze			2022-12-26	WOS:000457296600120
J	Santhanagopalan, I; Degiacomi, MT; Shepherd, DA; Hochberg, GKA; Benesch, JLP; Vierling, E				Santhanagopalan, Indu; Degiacomi, Matteo T.; Shepherd, Dale A.; Hochberg, Georg K. A.; Benesch, Justin L. P.; Vierling, Elizabeth			It takes a dimer to tango: Oligomeric small heat shock proteins dissociate to capture substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; small heat shock protein (sHsp); small-angle X-ray scattering (SAXS); oligomerization; protein stability; protein design; protein engineering; chaperone efficiency; disulfides; dynamic light scattering (DLS); native mass spectrometry; substrate recognition; thermal stability; stress response; protein folding	ALPHA-B-CRYSTALLIN; CHAPERONE ACTIVITY; SUBUNIT EXCHANGE; QUATERNARY ORGANIZATION; A-CRYSTALLIN; COMPLEXES; DYNAMICS; HSP26; MECHANISM; REVEALS	Small heat-shock proteins (sHsps) are ubiquitous molecular chaperones, and sHsp mutations or altered expression are linked to multiple human disease states. sHsp monomers assemble into large oligomers with dimeric substructure, and the dynamics of sHsp oligomers has led to major questions about the form that captures substrate, a critical aspect of their mechanism of action. We show here that substructural dimers of two plant dodecameric sHsps, Ta16.9 and homologous Ps18.1, are functional units in the initial encounter with unfolding substrate. We introduced inter-polypeptide disulfide bonds at the two dodecameric interfaces, dimeric and nondimeric, to restrict how their assemblies can dissociate. When disulfide-bonded at the nondimeric interface, mutants of Ta16.9 and Ps18.1 (TaCT-ACD and Ps(CT-ACD)) were inactive but, when reduced, had WT-like chaperone activity, demonstrating that dissociation at nondimeric interfaces is essential for sHsp activity. Moreover, the size of the TaCT-ACD and Ps(CT-ACD) covalent unit defined a new tetrahedral geometry for these sHsps, different from that observed in the Ta16.9 X-ray structure. Importantly, oxidized Ta-dimer (disulfide bonded at the dimeric interface) exhibited greatly enhanced ability to protect substrate, indicating that strengthening the dimeric interface increases chaperone efficiency. Temperature-induced size and secondary structure changes revealed that folded sHsp dimers interact with substrate and that dimer stability affects chaperone efficiency. These results yield a model in which sHsp dimers capture substrate before assembly into larger, heterogeneous sHsp-substrate complexes for substrate refolding or degradation, and suggest that tuning the strength of the dimer interface can be used to engineer sHsp chaperone efficiency.	[Santhanagopalan, Indu; Vierling, Elizabeth] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Degiacomi, Matteo T.; Shepherd, Dale A.; Hochberg, Georg K. A.; Benesch, Justin L. P.] Univ Oxford, Dept Chem Phys & Theoret Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England; [Degiacomi, Matteo T.] Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England; [Santhanagopalan, Indu] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Shepherd, Dale A.] Waters Corp, Stamford Ave, Wilmslow SK9 4AX, Cheshire, England; [Hochberg, Georg K. A.] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Oxford; Durham University; University of Cambridge; Waters UK; University of Chicago	Vierling, E (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	vierling@biochem.umass.edu	Degiacomi, Matteo/M-4342-2017; Hochberg, Georg/AAC-4185-2021	Degiacomi, Matteo/0000-0003-4672-471X; Vierling, Elizabeth/0000-0002-0066-4881; Benesch, Justin/0000-0002-1507-3742; Cooper-Shepherd, Dale/0000-0001-9301-1777; Hochberg, Georg/0000-0002-7155-0451	Engineering and Physical Sciences Research Council [EP/J01835X/1, EP/P016499/1]; National Institutes of Health [RO1 GM42762]; BBSRC [BB/K004247/1, BB/J018082/1] Funding Source: UKRI; EPSRC [EP/P016499/1, EP/J01835X/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042762] Funding Source: NIH RePORTER	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Engineering and Physical Sciences Research Council Grants EP/J01835X/1 (to J.L.P.B.) and EP/P016499/1 (to M.T.D.) and National Institutes of Health Grant RO1 GM42762 (to E.V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aquilina JA, 2005, J BIOL CHEM, V280, P14485, DOI 10.1074/jbc.M500135200; Arrigo AP, 2013, FEBS LETT, V587, P1959, DOI 10.1016/j.febslet.2013.05.011; Augusteyn RC, 2004, EXP EYE RES, V79, P781, DOI 10.1016/j.exer.2004.08.010; Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Baldwin AJ, 2011, J MOL BIOL, V413, P310, DOI 10.1016/j.jmb.2011.07.017; Baldwin AJ, 2011, J MOL BIOL, V413, P297, DOI 10.1016/j.jmb.2011.07.016; Basha E, 2013, J MOL BIOL, V425, P1683, DOI 10.1016/j.jmb.2013.02.011; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Benesch JLP, 2003, ANAL CHEM, V75, P2208, DOI 10.1021/ac034132x; Benesch JLP, 2010, CHEM BIOL, V17, P1008, DOI 10.1016/j.chembiol.2010.06.016; Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Charmpilas N, 2017, CELL STRESS CHAPERON, V22, P481, DOI 10.1007/s12192-016-0761-x; Cheng GL, 2008, J BIOL CHEM, V283, P26634, DOI 10.1074/jbc.M802946200; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Delbecq SP, 2013, FEBS LETT, V587, P1073, DOI 10.1016/j.febslet.2013.01.021; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Fleckenstein T, 2015, MOL CELL, V58, P1067, DOI 10.1016/j.molcel.2015.04.019; Franzmann TM, 2005, J MOL BIOL, V350, P1083, DOI 10.1016/j.jmb.2005.05.034; Friedrich KL, 2004, J BIOL CHEM, V279, P1080, DOI 10.1074/jbc.M311104200; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Hanazono Y, 2013, STRUCTURE, V21, P220, DOI 10.1016/j.str.2012.11.015; Hanazono Y, 2012, J MOL BIOL, V422, P100, DOI 10.1016/j.jmb.2012.05.017; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2004, J MOL BIOL, V343, P445, DOI 10.1016/j.jmb.2004.08.048; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hochberg GKA, 2018, SCIENCE, V359, P930, DOI 10.1126/science.aam7229; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Indu S, 2011, PROTEINS, V79, P244, DOI 10.1002/prot.22878; Jackson SE, 2013, TOP CURR CHEM, V328, P69, DOI 10.1007/128_2012_324; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Kim KP, 2011, BMB REP, V44, P816, DOI 10.5483/BMBRep.2011.44.12.816; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kirschner M, 2000, PLANT J, V24, P397, DOI 10.1046/j.1365-313x.2000.00887.x; Kondrat Frances D L, 2015, Methods Mol Biol, V1261, P349, DOI 10.1007/978-1-4939-2230-7_18; Makley LN, 2015, SCIENCE, V350, P674, DOI 10.1126/science.aac9145; Mani N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24019; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Painter AJ, 2008, CHEM BIOL, V15, P246, DOI 10.1016/j.chembiol.2008.01.009; Patel S, 2014, BIOPHYS J, V106, P2644, DOI 10.1016/j.bpj.2014.04.048; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Plater ML, 1996, J BIOL CHEM, V271, P28558, DOI 10.1074/jbc.271.45.28558; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Santhanagopalan I., 2015, BIG BOOK SMALL HEAT, P119, DOI [10.1007/978-3-319-16077-1_5, DOI 10.1007/978-3-319-16077-1_5]; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Shi J, 2013, J BIOL CHEM, V288, P4819, DOI 10.1074/jbc.M112.388132; Sobott F, 2002, J BIOL CHEM, V277, P38921, DOI 10.1074/jbc.M206060200; Stengel F, 2012, CHEM BIOL, V19, P599, DOI 10.1016/j.chembiol.2012.04.007; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Stromer T, 2003, J BIOL CHEM, V278, P18015, DOI 10.1074/jbc.M301640200; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tiroli AO, 2007, INT J BIOCHEM CELL B, V39, P818, DOI 10.1016/j.biocel.2007.01.014; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Waters ER, 2013, J EXP BOT, V64, P391, DOI 10.1093/jxb/ers355; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015; White HE, 2006, STRUCTURE, V14, P1197, DOI 10.1016/j.str.2006.05.021; Zhang KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08811; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650	68	29	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19511	19521		10.1074/jbc.RA118.005421	http://dx.doi.org/10.1074/jbc.RA118.005421			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30348902	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-26	WOS:000454294900001
J	Arnli, MB; Winther, TL; Lydersen, S; Torp, SH				Arnli, Magnus B.; Winther, Theo L.; Lydersen, Stian; Torp, Sverre H.			Prognostic value of ErbB2/HER2 in human meningiomas	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUE; CENTRAL-NERVOUS-SYSTEM; HER2 EXPRESSION; CANCER; RECEPTOR; ACTIVATION; SURVIVAL; PROTEIN; GLIOMAS; BENIGN	Introduction Among clinical challenges regarding human meningiomas is their propensity to recur even in cases with benign histology. Reliable biomarkers that can identify these cases are therefore highly desired. ErbB2/HER2 status is important in the medical management of patients with various human malignancies, whereas its clinical relevance in human meningiomas is ambiguous. For this reason, we wanted to investigate the expression of intra-and extracellular domains of ErbB2/HER2 as well as the level of activated receptor in these tumors. Further, we wanted to elucidate any clinicopathological associations to antibody expression and if gene amplification was present. Methods In total, 186 human meningiomas of all malignancy grades were included in the study, 163 of these were in tissue microarrays (TMA). Antibody expression was assessed by means of immunohistochemistry (IHC) and gene amplification by fluorescence in situ hybridization (FISH). Results All cases were immunoreactive with antibodies targeting the intracellular domain, whereas about 48% and 11% were positive with antibodies against the extracellular domain and against the activated receptor, respectively. Normal meninges were not immunoreactive. There were no relations to malignancy grade, and only the activated receptor was significantly correlated with increased risk for recurrence or death (time to recurrence: HR 1.568, CI (1.153 to 2.132), p = 0.004). No gene amplification was found. Conclusion ErbB2/HER2 is generally upregulated in human meningiomas, but in an activated state only in a few cases. Only the activated receptor is associated with poorer prognosis, a link that needs further investigations.	[Arnli, Magnus B.; Winther, Theo L.; Torp, Sverre H.] Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, Fac Med & Hlth Sci, Trondheim, Norway; [Lydersen, Stian] Norwegian Univ Sci & Technol NTNU, Reg Ctr Child & Youth Mental Hlth & Child Welf, Dept Mental Hlth, Fac Med & Hlth Sci, Trondheim, Norway; [Torp, Sverre H.] St Olavs Hosp, Dept Pathol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Arnli, MB (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, Fac Med & Hlth Sci, Trondheim, Norway.	magnus.b.arnli@ntnu.no	Torp, Sverre Helge/AAN-4229-2020	Torp, Sverre Helge/0000-0001-8345-6852	Norwegian University of Science and Technology; Department of Pathology at St. Olavs Hospital; Norwegian University of Science and Technology (NTNU); Department of Pathology	Norwegian University of Science and Technology; Department of Pathology at St. Olavs Hospital; Norwegian University of Science and Technology (NTNU); Department of Pathology	The project was funded by the Norwegian University of Science and Technology. The Department of Pathology at St. Olavs Hospital financed and performed the FISH staining procedure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Norwegian University of Science and Technology (NTNU) and the Department of Pathology for funding the laboratory procedures in this paper, and Unn S. Granli at the Cellular and Molecular Imaging Core Facility (CMIC) for outstanding laboratory services.	Abdelzaher E, 2011, BRIT J NEUROSURG, V25, P707, DOI 10.3109/02688697.2010.522743; Andersson U, 2004, ACTA NEUROPATHOL, V108, P135, DOI 10.1007/s00401-004-0875-6; Arnli MB, 2017, PEERJ, V5, DOI 10.7717/peerj.3140; Backer-Grondahl T, 2014, APMIS, V122, P856, DOI 10.1111/apm.12248; Backer-Grondahl T, 2012, INT J CLIN EXP PATHO, V5, P231; Bertelsen V, 2014, MEMBRANES, V4, P424, DOI 10.3390/membranes4030424; Chozick BS, 1996, J NEURO-ONCOL, V27, P117; Duffy MJ, 2017, EUR J CANCER, V75, P284, DOI 10.1016/j.ejca.2017.01.017; Fernebro E, 2002, ARCH PATHOL LAB MED, V126, P702; Gulati S, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-18; Heald JB, 2014, ACTA NEUROCHIR, V156, P383, DOI 10.1007/s00701-013-1923-6; Hilton DA, 2016, NEUROPATHOLOGY, V36, P250, DOI 10.1111/neup.12266; Hoos A, 2001, AM J PATHOL, V158, P1245, DOI 10.1016/S0002-9440(10)64075-8; Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI 10.1155/2014/852748; Laurendeau I, 2009, CANCER INVEST, V27, P691, DOI 10.1080/07357900802709175; Lei YY, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-017-1132-5; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Loussouarn D, 2006, HUM PATHOL, V37, P415, DOI 10.1016/j.humpath.2005.12.020; Mahzouni P, 2012, PATHOL RES PRACT, V208, P221, DOI 10.1016/j.prp.2012.01.009; McCarthy BJ, 1998, J NEUROSURG, V88, P831, DOI 10.3171/jns.1998.88.5.0831; Nanda A, 2017, J NEUROSURG, V126, P201, DOI 10.3171/2016.1.JNS151842; Ongaratti BR, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20155125; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Ozer O, 2009, TURK NEUROSURG, V19, P135; Potti A, 2004, AM J CLIN ONCOL-CANC, V27, P452, DOI 10.1097/01.coc.0000128724.63600.c7; Punt CJA, 2007, JNCI-J NATL CANCER I, V99, P998, DOI 10.1093/jnci/djm024; Rubin MA, 2002, AM J SURG PATHOL, V26, P312, DOI 10.1097/00000478-200203000-00004; SCHLEGEL J, 1993, ACTA NEUROPATHOL, V86, P473; SCHWECHHEIMER K, 1994, HUM PATHOL, V25, P772, DOI 10.1016/0046-8177(94)90246-1; SINGLETON TP, 1992, HUM PATHOL, V23, P1141, DOI 10.1016/0046-8177(92)90032-X; Thuijs NB, 2012, CHILD NERV SYST, V28, P1009, DOI 10.1007/s00381-012-1759-z; Torp SH, 2007, J EXP CLIN CANC RES, V26, P353; TORP SH, 1993, EUR J CANCER, V29A, P1604, DOI 10.1016/0959-8049(93)90305-Y; van Alkemade H, 2012, NEURO-ONCOLOGY, V14, P658, DOI 10.1093/neuonc/nos013; Waage IS, 2013, INT J SURG PATHOL, V21, P573, DOI 10.1177/1066896913492196; Wang WJ, 2015, MOL MED REP, V12, P3575, DOI 10.3892/mmr.2015.3805; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	39	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205846	10.1371/journal.pone.0205846	http://dx.doi.org/10.1371/journal.pone.0205846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335819	Green Submitted, gold, Green Published			2022-12-26	WOS:000447701300061
J	Miyamoto, A; Takeshita, T; Yanagiya, T				Miyamoto, Aya; Takeshita, Tomonari; Yanagiya, Toshio			Differences in sprinting performance and kinematics between preadolescent boys who are fore/mid and rear foot strikers	PLOS ONE			English	Article							PATTERNS; RUNNERS; BAREFOOT; SPEED; FOREFOOT; MATURITY; KINETICS	The purpose of this study was to clarify whether foot strike patterns are associated with different sprint performance and kinematics in preadolescent boys. The study enrolled 24 healthy 10-11-year-old boys in the fifth grade at public elementary schools in Japan. The participants performed the 50-m sprint with maximum effort. Sprint motion was recorded using a high-speed video camera (120 fps) placed in the sagittal plane on the left side of a line drawn at 35-m from the start line. Kinematic variables were calculated based on manually digitized body landmark coordinates. The participants were categorized into two groups according to their foot strike pattern (rearfoot strikers, RF group, n = 12; forefoot or midfoot strikers, FF/MF group, n = 12). The time taken to complete the 50-m sprint in the FF/MF group (9.08 +/- 0.52 s) was faster than that in the RF group (9.63 +/- 0.51 s). The FF/MF group had greater sprint speed, higher step frequency, and shorter foot contact time than the RF group. Regarding the association between foot strike pattern and sprint kinematics, we found that the RF group had a greater range of knee flexion during the support-leg phase, whereas the FF/MF group had shorter horizontal distance from the heel of the support leg to the centre of mass at the touchdown, greater maximal knee flexion velocity during the swing-leg phase, and higher the maximum hip extension velocity during the support-leg phase. The current results suggested that, in preadolescent boys, forefoot or midfoot strike (rather than rearfoot strike) is effective for obtaining a higher step frequency and sprint speed through greater magnitude of knee flexion and hip extension movement velocities during the swing and support phases, respectively. The current findings will be useful for understanding the characteristics of the development of sprinting performance in preadolescent children.	[Miyamoto, Aya; Takeshita, Tomonari; Yanagiya, Toshio] Juntendo Univ, Grad Sch Hlth & Sports Sci, Inzai City, Chiba, Japan	Juntendo University	Miyamoto, A (corresponding author), Juntendo Univ, Grad Sch Hlth & Sports Sci, Inzai City, Chiba, Japan.	a-miyamoto@niu.ac.jp		Aya, Miyamoto/0000-0001-6812-2141				Ahn AN, 2014, J SPORT HEALTH SCI, V3, P102, DOI 10.1016/j.jshs.2014.03.007; Almeida MO, 2015, J ORTHOP SPORT PHYS, V45, P738, DOI 10.2519/jospt.2015.6019; Breine B, 2014, MED SCI SPORT EXER, V46, P1595, DOI 10.1249/MSS.0000000000000267; Cheung RT, 2016, SPORTS BIOMECH, V4, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1080/14763141.2016.1226381; De Wit B, 2000, J BIOMECH, V33, P269, DOI 10.1016/S0021-9290(99)00192-X; Forrester SE, 2015, GAIT POSTURE, V41, P26, DOI 10.1016/j.gaitpost.2014.08.004; Golle K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142393; Hasegawa H, 2007, J STRENGTH COND RES, V21, P888, DOI 10.1519/R-22096.1; Hayes P, 2012, J SPORT SCI, V30, P1275, DOI 10.1080/02640414.2012.707326; Hunter JP, 2004, MED SCI SPORT EXER, V36, P261, DOI 10.1249/01.MSS.0000113664.15777.53; Krell JB, 2006, J SPORT SCI, V24, P175, DOI 10.1080/02640410500131621; Kuhman D, 2016, EUR J SPORT SCI, V16, P433, DOI 10.1080/17461391.2015.1086818; Kulmala JP, 2013, MED SCI SPORT EXER, V45, P2306, DOI 10.1249/MSS.0b013e31829efcf7; Larson P, 2011, J SPORT SCI, V29, P1665, DOI 10.1080/02640414.2011.610347; Lieberman DE, 2012, EXERC SPORT SCI REV, V40, P63, DOI 10.1097/JES.0b013e31824ab210; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Meyers RW, 2017, J STRENGTH COND RES, V31, P1009, DOI 10.1519/JSC.0000000000001310; Meyers RW, 2016, MED SCI SPORT EXER, V48, P2555, DOI 10.1249/MSS.0000000000001049; Meyers RW, 2015, PEDIATR EXERC SCI, V27, P85, DOI 10.1123/pes.2013-0096; Nobuoka S, 2015, JAPAN J PHYS ED HLTH, V60, P497, DOI [10.5432/jjpehss.14048, DOI 10.5432/JJPEHSS.14048]; Valenzuela KA, 2015, J SPORT SCI MED, V14, P225; Yokoi T, 1985, JAPAN J PHYS ED HLTH, V31, P53, DOI [10.5432/jjpehss.KJ00003392242, DOI 10.5432/JJPEHSS.KJ00003392242]; Yoshimoto T, 2015, JPN J PHYS FIT SPORT, V64, P155, DOI [10.7600/jspfsm.64.155, DOI 10.7600/JSPFSM.64.155]	23	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205906	10.1371/journal.pone.0205906	http://dx.doi.org/10.1371/journal.pone.0205906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335813	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300073
J	Hamilton, F; Berry, T; Sauer, T				Hamilton, Franz; Berry, Tyrus; Sauer, Timothy			Tracking intracellular dynamics through extracellular measurements	PLOS ONE			English	Article							DATA ASSIMILATION; MODELS	Extracellular recordings of neuronal cells are frequently a part of in vitro and in vivo experimental studies as a means of monitoring network-level dynamics. Their connections to intracellular dynamics are not well understood. Single-unit recordings are a more direct way to measure intracellular dynamics, but are typically difficult and expensive. On the other hand, simple differential equations models exist for single neurons. In this article, we apply a recent advance in data assimilation theory, designed to correct bias in general observation functions, toward the reconstruction of model-based intracellular dynamics from extracellular recordings.	[Hamilton, Franz] North Carolina State Univ, Dept Math, Box 8205, Raleigh, NC 27695 USA; [Berry, Tyrus; Sauer, Timothy] George Mason Univ, Dept Math Sci, Fairfax, VA 22030 USA	University of North Carolina; North Carolina State University; George Mason University	Hamilton, F (corresponding author), North Carolina State Univ, Dept Math, Box 8205, Raleigh, NC 27695 USA.	fwhamilt@ncsu.edu	Sauer, Timothy/S-2529-2019; Berry, Tyrus/ABB-8994-2020	Sauer, Timothy/0000-0002-8501-8722; Berry, Tyrus/0000-0002-0280-7508	National Science Foundation [RTG/DMS-1246991, DMS-1723175]	National Science Foundation(National Science Foundation (NSF))	This research was supported by grants RTG/DMS-1246991 (FH) and DMS-1723175 (TB, TS) from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Baek SJ, 2006, TELLUS A, V58, P293, DOI 10.1111/j.1600-0870.2006.00178.x; Berry T, 2017, MON WEATHER REV, V145, P2833, DOI 10.1175/MWR-D-16-0428.1; Berry T, 2013, TELLUS A, V65, DOI 10.3402/tellusa.v65i0.20331; Cummings JA, 2005, Q J ROY METEOR SOC, V131, P3583, DOI 10.1256/qj.05.105; Evensen G., 2009, DATA ASSIMILATION EN; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Hamilton F, 2018, PREPRINT; Hamilton F, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/68005; Hamilton F, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052715; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hunt BR, 2004, TELLUS A, V56, P273, DOI 10.1111/j.1600-0870.2004.00066.x; Julier S, 2000, IEEE T AUTOMAT CONTR, V45, P477, DOI 10.1109/9.847726; Julier SJ, 2004, P IEEE, V92, P401, DOI 10.1109/JPROC.2003.823141; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kalnay E., 2003, ATMOSPHERIC MODELING, DOI DOI 10.1017/CBO9780511802270; Kinney JP, 2013, J COMP NEUROL, V521, P448, DOI 10.1002/cne.23181; Law KJH, 2012, MON WEATHER REV, V140, P3757, DOI 10.1175/MWR-D-11-00257.1; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Pettersen KH, 2008, BIOPHYS J, V94, P784, DOI 10.1529/biophysj.107.111179; Rabier F, 2005, Q J ROY METEOR SOC, V131, P3215, DOI 10.1256/qj.05.129; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; Sauer TD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.198701; Schiff SJ, 2012, COMPUT NEUROSCI-MIT, P1; Simon D, 2006, OPTIMAL STATE ESTIMA, DOI DOI 10.1002/0470045345.CH11; Son J, 2008, NONLINEAR PROC GEOPH, V15, P1013, DOI 10.5194/npg-15-1013-2008; Tankens F., 1981, LECT NOTES MATH, V898; Toth Z, 2007, PHYSICA D, V230, P146, DOI 10.1016/j.physd.2006.08.016; Yoshida K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.014501	31	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205031	10.1371/journal.pone.0205031	http://dx.doi.org/10.1371/journal.pone.0205031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332448	Green Submitted, Green Published, gold			2022-12-26	WOS:000447638200047
J	Chorachoo, J; Lambert, S; Furnholm, T; Roberts, L; Reingold, L; Auepemkiate, S; Voravuthikunchai, SP; Johnston, A				Chorachoo, Julalak; Lambert, Sylviane; Furnholm, Teal; Roberts, Liza; Reingold, Laura; Auepemkiate, Sauvarat; Voravuthikunchai, Supayang P.; Johnston, Andrew			The small molecule rhodomyrtone suppresses TNF-alpha and IL-17A-induced keratinocyte inflammatory responses: A potential new therapeutic for psoriasis	PLOS ONE			English	Article							SEVERE PLAQUE PSORIASIS; THAI TRADITIONAL BOOKS; SKIN INFLAMMATION; MEDICINAL-PLANTS; BIOLOGIC AGENTS; DISEASES; EXPRESSION; CYTOKINES; TRIALS; SAFETY	Psoriasis is a common skin disease pathogenically driven by TNF and IL-17A-induced epidermal hyperproliferation and inflammatory responses. The ongoing need for new therapeutic agents for psoriasis has highlighted medicinal plants as sources of phytochemicals useful for treating psoriatic disease. Rhodomyrtone, a bioactive phytochemical from Rhodomyrtus tomentosa, has well-established anti-proliferative activities. This study assessed the potential of rhodomyrtone for curtailing TNF/IL-17A-driven inflammation. Stimulating human skin organ cultures with TNF+IL-17A to model the skin inflammation in psoriasis, we found that rhodomyrtone significantly decreased inflammatory gene expression and the expression and secretion of inflammatory proteins, assessed by qRT-PCR, immunohistochemistry and ELISA assays respectively. RNA-seq analysis of monolayer primary keratinocytes treated with IL-17A/TNF showed that rhodomyrtone inhibited 724/1587 transcripts >2-fold altered by IL-17A/TNF (p<0.01), a number of which were confirmed at the mRNA and protein level. Suggesting that rhodomyrtone acts by modulating MAP kinase and NF-kappa B signaling pathways, rhodomyrtone inhibited TNF-induced ERK, JNK, p38, and NF-kappa Bp65 phosphorylation. Finally, assessing the in vivo anti-inflammatory potential of rhodomyrtone, we examined its effects on imiquimod-induced skin inflammation in mice, finding rhodomyrtone reversed imiquimod-induced skin hyperplasia and epidermal thickening (p<0.001). Taken together, these results suggest that rhodomyrtone may be useful in preventing or slowing the progression of inflammatory skin disease.	[Chorachoo, Julalak; Lambert, Sylviane; Furnholm, Teal; Roberts, Liza; Reingold, Laura; Johnston, Andrew] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA; [Chorachoo, Julalak; Voravuthikunchai, Supayang P.] Prince Songkla Univ, Dept Microbiol, Hat Yai, Songkhla, Thailand; [Chorachoo, Julalak; Voravuthikunchai, Supayang P.] Prince Songkla Univ, Excellence Res Lab Nat Prod, Fac Sci, Hat Yai, Songkhla, Thailand; [Chorachoo, Julalak; Voravuthikunchai, Supayang P.] Prince Songkla Univ, Nat Prod Res Ctr Excellence, Hat Yai, Songkhla, Thailand; [Chorachoo, Julalak; Voravuthikunchai, Supayang P.] Prince Songkla Univ, Nat Prod Res Ctr Excellence, Hat Yai, Songkhla, Thailand; [Auepemkiate, Sauvarat] Prince Songkla Univ, Dept Pathol, Fac Med, Hat Yai, Songkhla, Thailand	University of Michigan System; University of Michigan; Prince of Songkla University; Prince of Songkla University; Prince of Songkla University; Prince of Songkla University; Prince of Songkla University	Johnston, A (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA.	andy@50fathomscuba.com	Johnston, Andrew/I-7904-2014	Johnston, Andrew/0000-0002-1313-9402	NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K01-AR064765]; National Psoriasis Foundation USA; Babcock Memorial Trust; Research and Researcher for Industry-RRI PhD Program [PHD 56I0079]; TRF, Thailand Research Fund [RTA6180006]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR064765] Funding Source: NIH RePORTER	NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Psoriasis Foundation USA; Babcock Memorial Trust; Research and Researcher for Industry-RRI PhD Program; TRF, Thailand Research Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) K01-AR064765, the National Psoriasis Foundation USA and the Babcock Memorial Trust, Research and Researcher for Industry-RRI PhD Program (Grant No. PHD 56I0079) and TRF Senior Research Scholar (Grant No. RTA6180006), The Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghasham A, 2014, AUTOIMMUNITY, V47, P77, DOI 10.3109/08916934.2013.873413; Baliwag J, 2015, CYTOKINE, V73, P342, DOI 10.1016/j.cyto.2014.12.014; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Chorachoo J, 2016, EUR J PHARMACOL, V772, P144, DOI 10.1016/j.ejphar.2015.12.005; D'Erme AM, 2015, J INVEST DERMATOL, V135, P1025, DOI 10.1038/jid.2014.532; Dachriyanus, 2002, AUST J CHEM, V55, P229, DOI 10.1071/CH01194; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Di Cesare A, 2015, J INVEST DERMATOL, V135, P318, DOI 10.1038/jid.2014.297; ELDER JT, 1991, J INVEST DERMATOL, V96, P425, DOI 10.1111/1523-1747.ep12469889; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; GEARING A J H, 1990, Cytokine, V2, P68, DOI 10.1016/1043-4666(90)90045-U; Gniadecki R, 2015, BRIT J DERMATOL, V172, P244, DOI 10.1111/bjd.13343; Gordon KB, 2016, NEW ENGL J MED, V375, P345, DOI 10.1056/NEJMoa1512711; Harden JL, 2015, J AUTOIMMUN, V64, P66, DOI 10.1016/j.jaut.2015.07.008; Herrington FD, 2016, J BIOMOL SCREEN, V21, P223, DOI 10.1177/1087057115617456; Hiranrat A, 2008, TETRAHEDRON, V64, P11193, DOI 10.1016/j.tet.2008.09.054; Johnston A, 2017, J ALLERGY CLIN IMMUN, V140, P109, DOI 10.1016/j.jaci.2016.08.056; Johnston A, 2013, J IMMUNOL, V190, P2252, DOI 10.4049/jimmunol.1201505; Johnston A, 2011, J INVEST DERMATOL, V131, P329, DOI 10.1038/jid.2010.313; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Killeen MJ, 2014, DRUG DISCOV TODAY, V19, P373, DOI 10.1016/j.drudis.2013.11.002; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kjaer TN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126599; Kurd SK, 2009, J AM ACAD DERMATOL, V60, P218, DOI 10.1016/j.jaad.2008.09.022; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Leonardi CL, 2015, DERMATOL CLIN, V33, P111, DOI 10.1016/j.det.2014.09.009; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; PANTHONG A, 1991, J ETHNOPHARMACOL, V31, P121, DOI 10.1016/0378-8741(91)90001-T; PANTHONG A, 1986, J ETHNOPHARMACOL, V18, P213, DOI 10.1016/0378-8741(86)90001-2; Patterson H, 2014, CLIN EXP IMMUNOL, V176, P1, DOI 10.1111/cei.12248; Perez-Alvarez R, 2013, CURR OPIN RHEUMATOL, V25, P56, DOI 10.1097/BOR.0b013e32835b1366; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rustin MHA, 2012, BRIT J DERMATOL, V167, P3, DOI 10.1111/j.1365-2133.2012.11208.x; Schmitt J, 2014, BRIT J DERMATOL, V170, P274, DOI 10.1111/bjd.12663; Shivaji UN, 2016, CLIN GASTROENTEROL H, V14, pE1, DOI 10.1016/j.cgh.2015.05.012; Srisuwan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110321; Sun Y, 2015, INT IMMUNOPHARMACOL, V24, P392, DOI 10.1016/j.intimp.2014.12.032; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van den Bogaard EH, 2014, J INVEST DERMATOL, V134, P719, DOI 10.1038/jid.2013.417; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wang CQF, 2013, J INVEST DERMATOL, V133, P2741, DOI 10.1038/jid.2013.237	44	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205340	10.1371/journal.pone.0205340	http://dx.doi.org/10.1371/journal.pone.0205340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321197	Green Submitted, Green Published, gold			2022-12-26	WOS:000447417900025
J	Ugur, I; Schatte, M; Marion, A; Glaser, M; Boenitz-Dulat, M; Antes, I				Ugur, Iike; Schatte, Martin; Marion, Antoine; Glaser, Manuel; Boenitz-Dulat, Mara; Antes, Iris			Ca2+ binding induced sequential allosteric activation of sortase A: An example for ion-triggered conformational selection	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; MOLECULAR-DYNAMICS SIMULATIONS; INTRINSICALLY DISORDERED PROTEINS; PARTICLE MESH EWALD; TO-ORDER TRANSITION; FORCE-FIELDS; CELL-WALL; SURFACE-PROTEINS; CATALYTIC MECHANISM; SUBSTRATE COMPLEX	The allosteric activation of the intrinsically disordered enzyme Staphylococcus aureus sortase A is initiated via binding of a Ca2+ ion. Although Ca2+ binding was shown to initiate structural changes inducing disorder-to-order transitions, the details of the allosteric activation mechanism remain elusive. We performed long-term molecular dynamics simulations of sortase A without (3 simulations of 1.6 mu s) and with bound Ca2+ (simulations of 1.6 mu s, 1.8 mu s, and 2.5 mu s). Our results show that Ca2+ binding causes not only ordering of the disordered beta 6/beta 7 loop of the protein, but also modulates hinge motions in the dynamic beta 7/beta 8 loop, which is important for the catalytic activity of the enzyme. Cation binding triggers signal transmission from the Ca2+ binding site to the dynamic beta 7/beta 8 loop via the repetitive folding/unfolding of short helical stretches of the disordered beta 6/beta 7 loop. These correlated structuralrearrangements lead to several distinct conformational states of the binding groove, which show optimal binding features for the sorting signal motif and feature binding energies up to 20 kcal/mol more favorable than observed for the sortase A without Ca2+. The presented results indicate a highly correlated, conformational selection-based activation mechanism of the enzyme triggered by cation binding. They also demonstrate the importance of the dynamics of intrinsically disordered regions for allosteric regulation.	[Ugur, Iike; Marion, Antoine; Glaser, Manuel; Antes, Iris] Tech Univ Munich, TUM Sch Life Sci, Ctr Integrated Prot Sci Munich, Freising Weihenstephan, Germany; [Schatte, Martin; Boenitz-Dulat, Mara] Roche GmbH, Enzymes & Prot Technol, Penzberg, Germany	Technical University of Munich	Antes, I (corresponding author), Tech Univ Munich, TUM Sch Life Sci, Ctr Integrated Prot Sci Munich, Freising Weihenstephan, Germany.	antes@tum.de	Ugur, Ilke/AHB-6841-2022; Marion, Antoine/AAC-4712-2019	Marion, Antoine/0000-0002-8266-8957	Deutsche Forschungsgemeinschaft [SFB 1035, SFB749]; Deutsche Forschungsgemeinschaft (CIPSM); Roche GmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (CIPSM)(German Research Foundation (DFG)); Roche GmbH	Financial support was provided in the form of salaries for IU, MG, and AM by the Deutsche Forschungsgemeinschaft (SFB 1035, project A10; SFB749, project C08; and CIPSM). Roche GmbH provided support in the form of salaries for MS and MBD. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antes I, 2010, PROTEINS, V78, P1084, DOI 10.1002/prot.22629; Barnett TC, 2004, J BACTERIOL, V186, P5865, DOI 10.1128/JB.186.17.5865-5875.2004; Beauchamp KA, 2012, J CHEM THEORY COMPUT, V8, P1409, DOI 10.1021/ct2007814; Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696; Bolken TC, 2001, INFECT IMMUN, V69, P75, DOI 10.1128/IAI.69.1.75-80.2001; Bradshaw WJ, 2015, FEBS J, V282, P2097, DOI 10.1111/febs.13288; Carballo-Pacheco M, 2017, PROTEIN SCI, V26, P174, DOI 10.1002/pro.3064; Cascioferro S, 2015, J MED CHEM, V58, P9108, DOI 10.1021/acs.jmedchem.5b00779; Cascioferro S, 2014, MICROB PATHOGENESIS, V77, P105, DOI 10.1016/j.micpath.2014.10.007; Case D., 2015, AMBER, V14; Cino EA, 2012, J CHEM THEORY COMPUT, V8, P2725, DOI 10.1021/ct300323g; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Dorr BM, 2014, P NATL ACAD SCI USA, V111, P13343, DOI 10.1073/pnas.1411179111; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; Gao CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20413; Genheden S, 2011, J COMPUT AID MOL DES, V25, P1085, DOI 10.1007/s10822-011-9486-1; Genheden S, 2011, J CHEM THEORY COMPUT, V7, P3768, DOI 10.1021/ct200163c; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Guimaraes CP, 2013, NAT PROTOC, V8, P1787, DOI 10.1038/nprot.2013.101; Hertig S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004746; Hirakawa H, 2012, BIOTECHNOL BIOENG, V109, P2955, DOI 10.1002/bit.24585; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Jacobitz AW, 2014, J BIOL CHEM, V289, P8891, DOI 10.1074/jbc.M113.509273; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kappel K, 2012, PROTEIN SCI, V21, P1858, DOI 10.1002/pro.2168; Levary DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018342; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; Maffucci I, 2016, J CHEM THEORY COMPUT, V12, P714, DOI 10.1021/acs.jctc.5b01211; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Marcinowski M, 2013, J MOL BIOL, V425, P466, DOI 10.1016/j.jmb.2012.11.030; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Marraffini LA, 2004, J BIOL CHEM, V279, P37763, DOI 10.1074/jbc.M405282200; McCormack N, 2014, MICROBIOL-SGM, V160, P659, DOI 10.1099/mic.0.074724-0; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Moritsugu K, 2012, J AM CHEM SOC, V134, P7094, DOI 10.1021/ja3008402; Myslinski JM, 2011, J AM CHEM SOC, V133, P18518, DOI 10.1021/ja2068752; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Pang XD, 2015, BIOPHYS J, V109, P1706, DOI 10.1016/j.bpj.2015.08.039; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; Quesne MG, 2013, FRONT CHEM, V1, DOI 10.3389/fchem.2013.00039; Rashidian M, 2013, BIOCONJUGATE CHEM, V24, P1277, DOI 10.1021/bc400102w; Rauscher S, 2015, J CHEM THEORY COMPUT, V11, P5513, DOI 10.1021/acs.jctc.5b00736; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Schatte M, 2016, BIOCONJUGATE CHEM, V27, P1484, DOI 10.1021/acs.bioconjchem.6b00111; Schillaci D, 2017, J MED CHEM, V60, P8268, DOI 10.1021/acs.jmedchem.7b00215; Schneider M, 2016, PROTEINS, V84, P1390, DOI 10.1002/prot.25084; Shrestha P, 2016, J MOL GRAPH MODEL, V67, P33, DOI 10.1016/j.jmgm.2016.04.006; Sillanpaa J, 2009, J BACTERIOL, V191, P6643, DOI 10.1128/JB.00909-09; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; Speziale P, 2009, FUTURE MICROBIOL, V4, P1337, DOI 10.2217/FMB.09.102; Srinivasan J, 1999, THEOR CHEM ACC, V101, P426, DOI 10.1007/s002140050460; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Theile CS, 2013, NAT PROTOC, V8, P1800, DOI 10.1038/nprot.2013.102; Tian BX, 2011, J PHYS CHEM B, V115, P13003, DOI 10.1021/jp2058113; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200	65	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205057	10.1371/journal.pone.0205057	http://dx.doi.org/10.1371/journal.pone.0205057			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321208	Green Submitted, Green Published, gold			2022-12-26	WOS:000447417900017
J	Matus-Hernandez, MA; Hernandez-Saavedra, NY; Martinez-Rincon, RO				Angel Matus-Hernandez, Miguel; Yolanda Hernandez-Saavedra, Norma; Octavio Martinez-Rincon, Raul			Predictive performance of regression models to estimate Chlorophyll-a concentration based on Landsat imagery	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; WATER-QUALITY; SEMIANALYTICAL MODEL; COASTAL WATERS; LAKE; FLORIDA; ALGORITHMS; RETRIEVAL; ALKALINE; BIOMASS	Chlorophyll-a (Chl-a) concentration is a key parameter to describe water quality in marine and freshwater environments. Nowadays, several products with Chl-a have derived from satellite imagery, but they are not available or reliable sometimes for coastal and/or small water bodies. Thus, in the last decade several methods have been described to estimate Chl-a with high-resolution (30 m) satellite imagery, such as Landsat, but a standardized method to estimate Chl-a from Landsat imagery has not been accepted yet. Therefore, this study evaluated the predictive performance of regression models (Simple Linear Regression [SLR], Multiple Linear Regression [MLR] and Generalized Additive Models [GAMs]) to estimate Chl-a based on Landsat imagery, using in situ Chl-a data collected (synchronized with the overpass of Landsat 8 satellite) and spectral reflectance in the visible light portion (bands 1-4) and near infrared (band 5). These bands were selected because of Chl-a absorbance/ reflectance properties in these wavelengths. According to goodness of fit, GAM outperformed SLR and MLR. However, the model validation showed that MLR performed better in predicting log-transformed Chl-a. Thus, MLR, constructed by using four spectral bands (1, 2, 3, and 5), was considered the best method to predict Chl-a. The coefficients of this model suggested that log-transformed Chl-a concentration had a positive linear relationship with bands 1 (coastal/aerosol), 3 (green), and 5 (NIR). On the other hand, band 2 (blue) suggested a negative relationship, which implied high coherence with Chl-a absorbance/ reflectance properties measured in the laboratory, indicating that Landsat 8 images could be applied effectively to estimate Chl-a concentrations in coastal environments.	[Angel Matus-Hernandez, Miguel; Yolanda Hernandez-Saavedra, Norma] Ctr Invest Biol Noroeste, La Paz, Baja California, Mexico; [Octavio Martinez-Rincon, Raul] CONACYT, Ctr Invest Biol Noroeste, La Paz, Baja California, Mexico	CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA	Martinez-Rincon, RO (corresponding author), CONACYT, Ctr Invest Biol Noroeste, La Paz, Baja California, Mexico.	raul.martinez.rincon@gmail.com	Martínez-Rincón, Raúl/E-6641-2019; Martínez-Rincón, Raúl Octavio/AAJ-2658-2021; Hernandez Saavedra, Norma Yolanda/ABB-4249-2021	Martínez-Rincón, Raúl/0000-0002-1204-716X; Martínez-Rincón, Raúl Octavio/0000-0002-1204-716X; Hernandez Saavedra, Norma Yolanda/0000-0002-7004-299X; Matus-Hernandez, Miguel A./0000-0002-7046-2791	CONACyT [PD-CPN-213849]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACyT (PD-CPN-213849) who also provided a scholarship to the first author, MAMH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Mario Cota Castro for help provided during the sampling survey and Diana Fischer for editing and improving English in this manuscript. First author would like to thank CONACyT for the scholarship provided.	Allan MG, 2011, INT J REMOTE SENS, V32, P2037, DOI 10.1080/01431161003645840; Allan MG, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4585-4; Antoine D, 1996, GLOBAL BIOGEOCHEM CY, V10, P57, DOI 10.1029/95GB02832; Arenz RF, 1996, INT J REMOTE SENS, V17, P1547, DOI 10.1080/01431169608948723; Boyer JN, 2009, ECOL INDIC, V9, pS56, DOI 10.1016/j.ecolind.2008.11.013; Brezonik P, 2005, LAKE RESERV MANAGE, V21, P373, DOI 10.1080/07438140509354442; Brivio PA, 2001, INT J REMOTE SENS, V22, P487, DOI 10.1080/014311601450059; Cervantes-Duarte R, 1987, BCS I CIENC MAR LIMN, V15, P129; Chang KW, 2004, INT J REMOTE SENS, V25, P3411, DOI 10.1080/01431160310001620786; Dalu T, 2015, GEOCARTO INT, V30, P1130, DOI 10.1080/10106049.2015.1027292; DEKKER AG, 1993, INT J REMOTE SENS, V14, P799, DOI 10.1080/01431169308904379; Del Castillo CE, 2000, LIMNOL OCEANOGR, V45, P1425, DOI 10.4319/lo.2000.45.6.1425; Dube T., 2012, PRIMARY PRODUCTIVITY; Giardino C, 2001, SCI TOTAL ENVIRON, V268, P19, DOI 10.1016/S0048-9697(00)00692-6; Gitelson AA, 2008, REMOTE SENS ENVIRON, V112, P3582, DOI 10.1016/j.rse.2008.04.015; Vilas LG, 2011, REMOTE SENS ENVIRON, V115, P524, DOI 10.1016/j.rse.2010.09.021; Griffin CG, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001634; Guo QZ, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8080758; Han LH, 2005, INT J REMOTE SENS, V26, P5245, DOI 10.1080/01431160500219182; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hellweger FL, 2004, ESTUAR COAST SHELF S, V61, P437, DOI 10.1016/j.ecss.2004.06.019; Hijmans RJ, 2017, RASTER GEOGRAPHIC DA; Ivarez-Arellano AD, 1997, LA BAHIA DE LA PAZ I, P345; Jimenez-Illescas AR, 1997, BAHIA PAZ INVESTIGAC, P345; Jimenez-Illescas AR, 2008, EFECTOS CONSTRUCCION; Jimenez-Munoz JC, 2014, IEEE GEOSCI REMOTE S, V11, P1840, DOI 10.1109/LGRS.2014.2312032; Joshi I, 2015, REMOTE SENS-BASEL, V7, P12478, DOI 10.3390/rs70912478; Kim HH, 2016, INT J REMOTE SENS, V37, P3255, DOI 10.1080/01431161.2016.1196839; Kloiber SN, 2002, REMOTE SENS ENVIRON, V82, P38, DOI 10.1016/S0034-4257(02)00022-6; Kong JL, 2015, REMOTE SENS-BASEL, V7, P5373, DOI 10.3390/rs70505373; Lee Z, 2016, REMOTE SENS ENVIRON, V177, P101, DOI 10.1016/j.rse.2016.02.033; Lim J., 2015, ENVIRON MONIT ASSESS, V187, P1; Liu DY, 2013, PROG OCEANOGR, V116, P154, DOI 10.1016/j.pocean.2013.07.003; Liu YS, 2003, PROG PHYS GEOG, V27, P24, DOI 10.1191/0309133303pp357ra; Loyd C, 2013, PUTTING LANDSAT 8S B; Masocha M, 2018, GEOCARTO INT, V33, P667, DOI 10.1080/10106049.2017.1289561; Nazeer M, 2016, J HYDROL, V532, P80, DOI 10.1016/j.jhydrol.2015.11.037; O'Reilley J. E., 2000, SEAWIFS POSTLAUNCH T, P1; O'Reilly JE, 1998, J GEOPHYS RES-OCEANS, V103, P24937, DOI 10.1029/98JC02160; Olmanson LG, 2008, REMOTE SENS ENVIRON, V112, P4086, DOI 10.1016/j.rse.2007.12.013; Ouillon S, 2008, SENSORS-BASEL, V8, P4165, DOI 10.3390/s8074165; Patra Pulak Priti, 2016, ESTIMATION CHLOROPHY, P18, DOI [10.20944/preprints201608.0149.v1, DOI 10.20944/PREPRINTS201608.0149.V1]; R Core Team, 2018, R LANG ENV STAT COMP; SCHIEBE FR, 1992, INT J REMOTE SENS, V13, P1487, DOI 10.1080/01431169208904204; Singh K, 2014, IEEE J-STARS, V7, P3553, DOI 10.1109/JSTARS.2014.2340856; Slonecker ET, 2016, MAR POLLUT BULL, V107, P518, DOI 10.1016/j.marpolbul.2016.02.076; Tebbs EJ, 2013, REMOTE SENS ENVIRON, V135, P92, DOI 10.1016/j.rse.2013.03.024; Teodoro A., 2016, ENV APPL REMOTE SENS, P165, DOI DOI 10.5772/60828; Torbick N, 2015, INT J ENV RES PUB HE, V12, P11560, DOI 10.3390/ijerph120911560; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Xing QG, 2016, REMOTE SENS ENVIRON, V178, P113, DOI 10.1016/j.rse.2016.02.065; Watanabe FSY, 2015, INT J ENV RES PUB HE, V12, P10391, DOI 10.3390/ijerph120910391; Zanter K, 2015, LANDSAT 8 L8 DATA US, V8; Zuur Alain F., 2009, P1	54	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205682	10.1371/journal.pone.0205682	http://dx.doi.org/10.1371/journal.pone.0205682			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312339	Green Submitted, gold, Green Published			2022-12-26	WOS:000447427300046
J	Deflesselle, E; Colle, R; Rigal, L; David, DJ; Vievard, A; Martin, S; Becquemont, L; Verstuyft, C; Corruble, E				Deflesselle, Eric; Colle, Romain; Rigal, Laurent; David, Denis J.; Vievard, Albane; Martin, Severine; Becquemont, Laurent; Verstuyft, Celine; Corruble, Emmanuelle			The TRKB rs2289656 genetic polymorphism is associated with acute suicide attempts in depressed patients: A transversal case control study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NTRK2; DISORDERS; IDEATION; EXPRESSION; VARIANTS; ISOFORMS; RISK	Introduction Suicide Attempts (SA) are the main complications of Major Depressive Episodes (MDE) and are difficult to predict. Suicide is associated with the expression of Receptor Tyrosin-Kinase B (TRKB), the receptor of the Brain Derived Neurotrophic Factor (BDNF) involved in MDE. However, the impact of its genetic polymorphisms as predictive factors of SA should be clarified. Our main aim is to assess the association of 8 TRKB genetic polymorphisms and SA in depressed patients. Material and methods In 624 patients currently experiencing an MDE in the context of Major Depressive Disorder (MDD) (METADAP study), we assessed the association between 8 TRKB genetic polymorphisms (rs1778933, rs1187352, rs2289658, rs2289657, rs2289656, rs3824519, rs56142442 and rs1439050) and acute (previous month) or past (older than one month) SA. Bonferroni corrections and multivariate analysis adjusted for age, sex, level of education, marital status, Hamilton Depression Rating Scale score and previous MDE were used. Results The rs2289656 was associated with acute SA (CC = 28.5%, CT = 15.0% and TT = 11.5%, p = 0.0008). However, the other SNPs were not. Patients with the CC genotype had a higher rate of acute SA (28.5%) as compared to T carriers (14.6%) (adjusted OR = 2.2, CI95% [1.4; 3.5], p<0.0001). Conclusion The TRKB rs2289656 CC genotype is associated with a 2.2 fold higher risk of acute SA in depressed patients. If this result could be confirmed, this TRKB SNP may be assessed to contribute to the prediction of SA in depressed patients.	[Deflesselle, Eric; Colle, Romain; Vievard, Albane; Martin, Severine; Becquemont, Laurent; Verstuyft, Celine; Corruble, Emmanuelle] Univ Paris Sud, CESP, Fac Med, INSERM UMR S1178,Equipe Depress & Antidepresseurs, Le Kremlin Bicetre, France; [Deflesselle, Eric; Rigal, Laurent] Univ Paris Sud, Fac Med, Dept Med Gen, Le Kremlin Bicetre, France; [Colle, Romain; Vievard, Albane; Martin, Severine; Corruble, Emmanuelle] Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Hosp Univ Psychiat, Le Kremlin Bicetre, France; [David, Denis J.] Univ Paris Saclay, CESP, Fac Pharm, INSERM UMR S1178,Univ Paris Sud, Chatenay Malabry, France; [Becquemont, Laurent; Verstuyft, Celine] Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Verstuyft, Celine] Hop Bicetre, AP HP, Ctr Ressources Biol Paris Sud, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Colle, R (corresponding author), Univ Paris Sud, CESP, Fac Med, INSERM UMR S1178,Equipe Depress & Antidepresseurs, Le Kremlin Bicetre, France.; Colle, R (corresponding author), Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Hosp Univ Psychiat, Le Kremlin Bicetre, France.	romain.colle@aphp.fr	DAVID, Denis/K-1173-2014; verstuyft, celine/AAU-3343-2021	DAVID, Denis/0000-0002-0506-6688; verstuyft, celine/0000-0002-8534-224X; Colle, Romain/0000-0002-2549-4495; rigal, laurent/0000-0001-6807-2738	Programme Hospitalier de Recherche Clinique National of the French Ministry of Health [AOM06022]	Programme Hospitalier de Recherche Clinique National of the French Ministry of Health	Funding for this study was provided by the Programme Hospitalier de Recherche Clinique National of the French Ministry of Health (AOM06022 - E Corruble). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton JM, 2010, J PSYCHIATR RES, V44, P817, DOI 10.1016/j.jpsychires.2010.01.003; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; Brent DA, 2008, PSYCHIAT CLIN N AM, V31, P157, DOI 10.1016/j.psc.2008.02.001; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Chen YW, 1996, BIOL PSYCHIAT, V39, P896, DOI 10.1016/0006-3223(95)00295-2; Christl Bettina, 2006, Arch Suicide Res, V10, P253, DOI 10.1080/13811110600582539; Corruble E, 2004, PSYCHIAT CLIN NEUROS, V58, P285, DOI 10.1111/j.1440-1819.2004.01233.x; Corruble E, 2015, WORLD PSYCHIATRY, V14, P366, DOI 10.1002/wps.20260; Costanza A, 2014, INT J LEGAL MED, V128, P73, DOI 10.1007/s00414-013-0835-6; Coulbault L, 2006, CLIN PHARMACOL THER, V79, P316, DOI 10.1016/j.clpt.2006.01.007; Cozza A, 2008, J ALZHEIMERS DIS, V15, P61; Dong C, 2009, MOL PSYCHIATR, V14, P1105, DOI 10.1038/mp.2009.92; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Eikelenboom M, 2014, INT J METH PSYCH RES, V23, P257, DOI 10.1002/mpr.1423; Fabbri C, 2014, CAN J PSYCHIAT, V59, P62, DOI 10.1177/070674371405900202; Galfalvy H, 2015, AM J MED GENET B, V168, P557, DOI 10.1002/ajmg.b.32330; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hart SR, 2013, DEPRESS ANXIETY, V30, P997, DOI 10.1002/da.22135; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; Klonsky ED, 2014, SUICIDE LIFE-THREAT, V44, P1, DOI 10.1111/sltb.12068; Kohli MA, 2010, ARCH GEN PSYCHIAT, V67, P348, DOI 10.1001/archgenpsychiatry.2009.201; Kumanogoh H, 2008, MOL CELL NEUROSCI, V39, P465, DOI 10.1016/j.mcn.2008.07.024; Laje G, 2009, PHARMACOGENET GENOM, V19, P666, DOI 10.1097/FPC.0b013e32832e4bcd; Mirkovic B, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00158; Molendijk ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048046; Mullins N, 2014, AM J MED GENET B, V165, P428, DOI 10.1002/ajmg.b.32247; Murphy TM, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-22; Oquendo MA, 2014, AM J PSYCHIAT, V171, P1259, DOI 10.1176/appi.ajp.2014.14020194; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Perroud N, 2012, PHARMACOGENOMICS J, V12, P68, DOI 10.1038/tpj.2010.70; Perroud N, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-60; Ploderl M, 2011, SUICIDE LIFE-THREAT, V41, P1, DOI 10.1111/j.1943-278X.2010.00005.x; Ropret S, 2015, PSYCHIAT GENET, V25, P241, DOI 10.1097/YPG.0000000000000109; Roy B, 2018, PROG MOL BIOL TRANSL, V157, P233, DOI 10.1016/bs.pmbts.2018.01.007; Sarchiapone M, 2008, NEUROPSYCHOBIOLOGY, V57, P139, DOI 10.1159/000142361; Schosser A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020690; Sokolowski M, 2016, MOL PSYCHIATR, V21, P1381, DOI 10.1038/mp.2015.187; Stein MB, 2017, AM J MED GENET B, V174, P786, DOI 10.1002/ajmg.b.32594; Tregouet DA, 2002, HUM MOL GENET, V11, P2015, DOI 10.1093/hmg/11.17.2015; Vaz-Drago R, 2017, HUM GENET, DOI [10.1016/j.mcn.2008.07.024, DOI 10.1016/J.MCN.2008.07.024]; Voegeli G, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw059; Willour VL, 2012, MOL PSYCHIATR, V17, P433, DOI 10.1038/mp.2011.4; Zarrilli F, 2014, PSYCHIAT RES, V220, P725, DOI 10.1016/j.psychres.2014.07.036	44	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205648	10.1371/journal.pone.0205648	http://dx.doi.org/10.1371/journal.pone.0205648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW7TO	30308049	Green Submitted, gold, Green Published			2022-12-26	WOS:000447173500113
J	Labus, K				Labus, Karolina			Effective detection of biocatalysts with specified activity by using a hydrogel-based colourimetric assay - beta-galactosidase case study	PLOS ONE			English	Article							LACTOSE; IMMOBILIZATION; ENCAPSULATION; HYDROLYSIS; ENZYMES; BEADS	The main aim of this study was to prepare gelatine-based hydrogels containing entrapped substrate and to examine the applicability of these matrices for detection of enzymes with a specified catalytic activity. The general research concept assumed the use of a substrate that, in the presence of a particular enzyme, will quickly undergo conversion to a coloured product. ortho-Nitrophenyl-beta-D-galactopyranoside (ONPG) was used as the immobilized substrate and beta-galactosidase from Kluyveromyces lactis as the biocatalyst to be determined. Among other factors, the range of detectable concentrations of galactosidase, the operational pH range, the time necessary to achieve a visible response and the preferred storage conditions for the test were determined. As a result, an effective colourimetric test for beta-galactosidase detection was obtained. Its main advantages include (i) the effective detection of the enzyme at concentrations greater than or equal to 0.6 mg(.)L(-1), (ii) the ability to perform initial quantification of the enzyme on the basis of the intensity of the obtained colour (iii) applicability in a wide pH range (from 4.0 to 9.0), (iv) a relatively short response time (from 1 to a maximum of 30 minutes) and (v) stability in long-term storage at 4 degrees C (90 days without loss of specific properties).	[Labus, Karolina] Wroclaw Univ Sci & Technol, Fac Chem, Div Bioproc & Biomed Engn, Wroclaw, Poland	Wroclaw University of Science & Technology	Labus, K (corresponding author), Wroclaw Univ Sci & Technol, Fac Chem, Div Bioproc & Biomed Engn, Wroclaw, Poland.	karolina.labus@pwr.edu.pl		Labus, Karolina/0000-0001-5705-8906	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (Poland) [688/2017/KNOW]	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (Poland)	This research was supported by the Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (688/2017/KNOW to KL) for the years 2014 - 2018 (Poland). The funding sponsor had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.	Ahmed EM, 2015, J ADV RES, V6, P105, DOI 10.1016/j.jare.2013.07.006; Akhtar MF, 2016, SAUDI PHARM J, V24, P554, DOI 10.1016/j.jsps.2015.03.022; Betancor L, 2008, TRENDS BIOTECHNOL, V26, P566, DOI 10.1016/j.tibtech.2008.06.009; Blandino A, 2001, PROCESS BIOCHEM, V36, P601, DOI 10.1016/S0032-9592(00)00240-5; Campbell KT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181484; DeGroot AR, 2001, ENZYME MICROB TECH, V29, P321, DOI 10.1016/S0141-0229(01)00393-3; Ebrahimi MMS, 2014, LANGMUIR, V30, P7842, DOI 10.1021/la501482u; Ebrahimi MMS, 2015, MACROMOL RAPID COMM, V36, P2123, DOI 10.1002/marc.201500485; Emregul E, 2006, FOOD CHEM, V97, P591, DOI 10.1016/j.foodchem.2005.05.017; Gan ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047154; Gargova S, 1995, BIOTECHNOL BIOTEC EQ, V9, P47, DOI 10.1080/13102818.1995.10818861; Good MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186268; Gyles DA, 2017, EUR POLYM J, V88, P373, DOI 10.1016/j.eurpolymj.2017.01.027; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Husain Q, 2010, CRIT REV BIOTECHNOL, V30, P41, DOI 10.3109/07388550903330497; Jia ZY, 2018, ACS APPL MATER INTER, V10, P5175, DOI 10.1021/acsami.7b15147; JIANG B, 1993, EUR POLYM J, V29, P1251, DOI 10.1016/0014-3057(93)90157-B; Kamoun EA, 2017, J ADV RES, V8, P217, DOI 10.1016/j.jare.2017.01.005; Kim SH, 1997, J DAIRY SCI, V80, P2264, DOI 10.3168/jds.S0022-0302(97)76175-7; Kunkel J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086785; Labus K, 2016, CHEM PAP, V70, P523, DOI 10.1515/chempap-2015-0235; Ladero M, 2001, ENZYME MICROB TECH, V29, P181, DOI 10.1016/S0141-0229(01)00366-0; Lai WF, 2016, J CONTROL RELEASE, V243, P269, DOI 10.1016/j.jconrel.2016.10.013; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Lin CP, 2010, MACROMOLECULES, V43, P3256, DOI 10.1021/ma9026564; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mathur AM, 1996, J MACROMOL SCI R M C, VC36, P405; Montalto M, 2005, EUR J CLIN NUTR, V59, P489, DOI 10.1038/sj.ejcn.1602098; Niu DD, 2017, ELECTRON J BIOTECHN, V27, P37, DOI 10.1016/j.ejbt.2017.03.001; Patel A, 2011, BIOMEDICAL ENGINEERING - FRONTIERS AND CHALLENGES, P275; Santos A, 1998, ENZYME MICROB TECH, V22, P558, DOI 10.1016/S0141-0229(97)00236-6; Scheibel DM, 2018, ACS OMEGA, V3, P1700, DOI 10.1021/acsomega.7b01721; Shukla T. P., 1975, CRC Critical Reviews in Food Technology, V5, P325; Valero C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195820; Xu YS, 2018, BIOSENS BIOELECTRON, V100, P404, DOI 10.1016/j.bios.2017.09.032; Yahsi A, 2005, INT J BIOL MACROMOL, V36, P253, DOI 10.1016/j.ijbiomac.2005.06.011; Yang DH, 2017, J IND ENG CHEM, V53, P360, DOI 10.1016/j.jiec.2017.05.007; Zhang HQ, 2009, PROCESS BIOCHEM, V44, P1374, DOI 10.1016/j.procbio.2009.07.015	38	2	2	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2018	13	10							e0205532	10.1371/journal.pone.0205532	http://dx.doi.org/10.1371/journal.pone.0205532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW7TO	30308030	Green Published, gold, Green Submitted			2022-12-26	WOS:000447173500098
J	Cauvi, DM; Hawisher, D; Dores-Silva, PR; Lizardo, RE; De Maio, A				Cauvi, David M.; Hawisher, Dennis; Dores-Silva, Paulo R.; Lizardo, Radhames E.; De Maio, Antonio			Macrophage reprogramming by negatively charged membrane phospholipids controls infection	FASEB JOURNAL			English	Article						phosphatidylserine; extracellular vesicles; sepsis; inflammation	MYRISTOYL-ELECTROSTATIC SWITCH; NEUTROPHIL RECRUITMENT; PHOSPHATIDYLSERINE; VESICLES; BINDING; ALPHA; ACTIVATION; CHEMOKINES; RESOLUTION; CLEARANCE	Extracellular vesicles (ECVs) are heterogeneous membrane-enclosed structures containing proteins, nucleic acids, and lipids that participate in intercellular communication by transferring their contents to recipient cells. Although most of the attention has been directed at the biologic effect of proteins and microRNA, the contribution of phospholipids present in ECVs on cellular activation has not been extensively addressed. We investigated the biologic effect of phosphatidylserine (PS) and phosphatidylcholine (PC), 2 phospholipids highly abundant in ECVs. A transcriptomic analysis revealed that approximate to 4700 genes were specifically modified by exposing peritoneal macrophages to PS or PC liposomes in vivo. Among them, the expression of several chemokines and cytokines was highly upregulated by PS liposome treatment, translating into a massive neutrophil infiltration of the peritoneum capable of neutralizing a septic polymicrobial insult. Both the l and d stereoisomers of PS induced the same response, suggesting that the effect was related to the negative charge of the phospholipid head. We concluded that an increase in the internal negative charge of the cell triggers a signaling cascade activating an innate immune response capable of controlling infection.Cauvi, D. M., Hawisher, D., Dores-Silva, P. R., Lizardo, R. E., De Maio, A. Macrophage reprogramming by negatively charged membrane phospholipids controls infection.	[Cauvi, David M.; Hawisher, Dennis; Dores-Silva, Paulo R.; De Maio, Antonio] Univ Calif San Diego, Sch Med, Dept Surg, La Jolla, CA 92093 USA; [Lizardo, Radhames E.] Naval Med Ctr, Dept Surg, San Diego, CA USA	University of California System; University of California San Diego; United States Department of Defense; United States Navy; Naval Medical Center San Diego	De Maio, A (corresponding author), Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ademaio@ucsd.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences [R01 GM098455-04, R01 GM114473-01]; University of California San Diego (UCSD) Clinical and Translational Research Institute (CTRI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114473] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of California San Diego (UCSD) Clinical and Translational Research Institute (CTRI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by U.S. National Institutes of Health, National Institute of General Medical Sciences Grants R01 GM098455-04 and R01 GM114473-01, as well as a grant from the University of California San Diego (UCSD) Clinical and Translational Research Institute (CTRI). The authors thank the UCSD Institute for Genomic Medicine and the Center for Computational Biology and Bioinformatics (CCBB) for their work, and Barbara Rho for her excellent editing of the manuscript. The authors declare no conflicts of interest.	BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Cauvi DM, 2012, J BIOL CHEM, V287, P19804, DOI 10.1074/jbc.M112.359562; Colao IL, 2018, TRENDS MOL MED, V24, P242, DOI 10.1016/j.molmed.2018.01.006; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; De Maio A, 2011, CELL STRESS CHAPERON, V16, P235, DOI 10.1007/s12192-010-0236-4; Epand RM, 1998, BIOCHEMISTRY-US, V37, P12068, DOI 10.1021/bi980527c; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Greenlee-Wacker MC, 2016, IMMUNOL REV, V273, P357, DOI 10.1111/imr.12453; Haraszti RA, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32570; Kalra H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020170; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Leventis R, 1998, BIOCHEMISTRY-US, V37, P7640, DOI 10.1021/bi973077h; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Lo Cicero A, 2015, CURR OPIN CELL BIOL, V35, P69, DOI 10.1016/j.ceb.2015.04.013; Lucas N, 2011, J BIOL CHEM, V286, P41265, DOI 10.1074/jbc.M111.300806; McKelvey KJ, 2015, J CIRC BIOMARK, V4, P7, DOI [10.5772/61186, DOI 10.5772/61186]; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; McPherson RA, 1999, ONCOGENE, V18, P3862, DOI 10.1038/sj.onc.1202730; Olivotto M, 1996, BIOESSAYS, V18, P495, DOI 10.1002/bies.950180612; Pugin J, 1999, AM J RESP CELL MOL, V20, P458, DOI 10.1165/ajrcmb.20.3.3311; Roy MO, 2000, BIOCHEMISTRY-US, V39, P8298, DOI 10.1021/bi000512q; Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797; Skotland T, 2017, PROG LIPID RES, V66, P30, DOI 10.1016/j.plipres.2017.03.001; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Vieira SM, 2009, BRIT J PHARMACOL, V158, P779, DOI 10.1111/j.1476-5381.2009.00367.x; Yang F, 2017, INFLAMMATION, V40, P311, DOI 10.1007/s10753-016-0458-4; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	38	6	6	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2995	3009		10.1096/fj.201801579R	http://dx.doi.org/10.1096/fj.201801579R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30325674	Green Published			2022-12-26	WOS:000457296600116
J	Weingarten, G; Ben Yaakov, A; Dror, E; Russ, J; Magin, TM; Kahn, CR; Wertheimer, E				Weingarten, Galina; Ben Yaakov, Aya; Dror, Erez; Russ, Jenny; Magin, Thomas M.; Kahn, C. Ronald; Wertheimer, Efrat			Insulin receptor plays a central role in skin carcinogenesis by regulating cytoskeleton assembly	FASEB JOURNAL			English	Article						epidermis; keratin; keratinocyte; transformation	METABOLIC SYNDROME; CANCER; KERATINS; MOUSE; PHOSPHORYLATION; DIFFERENTIATION; COMPLICATIONS; PATHOGENESIS; PROTEINS; KNOCKOUT	Diabetes mellitus prevalence is increasing rapidly and is a major cause of mortality and morbidity worldwide. In addition to the known severe complications associated with the disease, in recent years diabetes has been recognized as a major risk factor for cancer. Patients with diabetes experience significantly higher incidence of and higher mortality rates from many types of cancer. However, to date there are no conclusive data on the pathophysiology underlying the association between these two diseases. We previously reported that insulin regulates skin proliferation and differentiation, while IGF1 had different sometimes contrasting effects to those of insulin, suggesting direct involvement of insulin in transformation. To this end, we developed an epidermal skin-specific insulin receptor knockout (SIRKO) mouse, in which the insulin receptor (IR) is inactivated only in skin, with no other metabolic consequences. We found that IR inactivation by itself resulted in a marked decrease in skin tumorigenesis. In the control group 100% of the mice developed tumors, but in the SIRKO group tumor incidence was over 60% lower, and 25% of the SIRKO mice did not develop tumors at all, and the tumors that did develop were smaller and benign in their appearance. Furthermore, IR inactivation in vitro not only prevented cell transformation but also reversed the keratinocyte-transformed phenotype. We found that IR inactivation led to a striking abnormality in the major keratin cytoskeleton filaments structure in both in vivo and in vitro, a change that we were able to link to the decreased transformation potential in IR-null cells. In summary, we identified a unique pathway in which IR regulates cytoskeletal assembly, thus affecting skin transformation, opening a new potential target for cancer treatment and prevention.Weingarten, G., Ben Yaakov, A., Dror, E., Russ, J., Magin, T. M., Kahn, C. R., Wertheimer, E. Insulin receptor plays a central role in skin carcinogenesis by regulating cytoskeleton assembly.	[Weingarten, Galina; Ben Yaakov, Aya; Dror, Erez; Russ, Jenny; Wertheimer, Efrat] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel; [Magin, Thomas M.] Univ Leipzig, Inst Biol, Leipzig, Germany; [Magin, Thomas M.] Univ Leipzig, SIKT, Leipzig, Germany; [Kahn, C. Ronald] Joslin Diabet Ctr, Boston, MA 02215 USA; [Kahn, C. Ronald] Harvard Med Sch, Boston, MA USA	Tel Aviv University; Sackler Faculty of Medicine; Leipzig University; Leipzig University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Wertheimer, E (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel.	effyw@post.tau.ac.il	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	Israel Cancer Research Fund (ICRF); Tel Aviv University (TAU) Citernik Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031036, P30DK036836, R37DK031036] Funding Source: NIH RePORTER	Israel Cancer Research Fund (ICRF); Tel Aviv University (TAU) Citernik Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We dedicate this article to the memory of I. Hammel (1950-2016), an EM-acknowledged scientist and the chair of the Pathology Department at Sackler Faculty of Medicine, Tel Aviv University. This work was supported by the Israel Cancer Research Fund (ICRF; to E.W.) and by the Tel Aviv University (TAU) Citernik Fund (to E.W.). The authors declare no conflicts of interest.	Ben-Shmuel S, 2016, HANDB EXP PHARMACOL, V233, P355, DOI 10.1007/164_2015_12; Boucher J, 2014, COLD SPRING HARB PER, V6; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Chen HX, 2013, CHIN J CANCER, V32, P242, DOI 10.5732/cjc.012.10263; Coulombe PA, 2017, J INVEST DERMATOL, V137, pE67, DOI 10.1016/j.jid.2016.04.039; De Meyts P., 2000, INSULIN RECEPTOR ITS; Garcia-Jimenez C, 2016, BRIT J CANCER, V114, P716, DOI 10.1038/bjc.2016.37; Gonzalez-Saldivar G, 2017, DERMATOLOGY THER, V7, P37, DOI 10.1007/s13555-016-0160-3; GRAHAM RC, 1965, J HISTOCHEM CYTOCHEM, V13, P604, DOI 10.1177/13.7.604; Gregg EW, 2016, LANCET DIABETES ENDO, V4, P537, DOI 10.1016/S2213-8587(16)30010-9; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; HAMMEL I, 1989, J ELECTRON MICR TECH, V11, P27, DOI 10.1002/jemt.1060110105; Holden SE, 2016, ENDOCR DEV, V31, P135, DOI 10.1159/000439410; Homberg M, 2014, INT REV CEL MOL BIO, V311, P265, DOI 10.1016/B978-0-12-800179-0.00007-6; Hua F, 2016, CANCER LETT, V374, P54, DOI 10.1016/j.canlet.2016.02.006; Janssen JAMJL, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00224; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Kim HJ, 2015, BIOMOL THER, V23, P301, DOI 10.4062/biomolther.2015.032; Klil-Drori AJ, 2017, NAT REV CLIN ONCOL, V14, P85, DOI 10.1038/nrclinonc.2016.120; Knobel M, 2015, CELL TISSUE RES, V360, P583, DOI 10.1007/s00441-014-2105-4; Kurdi AT, 2013, LANCET, V382, pE31, DOI 10.1016/S0140-6736(13)60145-2; Li CY, 2013, DIABETES CARE, V36, P1569, DOI 10.2337/dc12-1432; Loschke F, 2015, CURR OPIN CELL BIOL, V32, P56, DOI 10.1016/j.ceb.2014.12.006; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Napolitano M, 2015, SCI WORLD J, V2015; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Quondamatteo F, 2014, CELL TISSUE RES, V355, P1, DOI 10.1007/s00441-013-1751-2; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Roth J, 2012, DIABETES-METAB RES, V28, P293, DOI 10.1002/dmrr.2300; Sadagurski M, 2006, MOL CELL BIOL, V26, P2675, DOI 10.1128/MCB.26.7.2675-2687.2006; Sadagurski M, 2005, J BIOL CHEM, V280, P14536, DOI 10.1074/jbc.M410227200; Sadagurski M, 2007, J CELL PHYSIOL, V213, P519, DOI 10.1002/jcp.21131; Sawant MS, 2017, INT REV CEL MOL BIO, V330, P171, DOI 10.1016/bs.ircmb.2016.09.005; Shlomai G, 2016, J CLIN ONCOL, V34, P4261, DOI 10.1200/JCO.2016.67.4044; Shoichetman T, 2001, J HISTOCHEM CYTOCHEM, V49, P1199, DOI 10.1177/002215540104901001; Singh P, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0805-3; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Tennenbaum T, 1998, CANCER RES, V58, P1435; Terron-Kwiatkowski A, 2006, J INVEST DERMATOL, V126, P607, DOI 10.1038/sj.jid.5700152; Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008; Tseng HW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004070; Vigneri R, 2016, J ENDOCRINOL INVEST, V39, P1365, DOI 10.1007/s40618-016-0508-7; Wang FR, 2016, METHOD ENZYMOL, V568, P303, DOI 10.1016/bs.mie.2015.09.032; Wertheimer E, 2000, J INVEST DERMATOL, V115, P24, DOI 10.1046/j.1523-1747.2000.00008.x; Wertheimer E, 2004, ISR MED ASSOC J, V6, P287; Wertheimer E, 2001, ENDOCRINOLOGY, V142, P1234, DOI 10.1210/en.142.3.1234; Wertheimer E., 2004, DIABETES MELLITUS, P1411; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095; Wojciechowska J, 2016, EXP CLIN ENDOCR DIAB, V124, P263, DOI 10.1055/s-0042-100910; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6	51	2	2	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2241	2251		10.1096/fj.201800847R	http://dx.doi.org/10.1096/fj.201800847R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30332298	Green Published			2022-12-26	WOS:000457296600057
J	Li, YW; Hamlin, DK; Chyan, MK; Wong, R; Dorman, EF; Emery, RC; Woodle, DR; Manger, RL; Nartea, M; Kenoyer, AL; Orozco, JJ; Green, DJ; Press, OW; Storb, R; Sandmaier, BM; Wilbur, DS				Li, Yawen; Hamlin, Donald K.; Chyan, Ming-Kuan; Wong, Roger; Dorman, Eric F.; Emery, Robert C.; Woodle, Douglas R.; Manger, Ronald L.; Nartea, Margaret; Kenoyer, Aimee L.; Orozco, Johnnie J.; Green, Damian J.; Press, Oliver W.; Storb, Rainer; Sandmaier, Brenda M.; Wilbur, D. Scott			cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies	PLOS ONE			English	Article							PARTICLE-EMITTING AT-211; ACUTE-LEUKEMIA; RADIOIMMUNOTHERAPY; CYCLOPHOSPHAMIDE; ASTATINATION; REAGENTS; THERAPY; IRRADIATION	The objective of this study was to translate reaction conditions and quality control methods used for production of an astatine-211(At-211)-labeled anti-CD45 monoclonal antibody (MAb) conjugate, At-211-BC8-B10, from the laboratory setting to cGMP production. Five separate materials were produced in the preparation of At-211-BC8-B10: (1) p-isothiocyanato-phenethyl-closo-decaborate(2-) (B10-NCS), (2) anti-CD45 MAb, BC8, (3) BC8-B10 MAb conjugate, (4) [At-211] NaAt, and (5) At-211-BC8-B10. The At-211-labeling reagent, B10-NCS, was synthesized as previously reported. BC8 was produced, then conjugated with B10-NCS under cGMP conditions to form BC8-B10. [At-211] NaAt was produced by alpha-irradiation of Bi targets, followed by isolation of the At-211 using a "wet chemistry" method. The clinical product, At-211-BC8-B10, was prepared by reacting [At-211] NaAt with BC8-B10 in NH4OAc buffer (pH 5.5) for 2 min at room temperature, followed by size-exclusion chromatography purification. Quality control tests conducted on the At-211-BC8-B10 included evaluations for purity and identity, as well as pyrogen and sterility tests. Stability of the At-211-BC8-B10 in 25 mg/mL sodium ascorbate solution was evaluated at 1, 2, 4, 6 and 21 h post isolation. For qualification, three consecutive At-211-BC8-B10 clinical preparations were successfully conducted in the cGMP suite, and an additional cGMP clinical preparation was carried out to validate each step required to deliver At-211-BC8-B10 to a patient. These cGMP preparations provided 0.80-1.28 Gbq (21.5-34.5 mCi) of At-211-BC8-B10 with radiochemical purity of >97%. The preparations were found to be sterile and have a pyrogen level <0.50 EU/mL. Cell binding was retained by the At-211-BC8-B10. At-211-BC8-B10 in ascorbic acid solution demonstrated a radiochemical stability of >95% for up to 21 h at room temperature. The experiments conducted have defined conditions for translation of At-211-BC8-B10 production from the laboratory to cGMP suite. This study has allowed the initiation of a phase I/II clinical trial using At-211-BC8-B10 (NCT03128034).	[Li, Yawen; Hamlin, Donald K.; Chyan, Ming-Kuan; Wong, Roger; Dorman, Eric F.; Emery, Robert C.; Wilbur, D. Scott] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA; [Woodle, Douglas R.; Nartea, Margaret; Kenoyer, Aimee L.; Orozco, Johnnie J.; Green, Damian J.; Press, Oliver W.; Storb, Rainer; Sandmaier, Brenda M.] Fred Hutchinson Canc Res Ctr, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA; [Manger, Ronald L.; Green, Damian J.; Press, Oliver W.; Storb, Rainer; Sandmaier, Brenda M.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Wilbur, DS (corresponding author), Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA.	dswilbur@uw.edu			NIH: National Cancer Institute [CA078902, CA205248]; NIH: National Institute of Allergy and Infectious Diseases [AI116225]; NIH: National Heart, Lung and Blood Institute [HL122173]; Department of Energy, Office of Science [DE-SC0013618]; National Institutes of Health [CA078902, CA205248, AI116225, HL122173]; Department of Energy [DE-SC0013618]; NATIONAL CANCER INSTITUTE [R01CA205248, P01CA078902] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL122173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI116225, R33AI116225] Funding Source: NIH RePORTER	NIH: National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH: National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH: National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Energy, Office of Science(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We appreciate the funding provided by NIH institutes; National Cancer Institute (CA078902; BMS) (CA205248; DJG), National Institute of Allergy and Infectious Diseases (AI116225; BMS), National Heart, Lung and Blood Institute (HL122173; RS) and Department of Energy, Office of Science (DE-SC0013618; DSW) for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate the funding provided by National Institutes of Health (CA078902; CA205248; HL122173; AI116225) and Department of Energy (DE-SC0013618) for this work.	Andersson H, 2009, J NUCL MED, V50, P1153, DOI 10.2967/jnumed.109.062604; Balkin ER, 2013, APPL SCI-BASEL, V3, P636, DOI 10.3390/app3030636; Chen Y, 2012, BLOOD, V119, P1130, DOI 10.1182/blood-2011-09-380436; DOBERENZ I, 1990, NUC COMPACT, V21, P124; Gagnon K, 2012, J LABELLED COMPD RAD, V55, P436, DOI 10.1002/jlcr.2968; HAMILTON JG, 1954, P SOC EXP BIOL MED, V86, P366; MATTHEWS DC, 1995, BLOOD, V85, P1122, DOI 10.1182/blood.V85.4.1122.bloodjournal8541122; Matthews DC, 1999, BLOOD, V94, P1237, DOI 10.1182/blood.V94.4.1237.416k34_1237_1247; McDevitt MR, 1998, EUR J NUCL MED, V25, P1341, DOI 10.1007/s002590050306; McDevitt MR, 1999, J NUCL MED, V40, P1722; Mulford DA, 2005, J NUCL MED, V46, p199S; Nakamae H, 2009, CANCER RES, V69, P2408, DOI 10.1158/0008-5472.CAN-08-4363; Orozco JJ, 2013, BLOOD, V121, P3759, DOI 10.1182/blood-2012-11-467035; Pagel JM, 2006, BLOOD, V107, P2184, DOI 10.1182/blood-2005-06-2317; Pagel JM, 2009, BLOOD; PRESS OW, 1993, NEW ENGL J MED, V329, P1219, DOI 10.1056/NEJM199310213291702; PRESS OW, 1995, LANCET, V346, P336, DOI 10.1016/S0140-6736(95)92225-3; Sgouros G, 2008, ADV DRUG DELIVER REV, V60, P1402, DOI 10.1016/j.addr.2008.04.007; Wilbur DS, 2007, BIOCONJUGATE CHEM, V18, P1226, DOI 10.1021/bc060345s; Wilbur DS, 2012, BIOCONJUGATE CHEM, V23, P409, DOI 10.1021/bc200401b; Wilbur DS, 2011, CURR RADIOPHARM, V4, P214, DOI 10.2174/1874471011104030214; Wilbur DS, 2010, NUCL MED BIOL, V37, P167, DOI 10.1016/j.nucmedbio.2009.10.004; Wilbur DS, 2009, BIOCONJUGATE CHEM, V20, P591, DOI 10.1021/bc800515d; Zalutsky MR, 2008, J NUCL MED, V49, P30, DOI 10.2967/jnumed.107.046938; Zalutsky MR, 2001, J NUCL MED, V42, P1508	25	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205135	10.1371/journal.pone.0205135	http://dx.doi.org/10.1371/journal.pone.0205135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335787	Green Submitted, Green Published, gold			2022-12-26	WOS:000447701300022
J	Waterborg, CEJ; Koenders, MI; van Lent, PLEM; van der Kraan, PM; de Loo, FAJV				Waterborg, Claire E. J.; Koenders, Marije I.; van Lent, Peter L. E. M.; van der Kraan, Peter M.; de Loo, Fons A. J. ven			Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis	PLOS ONE			English	Article							MER TYROSINE KINASE; EROSIVE PROGRESSION; SUBCHONDRAL BONE; DISEASE-ACTIVITY; TYRO-3 FAMILY; MRI BONE; T-CELLS; RECEPTOR; PATHOGENESIS; AXL	Rheumatoid arthritis is an auto-immune disease of the synovial joints, hallmarked by chronic inflammation and subsequent progressive tissue destruction. TYRO3, AXL and MER (gene name Mertk) (TAM) receptors are part of a negative feedback signaling system in the immune reaction and mediate efferocytosis thereby tempering the inflammatory process. We have shown that Axl(-/-) and Mertk(-/-) mice develop more severe arthritis whereas activating these receptors by overexpressing their ligands Pros1 and Gas6 ameliorates arthritis. Mice genetically ablated for the three genes of the TAM receptor family Tyro3/Axl/Mertk (TAM triple knock-out or TKO) have been described to spontaneously develop macroscopic signs of arthritis. In this study we aimed to analyze arthritis development in TAM TKO mice histologically to determine the extent and sequence of pathological changes in the joint. Ankle joints of three different age groups, adolescence (14 weeks), mature adult (34 weeks) and middle-age (52 weeks), of TAM TKO or wild-type mice were examined macroscopically, histologically and immunohistochemically. Surprisingly, until the age of 52 weeks, none of the mice examined developed spontaneous macroscopic signs of arthritis. There was no synovial inflammation nor any signs of damage to the cartilage or bone. However, bone marrow edema was observed in TAM TKO mice in the two latter age groups. The infiltrate in the bone marrow was characterized by both myeloid cells and lymphocytes. This study showed that TAM TKO mice developed a pre-stage (pre-clinical phase) of arthritis marked by bone marrow edema.	[Waterborg, Claire E. J.; Koenders, Marije I.; van Lent, Peter L. E. M.; van der Kraan, Peter M.; de Loo, Fons A. J. ven] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Rheumatol,Expt Rheumatol, Nijmegen, Netherlands	Radboud University Nijmegen	de Loo, FAJV (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Rheumatol,Expt Rheumatol, Nijmegen, Netherlands.	Fons.vandeloo@radboudumc.nl	Koenders, Marije I/A-1341-2012; van de Loo, Fons AJ/A-3425-2014; van der Kraan, Peter M/D-9115-2011	Koenders, Marije I/0000-0001-5845-8362; van de Loo, Fons AJ/0000-0002-5851-099X; 	Dutch Arthritis Foundation [RF15-2-403]	Dutch Arthritis Foundation	This work was supported by the Dutch Arthritis Foundation [RF15-2-403], received by F.A. J. van de Loo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Angelotti F, 2017, CLIN EXP RHEUMATOL, V35, P368; Bassyouni IH, 2017, INT J RHEUM DIS, V20, P53, DOI 10.1111/1756-185X.12367; Boyesen P, 2011, ANN RHEUM DIS, V70, P176, DOI 10.1136/ard.2009.126953; Brusca SB, 2014, CURR OPIN RHEUMATOL, V26, P101, DOI 10.1097/BOR.0000000000000008; Bugatti S, 2005, ARTHRITIS RHEUM-US, V52, P3448, DOI 10.1002/art.21377; Dalbeth N, 2009, ANN RHEUM DIS, V68, P279, DOI 10.1136/ard.2008.096024; Duer-Jensen A, 2011, ARTHRITIS RHEUM-US, V63, P2192, DOI 10.1002/art.30396; Ey E, 2012, GENES BRAIN BEHAV, V11, P928, DOI 10.1111/j.1601-183X.2012.00849.x; Farquharson D, 2012, MUCOSAL IMMUNOL, V5, P112, DOI 10.1038/mi.2011.66; Haavardsholm EA, 2008, ANN RHEUM DIS, V67, P794, DOI 10.1136/ard.2007.071977; Hetland ML, 2009, ANN RHEUM DIS, V68, P384, DOI 10.1136/ard.2008.088245; Hetland ML, 2010, ANN RHEUM DIS, V69, P1789, DOI 10.1136/ard.2009.125534; Jimenez-Boj E, 2005, J IMMUNOL, V175, P2579, DOI 10.4049/jimmunol.175.4.2579; Jimenez-Boj E, 2007, ARTHRITIS RHEUM-US, V56, P1118, DOI 10.1002/art.22496; Konig MF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaj1921; Kuca-Warnawin E, 2011, ANN RHEUM DIS, V70, P227, DOI 10.1136/ard.2009.124966; Kurowska-Stolarska M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15877; Laukens D, 2016, FEMS MICROBIOL REV, V40, P117, DOI 10.1093/femsre/fuv036; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; McQueen FM, 2007, ANN RHEUM DIS, V66, P1581, DOI 10.1136/ard.2007.070326; McQueen FM, 1998, ANN RHEUM DIS, V57, P350, DOI 10.1136/ard.57.6.350; McQueen FM, 2003, ARTHRITIS RHEUM, V48, P1814, DOI 10.1002/art.11162; Nassar M, 2017, P NATL ACAD SCI USA, V114, pE337, DOI 10.1073/pnas.1614926114; O'Donnell K, 1999, AM J PATHOL, V154, P1171, DOI 10.1016/S0002-9440(10)65369-2; Ostendorf B, 2004, ARTHRITIS RHEUM, V50, P2094, DOI 10.1002/art.20314; Proulx ST, 2008, ARTHRITIS RHEUM-US, V58, P2019, DOI 10.1002/art.23546; Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103; Ruiz-Heiland G, 2014, ANN RHEUM DIS, V73, P771, DOI 10.1136/annrheumdis-2012-202907; van den Brand BT, 2013, ARTHRITIS RHEUM-US, V65, P671, DOI 10.1002/art.37786; Waterborg CEJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00742; Wu J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3316; Xu L, 2018, CLIN EXP IMMUNOL, V192, P95, DOI 10.1111/cei.13082; You S, 2018, ARTHRITIS RHEUMATOL, V70, P637, DOI 10.1002/art.40406	35	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205902	10.1371/journal.pone.0205902	http://dx.doi.org/10.1371/journal.pone.0205902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335822	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300071
J	Zhang, L; Liu, Y				Zhang, Lei; Liu, Yong			Seismic responses of rectangular subway tunnels in a clayey ground	PLOS ONE			English	Article							DEEP IMMERSED TUNNEL; UNDERGROUND STRUCTURES; SOFT CLAY; CIRCULAR TUNNELS; DYNAMIC-RESPONSE; SQUARE TUNNELS; CENTRIFUGE; SHAKING; SOIL; DEFORMATION	Observations from past earthquakes have shown that subway tunnels can suffer severe damage or excessive deformation due to seismic shaking. This study presents the results of finite element analyses on subway tunnels installed in normally consolidated clay deposits subjected to far-field ground motions. The clay strata were modelled by a hyperbolic-hysteretic constitutive model. The influences of three factors on the seismic response of the clay tunnel systems were examined, namely ground motion intensity, tunnel wall thickness and clay stiffness. Furthermore, the computed racking deformations of the tunnel were compared with several analytical estimations from the literature, and the relationship between racking ratio and flexibility ratio for rectangular tunnels installed in normally consolidated clay deposits was proposed. The findings may provide a useful reference for practical seismic design of tunnels.	[Zhang, Lei] Wuhan Univ Technol, Sch Civil Engn & Architecture, Wuhan, Hubei, Peoples R China; [Liu, Yong] Wuhan Univ, Inst Engn Risk & Disaster Prevent, State Key Lab Water Resources & Hydropower Engn S, Wuhan, Hubei, Peoples R China	Wuhan University of Technology; Wuhan University	Liu, Y (corresponding author), Wuhan Univ, Inst Engn Risk & Disaster Prevent, State Key Lab Water Resources & Hydropower Engn S, Wuhan, Hubei, Peoples R China.	liuy203@whu.edu.cn	Liu, Yong/R-4019-2017; Lantsoght, Eva/D-2864-2015	Liu, Yong/0000-0003-1006-7842; Lantsoght, Eva/0000-0003-4548-7644	National Natural Science Foundation of China [51808421, 51879203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 51808421, 51879203).	Abate G, 2017, B EARTHQ ENG, V15, P469, DOI 10.1007/s10518-016-9973-9; Amorosi A, 2009, SOIL DYN EARTHQ ENG, V29, P1059, DOI 10.1016/j.soildyn.2008.12.004; Anastasopoulos I, 2008, B EARTHQ ENG, V6, P213, DOI 10.1007/s10518-007-9055-0; Anastasopoulos I, 2007, J GEOTECH GEOENVIRON, V133, P1067, DOI 10.1061/(ASCE)1090-0241(2007)133:9(1067); Anderson DG, 2008, TRANSP RES BOARD, P105; [Anonymous], 2005, I23469 ISO; Banerjee S, 2014, GEOTECHNIQUE, V64, P431, DOI 10.1680/geot.12.P.195; Banerjee S, 2009, CENTRIFUGE NUMERICAL; Bao XH, 2017, TUNN UNDERGR SP TECH, V66, P91, DOI 10.1016/j.tust.2017.04.005; Baziar MH, 2014, TUNN UNDERGR SP TECH, V44, P10, DOI 10.1016/j.tust.2014.07.004; Bobet A, 2008, CAN GEOTECH J, V45, P923, DOI 10.1139/T08-026; Bobet A, 2010, TUNN UNDERGR SP TECH, V25, P21, DOI 10.1016/j.tust.2009.08.001; Chen GX, 2015, SOIL DYN EARTHQ ENG, V76, P13, DOI 10.1016/j.soildyn.2014.12.012; Chen GX, 2013, EARTHQ ENG STRUCT D, V42, P1489, DOI 10.1002/eqe.2283; Chian SC, 2012, SOIL DYN EARTHQ ENG, V41, P181, DOI 10.1016/j.soildyn.2012.05.020; Chou JC, 2011, J GEOTECH GEOENVIRON, V137, P754, DOI 10.1061/(ASCE)GT.1943-5606.0000489; Cilingir U, 2011, SOILS FOUND, V51, P449; Cilingir U, 2011, SOIL DYN EARTHQ ENG, V31, P452, DOI 10.1016/j.soildyn.2010.10.004; Dadashi Reza, 2015, International Journal of Advanced Structural Engineering, V7, P171, DOI 10.1007/s40091-015-0090-9; Debiasi E, 2013, TUNN UNDERGR SP TECH, V38, P19; FHWA, 2009, TECHN MAN DES CONSTR; Filiatrault A., 1993, SOIL DYN EARTHQ ENG, V12, P469; Goh SH, 2017, J GEOTECH GEOENVIRON, V143, DOI 10.1061/(ASCE)GT.1943-5606.0001779; Hashash YMA, 2005, TUNN UNDERGR SP TECH, V20, P435, DOI 10.1016/j.tust.2005.02.004; Hashash YMA, 2001, TUNN UNDERGR SP TECH, V16, P247, DOI 10.1016/S0886-7798(01)00051-7; Huo H, 2006, TUNN UNDERGR SP TECH, V21, P613, DOI 10.1016/j.tust.2005.12.135; Iida H., 1996, SOILS FOUND, V36, P283, DOI 10.3208/sandf.36.Special_283; Kontoe S, 2014, SOIL DYN EARTHQ ENG, V66, P206, DOI 10.1016/j.soildyn.2014.07.004; Kontoe S, 2011, GEOTECHNIQUE, V61, P815, DOI 10.1680/geot.9.P.141; Kontoe S, 2008, CAN GEOTECH J, V45, P1743, DOI 10.1139/T08-087; Kramer S.L., 1996, GEOTECHNICAL EARTHQU; Lanzano G, 2015, EUR J ENVIRON CIV EN, V19, P539, DOI 10.1080/19648189.2014.893211; Lanzano G, 2012, GEOTECH TEST J, V35, P854, DOI 10.1520/GTJ104348; Liu Y, 2019, GEOTECHNIQUE, V69, P638, DOI 10.1680/jgeot.17.T.015; Lysmer J, 1969, J ENG MECH DIV ASCE, V95, P859, DOI 10.1061/JMCEA3.0001144; Mayoral JM, 2009, SOIL DYN EARTHQ ENG, V29, P925, DOI 10.1016/j.soildyn.2008.10.007; Moss RES, 2013, EARTHQ SPECTRA, V29, P1413, DOI 10.1193/070611EQS162M; NSPRC (National Standard of the People's Republic of China), 2004, JTGD702004 NSPRC MIN; Pan TC, 1997, EARTHQ SPECTRA, V13, P475; Penzien J, 2000, EARTHQUAKE ENG STRUC, V29, P683, DOI 10.1002/(SICI)1096-9845(200005)29:5<683::AID-EQE932>3.0.CO;2-1; Semblat JF, 2000, J SOUND VIB, V231, P460, DOI 10.1006/jsvi.1999.2636; Shibayama S, 2010, SOILS FOUND, V50, P281, DOI 10.3208/sandf.50.281; Tsinidis G, 2015, GEOTECHNIQUE, V65, P401, DOI 10.1680/geot.SIP.15.P.004; Tsinidis G, 2017, TUNN UNDERGR SP TECH, V62, P1, DOI 10.1016/j.tust.2016.11.003; Tsinidis G, 2016, TUNN UNDERGR SP TECH, V59, P199, DOI 10.1016/j.tust.2016.07.008; Ulgen D, 2015, GEOTECH LETT, V5, P261, DOI 10.1680/jgele.15.00097; Ulgen D, 2015, B EARTHQ ENG, V13, P2547, DOI 10.1007/s10518-015-9736-z; Viggiani G, 1995, GEOTECHNIQUE, V45, P249, DOI 10.1680/geot.1995.45.2.249; Wang J.N., 1993, SEISMIC DESIGN TUNNE; Wang WL, 2001, TUNN UNDERGR SP TECH, V16, P133, DOI 10.1016/S0886-7798(01)00047-5; Zhang L, 2017, GEOTECHNIQUE, V67, P479, DOI 10.1680/jgeot.15.P.099; Zhang L., 2014, THESIS; Zhang L, 2017, SOIL DYN EARTHQ ENG, V101, P209, DOI 10.1016/j.soildyn.2017.08.004; Zhang L, 2017, J ENG MECH, V143, DOI 10.1061/(ASCE)EM.1943-7889.0001269; Zhang L, 2017, SOIL DYN EARTHQ ENG, V92, P488, DOI 10.1016/j.soildyn.2016.10.018	56	6	6	7	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204672	10.1371/journal.pone.0204672	http://dx.doi.org/10.1371/journal.pone.0204672			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332445	Green Submitted, Green Published, gold			2022-12-26	WOS:000447638200021
J	Dhage, S; Ernlund, A; Ruggles, K; Axelrod, D; Berman, R; Roses, D; Schneider, RJ				Dhage, Shubhada; Ernlund, Amanda; Ruggles, Kelly; Axelrod, Deborah; Berman, Russell; Roses, Daniel; Schneider, Robert J.			A genomic ruler to assess oncogenic transition between breast tumor and stroma	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; 20-YEAR FOLLOW-UP; CONSERVING SURGERY; TARGETING STROMA; LOCAL RECURRENCE; TOTAL MASTECTOMY; MICROENVIRONMENT; ANGIOGENESIS; GROWTH; EXPRESSION	Background Cancers induce gene expression alterations in stroma surrounding tumors that supports cancer progression. However, it is actually not at all known the extent of altered stromal gene expression enacted by tumors nor the extent to which altered stromal gene expression penetrates the stromal tissue. Presently, post-surgical "tumor-free" stromal tissue is determined to be cancer-free based on solely on morphological normality-a criteria that has not changed in more than 100 years despite the existence of sophisticated gene expression data to the contrary. We therefore investigated the extent to which breast tumors alter stromal gene expression in three dimensions in women undergoing mastectomy with the intent of providing a genomic determination for development of future risk of recurrence criteria, and to inform the need for adjuvant full-breast irradiation. Methods and findings Genome-wide gene expression changes were determined in histopathologically normal breast tissue in 33 women undergoing mastectomy for stage II and III primary invasive ductal carcinoma at serial distances in three dimensions from the tumor. Gene expression was determined by genome-wide mRNA analysis and subjected to metagene mRNA characterization. Tumor-like gene expression signatures in stroma were identified that surprisingly transitioned to a plastic, normalizing homeostatic signature with distance from tumor. Stroma closest to tumor displayed a pronounced tumor-like signature enriched in cancer-promoting pathways involved in disruption of basement membrane, cell migration and invasion, WNT signaling and angiogenesis. By 2 cm from tumor in all dimensions, stromal tissues were in transition, displaying homeostatic and tumor suppressing gene activity, while also expressing cancer supporting pathways. Conclusions The dynamics of gene expression in the post-tumor breast stroma likely co-determines disease outcome: reversion to normality or transition to transformation in morphologically normal tissue. Our stromal genomic signature may be important for personalizing surgical and adjuvant therapeutic decisions and risk of recurrence.	[Dhage, Shubhada; Axelrod, Deborah; Berman, Russell; Roses, Daniel] NYU, Dept Surg, Sch Med, New York, NY 10016 USA; [Dhage, Shubhada; Schneider, Robert J.] NYU, Sch Med, Perlmutter Canc Ctr, New York, NY 10016 USA; [Ernlund, Amanda; Schneider, Robert J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Ruggles, Kelly] NYU, Sch Med, Dept Med, New York, NY USA	New York University; New York University; New York University; New York University	Schneider, RJ (corresponding author), NYU, Sch Med, Perlmutter Canc Ctr, New York, NY 10016 USA.; Schneider, RJ (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	Robert.schneider@nyumc.org		Ruggles, Kelly/0000-0002-0152-0863; Axelrod, Deborah/0000-0002-9929-3389; Berman, Russell/0000-0002-5026-5651; Schneider, Robert/0000-0001-5807-5564; Ernlund, Amanda/0000-0003-1113-4103	Shifrin Myer Fund; Breast Cancer Research Foundation [BCRF 16-143]; Avon Foundation; NIH [T32 CA009161]; NATIONAL CANCER INSTITUTE [T32CA009161] Funding Source: NIH RePORTER	Shifrin Myer Fund; Breast Cancer Research Foundation; Avon Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Shifrin Myer Fund (SD), The Breast Cancer Research Foundation (BCRF 16-143) and the Avon Foundation (RJS). AE was supported by NIH T32 CA009161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriagada R, 2003, ANN ONCOL, V14, P1617, DOI 10.1093/annonc/mdg452; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Casey T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007395; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Conklin MW, 2012, CELL ADHES MIGR, V6, P249, DOI 10.4161/cam.20567; Criscitiello C, 2014, CURR OPIN ONCOL, V26, P551, DOI 10.1097/CCO.0000000000000122; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gangadhara S, 2012, FUTURE ONCOL, V8, P1427, DOI [10.2217/FON.12.134, 10.2217/fon.12.134]; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Halyard MY, 2014, ONCOLOGY-NY, V28, P157; Heaphy CM, 2009, BREAST CANCER RES TR, V118, P229, DOI 10.1007/s10549-009-0504-0; Houssami N, 2014, ANN SURG ONCOL, V21, P717, DOI 10.1245/s10434-014-3480-5; Kim WY, 2009, J CLIN INVEST, V119, P2160, DOI 10.1172/JCI38443; Lakins MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03347-0; Lu Y, 2012, J CANCER, V3, P333, DOI 10.7150/jca.4046; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Mittal K, 2014, SEMIN ONCOL, V41, P235, DOI 10.1053/j.seminoncol.2014.02.007; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Moran MS, 2014, J CLIN ONCOL, V32, P1507, DOI 10.1200/JCO.2013.53.3935; Moy L, 2014, J AM COLL RADIOL, V11, P1160, DOI 10.1016/j.jacr.2014.08.020; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2007, CANCER BIOL THER, V6, P618, DOI 10.4161/cbt.6.4.4255; Paulsson J, 2014, SEMIN CANCER BIOL, V25, P61, DOI 10.1016/j.semcancer.2014.02.006; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Pure E, 2016, CANCER IMMUNOL RES, V4, P269, DOI 10.1158/2326-6066.CIR-16-0011; Qayyum MA, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0218-9; Rivenbark AG, 2012, EXP MOL PATHOL, V93, P391, DOI 10.1016/j.yexmp.2012.10.018; Roman-Perez E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3152; Tobin NP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-417; Triulzi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056761; Troester MA, 2009, CLIN CANCER RES, V15, P7020, DOI 10.1158/1078-0432.CCR-09-1126; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Volpert OV, 2002, CANCER CELL, V2, P473, DOI 10.1016/S1535-6108(02)00209-X; Vrieling C, 2017, JAMA ONCOL, V3, P42, DOI 10.1001/jamaoncol.2016.3031; Walker SR, 2014, MOL CELL ENDOCRINOL, V382, P616, DOI 10.1016/j.mce.2013.03.010; Wang Yifan, 2013, Cancer Hallm, V1, P38; Weinberg RA, 2008, NAT GENET, V40, P494, DOI 10.1038/ng0508-494; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; ZUKERBERG LR, 1995, MODERN PATHOL, V8, P560	53	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205602	10.1371/journal.pone.0205602	http://dx.doi.org/10.1371/journal.pone.0205602			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325954	Green Published, gold, Green Submitted			2022-12-26	WOS:000447430800027
J	Fall, J; Ciannelli, L; Skaret, G; Johannesen, E				Fall, Johanna; Ciannelli, Lorenzo; Skaret, Georg; Johannesen, Edda			Seasonal dynamics of spatial distributions and overlap between Northeast Arctic cod (Gadus morhua) and capelin (Mallotus villosus) in the Barents Sea	PLOS ONE			English	Article							PREDATOR-PREY INTERACTIONS; ATLANTIC COD; MODELS; POPULATION; ECOSYSTEM; SCALE; TEMPERATURE; SEABIRDS; ECOLOGY; CLIMATE	The trophic link between cod (Gadus sp.) and capelin (Mallotus sp.) is important in many panarctic ecosystems. Since the early 2000s, the Northeast Arctic cod stock (G. morhua) in the Barents Sea has increased greatly, and the sea has been exceptionally warm. Such changes have potentially large effects on species distributions and overlap, which in turn could affect the strength of species interactions. Due to its high latitude location, the Barents Sea has strong seasonal variation in physical conditions and interactions. To study drivers of variation in cod-capelin overlap, we use data from two annual surveys run in winter and in autumn of 2004-2015. We first model winter and autumn spatial distributions of mature and immature cod and capelin. We then calculate overlap from model predictions on a grid with similar spatial resolution as the survey data. Our approach allowed us to interpret changes in overlap as species-specific effects of stock size and temperature, while accounting for sampling variation due to sampling time and depth. We found that during winter both species expanded their distribution in response to increased stock sizes, but how strongly and where the expansion occurred varied. The effect of temperature on distributions varied in space, and differed for cod and capelin and for different components of the two species. The results for autumn were clearer and more consistent. Both species expanded their distribution areas as their stock sizes increased. A positive effect of temperature was found in the north-eastern Barents Sea, where temperatures were lowest at the start of the study. Overlap increased and shifted north-eastwards during the study period and remained high despite a decline in the capelin stock. The increased overlap during autumn could mainly be attributed to the shift in cod distribution with increased cod stock biomass.	[Fall, Johanna; Skaret, Georg; Johannesen, Edda] Inst Marine Res, Bergen, Norway; [Ciannelli, Lorenzo] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Institute of Marine Research - Norway; Oregon State University	Fall, J (corresponding author), Inst Marine Res, Bergen, Norway.	johanna.fall@hi.no		Fall, Johanna/0000-0002-6978-7986	Norwegian Research Council [243676/E40]; National Science Foundation SEES Research Coordination Network [1140207]	Norwegian Research Council(Research Council of NorwayEuropean Commission); National Science Foundation SEES Research Coordination Network	This study was funded by the Norwegian Research Council project 243676/E40 awarded to Institute of Marine Research, Norway, with EJ as project leader (https://www.forskningsradet.no). LC also acknowledges support from the National Science Foundation SEES Research Coordination Network (Grant No. 1140207, https://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo SH, 2003, ECOLOGY, V84, P1598, DOI 10.1890/0012-9658(2003)084[1598:EGISAT]2.0.CO;2; Astthorsson OS, 2007, DEEP-SEA RES PT II, V54, P2456, DOI 10.1016/j.dsr2.2007.07.030; Bartolino V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172004; BERGSTAD OA, 1987, FISH RES, V5, P119, DOI 10.1016/0165-7836(87)90037-3; Bergstrom U, 2006, AM NAT, V167, P246, DOI 10.1086/499372; Bogstad B, 2001, FISH RES, V53, P197, DOI 10.1016/S0165-7836(00)00288-5; Bogstad B, 2000, NAMMCO SCI PUBLICATI; Ciannelli L, 2008, J MARINE SYST, V71, P223, DOI 10.1016/j.jmarsys.2007.02.031; Ciannelli L, 2005, MAR ECOL PROG SER, V291, P227, DOI 10.3354/meps291227; Ciannelli L, 2012, P ROY SOC B-BIOL SCI, V279, P3635, DOI 10.1098/rspb.2012.0849; Dalpadado P, 2013, PROG OCEANOGR, V114, P97, DOI 10.1016/j.pocean.2013.05.007; Dolgov AV, 2002, ICES J MAR SCI, V59, P1034, DOI 10.1006/jmsc.2002.1237; DUNNING JB, 1995, ECOL APPL, V5, P3, DOI 10.2307/1942045; Eriksen E, 2009, JOINT SURVEY REPORT; Fauchald P, 2002, MAR ECOL PROG SER, V231, P279, DOI 10.3354/meps231279; Fauchald P, 2000, ECOLOGY, V81, P773, DOI 10.1890/0012-9658(2000)081[0773:SDPPIT]2.0.CO;2; Fauchald P, 2006, ECOLOGY, V87, P2915, DOI 10.1890/0012-9658(2006)87[2915:DMWITM]2.0.CO;2; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; Gjosaeter H, 1998, SARSIA, V83, P453, DOI 10.1080/00364827.1998.10420445; Gjosaeter H, 2002, ICES J MAR SCI, V59, P1086, DOI 10.1006/jmsc.2002.1238; Gjosaeter H, 2015, MAR BIOL RES, V11, P135, DOI 10.1080/17451000.2014.928414; Gjosaeter H, 2009, MAR BIOL RES, V5, P40, DOI 10.1080/17451000802454866; Godo O, 1993, ICES MAR SCI S; Godo OR, 2000, FISH RES, V48, P127, DOI 10.1016/S0165-7836(00)00177-6; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HORNE JK, 1994, J FISH BIOL, V45, P191, DOI 10.1111/j.1095-8649.1994.tb01093.x; Howell D, 2014, ICES J MAR SCI, V71, P72, DOI 10.1093/icesjms/fst172; Hunsicker ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066025; Huse G, 2008, CLIMATIC CHANGE, V87, P177, DOI 10.1007/s10584-007-9347-z; Hylen A, 2008, NORWEGIAN SPRING SPA, P177; ICES, 2017, CAP MALL VILL SUB 1; ICES, 2017, REP ARCT FISH WORK G; ICES, 2017, REP WORK GROUP INT A; Ingvaldsen RB, 2015, NAT CLIM CHANGE, V5, P788, DOI 10.1038/nclimate2761; Ingvaldsen RB, 2013, MAR BIOL RES, V9, P867, DOI 10.1080/17451000.2013.775450; Jakobsen T., 2011, BARENTS SEA ECOSYSTE; Johannesen E, 2016, CAN J FISH AQUAT SCI, V73, P235, DOI 10.1139/cjfas-2015-0052; Johannesen E, 2012, MAR ECOL PROG SER, V458, P181, DOI 10.3354/meps09818; Johansen GO, 2013, MAR BIOL RES, V9, P908, DOI 10.1080/17451000.2013.775456; Johansen GO, 2007, METHODOLOGY ASSESSME, P1503; Kjesbu OS, 2014, P NATL ACAD SCI USA, V111, P3478, DOI 10.1073/pnas.1316342111; Link JS, 2009, FISH FISH, V10, P58, DOI 10.1111/j.1467-2979.2008.00295.x; Llope M, 2009, LIMNOL OCEANOGR, V54, P512, DOI 10.4319/lo.2009.54.2.0512; MAMMEN E, 1992, PROBAB THEORY REL, V93, P439, DOI 10.1007/BF01192716; Mehl S, 2013, FISH INVESTIGATIONS; Mehl S, 2014, FISH INVESTIGATIONS, P1502; Michalsen K., 2011, P 15 RUSS NORW S LON; Michalsen K, 2008, ICES J MAR SCI, V65, P571, DOI 10.1093/icesjms/fsn019; O'Driscoll RL, 2000, CAN J FISH AQUAT SCI, V57, P1355, DOI 10.1139/f00-079; Orlova EL, 2005, ICES J MAR SCI, V62, P1281, DOI 10.1016/j.icesjms.2005.05.020; Orlova EL, 2001, AKSG0104 U AL SEA GR; Orlova EL, 2010, AQUAT BIOL, V10, P105, DOI 10.3354/ab00265; Ottersen G, 1998, ICES J MAR SCI, V55, P67, DOI 10.1006/jmsc.1997.0232; Palsson OK, 2011, ICES J MAR SCI, V68, P1488, DOI 10.1093/icesjms/fsr057; Puerta P, 2016, ICES J MAR SCI, V73, P1901, DOI 10.1093/icesjms/fsw053; R Core Team, 2018, R LANG ENV STAT COMP; Ribeiro P. J., 2018, GEOR ANAL GEOSTATIST; Rose GA, 2002, ICES J MAR SCI, V59, P1018, DOI 10.1006/jmsc.2002.1252; ROSE GA, 1990, ECOLOGY, V71, P33, DOI 10.2307/1940245; Sih Andrew, 2005, P240; Skjaeraasen JE, 2012, P NATL ACAD SCI USA, V109, P8995, DOI 10.1073/pnas.1200223109; Temming A, 2003, FISH RES, V63, P21, DOI 10.1016/S0165-7836(03)00041-9; Thorson JT, 2016, METHODS ECOL EVOL, V7, P990, DOI 10.1111/2041-210X.12567; Tjelmeland S, 1998, FISH RES, V37, P127, DOI 10.1016/S0165-7836(98)00132-5; Van Rij J, 2016, ITSADUG INTERPRETING; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wilke C., 2020, COWPLOT STREAMLINED; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2016, J AM STAT ASSOC, V111, P1548, DOI 10.1080/01621459.2016.1180986; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yaragina NA, 2011, BARENTS SEA ECOSYSTE, P825; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	72	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205921	10.1371/journal.pone.0205921	http://dx.doi.org/10.1371/journal.pone.0205921			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325964	Green Published, Green Submitted, gold			2022-12-26	WOS:000447430800050
J	Rod, NH; Dissing, AS; Clark, A; Gerds, TA; Lund, R				Rod, Naja Hulvej; Dissing, Agnete Skovlund; Clark, Alice; Gerds, Thomas Alexander; Lund, Rikke			Overnight smartphone use: A new public health challenge? A novel study design based on high-resolution smartphone data	PLOS ONE			English	Article							SHORT-SLEEP DURATION; MOBILE PHONES; DISTURBANCES; METAANALYSIS; ADOLESCENTS; MORTALITY; CHILDREN; QUALITY; OBESITY; STRESS	Background Round-the-clock use of smartphones holds a potential for awakenings and/ or shorter sleep duration, which may have adverse health consequences. We aim to describe overnight smartphone activity among young adults and to characterize those with smartphone interrupted sleep in terms of sleep impairment and mental and physical health indicators. Methods We use unique objective high-resolution information on timing of smartphone activity (based on >250,000 phone actions) continuously monitored over a four-week period among 815 young adults combined with indicators of mental and physical health. Results We find substantial overnight smartphone activity. More than 12% had smartphone activity in the middle of the night (3 to 5 hours after self-reported bedtime) and 41% had smartphone interrupted sleep on at least one weekday during a 4-week period. Those with frequent smartphone interrupted sleep had on average 48 minutes shorter self-reported sleep duration and higher body mass index, whereas there were no differences in physical or mental health symptoms. Conclusions The substantial smartphone activity during bed hours among young adults may pose a public health challenge and especially the relation to overweight warrants close attention.	[Rod, Naja Hulvej; Clark, Alice] Univ Copenhagen, Sect Epidemiol, Dept Publ Hlth, Oster Farigmagsgade 5, Copenhagen K, Denmark; [Rod, Naja Hulvej; Clark, Alice] Copenhagen Stress Res Ctr, Copenhagen, Denmark; [Dissing, Agnete Skovlund; Lund, Rikke] Univ Copenhagen, Sect Social Med, Dept Publ Hlth, Oster Farigmagsgade 5, Copenhagen K, Denmark; [Gerds, Thomas Alexander] Univ Copenhagen, Sect Biostat, Dept Publ Hlth, Oster Farigmagsgade 5, Copenhagen K, Denmark; [Lund, Rikke] Univ Copenhagen, Ctr Hlth Aging, Fac Hlth Sci, Blegdamsvej 3B, Copenhagen N, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Rod, NH (corresponding author), Univ Copenhagen, Sect Epidemiol, Dept Publ Hlth, Oster Farigmagsgade 5, Copenhagen K, Denmark.; Rod, NH (corresponding author), Copenhagen Stress Res Ctr, Copenhagen, Denmark.	nahuro@sund.ku.dk	; Rod, Naja Hulvej/B-9411-2015	Gerds, Thomas Alexander/0000-0002-5955-816X; Dissing, Agnete Skovlund/0000-0001-5968-1670; Rod, Naja Hulvej/0000-0002-6400-5105; Lund, Rikke/0000-0002-0381-4291	University of Copenhagen 2016-initiative	University of Copenhagen 2016-initiative	The Copenhagen Network Study was funded by the University of Copenhagen 2016-initiative.	Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Arora T, 2013, INT J OBESITY, V37, P1254, DOI 10.1038/ijo.2012.209; Arora T, 2014, SLEEP MED, V15, P240, DOI 10.1016/j.sleep.2013.08.799; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Broussard JL, 2016, OBESITY, V24, P132, DOI 10.1002/oby.21321; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chahal H, 2013, PEDIATR OBES, V8, P42, DOI 10.1111/j.2047-6310.2012.00085.x; Exelmans L, 2016, SOC SCI MED, V148, P93, DOI 10.1016/j.socscimed.2015.11.037; Hirotsu C, 2015, SLEEP SCI, V8, P143, DOI 10.1016/j.slsci.2015.09.002; Hysing M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006748; Lockley S., 2010, SLEEP HLTH SOC AETIO, P9; Loughran SP, 2005, NEUROREPORT, V16, P1973, DOI 10.1097/01.wnr.0000186593.79705.3c; Marshall NS., 2010, SLEEP DURATION RISK, P35; Munezawa T, 2011, SLEEP, V34, P1013, DOI 10.5665/SLEEP.1152; Rod NH, 2011, AM J EPIDEMIOL, V173, P300, DOI 10.1093/aje/kwq371; Tasali E, 2009, PROG CARDIOVASC DIS, V51, P381, DOI 10.1016/j.pcad.2008.10.002; Thomee S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-66; Thomee S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-66; Van den Bulck J, 2007, SLEEP, V30, P1220, DOI 10.1093/sleep/30.9.1220; Watson NF, 2015, SLEEP, V38, P1161, DOI 10.5665/sleep.4886; Weich S., 2010, SLEEP HLTH SOC AETIO, P178; Wood AW, 2006, INT J RADIAT BIOL, V82, P69, DOI 10.1080/09553000600599775	25	23	24	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0204811	10.1371/journal.pone.0204811	http://dx.doi.org/10.1371/journal.pone.0204811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0VS	30325929	Green Published, gold, Green Submitted			2022-12-26	WOS:000447430800012
J	Yang, SH; Xiao, YN; Xu, JZ; Liu, XY				Yang, Shihong; Xiao, Yanan; Xu, Junzeng; Liu, Xiaoyin			Effect of straw return on soil respiration and NEE of paddy fields under water-saving irrigation	PLOS ONE			English	Article							WHEAT ROTATION SYSTEM; CROPPING SYSTEM; SOUTHEAST CHINA; CARBON DYNAMICS; RICE PADDIES; MANAGEMENT; METHANE; YIELDS; EMISSIONS; DECOMPOSITION	Straw return (SR) and rice water-saving irrigation (WSI) affect the greenhouse gas emission of paddy fields. However, studies on CO2 exchange between paddy fields and the atmosphere with joint regulation of SR and WSI are few. We conducted a two-year field experiment to investigate the effects of SR on soil respiration and net ecosystem exchange of CO2 (NEE) in paddy fields under controlled irrigation (CI), which is a typical WSI technique. The rice yields, irrigation water use efficiency, seasonal variations in soil respiration, NEE, and soil organic carbon content were measured. Compared with the control (flooding irrigation and traditional chemical fertilizer), a significant increase in rice yield and irrigation water use efficiency in the paddy fields under CI and SR joint management (CS) was observed. CS increased the soil respiration rate during most of the rice growth stage and increased the net CO2 absorption rate before approximately 80 days after transplanting; afterward, the pattern reversed. Total CO2 emissions through soil respiration in CS paddy fields increased by 43.7% and 182% compared with the control in 2014 and 2015, respectively. However, CS also caused an increase in the total net CO2 absorption by 18.1% and 30.1% in these two years, respectively. The acceleration in the consumption and decomposition of soil organic carbon induced by frequent alternate wet-dry cycles of the CI paddy fields increased the soil respiration and decreased the net CO2 absorption. SR promoted soil respiration but also improved rice growth, increasing the net CO2 absorption. The soil organic carbon content of the CS paddy fields after harvesting increased by 23.2% compared with that before transplanting. The present study concluded that joint regulation of WSI and SR is an effective measure for maintaining yield, increasing irrigation water use efficiency, mitigating CO2 emission, and promoting paddy soil fertility.	[Yang, Shihong; Xu, Junzeng] Hohai Univ, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China; [Yang, Shihong; Xiao, Yanan; Xu, Junzeng; Liu, Xiaoyin] Hohai Univ, Coll Agr Engn, Nanjing, Jiangsu, Peoples R China	Hohai University; Hohai University	Yang, SH (corresponding author), Hohai Univ, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China.; Yang, SH (corresponding author), Hohai Univ, Coll Agr Engn, Nanjing, Jiangsu, Peoples R China.	ysh7731@hhu.edu.cn	Yang, Shihong/AAM-2188-2020; Liu, Xiaoyin/L-7568-2019	Liu, Xiaoyin/0000-0002-7026-1738	National Natural Science Foundation of China [51579070, 51879076]; National Natural Science Foundation of China; Fundamental Research Funds for the Central Universities [2018B634X14]; Hohai University; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX18_0628]; Jiangsu Education Department; Advanced Science and Technology Innovation Team in Colleges and Universities in Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hohai University; Postgraduate Research & Practice Innovation Program of Jiangsu Province; Jiangsu Education Department; Advanced Science and Technology Innovation Team in Colleges and Universities in Jiangsu Province	Funded by 1. The National Natural Science Foundation of China (No. 51579070, 51879076, Shihong Yang received the funding), Funder:National Natural Science Foundation of China, Website: http://www.nsfc.gov.cn/. 2. The Fundamental Research Funds for the Central Universities (No. 2018B634X14 Yanan Xiao received the funding). Funder: Hohai University, Website: http://www.hhu.edu.cn/. 3. The Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX18_0628 Yanan Xiao received the funding). Funder: Jiangsu Education Department, Website: http://jyt.jiangsu.gov.cn/. 4. The Advanced Science and Technology Innovation Team in Colleges and Universities in Jiangsu Province (Junzeng Xu received the funding). Funder: Jiangsu Education Department, Website: http://jyt.jiangsu.gov.cn/.; This research was financially supported by the National Natural Science Foundation of China (No. 51579070, 51879076), the Fundamental Research Funds for the Central Universities (No. 2018B634X14), the Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX18_0628) and the Advanced Science and Technology Innovation Team in Colleges and Universities in Jiangsu Province.	Ali MA, 2013, AMBIO, V42, P357, DOI 10.1007/s13280-012-0349-3; Badia D, 2013, SCI TOTAL ENVIRON, V465, P233, DOI 10.1016/j.scitotenv.2013.04.006; Bao ST, 1999, SOIL AGROCHEMISTRY A, P264; Baudron F, 2014, AGR ECOSYST ENVIRON, V187, P171, DOI 10.1016/j.agee.2013.08.020; Bouman B.A.M., 2007, WATER MANAGEMENT IRR, P53; Carrijo DR, 2017, FIELD CROP RES, V203, P173, DOI 10.1016/j.fcr.2016.12.002; Chen ZM, 2017, SOIL TILL RES, V165, P121, DOI 10.1016/j.still.2016.07.018; Gupta DK, 2016, AGR ECOSYST ENVIRON, V230, P1, DOI 10.1016/j.agee.2016.05.023; HADI A, 2010, PADDY WATER ENVIRON, V8, P319, DOI DOI 10.1007/s10333-010-0210-x; Hou HJ, 2012, CHEMOSPHERE, V89, P884, DOI 10.1016/j.chemosphere.2012.04.066; Hu NJ, 2016, AGR ECOSYST ENVIRON, V223, P115, DOI 10.1016/j.agee.2016.02.027; IPCC, 2014, CLIMATE CHANGE MITIG; Jiang XL, 2006, AQUACULT ENG, V35, P147, DOI 10.1016/j.aquaeng.2005.10.002; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kunlanit B, 2014, SOIL BIOL BIOCHEM, V76, P100, DOI 10.1016/j.soilbio.2014.05.006; Lenka NK, 2013, SOIL TILL RES, V126, P78, DOI 10.1016/j.still.2012.08.011; Li H, 2006, CROP RES, P401; Li H, 2018, ECOTOX ENVIRON SAFE, V159, P293, DOI 10.1016/j.ecoenv.2018.05.014; Li Tao, 2016, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V24, P1633; Liu C, 2014, GLOBAL CHANGE BIOL, V20, P1366, DOI 10.1111/gcb.12517; [刘军 Liu Jun], 2015, [生态环境学报, Ecology and Environmental Sciences], V24, P791; Luo Y, 2006, SOIL RESP ENV, DOI [10.1016/b978-0-12-088782-8.x5000-1, DOI 10.1016/B978-0-12-088782-8.X5000-1, 10.1016/B978-0-12-088782-8.X5000-1]; Malyan SK, 2016, SCI TOTAL ENVIRON, V572, P874, DOI 10.1016/j.scitotenv.2016.07.182; Mao Z., 2009, CHINA WATER RESOURCE, V21, P11; Mao Z, 2001, WATER EFFICIENT IRRI; [茆智 Mao Zhi], 2002, [中国工程科学, Engineering science], V4, P8; Pan JianLing, 2013, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V21, P526, DOI 10.3724/SP.J.1011.2013.00526; Pei Peng-gang, 2015, Zhongguo Shuidao Kexue, V29, P282, DOI 10.3969/j.issn.1001-7216.2015.03.007; Peng SL, 2013, SOIL BIOL BIOCHEM, V57, P411, DOI 10.1016/j.soilbio.2012.10.026; Raubuch M, 2010, PEDOBIOLOGIA, V53, P191, DOI 10.1016/j.pedobi.2009.10.001; Said-Pullicino D, 2014, GEODERMA, V228, P44, DOI 10.1016/j.geoderma.2013.06.020; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Shang Qing-yin, 2015, Chinese Journal of Rice Science, V29, P181, DOI 10.3969/j.issn.1001-7216.2015.02.010; Thippayarugs S, 2008, AGROFOREST SYST, V72, P137, DOI 10.1007/s10457-007-9062-9; Turmel MS, 2015, AGR SYST, V134, P6, DOI 10.1016/j.agsy.2014.05.009; Xia LL, 2014, AGR ECOSYST ENVIRON, V197, P118, DOI 10.1016/j.agee.2014.08.001; Xu Y, 2017, PLANT SOIL, V421, P337, DOI 10.1007/s11104-017-3467-7; Yan XY, 2005, GLOBAL CHANGE BIOL, V11, P1131, DOI 10.1111/j.1365-2486.2005.00976.x; Yang HS, 2016, SOIL TILL RES, V163, P21, DOI 10.1016/j.still.2016.05.003; Yang SH, 2016, AGR WATER MANAGE, V166, P42, DOI 10.1016/j.agwat.2015.12.015; Zhang J, 2017, SOIL TILL RES, V165, P302, DOI 10.1016/j.still.2016.09.004; [张庆忠 ZHANG QingZhong], 2005, [生态学报, Acta Ecologica Sinica], V25, P2883; Zhao X, 2014, J SOIL SEDIMENT, V14, P471, DOI 10.1007/s11368-013-0803-2; Zhao YaLi, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P155; Zhu LX, 2017, ENVIRON SCI POLLUT R, V24, P1019, DOI 10.1007/s11356-016-7829-0; Zhu ZL, 2010, BASIC RES NITROGEN B, P1; Zou JW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002401	47	10	13	12	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0204597	10.1371/journal.pone.0204597	http://dx.doi.org/10.1371/journal.pone.0204597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325941	Green Published, Green Submitted, gold			2022-12-26	WOS:000447430800009
J	Zavaleta, C; Berrang-Ford, L; Ford, J; Llanos-Cuentas, A; Carcamo, C; Ross, NA; Lancha, G; Sherman, M; Harper, SL				Zavaleta, Carol; Berrang-Ford, Lea; Ford, James; Llanos-Cuentas, Alejandro; Carcamo, Cesar; Ross, Nancy A.; Lancha, Guillermo; Sherman, Mya; Harper, Sherilee L.		Indigenous Hlth Adaption Climate	Multiple non-climatic drivers of food insecurity reinforce climate change maladaptation trajectories among Peruvian Indigenous Shawi in the Amazon	PLOS ONE			English	Article							VULNERABILITY; HEALTH; ADAPTATION; SYSTEMS; SECURITY; IMPACTS; COMMUNITIES; QUANTIFY; CHILDREN; QUALITY	Background Climate change is affecting food systems globally, with implications for food security, nutrition, and the health of human populations. There are limited data characterizing the current and future consequences of climate change on local food security for populations already experiencing poor nutritional indicators. Indigenous Amazonian populations have a high reported prevalence of nutritional deficiencies. This paper characterizes the food system of the Shawi of the Peruvian Amazon, climatic and non-climatic drivers of their food security vulnerability to climate change, and identifies potential maladaptation trajectories. Methods and findings Semi-structured interviews with key informants (n = 24), three photovoice workshops (n = 17 individuals), transect walks (n = 2), a food calendar exercise, and two community dissemination meetings (n = 30 individuals), were conducted within two Shawi communities in Balsapuerto District in the Peruvian Loreto region between June and September of 2014. The Shawi food system was based on three main food sub-systems (forest, farming and externally- sourced). Shawi reported collective, gendered, and emotional notions related to their food system activities. Climatic and non-climatic drivers of food security vulnerability among Shawi participants acted at proximal and distal levels, and mutually reinforced key maladaptation trajectories, including: 1) a growing population and natural resource degradation coupled with limited opportunities to increase incomes, and 2) a desire for education and deforestation reinforced by governmental social and food interventions. Conclusion A series of maladaptive trajectories have the potential to increase social and nutritional inequities for the Shawi. Transformational food security adaptation should include consideration of Indigenous perceptions and priorities, and should be part of Peruvian food and socioeconomic development policies.	[Zavaleta, Carol; Berrang-Ford, Lea; Ford, James; Ross, Nancy A.; Sherman, Mya] McGill Univ, Dept Geog, Montreal, PQ, Canada; [Zavaleta, Carol; Llanos-Cuentas, Alejandro; Carcamo, Cesar] Univ Peruana Cayetano Heredia, Fac Salud Publ, Lima, Peru; [Lancha, Guillermo] Shawi Community, Alto Amazonas, Loreto, Peru; [Harper, Sherilee L.] Univ Guelph, Dept Populat Med, Guelph, ON, Canada; [Berrang-Ford, Lea; Ford, James] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Sherman, Mya] Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Gulf Coast Environm Hlth Res Leadership & Str, New Orleans, LA USA; [Harper, Sherilee L.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	McGill University; Universidad Peruana Cayetano Heredia; University of Guelph; University of Leeds; Tulane University; University of Alberta	Zavaleta, C (corresponding author), McGill Univ, Dept Geog, Montreal, PQ, Canada.; Zavaleta, C (corresponding author), Univ Peruana Cayetano Heredia, Fac Salud Publ, Lima, Peru.	Claudia.zavaleta@mail.mcgill.ca	Ford, James/A-4284-2013	Ford, James/0000-0002-2066-3456; Zavaleta, Carol/0000-0003-4969-8959; Llanos-Cuentas, Alejandro/0000-0002-7567-5534	Canadian Institutes of Health Research (CIHR), International Development Research Centre (IDRC), Ottawa, Canada; IDRC (CIHR)	Canadian Institutes of Health Research (CIHR), International Development Research Centre (IDRC), Ottawa, Canada(Canadian Institutes of Health Research (CIHR)); IDRC (CIHR)(Canadian Institutes of Health Research (CIHR))	This research is part of the Indigenous Health Adaptation to Climate Change Project (http://www.ihacc.ca) and we received funding from: The Canadian Institutes of Health Research (CIHR), International Development Research Centre (IDRC), Ottawa, Canada. Information on the Centre is available on the web at www.idrc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. C.Z. received financial support from the Doctoral research award of IDRC (CIHR).	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Adger WN, 2009, CLIMATIC CHANGE, V93, P335, DOI 10.1007/s10584-008-9520-z; Agrawal A, 2010, NEW FRONT SOC POLICY, P173; [Anonymous], 2010, DIR TECN DEM IND SOC; Bedran-Martins AM, 2018, CLIMATIC CHANGE, V147, P283, DOI 10.1007/s10584-017-2105-y; Benefice E, 2006, PUBLIC HEALTH NUTR, V9, P327, DOI 10.1079/PHN2006852; Brondizio ES, 2016, ANN HUM BIOL, V43, P405, DOI 10.1080/03014460.2016.1193222; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; CHAMBERS R, 1994, WORLD DEV, V22, P1253, DOI 10.1016/0305-750X(94)90003-5; Diaz A, 2015, REV PANAM SALUD PUBL, V38, P49; Amaral Benedito Domingues do, 2005, Acta Amaz., V35, P133, DOI 10.1590/S0044-59672005000200004; Ebi KL, 2006, ENVIRON HEALTH PERSP, V114, P1930, DOI 10.1289/ehp.8430; Erfanian A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05373-2; Ericksen PJ, 2008, GLOBAL ENVIRON CHANG, V18, P234, DOI 10.1016/j.gloenvcha.2007.09.002; Eriksen S, 2005, NEW INDICATORS VULNE; Eriksen S, 2011, CLIM DEV, V3, P7, DOI 10.3763/cdev.2010.0060; Eriksen SH, 2015, GLOBAL ENVIRON CHANG, V35, P523, DOI 10.1016/j.gloenvcha.2015.09.014; Espinoza JC, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024008; ESPINOZA VJC, 2009, INT J CLIMATOL, V29, P1574, DOI DOI 10.1002/J0C.1791; FAO, 2008, CLIM CHANG FOOD SEC; Fazey I, 2016, CLIM DEV, V8, P26, DOI 10.1080/17565529.2014.989192; Fazey I, 2011, GLOBAL ENVIRON CHANG, V21, P1275, DOI 10.1016/j.gloenvcha.2011.07.006; Ford JD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-970; Ford JD, 2012, AM J PUBLIC HEALTH, V102, P1260, DOI 10.2105/AJPH.2012.300752; Ford JD, 2010, WIRES CLIM CHANGE, V1, P374, DOI 10.1002/wcc.48; Ford JD, 2009, REG ENVIRON CHANGE, V9, P83, DOI 10.1007/s10113-008-0060-x; Ford JD, 2004, ARCTIC, V57, P389, DOI 10.14430/arctic516; Fuentes Aldo., 1988, PORQUE PIEDRAS MUERE; Fussel HM, 2006, CLIMATIC CHANGE, V75, P301, DOI 10.1007/s10584-006-0329-3; Garcia Hierro P, 2002, HIST FUTURO TERRITOR; Gobierno regional de Loreto Instituto de Investigacion de la Amazonia Peruana, 2015, MUN PROV ALT AM ZON; Gonzales ML, 2013, ENTRE PREDACION DOCI; Granero FS, 1990, LIM SEM PERM INV AGR, VIII; Gregory PJ, 2005, PHILOS T R SOC B, V360, P2139, DOI 10.1098/rstb.2005.1745; Hansen A, 2017, LANCET PLANET HEALTH, V1, pE353, DOI 10.1016/S2542-5196(17)30160-2; Hern W., 1994, AMAZONIA PERUANA, V24, P161; Hofmeijer I, 2013, MITIG ADAPT STRAT GL, V18, P957, DOI 10.1007/s11027-012-9402-6; Horta BL, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-23; Huertas Castillo B, AGUA CULTURA TERRITO; INEI, 2009, RES EJ RES DEF CENS; Jimenez-Munoz JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep33130; Jimenez-Munoz JC, 2013, J GEOPHYS RES-ATMOS, V118, P5204, DOI 10.1002/jgrd.50456; Jurgilevich A, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5508; KEARNS RA, 1993, PROF GEOGR, V45, P139, DOI 10.1111/j.0033-0124.1993.00139.x; Kenny TA, 2018, PUBLIC HEALTH NUTR, V21, P1319, DOI 10.1017/S1368980017003810; Kovats S., 2003, METHODS ASSESSING HU; Kronik Jakob, 2010, INDIGENOUS PEOPLES C, DOI 10.1596/978-0-8213-8237-0; Kuhnlein HV, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12529; Kuhnlein HV, 2015, PUBLIC HEALTH NUTR, V18, P2415, DOI 10.1017/S1368980014002961; Lardeau MP., 2012, AJOB PRIM RES, V3, P53, DOI [10.1080/21507716.2012.714838, DOI 10.1080/21507716.2012.714838]; Casimiro WSL, 2013, HYDROL PROCESS, V27, P2944, DOI 10.1002/hyp.9418; Lemos MC, 2016, GLOBAL ENVIRON CHANG, V39, P170, DOI 10.1016/j.gloenvcha.2016.05.001; Lizot J., 1974, ANTROPOLOGICA, P37; Lloyd SJ, 2011, ENVIRON HEALTH PERSP, V119, P1817, DOI 10.1289/ehp.1003311; Lorenz LS, 2009, HEALTH EXPECT, V12, P262, DOI 10.1111/j.1369-7625.2009.00560.x; Lutz W, 2014, SCIENCE, V346, P1061, DOI 10.1126/science.1257975; Marengo JA, 2016, INT J CLIMATOL, V36, P1033, DOI 10.1002/joc.4420; Marengo JA, 2012, THEOR APPL CLIMATOL, V107, P73, DOI 10.1007/s00704-011-0465-1; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McDowell G, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/033001; McSweeney K, 2005, LAT AM RES REV, V40, P3, DOI 10.1353/lar.2005.0012; MEGGERS BJ, 1994, CLIMATIC CHANGE, V28, P321, DOI 10.1007/BF01104077; Miles M.B., 1994, ANAL DONNEES QUALITA, V2nd; Ministerio del Ambiente, 2016, TERC COM NAC PER CON; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; Muttarak R, 2014, ECOL SOC, V19, DOI 10.5751/ES-06476-190142; Myers SS, 2017, ANNU REV PUBL HEALTH, V38, P259, DOI 10.1146/annurev-publhealth-031816-044356; O'Brien K, 2007, CLIM POLICY, V7, P73, DOI 10.1080/14693062.2007.9685639; Obregon G., 2009, ESC CLIM CUENC RIO M; Ormaeche M, 2008, ASIS PUEBLO SHAWI 20; Ormaeche M, 2003, ANALISIS SITUACION S; Palibroda B., 2009, PRACTICAL GUIDE PHOT; Patterson K, 2017, PUBLIC HEALTH NUTR, V20, P1, DOI 10.1017/S1368980016002494; Pautrat L, 2009, SISTEMATIZACION MAPE; Perreault T., 2005, WHY CHACRAS SWIDDEN, P327; Phalkey RK, 2015, P NATL ACAD SCI USA, V112, pE4522, DOI 10.1073/pnas.1409769112; Pinstrup-Andersen P, 2009, FOOD SECUR, V1, P5, DOI 10.1007/s12571-008-0002-y; Pitman N, 2014, 26 FIELD MUSEUM, P541; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Programa Juntos, 2017, MIS PROGR JUNT LIM; Prosperi Paolo, 2016, Environment Systems & Decisions, V36, P3, DOI 10.1007/s10669-016-9584-7; Rasanen A, 2016, REG ENVIRON CHANGE, V16, P2291, DOI 10.1007/s10113-016-0974-7; Richmond CAM, 2009, HEALTH PLACE, V15, P403, DOI 10.1016/j.healthplace.2008.07.004; Roche ML, 2008, PUBLIC HEALTH NUTR, V11, P457, DOI 10.1017/S1368980007000560; Rosenzweig Cynthia, 2014, Proc Natl Acad Sci U S A, V111, P3268, DOI 10.1073/pnas.1222463110; Saxena AK, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00020; Sherman M, 2016, FOOD SECUR, V8, P551, DOI 10.1007/s12571-016-0583-9; Sherman M, 2015, NAT HAZARDS, V77, P2049, DOI 10.1007/s11069-015-1690-1; Siren AH, 2007, HUM ECOL, V35, P669, DOI 10.1007/s10745-006-9089-y; Sistema Nacional de Defensa Civil-Peru, 1995, DESCR PRINC EM LOC N; Springmann M, 2016, LANCET, V387, P1937, DOI 10.1016/S0140-6736(15)01156-3; Szlafsztein CF, 2014, MITIGATION ADAPTATIO, P1; Thornton PK, 2014, GLOBAL CHANGE BIOL, V20, P3313, DOI 10.1111/gcb.12581; Valentina Robiglio, 2015, ICRAF OFICINA REGION; Vermeulen SJ, 2012, ANNU REV ENV RESOUR, V37, P195, DOI 10.1146/annurev-environ-020411-130608; Wamsler C, 2012, ECOL SOC, V17, DOI 10.5751/ES-04645-170202; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6; Webb NP, 2017, FRONT ECOL ENVIRON, V15, P450, DOI 10.1002/fee.1530; Webb Patrick, 2006, J Nutr, V136, p1404S; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wiles JL, 2005, AREA, V37, P89, DOI 10.1111/j.1475-4762.2005.00608.x; Wise RM, 2014, GLOBAL ENVIRON CHANG, V28, P325, DOI 10.1016/j.gloenvcha.2013.12.002; Wu SH, 2014, CRIT REV FOOD SCI, V54, P151, DOI 10.1080/10408398.2011.578764; Zavaleta C, 2017, FOOD POLICY, V73, P75, DOI 10.1016/j.foodpol.2017.10.001	104	26	26	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205714	10.1371/journal.pone.0205714	http://dx.doi.org/10.1371/journal.pone.0205714			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0VS	30325951	Green Published, Green Submitted, gold			2022-12-26	WOS:000447430800035
J	Dupont, G; Flory, L; Morel, J; Lukaszewicz, AC; Patoir, A; Presles, E; Monneret, G; Molliex, S				Dupont, Guillaume; Flory, Laura; Morel, Jerome; Lukaszewicz, Anne-Claire; Patoir, Arnaud; Presles, Emilie; Monneret, Guillaume; Molliex, Serge			Postoperative lymphopenia: An independent risk factor for postoperative pneumonia after lung cancer surgery, results of a case-control study	PLOS ONE			English	Article							SURGICAL TRAUMA; IMMUNOSUPPRESSION; REGRESSION; CHOLECYSTECTOMY; VALIDATION; RESECTION; IMMUNITY; EVENTS; SEPSIS; SYSTEM	Objective Postoperative lymphopenia has been proposed as a risk factor for postoperative infections but has never been identified as such in a multivariate analysis. Postoperative pneumonia (POP) is one of the most common complications after lung cancer surgery and is associated with a worse outcome. We aimed to evaluate the association between postoperative lymphopenia and POP after lung cancer surgery. Methods Patients admitted for lung cancer surgery (lobectomy, bilobectomy, or pneumonectomy) aged. 18 years and with no history of an immunosuppressive state were eligible for inclusion. Lymphocyte counts were determined in blood drawn on the day before surgery and at postoperative days 1, 3 and 7. POP diagnosis was based on clinical, biological and radiological data. A logistic regression model adjusted on currently described risk factors for POP was used to explain the onset of this condition. Results Two hundred patients were included, of whom 43 (21.5%) developed POP. Preoperative lymphocyte count was 1.8 +/- 0.6x10(9) cells/L and 2.0 +/- 0.7x10(9) cells/L in patients with and without POP, respectively (P = .091). In both groups, the lymphocyte count nadir occurred at postoperative day 1. In multivariate analysis, lymphopenia at postoperative day 1 was significantly associated with increased risk of POP (odds ratio: 2.63, 95% CI [1.03-5.40]). POP rate at postoperative day 7 was higher in patients presenting low lymphocyte counts (<= 1.19x10(9) cells/L) at postoperative day 1 (P = .003). Conclusions Our study showed that lymphopenia following lung cancer surgery was maximal at postoperative day 1 and was associated with POP.	[Dupont, Guillaume; Flory, Laura; Morel, Jerome; Molliex, Serge] CHU St Etienne, Dept Anesthesie Reanimat, Ave Albert Raimond, St Etienne, France; [Dupont, Guillaume; Lukaszewicz, Anne-Claire; Monneret, Guillaume] Univ Claude Bernard Lyon 1, EA Pathophysiol Injury Induced Immunosuppress 742, HCL, bioMerieux,Hop E, Villeurbanne, France; [Lukaszewicz, Anne-Claire] Hop Neurol & Neurochirurg P Wertheimer, Serv Anesthesie Reanimat, Grp Hosp Est, Bron, France; [Patoir, Arnaud] CHU St Etienne, Dept Chirurg Thorac, St Etienne, France; [Presles, Emilie] INSERM, CIC1408, Paris, France; [Presles, Emilie] CHU St Etienne, Serv Unite Rech Clin Innovat & Pharmacol, Hop Nord, St Etienne, France; [Monneret, Guillaume] Hop Edouard Herriot, Hosp Civils Lyon, Lab Immunol, Lyon, France	CHU de St Etienne; bioMerieux; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de St Etienne; CHU Lyon	Dupont, G (corresponding author), CHU St Etienne, Dept Anesthesie Reanimat, Ave Albert Raimond, St Etienne, France.; Dupont, G (corresponding author), Univ Claude Bernard Lyon 1, EA Pathophysiol Injury Induced Immunosuppress 742, HCL, bioMerieux,Hop E, Villeurbanne, France.	guillaume.dupont@chu-st-etienne.fr	Lukaszewicz, Anne-Claire/GXG-4590-2022					Agostini PJ, 2018, J CARDIOTHORAC SURG, V13, DOI 10.1186/s13019-018-0717-6; Albertsmeier M, 2015, INNATE IMMUN-LONDON, V21, P55, DOI 10.1177/1753425913516659; Angele MK, 2005, LANGENBECK ARCH SURG, V390, P333, DOI 10.1007/s00423-005-0557-4; Arozullah AM, 2001, ANN INTERN MED, V135, P847, DOI 10.7326/0003-4819-135-10-200111200-00005; Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Bolla G, 2003, SURG ENDOSC, V17, P1247, DOI 10.1007/s00464-002-9135-9; Courvoisier DS, 2011, J CLIN EPIDEMIOL, V64, P993, DOI 10.1016/j.jclinepi.2010.11.012; Cristaldi M, 1997, SURG LAPAROSC ENDOSC, V7, P255, DOI 10.1097/00019509-199706000-00017; Edwards MR, 2015, CLIN SCI, V129, P423, DOI 10.1042/CS20150024; Falcoz PE, 2016, EUR J CARDIO-THORAC, V49, P602, DOI 10.1093/ejcts/ezv154; GENNARI R, 1995, EUR J SURG, V161, P493; GRIFFITH JP, 1995, BRIT J SURG, V82, P677, DOI 10.1002/bjs.1800820539; GUILLOU PJ, 1993, LANCET, V342, P217, DOI 10.1016/0140-6736(93)92303-B; Gupta H, 2013, MAYO CLIN PROC, V88, P1241, DOI 10.1016/j.mayocp.2013.06.027; Hogan BV, 2011, SURG-J R COLL SURG E, V9, P38, DOI 10.1016/j.surge.2010.07.011; Hotchkiss RS, 2014, NEW ENGL J MED, V371, P380, DOI 10.1056/NEJMcibr1404664; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Iwata E, 2016, SPINE, V41, P1173, DOI 10.1097/BRS.0000000000001501; Leaver HA, 2000, EUR J CLIN INVEST, V30, P230; LENNARD TWJ, 1985, BRIT J SURG, V72, P771, DOI 10.1002/bjs.1800721002; Marik PE, 2012, J TRAUMA ACUTE CARE, V73, P801, DOI 10.1097/TA.0b013e318265cf87; MOONS KGM, 2009, BRIT MED J, V338; Ogawa K, 2000, SURGERY, V127, P329, DOI 10.1067/msy.2000.103498; Sato T, 2015, GEN THORAC CARDIOVAS, V63, P164, DOI 10.1007/s11748-014-0487-6; Schussler O, 2006, AM J RESP CRIT CARE, V173, P1161, DOI 10.1164/rccm.200510-1556OC; Simonsen DF, 2015, RESP MED, V109, P1340, DOI 10.1016/j.rmed.2015.07.008; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; Takahashi J, 2006, SPINE, V31, P1020, DOI 10.1097/01.brs.0000214895.67956.60; Torrance HDT, 2016, CURR OPIN ANESTHESIO, V29, P376, DOI 10.1097/ACO.0000000000000331; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; WALTON B, 1978, ANAESTHESIA, V33, P322, DOI 10.1111/j.1365-2044.1978.tb12415.x	31	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205237	10.1371/journal.pone.0205237	http://dx.doi.org/10.1371/journal.pone.0205237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321194	Green Published, Green Submitted, gold			2022-12-26	WOS:000447417900021
J	Thomson, CE; Winney, IS; Salles, OC; Pujol, B				Thomson, Caroline E.; Winney, Isabel S.; Salles, Oceane C.; Pujol, Benoit			A guide to using a multiple-matrix animal model to disentangle genetic and nongenetic causes of phenotypic variance	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION; QUANTITATIVE GENETICS; EVOLUTIONARY CONSEQUENCES; EPIGENETIC VARIATION; DIFFUSION ANALYSIS; CLIMATE-CHANGE; BODY-SIZE; INHERITANCE; SELECTION; HERITABILITY	Non-genetic influences on phenotypic traits can affect our interpretation of genetic variance and the evolutionary potential of populations to respond to selection, with consequences for our ability to predict the outcomes of selection. Long-term population surveys and experiments have shown that quantitative genetic estimates are influenced by nongenetic effects, including shared environmental effects, epigenetic effects, and social interactions. Recent developments to the "animal model" of quantitative genetics can now allow us to calculate precise individual-based measures of non-genetic phenotypic variance. These models can be applied to a much broader range of contexts and data types than used previously, with the potential to greatly expand our understanding of nongenetic effects on evolutionary potential. Here, we provide the first practical guide for researchers interested in distinguishing between genetic and nongenetic causes of phenotypic variation in the animal model. The methods use matrices describing individual similarity in nongenetic effects, analogous to the additive genetic relatedness matrix. In a simulation of various phenotypic traits, accounting for environmental, epigenetic, or cultural resemblance between individuals reduced estimates of additive genetic variance, changing the interpretation of evolutionary potential. These variances were estimable for both direct and parental nongenetic variances. Our tutorial outlines an easy way to account for these effects in both wild and experimental populations. These models have the potential to add to our understanding of the effects of genetic and nongenetic effects on evolutionary potential. This should be of interest both to those studying heritability, and those who wish to understand nongenetic variance.	[Thomson, Caroline E.; Winney, Isabel S.; Salles, Oceane C.; Pujol, Benoit] Univ Fed Toulouse, Lab Evolut & Diversite Biol, EDB UMR 5174, Midi Pyrenees,CNRS,ENSFEA,IRD,UPS, Toulouse, France; [Pujol, Benoit] Lab Excellence CORAIL, Perpignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Thomson, CE (corresponding author), Univ Fed Toulouse, Lab Evolut & Diversite Biol, EDB UMR 5174, Midi Pyrenees,CNRS,ENSFEA,IRD,UPS, Toulouse, France.	cethomson2@gmail.com	Pujol, Benoit/N-1575-2019	Pujol, Benoit/0000-0001-9703-6760; Winney, Isabel/0000-0001-8606-3720	European Research Council (ERC) under the European Union's horizon 2020 research and innovation program [ERC-CoG-2015-681484-ANGI]; French "Agence Nationale de la Recherche" [ANR-13-JSV7-002]; ANR [ANR-10-LABX-41, ANR-10-LABX-25-01, ANR11-IDEX-0002-02]	European Research Council (ERC) under the European Union's horizon 2020 research and innovation program(European Research Council (ERC)); French "Agence Nationale de la Recherche"(French National Research Agency (ANR)); ANR(French National Research Agency (ANR))	This work is part of a project that received funding from the European Research Council (ERC) under the European Union's horizon 2020 research and innovation program (grant agreement ERC-CoG-2015-681484-ANGI to BP). This work was also supported by the French "Agence Nationale de la Recherche" (ANR-13-JSV7-002 "CAPA" to BP). CET, ISW, OCS and BP were also supported by the ANR funded French Laboratory of Excellence projects "LABEX TULIP" and "LABEX CEBA" (ANR-10-LABX-41, ANR-10-LABX-25-01) and ANR funded Toulouse Initiative of Excellence "IDEX UNITI" (ANR11-IDEX-0002-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Laura Gervais, Delphine Gourcilleau, Mathieu Latutrie, Pascal Marrot, Mathilde Mousset, and Charlotte Regan for useful feedback. We are also grateful to Matthew Silk for aid with social network simulation and analysis. We thank Bruce Walsh, Matthew Wolak, and two anonymous reviewers for their helpful comments. This work is part of a project that received funding from the European Research Council (ERC) under the European Union's horizon 2020 research and innovation program (grant agreement ERC-CoG-2015-681484-ANGI to BP). This work was also supported by the French "Agence Nationale de la Recherche" (ANR-13-JSV7-002 "CAPA" to BP). CET, ISW, OCS and BP were also supported by the ANR funded French Laboratory of Excellence projects "LABEX TULIP" and "LABEX CEBA" (ANR-10-LABX-41, ANR-10-LABX-25-01) and ANR funded Toulouse Initiative of Excellence "IDEX UNITI" (ANR11-IDEX-0002-02).	Adams MJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0689; Allen J, 2013, SCIENCE, V340, P485, DOI 10.1126/science.1231976; Aplin LM, 2015, NATURE, V518, P538, DOI 10.1038/nature13998; Arango J, 2005, J ANIM SCI, V83, P1241; Berenos C, 2014, MOL ECOL, V23, P3434, DOI 10.1111/mec.12827; Berteaux D, 2000, ECOLOGY, V81, P1311, DOI 10.1890/0012-9658(2000)081[1311:BDIFNA]2.0.CO;2; Bijma P, 2014, HEREDITY, V112, P61, DOI 10.1038/hdy.2013.15; Bijma P, 2007, GENETICS, V175, P277, DOI 10.1534/genetics.106.062711; Bonduriansky R, 2012, EVOL APPL, V5, P192, DOI 10.1111/j.1752-4571.2011.00213.x; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Brommer JE, 2008, EVOLUTION, V62, P2326, DOI 10.1111/j.1558-5646.2008.00451.x; Butler D, 2009, ASREML ASREML FITS L; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Charmantier A, 2006, P ROY SOC B-BIOL SCI, V273, P225, DOI 10.1098/rspb.2005.3294; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Charmantier A, 2014, EVOL APPL, V7, P15, DOI 10.1111/eva.12126; Cortijo S, 2014, SCIENCE, V343, P1145, DOI 10.1126/science.1248127; Silva JCE, 2017, HEREDITY, V119, P125, DOI 10.1038/hdy.2017.25; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; CULLIS BR, 1991, BIOMETRICS, V47, P1449, DOI 10.2307/2532398; Danchin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061254; Danchin E, 2011, NAT REV GENET, V12, P475, DOI 10.1038/nrg3028; Day T, 2011, AM NAT, V178, pE18, DOI 10.1086/660911; de Vries EJ, 2001, J INVERTEBR PATHOL, V77, P129, DOI 10.1006/jipa.2001.5010; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Dutkowski GW, 2006, CAN J FOREST RES, V36, P1851, DOI 10.1139/X06-059; Dutkowski GW, 2002, CAN J FOREST RES, V32, P2201, DOI 10.1139/X02-111; Falconer D. S., 1996, Introduction to quantitative genetics.; Fang W, 2006, AM J BOT, V93, P1125, DOI 10.3732/ajb.93.8.1125; Firth JA, 2015, EVOLUTION, V69, P1336, DOI 10.1111/evo.12649; Foust CM, 2016, MOL ECOL, V25, P1639, DOI 10.1111/mec.13522; Fowler JH, 2009, P NATL ACAD SCI USA, V106, P1720, DOI 10.1073/pnas.0806746106; Franz M, 2009, P R SOC B, V276, P1829, DOI 10.1098/rspb.2008.1824; Frere CH, 2010, P NATL ACAD SCI USA, V107, P19949, DOI 10.1073/pnas.1007997107; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Germain RR, 2016, J ANIM ECOL, V85, P1613, DOI 10.1111/1365-2656.12575; Gilmour AR, 2009, ASREML USER GUIDE RE, P398; GLEESON AC, 1987, BIOMETRICS, V43, P277, DOI 10.2307/2531812; Grant BR, 1996, EVOLUTION, V50, P2471, DOI 10.1111/j.1558-5646.1996.tb03633.x; Green BS, 2008, ADV MAR BIOL, V54, P1, DOI 10.1016/S0065-2881(08)00001-1; GRIFFING B, 1976, GENETICS, V82, P723; Hadfield JD, 2017, METHODS ECOL EVOL, V8, P688, DOI 10.1111/2041-210X.12802; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hirsch BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037301; Holand AM, 2016, ANIMALINLA BAYESIAN; Holekamp KE, 2012, MOL ECOL, V21, P613, DOI 10.1111/j.1365-294X.2011.05240.x; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Karin Meyer, 2007, Journal of Zhejiang University-Science B, V8, P815, DOI 10.1631/jzus.2007.B0815; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kim K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-29; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Kovalchuk I., 2013, NONGENETIC INHERITAN, V1, P51, DOI [10.2478/ngi-2013-0006, DOI 10.2478/NGI-2013-0006]; Kronholm I, 2016, MOL ECOL, V25, P1856, DOI 10.1111/mec.13296; Kruuk LEB, 2007, J EVOLUTION BIOL, V20, P1890, DOI 10.1111/j.1420-9101.2007.01377.x; Kruuk LEB, 2001, AM NAT, V158, P557, DOI 10.1086/323585; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; LANDE R, 1979, EVOLUTION, V33, P234, DOI [10.2307/2407380, 10.1111/j.1558-5646.1979.tb04678.x]; Latzel V, 2012, ANN BOT-LONDON, V110, P1423, DOI 10.1093/aob/mcs088; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Liedvogel M, 2012, J EVOLUTION BIOL, V25, P813, DOI 10.1111/j.1420-9101.2012.02480.x; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lush JL, 1937, ANIMAL BREEDING PLAN, P350; Lynch Michael, 1998; MAGNUSSEN S, 1993, THEOR APPL GENET, V86, P349, DOI 10.1007/BF00222101; McAdam AG, 2002, EVOLUTION, V56, P846; McFarlane SE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2422; Merila J, 2001, AVIAN QUANTITATIVE G, P177, DOI [10.1007/978-1-4615-1211-0, DOI 10.1007/978-1-4615-1211-0]; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Morrissey MB, 2014, EVOLUTION, V68, P1748, DOI 10.1111/evo.12385; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Mrode RA, 1996, LINEAR MODELS PREDIC; Muir WM, 2005, GENETICS, V170, P1247, DOI 10.1534/genetics.104.035956; Noble DWA, 2014, BEHAV ECOL, V25, DOI 10.1093/beheco/aru032; Odling-Smee John, 2011, Biology Theory, V6, P283, DOI 10.1007/s13752-012-0029-3; Otto SP, 1994, 0064 MORR I POP RES; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Peaston AE, 2006, MAMM GENOME, V17, P365, DOI 10.1007/s00335-005-0180-2; Pigeon G, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0222; Polanowski AM, 2014, MOL ECOL RESOUR, V14, P976, DOI 10.1111/1755-0998.12247; Pujol B, 2018, TRENDS ECOL EVOL, V33, P337, DOI 10.1016/j.tree.2018.02.007; Pujol B, 2014, CURR BIOL, V24, P744, DOI 10.1016/j.cub.2014.02.012; RCore Team, 2020, R LANG ENV STAT COMP; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Regan CE, 2017, J EVOLUTION BIOL, V30, P96, DOI 10.1111/jeb.12990; Richards CL, 2017, BIORXIV, V5905, DOI [10.1101/130708, DOI 10.1101/130708, DOI 10.1111/ELE.12858]; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Santostefano F, 2016, BEHAV ECOL, V27, P1235, DOI 10.1093/beheco/arw037; Stopher KV, 2012, EVOLUTION, V66, P2411, DOI 10.1111/j.1558-5646.2012.01620.x; Tal O, 2010, GENETICS, V184, P1037, DOI 10.1534/genetics.109.112466; Taudt A, 2016, NAT REV GENET, V17, P319, DOI 10.1038/nrg.2016.45; Teplitsky C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090444; Thompson CK, 2017, EPIDEMIOL INFECT, V145, P2062, DOI [10.1017/S0950268817000693, 10.1017/s0950268817000693]; Townley S, 2013, J EVOLUTION BIOL, V26, P1234, DOI 10.1111/jeb.12089; van de Waal E, 2013, SCIENCE, V340, P483, DOI 10.1126/science.1232769; van der Jeugd HP, 2002, J EVOLUTION BIOL, V15, P380, DOI 10.1046/j.1420-9101.2002.00411.x; Van Vleck LD, 2005, J ANIM SCI, V83, P68; Walsh J. B., 2018, EVOLUTION SELECTION; Wey TW, 2010, ANIM BEHAV, V79, P1343, DOI 10.1016/j.anbehav.2010.03.008; WILLHAM RL, 1972, J ANIM SCI, V35, P1288; WILLHAM RL, 1963, BIOMETRICS, V19, P18, DOI 10.2307/2527570; Wilson AJ, 2005, J EVOLUTION BIOL, V18, P405, DOI 10.1111/j.1420-9101.2004.00824.x; Wilson AJ, 2005, AM NAT, V166, pE177, DOI 10.1086/497441; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; Wilson AJ, 2009, P ROY SOC B-BIOL SCI, V276, P533, DOI 10.1098/rspb.2008.1193; Winney I, 2015, METHODS ECOL EVOL, V6, P584, DOI 10.1111/2041-210X.12341; Wolak ME, 2014, QUANTITATIVE GENETICS IN THE WILD, P104; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116	111	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0197720	10.1371/journal.pone.0197720	http://dx.doi.org/10.1371/journal.pone.0197720			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312317	gold, Green Submitted, Green Published			2022-12-26	WOS:000447427300001
J	Chauhan, AS; Liu, XG; Jing, J; Lee, H; Yadav, RK; Liu, JD; Zhou, YB; Gan, BY				Chauhan, Anoop Singh; Liu, Xiaoguang; Jing, Ji; Lee, Hyemin; Yadav, Raj Kumar; Liu, Jindou; Zhou, Yubin; Gan, Boyi			STIM2 interacts with AMPK and regulates calcium-induced AMPK activation	FASEB JOURNAL			English	Article						CaMKK2; energy stress; LKB1; STIM1	DEPENDENT PROTEIN-KINASE; UPSTREAM KINASE; CELL-GROWTH; CA2+; COMPLEX; BETA; PHOSPHORYLATION; ARCHITECTURE; PATHWAY; GLUCOSE	AMPK is a crucial regulator of energy homeostasis that acts downstream of its upstream kinase liver kinase B1 (LKB1) and calcium/calmodulin-dependent protein kinase 2 (CaMKK2). LKB1 primarily phosphorylates AMPK after energy stress, whereas calcium-mediated activation of AMPK requires CaMKK2, although the regulatory mechanisms of calcium-mediated AMPK activation remain unclear. Using biochemical, microscopic, and genetic approaches, we demonstrate that the stromal interaction molecule (STIM)2, a calcium sensor, acts as a novel regulator of CaMKK2-AMPK signaling. We reveal that STIM2 interacts with AMPK and CaMKK2 and that the increase in intracellular calcium levels promotes AMPK colocalization and interaction with STIM2. We further show that STIM2 deficiency attenuates calcium-induced but not energy stress-induced AMPK activation, possibly by regulating the CaMKK2-AMPK interaction. Together, our results identify a previously unappreciated mechanism that modulates calcium-mediated AMPK activation.Chauhan, A. S., Liu, X., Jing, J., Lee, H., Yadav, R. K., Liu, J., Zhou, Y., Gan B. STIM2 interacts with AMPK and regulates calcium-induced AMPK activation.	[Chauhan, Anoop Singh; Liu, Xiaoguang; Lee, Hyemin; Yadav, Raj Kumar; Gan, Boyi] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Gan, Boyi] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Gan, Boyi] Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Jing, Ji; Liu, Jindou; Zhou, Yubin] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Zhou, Yubin] Texas A&M Univ, Coll Med, Dept Med Physiol, Temple, TX 76508 USA; [Chauhan, Anoop Singh] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Liu, Jindou] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; University of Birmingham; Beijing Normal University	Gan, BY (corresponding author), Univ Texas MD Anderson Canc Ctr, Zayed Bldg,Z7-3034,6565 MD Anderson Blvd, Houston, TX 77030 USA.	bgan@mdanderson.org	Chauhan, Anoop/GYD-7325-2022; Gan, Boyi/HDM-4206-2022; Zhou, Yubin/D-4748-2011	Chauhan, Anoop/0000-0001-8722-2404; Zhou, Yubin/0000-0001-7962-0517; LIU, XIAOGUANG/0000-0001-6977-5128	Andrew Sabin Family Fellow Award; Sister Institution Network Fund; U.S. National Institutes of Health (NIH) National Cancer Institute [CA181196]; NIH National Institute of General Medical Sciences [R01GM112003]; Welch Foundation [BE-1913]; American Cancer Society [RSG-16-215-01 TBE]; NIH Cancer Center Support Grant [P30CA016672]; Anna Fuller Fund; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA181196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112003] Funding Source: NIH RePORTER	Andrew Sabin Family Fellow Award; Sister Institution Network Fund; U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); American Cancer Society(American Cancer Society); NIH Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anna Fuller Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank all members of the B.G. laboratory for their advice and technical assistance. This research was supported by the Andrew Sabin Family Fellow Award, the Sister Institution Network Fund, the Anna Fuller Fund, U.S. National Institutes of Health (NIH) National Cancer Institute Grant CA181196 (to B.G.), NIH National Institute of General Medical Sciences Grant R01GM112003, Welch Foundation Grant BE-1913, American Cancer Society Grant RSG-16-215-01 TBE (to Y.Z.), and NIH Cancer Center Support Grant P30CA016672 to The University of Texas M.D. Anderson Cancer Center. The authors declare no conflicts of interest.	Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dai FY, 2017, P NATL ACAD SCI USA, V114, P3192, DOI 10.1073/pnas.1619588114; Fogarty S, 2016, MOL CANCER RES, V14, P683, DOI 10.1158/1541-7786.MCR-15-0479; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Gudlur A, 2013, CURR TOP MEMBR, V71, P33, DOI 10.1016/B978-0-12-407870-3.00002-0; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hogan PG, 2015, BIOCHEM BIOPH RES CO, V460, P40, DOI 10.1016/j.bbrc.2015.02.110; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jing J, 2015, NAT CELL BIOL, V17, P1339, DOI 10.1038/ncb3234; Koppula P, 2017, J BIOL CHEM, V292, P14240, DOI 10.1074/jbc.M117.798405; Lin A, 2014, ONCOGENE, V33, P3183, DOI 10.1038/onc.2013.273; Lin AF, 2014, CANCER RES, V74, P1682, DOI 10.1158/0008-5472.CAN-13-1729; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XW, 2016, CELL CYCLE, V15, P1948, DOI 10.1080/15384101.2016.1184515; Liu XW, 2016, NAT CELL BIOL, V18, P431, DOI 10.1038/ncb3328; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosado JA, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00325; Ross FA, 2016, FEBS J, V283, P2987, DOI 10.1111/febs.13698; Ross FA, 2016, BIOCHEM J, V473, P189, DOI 10.1042/BJ20150910; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Wang WQ, 2015, CELL REP, V13, P524, DOI 10.1016/j.celrep.2015.09.014; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Wedel B, 2007, J PHYSIOL-LONDON, V579, P679, DOI 10.1113/jphysiol.2006.125641; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xiao ZD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00902-z; Xiao ZD, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2016.1187322; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zhang YL, 2013, CELL METAB, V18, P546, DOI 10.1016/j.cmet.2013.09.005; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	47	28	28	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2957	2970		10.1096/fj.201801225R	http://dx.doi.org/10.1096/fj.201801225R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30335546	Green Published, hybrid			2022-12-26	WOS:000457296600113
J	Jiang, Y; Yan, L; Xia, LK; Lu, XY; Zhu, WL; Ding, DW; Du, MX; Zhang, D; Wang, HM; Hu, BY				Jiang, Yuan; Yan, Long; Xia, Longkuo; Lu, Xiaoyin; Zhu, Wenliang; Ding, Dewen; Du, Mingxia; Zhang, Da; Wang, Hongmei; Hu, Baoyang			Zinc finger E-box-binding homeobox 1 (ZEB1) is required for neural differentiation of human embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; neuron; differentiation; adhesion; transplantation; ZEB1	DIRECTED DIFFERENTIATION; ICRISPR PLATFORM; IN-VITRO; NEURONS; SPECIFICATION; METASTASIS; PRECURSORS; EXPRESSION; INDUCTION	Human pluripotent stem cells hold great promise for improving regenerative medicine. However, a risk for tumor formation and difficulties in generating large amounts of subtype derivatives remain the major obstacles for clinical applications of stem cells. Here, we discovered that zinc finger E-box-binding homeobox 1 (ZEB1) is highly expressed upon differentiation of human embryonic stem cells (hESCs) into neuronal precursors. CRISPR/Cas9-mediated ZEB1 depletion did not impede neural fate commitment, but prevented hESC-derived neural precursors from differentiating into neurons, indicating that ZEB1 is required for neuronal differentiation. ZEB1 overexpression not only expedited neural differentiation and neuronal maturation, which ensured safer neural cell transplantation, but also facilitated the generation of excitatory cortical neurons, which were valuable for managing certain neurological disorders, such as Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS). Our study provides useful information on how human neural cells are generated, which may help in forming strategies for developing and improving replacement therapies for treating patients with neurological diseases.	[Jiang, Yuan; Yan, Long; Xia, Longkuo; Lu, Xiaoyin; Zhu, Wenliang; Ding, Dewen; Du, Mingxia; Zhang, Da; Wang, Hongmei; Hu, Baoyang] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Jiang, Yuan; Xia, Longkuo; Zhu, Wenliang; Ding, Dewen; Wang, Hongmei; Hu, Baoyang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, HM; Hu, BY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Wang, HM; Hu, BY (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	wanghm@ioz.ac.cn; byhu@ioz.ac.cn	jiang, anyi/GPT-0379-2022; Lu, Xiaoyin/AAO-5561-2021; Hu, Baoyang/R-8374-2016	Lu, Xiaoyin/0000-0002-9244-325X; Hu, Baoyang/0000-0003-3993-4014	Natural Science Foundation of China [31501102, 81225004, 31171430]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China Grants 31501102, 81225004, and 31171430. The authors declare that they have no conflicts of interest with the contents of this article.	Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Du ZW, 2013, DEVELOPMENT, V140, P2611, DOI 10.1242/dev.092809; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Jiang Y, 2012, PROTEIN CELL, V3, P818, DOI 10.1007/s13238-012-2086-6; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Liu HS, 2011, CELL MOL LIFE SCI, V68, P3995, DOI 10.1007/s00018-011-0770-y; Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Miyoshi T, 2006, DEV DYNAM, V235, P1941, DOI 10.1002/dvdy.20799; Nitta KR, 2004, DEV BIOL, V275, P258, DOI 10.1016/j.ydbio.2004.08.010; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Sabourin JC, 2009, STEM CELLS, V27, P2722, DOI 10.1002/stem.226; Singh S, 2016, ELIFE, V5, DOI [10.7554/elife.12717, 10.7554/eLife.12717]; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ullian EM, 2004, MOL CELL NEUROSCI, V25, P241, DOI 10.1016/j.mcn.2003.10.011; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Yen G, 2001, MOL BRAIN RES, V96, P59, DOI 10.1016/S0169-328X(01)00267-4; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhu ZR, 2014, METHOD ENZYMOL, V546, P215, DOI 10.1016/B978-0-12-801185-0.00011-8	36	13	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19317	19329		10.1074/jbc.RA118.005498	http://dx.doi.org/10.1074/jbc.RA118.005498			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30337365	hybrid, Green Published			2022-12-26	WOS:000453537300014
J	Vlach, J; Eastep, GN; Ghanam, RH; Watanabe, SM; Carter, CA; Saad, JS				Vlach, Jiri; Eastep, Gunnar N.; Ghanam, Ruba H.; Watanabe, Susan M.; Carter, Carol A.; Saad, Jamil S.			Structural basis for targeting avian sarcoma virus Gag polyprotein to the plasma membrane for virus assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 MATRIX PROTEIN; TYPE-1 GAG; MOLECULAR DETERMINANTS; NMR STRUCTURE; M-DOMAIN; BINDING; PHOSPHATIDYLINOSITOL-(4,5)-BISPHOSPHATE; RNA; ELECTROSTATICS; ASSOCIATION	For most retroviruses, including HIV-1, binding of the Gag polyprotein to the plasma membrane (PM) is mediated by interactions between Gag's N-terminal myristoylated matrix (MA) domain and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) in the PM. The Gag protein of avian sarcoma virus (ASV) lacks the N-myristoylation signal but contains structural domains having functions similar to those of HIV-1 Gag. The molecular mechanism by which ASV Gag binds to the PM is incompletely understood. Here, we employed NMR techniques to elucidate the molecular determinants of the membrane-binding domain of ASV MA (MA(87)) to lipids and liposomes. We report that MA(87) binds to the polar head of phosphoinositides such as PI(4,5)P-2. We found that MA(87) binding to inositol phosphates (IPs) is significantly enhanced by increasing the number of phosphate groups, indicating that the MA(87)-IP binding is governed by charge-charge interactions. Using a sensitive NMR-based liposome-binding assay, we show that binding of MA(87) to liposomes is enhanced by incorporation of PI(4,5)P-2 and phosphatidylserine. We also show that membrane binding is mediated by a basic surface formed by Lys-6, Lys-13, Lys-23, and Lys-24. Substitution of these residues to glutamate abolished binding of MA(87) to both IPs and liposomes. In an accompanying paper, we further report that mutation of these lysine residues diminishes Gag assembly on the PM and inhibits ASV particle release. These findings provide a molecular basis for ASV Gag binding to the inner leaflet of the PM and advance our understanding of the basic mechanisms of retroviral assembly.	[Vlach, Jiri; Eastep, Gunnar N.; Ghanam, Ruba H.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Watanabe, Susan M.; Carter, Carol A.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Saad, JS (corresponding author), 845 19th St South, Birmingham, AL 35294 USA.	saad@uab.edu		Saad, Jamil/0000-0001-9503-6484; Eastep, Gunnar/0000-0003-3567-8500; Vlach, Jiri/0000-0002-0874-2055	National Institutes of Health [5R01 GM117837]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117837, R01GM111028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 5R01 GM117837 (to J. S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfadhli A, 2011, J MOL BIOL, V410, P653, DOI 10.1016/j.jmb.2011.04.063; Alfadhli A, 2009, J VIROL, V83, P12196, DOI 10.1128/JVI.01197-09; Anraku K, 2010, BIOCHEMISTRY-US, V49, P5109, DOI 10.1021/bi9019274; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bouamr F, 2003, BIOCHEMISTRY-US, V42, P6408, DOI 10.1021/bi020692z; Brown LA, 2015, VIRUSES-BASEL, V7, P2210, DOI 10.3390/v7052210; Callahan EM, 2000, J VIROL, V74, P11222, DOI 10.1128/JVI.74.23.11222-11229.2000; Ceccon A, 2013, PROTEINS, V81, P1776, DOI 10.1002/prot.24329; Chan J, 2011, J VIROL, V85, P10851, DOI 10.1128/JVI.00760-11; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2013, J VIROL, V87, P7155, DOI 10.1128/JVI.00075-13; Chukkapalli V, 2011, J MOL BIOL, V410, P512, DOI 10.1016/j.jmb.2011.04.015; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Dalton AK, 2005, J VIROL, V79, P6227, DOI 10.1128/JVI.79.10.6227-6238.2005; Dalton AK, 2007, J VIROL, V81, P6434, DOI 10.1128/JVI.02757-06; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dick RA, 2016, J VIROL, V90, P2473, DOI 10.1128/JVI.02733-15; Dick RA, 2015, J VIROL, V89, P10371, DOI 10.1128/JVI.01628-15; Doktorova M, 2017, BIOPHYS J, V113, P2004, DOI 10.1016/j.bpj.2017.08.055; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Ehrlich LS, 2011, J MOL BIOL, V410, P716, DOI 10.1016/j.jmb.2011.04.069; Ehrlich LS, 1996, BIOCHEMISTRY-US, V35, P3933, DOI 10.1021/bi952337x; ERDIE CR, 1990, J VIROL, V64, P5204, DOI 10.1128/JVI.64.10.5204-5208.1990; Fernandes F, 2011, TRAFFIC, V12, P438, DOI 10.1111/j.1600-0854.2010.01153.x; Figueira Thais Rezende e Silva, 2012, BMC Res Notes, V5, P185, DOI 10.1186/1756-0500-5-185; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ghanam RH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00055; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Guerry P, 2012, METHODS MOL BIOL, V831, P429, DOI 10.1007/978-1-61779-480-3_22; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hamard-Peron E, 2010, J VIROL, V84, P503, DOI 10.1128/JVI.01134-09; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hearps AC, 2008, BIOCHEMISTRY-US, V47, P2199, DOI 10.1021/bi701360j; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inlora J, 2014, MBIO, V5, DOI 10.1128/mBio.02202-14; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Keller R., 2004, COMPUTER AIDED RESON, V1; KINGSLEY PB, 1979, CHEM PHYS LIPIDS, V24, P135, DOI 10.1016/0009-3084(79)90083-5; Kolay S, 2016, BIOCHEM J, V473, P1681, DOI 10.1042/BCJ20160069; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; LADNER HK, 1975, J MAGN RESON, V20, P530, DOI 10.1016/0022-2364(75)90010-4; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; McDonnell JM, 1998, J MOL BIOL, V279, P921, DOI 10.1006/jmbi.1998.1788; Mercredi PY, 2016, J MOL BIOL, V428, P1637, DOI 10.1016/j.jmb.2016.03.005; Murray PS, 2005, STRUCTURE, V13, P1521, DOI 10.1016/j.str.2005.07.010; Nadaraia-Hoke S, 2013, J VIROL, V87, P3609, DOI 10.1128/JVI.03059-12; Nelle TD, 1996, J VIROL, V70, P2269, DOI 10.1128/JVI.70.4.2269-2276.1996; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Prchal J, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00423; Prchal J, 2012, J MOL BIOL, V423, P427, DOI 10.1016/j.jmb.2012.07.021; Provitera P, 2000, J MOL BIOL, V296, P887, DOI 10.1006/jmbi.1999.3482; Purohit P, 2001, RNA, V7, P576, DOI 10.1017/S1355838201002023; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Scarlata S, 1998, J MOL BIOL, V277, P161, DOI 10.1006/jmbi.1997.1615; Stansell E, 2007, J VIROL, V81, P8977, DOI 10.1128/JVI.00657-07; Vlach J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00232; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Watanabe SM, 2018, J BIOL CHEM, V293, P18841, DOI 10.1074/jbc.RA118.003947; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Wen Y, 2016, J VIROL, V90, P9518, DOI 10.1128/JVI.01102-16; Zhang ZL, 2016, J VIROL, V90, P1824, DOI 10.1128/JVI.02814-15; Zhou WJ, 1996, J VIROL, V70, P8540, DOI 10.1128/JVI.70.12.8540-8548.1996	79	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18828	18840		10.1074/jbc.RA118.003944	http://dx.doi.org/10.1074/jbc.RA118.003944			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30309983	Green Published, hybrid			2022-12-26	WOS:000458467400002
J	Zeng, F; Yang, CP; Gao, XY; Li, X; Zhang, Z; Gong, R				Zeng, Fang; Yang, Chunpeng; Gao, Xinyu; Li, Xuan; Zhang, Zhe; Gong, Rui			Comprehensive elucidation of the structural and functional roles of engineered disulfide bonds in antibody Fc fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNOGLOBULIN G; HUMAN IGG1; COLLOIDAL STABILITIES; CONSTANT DOMAINS; AGGREGATION; RECEPTOR; BINDING; DESIGN	Therapeutic monoclonal antibodies and Fc-fusion proteins containing antibody Fc fragment may tend to destabilize (e.g. unfold and aggregate), which leads to loss of functions and increase of adverse risks. Although engineering of an additional disulfide bond has been performed in Fc or Fc domains for optimization, the relationships between introduced disulfide bond and alteration of the stability, aggregation propensity and function were still unclear and should be addressed for achievement of better therapeutic outcome. Here, we constructed three human IgG1 Fc mutants including Fc(CH2-s-s-) (one engineered disulfide bond in CH2 domain), Fc(CH3-s-s-) (one engineered disulfide bond in CH3 domain), and Fc(CH3-s-s-)(CH2-s-s-) (two engineered disulfide bonds in CH2 and CH3 domains, respectively) for evaluation. As expected, each mutated domain shows obviously increased stability during thermo-induced unfolding, and Fc(CH3-s-s-)(CH2-s-s-) is most thermo-stable among wildtype Fc (wtFc) and three mutants. The order of overall stability against denaturant is Fc(CH3-s-s-)(CH2-s-s-) > Fc(CH2-s-s-) > Fc(CH3-s-s-) > wtFc. Then the aggregation propensity was compared among these four proteins. Under conditions of incubation at 60 degrees C, their aggregation resistance is in the order of Fc(CH3-s-s-)(CH2-s-s-) > Fc(CH2-s-s-) > Fc(CH3-s-s-) approximate to wtFc. In contrast, the order is Fc(CH3-s-s-)(CH2-s-s-) > Fc(CH3-s-s-) > Fc(CH2-s-s-) approximate to wtFc under acidic conditions. In addition, the Fc-mediated functions are not obviously affected by engineered disulfide bond. Our results give a comprehensive elucidation of structural and functional effects caused by additional disulfide bonds in the Fc fragment, which is important for Fc engineering toward the desired clinical performance.	[Zeng, Fang; Yang, Chunpeng; Gao, Xinyu; Li, Xuan; Zhang, Zhe; Gong, Rui] Chinese Acad Sci, Key Lab Special Pathogens & Biosafety, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China; [Zeng, Fang; Yang, Chunpeng; Gao, Xinyu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gong, R (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Ctr Emerging Infect Dis, 44 Xiao Hong Shan, Wuhan 430071, Hubei, Peoples R China.	gongr@wh.iov.cn			Key Program of Chinese Academy of Sciences Grant [ZDRW-ZS-2016-4]; National Key Research and Development Program of China [2016YFC1202902]; National Natural Science Foundation of China Young Scientists Program Grant [81302690]; Novo Nordisk-Chinese Academy of Sciences Research Fund [NNCAS-2014-10]	Key Program of Chinese Academy of Sciences Grant; National Key Research and Development Program of China; National Natural Science Foundation of China Young Scientists Program Grant; Novo Nordisk-Chinese Academy of Sciences Research Fund	This work was supported by Key Program of Chinese Academy of Sciences Grant ZDRW-ZS-2016-4, National Key Research and Development Program of China Grant 2016YFC1202902, National Natural Science Foundation of China Young Scientists Program Grant 81302690, and Novo Nordisk-Chinese Academy of Sciences Research Fund Grant NNCAS-2014-10. The authors declare that they have no conflicts of interest with the contents of this article.	Chen W, 2016, ACS CHEM BIOL, V11, P1852, DOI 10.1021/acschembio.5b01035; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Demarest SJ, 2004, J MOL BIOL, V335, P41, DOI 10.1016/j.jmb.2003.10.040; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; Gong R, 2013, MOL PHARMACEUT, V10, P2642, DOI 10.1021/mp400075f; Gong R, 2011, J BIOL CHEM, V286, P27288, DOI 10.1074/jbc.M111.254219; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; Jacobsen FW, 2017, J BIOL CHEM, V292, P1865, DOI 10.1074/jbc.M116.748525; Latypov RF, 2012, J BIOL CHEM, V287, P1381, DOI 10.1074/jbc.M111.297697; MaAuley A, 2008, PROTEIN SCI, V17, P95, DOI 10.1110/ps.073134408; Majumdar R, 2015, MABS-AUSTIN, V7, P84, DOI 10.4161/19420862.2014.985494; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sakurai K, 2015, BBA-PROTEINS PROTEOM, V1854, P1526, DOI 10.1016/j.bbapap.2015.02.020; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Thies MJW, 2002, J MOL BIOL, V319, P1267, DOI 10.1016/S0022-2836(02)00375-3; Wozniak-Knopp G, 2012, ARCH BIOCHEM BIOPHYS, V526, P181, DOI 10.1016/j.abb.2012.03.024; Wozniak-Knopp G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030083; Yageta S, 2017, MOL PHARMACEUT, V14, P699, DOI 10.1021/acs.molpharmaceut.6b00983; Yageta S, 2015, MOL PHARMACEUT, V12, P1443, DOI 10.1021/mp500759p; Yang CP, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01860; Ying TL, 2014, MABS-AUSTIN, V6, P1201, DOI 10.4161/mabs.29835; Ying TL, 2013, J BIOL CHEM, V288, P25154, DOI 10.1074/jbc.M113.484154	25	8	8	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19127	19135		10.1074/jbc.RA118.005367	http://dx.doi.org/10.1074/jbc.RA118.005367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30327432	hybrid, Green Published			2022-12-26	WOS:000458467400024
J	Bitew, MA; Khoo, CA; Neha, N; De Souza, DP; Tull, D; Wawegama, NK; Newton, HJ; Sansom, FM				Bitew, Mebratu A.; Khoo, Chen Ai; Neha, Nitika; De Souza, David P.; Tull, Dedreia; Wawegama, Nadeeka K.; Newton, Hayley J.; Sansom, Fiona M.			De novo NAD synthesis is required for intracellular replication of Coxiella burnetii, the causative agent of the neglected zoonotic disease Q fever	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ASPARTATE OXIDASE; QUINOLINATE; BIOSYNTHESIS; METABOLISM	Coxiella burnetii is an intracellular Gram-negative bacterium responsible for the important zoonotic disease Q fever. Improved genetic tools and the ability to grow this bacterium in host cell-free media has advanced the study of C. burnetii pathogenesis, but the mechanisms that allow it to survive inside the hostile phagolysosome remain incompletely understood. Previous screening of a transposon mutant library for replication within HeLa cells has suggested that nadB, encoding a putative L-aspartate oxidase required for de novo NAD synthesis, is needed for intracellular replication. Here, using genetic complementation of two independent nadB mutants and intracellular replication assays, we confirmed this finding. Untargeted metabolite analyses demonstrated key changes in metabolites in the NAD biosynthetic pathway in the nadB mutant compared with the WT, confirming the involvement of NadB in de novo NAD synthesis. Bioinformatic analysis revealed the presence of a functionally conserved arginine residue at position 275. Using site-directed mutagenesis to substitute this residue with leucine, which abolishes the activity of Escherichia coli NadB, and expression of WT and R275L GST-NadB fusion proteins in E. coli JM109, we found that purified recombinant WT GST-NadB has L-aspartate oxidase activity and that the R275L NadB variant is inactive. Complementation of the C. burnetii nadB mutant with a plasmid expressing this inactive R275L NadB failed to restore replication to WT levels, confirming the link between de novo NAD synthesis and intracellular replication of C. burnetii. This suggests that targeting this prokaryotic-specific pathway could advance the development of therapeutics to combat C. burnetii infections.	[Bitew, Mebratu A.; Neha, Nitika; Wawegama, Nadeeka K.; Sansom, Fiona M.] Univ Melbourne, Asia Pacific Ctr Anim Hlth, Melbourne Vet Sch, Parkville, Vic 3010, Australia; [Neha, Nitika; De Souza, David P.; Tull, Dedreia] Univ Melbourne, Metabol Australia, Bio21 Inst Mol Sci & Biotechnol, Parkville, Vic 3010, Australia; [Khoo, Chen Ai; Newton, Hayley J.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3000, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Sansom, FM (corresponding author), Univ Melbourne, Melbourne Vet Sch, Parkville, Vic 3010, Australia.	fsansom@unimelb.edu.au	De Souza, David P/O-9800-2016; Sansom, Fiona M/W-8445-2019; Wawegama, Nadeeka K/C-7253-2019	De Souza, David P/0000-0002-7225-2632; Wawegama, Nadeeka K/0000-0003-4426-5011; Tull, Dedreia/0000-0003-2546-6707; Sansom, Fiona/0000-0002-9433-2545; Bitew, Mebratu Asaye/0000-0003-3684-9316; Newton, Hayley/0000-0002-9240-2001	Australian National Health and Medical Research Council [APP1063646, APP1120344]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Australian National Health and Medical Research Council Grants APP1063646 and APP1120344 (to H. J. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; Beare PA, 2012, ADV EXP MED BIOL, V984, P249, DOI 10.1007/978-94-007-4315-1_13; Beare PA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00097; Beron W, 2002, INFECT IMMUN, V70, P5816, DOI 10.1128/IAI.70.10.5816-5821.2002; Best SA, 2018, CELL METAB, V27, P935, DOI 10.1016/j.cmet.2018.02.006; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Brickman TJ, 2017, MOL MICROBIOL, V103, P423, DOI 10.1111/mmi.13566; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; Coleman SA, 2007, INFECT IMMUN, V75, P290, DOI 10.1128/IAI.00883-06; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Howe D, 2000, INFECT IMMUN, V68, P3815, DOI 10.1128/IAI.68.7.3815-3821.2000; Howe D, 2003, ANN NY ACAD SCI, V990, P556, DOI 10.1111/j.1749-6632.2003.tb07426.x; Jaton K, 2013, New Microbes New Infect, V1, P6, DOI 10.1002/2052-2975.8; Kazar J, 2005, ANN NY ACAD SCI, V1063, P105, DOI 10.1196/annals.1355.018; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Marinoni I, 2008, FEBS J, V275, P5090, DOI 10.1111/j.1742-4658.2008.06641.x; Masukagami Y, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00055-17; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mesquita I, 2016, CELL MOL LIFE SCI, V73, P1225, DOI 10.1007/s00018-015-2119-4; Moffatt JH, 2015, CELL MICROBIOL, V17, P621, DOI 10.1111/cmi.12432; Newton HJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004286; Omsland A, 2011, ANNU REV MICROBIOL, V65, P111, DOI 10.1146/annurev-micro-090110-102927; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Osterman A, 2009, ECOSAL PLUS, V3; Prunier AL, 2007, MICROBIOL-SGM, V153, P2363, DOI 10.1099/mic.0.2007/006916-0; Rodionova IA, 2014, MBIO, V5, DOI 10.1128/mBio.00747-13; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sorci L, 2009, CHEM BIOL, V16, P849, DOI 10.1016/j.chembiol.2009.07.006; Tedeschi G, 2001, BIOCHEMISTRY-US, V40, P4738, DOI 10.1021/bi002406u; van Asseldonk MAPM, 2013, PREV VET MED, V112, P27, DOI 10.1016/j.prevetmed.2013.06.002; Yang ZR, 2003, J BIOL CHEM, V278, P8804, DOI 10.1074/jbc.M211892200	33	8	8	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18636	18645		10.1074/jbc.RA118.005190	http://dx.doi.org/10.1074/jbc.RA118.005190			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30315113	hybrid, Green Published			2022-12-26	WOS:000458467300018
J	Baumeister, P; Canis, M; Reiter, M				Baumeister, Philipp; Canis, Martin; Reiter, Maximilian			Preoperative anemia and perioperative blood transfusion in head and neck squamous cell carcinoma	PLOS ONE			English	Article							CANCER-PATIENTS; PRIMARY SURGERY; IMPACT; PROGNOSIS; SURVIVAL; STORAGE; RECURRENCE	Objectives To evaluate the impact of preoperative anemia and perioperative blood transfusion (PBT) on disease free (DFS) and overall survival (OS) of patients with head and neck squamous cell carcinoma (HNSCC). Methods Retrospective study of 354 patients primarily treated with surgery between 2006 and 2016. Cases were selected according to completeness and accuracy of available clinical data. Thus, a selection bias cannot be excluded. Patients who received PBT were identified by our controlling department and verified by our blood bank data base. Results Both, preoperative anemia and PBT significantly decreased OS in univariate analysis. Although PBT was needed more frequently by older patients in worse physical conditions with more advanced HNSCC, subgroup analysis also demonstrate a profoundly negative effect of PBT on OS in younger patients and early stage HNSCC. According to a restrictive transfusion policy at our hospital the transfusion rate was comparably low. We could not verify increasing effects of PBT on cancer recurrence rates as it was previously shown. Discussion Preoperative anemia is the most common paraneoplastic syndrome in HNSCC. Despite its devastating prognostic effect we suggest a restrictive transfusion policy whenever possible. Our data also show that anemia as an independent prognostic factor in head and neck surgical oncology is defined not only by low hemoglobin concentrations but low red blood cell counts as well.	[Baumeister, Philipp; Canis, Martin; Reiter, Maximilian] Ludwig Maximilians Univ Munchen, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany; [Baumeister, Philipp] Helmholtz Ctr, Clin Cooperat Grp Personalized Radiotherapy Head, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Baumeister, P (corresponding author), Ludwig Maximilians Univ Munchen, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany.; Baumeister, P (corresponding author), Helmholtz Ctr, Clin Cooperat Grp Personalized Radiotherapy Head, Munich, Germany.	Philipp.Baumeister@med.uni-muenchen.de						Alshadwi A, 2013, J ORAL MAXIL SURG, V71, P1853, DOI 10.1016/j.joms.2013.04.028; Bal SH, 2017, BLOOD TRANSFUS, P1, DOI [10.2450/2016.0058-16, DOI 10.2450/2016.0058-16]; Baumeister P, 2017, HEAD NECK-J SCI SPEC, V39, P7, DOI 10.1002/hed.24528; Bennett S, 2017, HPB, V19, P321, DOI 10.1016/j.hpb.2016.12.008; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; Carson JL, 2016, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD002042; Cata JP, 2013, BRIT J ANAESTH, V110, P690, DOI 10.1093/bja/aet068; Cata JP, 2016, J BLOOD TRANSFUS, V2016, DOI [10.1155/2016/9876394, DOI 10.1155/2016/9876394]; Chau JKM, 2010, J OTOLARYNGOL-HEAD N, V39, P516, DOI 10.2310/7070.2010.090256; Danan D, 2015, LARYNGOSCOPE, V125, P86, DOI 10.1002/lary.24847; Dicato M, 2010, ANN ONCOL S7, V21; Fenner M, 2009, CANCER, V115, P1481, DOI 10.1002/cncr.24132; Franchini M, 2017, BLOOD TRANSFUS-ITALY, V15, P307, DOI 10.2450/2017.0059-17; Goubran HA, 2016, CANCER GROWTH METAST, V9, DOI 10.4137/CGM.S32797; Jacobi KE, 2000, J CLIN ANESTH, V12, P94, DOI 10.1016/S0952-8180(00)00122-7; Jager-Wittenaar H, 2017, NUTRITION, V35, P114, DOI 10.1016/j.nut.2016.11.008; Lechner M, 2016, ADV GENET, V93, P1, DOI 10.1016/bs.adgen.2015.12.001; Leifert JA, 2008, INT J LAB HEMATOL, V30, P177, DOI 10.1111/j.1751-553X.2008.01067.x; Luan H, 2014, BMC SURG, P14, DOI [10.1186/1471-2482-14-14, DOI 10.1186/1471-2482-14-14]; Lutterbach J, 2000, INT J RADIAT ONCOL, V48, P1345, DOI 10.1016/S0360-3016(00)01382-1; Lydiatt WM, 2017, CA-CANCER J CLIN, V67, P122, DOI 10.3322/caac.21389; Mavros MN, 2015, ANN SURG ONCOL, V22, P4382, DOI 10.1245/s10434-015-4823-6; Nebe T, 2011, LABORATORIUMSMEDIZIN, V35, P3, DOI 10.1515/JLM.2011.004; OPELZ G, 1978, NEW ENGL J MED, V299, P799, DOI 10.1056/NEJM197810122991503; Reichel O, 2003, EUR ARCH OTO-RHINO-L, V260, P248, DOI 10.1007/s00405-002-0513-7; Shanwell A, 1997, TRANSFUSION, V37, P678, DOI 10.1046/j.1537-2995.1997.37797369441.x; SILLIMAN CC, 1994, J LAB CLIN MED, V124, P684; Spivak JL, 2005, NAT REV CANCER, V5, P543, DOI 10.1038/nrc1648; Sun C, 2015, INT J SURG, V13, P102, DOI 10.1016/j.ijsu.2014.11.044; Sut C, 2017, BLOOD TRANSFUS-ITALY, V15, P145, DOI 10.2450/2017.0343-16; Szakmany T, 2006, BRIT J CANCER, V94, P647, DOI 10.1038/sj.bjc.6603013; Taniguchi Y, 2003, HEAD NECK-J SCI SPEC, V25, P931, DOI 10.1002/hed.10313; Upile T, 2008, MED HYPOTHESES, V71, P489, DOI 10.1016/j.mehy.2008.04.027; van de Pol SMG, 2006, ORAL ONCOL, V42, P131, DOI 10.1016/j.oraloncology.2005.06.021; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang Q, 2016, EUR J GASTROEN HEPAT, V28, P1233, DOI 10.1097/MEG.0000000000000706; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260	37	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205712	10.1371/journal.pone.0205712	http://dx.doi.org/10.1371/journal.pone.0205712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30347001	Green Published, Green Submitted, gold			2022-12-26	WOS:000447938400015
J	de Bree, K; de Bakker, BS; Oostra, RJ				de Bree, Karel; de Bakker, Bernadette S.; Oostra, Roelof-Jan			The development of the human notochord	PLOS ONE			English	Article							HUMAN EMBRYOS; MOUSE EMBRYOS; ENDODERM; CLOSURE; CHORDOMA	The notochord is a major regulator of embryonic patterning in vertebrates and abnormal notochordal development is associated with a variety of birth defects in man. Proper knowledge of the development of the human notochord, therefore, is important to understand the pathogenesis of these birth defects. Textbook descriptions vary significantly and seem to be derived from both human and animal data whereas the lack of references hampers verification of the presented data. Therefore, a verifiable and comprehensive description of the development of the human notochord is needed. Our analysis and three-dimensional (3D) reconstructions of 27 sectioned human embryos ranging from Carnegie Stage 8 to 15 (17-41 days of development), resulted in a comprehensive and verifiable new model of notochordal development. Subsequent to gastrulation, a transient group of cells briefly persists as the notochordal process which is incorporated into the endodermal roof of the gut while its dorsal side attaches to the developing neural tube. Then, the notochordal process embeds entirely into the endoderm, forming the epithelial notochordal plate, which remains intimately associated with the neural tube. Subsequently, the notochordal cells detach from the endoderm to form the definitive notochord, allowing the paired dorsal aortae to fuse between the notochord and the gut. We show that the formation of the notochordal process and plate proceeds in cranio-caudal direction. Moreover, in contrast to descriptions in the modern textbooks, we report that the formation of the definitive notochord in humans starts in the middle of the embryo, and proceeds in both cranial and caudal directions.	[de Bree, Karel; de Bakker, Bernadette S.; Oostra, Roelof-Jan] Univ Amsterdam, Amsterdam UMC, Dept Med Biol, Sect Clin Anat & Embryol, Amsterdam, Netherlands	University of Amsterdam	de Bakker, BS (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Med Biol, Sect Clin Anat & Embryol, Amsterdam, Netherlands.	b.s.debakker@amc.uva.nl	Bree, Karel/ABB-6971-2020	Bree, Karel/0000-0002-1576-9061; Oostra, Roelof-Jan/0000-0002-2452-8307; de Bakker, Bernadette/0000-0003-0758-4064	Academic Medical Center in Amsterdam	Academic Medical Center in Amsterdam	This study was supported by a grant from the board of directors of the Academic Medical Center in Amsterdam (BSdB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABIC M S, 1991, International Journal of Developmental Biology, V35, P345; BABIC MS, 1990, CELL DIFFER DEV, V32, P125; Blechschmidt Erich, 2004, ONTOGENETIC BASIS HU; Carlson B. M, 2014, HUMAN EMBRYOLOGY DEV, V5th; Cleaver O, 2001, DEV BIOL, V234, P1, DOI 10.1006/dbio.2001.0214; Cochard LR., 2012, NETTERS ATLAS HUMAN, P27; de Bakker BS, 2017, CLIN ANAT, V30, P988, DOI 10.1002/ca.22977; de Bakker BS, 2016, SCIENCE, V354, DOI 10.1126/science.aag0053; de Bakker BS, 2017, HEUSER EMBRYO UNPUB; Farkas DR, 2009, DEV DYNAM, V238, P3237, DOI 10.1002/dvdy.22141; Gasser RF, 2014, VIRTUAL HUMAN EMBRYO; Hajduk P, 2012, BIRTH DEFECTS RES B, V95, P175, DOI 10.1002/bdrb.21002; Hamilton W., 1945, HUMAN EMBRYOLOGY PRE; Horwitz T, 1941, ARCH PATHOL, V31, P354; JURAND A, 1974, J EMBRYOL EXP MORPH, V32, P1; JURAND A, 1962, J EMBRYOL EXP MORPH, V10, P602; LAMERS WH, 1987, ANAT EMBRYOL, V176, P259, DOI 10.1007/BF00310060; Lee JD, 2008, DEV DYNAM, V237, P3464, DOI 10.1002/dvdy.21598; Lockett E, 2001, HISTOLOGY FILE CARNE; Mekonen HK, 2017, J ANAT, V231, P260, DOI 10.1111/joa.12638; Moore K., 2020, DEV HUMAN CLIN ORIEN, V11th ed., P263; Morgan LM, 2009, ICONS LIFE CULTURAL; Muller F, 2003, CELLS TISSUES ORGANS, V173, P1, DOI 10.1159/000068214; MULLER F, 1987, ANAT EMBRYOL, V176, P413, DOI 10.1007/BF00310083; MULLER F, 1991, AM J ANAT, V190, P193, DOI 10.1002/aja.1001900302; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Postma AV, 2014, J MED GENET, V51, P90, DOI 10.1136/jmedgenet-2013-102001; Risbud MV, 2011, CRIT REV EUKAR GENE, V21, P29, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.30; Sadler T.W., 2005, LANGMANS ESSENTIAL M; Sadler TW., 2015, LANGMANS MED EMBRYOL; SALISBURY JR, 1993, J PATHOL, V171, P253, DOI 10.1002/path.1711710404; Sato Y, 2013, DEV GROWTH DIFFER, V55, P113, DOI 10.1111/dgd.12010; Schneider H, 2000, J MED GENET; Schoenwolf GC, 2015, LARSENS HUMAN EMBRYO; Streeter G, 1942, CONTRIB EMBRYOL CARN, V30, P211; Streeter G. L, 1948, PUBL CONTRIB EMBRYOL, V32, P133; Streeter George L., 1945, CARNEGIE INST WASHINGTON CONTR EMBRYOL, V31, P27; STREETER GL, 1951, CONTRIB EMBRYOL, V34, P167; Tuchmann-Duplessis H, 1982, ILLUSTRATED HUMAN EM, V1; Yakldoui Y, 2014, BBA-REV CANCER, V1846, P655, DOI 10.1016/j.bbcan.2014.07.012; Yamanaka Y, 2007, DEV CELL, V13, P884, DOI 10.1016/j.devcel.2007.10.016	41	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205752	10.1371/journal.pone.0205752	http://dx.doi.org/10.1371/journal.pone.0205752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346967	Green Published, gold, Green Submitted			2022-12-26	WOS:000447938400016
J	da Silva, RF; Trape, AA; Reia, TA; Lacchini, R; Oliveira-Paula, GH; Pinheiro, LC; Tanus-Santos, JE; Jacomini, AM; Bueno, CR; Zago, AS				da Silva, Roberta Fernanda; Trape, Atila Alexandre; Reia, Thais Amanda; Lacchini, Riccardo; Oliveira-Paula, Gustavo Henrique; Pinheiro, Lucas Cezar; Tanus-Santos, Jose Eduardo; Jacomini, Andre Mourao; Bueno Junior, Carlos Roberto; Zago, Anderson Saranz			Association of endothelial nitric oxide synthase (eNOS) gene polymorphisms and physical fitness levels with plasma nitrite concentrations and arterial blood pressure values in older adults	PLOS ONE			English	Article							RISK-FACTORS; HYPERTENSION; DISEASE; POPULATION; HAPLOTYPES	Endothelial nitric oxide synthase (eNOS) gene polymorphisms are associated with reduced eNOS activity and nitric oxide (NO) production leading to an increase in blood pressure (BP). Regular exercise is the main strategy to minimize the deleterious effects of polymorphisms. However, due to the differences that physical exercise can be performed, some controversial results are found. Therefore it seems reasonable to evaluate the training status (TS). Thus, this study aimed to investigate the association of eNOS gene haplotypes and different levels of TS on nitrite concentrations (NO2-) and BP values in older adult. 424 elderly performed the following assessments: General Functional Fitness Index (GFFI) to estimate TS, systolic and diastolic blood pressure (SBP and DBP), blood collection for analysis of NO2- and g.-786T>C, intron 4b/a (VNTR) and 894G>T polymorphisms. Multivariate logistic regression showed that NO2- was influenced by GFFI and 4b/4a Intron 4. Regarding BP, GFFI influenced SBP and DBP, and just intron 4 was associated with variations in DBP. It can be observed that GFFI affected the NO2-, SBP and DBP independently of haplotypes. Therefore, maintenance of good level of TS can overcome the negative influence of genetics factors (intron 4) by increasing NO2- concentration and decreasing BP values.	[da Silva, Roberta Fernanda; Reia, Thais Amanda; Jacomini, Andre Mourao; Zago, Anderson Saranz] Sao Paulo State Univ UNESP, Dept Phys Educ, Sch Sci, Bauru, SP, Brazil; [Trape, Atila Alexandre; Lacchini, Riccardo; Bueno Junior, Carlos Roberto] Univ Sao Paulo, Ribeirao Preto Coll Nursing, Ribeirao Preto, SP, Brazil; [Oliveira-Paula, Gustavo Henrique; Pinheiro, Lucas Cezar; Tanus-Santos, Jose Eduardo] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo	Zago, AS (corresponding author), Sao Paulo State Univ UNESP, Dept Phys Educ, Sch Sci, Bauru, SP, Brazil.	aszago@fc.unesp.br	Zago, Anderson Saranz/G-4551-2013; Trapé, Atila Alexandre/X-5252-2019; Oliveira-Paula, Gustavo H./J-4895-2014; Lacchini, Riccardo/F-8745-2012	Zago, Anderson Saranz/0000-0002-0081-0797; Trapé, Atila Alexandre/0000-0001-6487-8160; Oliveira-Paula, Gustavo H./0000-0002-8248-9713; Lacchini, Riccardo/0000-0002-3738-2036; Silva, Roberta Fernanda da/0000-0002-8177-9356	Sao Paulo Research Foundation (FAPESP) [2015/24847-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Sao Paulo Research Foundation (FAPESP): Grant nos. 2015/24847-8 to ASZ.	Abdel-Aziz TA, 2013, MOL BIOL REP, V40, P3065, DOI 10.1007/s11033-012-2380-7; Aidar FJ, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-89; American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Benedetti Tânia R. Bertoldo, 2007, Rev Bras Med Esporte, V13, P11, DOI 10.1590/S1517-86922007000100004; da Silva RF, 2014, AGING CLIN EXP RES, V26, P591, DOI 10.1007/s40520-014-0218-y; De Freitas RS, 2007, J MED PHILOS, V32, P25, DOI 10.1080/03605310601162940; de Marco KC, 2012, SCI TOTAL ENVIRON, V414, P708, DOI 10.1016/j.scitotenv.2011.11.010; De Moraes WM, 2011, REV BRAS FISIOTER, V15; DOMINICZAK AF, 1995, HYPERTENSION, V25, P1202, DOI 10.1161/01.HYP.25.6.1202; Goncalves Lino M, 2002, Rev Port Cardiol, V21, P39; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM; Marroni AS, 2005, NITRIC OXIDE-BIOL CH, V12, P177, DOI 10.1016/j.niox.2005.02.002; Mazo Giovana Zarpellon, 2010, Rev. bras. cineantropom. desempenho hum., V12, P316, DOI 10.5007/1980-0037.2010V12N5P316; Metzger IF, 2007, FREE RADICAL BIO MED, V43, P987, DOI 10.1016/j.freeradbiomed.2007.06.012; Moreira LFP, 2010, ARQ BRAS CARDIOL, V95, P1, DOI 10.1590/S0066-782X2010001100001; Nagassaki S, 2005, THROMB RES, V115, P375, DOI 10.1016/j.thromres.2004.09.003; Nejatizadeh A, 2008, FREE RADICAL BIO MED, V44, P1912, DOI 10.1016/j.freeradbiomed.2008.02.004; Ong KL, 2008, HYPERTENSION, V51, P1142, DOI 10.1161/HYPERTENSIONAHA.107.105205; Osness WH., 1989, JOPERD, V60, P64; Pollock ML, 1990, EXERCISE HLTH DIS EV; Riis L, 2007, INFLAMM BOWEL DIS, V13, P24, DOI 10.1002/ibd.20047; Sandrini VC, 2008, PHARMACOGENOMICS, V9, P1467, DOI 10.2217/14622416.9.10.1467; Silva A. C. M., 2015, THESIS; Sung JH, 2015, GENET MOL RES, V14, P16508, DOI 10.4238/2015.December.9.23; Tang WR, 2008, ARCH MED RES, V39, P222, DOI 10.1016/j.arcmed.2007.08.002; Tanus-Santos JE, 2001, PHARMACOGENETICS, V11, P719, DOI 10.1097/00008571-200111000-00011; Trape AA, 2015, MED RIBEIRAO PRETO, V47, P165; Trape AA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2578950; Trape AA, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-44; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; WHO. Word Health Organization, AG 2012; Wiswell, 1990, FUNCTIONAL FITNESS A; Xie XC, 2017, CLIN EXP HYPERTENS, V39, P175, DOI 10.1080/10641963.2016.1235177; Yang YJ, 2014, INT J MOL SCI, V15, P7987, DOI 10.3390/ijms15057987; Yazdanyar A, 2009, CLIN GERIATR MED, V25, P563, DOI 10.1016/j.cger.2009.07.007; Zago AS, 2010, ARQ BRAS CARDIOL, V95, P510, DOI 10.1590/S0066-782X2010005000126; Zago AS, 2010, EUR J APPL PHYSIOL, V110, P825, DOI 10.1007/s00421-010-1568-6; Zago Anderson Saranz, 2006, Arq. Bras. Cardiol., V87, pe264, DOI 10.1590/S0066-782X2006001900029; Zago AS, 2003, R BRAS CI MOV, V11, P77; Zintzaras E, 2006, HYPERTENSION, V48, P700, DOI 10.1161/01.HYP.0000238124.91161.02	41	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206254	10.1371/journal.pone.0206254	http://dx.doi.org/10.1371/journal.pone.0206254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335864	gold, Green Published, Green Submitted			2022-12-26	WOS:000447701300102
J	Hsu, YH; Yen, YC; Lin, YC; Sung, LC				Hsu, Yung-Ho; Yen, Yu-Chun; Lin, Yi-Chun; Sung, Li-Chin			Antiplatelet agents maintain arteriovenous fistula and graft function in patients receiving hemodialysis: A nationwide case-control study	PLOS ONE			English	Article							VENOUS NEOINTIMAL HYPERPLASIA; RANDOMIZED CONTROLLED-TRIAL; VASCULAR ACCESS OUTCOMES; CHRONIC KIDNEY-DISEASE; INFLUENZA VACCINATION; ELDERLY-PATIENTS; DIALYSIS ACCESS; PRIMARY FAILURE; RISK-FACTORS; PATENCY	Background In this study, we evaluated the effects of various medications on the patency of vascular access (VA) for hemodialysis. Methods We analyzed data from the Longitudinal Health Insurance Database of Taiwan. We adopted a case-control study design within a cohort of patients who had received regular hemodialysis between 2002 and 2012; 34,354 patients with first VA failure were identified, and the duration from VA creation date to the first VA failure date was calculated. We then classified these patients into two groups, namely arteriovenous fistula (AVF, n = 25,933) and arteriovenous graft (AVG, n = 8,421). Each group was further divided into two subgroups, namely short-term (< 1 year) and long-term (>= 1 year) patency. Results The risk factors for early VA failure were age >= 65 years, diabetes mellitus, hyperlipidemia, cerebral vascular disease, congestive heart failure, peripheral artery disease, and sepsis. Male sex, hypertension, cancer, and peptic ulcer were associated with early AVF failure. Antiplatelet therapy increased the AVF and AVG patency times with adjusted odds ratios of 0.748 (95% confidence interval [CI]: 0.703-0.796, p < 0.0001) and 0.810 (95% CI: 0.7280.901, p = 0.0001), respectively. A significant decrease in the VA failure risk was observed with an increase in the cumulative defined daily dose of antiplatelet agents. Conclusion This nationwide study demonstrated that some risk factors were associated with early VA failure and that the use of antiplatelet agents prevented the loss of VA patency in a dose-response manner. Thus, antiplatelet drugs should be routinely administered to high-risk patients receiving dialysis.	[Hsu, Yung-Ho] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Nephrol, New Taipei, Taiwan; [Hsu, Yung-Ho; Sung, Li-Chin] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Yen, Yu-Chun; Lin, Yi-Chun] Taipei Med Univ, Coll Management, Res Ctr Biostat, Taipei, Taiwan; [Sung, Li-Chin] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Cardiol, New Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Sung, LC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan.; Sung, LC (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Cardiol, New Taipei, Taiwan.	10204@s.tmu.edu.tw		sung, lichin/0000-0001-6292-7117	Taipei Medical University [105-6102-001-102]	Taipei Medical University	This work was supported by Taipei Medical University (105-6102-001-102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreucci VE, 2004, AM J KIDNEY DIS, V44, pS61, DOI 10.1053/j.ajkd.2004.08.013; Birch N, 2013, HEMODIAL INT, V17, P586, DOI 10.1111/j.1542-4758.2012.00762.x; Chang CJ, 2004, AM J KIDNEY DIS, V43, P74, DOI 10.1053/j.ajkd.2003.09.015; Chang HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22197; Chen CI, 2016, MEDICINE, V95, P1, DOI 10.1097/MD.0000000000002588; Chen FA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166362; Coleman CI, 2010, INT J CLIN PRACT, V64, P1239, DOI 10.1111/j.1742-1241.2009.02329.x; Crowther MA, 2002, J AM SOC NEPHROL, V13, P2331, DOI 10.1097/01.ASN.0000027356.16598.99; DeMarchi S, 1996, J AM SOC NEPHROL, V7, P1169; Dember LM, 2008, JAMA-J AM MED ASSOC, V299, P2164, DOI 10.1001/jama.299.18.2164; Dixon BS, 2009, NEW ENGL J MED, V360, P2191, DOI 10.1056/NEJMoa0805840; Dukkipati R, 2014, SEMIN DIALYSIS, V27, P415, DOI 10.1111/sdi.12146; Fang YA, 2016, ACTA CARDIOL SIN, V32, P290, DOI 10.6515/ACS20150424L; Group VAW, 2001, AM J KIDNEY DIS S, V37, pS137; HARTER HR, 1979, NEW ENGL J MED, V301, P577, DOI 10.1056/NEJM197909133011103; Hemachandar R, 2015, J CLIN DIAGN RES, V9, pOC01, DOI 10.7860/JCDR/2015/13342.6611; Huijbregts HJTAM, 2007, J VASC SURG, V45, P962, DOI 10.1016/j.jvs.2007.01.014; Janardhanan R, 2013, KIDNEY INT, V84, P338, DOI 10.1038/ki.2013.112; Kuo TH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001032; Lee T, 2009, ADV CHRONIC KIDNEY D, V16, P329, DOI 10.1053/j.ackd.2009.06.009; Lin CF, 2016, PHARMACOEPIDEM DR S, V25, P889, DOI 10.1002/pds.3963; Liu JC, 2016, ONCOTARGET, V7, P59618, DOI 10.18632/oncotarget.11162; Lok CE, 2013, CLIN J AM SOC NEPHRO, V8, P1213, DOI 10.2215/CJN.01690213; Masengu A, 2016, CLIN KIDNEY J, V9, P142, DOI 10.1093/ckj/sfv131; Miller CD, 2003, KIDNEY INT, V63, P346, DOI 10.1046/j.1523-1755.2003.00740.x; Palmer SC, 2013, AM J KIDNEY DIS, V61, P112, DOI 10.1053/j.ajkd.2012.08.031; Paraskevas KI, 2012, ANGIOLOGY, V63, P5, DOI 10.1177/0003319711414177; Peng YC, 2016, J GASTROEN HEPATOL, V31, P1816, DOI 10.1111/jgh.13389; Pisoni R, 2010, CLIN J AM SOC NEPHRO, V5, P1447, DOI 10.2215/CJN.02740310; Rayner HC, 2004, NEPHROL DIAL TRANSPL, V19, P108, DOI 10.1093/ndt/gfg483; Righetti M, 2009, ANN VASC SURG, V23, P491, DOI 10.1016/j.avsg.2008.08.033; Rooijens PPGM, 2004, EUR J VASC ENDOVASC, V28, P583, DOI 10.1016/j.ejvs.2004.08.014; Roy-Chaudhury P, 2001, KIDNEY INT, V59, P2325, DOI 10.1046/j.1523-1755.2001.00750.x; Roy-Chaudhury P, 2012, SEMIN NEPHROL, V32, P558, DOI 10.1016/j.semnephrol.2012.10.007; Santoro D, 2014, INT J NEPHROL RENOV, V7, P281, DOI 10.2147/IJNRD.S46643; Smith GE, 2012, J VASC SURG, V55, P849, DOI 10.1016/j.jvs.2011.07.095; SREEDHARA R, 1994, KIDNEY INT, V45, P1477, DOI 10.1038/ki.1994.192; Tanaka A, 2013, THER APHER DIAL, V17, P620, DOI 10.1111/1744-9987.12021; Tanner NC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002786.pub3; Tayebi Pouya, 2018, Electron Physician, V10, P6135, DOI 10.19082/6135; Torsney E, 2004, CIRC RES, V94, P1466, DOI 10.1161/01.RES.0000129570.06647.00; Verest S, 2014, ACTA CHIR BELG, V114, P324, DOI 10.1080/00015458.2014.11681036; Wu CC, 2010, ATHEROSCLEROSIS, V209, P598, DOI 10.1016/j.atherosclerosis.2009.10.021; Wu SC., 2010, TAIWAN J PUBLIC HLTH, V29, P191; Yap YS, 2016, THER APHER DIAL, V20, P112, DOI 10.1111/1744-9987.12383; Yeh CH, 2016, CURR VASC PHARMACOL, V14, P353, DOI 10.2174/1570161114666160229115844; Yevzlin AS, 2006, SEMIN DIALYSIS, V19, P535, DOI 10.1111/j.1525-139X.2006.00218.x	47	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206011	10.1371/journal.pone.0206011	http://dx.doi.org/10.1371/journal.pone.0206011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335833	Green Submitted, Green Published, gold			2022-12-26	WOS:000447701300088
J	Lea, MV; Syring, J; Jennings, T; Cronn, R; Bruederle, LP; Neale, JR; Tomback, DF				Lea, Marian V.; Syring, John; Jennings, Tara; Cronn, Richard; Bruederle, Leo P.; Neale, Jennifer Ramp; Tomback, Diana F.			Development of nuclear microsatellite loci for Pinus albicaulis Engelm. (Pinaceae), a conifer of conservation concern	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; WHITEBARK-PINE; CLARK NUTCRACKER; UNITED-STATES; BLISTER RUST; FIRE REGIMES; MARKERS; DISPERSAL; DIVERSITY; DYNAMICS	Pinus albicaulis (whitebark pine) is a widely-distributed but rapidly declining high elevation western North American tree and a candidate for listing under the U.S. Endangered Species Act. Our objectives were to develop reliable nuclear microsatellite markers that can be used to assess within-population genetic diversity as well as seed and pollen migration dynamics, and to validate markers using two geographically proximal P. albicaulis populations. We identified 1,667 microsatellite-containing sequences from shotgun DNA libraries of P. albicaulis. Primer pairs were designed for 308 unique microsatellite-containing loci, and these were evaluated for PCR amplification success and segregation in a panel of diploid needle tissue. DNA was extracted with an SDS protocol, and primers were screened through gel electrophoresis. Microsatellites were genotyped through fluorescent primer fragment analysis. Ten novel and 13 transferred loci were found to be reproducible in analyses based on 20 foliage samples from each of two locations: Henderson Mountain, Custer Gallatin National Forest, Montana, and Mt. Washburn, Yellowstone National Park, Wyoming (USA). Transferred loci had higher numbers of alleles and expected heterozygosities than novel loci, but also revealed evidence for a higher frequency of null alleles. Eight of the 13 transferred loci deviated significantly from Hardy-Weinberg Equilibrium, and showed large positive F-IS values that were likely inflated by null alleles. Mantel's tests of transferred and novel markers showed no correlation between genetic and geographic distances within or among the two sampled populations. AMOVA suggests that 91% of genetic variability occurs within populations and 9% between the two populations. Studies assessing genetic diversity using these microsatellite loci can help guide future management and restoration activities for P. albicaulis.	[Lea, Marian V.; Bruederle, Leo P.; Tomback, Diana F.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Syring, John] Linfield Coll, Dept Biol, Mcminnville, OR USA; [Jennings, Tara; Cronn, Richard] US Forest Serv, Pacific Northwest Res Stn, USDA, Corvallis, OR USA; [Neale, Jennifer Ramp] Denver Bot Gardens, Denver, CO USA	University of Colorado System; University of Colorado Denver; Linfield University; United States Department of Agriculture (USDA); United States Forest Service	Tomback, DF (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	Diana.Tomback@ucdenver.edu		Tomback, Diana/0000-0002-0536-8758; Lea, Marian/0000-0002-9445-2184	University of Colorado Denver Office of Research Services; Wyoming Native Plant Society; U.S. Forest Service Pacific Northwest Region; Pacific Northwest Region of the U.S.D.A. Forest Service	University of Colorado Denver Office of Research Services; Wyoming Native Plant Society; U.S. Forest Service Pacific Northwest Region; Pacific Northwest Region of the U.S.D.A. Forest Service	In-house funding from the University of Colorado Denver Office of Research Services to Diana F. Tomback and Assistant Professor A. Moisier (who had no role in this particular aspect of our research). This work was also supported by Wyoming Native Plant Society (http://www.wynps.org/) and U.S. Forest Service Pacific Northwest Region (https://www.fs.fed.us/wildflowers/regions/Pacific_Northwest/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Custer Gallatin National Forest and Yellowstone National Park for permission to sample whitebark pine (Yellowstone National Park research permit number YELL-2016-SCI-6064). We also thank Andrew Boddicker, Bhargavi Ramanathan, Aaron Wagner, Elizabeth Pansing, Andres Andrade, and Amy Halbach for assisting with sample collection; Dr. Mitchell McGlaughlin from the University of Northern Colorado for assisting with the fragment analysis preparation protocols; and, Scott Bingham at the Arizona State University DNA Lab for the fragment analysis results. Camille Scelfo-Dalbey, Dylan Bartholomew, Kylie Nomi, and Evan Tracy conducted the early screens of the novel loci. We are grateful to Doug Turnbull and the University of Oregon Sequencing Facility for assistance with high-throughput DNA sequencing, and to the University of Colorado Denver Office of Research Services (DFT and Dr. A.C. Mosier), Wyoming Native Plant Society (MVL), and the Pacific Northwest Region of the U.S.D.A. Forest Service for financial support for this research (RC).	[Anonymous], 2021, LANG ENV STAT COMP; ARNO S.F., 1990, SILVICS N AM AGR HDB, V1, P268; Arno SF, WHITEBARK PINE COMMU; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Belokon MM, 2016, RUSS J GENET+, V52, P1263, DOI 10.1134/S1022795416120036; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Bowman DMJS, 2014, GLOBAL CHANGE BIOL, V20, P1008, DOI 10.1111/gcb.12433; Bruederle LP, 1998, CAN J BOT, V76, P83, DOI 10.1139/cjb-76-1-83; Chagne D, 2004, THEOR APPL GENET, V109, P1204, DOI 10.1007/s00122-004-1683-z; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Collevatti RG, 2001, MOL ECOL, V10, P349, DOI 10.1046/j.1365-294x.2001.01226.x; COSEWIC, 2010, COSEWIC ASS STAT REP; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; DeWoody JA, 2006, MOL ECOL NOTES, V6, P951, DOI 10.1111/j.1471-8286.2006.01449.x; Echt CS, 1997, GENOME, V40, P9, DOI 10.1139/g97-002; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Eckert AJ, 2009, GENETICS, V182, P1289, DOI 10.1534/genetics.109.102350; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Elsik CG, 2001, THEOR APPL GENET, V103, P1189, DOI 10.1007/s001220100725; Elsik CG, 2001, MOL GENET GENOMICS, V265, P535, DOI 10.1007/s004380100443; Enright NJ, 2015, FRONT ECOL ENVIRON, V13, P265, DOI 10.1890/140231; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gonzalez-Martinez SC, 2004, THEOR APPL GENET, V109, P103, DOI 10.1007/s00122-004-1596-x; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hao ZZ, 2015, MOL PHYLOGENET EVOL, V87, P65, DOI 10.1016/j.ympev.2015.03.013; HUTCHINS HE, 1982, OECOLOGIA, V55, P192, DOI 10.1007/BF00384487; Iwasaki T, 2013, TREE GENET GENOMES, V9, P693, DOI 10.1007/s11295-012-0585-5; Jennings TN, 2011, AM J BOT, V98, pE323, DOI 10.3732/ajb.1100317; Jorgensen SM, 1997, CAN J FOREST RES, V27, P1574, DOI 10.1139/cjfr-27-10-1574; Kalinowski ST, 2006, CONSERV GENET, V7, P991, DOI 10.1007/s10592-006-9134-9; Karhu A, 2000, MOL BIOL EVOL, V17, P259, DOI 10.1093/oxfordjournals.molbev.a026305; Keane R.E., 2012, RMRSGTR279 USDA FOR; Keane RE., 2017, RMRSGTR361 USDA FOR; Krakowski J, 2003, CONSERV GENET, V4, P581, DOI 10.1023/A:1025667700479; Leirfallom SB, 2015, CAN J FOREST RES, V45, P1597, DOI 10.1139/cjfr-2015-0043; Lendvay B, 2014, TREE GENET GENOMES, V10, P1419, DOI 10.1007/s11295-014-0770-9; Liewlaksaneeyanawin C, 2004, THEOR APPL GENET, V109, P361, DOI 10.1007/s00122-004-1635-7; Lind BM, 2017, MOL ECOL, V26, P3168, DOI 10.1111/mec.14106; Little EL, 1969, SUBDIVISIONS GENUS P; Liu JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167986; Lovett GM, 2016, ECOL APPL, V26, P1437, DOI 10.1890/15-1176; Mahalovich MF, 2011, US FOR SERV RMRS-P, V63, P118; MANTEL N, 1967, CANCER RES, V27, P209; McDonald G.I., 2001, WHITEBARK PINE COMMU, P193; Millar CI, 2015, SCIENCE, V349, P823, DOI 10.1126/science.aaa9933; Miller MP, 2013, J HERED, V104, P881, DOI 10.1093/jhered/est056; Moraga-Suazo P, 2014, TREES-STRUCT FUNCT, V28, P1823, DOI 10.1007/s00468-014-1090-2; Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1; Morse AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004332; Mosseler A, 2003, THEOR APPL GENET, V106, P931, DOI 10.1007/s00122-002-1156-1; Nurtjahjaningsih ILG, 2005, MOL ECOL NOTES, V5, P552, DOI 10.1111/j.1471-8286.2005.00984.x; O'Neill GA, 2007, CAN J FOREST RES, V37, P2724, DOI 10.1139/X07-100; Oreshkova NV, 2014, RUSS J GENET+, V50, P934, DOI 10.1134/S1022795414090105; Payseur BA, 2011, MOL BIOL EVOL, V28, P303, DOI 10.1093/molbev/msq198; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Phong DT, 2015, GENET MOL RES, V14, P7727, DOI 10.4238/2015.July.13.19; Price Robert A., 1998, P49; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Rajora OP, 2003, THEOR APPL GENET, V106, P1203, DOI 10.1007/s00122-002-1169-9; Resler LM, 2008, ARCT ANTARCT ALP RES, V40, P161, DOI 10.1657/1523-0430(06-116)[RESLER]2.0.CO;2; Richardson BA, 2002, MOL ECOL, V11, P215, DOI 10.1046/j.1365-294X.2002.01435.x; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Salzer K, 2009, MOL ECOL RESOUR, V9, P858, DOI 10.1111/j.1755-0998.2008.02396.x; Schwabe AL, 2015, CONSERV GENET, V16, P443, DOI 10.1007/s10592-014-0671-3; Schwandt JW, 2010, FOREST PATHOL, V40, P226, DOI 10.1111/j.1439-0329.2010.00656.x; Sniezko RA, 2010, FUTURE HIGH ELEVATIO; Syring J, 2005, AM J BOT, V92, P2086, DOI 10.3732/ajb.92.12.2086; Syring JV, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00484; Thao DV, 2013, CONSERV GENET RESOUR, V5, P433, DOI 10.1007/s12686-012-9821-4; Tomback D., WHITEBARK PINE COMMU; Tomback D., 2001, WHITEBARK PINE COMMU, P3; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; Tomback DF, 2005, ECOSCIENCE, V12, P519, DOI 10.2980/i1195-6860-12-4-519.1; TOMBACK DF, 1990, EVOL ECOL, V4, P185, DOI 10.1007/BF02214330; Tomback DF, 2001, ECOLOGY, V82, P2587, DOI 10.1890/0012-9658(2001)082[2587:DSGIWP]2.0.CO;2; TOMBACK DF, 1990, USDA INTERM, V270, P118; TOMBACK DF, 1982, J ANIM ECOL, V51, P451, DOI 10.2307/3976; TOMBACK DF, 1993, CAN J FOREST RES, V23, P113, DOI 10.1139/x93-018; Tomback DF, 2016, FORESTS, V7, DOI 10.3390/f7010021; Tomback DF, 2014, ARCT ANTARCT ALP RES, V46, P407, DOI 10.1657/1938-4246-46.2.407; USFWS, 2011, FED REGISTER, V76, P42631; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Villalobos-Arambula AR, 2014, GENET MOL RES, V13, P7571, DOI 10.4238/2014.September.12.24; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; Willyard A, 2006, MOL BIOL EVOL, V24, P90; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Yu JH, 2012, AM J BOT, V99, pE421, DOI 10.3732/ajb.1200145	91	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205423	10.1371/journal.pone.0205423	http://dx.doi.org/10.1371/journal.pone.0205423			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335779	Green Submitted, Green Published, gold			2022-12-26	WOS:000447701300032
J	Su, L; Chang, LY; Sun, Q; Hu, LL; Wu, Y; Gao, JB				Su, Lei; Chang, Liyang; Sun, Qiang; Hu, Lili; Wu, Yan; Gao, Jianbo			Effects of low-dose energy spectrum scanning combined with adaptive statistical iterative reconstruction on the quality of imaging in Budd-Chiari syndrome	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; CHEST CT; MODEL; ALGORITHMS; REDUCTION; NODULES	Objective To assess the quality and diagnostic accuracy of monochromatic images combined with adaptive statistical iterative reconstruction (ASIR) performed via spectral computed tomography (CT) in patients with Budd-Chiari syndrome (BCS). Methods Sixty-two patients with BCS underwent pectral CT with upper abdominal two-phase contrast-enhanced scanning to generate a 60keV monochromatic energy level combined with ASIR (ranging from 0% - 100%) during the portal venous phase (PVP) and the hepatic venous phase (HVP). One-way ANOVA was used to compare vessel-to-liver contrast-to-noise ratio (CNR) for the portal vein (PV), hepatic vein (HV), and inferior vena cava (IVC). Subjective evaluations of the images in the three groups were conducted by image quality assessors and compared via Kruskal-Wallis H test. Results The CNR values of the PV trunk, HV, IVC, liver parenchyma and pancreas were within ASIR (ranging from 0% - 100%) weight, and the difference were statistically significant (p < 0.05). The highest overall image score was distributed at 50% ASIR weight value. Higher CNR values of HV, hepatic parenchyma and pancreas were obtained in the IVC type than in mixed and HV types (respective p values = 0.035, 0.019 and 0.042). Higher CNR values of the IVC were obtained in the HV type than in mixed and IVC types (p = 0.032). The CNR value of the IVC in the mixed type was less than that of the HV type (p = 0.028). The CNR values of the HV and liver parenchyma in mixed type were lower than those of the IVC type (p = 0.016 and 0.038, respectively). The CNR value of pancreas in IVC type was higher than that of the HV type (p = 0.037). The diagnostic value of CNR in patients with the IVC type was higher than that in patients with mixed and HV type, while the diagnostic value of CNR was found to be the lowest for the HV type (p = 0.043). Conclusion A monochromatic energy level of 60 keV with 50% ASIR can significantly improve image quality in cases of BCS.	[Su, Lei; Chang, Liyang; Hu, Lili; Wu, Yan; Gao, Jianbo] Zhengzhou Univ, Affiliated Hosp 1, Dept Radiol, Zhengzhou, Henan, Peoples R China; [Sun, Qiang] Zhengzhou Univ, Affiliated Hosp 1, Dept Stomatol, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Gao, JB (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Radiol, Zhengzhou, Henan, Peoples R China.	878574853@qq.com			National Natural Science Foundation of China (NSFC) [81402231, 31400839]; basic and frontier technology research projects by Science and Technology Department of Henan province [142300410315]; Youth Foundation of The First Affiliated Hospital of Zhengzhou University; oral and maxillofacial surgery academician workstation of Zhengzhou [152PYSGZ040]; National Natural Science Foundation of China [81402231]; Basic and Frontier Technology Research Projects by Science and Technology Department of Henan [142300410315]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); basic and frontier technology research projects by Science and Technology Department of Henan province; Youth Foundation of The First Affiliated Hospital of Zhengzhou University; oral and maxillofacial surgery academician workstation of Zhengzhou; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic and Frontier Technology Research Projects by Science and Technology Department of Henan	This work was supported by grants of the National Natural Science Foundation of China (NSFC 81402231, 31400839), the basic and frontier technology research projects by Science and Technology Department of Henan province (142300410315) and the funding from Youth Foundation of The First Affiliated Hospital of Zhengzhou University and the oral and maxillofacial surgery academician workstation of Zhengzhou (152PYSGZ040).; The present manuscript was supported by the National Natural Science Foundation of China (grant no. 81402231), the Basic and Frontier Technology Research Projects by Science and Technology Department of Henan (grant no. 142300410315).S	Chen S, 2014, EUR J RADIOL, V83, P564, DOI 10.1016/j.ejrad.2013.11.024; de Margerie-Mellon C, 2016, ACAD RADIOL, V23, P1246, DOI 10.1016/j.acra.2016.05.019; Fang JM, 2017, ABDOM RADIOL, V42, P742, DOI 10.1007/s00261-016-1023-1; Guimaraes LS, 2010, RADIOLOGY, V257, P732, DOI 10.1148/radiol.10092016; Kukuk GM, 2011, RADIOLOGY, V259, P421, DOI 10.1148/radiol.11101429; Lee SH, 2012, EUR J RADIOL, V81, pE938, DOI 10.1016/j.ejrad.2012.06.013; Li HG, 2015, ABDOM IMAGING, V40, P1587, DOI 10.1007/s00261-015-0387-y; Li M, 2016, RADIOL MED, V121, P279, DOI 10.1007/s11547-015-0601-6; Liu L, 2016, RADIOL MED, V121, P261, DOI 10.1007/s11547-015-0602-5; Okamoto EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003227; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Su L, 2014, CELL BIOCHEM BIOPHYS, V70, P1043, DOI 10.1007/s12013-014-0021-6; Vardhanabhuti V, 2013, AM J ROENTGENOL, V200, P545, DOI 10.2214/AJR.12.9424; Wang RH, 2013, EXP THER MED, V5, P1254, DOI 10.3892/etm.2013.961; Xiao HJ, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0096-6; Yin XP, 2017, EUR J RADIOL, V89, P47, DOI 10.1016/j.ejrad.2017.01.022; Zhang F, 2015, ABDOM IMAGING, V40, P601, DOI 10.1007/s00261-014-0240-8; Zhao LQ, 2012, EUR J RADIOL, V81, P1677, DOI 10.1016/j.ejrad.2011.02.063; Zhou PL, 2017, RADIOL MED; Zhou Y, 2016, ACAD RADIOL, V23, P486, DOI 10.1016/j.acra.2015.12.001	20	0	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0204797	10.1371/journal.pone.0204797	http://dx.doi.org/10.1371/journal.pone.0204797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335782	gold, Green Published, Green Submitted			2022-12-26	WOS:000447701300015
J	Seixas, GHF; Mourao, G				Fernandes Seixas, Glaucia Helena; Mourao, Guilherme			Communal roosts of the Blue-fronted Amazons (Amazona aestiva) in a large tropical wetland: Are they of different types?	PLOS ONE			English	Article							SOUTHERN PANTANAL BRAZIL; POPULATION-SIZE; GALLERY FOREST; FLOCK SIZE; COSTA-RICA; PARROTS; INFORMATION; CONSERVATION; VARIABILITY; ABUNDANCE	Psittacidae species are among the most threatened birds in the world. Approximately one-half of the 390 parrot species are experiencing population declines. The Blue-fronted Amazon (Amazona aestiva) is the most traded parrot worldwide and suffers from poaching and habitat loss. Many species of parrots, including the Blue-fronted Amazon, form communal roosts where they spend the night. Under certain circumstances, roost surveys can be a rapid and cost-effective way to obtain information about the demography of parrots or the consequences of threats. We surveyed an area of 2,700 km(2) in a large wetland in mid-western of Brazil and located five Blue-fronted Amazon roosts. We conducted monthly counts of the birds arriving at these roosts for 28-61 months and stratified the counts into flock sizes. We used this information to estimate the number of parrots using these roosts to determine whether the roosts follow seasonal patterns and whether they have different flock-size structures and different dynamics throughout the year, as well as to determine the trends of the roosting parrots, which are stratified by flock size. The roosts were different, as they followed different seasonal patterns and had different flock-size structures, which could be interpreted in relation to the parrot breeding cycle. The trends of singletons, which index the number of reproductive couples each year, and the number of pairs parrots increased or fluctuated around a baseline, but the number of fledged young in the year declined throughout the study. This is of concern, as it indicates problems in population recruitment, which could have been unnoticed by the management authorities, as the total numbers were not decreasing. Although every monitored roost had birds of each age or reproductive condition strata, the fact that the roosts were different could be important in terms of management, as it will be more effective for the conservation of the Blue-fronted Amazon to protect a carefully chosen set of complementary roosts.	[Fernandes Seixas, Glaucia Helena] Fdn Neotrop Brasil, Bonito, MS, Brazil; [Mourao, Guilherme] Embrapa Pentanel, Corumba, MS, Brazil		Seixas, GHF (corresponding author), Fdn Neotrop Brasil, Bonito, MS, Brazil.	glaucia@fundacaoneotropica.org.br	Mourão, Guilherme M/C-3319-2013	Mourão, Guilherme M/0000-0002-8300-4191; Helena Fernandes Seixas, Glaucia/0000-0002-6645-9135	Parque das Aves; Refugio Ecologico Caiman; Conservacao Internacional do Brasil; Sea World Busch Garden; Instituto Arara Azul; Parrots International; McGrath Family; Fundacao Grupo Boticario de Protecao a Natureza; Fundacao de Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect/CNPq grant) [PRONEX 006/2015]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundect/CNPq [DCR 278/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [308934/2017-2]	Parque das Aves; Refugio Ecologico Caiman; Conservacao Internacional do Brasil; Sea World Busch Garden; Instituto Arara Azul; Parrots International; McGrath Family; Fundacao Grupo Boticario de Protecao a Natureza; Fundacao de Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect/CNPq grant); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundect/CNPq; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was funded by Parque das Aves, Refugio Ecologico Caiman, Conservacao Internacional do Brasil, Sea World Busch Garden, Instituto Arara Azul, Parrots International, McGrath Family, Fundacao Grupo Boticario de Protecao a Natureza and Fundacao de Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect/CNPq grant PRONEX 006/2015). Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) provided a scholarship to GHFS (2005-2009) and Fundect/CNPq provide a fellowship to GHFS (DCR 278/2014). Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) awarded a productivity fellowship to GM (308934/2017-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Becker R.A., 2017, MAPS DRAW GEOGRAPHIC; Beissinger S.R., 1992, P73; Beissinger SR, 1994, BIOL CONSERVACION PS, P147; Berg KS, 2006, J FIELD ORNITHOL, V77, P95, DOI 10.1111/j.1557-9263.2006.00028.x; Berkunsky I, 2017, BIOL CONSERV, V214, P278, DOI 10.1016/j.biocon.2017.08.016; Berkunsky I, 2009, IBIS, V151, P145, DOI 10.1111/j.1474-919X.2008.00896.x; Berkunsky I, 2017, AVIAN CONSERV ECOL, V12, DOI 10.5751/ACE-01071-120206; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; BLISS CI, 1953, BIOMETRICS, V9, P176, DOI 10.2307/3001850; Bonadie WA, 2000, BIOL CONSERV, V95, P1, DOI 10.1016/S0006-3207(00)00018-5; Buckley NJ, 1996, AUK, V113, P473, DOI 10.2307/4088913; CANNON CE, 1984, AUST WILDLIFE RES, V11, P349; Carrara LA, 2007, REV BRAS ORNITOL, V15, P135; Casagrande DG, 1997, CONDOR, V99, P445, DOI 10.2307/1369951; CHAPMAN CA, 1989, CONDOR, V91, P842, DOI 10.2307/1368068; Cleveland R.B., 1990, J OFF STAT, V6, P3; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cougill S, 2004, J FIELD ORNITHOL, V75, P67, DOI 10.1648/0273-8570-75.1.67; Crook J. H., 1965, Symposia of the Zoological Society of London, VNo. 14, P181; Denes FV, 2018, EMU, V118, P67, DOI 10.1080/01584197.2017.1401903; Faegre S, 2014, ORNITOL NEOTROP, V25, P55; Galetti Mauro, 2006, Revista Brasileira de Ornitologia, V14, P239; Gilardi JD, 1998, CONDOR, V100, P641, DOI 10.2307/1369745; Guix J., 1997, ARARAJUBA, V5, P156; Harms Kyle E., 2003, Ornitologia Neotropical, V14, P79; Hobson EA, 2014, AUK, V131, P756, DOI 10.1642/AUK-14-14.1; Juniper T., 1998, PARROTS A GUIDE PARR; Mabb Karen T., 1997, Western Birds, V28, P202; Martens JM, 2017, J ORNITHOL, V158, P823, DOI 10.1007/s10336-017-1436-9; Martinez J, 2008, BIOLOGIA CONSERVACAO, P105; Martuscelli Paulo, 1995, Bird Conservation International, V5, P405; Matuzak GD, 2007, J FIELD ORNITHOL, V78, P159, DOI 10.1111/j.1557-9263.2007.00099.x; Moura L. N., 2008, BIOL CONSERVACAO EST, P223, DOI 10.1676/09-013.1; Ndithia H, 2006, OSTRICH, V77, P52, DOI 10.2989/00306520609485508; Pitter Elin, 1995, Bird Conservation International, V5, P61; PIZO MA, 2002, ECOLOGIA CONSERVACAO, P49; Pott A. A., 1997, PLANO CONSERVACAO BA, P1; Ragusa-Netto J., 2006, Braz. J. Biol., V66, P1021, DOI 10.1590/S1519-69842006000600008; Ragusa-Netto J, 2007, STUD NEOTROP FAUNA E, V42, P93, DOI 10.1080/01650520600979643; Salinas-Melgoza A, 2005, WILSON BULL, V117, P291, DOI 10.1676/04-096.1; Scherer Neto Pedro, 2007, Ornitologia Neotropical, V18, P379; Seixas GHF, 2002, J FIELD ORNITHOL, V73, P399, DOI 10.1648/0273-8570-73.4.399; Seixas GHF, 2009, ECOLOGIA ALIMENTAR A; Seixas Glaucia Helena Fernandes, 2000, Ararajuba, V8, P73; Sick H., 1984, ORNITOLOGIA BRASILEI, V1; Sipinski EAB, 2014, ORNITHOLOGIA, V6, P136; Snyder NF, 1987, PARROTS OF LUQUILLO; Stahala C, 2008, ORNITOL NEOTROP, V19, P165; Vaughan C, 2005, BIRD CONSERV INT, V15, P119; Venables WN., 2002, MODERN APPL STAT S 4; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; WEATHERHEAD PJ, 1983, AM NAT, V121, P237, DOI 10.1086/284053; Wheeler B., 2014, PACKAGE IMPERM R PAC, P1; White GC, 1996, ECOLOGY, V77, P2549, DOI 10.2307/2265753; Wright TF, 2001, CONSERV BIOL, V15, P710, DOI 10.1046/j.1523-1739.2001.015003710.x	56	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0204824	10.1371/journal.pone.0204824	http://dx.doi.org/10.1371/journal.pone.0204824			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332447	Green Submitted, Green Published, gold			2022-12-26	WOS:000447638200036
J	Kang, J; Lim, LZ; Song, JX				Kang, Jian; Lim, Liangzhong; Song, Jianxing			TMEM106B, a risk factor for FTLD and aging, has an intrinsically disordered cytoplasmic domain	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; SECONDARY STRUCTURE; NMR; PROTEIN; DEMENTIA; MODIFIER; VARIANTS; SEQUENCE; DISEASE; BINDING	TMEM106B was initially identified as a risk factor for FTLD, but recent studies highlighted its general role in neurodegenerative diseases. Very recently TMEM106B has also been characterized to regulate aging phenotypes. TMEM106B is a 274-residue lysosomal protein whose cytoplasmic domain functions in the endosomal/autophagy pathway by dynamically and transiently interacting with diverse categories of proteins but the underlying structural basis remains completely unknown. Here we conducted bioinformatics analysis and biophysical characterization by CD and NMR spectroscopy, and obtained results reveal that the TMEM106B cytoplasmic domain is intrinsically disordered with no well-defined three-dimensional structure. Nevertheless, detailed analysis of various multi-dimensional NMR spectra allowed defining residue-specific conformations and dynamics. Overall, the TMEM106B cytoplasmic domain is lacking of any tight tertiary packing and relatively flexible. However, several segments are populated with dynamic/nascent secondary structures and have relatively restricted backbone motions on ps-ns time scale, as indicated by their positive {H-1}-N-15 steady-state NOE. Our study thus decodes that being intrinsically disordered may allow the TMEM106B cytoplasmic domain to dynamically and transiently interact with a variety of distinct partners.	[Kang, Jian; Lim, Liangzhong; Song, Jianxing] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore, Singapore	National University of Singapore	Song, JX (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore, Singapore.	dbssjx@nus.edu.sg	Kang, Jian/AAN-8616-2020	Kang, Jian/0000-0001-9935-4172; Song, Jianxing/0000-0003-0224-6322	Ministry of Education of Singapore (MOE) Tier 2 Grant [MOE2015-T2-1-111]	Ministry of Education of Singapore (MOE) Tier 2 Grant	This study is supported by Ministry of Education of Singapore (MOE) Tier 2 Grant MOE2015-T2-1-111 to Jianxing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HHH, 2014, BIOL PSYCHIAT, V76, P503, DOI 10.1016/j.biopsych.2014.03.006; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; Chen-Plotkin AS, 2012, J NEUROSCI, V32, P11213, DOI 10.1523/JNEUROSCI.0521-12.2012; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Gallagher MD, 2014, ACTA NEUROPATHOL, V127, P407, DOI 10.1007/s00401-013-1239-x; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gupta GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033035; Gupta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134823; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jun MH, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0177-z; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lang CM, 2012, J BIOL CHEM, V287, P19355, DOI 10.1074/jbc.M112.365098; Li LZ, 2017, BBA-BIOMEMBRANES, V1859, P2161, DOI 10.1016/j.bbamem.2017.08.013; Li MF, 2007, PROTEINS, V68, P100, DOI 10.1002/prot.21385; Lim LZ, 2016, BBA-BIOMEMBRANES, V1858, P2223, DOI 10.1016/j.bbamem.2016.06.027; Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P87, DOI 10.1007/s00401-011-0838-7; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Nicholson AM, 2016, ACTA NEUROPATHOL, V132, P639, DOI 10.1007/s00401-016-1610-9; Nicholson AM, 2013, J NEUROCHEM, V126, P781, DOI 10.1111/jnc.12329; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Qin HN, 2014, P NATL ACAD SCI USA, V111, P18619, DOI 10.1073/pnas.1413994112; Rhinn H, 2017, CELL SYST, V4, P404, DOI 10.1016/j.cels.2017.02.009; Rutherford NJ, 2012, NEUROLOGY, V79, P717, DOI 10.1212/WNL.0b013e318264e3ac; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwenk BM, 2014, EMBO J, V33, P450, DOI 10.1002/embj.201385857; Stagi M, 2014, MOL CELL NEUROSCI, V61, P226, DOI 10.1016/j.mcn.2014.07.006; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Wang W, 2013, BIOCHEM BIOPH RES CO, V438, P169, DOI 10.1016/j.bbrc.2013.07.047; Wei Z, 2005, J MOL BIOL, V348, P205, DOI 10.1016/j.jmb.2005.02.028; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205856	10.1371/journal.pone.0205856	http://dx.doi.org/10.1371/journal.pone.0205856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332472	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200073
J	Dosemeci, A; Tao-Cheng, JH; Loo, H; Reese, TS				Dosemeci, Ayse; Tao-Cheng, Jung-Hwa; Loo, Hannah; Reese, Thomas S.			Distribution of densin in neurons	PLOS ONE			English	Article							PROTEIN-KINASE-II; POSTSYNAPTIC DENSITY; CA2+ CHANNELS; SYNAPTIC PROTEIN; REPEAT PROTEIN; CAMKII; CORE; LOCALIZATION; ORGANIZATION; EXPRESSION	Densin is a scaffold protein known to associate with key elements of neuronal signaling. The present study examines the distribution of densin at the ultrastructural level in order to reveal potential sites that can support specific interactions of densin. Immunogold electron microscopy on hippocampal cultures shows intense labeling for densin at postsynaptic densities (PSDs), but also some labeling at extrasynaptic plasma membranes of soma and dendrites and endoplasmic reticulum. At the PSD, the median distance of label from the postsynaptic membrane was similar to 27 nm, with the majority of label (90%) confined within 40 nm from the postsynaptic membrane, indicating predominant localization of densin at the PSD core. Depolarization (90 mM K+ for 2 min) promoted a slight shift of densin label within the PSD complex resulting in 77% of label remaining within 40 nm from the postsynaptic membrane. Densin molecules firmly embedded within the PSD may target a minor pool of CaMKII to substrates at the PSD core.	[Dosemeci, Ayse; Loo, Hannah; Reese, Thomas S.] NINDS, Lab Neurobiol, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Tao-Cheng, Jung-Hwa] NINDS, EM Facil, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Dosemeci, A (corresponding author), NINDS, Lab Neurobiol, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	dosemeca@mail.nih.gov			National Institute of Neurological Disorders and Stroke; NIH, NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003113] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke, intramural funds (TSR).; We thank Virginia Crocker and Sandra Lara for expert EM technical support, Christine A. Winters for the preparation of hippocampal neuronal cultures. This research was supported by the Intramural Research Program of NIH, NINDS.	Apperson ML, 1996, J NEUROSCI, V16, P6839; Carlisle HJ, 2011, J NEUROSCI, V31, P16194, DOI 10.1523/JNEUROSCI.5877-10.2011; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; Di Biase V, 2008, J NEUROSCI, V28, P13845, DOI 10.1523/JNEUROSCI.3213-08.2008; Ding JD, 2013, J COMP NEUROL, V521, P3570, DOI 10.1002/cne.23372; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Dosemeci A, 2016, FEBS LETT, V590, P2934, DOI 10.1002/1873-3468.12334; Dosemeci Ayse, 2016, Front Synaptic Neurosci, V8, P23, DOI 10.3389/fnsyn.2016.00023; Fera A, 2012, J COMP NEUROL, V520, P4218, DOI 10.1002/cne.23151; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Jenkins MA, 2010, J NEUROSCI, V30, P5125, DOI 10.1523/JNEUROSCI.4367-09.2010; Jiao YX, 2008, J NEUROCHEM, V105, P1746, DOI 10.1111/j.1471-4159.2008.05280.x; Jiao YX, 2011, J BIOL CHEM, V286, P24806, DOI 10.1074/jbc.M110.216010; Lowenthal MS, 2015, J PROTEOME RES, V14, P2528, DOI 10.1021/acs.jproteome.5b00109; Ohtakara K, 2002, GENES CELLS, V7, P1149, DOI 10.1046/j.1365-2443.2002.00589.x; Penny CJ, 2018, CELL SIGNAL, V49, P46, DOI 10.1016/j.cellsig.2018.05.010; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Tao-Cheng JH, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0366-7; Tao-Cheng JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153979; Tao-Cheng JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118750; Tippens AL, 2008, J COMP NEUROL, V506, P569, DOI 10.1002/cne.21567; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wang SY, 2017, J NEUROSCI, V37, P4679, DOI 10.1523/JNEUROSCI.2583-16.2017; Yang Y, 2011, NEUROSCIENCE, V192, P132, DOI 10.1016/j.neuroscience.2011.06.061; Yang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071795; Zhang ML, 2008, J COMP NEUROL, V507, P1109, DOI 10.1002/cne.21595	28	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205859	10.1371/journal.pone.0205859	http://dx.doi.org/10.1371/journal.pone.0205859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325965	Green Submitted, Green Published, gold			2022-12-26	WOS:000447430800048
J	Weiss, A; Spektor, L; Cohen, LA; Lifshitz, L; Gold, IM; Zhang, DL; Truman-Rosentsvit, M; Leichtmann-Bardoogo, Y; Nyska, A; Addadi, S; Rouault, TA; Meyron-Holtz, EG				Weiss, Avital; Spektor, Lior; Cohen, Lyora A.; Lifshitz, Lena; Gold, Inbar Magid; Zhang, De-Liang; Truman-Rosentsvit, Marianna; Leichtmann-Bardoogo, Yael; Nyska, Abraham; Addadi, Sefi; Rouault, Tracey A.; Meyron-Holtz, Esther G.			Orchestrated regulation of iron trafficking proteins in the kidney during iron overload facilitates systemic iron retention	PLOS ONE			English	Article							OXYGENASE 1-DEFICIENT MICE; PROXIMAL TUBULE; TARGETED DELETION; HUMAN-TISSUES; RAT-KIDNEY; YOLK-SAC; DISEASE; FERROPORTIN; HEPCIDIN; TRANSFERRIN	The exact route of iron through the kidney and its regulation during iron overload are not completely elucidated. Under physiologic conditions, non-transferrin and transferrin bound iron passes the glomerular filter and is reabsorbed through kidney epithelial cells, so that hardly any iron is found in the urine. To study the route of iron reabsorption through the kidney, we analyzed the location and regulation of iron metabolism related proteins in kidneys of mice with iron overload, elicited by iron dextran injections. Transferrin Receptor 1 was decreased as expected, following iron overload. In contrast, the multi-ligand hetero-dimeric receptor-complex megalin/cubilin, which also mediates the internalization of transferrin, was highly up-regulated. Moreover, with increasing iron, intracellular ferritin distribution shifted in renal epithelium from an apical location to a punctate distribution throughout the epithelial cells. In addition, in contrast to many other tissues, the iron exporter ferroportin was not reduced by iron overload in the kidney. Iron accumulated mainly in interstitial macrophages, and more prominently in the medulla than in the cortex. This suggests that despite the reduction of Transferrin Receptor 1, alternative pathways may effectively mediate reabsorption of iron that cycles through the kidney during parenterally induced iron-overload. The most iron consuming process of the body, erythropoiesis, is regulated by the renal erythropoietin producing cells in kidney interstitium. We propose, that the efficient reabsorption of iron by the kidney, also during iron overload enables these cells to sense systemic iron and regulate its usage based on the systemic iron state.	[Weiss, Avital; Spektor, Lior; Cohen, Lyora A.; Lifshitz, Lena; Gold, Inbar Magid; Truman-Rosentsvit, Marianna; Leichtmann-Bardoogo, Yael; Meyron-Holtz, Esther G.] Technion Israel Inst Technol, Lab Mol Nutr, Fac Biotechnol & Food Engn, Haifa, Israel; [Zhang, De-Liang; Rouault, Tracey A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Mol Med, NIH, Bethesda, MD USA; [Nyska, Abraham] Tel Aviv Univ, Sackler Sch Med, Timrat, Israel; [Nyska, Abraham] Toxicol Pathol, Timrat, Israel; [Addadi, Sefi] B Nano Ltd, Rehovot, Israel	Technion Israel Institute of Technology; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Tel Aviv University; Sackler Faculty of Medicine	Meyron-Holtz, EG (corresponding author), Technion Israel Inst Technol, Lab Mol Nutr, Fac Biotechnol & Food Engn, Haifa, Israel.	meyron@technion.ac.il	Truman-Rosentsvit, Marianna/C-7682-2019	Truman-Rosentsvit, Marianna/0000-0002-9239-3854; Bardoogo, Yael/0000-0003-1130-5064; Zhang, Deliang/0000-0001-9478-5344; Addadi, Sefi/0000-0001-9827-0436	US-Israel Binational Science Foundation [2007466]; Israel Science Foundation; Israel Academy of Sciences and Humanities [1444/13]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008814, ZIAHD001602] Funding Source: NIH RePORTER	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Israel Academy of Sciences and Humanities; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We greatly acknowledge the funding of this research by The US-Israel Binational Science Foundation, Grant 2007466 to Esther Meyron-Holtz and Tracey Rouault and by The Israel Science Foundation, founded by the Israel Academy of Sciences and Humanities, grant number 1444/13 to Esther Meyron-Holtz. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company, B-nano Ltd. (http://b-nano.com/), Rehovot, Israel, provided support in the form of salary for author S. A. and was involved in specific data collection and analyses for figures 6 d-g. B-nano had no role in study design, other data collection and analyses, decision to publish, or preparation of the manuscript. They proofread the relevant materials, methods and results sections and did not contribute to data interpretation.	Abouhamed M, 2006, AM J PHYSIOL-RENAL, V290, pF1525, DOI 10.1152/ajprenal.00359.2005; Adams PC, 2007, LANCET, V370, P1855, DOI 10.1016/S0140-6736(07)61782-6; Aisen P, 1976, Ciba Found Symp, P1; Aschemeyer S, 2018, BLOOD, V131, P899, DOI 10.1182/blood-2017-05-786590; Bellelli R, 2016, CELL REP, V14, P411, DOI 10.1016/j.celrep.2015.12.065; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Burne MJ, 1999, KIDNEY INT, V55, P261, DOI 10.1046/j.1523-1755.1999.00234.x; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chepelev NL, 2011, FREE RADICAL BIO MED, V50, P645, DOI 10.1016/j.freeradbiomed.2010.12.023; Christensen EI, 2012, PHYSIOLOGY, V27, P223, DOI 10.1152/physiol.00022.2012; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Dachy A, 2015, PEDIATR NEPHROL, V30, P1027, DOI 10.1007/s00467-014-3037-7; Das A, 2016, J CELL BIOL, V214, P831, DOI 10.1083/jcb.201602069; Ferguson CJ, 2001, AM J PHYSIOL-RENAL, V280, pF803, DOI 10.1152/ajprenal.2001.280.5.F803; FUJIGAKI Y, 1993, KIDNEY INT, V43, P567, DOI 10.1038/ki.1993.84; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Ganz T, 2016, SEMIN NEPHROL, V36, P87, DOI 10.1016/j.semnephrol.2016.02.001; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Haldar S, 2015, J BIOL CHEM, V290, P5512, DOI 10.1074/jbc.M114.607507; Haley M, 2012, P PHYSL SOC, V27, pC41; Hamdi A, 2016, BBA-MOL CELL RES, V1863, P2859, DOI 10.1016/j.bbamcr.2016.09.008; Jeong SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025404; Koury MJ, 2015, NAT REV NEPHROL, V11, P394, DOI 10.1038/nrneph.2015.82; Kovtunovych G, 2014, BLOOD, V124, P1522, DOI 10.1182/blood-2014-02-554162; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Leichtmann-Bardoogo Y, 2012, AM J PHYSIOL-ENDOC M, V302, pE1519, DOI 10.1152/ajpendo.00007.2012; LU JP, 1989, ACTA PATHOL JAPON, V39, P759; Luthje P, 2014, ADV MICROB PHYSIOL, V65, P337, DOI 10.1016/bs.ampbs.2014.08.006; Mckie AT, 2008, BIOCHEM SOC T, V36, P1239, DOI 10.1042/BST0361239; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Meyron-Holtz EG, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00194; Millot S, 2017, HAEMATOLOGICA, V102, P260, DOI 10.3324/haematol.2016.151621; Moulouel B, 2013, KIDNEY INT, V84, P756, DOI 10.1038/ki.2013.142; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; NIEDERAU C, 1994, BAILLIERE CLIN HAEM, V7, P881, DOI 10.1016/S0950-3536(05)80129-5; Nielsen R, 2016, KIDNEY INT, V89, P58, DOI 10.1016/j.kint.2015.11.007; Norden AGW, 2001, KIDNEY INT, V60, P1885, DOI 10.1046/j.1523-1755.2001.00016.x; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ozkurt S, 2014, RENAL FAILURE, V36, P814, DOI 10.3109/0886022X.2014.892391; Pan XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025839; Radhakrishnan N, 2011, J PEDIAT HEMATOL ONC, V33, P74, DOI 10.1097/MPH.0b013e3181fd2aae; Rodriguez A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-379; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SAHALI D, 1988, J EXP MED, V167, P213, DOI 10.1084/jem.167.1.213; Seetharam B, 1997, J CLIN INVEST, V99, P2317, DOI 10.1172/JCI119411; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Solomonov I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05987; Starzynski RR, 2013, BIOCHEM J, V449, P69, DOI 10.1042/BJ20121139; Subashchandrabose S, 2015, METALLOMICS, V7, P935, DOI 10.1039/c4mt00329b; Thevenod F, 2016, METALLOMICS, V8, P17, DOI 10.1039/c5mt00215j; Truman-Rosentsvit M, 2018, BLOOD, V131, P342, DOI 10.1182/blood-2017-02-768580; Vidavsky N, 2014, P NATL ACAD SCI USA, V111, P39, DOI 10.1073/pnas.1312833110; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Wolff NA, 2011, J CELL MOL MED, V15, P209, DOI 10.1111/j.1582-4934.2009.00985.x; Yuste Claudia, 2015, World J Nephrol, V4, P185, DOI 10.5527/wjn.v4.i2.185; Zhang DL, 2018, SCIENCE, V359, P1520, DOI 10.1126/science.aal2022; Zhang DL, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00124; Zhang DL, 2007, J AM SOC NEPHROL, V18, P401, DOI 10.1681/ASN.2006080908	62	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0204471	10.1371/journal.pone.0204471	http://dx.doi.org/10.1371/journal.pone.0204471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321179	Green Submitted, Green Published, gold			2022-12-26	WOS:000447417900008
J	Coyer, L; van Bilsen, W; Bil, J; Davidovich, U; Hoornenborg, E; Prins, M; Matser, A				Coyer, Liza; van Bilsen, Ward; Bil, Janneke; Davidovich, Udi; Hoornenborg, Elske; Prins, Maria; Matser, Amy			Pre-exposure prophylaxis among men who have sex with men in the Amsterdam Cohort Studies: Use, eligibility, and intention to use	PLOS ONE			English	Article							MSM; RISK	Objective Currently, HIV pre-exposure prophylaxis (PrEP) is not covered by health insurance in the Netherlands. We examined time trends in use of PrEP, characteristics of PrEP users, PrEP eligibility and intention to use PrEP among HIV-negative men who have sex with men (MSM) participating in the Amsterdam Cohort Studies (ACS). Design Prospective cohort study. Methods We used data from four 6-monthly questionnaire waves, collected between 2015-2017. PrEP use over time was examined in logistic regression models using generalized estimating equations. Using descriptive statistics, we compared PrEP users before first-time initiation to non-PrEP-users. We used national guidelines to assess PrEP eligibility. Results We included 687 MSM. Median age was 40 (IQR 33-47) years in 2015. Recent PrEP use was reported by 57/687 (8%) MSM. PrEP use increased over calendar time (P< 0.001) to 7% in 2017. PrEP users did not differ from non-PrEP users in socio-demographic characteristics, but reported a significantly higher median number of casual sex partners, more often reported condomless anal sex and chemsex with casual partners, and more often had an sexually transmitted infection in the preceding 6 months (all P < 0.05). PrEP eligibility increased over time, but the effect was not statistically significant (P = 0.075). PrEP eligibility criteria were met by 149/460 (32%) at wave 4, of whom 31/149 (21%) reported use of PrEP. The proportion with a high intention to use PrEP was greater among eligible than non- eligible MSM (51% vs. 24%, P < 0.001). Conclusion PrEP use increased over time but remained under 10%, even though 32% met the eligibility criteria, of whom 51% had a high intention to use PrEP. This suggests that a large proportion of Dutch MSM at risk could benefit from PrEP.	[Coyer, Liza; van Bilsen, Ward; Bil, Janneke; Davidovich, Udi; Hoornenborg, Elske; Matser, Amy] Publ Hlth Serv Amsterdam, Dept Infect Dis Res & Prevent, Amsterdam, Netherlands; [Hoornenborg, Elske] Publ Hlth Serv Amsterdam, Dept Infect Dis, Clin Sexually Transmitted Infect, Amsterdam, Netherlands; [Prins, Maria] Univ Amsterdam, Amsterdam UMC, AIII, Dept Infect Dis, Amsterdam, Netherlands	Public Health Service Amsterdam; Public Health Service Amsterdam; University of Amsterdam	Coyer, L (corresponding author), Publ Hlth Serv Amsterdam, Dept Infect Dis Res & Prevent, Amsterdam, Netherlands.	lcoyer@ggd.amsterdam.nl	Coyer, Liza/L-9054-2019	Coyer, Liza/0000-0001-5830-2982; Matser, Amy/0000-0003-4291-1905	Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment	Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment	The authors gratefully acknowledge the Amsterdam Cohort Studies (ACS) on HIV infection and AIDS, which is a collaboration between the Public Health Service of Amsterdam, the Academic Medical Center of the University of Amsterdam, Sanquin Blood Supply Foundation, Medical Center Jan van Goyen, and the HIV Focus Center of the DC-Clinics. ACS is part of the Netherlands HIV Monitoring Foundation and is financially supported by the Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment. The authors thank all ACS participants, research nurses and data managers for their contribution. They also explicitly thank Lucy Phillips for editing this manuscript and Anders Boyd for his input on the statistical analysis.	Aidsfonds, 2018, PREP 50 EUR BESCH BI; [Anonymous], 2016, DISCOVER TRIAL REGIS; Bil JP, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004910; Bil JP, 2015, AIDS, V29, P955, DOI 10.1097/QAD.0000000000000639; Coleman R, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.42.17-00698; de Coul ELMO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133232; Dijkshoorn H, 2018, AMSTERDAMSE GEZONDHE; European Medicines Agency, 2016, 1 MED HIV PREEX PROP; Gezondheidsraad, 2018, PREV GEBR VAN HIV RE; Gredig D, 2016, AIDS CARE, V28, P44, DOI 10.1080/09540121.2016.1146212; Health Council of the Netherlands, 2017, WORK PROGR 2018; Hoornenborg E, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25105; Hoornenborg E, 2017, AIDS, V31, P2179, DOI 10.1097/QAD.0000000000001627; Hoornenborg E, 2017, AIDS, V31, P1603, DOI 10.1097/QAD.0000000000001522; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Nederlandse Vereniging voor HIV Behandelaren, 2016, HIV PREEXP PROF PREP; Public Health Service of Amsterdam, 2018, DEC MIN BRUINS REIMB; Stuart D., 2013, HIV NURSING; Urbanus AT, 2017, PREEXPOSITIE PROFYLA; VANGRIENSVEN GJP, 1989, BMJ-BRIT MED J, V298, P218, DOI 10.1136/bmj.298.6668.218; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249	22	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2018	13	10							e0205663	10.1371/journal.pone.0205663	http://dx.doi.org/10.1371/journal.pone.0205663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0UN	30312336	Green Submitted, Green Published, gold			2022-12-26	WOS:000447427300044
J	Boyle, AK; Rinaldi, SF; Rossi, AG; Saunders, PTK; Norman, JE				Boyle, Ashley K.; Rinaldi, Sara F.; Rossi, Adriano G.; Saunders, Philippa T. K.; Norman, Jane E.			Repurposing simvastatin as a therapy for preterm labor: evidence from preclinical models	FASEB JOURNAL			English	Article						pregnancy; preterm birth; statins; inflammation; contraction	VASCULAR SMOOTH-MUSCLE; INFLAMMATORY CYTOKINE PRODUCTION; COA REDUCTASE INHIBITOR; RHO-ASSOCIATED KINASE; NF-KAPPA-B; MURINE MODEL; ANTIINFLAMMATORY ROLE; HUMAN PARTURITION; UTERINE MYOCYTES; MOUSE MODEL	Preterm birth (PTB), the leading cause of neonatal morbidity and mortality, urgently requires novel therapeutic agents. Spontaneous PTB, resulting from preterm labor, is commonly caused by intrauterine infection/inflammation. Statins are well-established, cholesterol-lowering drugs that can reduce inflammation and inhibit vascular smooth muscle contraction. We show that simvastatin reduced the incidence of PTB in a validated intrauterine LPS-induced PTB mouse model, decreased uterine proinflammatory mRNA concentrations (IL-6, Cxcl1, and Ccl2), and reduced serum IL-6 concentration. In human myometrial cells, simvastatin reduced proinflammatory mediator mRNA and protein expression (IL-6 and IL-8) and increased anti-inflammatory cytokine mRNA expression (IL-10 and IL-13). Critically, simvastatin inhibited myometrial cell contraction, basally and during inflammation, and reduced phosphorylated myosin light chain concentration. Supplementation with mevalonate and geranylgeranyl pyrophosphate, but not farnesyl pyrophosphate, abolished these anticontractile effects, indicating that the Rho/Rho-associated protein kinase pathway is critically involved. Thus, simvastatin reduces PTB incidence in mice, inhibits myometrial contractions, and exhibits key anti-inflammatory effects, providing a rationale for investigation into the repurposing of statins to treat preterm labor in women.Boyle, A. K., Rinaldi, S. F., Rossi, A. G., Saunders, P. T. K., Norman, J. E. Repurposing simvastatin as a therapy for preterm labor: evidence from preclinical models.	[Boyle, Ashley K.; Rinaldi, Sara F.; Norman, Jane E.] Univ Edinburgh, Ctr Reprod Hlth, MRC, Tommys Ctr Maternal & Fetal Hlth, Edinburgh, Midlothian, Scotland; [Rossi, Adriano G.; Saunders, Philippa T. K.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Boyle, AK (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	ashley.boyle@ed.ac.uk	Saunders, Philippa TK/C-7489-2013	Saunders, Philippa TK/0000-0001-9051-9380; Norman, Jane/0000-0001-6031-6953	Tommy's Centre for Maternal and Fetal Health in the Medical Research Council (MRC) Centre for Reproductive Health [MR/N022556/1]; National Health Service (NHS) Research Scotland (NRS), through the Edinburgh Clinical Research Facility (CRF); MRC [MR/N022556/1, G0601481, MR/K013386/1] Funding Source: UKRI	Tommy's Centre for Maternal and Fetal Health in the Medical Research Council (MRC) Centre for Reproductive Health; National Health Service (NHS) Research Scotland (NRS), through the Edinburgh Clinical Research Facility (CRF); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by and undertaken in the Tommy's Centre for Maternal and Fetal Health in the Medical Research Council (MRC) Centre for Reproductive Health (Grant MR/N022556/1). The authors also acknowledge the financial support of the National Health Service (NHS) Research Scotland (NRS), through the Edinburgh Clinical Research Facility (CRF). The authors declare no conflicts of interest.	Aguilar HN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009965; Ali N, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0086-5; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; [Anonymous], 1977, Acta Obstet Gynecol Scand, V56, P247; Basraon SK, 2015, AM J REPROD IMMUNOL, V74, P54, DOI 10.1111/aji.12372; Basraon SK, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.020; Bateman BT, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1035; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; BRADFUTE DL, 1994, J BIOL CHEM, V269, P6645; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Chen YL, 2016, BIOMED REP, V5, P491, DOI 10.3892/br.2016.756; Costantine M, 2016, AM J OBSTET GYNECOL, V214, pS201, DOI 10.1016/j.ajog.2015.10.399; CRANKSHAW DJ, 1994, CAN J PHYSIOL PHARM, V72, P870, DOI 10.1139/y94-123; de Sotomayor MA, 2001, EUR J PHARMACOL, V415, P217, DOI 10.1016/S0014-2999(01)00819-6; Dichtl W, 2003, ARTERIOSCL THROM VAS, V23, P58, DOI 10.1161/01.ATV.0000043456.48735.20; Dunn SE, 2006, J EXP MED, V203, P401, DOI 10.1084/jem.20051129; Edison RJ, 2004, AM J MED GENET A, V131A, P287, DOI 10.1002/ajmg.a.30386; Gibb H, 2005, AM J MED GENET A, V135A, P230, DOI 10.1002/ajmg.a.30685; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gonzalez JM, 2014, MOL HUM REPROD, V20, P579, DOI 10.1093/molehr/gau019; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Haas DM, 2014, INT J WOMENS HEALTH, V6, P343, DOI 10.2147/IJWH.S44048; Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226; Harrison MS, 2016, SEMIN FETAL NEONAT M, V21, P74, DOI 10.1016/j.siny.2015.12.007; Hilgendorff A, 2003, INT J CLIN PHARM TH, V41, P397; Hudson CA, 2012, MOL HUM REPROD, V18, P265, DOI 10.1093/molehr/gar078; Hutchinson JL, 2014, FASEB J, V28, P94, DOI 10.1096/fj.13-237040; Iwata A, 2012, CLIN EXP IMMUNOL, V168, P234, DOI 10.1111/j.1365-2249.2012.04564.x; Kang S, 2014, TOXICOL SCI, V138, P446, DOI 10.1093/toxsci/kfu011; Karalis DG, 2016, J CLIN LIPIDOL, V10, P1081, DOI 10.1016/j.jacl.2016.07.002; Kawahara S, 2008, DIABETES, V57, P2784, DOI 10.2337/db08-0302; Kidera Yasuhiro, 2010, J Exp Clin Cancer Res, V29, P127, DOI 10.1186/1756-9966-29-127; Kusters DM, 2012, EXPERT REV CARDIOVAS, V10, P363, DOI [10.1586/erc.11.196, 10.1586/ERC.11.196]; Kuzuya M, 2004, J CARDIOVASC PHARM, V43, P808, DOI 10.1097/00005344-200406000-00010; Lampi MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147033; Lefkou E, 2016, J CLIN INVEST, V126, P2933, DOI 10.1172/JCI86957; Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524; Mackler AM, 2003, BIOL REPROD, V69, P1165, DOI 10.1095/biolreprod.103.015586; Makieva S, 2016, J CLIN ENDOCR METAB, V101, P1055, DOI 10.1210/jc.2015-2851; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Merx MW, 2004, CIRCULATION, V109, P2560, DOI 10.1161/01.CIR.0000129774.09737.5B; Monga M, 1996, BIOL REPROD, V55, P427, DOI 10.1095/biolreprod55.2.427; Moran CJ, 2002, MOL HUM REPROD, V8, P196, DOI 10.1093/molehr/8.2.196; Mraiche F, 2005, BRIT J PHARMACOL, V144, P715, DOI 10.1038/sj.bjp.0706114; Nagaoka T, 2007, INVEST OPHTH VIS SCI, V48, P825, DOI 10.1167/iovs.06-0856; Najib NM, 2003, BIOPHARM DRUG DISPOS, V24, P183, DOI 10.1002/bdd.347; Nasu K, 2009, FERTIL STERIL, V92, P2097, DOI 10.1016/j.fertnstert.2009.06.055; Nurenberg G, 2012, ANAL BIOANAL CHEM, V402, P671, DOI 10.1007/s00216-011-5262-2; Pedroni SMA, 2014, BBA-MOL BASIS DIS, V1842, P107, DOI 10.1016/j.bbadis.2013.10.011; Pehlivanoglu B, 2013, J TURK-GER GYNECOL A, V14, P230, DOI 10.5152/jtgga.2013.67763; Perez-Guerrero C, 2005, PHARMACOLOGY, V74, P209, DOI 10.1159/000085957; Petersen EE, 2008, AM J MED GENET A, V146A, P2701, DOI 10.1002/ajmg.a.32493; Rajagopal SP, 2015, MOL HUM REPROD, V21, P672, DOI 10.1093/molehr/gav027; Redecha P, 2008, J CLIN INVEST, V118, P3453, DOI 10.1172/JCI36089; Redecha P, 2009, BLOOD, V113, P4101, DOI 10.1182/blood-2008-12-194258; Rezaie-Majd A, 2002, ARTERIOSCL THROM VAS, V22, P1194, DOI 10.1161/01.ATV.0000022694.16328.CC; Rinaldi SF, 2015, AM J PATHOL, V185, P1201, DOI 10.1016/j.ajpath.2015.01.009; Rinaldi SF, 2011, EXPERT REV CLIN IMMU, V7, P675, DOI [10.1586/ECI.11.58, 10.1586/eci.11.58]; ROMERO R, 1994, ANN NY ACAD SCI, V734, P414, DOI 10.1111/j.1749-6632.1994.tb21771.x; Samizo K, 1999, BIOCHEM BIOPH RES CO, V261, P95, DOI 10.1006/bbrc.1999.0956; Schaafsma D, 2008, AM J PHYSIOL-LUNG C, V295, pL214, DOI 10.1152/ajplung.00498.2007; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; SOMLYO AP, 1994, NATURE, V372, P812; Tanaka S, 2010, J PHARMACOL SCI, V114, P454, DOI 10.1254/jphs.10229FP; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Veillard NR, 2006, ATHEROSCLEROSIS, V188, P51, DOI 10.1016/j.atherosclerosis.2005.10.015; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Xiao HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059233; Xu HS, 2006, ARTHRITIS RHEUM-US, V54, P3441, DOI 10.1002/art.22169; Yildirim FIA, 2016, FUND CLIN PHARMACOL, V30, P96, DOI 10.1111/fcp.12173; Young A, 2002, BIOL REPROD, V66, P445, DOI 10.1095/biolreprod66.2.445; Zarek J, 2014, J OBSTET GYNAECOL CA, V36, P506, DOI 10.1016/S1701-2163(15)30565-X; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110	79	18	18	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2743	2758		10.1096/fj.201801104R	http://dx.doi.org/10.1096/fj.201801104R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30312114	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000457296600097
J	Michel-Souzy, S; Douzi, B; Cadoret, F; Raynaud, C; Quinton, L; Ball, G; Voulhoux, R				Michel-Souzy, Sandra; Douzi, Badreddine; Cadoret, Frederic; Raynaud, Claire; Quinton, Loic; Ball, Genevieve; Voulhoux, Rome			Direct interactions between the secreted effector and the T2SS components GspL and GspM reveal a new effector-sensing step during type 2 secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; protein secretion; type II secretion system (T2SS); Pseudomonas aeruginosa (P; aeruginosa); protein assembly; protein complex; protein export; protein sorting; effector recognition; type 2 secretion; Xcp; Gsp	CYTOPLASMIC DOMAIN; PROTEIN SECRETION; CRYSTAL-STRUCTURE; VIBRIO-CHOLERAE; SYSTEM; MEMBRANE; BINDING; EPSL; PATHWAY; SPECIFICITY	In many Gram-negative bacteria, the type 2 secretion system (T2SS) plays an important role in virulence because of its capacity to deliver a large amount of fully folded protein effectors to the extracellular milieu. Despite our knowledge of most T2SS components, the mechanisms underlying effector recruitment and secretion by the T2SS remain enigmatic. Using complementary biophysical and biochemical approaches, we identified here two direct interactions between the secreted effector CbpD and two components, XcpY(L) and XcpZ(M), of the T2SS assembly platform (AP) in the opportunistic pathogen Pseudomonas aeruginosa. Competition experiments indicated that CbpD binding to XcpY(L) is XcpZ(M)-dependent, suggesting sequential recruitment of the effector by the periplasmic domains of these AP components. Using a bacterial two-hybrid system, we then tested the influence of the effector on the AP protein-protein interaction network. Our findings revealed that the presence of the effector modifies the AP interactome and, in particular, induces XcpZ(M) homodimerization and increases the affinity between XcpY(L) and XcpZ(M). The observed direct relationship between effector binding and T2SS dynamics suggests an additional synchronizing step during the type 2 secretion process, where the activation of the AP of the T2SS nanomachine is triggered by effector binding.	[Michel-Souzy, Sandra; Douzi, Badreddine; Cadoret, Frederic; Raynaud, Claire; Ball, Genevieve; Voulhoux, Rome] Aix Marseille Univ, CNRS, LISM, IMM,UMR7255, F-13009 Marseille, France; [Douzi, Badreddine; Raynaud, Claire; Ball, Genevieve; Voulhoux, Rome] Aix Marseille Univ, CNRS, IMM, LCB,UMR7283, F-13009 Marseille, France; [Quinton, Loic] Univ Liege, Dept Chem, Lab Mass Spectrometry MolSys, B-4000 Liege, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Liege	Voulhoux, R (corresponding author), Aix Marseille Univ, CNRS, LISM, IMM,UMR7255, F-13009 Marseille, France.; Voulhoux, R (corresponding author), Aix Marseille Univ, CNRS, IMM, LCB,UMR7283, F-13009 Marseille, France.	voulhoux@imm.cnrs.fr	Douzi, Badreddine/ABA-4540-2021; douzi, Badreddine/Z-5707-2019; Voulhoux, Rome/AAT-5333-2021	Douzi, Badreddine/0000-0003-3140-4713; Voulhoux, Rome/0000-0002-5258-5958; Loic, Quinton/0000-0001-8153-9590; Raynaud, Claire/0000-0002-7121-8424; Michel-Souzy, Sandra/0000-0003-4774-9417	Agence Nationale de la Recherche [ANR-14-CE09-0027-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche Grant ANR-14-CE09-0027-01 (to R. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Abendroth J, 2004, J MOL BIOL, V338, P585, DOI 10.1016/j.jmb.2004.01.064; Abendroth J, 2009, J STRUCT BIOL, V168, P313, DOI 10.1016/j.jsb.2009.07.022; Abendroth J, 2009, J STRUCT BIOL, V166, P303, DOI 10.1016/j.jsb.2009.03.009; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; Ball G, 1999, J BACTERIOL, V181, P382, DOI 10.1128/JB.181.2.382-388.1999; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Cadoret F, 2014, J BACTERIOL, V196, P2376, DOI 10.1128/JB.01563-14; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Chen YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059123; Cianciotto NP, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00014-17; Cisneros DA, 2012, EMBO J, V31, P1041, DOI 10.1038/emboj.2011.454; Douzi B, 2017, MBIO, V8, DOI 10.1128/mBio.01185-17; Douzi B, 2016, SCI REP-UK, V6, DOI 10.1038/srep34405; Douzi B, 2012, PHILOS T R SOC B, V367, P1059, DOI 10.1098/rstb.2011.0204; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Douzi B, 2009, J BIOL CHEM, V284, P34580, DOI 10.1074/jbc.M109.042366; Georgiadou M, 2012, MOL MICROBIOL, V84, P857, DOI 10.1111/j.1365-2958.2012.08062.x; Gerard-Vincent M, 2002, MOL MICROBIOL, V44, P1651, DOI 10.1046/j.1365-2958.2002.02991.x; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; Gu S, 2017, BBA-PROTEINS PROTEOM, V1865, P1255, DOI 10.1016/j.bbapap.2017.07.006; Hay ID, 2017, MBIO, V8, DOI 10.1128/mBio.01344-17; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Lallemand M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079562; Leighton TL, 2016, J BIOL CHEM, V291, P19923, DOI 10.1074/jbc.M116.738377; Login FH, 2006, J BIOL CHEM, V281, P33152, DOI 10.1074/jbc.M606245200; Lu C, 2014, J STRUCT BIOL, V187, P223, DOI 10.1016/j.jsb.2014.07.006; Miller J. H., 1972, EXPT MOL GENETICS, P156; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Nivaskumar M, 2016, MOL MICROBIOL, V101, P924, DOI 10.1111/mmi.13432; Nivaskumar M, 2014, STRUCTURE, V22, P685, DOI 10.1016/j.str.2014.03.001; Pineau C, 2014, MOL MICROBIOL, V94, P126, DOI 10.1111/mmi.12744; PUGSLEY AP, 1991, MOL MICROBIOL, V5, P343, DOI 10.1111/j.1365-2958.1991.tb02115.x; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Sandkvist M, 1999, J BACTERIOL, V181, P3129, DOI 10.1128/JB.181.10.3129-3135.1999; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Santos-Moreno J, 2017, J MOL BIOL, V429, P1746, DOI 10.1016/j.jmb.2017.04.005; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Shiue SJ, 2006, EMBO J, V25, P1426, DOI 10.1038/sj.emboj.7601036; Thomassin JL, 2017, MOL MICROBIOL, V105, P211, DOI 10.1111/mmi.13704; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Wang XH, 2012, J BIOL CHEM, V287, P19082, DOI 10.1074/jbc.M112.346338; Yan ZF, 2017, NAT STRUCT MOL BIOL, V24, P177, DOI 10.1038/nsmb.3350	48	9	10	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19441	19450		10.1074/jbc.RA117.001127	http://dx.doi.org/10.1074/jbc.RA117.001127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30337370	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000453537300024
J	Winter, AJ; Williams, C; Isupov, MN; Crocker, H; Gromova, M; Marsh, P; Wilkinson, OJ; Dillingham, MS; Harmer, NJ; Titball, RW; Crump, MP				Winter, Ashley J.; Williams, Christopher; Isupov, Michail N.; Crocker, Hannah; Gromova, Mariya; Marsh, Philip; Wilkinson, Oliver J.; Dillingham, Mark S.; Harmer, Nicholas J.; Titball, Richard W.; Crump, Matthew P.			The molecular basis of protein toxin HicA-dependent binding of the protein antitoxin HicB to DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structural biology; X-ray crystallography; DNA-binding protein; protein-protein interaction; bacterial toxin; antibiotic resistance; conditional cooperativity; HicAB; persistence; toxin-antitoxin system; type II TA system	TRANSCRIPTIONAL REPRESSION; BACTERIAL PERSISTENCE; CRYSTAL-STRUCTURE; SYSTEM; MECHANISMS; RESOLUTION; INHIBITION; REFINEMENT; ALLOSTERY; DISORDER	Toxin-antitoxin (TA) systems are present in many bacteria and play important roles in bacterial growth, physiology, and pathogenicity. Those that are best studied are the type II TA systems, in which both toxins and antitoxins are proteins. The HicAB system is one of the prototypic TA systems, found in many bacterial species. Complex interactions between the protein toxin (HicA), the protein antitoxin (HicB), and the DNA upstream of the encoding genes regulate the activity of this system, but few structural details are available about how HicA destabilizes the HicB-DNA complex. Here, we determined the X-ray structures of HicB and the HicAB complex to 1.8 and 2.5 angstrom resolution, respectively, and characterized their DNA interactions. This revealed that HicB forms a tetramer and HicA and HicB form a heterooctameric complex that involves structural reorganization of the C-terminal (DNA-binding) region of HicB. Our observations indicated that HicA has a profound impact on binding of HicB to DNA sequences upstream of hicAB in a stoichiometric-dependent way. At low ratios of HicA:HicB, there was no effect on DNA binding, but at higher ratios, the affinity for DNA declined cooperatively, driving dissociation of the HicA:HicB:DNA complex. These results reveal the structural mechanisms by which HicA de-represses the HicB-DNA complex.	[Winter, Ashley J.; Williams, Christopher; Crocker, Hannah; Gromova, Mariya; Marsh, Philip; Crump, Matthew P.] Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England; [Isupov, Michail N.; Harmer, Nicholas J.; Titball, Richard W.] Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter EX4 4QD, Devon, England; [Wilkinson, Oliver J.; Dillingham, Mark S.] Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England	University of Bristol; University of Exeter; University of Bristol	Crump, MP (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.; Titball, RW (corresponding author), Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter EX4 4QD, Devon, England.	R.W.Titball@exeter.ac.uk; Matt.crump@bristol.ac.uk	Wiliams, Christopher/P-4904-2015; Isupov, Mikhail/AAA-8280-2019	Wiliams, Christopher/0000-0001-5806-9842; Crump, Matthew/0000-0002-7868-5818; Winter, Ash/0000-0003-3684-9383; Isupov, Michail/0000-0001-6842-4289; Dillingham, Mark/0000-0002-4612-7141	Biotechnology and Biological Sciences Research Council-funded South West Biosciences Doctoral Training Partnership Training Grant [BB/J014400/1]; Engineering and Physical Sciences Research Council [EP/K03927X/1] Funding Source: researchfish; BBSRC [BB/L01386X/1] Funding Source: UKRI; EPSRC [EP/K03927X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council-funded South West Biosciences Doctoral Training Partnership Training Grant; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council-funded South West Biosciences Doctoral Training Partnership Training Grant BB/J014400/1. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bibi-Triki S, 2014, J BACTERIOL, V196, P3712, DOI 10.1128/JB.01932-14; Boggild A, 2012, STRUCTURE, V20, P1641, DOI 10.1016/j.str.2012.08.017; Brown BL, 2013, J BIOL CHEM, V288, P1286, DOI 10.1074/jbc.M112.421008; Butt A, 2014, BIOCHEM J, V459, P333, DOI 10.1042/BJ20140073; Cheverton AM, 2016, MOL CELL, V63, P86, DOI 10.1016/j.molcel.2016.05.002; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Garcia-Pino A, 2016, NAT CHEM BIOL, V12, P490, DOI [10.1038/nchembio.2078, 10.1038/NCHEMBIO.2078]; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Goormaghtigh F, 2018, MBIO, V9, DOI 10.1128/mBio.01838-18; Hall AMJ, 2017, CURR OPIN MICROBIOL, V36, P102, DOI 10.1016/j.mib.2017.02.003; Harms A, 2018, MOL CELL, V70, P768, DOI 10.1016/j.molcel.2018.01.003; Harms A, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4268; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Huang XY, 2003, J BIOMOL SCREEN, V8, P34, DOI 10.1177/1087057102239666; Johnson EP, 1996, J BACTERIOL, V178, P1420, DOI 10.1128/jb.178.5.1420-1429.1996; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kedzierska B, 2007, NUCLEIC ACIDS RES, V35, P325, DOI 10.1093/nar/gkl1028; Kedzierska B, 2016, MOLECULES, V21, DOI 10.3390/molecules21060790; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kim DH, 2018, NUCLEIC ACIDS RES, V46, P6371, DOI 10.1093/nar/gky469; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee KY, 2016, TOXINS, V8, DOI 10.3390/toxins8100305; Lewis ERG, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw070; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Lobato-Marquez D, 2016, FEMS MICROBIOL REV, V40, P592, DOI 10.1093/femsre/fuw022; Loris R, 2014, CHEM REV, V114, P6933, DOI 10.1021/cr400656f; Magnuson R, 1998, J BACTERIOL, V180, P6342; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; Mate MJ, 2012, NUCLEIC ACIDS RES, V40, P3245, DOI 10.1093/nar/gkr1167; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Milo R, 2013, BIOESSAYS, V35, P1050, DOI 10.1002/bies.201300066; Monti MC, 2007, NUCLEIC ACIDS RES, V35, P1737, DOI 10.1093/nar/gkm073; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Muthuramalingam M, 2016, TOXINS, V8, DOI 10.3390/toxins8070214; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Ruangprasert A, 2014, J BIOL CHEM, V289, P20559, DOI 10.1074/jbc.M114.573006; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Song S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00814; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TAYYAB S, 1991, BIOCHEM EDUC, V19, P149, DOI 10.1016/0307-4412(91)90060-L; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Turnbull KJ, 2017, MOL MICROBIOL, V104, P781, DOI 10.1111/mmi.13662; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wen YR, 2016, ANAL BIOANAL CHEM, V408, P5925, DOI 10.1007/s00216-016-9709-3; Wilbur JS, 2005, BIOCHEMISTRY-US, V44, P12515, DOI 10.1021/bi0511080; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Zorzini V, 2014, NUCLEIC ACIDS RES, V42, P6709, DOI 10.1093/nar/gku266	68	6	6	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19429	19440		10.1074/jbc.RA118.005173	http://dx.doi.org/10.1074/jbc.RA118.005173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30337369	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000453537300023
J	Hintze, J; Ye, ZL; Narimatsu, Y; Madsen, TD; Joshi, HJ; Goth, CK; Linstedt, A; Bachert, C; Mandel, U; Bennett, EP; Vakhrushev, SY; Schjoldager, KT				Hintze, John; Ye, Zilu; Narimatsu, Yoshiki; Madsen, Thomas Daugbjerg; Joshi, Hiren J.; Goth, Christoffer K.; Linstedt, Adam; Bachert, Collin; Mandel, Ulla; Bennett, Eric P.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.			Probing the contribution of individual polypeptide GalNAc- transferase isoforms to the O-glycoproteome by inducible expression in isogenic cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; ALPHA-D-GALACTOSAMINE; LINKED GLYCOSYLATION; UDP-GALNAC; SUBSTRATE SPECIFICITIES; 3 MEMBERS; LOCI; ASSOCIATION; ACTIVATION; INITIATION	The GalNAc-type O-glycoproteome is orchestrated by a large family of polypeptide GalNAc-transferase isoenzymes (GalNAc-Ts) with partially overlapping contributions to the O-glycoproteome besides distinct nonredundant functions. Increasing evidence indicates that individual GalNAc-Ts co-regulate and fine-tune specific protein functions in health and disease, and deficiencies in individual GALNT genes underlie congenital diseases with distinct phenotypes. Studies of GalNAc-T specificities have mainly been performed with in vitro enzyme assays using short peptide substrates, but recently quantitative differential O-glycoproteomics of isogenic cells with and without GALNT genes has enabled a more unbiased exploration of the nonredundant contributions of individual GalNAc-Ts. Both approaches suggest that fairly small subsets of O-glycosites are nonredundantly regulated by specific GalNAc-Ts, but how these isoenzymes orchestrate regulation among competing redundant substrates is unclear. To explore this, here we develop disogenic cell model systems with Tet-On inducible expression of two GalNAc-T genes, GALNT2 and GALNT11, in a knockout background in HEK293 cells. Using quantitative O-glycoproteomics with tandem-mass-tag (TMT) labeling, we found that isoform-specific glycosites are glycosylated in a dose-dependent manner and that induction of GalNAc-T2 or-T11 produces discrete glycosylation effects without affecting the major part of the O-glycoproteome. These results support previous findings indicating that individual GalNAc-T isoenzymes can serve in fine-tuned regulation of distinct protein functions.	[Hintze, John; Ye, Zilu; Narimatsu, Yoshiki; Madsen, Thomas Daugbjerg; Joshi, Hiren J.; Goth, Christoffer K.; Mandel, Ulla; Bennett, Eric P.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Hintze, John; Ye, Zilu; Narimatsu, Yoshiki; Madsen, Thomas Daugbjerg; Joshi, Hiren J.; Goth, Christoffer K.; Mandel, Ulla; Bennett, Eric P.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Mol Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Hintze, John; Ye, Zilu; Narimatsu, Yoshiki; Madsen, Thomas Daugbjerg; Joshi, Hiren J.; Goth, Christoffer K.; Mandel, Ulla; Bennett, Eric P.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.] Univ Copenhagen, Fac Hlth Sci, Sch Dent, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Linstedt, Adam; Bachert, Collin] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA	University of Copenhagen; University of Copenhagen; University of Copenhagen; Carnegie Mellon University	Schjoldager, KT (corresponding author), Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	schjoldager@sund.ku.dk	Bennett, Eric/AAG-6120-2020; Vakhrushev, Sergey Y/A-7638-2014; Joshi, Hiren/B-5739-2016; Narimatsu, Yoshiki/G-8388-2019	Bennett, Eric/0000-0002-4976-0647; Vakhrushev, Sergey Y/0000-0002-0418-5765; Ye, Zilu/0000-0001-8829-6579; Mandel, Ulla/0000-0001-7012-9836; Hintze, John/0000-0003-1420-7398; Goth, Christoffer/0000-0002-5766-1411; Madsen, Thomas Daugbjerg/0000-0002-7598-4636; Joshi, Hiren/0000-0002-8192-2829; Narimatsu, Yoshiki/0000-0003-1428-5695	Laege Sofus Carl Emil Friis og hustru Olga Doris Friis' Legat; Kirsten og Freddy Johansen Fonden; Lundbeck Foundation; Mizutani Foundation; Novo Nordisk Foundation; Danish Research Council Sapere Aude Research Talent Grant; Danish National Research Foundation [DNRF107]; A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; NATIONAL CANCER INSTITUTE [U01CA230677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE026714] Funding Source: NIH RePORTER	Laege Sofus Carl Emil Friis og hustru Olga Doris Friis' Legat; Kirsten og Freddy Johansen Fonden; Lundbeck Foundation(Lundbeckfonden); Mizutani Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Council Sapere Aude Research Talent Grant; Danish National Research Foundation(Danmarks Grundforskningsfond); A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Laege Sofus Carl Emil Friis og hustru Olga Doris Friis' Legat, Kirsten og Freddy Johansen Fonden, the Lundbeck Foundation, A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal, the Mizutani Foundation, the Novo Nordisk Foundation, the Danish Research Council Sapere Aude Research Talent Grant (to K. T. S.), and Danish National Research Foundation Grant DNRF107. The authors declare that they have no conflicts of interest with the contents of this article.	Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bennett EP, 2010, GLYCOCONJUGATE J, V27, P435, DOI 10.1007/s10719-010-9290-5; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Cavalli M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0183-x; Chia PZC, 2014, TRAFFIC, V15, P572, DOI 10.1111/tra.12161; de las Rivas M, 2018, CHEM-EUR J, V24, P8382, DOI 10.1002/chem.201800701; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Gerken TA, 2013, J BIOL CHEM, V288, P19900, DOI 10.1074/jbc.M113.477877; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gorski M, 2015, KIDNEY INT, V87, P1017, DOI 10.1038/ki.2014.361; Goth CK, 2018, TRENDS BIOCHEM SCI, V43, P269, DOI 10.1016/j.tibs.2018.02.005; Hansen L, 2015, GLYCOBIOLOGY, V25, P211, DOI 10.1093/glycob/cwu104; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hirst J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004411; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Joshi HJ, 2018, GLYCOBIOLOGY, V28, P284, DOI 10.1093/glycob/cwy015; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Khetarpal SA, 2016, CELL METAB, V24, P234, DOI 10.1016/j.cmet.2016.07.012; King SL, 2017, BLOOD ADV, V1, P429, DOI 10.1182/bloodadvances.2016002121; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Lavrsen K, 2018, J BIOL CHEM, V293, P1298, DOI 10.1074/jbc.M117.812826; Lira-Navarrete E, 2014, ANGEW CHEM INT EDIT, V53, P8206, DOI 10.1002/anie.201402781; Liu M, 2017, J BIOL CHEM, V292, P8412, DOI 10.1074/jbc.M117.779256; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Maxson JE, 2014, J BIOL CHEM, V289, P5820, DOI 10.1074/jbc.M113.508440; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Miwa HE, 2010, J BIOL CHEM, V285, P1208, DOI 10.1074/jbc.M109.035436; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Nakayama Y, 2014, GENE EXPR PATTERNS, V16, P1, DOI 10.1016/j.gep.2014.07.001; Nehrke K, 1998, GLYCOBIOLOGY, V8, P367, DOI 10.1093/glycob/8.4.367; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Pedersen NB, 2014, J BIOL CHEM, V289, P17312, DOI 10.1074/jbc.M113.545053; Pinto R, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx371; Puthenveedu MA, 2001, J CELL BIOL, V155, P227, DOI 10.1083/jcb.200105005; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Revoredo L, 2016, GLYCOBIOLOGY, V26, P360, DOI 10.1093/glycob/cwv108; Roman TS, 2015, AM J HUM GENET, V97, P801, DOI 10.1016/j.ajhg.2015.10.016; Rottger S, 1998, J CELL SCI, V111, P45; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Song K, 2017, J BIOL CHEM, V292, P16491, DOI 10.1074/jbc.M117.798512; Song LN, 2014, J BIOL CHEM, V289, P30556, DOI 10.1074/jbc.M114.599563; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Tian E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115861; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Tran DT, 2012, J BIOL CHEM, V287, P5243, DOI 10.1074/jbc.M111.306159; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Walsh G, 2010, DRUG DISCOV TODAY, V15, P773, DOI 10.1016/j.drudis.2010.06.009; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang SJ, 2018, J BIOL CHEM, V293, P7408, DOI 10.1074/jbc.M117.817981; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yu HJ, 2015, NAT CHEM BIOL, V11, P847, DOI 10.1038/nchembio.1927	70	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19064	19077		10.1074/jbc.RA118.004516	http://dx.doi.org/10.1074/jbc.RA118.004516			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30327431	hybrid, Green Published			2022-12-26	WOS:000458467400020
J	Strakova, K; Kowalski-Jahn, M; Gybel, T; Valnohova, J; Dhople, VM; Harnos, J; Bernatik, O; Ganji, RS; Zdrahal, Z; Mulder, J; Lindskog, C; Bryja, V; Schulte, G				Strakova, Katerina; Kowalski-Jahn, Maria; Gybel, Tomas; Valnohova, Jana; Dhople, Vishnu M.; Harnos, Jakub; Bernatik, Ondrej; Ganji, Ranjani Sri; Zdrahal, Zbynek; Mulder, Jan; Lindskog, Cecilia; Bryja, Vitezslav; Schulte, Gunnar			Dishevelled enables casein kinase 1-mediated phosphorylation of Frizzled 6 required for cell membrane localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEP DOMAIN; FUNCTIONAL-ANALYSIS; PLANAR POLARITY; BETA-ARRESTINS; DIX DOMAIN; I-EPSILON; RECEPTOR; RECRUITMENT; COMPLEX; GROWTH	Frizzleds (FZDs) are receptors for secreted lipoglycoproteins of the Wingless/Int-1(WNT) family, initiating an important signal transduction network in multicellular organisms. FZDs are G protein-coupled receptors (GPCRs), which are well known to be regulated by phosphorylation, leading to specific downstream signaling or receptor desensitization. The role and underlying mechanisms of FZD phosphorylation remain largely unexplored. Here, we investigated the phosphorylation of human FZD(6). Using MS analysis and a phospho-state- and -site-specific antibody, we found that Ser-648, located in the FZD(6) C terminus, is efficiently phosphorylated by casein kinase 1 is an element of (CK1 is an element of) and that this phosphorylation requires the scaffolding protein Dishevelled (DVL). In an overexpression system, DVL1, -2, and -3 promoted CK1-mediated FZD(6) phosphorylation on Ser-648. This DVL activity required an intact DEP domain and FZD-mediated recruitment of this domain to the cell membrane. Substitution of the CK1 is an element of-targeted phosphomo-tif reduced FZD(6) surface expression, suggesting that Ser-648 phosphorylation controls membrane trafficking of FZD(6). Phos-pho-Ser-648 FZD(6) immunoreactivity in human fallopian tube epithelium was predominantly apical, associated with cilia in a subset of epithelial cells, compared with the total FZD(6) protein expression, suggesting that FZD(6) phosphorylation contributes to asymmetric localization of receptor function within the cell and to epithelial polarity. Given the key role of FZD(6) in planar cell polarity, our results raise the possibility that asymmetric phosphorylation of FZD(6) rather than asymmetric protein distribution accounts for polarized receptor signaling.	[Strakova, Katerina; Gybel, Tomas; Harnos, Jakub; Bernatik, Ondrej; Ganji, Ranjani Sri; Bryja, Vitezslav; Schulte, Gunnar] Masaryk Univ, Fac Sci, Lab WNT Signaling, Inst Expt Biol, Kotlarska 2, CS-61137 Brno, Czech Republic; [Strakova, Katerina; Kowalski-Jahn, Maria; Valnohova, Jana; Schulte, Gunnar] Karolinska Inst, Biomedicum 6D, Dept Physiol & Pharmacol, Sect Receptor Biol & Signaling, Tomtebodavagen 16, SE-17165 Stockholm, Sweden; [Dhople, Vishnu M.] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Funct Genom, Friedrich Ludwig Jahn Str 15, D-17487 Greifswald, Germany; [Ganji, Ranjani Sri; Zdrahal, Zbynek] Masaryk Univ, Cent European Inst Technol, Kamenice 5, Brno 62500, Czech Republic; [Mulder, Jan] Karolinska Inst, Dept Neurosci, Sci Life Lab, Tomtebodavagen 16, S-17165 Stockholm, Sweden; [Lindskog, Cecilia] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Sci Life Lab, Dag Hammarskjolds Vag 20, S-75185 Uppsala, Sweden	Masaryk University Brno; Karolinska Institutet; Ernst Moritz Arndt Universitat Greifswald; Masaryk University Brno; Karolinska Institutet; Uppsala University	Bryja, V (corresponding author), Masaryk Univ, Fac Sci, Lab Cellular Commun, Dept Expt Biol, Kotlarska 2, CS-61137 Brno, Czech Republic.; Schulte, G (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Receptor Biol & Signaling, S-17177 Stockholm, Sweden.	bryja@sci.muni.cz; gunnar.schulte@ki.se	Bryja, Vítězslav/P-4217-2019; Mulder, Jan/G-3909-2011; Ganji, Ranjani/AGD-5702-2022; Lindskog, Cecilia/AAE-5462-2019; Zdrahal, Zbynek/D-9491-2012; Lindskog, Cecilia/AAO-2441-2021; Mulder, Jan/AAG-9761-2021; Harnos, Jakub/AAE-7855-2021	Bryja, Vítězslav/0000-0002-9136-5085; Mulder, Jan/0000-0003-3717-5018; Gybel, Tomas/0000-0002-5244-1524; Harnos, Jakub/0000-0002-0752-9260; Schulte, Gunnar/0000-0002-2700-7013; Bernatik, Ondrej/0000-0002-2188-332X; Kowalski-Jahn, Maria/0000-0003-1442-3656; Lindskog, Cecilia/0000-0001-5611-1015; Zdrahal, Zbynek/0000-0003-3044-5548	Karolinska Institutet; Swedish Research Council [2013-5708, 2015-02899]; Science for Life Laboratory; Swedish Cancer Society [CAN2014/659, CAN2017/561]; Knut and Alice Wallenberg Foundation [KAW2008.0149]; Stiftelsen Olle Engkvist Byggmastare [2016/193]; Czech Science Foundation [13-32990S, GA17-16680S]; Program "KI-MU" [CZ.1.07/2.3.00/20.0180]; European Social Fund; state budget of the Czech Republic, Marie Curie ITN WntsApp Grant [608180]; Deutsche Forschungsgemeinschaft (DFG) German Research Foundation [KO 5463/1-1]	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Science for Life Laboratory; Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Czech Science Foundation(Grant Agency of the Czech Republic); Program "KI-MU"; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic, Marie Curie ITN WntsApp Grant; Deutsche Forschungsgemeinschaft (DFG) German Research Foundation(German Research Foundation (DFG))	The work was supported by the Karolinska Institutet, the Swedish Research Council Grants 2013-5708 and 2015-02899, the Science for Life Laboratory, Swedish Cancer Society Grants CAN2014/659 and CAN2017/561), Knut and Alice Wallenberg Foundation Grant KAW2008.0149, Stiftelsen Olle Engkvist Byggmastare Grant 2016/193, Czech Science Foundation Grants 13-32990S and GA17-16680S, Program "KI-MU" Grant CZ.1.07/2.3.00/20.0180 cofinanced by the European Social Fund and the state budget of the Czech Republic, Marie Curie ITN WntsApp Grant 608180, and Deutsche Forschungsgemeinschaft (DFG) German Research Foundation Grant KO 5463/1-1. The authors declare that they have no conflicts of interest with the contents of this article.	Arthofer E, 2016, MOL PHARMACOL, V90, P447, DOI 10.1124/mol.116.104919; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Bernatik O, 2014, J BIOL CHEM, V289, P23520, DOI 10.1074/jbc.M114.590638; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Bryja V, 2008, EMBO REP, V9, P1244, DOI 10.1038/embor.2008.193; Cervenka I, 2016, P NATL ACAD SCI USA, V113, P9304, DOI 10.1073/pnas.1608783113; Chen MY, 2009, J BIOL CHEM, V284, P35040, DOI 10.1074/jbc.M109.047456; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Corda G, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.69; Cui CY, 2013, J INVEST DERMATOL, V133, P1990, DOI 10.1038/jid.2013.84; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Fiedler M, 2011, P NATL ACAD SCI USA, V108, P1937, DOI 10.1073/pnas.1017063108; Frojmark AS, 2011, AM J HUM GENET, V88, P852, DOI 10.1016/j.ajhg.2011.05.013; Gammons MV, 2016, J CELL SCI, V129, P3892, DOI 10.1242/jcs.195685; Gammons MV, 2016, MOL CELL, V64, P92, DOI 10.1016/j.molcel.2016.08.026; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Hua ZL, 2014, DEVELOPMENT, V141, P3944, DOI 10.1242/dev.110189; Kaucka M, 2013, CANCER RES, V73, P1491, DOI 10.1158/0008-5472.CAN-12-1752; Kilander MBC, 2014, CELL SIGNAL, V26, P1943, DOI 10.1016/j.cellsig.2014.05.012; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Komolov KE, 2017, CELL, V169, P407, DOI 10.1016/j.cell.2017.03.047; Koval A, 2011, BIOCHEM PHARMACOL, V82, P1311, DOI 10.1016/j.bcp.2011.06.005; Ma TJ, 2018, J BIOL CHEM, V293, P8410, DOI 10.1074/jbc.RA118.001906; Mlodzik M, 2016, CURR TOP DEV BIOL, V117, P75, DOI 10.1016/bs.ctdb.2015.11.027; Naz G, 2012, BRIT J DERMATOL, V166, P1088, DOI 10.1111/j.1365-2133.2011.10800.x; Onishi K, 2013, J NEUROSCI, V33, P19071, DOI 10.1523/JNEUROSCI.2800-13.2013; Paclikova P, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00145-17; Pau Milly S, 2015, J Mol Signal, V10, P5, DOI 10.5334/1750-2187-10-6; Petersen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00253-9; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Schulte G, 2010, GPCR MOL PHARM DRUG; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Schulte G, 2010, BRIT J PHARMACOL, V159, P1051, DOI 10.1111/j.1476-5381.2009.00466.x; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Shafer B, 2011, DEV CELL, V20, P177, DOI 10.1016/j.devcel.2011.01.002; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Strakova K, 2017, CELL SIGNAL, V38, P85, DOI 10.1016/j.cellsig.2017.06.018; Strutt H, 2006, CURR BIOL, V16, P1329, DOI 10.1016/j.cub.2006.04.041; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang YS, 2016, CURR TOP DEV BIOL, V117, P113, DOI 10.1016/bs.ctdb.2015.11.028; Wang YF, 2006, J BIOL CHEM, V281, P11603, DOI 10.1074/jbc.M600713200; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wang YS, 2002, J NEUROSCI, V22, P8563; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Yang Z, 2017, MOL PHARMACOL, V92, P201, DOI 10.1124/mol.116.107839; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002	61	9	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18477	18493		10.1074/jbc.RA118.004656	http://dx.doi.org/10.1074/jbc.RA118.004656			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30309985	Green Published, hybrid			2022-12-26	WOS:000458467300006
J	Mendoza-Topaz, C; Nelson, G; Howard, G; Hafner, S; Rademacher, P; Frick, M; Nichols, BJ				Mendoza-Topaz, C.; Nelson, G.; Howard, G.; Hafner, S.; Rademacher, P.; Frick, M.; Nichols, B. J.			Cells respond to deletion of CAV1 by increasing synthesis of extracellular matrix	PLOS ONE			English	Article							TRANSCRIPT-RELEASE FACTOR; LIPID-METABOLISM; POLYMERASE-I; MECHANICAL-STRESS; PLASMA-MEMBRANE; CAVEOLAE; PROTEIN; GENE; SYSTEM; LUNG	A range of cellular functions have been attributed to caveolae, flask-like invaginations of the plasma membrane. Here, we have used RNA-seq to achieve quantitative transcriptional profiling of primary embryonic fibroblasts from caveolin 1 knockout mice (CAV1-/- MEFs), and thereby to gain hypothesis-free insight into how these cells respond to the absence of caveolae. Components of the extracellular matrix were decisively over-represented within the set of genes displaying altered expression in CAV1-/- MEFs when compared to congenic wild-type controls. This was confirmed biochemically and by imaging for selected examples. Up-regulation of components of the extracellular matrix was also observed in a second cell line, NIH-3T3 cells genome edited to delete CAV1. Up-regulation of components of the extracellular matrix was detected in vivo by assessing collagen deposition and compliance of CAV1-/- lungs. We discuss the implications of these findings in terms of the cellular function of caveolae.	[Mendoza-Topaz, C.; Nelson, G.; Howard, G.; Nichols, B. J.] MRC, Lab Mol Biol, Cambridge, England; [Hafner, S.; Rademacher, P.] Univ Ulm, Inst Pathophysiol Anesthesiol & Proc Engn, Ulm, Germany; [Frick, M.] Univ Ulm, Inst Gen Physiol, Ulm, Germany; [Nelson, G.] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA	MRC Laboratory Molecular Biology; Ulm University; Ulm University; Harvard University; Harvard Medical School	Nichols, BJ (corresponding author), MRC, Lab Mol Biol, Cambridge, England.	ben@mrc-imb.cam.ac.uk	Frick, Manfred/E-1374-2012; Hafner, Sebastian/R-7482-2019	Frick, Manfred/0000-0002-4763-1104; Nelson, Geoffrey/0000-0001-9825-4241	Medical Research Council [MC_U105178778]; British Heart Foundation [PG/14/25/30726]; Ministry of Science, Research and the Arts of Baden-Wurttemberg [Az: 32-7533.-6-10/15/5]; Deutsche Forschungsgemeinschaft, Research training group GRK 2203; MRC [MC_U105178778] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Ministry of Science, Research and the Arts of Baden-Wurttemberg; Deutsche Forschungsgemeinschaft, Research training group GRK 2203(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council, MC_U105178778, Dr. Benjamin J Nichols British Heart Foundation, PG/14/25/30726, Dr. Benjamin J Nichols Ministry of Science, Research and the Arts of Baden-Wurttemberg Az: 32-7533.-6-10/15/5, Manfred Frick Deutsche Forschungsgemeinschaft, Research training group GRK 2203, Manfred Frick.	Andrews NW, 2014, TRENDS CELL BIOL, V20; Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004; Bastiani M, 2009, J CELL BIOL, V22, P22, DOI DOI 10.1083/JCB; Brandenberger C, 2017, CELL TISSUE RES, V367, P469, DOI 10.1007/s00441-016-2511-x; Cheng JPX, 2016, TRENDS CELL BIOL, V26, P177, DOI 10.1016/j.tcb.2015.10.010; Cheng JPX, 2015, J CELL BIOL, V211, P53, DOI 10.1083/jcb.201504042; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Collins BM, 2012, DEV CELL, V23, P11, DOI 10.1016/j.devcel.2012.06.012; Corrotte M, 2013, ELIFE, V2, DOI 10.7554/eLife.00926; Dancevic CM, 2016, BIOCHEM J, V473, P2011, DOI 10.1042/BCJ20160148; Davis MR, 2012, MOL GENET METAB, V107, P635, DOI 10.1016/j.ymgme.2012.07.023; Ding SY, 2014, J BIOL CHEM, V289, P8473, DOI 10.1074/jbc.M113.546242; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fernandez-Rojo MA, 2013, CELL REP, V4, P238, DOI 10.1016/j.celrep.2013.06.017; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Govender P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062045; Grover J, 2001, MATRIX BIOL, V20, P555, DOI 10.1016/S0945-053X(01)00165-2; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2808; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Hasegawa T, 2000, BIOCHEM J, V347, P55, DOI 10.1042/0264-6021:3470055; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Lo HP, 2015, J CELL BIOL, V210, P833, DOI 10.1083/jcb.201501046; Ludwig A, 2016, J CELL SCI, V129, P3077, DOI 10.1242/jcs.191262; Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Melo AA, 2017, P NATL ACAD SCI USA; MILICI AJ, 1987, J CELL BIOL, V105, P2603, DOI 10.1083/jcb.105.6.2603; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; Newman GR, 1999, CELL TISSUE RES, V295, P111, DOI 10.1007/s004410051217; OLDMIXON EH, 1988, STAIN TECHNOL, V63, P165, DOI 10.3109/10520298809107178; Parker S, 2009, MOL BIOL CELL, V20, P1763, DOI 10.1091/mbc.E08-08-0837; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pavlakis E, 2011, INT J BIOCHEM CELL B, V43, P487, DOI 10.1016/j.biocel.2010.12.016; Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001; Predescu SA, 2007, AM J PHYSIOL-LUNG C, V293, pL823, DOI 10.1152/ajplung.00436.2006; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Razani B, 2001, J BIOL CHEM, V276, P38121; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Rubini A, 2014, LUNG, V192, P833, DOI 10.1007/s00408-014-9630-5; Schrenk S, 2018, INT J MOL MED, V41, P1213, DOI 10.3892/ijmm.2017.3343; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Shvets E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7867; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98; Stralfors P, 2012, ADV EXP MED BIOL, V729, P111, DOI 10.1007/978-1-4614-1222-9_8; Thompson C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172067; Thomson J, 2018, SEMIN CELL DEV BIOL; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Verma P, 2010, MOL BIOL CELL, V21, P2226, DOI 10.1091/mbc.E09-05-0417; Yeow I, 2017, CURR BIOL, V27, P2951, DOI 10.1016/j.cub.2017.07.047	61	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205306	10.1371/journal.pone.0205306	http://dx.doi.org/10.1371/journal.pone.0205306			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX7HS	30346954	gold, Green Published, Green Submitted			2022-12-26	WOS:000447938400006
J	Pandey, A; Kumar, GA; Dandona, R; Dandona, L				Pandey, Anamika; Kumar, G. Anil; Dandona, Rakhi; Dandona, Lalit			Variations in catastrophic health expenditure across the states of India: 2004 to 2014	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; EPIDEMIOLOGIC TRANSITION; HOUSEHOLD; CARE	Background Financial protection is a key dimension of universal health coverage. Catastrophic health expenditure (CHE) has increased in India over time. The overall figures mask the subnational heterogeneity crucial for designing insurance coverage for 1.3 billion population across India. We estimated CHE in every state of India and the changes over a decade. Methods We used National Sample Survey data on health care utilisation in 2004 and 2014. The states were placed in four groups based on epidemiological transition level (ETL), defined on the basis of ratio of disability-adjusted life-years from communicable diseases to those from non-communicable diseases and injuries combined, with a low ratio denoting high ETL state group. CHE was defined as the proportion of households that had out-of-pocket payments for health care equalling or exceeding 10% of the household expenditure. We assessed variation in the magnitude and distribution of CHE between ETL state groups and between states of India. Results In 2014, CHE was higher in the high (30.3%, 95% confidence interval: 28.5 to 32.1) and higher-middle (27.4%, 26.3 to 28.6) ETL state groups than the low (21.8%, 20.8 to 22.8) and lower-middle (19.0%, 17.1 to 21.0) groups. From 2004 to 2014, CHE increased only in the high and higher-middle ETL groups (1.19 and 1.34 times, respectively). However, the individual states with substantial increase in CHE were spread across all ETL groups. The gap between the highest CHE of an individual state and the lowest was 8-fold in 2014. CHE was disproportionately concentrated among the rich in 2004 for most of India, but in 2014 CHE was distributed equally among the rich and poor because of the substantial increase in CHE among the poor over time. Conclusions Better provision of quality health care should be accompanied by financial protection measures to safeguard the poor from increasing CHE in India. The state-specific CHE trends can provide useful input for the planning of the recently launched National Health Protection Mission such that it meets the requirement of each state.	[Pandey, Anamika; Kumar, G. Anil; Dandona, Rakhi; Dandona, Lalit] Publ Hlth Fdn India, Gurugram, National Capita, India; [Dandona, Rakhi; Dandona, Lalit] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Public Health Foundation of India; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Pandey, A (corresponding author), Publ Hlth Fdn India, Gurugram, National Capita, India.	anamika.pandey@phfi.org	KUMAR, ANIL/ACD-8340-2022; Boothapati, Anil Kumar/HHS-1813-2022	Pandey, Anamika/0000-0001-5063-9898; Dandona, Rakhi/0000-0003-0926-788X	Wellcome Trust Capacity Strengthening Strategic Award; consortium of UK universities	Wellcome Trust Capacity Strengthening Strategic Award(Wellcome Trust); consortium of UK universities	This work was supported by a Wellcome Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India and a consortium of UK universities.	[Anonymous], HLTH 2015 MDGS MILL; [Anonymous], 2008, ANAL HLTH EQUITY USI; Arsenijevic J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157765; Bonu S, 2007, 102 ERD AS DEV BANK; Bonu S, 2009, HEALTH POLICY PLANN, V24, P445, DOI 10.1093/heapol/czp032; Dandona L, 2017, LANCET, V390, P2437, DOI 10.1016/S0140-6736(17)32804-0; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; Debroy B, 2015, LANCET, V386, pE56, DOI 10.1016/S0140-6736(15)01173-3; Dwivedi R, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0517-y; Fan V, 2016, HLTH WORKFORCE INDIA; Indian Council of Medical Research Public Health Foundation of India and Institute for Health Metrics and Evaluation, 2017, IND HLTH NAT STAT IN; Institute for Health Metrics and Evaluation (IHME) and Public Health Foundation of India (PHFI), 2018, HLTH SERV PROV GUJ A; Institute for Health Metrics and Evaluation (IHME) and Public Health Foundation of India (PHFI), 2018, HLTH SERV PROV ANDHR; Institute for Health Metrics and Evaluation (IHME) and Public Health Foundation of India (PHFI), 2018, HLTH SERV PROV OD AS; Institute for Health Metrics and Evaluation (IHME) and Public Health Foundation of India (PHFI), 2018, HLTH SERV PROV TAM N; Institute for Health Metrics and Evaluation (IHME) and Public Health Foundation of India (PHFI), 2018, HLTH SERV PROV MADH; International Monetary Fund, 2016, ENH PRINC GLOB IND P; International Monetary Fund, 2016, WORLD EC OUTLOOK DAT; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Kakwani NC, 1980, INCOME INEQUALITY PO; Karan A, 2017, SOC SCI MED, V181, P83, DOI 10.1016/j.socscimed.2017.03.053; Kastor A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196106; Kea Xu, 2011, DETERMINANTS HLTH EX; Koolman X, 2004, HEALTH ECON, V13, P649, DOI 10.1002/hec.884; McKeown RE, 2009, AM J LIFESTYLE MED, V3, p19S, DOI 10.1177/1559827609335350; Ministry of Health and Family Welfare, 2008, RASHTR SWASTH BIM YO; Ministry of Health Family Welfare GoI, 2017, NAT HLTH POL 2017; Mohanty SK, 2018, MILBANK Q, V96, P167, DOI 10.1111/1468-0009.12315; National Health Systems Resource Centre, 2016, NAT HLTH ACC EST IND; National Sample Survey Organisation, 2004, SURV MORB HLTH CAR N; National Sample Survey Organisation, 2014, SOC CONS HLTH NSS 71; Pandey A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014188; Pandey A, 2018, B WORLD HEALTH ORGAN, V96, P18, DOI 10.2471/BLT.17.191759; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Press Information Bureau Ministry of Finance Government of India, 2018, NAT HLTH PROT SCHEM; Prinja S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043093, 10.1371/journal.pone.0030362]; Raban MZ, 2013, B WORLD HEALTH ORGAN, V91, P726, DOI 10.2471/BLT.12.113100; Ranjan A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5431-8; Rao KD, 2014, SITUATION ANAL HLTH, V1; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Saito E, 2014, B WORLD HEALTH ORGAN, V92, P760, DOI 10.2471/BLT.13.126615; Selvaraj Sakthivel, 2012, ECON POLIT WEEKLY, V47, P61; Somkotra T, 2009, HEALTH AFFAIR, V28, pW467, DOI 10.1377/hlthaff.28.3.w467; Tolla MT, 2017, BMJ GLOB HEALTH, V2, DOI [10.1136/bmjgh-2016-000216, 10.1136/bmjgh-2016-000280]; UN Economic and Social Council, 2000, 1220004 EC UN EC SOC; United Nations, SUST DEV GOALS; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Kien VD, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0460-3; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Wagstaff A, 2018, LANCET GLOB HEALTH, V6, pE192, DOI 10.1016/S2214-109X(17)30429-1; World Health Organization World Bank, 2017, TRACK UN HLTH COV 20; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu YJ, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0892-2	53	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2018	13	10							e0205510	10.1371/journal.pone.0205510	http://dx.doi.org/10.1371/journal.pone.0205510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX7HS	30346971	gold, Green Published, Green Submitted			2022-12-26	WOS:000447938400011
J	Ejeta, E; Beyene, G; Balay, G; Bonsa, Z; Abebe, G				Ejeta, Eyasu; Beyene, Getenet; Balay, Getu; Bonsa, Zegeye; Abebe, Gemeda			Factors associated with unsuccessful treatment outcome in tuberculosis patients among refugees and their surrounding communities in Gambella Regional State, Ethiopia	PLOS ONE			English	Article							SOUTHERN REGION; POPULATIONS; PREVALENCE; COUNTRIES; GENDER; INDIA; HIV; TB	Background Tuberculosis (TB) is a leading cause of public health challenges among immigrant refugees and their surrounding communities in developing countries. Evaluating the treatment outcome of TB patients is one of the key indicators to understand the performance of TB control program. Hence, this study aims to assess profile, treatment outcome and factors associated with unsuccessful outcome of TB patients treated under the TB control program among refugees and their surrounding communities (SCs) in Gambella Regional State, Ethiopia. Methodology Retrospective study was conducted in the health facilities of refugee and their SCs in Gambella Regional State from March 1 to May 30, 2017. Demographic and related data of all TB patients registered in TB Control Program between September, 2008 and October, 2017 in health facilities of refugee and the SCs was extracted using data extraction format. Eight years trend of TB, treatment outcome and factors associated with unsuccessful outcome among refugees and the SCs were computed using SPSS version 20.0 software. Result A total of 886 refugees and 3284 SCs TB patients, registered for anti TB treatment in the last eight years, were evaluated in the study. The trend of all forms of TB is progressively increasing among refugees contrary to the SCs in the course of the study period (X-2 trend = 207.7; P<0.0001). Smear positive pulmonary TB (PTB+) was found to be predominant (57.6%) TB form in refugees while smear negative pulmonary TB (PTB-) (44.8%) is in the SCs (X-2 = 185.834; P<0.0001). There was also significant difference in the treatment outcome (X-2 = 170.915; P<0.0001). Mean treatment success rate was 74.2% and 88.1% for refugees and the SCs, respectively (X-2 = 92.887; P<0.0001). The study also revealed that the risk of unsuccessful TB treatment outcome was significantly higher among refugee (AOR = 2.17; 95% CI: 1.69-2.77), retreated cases (AOR = 1.53; 95% CI: 1.07-2.17), patients aged between 35-44 years (AOR = 1.38; 95% CI: 1.0-1.91), and greater than 44 years old (AOR = 1.77; 95% CI: 1.28-2.44), and patients with extra pulmonary TB (EPTB) form (AOR = 1.34; 95% CI: 1.04-1.73) compared to their counterparts. Patient coming from rural area (AOR = 0.77; 95% CI: 0.62-0.97), who are female (AOR = 0.76; 95% CI: 0.63-0.91) and TB/HIV non-infected (AOR = 0.63; 95% CI: 0.51-0.77) were more likely to be successfully treated. Conclusion The study confirmed that there was low treatment success rate among refugees compared to the SCs. Being refugee, retreated case, patient's age. 35 years old, EPTB form, gender, rural patient address and HIV status were predictor factors for unsuccessful treatment outcome. Hence, the study urges the need for strengthened TB prevention program among refugees with due consideration of identified predictor factors to prevent the potential effect of hosting refugee to the SCs and the nations at large.	[Ejeta, Eyasu; Balay, Getu; Bonsa, Zegeye; Abebe, Gemeda] Jimma Univ, Mycobacteriol Res Ctr, Jimma, Ethiopia; [Ejeta, Eyasu; Beyene, Getenet; Abebe, Gemeda] Jimma Univ, Dept Med Lab Sci & Pathol, Fac Hlth Sci, Jimma, Ethiopia; [Ejeta, Eyasu] Wollega Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Nekemte, Ethiopia	Jimma University; Jimma University	Ejeta, E (corresponding author), Jimma Univ, Mycobacteriol Res Ctr, Jimma, Ethiopia.; Ejeta, E (corresponding author), Jimma Univ, Dept Med Lab Sci & Pathol, Fac Hlth Sci, Jimma, Ethiopia.; Ejeta, E (corresponding author), Wollega Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Nekemte, Ethiopia.	eyasu.ejeta@gmail.com	Abebe, Gemeda/AAB-8789-2019; Ejeta, Eyasu/A-9493-2019	Abebe, Gemeda/0000-0002-7172-9136; Ejeta, Eyasu/0000-0001-7999-9440	Jimma University Mega Research Project; Jimma University Research Grant	Jimma University Mega Research Project; Jimma University Research Grant	Funding for this work was secured from Jimma University Mega Research Project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is part of a mega research project on Tuberculosis among refugees, and its impact in the surrounding communities in Ethiopia. It was funded by Jimma University Research Grant. The funding agents had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe Y, 2003, AIDS, V17, P1835, DOI 10.1097/00002030-200308150-00013; Administration for refuge and returnee affairs (ARRA), 2011, CLIM CHANG AD PROGR; Bao Q S, 2007, BMC PUBLIC HEALTH, V7, P344, DOI DOI 10.1186/; Belay M, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.27949; Berhe G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-537; Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Bodiang CK, 2000, SCOT MED J, V45, P25, DOI 10.1177/00369330000450S112; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Dangisso MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125135; Dogar OF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-244; Eshetie S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194675; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Federal Ministry of Health of Ethiopia, 2010, NAT TRAIN PACK PROV; Federal Ministry of Health of Ethiopia (FMoH), 2011, NAT TB LEPR CONTR PR; Gebrezgabiher G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150560; Gelaw M, 2001, East Afr Med J, V78, P382; Getahun B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-127; Gosoniu GD, 2008, INT J TUBERC LUNG D, V12, P848; Hamusse SD, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25382; Kimbrough W, 2012, LANCET INFECT DIS, V12, P950, DOI 10.1016/S1473-3099(12)70225-6; Lillebaek T, 2002, EMERG INFECT DIS, V8, P679, DOI 10.3201/eid0807.010482; Melese Addisu, 2016, Tuberc Res Treat, V2016, P1354356, DOI 10.1155/2016/1354356; Minetti A, 2010, INT J TUBERC LUNG D, V14, P1589; Muniyandi M, 2006, J Commun Dis, V38, P204; Muniyandi M, 2008, EXPERT OPIN PHARMACO, V9, P1623, DOI 10.1517/14656566.9.10.1623 ; Munoz-Sellart M, 2010, INT J TUBERC LUNG D, V14, P973; PORTER J, 1995, T ROY SOC TROP MED H, V89, P241, DOI 10.1016/0035-9203(95)90522-7; RIEDER HL, 1994, EUR RESPIR J, V7, P1545, DOI 10.1183/09031936.94.07081545; Rutta E, 2001, INT J TUBERC LUNG D, V5, P628; SHEARS P, 1984, TUBERCLE, V65, P111, DOI 10.1016/0041-3879(84)90062-X; Sisay Solomon, 2014, BMC Res Notes, V7, P44, DOI 10.1186/1756-0500-7-44; SUKRAKANCHANATRIKHAM P, 1992, TUBERCLE LUNG DIS, V73, P384, DOI 10.1016/0962-8479(92)90045-L; Tadesse S., 2014, Health, V6, P306, DOI 10.4236/health.2014.65044; Tessema B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-371; UNHCR, 2017, REF AS SEEK ETH; United Nations High Commissioner for Refugees (UNHCR), 2015, GLOB APP 2014 2015; van Hest R, 2013, EUR RESPIR J, V41, P635, DOI 10.1183/09031936.00030612; Wen YF, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3019-7; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Yassin MA, 2004, SCAND J INFECT DIS, V36, P670, DOI 10.1080/00365540410020848	40	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0205468	10.1371/journal.pone.0205468	http://dx.doi.org/10.1371/journal.pone.0205468			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335777	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300033
J	Hara, T; Kin, A; Aoki, S; Nakamura, S; Shirasuna, K; Kuwayama, T; Iwata, H				Hara, Tomotaka; Kin, Airi; Aoki, Sogo; Nakamura, Shinsuke; Shirasuna, Koumei; Kuwayama, Takehito; Iwata, Hisataka			Resveratrol enhances the clearance of mitochondrial damage by vitrification and improves the development of vitrified-warmed bovine embryos	PLOS ONE			English	Article							OOCYTE VITRIFICATION; QUALITY-CONTROL; MATURATION; DEGRADATION; GLUCOSE; SIRT1	The present study investigated the vitrification-induced deterioration of mitochondrial functions that may reduce the developmental ability of post-warming bovine embryos. In addition, the effect of supplementation of the culture medium with resveratrol on the mitochondrial functions and post-warming embryonic development was examined. Two days after in vitro fertilization, embryos with 8-12 cells (referred to hereafter as 8-cell embryos) were vitrified and warmed, followed by in vitro incubation for 5 days in a culture medium containing either the vehicle or 0.5 mu M resveratrol. Vitrification reduced embryonic development until the blastocyst stage, reduced the ATP content of embryos, and impaired the mitochondrial genome integrity, as determined by real-time polymerase chain reaction. Although the total cell number and mitochondrial DNA copy number (Mt-number) of blastocysts were low in the vitrified embryos, the Mt-number per blastomere was similar among the blastocysts derived from fresh (non-vitrified) and vitrified-warmed embryos. Supplementation of the culture medium with resveratrol enhanced the post-warming embryonic development and reduced the Mt-number and reactive oxygen species level in blastocysts and blastomeres without affecting the ATP content. An increase in the content of cell-free mitochondrial DNA in the spent culture medium was observed following cultivation of embryos with resveratrol. These results suggested that vitrification induces mitochondrial damages and that resveratrol may enhance the development of post-warming embryos and activates the degeneration of damaged mitochondria, as indicated by the increase in the cell-free mitochondrial DNA content in the spent culture medium and the decrease in the Mt-number of blastocysts and blastomeres.	[Hara, Tomotaka; Kin, Airi; Aoki, Sogo; Nakamura, Shinsuke; Shirasuna, Koumei; Kuwayama, Takehito; Iwata, Hisataka] Tokyo Univ Agr, Dept Anim Sci, Atsugi, Kanagawa, Japan	Tokyo University of Agriculture	Iwata, H (corresponding author), Tokyo Univ Agr, Dept Anim Sci, Atsugi, Kanagawa, Japan.	h1iwata@nodai.ac.jp		Iwata, HIsataka/0000-0001-7238-8997	The Science Research Promotion Fund by the Promotion and Mutual Aid Corporation for Private Schools of Japan; Japan Society for the Promotion of Science [16K07996]	The Science Research Promotion Fund by the Promotion and Mutual Aid Corporation for Private Schools of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by The Science Research Promotion Fund by the Promotion and Mutual Aid Corporation for Private Schools of Japan; Grant-in-Aid for Scientific Research C (KAKENHI, grant number: 16K07996) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2017, J REPROD DEVELOP, V63, P455, DOI 10.1262/jrd.2016-182; Chen HH, 2016, THERIOGENOLOGY, V86, P868, DOI 10.1016/j.theriogenology.2016.03.008; Dai JJ, 2015, CRYOBIOLOGY, V71, P291, DOI 10.1016/j.cryobiol.2015.08.002; Dalcin L, 2013, CRYOBIOLOGY, V67, P137, DOI 10.1016/j.cryobiol.2013.05.012; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Gualtieri R, 2009, FERTIL STERIL, V91, P1023, DOI 10.1016/j.fertnstert.2008.01.076; Ha AN, 2014, CRYOBIOLOGY, V68, P57, DOI 10.1016/j.cryobiol.2013.11.007; Hara H, 2012, THERIOGENOLOGY, V77, P908, DOI 10.1016/j.theriogenology.2011.09.018; Hashimoto S, 2017, J ASSIST REPROD GEN, V34, P573, DOI 10.1007/s10815-017-0886-6; Hayashi T, 2018, THERIOGENOLOGY, V106, P271, DOI 10.1016/j.theriogenology.2017.10.022; Itami N, 2015, REPRODUCTION, V150, P97, DOI 10.1530/REP-15-0037; Itami N, 2015, THERIOGENOLOGY, V83, P1360, DOI 10.1016/j.theriogenology.2015.01.029; Iwata H, 2004, REPRODUCTION, V127, P159, DOI 10.1530/rep.1.00084; Iwata H, 2011, REPROD FERT DEVELOP, V23, P424, DOI 10.1071/RD10133; Kansaku K, 2018, J REPROD DEVELOP, V64, P261, DOI 10.1262/jrd.2018-012; Kansaku K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188099; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee K, 2010, J REPROD DEVELOP, V56, P330, DOI 10.1262/jrd.09-174K; Lei T, 2014, J HUAZHONG U SCI-MED, V34, P99, DOI 10.1007/s11596-014-1238-8; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Nagai S, 2006, TOHOKU J EXP MED, V210, P137, DOI 10.1620/tjem.210.137; Papadopoulos S, 2002, ANIM REPROD SCI, V74, P35, DOI 10.1016/S0378-4320(02)00162-8; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082; Sato D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094488; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Shi LY, 2007, ANIM REPROD SCI, V100, P128, DOI 10.1016/j.anireprosci.2006.06.020; Sosulski ML, 2015, AGING CELL, V14, P774, DOI 10.1111/acel.12357; Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536; Stigliani S, 2013, HUM REPROD, V28, P2652, DOI 10.1093/humrep/det314; Sugiyama M, 2015, J REPROD DEVELOP, V61, P251, DOI 10.1262/jrd.2015-001; TAKAHASHI Y, 1992, THERIOGENOLOGY, V37, P963, DOI 10.1016/0093-691X(92)90096-A; Voos W, 2016, ESSAYS BIOCHEM, V60, P213, DOI 10.1042/EBC20160009; Wang F, 2014, FERTIL STERIL, V101, P577, DOI 10.1016/j.fertnstert.2013.10.041; Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018; Wu YC, 2011, NEUROSIGNALS, V19, P163, DOI 10.1159/000328516; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhang JQ, 2009, J ASSIST REPROD GEN, V26, P621, DOI 10.1007/s10815-009-9370-2; Zhao XM, 2011, MOL REPROD DEV, V78, P942, DOI 10.1002/mrd.21389	39	23	25	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0204571	10.1371/journal.pone.0204571	http://dx.doi.org/10.1371/journal.pone.0204571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335749	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300010
J	Sticht, C; De La Torre, C; Parveen, A; Gretz, N				Sticht, Carsten; De La Torre, Carolina; Parveen, Alisha; Gretz, Norbert			miRWalk: An online resource for prediction of microRNA binding sites	PLOS ONE			English	Article							TARGET INTERACTIONS	miRWalk is an open-source platform providing an intuitive interface that generates predicted and validated miRNA-binding sites of known genes of human, mouse, rat, dog and cow. The core of miRWalk is the miRNA target site prediction with the random-forest-based approach software TarPmiR searching the complete transcript sequence including the 5'-UTR, CDS and 3'-UTR. Moreover, it integrates results other databases with predicted and validated miRNA-target interactions. The focus is set on a modular design and extensibility as well as a fast update cycle. The database is available using Python, MySQL and HTML/Javascript Database URL: http://mirwalk.umm.uni-heidelberg.de.	[Sticht, Carsten; De La Torre, Carolina; Parveen, Alisha; Gretz, Norbert] Heidelberg Univ, Med Res Ctr, Med Fac Mannheim, Mannheim, Germany	Ruprecht Karls University Heidelberg	Sticht, C (corresponding author), Heidelberg Univ, Med Res Ctr, Med Fac Mannheim, Mannheim, Germany.	carsten.sticht@medma.uni-heidelberg.de		parveen, Alisha/0000-0002-9236-6821				Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bandyopadhyay S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08004; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Ding J, 2016, BIOINFORMATICS, V32, P2768, DOI 10.1093/bioinformatics/btw318; Dweep H, 2014, METHODS MOL BIOL, V1182, P289, DOI 10.1007/978-1-4939-1062-5_25; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Xu J, 2013, GENOME RES, V23, P1810, DOI 10.1101/gr.148916.112	8	631	639	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2018	13	10							e0206239	10.1371/journal.pone.0206239	http://dx.doi.org/10.1371/journal.pone.0206239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4KR	30335862	Green Published, Green Submitted, gold			2022-12-26	WOS:000447701300101
J	Saito, MM; Nishiura, H; Higuchi, T				Saito, Masaya M.; Nishiura, Hiroshi; Higuchi, Tomoyuki			Reconstructing the transmission dynamics of rubella in Japan, 2012-2013	PLOS ONE			English	Article							VACCINATION; IMMUNIZATION; EPIDEMIC; MEASLES; EUROPE; MODELS; IMPACT; RISK	Background Japan experienced a nationwide rubella epidemic from 2012 to 2013, mostly in urban prefectures with large population sizes. The present study aimed to capture the spatiotemporal patterns of rubella using a parsimonious metapopulation epidemic model and examine the potential usefulness of spatial vaccination. Methodology/Principal findings A metapopulation epidemic model in discrete time and space was devised and applied to rubella notification data from 2012 to 2013. Employing a piecewise constant model for the linear growth rate in six different time periods, and using the particle Markov chain Monte Carlo method, the effective reproduction numbers were estimated at 1.37 (95% Crl: 1.12, 1.77) and 1.37 (95% Crl: 1.24, 1.48) in Tokyo and Osaka groups, respectively, during the growing phase of the epidemic in 2013. The rubella epidemic in 2012 involved substantial uncertainties in its parameter estimates and forecasts. We examined multiple scenarios of spatial vaccination with coverages of 1%, 3% and 5% for all of Japan to be distributed in different combinations of prefectures. Scenarios indicated that vaccinating the top six populous urban prefectures (i.e., Tokyo, Kanagawa, Osaka, Aichi, Saitama and Chiba) could potentially be more effective than random allocation. However, greater uncertainty was introduced by stochasticity and initial conditions such as the number of infectious individuals and the fraction of susceptibles. Conclusions While the forecast in 2012 was accompanied by broad uncertainties, a narrower uncertainty bound of parameters and reliable forecast were achieved during the greater rubella epidemic in 2013. By better capturing the underlying epidemic dynamics, spatial vaccination could substantially outperform the random vaccination.	[Saito, Masaya M.; Higuchi, Tomoyuki] Inst Stat Math, Tachikawa, Tokyo, Japan; [Saito, Masaya M.; Nishiura, Hiroshi; Higuchi, Tomoyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan	Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Japan Science & Technology Agency (JST); Hokkaido University	Nishiura, H (corresponding author), Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan.; Nishiura, H (corresponding author), Hokkaido Univ, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan.	nishiurah@med.hokudai.ac.jp			Japan Agency for Medical Research and Development (AMED) [JP18fk0108050, JP18fk0108066]; Japanese Society for the Promotion of Science (JSPS) KAKENHI [16KT0130, 16K15356, 17H04701]; Telecommunications Advancement Foundation; Inamori Foundation; Japan Science and Technology Agency (JST) CREST program [JPMJCR1413]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japanese Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Telecommunications Advancement Foundation(Telecommunications Advancement Foundation); Inamori Foundation; Japan Science and Technology Agency (JST) CREST program	HN received funding from the Japan Agency for Medical Research and Development (AMED; grant numbers JP18fk0108050 and JP18fk0108066), Japanese Society for the Promotion of Science (JSPS) KAKENHI (grant numbers 16KT0130, 16K15356 and 17H04701), The Telecommunications Advancement Foundation and Inamori Foundation. All authors were financially supported by Japan Science and Technology Agency (JST) CREST program (JPMJCR1413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1984, J HYG-CAMBRIDGE, V93, P587, DOI 10.1017/S0022172400065177; Andrieu C, 2010, J R STAT SOC B, V72, P269, DOI 10.1111/j.1467-9868.2009.00736.x; Best JM, 2005, J INFECT DIS, V192, P1890, DOI 10.1086/497607; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Colizza V, 2006, B MATH BIOL, V68, P1893, DOI 10.1007/s11538-006-9077-9; d'Onofrio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045653; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P617, DOI 10.1017/S0950268800004660; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672; Gao ZH, 2013, VACCINE, V31, P691, DOI 10.1016/j.vaccine.2012.11.043; Gelfand AE, 2000, J ROY STAT SOC C-APP, V49, P385, DOI 10.1111/1467-9876.00199; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Hori A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129900; Kinoshita R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009928; Kitagawa G., 1996, J OF COMPUTATIONAL A, V5, P1, DOI DOI 10.2307/1390750; MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281; Metcalf CJE, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0756; Metcalf CJE, 2012, EPIDEMIOL INFECT, V140, P2290, DOI 10.1017/S0950268812000131; Metcalf CJE, 2011, J R SOC INTERFACE, V8, P369, DOI 10.1098/rsif.2010.0320; Ministry of Land Infrastructure Transport and Tourism (MLIT), 2011, STAT INT MOV PASS JA; Nakano S, 2016, NONLINEAR PROC GEOPH, V23, P31, DOI 10.5194/npg-23-31-2016; Nishiura H, 2015, INT J INFECT DIS, V38, P16, DOI 10.1016/j.ijid.2015.07.006; Panagiotopoulos T, 1999, BRIT MED J, V319, P1462, DOI 10.1136/bmj.319.7223.1462; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; van der Heijden OG, 1998, EPIDEMIOL INFECT, V121, P653, DOI 10.1017/S0950268898001472; Vynnycky E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149160; Vynnycky E, 2016, HUM VACC IMMUNOTHER, V12, P150, DOI 10.1080/21645515.2015.1060380	26	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205889	10.1371/journal.pone.0205889	http://dx.doi.org/10.1371/journal.pone.0205889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX3PM	30332469	gold, Green Published, Green Submitted			2022-12-26	WOS:000447638200075
J	Takeuchi, T; Ikudome, S; Unenaka, S; Ishii, Y; Mori, S; Mann, DL; Nakamoto, H				Takeuchi, Tatsuya; Ikudome, Sachi; Unenaka, Satoshi; Ishii, Yasumitsu; Mori, Shiro; Mann, David L.; Nakamoto, Hiroki			The inhibition of motor contagion induced by action observation	PLOS ONE			English	Article							ACTION ANTICIPATION; BASKETBALL PLAYERS; MIRROR-NEURON; SELF-TALK; IMITATION; SPORT; RESONANCE; GESTURES; EXPERT; ATTRIBUTION	In sports, success and failure are believed to be contagious. Yet it is unclear what might cause contagion. This study investigated whether motor contagion is associated with the active observation of the kinematic actions of others. In Experiment 1, six skilled hammer throwers threw a hammer after watching a video of a model throwing toward the left, center, or right. The video included two types of action kinematics which resulted in throw directions that were either easy or difficult to predict based on the model's kinematics. In Experiment 2, the athletes threw hammers after watching the same stimuli as Experiment 1, but while engaging in one of two types of focus (self-focus or non-self-focus) to determine whether motor contagion could be diminished. Results demonstrated that the direction of each participant's throw was more influenced by the videos that contained easy action kinematics, supporting a critical role for the meaningfulness of the link between an action and its outcome in producing motor contagion. Motion analysis revealed that motor contagion was not likely to be a result of the observer imitating the model's action kinematics. The contagion observed in Experiment 1 disappeared when participants engaged in self-focus. These results suggest that motor contagion is influenced by the predictability of an action outcome when observing an action, and that motor contagion can be inhibited through self-focus when observing.	[Takeuchi, Tatsuya; Ikudome, Sachi; Mori, Shiro; Nakamoto, Hiroki] Natl Inst Fitness & Sports Kanoya, Fac Phys Educ, Kagoshima, Japan; [Unenaka, Satoshi] Hokusho Univ, Sch Lifelong Sport, Dept Sport Educ, Ebetsu, Hokkaido, Japan; [Ishii, Yasumitsu] Japan Inst Sports Sci, Dept Sports Sci, Tokyo, Japan; [Mann, David L.] Vrije Univ Amsterdam, Fac Human Movement Sci, Amsterdam Movement Sci, Amsterdam, Netherlands; [Mann, David L.] Inst Brain & Behav Amsterdam, Amsterdam, Netherlands	National Institute Fitness & Sports Kanoya; Vrije Universiteit Amsterdam	Nakamoto, H (corresponding author), Natl Inst Fitness & Sports Kanoya, Fac Phys Educ, Kagoshima, Japan.	nakamoto@nifs-k.ac.jp	Mann, David/D-1429-2011	Mann, David/0000-0001-7476-6939; Nakamoto, Hiroki/0000-0002-3778-1571	JSPS KAKENHI [16K12999]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 16K12999. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy B, 1990, J SPORT SCI, V8, P17, DOI 10.1080/02640419008732128; Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Bekkering H, 2000, Q J EXP PSYCHOL-A, V53, P153, DOI 10.1080/027249800390718; Bishop DT, 2013, J SPORT EXERCISE PSY, V35, P98, DOI 10.1123/jsep.35.1.98; Blakemore SJ, 2005, NEUROPSYCHOLOGIA, V43, P260, DOI 10.1016/j.neuropsychologia.2004.11.012; Bock JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051367; Boss M, 2015, PSYCHOL SPORT EXERC, V16, P160, DOI 10.1016/j.psychsport.2014.10.006; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Cook R, 2012, P ROY SOC B-BIOL SCI, V279, P780, DOI 10.1098/rspb.2011.1024; Craighero L, 1996, NEUROREPORT, V8, P347, DOI 10.1097/00001756-199612200-00068; Cross KA, 2014, NEUROIMAGE, V91, P228, DOI 10.1016/j.neuroimage.2014.01.027; Cross KA, 2013, NEUROIMAGE, V83, P493, DOI 10.1016/j.neuroimage.2013.06.060; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Eaves DL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00028; Edwards MG, 2003, BRAIN COGNITION, V53, P495, DOI 10.1016/S0278-2626(03)00210-0; Gleissner B, 2000, DEVELOPMENTAL SCI, V3, P405, DOI 10.1111/1467-7687.00135; Gray R, 2011, J EXP PSYCHOL-APPL, V17, P49, DOI 10.1037/a0022846; Hardy J, 2006, PSYCHOL SPORT EXERC, V7, P81, DOI 10.1016/j.psychsport.2005.04.002; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Ikegami T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06989; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Moll T, 2010, J SPORT SCI, V28, P983, DOI 10.1080/02640414.2010.484068; Olsson CJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00819; Parmigiani S, 2018, BRAIN TOPOGR, V31, P795, DOI 10.1007/s10548-018-0635-x; Parmigiani S, 2015, EXP BRAIN RES, V233, P3253, DOI 10.1007/s00221-015-4393-7; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Prinz W, 1987, PERSPECTIVES PERCEPT, P47, DOI DOI 10.2307/1423061; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2006, MIRRORS BRAIN OUR MI; Ross W., 2004, MATH BALLPARK ODDS P; Schutz-Bosbach S, 2009, J COGNITIVE NEUROSCI, V21, P1215, DOI 10.1162/jocn.2009.21068; Spengler S, 2010, CONSCIOUS COGN, V19, P98, DOI 10.1016/j.concog.2009.12.014; Spengler S, 2009, HUM BRAIN MAPP, V30, P3704, DOI 10.1002/hbm.20800; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Theodorakis Y, 2000, SPORT PSYCHOL, V14, P253, DOI 10.1123/tsp.14.3.253; Totterdell P, 2000, J APPL PSYCHOL, V85, P848, DOI 10.1037/0021-9010.85.6.848; Ubaldi S, 2015, CEREB CORTEX, V25, P1032, DOI 10.1093/cercor/bht295; Williams AM, 1999, INT J SPORT PSYCHOL, V30, P194; Wright MJ, 2011, NEUROSCI LETT, V500, P216, DOI 10.1016/j.neulet.2011.06.045; Zell E, 2012, SOC PSYCHOL PERS SCI, V3, P549, DOI 10.1177/1948550611430164	46	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2018	13	10							e0205725	10.1371/journal.pone.0205725	http://dx.doi.org/10.1371/journal.pone.0205725			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX3PM	30332470	Green Published, gold, Green Submitted			2022-12-26	WOS:000447638200066
J	Wongsaroj, L; Saninjuk, K; Romsang, A; Duang-nkern, J; Trinachartvanit, W; Vattanaviboon, P; Mongkolsuk, S				Wongsaroj, Lampet; Saninjuk, Kritsakorn; Romsang, Adisak; Duang-nkern, Jintana; Trinachartvanit, Wachareeporn; Vattanaviboon, Paiboon; Mongkolsuk, Skorn			Pseudomonas aeruginosa glutathione biosynthesis genes play multiple roles in stress protection, bacterial virulence and biofilm formation	PLOS ONE			English	Article							ESCHERICHIA-COLI; OXIDATIVE STRESS; SWARMING MOTILITY; SACCHAROMYCES-CEREVISIAE; GLYOXALASE I; DETOXIFICATION; METHYLGLYOXAL; ACTIVATION; MECHANISMS; PYOCYANIN	Pseudomonas aeruginosa PAO1 contains gshA and gshB genes, which encode enzymes involved in glutathione (GSH) biosynthesis. Challenging P. aeruginosa with hydrogen peroxide, cumene hydroperoxide, and t-butyl hydroperoxide increased the expression of gshA and gshB. The physiological roles of these genes in P. aeruginosa oxidative stress, bacterial virulence, and biofilm formation were examined using P. aeruginosa Delta gshA, Delta gshB, and double Delta gshA Delta gshB mutant strains. These mutants exhibited significantly increased susceptibility to methyl viologen, thiol-depleting agent, and methylglyoxal compared to PAO1. Expression of functional gshA, gshB or exogenous supplementation with GSH complemented these phenotypes, which indicates that the observed mutant phenotypes arose from their inability to produce GSH. Virulence assays using a Drosophila melanogaster model revealed that the Delta gshA, Delta gshB and double Delta gshA Delta gshB mutants exhibited attenuated virulence phenotypes. An analysis of virulence factors, including pyocyanin, pyoverdine, and cell motility (swimming and twitching), showed that these levels were reduced in these gsh mutants compared to PAO1. In contrast, biofilm formation increased in mutants. These data indicate that the GSH product and the genes responsible for GSH synthesis play multiple crucial roles in oxidative stress protection, bacterial virulence and biofilm formation in P. aeruginosa.	[Wongsaroj, Lampet] Mahidol Univ, Fac Sci, Mol Med Grad Program, Bangkok, Thailand; [Saninjuk, Kritsakorn; Romsang, Adisak; Mongkolsuk, Skorn] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok, Thailand; [Romsang, Adisak; Mongkolsuk, Skorn] Mahidol Univ, Fac Sci, Ctr Emerging Bacterial Infect, Bangkok, Thailand; [Duang-nkern, Jintana; Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Chulabhorn Res Inst, Lab Biotechnol, Bangkok, Thailand; [Trinachartvanit, Wachareeporn] Mahidol Univ, Fac Sci, Dept Biol, Bangkok, Thailand; [Vattanaviboon, Paiboon] Chulabhorn Grad Inst, Program Appl Biol Sci Environm Hlth, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Chulabhorn Research Institute; Mahidol University; Chulabhorn Graduate Institute	Mongkolsuk, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Mahidol Univ, Fac Sci, Ctr Emerging Bacterial Infect, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Chulabhorn Res Inst, Lab Biotechnol, Bangkok, Thailand.	skorn@cri.or.th	Romsang, Adisak/K-2630-2019; Saninjuk, Kritsakorn/V-1916-2019; Vattanaviboon, Paiboon/V-1380-2019; Romsang, Adisak/H-7142-2014	Romsang, Adisak/0000-0002-5339-5443; Saninjuk, Kritsakorn/0000-0002-7511-2985; Romsang, Adisak/0000-0002-5339-5443	Chulabhorn Research Institute; Mahidol University; Royal Golden Jubilee Ph.D. Scholarship from Thailand Research Fund [PHD/0132/2557, PHD/0047/2557]; Center for Emerging Bacterial Infections (EBI); Central Instrument Facility (CIF grant) of Faculty of Science, the Mahidol University; Office of the Higher Education Commission [MRG5980047]; Thailand Research Fund, Thailand [MRG5980047]	Chulabhorn Research Institute; Mahidol University; Royal Golden Jubilee Ph.D. Scholarship from Thailand Research Fund; Center for Emerging Bacterial Infections (EBI); Central Instrument Facility (CIF grant) of Faculty of Science, the Mahidol University; Office of the Higher Education Commission; Thailand Research Fund, Thailand(Thailand Research Fund (TRF))	This work was supported by grants from the Chulabhorn Research Institute (http://www.cri.or.th/en/index.php) and Mahidol University (https://www.mahidol.ac.th). L.W. and K.S. were supported by the Royal Golden Jubilee Ph.D. Scholarship (PHD/0132/2557 and PHD/0047/2557) from Thailand Research Fund (http://rgj.trf.or.th/eng/rgje11.asp). A.R. was supported by the grants from the Center for Emerging Bacterial Infections (EBI) and the Central Instrument Facility (CIF grant) of Faculty of Science, the Mahidol University (http://science.mahidol.ac.th) and the joint funding of the Office of the Higher Education Commission and the Thailand Research Fund (MRG5980047), Thailand (https://www.trf.or.th). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albesa I, 2004, BIOCHEM BIOPH RES CO, V317, P605, DOI 10.1016/j.bbrc.2004.03.085; An BC, 2010, MOL CELLS, V29, P145, DOI 10.1007/s10059-010-0023-1; Barraud N, 2014, METHODS MOL BIOL, V1149, P643, DOI 10.1007/978-1-4939-0473-0_49; Boonma S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172071; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Chen WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32950; Choy MH, 2008, J MED MICROBIOL, V57, P1539, DOI 10.1099/jmm.0.2008/003723-0; Cifani N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071717; COX CD, 1980, J BACTERIOL, V141, P199, DOI 10.1128/JB.141.1.199-204.1980; Das T, 2016, MICROBIAL BIOFILMS I, DOI [10.1038/srep32950, DOI 10.1038/SREP32950]; Dietrich LEP, 2011, MOL MICROBIOL, V79, P1119, DOI 10.1111/j.1365-2958.2011.07552.x; Dionne MS, 2008, DIS MODEL MECH, V1, P43, DOI 10.1242/dmm.000307; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; FERGUSON GP, 1993, MOL MICROBIOL, V9, P1297, DOI 10.1111/j.1365-2958.1993.tb01259.x; Ferguson GP, 1998, J BACTERIOL, V180, P4314, DOI 10.1128/JB.180.16.4314-4318.1998; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Khalifa AB, 2011, ANN BIOL CLIN-PARIS, V69, P393, DOI 10.1684/abc.2011.0589; Klare W, 2016, ANTIMICROB AGENTS CH, V60, P4539, DOI 10.1128/AAC.02919-15; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Lee C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010169; Li KY, 2004, J BACTERIOL, V186, P6800, DOI 10.1128/JB.186.20.6800-6808.2004; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; MacLean MJ, 1998, MOL MICROBIOL, V27, P563, DOI 10.1046/j.1365-2958.1998.00701.x; Manos J, 2008, J MED MICROBIOL, V57, P1454, DOI 10.1099/jmm.0.2008/005009-0; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; McLaggan D, 2000, APPL ENVIRON MICROB, V66, P1393, DOI 10.1128/AEM.66.4.1393-1399.2000; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; MIDORIKAWA Y, 1991, J APPL BACTERIOL, V70, P291, DOI 10.1111/j.1365-2672.1991.tb02938.x; Murata-Kamiya N, 2001, NUCLEIC ACIDS RES, V29, P3433, DOI 10.1093/nar/29.16.3433; Murray TS, 2010, J MED MICROBIOL, V59, P511, DOI 10.1099/jmm.0.017715-0; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Ochsner UA, 2001, J BACTERIOL, V183, P773, DOI 10.1128/JB.183.2.773-778.2001; OWENS RA, 1986, J BACTERIOL, V168, P109, DOI 10.1128/jb.168.1.109-114.1986; Panmanee W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189066; Phillips PL, 2012, ADV WOUND CARE, V1, P109, DOI 10.1089/wound.2011.0301; Pittman MS, 2005, J BIOL CHEM, V280, P32254, DOI 10.1074/jbc.M503075200; Rada B, 2013, TRENDS MICROBIOL, V21, P73, DOI 10.1016/j.tim.2012.10.004; Reimmann C, 2002, MICROBIOL-SGM, V148, P923, DOI 10.1099/00221287-148-4-923; Riccillo PM, 2000, J BACTERIOL, V182, P1748, DOI 10.1128/JB.182.6.1748-1753.2000; Romsang A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202151; Romsang A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30368-y; Romsang A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134374; Romsang A, 2015, INT J ANTIMICROB AG, V45, P314, DOI 10.1016/j.ijantimicag.2014.10.024; Romsang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086763; Romsang A, 2013, J BACTERIOL, V195, P3299, DOI 10.1128/JB.00167-13; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Sambrook J., 2001, MOL CLONING LAB MANU; Shepherd M, 2015, BIOCHEM SOC T, V43, P908, DOI 10.1042/BST20150098; Smirnova GV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1199, DOI 10.1007/s10541-005-0248-3; Somprasong N, 2012, J BACTERIOL, V194, P3904, DOI 10.1128/JB.00347-12; Song M, 2013, MOL MICROBIOL, V87, P609, DOI 10.1111/mmi.12119; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Sukdeo N, 2007, BBA-PROTEINS PROTEOM, V1774, P756, DOI 10.1016/j.bbapap.2007.04.005; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Van Laar TA, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00155-18; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; Zhang W, 2014, WATER ENVIRON RES, V86, P462, DOI 10.2175/106143013X13807328849855; Zhang YN, 2014, ASIAN J CHEM, V26, P3265, DOI 10.14233/ajchem.2014.17507	61	31	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205815	10.1371/journal.pone.0205815	http://dx.doi.org/10.1371/journal.pone.0205815			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325949	Green Published, Green Submitted, gold			2022-12-26	WOS:000447430800043
J	Wu, HN; Nakura, Y; Yoshimura, M; Tantengco, OAG; Nomiyama, M; Takayanagi, T; Fujita, T; Yasukawa, K; Yanagihara, I				Wu, Heng Ning; Nakura, Yukiko; Yoshimura, Michinobu; Tantengco, Ourlad Alzeus Gaddi; Nomiyama, Makoto; Takayanagi, Toshimitsu; Fujita, Tomio; Yasukawa, Kiyoshi; Yanagihara, Itaru			Type II restriction modification system in Ureaplasma parvum OMC-P162 strain	PLOS ONE			English	Article							UREALYTICUM; COLONIZATION	Ureaplasma parvum serovar 3 strain, OMC-P162, was isolated from the human placenta of a preterm delivery at 26 weeks' gestation. In this study, we sequenced the complete genome of OMC-P162 and compared it with other serovar 3 strains isolated from patients with different clinical conditions. Ten unique genes in OMC-P162, five of which encoded for hypothetical proteins, were identified. Of these, genes UPV_229 and UPV_230 formed an operon whose open reading frames were predicted to code for a DNA methyltransferase and a hypothetical protein, respectively. DNA modification analysis of the OMC-P162 genome identified N4-methylcytosine (m4C) and N6-methyladenine (m6A), but not 5-methylocytosine (m5C). UPV230 recombinant protein displayed endonuclease activity and recognized the CATG sequence, resulting in a blunt cut between A and T. This restriction enzyme activity was identical to that of the cultivated OMC-P162 strain, suggesting that this restriction enzyme was naturally expressed in OMC-P162. We designated this enzyme as UpaP162. Treatment of pT7Blue plasmid with recombinant protein UPV229 completely blocked UpaP162 restriction enzyme activity. These results suggest that the UPV_229 and UPV_230 genes act as a type II restriction-modification system in Ureaplasma OMC-P162.	[Wu, Heng Ning; Nakura, Yukiko; Yoshimura, Michinobu; Tantengco, Ourlad Alzeus Gaddi; Yanagihara, Itaru] Osaka Womens & Childrens Hosp, Res Inst, Dept Dev Med, Izumi, Osaka, Japan; [Tantengco, Ourlad Alzeus Gaddi] Univ Philippines Manila, Coll Med, Manila, Philippines; [Nomiyama, Makoto] Saga Hosp, Natl Hosp Org, Dept Obstet & Gynecol, Saga, Japan; [Takayanagi, Toshimitsu] Saga Hosp, Natl Hosp Org, Dept Pediat, Saga, Japan; [Fujita, Tomio] Fujita Clin, Osaka, Osaka, Japan; [Yasukawa, Kiyoshi] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto, Japan	University of the Philippines System; University of the Philippines Manila; Kyoto University	Yanagihara, I (corresponding author), Osaka Womens & Childrens Hosp, Res Inst, Dept Dev Med, Izumi, Osaka, Japan.	itaruy@mch.pref.osaka.jp	Tantengco, Ourlad Alzeus/L-4740-2019	Tantengco, Ourlad Alzeus/0000-0002-4535-8837; Yanagihara, Itaru/0000-0001-9882-8196	JSPS KAKENHI [JP17H04237, JP18K16788]; Japan Agency for Medical Research and Development (AMED) [JP17fk0108210]; SENTAN, Japan Science and Technology Agency [14533524]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); SENTAN, Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by research grants from the JSPS KAKENHI, Grant Numbers JP17H04237 (I. Y.) and JP18K16788 (M. Y.) https://www.jsps.go.jp/english/index.html; the Japan Agency for Medical Research and Development (AMED), JP17fk0108210 (I. Y.) https://www.amed.go.jp/en/index.html; and the SENTAN, Japan Science and Technology Agency, 14533524 (K. Y. and I. Y.) https://www.jst.go.jp/sentan/en/index.html.	BLANCHARD A, 1988, J BACTERIOL, V170, P2692, DOI 10.1128/jb.170.6.2692-2697.1988; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; COCKS BG, 1987, INT J SYST BACTERIOL, V37, P451, DOI 10.1099/00207713-37-4-451; Couturier M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00137; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Gumulak-Smith J, 2001, MOL MICROBIOL, V40, P1037, DOI 10.1046/j.1365-2958.2001.02464.x; Kong FR, 2000, J CLIN MICROBIOL, V38, P1175, DOI 10.1128/JCM.38.3.1175-1179.2000; Li J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005762; LIGON JV, 1991, INFECT IMMUN, V59, P1170, DOI 10.1128/IAI.59.3.1170-1171.1991; Martinez MA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-44; Namba F, 2010, PEDIATR RES, V67, P166, DOI 10.1203/PDR.0b013e3181c6e58e; OHLSSON A, 1993, CLIN INFECT DIS, V17, pS144, DOI 10.1093/clinids/17.Supplement_1.S144; Ollikainen J, 1998, ACTA PAEDIATR, V87, P1075, DOI 10.1080/080352598750031419; Paralanov V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-88; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Roberts RJ, 2007, NUCLEIC ACIDS RES, V35, pD269, DOI 10.1093/nar/gkl891; Robertson JA, 2002, INT J SYST EVOL MICR, V52, P587, DOI 10.1099/00207713-52-2-587; Sasnauskas G, 2017, NUCLEIC ACIDS RES, V45, P9583, DOI 10.1093/nar/gkx634; Shepard MC, 1979, MYCOPLASMAS, V1, P452; SMITH DGE, 1993, J BACTERIOL, V175, P3253, DOI 10.1128/jb.175.11.3253-3258.1993; Uchida K, 2013, J REPROD IMMUNOL, V100, P118, DOI 10.1016/j.jri.2013.10.001; Waites KB, 2009, SEMIN FETAL NEONAT M, V14, P190, DOI 10.1016/j.siny.2008.11.009; Wu HN, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00256-14; Zhang CC, 1996, MOL MICROBIOL, V20, P9, DOI 10.1111/j.1365-2958.1996.tb02483.x	27	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2018	13	10							e0205328	10.1371/journal.pone.0205328	http://dx.doi.org/10.1371/journal.pone.0205328			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0VS	30325937	Green Published, Green Submitted, gold			2022-12-26	WOS:000447430800018
J	Fizil, A; Sonderegger, C; Czajlik, A; Fekete, A; Komaromi, I; Hajdu, D; Marx, F; Batta, G				Fizil, Adam; Sonderegger, Christoph; Czajlik, Andras; Fekete, Attila; Komaromi, Istvan; Hajdu, Dorottya; Marx, Florentine; Batta, Gyula			Calcium binding of the antifungal protein PAF: Structure, dynamics and function aspects by NMR and MD simulations	PLOS ONE			English	Article							MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; CHRYSOGENUM; MACROMOLECULES; HOMEOSTASIS	Calcium ions (Ca2+) play an important role in the toxicity of the cysteine-rich and cationic antifungal protein PAF from Penicillium chrysogenum: high extracellular Ca2+ levels reduce the toxicity of PAF in the sensitive model fungus Neurospora crassa in a concentration dependent way. However, little is known about the mechanistic details of the Ca2+ ion impact and the Ca2+ binding capabilities of PAF outside the fungal cell, which might be the reason for the activity loss. Using nuclear magnetic resonance (NMR), isothermal titration calorimetry and molecular dynamics (MD) simulations we demonstrated that PAF weakly, but specifically binds Ca2+ ions. MD simulations of PAF predicted one major Ca2+ binding site at the C-terminus involving Asp53 and Asp55, while Asp19 was considered as putative Ca2+ binding site. The exchange of Asp19 to serine had little impact on the Ca2+ binding, however caused the loss of antifungal activity, as was shown in our recent study. Now we replaced the C-terminal aspartates and expressed the serine variant PAF(D53S/D55S). The specific Ca2+ binding affinity of PAF(D53S/D55S) decreased significantly if compared to PAF, whereas the antifungal activity was retained. To understand more details of Ca2+ interactions, we investigated the NMR and MD structure/dynamics of the free and Ca2+-bound PAF and PAF(D53S/D55S). Though we found some differences between these protein variants and the Ca2+ complexes, these effects cannot explain the observed Ca2+ influence. In conclusion, PAF binds Ca2+ ions selectively at the C-terminus; however, this Ca2+ binding does not seem to play a direct role in the previously documented modulation of the antifungal activity of PAF.	[Fizil, Adam; Czajlik, Andras; Fekete, Attila; Hajdu, Dorottya; Batta, Gyula] Univ Debrecen, Fac Sci & Technol, Dept Organ Chem, Debrecen, Hungary; [Sonderegger, Christoph; Marx, Florentine] Med Univ Innsbruck, Div Mol Biol, Bioctr, Innsbruck, Austria; [Komaromi, Istvan] Univ Debrecen, Div Clin Lab Sci, Dept Lab Med, Fac Med, Debrecen, Hungary	University of Debrecen; Medical University of Innsbruck; University of Debrecen	Batta, G (corresponding author), Univ Debrecen, Fac Sci & Technol, Dept Organ Chem, Debrecen, Hungary.; Marx, F (corresponding author), Med Univ Innsbruck, Div Mol Biol, Bioctr, Innsbruck, Austria.	florentine.marx@i-med.ac.at; batta@unideb.hu		Marx, Florentine/0000-0002-8408-1842	Austrian Science Fund [FWF P25894, FWF I1644]; Hungarian Science Fund (OTKA) [ANN 110821]; ITC investment grant [TAMOP-4.2.1.B-09/1/KONV]; Bio-NMR grant [261863]; EU; European Regional Development Fund [GINOP-2.3.2-15-2016-00008, GINOP-2.3.3-15-2016-00004]	Austrian Science Fund(Austrian Science Fund (FWF)); Hungarian Science Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ITC investment grant; Bio-NMR grant; EU(European Commission); European Regional Development Fund(European Commission)	GITDA, Hungary is thanked for supercomputer resources. This study was financially supported by the Austrian Science Fund (FWF P25894 and FWF I1644 to F.M.), the Hungarian Science Fund (OTKA ANN 110821 to G. B.) and ITC investment grant (TAMOP-4.2.1.B-09/1/KONV to G.B). Bio-NMR grant 261863 to A.F. & G.B. allowed access to CEITEC NMR facilities in Brno (Czech Republic) and MedinProt (Budapest) for financial support of 700 MHz NOESY experiments with Ca<SUP>2+</SUP> saturated PAF (kindly carried out by Dr. Andrea Bodor). The research was supported by the EU and co-financed by the European Regional Development Fund under the projects GINOP-2.3.2-15-2016-00008 (G.B. and A. C.) and GINOP-2.3.3-15-2016-00004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Batta G, 2009, FEBS J, V276, P2875, DOI 10.1111/j.1742-4658.2009.07011.x; Binder U, 2015, FEBS LETT, V589, P1266, DOI 10.1016/j.febslet.2015.03.037; Binder U, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-209; Binder U, 2010, EUKARYOT CELL, V9, P1374, DOI 10.1128/EC.00050-10; CAMPOSOLIVAS R, 1995, BIOCHEMISTRY-US, V34, P3009, DOI 10.1021/bi00009a032; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Fizil A, 2015, CHEM-EUR J, V21, P5136, DOI 10.1002/chem.201404879; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hegedus N, 2011, J BASIC MICROB, V51, P253, DOI 10.1002/jobm.201000321; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kaiserer L, 2003, ARCH MICROBIOL, V180, P204, DOI 10.1007/s00203-003-0578-8; Keller R., 2004, COMPUTER AIDED RESON, V1; Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784; Leiter E, 2005, ANTIMICROB AGENTS CH, V49, P2445, DOI 10.1128/AAC.49.6.2445-2453.2005; Lepre CA, 2004, CHEM REV, V104, P3641, DOI 10.1021/cr030409h; Li DW, 2010, ANGEW CHEM INT EDIT, V49, P6778, DOI 10.1002/anie.201001898; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Marx F, 2008, CELL MOL LIFE SCI, V65, P445, DOI 10.1007/s00018-007-7364-8; Munoz A, 2014, MOL MICROBIOL, V92, P1357, DOI 10.1111/mmi.12634; Munoz A, 2012, MOL MICROBIOL, V85, P89, DOI 10.1111/j.1365-2958.2012.08091.x; Onishi J, 2000, ANTIMICROB AGENTS CH, V44, P368, DOI 10.1128/AAC.44.2.368-377.2000; Palicz Z, 2013, TOXICOL APPL PHARM, V269, P8, DOI 10.1016/j.taap.2013.02.014; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; Sonderegger C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169920; Sonderegger C, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0586-4; Szappanos H, 2005, N-S ARCH PHARMACOL, V371, P122, DOI 10.1007/s00210-004-1013-7; Varadi G, 2013, CHEM-EUR J, V19, P12684, DOI 10.1002/chem.201301098; Vogel HJ, 1956, MICROB GENET B, V13, P42; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449	35	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0204825	10.1371/journal.pone.0204825	http://dx.doi.org/10.1371/journal.pone.0204825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321182	gold, Green Published, Green Submitted			2022-12-26	WOS:000447417900013
J	Ley, AC; Nissen, J; Wolk, A; Roser, M				Ley, Alexandra C.; Nissen, Jana; Woelk, Alexandra; Roeser, Martin			Glacial refugia and speciation in a group of wind-pollinated and -dispersed, endemic Alpine species of Helictotrichon (Poaceae)	PLOS ONE			English	Article							SPATIAL GENETIC-STRUCTURE; DNA; CONSEQUENCES; EVOLUTION; HISTORY; PLANTS; DIFFERENTIATION; PHYLOGENY; SEQUENCES; PATTERNS	In the Alps phylogeographic studies indicate for small insect-pollinated herbs that climatic fluctuations caused significant population migrations and fragmentations into glacial refugia at the periphery of the Alps. Here we investigate whether this holds also for wind-pollinated and -dispersed species. We therefore analysed the phylogeographic pattern (nuclear and chloroplast dataset) of a clade of the four species of the Helictotrichon parlatorei species group (Poaceae) endemic to the Alps. In contrast to earlier findings for small insect-pollinated herbs no clear barriers to gene flow could be detected in this species group. Instead a few haplotypes are widespread across the entire Alpine region. While the complete absence of a phylogeographic structure in the plastid dataset hints towards very efficient long distance seed dispersal, the moderate phylogeographic structure in the nuclear dataset indicates at least some spatial restriction to pollen dispersal. Rare haplotypes cluster solely in the Western and Southern central Alps and thereby suggest this to be the area of origin for the H. parlatorei species group from where expansion occurred following the presence of calcareous bedrock into the Eastern Alps. We thus conclude that the inclusion of taxa with complementary life-history traits is vital in understanding the glacial history of the Alpine flora.	[Ley, Alexandra C.; Nissen, Jana; Woelk, Alexandra; Roeser, Martin] Univ Halle Wittenberg, Inst Geobot & Bot Garden, Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Ley, AC; Roser, M (corresponding author), Univ Halle Wittenberg, Inst Geobot & Bot Garden, Halle, Saale, Germany.	Alexandra.Ley@botanik.uni-halle.de; Martin.Roeser@botanik.uni-halle.de		Ley, Alexandra/0000-0002-8388-7334	German Research Foundation (DFG) [RO 865/8-2]; Open Access Publication Fund of the Martin Luther University Halle-Wittenberg	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of the Martin Luther University Halle-Wittenberg	A research grant of the German Research Foundation (DFG RO 865/8-2) is gratefully acknowledged. We also acknowledge the financial support of the Open Access Publication Fund of the Martin Luther University Halle-Wittenberg.	Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Duminil J, 2006, MOL ECOL, V15, P3505, DOI 10.1111/j.1365-294X.2006.03040.x; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fjellheim S, 2006, J BIOGEOGR, V33, P1470, DOI 10.1111/j.1365-2699.2006.01521.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heuchert B., 2004, SCHLECHTENDALIA, V12, P69; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Holub J, 1980, FLORA EUROPAEA, V5, P208; J_ackli H., 1970, ATLAS SCHWEIZ; Jarvis A, 2008, HOLE FILLED SEAMLESS; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Korner C, 2003, ALPINE PLANT LIFE FU, P22; Kuss P, 2011, PERSPECT PLANT ECOL, V13, P101, DOI 10.1016/j.ppees.2011.02.003; Lange D, 1995, BIBLIOTH BOT, V144, P1; Lexer C, 2006, MOL ECOL, V15, P2007, DOI 10.1111/j.1365-294X.2006.02896.x; Ley AC, 2010, MOL PHYLOGENET EVOL, V57, P859, DOI 10.1016/j.ympev.2010.08.027; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Melzer H., 1967, OSTERREICHISCHE BOT, V114, P309; Merxmueller H, 1952, ALPENPFLANZEN TIERE, V17, P96; Nagl H, 1972, OSTERREICH GESCHICHT, V16, P163; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; PAWLOWSKI B, 1970, Vegetatio, V21, P181; Pellissier L, 2010, PLANT ECOL, V211, P351, DOI 10.1007/s11258-010-9794-x; Penck A, 1909, ALPEN EISZEITALTER; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pons O, 1996, GENETICS, V144, P1237; QGIS, 2020, QGIS GEOGR INF SYST; Reisch C, 2003, HEREDITY, V91, P519, DOI 10.1038/sj.hdy.6800350; Reisch C, 2014, PLANT ECOL, V215, P1493, DOI 10.1007/s11258-014-0409-9; Roser M, 1996, PLANT SYST EVOL, V203, P181, DOI 10.1007/BF00983512; Roser M, 1989, DISS BOT, V145, P1; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; Scarcelli N, 2011, PLOS ONE, V6, pe19954, DOI [10.1371/journal.pone.0019954, DOI 10.1371/JOURNATPONE.0019954]; Scheepens JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073854; Schneeweiss GM, 2013, MOL PHYLOGENET EVOL, V69, P634, DOI 10.1016/j.ympev.2013.07.015; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Tribsch A, 2003, TAXON, V52, P477, DOI 10.2307/3647447; Tyler T, 2002, PLANT SYST EVOL, V236, P73, DOI 10.1007/s00606-002-0235-8; Tzvelev NN., 1976, ZLAKI SSSR; vanHusen D, 1997, QUATERN INT, V38-9, P109, DOI 10.1016/S1040-6182(96)00017-1; Voges A., 1995, INT QUATERNARY MAP E; Winterfeld G., 2006, STAPFIA, V86, P1; Winterfeld G, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw039; Winterfeld G, 2009, SYST BIODIVERS, V7, P277, DOI 10.1017/S1477200009003041; Wolk A, 2017, TAXON, V66, P20, DOI 10.12705/661.2; Wolk A, 2015, SYST BIODIVERS, V13, P326, DOI 10.1080/14772000.2015.1023867; Wolk A, 2014, TAXON, V63, P773, DOI 10.12705/634.1	54	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205354	10.1371/journal.pone.0205354	http://dx.doi.org/10.1371/journal.pone.0205354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321199	Green Submitted, Green Published, gold			2022-12-26	WOS:000447417900026
J	Lim, LM; Woo, YY; de Bruyne, JA; Nathan, AM; Kee, SY; Chan, YF; Chiam, CW; Eg, KP; Thavagnanam, S; Sam, IC				Lim, Li Min; Woo, Yen Yen; de Bruyne, Jessie Anne; Nathan, Anna Marie; Kee, Sze Ying; Chan, Yoke Fun; Chiam, Chun Wei; Eg, Kah Peng; Thavagnanam, Surendran; Sam, I-Ching			Epidemiology, clinical presentation and respiratory sequelae of adenovirus pneumonia in children in Kuala Lumpur, Malaysia	PLOS ONE			English	Article							BRONCHIOLITIS OBLITERANS; RISK-FACTORS; COMMUNITY OUTBREAK; UNITED-STATES; INFECTIONS; FEATURES; TAIWAN; SEROTYPES; SINGAPORE; DISEASE	Objectives To describe the severity, human adenovirus (HAdV) type and respiratory morbidity following adenovirus pneumonia in children. Methodology Retrospective review of children under 12 years of age, admitted with HAdV pneumonia, between January 2011 and July 2013, in a single centre in Malaysia. HAdV isolated from nasopharyngeal secretions were typed by sequencing hypervariable regions 1-6 of the hexon gene. Patients were reviewed for respiratory complications. Results HAdV was detected in 131 children of whom 92 fulfilled inclusion criteria. Median (range) age was 1.1 (0.1-8.0) years with 80% under 2 years. Twenty percent had severe disease with a case-fatality rate of 5.4%. Duration of admission (p = 0.02) was independently associated with severe illness. Twenty-two percent developed respiratory complications, the commonest being bronchiolitis obliterans (15.2%) and recurrent wheeze (5.4%). The predominant type shifted from HAdV1 and HAdV3 in 2011 to HAdV7 in 2013. The commonest types identified were types 7 (54.4%), 1(17.7%) and 3 (12.6%). Four out of the five patients who died were positive for HAdV7. Infection with type 7 (OR 8.90, 95% CI 1.32, 59.89), family history of asthma (OR 14.80, 95% CI 2.12-103.21) and need for invasive or non-invasive ventilation (OR 151.84, 95% CI 9.93-2.32E) were independent predictors of respiratory complications. Conclusions One in five children admitted with HAdV pneumonia had severe disease and 22% developed respiratory complications. Type 7 was commonly isolated in children with severe disease. Family history of asthma need for invasive or non-invasive ventilation and HAdV 7 were independent predictors of respiratory complications.	[Lim, Li Min; de Bruyne, Jessie Anne; Nathan, Anna Marie; Eg, Kah Peng; Thavagnanam, Surendran] Univ Malaya, Dept Paediat, Kuala Lumpur, Malaysia; [Woo, Yen Yen; Chan, Yoke Fun; Chiam, Chun Wei; Sam, I-Ching] Univ Malaya, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Kee, Sze Ying] Univ Putra Malaysia, Dept Paediat, Serdang, Selangor Darul, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Putra Malaysia	Nathan, AM (corresponding author), Univ Malaya, Dept Paediat, Kuala Lumpur, Malaysia.	psr9900@hotmail.com	Sam, Jamal I-Ching/B-8688-2010; Nathan, Anna M/G-4148-2015; Chan, Yoke Fun/B-5351-2010; eg, kah peng/W-8347-2018; Nathan, Anna/ABH-2362-2021	Sam, Jamal I-Ching/0000-0002-1296-7898; Chan, Yoke Fun/0000-0001-7089-0510; eg, kah peng/0000-0002-6814-7418; Nathan, Anna/0000-0003-3618-5820; thavagnanam, surendran/0000-0002-4414-7915	University Malaya [UM.TNC2/RC/HTM/RP026-14HTM, PO027-2015A, UM.C/625/1/HIR/MOHE/MED/42]	University Malaya(Universiti Malaya)	This study was funded by University Malaya (Research Grant UM.TNC2/RC/HTM/RP026-14HTM to AMN, Postgraduate Research Grant PO027-2015A to YYW and High Impact Research Grant UM.C/625/1/HIR/MOHE/MED/42 to ICS. The funders had no role in the study design, data collection and analysis, decision to publish nor preparation of the manuscript.	Abd-Jamil J, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-46; [Anonymous], 2017, GROUP; CASTRORODRIGUEZ JA, 1947, PEDIATR PULMONOL, V10, P15974; Chang AB, 1998, PEDIATR RADIOL, V28, P23, DOI 10.1007/s002470050286; Colom AJ, 2009, PEDIATR PULM, V44, P1065, DOI 10.1002/ppul.21080; ERDMAN D, 2000, EMERG INFECT DIS, V8, P3; Foong Ng K, 2015, MALAYSIA TRANS R SOC, V109, P433, DOI 10.1093/trstmh/trv042; Ganapathi Lakshmi, 2016, F1000Res, V5, P758, DOI 10.12688/f1000research.8374.1; Gavin PJ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e9; GRAY GC, 2006, CLIN INFECT DIS, V45, P9; HASHIMOTO S, 2015, J MED VIROL, V90, P5; Hong JY, 2001, CLIN INFECT DIS, V32, P1423, DOI 10.1086/320146; KUMAR S, 1970, MOL BIOL EVOL, V7, P15974; LAI C, 2011, PLOS ONE, V8, P1; LIN MR, 2011, CLIN MICROBIOL INFEC, V7, P2; LU QB, 2012, INFLUENZA OTHER RESP, V8, P3; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; Lynch JP, 2016, SEMIN RESP CRIT CARE, V37, P586, DOI 10.1055/s-0036-1584923; Murtagh P, 2009, PEDIATR PULM, V44, P450, DOI 10.1002/ppul.20984; Newcombe PA, 2013, J ALLERGY CLIN IMMUN, V131, P1069, DOI 10.1016/j.jaci.2012.10.004; PONE, 2017, EMERG INFECT DIS, P15974; PONE, EMERG INFECT DIS, P15974; PONE, 1992, EMERG INFECT DIS, V7, P15974; Rajkumar V, 2015, ANN ACAD MED SINGAP, V44, P50; Sun H., 2015, J MAR TECHNOL, V34, P1; Tabain I, 2012, PEDIATR INFECT DIS J, V31, P680, DOI 10.1097/INF.0b013e318256605e; TAKAHASHI I, 1969, TOHOKU J EXP MED, V1, P15974; TSOU T, 2011, EMERG INFECT DIS, V18, P11; Wu PQ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3237-7; Wu PQ, 2016, EMERG INFECT DIS, V5, P1622, DOI 10.1186/s40064-016-3237-7; Yoon BW, 2017, BMC INFECT DIS, V10, P47, DOI 10.1186/s13104-016-2370-2; Yoon Byung Woo, 2017, BMC Res Notes, V10, P47, DOI 10.1186/s13104-016-2370-2; YU PMAC, 1953, MICROBIOL IMMUNOL, V8, P15974; Yusof MA, 2012, EMERG INFECT DIS, V18, P852, DOI 10.3201/eid1805.110865; Zampoli M, 2017, SAMJ S AFR MED J, V107, P123, DOI [10.7196/SAMJ.2017.v107i2.11451, 10.7196/samj.2017.v107i2.11451]; EMERG INFECT DIS, P1192	36	24	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2018	13	10							e0205795	10.1371/journal.pone.0205795	http://dx.doi.org/10.1371/journal.pone.0205795			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX0RD	30321228	Green Submitted, Green Published, gold			2022-12-26	WOS:000447417900054
